PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Han, KH; Gonzalez-Quintial, R; Peng, YJ; Baccala, R; Theofilopoulos, AN; Lerner, RA				Han, Kyung Ho; Gonzalez-Quintial, Rosana; Peng, Yingjie; Baccala, Roberto; Theofilopoulos, Argyrios N.; Lerner, Richard A.			An agonist antibody that blocks autoimmunity by inducing anti-inflammatory macrophages	FASEB JOURNAL			English	Article						cathepsin G; CTSG; CD14; M2 macrophage	INTRACELLULAR COMBINATORIAL LIBRARIES; CATHEPSIN-G; PROTEOLYTIC ACTIVATION; MRL-FAS(LPR) MICE; RENAL-DISEASE; STEM-CELLS; LUPUS; CD14; INFLAMMATION; EXPRESSION	We have devised a method of using intracellular combinatorial libraries to select antibodies that control cell fates. Many agonist antibodies have been selected with this method, and the process appears to be limited only by the availability of a phenotypic selection system. We demonstrate the utility of this approach to discover agonist antibodies that engage an unanticipated target and regulate macrophage polarization by selective induction of anti-inflammatory M2 macrophages. This antibody was used therapeutically to block autoimmunity in a classic mouse model of spontaneous systemic lupus erythematosus.	[Han, Kyung Ho; Peng, Yingjie; Lerner, Richard A.] Scripps Res Inst, Dept Cell & Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Gonzalez-Quintial, Rosana; Baccala, Roberto; Theofilopoulos, Argyrios N.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Lerner, RA (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlerner@scripps.edu		Baccala, Roberto/0000-0002-3159-8469; HAN, KYUNG HO/0000-0001-6907-1462	TSRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065919] Funding Source: NIH RePORTER	TSRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. C. Pham (Washington University, St. Louis, MO, USA) and Dr. A. Rao (La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA) for knockout mice; and Drs. T. Bartfai, B. Felding, and Y. J. Kang [The Scripps Research Institute (TSRI)] for scientific discussions. Funding was provided by TSRI. K.H. and R.A.L. are the inventors of the LKAb agonist antibody, which has been patented by TSRI. The patent has been licensed to Zebra Technologies. The remaining authors declare no conflicts of interest.	Andreasson C, 2006, GENE DEV, V20, P1563, DOI 10.1101/gad.374206; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Beaufort N, 2004, J IMMUNOL, V172, P540, DOI 10.4049/jimmunol.172.1.540; Driesbaugh KH, 2015, J BIOL CHEM, V290, P3529, DOI 10.1074/jbc.M114.628560; Iwata Y, 2012, J IMMUNOL, V188, P4568, DOI 10.4049/jimmunol.1102154; Kuroiwa T, 1998, LUPUS, V7, P597, DOI 10.1191/096120398678920712; Le-Barillec K, 2000, J LEUKOCYTE BIOL, V68, P209; Lenda DM, 2004, J IMMUNOL, V173, P4744, DOI 10.4049/jimmunol.173.7.4744; Mackie EJ, 2002, IUBMB LIFE, V53, P277, DOI 10.1080/15216540213469; Orme J, 2012, DISCOV MED, V13, P151; Owen CA, 2008, INT J BIOCHEM CELL B, V40, P1246, DOI 10.1016/j.biocel.2008.01.020; Pedron T, 2000, FEMS IMMUNOL MED MIC, V28, P247; Perdiguero E, 2011, J CELL BIOL, V195, P307, DOI 10.1083/jcb.201104053; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Sahay B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000687; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Tesch GH, 1999, J EXP MED, V190, P1813, DOI 10.1084/jem.190.12.1813; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Tundup S, 2014, INFECT IMMUN, V82, P3240, DOI 10.1128/IAI.01780-14; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wang YP, 2011, J AM SOC NEPHROL, V22, P21, DOI 10.1681/ASN.2010030269; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WATSON ML, 1992, J EXP MED, V176, P1645, DOI 10.1084/jem.176.6.1645; Wilson TJ, 2009, CANCER RES, V69, P3188, DOI 10.1158/0008-5472.CAN-08-1956; Xie J, 2014, CHEM BIOL, V21, P274, DOI 10.1016/j.chembiol.2013.12.006; Xie J, 2013, P NATL ACAD SCI USA, V110, P8099, DOI 10.1073/pnas.1306263110; Yang NS, 1998, KIDNEY INT, V54, P143, DOI 10.1046/j.1523-1755.1998.00978.x; Yea K, 2015, CURR OPIN CHEM BIOL, V26, P1, DOI 10.1016/j.cbpa.2015.01.002; Yea K, 2013, P NATL ACAD SCI USA, V110, P14966, DOI 10.1073/pnas.1313671110; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zhang HK, 2014, BIOCHEM BIOPH RES CO, V454, P251, DOI 10.1016/j.bbrc.2014.10.085; Zhang HK, 2013, CHEM BIOL, V20, P734, DOI 10.1016/j.chembiol.2013.04.012; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016; Zhou W, 2014, NAT REV CANCER, V14, P26, DOI 10.1038/nrc3622	34	10	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					738	747		10.1096/fj.15-281329	http://dx.doi.org/10.1096/fj.15-281329			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26481307	Green Published			2022-12-26	WOS:000369391900024
J	Ernst, M; Romero, JM; Buhk, JH; Cheng, B; Herrmann, J; Fiehler, J; Groth, M				Ernst, Marielle; Romero, Javier M.; Buhk, Jan-Hendrik; Cheng, Bastian; Herrmann, Jochen; Fiehler, Jens; Groth, Michael			Sensitivity of Hyperdense Basilar Artery Sign on Non-Enhanced Computed Tomography	PLOS ONE			English	Article							CT ANGIOGRAPHY; STATISTICAL-METHODS; OCCLUSION; AGREEMENT; DIAGNOSIS; THROMBUS; STROKE	Purpose The hyperdense basilar artery sign (HBAS) is an indicator of vessel occlusion on non contrast-enhanced computer tomography (NECT) in acute stroke patients. Since basilar artery occlusion (BAO) is associated with a high mortality and morbidity, its early detection is of great clinical value. We sought to analyze the influence of density measurement as well as a normalized ratio of Hounsfield unit/hematocrit (HU/Hct) ratio on the detection of BAO on NECT in patients with suspected BAO. Materials and Methods 102 patients with clinically suspected BAO were examined with NECT followed immediately by Multidetector computed tomography Angiography. Two observers independently analyzed the images regarding the presence or absence of HBAS on NECT and performed HU measurements in the basilar artery. Receiver operating characteristic curve analysis was performed to determine the optimal density threshold for BAO using attenuation measurements or HU/Hct ratio. Results Sensitivity of visual detection of the HBAS on NECT was relatively low 81% (95%-CI, 54-95%) while specificity was high 91% (95%-CI, 82-96%). The highest sensitivity was achieved by the combination of visual assessment and additional quantitative attenuation measurements applying a cut-off value of 46.5 HU with 94% sensitivity and 81% specificity for BAO. A HU/Hct ratio >1.32 revealed sensitivity of 88% (95%-CI, 60-98%) and specificity of 84% (95%-CI, 74-90%). Conclusion In patients with clinically suspected acute BAO the combination of visual assessment and additional attenuation measurement with a cut-off value of 46.5 HU is a reliable approach with high sensitivity in the detection of BAO on NECT.	[Ernst, Marielle; Buhk, Jan-Hendrik; Fiehler, Jens; Groth, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Ctr Radiol & Endoscopy, Hamburg, Germany; [Romero, Javier M.] Harvard Univ, Sch Med, Dept Radiol, Div Neuroradiol,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Cheng, Bastian] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Herrmann, Jochen; Groth, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol, Ctr Radiol & Endoscopy, Div Pediat Radiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Ernst, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Ctr Radiol & Endoscopy, Hamburg, Germany.	m.ernst@uke.de	Herrmann, Jochen/AFQ-5508-2022	Romero, Javier/0000-0001-5749-3000				Beyer SE, 2015, STROKE, V46, P1840, DOI 10.1161/STROKEAHA.115.008841; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brandt T, 1999, STROKE, V30, P606, DOI 10.1161/01.STR.30.3.606; BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; Buyck PJ, 2013, AM J NEURORADIOL, V34, P1568, DOI 10.3174/ajnr.A3469; Connell L, 2012, NEURORADIOLOGY, V54, P321, DOI 10.1007/s00234-011-0887-6; Costa-Santos C, 2011, J CLIN EPIDEMIOL, V64, P264, DOI 10.1016/j.jclinepi.2009.11.010; Ernst M, 2014, NEURORADIOLOGY, V56, P1063, DOI 10.1007/s00234-014-1443-y; Esquevin A, 2013, AM J EMERG MED, V31, P494, DOI 10.1016/j.ajem.2012.09.024; Goldmakher GV, 2009, STROKE, V40, P134, DOI 10.1161/STROKEAHA.108.516690; Groth M, 2015, THORACIC PATHOLOGIES; KUCKEIN D, 1982, COMPUTERTOM SONOGRAP, V2, P120; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lev MH, 2001, J COMPUT ASSIST TOMO, V25, P520, DOI 10.1097/00004728-200107000-00003; Mair G, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140216; Schonewille WJ, 2009, LANCET NEUROL, V8, P724, DOI 10.1016/S1474-4422(09)70173-5; Vergouwen MDI, 2012, STROKE, V43, P3003, DOI 10.1161/STROKEAHA.112.666867; VONOFAKOS D, 1983, AM J NEURORADIOL, V4, P525; ZATZ LM, 1977, RADIOLOGY, V124, P91, DOI 10.1148/124.1.91	19	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0141096	10.1371/journal.pone.0141096	http://dx.doi.org/10.1371/journal.pone.0141096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479718	gold, Green Published, Green Submitted			2022-12-26	WOS:000363026600030
J	Wang, T; Li, R; Wen, LW; Fu, DQ; Zhu, BZ; Luo, YB; Zhu, HL				Wang, Tian; Li, Rui; Wen, Liwei; Fu, Daqi; Zhu, Benzhong; Luo, Yunbo; Zhu, Hongliang			Functional Analysis and RNA Sequencing Indicate the Regulatory Role of Argonaute1 in Tomato Compound Leaf Development	PLOS ONE			English	Article							GENE-EXPRESSION; ARABIDOPSIS; AGO1; PROTEINS; MERISTEM; PLANTS; MORPHOGENESIS; POLARITY; SHOOTS; LEAVES	Regardless of whether a leaf is simple or compound, the mechanism underlying its development will give rise to a full comprehension of plant morphogenesis. The role of Argonaute1 (AGO1) in the development of simple leaves has been established, but its role in the development of compound leaves remains to be characterized. In this paper, a virus-induced gene silencing (VIGS) strategy was used to dramatically down-regulate the expression of AGO1 ortholog in tomatoes, a model plant for research into compound leaves. AGO1-silenced tomato compound leaves exhibited morphological defects of leaf adaxial-abaxial and trichome development. Analysis of global gene expression profiles indicated that the silencing of AGO1 in tomato compound leaf caused significant changes in the expression of several critical genes, including Auxin Response Factor 4 (ARF4) and Non-expressor of PR5 (NPR5), which were involved in adaxial-abaxial formation and IAA15 that was found to contribute to growth of trichomes as well as Gibberellic Acid Insensitive (GAI) which participated in hormone regulation. Collectively, these results shed light on the complicated mechanism by which AGO1 regulates compound leaf development.	[Wang, Tian; Li, Rui; Wen, Liwei; Fu, Daqi; Zhu, Benzhong; Luo, Yunbo; Zhu, Hongliang] China Agr Univ, Coll Food Sci & Nutr Engn, Dept Food Biotechnol, Beijing 100094, Peoples R China	China Agricultural University	Zhu, HL (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Dept Food Biotechnol, Beijing 100094, Peoples R China.	hlzhu@cau.edu.cn	Zhu, Hongliang/I-7035-2019	Zhu, Hongliang/0000-0002-1484-2212				Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bar M, 2015, CURR OPIN PLANT BIOL, V23, P61, DOI 10.1016/j.pbi.2014.10.007; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; Blein T, 2010, CURR OPIN PLANT BIOL, V13, P75, DOI 10.1016/j.pbi.2009.09.017; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Burko Yogev, 2013, Methods Mol Biol, V959, P1, DOI 10.1007/978-1-62703-221-6_1; Deng W, 2012, NEW PHYTOL, V194, P379, DOI 10.1111/j.1469-8137.2012.04053.x; Efroni I, 2010, PLANT CELL, V22, P1019, DOI 10.1105/tpc.109.073601; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Fambrini M, 2013, PLANT CELL REP, V32, P899, DOI 10.1007/s00299-013-1426-1; Fernandez-Moreno J.-P., 2013, VIRUS INDUCED GENE S, V975, P183, DOI DOI 10.1007/978-1-62703-278-0_14; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Gan Y, 2007, PLANT PHYSIOL, V145, P1031, DOI 10.1104/pp.107.104794; Ha CM, 2007, PLANT CELL, V19, P1809, DOI 10.1105/tpc.107.051938; Hay A, 2009, CURR OPIN PLANT BIOL, V12, P593, DOI 10.1016/j.pbi.2009.06.006; Hendelman A, 2013, PLANTA, V237, P363, DOI 10.1007/s00425-012-1778-8; Hu GJ, 2014, PLANT SCI, V229, P86, DOI 10.1016/j.plantsci.2014.08.010; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jones L, 2006, PLANT PHYSIOL, V141, P598, DOI 10.1104/pp.105.076109; Jover-Gil S, 2012, PLANT CELL PHYSIOL, V53, P1322, DOI 10.1093/pcp/pcs077; Kidner CA, 2005, DEV BIOL, V280, P504, DOI 10.1016/j.ydbio.2005.01.031; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Langford M, 2013, MILLENNIUM DEVELOPMENT GOALS AND HUMAN RIGHTS: PAST, PRESENT AND FUTURE, P1, DOI 10.1007/978-1-62703-278-0_1; Lee BH, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.988071; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XF, 2015, J EXP BOT, V66, P919, DOI 10.1093/jxb/eru447; Maunoury N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028729; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Miyashima S, 2011, DEVELOPMENT, V138, P2303, DOI 10.1242/dev.060491; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Ochando I, 2006, PLANT PHYSIOL, V141, P607, DOI 10.1104/pp.106.077149; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; Pulido A, 2010, J EXP BOT, V61, P1277, DOI 10.1093/jxb/erp397; Robertson D, 2004, ANNU REV PLANT BIOL, V55, P495, DOI 10.1146/annurev.arplant.55.031903.141803; Rodriguez RE, 2014, WIRES DEV BIOL, V3, P41, DOI 10.1002/wdev.115; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; Shani E, 2009, PLANT CELL, V21, P3078, DOI 10.1105/tpc.109.068148; Shao CG, 2014, J EXP BOT, V65, P6293, DOI [10.1093/jxb/eru382, 10.1093/jxb/e]; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Yang KZ, 2014, J INTEGR PLANT BIOL, V56, P539, DOI 10.1111/jipb.12154; Yifhar T, 2012, PLANT CELL, V24, P3575, DOI 10.1105/tpc.112.100222	49	5	8	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140756	10.1371/journal.pone.0140756	http://dx.doi.org/10.1371/journal.pone.0140756			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479258	Green Submitted, gold, Green Published			2022-12-26	WOS:000363026600018
J	Jordaens, K; Goergen, G; Virgilio, M; Backeljau, T; Vokaer, A; De Meyer, M				Jordaens, Kurt; Goergen, Georg; Virgilio, Massimiliano; Backeljau, Thierry; Vokaer, Audrey; De Meyer, Marc			DNA Barcoding to Improve the Taxonomy of the Afrotropical Hoverflies (Insecta: Diptera: Syrphidae)	PLOS ONE			English	Article							INCLUDING DESCRIPTION; MUSEUM SPECIMENS; IDENTIFICATION; PHYLOGENETICS; SEQUENCES; BIOLOGY; LARVAL; RATES	The identification of Afrotropical hoverflies is very difficult because of limited recent taxonomic revisions and the lack of comprehensive identification keys. In order to assist in their identification, and to improve the taxonomy of this group, we constructed a reference dataset of 513 COI barcodes of 90 of the more common nominal species from Ghana, Togo, Benin and Nigeria (W Africa) and added ten publically available COI barcodes from nine nominal Afrotropical species to this (total: 523 COI barcodes; 98 nominal species; 26 genera). The identification accuracy of this dataset was evaluated with three methods (K2P distance-based, Neighbor-Joining (NJ) / Maximum Likelihood (ML) analysis, and using SpeciesIdentifier). Results of the three methods were highly congruent and showed a high identification success. Nine species pairs showed a low (< 0.03) mean interspecific K2P distance that resulted in several incorrect identifications. A high (> 0.03) maximum intraspecific K2P distance was observed in eight species and barcodes of these species not always formed single clusters in the NJ / ML analayses which may indicate the occurrence of cryptic species. Optimal K2P thresholds to differentiate intra-from interspecific K2P divergence were highly different among the three subfamilies (Eristalinae: 0.037, Syrphinae: 0.06, Microdontinae: 0.007-0.02), and among the different general suggesting that optimal thresholds are better defined at the genus level. In addition to providing an alternative identification tool, our study indicates that DNA barcoding improves the taxonomy of Afrotropical hoverflies by selecting (groups of) taxa that deserve further taxonomic study, and by attributing the unknown sex to species for which only one of the sexes is known.	[Jordaens, Kurt; Virgilio, Massimiliano; Vokaer, Audrey; De Meyer, Marc] Royal Museum Cent Africa, Dept Biol, Invertebrate Sect, B-3080 Tervuren, Belgium; [Jordaens, Kurt; Virgilio, Massimiliano; Vokaer, Audrey; De Meyer, Marc] Royal Museum Cent Africa, JEMU, B-3080 Tervuren, Belgium; [Goergen, Georg] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Backeljau, Thierry] Int Inst Trop Agr, Cotonou, Benin; [Backeljau, Thierry] Royal Belgian Inst Nat Sci OD Taxon & Phylogeny, B-1000 Brussels, Belgium; [Backeljau, Thierry] JEMU, B-1000 Brussels, Belgium	Royal Museum for Central Africa; Royal Museum for Central Africa; University of Antwerp; Royal Belgian Institute of Natural Sciences	Jordaens, K (corresponding author), Royal Museum Cent Africa, Dept Biol, Invertebrate Sect, Leuvensesteenweg 13, B-3080 Tervuren, Belgium.	kurt.jordaens@africamuseum.be		Goergen, Georg/0000-0003-4496-0495; Virgilio, Massimiliano/0000-0002-1323-6886	Belgian Science Policy (BELSPO); Fund for Scientific Research - Flanders (FWO-Vlaanderen); National Museum Bloemfontein; Kwa Zulu Natal Museum Pietermaritzburg in South Africa; Belspo BRAIN pioneer project [BR/314/PI/Syrpintine]	Belgian Science Policy (BELSPO)(Belgian Federal Science Policy Office); Fund for Scientific Research - Flanders (FWO-Vlaanderen)(FWO); National Museum Bloemfontein; Kwa Zulu Natal Museum Pietermaritzburg in South Africa; Belspo BRAIN pioneer project	The Joint Experimental Molecular Unit (JEMU) is an integrated research infrastructure funded by the Belgian Science Policy (BELSPO) (to TB and MDM). KJ and MDM benefited from travel grants of the Fund for Scientific Research - Flanders (FWO-Vlaanderen) to the International Institute of Tropical Agriculture, Cotonou (MDM) in Benin, the National Museum Bloemfontein (KJ & MDM) and the Kwa Zulu Natal Museum Pietermaritzburg (KJ) in South Africa. This work was financially supported by the Belspo BRAIN pioneer project BR/314/PI/Syrpintine to KJ and was conducted in the context of the FWO Research Community W0.009.11N Belgian Network for DNA Barcoding.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andric A, 2014, ACTA ENT MUS NAT PRA, V54, P741; Marcos-Garcia MA, 2011, CAN ENTOMOL, V143, P332, DOI 10.4039/n11-013; [Anonymous], SYSTEMA DIPTERORUM V; Burgess N., 2004, Terrestrial ecoregions of Africa and Madagascar: a conservation assessment; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; CURRAN C. H., 1939, AMER MUS NOVITATES, V1025-1026, P1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dirickx H. G., 1998, CATALOGUE SYNONYMIQU; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Goldstein PZ, 2003, MOL ECOL, V12, P1993, DOI 10.1046/j.1365-294X.2003.01860.x; Groom SVC, 2014, BIOL INVASIONS, V16, P2293, DOI 10.1007/s10530-014-0664-7; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Han T, 2014, J ASIA-PAC ENTOMOL, V17, P679, DOI 10.1016/j.aspen.2014.06.007; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hernandez-Triana LM, 2014, MOL ECOL RESOUR, V14, P508, DOI 10.1111/1755-0998.12208; HULL FRANK MONTGOMERY, 1964, P442; Jordaens K, 1798, TOXOMERUS F IN PRESS; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lees DC, 2014, MOL ECOL RESOUR, V14, P286, DOI 10.1111/1755-0998.12178; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lyneborg Leif, 2005, Entomonograph, V15, P1; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2008, SYST ASSOC SPEC VOL, V76, P95; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Mengual X, 2015, PHYLOGENETIC RELATIO; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Pape T, 2009, DIPTERA DIVERSITY: STATUS, CHALLENGES AND TOOLS, P121; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Proctor Michael, 1996, P1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; RIZZA A, 1988, ANN ENTOMOL SOC AM, V81, P225, DOI 10.1093/aesa/81.2.225; Rojo S, 2006, EUR J ENTOMOL, V103, P443, DOI 10.14411/eje.2006.058; Rojo S., 2003, WORLD REV PREDATORY; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Rotheray G, 1999, ZOOL J LINN SOC-LOND, V127, P1, DOI 10.1111/j.1096-3642.1999.tb01305.x; Rotheray Graham E., 1993, Dipterists Digest, V9, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shokralla S, 2014, MOL ECOL RESOUR, V14, P892, DOI 10.1111/1755-0998.12236; Skevington JH, 2012, CAN ENTOMOL, V144, P216, DOI 10.4039/tce.2012.24; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Stahls G, 2009, MOL ECOL RESOUR, V9, P1431, DOI 10.1111/j.1755-0998.2009.02592.x; Suk SW, 2013, ANIM CELLS SYST, V17, P277, DOI 10.1080/19768354.2013.814588; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TENHUMBERG B, 1995, AGR ECOSYST ENVIRON, V52, P39, DOI 10.1016/0167-8809(94)09007-T; Thompson FC, 2014, ZOOTAXA, V3847, P97, DOI 10.11646/zootaxa.3847.1.5; Thompson F. Christian, 1998, P81; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Wang Gang, 2014, Jishengchong Yu Yixue Kunchong Xuebao, V21, P65, DOI 10.3969/j.issn.1005-0507.2014.01.010; Whittington Andrew E., 2004, Studia Dipterologica, V10, P579; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Zwickl D. J, 2006, GENETIC ALGORITHM AP	57	21	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140264	10.1371/journal.pone.0140264	http://dx.doi.org/10.1371/journal.pone.0140264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473612	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500036
J	Liang, HY; Shi, YS; Kou, ZW; Peng, YH; Chen, WJ; Li, XW; Li, SJ; Wang, Y; Wang, F; Zhang, XM				Liang, Huiyu; Shi, Yusheng; Kou, Zhewen; Peng, Yonghua; Chen, Wenjun; Li, Xiaowen; Li, Shuji; Wang, Ying; Wang, Fang; Zhang, Xingmei			Inhibition of BACE1 Activity by a DNA Aptamer in an Alzheimer's Disease Cell Model	PLOS ONE			English	Article							BETA-SECRETASE BACE1; AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; THERAPEUTICS; BRAIN; REDUCTION; DISCOVERY; DEFICITS; TAK-070	An initial step in amyloid-beta (A beta) production includes amyloid precursor protein (APP) cleavage via beta-Site amyloid precursor protein cleaving enzyme 1 (BACE1). Increased levels of brain A beta have been implicated in the pathogenesis of Alzheimer's disease (AD). Thus, beta-secretase represents a primary target for inhibitor drug development in AD. In this study, aptamers were obtained from combinatorial oligonucleotide libraries using a technology referred to as systematic evolution of ligands by exponential enrichment (SELEX). A purified human BACE1 extracellular domain was used as a target to conduct an in vitro selection process using SELEX. Two DNA aptamers were capable of binding to BACE1 with high affinity and good specificity, with Kd values in the nanomolar range. We subsequently confirmed that one aptamer, A1, exhibited a distinct inhibitory effect on BACE1 activity in an AD cell model. We detected the effects of M17-APPsw cells that stably expressed Swedish mutant APP after aptamer A1 treatment. A beta 40 and A beta 42 concentrations secreted by M17-APPsw cells decreased intracellularly and in culture media. Furthermore, Western blot analysis indicated that sAPP beta expression significantly decreased in the A1 treated versus control groups. These findings support the preliminary feasibility of an aptamer evolved from a SELEX strategy to function as a potential BACE1 inhibitor. To our knowledge, this is the first study to acquire a DNA aptamer that exhibited binding specificity to BACE1 and inhibited its activity.	[Liang, Huiyu; Kou, Zhewen; Peng, Yonghua; Chen, Wenjun; Li, Xiaowen; Li, Shuji; Wang, Fang; Zhang, Xingmei] Southern Med Univ, Sch Basic Med Sci, Dept Neurobiol, Key Lab Psychiat Disorders Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Shi, Yusheng] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China; [Wang, Ying] Southern Med Univ, Sch Basic Med Sci, Canc Res Inst, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Zhang, XM (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Neurobiol, Key Lab Psychiat Disorders Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	zhangxm@smu.edu.cn		zhang, xingmei/0000-0001-9548-1289	National Science Foundation of China [81471388, 81272509]; Guangdong Natural Science Foundation [2014A030313351]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the National Science Foundation of China (No. 81471388 and No. 81272509) and the Guangdong Natural Science Foundation (No. 2014A030313351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgstaller P, 2002, CURR OPIN DRUG DISC, V5, P690; Cao XX, 2009, NUCLEIC ACIDS RES, V37, P4621, DOI 10.1093/nar/gkp489; Cerchia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007971; Cheng Y, 2014, ADV DRUG DELIVER REV, V66, P42, DOI 10.1016/j.addr.2013.09.006; Cole SL, 2008, CURR ALZHEIMER RES, V5, P100, DOI 10.2174/156720508783954758; de Franciscis V, 2009, CNS NEUROL DISORD-DR, V8, P393, DOI 10.2174/187152709789542023; Evin G, 2010, INT J BIOCHEM CELL B, V42, P1923, DOI 10.1016/j.biocel.2010.08.017; Fukumoto H, 2010, J NEUROSCI, V30, P11157, DOI 10.1523/JNEUROSCI.2884-10.2010; Giusti-Rodriguez P, 2011, J NEUROSCI, V31, P15751, DOI 10.1523/JNEUROSCI.3588-11.2011; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Jeppsson F, 2012, J BIOL CHEM, V287, P41245, DOI 10.1074/jbc.M112.409110; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kettenberger H, 2006, NAT STRUCT MOL BIOL, V13, P44, DOI 10.1038/nsmb1032; Kimura R, 2010, J NEUROCHEM, V113, P248, DOI 10.1111/j.1471-4159.2010.06608.x; Li SH, 2009, J PATHOL, V218, P327, DOI 10.1002/path.2543; Liu XM, 2003, J MOL RECOGNIT, V16, P23, DOI 10.1002/jmr.604; Lu Q, 2012, ACTA PHARMACOL SIN, V33, P1459, DOI 10.1038/aps.2012.74; Malamas MS, 2010, BIOORG MED CHEM LETT, V20, P6597, DOI 10.1016/j.bmcl.2010.09.029; McConnell EM, 2014, NUCLEIC ACID THER, V24, P388, DOI 10.1089/nat.2014.0492; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Probst G, 2012, EXPERT OPIN THER PAT, V22, P511, DOI 10.1517/13543776.2012.681302; Rentmeister A, 2006, RNA, V12, P1650, DOI 10.1261/rna.126306; Sankaranarayanan S, 2009, J PHARMACOL EXP THER, V328, P131, DOI 10.1124/jpet.108.143628; Schiller GJ, 2010, J CLIN ONCOL, V28, P815, DOI 10.1200/JCO.2009.24.2008; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Stockley JH, 2007, BIOCHEM SOC T, V35, P574, DOI 10.1042/BST0350574; Takahashi H, 2010, BRAIN RES, V1361, P146, DOI 10.1016/j.brainres.2010.09.032; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wu XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090752; Xu YC, 2012, ACTA CRYSTALLOGR D, V68, P13, DOI 10.1107/S0907444911047251; Yu YJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009835; Zhong ZY, 2007, ARCH GEN PSYCHIAT, V64, P718, DOI 10.1001/archpsyc.64.6.718	34	18	19	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140733	10.1371/journal.pone.0140733	http://dx.doi.org/10.1371/journal.pone.0140733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473367	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500094
J	Pesciotta, EN; Lam, HS; Kossenkov, A; Ge, JP; Showe, LC; Mason, PJ; Bessler, M; Speicher, DW				Pesciotta, Esther N.; Lam, Ho-Sun; Kossenkov, Andrew; Ge, Jingping; Showe, Louise C.; Mason, Philip J.; Bessler, Monica; Speicher, David W.			In-Depth, Label-Free Analysis of the Erythrocyte Cytoplasmic Proteome in Diamond Blackfan Anemia Identifies a Unique Inflammatory Signature	PLOS ONE			English	Article							RED-BLOOD-CELLS; MASS-SPECTROMETRY; INTERFERON-GAMMA; EXPRESSION; PROTEINS; GATA1; IMMUNOPROTEASOME; DIFFERENTIATION; QUANTIFICATION; TRANSCRIPTION	Diamond Blackfan Anemia (DBA) is a rare, congenital erythrocyte aplasia that is usually caused by haploinsufficiency of ribosomal proteins due to diverse mutations in one of several ribosomal genes. A striking feature of this disease is that a range of different mutations in ribosomal proteins results in similar disease phenotypes primarily characterized by erythrocyte abnormalities and macrocytic anemia, while most other cell types in the body are minimally affected. Previously, we analyzed the erythrocyte membrane proteomes of several DBA patients and identified several proteins that are not typically associated with this cell type and that suggested inflammatory mechanisms contribute to the pathogenesis of DBA. In this study, we evaluated the erythrocyte cytosolic proteome of DBA patients through in-depth analysis of hemoglobin-depleted erythrocyte cytosols. Simple, reproducible, hemoglobin depletion using nickel columns enabled in-depth analysis of over 1000 cytosolic erythrocyte proteins with only moderate total analysis time per proteome. Label-free quantitation and statistical analysis identified 29 proteins with significantly altered abundance levels in DBA patients compared to matched healthy control donors. Proteins that were significantly increased in DBA erythrocyte cytoplasms included three proteasome subunit beta proteins that make up the immunoproteasome and proteins induced by interferon. such as n-myc interactor and interferon-induced 35 kDa protein [NMI and IFI35 respectively]. Pathway analysis confirmed the presence of an inflammatory signature in erythrocytes of DBA patients and predicted key upstream regulators including mitogen activated kinase 1, interferon-gamma, tumor suppressor p53, and tumor necrosis factor. These results show that erythrocytes in DBA patients are intrinsically different from those in healthy controls which may be due to an inflammatory response resulting from the inherent molecular defect of ribosomal protein haploinsufficiency or changes in the bone marrow microenvironment that leads to red cell aplasia in DBA patients.	[Pesciotta, Esther N.; Lam, Ho-Sun; Ge, Jingping; Mason, Philip J.; Bessler, Monica] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA; [Pesciotta, Esther N.; Kossenkov, Andrew; Showe, Louise C.; Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol & Mol, Philadelphia, PA 19104 USA; [Pesciotta, Esther N.; Kossenkov, Andrew; Showe, Louise C.; Speicher, David W.] Wistar Inst Anat & Biol, Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Bessler, Monica] Univ Penn, Dept Internal Med, Div Hematol Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; The Wistar Institute; The Wistar Institute; University of Pennsylvania	Speicher, DW (corresponding author), Wistar Inst Anat & Biol, Ctr Syst & Computat Biol & Mol, 3601 Spruce St, Philadelphia, PA 19104 USA.	speicher@wistar.org			National Institute of Health (nih.gov)-The National Institute of Diabetes and Digestive and Kidney Diseases grant [RO1 DK084188]; National Institute of Health [RO1 HL38794]; Institutional Cancer Center [P30 CA010815];  [T32-DK7780]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084188, T32DK007780] Funding Source: NIH RePORTER	National Institute of Health (nih.gov)-The National Institute of Diabetes and Digestive and Kidney Diseases grant; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the federal training grant T32-DK7780 to EP, National Institute of Health (nih.gov)-The National Institute of Diabetes and Digestive and Kidney Diseases grant RO1 DK084188 to MB and PM, National Institute of Health grant RO1 HL38794 to DWS, and the Institutional Cancer Center support grant P30 CA010815. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball S, 2011, HEMATOL-AM SOC HEMAT, P487, DOI 10.1182/asheducation-2011.1.487; Basler M, 2013, CURR OPIN IMMUNOL, V25, P74, DOI 10.1016/j.coi.2012.11.004; Bhattacharya D, 2007, PROTEOM CLIN APPL, V1, P561, DOI 10.1002/prca.200700178; Bibikova E, 2014, BLOOD, V124, P3791, DOI 10.1182/blood-2014-06-584656; BOTTO M, 1990, BRIT J HAEMATOL, V75, P106, DOI 10.1111/j.1365-2141.1990.tb02624.x; Buck I, 2008, BIOCHEM PHARMACOL, V76, P1229, DOI 10.1016/j.bcp.2008.08.025; Buck I, 2009, INT J ONCOL, V34, P853, DOI 10.3892/ijo_00000212; Chakraborty A, 2011, WIRES RNA, V2, P507, DOI 10.1002/wrna.73; Chen J, 2002, J INTERF CYTOK RES, V22, P237, DOI 10.1089/107999002753536211; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Gazda HT, 2006, STEM CELLS, V24, P2034, DOI 10.1634/stemcells.2005-0554; Ge JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134878; GILES CM, 1987, CLIN EXP IMMUNOL, V69, P368; GROETTRUP M, 1995, J BIOL CHEM, V270, P23808, DOI 10.1074/jbc.270.40.23808; Haudek VJ, 2009, J PROTEOME RES, V8, P3834, DOI 10.1021/pr801085g; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; Ludwig LS, 2014, NAT MED, V20, P748, DOI 10.1038/nm.3557; MATOVCIK LM, 1985, BLOOD, V65, P1056; Miller Z, 2013, CURR PHARM DESIGN, V19, P4140, DOI 10.2174/1381612811319220018; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Pesciotta EN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085504; Pesciotta EN, 2012, J PROTEOMICS, V76, P194, DOI 10.1016/j.jprot.2012.08.010; Prabakaran S, 2007, J PROTEOME RES, V6, P141, DOI 10.1021/pr060308a; Quarello P, 2012, HAEMATOL-HEMATOL J, V97, P1813, DOI 10.3324/haematol.2012.062281; Ringrose JH, 2008, J PROTEOME RES, V7, P3060, DOI 10.1021/pr8001029; Roux-Dalvai F, 2008, MOL CELL PROTEOMICS, V7, P2254, DOI 10.1074/mcp.M800037-MCP200; Ruggero D, 2014, BLOOD, V124, P2784, DOI 10.1182/blood-2014-04-526301; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Sankaran VG, 2012, J CLIN INVEST, V122, P2439, DOI 10.1172/JCI63597; Sjogren SE, 2012, SCI WORLD J, DOI 10.1100/2012/184362; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vlachos A, 2001, J PEDIAT HEMATOL ONC, V23, P377, DOI 10.1097/00043426-200108000-00015; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Vlachos A, 2014, EXPERT REV HEMATOL, V7, P359, DOI 10.1586/17474086.2014.897923; Vlachos A, 2013, EUR J HUM GENET, V21, DOI 10.1038/ejhg.2013.34; Zheng W, 2014, ARCH VIROL, V159, P2925, DOI 10.1007/s00705-014-2147-7	41	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140036	10.1371/journal.pone.0140036	http://dx.doi.org/10.1371/journal.pone.0140036			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474164	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500020
J	Turner, NA; Moake, JL				Turner, Nancy A.; Moake, Joel L.			Factor VIII Is Synthesized in Human Endothelial Cells, Packaged in Weibel-Palade Bodies and Secreted Bound to ULVWF Strings	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; COAGULATION-FACTOR VIII; CLOTTING FACTOR-VIII; DESMOPRESSIN DDAVP; STORAGE ORGANELLES; FACTOR MULTIMERS; V2 RECEPTORS; HUMAN-LIVER; EXPRESSION; FVIII	The cellular synthesis site and ensuing storage location for human factor VIII (FVIII), the coagulation protein deficient in hemophilia A, has been elusive. FVIII stability and half-life is dependent on non-covalent complex formation with von Willebrand factor (VWF) to avoid proteolysis and clearance. VWF is synthesized in megakaryocytes and endothelial cells, and is stored and secreted from platelet alpha granules and Weibel-Palade bodies of endothelial cells. In this paper we provide direct evidence for FVIII synthesis in 2 types of primary human endothelial cells: glomerular microvascular endothelial cells (GMVECs) and umbilical vein endothelial cells (HUVECs). Gene expression quantified by real time PCR revealed that levels of F8 and VWF are similar in GMVECs and HUVECs. Previous clinical studies have shown that stimulation of vasopressin V2 receptors causes parallel secretion of both proteins. In this study, we found that both endothelial cell types express AVPR2 (vasopressin V2 receptor gene) and that AVPR2 mRNA levels are 5-fold higher in GMVECs than HUVECs. FVIII and VWF proteins were detected by fluorescent microscopy in Weibel-Palade bodies within GMVECs and HUVECs using antibodies proven to be target specific. Visual presence of FVIII and VWF in Weibel-Palade bodies was confirmed by correlation measurements. The high extent of correlation was compared with negative correlation values obtained from FVIII detection with cytoplasmic proteins, beta-actin and Factor H. FVIII activity was positive in GMVEC and HUVEC cell lysates. Stimulated GMVECs and HUVECs were found to secrete cell-anchored ultra-large VWF strings covered with bound FVIII.	[Turner, Nancy A.; Moake, Joel L.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Rice University	Turner, NA (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.	nturner@rice.edu			Mary R. Gibson Foundation [R02230-778000]; Mabel and Everett Hinkson Memorial Fund [G82567-778000]	Mary R. Gibson Foundation; Mabel and Everett Hinkson Memorial Fund	This work was supported by the Mary R. Gibson Foundation, R02230-778000 (JLM), and the Mabel and Everett Hinkson Memorial Fund, G82567-778000 (JLM).	Boedeker BGD, 2001, SEMIN THROMB HEMOST, V27, P385; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bouwens EAM, 2011, BLOOD, V118, P5947, DOI 10.1182/blood-2011-05-355354; Dashty M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00787; Do H, 1999, J BIOL CHEM, V274, P19587, DOI 10.1074/jbc.274.28.19587; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Everett LA, 2014, BLOOD, V123, P3697, DOI 10.1182/blood-2014-02-554501; Fahs SA, 2014, BLOOD, V123, P3706, DOI 10.1182/blood-2014-02-555151; Haberichter SL, 2006, PEDIATR BLOOD CANCER, V46, P547, DOI 10.1002/pbc.20658; Hannah MJ, 2002, SEMIN CELL DEV BIOL, V13, P313, DOI 10.1016/S1084-9521(02)00061-7; Jacquemin M, 2006, BLOOD, V108, P515, DOI 10.1182/blood-2005-11-4571; Juul KV, 2014, AM J PHYSIOL-RENAL, V306, pF931, DOI 10.1152/ajprenal.00604.2013; Kaufmann JE, 2000, J CLIN INVEST, V106, P107, DOI 10.1172/JCI9516; Kaufmann JE, 2003, J THROMB HAEMOST, V1, P682, DOI 10.1046/j.1538-7836.2003.00190.x; Lenting PJ, 1999, J BIOL CHEM, V274, P23734, DOI 10.1074/jbc.274.34.23734; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mannucci PM, 1997, BLOOD, V90, P2515, DOI 10.1182/blood.V90.7.2515.2515_2515_2521; Michaux G, 2006, DEV CELL, V10, P223, DOI 10.1016/j.devcel.2005.12.012; Montgomery RR, 2000, J PEDIAT HEMATOL ONC, V22, P269, DOI 10.1097/00043426-200005000-00017; Nolasco LH, 2005, BLOOD, V106, P4199, DOI 10.1182/blood-2005-05-2111; Orlova NA, 2013, ACTA NATURAE, V5, P19, DOI 10.32607/20758251-2013-5-2-19-39; Pemberton S, 1997, BLOOD, V89, P2413, DOI 10.1182/blood.V89.7.2413; Rosenberg JB, 1998, J CLIN INVEST, V101, P613, DOI 10.1172/JCI1250; Rosenberg JB, 2000, ARTERIOSCL THROM VAS, V20, P2689, DOI 10.1161/01.ATV.20.12.2689; ROTBLAT F, 1983, J LAB CLIN MED, V101, P736; Saenko EL, 1999, J BIOL CHEM, V274, P37685, DOI 10.1074/jbc.274.53.37685; Shahani T, 2014, J THROMB HAEMOST, V12, P36, DOI 10.1111/jth.12412; Shahani T, 2010, BLOOD, V115, P4902, DOI 10.1182/blood-2009-07-232546; Shovlin Claire L, 2010, PLoS One, V5, pe9154, DOI 10.1371/journal.pone.0009154; Tagliavacca L, 1997, J BIOL CHEM, V272, P27428, DOI 10.1074/jbc.272.43.27428; TIARKS C, 1987, THROMB RES, V45, P527, DOI 10.1016/0049-3848(87)90315-X; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; TRUETT MA, 1985, DNA-J MOLEC CELL BIO, V4, P333, DOI 10.1089/dna.1985.4.333; Turner NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121994; Turner NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059372; Turner NA, 2009, BLOOD, V114, P5102, DOI 10.1182/blood-2009-07-231597; van den Biggelaar M, 2009, BLOOD, V113, P3102, DOI 10.1182/blood-2008-05-159699; WAGNER DD, 1991, CELL, V64, P403, DOI 10.1016/0092-8674(91)90648-I; WEIBEL ER, 1964, J CELL BIOL, V23, P101, DOI 10.1083/jcb.23.1.101; WION KL, 1985, NATURE, V317, P726, DOI 10.1038/317726a0; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; Zinchuk V, 2009, PROG HISTOCHEM CYTO, V44, P125, DOI 10.1016/j.proghi.2009.03.001	44	47	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140740	10.1371/journal.pone.0140740	http://dx.doi.org/10.1371/journal.pone.0140740			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473492	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500095
J	Domingues, CS; Hardoim, DJ; Souza, CSF; Cardoso, FO; Mendes, VG; Previtalli-Silva, H; Abreu-Silva, AL; Pelajo-Machado, M; da Costa, SCG; Calabrese, KS				Domingues, Carolina S.; Hardoim, Daiana J.; Souza, Celeste S. F.; Cardoso, Flavia O.; Mendes, Veronica G.; Previtalli-Silva, Henrique; Abreu-Silva, Ana L.; Pelajo-Machado, Marcelo; Goncalves da Costa, Sylvio Celso; Calabrese, Katia S.			Oral Outbreak of Chagas Disease in Santa Catarina, Brazil: Experimental Evaluation of a Patient's Strain	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; TRANSMISSION; INFECTION; THROMBOCYTOPENIA; PARASITEMIA	Chagas disease is a worldwide public health problem. Although the vectorial transmission of Chagas disease has been controlled in Brazil there are other ways of transmission, such as the ingestion of T. cruzi contaminated food, which ensures the continuation of this zoonosis. Here, we demonstrate the influence of the inoculation route on the establishment and development of the SC2005 T. cruzi strain infection in mice. Groups of Swiss mice were infected intragastrically (IG) or intraperitoneally (IP) with the T. cruzi SC2005 strain derived from an outbreak of oral Chagas disease. The results revealed that 100% of IP infected mice showed parasitemia, while just 36% of IG infected showed the presence of the parasite in blood. The parasitemia peaks were later and less intense in the IG infected mice. Mortality of the IP infected animals was more intense and earlier when compared to the IG infected mice. In the IP infected mice leucopenia occurred in the early infection followed by leucocytosis, correlating positively with the increase of the parasites. However, in the IG infected mice only an increase in monocytes was observed, which was positively correlated with the increase of the parasites. Histopathological analyses revealed a myotropic pattern of the SC2005 strain with the presence of inflammatory infiltrates and parasites in different organs of the animals infected by both routes as well as fibrosis foci and collagen redistribution. The flow cytometric analysis demonstrated a fluctuation of the T lymphocyte population in the blood, spleen and mesenteric lymph nodes of the infected animals. T. cruzi DNA associated with the presence of inflammatory infiltrates was detected by PCR in the esophagus, stomach and intestine of all infected mice. These findings are important for the understanding of the pathogenesis of T. cruzi infection by both inoculation routes.	[Domingues, Carolina S.; Hardoim, Daiana J.; Souza, Celeste S. F.; Cardoso, Flavia O.; Previtalli-Silva, Henrique; Goncalves da Costa, Sylvio Celso; Calabrese, Katia S.] Inst Oswaldo Cruz, Lab Imunomodulacao & Protozool, BR-20001 Rio De Janeiro, Brazil; [Mendes, Veronica G.] Fiocruz MS, Inst Nacl Ciencia & Tecnol Doencas Negligenciadas, Ctr Desenvolvimento Tecnol Saude, BR-21045900 Rio De Janeiro, Brazil; [Abreu-Silva, Ana L.] Univ Estadual Maranhao, Dept Patol, Sao Luis, Maranhao, Brazil; [Pelajo-Machado, Marcelo] Inst Oswaldo Cruz, Lab Patol, BR-20001 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Universidade Estadual do Maranhao; Fundacao Oswaldo Cruz	Calabrese, KS (corresponding author), Inst Oswaldo Cruz, Lab Imunomodulacao & Protozool, BR-20001 Rio De Janeiro, Brazil.	calabrese@ioc.fiocruz.br	Calabrese, Katia S/V-2631-2018; Machado, Marcelo Pelajo/I-5359-2012; CARDOSO, FLÁVIA/AEX-9625-2022; CARDOSO, FLÁVIA/AAZ-8666-2021; Silva, Ana Lúcia Abreu/AAR-9739-2020	CARDOSO, FLAVIA/0000-0002-2026-1836; Pelajo Machado, Marcelo/0000-0002-7295-7018; Hardoim, Daiana de Jesus/0000-0002-2272-2472	CAPES Brazil; Oswaldo Cruz Institute	CAPES Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Oswaldo Cruz Institute	This work was supported by CAPES Brazil and Oswaldo Cruz Institute. Katia da Silva Calabrese (CNPq no 306271/2011-7) and Sylvio Celso Goncalves da Costa (306130/2011-4) are senior researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkmim-Oliveira SM, 2013, PARASITOL RES, V112, P671, DOI 10.1007/s00436-012-3184-3; Andrade SG, 2011, MEM I OSWALDO CRUZ, V106, P948, DOI 10.1590/S0074-02762011000800009; Bastos CJC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000711; Carvalho CME, 2003, AM J TROP MED HYG, V68, P683, DOI 10.4269/ajtmh.2003.68.683; Castro-Sesquen YE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001996; Cortez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042153; da Silva CV, 2006, MICROBES INFECT, V8, P2120, DOI 10.1016/j.micinf.2006.03.016; de Goes Cavalcanti LP, 2009, CAD SAUDE COLET, V17, P911; de Meis J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000417; LAGRANGE PH, 1975, J EXP MED, V141, P82, DOI 10.1084/jem.141.1.82; Langeron M, 1949, MASSON; LIDDELL FDK, 1978, MICROBIOL REV, V42, P237, DOI 10.1128/MMBR.42.1.237-249.1978; Dias GBM, 2013, EXP PARASITOL, V135, P511, DOI 10.1016/j.exppara.2013.08.013; Marcondes MCG, 2000, MICROBES INFECT, V2, P347, DOI 10.1016/S1286-4579(00)00333-6; Marquez E, 2013, NEFROLOGIA, V33, P128, DOI 10.3265/Nefrologia.pre2012.Sep.11636; Guedes PMM, 2012, REV BRAS PARASITOL V, V21, P151, DOI 10.1590/S1984-29612012000200015; MILES MA, 1972, PARASITOLOGY, V65, P1, DOI 10.1017/S0031182000044188; Moraes-Souza H, 2011, REV SOC BRAS MED TRO, V44, P64, DOI 10.1590/S0037-86822011000800010; Morrot A, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/747185; NERYGUIMARAES F, 1968, HOSPITAL, V73, P73; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; PAHO, 2006, QUANT EST CHAG DIS A; Pan American Health Organization (PAHO), 1992, DOC IN CON SUL; Dias JCP, 2006, REV SOC BRAS MED TRO, V39, P370, DOI 10.1590/S0037-86822006000400010; Pizzi T, 1952, BIOLOGICA, V16, P3; Quijano-Hernandez IA, 2012, SCI WORLD J, P1, DOI 10.1100/2012/635169; Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Shikanai-Yasuda M. A, 1987, REV SOC BRAS MED S2, V20, pM14; Shikanai-Yasuda MA, 2012, CLIN INFECT DIS, V54, P845, DOI 10.1093/cid/cir956; SHIKANAIYASUDA MA, 1991, REV I MED TROP, V33, P351, DOI 10.1590/S0036-46651991000500003; Silveira AC, 2002, CONTROLE DOENCA CHAG, P15; Souza W, 1999, TRYPANOSOMA CRUZI DO, P126; Teixeira ARL, 2011, CLIN MICROBIOL REV, V24, P592, DOI 10.1128/CMR.00063-10; Toso A, 2011, REV MED CHILE, V139, P258, DOI /S0034-98872011000200017; Tribulatti MV, 2005, INFECT IMMUN, V73, P201, DOI 10.1128/IAI.73.1.201-207.2005; Valente SAS, 1997, 33 C SOC BRAS MED TR, V53; Valente SAS, 2001, REV SOC BRAS MED S1, V34, P19; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	40	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0122566	10.1371/journal.pone.0122566	http://dx.doi.org/10.1371/journal.pone.0122566			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469517	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600001
J	Koya, SK; Meller, VH				Koya, S. Kiran; Meller, Victoria H.			Modulation of Heterochromatin by Male Specific Lethal Proteins and roX RNA in Drosophila melanogaster Males	PLOS ONE			English	Article							CHROMOSOME DOSAGE COMPENSATION; X-CHROMOSOME; MSL COMPLEX; CHROMATIN-STRUCTURE; HISTONE ACETYLATION; EARLY EMBRYOGENESIS; GENES; MOF; TRANSCRIPTION; EXPRESSION	The ribonucleoprotein Male Specific Lethal (MSL) complex is required for X chromosome dosage compensation in Drosophila melanogaster males. Beginning at 3 h of development the MSL complex binds transcribed X-linked genes and modifies chromatin. A subset of MSL complex proteins, including MSL1 and MSL3, is also necessary for full expression of autosomal heterochromatic genes in males, but not females. Loss of the non-coding roX RNAs, essential components of the MSL complex, lowers the expression of heterochromatic genes and suppresses position effect variegation (PEV) only in males, revealing a sex-limited disruption of heterochromatin. To explore the molecular basis of this observation we examined additional proteins that participate in compensation and found that MLE, but not Jil-1 kinase, contributes to heterochromatic gene expression. To determine if identical regions of roX RNA are required for dosage compensation and heterochromatic silencing, we tested a panel of roX1 transgenes and deletions and find that the X chromosome and heterochromatin functions are separable by some mutations. Chromatin immunoprecipitation of staged embryos revealed widespread autosomal binding of MSL3 before and after localization of the MSL complex to the X chromosome at 3 h AEL. Autosomal MSL3 binding was dependent on MSL1, supporting the idea that a subset of MSL proteins associates with chromatin throughout the genome during early development. The broad localization of these proteins early in embryogenesis supports the idea of direct action at autosomal sites. We postulate that this may contribute to the sex-specific differences in heterochromatin that we, and others, have noted.	[Koya, S. Kiran; Meller, Victoria H.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Meller, VH (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	vmeller@biology.biosci.wayne.edu			National Science Foundation [0641121]; National Institutes of Health [GM093110]; WSU Graduate Enhancement award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093110] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WSU Graduate Enhancement award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Science Foundation award 0641121 to VHM; National Institutes of Health award GM093110 to VHM; WSU Graduate Enhancement award to SKK. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Apte MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128114; Birchler J, 2011, J GENET GENOMICS, V38, P327, DOI 10.1016/j.jgg.2011.07.001; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Chen K, 2013, ELIFE, V2, DOI 10.7554/eLife.00861; Deng XX, 2009, GENETICS, V182, P481, DOI 10.1534/genetics.109.102087; Deng XX, 2009, GENESIS, V47, P49, DOI 10.1002/dvg.20463; Deng XX, 2005, MECH DEVELOP, V122, P1094, DOI 10.1016/j.mod.2005.06.004; Eisen A, 2001, J BIOL CHEM, V276, P3484, DOI 10.1074/jbc.M008159200; Feller C, 2012, NUCLEIC ACIDS RES, V40, P1509, DOI 10.1093/nar/gkr869; Franke A, 1999, MOL CELL, V4, P117, DOI 10.1016/S1097-2765(00)80193-8; FUKUNAGA A, 1975, GENETICS, V81, P135; Gelbart ME, 2009, NAT STRUCT MOL BIOL, V16, P825, DOI 10.1038/nsmb.1644; GORMAN M, 1995, DEVELOPMENT, V121, P463; Gu WG, 1998, DEV GENET, V22, P56, DOI 10.1002/(SICI)1520-6408(1998)22:1<56::AID-DVG6>3.0.CO;2-6; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Ilik IA, 2013, MOL CELL, V51, P156, DOI 10.1016/j.molcel.2013.07.001; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Kelley RL, 2008, MECH DEVELOP, V125, P1009, DOI 10.1016/j.mod.2008.08.003; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Konev AY, 2003, GENETICS, V165, P2039; Lam KC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002736; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Lee CG, 1997, EMBO J, V16, P2671, DOI 10.1093/emboj/16.10.2671; Li F, 2005, MOL CELL BIOL, V25, P8913, DOI 10.1128/MCB.25.20.8913-8924.2005; Liu LP, 2005, NAT GENET, V37, P1361, DOI 10.1038/ng1662; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucchesi JC, 1998, CURR OPIN GENET DEV, V8, P179, DOI 10.1016/S0959-437X(98)80139-1; Maenner S, 2013, MOL CELL, V51, P174, DOI 10.1016/j.molcel.2013.06.011; Marin I, 2003, J MOL EVOL, V56, P527, DOI 10.1007/s00239-002-2422-1; Martinez CA, 2008, MOL CELL BIOL, V28, P2792, DOI 10.1128/MCB.01203-07; Meller VH, 2003, MECH DEVELOP, V120, P759, DOI 10.1016/S0925-4773(03)00157-6; Meller VH, 2000, CURR BIOL, V10, P136, DOI 10.1016/S0960-9822(00)00311-0; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Oppikofer M, 2011, EMBO J, V30, P2610, DOI 10.1038/emboj.2011.170; Park SW, 2007, GENETICS, V177, P1429, DOI 10.1534/genetics.107.071001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; RASTELLI L, 1995, MECH DEVELOP, V53, P223, DOI 10.1016/0925-4773(95)00438-7; Regnard C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001327; Riddle NC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002954; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; SABiosciences C, 2008, CHAMPIONCHIP QPCR PR; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Straub T, 2005, GENE DEV, V19, P2284, DOI 10.1101/gad.1343105; Straub T, 2013, GENOME RES, V23, P473, DOI 10.1101/gr.146407.112; Stuckenholz C, 2003, GENETICS, V164, P1003; Sun L, 2013, P NATL ACAD SCI USA, V110, pE808, DOI 10.1073/pnas.1222542110; VLASSOVA IE, 1991, MOL GEN GENET, V229, P316, DOI 10.1007/BF00272172; WAKIMOTO BT, 1990, GENETICS, V125, P141; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Xhemalce B, 2010, GENE DEV, V24, P647, DOI 10.1101/gad.1881710; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008	57	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140259	10.1371/journal.pone.0140259	http://dx.doi.org/10.1371/journal.pone.0140259			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468879	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600034
J	Thome, AD; Standaert, DG; Harms, AS				Thome, Aaron D.; Standaert, David G.; Harms, Ashley S.			Fractalkine Signaling Regulates the Inflammatory Response in an alpha-Synuclein Model of Parkinson Disease	PLOS ONE			English	Article							MOUSE MODEL; MICROGLIAL ACTIVATION; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; OVER-EXPRESSION; NEURON LOSS; NEURODEGENERATION; BRAIN; NEUROINFLAMMATION; NEUROPROTECTION	Background Parkinson disease (PD) is a progressive neurodegenerative disorder characterized by loss of dopamine neurons in the substantia nigra pars compacta (SNpc) and widespread aggregates of the protein alpha-synuclein (alpha-syn). Increasing evidence points to inflammation as a chief mediator; however, the role of alpha-syn in triggering and sustaining inflammation remains unclear. In models of Alzheimer's disease (AD), multiple sclerosis (MS) and neurotoxin models of PD, the chemokine CX3CL1 (fractalkine) and its receptor (CX3CR1) have important roles in modulating neuroinflammation. Methods To examine the role of fractalkine signaling in alpha-syn-induced-neuroinflammation and neurodegeneration, we used an in vivo mouse model in which human alpha-syn is overexpressed by an adeno associated viral vector serotype 2 (AAV2) and in vitro phagocytosis and protein internalization assays with primary microglia treated with aggregated alpha-syn. Results We observed that loss of CX3CR1 expression led to a reduced inflammatory response, with reduced IgG deposition and expression of MHCII 4 weeks post-transduction. Six months post transduction, AAV2 mediated overexpression of alpha-syn leads to loss of dopaminergic neurons, and this loss was not exacerbated in animals with deletion of CX3CR1. To determine the mechanism by which CX3CR1affects inflammatory responses in alpha-syn-induced inflammation, phagocytosis was assessed using a fluorescent microsphere assay as well as by microglial uptake of aggregated alpha-syn. CX3CR1-/- microglia showed reduced uptake of fluorescent beads and aggregated alpha-syn. Conclusion Our results suggest that one mechanism by which CX3CR1-/- attenuates inflammation is at the level of phagocytosis of aggregated alpha-syn by microglia. These data implicate fractalkine signaling as a potential therapeutic target for regulating inflammatory response in alpha-syn models PD.	[Thome, Aaron D.; Standaert, David G.; Harms, Ashley S.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Harms, AS (corresponding author), Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, UAB Stn, Birmingham, AL 35294 USA.	anharms@uab.edu		Harms, Ashley/0000-0002-7054-2812; Thome, Aaron/0000-0002-1015-7111; Standaert, David/0000-0003-2921-8348				Appel SH, 2012, MOVEMENT DISORD, V27, P1075, DOI 10.1002/mds.25111; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Cao SW, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-259; Cao SW, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-42; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Cho SH, 2011, J BIOL CHEM, V286, P32713, DOI 10.1074/jbc.M111.254268; Cook DN, 2001, MOL CELL BIOL, V21, P3159, DOI 10.1128/MCB.21.9.3159-3165.2001; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Harms AS, 2013, J NEUROSCI, V33, P9592, DOI 10.1523/JNEUROSCI.5610-12.2013; Harms AS, 2012, GLIA, V60, P189, DOI 10.1002/glia.21254; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Limatola C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00229; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; Morganti JM, 2012, J NEUROSCI, V32, P14592, DOI 10.1523/JNEUROSCI.0539-12.2012; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nash KR, 2015, MOL THER, V23, P17, DOI 10.1038/mt.2014.175; Nash KR, 2013, NEUROBIOL AGING, V34, P1540, DOI 10.1016/j.neurobiolaging.2012.12.011; Orr CF, 2005, BRAIN, V128, P2665, DOI 10.1093/brain/awh625; Pabon MM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-9; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ramsey CP, 2014, EXP NEUROL, V256, P126, DOI 10.1016/j.expneurol.2013.05.014; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Reish HA, 2015, J PARKINSONS DIS; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Sheridan GK, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130181; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Theodore S, 2008, J NEUROPATH EXP NEUR, V67, P1149, DOI 10.1097/NEN.0b013e31818e5e99; Wang Y, 2014, INT J CLIN EXP PATHO, V7, P194	35	45	47	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140566	10.1371/journal.pone.0140566	http://dx.doi.org/10.1371/journal.pone.0140566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469270	Green Submitted, gold, Green Published			2022-12-26	WOS:000363184600077
J	Adetifa, IMO; Muhammad, AK; Jeffries, D; Donkor, S; Borgdorff, MW; Corrah, T; D'Alessandro, U				Adetifa, Ifedayo M. O.; Muhammad, Abdul Khalie; Jeffries, David; Donkor, Simon; Borgdorff, Martien W.; Corrah, Tumani; D'Alessandro, Umberto			A Tuberculin Skin Test Survey and the Annual Risk of Mycobacterium tuberculosis Infection in Gambian School Children	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; METHODOLOGICAL ISSUES; PREVALENCE; SENSITIVITY; GUIDELINES; DIAGNOSIS	Background A Tuberculin skin test (TST) survey was conducted to assess the prevalence of latent TB Infection (LTBI) and to estimate the annual risk of M. tuberculosis infection (ARTI) in Gambian school children. The results are expected to contribute to understanding of Tuberculosis epidemiology in The Gambia. Methods This was a nationwide, multi-cluster survey in children aged 6-11 years. Districts, 20 of 37, were selected by probability proportional to size and schools by simple random sampling. All TST were performed using the Mantoux method. Height and weight measurements were obtained for all participants. We calculated prevalence of LTBI using cut-off points of 10mm, the mirror and mixture modelling methods. Results TST readings were completed 13,386 children with median age of 9 years (interquartile range [IQR] 8-10 years). Mixture analysis yielded a cut-off point of 12 mm, and LTBI prevalence of 6.9% [95% CI 6.47-7.37] and the ARTI was 0.75%[95% CI 0.60-0.91]. LTBI was associated gender and urban residence (p < 0.01). Nutritional status was not associated with non-reactive TST or sizes of TST indurations. ARTI did not differ significantly by age, gender, BCG vaccination or residence. Conclusions This estimates for LTBI prevalence and ARTI were low but this survey provides updated data. Malnutrition did not affect estimates of LTBI and ARTI. Given the low ARTI in this survey and the overlapping distribution of indurations with mixture modelling, further surveys may require complementary tests such as interferon gamma release assays or novel diagnostic tools.	[Adetifa, Ifedayo M. O.; Muhammad, Abdul Khalie; Jeffries, David; Donkor, Simon; Corrah, Tumani; D'Alessandro, Umberto] Med Res Council Unit Gambia, Dis Control & Eliminat Theme, Banjul, Gambia; [Borgdorff, Martien W.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	University of London; London School of Hygiene & Tropical Medicine; University of Amsterdam; Academic Medical Center Amsterdam	Adetifa, IMO (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Ifedayo.Adetifa@lshtm.ac.uk		, Abdul Khalie/0000-0003-0040-2416	Global Fund to fight against AIDS, Tuberculosis and Malaria through grant GMD-T-MRC; Medical Research Council Unit-The Gambia; Medical Research Council [MC_UP_A900_1119] Funding Source: researchfish; MRC [MC_UP_A900_1119] Funding Source: UKRI	Global Fund to fight against AIDS, Tuberculosis and Malaria through grant GMD-T-MRC; Medical Research Council Unit-The Gambia; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by Global Fund to fight against AIDS, Tuberculosis and Malaria through grant GMD-T-MRC, and the Medical Research Council Unit-The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo KK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-35; Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; Adetifa IMO, 2010, PEDIATR INFECT DIS J, V29, P439, DOI 10.1097/INF.0b013e3181cb45da; [Anonymous], 1955, Bull World Health Organ, V12, P169; [Anonymous], 2014 HUM DEV REP; Arnadottir T, 1996, TUBERCLE LUNG DIS, V77, P1, DOI 10.1016/S0962-8479(96)90127-6; Arnadottir T, 2001, INT J TUBERC LUNG D, V5, P391; Bleiker MA, 1976, SKIN SENSITIVITY HUM; Chadha VK, 2000, IND J TUB, V47; Corrah PT, 1994, STUDIES TUBERCULOSIS; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Egwaga SA, 2006, AIDS, V20, P915, DOI 10.1097/01.aids.0000218557.44284.83; Eilers RHC, 2004, INT J TUBERC LUNG D, V8, P232; ELLIOTT A, 1985, ANN TROP PAEDIATR, V5, P185, DOI 10.1080/02724936.1985.11748389; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; Floyd S, 2000, INT J TUBERC LUNG D, V4, P1133; Gambia Bureau of Statistics [GBoS], 2014, GAMB 2013 POP HOUS C; Gninafon M, 2011, INT J TUBERC LUNG D, V15, P61; Hossain S, 2013, INT J TUBERC LUNG D, V17, P1267, DOI 10.5588/ijtld.13.0114; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Kritzinger FE, 2009, TROP MED INT HEALTH, V14, P136, DOI 10.1111/j.1365-3156.2008.02213.x; Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC; Minime-Lingoupou F, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1829-8; National Leprosy and Tuberculosis Control Programme Ministry of Health and Social Welfare, 2007, NAT GUID MAN TUB 200; Rieder HL, 2011, INT J TUBERC LUNG D, V15, P662, DOI 10.5588/ijtld.10.0433; Rieder HL, 2011, INT J TUBERC LUNG D, V15, pS1; RIEDER HL, 1995, TUBERCLE LUNG DIS, V76, P114, DOI 10.1016/0962-8479(95)90552-9; ROELSGAARD E., 1964, BULL WORLD HEALTH ORGAN, V30, P459; Royston P., 1991, STATA TECHNICAL B, V3, P23; Styblo K, 2001, INT J TUBERC LUNG D, V5, P103; UNAIDS, 2013, GAMB HIV AIDS EST; Wangchuk LZ, 2013, INT J TUBERC LUNG D, V17, P468, DOI 10.5588/ijtld.12.0668; WHO World Health Organization, IMM SUMM; World Health Organization, GROWTH REF 5 19 YEAR; World Health Organization, 2007, ASS TB PREV POP BAS	36	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139354	10.1371/journal.pone.0139354	http://dx.doi.org/10.1371/journal.pone.0139354			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465745	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000363183100046
J	Azlina, MFN; Kamisah, Y; Chua, KH; Ibrahim, IAA; Qodriyah, HMS				Azlina, Mohd Fahami Nur; Kamisah, Yusof; Chua, Kien Hui; Ibrahim, Ibrahim Abdel Aziz; Qodriyah, Hj Mohd Saad			Preventive Effects of Tocotrienol on Stress-Induced Gastric Mucosal Lesions and Its Relation to Oxidative and Inflammatory Biomarkers	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOGENOUS PROSTAGLANDINS; LIPID-PEROXIDATION; ULCER RECURRENCE; SENSORY NERVES; RAT MODEL; INDOMETHACIN; ANTIOXIDANT; DAMAGE; ASPIRIN	This study aimed to investigate the possible gastroprotective effect of tocotrienol against water-immersion restraint stress (WIRS) induced gastric ulcers in rats by measuring its effect on gastric mucosal nitric oxide (NO), oxidative stress, and inflammatory biomarkers. Twenty-eight male Wistar rats were randomly assigned to four groups of seven rats. The two control groups were administered vitamin-free palm oil (vehicle) and the two treatment groups were given omeprazole (20 mg/kg) or tocotrienol (60 mg/kg) orally. After 28 days, rats from one control group and both treated groups were subjected to WIRS for 3.5 hours once. Malondialdehyde (MDA), NO content, and superoxide dismutase (SOD) activity were assayed in gastric tissue homogenates. Gastric tissue SOD, iNOS, TNF-alpha and IL1-beta expression were measured. WIRS increased the gastric MDA, NO, and pro-inflammatory cytokines levels significantly when compared to the non-stressed control group. Administration of tocotrienol and omeprazole displayed significant protection against gastric ulcers induced by exposure to WIRS by correction of both ulcer score and MDA content. Tissue content of TNF-alpha and SOD activity were markedly reduced by the treatment with tocotrienol but not omeprazole. Tocotrienol significantly corrected nitrite to near normal levels and attenuated iNOS gene expression, which was upregulated in this ulcer model. In conclusion, oral supplementation with tocotrienol provides a gastroprotective effect in WIRS-induced ulcers. Gastroprotection is mediated through 1) free radical scavenging activity, 2) the increase in gastric mucosal antioxidant enzyme activity, 3) normalisation of gastric mucosal NO through reduction of iNOS expression, and 4) attenuation of inflammatory cytokines. In comparison to omeprazole, it exerts similar effectiveness but has a more diverse mechanism of protection, particularly through its effect on NO, SOD activity, and TNF-alpha.	[Azlina, Mohd Fahami Nur; Kamisah, Yusof; Qodriyah, Hj Mohd Saad] Univ Kebangsaan Malaysia, Dept Pharmacol, Fac Med, Kuala Lumpur, Malaysia; [Chua, Kien Hui] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia; [Ibrahim, Ibrahim Abdel Aziz] Umm Qura Univ, Coll Med, Mecca, Saudi Arabia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Umm Al Qura University	Azlina, MFN (corresponding author), Univ Kebangsaan Malaysia, Dept Pharmacol, Fac Med, Kuala Lumpur, Malaysia.	nazlina@medic.ukm.my	chua, kienhui kh/M-7245-2017; Kamisah, Yusof/D-8054-2012; Ibrahim, Ibrahim Abdel Aziz/AAE-4458-2022	Kamisah, Yusof/0000-0002-9363-8235; Ibrahim, Ibrahim Abdel Aziz/0000-0001-5757-8653; Kien Hui, Chua/0000-0002-2595-5087; Nur Azlina, Mohd Fahami/0000-0002-3458-0440	Universiti Kebangsaan Malaysia [UKM-DLP-066-2011, FF-032-2012]	Universiti Kebangsaan Malaysia	The study was funded by a grant from Universiti Kebangsaan Malaysia (Grant No. UKM-DLP-066-2011, FF-032-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Azlina MFN, 2009, INT J PHARMACOL, V5, P58, DOI 10.3923/ijp.2009.58.64; Azlina MFN, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/804796; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; Bregonzio C, 2003, AM J PHYSIOL-GASTR L, V285, pG414, DOI 10.1152/ajpgi.00058.2003; Brzozowska I, 2004, J PHYSIOL PHARMACOL, V55, P773; Brzozowski T, 2008, J PHYSIOL PHARMACOL, V59, P89; Brzozowski T, 2008, REGUL PEPTIDES, V148, P6, DOI 10.1016/j.regpep.2008.02.003; Dalia M, 2011, J AM SCI, V7, P760; Derin N, 2004, J PHYSIOL PHARMACOL, V55, P595; El-Moselhy M, 2009, APPL BIOCHEM BIOTECH, V152, P449, DOI 10.1007/s12010-008-8384-z; Fahami NAM, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-54; Guha P, 2010, BRIT J PHARMACOL, V159, P726, DOI 10.1111/j.1476-5381.2009.00572.x; Hajiani M, 2012, REDOX REP, V17, P101, DOI 10.1179/1351000212Y.0000000008; Ibrahim IAA, 2012, ARCH MED SCI, V8, P22, DOI 10.5114/aoms.2012.27276; Ibrahim IAA, 2011, INT MED J, V18, P47; Kamisah Y., 2011, Journal of Applied Pharmaceutical Science, V1, P118; Kato S, 2009, J PHYSIOL PHARMACOL, V60, P147; Konturek PC, 2008, J PHYSIOL PHARMACOL, V59, P53; Konturek PC, 2001, J PHYSIOLOGY-PARIS, V95, P361, DOI 10.1016/S0928-4257(01)00049-3; KONTUREK SK, 1995, DIGESTION, V56, P1, DOI 10.1159/000201214; Konturek SJ, 2008, J PINEAL RES, V44, P408, DOI 10.1111/j.1600-079X.2007.00543.x; Kwiecien S, 2008, J PHYSIOL PHARMACOL, V59, P103; Kwiecien S, 2004, J PHYSIOL PHARMACOL, V55, P337; Kwiecien S, 2012, J PHYSIOL PHARMACOL, V63, P515; Kwiecien S, 2012, J PHYSIOL PHARMACOL, V63, P143; Kwiecien S, 2003, J PHYSIOL PHARMACOL, V54, P423; Kwiecien S, 2002, J PHYSIOL PHARMACOL, V53, P39; Lanas A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2465; LEDWOZYW A, 1986, CLIN CHIM ACTA, V155, P275, DOI 10.1016/0009-8981(86)90247-0; Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902; Magierowski M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118972; Nakamura T, 2014, EVID-BASED COMPL ALT, V2014, P10, DOI [10.1155/2014/383482Nakamura2014, DOI 10.1155/2014/383482NAKAMURA2014]; Nur Azlina MF, 2005, NUTR FOOD SCI, V35, P403; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rodzian MNS, 2013, POL J PATHOL, V64, P52, DOI 10.5114/PJP.2013.34604; SERBINOVA EA, 1994, METHOD ENZYMOL, V234, P354; Takeuchi K, 1999, J PHYSIOLOGY-PARIS, V93, P423, DOI 10.1016/S0928-4257(99)00125-4; Tan P. V., 2013, ULCERS, V2013; Tariq M, 2007, J GASTROEN HEPATOL, V22, P2316, DOI 10.1111/j.1440-1746.2007.05021.x; Wang YB, 2011, WORLD J GASTROENTERO, V17, P657, DOI 10.3748/wjg.v17.i5.657; Watanabe T, 1997, AM J PATHOL, V150, P971; Watanabe T, 2001, GUT, V48, P774, DOI 10.1136/gut.48.6.774; Wilankar C, 2011, FREE RADICAL BIO MED, V51, P129, DOI 10.1016/j.freeradbiomed.2011.03.038; Zhang AG, 2005, J BIOMOL SCREEN, V10, P549, DOI 10.1177/1087057105277414	45	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139348	10.1371/journal.pone.0139348	http://dx.doi.org/10.1371/journal.pone.0139348			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465592	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100045
J	Bertola, LD; Tensen, L; van Hooft, P; White, PA; Driscoll, CA; Henschel, P; Caragiulo, A; Dias-Freedman, I; Sogbohossou, EA; Tumenta, PN; Jirmo, TH; de Snoo, GR; de Iongh, HH; Vrieling, K				Bertola, Laura D.; Tensen, Laura; van Hooft, Pim; White, Paula A.; Driscoll, Carlos A.; Henschel, Philipp; Caragiulo, Anthony; Dias-Freedman, Isabela; Sogbohossou, Etotepe A.; Tumenta, Pricelia N.; Jirmo, Tuqa H.; de Snoo, Geert R.; de Iongh, Hans H.; Vrieling, Klaas			Autosomal and mtDNA Markers Affirm the Distinctiveness of Lions in West and Central Africa	PLOS ONE			English	Article							PANTHERA-LEO; MITOCHONDRIAL-DNA; POPULATION-GENETICS; PHYLOGENETIC TREES; COMPUTER-PROGRAM; CONSERVATION; DIVERSITY; PHYLOGEOGRAPHY; EVOLUTIONARY; SOFTWARE	The evolutionary history of a species is key for understanding the taxonomy and for the design of effective management strategies for species conservation. The knowledge about the phylogenetic position of the lion (Panthera leo) in West/Central Africa is largely based on mitochondrial markers. Previous studies using mtDNA only have shown this region to hold a distinct evolutionary lineage. In addition, anthropogenic factors have led to a strong decline in West/Central African lion numbers, thus, the conservation value of these populations is particularly high. Here, we investigate whether autosomal markers are concordant with previously described phylogeographic patterns, and confirm the unique position of the West/Central African lion. Analysis of 20 microsatellites and 1,454 bp of the mitochondrial DNA in 16 lion populations representing the entire geographic range of the species found congruence in both types of markers, identifying four clusters: 1) West/Central Africa, 2) East Africa, 3) Southern Africa and 4) India. This is not in line with the current taxonomy, as defined by the IUCN, which only recognizes an African and an Asiatic subspecies. There are no indications that genetic diversity in West/Central Africa lions is lower than in either East or Southern Africa, however, given this genetic distinction and the recent declines of lion numbers in this region, we strongly recommend prioritization of conservation projects in West/Central Africa. As the current taxonomic nomenclature does not reflect the evolutionary history of the lion, we suggest that a taxonomic revision of the lion is warranted.	[Bertola, Laura D.; Sogbohossou, Etotepe A.; Tumenta, Pricelia N.; Jirmo, Tuqa H.; de Snoo, Geert R.; de Iongh, Hans H.] Leiden Univ, Inst Environm Sci CML, NL-2300 RA Leiden, Netherlands; [Bertola, Laura D.; Vrieling, Klaas] Leiden Univ, IBL, NL-2300 RA Leiden, Netherlands; [Tensen, Laura] Univ Johannesburg, Dept Zool, Johannesburg, South Africa; [van Hooft, Pim] Wageningen Univ, Resource Ecol Grp, NL-6708 PB Wageningen, Netherlands; [White, Paula A.] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA 90095 USA; [Driscoll, Carlos A.] Wildlife Inst India, Dehra Dun 248001, Uttarakhand, India; [Henschel, Philipp] Panthera, New York, NY 10018 USA; [Caragiulo, Anthony; Dias-Freedman, Isabela] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Sogbohossou, Etotepe A.] Univ dAbomey Calavi, Lab Ecol Appl, Cotonou, Benin; [Tumenta, Pricelia N.] Univ Dschang, Ctr Environm & Dev Studies Cameroon, Maroua, Cameroon; [de Iongh, Hans H.] Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Johannesburg; Wageningen University & Research; University of California System; University of California Los Angeles; Wildlife Institute of India; American Museum of Natural History (AMNH); University of Abomey Calavi; University of Antwerp	Bertola, LD (corresponding author), Leiden Univ, Inst Environm Sci CML, POB 9518, NL-2300 RA Leiden, Netherlands.	bertola@cml.leidenuniv.nl	SOGBOHOSSOU, Etotepe A/HDL-8938-2022; Bertola, Laura/U-5299-2019	Bertola, Laura/0000-0002-3445-0355; Caragiulo, Anthony/0000-0002-4629-7896; Driscoll, Carlos/0000-0003-2392-505X; Tensen, Laura/0000-0001-9333-4955; Dias-Freedman, Isabela/0000-0002-1924-5097	Division for Earth and Life Sciences (ALW); Netherlands Organization for Scientific Research (NWO) [820.01.002]	Division for Earth and Life Sciences (ALW); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The investigations were supported by the Division for Earth and Life Sciences (ALW) with financial aid from the Netherlands Organization for Scientific Research (NWO) (project no. 820.01.002).	Alpers DL, 2004, MOL ECOL, V13, P1771, DOI 10.1111/j.1365-294X.2004.02204.x; Antunes A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000251; Arctander P, 1999, MOL BIOL EVOL, V16, P1724, DOI 10.1093/oxfordjournals.molbev.a026085; Barnett R, 2006, P ROY SOC B-BIOL SCI, V273, P2119, DOI 10.1098/rspb.2006.3555; Barnett R, 2006, CONSERV GENET, V7, P507, DOI 10.1007/s10592-005-9062-0; Barnett R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-70; Bertola LD, 2011, J BIOGEOGR, V38, P1356, DOI 10.1111/j.1365-2699.2011.02500.x; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Bruche S, 2012, EUROPEAN J WILDLIFE, V59, P215; Burger J, 2004, MOL PHYLOGENET EVOL, V30, P841, DOI 10.1016/j.ympev.2003.07.020; Charruau P, 2011, MOL ECOL, V15, P367; Cornuet JM, 1996, GENETICS, V144, P2001; de Iongh Hans, 2009, Cat News, V50, P26; Debruyne R, 2005, CLADISTICS, V21, P31, DOI 10.1111/j.1096-0031.2004.00044.x; Driscoll CA, 2002, GENOME RES, V12, P414, DOI 10.1101/gr.185702; Dubach J, 2005, CONSERV GENET, V6, P15, DOI 10.1007/s10592-004-7729-6; Dubach JM, 2013, CONSERV GENET, V14, P741, DOI 10.1007/s10592-013-0453-3; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flagstad O, 2001, P ROY SOC B-BIOL SCI, V268, P667, DOI 10.1098/rspb.2000.1416; Freeman AR, 2001, HEREDITY, V86, P355, DOI 10.1046/j.1365-2540.2001.00840.x; Goudet J, 2001, FSTAT PROGRAM ESTIMA, P215; Haas Sarah K., 2005, Mammalian Species, P1; Hassanin A, 2007, CR BIOL, V330, P265, DOI 10.1016/j.crvi.2007.02.008; Hemmer H., 1974, UNTERSUCHUNGEN STAMM; IUCN SSC Cat Specialist Group, 2006, CONS STRAT LION W CE; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2002, MOL ECOL, V11, P1263, DOI 10.1046/j.1365-294X.2002.01520.x; Mazak JH, 2010, J ZOOL, V281, P194, DOI 10.1111/j.1469-7998.2010.00694.x; Miller SM, 2013, S AFR J WILDL RES, V43, P138, DOI 10.3957/056.043.0202; NEI M, 1978, GENETICS, V89, P583; OBRIEN SJ, 1987, NATL GEOGR RES, V3, P114; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pinho C, 2007, BIOL J LINN SOC, V91, P121, DOI 10.1111/j.1095-8312.2007.00774.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pitra C, 2002, MOL ECOL, V11, P1197, DOI 10.1046/j.1365-294X.2002.01516.x; Pritchard JK, 2000, GENETICS, V155, P945; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; Rato C, 2010, MOL PHYLOGENET EVOL, V56, P962, DOI 10.1016/j.ympev.2010.04.033; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Roca AL, 2007, QUATERN INT, V169, P4, DOI 10.1016/j.quaint.2006.08.008; Singh HS, 2011, BIOL CONSERV, V144, P1753, DOI 10.1016/j.biocon.2011.02.009; Smitz N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056235; Sota T, 2001, SYST BIOL, V50, P39, DOI 10.1080/713849547; Spong G, 2002, J EVOLUTION BIOL, V15, P945, DOI 10.1046/j.1420-9101.2002.00473.x; Takezaki N, 1996, GENETICS, V144, P389; Takezaki N, 2008, GENETICS, V178, P385, DOI 10.1534/genetics.107.081505; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tefera M, 2003, BIODIVERS CONSERV, V12, P1629, DOI 10.1023/A:1023641629538; Trinkel M, 2010, ANIM CONSERV, V13, P374, DOI 10.1111/j.1469-1795.2009.00344.x; Van Hooft WF, 2002, MOL ECOL, V11, P267, DOI 10.1046/j.1365-294X.2002.01429.x; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	55	21	21	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0137975	10.1371/journal.pone.0137975	http://dx.doi.org/10.1371/journal.pone.0137975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466139	Green Published, gold			2022-12-26	WOS:000363183100008
J	Esteves, CF; Costa, JM; Vargas, P; Freitas, H; Heleno, RH				Esteves, Carolina Franco; Costa, Jose Miguel; Vargas, Pablo; Freitas, Helena; Heleno, Ruben Huttel			On the Limited Potential of Azorean Fleshy Fruits for Oceanic Dispersal	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; SEED DISPERSAL; BIOGEOGRAPHY; MECHANISMS; EVOLUTION; ATLANTIC; PATTERNS; PLANTS	How plants arrived to originally sterile oceanic islands has puzzled naturalists for centuries. Dispersal syndromes (i.e., diaspore traits that promote dispersal by long-distance dispersal vectors), are generally considered to play a determinant role in assisting island colonization. However, the association between diaspore traits and the potential vectors by which diaspores are dispersed is not always obvious. Fleshy fruits, in particular, are considered to have evolved to promote the internal dispersal of seeds by frugivores (endozoochory), however some fleshy fruits can also float in saltwater, and thus be potentially transported by oceanic current (thalassochory). We performed saltwater floatation and viability experiments with fruits of the 14 European fleshy-fruited species that naturally colonized the Azores archipelago (North Atlantic Ocean). We show that only Corema album (a berry) and Juniperus oxycedrus (a fleshy cone) floated for as long as 60 days, the estimated minimum time needed to reach the Azores by oceanic currents. Regardless the floatation potential, exposure to saltwater largely reduced the viability of most seeds of the 14 species (46% of viability decline within 15 days and 77% within 60 days of immersion), including those of Corema album (61%) and Juniperus oxycedrus (83%). Floatability and viability trials suggest that while some fleshy-fruited species might have arrived to the Azores by oceanic currents, such would have required extreme meteorological events that could largely reduce the duration of the trip. Thus, the alternative hypothesis that fleshy-fruited species were mostly dependent on animal dispersers (endozoochory) to colonize these remote islands is reinforced.	[Esteves, Carolina Franco; Costa, Jose Miguel; Freitas, Helena; Heleno, Ruben Huttel] Univ Coimbra, Dept Life Sci, Ctr Funct Ecol, Coimbra, Portugal; [Vargas, Pablo] Real Jardin Bot Madrid CSIC RJB, Madrid, Spain	Universidade de Coimbra; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Heleno, RH (corresponding author), Univ Coimbra, Dept Life Sci, Ctr Funct Ecol, Coimbra, Portugal.	rheleno@uc.pt	Heleno, Ruben Huttel/A-5778-2011; Freitas, Helena/A-2803-2010; Freitas, Helena/ABE-6998-2020	Heleno, Ruben Huttel/0000-0002-4808-4907; Freitas, Helena/0000-0002-1907-9615; Franco Esteves, Carolina/0000-0003-4564-4101; Costa, Jose/0000-0002-4991-7122	Fundacao para a Ciencia e a Tecnologia [IF/00441/2013, SFRH/BD/96292/2013]; Marie Curie Career Integration Grant [FP7-PEOPLE-2012-CIG-321794]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Marie Curie Career Integration Grant	RHH was funded by Fundacao para a Ciencia e a Tecnologia (IF/00441/2013)-http://www.fct.pt/ and a Marie Curie Career Integration Grant (FP7-PEOPLE-2012-CIG-321794)-http://ec.europa.eu/research/mariecurieactions/index_en.htm. JMC was funded by Fundacao para a Ciencia e a Tecnologia (SFRH/BD/96292/2013)-http://www.fct.pt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfrey P., 2010, DUTCH BIRDING, V32, P299; Assing V, 2010, LIST TERRESTRIAL MAR; Calvino-Cancela M, 2011, PLANT ECOL, V212, P1149, DOI 10.1007/s11258-011-9894-2; CARLQUIST S, 1967, B TORREY BOT CLUB, V94, P129, DOI 10.2307/2484044; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; Carlquist S, 2009, BOT J LINN SOC, V161, P20, DOI 10.1111/j.1095-8339.2009.00990.x; Costa JM, 2014, J AVIAN BIOL, V45, P59, DOI 10.1111/j.1600-048X.2013.00271.x; Cowie RH, 2006, J BIOGEOGR, V33, P193, DOI 10.1111/j.1365-2699.2005.01383.x; CROWLEY TJ, 1981, MAR MICROPALEONTOL, V6, P97, DOI 10.1016/0377-8398(81)90001-3; Darwin C., 1856, J P LINNEAN SOC LOND, V1, P130; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; Fernandez-Palacios JM, 2015, FRONTIERS BIOGEOGRAP, V7; Fraser CI, 2011, P ROY SOC B-BIOL SCI, V278, P649, DOI 10.1098/rspb.2010.1117; Fridriksson S., 1975, SURTSEY EVOLUTION LI; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Gordinho L, 2009, BIRDING, V41, P38; Guja L, 2013, BOT J LINN SOC, V173, P129, DOI 10.1111/boj.12072; Guppy HB., 1906, OBSERVATIONS NATURAL; Guppy HB, 1917, PLANTS SEEDS CURRENT; HACKER JB, 1990, J BIOGEOGR, V17, P19, DOI 10.2307/2845184; Heleno R, 2015, GLOBAL ECOL BIOGEOGR, V24, P518, DOI 10.1111/geb.12273; Heleno RH, 2013, BIOL INVASIONS, V15, P1143, DOI 10.1007/s10530-012-0357-z; Heleno RH, 2011, IBIS, V153, P199, DOI 10.1111/j.1474-919X.2010.01088.x; Parejo SH, 2014, EUR J FOREST RES, V133, P383, DOI 10.1007/s10342-013-0769-z; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Jordan GJ, 2001, AUST J BOT, V49, P333, DOI 10.1071/BT00024; Fernandez-Palacios JM, 2011, J BIOGEOGR, V38, P226, DOI 10.1111/j.1365-2699.2010.02427.x; Marrero P, 2007, CHEMOECOLOGY, V17, P47, DOI 10.1007/s00049-006-0360-x; Martins CS, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000345; Meireles RP, 2013, SEDIMENTOLOGY, V60, P1769, DOI 10.1111/sed.12055; Murdoch AJ, 2014, SEEDS: THE ECOLOGY OF REGENERATION IN PLANT COMMUNITIES, 3RD EDITION, P151, DOI 10.1079/9781780641836.0151; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Nogales M, 2012, NEW PHYTOL, V194, P313, DOI 10.1111/j.1469-8137.2011.04051.x; PORTER RH, 1947, PLANT PHYSIOL, V22, P149, DOI 10.1104/pp.22.2.149; Qi ZC, 2013, BOT J LINN SOC, V173, P535, DOI 10.1111/boj.12096; R Development Core Team, 2014, R LANG ENV STAT COMP; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Rumeu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027697; Schaefer H, 2009, MONOGRAFIAS I ESTUDI, V78, P297; Schaefer H, 2011, ECOL LETT, V14, P389, DOI 10.1111/j.1461-0248.2011.01600.x; Schafer H, 2003, WILLDENOWIA, V33, P481; Silva L, 2004, BIOL INVASIONS, V6, P193, DOI 10.1023/B:BINV.0000022138.75673.8c; SORENSEN AE, 1986, ANNU REV ECOL SYST, V17, P443, DOI 10.1146/annurev.es.17.110186.002303; Thiel M, 2006, OCEANOGR MAR BIOL, V44, P323, DOI 10.1201/9781420006391.ch7; Traveset A, 1998, ECOL EVOL SYST, V1, P151, DOI DOI 10.1078/1433-8319-00057; Traveset A, 2014, SEEDS: THE ECOLOGY OF REGENERATION IN PLANT COMMUNITIES, 3RD EDITION, P62, DOI 10.1079/9781780641836.0062; TUTIN TG, 1953, J ECOL, V41, P53, DOI 10.2307/2257099; Tutin TG, 1964, FLORA EUROPAEA, V1-5; Van der Pijl L, 1982, PRINCIPLES DISPERSAL, V214; Vargas P, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv073; Vargas P, 2014, BOT J LINN SOC, V174, P349, DOI 10.1111/boj.12142; Vazacova K, 2014, FLORA, V209, P530, DOI 10.1016/j.flora.2014.05.001; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY	55	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138882	10.1371/journal.pone.0138882	http://dx.doi.org/10.1371/journal.pone.0138882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465934	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100031
J	Hogarth, LW; Burkett, BJ; McKean, MR				Hogarth, Luke W.; Burkett, Brendan J.; McKean, Mark R.			Influence of Yo-Yo IR2 Scores on Internal and External Workloads and Fatigue Responses of Tag Football Players during Tournament Competition	PLOS ONE			English	Article							RUGBY LEAGUE PLAYERS; SOCCER PLAYERS; PERCEIVED EXERTION; TRAINING LOAD; HEART-RATE; MATCH; RECOVERY; POSITION; SPORTS; RELIABILITY	The purpose of this study was to: a) identify changes in jump height and perceived wellbeing as indirect markers of fatigue, b) determine the internal and external workloads performed by players, and c) examine the influence of Yo-Yo IR2 on changes in jump height, perceived well-being and internal and external workloads during a tag football tournament. Microtechnology devices combined with heart rate (HR) chest straps provided external and internal measures of match work-rate and workload for twelve male tag football players during the 2014 Australian National Championships. Jump height and perceived well-being were assessed prior to and during the tournament as indirect measures of fatigue. Changes in work-rate, workload and fatigue measures between high- and low-fitness groups were examined based on players' Yo-Yo IR2 score using a median split technique. The low- and high-fitness groups reported similar mean HR, Playerload (TM)/min, and distance/min for matches, however the low-fitness group reported higher perceived match-intensities (ES = 0.90-1.35) for several matches. Further, the high-fitness group reported higher measures of tournament workload, including distance (ES = 0.71), Playerload (TM) (ES = 0.85) and Edwards' training impulse (TRIMP) (ES = 1.23) than the low-fitness group. High- and low-fitness groups both showed large decreases (ES = 1.46-1.49) in perceived well-being during the tournament, although jump height did not decrease below pre-tournament values. Increased Yo-Yo IR2 appears to offer a protective effect against player fatigue despite increased workloads during a tag football tournament. It is vital that training programs adequately prepare tag football players for tournament competition to maximise performance and minimise player fatigue.	[Hogarth, Luke W.; Burkett, Brendan J.; McKean, Mark R.] Univ Sunshine Coast, Sch Hlth & Sport Sci, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia	University of the Sunshine Coast	Hogarth, LW (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia.	luke.hogarth@research.usc.edu.au	Hogarth, Luke/L-4975-2016	Hogarth, Luke/0000-0001-7085-4501; Burkett, Brendan/0000-0002-1974-673X	Queensland Oztag; University of the Sunshine Coast [1.043.05662]	Queensland Oztag; University of the Sunshine Coast	This study was conducted as part of a PhD research project funded by Queensland Oztag (www.queenslandoztag.com.au). Further, this study was supported by a research grant from the University of the Sunshine Coast (1.043.05662). The funding organisations had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou H, 2008, INTJ SPORT PHYSIOL, V3, P320, DOI 10.1123/ijspp.3.3.320; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Barrett S, 2014, INT J SPORT PHYSIOL, V9, P945, DOI 10.1123/ijspp.2013-0418; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Boyd LJ, 2011, INT J SPORT PHYSIOL, V6, P311, DOI 10.1123/ijspp.6.3.311; Charlot K, 2015, J SPORTS SC IN PRESS; Clarke AC, 2015, INT J SPORT IN PRESS; Cormack SJ, 2008, INTJ SPORT PHYSIOL, V3, P359, DOI 10.1123/ijspp.3.3.359; Cummins C, 2013, SPORTS MED, V43, P1025, DOI 10.1007/s40279-013-0069-2; Fanchini M, 2015, INT J SPORT PHYSIOL, V10, P426, DOI 10.1123/ijspp.2014-0244; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Gabbett TJ, 2014, INT J SPORT PHYSIOL, V9, P680, DOI [10.1123/IJSPP.2013-0253, 10.1123/ijspp.2013-0253]; Gabbett TJ, 2013, J STRENGTH COND RES, V27, P1629, DOI 10.1519/JSC.0b013e318274f30e; Halson SL, 2014, SPORTS MED, V44, pS139, DOI 10.1007/s40279-014-0253-z; Hogarth LW, 2015, INT J PERF ANAL SPOR, V15, P147; Hogarth LW, 2015, INT J PERF ANAL SPOR, V15, P203; Hogarth LW, 2015, INT J SPORT PHYSIOL, V10, P559, DOI 10.1123/ijspp.2014-0355; Hogarth LW, 2014, INT J PERF ANAL SPOR, V14, P367; Hogarth LW, 2015, J SPORTS MED DOPING, V5; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Johnston RD, 2015, SPORTS MED OPEN, V1, P1, DOI DOI 10.1186/S40798-015-0015-Y; Johnston RD, 2015, PUBMED, V18, P209, DOI [10.1016/j.jsams.2014.01.009, DOI 10.1016/J.JSAMS.2014.01.009]; Johnston RD, 2013, J SCI MED SPORT, V16, P460, DOI 10.1016/j.jsams.2012.10.009; Johnston RD, 2013, J STRENGTH COND RES, V27, P643, DOI 10.1519/JSC.0b013e31825bb469; Krustrup P, 2010, J STRENGTH COND RES, V24, P437, DOI 10.1519/JSC.0b013e3181c09b79; Martin DT, 2000, J SPORT MED PHYS FIT, V40, P201; Matthew D, 2009, J SPORT SCI, V27, P813, DOI 10.1080/02640410902926420; McLean BD, 2010, INT J SPORT PHYSIOL, V5, P367, DOI 10.1123/ijspp.5.3.367; McLellan CP, 2011, J STRENGTH COND RES, V25, P1030, DOI 10.1519/JSC.0b013e3181cc22cc; Ronglan LT, 2006, SCAND J MED SCI SPOR, V16, P267, DOI 10.1111/j.1600-0838.2005.00474.x; Scott BR, 2013, INT J SPORT PHYSIOL, V8, P195, DOI 10.1123/ijspp.8.2.195; Smith MR, 2015, MED SCI SPORT EXER, V47, P1682, DOI 10.1249/MSS.0000000000000592; Twist C, 2013, INT J SPORT PHYSIOL, V8, P467, DOI 10.1123/ijspp.8.5.467; Twist C, 2012, J SPORT SCI, V30, P359, DOI 10.1080/02640414.2011.640707; West DJ, 2014, J SCI MED SPORT, V17, P688, DOI 10.1016/j.jsams.2013.11.003	35	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140547	10.1371/journal.pone.0140547	http://dx.doi.org/10.1371/journal.pone.0140547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465599	Green Published, gold			2022-12-26	WOS:000363183100141
J	Kawada, R; Lanes, GO; Azevedo, CO				Kawada, Ricardo; Lanes, Geane O.; Azevedo, Celso O.			Evolution of Metapostnotum in Flat Wasps (Hymenoptera, Bethylidae): Implications for Homology Assessments in Chrysidoidea	PLOS ONE			English	Article							PHYLOGENETIC SIGNIFICANCE; ANATOMY; WAIST	Some authors in the past based their conclusions about the limits of the metapostnotum of Chrysidoidea based on the position of the mesophragmo-metaphragmal muscle, rather than aspects of the skeleton and musculature associated with the metapectal-propodeal complex. The latter character system suggests another interpretation of the metapostnotum delimitation. Given this scenario, the main goal of this work is to present a new perspective on the metapostnotum in Chrysidoidea, especially Bethylidae, helping to resolve questions related to the evolution of the metapostnotum. This is based on homologies established by associating of insertion points of ph2-ph3 and ph3-T2 muscles with the delimitation of the respective sclerite the muscles insert into. Our results indicate that, according the position of the metaphragmal muscles, the metapostnotum in Bethylidae is medially expanded in the propodeal disc and has different forms of configuration. Internally, the limits of the metapostnotum can be tracked by the shape of the mesopostnotum, and vice versa. Thus, the anteromedian area of the propodeal disc sensu Evans was reinterpreted in the current study as the metapostnotum. In conjunction with associated structures, we provide evidence to clarify the relationships between the families within Chrysidoidea, although certain families like Embolemidae, Dryinidae and Chrysididae exhibit extreme modifications of the condition found in Aculeata, as observed in Bethylidae. We review the terminology used to describe anatomical features on the metapectal-propodeal complex in Bethylidae in general, and provide a list of recommended terms in accordance with the online Hymenoptera Anatomy Ontology. The morphology of the studied subfamilies are illustrated. Studies that focus on a single structure, across a larger number of taxa, are more insightful and present specific questions that can contribute to broader issues, thus providing a better understanding of the morphology and evolution of insects.	[Kawada, Ricardo; Lanes, Geane O.; Azevedo, Celso O.] Univ Fed Espirito Santo, Dept Ciencias Biol, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo	Kawada, R (corresponding author), Fundacao Univ Fed Grande Dourados, Dept Ciencias Biol & Ambientais, Dourados, MS, Brazil.	hyme.neo@gmail.com	Lanes, Geane/E-4629-2017; Azevedo, Celso O/D-1295-2014	Lanes, Geane/0000-0001-7679-5047; Azevedo, Celso O/0000-0002-2423-9388	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [151153/2013-2]; CNPq [151153/2013-2, 305746/2014-6]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grant #151153/2013-2, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, RK. The authors acknowledge CNPq grant #151153/2013-2 for providing scholarship to the first author; to CNPq grant #305746/2014-6 for providing scholarship and financial support to the third author.	Alencar IDCC, 2013, SYST ENTOMOL, V38, P45, DOI 10.1111/j.1365-3113.2012.00648.x; Alencar Isabel D.C.C., 2011, European Journal of Taxonomy, V4, P1; BROTHERS D J, 1975, University of Kansas Science Bulletin, V50, P483; Brothers DJ, 2011, ZOOKEYS, P515, DOI 10.3897/zookeys.130.1591; Brothers Denis J., 1993, Journal of Hymenoptera Research, V2, P227; BROTHERS DJ, 1976, SYST ENTOMOL, V1, P177, DOI 10.1111/j.1365-3113.1976.tb00036.x; Brothers DJ, 1999, ZOOL SCR, V28, P233, DOI 10.1046/j.1463-6409.1999.00003.x; Buffington M. L., 2005, American Entomologist, V51, P50; Buffington Matthew, 2008, American Entomologist, V54, P222; CARPENTER JM, 1986, J NEW YORK ENTOMOL S, V94, P303; Carpenter JM, 1999, ZOOL SCR, V28, P215, DOI 10.1046/j.1463-6409.1999.00011.x; Carr M, 2010, INSECT SYST EVOL, V41, P55, DOI 10.1163/187631210X486995; Chapman RF, 2013, J CHEM INF MODEL, V5th; DEPINNA MCC, 1991, CLADISTICS, V7, P367; EVANS H E, 1969, Entomological News, V80, P113; EVANS HOWARD E., 1964, BULL MUS COMP ZOOL HARVARD UNIV, V132, P1; Findley Bostik, 2001, TECHN DAT SHEET BLU; GIBSON GAP, 1985, CAN ENTOMOL, V117, P1395, DOI 10.4039/Ent1171395-11; GIBSON GAP, 1993, MEM ENTOMOL SOC CAN, P165, DOI 10.4039/entm125165165-1; GORDH G, 1990, J AUST ENTOMOL SOC, V29, P167; Kerr Peter H., 2008, American Entomologist, V54, P198; Marden JH, 2000, ANNU REV PHYSIOL, V62, P157, DOI 10.1146/annurev.physiol.62.1.157; Martini F.H, 2008, HUMAN ANATOMY; Matsuda R., 1976, MORPHOLOGY EVOLUTION; Miko I, 2007, ZOOTAXA, P1; Olmi M, 1984, MEM AM ENTOMOL I, V37, P1; Polaszek Andrew, 1994, Journal of Hymenoptera Research, V3, P91; Rasnitsyn A.P., 1980, Trudy Paleontologicheskogo Instituta, V174, P1; Rieppel O, 2002, BIOL J LINN SOC, V75, P59, DOI 10.1046/j.1095-8312.2002.00006.x; SAINI M S, 1986, Journal of Entomological Research (New Delhi), V10, P85; SAINI MS, 1984, J NEW YORK ENTOMOL S, V92, P150; Seltmann KC, 2012, J HYMENOPT RES, V27, P67, DOI 10.3897/JHR.27.2961; SNODGRASS R. E., 1927, SMITHSONIAN MISC COLL, V80, P1; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Sorg M., 1988, SONDERVEROFFENTLICHU, V63, P1; Terayama Mamoru, 2003, Academic Reports Tokyo Polytechnic University Faculty of Engineering, V26, P1; Vilhelmsen L, 2000, ZOOMORPHOLOGY, V119, P185, DOI 10.1007/PL00008493; Vilhelmsen L, 2010, ZOOL J LINN SOC-LOND, V159, P22, DOI 10.1111/j.1096-3642.2009.00576.x; WHITFIELD JB, 1989, ANN ENTOMOL SOC AM, V82, P663, DOI 10.1093/aesa/82.6.663; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991	40	64	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140051	10.1371/journal.pone.0140051	http://dx.doi.org/10.1371/journal.pone.0140051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465151	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100075
J	Marcinkevage, J; Mayen, AL; Zuleta, C; DiGirolamo, AM; Stein, AD; Ramirez-Zea, M				Marcinkevage, Jessica; Mayen, Ana-Lucia; Zuleta, Clara; DiGirolamo, Ann M.; Stein, Aryeh D.; Ramirez-Zea, Manuel			Relative Validity of Three Food Frequency Questionnaires for Assessing Dietary Intakes of Guatemalan Schoolchildren	PLOS ONE			English	Article							CALCIUM INTAKE; NUTRITION TRANSITION; MICRONUTRIENT INTAKE; VALIDATION; CHILDREN; ADOLESCENTS; DISEASES; INFANTS; RECORD; IRON	Objective To determine the relative validity of three food frequency questionnaires (FFQs) compared with results from 24-hour dietary recalls for measuring dietary intakes in Guatemalan schoolchildren. Design A cross-sectional study of primary caregivers (mothers or grandmothers) of 6-11 year-old children. Caregivers completed one of three constructed FFQs to measure the child's dietary consumption in the last week: FFQ1 did not incorporate portion sizes; FFQ2 provided portion sizes; and FFQ3 incorporated pictures of median portion sizes. During the same week, each caregiver also completed three 24-hour dietary recalls. Results from the FFQ were compared with corresponding results from the 24-hour dietary recalls. Setting Santa Catarina Pinula, peri-urban Guatemala City. Subjects Caregivers (n = 145) of 6-11 year-old children: 46 completed FFQ1, 49 completed FFQ2, and 50 completed FFQ3. Results The mean values for all nutrients obtained from the 24-hour dietary recall were lower than for those obtained from the FFQs, excluding folic acid in FFQ3, cholesterol and zinc in FFQ2, and cholesterol, folic acid, magnesium, potassium, sodium, and zinc in FFQ1. Energy-adjusted Pearson correlation coefficients ranged from 0.07 (protein) to 0.54 (cholesterol) for FFQ1 and from 0.05 to 0.74 for FFQ2 and FFQ3. Agreement by both methods (FFQ and 24-hour dietary recalls) of classifying children into the same or adjacent quartiles of energy-adjusted nutrient consumption ranged from 62.0% for cholesterol to 95.9% for vitamin B12 across all three FFQs. Conclusions Our FFQs had moderate to good relative validity in measuring energy and nutrient intakes for 6-11 year-old Guatemalan children. More evidence is needed to evaluate their reproducibility and applicability in similar populations.	[Marcinkevage, Jessica] Emory Univ, Grad Div Biol & Biomed Sci, Laney Grad Sch, Atlanta, GA 30322 USA; [Mayen, Ana-Lucia; Zuleta, Clara; Ramirez-Zea, Manuel] Inst Nutr Cent Amer & Panama, INCAP Res Ctr Prevent Chron Dis CIIPEC, Guatemala City, Guatemala; [DiGirolamo, Ann M.; Stein, Aryeh D.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [DiGirolamo, Ann M.] Georgia State Univ, Andrew Young Sch Policy Studies, Atlanta, GA 30303 USA	Emory University; Institute of Nutrition of Central America & Panama (INCAP); Emory University; Rollins School Public Health; University System of Georgia; Georgia State University	Ramirez-Zea, M (corresponding author), Inst Nutr Cent Amer & Panama, INCAP Res Ctr Prevent Chron Dis CIIPEC, Guatemala City, Guatemala.	mramirez@incap.int	Mayen, Ana L/R-6521-2017	Mayen, Ana L/0000-0001-9635-0416; Stein, Aryeh/0000-0003-1138-6458	Guatemala National Council of Science and Technology (CONCYT); United States National Institutes of Health [MH067981]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067981] Funding Source: NIH RePORTER	Guatemala National Council of Science and Technology (CONCYT); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the Guatemala National Council of Science and Technology (CONCYT) and a grant from the United States National Institutes of Health (MH067981). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LF, 2004, PUBLIC HEALTH NUTR, V7, P757, DOI 10.1079/PHN2004613; Andersen LF, VALIDATION ENERGY IN; Arnold Julie E., 1995, Annals of Epidemiology, V5, P369, DOI 10.1016/1047-2797(95)00034-5; BELLU R, 1995, NUTR RES, V15, P1121, DOI 10.1016/0271-5317(95)00071-P; Bertoli S, 2005, J PEDIATR GASTR NUTR, V40, P555, DOI 10.1097/01.MPG.0000153004.53610.0E; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318; Cano P., 2007, THESIS U SAN CARLOS; Dehghan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037958; Del Pino DL, 2011, PUBLIC HEALTH NUTR, V14, P826, DOI 10.1017/S1368980010003538; Delisle H, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S2-S10; Deschamps V, 2009, EUR J CLIN NUTR, V63, P282, DOI 10.1038/sj.ejcn.1602914; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; GARROW J, 1995, EUR J CLIN NUTR, V49, P231; Green TJ, 1998, J NUTR, V128, P1665, DOI 10.1093/jn/128.10.1665; Groeneveld IF, 2007, REV PANAM SALUD PUBL, V22, P169, DOI 10.1590/S1020-49892007000800003; Henn RL, 2010, CAD SAUDE PUBLICA, V26, P2068, DOI 10.1590/S0102-311X2010001100008; Instituto de Nutrition de Centroamerica y Panama, 2006, MAN INSTR EV DIET; JENNER DA, 1989, EUR J CLIN NUTR, V43, P663; Kobayashi T, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-27; Lillegaard ITL, 2007, EUR J CLIN NUTR, V61, P61, DOI 10.1038/sj.ejcn.1602487; Livingstone MBE, 2004, BRIT J NUTR, V92, pS213, DOI 10.1079/BJN20041169; Lombard M, 2013, NUTRIENTS, V5, P3118, DOI 10.3390/nu5083118; LUCAS F, 1995, J HUM NUTR DIET, V8, P65, DOI 10.1111/j.1365-277X.1995.tb00296.x; Magkos F, 2006, OSTEOPOROSIS INT, V17, P304, DOI 10.1007/s00198-004-1679-1; Marcinkevage J, 2009, J FEDERATION AM SOC; Mayen AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029; Menchu M, 2009, TABLA COMPOSICION AL; Menchu MT, 1991, GUIA METODOLOGICA RE; Moore M, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-24; Ortiz-Andrellucchi A, 2009, BRIT J NUTR, V102, pS87, DOI 10.1017/S0007114509993163; Papadopoulou SK, 2008, INT J FOOD SCI NUTR, V59, P148, DOI 10.1080/09637480701530004; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Ranka S, DEV FOOD FREQUENCY Q; Rockett HRH, 1997, PREV MED, V26, P808, DOI 10.1006/pmed.1997.0200; Rodriguez MM, 2002, PUBLIC HEALTH NUTR, V5, P691, DOI 10.1079/PHN2002333; Rogers LM, 2003, AM J CLIN NUTR, V77, P433, DOI 10.1093/ajcn/77.2.433; Roman-Vinas B, 2010, MATERN CHILD NUTR, V6, P112, DOI 10.1111/j.1740-8709.2010.00268.x; Scagliusi FB, 2011, CAD SAUDE PUBLICA, V27, P2196; Serra-Majem L, 2009, BRIT J NUTR, V102, pS38, DOI 10.1017/S0007114509993138; SPLETT PL, 1991, J AM DIET ASSOC, V91, P665; Wagner KH, 2012, PREV MED, V54, pS38, DOI 10.1016/j.ypmed.2011.11.012; Wakai K, 2009, J EPIDEMIOL, V19, P1, DOI 10.2188/jea.JE20081007; Willett W, 1998, IMPLICATIONS TOTAL E; Williams PL, 2005, CAN J DIET PRACT RES, V66, P176, DOI 10.3148/66.3.2005.176; Wilson AMR, 2004, J AM DIET ASSOC, V104, P373, DOI 10.1016/j.jada.2003.12.021; Xia W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019656	48	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139125	10.1371/journal.pone.0139125	http://dx.doi.org/10.1371/journal.pone.0139125			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465769	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100038
J	Matsubara, R; Aonuma, H; Kojima, M; Tahara, M; Andrabi, SBA; Sakakibara, H; Nagamune, K				Matsubara, Ryuma; Aonuma, Hiroka; Kojima, Mikiko; Tahara, Michiru; Andrabi, Syed Bilal Ahmad; Sakakibara, Hitoshi; Nagamune, Kisaburo			Plant Hormone Salicylic Acid Produced by a Malaria Parasite Controls Host Immunity and Cerebral Malaria Outcome	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SYSTEMIC ACQUIRED-RESISTANCE; PROSTAGLANDIN E-2; TOXOPLASMA-GONDII; ABSCISIC-ACID; PATHOGENESIS; RECEPTORS; CYCLOOXYGENASE-2; BIOSYNTHESIS; INFLAMMATION	The apicomplexan parasite Toxoplasma gondii produces the plant hormone abscisic acid, but it is unclear if phytohormones are produced by the malaria parasite Plasmodium spp., the most important parasite of this phylum. Here, we report detection of salicylic acid, an immune-related phytohormone of land plants, in P. berghei ANKA and T. gondii cell lysates. However, addition of salicylic acid to P. falciparum and T. gondii culture had no effect. We transfected P. falciparum 3D7 with the nahG gene, which encodes a salicylic acid-degrading enzyme isolated from plant-infecting Pseudomonas sp., and established a salicylic acid-deficient mutant. The mutant had a significantly decreased concentration of parasite-synthesized prostaglandin E-2, which potentially modulates host immunity as an adaptive evolution of Plasmodium spp. To investigate the function of salicylic acid and prostaglandin E-2 on host immunity, we established P. berghei ANKA mutants expressing nahG. C57BL/6 mice infected with nahG transfectants developed enhanced cerebral malaria, as assessed by Evans blue leakage and brain histological observation. The nahG-transfectant also significantly increased the mortality rate of mice. Prostaglandin E-2 reduced the brain symptoms by induction of T helper-2 cytokines. As expected, T helper-1 cytokines including interferon. and interleukin-2 were significantly elevated by infection with the nahG transfectant. Thus, salicylic acid of Plasmodium spp. may be a new pathogenic factor of this threatening parasite and may modulate immune function via parasite-produced prostaglandin E-2.	[Matsubara, Ryuma; Aonuma, Hiroka; Tahara, Michiru; Andrabi, Syed Bilal Ahmad; Nagamune, Kisaburo] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan; [Matsubara, Ryuma] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kojima, Mikiko; Sakakibara, Hitoshi] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Nagamune, Kisaburo] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	National Institute of Infectious Diseases (NIID); University of Tsukuba; RIKEN; University of Tsukuba	Nagamune, K (corresponding author), Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan.	nagamune@niid.go.jp	Kojima, Mikiko/D-1459-2017; Sakakibara, Hitoshi/A-6040-2010	Sakakibara, Hitoshi/0000-0001-5449-6492; Andrabi, Syed Bilal Ahmad/0000-0003-3009-0425; Matsubara, Ryuma/0000-0001-7989-4104	Ministry of Education, Culture, Sports, Science, and Technology, Japan [24390103, 23117007]; Program for the Promotion to Improve Independent Research Environments for Young Scientists by the Japan Science and Technology Agency; Ministry of Health, Labour and Welfare of Japan; Japan Health Sciences Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sumitomo Foundation; Takeda Science Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [15H04726] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for the Promotion to Improve Independent Research Environments for Young Scientists by the Japan Science and Technology Agency; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sumitomo Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by a Grant-in-Aid for JSPS Fellows (RM). This work was also supported in part by Grants-in-Aid for Scientific Research 24390103 and for Scientific Research on Innovative Areas 23117007 from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work was also supported by the Program for the Promotion to Improve Independent Research Environments for Young Scientists by the Japan Science and Technology Agency, a grant for research on emerging and re-emerging infectious diseases from the Ministry of Health, Labour and Welfare of Japan, a grant for research to promote the development of anti-AIDS pharmaceuticals from the Japan Health Sciences Foundation, the Naito Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Sumitomo Foundation, the Takeda Science Foundation, and the Uehara Memorial Foundation.	Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Ball HJ, 2004, J INFECT DIS, V189, P751, DOI 10.1086/381503; BETZ M, 1991, J IMMUNOL, V146, P108; BOYNTON C S, 1988, Journal of Clinical Pharmacology, V28, P512; Carollo M, 2001, BRIT J PHARMACOL, V134, P1166, DOI 10.1038/sj.bjp.0704371; Carroll RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013124; DEKOSSODO S, 1993, J IMMUNOL, V151, P4811; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; HO M, 1995, J INFECT DIS, V172, P838, DOI 10.1093/infdis/172.3.838; HOFFMANNBENNING S, 1992, PLANT PHYSIOL, V99, P1156, DOI 10.1104/pp.99.3.1156; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2010, PEDIATR RES, V68, P267, DOI 10.1203/00006450-201011001-00524; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Joshi PC, 2001, J IMMUNOL, V166, P885, DOI 10.4049/jimmunol.166.2.885; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kelley DR, 2012, PLANT PHYSIOL, V160, P47, DOI 10.1104/pp.112.200527; Kojima Mikiko, 2012, Methods Mol Biol, V918, P151, DOI 10.1007/978-1-61779-995-2_11; Kojima M, 2009, PLANT CELL PHYSIOL, V50, P1201, DOI 10.1093/pcp/pcp057; KRAAN TCTMV, 1995, J EXP MED, V181, P775, DOI 10.1084/jem.181.2.775; Kubata BK, 1998, J EXP MED, V188, P1197, DOI 10.1084/jem.188.6.1197; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; LEE HI, 1995, P NATL ACAD SCI USA, V92, P4076, DOI 10.1073/pnas.92.10.4076; Lin JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029289; Metraux JP, 2002, TRENDS PLANT SCI, V7, P332, DOI 10.1016/S1360-1385(02)02313-0; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Nagamune K, 2007, ANTIMICROB AGENTS CH, V51, P3816, DOI 10.1128/AAC.00582-07; Nakayama T, 2006, J LEUKOCYTE BIOL, V79, P95, DOI 10.1189/jlb.0405226; Penet MF, 2008, P NATL ACAD SCI USA, V105, P1321, DOI 10.1073/pnas.0706867105; Perkins DJ, 2001, J INFECT DIS, V183, P113, DOI 10.1086/317660; RASKIN I, 1990, ANN BOT-LONDON, V66, P369, DOI 10.1093/oxfordjournals.aob.a088037; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; RINGWALD P, 1991, J CLIN MICROBIOL, V29, P2076, DOI 10.1128/JCM.29.9.2076-2078.1991; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Sakura T, 2013, PARASITOL INT, V62, P157, DOI 10.1016/j.parint.2012.12.002; SNIJDEWINT FGM, 1993, J IMMUNOL, V150, P5321; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Villegas-Mendez A, 2012, J IMMUNOL, V189, P968, DOI 10.4049/jimmunol.1200688; Walker W, 2004, IMMUNOLOGY, V111, P298, DOI 10.1111/j.1365-2567.2004.01810.x; White NJ, 2010, TRENDS PARASITOL, V26, P11, DOI 10.1016/j.pt.2009.10.007; WHO, WORLD MAL REP 2013; Xiao LH, 1999, AM J TROP MED HYG, V60, P668, DOI 10.4269/ajtmh.1999.60.668; Yanez DM, 1996, J IMMUNOL, V157, P1620; Zhu XT, 2013, PARASITOL INT, V62, P215, DOI 10.1016/j.parint.2012.12.006	48	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140559	10.1371/journal.pone.0140559	http://dx.doi.org/10.1371/journal.pone.0140559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466097	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100144
J	Salles, MB; Gehrke, SA; Shibli, JA; Allegrini, S; Yoshimoto, M; Konig, B				Salles, Marcos Barbosa; Gehrke, Sergio Alexandre; Shibli, Jamil Awad; Allegrini, Sergio, Jr.; Yoshimoto, Marcelo; Koenig, Bruno, Jr.			Evaluating Nuclear Factor NF-kappa B Activation following Bone Trauma: A Pilot Study in a Wistar Rats Model	PLOS ONE			English	Article							OSTEOCLAST DIFFERENTIATION; PERICELLULAR MATRIX; SIGNALING PATHWAY; OSTEOPROTEGERIN; INFLAMMATION; OSTEOCYTES; EXPRESSION; RESORPTION; IMMUNITY; DISEASE	The present study investigated the moment of peak NF-kappa B activation and its dissipation in the cortical bone in the femur of Wistar rat stimulated by surgical trauma. Sixty-five Wistar rats were divided into 13 groups (n = 5 per group): eight experimental groups (expG 1-8) divided based on the euthanasia time point (zero, 1 h, 2 h, 4 h, 6 h, 8 h, 12 h and 24 h) and five sham control groups (conG 1-5) killed at zero, 1 h, 2 h, 4 h and 6 h, respectively. A 1.8-mm- diameter defect was generated 0.5 mm from the femur proximal joint using a round bur to induce the surgical trauma. Overall, the activation peak of NF-kappa B in the cortical bone was 6 h (expG5 group) independent of the evaluated position; this peak was significantly different compared to those in the other groups (p < 0.05). The surgical trauma resulted in a spread of immune markings throughout the cortical bone with an accentuation in the knee region. The present study provides the first evidence that the NF-kappa B activation peak was established after 6 hours in the cortical bone of Wistar rats. The signs from a surgical trauma can span the entire cortical bone and are not limited to the damaged region.	[Salles, Marcos Barbosa; Allegrini, Sergio, Jr.; Yoshimoto, Marcelo; Koenig, Bruno, Jr.] Univ Sao Paulo, Dept Anat, Inst Biomed Sci, Sao Paulo, Brazil; [Gehrke, Sergio Alexandre] Biotecnos Res Ctr, Santa Maria, RS, Brazil; [Gehrke, Sergio Alexandre] Catholic Univ Uruguay, Montevideo, Uruguay; [Gehrke, Sergio Alexandre; Shibli, Jamil Awad] Univ Guarulhos, Dent Res Div, Dept Periodontol & Oral Implantol, Guarulhos, SP, Brazil; [Salles, Marcos Barbosa; Yoshimoto, Marcelo] Sao Leopoldo Mand, Implantol Dept, Campinas, SP, Brazil; [Allegrini, Sergio, Jr.] Ernst Moritz Arndt Univ Greifswald, Orthopedy Dept, Greifswald, Germany	Universidade de Sao Paulo; Universidad Catolica del Uruguay; Universidade Guarulhos; Faculdade Sao Leopoldo Mandic; Ernst Moritz Arndt Universitat Greifswald	Gehrke, SA (corresponding author), Biotecnos Res Ctr, Santa Maria, RS, Brazil.	sergio.gehrke@hotmail.com	Gehrke, Sergio Alexandre/ABB-6500-2021; Allegrini, sergio/U-1824-2019; Gehrke, Sérgio/AAM-8233-2020; Shibli, Jamil/A-1361-2014	Gehrke, Sergio Alexandre/0000-0002-5863-9101; Shibli, Jamil/0000-0003-1971-0195; Allegrini Jr, Sergio/0000-0002-9411-4193	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Boyce BF, 2010, ANN NY ACAD SCI, V1192, P367, DOI 10.1111/j.1749-6632.2009.05315.x; Brechter AB, 2007, ARTHRITIS RHEUM-US, V56, P910, DOI 10.1002/art.22445; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Di Francesco D, 1995, CARDIAC ELECTROPHYSI, P96; DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x; Giannoudis P. V., 1996, INJURY, V27, P372; Giannoudis PV, 2002, CLIN ORTHOP RELAT R, P378, DOI 10.1097/01.blo.00000236813.17269.24; Giannoudis PV, 2004, J BONE JOINT SURG BR, V86B, P313, DOI 10.1302/0301-620X.86B3.15035; GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662, DOI 10.1002/jlb.55.5.662; Green PG, 1997, J NEUROSCI, V17, P3234; Hellweg CE, 2006, ANN NY ACAD SCI, V1091, P191, DOI 10.1196/annals.1378.066; Hofbauer LC, 2001, CANCER-AM CANCER SOC, V92, P460, DOI 10.1002/1097-0142(20010801)92:3<460::AID-CNCR1344>3.0.CO;2-D; Jimi E, 2005, IMMUNOL REV, V208, P80, DOI 10.1111/j.0105-2896.2005.00329.x; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karst M, 2004, J CELL PHYSIOL, V200, P99, DOI 10.1002/jcp.20036; KIMBLE RB, 1994, CALCIFIED TISSUE INT, V55, P260, DOI 10.1007/BF00310403; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; LITOVSKY SH, 1988, CIRC RES, V62, P116, DOI 10.1161/01.RES.62.1.116; Mashiba Tasuku, 2006, Clin Calcium, V16, P1985; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Rodriguez M, 2003, EXPRESION LIGANDO RE; Saidenberg-Kermanac'h N, 2004, BONE, V35, P1200, DOI 10.1016/j.bone.2004.07.004; Salles MB, 2011, MED ORAL PATOL ORAL, V16, pE124, DOI 10.4317/medoral.16.e124; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Siomek A, 2012, ACTA BIOCHIM POL, V59, P323; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Taylor AF, 2007, AM J PHYSIOL-CELL PH, V292, pC545, DOI 10.1152/ajpcell.00611.2005; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; TURNER CH, 1994, FASEB J, V8, P875, DOI 10.1096/fasebj.8.11.8070637; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; You LD, 2004, ANAT REC PART A, V278A, P505, DOI 10.1002/ar.a.20050; You LD, 2001, J BIOMECH, V34, P1375, DOI 10.1016/S0021-9290(01)00107-5; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140630	10.1371/journal.pone.0140630	http://dx.doi.org/10.1371/journal.pone.0140630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465330	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100156
J	Vogel, ER; Harrison, ME; Zulfa, A; Bransford, TD; Alavi, SE; Husson, S; Morrogh-Bernard, H; Santiano; Firtsman, T; Utami-Atmoko, SS; van Noordwijk, MA; Farida, WR				Vogel, Erin R.; Harrison, Mark E.; Zulfa, Astri; Bransford, Timothy D.; Alavi, Shauhin E.; Husson, Simon; Morrogh-Bernard, Helen; Santiano; Firtsman, Twentinolosa; Utami-Atmoko, Sri Suci; van Noordwijk, Maria A.; Farida, Wartika Rosa			Nutritional Differences between Two Orangutan Habitats: Implications for Population Density	PLOS ONE			English	Article							PAN-TROGLODYTES-SCHWEINFURTHII; KIBALE-NATIONAL-PARK; PEAT-SWAMP FOREST; PONGO-PYGMAEUS; BORNEAN ORANGUTANS; REPRODUCTIVE SUCCESS; LIFE-HISTORY; SUMATRAN ORANGUTANS; FRUIT AVAILABILITY; CENTRAL KALIMANTAN	Bottom-up regulatory factors have been proposed to exert a strong influence on mammalian population density. Studies relating habitat quality to population density have typically made comparisons among distant species or communities without considering variation in food quality among localities. We compared dietary nutritional quality of two Bornean orangutan populations with differing population densities in peatland habitats, Tuanan and Sabangau, separated by 63 km. We hypothesized that because Tuanan is alluvial, the plant species included in the orangutan diet would be of higher nutritional quality compared to Sabangau, resulting in higher daily caloric intake in Tuanan. We also predicted that forest productivity would be greater in Tuanan compared to Sabangau. In support of these hypotheses, the overall quality of the diet and the quality of matched dietary items were higher in Tuanan, resulting in higher daily caloric intake compared to Sabangau. These differences in dietary nutritional quality may provide insights into why orangutan population density is almost two times greater in Tuanan compared to Sabangau, in agreement with a potentially important influence of diet quality on primate population density.	[Vogel, Erin R.; Bransford, Timothy D.; Alavi, Shauhin E.] Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08903 USA; [Harrison, Mark E.] Univ Leicester, Dept Geog, Leicester LE1 7RH, Leics, England; [Harrison, Mark E.; Husson, Simon; Morrogh-Bernard, Helen; Santiano; Firtsman, Twentinolosa] Orangutan Trop Peatland Project, Palangka Raya, Indonesia; [Zulfa, Astri; Utami-Atmoko, Sri Suci] Univ Nasional Jakarta, Fak Biol, Jakarta, Indonesia; [Santiano; Firtsman, Twentinolosa] Ctr Int Cooperat Sustainable Management Trop Peat, Palangka Raya, Indonesia; [van Noordwijk, Maria A.] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Farida, Wartika Rosa] Indonesian Inst Sci LIPI, Biol Res Ctr, Cibinong Bogor, Indonesia	Rutgers State University New Brunswick; University of Leicester; University of Zurich; Indonesian Institute of Sciences	Vogel, ER (corresponding author), Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08903 USA.	erin.vogel@rutgers.edu	Harrison, Mark E./AAD-8741-2021	Harrison, Mark E./0000-0002-0729-8407; Farida, Wartika Rosa/0000-0002-5949-5760; utami, sri/0000-0002-5138-242X	USAID [APS-497-11-000001]; L.S.B. Leakey Foundation; A.H. Shultz Foundation; National Science Foundation [BCS-0643122]; Rutgers University; Center for Human Evolutionary Studies; George Washington University Selective Excellence Fund; Wildlife Conservation Society; US Fish and Wildlife Service Great Ape Conservation Fund; Arcus Foundation; Wingate Foundation; Primate Conservation Inc.; Conservation International Primate Action Fund; IdeaWild; Columbus Zoo; Rufford Foundation	USAID(United States Agency for International Development (USAID)); L.S.B. Leakey Foundation; A.H. Shultz Foundation; National Science Foundation(National Science Foundation (NSF)); Rutgers University; Center for Human Evolutionary Studies; George Washington University Selective Excellence Fund; Wildlife Conservation Society; US Fish and Wildlife Service Great Ape Conservation Fund(US Fish & Wildlife Service); Arcus Foundation; Wingate Foundation; Primate Conservation Inc.; Conservation International Primate Action Fund; IdeaWild; Columbus Zoo; Rufford Foundation	This research was funded by USAID (APS-497-11-000001 to E.R.V), L.S.B. Leakey Foundation (to E.R.V, S.S.U., M.E.H., S.H., H.M-B.), A.H. Shultz Foundation (to M.A.N.), National Science Foundation (to E.R.V. BCS-0643122), Rutgers University (to E.R.V), Center for Human Evolutionary Studies (to E.R.V.), George Washington University Selective Excellence Fund (to E.R.V.), Wildlife Conservation Society (to H.M-B.), US Fish and Wildlife Service Great Ape Conservation Fund (E.R.V., S.H., M.E.H.), Arcus Foundation (to Susan M. Cheyne) Wingate Foundation (to M.E.H.), Primate Conservation Inc. (to M.E.H.), Conservation International Primate Action Fund (to M.E.H.), IdeaWild (to Susan M. Cheyne, M. E.H.), Columbus Zoo (to Susan M. Cheyne, M.E.H.), and the Rufford Foundation (to Susan M. Cheyne, M.E.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi SE, UNPUB; Altmann J, 2003, AM J HUM BIOL, V15, P401, DOI 10.1002/ajhb.10157; Ancrenaz M., 2007, ORANGUTAN AERIAL SUR, P1; Anderson HB, 2008, J HUM EVOL, V54, P34, DOI 10.1016/j.jhevol.2007.05.014; [Anonymous], 2003, FOSS ANAL MANUAL; [Anonymous], [No title captured]; Arora N, 2010, P NATL ACAD SCI USA, V107, P21376, DOI 10.1073/pnas.1010169107; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borries C, 2001, BEHAV ECOL SOCIOBIOL, V50, P391, DOI 10.1007/s002650100391; BOURLIERE F, 1985, INT J PRIMATOL, V6, P1, DOI 10.1007/BF02693694; Cannon CH, 2007, CURR SCI INDIA, V93, P1558; Chapman CA, 2002, INT J PRIMATOL, V23, P283, DOI 10.1023/A:1013831511405; Chapman CA, 2004, AM J PRIMATOL, V62, P55, DOI 10.1002/ajp.20006; Chapman CA, 2003, INT J PRIMATOL, V24, P317, DOI 10.1023/A:1023049200150; Chapman CA, 1999, PRIMATES, V40, P215, DOI 10.1007/BF02557712; Chapman CA, 2010, ECOL APPL, V20, P179, DOI 10.1890/09-0128.1; Conklin-Brittain Nancy Lou, 2006, P445; Curran LM, 2000, ECOL MONOGR, V70, P101, DOI 10.1890/0012-9615(2000)070[0101:VRTSVI]2.0.CO;2; DeGabriel JL, 2014, OIKOS, V123, P298, DOI 10.1111/j.1600-0706.2013.00727.x; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Fashing PJ, 2007, INT J PRIMATOL, V28, P673, DOI 10.1007/s10764-006-9096-2; Felton AM, 2003, BIOL CONSERV, V114, P91, DOI 10.1016/S0006-3207(03)00013-2; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; GALDIKAS BMF, 1990, AM J PHYS ANTHROPOL, V83, P185, DOI 10.1002/ajpa.1330830207; Ganzhorn JU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008253; GANZHORN JU, 1992, OECOLOGIA, V91, P540, DOI 10.1007/BF00650329; Goering H.K., 1970, AGR HDB USDA; Hanya G, 2011, ECOGRAPHY, V34, P1009, DOI 10.1111/j.1600-0587.2010.06775.x; Harrison ME, 2010, INT J PRIMATOL, V31, P585, DOI 10.1007/s10764-010-9415-5; Harrison ME, 2009, AM J PRIMATOL, V71, P353, DOI 10.1002/ajp.20655; Harrison ME, 2009, ORANGUTAN FEEDING BE; Harrison ME, BIOTROPICA IN PRESS; Hawes JE, 2014, OIKOS, V123, P365, DOI 10.1111/j.1600-0706.2013.00745.x; Husson Simon J., 2009, P77; Jaeggi AV, 2010, AM J PRIMATOL, V72, P62, DOI 10.1002/ajp.20752; Kay RF, 1997, P NATL ACAD SCI USA, V94, P13023, DOI 10.1073/pnas.94.24.13023; Knott C., 2001, REPROD ECOLOGY HUMAN, P429; Knott C.D., 1999, REPROD PHYSL BEHAV R; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Knott CD, 2005, CAM S BIO EVOL ANTHR, V44, P351, DOI 10.1017/CBO9780511542343.013; Knott Cheryl D., 2009, P171; Kuze N, 2012, PRIMATES, V53, P181, DOI 10.1007/s10329-011-0285-z; Marshall Andrew J., 2006, P313; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Marshall AJ, 2014, INT J PRIMATOL, V35, P1178, DOI 10.1007/s10764-014-9774-4; Marshall Andrew J., 2009, P97; Marshall AJ, 2009, AM J PHYS ANTHROPOL, V140, P603, DOI 10.1002/ajpa.21082; Meijaard E, 2007, CURR BIOL, V17, pR540, DOI 10.1016/j.cub.2007.05.016; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027491; MILTON K, 1988, J NUTR, V118, P1082, DOI 10.1093/jn/118.9.1082; Milton K, 2004, INTEGR COMP BIOL, V44, P304, DOI 10.1093/icb/44.4.304; Morrogh-Bernard H, 2003, BIOL CONSERV, V110, P141, DOI 10.1016/S0006-3207(02)00186-6; Morrogh-Bernard H, UNPUB; Morrogh-Bernard H, 2009, ORANGUTAN BEHAV ECOL; Morrogh-Bernard Helen C., 2009, P119; Nantha HS, 2009, BIODIVERS CONSERV, V18, P487, DOI 10.1007/s10531-008-9512-3; Nater A, 2011, MOL BIOL EVOL, V28, P2275, DOI 10.1093/molbev/msr042; O'Malley RC, 2014, J HUM EVOL, V71, P46, DOI 10.1016/j.jhevol.2013.09.014; OATES JF, 1990, ECOLOGY, V71, P328, DOI 10.2307/1940272; Oyarzun SE, 1996, ZOO BIOL, V15, P509, DOI 10.1002/(SICI)1098-2361(1996)15:5<509::AID-ZOO7>3.0.CO;2-F; Page S.E., 1997, BIODIVERSITY SUSTAIN, P231; Page SE, 1999, PHILOS T R SOC B, V354, P1885, DOI 10.1098/rstb.1999.0529; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Pearce F, 2013, SPACE USE SCALING HO; PIERCE W, 1947, QUANTITATIVE ANAL; Potts KB., 2013, BUILDING BABIES PRIM, P83; Potts KB, 2009, J ANIM ECOL, V78, P1269, DOI 10.1111/j.1365-2656.2009.01578.x; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; R Core Team, 2016, R FDN STAT COMP; Robertson JB, 1980, DETERGENT SYSTEM ANA, P123; Rode KD, 2006, BIOTROPICA, V38, P625, DOI 10.1111/j.1744-7429.2006.00183.x; Rothman JM, 2007, J TROP ECOL, V23, P673, DOI 10.1017/S0266467407004555; Rothman JM, 2011, BIOL LETTERS, V7, P847, DOI 10.1098/rsbl.2011.0321; Russon Anne E., 2009, P327; Russon Anne E., 2009, P135; Schneider Jill E., 2000, P35; Sharp A, 2015, AUSTRAL ECOL, V40, P139, DOI 10.1111/aec.12185; Sinclair ARE, 2002, PHILOS T ROY SOC B, V357, P1221, DOI 10.1098/rstb.2002.1123; Singleton Ian, 2009, P205; Sulistiyanto Y, 2004, NUTR DYNAMICS DIFFER; Terborgh J., 1987, P205; Thomas LJ., 2002, COAL GEOLOGY; Thompson ME, 2008, HORM BEHAV, V53, P526, DOI 10.1016/j.yhbeh.2007.12.005; Thompson ME, 2008, AM J PHYS ANTHROPOL, V135, P171, DOI 10.1002/ajpa.20718; Thompson ME, 2007, ANIM BEHAV, V73, P501, DOI 10.1016/j.anbehav.2006.09.007; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; van Noordwijk MA, 1999, PRIMATES, V40, P105, DOI 10.1007/BF02557705; van Noordwijk MA, 2005, AM J PHYS ANTHROPOL, V127, P79, DOI 10.1002/ajpa.10426; van Noordwijk MA, 2013, BEHAV ECOL SOCIOBIOL, V67, P805, DOI 10.1007/s00265-013-1504-y; van Noordwijk MA, 2012, BEHAV ECOL SOCIOBIOL, V66, P823, DOI 10.1007/s00265-012-1330-7; van Schaik CP, 2005, CAM S BIO EVOL ANTHR, V44, P23, DOI 10.1017/CBO9780511542343.003; van Schaik CP, 2005, PRIMATES, V46, P249, DOI 10.1007/s10329-005-0134-z; van Schaik CP, 1999, PRIMATES, V40, P69, DOI 10.1007/BF02557703; Venter O, 2008, NATURE, V451, P16, DOI 10.1038/451016a; Vogel ER, NUTR ECOLOGY W UNPUB; Vogel ER, UNPUB; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; Vogel ER, 2014, AM J PHYS ANTHROPOL, V153, P262; Vogel ER, 2012, BIOL LETTERS, V8, P333, DOI 10.1098/rsbl.2011.1040; Vucetich JA, 2004, P ROY SOC B-BIOL SCI, V271, P183, DOI 10.1098/rspb.2003.2589; Wallis IR, 2012, OECOLOGIA, V169, P281, DOI 10.1007/s00442-011-2212-9; Wartmann FM, 2010, PRIMATES, V51, P119, DOI 10.1007/s10329-009-0186-6; Wasserman MD, 2003, J ANIM ECOL, V72, P650, DOI 10.1046/j.1365-2656.2003.00736.x; Wich S, 2004, PRIMATES, V45, P177, DOI 10.1007/s10329-004-0080-1; Wich SA, 2004, J HUM EVOL, V47, P385, DOI 10.1016/j.jhevol.2004.08.006; Wich SA, 2009, PREFACE ORANGUTANS G, pxix; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; Wich SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021278; Wright E, 2015, AM J PHYS ANTHROPOL, V158, P487, DOI 10.1002/ajpa.22808	109	26	26	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138612	10.1371/journal.pone.0138612	http://dx.doi.org/10.1371/journal.pone.0138612			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466370	Green Published, Green Accepted, gold			2022-12-26	WOS:000363183100018
J	Boshra, H; Truong, T; Babiuk, S; Hemida, MG				Boshra, Hani; Thang Truong; Babiuk, Shawn; Hemida, Maged Gomaa			Seroprevalence of Sheep and Goat Pox, Peste Des Petits Ruminants and Rift Valley Fever in Saudi Arabia	PLOS ONE			English	Article							VIRUS; CAPRIPOXVIRUSES; INFECTION; EPIDEMIC; DISEASES; REGION; PPR	Sheep and goat pox, peste des petits ruminants and Rift Valley fever are important diseases of small ruminant livestock. Sheep and goat pox, along with peste des petits ruminants, are endemic throughout most of Africa, Asia and the Middle East. Whereas Rift Valley fever is endemic in Africa, outbreaks in the Middle East have been reported over the past decade, including the Arabian Peninsula. Saudi Arabia is a major importer of livestock, and understanding the prevalence of these viral infections would be useful for disease control. In this study, sera from sheep and goats were collected from 3 regions in Saudi Arabia. They were evaluated for antibodies specific to sheep and goat pox, peste des petits ruminants and Rift Valley fever by virus neutralization assays. To the best of our knowledge, this is the first study to evaluate the seroprevalence of these viruses in sheep and goats.	[Boshra, Hani; Thang Truong; Babiuk, Shawn] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Babiuk, Shawn] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Hemida, Maged Gomaa] King Faisal Univ, Dept Microbiol & Parasitol, Coll Vet Med & Anim Resources, Al Hasa, Saudi Arabia; [Hemida, Maged Gomaa] Kafrelsheikh Univ, Dept Virol, Fac Vet Med, Kafrelsheikh, Egypt	Canadian Food Inspection Agency; University of Manitoba; King Faisal University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University	Babiuk, S (corresponding author), Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.	shawn.babiuk@inspection.gc.ca	Hemida, Maged/L-9888-2016; Truong, Thang/HGF-0213-2022; Boshra, Hani/M-2619-2014	Hemida, Maged/0000-0002-5986-7237; Truong, Thang/0000-0002-0707-7452; Boshra, Hani/0000-0001-9924-8126	Canadian International Food Security Research Fund [106930]; Deanship of Scientific Research-King Faisal University [15043]	Canadian International Food Security Research Fund; Deanship of Scientific Research-King Faisal University	HB, TT and SB are funded by the Canadian International Food Security Research Fund (106930). MGH is funded by the Deanship of Scientific Research-King Faisal University (15043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2005, PREV VET MED, V70, P51, DOI 10.1016/j.prevetmed.2005.02.011; ABUELZEIN EME, 1990, VET REC, V127, P309; Al-Afaleq AI, 2012, TROP ANIM HEALTH PRO, V44, P1535, DOI 10.1007/s11250-012-0100-x; Al-Dubaib M, 2009, TROP ANIM HEALTH PRO, V41, P217, DOI 10.1007/s11250-008-9178-6; Al-Naeem A, 2000, REV SCI TECH OIE, V19, P855, DOI 10.20506/rst.19.3.1261; Al-Shabebi A., 2014, Advances in Animal and Veterinary Sciences, V2, P31, DOI 10.14737/journal.aavs/2014/2.2s.31.34; Al-Shabebi A, 2014, ANIM VET SCI, V2, P34; Al-Shabebi A, 2014, ANIM VET SCI, V2, P33; ALI BE, 1984, RES VET SCI, V36, P1; Babiuk S, 2008, TRANSBOUND EMERG DIS, V55, P263, DOI 10.1111/j.1865-1682.2008.01043.x; Babiuk S, 2009, J GEN VIROL, V90, P105, DOI 10.1099/vir.0.004507-0; Bailey D, 2005, VIRUS RES, V110, P119, DOI 10.1016/j.virusres.2005.01.013; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; Baron MD, 2011, VET REC, V169, P16, DOI 10.1136/vr.d3947; Bengis RG, 2010, RIFT VALLEY FEVER CU, P2; Bhanuprakash V, 2006, COMP IMMUNOL MICROB, V29, P27, DOI 10.1016/j.cimid.2005.12.001; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Boshra H, 2013, ANTIVIR RES, V98, P217, DOI 10.1016/j.antiviral.2013.02.016; Boshra H, 2011, J VIROL, V85, P6098, DOI 10.1128/JVI.02641-10; Bowden TR, 2008, VIROLOGY, V371, P380, DOI 10.1016/j.virol.2007.10.002; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P982; Daubney R., 1931, ENZOOTIC HEPATITIS R, V34, P34; Davies FG, 2006, REV SCI TECH OIE, V25, P137, DOI 10.20506/rst.25.1.1648; El Mamy ABO, 2011, EMERG INFECT DIS, V17, P1894, DOI 10.3201/eid1710.110397; Elfadil AA, 2006, REV SCI TECH OIE, V25, P1131, DOI 10.20506/rst.25.3.1716; Gur S, 2010, J WILDLIFE DIS, V46, P673; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Jupp PG, 2002, MED VET ENTOMOL, V16, P245, DOI 10.1046/j.1365-2915.2002.00371.x; Kortekaas J, 2014, ANTIVIR RES, V106, P24, DOI 10.1016/j.antiviral.2014.03.008; Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747; Malik YS, 2011, TRANSBOUND EMERG DIS, V58, P268, DOI 10.1111/j.1865-1682.2011.01201.x; Mohamed AM, 2014, REV SCI TECH OIE, V33, P903, DOI 10.20506/rst.33.3.2328; Nfon CK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001623; OIE, 2012, MANUAL DIAGNOSTIC TE; OIE, 2010, AN OIE TERR MAN; Rweyemamu M, 2000, ANN NY ACAD SCI, V916, P61, DOI 10.1111/j.1749-6632.2000.tb05275.x; Sallam MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065786; SHIMSHONY A, 1983, ADV VET SCI COMP MED, V27, P347; Truong T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087145; Wang ZL, 2009, EMERG INFECT DIS, V15, P299, DOI 10.3201/eid1502.080817	40	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140328	10.1371/journal.pone.0140328	http://dx.doi.org/10.1371/journal.pone.0140328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462199	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300081
J	Hirabayashi, K; Yuda, E; Tanaka, N; Katayama, S; Iwasaki, K; Matsumoto, T; Kurisu, G; Outten, FW; Fukuyama, K; Takahashi, Y; Wada, K				Hirabayashi, Kei; Yuda, Eiki; Tanaka, Naoyuki; Katayama, Sumie; Iwasaki, Kenji; Matsumoto, Takashi; Kurisu, Genji; Outten, F. Wayne; Fukuyama, Keiichi; Takahashi, Yasuhiro; Wada, Kei			Functional Dynamics Revealed by the Structure of the SufBCD Complex, a Novel ATP-binding Cassette (ABC) Protein That Serves as a Scaffold for Iron-Sulfur Cluster Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SMC PROTEINS; CRYSTAL-STRUCTURE; TRANSPORTER; SYSTEM; SUFC; BACTERIA; CONDENSATION; ARCHITECTURE; RESISTANCE	ATP-binding cassette (ABC)-type ATPases are chemomechanical engines involved in diverse biological pathways. Recent genomic information reveals that ABC ATPase domains/subunits act not only in ABC transporters and structural maintenance of chromosome proteins, but also in iron-sulfur (Fe-S) cluster biogenesis. A novel type of ABC protein, the SufBCD complex, functions in the biosynthesis of nascent Fe-S clusters in almost all Eubacteria and Archaea, as well as eukaryotic chloroplasts. In this study, we determined the first crystal structure of the Escherichia coli SufBCD complex, which exhibits the common architecture of ABC proteins: two ABC ATPase components (SufC) with function-specific components (SufB-SufD protomers). Biochemical and physiological analyses based on this structure provided critical insights into Fe-S cluster assembly and revealed a dynamic conformational change driven by ABC ATPase activity. We propose a molecular mechanism for the biogenesis of the Fe-S cluster in the SufBCD complex.	[Hirabayashi, Kei] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan; [Hirabayashi, Kei; Wada, Kei] Miyazaki Univ, Org Promot Tenure Track, Miyazaki 8891692, Japan; [Yuda, Eiki; Tanaka, Naoyuki; Takahashi, Yasuhiro] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Saitama 3388570, Japan; [Katayama, Sumie; Iwasaki, Kenji; Kurisu, Genji] Osaka Univ, Inst Prot Res, Osaka 5650871, Japan; [Matsumoto, Takashi] Rigaku Corp, Tokyo 1968666, Japan; [Outten, F. Wayne] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Fukuyama, Keiichi] Osaka Univ, Grad Sch Engn, Div Appl Chem, Osaka 5650871, Japan	Osaka University; University of Miyazaki; Saitama University; Osaka University; Rigaku Corporation; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Osaka University	Takahashi, Y (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Saitama 3388570, Japan.	ytaka@molbiol.saitama-u.ac.jp; keiwada@med.miyazaki-u.ac.jp	Regan, Clinton/E-6250-2012; KURISU, GENJI/AAD-7109-2022; KURISU, GENJI/ABA-5960-2020; Takahashi, Yasuhiro/F-1119-2011	KURISU, GENJI/0000-0002-5354-0807; KURISU, GENJI/0000-0002-5354-0807; Takahashi, Yasuhiro/0000-0002-0588-6045; Outten, Franklin/0000-0002-9095-0194; Wada, Kei/0000-0001-7631-4151	Platform for Drug Discovery, Informatics, and Structural Life Science - Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program to Disseminate Tenure Tracking from the Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Education, Culture, Sports, Science, and Technology [25840023, 21770112, 15H04472, 23370052]; Japan Society for the Promotion of Science [12J01292]; Japan Foundation for Applied Enzymology; National Institutes of Health [GM 81706, GM 112919]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081706, R01GM112919] Funding Source: NIH RePORTER	Platform for Drug Discovery, Informatics, and Structural Life Science - Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program to Disseminate Tenure Tracking from the Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Foundation for Applied Enzymology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Platform for Drug Discovery, Informatics, and Structural Life Science funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The synchrotron radiation experiments were performed on BL44XU and BL32XU at SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute under Proposals 2011B6535, 2012B6726, 2013AB6828, 2013B6863, 2014AB6963, 2015A6557, and PDIS1235. This work was also supported by the Program to Disseminate Tenure Tracking (to K. W.) from the Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Education, Culture, Sports, Science, and Technology Grants-in-Aid for Scientific Research 25840023 and 21770112 (to K. W.), 15H04472 (to Y. T.), and 23370052 (to K.F.); a Grant-in-Aid for the Japan Society for the Promotion of Science Fellows 12J01292 (to K. H.); a grant from the Japan Foundation for Applied Enzymology (to K. W.); and National Institutes of Health Grants GM 81706 and GM 112919 (to F. W. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreeva A, 2014, NUCLEIC ACIDS RES, V42, pD310, DOI 10.1093/nar/gkt1242; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Chahal HK, 2009, BIOCHEMISTRY-US, V48, P10644, DOI 10.1021/bi901518y; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gisselberg JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003655; Graumann PL, 2001, BIOCHIMIE, V83, P53, DOI 10.1016/S0300-9084(00)01218-9; Gupta V, 2009, J AM CHEM SOC, V131, P6149, DOI 10.1021/ja807551e; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kitaoka S, 2006, FEBS LETT, V580, P137, DOI 10.1016/j.febslet.2005.11.058; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; NAMIHISA T, 1983, J IMMUNOL METHODS, V56, P125, DOI 10.1016/0022-1759(83)90055-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petrovic A, 2008, PROTEIN SCI, V17, P1264, DOI 10.1110/ps.034652.108; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rangachari K, 2002, FEBS LETT, V514, P225, DOI 10.1016/S0014-5793(02)02369-4; Rees DC, 2003, SCIENCE, V300, P929, DOI 10.1126/science.1083075; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saini A, 2010, BIOCHEMISTRY-US, V49, P9402, DOI 10.1021/bi1011546; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Shimomura Y, 2008, J MOL BIOL, V383, P133, DOI 10.1016/j.jmb.2008.08.015; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tokumoto U, 2004, J BIOCHEM, V136, P199, DOI 10.1093/jb/mvh104; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wada K, 2009, J MOL BIOL, V387, P245, DOI 10.1016/j.jmb.2009.01.054; Wollers S, 2010, J BIOL CHEM, V285, P23329, DOI 10.1074/jbc.M110.127449; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	55	42	42	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29717	29731		10.1074/jbc.M115.680934	http://dx.doi.org/10.1074/jbc.M115.680934			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26472926	Green Published, hybrid			2022-12-26	WOS:000366614700005
J	Meng, HZ; Zhang, WL; Liu, F; Yang, MW				Meng, Hong-Zheng; Zhang, Wei-Lin; Liu, Fei; Yang, Mao-Wei			Advanced Glycation End Products Affect Osteoblast Proliferation and Function by Modulating Autophagy Via the Receptor of Advanced Glycation End Products/Raf Protein/Mitogen-activated Protein Kinase/Extracellular Signalregulated Kinase Kinase/Extracellular Signal-regulated Kinase (RAGE/Raf/MEK/ERK) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MINERAL DENSITY; SMOOTH-MUSCLE-CELLS; FRACTURE RISK; APOPTOSIS; ENDPRODUCTS; DEATH; STRESS; RAGE; COMPLICATIONS; OSTEOPOROSIS	The interaction between advanced glycation end products (AGEs) and receptor of AGEs (RAGE) is associated with the development and progression of diabetes-associated osteoporosis, but the mechanisms involved are still poorly understood. In this study, we found that AGE-modified bovine serum albumin (AGE-BSA) induced a biphasic effect on the viability of hFOB1.19 cells; cell proliferation was stimulated after exposure to low dose AGE-BSA, but cell apoptosis was stimulated after exposure to high dose AGE-BSA. The low dose AGE-BSA facilitates proliferation of hEOB1.19 cells by concomitantly promoting autophagy, RAGE production, and the Raf/MEK/ERK signaling pathway activation. Furthermore, we investigated the effects of AGE-BSA on the function of hFOBL19 cells, Interestingly, the results suggest that the short term effects of low dose AGE-BSA increase osteogenic function and decrease osteoclastogenic function, which are likely mediated by autophagy and the RAGE/Raf/MEK/ERK signal pathway. In contrast, with increased treatment time, the opposite effects were observed. Collectively, AGE-BSA had a biphasic effect on the viability of hEOB1.19 cells in vitro, which was determined by the concentration of AGE-BSA and treatment time. A low concentration of AGE-BSA activated the Raf/MEK/ERK signal pathway through the interaction with RAGE, induced autophagy, and regulated the proliferation and function of hFOB1.19 cells.	[Meng, Hong-Zheng; Zhang, Wei-Lin; Liu, Fei; Yang, Mao-Wei] China Med Univ, Affiliated Hosp 1, Dept Orthopaed, Shenyang 110001, Peoples R China	China Medical University	Yang, MW (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Orthopaed, Shenyang 110001, Peoples R China.	maoweiyang@hotmail.com		Yang, Maowei/0000-0003-4304-7661	National Natural Science Foundation of China [81471094, 81170808]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 81471094 and 81170808. The authors declare that they have no conflicts of interest with the contents of this article.	Alikhani M, 2007, BONE, V40, P345, DOI 10.1016/j.bone.2006.09.011; Alva AS, 2004, CELL DEATH DIFFER, V11, P1046, DOI 10.1038/sj.cdd.4401445; Barbezier N, 2014, ANN BIOL CLIN-PARIS, V72, P669, DOI 10.1684/abc.2014.1010; Bartolome A, 2013, BIOCHEM J, V455, P329, DOI 10.1042/BJ20130562; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; de Liefde II, 2005, OSTEOPOROSIS INT, V16, P1713, DOI 10.1007/s00198-005-1909-1; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Deretic V, 2012, TRENDS CELL BIOL, V22, P397, DOI 10.1016/j.tcb.2012.04.008; Franke S, 2011, CLIN EXP RHEUMATOL, V29, P650; Franke Sybille, 2007, Archives of Physiology and Biochemistry, V113, P154, DOI 10.1080/13813450701602523; Galluzzi L, 2008, CURR MOL MED, V8, P78; Ge JB, 2005, ARTERIOSCL THROM VAS, V25, P2157, DOI 10.1161/01.ATV.0000181744.58265.63; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Hein GE, 2006, CLIN CHIM ACTA, V371, P32, DOI 10.1016/j.cca.2006.03.017; Hofbauer LC, 2001, J MOL MED, V79, P243, DOI 10.1007/s001090100226; Hu PF, 2012, INT J MOL MED, V29, P613, DOI 10.3892/ijmm.2012.891; Kang R, 2010, CELL DEATH DIFFER, V17, P666, DOI 10.1038/cdd.2009.149; Kang R, 2011, AUTOPHAGY, V7, P442, DOI 10.4161/auto.7.4.14681; Kim JH, 2014, EXP CELL RES, V327, P340, DOI 10.1016/j.yexcr.2014.08.001; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lai EHH, 2012, J ENDODONT, V38, P757, DOI 10.1016/j.joen.2012.02.023; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li LF, 2015, ACTA BIOCH BIOPH SIN, V47, P362, DOI 10.1093/abbs/gmv014; McCarthy AD, 1997, MOL CELL BIOCHEM, V170, P43, DOI 10.1023/A:1006816223292; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mercer N, 2007, MOL CELL BIOCHEM, V306, P87, DOI 10.1007/s11010-007-9557-8; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Nollet M, 2014, AUTOPHAGY, V10, P1965, DOI 10.4161/auto.36182; Odetti P, 2005, ANN NY ACAD SCI, V1043, P710, DOI 10.1196/annals.1333.082; Oei L, 2015, CURR OSTEOPOROS REP, V13, P106, DOI 10.1007/s11914-015-0260-5; Pietschmann P, 2010, HORM METAB RES, V42, P763, DOI 10.1055/s-0030-1262825; Platini F, 2010, CURR PHARM DESIGN, V16, P101, DOI 10.2174/138161210789941810; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Saito M, 2014, CURR OSTEOPOROS REP, V12, P181, DOI 10.1007/s11914-014-0202-7; Satoh H, 1997, BIOCHEM BIOPH RES CO, V239, P111, DOI 10.1006/bbrc.1997.7424; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Xie JL, 2013, CELL SIGNAL, V25, P2185, DOI 10.1016/j.cellsig.2013.06.013; Xie Y, 2011, MOL MED REP, V4, P459, DOI 10.3892/mmr.2011.460; Yamagishi S, 2005, MED HYPOTHESES, V65, P1013, DOI 10.1016/j.mehy.2005.07.017; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005	45	48	60	5	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28189	28199		10.1074/jbc.M115.669499	http://dx.doi.org/10.1074/jbc.M115.669499			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26472922	Green Published, hybrid			2022-12-26	WOS:000365761900014
J	Broglie, JJ; Alston, B; Yang, C; Ma, L; Adcock, AF; Chen, W; Yang, LJ				Broglie, Jessica Jenkins; Alston, Brittny; Yang, Chang; Ma, Lun; Adcock, Audrey F.; Chen, Wei; Yang, Liju			Antiviral Activity of Gold/Copper Sulfide Core/Shell Nanoparticles against Human Norovirus Virus-Like Particles	PLOS ONE			English	Article							HIGH-PRESSURE INACTIVATION; MURINE NOROVIRUS; NORWALK VIRUS; FULLERENE DERIVATIVES; THERMAL INACTIVATION; SILVER NANOPARTICLES; FELINE CALICIVIRUS; ENTERIC VIRUSES; SURROGATES; MECHANISMS	Human norovirus is a leading cause of acute gastroenteritis worldwide in a plethora of residential and commercial settings, including restaurants, schools, and hospitals. Methods for easily detecting the virus and for treating and preventing infection are critical to stopping norovirus outbreaks, and inactivation via nanoparticles (NPs) is a more universal and attractive alternative to other physical and chemical approaches. Using norovirus GI.1 (Norwalk) virus-like particles (VLPs) as a model viral system, this study characterized the antiviral activity of Au/CuS core/shell nanoparticles (NPs) against GI.1 VLPs for the rapid inactivation of HuNoV. Inactivation of VLPs (GI.1) by Au/CuS NPs evaluated using an absorbance-based ELISA indicated that treatment with 0.083 mu M NPs for 10 min inactivated similar to 50% VLPs in a 0.37 mu g/ml VLP solution and 0.83 mu M NPs for 10 min completely inactivated the VLPs. Increasing nanoparticle concentration and/or VLP-NP contact time significantly increased the virucidal efficacy of Au/CuS NPs. Changes to the VLP particle morphology, size, and capsid protein were characterized using dynamic light scattering, transmission electron microscopy, and Western blot analysis. The strategy reported here provides the first reported proof-of-concept Au/CuS NPs-based virucide for rapidly inactivating human norovirus.	[Broglie, Jessica Jenkins; Alston, Brittny; Adcock, Audrey F.; Yang, Liju] N Carolina Cent Univ, BRITE, Dept Pharmaceut Sci, Durham, NC 27701 USA; [Yang, Chang; Ma, Lun; Chen, Wei] Univ Texas Arlington, Dept Phys, Arlington, TX 76019 USA	University of North Carolina; North Carolina Central University; University of Texas System; University of Texas Arlington	Yang, LJ (corresponding author), N Carolina Cent Univ, BRITE, Dept Pharmaceut Sci, Durham, NC 27701 USA.	lyang@nccu.edu			Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture (NIFA) [329 2011-68003-30395]	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture (NIFA)	This study was supported by Agriculture and Food Research Initiative Competitive Grant no. 329 2011-68003-30395 from the USDA National Institute of Food and Agriculture (NIFA).	Addae E, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-11; Bae J, 2008, APPL ENVIRON MICROB, V74, P477, DOI 10.1128/AEM.02095-06; Bertrand I, 2012, J APPL MICROBIOL, V112, P1059, DOI 10.1111/j.1365-2672.2012.05267.x; Bozkurt H, 2014, J FOOD PROTECT, V77, P276, DOI 10.4315/0362-028X.JFP-13-289; Broglie JJ, 2014, J ANAL BIOANAL TECH, V5, P220; Cannon JL, 2006, J FOOD PROTECT, V69, P2761, DOI 10.4315/0362-028X-69.11.2761; Chang YN, 2012, MATERIALS, V5, P2850, DOI 10.3390/ma5122850; Citkowicz A, 2008, ANAL BIOCHEM, V376, P163, DOI 10.1016/j.ab.2008.02.011; Colvin RA, 2003, EUR J PHARMACOL, V479, P171, DOI 10.1016/j.ejphar.2003.08.067; Cromeans T, 2014, APPL ENVIRON MICROB, V80, P5743, DOI 10.1128/AEM.01532-14; Cuellar JL, 2010, J GEN VIROL, V91, P2449, DOI 10.1099/vir.0.021212-0; D'Souza DH, 2006, INT J FOOD MICROBIOL, V108, P84, DOI 10.1016/j.ijfoodmicro.2005.10.024; D'Souza DH, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P581; D'Souza DH, 2009, J FOOD PROTECT, V72, P2418, DOI 10.4315/0362-028X-72.11.2418; Duizer E, 2004, APPL ENVIRON MICROB, V70, P4538, DOI 10.1128/AEM.70.8.4538-4543.2004; El-Nahhal IM, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-14; England PH, 2014, PHE MONTHLY NAT 0710, P1; Escudero-Abarca BI, 2014, FOOD MICROBIOL, V41, P91, DOI 10.1016/j.fm.2014.01.009; Feng K, 2011, APPL ENVIRON MICROB, V77, P3507, DOI 10.1128/AEM.00081-11; Gajjar Priyanka, 2009, J Biol Eng, V3, P9, DOI 10.1186/1754-1611-3-9; Ganapathy R, 2013, IN VITRO TIME TEMPER; Girard M, 2010, J FOOD PROTECT, V73, P400, DOI 10.4315/0362-028X-73.2.400; Green KY, 2014, CLIN MICROBIOL INFEC, V20, P717, DOI 10.1111/1469-0691.12761; Grove SF, 2008, INNOV FOOD SCI EMERG, V9, P206, DOI 10.1016/j.ifset.2007.07.006; Hale A, 2000, J MED VIROL, V62, P99, DOI 10.1002/1096-9071(200009)62:1&lt;99::AID-JMV15&gt;3.0.CO;2-0; Hall AJ, 2011, MMWR, V60; Hardy ME, 1996, VIROLOGY, V217, P252, DOI 10.1006/viro.1996.0112; Herbst-Kralovetz M, 2010, EXPERT REV VACCINES, V9, P299, DOI [10.1586/erv.09.163, 10.1586/ERV.09.163]; Huang RZ, 2014, INT J FOOD MICROBIOL, V185, P1, DOI 10.1016/j.ijfoodmicro.2014.05.007; Ingle A, 2008, CURR NANOSCI, V4, P141, DOI 10.2174/157341308784340804; Ingle AP, 2014, APPL MICROBIOL BIOT, V98, P1001, DOI 10.1007/s00253-013-5422-8; Jensen AW, 1996, BIOORGAN MED CHEM, V4, P767, DOI 10.1016/0968-0896(96)00081-8; Kang S, 2008, LANGMUIR, V24, P6409, DOI 10.1021/la800951v; Kingsley DH, 2014, INT J FOOD MICROBIOL, V171, P94, DOI 10.1016/j.ijfoodmicro.2013.11.018; Kirking HL, 2010, CLIN INFECT DIS, V50, P1216, DOI 10.1086/651597; Koo HL, 2009, CLIN INFECT DIS, V49, P1069, DOI 10.1086/605558; Kornylo K, 2009, J TRAVEL MED, V16, P349, DOI 10.1111/j.1708-8305.2009.00344.x; Lakshmanan SB, 2012, J BIOMED NANOTECHNOL, V8, P883, DOI 10.1166/jbn.2012.1486; Lee JE, 2013, WATER RES, V47, P5607, DOI 10.1016/j.watres.2013.06.035; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Li XH, 2013, INT J FOOD MICROBIOL, V162, P37, DOI 10.1016/j.ijfoodmicro.2012.12.016; Liu PB, 2013, APPL ENVIRON MICROB, V79, P7875, DOI 10.1128/AEM.02576-13; Liu PB, 2009, FOOD ENVIRON VIROL, V1, P141, DOI 10.1007/s12560-009-9019-4; Lou FF, 2012, APPL ENVIRON MICROB, V78, P5320, DOI 10.1128/AEM.00532-12; Macinga DR, 2008, APPL ENVIRON MICROB, V74, P5047, DOI 10.1128/AEM.00487-08; Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966; Manuel CS, 2015, APPL ENVIRON MICROB, V81, P4940, DOI 10.1128/AEM.00388-15; Mashino T, 1999, BIOORG MED CHEM LETT, V9, P2959, DOI 10.1016/S0960-894X(99)00515-6; Morter S, 2011, J HOSP INFECT, V77, P106, DOI 10.1016/j.jhin.2010.09.035; Narayan RJ, 2005, MAT SCI ENG B-SOLID, V123, P123, DOI 10.1016/j.mseb.2005.07.007; Park GW, 2014, J PHOTOCH PHOTOBIO B, V140, P315, DOI 10.1016/j.jphotobiol.2014.08.009; Park S, 2014, APPL ENVIRON MICROB, V80, P2343, DOI 10.1128/AEM.03427-13; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Pattenden LK, 2005, TRENDS BIOTECHNOL, V23, P523, DOI 10.1016/j.tibtech.2005.07.011; PRASAD BVV, 1994, J VIROL, V68, P5117, DOI 10.1128/JVI.68.8.5117-5125.1994; PUMPENS P, 2002, ARTIFICIAL DNA METHO, P249; Seo K, 2012, J FOOD PROTECT, V75, P533, DOI 10.4315/0362-028X.JFP-11-199; Shionoiri N, 2012, J BIOSCI BIOENG, V113, P580, DOI 10.1016/j.jbiosc.2011.12.006; Su XW, 2009, J FOOD PROTECT, V72, P2623, DOI 10.4315/0362-028X-72.12.2623; Tang YJJ, 2007, NANO LETT, V7, P754, DOI 10.1021/nl063020t; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Thornton SA, 2005, CLIN INFECT DIS, V40, P519, DOI 10.1086/427501; Tsao N, 2002, J ANTIMICROB CHEMOTH, V49, P641, DOI 10.1093/jac/49.4.641; Vimont A, 2015, APPL ENVIRON MICROB, V81, P2950, DOI 10.1128/AEM.03840-14; Wadl M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-30; Warnes SL, 2015, APPL ENVIRON MICROB, V81, P1085, DOI 10.1128/AEM.03280-14; Warnes SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075017; Wigginton KR, 2012, CURR OPIN VIROL, V2, P84, DOI 10.1016/j.coviro.2011.11.003; Yap J, 2012, SINGAP MED J, V53, P249; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	70	61	61	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0141050	10.1371/journal.pone.0141050	http://dx.doi.org/10.1371/journal.pone.0141050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474396	gold, Green Published, Green Submitted			2022-12-26	WOS:000363185500142
J	Kendrick, P; Jackson, IR; Fazenda, BM; Cox, TJ; Li, FF				Kendrick, Paul; Jackson, Iain R.; Fazenda, Bruno M.; Cox, Trevor J.; Li, Francis F.			Microphone Handling Noise: Measurements of Perceptual Threshold and Effects on Audio Quality	PLOS ONE			English	Article								A psychoacoustic experiment was carried out to test the effects of microphone handling noise on perceived audio quality. Handling noise is a problem affecting both amateurs using their smartphones and cameras, as well as professionals using separate microphones and digital recorders. The noises used for the tests were measured from a variety of devices, including smartphones, laptops and handheld microphones. The signal features that characterise these noises are analysed and presented. The sounds include various types of transient, impact noises created by tapping or knocking devices, as well as more sustained sounds caused by rubbing. During the perceptual tests, listeners auditioned speech podcasts and were asked to rate the degradation of any unwanted sounds they heard. A representative design test methodology was developed that tried to encourage everyday rather than analytical listening. Signal-to-noise ratio (SNR) of the handling noise events was shown to be the best predictor of quality degradation. Other factors such as noise type or background noise in the listening environment did not significantly affect quality ratings. Podcast, microphone type and reproduction equipment were found to be significant but only to a small extent. A model allowing the prediction of degradation from the SNR is presented. The SNR threshold at which 50% of subjects noticed handling noise was found to be 4.2 +/- 0.6 dBA. The results from this work are important for the understanding of our perception of impact sound and resonant noises in recordings, and will inform the future development of an automated predictor of quality for handling noise.	[Kendrick, Paul; Jackson, Iain R.; Fazenda, Bruno M.; Cox, Trevor J.; Li, Francis F.] Univ Salford, Sch Comp Sci & Engn, Acoust Res Ctr, Salford M5 4WT, Lancs, England	University of Salford	Cox, TJ (corresponding author), Univ Salford, Sch Comp Sci & Engn, Acoust Res Ctr, Salford M5 4WT, Lancs, England.	t.j.cox@salford.ac.uk		Cox, Trevor/0000-0002-4075-7564; Fazenda, Bruno/0000-0002-3912-0582	Engineering and Physical Science Research Council, UK [EP/J013013/1]; EPSRC [EP/J013250/1, EP/J013013/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J013013/1, EP/J013250/1] Funding Source: researchfish	Engineering and Physical Science Research Council, UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Science Research Council, UK (http://www.epsrc.ac.uk/ EP/J013013/1) (PK, IRJ, BMF, TJC, and FFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, IEC616721; [Anonymous], 1996, METH SUBJ DET TRANSM; [Anonymous], 1998, ITU T RECOMMENDATION; Araujo D, 2007, ECOL PSYCHOL, V19, P69, DOI 10.1080/10407410709336951; Berglund B, 2006, ACTA ACUST UNITED AC, V92, P938; Binomial Logistic Regression using SPSS, 2013, LAERD STAT; Brunswik E, 1956, PERCEPTION REPRESENT, P154; ITU-R, 2015, BS11163 INT TEL UN R; Jackson I, 2012, GOOD RECORDING PROJE; Jackson IR, 2014, J ACOUST SOC AM, V136, P1176, DOI 10.1121/1.4892772; Knoll MA, 2011, BEHAV INFORM TECHNOL, V30, P845, DOI 10.1080/0144929X.2011.577192; Musch J., 2000, PSYCHOL EXPT INTERNE, P61, DOI [DOI 10.1016/B978-012099980-4/50004-6, 10.1016/B978-012099980-4/50004-6]; OConnell AA, 2006, LOGISTIC REGRESSION, P29; OConnell AA, 2006, LOGISTIC REGRESSION, P31; Oliver L., 2007, P 10 INT C DIG AUD E, P127; Recommendation ITU-R, 2003, METH SUBJ ASS INT QU; Shure Customer Help, 2003, HANDL NOIS MICR; Traux B, 2000, ACOUSTIC COMMUNICATI, V1, P163; Vastfjall D., 2004, Acoustical Science and Technology, V25, P170, DOI 10.1250/ast.25.170	19	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140256	10.1371/journal.pone.0140256	http://dx.doi.org/10.1371/journal.pone.0140256			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473498	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500035
J	Kosikowska, P; Pikula, M; Langa, P; Trzonkowski, P; Obuchowski, M; Lesner, A				Kosikowska, Paulina; Pikula, Michal; Langa, Paulina; Trzonkowski, Piotr; Obuchowski, Michal; Lesner, Adam			Synthesis and Evaluation of Biological Activity of Antimicrobial - Pro-Proliferative Peptide Conjugates	PLOS ONE			English	Article							DIFFERENTIATION; MECHANISMS; CULTURE; EVASION; SKIN	Skin represents the largest organ of the human body and plays a crucial role in its protection from the negative impact of the outside environment, maintains its homeostasis, enables sensory interaction and thermoregulation. The traumatized skin tissue undergoes several phenotype switches due to progressive reoxygenation and release of cytokine and growth factors, that activate mechanisms of reparative processes. However, in case of wounds colonized with pathogenic microflora natural regenerative mechanisms become substantially impaired, that could lead to chronic inflammatory states with non-healing skin lesions. Herein, we present the initial results of our studies aimed at the design of bifunctional peptide-based compounds. The chemical approach, that was utilized in this work, was based on the conjugation of antimicrobial peptides with the peptides, that have potential pro-proliferative and/or cytoprotective activity towards human keratinocytes and fibroblasts, in order to obtain antimicrobials with reduced cytotoxicity or compounds that maintain both activities, i.e. inhibit bacterial or fungi growth and activate cell proliferation/migration in in vitro tests. As a result, we obtained a group of peptide conjugates that effectively inhibited the growth of selected bacterial and fungi strains and were able to stimulate proliferation and migration of keratinocytes and fibroblasts under their effective microbicidal concentrations.	[Kosikowska, Paulina; Lesner, Adam] Univ Gdansk, Dept Biochem, Fac Chem, PL-80952 Gdansk, Poland; [Pikula, Michal; Langa, Paulina; Trzonkowski, Piotr] Med Univ Gdansk, Dept Clin Immunol & Transplantol, Gdansk, Poland; [Obuchowski, Michal] Med Univ Gdansk, Intercollegiate Fac Biotechnol UG MUG, Dept Med Biotechnol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Lesner, A (corresponding author), Univ Gdansk, Dept Biochem, Fac Chem, PL-80952 Gdansk, Poland.	adam.lesner@ug.edu.pl	Obuchowski, Michał/N-1118-2019; Langa, Paulina/AAL-2831-2020; Obuchowski, Michał/F-5836-2011; Trzonkowski, Piotr/U-1137-2018; Lesner, Adam/M-2732-2019	Obuchowski, Michał/0000-0001-5410-2350; Obuchowski, Michał/0000-0001-5410-2350; Trzonkowski, Piotr/0000-0001-5287-5210; Kosikowska-Adamus, Paulina/0000-0002-4737-2771; Pikula, Michal/0000-0001-7751-9781; Lesner, Adam/0000-0001-8335-3431	Polish National Science Center [UMO-2012/04/S/ST5/00074]	Polish National Science Center	This work was supported by Polish National Science Center under the grant number UMO-2012/04/S/ST5/00074	Baranska-Rybak W, 2013, ACTA POL PHARM, V70, P795; Belas R, 2004, INFECT IMMUN, V72, P5159, DOI 10.1128/IAI.72.9.5159-5167.2004; Boukamp P, 1997, GENE CHROMOSOME CANC, V19, P201, DOI 10.1002/(SICI)1098-2264(199708)19:4<201::AID-GCC1>3.0.CO;2-0; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Deyrieux AF, 2007, CYTOTECHNOLOGY, V54, P77, DOI 10.1007/s10616-007-9076-1; Gutowska-Owsiak D, 2014, J INVEST ALLERG CLIN, V24, P231; Hartmann R, 2007, CURR OPIN BIOTECH, V18, P163, DOI 10.1016/j.copbio.2007.01.013; Hong SY, 1999, ANTIMICROB AGENTS CH, V43, P1704, DOI 10.1128/AAC.43.7.1704; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Jenssen H, 2011, EXPERT OPIN DRUG DIS, V6, P171, DOI 10.1517/17460441.2011.545817; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jin T, 2004, J IMMUNOL, V172, P1169, DOI 10.4049/jimmunol.172.2.1169; Kondo T, 2010, FORENSIC SCI INT, V203, P93, DOI 10.1016/j.forsciint.2010.07.004; Krcmery V, 2002, J HOSP INFECT, V50, P243, DOI 10.1053/jhin.2001.1151; Lakshminarayanan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087730; Landis S.J., 2008, ADV SKIN WOUND CARE, V21, P531, DOI DOI 10.1097/01.ASW.0000323578.87700.A5; Matsuo M, 2011, MICROBIOL-SGM, V157, P1786, DOI 10.1099/mic.0.044727-0; McNeilly AD, 2012, DRUG METAB DISPOS, V40, P283, DOI 10.1124/dmd.111.042085; Mignot T, 2001, ENVIRON MICROBIOL, V3, P493, DOI 10.1046/j.1462-2920.2001.00220.x; Oh JE, 1999, J PEPT RES, V53, P41, DOI 10.1111/j.1399-3011.1999.tb01615.x; Papon N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003550; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Pushpanathan Muthuirulan, 2013, Int J Pept, V2013, P675391, DOI 10.1155/2013/675391; ROBSON MC, 1990, CLIN PLAST SURG, V17, P485; Ryu S, 2014, INT J MOL SCI, V15, P8753, DOI 10.3390/ijms15058753; Semlali A, 2011, PEPTIDES, V32, P859, DOI 10.1016/j.peptides.2011.01.020; Shang DJ, 2012, CHEM BIOL DRUG DES, V79, P653, DOI 10.1111/j.1747-0285.2012.01363.x; Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x; Slominski A, 2006, J CELL PHYSIOL, V206, P780, DOI 10.1002/jcp.20530; TrOstrup H, 2013, ULCERS, V2013, P8; van der Weerden NL, 2013, CELL MOL LIFE SCI, V70, P3545, DOI 10.1007/s00018-013-1260-1; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Werdin Frank, 2009, Eplasty, V9, pe19; Wilkins MR, 1999, METH MOL B, V112, P531; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yount NY, 2012, ANNU REV PHARMACOL, V52, P337, DOI 10.1146/annurev-pharmtox-010611-134535; Zbytek B, 2005, BRIT J DERMATOL, V152, P474, DOI 10.1111/J.1365-2133.2005.06217.X	39	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140377	10.1371/journal.pone.0140377	http://dx.doi.org/10.1371/journal.pone.0140377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473368	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500044
J	Noriega, V; Martinez-Laperche, C; Buces, E; Pion, M; Sanchez-Hernandez, N; Martin-Antonio, B; Guillem, V; Bosch-Vizcaya, A; Bento, L; Gonzalez-Rivera, M; Balsalobre, P; Kwon, M; Serrano, D; Gayoso, J; de la Camara, R; Brunet, S; Rojas-Contreras, R; Nieto, JB; Martinez, C; Gonzalez, M; Espigado, I; Vallejo, JC; Sampol, A; Jimenez-Velasco, A; Urbano-Ispizua, A; Solano, C; Gallardo, D; Diez-Martin, JL; Buno, I				Noriega, Victor; Martinez-Laperche, Carolina; Buces, Elena; Pion, Marjorie; Sanchez-Hernandez, Noemi; Martin-Antonio, Beatriz; Guillem, Vicent; Bosch-Vizcaya, Anna; Bento, Leyre; Gonzalez-Rivera, Milagros; Balsalobre, Pascual; Kwon, Mi; Serrano, David; Gayoso, Jorge; de la Camara, Rafael; Brunet, Salut; Rojas-Contreras, Rafael; Nieto, Jose B.; Martinez, Carmen; Gonzalez, Marcos; Espigado, Ildefonso; Vallejo, Juan C.; Sampol, Antonia; Jimenez-Velasco, Antonio; Urbano-Ispizua, Alvaro; Solano, Carlos; Gallardo, David; Diez-Martin, Jose L.; Buno, Ismael		Spanish Hematopoietic Stem Cell Tr	The Genotype of the Donor for the (GT)(n) Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation	PLOS ONE			English	Article							REGULATORY T-CELLS; BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; TRANSCRIPTION FACTOR FOXP3; FOXP3/SCURFIN GENE; GT MICROSATELLITE; LEUKEMIA; SUSCEPTIBILITY; TOLERANCE; PROMOTER	The FOXP3 gene encodes for a protein (Foxp3) involved in the development and functional activity of regulatory T cells (CD4+/CD25+/Foxp3+), which exert regulatory and suppressive roles over the immune system. After allogeneic stem cell transplantation, regulatory T cells are known to mitigate graft versus host disease while probably maintaining a graft versus leukemia effect. Short alleles (<=(GT)(15)) for the (GT)(n) polymorphism in the promoter/enhancer of FOXP3 are associated with a higher expression of FOXP3, and hypothetically with an increase of regulatory T cell activity. This polymorphism has been related to the development of auto-or alloimmune conditions including type 1 diabetes or graft rejection in renal transplant recipients. However, its impact in the allo-transplant setting has not been analyzed. In the present study, which includes 252 myeloablative HLA-identical allo-transplants, multivariate analysis revealed a lower incidence of grade III-IV acute graft versus host disease (GVHD) in patients transplanted from donors harboring short alleles (OR = 0.26, CI 0.08-0.82, p = 0.021); without affecting chronic GVHD or graft versus leukemia effect, since cumulative incidence of relapse, event free survival and overall survival rates are similar in both groups of patients.	[Noriega, Victor; Martinez-Laperche, Carolina; Buces, Elena; Sanchez-Hernandez, Noemi; Bento, Leyre; Balsalobre, Pascual; Kwon, Mi; Serrano, David; Gayoso, Jorge; Diez-Martin, Jose L.; Buno, Ismael] Hosp Gen Univ Gregorio Maranon, Dept Hematol, Madrid, Spain; [Noriega, Victor; Martinez-Laperche, Carolina; Buces, Elena; Pion, Marjorie; Gonzalez-Rivera, Milagros; Balsalobre, Pascual; Kwon, Mi; Serrano, David; Gayoso, Jorge; Diez-Martin, Jose L.; Buno, Ismael] Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain; [Pion, Marjorie] Hosp Gen Univ Gregorio Maranon, Dept Inmunol, Madrid, Spain; [Martin-Antonio, Beatriz; Urbano-Ispizua, Alvaro] Univ Barcelona, Hosp Clin, Inst Invest Josep Carreras IJC, Dept Hematol,IDIBAPS, Barcelona, Spain; [Guillem, Vicent; Solano, Carlos] Univ Valencia, Hosp Clin, Inst Invest Sanitaria INCLIVA, Dept Hematol & Med Oncol, Valencia, Spain; [Bosch-Vizcaya, Anna; Gallardo, David] Hosp Josep Trueta, IDIBGI Fdn, Dept Hematol, ICO Girona, Girona, Spain; [Gonzalez-Rivera, Milagros] Hosp Gen Univ Gregorio Maranon, DNA Sequencing Core Facil, Madrid, Spain; [de la Camara, Rafael] Hosp La Princesa, Dept Hematol, Madrid, Spain; [Brunet, Salut] Hosp Santa Creu & Sant Pau, Dept Clin Hematol, Barcelona, Spain; [Rojas-Contreras, Rafael] Hosp Reina Sofia, Dept Hematol, Cordoba, Spain; [Nieto, Jose B.] Hosp Morales Meseguer, Dept Hematol, Murcia, Spain; [Martinez, Carmen] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain; [Gonzalez, Marcos] Univ Hosp Salamanca, Dept Hematol, Salamanca, Spain; [Espigado, Ildefonso] Hosp Univ Virgen del Rocio, Dept Hematol & Hemotherapy, Seville, Spain; [Vallejo, Juan C.] Hosp Univ Cent Asturias, Dept Hematol, Oviedo, Spain; [Sampol, Antonia] Hosp Univ Son Espases, Dept Hematol, Palma De Mallorca, Islas Baleares, Spain; [Jimenez-Velasco, Antonio] Univ Malaga, Hosp Reg, Dept Hematol, E-29071 Malaga, Spain	General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Valencia; Catalan Institute of Oncology; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); General University Gregorio Maranon Hospital; Hospital de La Princesa; Hospital of Santa Creu i Sant Pau; Hospital Universitario Reina Sofia - Cordoba; University of Barcelona; Hospital Clinic de Barcelona; University of Salamanca; Virgen del Rocio University Hospital; Central University Hospital Asturias; Hospital Universitari Son Espases; Universidad de Malaga	Buno, I (corresponding author), Hosp Gen Univ Gregorio Maranon, Dept Hematol, Madrid, Spain.	ismaelbuno@gmail.com	Pion, Marjorie/D-8139-2012; Buno, Ismael/G-4524-2013; IBIS, BIOHEM/H-6478-2016; Martín-Antonio, Beatriz/D-4963-2014; de la Camara, Rafael/B-2106-2009; Pion, Marjorie/AAB-5812-2022; Solano, Carlos/AAW-4678-2020; Sánchez, Noemí/V-7150-2017; ESPIGADO, ILDEFONSO/C-9304-2015; Diez-Martin, Jose Luis/AAB-6526-2019; Martinez-Laperche, Carolina/G-8664-2013; Pion, Marjorie/D-8139-2012	Pion, Marjorie/0000-0003-1828-4745; Buno, Ismael/0000-0003-4931-9170; Martín-Antonio, Beatriz/0000-0003-0612-2693; de la Camara, Rafael/0000-0002-8189-5779; Solano, Carlos/0000-0003-3702-0817; Sánchez, Noemí/0000-0002-1697-2352; ESPIGADO, ILDEFONSO/0000-0002-4043-6613; Diez-Martin, Jose Luis/0000-0003-1869-0129; Gonzalez Diaz, Marcos/0000-0001-6637-1072; Martinez-Laperche, Carolina/0000-0001-6802-3485; Pion, Marjorie/0000-0002-6406-747X; Noriega, Victor/0000-0001-8931-5567; Gallardo, David/0000-0003-1615-4592	Ministry of Economy and Competitiveness ISCIII-FIS [PI08/1463, PI11/00708, PI14-01731, RD12/0036/0061]; ERDF (FEDER) Funds from the European Commission; Fundacion LAIR; Asociacion Madrilena de Hematologia y Hemoterapia (AMHH); ISCIII-FIS grant [PI01-3624, PI08-36173]; Post-Residency Research Fellowship from the Instituto de Investigacion Sanitaria Gregorio Maranon (IiSGM)	Ministry of Economy and Competitiveness ISCIII-FIS; ERDF (FEDER) Funds from the European Commission; Fundacion LAIR; Asociacion Madrilena de Hematologia y Hemoterapia (AMHH); ISCIII-FIS grant; Post-Residency Research Fellowship from the Instituto de Investigacion Sanitaria Gregorio Maranon (IiSGM)	This work was partially supported by the Ministry of Economy and Competitiveness ISCIII-FIS grants PI08/1463, PI11/00708, PI14-01731 and RD12/0036/0061, co-financed by ERDF (FEDER) Funds from the European Commission, as well as grants from the Fundacion LAIR and Asociacion Madrilena de Hematologia y Hemoterapia (AMHH). Sequencer 3130xl Genetic Analyzer was partially supported by ISCIII-FIS grants PI01-3624, PI08-36173. VN and CML were partially supported by a Post-Residency Research Fellowship from the Instituto de Investigacion Sanitaria Gregorio Maranon (IiSGM).	Cahn JY, 2005, BLOOD, V106, P1495, DOI 10.1182/blood-2004-11-4557; Chen XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059696; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Dickinson AM, 2004, BRIT J HAEMATOL, V127, P479, DOI 10.1111/j.1365-2141.2004.05216.x; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Engela AU, 2013, HUM IMMUNOL, V74, P751, DOI 10.1016/j.humimm.2013.02.008; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; HOROWITZ MM, 1990, BLOOD, V75, P555; Kolb HJ, 2008, BLOOD, V112, P4371, DOI 10.1182/blood-2008-03-077974; lanni MD, 2011, BLOOD, V117, P3921, DOI [10.1182/blood-2010-10-311894, DOI 10.1182/BL00D-2010-10-311894]; Mielke S, 2007, BLOOD, V110, P1689, DOI 10.1182/blood-2007-03-079160; Mullighan CG, 2007, BIOL BLOOD MARROW TR, V13, P127, DOI 10.1016/j.bbmt.2006.10.018; Nadal E, 2007, LEUKEMIA, V21, P472, DOI 10.1038/sj.leu.2404522; Nakanishi K, 2007, CLIN CHIM ACTA, V384, P171, DOI 10.1016/j.cca.2007.06.002; Nakasone H, 2015, BONE MARROW TRANSPL, V50, P559, DOI 10.1038/bmt.2014.293; Rezvani K, 2006, BLOOD, V108, P1291, DOI 10.1182/blood-2006-02-003996; Rowe JH, 2012, IMMUNOLOGY, V136, P1, DOI 10.1111/j.1365-2567.2011.03551.x; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sanchez E, 2005, HUM IMMUNOL, V66, P869, DOI 10.1016/j.humimm.2005.06.001; Urbieta M, 2010, BLOOD, V115, P4934, DOI 10.1182/blood-2009-04-218826; Wing K, 2005, IMMUNOLOGY, V115, P516, DOI 10.1111/j.1365-2567.2005.02186.x; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yang Kai, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P547	29	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140454	10.1371/journal.pone.0140454	http://dx.doi.org/10.1371/journal.pone.0140454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473355	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500054
J	Slator, PJ; Cairo, CW; Burroughs, NJ				Slator, Paddy J.; Cairo, Christopher W.; Burroughs, Nigel J.			Detection of Diffusion Heterogeneity in Single Particle Tracking Trajectories Using a Hidden Markov Model with Measurement Noise Propagation	PLOS ONE			English	Article							MARGINAL LIKELIHOOD; LATERAL DIFFUSION; MOLECULE TRACKING; INTEGRIN LFA-1; CONFINEMENT; MOBILITY; MOTION; ORGANIZATION; ACTIVATION; MICROSCOPY	We develop a Bayesian analysis framework to detect heterogeneity in the diffusive behaviour of single particle trajectories on cells, implementing model selection to classify trajectories as either consistent with Brownian motion or with a two-state (diffusion coefficient) switching model. The incorporation of localisation accuracy is essential, as otherwise false detection of switching within a trajectory was observed and diffusion coefficient estimates were inflated. Since our analysis is on a single trajectory basis, we are able to examine heterogeneity between trajectories in a quantitative manner. Applying our method to the lymphocyte function-associated antigen 1 (LFA-1) receptor tagged with latex beads (4 s trajectories at 1000 frames s(-1)), both intra- and inter-trajectory heterogeneity were detected; 12-26% of trajectories display clear switching between diffusive states dependent on condition, whilst the inter-trajectory variability is highly structured with the diffusion coefficients being related by D-1 = 0.68D(0) - 1.5 x 10(4) nm(2) s(-1), suggestive that on these time scales we are detecting switching due to a single process. Further, the inter-trajectory variability of the diffusion coefficient estimates (1.6 x 10(2) - 2.6 x 10(5) nm(2) s(-1)) is very much larger than the measurement uncertainty within trajectories, suggesting that LFA-1 aggregation and cytoskeletal interactions are significantly affecting mobility, whilst the timescales of these processes are distinctly different giving rise to inter-and intra- trajectory variability. There is also an 'immobile' state (defined as D < 3.0 x 10(3) nm(2) s(-1)) that is rarely involved in switching, immobility occurring with the highest frequency (47%) under T cell activation (phorbol-12-myristate-13-acetate (PMA) treatment) with enhanced cytoskeletal attachment (calpain inhibition). Such 'immobile' states frequently display slow linear drift, potentially reflecting binding to a dynamic actin cortex. Our methods allow significantly more information to be extracted from individual trajectories (ultimately limited by time resolution and time-series length), and allow statistical comparisons between trajectories thereby quantifying inter-trajectory heterogeneity. Such methods will be highly informative for the construction and fitting of molecule mobility models within membranes incorporating aggregation, binding to the cytoskeleton, or traversing membrane microdomains.	[Slator, Paddy J.; Burroughs, Nigel J.] Univ Warwick, Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Slator, Paddy J.] Univ Warwick, Syst Biol Doctoral Training Ctr, Coventry CV4 7AL, W Midlands, England; [Cairo, Christopher W.] Univ Alberta, Dept Chem, Edmonton, AB, Canada	University of Warwick; University of Warwick; University of Alberta	Burroughs, NJ (corresponding author), Univ Warwick, Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England.	N.J.Burroughs@warwick.ac.uk	Cairo, Christopher W/B-5355-2009	Cairo, Christopher W/0000-0003-3363-8708; Slator, Paddy/0000-0001-6967-989X	University of Warwick; Natural Sciences and Engineering Research Council of Canada	University of Warwick; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	PJS received funding from the University of Warwick to study at the Warwick Systems Biology Doctoral Training Centre. CWC received funding from the Natural Sciences and Engineering Research Council of Canada.	[Anonymous], 2013, TEXTS STAT SCI SERIE; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Chen MH, 2005, STAT NEERL, V59, P16, DOI 10.1111/j.1467-9574.2005.00276.x; Chib S, 1995, J AM STAT ASSOC, V90, P1313, DOI 10.2307/2291521; Chib S, 2001, J AM STAT ASSOC, V96, P270, DOI 10.1198/016214501750332848; Clausen MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097671; Clausen MP, 2013, NANO LETT, V13, P2332, DOI 10.1021/nl303151f; Das R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000556; Drbal K, 2001, IMMUNOBIOLOGY, V203, P687, DOI 10.1016/S0171-2985(01)80017-6; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; Helmuth JA, 2007, J STRUCT BIOL, V159, P347, DOI 10.1016/j.jsb.2007.04.003; Hofling F, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/4/046602; Hogg N, 2004, IMMUNOL LETT, V92, P51, DOI 10.1016/j.imlet.2003.10.014; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Hui KL, 2015, MOL BIOL CELL, V26, P685, DOI 10.1091/mbc.E14-03-0830; Bakker GJ, 2012, P NATL ACAD SCI USA, V109, P4869, DOI 10.1073/pnas.1116425109; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LOLLO BA, 1993, J BIOL CHEM, V268, P21693; Mascalchi P, 2012, SOFT MATTER, V8, P4462, DOI 10.1039/c2sm07018a; Massignan P, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.150603; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Meilhac N, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011915; Michalet X, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061916; Michalet X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041914; Monnier N, 2015, NATURE METHODS, P1; Monnier N, 2013, THESIS HARVARD U; Monnier N, 2012, BIOPHYS J, V103, P616, DOI 10.1016/j.bpj.2012.06.029; Montiel D, 2006, J PHYS CHEM B, V110, P19763, DOI 10.1021/jp062024j; Persson F, 2013, NAT METHODS, V10, P265, DOI [10.1038/NMETH.2367, 10.1038/nmeth.2367]; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; POWLES JG, 1992, P ROY SOC LOND A MAT, V436, P391, DOI 10.1098/rspa.1992.0025; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rajani V, 2011, BIOPHYS J, V100, P1463, DOI 10.1016/j.bpj.2011.01.064; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Sahl SJ, 2010, P NATL ACAD SCI USA, V107, P6829, DOI 10.1073/pnas.0912894107; SAXTON MJ, 1994, BIOPHYS J, V67, P2110, DOI 10.1016/S0006-3495(94)80694-0; SAXTON MJ, 1993, BIOPHYS J, V64, P1766, DOI 10.1016/S0006-3495(93)81548-0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Simonson WTN, 2006, J IMMUNOL, V177, P7707, DOI 10.4049/jimmunol.177.11.7707; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Wieser S, 2008, METHODS, V46, P131, DOI 10.1016/j.ymeth.2008.06.010	54	28	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140759	10.1371/journal.pone.0140759	http://dx.doi.org/10.1371/journal.pone.0140759			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473352	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500104
J	Allen, CD; Robbins, MN; Eguchi, T; Owens, DW; Meylan, AB; Meylan, PA; Kellar, NM; Schwenter, JA; Nollens, HH; LeRoux, RA; Dutton, PH; Seminoff, JA				Allen, Camryn D.; Robbins, Michelle N.; Eguchi, Tomoharu; Owens, David W.; Meylan, Anne B.; Meylan, Peter A.; Kellar, Nicholas M.; Schwenter, Jeffrey A.; Nollens, Hendrik H.; LeRoux, Robin A.; Dutton, Peter H.; Seminoff, Jeffrey A.			First Assessment of the Sex Ratio for an East Pacific Green Sea Turtle Foraging Aggregation: Validation and Application of a Testosterone ELISA	PLOS ONE			English	Article							CHELONIA-MYDAS; CARETTA-CARETTA; SAN-DIEGO; TEMPERATURE; POPULATION; STEROIDS; GROWTH; DIFFERENTIATION; PREGNANCY; RESIDENT	Determining sex ratios of endangered populations is important for wildlife management, particularly species subject to sex-specific threats or that exhibit temperature-dependent sex determination. Sea turtle sex is determined by incubation temperature and individuals lack external sex-based traits until sexual maturity. Previous research utilized serum/plasma testosterone radioimmunoassays (RIA) to determine sex in immature/juvenile sea turtles. However, there has been a growing application of enzyme-linked immunosorbent assay (ELISA) for wildlife endocrinology studies, but no study on sea turtles has compared the results of ELISA and RIA. This study provides the first sex ratio for a threatened East Pacific green sea turtle (Chelonia mydas) foraging aggregation, a critical step for future management of this species. Here, we validate a testosterone ELISA and compare results between RIA and ELISA of duplicate samples. The ELISA demonstrated excellent correspondence with the RIA for providing testosterone concentrations for sex determination. Neither assay proved reliable for predicting the sex of reproductively active females with increased testosterone production. We then applied ELISA to examine the sex ratio of 69 green turtles foraging in San Diego Bay, California. Of 45 immature turtles sampled, sex could not be determined for three turtles because testosterone concentrations fell between the ranges for either sex (females: 4.1-113.1 pg/mL, males: 198.4-2,613.0 pg/mL) and these turtles were not subsequently recaptured to enable sex determination; using a Bayesian model to predict probabilities of turtle sex we predicted all three 'unknowns' were female (> 0.86). Additionally, the model assigned all turtles with their correct sex (if determined at recapture) with 100% accuracy. Results indicated a female bias (2.83F: 1M) among all turtles in the aggregation; when focusing only on putative immature turtles the sex ratio was 3.5F:1M. With appropriate validation, ELISA sexing could be applied to other sea turtle species, and serve as a crucial conservation tool.	[Allen, Camryn D.; Robbins, Michelle N.; Eguchi, Tomoharu; Kellar, Nicholas M.; LeRoux, Robin A.; Dutton, Peter H.; Seminoff, Jeffrey A.] NOAA, Marine Mammal & Turtle Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA; [Owens, David W.; Schwenter, Jeffrey A.] Univ Charleston South Carolina, Grice Marine Lab, Charleston, SC USA; [Meylan, Anne B.] Fish & Wildlife Res Inst, Florida Fish & Wildlife Conservat Commiss, St Petersburg, FL USA; [Meylan, Peter A.] Eckerd Coll, Nat Sci, St Petersburg, FL 33733 USA; [Nollens, Hendrik H.] SeaWorld San Diego, Vet Serv, San Diego, CA USA	National Oceanic Atmospheric Admin (NOAA) - USA; Florida Fish & Wildlife Conservation Commission	Allen, CD (corresponding author), NOAA, Marine Mammal & Turtle Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA.	camryn.allen@noaa.gov	Kellar, Nicholas/AAA-4606-2021		Wildlife Conservation Society; Smithsonian Tropical Research Institute; Sea Turtle Conservancy; Bermuda Aquarium, Museum and Zoo	Wildlife Conservation Society; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Sea Turtle Conservancy; Bermuda Aquarium, Museum and Zoo	Support for the Panama research was provided to ABM and PAM by the Wildlife Conservation Society and the Smithsonian Tropical Research Institute. The funding is renewed annually but there is not a grant number. Wildlife Conservation Society is at: http://www.wcs.org/. The Smithsonian Tropical Research Institute is at: https://www.stri.si.edu/. The research in Bermuda was conducted as part of the Bermuda Turtle Project and was supported by the Sea Turtle Conservancy and the Bermuda Aquarium, Museum and Zoo. The funding is provided to ABM and PAM and is renewed annually. There are no grant numbers. Sea Turtle Conservancy is at: http://www.conserveturtles.org/. The Bermuda Aquarium, Museum and Zoo is at: www.bamz.org.	Alvarado-Diaz J, 1990, FINAL REP USFWS WWF, P139; Best N, BAYESIAN APPROACHES; Blanco Gabriela S., 2012, Endangered Species Research, V18, P233, DOI 10.3354/esr00451; Blanvillain Gaelle, 2008, Endangered Species Research, V6, P75, DOI 10.3354/esr00136; Blanvillain G, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 3: REPTILES, P277; Blanvillain G, 2008, HERPETOL CONSERV BIO, V3, P21; BOLTEN AB, 1992, COPEIA, P1098; Booth DT, 2006, CORAL REEFS, V25, P629, DOI 10.1007/s00338-006-0135-4; Braun-McNeill J, 2007, HERPETOLOGICA, V63, P275, DOI 10.1655/0018-0831(2007)63[275:SROTRR]2.0.CO;2; Broderick AC, 2000, MAR ECOL PROG SER, V202, P273, DOI 10.3354/meps202273; Broderick AC, 2001, PHYSIOL BIOCHEM ZOOL, V74, P161, DOI 10.1086/319661; Casale P, 2005, HERPETOL J, V15, P145; Cocci P, 2014, MAR BIOL, V161, P165, DOI 10.1007/s00227-013-2326-1; Conforti VA, 2012, ZOO BIOL, V31, P426, DOI 10.1002/zoo.20409; Delgado C, 2006, RECOVERY BLACK SEA T; DiMaggio C, BAYESIAN ANAL EPID 5; DUTTON PH, 1985, BIOL CONSERV, V31, P249, DOI 10.1016/0006-3207(85)90070-9; Dutton PH, 2010, P 28 ANN INT S SEA T, P232; Eguchi T, 2012, HERPETOLOGICA, V68, P76, DOI 10.1655/HERPETOLOGICA-D-11-00050.1; Eguchi T, 2010, MAR BIOL, V157, P1869, DOI 10.1007/s00227-010-1458-9; Ekanayake EML, 2001, 4 WORLD C HERP 3 9 D, P28; Figueroa A, 1992, FINAL REPORT 1991 19; Foley AM, 2000, HERPETOLOGICA, V56, P433; Fuentes M. M. P. B., 2009, Endangered Species Research, V9, P33, DOI 10.3354/esr00224; Fuentes MMPB, 2010, J EXP MAR BIOL ECOL, V383, P56, DOI 10.1016/j.jembe.2009.11.003; Fuller WJ, 2013, MAR ECOL PROG SER, V488, P267, DOI 10.3354/meps10419; Gelman A., 2021, BAYESIAN DATA ANAL; Hamann Mark, 2006, Endangered Species Research, V2, P81, DOI 10.3354/esr002081; Jensen MP, ENDANGER SPECIES RES; Juarez J.A., 2003, NOAA TECHNICAL MEMOR, P70; Kellar NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115257; Kellar NM, 2006, MAR MAMMAL SCI, V22, P1, DOI 10.1111/j.1748-7692.2006.00001.x; King R, 2013, J EXP MAR BIOL ECOL, V445, P140, DOI 10.1016/j.jembe.2013.03.016; Komoroske LM, 2011, CHEMOSPHERE, V84, P544, DOI 10.1016/j.chemosphere.2011.04.023; Labrada-Martagon V, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cot035; Labrada-Martagon V, 2013, COMP BIOCHEM PHYS A, V166, P91, DOI 10.1016/j.cbpa.2013.05.010; Laloe JO, 2014, NAT CLIM CHANGE, V4, P513, DOI 10.1038/NCLIMATE2236; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lang T.W., 1987, P301; Larios Horacio Merchant, 1999, P130; Lee AM, 2008, P 25 ANN S SEA TURTL, P63; Lemons G, 2011, J EXP MAR BIOL ECOL, V405, P25, DOI 10.1016/j.jembe.2011.05.012; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Limpus C. J., 1985, QUEENSLAND PRELIMINA, P47; LIMPUS CJ, 1993, WILDLIFE RES, V20, P513, DOI 10.1071/WR9930513; Limpus CJ, 1985, THESIS U QUEENSLAND, P212; Limpus Colin J., 2009, Marine Turtle Newsletter, P3; Limpus Colin J., 1994, NOAA Technical Memorandum NMFS-SEFSC, V341, P85; MacDonald BD, 2013, J EXP MAR BIOL ECOL, V443, P56, DOI 10.1016/j.jembe.2013.02.033; MacDonald BD, 2012, MAR ECOL PROG SER, V461, P211, DOI 10.3354/meps09820; Maffucci F, 2013, MAR BIOL, V160, P1097, DOI 10.1007/s00227-012-2160-x; MARQUEZ R, 1982, BIOL CONSERVATION SE, P153; Meylan PA, 2011, B AM MUS NAT HIST, V357, P77; MROSOVSKY N, 1991, Amphibia-Reptilia, V12, P169, DOI 10.1163/156853891X00149; MROSOVSKY N, 1980, BIOL CONSERV, V18, P271, DOI 10.1016/0006-3207(80)90003-8; National Research Council, 2010, ASS SEA TURTL STAT T; NMFS, 2013, NMFSFSPO131 NOAA; NMFS and USFWS, 2007, GREEN SEA TURTL CHEL; O'Connor G, 2007, DIS AQUAT ORGAN, V77, P137, DOI 10.3354/dao01839; O'Steen S, 1998, J EXP BIOL, V201, P439; Owens David W., 1997, P315; OWENS DW, 1978, HERPETOLOGICA, V34, P270; Owens DW, 2012, P 31 ANN S SEA TURTL, P184; Parmenter C.J, 2005, RES PUBLICATION; Patino-Martinez J, 2012, GLOBAL CHANGE BIOL, V18, P401, DOI 10.1111/j.1365-2486.2011.02532.x; Pilcher N, 2010, J HERPETOL, V44, P168, DOI 10.1670/08-115.1; Plummer M, 2014, RJAGS BAYESIAN GRAPH; Plummer M, 2013, JUST ANOTHER GIBBS S; R Development Core Team, 2014, R LANG ENV STAT COMP; Ralls K, 2002, ENCY MARINE MAMMALS, P1005; ROSS JP, 1984, COPEIA, P774, DOI 10.2307/1445166; Schroeder Barbara A., 1994, NOAA Technical Memorandum NMFS-SEFSC, V341, P157; Seminoff J.A., 2015, NOAATMNMFSSWFSC539 C; Seminoff JA, 2003, J MAR BIOL ASSOC UK, V83, P1355, DOI 10.1017/S0025315403008816; Sims David W., 2005, P127; Stinson ML., 1984, BIOL SEA TURTLES SAN; Tarsi K, 2012, NATURE ED KNOWLEDGE, P3, DOI DOI 10.4324/9780203183403-5; Turner-Tomaszewicz C, 2012, COAST MANAGE, V40, P73, DOI 10.1080/08920753.2012.640267; Umapathy G, 2013, GEN COMP ENDOCR, V180, P33, DOI 10.1016/j.ygcen.2012.10.009; US Department of the Navy, 2010, SAN DIEG BAY INT NAT; Valverde R.A, 1996, NOAA TECHNICAL MEMOR, P326; Velez-Zuazo X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113068; WIBBELS T, 1991, CAN J ZOOL, V69, P2973, DOI 10.1139/z91-419; Wibbels T, 2003, CRC MAR BIOL SER, P103; WIBBELS T, 1992, GEN COMP ENDOCR, V87, P71, DOI 10.1016/0016-6480(92)90151-9; WIBBELS T, 1990, GEN COMP ENDOCR, V79, P154, DOI 10.1016/0016-6480(90)90099-8; Wibbels T., 1987, NOAA Technical Report NMFS, V53, P65; WIBBELS T, 1993, J HERPETOL, V27, P327, DOI 10.2307/1565155; Wibbels T, 1989, P 2 W ATL TURTL S PA, P349; Wibbels Thane, 1999, P139; Wibbels Thane, 2000, Chelonian Conservation and Biology, V3, P756; Wood J.R., 1983, British Journal of Herpetology, V6, P323; YNTEMA CL, 1980, HERPETOLOGICA, V36, P33	93	26	26	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138861	10.1371/journal.pone.0138861	http://dx.doi.org/10.1371/journal.pone.0138861			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465620	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100029
J	Chen, Z; Sun, H; Huang, JH; Wu, Y; Liu, DH				Chen, Zhen; Sun, He; Huang, Jinhai; Wu, Yao; Liu, Dehua			Metabolic Engineering of Klebsiella pneumoniae for the Production of 2-Butanone from Glucose	PLOS ONE			English	Article							ENHANCED 2,3-BUTANEDIOL PRODUCTION; COENZYME B-12-DEPENDENT GLYCEROL; MICROBIAL-PRODUCTION; ESCHERICHIA-COLI; DIOL-DEHYDRATASE; ENCODING GENES; PROTEIN DESIGN; STRAIN; 1,3-PROPANEDIOL; INACTIVATION	2-Butanone is an important commodity chemical of wide application in different areas. In this study, Klebsiella pneumoniae was engineered to directly produce 2-butanone from glucose by extending its native 2, 3-butanediol synthesis pathway. To identify the potential enzyme for the efficient conversion of 2, 3-butanediol to 2-butanone, we screened different glycerol dehydratases and diol dehydratases. By introducing the diol dehydratase from Lactobacillus brevis and deleting the ldhA gene encoding lactate dehydrogenase, the engineered K. pneumoniae was able to accumulate 246 mg/L of 2-butanone in shake flask. With further optimization of culture condition, the titer of 2-butanone was increased to 450 mg/L. This study lays the basis for developing an efficient biological process for 2-butanone production.	[Chen, Zhen; Sun, He; Huang, Jinhai; Wu, Yao; Liu, Dehua] Tsinghua Univ, Inst Appl Chem, Dept Chem Engn, Beijing 100084, Peoples R China; [Chen, Zhen; Liu, Dehua] Tsinghua Innovat Ctr Dongguan, Dongguan 523808, Peoples R China	Tsinghua University	Chen, Z (corresponding author), Tsinghua Univ, Inst Appl Chem, Dept Chem Engn, Beijing 100084, Peoples R China.	zhenchen2013@mail.tsinghua.edu.cn	Chen, Zhen/AAP-9592-2020		National Natural Science Foundation of China [21406131]; Tsinghua University Initiative Scientific Research Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program	This work was supported by the National Natural Science Foundation of China (Grant no. 21406131, grant receiver ZC) and Tsinghua University Initiative Scientific Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashok S, 2013, BIOTECHNOL BIOENG, V110, P511, DOI 10.1002/bit.24726; Chen Z, 2015, BIORESOURCE TECHNOL, V197, P260, DOI 10.1016/j.biortech.2015.08.086; Chen Z, 2015, BIOTECHNOL J, V10, P284, DOI 10.1002/biot.201400235; Chen Z, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/518743; Chen Z, 2013, BIOTECHNOL J, V8, P523, DOI 10.1002/biot.201200238; Chen Z, 2009, PROCESS BIOCHEM, V44, P862, DOI 10.1016/j.procbio.2009.04.004; Daniel R, 1998, FEMS MICROBIOL REV, V22, P553, DOI 10.1111/j.1574-6976.1998.tb00387.x; Ghiaci P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102774; Guo XW, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-44; Jung MY, 2014, APPL ENVIRON MICROB, V80, P6195, DOI 10.1128/AEM.02069-14; Kim B, 2012, J MICROBIOL BIOTECHN, V22, P1258, DOI 10.4014/jmb.1201.01044; Kim DK, 2013, J BIOSCI BIOENG, V116, P186, DOI 10.1016/j.jbiosc.2013.02.021; Knietsch A, 2003, APPL ENVIRON MICROB, V69, P3048, DOI 10.1128/AEM.69.6.3048-3060.2003; Lide D.R., 2005, CRC HDB CHEM PHYS IN; MOORE KW, 1979, BIOCHEM BIOPH RES CO, V87, P1052, DOI 10.1016/S0006-291X(79)80014-5; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Xu YZ, 2009, BIOTECHNOL BIOENG, V104, P965, DOI 10.1002/bit.22455; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Yoneda H, 2014, CHEMSUSCHEM, V7, P92, DOI 10.1002/cssc.201300853; Zhang WG, 2012, GREEN CHEM, V14, P3441, DOI 10.1039/c2gc36324k	21	14	14	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140508	10.1371/journal.pone.0140508	http://dx.doi.org/10.1371/journal.pone.0140508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465746	gold, Green Submitted, Green Published			2022-12-26	WOS:000363183100134
J	Choma, MK; Lumb, J; Kozik, P; Robinson, MS				Choma, Maja K.; Lumb, Jennifer; Kozik, Patrycja; Robinson, Margaret S.			A Genome-Wide Screen for Machinery Involved in Downregulation of MHC Class I by HIV-1 Nef	PLOS ONE			English	Article							CELL-SURFACE; AP-1; ENDOCYTOSIS; MODULATION; TRANSPORT; EVASION; PROTEIN; RNA	The HIV-1-encoded protein, Nef, plays a key role in the development of AIDS. One of Nef's functions is to keep MHC class I off the surface of infected cells, a process that requires the host proteins clathrin and AP-1. To identify other proteins involved in this pathway, we carried out a genome-wide siRNA library screen on HeLa cells co-expressing HLA-A2 and an inducible form of Nef. Out of 21,121 siRNA pools, 100 were selected for further analysis, based on their ability to either inhibit or enhance downregulation of MHC-I by Nef. When cells were treated with the same siRNA pools as those used in the screen, 79% produced a similar phenotype. However, when the cells were treated with different siRNA reagents targeting the same genes, only 16% produced a similar phenotype. This indicates that most of the hits found in the original screen are likely to have been off-target, an important concern that is often not taken into account in siRNA screening studies. Nevertheless, we identified novel host factors involved in Nef-induced downregulation of MHC-I, including four genes, MIIP, CAMSAP3, SLC6A3, and KCTD19, where multiple reagents produced a strong inhibitory effect on Nef activity. Other hits slightly below our very high stringency cutoff point may also deserve further study. Thus, our dataset is a valuable resource for scientists investigating the pathogenesis of HIV.	[Choma, Maja K.; Lumb, Jennifer; Kozik, Patrycja; Robinson, Margaret S.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Cambridge	Robinson, MS (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England.	msr12@cam.ac.uk		Kozik, Patrycja/0000-0001-8596-843X	Wellcome Trust [086598]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funding was provided by the Wellcome Trust 086598, http://www.wellcome.ac.uk/, to MSR, MKC, PK, and JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines AJ, 2009, MOL BIOL EVOL, V26, P2005, DOI 10.1093/molbev/msp115; Birch MR, 2001, J CLIN VIROL, V22, P263, DOI 10.1016/S1386-6532(01)00198-6; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Goktug AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049386; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hirst J, 2012, CURR BIOL, V22, P1711, DOI 10.1016/j.cub.2012.07.012; Ji P, 2010, ONCOGENE, V29, P3501, DOI 10.1038/onc.2010.114; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Kasper MR, 2005, J BIOL CHEM, V280, P12840, DOI 10.1074/jbc.M413538200; Kasper MR, 2003, J VIROL, V77, P3041, DOI 10.1128/JVI.77.5.3041-3049.2003; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kozik P, 2013, NAT CELL BIOL, V15, P50, DOI 10.1038/ncb2652; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Song SW, 2003, P NATL ACAD SCI USA, V100, P13970, DOI 10.1073/pnas.2332186100; Tanaka N, 2012, P NATL ACAD SCI USA, V109, P20029, DOI 10.1073/pnas.1218017109; TIWARI RK, 1987, EMBO J, V6, P3373, DOI 10.1002/j.1460-2075.1987.tb02659.x; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Walk SF, 2001, J VIROL, V75, P834, DOI 10.1128/JVI.75.2.834-843.2001; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	29	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140404	10.1371/journal.pone.0140404	http://dx.doi.org/10.1371/journal.pone.0140404			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466362	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100114
J	Fahr, J; Abedi-Lartey, M; Esch, T; Machwitz, M; Suu-Ire, R; Wikelski, M; Dechmann, DKN				Fahr, Jakob; Abedi-Lartey, Michael; Esch, Thomas; Machwitz, Miriam; Suu-Ire, Richard; Wikelski, Martin; Dechmann, Dina K. N.			Pronounced Seasonal Changes in the Movement Ecology of a Highly Gregarious Central-Place Forager, the African Straw-Coloured Fruit Bat (Eidolon helvum)	PLOS ONE			English	Article							HEADED FLYING-FOX; PTEROPUS-POLIOCEPHALUS; SEED DISPERSAL; HOME RANGES; HENIPAVIRUS; BUSHMEAT; TRACKING; FOOD; ACCELERATION; CIRCULATION	Background Straw-coloured fruit bats (Eidolon helvum) migrate over vast distances across the African continent, probably following seasonal bursts of resource availability. This causes enormous fluctuations in population size, which in turn may influence the bats' impact on local ecosystems. We studied the movement ecology of this central-place forager with state-of-the-art GPS/acceleration loggers and concurrently monitored the seasonal fluctuation of the colony in Accra, Ghana. Habitat use on the landscape scale was assessed with remote sensing data as well as ground-truthing of foraging areas. Principal Findings During the wet season population low (similar to 4000 individuals), bats foraged locally (3.5-36.7 km) in urban areas with low tree cover. Major food sources during this period were fruits of introduced trees. Foraging distances almost tripled (24.1-87.9 km) during the dry season population peak (similar to 150,000 individuals), but this was not compensated for by reduced resting periods. Dry season foraging areas were random with regard to urban footprint and tree cover, and food consisted almost exclusively of nectar and pollen of native trees. Conclusions and Significance Our study suggests that straw-coloured fruit bats disperse seeds in the range of hundreds of meters up to dozens of kilometres, and pollinate trees for up to 88 km. Straw-coloured fruit bats forage over much larger distances compared to most other Old World fruit bats, thus providing vital ecosystem services across extensive landscapes. We recommend increased efforts aimed at maintaining E. helvum populations throughout Africa since their keystone role in various ecosystems is likely to increase due to the escalating loss of other seed dispersers as well as continued urbanization and habitat fragmentation.	[Fahr, Jakob; Abedi-Lartey, Michael; Wikelski, Martin; Dechmann, Dina K. N.] Max Planck Inst Ornithol MPIO, Dept Migrat & Immunoecol, D-78315 Radolfzell am Bodensee, Germany; [Fahr, Jakob; Abedi-Lartey, Michael; Wikelski, Martin; Dechmann, Dina K. N.] Univ Konstanz, Dept Biol, Constance, Germany; [Fahr, Jakob] TU Braunschweig, Inst Zool, Braunschweig, Germany; [Esch, Thomas] German Aerosp Ctr DLR, German Remote Sensing Data Ctr DFD, Oberpfaffenhofen, Germany; [Machwitz, Miriam] Luxembourg Inst Sci & Technol LIST, Belvaux, Luxembourg; [Suu-Ire, Richard] Forestry Commiss, Wildlife Div, Accra, Ghana; [Suu-Ire, Richard] Univ Ghana, Legon, Accra, Ghana	University of Konstanz; Braunschweig University of Technology; Helmholtz Association; German Aerospace Centre (DLR); Luxembourg Institute of Science & Technology; University of Ghana	Fahr, J (corresponding author), Max Planck Inst Ornithol MPIO, Dept Migrat & Immunoecol, Obstberg 1, D-78315 Radolfzell am Bodensee, Germany.	jakob.fahr@gmail.com	Fahr, Jakob/E-8831-2012	Fahr, Jakob/0000-0002-9174-1204; Dechmann, Dina/0000-0003-0043-8267	Karl Mayer Stiftung (Triesen, Liechtenstein) [2010/ZD-089]	Karl Mayer Stiftung (Triesen, Liechtenstein)	The study was funded with the budgets of the Max Planck Society (www.mpg.de) and the University of Konstanz (www.uni-konstanz.de), and a grant by the Karl Mayer Stiftung (Triesen, Liechtenstein; Ref-Nr. 2010/ZD-089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; [Anonymous], 2002, HRE HOME RANGE EXTEN; AYENSU ES, 1974, ANN MO BOT GARD, V61, P702, DOI 10.2307/2395025; Baker KS, 2012, J GEN VIROL, V93, P850, DOI 10.1099/vir.0.039339-0; Ballance LT, 2009, J AVIAN BIOL, V40, P279, DOI 10.1111/j.1600-048X.2008.04538.x; Bizoux JP, 2009, MOL ECOL, V18, P4398, DOI 10.1111/j.1365-294X.2009.04365.x; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; BOULGER L. R., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P421, DOI 10.1016/0035-9203(58)90127-5; Brown DD, 2012, WILDLIFE SOC B, V36, P139, DOI 10.1002/wsb.111; Carbone C, 2005, AM NAT, V165, P290, DOI 10.1086/426790; Corlett RT, 2009, BIOTROPICA, V41, P592, DOI 10.1111/j.1744-7429.2009.00503.x; Dainou K, 2012, AM J BOT, V99, P1453, DOI 10.3732/ajb.1200147; Dzikwi AA, 2010, J WILDLIFE DIS, V46, P267, DOI 10.7589/0090-3558-46.1.267; Epstein JH, 2009, J APPL ECOL, V46, P991, DOI 10.1111/j.1365-2664.2009.01699.x; Esch T, 2010, IEEE T GEOSCI REMOTE, V48, P905, DOI 10.1109/TGRS.2009.2037144; Esch T, 2012, J APPL REMOTE SENS, V6, DOI 10.1117/1.JRS.6.061702; Fahr J, 2011, ECOGRAPHY, V34, P177, DOI 10.1111/j.1600-0587.2010.05510.x; FAYENUWO JO, 1974, J MAMMAL, V55, P453, DOI 10.2307/1379016; FUJITA MS, 1991, CONSERV BIOL, V5, P455, DOI 10.1111/j.1523-1739.1991.tb00352.x; FUNMILAYO O, 1979, Revue de Zoologie Africaine, V93, P589; GARLAND T, 1983, AM NAT, V121, P571, DOI 10.1086/284084; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Gschweng M, 2012, J APPL ECOL, V49, P803, DOI 10.1111/j.1365-2664.2012.02170.x; Hayman DTS, 2012, J MAMMAL, V93, P1393, DOI 10.1644/11-MAMM-A-270.1; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Hooge P. M., 2000, ANIMAL MOVEMENT EXTE, P2; HUGGEL-WOLF H., 1965, ACTA TROP, V22, P1; Iehle C, 2007, EMERG INFECT DIS, V13, P159, DOI 10.3201/eid1301.060791; Jordaan LA, 2012, BIOL INVASIONS, V14, P959, DOI 10.1007/s10530-011-0131-7; Kamins AO, 2011, BIOL CONSERV, V144, P3000, DOI 10.1016/j.biocon.2011.09.003; Kankam BO, 2009, J TROP ECOL, V25, P201, DOI 10.1017/S0266467409005835; KUNZ TH, 1995, BIOTROPICA, V27, P106, DOI 10.2307/2388908; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; LAVER P. N., 2005, ABODE KERNEL HOME RA; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; Machwitz M, 2011, THESIS JULIUS MAXIMI; Machwitz M, 2015, INT J APPL EARTH OBS, V43, P177, DOI 10.1016/j.jag.2015.04.007; Malagnoux M, 1976, REV BOIS FORETS  JAN, P35; Marazzi B, 2007, INT J PLANT SCI, V168, P371, DOI 10.1086/512105; Markus N, 2004, WILDLIFE RES, V31, P345, DOI 10.1071/WR01117; Mickleburgh S, 2009, ORYX, V43, P217, DOI 10.1017/S0030605308000938; Moller-Jensen L., 2005, GEOGR TIDSSKR DAN J, V105, P39, DOI [10.1080/00167223.2005.10649538, DOI 10.1080/00167223.2005.10649538]; Muscarella R, 2007, BIOL REV, V82, P573, DOI 10.1111/j.1469-185X.2007.00026.x; Nakamoto A, 2008, TROPICS, V17, P43; Niamien CJM, 2009, AGRONOMIE AFRICAINE, V21, P231; O'Mara MT, 2014, METHODS ECOL EVOL, V5, P311, DOI 10.1111/2041-210X.12172; Olsson O, 2008, THEOR POPUL BIOL, V74, P22, DOI 10.1016/j.tpb.2008.04.005; Osmaston HA., 1965, COMMONWEALTH FORESTR, V44, P97; Parry-Jones KA, 2001, AUSTRAL ECOL, V26, P47, DOI 10.1046/j.1442-9993.2001.01072.x; Pernet O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6342; Rautenbach IL, 1986, KOEDOE, V28, P81, DOI DOI 10.4102/K0ED0E.V28I1.538; Richter HV, 2006, J ZOOL, V268, P35, DOI 10.1111/j.1469-7998.2005.00020.x; Rosenberg DK, 1999, J WILDLIFE MANAGE, V63, P1028, DOI 10.2307/3802818; Rosevear D.R., 1965, BATS W AFRICA, P418; Seltzer CE, 2013, BIOTROPICA, V45, P450, DOI 10.1111/btp.12029; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Taylor D.A.R., 2000, RES ADV RESTORATION, P29; THOMAS DW, 1983, CAN J ZOOL, V61, P2266, DOI 10.1139/z83-299; Thomas DW, 2013, MAMMALS AFRICA, VIV, P232; Thomas DW, 1982, THESIS U ABERDEEN; Tidemann CR, 1999, J ZOOL, V247, P155, DOI 10.1111/j.1469-7998.1999.tb00979.x; Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013; Tsoar A, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P103; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; Webala PW, 2014, ACTA CHIROPTEROL, V16, P85, DOI 10.3161/150811014X683291; Weber N, 2015, J WILDLIFE MANAGE, V79, P957, DOI 10.1002/jwmg.904; Weiss S, 2012, EMERG INFECT DIS, V18, P1536, DOI 10.3201/eid1809.111607; Welbergen JA, 2006, BEHAV ECOL SOCIOBIOL, V60, P311, DOI 10.1007/s00265-006-0167-3; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Williams NSG, 2006, AUSTRAL ECOL, V31, P190, DOI 10.1111/j.1442-9993.2006.01590.x; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x	73	44	44	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138985	10.1371/journal.pone.0138985	http://dx.doi.org/10.1371/journal.pone.0138985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465139	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000363183100035
J	Gaudreault, V; Wirbel, J; Jardim, A; Rohrbach, P; Scorza, T				Gaudreault, Veronique; Wirbel, Jakob; Jardim, Armando; Rohrbach, Petra; Scorza, Tatiana			Red Blood Cells Preconditioned with Hemin Are Less Permissive to Plasmodium Invasion In Vivo and In Vitro	PLOS ONE			English	Article							MALARIA-INFECTED ERYTHROCYTES; FALCIPARUM-MALARIA; OXIDATIVE STRESS; PARASITE INVASION; CEREBRAL MALARIA; FLOW-CYTOMETRY; HEMOGLOBIN; ANEMIA; HEMOPEXIN; MEMBRANE	Malaria is a parasitic disease that causes severe hemolytic anemia in Plasmodium-infected hosts, which results in the release and accumulation of oxidized heme (hemin). Although hemin impairs the establishment of Plasmodium immunity in vitro and in vivo, mice preconditioned with hemin develop lower parasitemia when challenged with Plasmodium chabaudi adami blood stage parasites. In order to understand the mechanism accounting for this resistance as well as the impact of hemin on eryptosis and plasma levels of scavenging hemopexin, red blood cells were labeled with biotin prior to hemin treatment and P. c. adami infection. This strategy allowed discriminating hemin-treated from de novo generated red blood cells and to follow the infection within these two populations of cells. Fluorescence microscopy analysis of biotinylated-red blood cells revealed increased P. c. adami red blood cells selectivity and a decreased permissibility of hemin-conditioned red blood cells for parasite invasion. These effects were also apparent in in vitro P. falciparum cultures using hemin-preconditioned human red blood cells. Interestingly, hemin did not alter the turnover of red blood cells nor their replenishment during in vivo infection. Our results assign a function for hemin as a protective agent against high parasitemia, and suggest that the hemolytic nature of blood stage human malaria may be beneficial for the infected host.	[Gaudreault, Veronique; Scorza, Tatiana] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Wirbel, Jakob; Jardim, Armando; Rohrbach, Petra] McGill Univ, Inst Parasitol, Montreal, PQ, Canada	University of Quebec; University of Quebec Montreal; McGill University	Scorza, T (corresponding author), Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada.	scorza.tatiana@uqam.ca	Rohrbach, Petra/F-3201-2011; Scorza, Tatiana/AAM-8992-2020	Wirbel, Jakob/0000-0002-4073-3562	New Initiative Grant (Center for Host Parasite Interactions, FQRNT)	New Initiative Grant (Center for Host Parasite Interactions, FQRNT)	This work was supported by a New Initiative Grant (Center for Host Parasite Interactions, FQRNT).	Amer J, 2004, CYTOM PART A, V60A, P73, DOI 10.1002/cyto.a.20017; Ando K, 2002, FREE RADICAL RES, V36, P1079, DOI 10.1080/1071576021000028307; [Anonymous], 2014, WORLD MALARIA REPORT; Antonelou MH, 2010, BLOOD TRANSFUS-ITALY, V8, pS39, DOI 10.2450/2010.007S; Arashiki N, 2013, BIOCHEMISTRY-US, V52, P5760, DOI 10.1021/bi400405p; Ascenzi P, 2005, IUBMB LIFE, V57, P749, DOI 10.1080/15216540500380871; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412; Bunn HF, 2013, BLOOD, V121, P20, DOI 10.1182/blood-2012-08-449397; Cambos M, 2010, INT J PARASITOL, V40, P1003, DOI 10.1016/j.ijpara.2010.02.007; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; Chotivanich K, 2000, J INFECT DIS, V181, P1206, DOI 10.1086/315353; CHOU AC, 1981, J CLIN INVEST, V68, P672, DOI 10.1172/JCI110302; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Costa G, 2011, BLOOD, V118, P6952, DOI 10.1182/blood-2011-08-376111; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Dalko E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054744; Delanghe JR, 2001, CLIN CHIM ACTA, V312, P13, DOI 10.1016/S0009-8981(01)00586-1; Dhangadamajhi G, 2010, MALAR RES TREAT, V2010, P973094, DOI DOI 10.4061/2010/973094; Dondorp AM, 1999, AM J TROP MED HYG, V60, P733, DOI 10.4269/ajtmh.1999.60.733; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; Evans KJ, 2006, BLOOD, V107, P1192, DOI 10.1182/blood-2005-08-3460; Fendel R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010038; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Gallo V, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-428; Gatidis S, 2009, ANN HEMATOL, V88, P721, DOI 10.1007/s00277-009-0697-7; GINSBURG H, 1994, PARASITE, V1, P5, DOI 10.1051/parasite/1994011005; Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011; Grinberg LN, 1999, FREE RADICAL BIO MED, V27, P214, DOI 10.1016/S0891-5849(99)00082-9; Haldane J.B.S., 1949, HEREDITAS, V35, P267; KANBARA T, 1988, ZBL BAKT-INT J MED M, V269, P100; KATAAHA PK, 1984, PARASITE IMMUNOL, V6, P481, DOI 10.1111/j.1365-3024.1984.tb00818.x; Kumar D, 2014, REJUV RES, V17, P446, DOI 10.1089/rej.2014.1573; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Mohandas N, 2012, MED MICROBIOL IMMUN, V201, P593, DOI 10.1007/s00430-012-0272-z; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Nagababu E, 2008, BLOOD CELL MOL DIS, V41, P60, DOI 10.1016/j.bcmd.2007.12.003; Omodeo-Sale F, 2003, BLOOD, V102, P705, DOI 10.1182/blood-2002-08-2437; Pabon A, 2003, CLIN BIOCHEM, V36, P71, DOI 10.1016/S0009-9120(02)00423-X; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Pamplona A, 2009, INT J BIOCHEM CELL B, V41, P711, DOI 10.1016/j.biocel.2008.09.020; Pattanapanyasat K, 1996, CYTOMETRY, V25, P287, DOI 10.1002/(SICI)1097-0320(19961101)25:3&lt;287::AID-CYTO10&gt;3.0.CO;2-S; PHILLIPS S, 1994, IMMUNOL LETT, V41, P109, DOI 10.1016/0165-2478(94)90117-1; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; SHAKLAI N, 1985, BIOCHIM BIOPHYS ACTA, V821, P355, DOI 10.1016/0005-2736(85)90106-3; Simpson JA, 1999, T ROY SOC TROP MED H, V93, P165, DOI 10.1016/S0035-9203(99)90295-X; SMITH A, 1990, EUR J CELL BIOL, V53, P234; Smith RC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-313; SOLAR I, 1991, BIOCHIM BIOPHYS ACTA, V1062, P51, DOI 10.1016/0005-2736(91)90334-5; Tangpukdee N, 2012, INT J LAB HEMATOL, V34, P320, DOI 10.1111/j.1751-553X.2011.01398.x; Taylor SM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003327; TAYLORROBINSON AW, 1993, SCIENCE, V260, P1931, DOI 10.1126/science.8100366; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738; Vinchi F, 2008, AM J PATHOL, V173, P289, DOI 10.2353/ajpath.2008.071130; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Waitumbi JN, 2000, BLOOD, V95, P1481, DOI 10.1182/blood.V95.4.1481.004k15_1481_1486; WARD GE, 1993, J CELL SCI, V106, P237; Watanabe-Matsui M, 2011, BLOOD, V117, P5438, DOI 10.1182/blood-2010-07-296483; Yahata K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050780; Zuccala ES, 2011, BRIT J HAEMATOL, V154, P680, DOI 10.1111/j.1365-2141.2011.08766.x	64	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140805	10.1371/journal.pone.0140805	http://dx.doi.org/10.1371/journal.pone.0140805			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465787	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100166
J	McCue, MD; Guzman, RM; Passement, CA; Davidowitz, G				McCue, Marshall D.; Guzman, R. Marena; Passement, Celeste A.; Davidowitz, Goggy			How and When Do Insects Rely on Endogenous Protein and Lipid Resources during Lethal Bouts of Starvation? A New Application for C-13-Breath testing	PLOS ONE			English	Article							AMINO-ACIDS; ENERGY-EXPENDITURE; FOOD-DEPRIVATION; BODY-COMPOSITION; FAT-BODY; REPRODUCTIVE ALLOCATION; AMERICAN COCKROACH; OXIDATIVE KINETICS; DYNAMIC ACTION; HOUSE SPARROW	Most of our understanding about the physiology of fasting and starvation comes from studies of vertebrates; however, for ethical reasons, studies thatmonitor vertebrates through the lethal endpoint are scant. Insects are convenientmodels to characterize the comparative strategies used to cope with starvation because they have diverse life histories and have evolved under the omnipresent challenge of food limitation. Moreover, we can study the physiology of starvation through its natural endpoint. In this study we raised populations of five species of insects (adult grasshoppers, crickets, cockroaches, and larval beetles and moths) on diets labeled with either C-13-palmitic acid or C-13-leucine to isotopically enrich the lipids or the proteins in their bodies, respectively. The insects were allowed to become postabsorptive and then starved. We periodically measured the delta C-13 of the exhaled breath to characterize how each species adjusted their reliance on endogenous lipids and proteins as energy sources. We found that starving insects employ a wide range of strategies for regulating lipid and protein oxidation. All of the insects except for the beetle larvae were capable of sharply reducing reliance on protein oxidation; however, this protein sparing strategy was usually unsustainable during the entire starvation period. All insects increased their reliance on lipid oxidation, but while some species (grasshoppers, cockroaches, and beetle larvae) were still relying extensively on lipids at the time of death, other species (crickets and moth larvae) allowed rates of lipid oxidation to return to prestarvation levels. Although lipids and proteins are criticalmetabolic fuels for both vertebrates and insects, insects apparently exhibit a much wider range of strategies for rationing these limited resources during starvation.	[McCue, Marshall D.; Guzman, R. Marena; Passement, Celeste A.] St Marys Univ, Dept Biol Sci, San Antonio, TX 78228 USA; [Davidowitz, Goggy] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	University of Arizona	McCue, MD (corresponding author), St Marys Univ, Dept Biol Sci, San Antonio, TX 78228 USA.	mmccue1@stmarytx.edu			Biaggini Endowment; St. Mary's University; NSFgrant [IOS-1053318]	Biaggini Endowment; St. Mary's University; NSFgrant(National Science Foundation (NSF))	Funding for this research was provided by the Biaggini Endowment and a Faculty Grant both awarded to MDM from St. Mary's University and NSFgrant IOS-1053318 to GD. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Abbott KC, 2007, J ANIM ECOL, V76, P1004, DOI 10.1111/j.1365-2656.2007.01263.x; Arnett AE, 2003, ECOL ENTOMOL, V28, P645, DOI 10.1111/j.1365-2311.2003.00554.x; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Beauplet G, 2003, PHYSIOL BIOCHEM ZOOL, V76, P262, DOI 10.1086/367951; Bede JC, 2007, PEPTIDES, V28, P185, DOI 10.1016/j.peptides.2006.08.030; BELKHOU R, 1991, NUTR RES, V11, P365, DOI 10.1016/S0271-5317(05)80312-4; Boggs CL, 2014, INTEGR COMP BIOL, V54, P880, DOI 10.1093/icb/icu074; Boggs CL, 1997, ECOLOGY, V78, P181, DOI 10.1890/0012-9658(1997)078[0181:RAFRAI]2.0.CO;2; Bos C, 2003, J NUTR, V133, P1308; BOUTTON TW, 1980, OECOLOGIA, V45, P299, DOI 10.1007/BF00540196; Bukkens SGF, 1997, ECOL FOOD NUTR, V36, P287, DOI 10.1080/03670244.1997.9991521; CASTELLINI MA, 1992, EXPERIENTIA, V48, P575, DOI 10.1007/BF01920242; Couvillon MJ, 2010, INSECT SOC, V57, P193, DOI 10.1007/s00040-010-0064-7; Davidowitz G, 2004, EVOL ECOL RES, V6, P49; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; Gergs A, 2014, J ANIM ECOL, V83, P758, DOI 10.1111/1365-2656.12195; Gerson AR, 2011, AM J PHYSIOL-REG I, V300, pR925, DOI 10.1152/ajpregu.00701.2010; Gibbs AG, 2012, COMP PHYSL FASTING S, P37, DOI DOI 10.1007/978-3-642-29056-5; GOODMAN MN, 1981, AM J PHYSIOL, V241, pE321, DOI 10.1152/ajpendo.1981.241.4.E321; Gullan PJ, 2010, INSECTS OUTLINE ENTO; Hervant F, 2001, J EXP BIOL, V204, P269; Irwin JT, 2003, OIKOS, V100, P71, DOI 10.1034/j.1600-0706.2003.11738.x; Jenni-Eiermann Susanne, 1999, Biologia e Conservazione della Fauna, V102, P312; Jensen K, 2010, J INSECT PHYSIOL, V56, P1095, DOI 10.1016/j.jinsphys.2010.03.001; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; Kalm LM, 2005, J NUTR, V135, P1347, DOI 10.1093/jn/135.6.1347; Khalilieh A, 2012, AM J PHYSIOL-REG I, V303, pR551, DOI 10.1152/ajpregu.00076.2012; Kirk Kevin L., 2012, P25; Kleiber M., 1975, FIRE LIFE; Konuma T, 2012, ENDOCRINOLOGY, V153, P3111, DOI 10.1210/en.2011-1533; LEMAHO Y, 1981, AM J PHYSIOL, V241, pE342, DOI 10.1152/ajpendo.1981.241.5.E342; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Lignot J.-H., 2012, COMP PHYSL FASTING S, P7; LINDSTEDT SL, 1985, AM NAT, V125, P873, DOI 10.1086/284385; Lusk G, 1928, ELEMENTS SCI NUTR; Marron MT, 2003, J INSECT PHYSIOL, V49, P261, DOI 10.1016/S0022-1910(02)00287-1; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; McCue MD, 2006, COMP BIOCHEM PHYS A, V144, P381, DOI 10.1016/j.cbpa.2006.03.011; McCue MD, 2010, J EXP BIOL, V213, P782, DOI 10.1242/jeb.039842; McCue M. D., 2012, COMP PHYSL FASTING S, P409; McCue MD, 2007, PHYSIOL BIOCHEM ZOOL, V80, P25, DOI 10.1086/509057; McCue MD, 2014, J EXP ZOOL PART A, V321, P503, DOI 10.1002/jez.1882; McCue MD, 2013, J COMP PHYSIOL B, V183, P1039, DOI 10.1007/s00360-013-0774-z; McCue MD, 2013, COMP BIOCHEM PHYS A, V166, P546, DOI 10.1016/j.cbpa.2013.08.009; McCue Marshall D., 2012, P103; McCue MD, 2011, BIOSCIENCE, V61, P217, DOI 10.1525/bio.2011.61.3.7; McCue MD, 2011, PHYSIOL BIOCHEM ZOOL, V84, P32, DOI 10.1086/657285; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; Mccue MD, 2009, COMP BIOCHEM PHYS A, V154, P165, DOI 10.1016/j.cbpa.2009.06.002; McKenzie DJ, 2014, J EXP BIOL, V217, P3283, DOI 10.1242/jeb.101857; McNab BK, 1999, PHYSIOL BIOCHEM ZOOL, V72, P642, DOI 10.1086/316701; MROSOVSKY N, 1980, SCIENCE, V207, P837, DOI 10.1126/science.6928327; Navarro Isabel, 1995, Biochemistry and Molecular Biology of Fishes, V4, P393; Newsome SD, 2014, INTEGR COMP BIOL, V54, P890, DOI 10.1093/icb/icu106; Nicholas J, 2015, INTEGR COMP BIOL, V55, pE308; Nijhout H.F., 2006, Journal of Biology, V5, P1; O'Regan SM, 2012, INVERTEBR BIOL, V131, P216, DOI 10.1111/j.1744-7410.2012.00273.x; Overgaard Johannes, 2012, P53; Park MS, 2008, J INSECT PHYSIOL, V54, P386, DOI 10.1016/j.jinsphys.2007.10.011; Park MS, 2014, CELL TISSUE RES, V356, P405, DOI 10.1007/s00441-014-1802-3; Park MS, 2013, ARTHROPOD STRUCT DEV, V42, P287, DOI 10.1016/j.asd.2013.03.004; Price Edwin R., 2012, P237; Renault D, 2003, PHYSIOL ENTOMOL, V28, P261, DOI 10.1111/j.1365-3032.2003.00338.x; Schilling F, 2012, J EXP BIOL, V215, P3137, DOI 10.1242/jeb.071209; Schimpf NG, 2012, EVOLUTION, V66, P597, DOI 10.1111/j.1558-5646.2011.01456.x; SCHOWALTER T. D., 2006, INSECT ECOLOGY ECOSY; Secor SM, 2009, J COMP PHYSIOL B, V179, P1, DOI 10.1007/s00360-008-0283-7; Sinclair BJ, 2011, PHYSIOL ENTOMOL, V36, P84, DOI 10.1111/j.1365-3032.2010.00765.x; Slater C, 2001, RAPID COMMUN MASS SP, V15, P1270, DOI 10.1002/rcm.328; Sonko BJ, 2005, J NUTR, V135, P2159, DOI 10.1093/jn/135.9.2159; Voigt CC, 2012, P ROY SOC B-BIOL SCI, V279, P3772, DOI 10.1098/rspb.2012.0902; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Welch KC, 2015, ANN NEW YOR IN PRESS; Werner RA, 2001, RAPID COMMUN MASS SP, V15, P501, DOI 10.1002/rcm.258; WU L, 1994, J GREAT LAKES RES, V20, P537, DOI 10.1016/S0380-1330(94)71170-9; Zera AJ, 2006, AM NAT, V167, P889, DOI 10.1086/503578; Zhao Z, 2006, J INSECT PHYSIOL, V52, P646, DOI 10.1016/j.jinsphys.2006.03.003	77	31	31	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140053	10.1371/journal.pone.0140053	http://dx.doi.org/10.1371/journal.pone.0140053			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465334	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100076
J	Zapata, F; Goetz, FE; Smith, SA; Howison, M; Siebert, S; Church, SH; Sanders, SM; Ames, CL; McFadden, CS; France, SC; Daly, M; Collins, AG; Haddock, SHD; Dunn, CW; Cartwright, P				Zapata, Felipe; Goetz, Freya E.; Smith, Stephen A.; Howison, Mark; Siebert, Stefan; Church, Samuel H.; Sanders, Steven M.; Ames, Cheryl Lewis; McFadden, Catherine S.; France, Scott C.; Daly, Marymegan; Collins, Allen G.; Haddock, Steven H. D.; Dunn, Casey W.; Cartwright, Paulyn			Phylogenomic Analyses Support Traditional Relationships within Cnidaria	PLOS ONE			English	Article							CLASS-LEVEL RELATIONSHIPS; PHYLUM CNIDARIA; OCTOCORALLIA CNIDARIA; MITOCHONDRIAL GENOME; CHARACTER EVOLUTION; MEDUSOZOA; HYDROZOA; PHYLOGENETICS; ORGANIZATION; 5-END	Cnidaria, the sister group to Bilateria, is a highly diverse group of animals in terms of morphology, lifecycles, ecology, and development. How this diversity originated and evolved is not well understood because phylogenetic relationships among major cnidarian lineages are unclear, and recent studies present contrasting phylogenetic hypotheses. Here, we use transcriptome data from 15 newly-sequenced species in combination with 26 publicly available genomes and transcriptomes to assess phylogenetic relationships among major cnidarian lineages. Phylogenetic analyses using different partition schemes and models of molecular evolution, as well as topology tests for alternative phylogenetic relationships, support the monophyly of Medusozoa, Anthozoa, Octocorallia, Hydrozoa, and a clade consisting of Staurozoa, Cubozoa, and Scyphozoa. Support for the monophyly of Hexacorallia is weak due to the equivocal position of Ceriantharia. Taken together, these results further resolve deep cnidarian relationships, largely support traditional phylogenetic views on relationships, and provide a historical framework for studying the evolutionary processes involved in one of the most ancient animal radiations.	[Zapata, Felipe; Goetz, Freya E.; Smith, Stephen A.; Howison, Mark; Siebert, Stefan; Church, Samuel H.; Dunn, Casey W.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Howison, Mark] Brown Univ, Comp Serv, Providence, RI 02912 USA; [Howison, Mark] Brown Univ, Informat Serv, Providence, RI 02912 USA; [Sanders, Steven M.; Cartwright, Paulyn] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Ames, Cheryl Lewis; Collins, Allen G.] Smithsonian Museum Nat Hist, Dept Invertebrate Zool, Washington, DC USA; [Ames, Cheryl Lewis] Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA; [McFadden, Catherine S.] Harvey Mudd Coll, Dept Biol, Claremont, CA 91711 USA; [France, Scott C.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Daly, Marymegan] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Collins, Allen G.] NOAA, Natl Systemat Lab, Fisheries Serv, Natl Museum Nat Hist, Washington, DC USA; [Haddock, Steven H. D.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA	Brown University; Brown University; Brown University; University of Kansas; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Maryland; University of Maryland College Park; Claremont Colleges; Harvey Mudd College; University of Louisiana Lafayette; University System of Ohio; Ohio State University; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History; Monterey Bay Aquarium Research Institute	Zapata, F (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	felipe_zapata@brown.edu	Smith, Stephen/AAE-8623-2019; Ames, Cheryl/T-2647-2019; Daly, Marymegan/F-9178-2011; Collins, Allen/A-7944-2008	Smith, Stephen/0000-0003-2035-9531; Ames, Cheryl/0000-0003-1132-6834; Cartwright, Paulyn/0000-0002-8174-6933; France, Scott/0000-0002-2114-5968; Sanders, Steven/0000-0002-5334-4785; Zapata, Felipe/0000-0002-9386-0573; Collins, Allen/0000-0002-3664-9691; Dunn, Casey/0000-0003-0628-5150; Siebert, Stefan/0000-0001-8181-912X; Howison, Mark/0000-0002-0764-4090	National Science Foundation Cnidarian Tree of Life Project [DEB 05-31799]; National Science Foundation [DEB-0953571, RII-C2 EPS-1005789]; National Science Foundation Alan T Waterman Award; National Institutes of Health [P30RR031153]; National Science Foundation EPSCoR [EPS-1004057]; State of Rhode Island; Smithsonian Peter Buck Fellowship; Iridian Genomes Inc.; Direct For Biological Sciences [0953571] Funding Source: National Science Foundation; Division Of Environmental Biology [1256695] Funding Source: National Science Foundation	National Science Foundation Cnidarian Tree of Life Project(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Alan T Waterman Award(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation EPSCoR(National Science Foundation (NSF)); State of Rhode Island; Smithsonian Peter Buck Fellowship; Iridian Genomes Inc.; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by the National Science Foundation (http://www.nsf.gov) Cnidarian Tree of Life Project (DEB 05-31799 to PC and AGC), National Science Foundation DEB-0953571 to PC and the National Science Foundation Alan T Waterman Award to CWD. Sequencing at the Brown Genomics Core facility was supported in part by National Institutes of Health (http://www.nih.gov) P30RR031153 and National Science Foundation EPSCoR EPS-1004057. Data transfer was supported by National Science Foundation RII-C2 EPS-1005789. Analyses were conducted with computational resources and services at the Center for Computation and Visualization at Brown University, supported in part by the National Science Foundation EPSCoR EPS-1004057 and the State of Rhode Island. Cubozoan samples were collected by CLA thanks to research funds from a Smithsonian Peter Buck Fellowship and Iridian Genomes Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Bayer FM, 1956, OCTOCORALLIA TREATIS, P166; Beagley CT, 1995, PROG CELL R, V5, P149; Berntson EA, 1999, MOL PHYLOGENET EVOL, V13, P417, DOI 10.1006/mpev.1999.0649; Berntson EA, 2001, MAR BIOL, V138, P235, DOI 10.1007/s002270000457; Bilewitch JP, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-228; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Cartwright P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001121; Cartwright P, 2007, INTEGR COMP BIOL, V47, P744, DOI 10.1093/icb/icm071; Cartwright P, 2010, INTEGR COMP BIOL, V50, P456, DOI 10.1093/icb/icq089; Cartwright P, 2008, J MAR BIOL ASSOC UK, V88, P1663, DOI 10.1017/S0025315408002257; CHEN CA, 1995, MOL PHYLOGENET EVOL, V4, P175, DOI 10.1006/mpev.1995.1017; Church S. H., 2014, AUTOMATION EVALUATIO, DOI [10.1101/005264, DOI 10.1101/005264]; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; Daly M, 2007, ZOOTAXA, P127, DOI 10.11646/zootaxa.1668.1.11; Dunn CW, 2014, ANNU REV ECOL EVOL S, V45, P371, DOI 10.1146/annurev-ecolsys-120213-091627; Dunn CW, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-330; Dunn CW, 2005, SYST BIOL, V54, P916, DOI 10.1080/10635150500354837; Dunn CW, 2005, DEV DYNAM, V234, P835, DOI 10.1002/dvdy.20483; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P15; HYMAN LH, 1940, INVERTEBRATES PROTOZ; Kayal E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-5; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2013, SYST BIOL, V62, P611, DOI 10.1093/sysbio/syt022; Manuel M, 2009, CR BIOL, V332, P184, DOI 10.1016/j.crvi.2008.07.009; Mariscal R.N., 1974, pUnpaginated; Marques AC, 2004, INVERTEBR BIOL, V123, P23; McFadden CS, 2006, MOL PHYLOGENET EVOL, V41, P513, DOI 10.1016/j.ympev.2006.06.010; McFadden CS, 2010, INTEGR COMP BIOL, V50, P389, DOI 10.1093/icb/icq056; Nawrocki AM, 2013, MOL PHYLOGENET EVOL, V67, P60, DOI 10.1016/j.ympev.2012.12.016; Nawrocki AM, 2012, CURR BIOL, V22, P825, DOI 10.1016/j.cub.2012.03.026; Odorico DM, 1997, P ROY SOC B-BIOL SCI, V264, P77, DOI 10.1098/rspb.1997.0011; Park E, 2012, MOL PHYLOGENET EVOL, V62, P329, DOI 10.1016/j.ympev.2011.10.008; Park TY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1457; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Reft AJ, 2012, J MORPHOL, V273, P121, DOI 10.1002/jmor.11014; Rodriguez E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096998; Song Jun-Im, 1997, Korean Journal of Biological Sciences, V1, P43; Stamatakis A, 2013, INT PARALL DISTRIB P, P1195, DOI 10.1109/IPDPS.2013.70; Stampar SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086612; Swofford David L., 1996, P407; Van Iten H, 2006, J SYST PALAEONTOL, V4, P109, DOI 10.1017/S1477201905001793; Werner B., 1973, Publications Seto Mar Biol Lab, V20, P35; Won JH, 2001, CORAL REEFS, V20, P39; Yoffe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031902	49	110	114	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139068	10.1371/journal.pone.0139068	http://dx.doi.org/10.1371/journal.pone.0139068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465609	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100037
J	Andersen, IB; Brasen, CL; Christensen, H; Noehr-Jensen, L; Nielsen, DE; Brandslund, I; Madsen, JS				Andersen, Ida B.; Brasen, Claus L.; Christensen, Henry; Noehr-Jensen, Lene; Nielsen, Dorthe E.; Brandslund, Ivan; Madsen, Jonna S.			Standardised Resting Time Prior to Blood Sampling and Diurnal Variation Associated with Risk of Patient Misclassification: Results from Selected Biochemical Components	PLOS ONE			English	Article							REFERENCE INTERVALS; SYSTEM	Background According to current recommendations, blood samples should be taken in the morning after 15 minutes' resting time. Some components exhibit diurnal variation and in response to pressures to expand opening hours and reduce waiting time, the aims of this study were to investigate the impact of resting time prior to blood sampling and diurnal variation on biochemical components, including albumin, thyrotropin (TSH), total calcium and sodium in plasma. Methods All patients referred to an outpatient clinic for blood sampling were included in the period Nov 2011 until June 2014 (opening hours: 7am-3pm). Each patient's arrival time and time of blood sampling were registered. The impact of resting time and the time of day for all components was analysed using simple linear regression. The "maximum allowable bias" was used as quality indicator for the change in reference interval. Results Significant diurnal variation was found for albumin (n = 15,544; p<2x10(-16)), TSH (n = 20,019; p<2x10(-16)), calcium (n = 13,588; p = 2.8x10(-12)) and sodium (n = 51,917; p<2x10(-16)). Further significant influence for resting time was found for albumin (p = 2.6x10(-4)), TSH (p = 0.004), calcium (p = 8.9x10(-7)) and sodium (p = 8.7x10(-16)). Only TSH and albumin were clinically significantly influenced by diurnal variation. Resting time had no clinically significant effect. Conclusions We found no need for resting 15 minutes prior to blood sampling. However, diurnal variation was found to have a significant and considerable impact on TSH and, to a minor degree, albumin. This has to be taken into account to ensure that reference intervals provided by the laboratory are valid on a 24-hour basis.	[Andersen, Ida B.; Brasen, Claus L.; Christensen, Henry; Brandslund, Ivan; Madsen, Jonna S.] Lillebaelt Hosp, Dept Clin Immunol & Biochem, Vejle, Denmark; [Brasen, Claus L.; Noehr-Jensen, Lene; Nielsen, Dorthe E.; Madsen, Jonna S.] Lillebaelt Hosp, Dept Clin Immunol & Biochem, Kolding, Denmark; [Brandslund, Ivan; Madsen, Jonna S.] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark	University of Southern Denmark	Andersen, IB (corresponding author), Lillebaelt Hosp, Dept Clin Immunol & Biochem, Vejle, Denmark.	Ida.Bogh.Andersen@rsyd.dk	Madsen, Jonna Skov/AAF-7054-2019; Brasen, Claus/ABG-9421-2021	Madsen, Jonna Skov/0000-0001-6668-4714; Andersen, Ida Bogh/0000-0001-9446-1710; Brandslund, Ivan/0000-0002-4203-5442				Behrends J, 1998, HORM RES, V49, P173, DOI 10.1159/000023167; Firsov D, 2012, MOL CELL ENDOCRINOL, V349, P51, DOI 10.1016/j.mce.2011.06.037; Fraser CG, 1999, SCAND J CLIN LAB INV, V59, P487, DOI 10.1080/00365519950185210; GOWANS EMS, 1988, SCAND J CLIN LAB INV, V48, P757, DOI 10.3109/00365518809088757; Hankins J, 2006, J INFUS MURS, V29, P260, DOI 10.1097/00129804-200609000-00004; Horowitz G.L., 2012, TIETZ TXB CLIN CHEM, Vfifth, P95; Jensen E, 2007, CLIN CHEM, V53, P355, DOI 10.1373/clinchem.2006.078964; Lippi G, 2015, CLIN CHIM ACTA, V440, P164, DOI 10.1016/j.cca.2014.11.024; Lippi G, 2013, CLIN CHEM LAB MED, V51, P229, DOI 10.1515/cclm-2012-0597; PETERSEN PH, 1981, SCAND J CLIN LAB INV, V41, P143, DOI 10.3109/00365518109092026; Simundic AM, 2014, CLIN CHIM ACTA, V432, P33, DOI 10.1016/j.cca.2013.11.008; WEEKE J, 1978, ACTA ENDOCRINOL-COP, V89, P659, DOI 10.1530/acta.0.0890659; WEEKE J, 1973, SCAND J CLIN LAB INV, V31, P337, DOI 10.3109/00365517309082440	13	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140475	10.1371/journal.pone.0140475	http://dx.doi.org/10.1371/journal.pone.0140475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461522	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300100
J	Lee, SY; Choi, JE; Jeon, HS; Choi, YY; Lee, WK; Lee, EB; Lee, HC; Kang, HG; Yoo, SS; Lee, J; Cha, SI; Kim, CH; Lee, MH; Kim, YT; Jheon, S; Park, JY				Lee, Shin Yup; Choi, Jin Eun; Jeon, Hyo-Sung; Choi, Yi-Young; Lee, Won Kee; Lee, Eung Bae; Lee, Hyun Cheol; Kang, Hyo-Gyoung; Yoo, Seung Soo; Lee, Jaehee; Cha, Seung Ick; Kim, Chang Ho; Lee, Myung Hoon; Kim, Young Tae; Jheon, Sanghoon; Park, Jae Yong			A Panel of Genetic Polymorphism for the Prediction of Prognosis in Patients with Early Stage Non-Small Cell Lung Cancer after Surgical Resection	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; SURVIVAL; RACK1; EXPRESSION; CHEMOTHERAPY; COMPLEMENT; PROTEIN; ACTIVATION; VARIANTS; GROWTH	Background This study was conducted to investigate whether a panel of eight genetic polymorphisms can predict the prognosis of patients with early stage non-small cell lung cancer (NSCLC) after surgical resection. Materials and Methods We selected eight single nucleotide polymorphisms (SNPs) which have been associated with the prognosis of lung cancer patients after surgery in our previous studies. A total of 814 patients with early stage NSCLC who underwent curative surgical resection were enrolled. The association of the eight SNPs with overall survival (OS) and disease-free survival (DFS) was analyzed. Results The eight SNPs (CD3EAP rs967591, TNFRSF10B rs1047266, AKT1 rs3803300, C3 rs2287845, HOMER2 rs1256428, GNB2L1 rs3756585, ADAMTSL3 rs11259927, and CD3D rs3181259) were significantly associated with OS and/or DFS. Combining those eight SNPs, we designed a prognostic index to predict the prognosis of patients. According to relative risk of death, a score value was assigned to each genotype of the SNPs. A worse prognosis corresponded to a higher score value, and the sum of score values of eight SNPs defined the prognostic index of a patient. When we categorized the patients into two groups based on the prognostic index, high risk group was significantly associated with worse OS and DFS compared to low risk group (aHR for OS = 2.21, 95% CI = 1.69-2.88, P = 8.0 x 10(-9), and aHR for DFS = 1.58, 95% CI = 1.29-1.94, P = 1.0 x 10(-5)). Conclusions Prognostic index using eight genetic polymorphisms may be useful for the prognostication of patients with surgically resected NSCLC.	[Lee, Shin Yup; Yoo, Seung Soo; Lee, Jaehee; Cha, Seung Ick; Kim, Chang Ho; Park, Jae Yong] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Choi, Jin Eun; Jeon, Hyo-Sung; Choi, Yi-Young; Kang, Hyo-Gyoung; Park, Jae Yong] Kyungpook Natl Univ, Sch Med, Dept Biochem, Daegu, South Korea; [Choi, Jin Eun; Jeon, Hyo-Sung; Choi, Yi-Young; Kang, Hyo-Gyoung; Park, Jae Yong] Kyungpook Natl Univ, Sch Med, Dept Cell Biol, Daegu, South Korea; [Lee, Shin Yup; Choi, Jin Eun; Jeon, Hyo-Sung; Lee, Eung Bae; Yoo, Seung Soo; Park, Jae Yong] Kyungpook Natl Univ, Med Ctr, Lung Canc Ctr, Daegu, South Korea; [Lee, Won Kee] Kyungpook Natl Univ, Sch Med, Ctr Biostat, Daegu, South Korea; [Lee, Eung Bae] Kyungpook Natl Univ, Sch Med, Dept Thorac Surg, Daegu, South Korea; [Lee, Hyun Cheol; Lee, Myung Hoon] Kyungpook Natl Univ, Sch Med, Diag & Predict Biotechnol, Daegu, South Korea; [Kim, Young Tae; Jheon, Sanghoon] Seoul Natl Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Seoul National University (SNU)	Park, JY (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea.	jaeyong@knu.ac.kr		Kim, Young Tae/0000-0001-9006-4881	R&D program of MKE/KEIT [10040393]	R&D program of MKE/KEIT	The work was supported by R&D program of MKE/KEIT (10040393, Development and commercialization of molecular diagnostic technologies for lung cancer through clinical validation), http://www.keit.re.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Ajima R, 2007, BIOCHEM BIOPH RES CO, V356, P851, DOI 10.1016/j.bbrc.2007.03.060; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Berns H, 2000, FASEB J, V14, P2549, DOI 10.1096/fj.99-1038com; Brognard J, 2001, CANCER RES, V61, P3986; Cao XX, 2010, INT J CANCER, V127, P1172, DOI 10.1002/ijc.25120; Cao XX, 2011, BREAST CANCER RES TR, V126, P555, DOI 10.1007/s10549-010-0955-3; Choi YY, 2015, ONCOTARGET, V6, P4451, DOI 10.18632/oncotarget.2865; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; Dadi HK, 2003, NEW ENGL J MED, V349, P1821, DOI 10.1056/NEJMoa031178; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Gminski J., 1992, Revue Roumaine de Medecine Interne, V30, P39; Grille SJ, 2003, CANCER RES, V63, P2172; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hong MJ, 2013, J THORAC ONCOL, V8, P703, DOI 10.1097/JTO.0b013e318288dc0a; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jeon HS, 2013, CLIN CANCER RES, V19, P4185, DOI 10.1158/1078-0432.CCR-12-2792; Jin H, 2004, CANCER RES, V64, P4900, DOI 10.1158/0008-5472.CAN-04-0408; Kim M, 2010, CANCER SCI, V101, P2436, DOI 10.1111/j.1349-7006.2010.01699.x; Kim MJ, 2012, J SURG ONCOL, V105, P167, DOI 10.1002/jso.22071; Kolev M, 2011, ARCH IMMUNOL THER EX, V59, P407, DOI 10.1007/s00005-011-0146-x; Koo BH, 2007, INT J CANCER, V121, P1710, DOI 10.1002/ijc.22882; Lakshmi Narendra Bodduluru, 2013, Inflamm Res, V62, P823, DOI 10.1007/s00011-013-0645-9; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lee EB, 2010, ANN SURG ONCOL, V17, P2608, DOI 10.1245/s10434-010-1082-4; Leithner K, 2009, LUNG CANCER, V65, P98, DOI 10.1016/j.lungcan.2008.10.015; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Mamidipudi V, 2007, ONCOGENE, V26, P2914, DOI 10.1038/sj.onc.1210091; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Mazzoni F, 2013, LUNG CANCER, V82, P288, DOI 10.1016/j.lungcan.2013.08.018; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Nagashio R, 2010, LUNG CANCER, V69, P54, DOI 10.1016/j.lungcan.2009.09.015; NISHIOKA K, 1976, ANN NY ACAD SCI, V276, P303, DOI 10.1111/j.1749-6632.1976.tb41656.x; Nishioka M, 2002, P NATL ACAD SCI USA, V99, P12269, DOI 10.1073/pnas.192445899; Pankratz VS, 2011, J THORAC ONCOL, V6, P1488, DOI 10.1097/JTO.0b013e318223bf05; Rutkowski MJ, 2010, MOL CANCER RES, V8, P1453, DOI 10.1158/1541-7786.MCR-10-0225; Shah A, 2005, CLIN CANCER RES, V11, P2930, DOI 10.1158/1078-0432.CCR-04-1385; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tani M, 2004, GENE CHROMOSOME CANC, V40, P146, DOI 10.1002/gcc.20027; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wagner KW, 2012, CLIN CANCER RES, V18, P585, DOI 10.1158/1078-0432.CCR-11-2087; Whitehead CM, 1997, CHROMOSOMA, V106, P493, DOI 10.1007/s004120050271; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Yoo SS, 2009, J CLIN ONCOL, V27, P5823, DOI 10.1200/JCO.2009.23.1738; Zhuang LQ, 2006, HUM PATHOL, V37, P1286, DOI 10.1016/j.humpath.2006.04.026	47	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140216	10.1371/journal.pone.0140216	http://dx.doi.org/10.1371/journal.pone.0140216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462029	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300068
J	Nechaev, DI; Milekhina, ON; Supin, AY				Nechaev, Dmitry I.; Milekhina, Olga N.; Supin, Alexander Ya.			Hearing Sensitivity to Shifts of Rippled-Spectrum Sound Signals in Masking Noise	PLOS ONE			English	Article							FREQUENCY DISCRIMINATION; RESOLUTION DEPENDENCE; DENSITY RESOLUTION; NOTCHED-NOISE; TONES; LEVEL; SELECTIVITY; PATTERNS; RATIO; PITCH	The goal of the study was to enlarge knowledge of discrimination of complex sound signals by the auditory system in masking noise. For that, influence of masking noise on detection of shift of rippled spectrum was studied in normal listeners. The signal was a shift of ripple phase within a 0.5-oct wide rippled spectrum centered at 2 kHz. The ripples were frequency-proportional (throughout the band, ripple spacing was a constant proportion of the ripple center frequency). Simultaneous masker was a 0.5-oct noise below-, on-, or above the signal band. Both the low-frequency (center frequency 1 kHz) and on-frequency (the same center frequency as for the signal) maskers increased the thresholds for detecting ripple phase shift. However, the threshold dependence on the masker level was different for these two maskers. For the on-frequency masker, the masking effect primarily depended on the masker/signal ratio: the threshold steeply increased at a ratio of 5 dB, and no shift was detectable at a ratio of 10 dB. For the low-frequency masker, the masking effect primarily depended on the masker level: the threshold increased at a masker level of 80 dB SPL, and no shift was detectable at a masker level of 90 dB (for a signal level of 50 dB) or 100 dB (for a signal level of 80 dB). The high-frequency masker had little effect. The data were successfully simulated using an excitation-pattern model. In this model, the effect of the on-frequency masker appeared to be primarily due to a decrease of ripple depth. The effect of the low-frequency masker appeared due to widening of the auditory filters at high sound levels.	[Nechaev, Dmitry I.; Milekhina, Olga N.; Supin, Alexander Ya.] Russian Acad Sci, Inst Ecol & Evolut, Moscow, Russia	Russian Academy of Sciences	Supin, AY (corresponding author), Russian Acad Sci, Inst Ecol & Evolut, Moscow, Russia.	alex_supin@mail.ru			Russian Foundation for Basic Research [14-04-00237a]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the Russian Foundation for Basic Research, Grant 14-04-00237a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, PROFILE ANAL AUDITOR; Buus S., 1995, ADV HEARING RES, P401; EMMERICH DS, 1983, J ACOUST SOC AM, V74, P1702, DOI 10.1121/1.390278; EMMERICH DS, 1986, J ACOUST SOC AM, V80, P1668, DOI 10.1121/1.394278; FANTINI DA, 1989, J ACOUST SOC AM, V85, P1691, DOI 10.1121/1.397958; Glasberg BR, 2000, J ACOUST SOC AM, V108, P2318, DOI 10.1121/1.1315291; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; GREEN DM, 1983, AM PSYCHOL, V38, P133, DOI 10.1037/0003-066X.38.2.133; HENNING GB, 1967, J ACOUST SOC AM, V41, P774, DOI 10.1121/1.1910405; Jackson HM, 2014, J ACOUST SOC AM, V135, P1356, DOI 10.1121/1.4864306; JESTEADT W, 1975, J ACOUST SOC AM, V57, P1161, DOI 10.1121/1.380574; Masking Zwicker E., 1970, FREQUENCY ANAL PERIO, P376; MOORE BCJ, 1973, J ACOUST SOC AM, V54, P610, DOI 10.1121/1.1913640; MOORE BCJ, 1989, J ACOUST SOC AM, V85, P820, DOI 10.1121/1.397554; MOORE BCJ, 1989, J ACOUST SOC AM, V86, P1722, DOI 10.1121/1.398603; Nechaev DI, 2013, J ACOUST SOC AM, V134, P2913, DOI 10.1121/1.4820789; NELSON DA, 1982, J ACOUST SOC AM, V71, P660, DOI 10.1121/1.387541; PATTERSON RD, 1982, J ACOUST SOC AM, V72, P1788, DOI 10.1121/1.388652; SEK A, 1995, J ACOUST SOC AM, V97, P2479, DOI 10.1121/1.411968; Shower EG, 1931, J ACOUST SOC AM, V3, P275, DOI 10.1121/1.1915561; Supin AY, 2005, HEARING RES, V204, P191, DOI 10.1016/j.heares.2005.01.010; Supin AY, 2003, HEARING RES, V185, P1, DOI 10.1016/S0378-5955(03)00215-6; Supin AY, 1999, J ACOUST SOC AM, V106, P2800, DOI 10.1121/1.428105; SUPIN AY, 1994, HEARING RES, V78, P31, DOI 10.1016/0378-5955(94)90041-8; Supin AY, 1997, HEARING RES, V108, P17, DOI 10.1016/S0378-5955(97)00035-X; Supin AY, 1998, J ACOUST SOC AM, V103, P2042, DOI 10.1121/1.421351; Supin AY, 2001, HEARING RES, V151, P157, DOI 10.1016/S0378-5955(00)00223-9; WIER CC, 1977, J ACOUST SOC AM, V61, P178, DOI 10.1121/1.381251; YOST WA, 1978, J ACOUST SOC AM, V63, P1166, DOI 10.1121/1.381824	29	5	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140313	10.1371/journal.pone.0140313	http://dx.doi.org/10.1371/journal.pone.0140313			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462066	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300080
J	Kim, SB; Bozeman, RG; Kaisani, A; Kim, W; Zhang, L; Richardson, JA; Wright, WE; Shay, JW				Kim, S. B.; Bozeman, R. G.; Kaisani, A.; Kim, W.; Zhang, L.; Richardson, J. A.; Wright, W. E.; Shay, J. W.			Radiation promotes colorectal cancer initiation and progression by inducing senescence-associated inflammatory responses	ONCOGENE			English	Article							SOLAR PARTICLE EVENT; PROTON-BEAM THERAPY; CDDO-METHYL ESTER; EPITHELIAL-CELLS; MOUSE MODEL; DNA-DAMAGE; SPACE RADIATION; LUNG-CANCER; AUGUST 1972; TRITERPENOIDS	Proton radiotherapy is becoming more common as protons induce more precise DNA damage at the tumor site with reduced side effects to adjacent normal tissues. However, the long-term biological effects of proton irradiation in cancer initiation compared with conventional photon irradiation are poorly characterized. In this study, using a human familial adenomatous polyposis syndrome susceptible mouse model, we show that whole-body irradiation with protons are more effective in inducing senescence-associated inflammatory responses (SIRs), which are involved in colon cancer initiation and progression. After proton irradiation, a subset of SIR genes (Troy, Sox17, Opg, Faim2, Lpo, Tlr2 and Ptges) and a gene known to be involved in invasiveness (Plat), along with the senescence-associated gene (P19Arf), are markedly increased. Following these changes, loss of Casein kinase I alpha and induction of chronic DNA damage and TP53 mutations are increased compared with X-ray irradiation. Proton irradiation also increases the number of colonic polyps, carcinomas and invasive adenocarcinomas. Pretreatment with the non-steroidal anti-inflammatory drug, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid-ethyl amide (CDDO-EA), reduces proton irradiation-associated SIR and tumorigenesis. Thus exposure to proton irradiation elicits significant changes in colorectal cancer initiation and progression that can be mitigated using CDDO-EA.	[Kim, S. B.; Bozeman, R. G.; Kaisani, A.; Kim, W.; Zhang, L.; Wright, W. E.; Shay, J. W.] Univ Texas Southwestern Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd,MC9039, Dallas, TX 75390 USA; [Richardson, J. A.] Univ Texas Southwestern Med Ctr, Dept Pathol, Dallas, TX USA; [Richardson, J. A.] Univ Texas Southwestern Med Ctr, Dept Mol Biol, Dallas, TX USA; [Richardson, J. A.] Univ Texas Southwestern Med Ctr, Dept Plast Surg, Dallas, TX USA; [Shay, J. W.] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah, Saudi Arabia	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; King Abdulaziz University	Shay, JW (corresponding author), Univ Texas Southwestern Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd,MC9039, Dallas, TX 75390 USA.	jerry.shay@utsouthwestern.edu		Kim, Sang Bum/0000-0001-5965-3354	NIH grant [C06 RR30414]; NASA Grant [NNX15AI21G, NNX11AC15G, NNJ05HD36G, NNX09AU95G]; NATIONAL CANCER INSTITUTE [P50CA070907, T32CA124334] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR030414] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA Grant(National Aeronautics & Space Administration (NASA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the support team at Brookhaven National Laboratory (BNL) and NASA Space Radiation Laboratory (NSRL) (Upton, NY, USA) for helping with the Proton and HZE particles delivery to animals. We thank Dr Michael Sporn (Hanover, NH, USA) and Reata Pharmaceuticals (Irving, TX, USA) for providing CDDO-EA reagent, Summer Barron (UT Southwestern, Dallas, TX, USA) for mouse colony maintenance and Gail Fasciani (UT Southwestern, Dallas, TX, USA) for histological processing. This work was performed in laboratories constructed with support from NIH grant C06 RR30414. This work was supported by NASA Grant nos. NNX15AI21G, NNX11AC15G, NNJ05HD36G and NNX09AU95G to JWS.	Ahn PH, 2014, CANCER J, V20, P421, DOI 10.1097/PPO.0000000000000077; Arnold CN, 2005, CANCER-AM CANCER SOC, V104, P2035, DOI 10.1002/cncr.21462; Bahnassy AA, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-22; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Breuer H, 2013, PROTON THERAPY RADIO; Collis SJ, 2004, J BIOL CHEM, V279, P49624, DOI 10.1074/jbc.M409600200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DANGIO GJ, 1963, NUCLEONICS, V21, P56; Delgado O, 2014, CLIN CANCER RES, V20, P1610, DOI 10.1158/1078-0432.CCR-13-2589; Dicello JF, 2002, J RADIAT RES, V43, pS1; Eaton BR, 2014, CANCER J, V20, P403, DOI 10.1097/PPO.0000000000000079; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Eskiocak U, 2010, RADIAT RES, V174, P27, DOI 10.1667/RR2155.1; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; George K, 2003, RADIAT RES, V160, P425, DOI 10.1667/RR3064; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Hellweg CE, 2007, NATURWISSENSCHAFTEN, V94, P517, DOI 10.1007/s00114-006-0204-0; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Keole S, 2014, CANCER J, V20, P409, DOI 10.1097/PPO.0000000000000084; Kim SB, 2014, LIFE SCI SPACE RES, V1, P67, DOI 10.1016/j.lssr.2014.02.001; Kim SB, 2013, RADIAT RES, V180, P259, DOI 10.1667/RR3371.1; Kim SB, 2012, P NATL ACAD SCI USA, V109, pE2949, DOI 10.1073/pnas.1207718109; Kim SB, 2014, GRAVIT SPACE RES, V2, P32; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Lawrence J H, 1964, Trans Am Clin Climatol Assoc, V75, P111; Liby K, 2007, CANCER RES, V67, P2414, DOI 10.1158/0008-5472.CAN-06-4534; Ludlow AT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku439; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Moravek Z, 2009, Z MED PHYS, V19, P174, DOI 10.1016/j.zemedi.2009.04.006; Neymotin A, 2011, FREE RADICAL BIO MED, V51, P88, DOI 10.1016/j.freeradbiomed.2011.03.027; Parsons JL, 2000, RADIAT RES, V153, P729, DOI 10.1667/0033-7587(2000)153[0729:ICDRFT]2.0.CO;2; Petronelli A, 2009, ANTI-CANCER DRUG, V20, P880, DOI 10.1097/CAD.0b013e328330fd90; Pribluda A, 2013, CANCER CELL, V24, P242, DOI 10.1016/j.ccr.2013.06.005; Pugh TJ, 2014, CANCER J, V20, P415, DOI 10.1097/PPO.0000000000000083; Reisman SA, 2014, RADIAT RES, V181, P512, DOI 10.1667/RR13578.1; Rithidech KN, 2013, MUTAT RES-GEN TOX EN, V756, P127, DOI 10.1016/j.mrgentox.2013.06.001; Rutter MD, 2010, FRONTLINE GASTROENTE, V1, P126, DOI 10.1136/fg.2010.001438; Simone CB, 2014, CANCER J, V20, P427, DOI 10.1097/PPO.0000000000000080; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; SUIT HD, 1975, CANCER-AM CANCER SOC, V35, P1646, DOI 10.1002/1097-0142(197506)35:6<1646::AID-CNCR2820350626>3.0.CO;2-1; Thimmulappa RK, 2007, ANTIOXID REDOX SIGN, V9, P1963, DOI 10.1089/ars.2007.1745; TOWNSEND LW, 1991, RADIAT RES, V126, P108, DOI 10.2307/3578178; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Vannini N, 2007, MOL CANCER THER, V6, P3139, DOI 10.1158/1535-7163.MCT-07-0451; VERHEY LJ, 1982, ANNU REV BIOPHYS BIO, V11, P331, DOI 10.1146/annurev.bb.11.060182.001555; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Williams JR, 1999, MUTAT RES-FUND MOL M, V430, P255, DOI 10.1016/S0027-5107(99)00137-2; Wilson JW, 1999, RADIAT MEAS, V30, P361, DOI 10.1016/S1350-4487(99)00063-3	50	25	25	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 30	2016	35	26					3365	3375		10.1038/onc.2015.395	http://dx.doi.org/10.1038/onc.2015.395			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DQ5UI	26477319	Green Accepted			2022-12-26	WOS:000379270100002
J	Abd Ellah, N; Taylor, L; Troja, W; Owens, K; Ayres, N; Pauletti, G; Jones, H				Abd Ellah, Noura; Taylor, Leeanne; Troja, Weston; Owens, Kathryn; Ayres, Neil; Pauletti, Giovanni; Jones, Helen			Development of Non-Viral, Trophoblast-Specific Gene Delivery for Placental Therapy	PLOS ONE			English	Article							GROWTH; COPOLYMERS; IGF-1	Low birth weight is associated with both short term problems and the fetal programming of adult onset diseases, including an increased risk of obesity, diabetes and cardiovascular disease. Placental insufficiency leading to intrauterine growth restriction (IUGR) contributes to the prevalence of diseases with developmental origins. Currently there are no therapies for IUGR or placental insufficiency. To address this and move towards development of an in utero therapy, we employ a nanostructure delivery system complexed with the IGF-1 gene to treat the placenta. IGF-1 is a growth factor critical to achieving appropriate placental and fetal growth. Delivery of genes to a model of human trophoblast and mouse placenta was achieved using a diblock copolymer (pHPMA-b-pDMAEMA) complexed to hIGF-1 plasmid DNA under the control of trophoblast-specific promoters (Cyp19a or PLAC1). Transfection efficiency of pEGFP-C1-containing nanocarriers in BeWo cells and non-trophoblast cells was visually assessed via fluorescence microscopy. In vivo transfection and functionality was assessed by direct placental-injection into a mouse model of IUGR. Complexes formed using pHPMA-b-pDMAEMA and CYP19a-923 or PLAC1-modified plasmids induce trophoblast-selective transgene expression in vitro, and placental injection of PLAC1-hIGF-1 produces measurable RNA expression and alleviates IUGR in our mouse model, consequently representing innovative building blocks towards human placental gene therapies.	[Abd Ellah, Noura; Pauletti, Giovanni] Univ Cincinnati, James L Winkle Coll Pharm, Cincinnati, OH 45267 USA; [Abd Ellah, Noura] Assiut Univ, Fac Pharm, Assiut 71515, Egypt; [Taylor, Leeanne; Ayres, Neil] Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA; [Troja, Weston; Owens, Kathryn; Jones, Helen] Cincinnati Childrens Hosp Med Ctr, Div Gen & Thorac Surg, Cincinnati, OH 45229 USA; [Troja, Weston; Owens, Kathryn; Jones, Helen] Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Egyptian Knowledge Bank (EKB); Assiut University; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Jones, H (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Gen & Thorac Surg, Cincinnati, OH 45229 USA.	Helen.Jones@cchmc.org	Pauletti, Giovanni M./I-5468-2015	Pauletti, Giovanni M./0000-0002-0053-4964; Abd Ellah, Noura/0000-0002-8326-4364	Egyptian Ministry of Higher Education; University of Cincinnati URC Interdisciplinary Grant; Eunice Kennedy Shriver NICHD award [K99HD068504, R00HD068504]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD068504, R00HD068504] Funding Source: NIH RePORTER	Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF)); University of Cincinnati URC Interdisciplinary Grant; Eunice Kennedy Shriver NICHD award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported in part by a predoctoral fellowship from the Egyptian Ministry of Higher Education awarded to NHAE. HNJ, NA and GMP were funded by a University of Cincinnati URC Interdisciplinary Grant, and HNJ is funded by Eunice Kennedy Shriver NICHD award K99HD068504 and R00HD068504. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Ellah N.H., 2014, J PHARM TECHNOLOGY D, V3, P7243, DOI DOI 10.7243/2050-120X-3-2; Barker DJP, 2003, EUR J EPIDEMIOL, V18, P733, DOI 10.1023/A:1025388901248; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Convertine AJ, 2006, MACROMOLECULES, V39, P1724, DOI 10.1021/ma0523419; Dubruel P, 2006, MACROMOL BIOSCI, V6, P789, DOI 10.1002/mabi.200600110; Duvall CL, 2010, MOL PHARMACEUT, V7, P468, DOI 10.1021/mp9002267; Fant M, 2010, PRENATAL DIAG, V30, P497, DOI 10.1002/pd.2506; Fowden AL, 2003, PLACENTA, V24, P803, DOI 10.1016/S0143-4004(03)00080-8; Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038; Habli M, 2013, PLACENTA, V34, P1150; Jones H, 2014, PLACENTA, V35, P132, DOI 10.1016/j.placenta.2013.11.012; Jones HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074632; Kamat A, 1999, P NATL ACAD SCI USA, V96, P4575, DOI 10.1073/pnas.96.8.4575; Keswani SG, 2004, MOL THER, V9, pS24; KOPECEK J, 1991, ANN NY ACAD SCI, V618, P335, DOI 10.1111/j.1749-6632.1991.tb27253.x; Liu JH, 2010, J CONTROL RELEASE, V143, P71, DOI 10.1016/j.jconrel.2009.12.022; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Lu XY, 2011, PROG MOL BIOL TRANSL, V104, P299, DOI 10.1016/B978-0-12-416020-0.00007-3; Mahmood M, 2012, J APPL TOXICOL, V32, P10, DOI 10.1002/jat.1718; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Rowe MD, 2009, LANGMUIR, V25, P9487, DOI 10.1021/la900730b; Saunders M, 2009, WIRES NANOMED NANOBI, V1, P671, DOI 10.1002/wnan.53; Tanaka S, 2001, BIOL REPROD, V65, P1813, DOI 10.1095/biolreprod65.6.1813; Troja W, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.244; Vega-Avila Elisa, 2011, Proc West Pharmacol Soc, V54, P10; Ventolini G, 2011, Minerva Ginecol, V63, P459	27	26	26	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140879	10.1371/journal.pone.0140879	http://dx.doi.org/10.1371/journal.pone.0140879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473479	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500125
J	Alcantara-Hernandez, R; Hernandez-Mendez, A; Campos-Martinez, GA; Meizoso-Huesca, A; Garcia-Sainz, JA				Alcantara-Hernandez, Rocio; Hernandez-Mendez, Aurelio; Campos-Martinez, Gisselle A.; Meizoso-Huesca, Aldo; Adolfo Garcia-Sainz, J.			Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA(1), LPA(2), and LPA(3)	PLOS ONE			English	Article							PROTEIN-KINASE-C; GROWTH-FACTOR-I; G-BETA-GAMMA; COUPLED RECEPTORS; EGF RECEPTOR; CANCER CELLS; TRANSACTIVATION; ENDOCYTOSIS; DESENSITIZATION; ACTIVATION	Results The lysophosphatidic acid receptors LPA(1), LPA(2), and LPA(3) were individually expressed in C9 cells and their signaling and regulation were studied. Agonist-activation increases intracellular calcium concentration in a concentration- dependent fashion. Phorbol myristate acetate markedly inhibited LPA(1)- and LPA(3)-mediated effect, whereas that mediated by LPA(2) was only partially diminished; the actions of the phorbol ester were inhibited by bisindolylmaleimide I and by overnight incubation with the protein kinase C activator, which leads to down regulation of this protein kinase. Homologous desensitization was also observed for the three LPA receptors studied, with that of LPA(2) receptors being consistently of lesser magnitude; neither inhibition nor down-regulation of protein kinase C exerted any effect on homologous desensitization. Activation of LPA(1-3) receptors induced ERK 1/2 phosphorylation; this effect was markedly attenuated by inhibition of epidermal growth factor receptor tyrosine kinase activity, suggesting growth factor receptor transactivation in this effect. Lysophosphatidic acid and phorbol myristate acetate were able to induce LPA(1-3) phosphorylation, in time- and concentration-dependent fashions. It was also clearly observed that agonists and protein kinase C activation induced internalization of these receptors. Phosphorylation of the LPA(2) subtype required larger concentrations of these agents and its internalization was less intense than that of the other subtypes. Conclusion Our data show that these three LPA receptors are phosphoproteins whose phosphorylation state is modulated by agonist-stimulation and protein kinase C-activation and that differences in regulation and cellular localization exist, among the subtypes.	[Alcantara-Hernandez, Rocio; Hernandez-Mendez, Aurelio; Campos-Martinez, Gisselle A.; Meizoso-Huesca, Aldo; Adolfo Garcia-Sainz, J.] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Garcia-Sainz, JA (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Apartado Postal 70-248, Mexico City 04510, DF, Mexico.	agarcia@ifc.unam.mx	GARCIA-SAINZ, JESUS ADOLFO/A-5389-2008	GARCIA-SAINZ, JESUS ADOLFO/0000-0002-5235-0657; Meizoso Huesca, Aldo/0000-0001-7873-5398	National Council of Science and Technology of Mexico (CONACyT) [177556]; PAPIIT-UNAM [IN200812, IN200915]	National Council of Science and Technology of Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was partially supported by grants from the National Council of Science and Technology of Mexico (CONACyT [177556]) and our University (PAPIIT-UNAM [IN200812 and IN200915]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Morquecho-Leon MA, 2014, BBA-MOL CELL RES, V1843, P327, DOI 10.1016/j.bbamcr.2013.11.002; Avendafio-Vazguez SE, 2007, SIGNAL TRANSDUCT, V7, P351; Avendano-Vazquez SEA, 2005, BIOCHEM J, V385, P677, DOI 10.1042/BJ20040891; Aziziyeh AI, 2009, CELL SIGNAL, V21, P1207, DOI 10.1016/j.cellsig.2009.03.011; Brusevold IJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-432; Budd DC, 2001, J BIOL CHEM, V276, P4581, DOI 10.1074/jbc.M008827200; Butcher AJ, 2014, J BIOL CHEM, V289, P18451, DOI 10.1074/jbc.M114.568816; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Callihan P, 2014, ASN NEURO, V6, DOI 10.1177/1759091414558416; Casas-Gonzalez P, 2003, BBA-MOL CELL BIOL L, V1633, P75, DOI 10.1016/S1388-1981(03)00089-1; Casas-Gonzalez P, 2006, EUR J PHARMACOL, V542, P31, DOI 10.1016/j.ejphar.2006.05.031; Castillo-Badillo JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121165; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Colin-Santana CC, 2011, BBA-GEN SUBJECTS, V1810, P1170, DOI 10.1016/j.bbagen.2011.08.016; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Fukushima N, 2015, CELL MOL LIFE SCI, V72, P2377, DOI 10.1007/s00018-015-1872-8; Garcia-Regalado A, 2008, MOL BIOL CELL, V19, P4188, DOI 10.1091/mbc.E07-10-1089; Garcia-Sainz JA, 2000, EUR J PHARMACOL, V389, P1, DOI 10.1016/S0014-2999(99)00896-1; George AJ, 2013, FEBS J, V280, P5258, DOI 10.1111/febs.12509; Gonzalez-Arenas A, 2008, BBA-MOL CELL RES, V1783, P253, DOI 10.1016/j.bbamcr.2007.11.014; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Harlow E., 1988, ANTIBODIES LAB MANUA; Hernandez-Mendez A, 2014, RECEPT CLIN INVEST, V1, P236, DOI 10.14800/rci.193; Hernandez-Mendez A, 2014, EUR J PHARMACOL, V723, P124, DOI 10.1016/j.ejphar.2013.11.043; Huang LS, 2013, AM J RESP CELL MOL, V49, P912, DOI 10.1165/rcmb.2013-0070OC; Iacovelli L, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740103; Im DS, 2010, ACTA PHARMACOL SIN, V31, P1213, DOI 10.1038/aps.2010.135; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jeong KJ, 2008, EXP MOL MED, V40, P607, DOI 10.3858/emm.2008.40.6.607; Jia W, 2015, CANCER LETT, V356, P589, DOI 10.1016/j.canlet.2014.10.001; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Kihara Y, 2014, BRIT J PHARMACOL, V171, P3575, DOI 10.1111/bph.12678; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; KRUG E, 1987, CANCER RES, V47, P2243; Kuriyama S, 2014, J CELL BIOL, V206, P113, DOI 10.1083/jcb.201402093; Leserer M, 2000, IUBMB LIFE, V49, P405; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; McCaffrey G, 2009, TRAFFIC, V10, P938, DOI 10.1111/j.1600-0854.2009.00909.x; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Molina-Munoz T, 2008, EUR J PHARMACOL, V578, P1, DOI 10.1016/j.ejphar.2007.08.047; Molina-Munoz T, 2006, MOL ENDOCRINOL, V20, P2773, DOI 10.1210/me.2006-0090; Murph MM, 2008, BBA-MOL CELL BIOL L, V1781, P547, DOI 10.1016/j.bbalip.2008.04.007; Murph MM, 2003, J CELL SCI, V116, P1969, DOI 10.1242/jcs.00397; Nieto-Posadas A, 2012, NAT CHEM BIOL, V8, P78, DOI 10.1038/nchembio.712; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; Olianas MC, 2015, BIOCHEM PHARMACOL, V95, P311, DOI 10.1016/j.bcp.2015.04.002; Penn RB, 2000, TRENDS CARDIOVAS MED, V10, P81, DOI 10.1016/S1050-1738(00)00053-0; Ren AX, 2014, J BIOL CHEM, V289, P35757, DOI 10.1074/jbc.M114.595512; Sanchez-Reyes OB, 2014, EUR J PHARMACOL, V723, P368, DOI 10.1016/j.ejphar.2013.11.003; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Tigyi G, 2010, BRIT J PHARMACOL, V161, P241, DOI 10.1111/j.1476-5381.2010.00815.x; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Urs NM, 2008, J BIOL CHEM, V283, P5249, DOI 10.1074/jbc.M710003200; Urs NM, 2005, J CELL SCI, V118, P5291, DOI 10.1242/jcs.02634; Varsano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049227; Vazquez-Prado J, 2003, CELL SIGNAL, V15, P549, DOI 10.1016/S0898-6568(02)00151-1; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Yamamoto M, 1999, HISTOCHEM J, V31, P241, DOI 10.1023/A:1003598614323; Yun CC, 2005, AM J PHYSIOL-CELL PH, V289, pC2, DOI 10.1152/ajpcell.00610.2004; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	69	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140583	10.1371/journal.pone.0140583	http://dx.doi.org/10.1371/journal.pone.0140583			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473723	gold, Green Published, Green Submitted			2022-12-26	WOS:000363185500067
J	Cheng, QJ; Chang, SS; Guo, YQ; Yip, PSF				Cheng, Qijin; Chang, Shu-Sen; Guo, Yingqi; Yip, Paul S. F.			Information Accessibility of the Charcoal Burning Suicide Method in Mainland China	PLOS ONE			English	Article							MEDIA GUIDELINES; HONG-KONG; RATES; PREVENTION; TAIWAN; TRENDS; IMPACT	Background There has been a marked rise in suicide by charcoal burning (CB) in some East Asian countries but little is known about its incidence in mainland China. We examined media-reported CB suicides and the availability of online information about the method in mainland China. Methods We extracted and analyzed data for i) the characteristics and trends of fatal and nonfatal CB suicides reported by mainland Chinese newspapers (1998-2014); ii) trends and geographic variations in online searches using keywords relating to CB suicide (2011-2014); and iii) the content of Internet search results. Results 109 CB suicide attempts (89 fatal and 20 nonfatal) were reported by newspapers in 13 out of the 31 provinces or provincial-level-municipalities in mainland China. There were increasing trends in the incidence of reported CB suicides and in online searches using CB-related keywords. The province-level search intensities were correlated with CB suicide rates (Spearman's correlation coefficient = 0.43 [95% confidence interval: 0.08-0.68]). Two-thirds of the web links retrieved using the search engine contained detailed information about the CB suicide method, of which 15% showed pro-suicide attitudes, and the majority (86%) did not encourage people to seek help. Limitations The incidence of CB suicide was based on newspaper reports and likely to be underestimated. Conclusions Mental health and suicide prevention professionals in mainland China should be alert to the increased use of this highly lethal suicide method. Better surveillance and intervention strategies need to be developed and implemented.	[Cheng, Qijin; Yip, Paul S. F.] Univ Hong Kong, HKJC Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China; [Chang, Shu-Sen] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Behav & Community Sci, Taipei 10764, Taiwan; [Chang, Shu-Sen] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Guo, Yingqi; Yip, Paul S. F.] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; National Taiwan University; National Taiwan University; University of Hong Kong	Yip, PSF (corresponding author), Univ Hong Kong, HKJC Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China.	sfpyip@hku.hk	Chang, Shu-Sen/AAH-6733-2021; Chang, Shu-Sen/B-3518-2012	Chang, Shu-Sen/0000-0001-5012-1132; Chang, Shu-Sen/0000-0001-5012-1132; Cheng, Qijin/0000-0002-6223-5345; Guo, Yingqi/0000-0002-3682-2917	University of Hong Kong Small Project [201309176175]; Fogarty International Center of US NIH [D43 TW009101]; Chiang Ching-kuo Foundation, Taiwan [RG014-P-12]; Strategic Public Policy Research Funding, Hong Kong [HKU 7003-SPPR-12]; FOGARTY INTERNATIONAL CENTER [D43TW009101] Funding Source: NIH RePORTER	University of Hong Kong Small Project(University of Hong Kong); Fogarty International Center of US NIH; Chiang Ching-kuo Foundation, Taiwan; Strategic Public Policy Research Funding, Hong Kong; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	QC's work was supported by The University of Hong Kong Small Project Funding (201309176175) and grant D43 TW009101 from the Fogarty International Center of US NIH. SSC was supported by the Chiang Ching-kuo Foundation, Taiwan (Grant number RG014-P-12). PSFY's work was supported by Strategic Public Policy Research Funding, Hong Kong (HKU 7003-SPPR-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, CHINA DAILY; Biddle L, 2008, BRIT MED J, V336, P800, DOI 10.1136/bmj.39525.442674.AD; Biddle L, 2012, J AFFECT DISORDERS, V136, P702, DOI 10.1016/j.jad.2011.10.004; Bohanna I, 2012, CRISIS, V33, P190, DOI 10.1027/0227-5910/a000137; Chan KPM, 2005, BRIT J PSYCHIAT, V186, P67, DOI 10.1192/bjp.186.1.67; Chang SS, 2015, SOC PSYCH PSYCH EPID, V50, P1451, DOI 10.1007/s00127-015-1057-7; Chang SS, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001622; Chang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000212; Chen X., 2004, ZHEJIANG SOC SCI, V6, P71; Chen YY, 2013, J PUBLIC HEALTH-UK, V35, P223, DOI 10.1093/pubmed/fds095; Chen YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055000, 10.1371/journal.pone.0059263]; Cheng QJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108724; Cheng QJ, 2014, CRISIS, V35, P74, DOI 10.1027/0227-5910/a000241; Cheng QJ, 2012, LANCET, V379, pE53, DOI 10.1016/S0140-6736(12)60856-3; Cheng QJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d2113; Cheng QJ, 2011, J CLIN PSYCHIAT, V72, P313, DOI 10.4088/JCP.09m05440blu; China Internet Network Information Center, 2014, 33 CHIN INT NETW INF; China Internet Network Information Center, 2014, STAT REP INT DEV CHI; Facebook Help Center, SUIC PREV; Florentine JB, 2010, SOC SCI MED, V70, P1626, DOI 10.1016/j.socscimed.2010.01.029; Fu KW, 2011, J EPIDEMIOL COMMUN H, V65, P928, DOI 10.1136/jech.2009.105650; Hagihara A, 2014, SOC PSYCH PSYCH EPID, V49, P221, DOI 10.1007/s00127-013-0741-8; Hagihara A, 2012, EUR ARCH PSY CLIN N, V262, P39, DOI 10.1007/s00406-011-0212-8; Incitez China, 2014, CHIN SEARCH ENG MARK; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Ji NJ, 2014, J KOREAN MED SCI, V29, P1174, DOI 10.3346/jkms.2014.29.8.1174; Lee DTS, 2002, ARCH GEN PSYCHIAT, V59, P293, DOI 10.1001/archpsyc.59.3.293; Li F, 2015, FORENSIC SCI INT, V253, P112, DOI 10.1016/j.forsciint.2015.06.007; Milian M, 2011, GOOGLE REFER SUICIDA; National Bureau of Statistics of the Peoples Republic of China, 2010, 2010 POP CENS PEOPL; Niederkrotenthaler T, 2012, J EPIDEMIOL COMMUN H, V66, P1037, DOI 10.1136/jech-2011-200707; Thomas K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-314; Tian L., 2009, J FORENSIC MED, V25, P306; Tsai CW, 2011, J AFFECT DISORDERS, V131, P402, DOI 10.1016/j.jad.2010.12.013; Twitter Help Center, DEAL SELF HARM SUIC; Wang CW, 2014, SOC PSYCH PSYCH EPID, V49, P929, DOI 10.1007/s00127-013-0789-5; World Health Organization, 2014, PREV SUIC PREV SUIC; Xinhua News Agency, 2014, LIV ONL SUIC RAIS CO; Yip PSF, 2013, J AFFECT DISORDERS, V148, P98, DOI 10.1016/j.jad.2012.11.056; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2; Zeng D., 2008, J FORENSIC MED, V24, P392	41	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140686	10.1371/journal.pone.0140686	http://dx.doi.org/10.1371/journal.pone.0140686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0DF	26474297	gold, Green Published			2022-12-26	WOS:000363185500081
J	Ishii, Y; Nhiayi, MK; Tse, E; Cheng, J; Massimino, M; Durden, DL; Vigneri, P; Wang, JYJ				Ishii, Yuki; Nhiayi, May Keu; Tse, Edison; Cheng, Jonathan; Massimino, Michele; Durden, Donald L.; Vigneri, Paolo; Wang, Jean Y. J.			Knockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C Release	PLOS ONE			English	Article							LEUKEMIA STEM-CELLS; CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL; REDOX REGULATION; AKT INHIBITOR; KINASE INHIBITION; DRUG-RESISTANCE; GENE-EXPRESSION; CANCER-CELLS; APOPTOSIS	Knockout serum replacement (KOSR) is a nutrient supplement commonly used to replace serum for culturing stem cells. We show here that KOSR has pro-survival activity in chronic myelogenous leukemia (CML) cells transformed by the BCR-ABL oncogene. Inhibitors of BCR-ABL tyrosine kinase kill CML cells by stimulating pro-apoptotic BIM and inhibiting antiapoptotic BCL2, BCLxL and MCL1. We found that KOSR protects CML cells from killing by BCR-ABL inhibitors-imatinib, dasatinib and nilotinib. The protective effect of KOSR is reversible and not due to the selective outgrowth of drug-resistant clones. In KOSR-protected CML cells, imatinib still inhibited the BCR-ABL tyrosine kinase, reduced the phosphorylation of STAT, ERK and AKT, down-regulated BCL2, BCLxL, MCL1 and up-regulated BIM. However, these pro-apoptotic alterations failed to cause cytochrome c release from the mitochondria. With mitochondria isolated from KOSR-cultured CML cells, we showed that addition of recombinant BIM protein also failed to cause cytochrome c release. Besides the kinase inhibitors, KOSR could protect cells from menadione, an inducer of oxidative stress, but it did not protect cells from DNA damaging agents. Switching from serum to KOSR caused a transient increase in reactive oxygen species and AKT phosphorylation in CML cells that were protected by KOSR but not in those that were not protected by this nutrient supplement. Treatment of KOSR-cultured cells with the PH-domain inhibitor MK2206 blocked AKT phosphorylation, abrogated the formation of BIM-resistant mitochondria and stimulated cell death. These results show that KOSR has cell-context dependent pro-survival activity that is linked to AKT activation and the inhibition of BIM-induced cytochrome c release from the mitochondria.	[Ishii, Yuki; Nhiayi, May Keu; Tse, Edison; Wang, Jean Y. J.] Univ Calif San Diego, Sch Med, Dept Med, Div Hematol Oncol, San Diego, CA 92103 USA; [Ishii, Yuki; Nhiayi, May Keu; Tse, Edison; Durden, Donald L.; Wang, Jean Y. J.] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA; [Cheng, Jonathan; Wang, Jean Y. J.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA; [Durden, Donald L.] Univ Calif San Diego, Sch Med, Dept Pediat, San Diego, CA 92103 USA; [Massimino, Michele; Vigneri, Paolo] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Catania	Wang, JYJ (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Div Hematol Oncol, San Diego, CA 92103 USA.	jywang@ucsd.edu	Vigneri, Paolo G/K-8504-2016	Vigneri, Paolo G/0000-0002-5943-6066; Ishii, Yuki/0000-0001-7767-7448; Massimino, Michele/0000-0001-5896-8573	National Cancer Institute Grant [RO1CA043054]; NATIONAL CANCER INSTITUTE [R01CA043054] Funding Source: NIH RePORTER	National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Cancer Institute Grant (RO1CA043054) to JYJW (http://www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; ALITALO R, 1990, LEUKEMIA RES, V14, P501, DOI 10.1016/0145-2126(90)90002-Q; Amann J, 2005, CANCER RES, V65, P226; ANDERSSON LC, 1979, NATURE, V278, P364, DOI 10.1038/278364a0; Asmussen J, 2014, CANCER DISCOV, V4, P200, DOI 10.1158/2159-8290.CD-13-0235; Belikova NA, 2009, FEBS LETT, V583, P3437, DOI 10.1016/j.febslet.2009.10.013; Belloc F, 2007, CANCER BIOL THER, V6, P912, DOI 10.4161/cbt.6.6.4101; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; CASHMAN JD, 1990, BLOOD, V75, P96; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Deininger MWN, 2007, EXP HEMATOL, V35, P144, DOI 10.1016/j.exphem.2007.01.023; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Dong YQ, 2014, APOPTOSIS, V19, P1281, DOI 10.1007/s10495-014-0997-9; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Drullion C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.111; Eiring AM, 2015, LEUKEMIA, V29, P586, DOI 10.1038/leu.2014.245; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Fava C, 2015, EXPERT OPIN EMERG DR, V20, P183, DOI 10.1517/14728214.2015.1031217; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; GAHMBERG CG, 1981, SEMIN HEMATOL, V18, P72; Gallego MA, 2008, ONCOGENE, V27, P1981, DOI 10.1038/sj.onc.1210833; Garlich JR, 2008, CANCER RES, V68, P206, DOI 10.1158/0008-5472.CAN-07-0669; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Georgescu Maria-Magdalena, 2010, Genes Cancer, V1, P1170, DOI 10.1177/1947601911407325; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Gregory MA, 2010, CANCER CELL, V18, P74, DOI 10.1016/j.ccr.2010.04.025; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hiwase DK, 2010, LEUKEMIA, V24, P771, DOI 10.1038/leu.2009.299; Holyoake TL, 2015, IMMUNOL REV, V263, P106, DOI 10.1111/imr.12234; Hu Y, 2009, LEUKEMIA, V23, P109, DOI 10.1038/leu.2008.262; Hurtz C, 2011, J EXP MED, V208, P2163, DOI 10.1084/jem.20110304; Ishii Y, 2008, CANCER RES, V68, P852, DOI 10.1158/0008-5472.CAN-07-2879; Joshi S, 2014, MOL CANCER RES, V12, P1520, DOI 10.1158/1541-7786.MCR-13-0682; Kang KH, 2009, TRENDS MOL MED, V15, P191, DOI 10.1016/j.molmed.2009.03.005; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kirschner KM, 2003, MOL CANCER RES, V1, P970; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Kushnareva Y, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001394; Leary J F, 1987, J Biol Regul Homeost Agents, V1, P73; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Morales GA, 2013, J MED CHEM, V56, P1922, DOI 10.1021/jm301522m; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; O'Brien S, 2013, J NATL COMPR CANC NE, V11, P1327, DOI 10.6004/jnccn.2013.0157; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Peirce SK, 2011, CANCER CHEMOTH PHARM, V68, P325, DOI 10.1007/s00280-010-1486-7; Pellicano F, 2014, STEM CELLS, V32, P1373, DOI 10.1002/stem.1678; Poot M, 2001, CURR PROTOC CYTOM, DOI DOI 10.1002/0471142956.CY0908S02; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sarosiek KA, 2013, MOL CELL, V51, P751, DOI 10.1016/j.molcel.2013.08.048; Simioni C, 2012, LEUKEMIA, V26, P2336, DOI 10.1038/leu.2012.136; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Stuart SA, 2009, CELL CYCLE, V8, P1338, DOI 10.4161/cc.8.9.8209; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Wang Y, 2007, BLOOD, V109, P2147, DOI 10.1182/blood-2006-08-040022; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yamaguchi H, 2002, J BIOL CHEM, V277, P41604, DOI 10.1074/jbc.M207516200; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu CX, 2005, MOL PHARMACOL, V68, P847, DOI 10.1124/mol.104.010504; Zabriskie MS, 2014, CANCER CELL, V26, P428, DOI 10.1016/j.ccr.2014.07.006; Zanella F, 2010, CURR CANCER DRUG TAR, V10, P135, DOI 10.2174/156800910791054158; Zhang LN, 2013, CANCER GENE THER, V20, P1, DOI 10.1038/cgt.2012.84; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006; Zhou H, 2015, PROTEIN CELL, V6, P403, DOI 10.1007/s13238-015-0143-7	77	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140585	10.1371/journal.pone.0140585	http://dx.doi.org/10.1371/journal.pone.0140585			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473951	gold, Green Submitted, Green Published			2022-12-26	WOS:000363185500068
J	Tsu, BV; Saier, MH				Tsu, Brian V.; Saier, Milton H., Jr.			The LysE Superfamily of Transport Proteins Involved in Cell Physiology and Pathogenesis	PLOS ONE			English	Article							WEB-BASED PROGRAM; ESCHERICHIA-COLI; PHYLOGENETIC CHARACTERIZATION; TRANSMEMBRANE TOPOLOGY; RESISTANCE; PREDICTION; FAMILY; AMPHIPATHICITY; HOMEOSTASIS; HYDROPATHY	The LysE superfamily consists of transmembrane transport proteins that catalyze export of amino acids, lipids and heavy metal ions. Statistical means were used to show that it includes newly identified families including transporters specific for (1) tellurium, (2) iron/lead, (3) manganese, (4) calcium, (5) nickel/cobalt, (6) amino acids, and (7) peptidoglycolipids as well as (8) one family of transmembrane electron carriers. Internal repeats and conserved motifs were identified, and multiple alignments, phylogenetic trees and average hydropathy, amphipathicity and similarity plots provided evidence that all members of the superfamily derived from a single common 3-TMS precursor peptide via intragenic duplication. Their common origin implies that they share common structural, mechanistic and functional attributes. The transporters of this superfamily play important roles in ionic homeostasis, cell envelope assembly, and protection from excessive cytoplasmic heavy metal/metabolite concentrations. They thus influence the physiology and pathogenesis of numerous microbes, being potential targets of drug action.	[Tsu, Brian V.; Saier, Milton H., Jr.] Univ Calif San Diego, Div Biol Sci, Dept Mol Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Saier, MH (corresponding author), Univ Calif San Diego, Div Biol Sci, Dept Mol Biol, La Jolla, CA 92093 USA.	msaier@ucsd.edu		Saier, Milton/0000-0001-5530-0017; Tsu, Brian/0000-0003-0268-8323	National Institutes of Health [GM077402]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077402] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (http://grants.nih.gov/grants/oer.htm), Grant #: GM077402. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahane S, 2003, J BIOCHEM, V133, P173, DOI 10.1093/jb/mvg021; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2012, MOL BIOSYST, V8, P3142, DOI 10.1039/c2mb25239b; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BRENNER S, 1987, NATURE, V329, P496; Burian J, 1998, FOLIA MICROBIOL, V43, P589, DOI 10.1007/BF02816374; Chen JS, 2011, J MOL MICROB BIOTECH, V21, P83, DOI 10.1159/000334611; Crupper SS, 1999, J BACTERIOL, V181, P4071, DOI 10.1128/JB.181.13.4071-4075.1999; Debut AJ, 2006, J MOL MICROB BIOTECH, V11, P1, DOI 10.1159/000092814; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Denoncin K, 2013, ANTIOXID REDOX SIGN, V19, P63, DOI 10.1089/ars.2012.4864; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; DOOLITTLE RF, 1981, SCIENCE, V214, P149, DOI 10.1126/science.7280687; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Haier B, 2001, FUNKTIONELLE ANAL LY, P83; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kaur G, 2014, J BACTERIOL, V196, P2587, DOI 10.1128/JB.01717-14; Kimball RA, 2003, J MOL MICROB BIOTECH, V5, P133, DOI 10.1159/000070263; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; KUAN J, 1993, CRIT REV BIOCHEM MOL, V28, P209, DOI 10.3109/10409239309086795; Kunji ERS, 2010, CURR OPIN STRUC BIOL, V20, P440, DOI 10.1016/j.sbi.2010.06.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee A, 2014, MICROBIOL-SGM, V160, P1679, DOI 10.1099/mic.0.077776-0; Marrero J, 2007, MICROB ECOL, V53, P123, DOI 10.1007/s00248-006-9152-7; McDermottt PF, 2008, ANTIMICROB AGENTS CH, V52, P382, DOI 10.1128/AAC.00930-07; Page Roderic D M, 2002, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0602s01; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Reddy BL, 2013, BBA-BIOMEMBRANES, V1828, P2654, DOI 10.1016/j.bbamem.2013.07.004; Reddy VS, 2012, FEBS J, V279, P2036, DOI 10.1111/j.1742-4658.2012.08590.x; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Sonden B, 2005, MOL MICROBIOL, V58, P426, DOI 10.1111/j.1365-2958.2005.04847.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vastermark A, 2014, PROTEINS, V82, P2797, DOI 10.1002/prot.24643; Vrljic M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P327; Waters LS, 2011, J BACTERIOL, V193, P5887, DOI 10.1128/JB.05872-11; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Yen MR, 2010, METHODS MOL BIOL, V637, P47, DOI 10.1007/978-1-60761-700-6_3; Yen MR, 2009, J MOL MICROB BIOTECH, V17, P163, DOI 10.1159/000239667; Zakataeva NP, 1999, FEBS LETT, V452, P228, DOI 10.1016/S0014-5793(99)00625-0; Zhai YF, 2002, J MOL MICROB BIOTECH, V4, P375; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P501; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P285	46	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0137184	10.1371/journal.pone.0137184	http://dx.doi.org/10.1371/journal.pone.0137184			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474485	Green Published, gold			2022-12-26	WOS:000363185500003
J	Brehme, N; Bayer-Csaszar, E; Glass, F; Takenaka, M				Brehme, Nadja; Bayer-Csaszar, Eszter; Glass, Franziska; Takenaka, Mizuki			The DYW Subgroup PPR Protein MEF35 Targets RNA Editing Sites in the Mitochondrial rpl16, nad4 and cob mRNAs in Arabidopsis thaliana	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; CHLORAMPHENICOL-BINDING PROTEIN; ESCHERICHIA-COLI RIBOSOMES; SUBCELLULAR-LOCALIZATION; STRUCTURAL BASIS; RECOGNITION; IDENTIFICATION; EXPRESSION; INSIGHTS; GENES	RNA editing in plant mitochondria and plastids alters specific nucleotides from cytidine (C) to uridine (U) mostly in mRNAs. A number of PLS-class PPR proteins have been characterized as RNA recognition factors for specific RNA editing sites, all containing a C-terminal extension, the E domain, and some an additional DYW domain, named after the characteristic C-terminal amino acid triplet of this domain. Presently the recognition factors for more than 300 mitochondrial editing sites are still unidentified. In order to characterize these missing factors, the recently proposed computational prediction tool could be of use to assign target RNA editing sites to PPR proteins of yet unknown function. Using this target prediction approach we identified the nuclear gene MEF35 (Mitochondrial Editing Factor 35) to be required for RNA editing at three sites in mitochondria of Arabidopsis thaliana. The MEF35 protein contains eleven PPR repeats and E and DYW extensions at the C-terminus. Two TDNA insertion mutants, one inserted just upstream and the other inside the reading frame encoding the DYW domain, show loss of editing at a site in each of the mRNAs for protein 16 in the large ribosomal subunit (site rpl16-209), for cytochrome b (cob-286) and for subunit 4 of complex I (nad4-1373), respectively. Editing is restored upon introduction of the wild type MEF35 gene in the reading frame mutant. The MEF35 protein interacts in Y2H assays with the mitochondrial MORF1 and MORF8 proteins, mutation of the latter also influences editing at two of the three MEF35 target sites. Homozygous mutant plants develop indistinguishably from wild type plants, although the RPL16 and COB/CYTB proteins are essential and the amino acids encoded after the editing events are conserved in most plant species. These results demonstrate the feasibility of the computational target prediction to screen for target RNA editing sites of E domain containing PLS-class PPR proteins.	[Brehme, Nadja; Bayer-Csaszar, Eszter; Glass, Franziska; Takenaka, Mizuki] Univ Ulm, Mol Bot, D-89069 Ulm, Germany	Ulm University	Takenaka, M (corresponding author), Univ Ulm, Mol Bot, D-89069 Ulm, Germany.	mizuki.takenaka@uni-ulm.de	Takenaka, Mizuki/AAK-9884-2020	Takenaka, Mizuki/0000-0002-3242-5092; Brehme, Nadja/0000-0002-0900-9170	Deutsche Forschungsgemeinschaft [TA624/2-2, TA624/3-1, TA624/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants TA624/2-2, TA624/3-1 and TA624/6-1 from the Deutsche Forschungsgemeinschaft (www.dfg.de). MT is a Heisenberg fellow of the Deutsche Forschungsgemeinschaft TA624/4-1 and TA624/4-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres C, 2007, PHYSIOL PLANTARUM, V129, P14, DOI 10.1111/j.1399-3054.2006.00766.x; Ban T, 2013, J BIOL CHEM, V288, P31540, DOI 10.1074/jbc.M113.496828; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Bock LV, 2013, NAT STRUCT MOL BIOL, V20, P1390, DOI 10.1038/nsmb.2690; Braun P, 2013, ANNU REV PLANT BIOL, V64, P161, DOI 10.1146/annurev-arplant-050312-120140; Braun P, 2012, PROTEOMICS, V12, P1499, DOI 10.1002/pmic.201100598; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chateigner-Boutin AL, 2011, PLANT J, V65, P532, DOI 10.1111/j.1365-313X.2010.04441.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Forner J, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-28; Glass F, 2015, MOL PLANT; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gulati M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004694; Gully BS, 2015, NUCLEIC ACIDS RES, V43, P1918, DOI 10.1093/nar/gkv027; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; HUNT MD, 1991, EMBO J, V10, P1045, DOI 10.1002/j.1460-2075.1991.tb08043.x; Ichinose M, 2012, PLANT J, V70, P271, DOI 10.1111/j.1365-313X.2011.04869.x; James P, 1996, GENETICS, V144, P1425; Ke JY, 2013, NAT STRUCT MOL BIOL, V20, P1377, DOI 10.1038/nsmb.2710; Kindgren P, 2015, PLANT CELL, V27, P403, DOI 10.1105/tpc.114.134189; Kobayashi K, 2012, NUCLEIC ACIDS RES, V40, P2712, DOI 10.1093/nar/gkr1084; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Liu YJ, 2013, PLANT CELL, V25, P868, DOI 10.1105/tpc.112.106781; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Maier UG, 2013, GENOME BIOL EVOL, V5, P2318, DOI 10.1093/gbe/evt181; McNicholas PM, 2001, ANTIMICROB AGENTS CH, V45, P79, DOI 10.1128/AAC.45.1.79-83.2001; Nakamura T, 2012, PLANT CELL PHYSIOL, V53, P1171, DOI 10.1093/pcp/pcs069; NIERHAUS D, 1973, P NATL ACAD SCI USA, V70, P2224, DOI 10.1073/pnas.70.8.2224; Okuda K, 2008, NUCLEIC ACIDS RES, V36, P6155, DOI 10.1093/nar/gkn629; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; PONGS O, 1973, P NATL ACAD SCI USA, V70, P2229, DOI 10.1073/pnas.70.8.2229; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Sakamoto W, 1996, PLANT CELL, V8, P1377, DOI 10.1105/tpc.8.8.1377; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Shi XW, 2015, NUCLEIC ACIDS RES, V43, P3814, DOI 10.1093/nar/gkv245; Shikanai T, 2006, CELL MOL LIFE SCI, V63, P698, DOI 10.1007/s00018-005-5449-9; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Sun T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005028; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Takenaka M, 2007, RNA EDITING PLANT MI; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; TERAOKA H, 1978, FEBS LETT, V88, P223, DOI 10.1016/0014-5793(78)80179-3; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Yu QB, 2009, PLANT J, V59, P1011, DOI 10.1111/j.1365-313X.2009.03930.x; Zehrmann A, 2015, J BIOL CHEM, V290, P6445, DOI 10.1074/jbc.M114.602086; Zhang F, 2014, P NATL ACAD SCI USA, V111, P2023, DOI 10.1073/pnas.1316183111; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x	54	29	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140680	10.1371/journal.pone.0140680	http://dx.doi.org/10.1371/journal.pone.0140680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26470017	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600096
J	Denton, JA; Ghosh, A; Marquez-Lago, TT				Denton, Jai A.; Ghosh, Atiyo; Marquez-Lago, Tatiana T.			Asymmetrical Inheritance of Plasmids Depends on Dynamic Cellular Geometry and Volume Exclusion Effects	PLOS ONE			English	Article							LIFE-SPAN; SEGREGATION	The asymmetrical inheritance of plasmid DNA, as well as other cellular components, has been shown to be involved in replicative aging. In Saccharomyces cerevisiae, there is an ongoing debate regarding the mechanisms underlying this important asymmetry. Currently proposed models suggest it is established via diffusion, but differ on whether a diffusion barrier is necessary or not. However, no study so far incorporated key aspects to segregation, such as dynamic morphology changes throughout anaphase or plasmids size. Here, we determine the distinct effects and contributions of individual cellular variability, plasmid volume and moving boundaries in the asymmetric segregation of plasmids. We do this by measuring cellular nuclear geometries and plasmid diffusion rates with confocal microscopy, subsequently incorporating this data into a growing domain stochastic spatial simulator. Our modelling and simulations confirms that plasmid asymmetrical inheritance does not require an active barrier to diffusion, and provides a full analysis on plasmid size effects.	[Denton, Jai A.; Ghosh, Atiyo; Marquez-Lago, Tatiana T.] Okinawa Inst Sci & Technol, Integrat Syst Biol Unit, Okinawa 9040495, Japan	Okinawa Institute of Science & Technology Graduate University	Marquez-Lago, TT (corresponding author), Okinawa Inst Sci & Technol, Integrat Syst Biol Unit, Okinawa 9040495, Japan.	tatiana.marquezlago@gmail.com	; Denton, Jai Andrew/G-4985-2015	Ghosh, Atiyo/0000-0003-1606-8520; Denton, Jai Andrew/0000-0002-5259-4221	Cabinet Office of Japan	Cabinet Office of Japan	JAD, AG and TML were supported by subsidy from the Cabinet Office of Japan given to the Integrative Systems Biology Unit (Marquez-Lago lab), OIST. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000705; Ansari A, 1997, MOL CELL BIOL, V17, P7061, DOI 10.1128/MCB.17.12.7061; Arlia-Ciommo A, 2014, CELL CYCLE, V13, P3336, DOI 10.4161/15384101.2014.965063; Boettcher B, 2012, J CELL BIOL, V197, P921, DOI 10.1083/jcb.201112117; Colombi P, 2013, J CELL BIOL, V203, P215, DOI 10.1083/jcb.201305115; Denoth-Lippuner A, 2014, ELIFE, V3, DOI 10.7554/eLife.03790; Falcon AA, 2003, J BIOL CHEM, V278, P41607, DOI 10.1074/jbc.M307025200; Freedman Diaconis, 1981, ON THE HISTOGRAM AS; Gehlen LR, 2011, CURR BIOL, V21, P25, DOI 10.1016/j.cub.2010.12.016; Ghosh A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133401; GUNGE N, 1983, ANNU REV MICROBIOL, V37, P253, DOI 10.1146/annurev.mi.37.100183.001345; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; HYMAN BC, 1982, P NATL ACAD SCI-BIOL, V79, P1578, DOI 10.1073/pnas.79.5.1578; Khmelinskii A, 2012, NAT BIOTECHNOL, V30, P708, DOI 10.1038/nbt.2281; Khmelinskii A, 2010, NATURE, V466, DOI 10.1038/nature09255; Kinkhabwala A, 2014, BMC BIOPHYS, V7, DOI 10.1186/s13628-014-0010-6; LONGTINE MS, 1992, MOL CELL BIOL, V12, P1997, DOI 10.1128/MCB.12.5.1997; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; MURRAY AW, 1983, CELL, V34, P961, DOI 10.1016/0092-8674(83)90553-6; Parslow AC, 2014, JOVE-J VIS EXP, DOI 10.3791/51086; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 2002, MECH AGEING DEV, V123, P857, DOI 10.1016/S0047-6374(02)00023-4; ZAKIAN VA, 1982, PLASMID, V8, P15, DOI 10.1016/0147-619X(82)90037-3; Zhou CK, 2014, CELL, V159, P530, DOI 10.1016/j.cell.2014.09.026; Zhou CK, 2011, CELL, V147, P1186, DOI 10.1016/j.cell.2011.11.002	29	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0139443	10.1371/journal.pone.0139443	http://dx.doi.org/10.1371/journal.pone.0139443			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468952	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600009
J	Ikeda, K; Iwasaki, Y				Ikeda, Ken; Iwasaki, Yasuo			Edaravone, a Free Radical Scavenger, Delayed Symptomatic and Pathological Progression of Motor Neuron Disease in the Wobbler Mouse	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NITRIC-OXIDE SYNTHASE; SPINAL-CORD-INJURY; SUPEROXIDE-DISMUTASE; CEREBRAL INFARCTION; MOTONEURON DISEASE; PROTEIN; MODEL; ALS; DYSFUNCTION	Edaravone, a free radical scavenger is used widely in Japanese patients with acute cerebral infarction. This antioxidant could have therapeutic potentials for other neurological diseases. Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects the upper and the lower motor neuron, leading to death within 3-5 years after onset. A phase III clinical trial of edaravone suggested no significant effects in ALS patients. However, recent 2nd double-blind trial has demonstrated therapeutic benefits of edaravone in definite patients diagnosed by revised El Escorial diagnostic criteria of ALS. Two previous studies showed that edaravone attenuated motor symptoms or motor neuron degeneration in mutant superoxide dismutase 1-transgenic mice or rats, animal models of familial ALS. Herein we examined whether this radical scavenger can retard progression of motor dysfunction and neuropathological changes in wobbler mice, sporadic ALS-like model. After diagnosis of the disease onset at the postnatal age of 3-4 weeks, wobbler mice received edaravone (1 or 10 mg/kg, n = 10/group) or vehicle (n = 10), daily for 4 weeks by intraperitoneal administration. Motor symptoms and neuropathological changes were compared among three groups. Higher dose (10 mg/kg) of edaravone treatment significantly attenuated muscle weakness and contracture in the forelimbs, and suppressed denervation atrophy in the biceps muscle and degeneration in the cervical motor neurons compared to vehicle. Previous and the present studies indicated neuroprotective effects of edaravone in three rodent ALS-like models. This drug seems to be worth performing the clinical trial in ALS patients in the United States of American and Europe, in addition to Japan.	[Ikeda, Ken; Iwasaki, Yasuo] Toho Univ, Omori Med Ctr, Dept Neurol, Tokyo, Japan	Toho University	Ikeda, K (corresponding author), Toho Univ, Omori Med Ctr, Dept Neurol, Tokyo, Japan.	keni@med.toho-u.ac.jp						Abe K, 2014, AMYOTROPH LAT SCL FR, V15, P610, DOI 10.3109/21678421.2014.959024; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Aoki M, 2011, BRAIN RES, V1382, P321, DOI 10.1016/j.brainres.2011.01.058; Aoyama T, 2008, NEUROL MED-CHIR, V48, P539, DOI 10.2176/nmc.48.539; Dennis JS, 2009, NEUROSCIENCE, V158, P745, DOI 10.1016/j.neuroscience.2008.10.030; DUCHEN LW, 1968, J NEUROL NEUROSUR PS, V31, P535, DOI 10.1136/jnnp.31.6.535; Falconer D., 1956, MOUSE NEWS LETT, V15, P23; Higashi Yukihito, 2006, Recent Pat Cardiovasc Drug Discov, V1, P85; Hirayama T, 2011, J NEUROLOGY RES, V1, P139, DOI DOI 10.4021/JNR59W; Ikeda K, 2000, AMYOTROPH LATERAL SC, V1, P207, DOI 10.1080/14660820050515205; Ikeda K, 1998, J NEUROL SCI, V160, P9, DOI 10.1016/S0022-510X(98)00224-X; IKEDA K, 1995, NEUROMUSCULAR DISORD, V5, P383, DOI 10.1016/0960-8966(95)00003-6; IKEDA K, 1995, ANN NEUROL, V37, P505, DOI 10.1002/ana.410370413; Ikeda K, 2000, BRAIN RES, V858, P84, DOI 10.1016/S0006-8993(99)02427-0; Ikeda K, 2015, J NEUROL SCI, V354, P70, DOI 10.1016/j.jns.2015.04.052; Ito H, 2008, EXP NEUROL, V213, P448, DOI 10.1016/j.expneurol.2008.07.017; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kikuchi K, 2011, EXP THER MED, V2, P771, DOI 10.3892/etm.2011.281; Kikuchi K, 2009, BIOCHEM BIOPH RES CO, V390, P1121, DOI 10.1016/j.bbrc.2009.09.015; Kikuchi K, 2009, J PHARMACOL EXP THER, V329, P865, DOI 10.1124/jpet.108.149484; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; MITSUMOTO H, 1982, BRAIN, V105, P811, DOI 10.1093/brain/105.4.811; MITSUMOTO H, 1994, SCIENCE, V265, P1107, DOI 10.1126/science.8066451; Mitsumoto H, 2014, LANCET NEUROL, V13, P1127, DOI 10.1016/S1474-4422(14)70129-2; Moser JM, 2013, MOL GENET GENOMICS, V288, P207, DOI 10.1007/s00438-013-0741-0; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Peviani M, 2014, NEUROBIOL DIS, V62, P218, DOI 10.1016/j.nbd.2013.10.010; Quenneville NR, 2006, MOL BIOL CELL, V17, P1859, DOI 10.1091/mbc.E05-11-1002; Suzuki K, 2005, J THORAC CARDIOV SUR, V130, P1586, DOI 10.1016/j.jtcvs.2005.08.049; Takahashi G, 2003, J THORAC CARDIOV SUR, V126, P1461, DOI 10.1016/S0022-5223(03)00693-7; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	32	42	46	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140316	10.1371/journal.pone.0140316	http://dx.doi.org/10.1371/journal.pone.0140316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469273	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600038
J	Aberle, JH; Schwaiger, J; Aberle, SW; Stiasny, K; Scheinost, O; Kundi, M; Chmelik, V; Heinz, FX				Aberle, Judith H.; Schwaiger, Julia; Aberle, Stephan W.; Stiasny, Karin; Scheinost, Ondrej; Kundi, Michael; Chmelik, Vaclav; Heinz, Franz X.			Human CD4(+) T Helper Cell Responses after Tick-Borne Encephalitis Vaccination and Infection	PLOS ONE			English	Article							GAMMA-SECRETING CELLS; CYTOKINE RESPONSES; IMMUNE-RESPONSES; CENTRAL MEMORY; IN-VIVO; EFFECTOR; CLONES; DIFFERENTIATION; PROTECTION; VACCINES	Tick-borne encephalitis virus (TBEV) is a human-pathogenic flavivirus that is endemic in large parts of Europe and Asia and causes severe neuroinvasive illness. A formalin-inactivated vaccine induces strong neutralizing antibody responses and confers protection from TBE disease. CD4(+) T cell responses are essential for neutralizing antibody production, but data on the functionalities of TBEV-specific CD4(+) T cells in response to vaccination or infection are lacking. This study provides a comprehensive analysis of the cytokine patterns of CD4(+) T cell responses in 20 humans after TBE vaccination in comparison to those in 18 patients with TBEV infection. Specifically, Th1-specific cytokines (IFN-gamma, IL-2, TNF-alpha), CD40 ligand and the Th1 lineage-specifying transcription factor Tbet were determined upon stimulation with peptides covering the TBEV structural proteins contained in the vaccine (C-capsid, prM/M-membrane and E-envelope). We show that TBEV-specific CD4(+) T cell responses are polyfunctional, but the cytokine patterns after vaccination differed from those after infection. TBE vaccine responses were characterized by lower IFN-gamma responses and high proportions of TNF-alpha+IL-2(+) cells. In vaccine-induced responses-consistent with the reduced IFN-gamma expression patterns-less than 50% of TBEV peptides were detected by IFN-gamma(+) cells as compared to 96% detected by IL-2(+) cells, indicating that the single use of IFN-gamma as a read-out strongly underestimates the magnitude and breadth of such responses. The results provide important insights into the functionalities of CD4(+) T cells that coordinate vaccine responses and have direct implications for future studies that address epitope specificity and breadth of these responses.	[Aberle, Judith H.; Schwaiger, Julia; Aberle, Stephan W.; Stiasny, Karin; Heinz, Franz X.] Med Univ Vienna, Dept Virol, Vienna, Austria; [Scheinost, Ondrej] Hosp Ceske Budejovice, Mol Genet Lab, Ceske Budejovice, Czech Republic; [Kundi, Michael] Med Univ Vienna, Ctr Publ Hlth, Vienna, Austria; [Chmelik, Vaclav] Hosp Ceske Budejovice, Dept Infect Dis, Ceske Budejovice, Czech Republic	Medical University of Vienna; Hospital Ceske Budejovice; Medical University of Vienna; Hospital Ceske Budejovice	Aberle, JH (corresponding author), Med Univ Vienna, Dept Virol, Vienna, Austria.	judith.aberle@meduniwien.ac.at		Stiasny, Karin/0000-0002-1902-8674				Aberle JH, 2013, AGE, V35, P371, DOI 10.1007/s11357-011-9371-9; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P241; Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; De Rosa SC, 2004, J IMMUNOL, V173, P5372, DOI 10.4049/jimmunol.173.9.5372; Deng N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095986; Divekar AA, 2006, J IMMUNOL, V176, P1465, DOI 10.4049/jimmunol.176.3.1465; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Foulds KE, 2006, IMMUNOL REV, V211, P58, DOI 10.1111/j.0105-2896.2006.00400.x; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Gagnon SJ, 1999, J VIROL, V73, P3623, DOI 10.1128/JVI.73.5.3623-3629.1999; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Geginat J, 2003, PATHOL BIOL, V51, P64, DOI 10.1016/S0369-8114(03)00098-1; Genesca M, 2007, J IMMUNOL, V179, P4732, DOI 10.4049/jimmunol.179.7.4732; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Heinz FX, 2013, EMERG INFECT DIS, V19, P69, DOI 10.3201/eid1901.120458; Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114; Helmstetter C, 2015, IMMUNITY, V42, P108, DOI 10.1016/j.immuni.2014.12.018; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; KURANE I, 1989, J EXP MED, V170, P763, DOI 10.1084/jem.170.3.763; Lindenbach DB MC, 2013, FIELDS VIROLOGY; Litjens NHR, 2008, J IMMUNOL, V181, P3665, DOI 10.4049/jimmunol.181.5.3665; Makedonas G, 2006, SPRINGER SEMIN IMMUN, V28, P209, DOI 10.1007/s00281-006-0025-4; Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676; Mangada MM, 2002, J INFECT DIS, V185, P1697, DOI 10.1086/340822; MILICH DR, 1987, NATURE, V329, P547, DOI 10.1038/329547a0; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; O'Garra A, 2011, NAT IMMUNOL, V12, P288, DOI 10.1038/ni.2003; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Paulke-Korinek M, 2013, VACCINE, V31, P1293, DOI 10.1016/j.vaccine.2012.12.075; Pierson TC DM, 2013, FIELDS VIROLOGY, V2; Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004; Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Richmond M, 2011, J VIROL, V85, P1275, DOI 10.1128/JVI.01707-10; RUSSELL SM, 1979, NATURE, V280, P147, DOI 10.1038/280147a0; SAD S, 1994, J IMMUNOL, V153, P3514; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; SCHERLE PA, 1986, J EXP MED, V164, P1114, DOI 10.1084/jem.164.4.1114; SCHERLE PA, 1988, P NATL ACAD SCI USA, V85, P4446, DOI 10.1073/pnas.85.12.4446; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Schwaiger J, 2014, J VIROL, V88, P7828, DOI 10.1128/JVI.00196-14; Silva ML, 2011, VACCINE, V29, P583, DOI 10.1016/j.vaccine.2010.08.046; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Stiasny K, 2012, J CLIN VIROL, V54, P115, DOI 10.1016/j.jcv.2012.02.016; Stiasny K, 2009, VACCINE, V27, P7021, DOI 10.1016/j.vaccine.2009.09.069; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Weaver JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057275; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Yang L, 2004, EUR J IMMUNOL, V34, P1617, DOI 10.1002/eji.200424939	54	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140545	10.1371/journal.pone.0140545	http://dx.doi.org/10.1371/journal.pone.0140545			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465323	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100140
J	Akram, U; Ellis, JG; Barclay, NL				Akram, Umair; Ellis, Jason G.; Barclay, Nicola L.			Anxiety Mediates the Relationship between Perfectionism and Insomnia Symptoms: A Longitudinal Study	PLOS ONE			English	Article							MULTIDIMENSIONAL PERFECTIONISM; COGNITIVE MODEL; DEPRESSION; SLEEP; DIMENSIONS; EPIDEMIOLOGY; SEVERITY; SELF	Objectives Individuals with insomnia often report aspects of perfectionism and symptoms of anxiety and depression. Investigation of these factors together has been limited. As such, the aim of the present study was to examine the extent to which the association between perfectionism and insomnia symptoms was mediated by anxiety and depression, concurrently and longitudinally. Methods Seventy-six members from the general-population participated at baseline. Data from 57 participants were subsequently analysed at twelve-month follow-up. Insomnia symptoms were assessed using The Insomnia Severity Index (ISI). Perfectionism was assessed using two Multidimensional Perfectionism Scales (F-MPS; HF-MPS). Symptoms of anxiety and depression were assessed using The Hospital Anxiety and Depression Scale (HADS). Correlational analysis examined longitudinal associations between perfectionism and insomnia symptoms. Hierarchical regression analysis examined whether significant associations remained after controlling for anxiety and depression. Results Baseline insomnia symptoms were associated with future doubts about action. Further, this relationship was mediated by preceding symptoms of anxiety and concurrent symptoms of insomnia. Similarly, baseline insomnia symptoms were also associated with future parental criticism. However this relationship was partially mediated by preceding symptoms of anxiety, and was not mediated by concurrent insomnia symptoms. Conclusions Symptoms of insomnia appear to be related to an increase in negative perfectionistic thinking in the form of doubts about action and parental criticism, however these relationships appear to be mediated by symptoms of anxiety. Therefore, treatments for insomnia should address anxiety symptoms with the prospect of preventing the accentuation of aspects of perfectionism due to poor sleep.	[Akram, Umair; Ellis, Jason G.; Barclay, Nicola L.] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	Northumbria University	Akram, U (corresponding author), Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	umair.akram@northumbria.ac.uk	Akram, Umair/F-3372-2014; Akram, Dr Umair/L-2430-2019; Ellis, Jason/E-7783-2013; Barclay, Nicola/D-8981-2013	Akram, Umair/0000-0002-4012-7941; Akram, Dr Umair/0000-0003-0150-9274; Ellis, Jason/0000-0002-8496-520X; Barclay, Nicola/0000-0002-6500-9909	Department of Psychology, Northumbria University, United Kingdom	Department of Psychology, Northumbria University, United Kingdom	This study was supported by funds supplied by the Department of Psychology, Northumbria University, United Kingdom.	Ashbaugh A, 2007, DEPRESS ANXIETY, V24, P169, DOI 10.1002/da.20219; Azevedo MH, 2010, WORLD J BIOL PSYCHIA, V11, P476, DOI 10.3109/15622970903304467; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Enns MW, 1999, BEHAV RES THER, V37, P783, DOI 10.1016/S0005-7967(98)00188-0; FLETT GL, 1991, PERS INDIV DIFFER, V12, P61, DOI 10.1016/0191-8869(91)90132-U; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; FROST RO, 1990, COGNITIVE THER RES, V14, P449, DOI 10.1007/BF01172967; FROST RO, 1993, PERS INDIV DIFFER, V14, P119, DOI 10.1016/0191-8869(93)90181-2; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; HEWITT PL, 1991, J ABNORM PSYCHOL, V100, P98, DOI 10.1037/0021-843X.100.1.98; HEWITT PL, 1991, J PERS SOC PSYCHOL, V60, P456, DOI 10.1037/0022-3514.60.3.456; INSEL TR, 1982, ARCH GEN PSYCHIAT, V39, P1372; Jansson M, 2006, PSYCHOL HEALTH, V21, P383, DOI 10.1080/14768320500129015; Jansson-Frojmark M, 2007, BRIT J CLIN PSYCHOL, V46, P119, DOI 10.1348/014466506X158824; Juster HR, 1996, PERS INDIV DIFFER, V21, P403, DOI 10.1016/0191-8869(96)00075-X; Kawamura KY, 2001, COGNITIVE THER RES, V25, P291, DOI 10.1023/A:1010736529013; Lloyd S, 2015, BEHAV COGN PSYCHOTH, V43, P705, DOI 10.1017/S1352465814000162; Lundh Lars-Gunnar, 1994, Scandinavian Journal of Behaviour Therapy, V23, P3; Maher MJ, 2006, CNS DRUGS, V29, P1372; Minarik ML, 1996, COGNITIVE THER RES, V20, P155, DOI 10.1007/BF02228032; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ohayon MM, 2003, J PSYCHIAT RES, V37, P9, DOI 10.1016/S0022-3956(02)00052-3; De Azevedo MHP, 2009, WORLD J BIOL PSYCHIA, V10, P225, DOI 10.1080/15622970701367930; Rachman SJ., 1980, OBSESSIONS COMPULSIO; Ree MJ, 2006, SLEEP, V29, P1359, DOI 10.1093/sleep/29.10.1359; Roth T, 2007, J CLIN SLEEP MED, V3, P7, DOI DOI 10.1080/08098130802697269; SADDLER CD, 1995, PSYCHOL REP, V77, P483, DOI 10.2466/pr0.1995.77.2.483; SADDLER CD, 1993, PSYCHOL REP, V73, P863, DOI 10.2466/pr0.1993.73.3.863; Smith MT, 2005, CLIN PSYCHOL REV, V25, P559, DOI 10.1016/j.cpr.2005.04.004; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; Staner L, 2010, SLEEP MED REV, V14, P35, DOI 10.1016/j.smrv.2009.09.003; Taylor DJ, 2005, SLEEP, V28, P1457, DOI 10.1093/sleep/28.11.1457; van de Laar M, 2010, SLEEP MED REV, V14, P61, DOI 10.1016/j.smrv.2009.07.007; Vincent NK, 2000, J PSYCHOSOM RES, V49, P349, DOI 10.1016/S0022-3999(00)00175-6; Wicklow A, 2000, BEHAV RES THER, V38, P679, DOI 10.1016/S0005-7967(99)00136-9; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	16	17	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138865	10.1371/journal.pone.0138865	http://dx.doi.org/10.1371/journal.pone.0138865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0CK	26465774	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000363183100030
J	Amm, I; Norell, D; Wolf, DH				Amm, Ingo; Norell, Derrick; Wolf, Dieter H.			Absence of the Yeast Hsp31 Chaperones of the DJ-1 Superfamily Perturbs Cytoplasmic Protein Quality Control in Late Growth Phase	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME-SYSTEM; END RULE PATHWAY; RETICULUM-ASSOCIATED DEGRADATION; RESOLUTION CRYSTAL-STRUCTURE; ER-ASSOCIATED DEGRADATION; ONSET PARKINSONS-DISEASE; ESCHERICHIA-COLI K-12; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONES	The Saccharomyces cerevisiae heat shock proteins Hsp31, Hsp32, Hsp33 and Hsp34 belong to the DJ-1/ThiJ/PfpI superfamily which includes the human protein DJ-1 (PARK7) as the most prominent member. Mutations in the DJ-1 gene are directly linked to autosomal recessive, early-onset Parkinson's disease. DJ-1 acts as an oxidative stress-induced chaperone preventing aggregation and fibrillation of a-synuclein, a critical factor in the development of the disease. In vivo assays in Saccharomyces cerevisiae using the model substrate Delta ssCPY*Leu2myc (Delta ssCL*myc) as an aggregation-prone misfolded cytoplasmic protein revealed an influence of the Hsp31 chaperone family on the steady state level of this substrate. In contrast to the ubiquitin ligase of the N-end rule pathway Ubr1, which is known to be prominently involved in the degradation process of misfolded cytoplasmic proteins, the absence of the Hsp31 chaperone family does not impair the degradation of newly synthesized misfolded substrate. Also degradation of substrates with strong affinity to Ubr1 like those containing the type 1 N-degron arginine is not affected by the absence of the Hsp31 chaperone family. Epistasis analysis indicates that one function of the Hsp31 chaperone family resides in a pathway overlapping with the Ubr1-dependent degradation of misfolded cytoplasmic proteins. This pathway gains relevance in late growth phase under conditions of nutrient limitation. Additionally, the Hsp31 chaperones seem to be important for maintaining the cellular Ssa Hsp70 activity which is important for Ubr1-dependent degradation.	[Amm, Ingo; Norell, Derrick; Wolf, Dieter H.] Univ Stuttgart, Inst Biochem, D-70174 Stuttgart, Germany	University of Stuttgart	Wolf, DH (corresponding author), Univ Stuttgart, Inst Biochem, Pfaffenwaldring 55, D-70174 Stuttgart, Germany.	dieter.wolf@ibc.uni-stuttgart.de			Deutsche Forschungsgemeinschaft (DFG) [WO 210/18-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) www.dfg.de, grant number WO 210/18-2 to DHW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Chiang HL, 1996, J BIOL CHEM, V271, P9934, DOI 10.1074/jbc.271.17.9934; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; FLINTA C, 1986, EUR J BIOCHEM, V154, P193, DOI 10.1111/j.1432-1033.1986.tb09378.x; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Graille M, 2004, STRUCTURE, V12, P839, DOI 10.1016/S0969-2126(04)00113-3; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guo PC, 2010, ACTA CRYSTALLOGR F, V66, P1557, DOI 10.1107/S1744309110039965; Guthrie C, 1991, METHODS ENZYMOL, V194; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; HARSHMAN KD, 1988, CELL, V53, P321, DOI 10.1016/0092-8674(88)90393-5; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hasin N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-194; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; HUANG S, 1987, BIOCHEMISTRY-US, V26, P8242, DOI 10.1021/bi00399a033; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kohlmann S, 2008, J BIOL CHEM, V283, P16374, DOI 10.1074/jbc.M801702200; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Malki A, 2005, J BIOL CHEM, V280, P14420, DOI 10.1074/jbc.M408296200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 2000, GENETICS, V156, P501; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Miller-Fleming L, 2014, P NATL ACAD SCI USA, V111, P7012, DOI 10.1073/pnas.1319221111; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; Mujacic M, 2004, MOL MICROBIOL, V51, P849, DOI 10.1046/j.1365-2958.2003.03871.x; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Quigley PM, 2004, PROTEIN SCI, V13, P269, DOI 10.1110/ps.03399604; Scazzari M, 2015, J BIOL CHEM, V290, P4677, DOI 10.1074/jbc.M114.596064; Schafer A, 2005, METHOD ENZYMOL, V399, P459, DOI 10.1016/S0076-6879(05)99031-9; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; SIKORSKI RS, 1989, GENETICS, V122, P19; Skoneczna A, 2007, FREE RADICAL BIO MED, V42, P1409, DOI 10.1016/j.freeradbiomed.2007.01.042; Stolz A, 2012, METHODS MOL BIOL, V832, P489, DOI 10.1007/978-1-61779-474-2_35; Subedi KP, 2011, MOL MICROBIOL, V81, P926, DOI 10.1111/j.1365-2958.2011.07736.x; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; TEICHERT U, 1989, J BIOL CHEM, V264, P16037; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Trempe JF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00038; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; TSUNASAWA S, 1985, J BIOL CHEM, V260, P5382; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; WERNERWASHBURNE M, 1989, J BACTERIOL, V171, P2680, DOI 10.1128/jb.171.5.2680-2688.1989; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; WOLF DH, 1975, J BACTERIOL, V123, P1150, DOI 10.1128/JB.123.3.1150-1156.1975; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	72	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140363	10.1371/journal.pone.0140363	http://dx.doi.org/10.1371/journal.pone.0140363			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466368	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100106
J	Corner, LAL; Stuart, LJ; Kelly, DJ; Marples, NM				Corner, Leigh A. L.; Stuart, Lynsey J.; Kelly, David J.; Marples, Nicola M.			Reproductive Biology Including Evidence for Superfetation in the European Badger Meles meles (Carnivora: Mustelidae)	PLOS ONE			English	Article							DELAYED IMPLANTATION; POPULATION-DYNAMICS; EMBRYONIC DIAPAUSE; DENSITY; TUBERCULOSIS; L.	The reproductive biology of the European badger (Meles meles) is of wide interest because it is one of the few mammal species that show delayed implantation and one of only five which are suggested to show superfetation as a reproductive strategy. This study aimed to describe the reproductive biology of female Irish badgers with a view to increasing our understanding of the process of delayed implantation and superfetation. We carried out a detailed histological examination of the reproductive tract of 264 female badgers taken from sites across 20 of the 26 counties in the Republic of Ireland. The key results show evidence of multiple blastocysts at different stages of development present simultaneously in the same female, supporting the view that superfetation is relatively common in this population of badgers. In addition we present strong evidence that the breeding rate in Irish badgers is limited by failure to conceive, rather than failure at any other stages of the breeding cycle. We show few effects of age on breeding success, suggesting no breeding suppression by adult females in this population. The study sheds new light on this unusual breeding strategy of delayed implantation and superfetation, and highlights a number of significant differences between the reproductive biology of female Irish badgers and those of Great Britain and Swedish populations.	[Corner, Leigh A. L.] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [Stuart, Lynsey J.; Kelly, David J.; Marples, Nicola M.] Univ Dublin Trinity Coll, Dept Zool, Sch Nat Sci, Dublin 2, Ireland; [Kelly, David J.; Marples, Nicola M.] Univ Dublin Trinity Coll, Trinity Ctr Biodivers Res, Dublin 2, Ireland	University College Dublin; Trinity College Dublin; Trinity College Dublin	Marples, NM (corresponding author), Univ Dublin Trinity Coll, Dept Zool, Sch Nat Sci, Dublin 2, Ireland.	nmarples@tcd.ie	Kelly, David/AAE-8278-2019	Marples, Nicola/0000-0003-4693-2607; Kelly, David/0000-0002-5880-4162	Department of Agriculture, Food and the Marine in Ireland [G01258]	Department of Agriculture, Food and the Marine in Ireland	LJS received funding from a grant (no G01258) from the Department of Agriculture, Food and the Marine in Ireland (url: www.agriculture.gov.ie), which was involved in the study design, but not in the analysis or publication of this work. NMM and LALC received no funding to support their contribution to this study. Preparation of the manuscript has taken place entirely outside the time frame of the grant to LJS.	AHNLUND H, 1980, J ZOOL, V190, P77; ANDERSON RM, 1985, PHILOS T R SOC B, V310, P327, DOI 10.1098/rstb.1985.0123; [Anonymous], 2014, R LANG ENV STAT COMP; Bacha W.J., 2000, COLOR ATLAS VET HIST; BONNIN M, 1978, J REPROD FERTIL, V52, P55; Bryne AW, 2012, BIOL ENVIRON, V112, P69; CANIVENC R, 1979, NATURE, V278, P849, DOI 10.1038/278849a0; Canivenc R, 1981, J Reprod Fertil Suppl, V29, P25; Carpenter PJ, 2005, MOL ECOL, V14, P273, DOI 10.1111/j.1365-294X.2004.02401.x; Carter F, 2008, REPROD FERT DEVELOP, V20, P368, DOI 10.1071/RD07204; Cleary GP, 2009, MAMM BIOL, V74, P438, DOI 10.1016/j.mambio.2009.07.003; CRESSWELL WJ, 1992, PHILOS T ROY SOC B, V338, P393, DOI 10.1098/rstb.1992.0157; Del Cerro I, 2010, ZOOL SCR, V39, P415, DOI 10.1111/j.1463-6409.2010.00436.x; Dellmann H., 1998, TXB VET HISTOLOGY; Gormley E, 2011, VET J, V189, P239, DOI 10.1016/j.tvjl.2011.03.007; HAFS HD, 1968, J ANIM SCI, V27, P134; HANCOX M, 1988, Lynx (Prague), V24, P77; Hill T., 2006, STAT METHODS APPL CO; Hogarth PJ., 1978, BIOL REPROD; IVANTER EV, 1973, T GOSUDARSTVENNOGO Z, V2, P164; Johnson DDP, 2000, MAMMAL REV, V30, P171, DOI 10.1046/j.1365-2907.2000.00066.x; Kowalczyk R, 2003, CAN J ZOOL, V81, P74, DOI 10.1139/Z02-233; Lynch JM, 1997, J ZOOL, V242, P31, DOI 10.1111/j.1469-7998.1997.tb02927.x; Macdonald DW, 2002, J ZOOL, V256, P121, DOI 10.1017/S0952836902000158; MacWhite Teresa, 2013, Irish Naturalists' Journal, V32, P99; MATTHEWS J, 1991, J ANAT, V178, P101; Mead R A, 1981, J Reprod Fertil Suppl, V29, P11; MEAD RA, 1993, J EXP ZOOL, V266, P629, DOI 10.1002/jez.1402660611; Mullen EM, 2013, APPL ANIM BEHAV SCI, V144, P130, DOI 10.1016/j.applanim.2013.01.013; Neal E., 1996, BADGERS; NEAL E. G., 1958, TRANS ZOOL SOC LONDON, V29, P67; O'Meara DB, 2012, BIOL J LINN SOC, V106, P893, DOI 10.1111/j.1095-8312.2012.01927.x; OKEEFFE JJ, 2006, BIENNIAL REPORT 2004, P101; PAGE RJC, 1994, J ZOOL, V233, P69, DOI 10.1111/j.1469-7998.1994.tb05263.x; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Revilla E, 1999, Z SAUGETIERKD, V64, P269; Roellig K, 2011, BIOL REV, V86, P77, DOI 10.1111/j.1469-185X.2010.00135.x; Roper T, 2010, BADGER; SANDELL M, 1990, Q REV BIOL, V65, P23, DOI 10.1086/416583; SCHEIRER CJ, 1976, BIOMETRICS, V32, P429, DOI 10.2307/2529511; Sleeman DP, 2009, EUR J WILDLIFE RES, V55, P333, DOI 10.1007/s10344-008-0244-1; Sternberg SS, 1997, HISTOLOGY PATHOLOGIS, V2nd; TOOTHAKER LE, 1994, J EDUC BEHAV STAT, V19, P237, DOI 10.3102/10769986019003237; Ward AI, 2010, PREV VET MED, V93, P2, DOI 10.1016/j.prevetmed.2009.09.014; Warning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360; Whelan R., 1993, P64; WOODROFFE R, 1995, J ZOOL, V236, P183, DOI 10.1111/j.1469-7998.1995.tb04486.x; Yamaguchi N, 2006, Q REV BIOL, V81, P33, DOI 10.1086/503923; Zimmerman DW, 2012, BRIT J MATH STAT PSY, V65, P122, DOI 10.1111/j.2044-8317.2011.02017.x	49	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138093	10.1371/journal.pone.0138093	http://dx.doi.org/10.1371/journal.pone.0138093			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465324	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100012
J	Kang, J; Cho, YS; Kim, SW; Park, JJ; Yoon, YE; Oh, IY; Yoon, CH; Suh, JW; Youn, TJ; Chae, IH; Choi, DJ				Kang, Jeehoon; Cho, Young-Seok; Kim, Seong-Wook; Park, Jin Joo; Yoon, Yeonyee E.; Oh, Il-Young; Yoon, Chang-Hwan; Suh, Jung-Won; Youn, Tae-Jin; Chae, In-Ho; Choi, Dong-Ju			Intravascular Ultrasound and Angiographic Predictors of In-Stent Restenosis of Chronic Total Occlusion Lesions	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; SIROLIMUS-ELUTING STENT; IMPLANTATION; RECANALIZATION; ANGIOPLASTY; PATTERNS; EFFICACY; OUTCOMES; SAFETY; TRIAL	Despite the benefits of successful percutaneous coronary interventions (PCIs) for chronic total occlusion (CTO) lesions, PCIs of CTO lesions still carry a high rate of adverse events, including in-stent restenosis (ISR). Because previous reports have not specifically investigated the intravascular ultrasound (IVUS) predictors of ISR in CTO lesions, we focused on these predictors. We included 126 patients who underwent successful PCIs, using drug-eluting stents, and post-PCI IVUS of CTO lesions. Patient and lesion characteristics were analyzed to elucidate the ISR predictors. In each lesion, an average of 1.7 +/- 0.7 (mean length, 46.4 +/- 20.3 mm) stents were used. At 9 months follow-up, 14 (11%) patients demonstrated ISR, and 8 (6.3%) underwent target lesion revascularization. Multivariate logistic regression analysis showed that the independent predictors of ISR were the post-PCI minimal luminal diameter (MLD) and the stent expansion ratio (SER; minimal stent cross-sectional area (CSA) over the nominal CSA of the implanted stent), measured using quantitative coronary angiography (QCA) and IVUS, respectively. A receiver operating characteristic analysis indicated that the best post-PCI MLD and SER cut-off values for predicting ISR were 2.4 mm (area under the curve [AUC], 0.762; 95% confidence interval (CI), 0.639-0.885) and 70% (AUC, 0.714; 95% CI, 0.577-0.852), respectively. Lesions with post-PCI MLD and SER values less than these threshold values were at a higher risk of ISR, with an odds ratio of 23.3 (95% CI, 2.74-198.08), compared with lesions having larger MLD and SER values. Thus, the potential predictors of ISR, after PCI of CTO lesions, are the post-PCI MLD and SER values. The ISR rate was highest in lesions with a post-PCI MLD <= 2.4 mm and an SER <= 70%.	[Kang, Jeehoon; Cho, Young-Seok; Kim, Seong-Wook; Park, Jin Joo; Yoon, Yeonyee E.; Oh, Il-Young; Yoon, Chang-Hwan; Suh, Jung-Won; Youn, Tae-Jin; Chae, In-Ho; Choi, Dong-Ju] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Songnam, South Korea; [Kang, Jeehoon] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Cho, Young-Seok; Youn, Tae-Jin; Chae, In-Ho; Choi, Dong-Ju] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Cho, YS (corresponding author), Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Songnam, South Korea.	flammeus1@gmail.com		Yoon, Chang-Hwan/0000-0001-6305-4442				Cassese S, 2014, HEART, V100, P153, DOI 10.1136/heartjnl-2013-304933; Chieffo A, 2013, AM HEART J, V165, P65, DOI 10.1016/j.ahj.2012.09.017; Costa JD, 2007, AM HEART J, V153, P297, DOI 10.1016/j.ahj.2006.08.026; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Fefer P, 2012, J AM COLL CARDIOL, V59, P991, DOI 10.1016/j.jacc.2011.12.007; Grantham JA, 2009, JACC-CARDIOVASC INTE, V2, P479, DOI 10.1016/j.jcin.2009.02.008; Hong MK, 2006, EUR HEART J, V27, P1305, DOI 10.1093/eurheartj/ehi882; Jakabcin J, 2010, CATHETER CARDIO INTE, V75, P578, DOI 10.1002/ccd.22244; Joyal D, 2010, AM HEART J, V160, P179, DOI 10.1016/j.ahj.2010.04.015; Kang SJ, 2013, JACC-CARDIOVASC IMAG, V6, P1183, DOI 10.1016/j.jcmg.2013.09.006; Kastrati A, 2006, CIRCULATION, V113, P2293, DOI 10.1161/CIRCULATIONAHA.105.601823; Kato M, 2012, AM J CARDIOL, V110, P1282, DOI 10.1016/j.amjcard.2012.06.032; Kimura T, 2012, CIRCULATION, V126, P1225, DOI 10.1161/CIRCULATIONAHA.112.104059; Kume T, 2012, J INVASIVE CARDIOL, V24, P13; Lee SP, 2012, INT J CARDIOL, V156, P180, DOI 10.1016/j.ijcard.2010.10.138; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Liu W, 2011, J INTERV CARDIOL, V24, P137, DOI 10.1111/j.1540-8183.2010.00608.x; Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872; Moreno R, 2013, CIRC-CARDIOVASC INTE, V6, P21, DOI 10.1161/CIRCINTERVENTIONS.112.000076; Noguchi T, 2000, CATHETER CARDIO INTE, V49, P258, DOI 10.1002/(SICI)1522-726X(200003)49:3<258::AID-CCD7>3.0.CO;2-L; Park CB, 2013, EXP THER MED, V5, P1486, DOI 10.3892/etm.2013.1024; Park DW, 2010, J AM COLL CARDIOL, V56, P1187, DOI 10.1016/j.jacc.2010.03.086; Park HJ, 2012, CIRC J, V76, P868, DOI 10.1253/circj.CJ-11-1021; Shah PB, 2011, CIRCULATION, V123, P1780, DOI 10.1161/CIRCULATIONAHA.110.972802; Song HG, 2014, CATHETER CARDIO INTE, V83, P873, DOI 10.1002/ccd.24560; Stone GW, 2005, CIRCULATION, V112, P2364, DOI 10.1161/CIRCULATIONAHA.104.481283; Tahara S, 2011, CIRC J, V75, P2113, DOI 10.1253/circj.CJ-10-0647; Takebayashi H, 2004, CIRCULATION, V110, P3430, DOI 10.1161/01.CIR.0000148371.53174.05; Valenti R, 2013, J AM COLL CARDIOL, V61, P545, DOI 10.1016/j.jacc.2012.10.036	29	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140421	10.1371/journal.pone.0140421	http://dx.doi.org/10.1371/journal.pone.0140421			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465755	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100118
J	Knudsen, KN; Nielsen, BS; Lindebjerg, J; Hansen, TF; Holst, R; Sorensen, FB				Knudsen, Kirsten Nguyen; Nielsen, Boye Schnack; Lindebjerg, Jan; Hansen, Torben Frostrup; Holst, Rene; Sorensen, Flemming Brandt			microRNA-17 Is the Most Up-Regulated Member of the miR-17-92 Cluster during Early Colon Cancer Evolution	PLOS ONE			English	Article							KEY ONCOGENIC COMPONENT; COLORECTAL-CANCER; BETA-CATENIN; CLINICOPATHOLOGICAL SIGNIFICANCE; EXPRESSION PROFILES; MIR-21; IDENTIFICATION; SURVIVAL; PROLIFERATION; PROGRESSION	Deregulated microRNAs play a role in the development and progression of colon cancer, but little is known about their tissue and cell distribution in the continuum of normal mucosa through the premalignant adenoma to invasive adenocarcinoma. The aim of this study was to examine the expression pattern of the miR-17-92 cluster (miR-17, miR-18, miR-19, miR-20 and miR-92) as well as miR-21, miR-31, miR-135b, and miR-145 in early clinically diagnosed colon cancer. MicroRNAs were analysed by chromogenic in situ hybridisation in the normal-adenoma-adenocarcinoma sequence of nine adenocarcinomas developed in mucosal colon polyps. Subsequently, the expression of selected microRNAs was validated in 24 mucosal colon cancer polyps. Expression of miR-17 was confined to the epithelial cells, and the expression levels increased in the transitional zone from normal to adenomatous tissue. The miR-17-92 cluster members, miR-19b, miR-20a, and miR-92a, followed the same expression pattern, but miR-17 was the most predominant. An increased expression of miR-21 was found in the tumour-associated stroma with the most dramatic increase from adenoma to adenocarcinoma, while the number of positive miR-145 fibroblast-like cells in the normal lamina propria (stroma) decreased in a stepwise manner throughout the normal-adenoma-adenocarcinoma sequence. It is concluded that the expression of miR-17, miR-21, and miR-145 changes at early stages of the normal-adenoma-adenocarcinoma sequence. Thus, these microRNAs may play a role in the development of colon cancer.	[Knudsen, Kirsten Nguyen; Lindebjerg, Jan; Sorensen, Flemming Brandt] Vejle Hosp, Dept Clin Pathol, Vejle, Denmark; [Knudsen, Kirsten Nguyen; Holst, Rene; Sorensen, Flemming Brandt] Univ So Denmark, Inst Reg Hlth Res, Odense, Denmark; [Nielsen, Boye Schnack] Bioneer AS, Horsholm, Denmark; [Hansen, Torben Frostrup] Vejle Hosp, Dept Oncol, Vejle, Denmark	University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Bioneer A/S; University of Southern Denmark; Lillebaelt Hospital	Knudsen, KN (corresponding author), Vejle Hosp, Dept Clin Pathol, Vejle, Denmark.	Kirsten.quyen.nguyen.knudsen@rsyd.dk	Hansen, Torben Frøstrup/K-5583-2019	Hansen, Torben Frøstrup/0000-0001-7476-671X; Sorensen, Flemming Brandt/0000-0002-5446-1035; Nguyen Knudsen, Kirsten/0000-0003-4258-4289	Region of Southern Denmark's PhD Fund [12/6786]; University of Southern Denmark; Research Council of Lillebaelt Hospital; King Christian X Foundation; Family Spogaard Foundation; Aase and Ejnar Danielsen Foundation [10-000789]; Parliament J. Christensen and wife K. Christensen Foundation	Region of Southern Denmark's PhD Fund; University of Southern Denmark; Research Council of Lillebaelt Hospital; King Christian X Foundation; Family Spogaard Foundation; Aase and Ejnar Danielsen Foundation; Parliament J. Christensen and wife K. Christensen Foundation	The study was funded by Region of Southern Denmark's PhD Fund (grant number 12/6786, http://www.regionsyddanmark.dk/wm325002), The University of Southern Denmark (www.sdu.dk), The Research Council of Lillebaelt Hospital (http://www.sygehuslillebaelt.dk/wm223295), King Christian X Foundation (http://kongehuset.dk/Menu/Fondelegater/Kong-Christian-den-Tiendes-Fond/kongchristian-den-tiendesfond), The Family Spogaard Foundation (http://www.cancer.dk/forskning/stoette-til-forskning/familien-spogaards-fond/), Aase and Ejnar Danielsen Foundation (grant number 10-000789, http://www.danielsensfond.dk/Default.aspx), and Member of Parliament J. Christensen and wife K. Christensen Foundation. All grants mentioned above were given to KNK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BSN is employed by a commercial company (Bioneer A/S, Denmark). The funder provided support in form of salary, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam MI, 2015, INT J SURG, V13, P272, DOI 10.1016/j.ijsu.2014.12.009; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartley AN, 2011, CLIN CANCER RES, V17, P7283, DOI 10.1158/1078-0432.CCR-11-1452; Bramis J, 2004, ANTICANCER RES, V24, P3041; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Cekaite L, 2012, NEOPLASIA, V14, P868, DOI 10.1593/neo.121094; Chang KH, 2011, EJSO-EUR J SURG ONC, V37, P597, DOI 10.1016/j.ejso.2011.04.001; Chang KH, 2011, INT J COLORECTAL DIS, V26, P1415, DOI 10.1007/s00384-011-1279-4; Chivukula RR, 2014, CELL, V157, P1104, DOI 10.1016/j.cell.2014.03.055; Diaz R, 2008, GENE CHROMOSOME CANC, V47, P794, DOI 10.1002/gcc.20580; Diosdado B, 2009, BRIT J CANCER, V101, P707, DOI 10.1038/sj.bjc.6605037; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Faber C, 2009, VIRCHOWS ARCH, V454, P359, DOI 10.1007/s00428-009-0751-9; Fang LK, 2014, ONCOTARGET, V5, P2974, DOI 10.18632/oncotarget.1614; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gattolliat CH, 2015, EUR J CANCER, V51, P409, DOI 10.1016/j.ejca.2014.12.007; Goel A, 2012, GASTROENTEROLOGY, V143, P1442, DOI 10.1053/j.gastro.2012.09.032; Hao XP, 1997, VIRCHOWS ARCH, V431, P167, DOI 10.1007/s004280050084; Herter P, 1999, J CANCER RES CLIN, V125, P297, DOI 10.1007/s004320050277; Humphreys KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112288; Imai K, 2008, CARCINOGENESIS, V29, P673, DOI 10.1093/carcin/bgm228; Ito M, 2014, INT J CANCER, V135, P2507, DOI 10.1002/ijc.28920; Jang KS, 2010, HISTOPATHOLOGY, V56, P229, DOI 10.1111/j.1365-2559.2009.03468.x; Kanaan Z, 2012, HUM MUTAT, V33, P551, DOI 10.1002/humu.22021; Kang WK, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0227-0; Kent OA, 2014, NUCLEIC ACIDS RES, V42, P7528, DOI 10.1093/nar/gku461; Kjaer-Frifeldt S, 2012, BRIT J CANCER, V107, P1169, DOI 10.1038/bjc.2012.365; Ma YL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2276; Ma YL, 2012, INT J CANCER, V130, P2077, DOI 10.1002/ijc.26232; Michael MZ, 2003, MOL CANCER RES, V1, P882; Molinari Francesca, 2013, Front Oncol, V3, P326, DOI 10.3389/fonc.2013.00326; Monzo M, 2008, CELL RES, V18, P823, DOI 10.1038/cr.2008.81; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Olive V, 2013, IMMUNOL REV, V253, P158, DOI 10.1111/imr.12054; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Schee K, 2010, AM J PATHOL, V177, P1592, DOI 10.2353/ajpath.2010.100024; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schetter AJ, 2012, CANCER J, V18, P244, DOI 10.1097/PPO.0b013e318258b78f; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102; Slattery ML, 2015, INT J CANCER, V137, P428, DOI 10.1002/ijc.29384; Trompeter HI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016138; Tsuchida A, 2011, CANCER SCI, V102, P2264, DOI 10.1111/j.1349-7006.2011.02081.x; Valentini AM, 2003, CURR PHARM DESIGN, V9, P1932, DOI 10.2174/1381612033454216; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; Wu CW, 2014, CLIN CANCER RES, V20, P2994, DOI 10.1158/1078-0432.CCR-13-1750; Xanthoulis A, 2013, WORLD J GASTROENTERO, V19, P3189, DOI 10.3748/wjg.v19.i21.3189; Xiong BH, 2013, INT J ONCOL, V42, P219, DOI 10.3892/ijo.2012.1707; Xu XM, 2012, ONCOL LETT, V4, P339, DOI 10.3892/ol.2012.714; Yamamichi N, 2009, CLIN CANCER RES, V15, P4009, DOI 10.1158/1078-0432.CCR-08-3257; Yang LD, 2009, WORLD J SURG, V33, P638, DOI 10.1007/s00268-008-9865-5; Yu G, 2012, J SURG ONCOL, V106, P232, DOI 10.1002/jso.22138; Zhang J, 2012, BRIT J CANCER, V107, P352, DOI 10.1038/bjc.2012.251	58	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140503	10.1371/journal.pone.0140503	http://dx.doi.org/10.1371/journal.pone.0140503			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465597	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100133
J	Liller, CB; Neuhaus, R; von Korff, M; Koornneef, M; van Esse, W				Liller, Corinna Brit; Neuhaus, Ren; von Korff, Maria; Koornneef, Maarten; van Esse, Wilma			Mutations in Barley Row Type Genes Have Pleiotropic Effects on Shoot Branching	PLOS ONE			English	Article							AXILLARY MERISTEM DEVELOPMENT; 6-ROW EAR TYPE; DEVELOPMENTAL CONSEQUENCES; INFLORESCENCE ARCHITECTURE; SPRING BARLEY; RICE; MAIZE; MUTANT; ARABIDOPSIS; OSSPL14	Cereal crop yield is determined by different yield components such as seed weight, seed number per spike and the tiller number and spikes. Negative correlations between these traits are often attributed to resource limitation. However, recent evidence suggests that the same genes or regulatory modules can regulate both inflorescence branching and tillering. It is therefore important to explore the role of genetic correlations between different yield components in small grain cereals. In this work, we studied pleiotropic effects of row type genes on seed size, seed number per spike, thousand grain weight, and tillering in barley to better understand the genetic correlations between individual yield components. Allelic mutants of nine different row type loci (36 mutants), in the original spring barley varieties Barke, Bonus and Foma and introgressed in the spring barley cultivar Bowman, were phenotyped under greenhouse and outdoor conditions. We identified two main mutant groups characterized by their relationships between seed and tillering parameters. The first group comprises all mutants with an increased number of seeds and significant change in tiller number at early development (group 1a) or reduced tillering only at full maturity (group 1b). Mutants in the second group are characterized by a reduction in seeds per spike and tiller number, thus exhibiting positive correlations between seed and tiller number. Reduced tillering at full maturity (group 1b) is likely due to resource limitations. In contrast, altered tillering at early development (groups 1a and 2) suggests that the same genes or regulatory modules affect inflorescence and shoot branching. Understanding the genetic bases of the trade-offs between these traits is important for the genetic manipulation of individual yield components.	[Liller, Corinna Brit; Neuhaus, Ren; Koornneef, Maarten; van Esse, Wilma] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, D-50829 Cologne, Germany; [von Korff, Maria] Univ Dusseldorf, Inst Plant Genet, D-40225 Dusseldorf, Germany; [von Korff, Maria; Koornneef, Maarten; van Esse, Wilma] Univ Dusseldorf, Cluster Excellence Plant Sci CEPLAS, D-40225 Dusseldorf, Germany; [Koornneef, Maarten] Wageningen Univ, Genet Lab, NL-6708 PB Wageningen, Netherlands	Max Planck Society; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Cologne; Wageningen University & Research	van Esse, W (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Carl von Linne Weg 10, D-50829 Cologne, Germany.	vanesse@mpipz.mpg.de	van Esse, Wilma/AAN-2145-2020	van Esse, Wilma/0000-0001-5012-2346; Koornneef, Maarten/0000-0002-7759-4869	Cluster of Excellence in Plant Sciences (CEPLAS), Heinrich-Heine-Universitat Dusseldorf, Universitatsstr, Dusseldorf, Germany; International Max Planck Research School, Department Plant Breeding and Genetics, Max Planck Institute for Plant Breeding Research, Carl-von-Linne-Weg, Koln, Germany	Cluster of Excellence in Plant Sciences (CEPLAS), Heinrich-Heine-Universitat Dusseldorf, Universitatsstr, Dusseldorf, Germany; International Max Planck Research School, Department Plant Breeding and Genetics, Max Planck Institute for Plant Breeding Research, Carl-von-Linne-Weg, Koln, Germany	This work was supported by the Cluster of Excellence in Plant Sciences (CEPLAS), Heinrich-Heine-Universitat Dusseldorf, Universitatsstr. 1, 40255 Dusseldorf, Germany, and the International Max Planck Research School, Department Plant Breeding and Genetics, Max Planck Institute for Plant Breeding Research, Carl-von-Linne-Weg 10, 50829, Koln, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub M, 2002, THEOR APPL GENET, V105, P237, DOI 10.1007/s00122-002-0941-1; Beveridge CA, 2003, PLANT PHYSIOL, V131, P927, DOI 10.1104/pp.102.017525; Conti L, 2007, PLANT CELL, V19, P767, DOI 10.1105/tpc.106.049767; Dabbert T, 2010, THEOR APPL GENET, V121, P705, DOI 10.1007/s00122-010-1342-5; Dabbert T, 2009, THEOR APPL GENET, V118, P1351, DOI 10.1007/s00122-009-0985-6; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evans LT., 1996, CROP EVOLUTION ADAPT; Food and Agriculture Organisation of the United Nations, FAOSTAT; Goto Y, 2005, PLANT PROD SCI, V8, P68, DOI 10.1626/pps.8.68; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; GUSTAFSSON A, 1980, HEREDITAS, V92, P229; Hussien A, 2014, PLANT GENOME, P7; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kebrom TH, 2012, PLANT PHYSIOL, V160, P308, DOI 10.1104/pp.112.197954; KIRBY EJM, 1978, J AGR SCI, V91, P207, DOI 10.1017/S002185960005677X; Kjaer B, 1996, EUPHYTICA, V90, P39; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Koppolu R, 2013, P NATL ACAD SCI USA, V110, P13198, DOI 10.1073/pnas.1221950110; Leyser O, 2009, PLANT CELL ENVIRON, V32, P694, DOI 10.1111/j.1365-3040.2009.01930.x; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Liu C, 2013, DEV CELL, V24, P612, DOI 10.1016/j.devcel.2013.02.013; LUNDQVIST U., 1997, BARLEY GENET NEWSL, V26, P22; Lundqvist U, 2014, HEREDITAS, V151, P123, DOI 10.1111/hrd2.00077; McSteen P, 2005, ANNU REV PLANT BIOL, V56, P353, DOI 10.1146/annurev.arplant.56.032604.144122; McSteen P, 2009, PLANT PHYSIOL, V149, P46, DOI 10.1104/pp.108.129056; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Mueller D, 2011, ANN BOT-LONDON, V107, P1203, DOI 10.1093/aob/mcr069; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; RIGGS TJ, 1978, J AGR SCI, V91, P199, DOI 10.1017/S0021859600056768; Ritter MK, 2002, AM J BOT, V89, P203, DOI 10.3732/ajb.89.2.203; Sakuma S, 2011, PLANT CELL PHYSIOL, V52, P738, DOI 10.1093/pcp/pcr025; Sakuma S, 2010, FUNCT INTEGR GENOMIC, V10, P123, DOI 10.1007/s10142-009-0134-y; Schmitz G, 2005, CURR OPIN PLANT BIOL, V8, P506, DOI 10.1016/j.pbi.2005.07.010; Studer A, 2011, NAT GENET, V43, P1160, DOI 10.1038/ng.942; Tanaka W, 2013, PLANT CELL PHYSIOL, V54, P313, DOI 10.1093/pcp/pct016; WADDINGTON SR, 1983, ANN BOT-LONDON, V51, P119, DOI 10.1093/oxfordjournals.aob.a086434	38	29	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140246	10.1371/journal.pone.0140246	http://dx.doi.org/10.1371/journal.pone.0140246			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465604	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100093
J	Mahran, YF; El-Demerdash, E; Nada, AS; El-Naga, RN; Ali, AA; Abdel-Naim, AB				Mahran, Yasmen F.; El-Demerdash, Ebtehal; Nada, Ahmed S.; El-Naga, Reem N.; Ali, Azza A.; Abdel-Naim, Ashraf B.			Growth Hormone Ameliorates the Radiotherapy-Induced Ovarian Follicular Loss in Rats: Impact on Oxidative Stress, Apoptosis and IGF-1/IGF-1R Axis	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; ESTROGEN-RECEPTOR-ALPHA; CELL NUCLEAR ANTIGEN; FACTOR-I; IONIZING-RADIATION; CANCER-TREATMENT; EXPRESSION; FERTILITY; KINASE; WOMEN	Radiotherapy is one of the standard cytotoxic therapies for cancer. However, it has a profound impact on ovarian function leading to premature ovarian failure and infertility. Since none of the currently available methods for fertility preservation guarantees future fertility, the need for an effective radioprotective agent is highly intensified. The present study investigated the mechanisms of the potential radioprotective effect of growth hormone (GH) on. irradiation-induced ovarian failure and the impact of the insulin like growth factor 1 (IGF-1) in the underlying protection. Immature female Sprague-Dawley rats were either exposed to single whole body irradiation (3.2 Gy) and/or treated with GH (1 mg/kg s. c). Experimental.irradiation produced an array of ovarian dysfunction that was evident by assessment of hormonal changes, follicular development, proliferation marker (PCNA), oxidative stress as well as apoptotic markers. In addition, IGF-1/IGF-1R axis expression was assessed using real-time PCR and immunolocalization techniques. Furthermore, after full maturity, fertility assessment was performed. GH significantly enhanced follicular development and restored anti-Mullerian hormone serum level as compared with the irradiated group. In addition, GH significantly ameliorated the deleterious effects of irradiation on oxidative status, PCNA and apoptosis. Interestingly, GH was shown to enhance the ovarian IGF-1 at transcription and translation levels, a property that contributes significantly to its radioprotective effect. Finally, GH regained the fertility that was lost following irradiation. In conclusion, GH showed a radioprotective effect and rescued the ovarian reserve through increasing local IGF-1 level and counteracting the oxidative stress-mediated apoptosis.	[Mahran, Yasmen F.; El-Demerdash, Ebtehal; El-Naga, Reem N.; Abdel-Naim, Ashraf B.] Ain Shams Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo 11566, Egypt; [Nada, Ahmed S.] Atom Energy Author, NCRRT, Cairo 113701, Egypt; [Ali, Azza A.] Al Azhar Univ, Dept Pharmacol & Toxicol, Faulty Pharm, Cairo 11787, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Egyptian Atomic Energy Authority (EAEA); Egyptian Knowledge Bank (EKB); Al Azhar University	El-Demerdash, E (corresponding author), Ain Shams Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo 11566, Egypt.	ebtehal_dm@yahoo.com	Ali, Azza/AAA-5374-2022; El-Demerdash, Ebtehal/ABE-6729-2020; Abdel-Naim, Ashraf B/J-3199-2012	Ali, Azza/0000-0002-3700-7199; Abdel-Naim, Ashraf B/0000-0002-0400-9075; Mahran, Yasmen/0000-0002-6306-5616				Absolom K, 2008, HUM REPROD, V23, P2506, DOI 10.1093/humrep/den285; Anderson RA, 2011, J CLIN ENDOCR METAB, V96, P1336, DOI 10.1210/jc.2010-2582; Bachelot A, 2002, ENDOCRINOLOGY, V143, P4104, DOI 10.1210/en.2002-220087; Baeza I, 2010, BIOGERONTOLOGY, V11, P687, DOI 10.1007/s10522-010-9282-7; Benedict JC, 2003, BIOL REPROD, V68, P1511, DOI 10.1095/biolreprod.102.007492; BOKEMEYER C, 1994, ANN HEMATOL, V68, P105, DOI 10.1007/BF01727413; Bondy CA, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P527; Borek C, 2004, J NUTR, V134, p3207S, DOI 10.1093/jn/134.11.3207S; BRAW RH, 1980, J REPROD FERTIL, V59, P267, DOI 10.1530/jrf.0.0590267; Britt KL, 2000, ENDOCRINOLOGY, V141, P2614, DOI 10.1210/en.141.7.2614; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; CONSTINE LS, 1993, NEW ENGL J MED, V328, P87, DOI 10.1056/NEJM199301143280203; Cosaceanu D, 2007, ONCOGENE, V26, P2423, DOI 10.1038/sj.onc.1210037; de Boer JAM, 1999, J CLIN ENDOCR METAB, V84, P590, DOI 10.1210/jc.84.2.590; deBoer JAM, 1997, CLIN ENDOCRINOL, V46, P681, DOI 10.1046/j.1365-2265.1997.1800999.x; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1018, DOI 10.1210/me.13.6.1018; England K, 2005, REDOX REP, V10, P237, DOI 10.1179/135100005X70224; Fanchin R, 2003, HUM REPROD, V18, P323, DOI 10.1093/humrep/deg042; Fanchin R, 2005, HUM REPROD, V20, P923, DOI 10.1093/humrep/deh688; FERNANDEZCHECA JC, 1990, ANAL BIOCHEM, V190, P212, DOI 10.1016/0003-2697(90)90183-A; Floratou K, 2012, J RADIAT RES, V53, P672, DOI 10.1093/jrr/rrs019; Glubb DM, 2011, CLIN CANCER RES, V17, P5257, DOI 10.1158/1078-0432.CCR-11-0379; Gomez-De-Segura IA, 1998, ACTA ONCOL, V37, P179, DOI 10.1080/028418698429748; Gosden RG, 1997, HUM REPROD, V12, P2483, DOI 10.1093/humrep/12.11.2483; Gurgan T, 2008, PLACENTA, V29, pS152, DOI 10.1016/j.placenta.2008.07.007; Harper K, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000099; Hassan HA, 2001, J ASSIST REPROD GEN, V18, P417, DOI 10.1023/A:1016630603560; Herrington J, 2001, TRENDS ENDOCRIN MET, V12, P252, DOI 10.1016/S1043-2760(01)00423-4; Homburg R, 1995, HUM REPROD UPDATE, V1, P264, DOI 10.1093/humupd/1.3.264; Hrabia A, 2011, CELL TISSUE RES, V345, P191, DOI 10.1007/s00441-011-1187-5; Hugues JN, 1996, HUM REPROD, V11, P50; Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001; HUTCHINSON LA, 1988, MOL CELL ENDOCRINOL, V55, P61, DOI 10.1016/0303-7207(88)90091-3; JARRELL J, 1987, CANCER RES, V47, P5005; Klotz DM, 2002, J BIOL CHEM, V277, P8531, DOI 10.1074/jbc.M109592200; Krawczuk-Rybak M, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/125080; Kucuk T, 2008, J ASSIST REPROD GEN, V25, P123, DOI 10.1007/s10815-008-9212-7; Lee Young-Keun, 1998, Arhiv za Higijenu Rada i Toksikologiju, V49, P147; Li A, 1999, Hua Xi Yi Ke Da Xue Xue Bao, V30, P158; Liu DW, 2011, INT J MOL SCI, V12, P6781, DOI 10.3390/ijms12106781; Loh KP, 2006, NEUROSCI LETT, V398, P28, DOI 10.1016/j.neulet.2005.12.083; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucy MC, 2000, J DAIRY SCI, V83, P1635, DOI 10.3168/jds.S0022-0302(00)75032-6; Madrid O, 2002, EUR J ENDOCRINOL, V147, P535, DOI 10.1530/eje.0.1470535; Mahran YF, 2013, ENDOCRINOLOGY, V154, P3888, DOI 10.1210/en.2013-1214; Meirow D, 2000, MOL CELL ENDOCRINOL, V169, P123, DOI 10.1016/S0303-7207(00)00365-8; Morita Y, 1999, DEV BIOL, V213, P1, DOI 10.1006/dbio.1999.9344; Muskhelishvili L, 2005, TOXICOL PATHOL, V33, P365, DOI 10.1080/01926230590930164; Nair CKK, 2001, J RADIAT RES, V42, P21, DOI 10.1269/jrr.42.21; Navarro J, 1997, FREE RADICAL BIO MED, V22, P1203, DOI 10.1016/S0891-5849(96)00554-0; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; OKTAY K, 1995, BIOL REPROD, V53, P295, DOI 10.1095/biolreprod53.2.295; Pacey AA, 2007, CANCER TREAT REV, V33, P646, DOI 10.1016/j.ctrv.2007.02.001; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Peinnequin Andre, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-3; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Poretsky L, 1999, ENDOCR REV, V20, P535, DOI 10.1210/er.20.4.535; Quirk S M, 2004, J Anim Sci, V82 E-Suppl, pE40; Said RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050928; Shinomiya N, 2001, J CELL MOL MED, V5, P240, DOI 10.1111/j.1582-4934.2001.tb00158.x; Shirazi A, 2007, J RADIAT RES, V48, P263, DOI 10.1269/jrr.06070; Simon B, 2005, CA-CANCER J CLIN, V55, P211, DOI 10.3322/canjclin.55.4.211; Singh KL, 2005, HUM REPROD UPDATE, V11, P69, DOI 10.1093/humupd/dmh052; Sirotkin AV, 1999, J ENDOCRINOL, V163, P317, DOI 10.1677/joe.0.1630317; Slot KA, 2006, REPRODUCTION, V131, P525, DOI 10.1530/rep.1.00946; Sonmezer M, 2006, ONCOLOGIST, V11, P422, DOI 10.1634/theoncologist.11-5-422; Steel GG, 2002, BASIC CLIN RADIOBIOL; Stoica A, 2000, J CELL BIOCHEM, V76, P605, DOI 10.1002/(SICI)1097-4644(20000315)76:4<605::AID-JCB9>3.0.CO;2-T; Stroud JS, 2009, FERTIL STERIL, V92, P417, DOI 10.1016/j.fertnstert.2008.07.1714; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; van Disseldorp J, 2010, HUM REPROD, V25, P221, DOI 10.1093/humrep/dep366; Wallace WHB, 2005, INT J RADIAT ONCOL, V62, P738, DOI 10.1016/j.ijrobp.2004.11.038; Wandji SA, 1998, ENDOCRINOLOGY, V139, P5205, DOI 10.1210/en.139.12.5205; Wu XY, 2014, MOL MED REP, V10, P486, DOI 10.3892/mmr.2014.2185; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Yacobi K, 2004, ENDOCRINOLOGY, V145, P1943, DOI 10.1210/en.2003-1395; Yigiter M, 2011, EUR J OBSTET GYN R B, V157, P94, DOI 10.1016/j.ejogrb.2011.02.012; Zelinski MB, 2010, J ASSIST REPROD GEN, V27, P197	82	14	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140055	10.1371/journal.pone.0140055	http://dx.doi.org/10.1371/journal.pone.0140055			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465611	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100077
J	Song, C; Ortiz-Urquiza, A; Ying, SH; Zhang, JX; Keyhani, NO				Song, Chi; Ortiz-Urquiza, Almudena; Ying, Sheng-Hua; Zhang, Jin-Xia; Keyhani, Nemat O.			Interaction between TATA-Binding Protein (TBP) and Multiprotein Bridging Factor-1 (MBF1) from the Filamentous Insect Pathogenic Fungus Beauveria bassiana	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR MBF1; CUTICLE-DEGRADING PROTEASE; MOBILITY SHIFT ASSAY; ENTOMOPATHOGENIC FUNGUS; METARHIZIUM-ANISOPLIAE; BIOLOGICAL-CONTROL; CRYSTAL-STRUCTURE; PROMOTER DNA; VIRULENCE; YEAST	TATA-binding protein (TBP) is a ubiquitous component of eukaryotic transcription factors that acts to nucleate assembly and position pre-initiation complexes. Multiprotein bridging factor 1 (MBF1) is thought to interconnect TBP with gene specific transcriptional activators, modulating transcriptional networks in response to specific signal and developmental programs. The insect pathogen, Beauveria bassiana, is a cosmopolitan fungus found in most ecosystems where it acts as an important regulator of insect populations and can form intimate associations with certain plants. In order to gain a better understanding of the function of MBF1 in filamentous fungi, its interaction with TBP was demonstrated. The MBF1 and TBP homologs in B. bassiana were cloned and purified from a heterologous E. coli expression system. Whereas purified BbTBP was shown to be able to bind oligonucleotide sequences containing the TATA-motif (Kd approximate to 1.3 nM) including sequences derived from the promoters of the B. bassiana chitinase and protease genes. In contrast, BbMBF1 was unable to bind to these same target sequences. However, the formation of a ternary complex between BbMBF1, BbTBP, and a TATA-containing target DNA sequence was seen in agarose gel electrophoretic mobility shift assays (EMSA). These data indicate that BbMBF1 forms direct interactions with BbTBP, and that the complex is capable of binding to DNA sequences containing TATA-motifs, confirming that BbTBP can link BbMBF1 to target sequences as part of the RNA transcriptional machinery in fungi.	[Song, Chi; Zhang, Jin-Xia] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100081, Peoples R China; [Song, Chi; Zhang, Jin-Xia] Minist Agr, Key Lab Microbial Resources, Beijing 100081, Peoples R China; [Song, Chi; Ortiz-Urquiza, Almudena; Keyhani, Nemat O.] Univ Florida, Dept Microbiol & Cell Sci, Inst Food & Agr Sci, Gainesville, FL 32611 USA; [Ying, Sheng-Hua] Zhejiang Univ, Inst Microbiol, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; State University System of Florida; University of Florida; Zhejiang University	Keyhani, NO (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100081, Peoples R China.	keyhani@ufl.edu	Keyhani, Nemat O/I-8150-2013		National Science Foundation [IOS-1121392]; University of Florida, Institute of Food and Agricultural Science funds; China Scholarship Council Fellowship [201303250074]	National Science Foundation(National Science Foundation (NSF)); University of Florida, Institute of Food and Agricultural Science funds; China Scholarship Council Fellowship(China Scholarship Council)	Funding provided by National Science Foundation grant (IOS-1121392) to NOK, University of Florida, Institute of Food and Agricultural Science funds to NOK, and a China Scholarship Council Fellowship (No. 201303250074) to CS.	Akhtar W, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-23; Bidochka MJ, 2010, MICROBIOL-SGM, V156, P2164, DOI 10.1099/mic.0.038216-0; BIDOCHKA MJ, 1988, EXP MYCOL, V12, P161, DOI 10.1016/0147-5975(88)90005-9; Cohen SM, 2000, BIOCHEMISTRY-US, V39, P8259, DOI 10.1021/bi0004495; Coto JM, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-18; de Koning B, 2009, BIOCHEM SOC T, V37, P52, DOI 10.1042/BST0370052; Denissov S, 2007, EMBO J, V26, P944, DOI 10.1038/sj.emboj.7601550; Fan YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026924; Fan YH, 2010, MICROB PATHOGENESIS, V49, P376, DOI 10.1016/j.micpath.2010.06.013; Fang WG, 2009, J INVERTEBR PATHOL, V102, P155, DOI 10.1016/j.jip.2009.07.013; Fang WG, 2005, APPL ENVIRON MICROB, V71, P363, DOI 10.1128/AEM.71.1.363-370.2005; Gietl A, 2014, NUCLEIC ACIDS RES, V42, P6219, DOI 10.1093/nar/gku273; Glare T, 2012, TRENDS BIOTECHNOL, V30, P250, DOI 10.1016/j.tibtech.2012.01.003; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Holder DJ, 2005, APPL ENVIRON MICROB, V71, P5260, DOI 10.1128/AEM.71.9.5260-5266.2005; Jing D, 2003, PROTEOMICS, V3, P1172, DOI 10.1002/pmic.200300438; JOSHI L, 1995, FEMS MICROBIOL LETT, V125, P211, DOI 10.1111/j.1574-6968.1995.tb07360.x; Jung YW, 2001, J BIOL CHEM, V276, P43589, DOI 10.1074/jbc.M108299200; Kabe Y, 1999, J BIOL CHEM, V274, P34196, DOI 10.1074/jbc.274.48.34196; Keyhani NO, 2012, VIRULENCE, V3, P415, DOI 10.4161/viru.20956; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Kirkland BH, 2004, J MED ENTOMOL, V41, P705, DOI 10.1603/0022-2585-41.4.705; Kosa PF, 1997, P NATL ACAD SCI USA, V94, P6042, DOI 10.1073/pnas.94.12.6042; Kucharski R, 1997, MICROBIOL-UK, V143, P1263, DOI 10.1099/00221287-143-4-1263; Kurtti TJ, 2008, MICROBIOL-SGM, V154, P1700, DOI 10.1099/mic.0.2008/016667-0; Lewis MW, 2009, MICROBIOL-SGM, V155, P3110, DOI 10.1099/mic.0.029165-0; LI FQ, 1994, MOL CELL BIOL, V14, P3013, DOI 10.1128/MCB.14.5.3013; Liu QX, 2007, MOL BIOL EVOL, V24, P1458, DOI 10.1093/molbev/msm073; Luo ZB, 2015, ENVIRON MICROBIOL, V17, P1189, DOI 10.1111/1462-2920.12542; Luo ZB, 2014, ENVIRON MICROBIOL, V16, P1122, DOI 10.1111/1462-2920.12352; Ortiz-Urquiza A, 2015, CURR GENET, V61, P239, DOI 10.1007/s00294-014-0439-9; Ortiz-Urquiza A, 2015, APPL MICROBIOL BIOT, V99, P1057, DOI 10.1007/s00253-014-6270-x; Ortiz-Urquiza Almudena, 2013, Insects, V4, P357, DOI 10.3390/insects4030357; Ozaki J, 1999, GENES CELLS, V4, P415, DOI 10.1046/j.1365-2443.1999.00267.x; Parkhurst KM, 1996, BIOCHEMISTRY-US, V35, P7459, DOI 10.1021/bi9530301; Pedrini N, 2015, P NATL ACAD SCI USA, V112, pE3651, DOI 10.1073/pnas.1504552112; PEREZHOWARD GM, 1995, BIOCHEMISTRY-US, V34, P8005, DOI 10.1021/bi00025a006; Pongsunk S, 2005, FUNGAL GENET BIOL, V42, P893, DOI 10.1016/j.fgb.2005.07.002; Salinas RK, 2009, PROTEINS, V75, P518, DOI 10.1002/prot.22344; SMITH RJ, 1983, J INVERTEBR PATHOL, V42, P319, DOI 10.1016/0022-2011(83)90170-2; Takemaru K, 1997, P NATL ACAD SCI USA, V94, P7251, DOI 10.1073/pnas.94.14.7251; Takemaru K, 1998, MOL CELL BIOL, V18, P4971, DOI 10.1128/MCB.18.9.4971; Tsuda K, 2004, PLANT CELL PHYSIOL, V45, P225, DOI 10.1093/pcp/pch017; Wanchoo A, 2009, MICROBIOL-SGM, V155, P3121, DOI 10.1099/mic.0.029157-0; Xiao GH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00483; Yang LZ, 2014, APPL ENVIRON MICROB, V80, P4531, DOI 10.1128/AEM.01197-14; Ying SH, 2014, ENVIRON MICROBIOL, V16, P1879, DOI 10.1111/1462-2920.12450; Zhang YJ, 2008, BIOCONTROL SCI TECHN, V18, P551, DOI 10.1080/09583150802082239	50	6	8	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140538	10.1371/journal.pone.0140538	http://dx.doi.org/10.1371/journal.pone.0140538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466369	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100138
J	Sridhar, S; Nagamruta, M; Guruprasad, K				Sridhar, Settu; Nagamruta, Mallapragada; Guruprasad, Kunchur			Analyses of the Sequence and Structural Properties Corresponding to Pentapeptide and Large Palindromes in Proteins	PLOS ONE			English	Article							SECONDARY STRUCTURE; CONFORMATIONS; PSSARD	The analyses of 3967 representative proteins selected from the Protein Data Bank revealed the presence of 2803 pentapeptide and large palindrome sequences with known secondary structure conformation. These represent 2014 unique palindrome sequences. 60% palindromes are not associated with any regular secondary structure and 28% are in helix conformation, 11% in strand conformation and 1% in the coil conformation. The average solvent accessibility values are in the range between 0-155.28 angstrom(2) suggesting that the palindromes in proteins can be either buried, exposed to the solvent or share an intermittent property. The number of residue neighborhood contacts defined by interactions <= 3.2 angstrom is in the range between 0-29 residues. Palindromes of the same length in helix, strand and coil conformation are associated with different amino acid residue preferences at the individual positions. Nearly, 20% palindromes interact with catalytic/active site residues, ligand or metal ions in proteins and may therefore be important for function in the corresponding protein. The average hydrophobicity values for the pentapeptide and large palindromes range between -4.3 to +4.32 and the number of palindromes is almost equally distributed between the negative and positive hydrophobicity values. The palindromes represent 107 different protein families and the hydrolases, transferases, oxidoreductases and lyases contain relatively large number of palindromes.	[Sridhar, Settu; Nagamruta, Mallapragada; Guruprasad, Kunchur] CCMB, Bioinformat, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Guruprasad, K (corresponding author), CCMB, Bioinformat, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	guru@ccmb.res.in						[Anonymous], PYMOL MOL GRAPH SYST; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; Gayatri M, 2010, PROTEIN PEPTIDE LETT, V17, P1459, DOI 10.2174/0929866511009011459; Giel-Pietraszuk M, 2003, J PROTEIN CHEM, V22, P109, DOI 10.1023/A:1023454111924; Griep S, 2010, NUCLEIC ACIDS RES, V38, pD318, DOI 10.1093/nar/gkp786; Guruprasad K, 2005, INT J BIOL MACROMOL, V36, P259, DOI 10.1016/j.ijbiomac.2005.06.005; Hoffmann M., 1999, COMPUT METHODS SCI T, V5, P21; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; OHNO S, 1993, LEUKEMIA, V7, pS157; OHNO S, 1992, HUM GENET, V90, P342; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Sheari A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-274; Sridhar S, 2014, PLOS ONE, V11, DOI [10.1371/journal.pone.0107647, DOI 10.1371/J0URNAL.P0NE.0107647]; Sridhar S, 2007, INT J BIOL MACROMOL, V41, P109, DOI 10.1016/j.ijbiomac.2006.10.006; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	20	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139568	10.1371/journal.pone.0139568	http://dx.doi.org/10.1371/journal.pone.0139568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465610	gold, Green Submitted, Green Published			2022-12-26	WOS:000363183100053
J	Goldblatt, A; Kwena, Z; Lahiff, M; Agot, K; Minnis, A; Prata, N; Lin, J; Bukusi, EA; Auerswald, CL				Goldblatt, Ariella; Kwena, Zachary; Lahiff, Maureen; Agot, Kawango; Minnis, Alexandra; Prata, Ndola; Lin, Jessica; Bukusi, Elizabeth A.; Auerswald, Colette L.			Prevalence and Correlates of HIV Infection among Street Boys in Kisumu, Kenya	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; SUBSTANCE USE; RISK BEHAVIOR; DRUG-USE; ORPHAN STATUS; CHILDREN; YOUTH; HEALTH; SEROPREVALENCE; ADOLESCENTS	Introduction Despite their perceived vulnerability to HIV, East African street youth have been neglected in HIV prevention research. We examined HIV seroprevalence and correlates of HIV infection in a sample of male street youth in Kisumu, Kenya. Methods We enrolled a street-recruited sample of 13-21 year old street youth. Participants completed a survey followed by voluntary HIV counseling and testing. Survey items included demographics, homelessness history, survival activities, sexual behavior and substance use. We examined the relationship between predictor variables, markers of coercion and marginalization and HIV. Results The sample included 296 males. Survival activities included garbage picking (55%), helping market vendors (55%), begging (17%), and working as porters (46%) or domestic workers (4%). Forty-nine percent of participants reported at least weekly use of alcohol and 32% marijuana. Forty-six percent of participants reported lifetime inhalation of glue and 8% fuel. Seventy-nine percent of participants reported lifetime vaginal sex, 6% reported lifetime insertive anal sex and 8% reported lifetime receptive anal sex. Twelve (4.1%; 95% CI: 2.3-7.0) participants tested positive for HIV. Of those, all had been on the street for at least one year and all had engaged in vaginal sex. Occupations placing youth at particular risk of coercion by adults, including helping market vendors (prevalence ratio (PR) = 8.8; 95% CI: 1.2-67.5) and working as domestic workers (PR = 4.6; 95% CI: 1.1-19.0), were associated with HIV infection. Both insertive anal sex (PR = 10.2; 95% CI: 3.6-29.4) and receptive anal sex (PR = 3.9; 95% CI: 1.1-13.4) were associated with HIV infection. Drug use, begging, and garbage picking were not associated with HIV infection. Conclusions Although HIV prevalence in our sample of street youth is comparable to that of similarly-aged male youth in Nyanza Province, our findings highlight behavioral factors associated with HIV infection that offer opportunities for targeted prevention among street youth in East Africa.	[Goldblatt, Ariella; Auerswald, Colette L.] Univ Calif Berkeley, Sch Publ Hlth, Univ Calif Berkeley Univ Calif San Francisco Join, Berkeley, CA 94720 USA; [Kwena, Zachary; Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, CMR, Nairobi, Kenya; [Lahiff, Maureen; Minnis, Alexandra; Lin, Jessica] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Agot, Kawango] Impact Res & Dev Org, Kisumu, Kenya; [Minnis, Alexandra] RTI Int, Womens Global Hlth Imperat, San Francisco, CA USA; [Prata, Ndola] Univ Calif Berkeley, Sch Publ Hlth, Bixby Ctr Populat Hlth & Sustainabil, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Kenya Medical Research Institute; University of California System; University of California Berkeley; Research Triangle Institute; University of California System; University of California Berkeley	Auerswald, CL (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Univ Calif Berkeley Univ Calif San Francisco Join, Berkeley, CA 94720 USA.	coco.auerswald@berkeley.edu		Minnis, Alexandra/0000-0002-2943-2005	University of California, Berkeley Center for Global Public Health; University of California, Berkeley-University of California at San Francisco Joint Medical Program Albert Brodie Smith and Margaret Gretchen Smith Scholarship; University of California at San Francisco Department of Pediatrics; University of California, Berkeley-University of California at San Francisco Joint Medical Program Schoeneman Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	University of California, Berkeley Center for Global Public Health(University of California System); University of California, Berkeley-University of California at San Francisco Joint Medical Program Albert Brodie Smith and Margaret Gretchen Smith Scholarship(University of California System); University of California at San Francisco Department of Pediatrics; University of California, Berkeley-University of California at San Francisco Joint Medical Program Schoeneman Grant(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project and analyses were supported by grants from the University of California, Berkeley Center for Global Public Health, the University of California, Berkeley-University of California at San Francisco Joint Medical Program Albert Brodie Smith and Margaret Gretchen Smith Scholarship, the University of California at San Francisco Department of Pediatrics, and the University of California, Berkeley-University of California at San Francisco Joint Medical Program Schoeneman Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderinto AA, 2000, CHILD ABUSE NEGLECT, V24, P1199, DOI 10.1016/S0145-2134(00)00172-1; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Anarfi J K, 1997, Health Transit Rev, V7 Suppl, P281; Asante KO, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-45; Auerswald C, 2012, SOC AD MED HLTH ANN; Auerswald C, 2010, INT AIDS C; Auma S, 2005, NEEDS ASSESSMENT SEM; Ayaya S O, 2001, East Afr Med J, V78, P624; Ayuku D., 2005, East African Journal of Public Health, V2, P6; Ayuku D, 2003, HEALTH POLICY PLANN, V18, P109, DOI 10.1093/heapol/18.1.109; Bal B, 2010, SUBST USE MISUSE, V45, P1668, DOI 10.3109/10826081003674856; Baybuga MS, 2004, INT J NURS STUD, V41, P591, DOI 10.1016/j.ijnurstu.2003.12.010; Bellamy C, 2005, STATE WORLDS CHILDRE; Beyene Y, 1997, E AFR MED J, V74, P85; Birdthistle IJ, 2008, AIDS, V22, P759, DOI 10.1097/QAD.0b013e3282f4cac7; Cohen CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004573; Dalkey N., 1969, RM5888PR RAND CORP; Dematteo D, 1999, J ADOLESCENT HEALTH, V25, P358, DOI 10.1016/S1054-139X(99)00059-2; Eaton L, 2000, S AFRICAN J CHILD AD, V12, P97; Embleton L, 2013, ADDICTION, V108, P1722, DOI 10.1111/add.12252; Embleton L, 2013, ADDICTION, V108, P1735, DOI 10.1111/add.12301; Embleton L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053435; Embleton L, 2012, SUBST USE MISUSE, V47, P1234, DOI 10.3109/10826084.2012.700678; Forster LMK, 1996, DRUG ALCOHOL DEPEN, V43, P57, DOI 10.1016/S0376-8716(96)01288-4; Griaule Biometrics, 2009, FING SDK; Hillis SD, 2012, AIDS, V26, P105, DOI 10.1097/QAD.0b013e32834c4be4; Human Rights Watch, 1997, JUV INJ POL AB DET S; Juma M, 2013, AIDS BEHAV, V17, P951, DOI 10.1007/s10461-012-0336-5; Kahuthia-Gathu R., 2013, Journal of Applied Biosciences, V67, P5308; Kaime-Atterhog W, 2007, CHILD YOUTH SERV REV, V29, P600, DOI 10.1016/j.childyouth.2007.01.005; Kaime-Atterhog W, 2008, CHILD YOUTH SERV REV, V30, P1345, DOI 10.1016/j.childyouth.2008.04.003; Karmacharya D, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-25; Kayembe Patrick K, 2008, East Afr J Public Health, V5, P186; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kilbride PL., 2000, STREET CHILDREN KENY; Kissin DM, 2007, AIDS, V21, P2333, DOI 10.1097/QAD.0b013e3282f125b3; Kisumu Area Advisory Council, 2005, DIV STREET CHILDR KI; LeRoux J, 1996, ADOLESCENCE, V31, P423; Lockhart C, 2002, MED ANTHROPOL Q, V16, P294, DOI 10.1525/maq.2002.16.3.294; Lockhart C, 2008, MED ANTHROPOL Q, V22, P94, DOI 10.1111/j.1548-1387.2008.00005.x; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Mandalazi P, 2013, MALAWI MED J, V25, P1; Margaretten E, 2011, CITY SOC, V23, P45, DOI 10.1111/j.1548-744X.2011.01055.x; McAlpine K, 2010, COMMUNITY MENT HLT J, V46, P26, DOI 10.1007/s10597-009-9196-5; Morakinyo J, 2003, DRUG ALCOHOL DEPEN, V71, P109, DOI 10.1016/S0376-8716(03)00093-0; Mthembu S, 2012, East Afr J Public Health, V9, P74; Mudingayi A, 2011, PAN AFR MED J, V10; Nada KH, 2010, AIDS, V24, pS39, DOI 10.1097/01.aids.0000386732.02425.d1; Naing L, 2006, ARCH OROFAC SCI, V1, P9; NASCOP, 2001, NAT GUID VOL COUNS T; National AIDS and STI Control Programme, 2013, KEN AIDS IND SURV KA; Nzimakwe D, 1994, Curationis, V17, P27; Oindo J, 2007, SEXUAL ACTIVITY AMON; Okal J, 2013, SEX TRANSM INFECT, V89, P366, DOI 10.1136/sextrans-2013-051071; Olley BO, 2006, CHILD ABUSE NEGLECT, V30, P271, DOI 10.1016/j.chiabu.2005.10.011; Operario D, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-25; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; PINTO JA, 1994, J ADOLESCENT HEALTH, V15, P179, DOI 10.1016/1054-139X(94)90547-9; Prinsloo L, 2003, Curationis, V26, P78; Puffer ES, 2012, J PEDIATR PSYCHOL, V37, P868, DOI 10.1093/jpepsy/jss077; RICHTER LM, 1995, S AFR J PSYCHOL, V25, P31, DOI 10.1177/008124639502500105; Robbins CL, 2010, INT J STD AIDS, V21, P489, DOI 10.1258/ijsa.2010.010097; Rosner B., 2000, FUNDAMENTALS BIOSTAT; Seth R, 2005, SUBST USE MISUSE, V40, P1659, DOI 10.1080/10826080500222792; Sherman SS, 2005, J URBAN HEALTH, V82, pIV113, DOI 10.1093/jurban/jti113; Sorber R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097587; StataCorp, 2011, STAT 12 BAS REF MAN; Suda C., 1997, CHILD ABUSE REV, V6, P199, DOI DOI 10.1002/(SICI)1099-0852(199708)6:3<199::AID-CAR306>3.0.CO;2-D; Swahn MH, 2014, DEV STRUCTURAL INTER; SwartKruger J, 1997, SOC SCI MED, V45, P957, DOI 10.1016/S0277-9536(96)00417-0; Tadesse Negash, 2013, BMC Res Notes, V6, P234, DOI 10.1186/1756-0500-6-234; Thurman TR, 2006, AIDS BEHAV, V10, P627, DOI 10.1007/s10461-006-9104-8; UNICEF, PROGR CHILDR REP CAR; Winston SE, 2015, SEX TRANSM INFECT, V91, P353, DOI 10.1136/sextrans-2014-051797; Woan J, 2013, J ADOLESCENT HEALTH, V53, P314, DOI 10.1016/j.jadohealth.2013.03.013; World Health Organization, 2000, WORKING WITH STREET; Wutoh AK, 2006, AIDS BEHAV, V10, P209, DOI 10.1007/s10461-005-9038-6	77	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140005	10.1371/journal.pone.0140005	http://dx.doi.org/10.1371/journal.pone.0140005			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT6ZJ	26461494	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300045
J	Kim, SY; Sim, S; Kim, SG; Park, B; Choi, HG				Kim, So Young; Sim, Songyong; Kim, Sung-Gyun; Park, Bumjung; Choi, Hyo Geun			Prevalence and Associated Factors of Subjective Halitosis in Korean Adolescents	PLOS ONE			English	Article							VOLATILE SULFUR-COMPOUNDS; ORAL MALODOR; GENDER; STRESS; HEALTH	This study was conducted to estimate the prevalence and associated factors of subjective halitosis in adolescents. In total, 359,263 participants were selected from the Korea Youth Risk Behavior Web-based Survey (KYRBWS) from 2009 through 2013. Demographic data including age, sex, obesity and residency; psychosocial factors such as subjective health, stress, and economic levels; and dietary factors such as alcohol consumption; smoking; and fruit, soda, fast food, instant noodle, confection, and vegetable consumption were analyzed for correlations with halitosis using simple and multiple logistic regression analyses with complex sampling. In total, 23.6% of the participants reported the presence of halitosis. The following subjectively assessed factors were related to halitosis: poor health status (adjusted odds ratio [AOR] = 2.56), overweight or obese (AOR = 1.37), stress (AOR = 2.56), and lower economic levels (AOR = 1.85). The high intake of fast food (AOR = 1.15), instant noodles (AOR = 1.17), and confections (AOR = 1.17) and the low intake of fruits (AOR = 1.22) and vegetables (AOR = 1.19) were also related to halitosis. The prevalence of subjective halitosis in the studied adolescents was 23.6%. Specific psychosocial factors and dietary intake were related to halitosis.	[Kim, So Young] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, So Young] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Sim, Songyong] Hallym Univ, Dept Stat, Chunchon, South Korea; [Kim, Sung-Gyun] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea; [Park, Bumjung; Choi, Hyo Geun] Hallym Univ Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hallym University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	Hallym University Sacred Heart Hospital [HURF-2014-58]	Hallym University Sacred Heart Hospital	This study was supported by a research grant funded by Hallym University Sacred Heart Hospital (HURF-2014-58).	Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Bae Jisuk, 2010, J Prev Med Public Health, V43, P396, DOI 10.3961/jpmph.2010.43.5.396; Calil CM, 2008, ARCH ORAL BIOL, V53, P1107, DOI 10.1016/j.archoralbio.2008.06.008; Chen Xi, 2006, Shanghai Kou Qiang Yi Xue, V15, P575; Clarke DE, 2011, J VET DENT, V28, P230; Cortelli José Roberto, 2008, Braz. oral res., V22, P44, DOI 10.1590/S1806-83242008000500007; Deinzer R, 2000, INT J PSYCHOPHYSIOL, V37, P219, DOI 10.1016/S0167-8760(99)00112-9; Delanghe G, 1997, LANCET, V350, P187, DOI 10.1016/S0140-6736(05)62354-9; Ehizele A O, 2013, Niger Postgrad Med J, V20, P311; Han Jiang, 2010, Hua Xi Kou Qiang Yi Xue Za Zhi, V28, P626; Harris Rebecca, 2004, Community Dent Health, V21, P71; Hughes FJ, 2008, ARCH ORAL BIOL, V53, pS1, DOI 10.1016/S0003-9969(08)70002-5; Johannsen A, 2010, INT J DENT HYG, V8, P22, DOI 10.1111/j.1601-5037.2009.00397.x; Jung SH, 2011, COMMUNITY DENT ORAL, V39, P221, DOI 10.1111/j.1600-0528.2010.00595.x; Lima PO, 2013, ORAL DIS, V19, P366, DOI 10.1111/odi.12011; Mathur MR, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006391; MIYAZAKI H, 1995, J PERIODONTOL, V66, P679, DOI 10.1902/jop.1995.66.8.679; Motta LJ, 2011, CLINICS, V66, P939, DOI 10.1590/S1807-59322011000600003; Nadanovsky P, 2007, ORAL DIS, V13, P105, DOI 10.1111/j.1601-0825.2006.01257.x; Newby EE, 2008, ARCH ORAL BIOL, V53, pS19, DOI 10.1016/S0003-9969(08)70005-0; Piko B, 2001, SOC SCI MED, V53, P817, DOI 10.1016/S0277-9536(00)00379-8; Pitts N, 2011, Adv Dent Res, V23, P211, DOI 10.1177/0022034511402016; Porter SR, 2006, BMJ-BRIT MED J, V333, P632, DOI 10.1136/bmj.38954.631968.AE; Queiroz CS, 2002, EUR J ORAL SCI, V110, P337, DOI 10.1034/j.1600-0722.2002.21320.x; Quirynen M, 2009, J CLIN PERIODONTOL, V36, P970, DOI 10.1111/j.1600-051X.2009.01478.x; Rayman S, 2008, Int J Dent Hyg, V6, P2, DOI 10.1111/j.1601-5037.2007.00274.x; Romano F, 2010, INT J DENT HYG, V8, P41, DOI 10.1111/j.1601-5037.2009.00368.x; Scully C, 2012, ORAL DIS, V18, P333, DOI 10.1111/j.1601-0825.2011.01890.x; Seemann R, 2006, INT DENT J, V56, P77; Seemann R, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/017101; van den Broek AMWT, 2007, J DENT, V35, P627, DOI 10.1016/j.jdent.2007.04.009; Villa A, 2014, INT J DENT HYG, V12, P208, DOI 10.1111/idh.12077; Von Schonfeld J, 2007, Z GASTROENTEROL, V45, P171, DOI 10.1055/s-2006-927271; Yaegaki K, 2000, COMPEND CONTIN ED DE, V21, P888; Zeng QC, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/3/036005	35	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140214	10.1371/journal.pone.0140214	http://dx.doi.org/10.1371/journal.pone.0140214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461837	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300067
J	D'Abramo, M; Besker, N; Desideri, A; Levine, AJ; Melino, G; Chillemi, G				D'Abramo, M.; Besker, N.; Desideri, A.; Levine, A. J.; Melino, G.; Chillemi, G.			The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain	ONCOGENE			English	Article							TUMOR-SUPPRESSOR; MUTANT P53; CELL-DEATH; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; LUNG-CANCER; TRANSCRIPTIONAL ACTIVATION; ENZYME SPECIFICITY; LYSINE METHYLATION; STRUCTURAL BASIS	The Trp53 gene is the most frequently mutated gene in all human cancers. Its protein product p53 is a very powerful transcription factor that can activate different biochemical pathways and affect the regulation of metabolism, senescence, DNA damage response, cell cycle and cell death. The understanding of its function at the molecular level could be of pivotal relevance for therapy. Investigation of long-range intra- and interdomain communications in the p53 tetramer-DNA complex was performed by means of an atomistic model that included the tetramerization helices in the C-terminal domain, the DNA-binding domains and a consensus DNA-binding site of 18 base pairs. Nonsymmetric dynamics are illustrated in the four DNA-binding domains, with loop L1 switching from inward to outward conformations with respect to the DNA major groove. Direct intra- and intermonomeric longrange communications between the tetramerization and DNA-binding domains are noted. These long-distance conformational changes link the C terminus with the DNA-binding domain and provide a biophysical rationale for the reported functional regulation of the p53 C-terminal region. A fine characterization of the DNA deformation caused by p53 binding is obtained, with `static' deformations always present and measured by the slide parameter in the central thymine-adenine base pairs; we also detect `dynamic' deformations switched on and off by particular p53 tetrameric conformations and measured by the roll and twist parameters in the same base pairs. These different conformations can indeed modulate the electrostatic potential isosurfaces of the whole p53-DNA complex. These results provide a molecular/biophysical understanding of the evident role of the C terminus in post-translational modification that regulates the transcriptional function of p53. Furthermore, the unstructured C terminus is able to facilitate contacts between the core DNA-binding domains of the tetramer.	[D'Abramo, M.] Univ Roma La Sapienza, Dipartimento Chim, Via Tizii 6, I-00185 Rome, Italy; [Besker, N.; Chillemi, G.] CINECA, SCAI SuperComp Applicat & Innovat Dept, Via Tizii 6, I-00185 Rome, Italy; [Desideri, A.] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Levine, A. J.] Inst Adv Study, Olden Lane, Princeton, NJ 08540 USA; [Levine, A. J.] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA; [Melino, G.] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Melino, G.] Univ Leicester, MRC, Toxicol Unit, Leicester, Leics, England	Sapienza University Rome; CINECA, Italy; University of Rome Tor Vergata; Institute for Advanced Study - USA; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University of Rome Tor Vergata; University of Leicester	Chillemi, G (corresponding author), CINECA, SCAI SuperComp Applicat & Innovat Dept, Via Tizii 6, I-00185 Rome, Italy.	giochillemi@gmail.com	D'Abramo, Marco/B-7035-2008; Chillemi, Giovanni/E-5201-2010; Chillemi, Giovanni/O-2825-2019; Deri, Desi/K-1086-2018	D'Abramo, Marco/0000-0001-6020-8581; Chillemi, Giovanni/0000-0003-3901-6926; Chillemi, Giovanni/0000-0003-3901-6926; desideri, alessandro/0000-0003-1541-4217; Besker, Neva/0000-0002-7024-7178	MIUR-FIRB grant [RBFR12BGHO]; 'Rita Levi Montalcini' research program; MRC [MC_U132670600] Funding Source: UKRI; Medical Research Council [MC_U132670600] Funding Source: researchfish	MIUR-FIRB grant(Ministry of Education, Universities and Research (MIUR)); 'Rita Levi Montalcini' research program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a MIUR-FIRB grant (no. RBFR12BGHO) and 'Rita Levi Montalcini' research program. We acknowledge the Cineca Supercomputing centre for computational resources.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amelio I, 2014, ONCOGENE, V33, P5039, DOI 10.1038/onc.2013.456; Antonov AV, 2014, ONCOGENE, V33, P1621, DOI 10.1038/onc.2013.119; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balatti V, 2015, P NATL ACAD SCI USA, V112, P2169, DOI 10.1073/pnas.1500010112; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Brune M, 2013, ONCOGENE, V32, P1460, DOI 10.1038/onc.2012.150; Buckley NE, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.31; Burns DM, 2011, NATURE, V473, P105, DOI 10.1038/nature09908; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Carr SM, 2012, ESSAYS BIOCHEM, V52, P79, DOI [10.1042/bse0520079, 10.1042/BSE0520079]; Chari NS, 2009, APOPTOSIS, V14, P336, DOI 10.1007/s10495-009-0327-9; Chen YH, 2010, STRUCTURE, V18, P246, DOI 10.1016/j.str.2009.11.011; Chillemi G, 2013, CELL CYCLE, V12, P3098, DOI 10.4161/cc.26162; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Ci Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.506; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dashzeveg N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.176; Demir O, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002238; Drosten M, 2014, P NATL ACAD SCI USA, V111, P15155, DOI 10.1073/pnas.1417549111; Dudgeon C, 2014, GENE DEV, V28, P2613, DOI 10.1101/gad.252148.114; Emamzadah S, 2014, J MOL BIOL, V426, P936, DOI 10.1016/j.jmb.2013.12.020; Emerling BM, 2013, CELL, V155, P844, DOI 10.1016/j.cell.2013.09.057; Evstafieva AG, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.469; Fan YH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.400; Fatt MP, 2014, CELL DEATH DIFFER, V21, P1546, DOI 10.1038/cdd.2014.61; Feng HQ, 2009, STRUCTURE, V17, P202, DOI 10.1016/j.str.2008.12.009; Fiori ME, 2014, CELL DEATH DIFFER, V21, P774, DOI 10.1038/cdd.2014.6; Foijer F, 2014, P NATL ACAD SCI USA, V111, P13427, DOI 10.1073/pnas.1400892111; Fortunato O, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.507; Garufi A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.217; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Gomes LR, 2015, ONCOGENE, V34, P5329, DOI 10.1038/onc.2014.461; Gorrini C, 2014, P NATL ACAD SCI USA, V111, P11576, DOI 10.1073/pnas.1405580111; Han F, 2015, ONCOGENE, V34, P4391, DOI 10.1038/onc.2014.370; He Z, 2013, CELL DEATH DIFFER, V20, P1415, DOI 10.1038/cdd.2013.104; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hoffman Y, 2014, CELL DEATH DIFFER, V21, P302, DOI 10.1038/cdd.2013.146; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kelly GL, 2014, GENE DEV, V28, P58, DOI 10.1101/gad.232009.113; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kim J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.87; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kuszewski J, 1999, J AM CHEM SOC, V121, P2337, DOI 10.1021/ja9843730; Lange OF, 2008, PROTEINS, V70, P1294, DOI 10.1002/prot.21618; Laptenko O, 2015, MOL CELL, V57, P1034, DOI 10.1016/j.molcel.2015.02.015; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Leroy B, 2013, NUCLEIC ACIDS RES, V41, pD962, DOI 10.1093/nar/gks1033; Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086; Lezina L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.483; Li D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.158; Li H, 2014, CELL DEATH DIFFER, V21, P1493, DOI 10.1038/cdd.2014.69; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Link N, 2013, GENE DEV, V27, P2433, DOI 10.1101/gad.225565.113; Lu Q, 2007, J PHYS CHEM B, V111, P11538, DOI 10.1021/jp0742261; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Lubin DJ, 2010, J MOL BIOL, V395, P705, DOI 10.1016/j.jmb.2009.11.013; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Malatesta M, 2013, ONCOGENE, V32, P4721, DOI 10.1038/onc.2012.463; Manzl C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.470; Marcel V, 2014, CELL DEATH DIFFER, V21, P1377, DOI 10.1038/cdd.2014.73; McCammon JA, 1988, DYNAMICS PROTEINS NU, P289; Melero R, 2011, P NATL ACAD SCI USA, V108, P557, DOI [10.1073/pnas.1015520107, 10.1073/pnas.101S520107]; Mello SS, 2013, CELL DEATH DIFFER, V20, P855, DOI 10.1038/cdd.2013.53; Meniel V, 2015, ONCOGENE, V34, P4118, DOI 10.1038/onc.2014.342; Merlo P, 2014, P NATL ACAD SCI USA, V111, P18055, DOI 10.1073/pnas.1419083111; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Nair BC, 2014, CELL DEATH DIFFER, V21, P1409, DOI 10.1038/cdd.2014.55; Okada N, 2014, GENE DEV, V28, P438, DOI 10.1101/gad.233585.113; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Pan YP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000878; Pant V, 2014, GENE DEV, V28, P1739, DOI 10.1101/gad.247452.114; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Petty TJ, 2011, EMBO J, V30, P2167, DOI 10.1038/emboj.2011.127; Peuget S, 2014, CELL DEATH DIFFER, V21, P1107, DOI 10.1038/cdd.2014.28; Phesse TJ, 2014, CELL DEATH DIFFER, V21, P956, DOI 10.1038/cdd.2014.15; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ren ZJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.327; Rossi M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.113; Rowell JP, 2012, STRUCTURE, V20, P2014, DOI 10.1016/j.str.2012.09.004; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Rufini A, 2012, GENE DEV, V26, P2009, DOI 10.1101/gad.197640.112; Saldana-Meyer R, 2014, GENE DEV, V28, P723, DOI 10.1101/gad.236869.113; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Senturk S, 2014, P NATL ACAD SCI USA, V111, pE3287, DOI 10.1073/pnas.1321640111; Shetzer Y, 2014, CELL DEATH DIFFER, V21, P1419, DOI 10.1038/cdd.2014.57; Shi Y, 2014, CELL DEATH DIFFER, V21, P612, DOI 10.1038/cdd.2013.186; Simon HU, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.308; Solomon H, 2014, CELL DEATH DIFFER, V21, P1347, DOI 10.1038/cdd.2014.99; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Tan EH, 2014, ONCOGENE, V33, P3325, DOI 10.1038/onc.2013.287; Tang ZY, 2013, CELL, V154, P297, DOI 10.1016/j.cell.2013.06.027; Terrinoni A, 2011, ONCOGENE, V30, P3096, DOI 10.1038/onc.2011.31; Tidow H, 2007, P NATL ACAD SCI USA, V104, P12324, DOI 10.1073/pnas.0705069104; Tomasini R, 2008, TRENDS CELL BIOL, V18, P244, DOI 10.1016/j.tcb.2008.03.003; Tschaharganeh DF, 2014, CELL, V158, P579, DOI 10.1016/j.cell.2014.05.051; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Van Nostrand JL, 2014, NATURE, V514, P228, DOI 10.1038/nature13585; VanAalten DMF, 1997, J COMPUT CHEM, V18, P169, DOI 10.1002/(SICI)1096-987X(19970130)18:2<169::AID-JCC3>3.0.CO;2-T; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Venkatanarayan A, 2015, NATURE, V517, P626, DOI 10.1038/nature13910; Wang GZ, 2015, P NATL ACAD SCI USA, V112, P2437, DOI 10.1073/pnas.1500243112; Wang GZ, 2015, P NATL ACAD SCI USA, V112, P2443, DOI 10.1073/pnas.1500262112; Wassman CD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2361; Weilbacher A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.284; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Xu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.75; Yang-Hartwich Y, 2015, ONCOGENE, V34, P3605, DOI 10.1038/onc.2014.296; Yoshida K, 2010, CANCER SCI, V101, P831, DOI 10.1111/j.1349-7006.2010.01488.x; Zaccara S, 2014, CELL DEATH DIFFER, V21, P1522, DOI 10.1038/cdd.2014.79; Zhang EB, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.201; Zhang HH, 2014, CELL DEATH DIFFER, V21, P1656, DOI 10.1038/cdd.2014.78; Zhu L, 2015, ONCOGENE, V34, P4547, DOI 10.1038/onc.2014.399	120	33	33	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 23	2016	35	25					3272	3281		10.1038/onc.2015.388	http://dx.doi.org/10.1038/onc.2015.388			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP2GN	26477317	Green Published, hybrid			2022-12-26	WOS:000378306400006
J	Mattheij, NJA; Braun, A; van Kruchten, R; Castoldi, E; Pircher, J; Baaten, CCFMJ; Wulling, M; Kuijpers, MJE; Kohler, R; Poole, AW; Schreiber, R; Vortkamp, A; Collins, PW; Nieswandt, B; Kunzelmann, K; Cosemans, JMEM; Heemskerk, JWM				Mattheij, Nadine J. A.; Braun, Attila; van Kruchten, Roger; Castoldi, Elisabetta; Pircher, Joachim; Baaten, Constance C. F. M. J.; Wuelling, Manuela; Kuijpers, Marijke J. E.; Koehler, Ralf; Poole, Alastair W.; Schreiber, Rainer; Vortkamp, Andrea; Collins, Peter W.; Nieswandt, Bernhard; Kunzelmann, Karl; Cosemans, Judith M. E. M.; Heemskerk, Johan W. M.			Survival protein anoctamin-6 controls multiple platelet responses including phospholipid scrambling, swelling, and protein cleavage	FASEB JOURNAL			English	Article						bleeding; embryonic lethality; phosphatidylserine; Scott syndrome; TMEM16F	THROMBUS FORMATION; SCOTT SYNDROME; PHOSPHATIDYLSERINE EXPOSURE; PROCOAGULANT RESPONSE; CHLORIDE CHANNEL; LIPID SCRAMBLASE; GLYCOPROTEIN-VI; BLOOD-CELLS; TMEM16F; COAGULATION	Scott syndrome is a rare bleeding disorder, characterized by altered Ca2+-dependent platelet signaling with defective phosphatidylserine (PS) exposure and microparticle formation, and is linked to mutations in the ANO6 gene, encoding anoctamin (Ano) 6. We investigated how the complex platelet phenotype of this syndrome is linked to defective expression of Anos or other ion channels. Mice were generated with heterozygous of homozygous deficiency in Ano6, Ano1, or Ca2+-dependent K(Ca)3.1Gardos channel. Platelets from these mice were extensively analyzed on molecular functions and compared with platelets from a patient with Scott syndrome. Deficiency in Ano1 or Gardos channel did not reduce platelet responses compared with control mice (P > 0.1). In 2 mouse strains, deficiency in Ano6 resulted in reduced viability with increased bleeding time to 28.6min (control 6.4min, P< 0.05). Platelets from the surviving Ano6-deficient mice resembled platelets from patients with Scott syndrome in: 1) normal collagen-induced aggregate formation (P > 0.05) with reduced PS exposure (265 to 90%); 2) lowered Ca2+-dependent swelling (280%) and membrane blebbing (-90%); 3) reduced calpain-dependent protein cleavage (-60%); and 4) moderately affected apoptosis-dependent PS exposure. In conclusion, mouse deficiency of Ano6 but not of other channels affects viability and phenocopies the complex changes in platelets from hemostatically impaired patients with Scott syndrome.	[Mattheij, Nadine J. A.; van Kruchten, Roger; Castoldi, Elisabetta; Baaten, Constance C. F. M. J.; Kuijpers, Marijke J. E.; Cosemans, Judith M. E. M.; Heemskerk, Johan W. M.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Dept Cell Biochem Thrombosis & Haemostasis Bioche, NL-6200 MD Maastricht, Netherlands; [Braun, Attila; Nieswandt, Bernhard] Univ Wurzburg, Univ Hosp, Dept Expt Biomed, D-97070 Wurzburg, Germany; [Braun, Attila; Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany; [Pircher, Joachim] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Pircher, Joachim] Univ Munich, German Ctr Cardiovasc Res, Munich Heart Alliance, Munich, Germany; [Koehler, Ralf] Univ Duisburg Essen, Ctr Med Biotechnol, Dept Dev Biol, Duisburg, Germany; [Wuelling, Manuela; Vortkamp, Andrea] Aragon Inst Hlth Sci I CS IIS & ARAID, Zaragoza, Spain; [Poole, Alastair W.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Collins, Peter W.] Cardiff Univ, Sch Med, Arthur Bloom Haemophilia Ctr, Cardiff CF10 3AX, S Glam, Wales	Maastricht University; University of Wurzburg; University of Wurzburg; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Munich; University of Duisburg Essen; University of Bristol; University of Regensburg; Cardiff University	Heemskerk, JWM (corresponding author), Maastricht Univ, CARIM, Chair Cell Biochem Thrombosis & Haemostasis Bioch, POB 616, NL-6200 MD Maastricht, Netherlands.	jwm.heemskerk@maastrichtuniversity.nl	Cosemans, Judith MEM/C-8161-2016; Kuijpers, Marijke/AAN-9876-2021; Heemskerk, Johan/AAM-8323-2021	Cosemans, Judith MEM/0000-0001-7429-0109; Heemskerk, Johan/0000-0002-2848-5121; Wuelling, Manuela/0000-0003-4534-3528; Poole, Alastair/0000-0002-0868-297X; Kohler, Ralf/0000-0001-9563-2913	Cardiovascular Center Maastricht; Dutch Heart Foundation [2011T6]; Deutsche Forschungsgemeinschaft DFG [SFB699]	Cardiovascular Center Maastricht; Dutch Heart Foundation(Netherlands Heart Foundation); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by grants from the Cardiovascular Center Maastricht, and the Dutch Heart Foundation 2011T6 (to N.J.A.M., J.M.E.M.C., and J.W.M.H.), and Deutsche Forschungsgemeinschaft DFG SFB699, project A7&A12 (to R.S. and K.K.). The authors declare no conflicts of interest.	BEVERS EM, 1983, BIOCHIM BIOPHYS ACTA, V736, P57, DOI 10.1016/0005-2736(83)90169-4; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Clark SR, 2013, P NATL ACAD SCI USA, V110, P5875, DOI 10.1073/pnas.1222419110; De Witt S., 2014, NAT PROTOCOL EXCHANG, V2014, P3309; de Witt SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5257; Deppermann C, 2013, J CLIN INVEST, V123, P3331, DOI 10.1172/JCI69210; Ehlen HWA, 2013, J BONE MINER RES, V28, P246, DOI 10.1002/jbmr.1751; Gilio K, 2009, J BIOL CHEM, V284, P33750, DOI 10.1074/jbc.M109.048439; Grgic I, 2009, PFLUG ARCH EUR J PHY, V458, P291, DOI 10.1007/s00424-008-0619-x; Harper MT, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003701; Heemskerk JWM, 2013, J THROMB HAEMOST, V11, P2, DOI 10.1111/jth.12045; Holme S, 1998, TRANSFUSION, V38, P31, DOI 10.1046/j.1537-2995.1998.38198141495.x; Kmit A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.135; Kuijpers MJE, 2014, ARTERIOSCL THROM VAS, V34, P1674, DOI 10.1161/ATVBAHA.114.303315; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; Kunzelmann K, 2014, PFLUG ARCH EUR J PHY, V466, P407, DOI 10.1007/s00424-013-1305-1; Lang PA, 2003, AM J PHYSIOL-CELL PH, V285, pC1553, DOI 10.1152/ajpcell.00186.2003; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Mattheij NJA, 2013, J BIOL CHEM, V288, P13325, DOI 10.1074/jbc.M112.428359; Munnix ICA, 2003, THROMB HAEMOSTASIS, V89, P687, DOI 10.1055/s-0037-1613576; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Satta N, 1997, PLATELETS, V8, P117, DOI 10.1080/09537109709169326; Schoenwaelder SM, 2009, BLOOD, V114, P663, DOI 10.1182/blood-2009-01-200345; Scudieri P, 2015, J PHYSIOL-LONDON, V593, P3829, DOI 10.1113/JP270691; Shimizu T, 2013, AM J PHYSIOL-CELL PH, V304, pC748, DOI 10.1152/ajpcell.00228.2012; Si H, 2006, CIRC RES, V99, P537, DOI 10.1161/01.RES.0000238377.08219.0c; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; Skals M, 2010, J BIOL CHEM, V285, P15557, DOI 10.1074/jbc.M109.082578; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Toti F, 1996, BLOOD, V87, P1409, DOI 10.1182/blood.V87.4.1409.bloodjournal8741409; van der Meijden PEJ, 2012, CELL MOL LIFE SCI, V69, P3481, DOI 10.1007/s00018-012-1033-2; van Kruchten R, 2013, BLOOD, V121, P1850, DOI 10.1182/blood-2012-09-454314; van Kruchten R, 2012, ARTERIOSCL THROM VAS, V32, P1717, DOI 10.1161/ATVBAHA.111.243907; Van Kruchten R, 2012, PLATELETS, V23, P229, DOI 10.3109/09537104.2011.630848; Wang M, 2012, CIRCULATION, V125, P697, DOI 10.1161/CIRCULATIONAHA.111.041806; Williamson P, 2001, BIOCHEMISTRY-US, V40, P8065, DOI 10.1021/bi001929z; Wolfs JL, 2006, BLOOD, V108, P2223, DOI 10.1182/blood-2006-01-009613; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	45	40	40	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					727	737		10.1096/fj.15-280446	http://dx.doi.org/10.1096/fj.15-280446			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26481309	Green Submitted			2022-12-26	WOS:000369391900023
J	Gizzi, AMC; Prucca, CG; Gaveglio, VL; Renner, ML; Pasquare, SJ; Caputto, BL				Cardozo Gizzi, Andres M.; Prucca, Cesar G.; Gaveglio, Virginia L.; Renner, Marianne L.; Pasquare, Susana J.; Caputto, Beatriz L.			The Catalytic Efficiency of Lipin 1 beta Increases by Physically Interacting with the Proto-oncoprotein c-Fos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID PHOSPHATASE; SUBCELLULAR-LOCALIZATION; PHOSPHOLIPID-METABOLISM; LYSOPHOSPHATIDIC ACID; ENDOPLASMIC-RETICULUM; SYNTHESIS ACTIVATION; PC12 CELLS; PROTEINS; PHOSPHORYLATION; ENZYMES	Phosphatidic acid (PA) is a central precursor for membrane phospholipid biosynthesis. The lipin family is a magnesium-dependent type I PA phosphatase involved in de novo synthesis of neutral lipids and phospholipids. The regulation of lipin activity may govern the pathways by which these lipids are synthesized and control the cellular levels of important signaling lipids. Moreover, the proto-oncoprotein c-Fos has an emerging role in glycerolipid synthesis regulation; by interacting with key synthesizing enzymes it is able to increase overall phospho-and glycolipid synthesis. We studied the lipin 1 beta enzyme activity in a cell-free system using PA/Triton X-100 mixed micelles as substrate, analyzing it in the presence/absence of c-Fos. We found that lipin 1 beta k(cat) value increases around 40% in the presence of c-Fos, with no change in the lipin 1 beta affinity for the PA/Triton X-100 mixed micelles. We also probed a physical interaction between both proteins. Although the c-Fos domain involved in lipin activation is its basic domain, the interaction domain is mapped to the N-terminal c-Fos. In conclusion, we provide evidence for a novel positive regulator of lipin 1 beta PA phosphatase activity that is not achieved via altering its subcellular localization or affinity for membranes but rather through directly increasing its catalytic efficiency.	[Cardozo Gizzi, Andres M.; Prucca, Cesar G.; Renner, Marianne L.; Caputto, Beatriz L.] Univ Nacl Cordoba, Fac Ciencias Quim, Consejo Nacl Invest Cient & Tecn, Ctr Invest Quim Biol Cordoba,Dept Quim Biol, RA-5000 Cordoba, Argentina; [Gaveglio, Virginia L.; Pasquare, Susana J.] Univ Nacl Sur, Inst Invest Bioquim Bahia Blanca, Consejo Nacl Invest Cient & Tecn CONICET, RA-8000 Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South	Caputto, BL (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Consejo Nacl Invest Cient & Tecn, Ctr Invest Quim Biol Cordoba,Dept Quim Biol, Ciudad Univ,X5000HUA, RA-5000 Cordoba, Argentina.	bcaputto@fcq.unc.edu.ar	Prucca, César Germán/AAC-4630-2021; Renner, Marianne/H-5315-2011; Prucca, César/AAQ-4401-2020	Prucca, César Germán/0000-0003-4165-4660; Cardozo Gizzi, Andres Mauricio/0000-0003-3894-1845	Instituto Nacional de Cancer; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (SeCyT); Agencia Nacional de Promocion Cientifica y Tecnologica, Secretaria de Ciencia, Tecnologia e Innovacion Productiva de Argentina	Instituto Nacional de Cancer; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (SeCyT)(Secretaria de Ciencia y Tecnologia (SECYT)); Agencia Nacional de Promocion Cientifica y Tecnologica, Secretaria de Ciencia, Tecnologia e Innovacion Productiva de Argentina	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica, Secretaria de Ciencia, Tecnologia e Innovacion Productiva de Argentina, Instituto Nacional de Cancer, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (SeCyT). The authors declare that they have no conflicts of interest with the contents of this article.	Pecchio ARA, 2011, MOL BIOL CELL, V22, P4716, DOI 10.1091/mbc.E11-03-0259; ARVIDSON GA, 1968, EUR J BIOCHEM, V4, P478, DOI 10.1111/j.1432-1033.1968.tb00237.x; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Bonifacino J. S., 2001, CURR PROTOC PROTEIN; Borioli GA, 2001, BIOCHEM BIOPH RES CO, V280, P9, DOI 10.1006/bbrc.2000.4081; Brose N, 2004, CURR OPIN NEUROBIOL, V14, P328, DOI 10.1016/j.conb.2004.05.006; Bussolino DF, 2001, FASEB J, V15, P556; Caputto BL, 2014, BBA-MOL CELL BIOL L, V1841, P1241, DOI 10.1016/j.bbalip.2014.05.007; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Crespo PM, 2008, J BIOL CHEM, V283, P31163, DOI 10.1074/jbc.M709257200; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; DEGARCIA SJP, 1986, BIOCHIM BIOPHYS ACTA, V875, P195, DOI 10.1016/0005-2760(86)90168-2; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Ferrero GO, 2012, ONCOGENE, V31, P3381, DOI 10.1038/onc.2011.510; Ferrero GO, 2014, BIOCHEM J, V461, P521, DOI 10.1042/BJ20131376; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; KOVARY K, 1992, MOL CELL BIOL, V12, P5015, DOI 10.1128/MCB.12.11.5015; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; Liu ZR, 2014, PROTEIN SCI, V23, P539, DOI 10.1002/pro.2443; Mahuren JD, 2001, ANAL BIOCHEM, V298, P241, DOI 10.1006/abio.2001.5402; Malnou CE, 2007, J BIOL CHEM, V282, P31046, DOI 10.1074/jbc.M702833200; Motrich RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053211; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Pasquare SJ, 2004, LIPIDS, V39, P553, DOI 10.1007/s11745-004-1262-y; Pasquare SJ, 2001, EXP GERONTOL, V36, P1387, DOI 10.1016/S0531-5565(01)00106-1; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Portal MM, 2007, ONCOGENE, V26, P3551, DOI 10.1038/sj.onc.1210137; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; SASTRY PS, 1966, CAN J BIOCHEM CELL B, V44, P459, DOI 10.1139/o66-056; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zerpa GAD, 1999, J NEUROCHEM, V73, P1228, DOI 10.1046/j.1471-4159.1999.0731228.x	55	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29578	29592		10.1074/jbc.M115.678821	http://dx.doi.org/10.1074/jbc.M115.678821			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26475860	Green Published, hybrid			2022-12-26	WOS:000366613400039
J	Rajasekhar, P; Poole, DP; Liedtke, W; Bunnett, NW; Veldhuis, NA				Rajasekhar, Pradeep; Poole, Daniel P.; Liedtke, Wolfgang; Bunnett, Nigel W.; Veldhuis, Nicholas A.			P2Y(1) Receptor Activation of the TRPV4 Ion Channel Enhances Purinergic Signaling in Satellite Glial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; G protein-coupled receptor (GPCR); inflammation; purinergic receptor; transient receptor potential channels (TRP channels); Satellite glial cells; nociception	PROTEIN-KINASE-C; MOUSE TRIGEMINAL GANGLIA; CAPSAICIN RECEPTOR; NEUROPATHIC PAIN; PROTEASE-ACTIVATED-RECEPTOR-2 SENSITIZES; MECHANICAL HYPERALGESIA; POTENTIAL VANILLOID-4; DEPENDENT MECHANISMS; INFLAMMATORY PAIN; SENSORY GANGLIA	Transient receptor potential (TRP) ion channels of peripheral sensory pathways are important mediators of pain, itch, and neurogenic inflammation. They are expressed by primary sensory neurons and by glial cells in the central nervous system, but their expression and function in satellite glial cells (SGCs) of sensory ganglia have not been explored. SGCs tightly ensheath neurons of sensory ganglia and can regulate neuronal excitability in pain and inflammatory states. Using a modified dissociation protocol, we isolated neurons with attached SGCs from dorsal root ganglia of mice. SGCs, which were identified by expression of immunoreactive Kir4.1 and glutamine synthetase, were closely associated with neurons, identified using the pan-neuronal marker NeuN. A subpopulation of SGCs expressed immunoreactive TRP vanilloid 4 (TRPV4) and responded to the TRPV4-selective agonist GSK1016790A by an influx of Ca2+ ions. SGCs did not express functional TRPV1, TRPV3, or TRP ankyrin 1 channels. Responses to GSK1016790A were abolished by the TRPV4 antagonist HC067047 and were absent in SGCs from Trpv4(-/-) mice. The P2Y(1)-selective agonist 2-methylthio-ADP increased [Ca2+](i) in SGCs, and responses were prevented by the P2Y1-selective antagonist MRS2500. P2Y(1) receptor-mediated responses were enhanced in TRPV4-expressing SGCs and HEK293 cells, suggesting that P2Y(1) couples to and activates TRPV4. PKC inhibitors prevented P2Y(1) receptor activation of TRPV4. Our results provide the first evidence for expression of TRPV4 in SGCs and demonstrate that TRPV4 is a purinergic receptor-operated channel in SGCs of sensory ganglia.	[Rajasekhar, Pradeep; Poole, Daniel P.; Bunnett, Nigel W.; Veldhuis, Nicholas A.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Rajasekhar, Pradeep; Poole, Daniel P.; Bunnett, Nigel W.; Veldhuis, Nicholas A.] Monash Univ, Australian Res Council Ctr Excellence Convergent, Parkville, Vic 3052, Australia; [Bunnett, Nigel W.] Monash Univ, Dept Anaesthesia & Peri Operat Med, Parkville, Vic 3052, Australia; [Poole, Daniel P.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia; [Veldhuis, Nicholas A.] Univ Melbourne, Dept Genet, Parkville, Vic 3010, Australia; [Bunnett, Nigel W.] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3010, Australia; [Liedtke, Wolfgang] Duke Univ, Sch Med, Dept Neurol, Durham, NC 27710 USA	Monash University; Monash University; Monash University; University of Melbourne; University of Melbourne; University of Melbourne; Duke University	Bunnett, NW (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	nigel.bunnett@monash.edu; nicholas.veldhuis@monash.edu	Liedtke, Wolfgang/GNH-1878-2022; Poole, Daniel/AET-6645-2022	Poole, Daniel/0000-0002-6168-8422; Veldhuis, Nicholas/0000-0002-8902-9365; Bunnett, Nigel W./0000-0003-3367-0644; Rajasekhar, Pradeep/0000-0002-1983-7244	National Health and Medical Research Council [63303, 1049682, 1031886]; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology; Monash University; Takeda Pharmaceuticals Inc.	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology(Australian Research Council); Monash University(Monash University); Takeda Pharmaceuticals Inc.(Takeda Pharmaceutical Company Ltd)	This work was supported by National Health and Medical Research Council Grants 63303, 1049682, and 1031886; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology; and Monash University (to N. W. B.). Research in the authors' laboratory was funded in part by Takeda Pharmaceuticals Inc.	Adapala RK, 2011, AM J PHYSIOL-HEART C, V301, pH757, DOI 10.1152/ajpheart.00142.2011; Alessandri-Haber N, 2004, J NEUROSCI, V24, P4444, DOI 10.1523/JNEUROSCI.0242-04.2004; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Alessandri-Haber N, 2008, J NEUROSCI, V28, P1046, DOI 10.1523/JNEUROSCI.4497-07.2008; Aley KO, 2000, J NEUROSCI, V20, P4680, DOI 10.1523/JNEUROSCI.20-12-04680.2000; Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Belzer V, 2010, NEURON GLIA BIOL, V6, P237, DOI 10.1017/S1740925X1100007X; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Blum E, 2014, NEUROSCIENCE, V274, P209, DOI 10.1016/j.neuroscience.2014.05.029; Brierley SM, 2008, GASTROENTEROLOGY, V134, P2059, DOI 10.1053/j.gastro.2008.01.074; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Cao DS, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-5; Cenac N, 2015, GASTROENTEROLOGY, V149, P433, DOI 10.1053/j.gastro.2015.04.011; Cenac N, 2010, GUT, V59, P481, DOI 10.1136/gut.2009.192567; Ceruti S, 2008, CELL CALCIUM, V43, P576, DOI 10.1016/j.ceca.2007.10.003; Ceruti S, 2011, J NEUROSCI, V31, P3638, DOI 10.1523/JNEUROSCI.6440-10.2011; Chen Y, 2008, P NATL ACAD SCI USA, V105, P16773, DOI 10.1073/pnas.0801793105; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; De Simone R, 2010, J NEUROCHEM, V115, P450, DOI 10.1111/j.1471-4159.2010.06937.x; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; Dublin P, 2007, BRAIN BEHAV IMMUN, V21, P592, DOI 10.1016/j.bbi.2006.11.011; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Ferrari LF, 2015, J NEUROSCI, V35, P6107, DOI 10.1523/JNEUROSCI.5085-14.2015; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Filosa JA, 2013, J CARDIOVASC PHARM, V61, P113, DOI 10.1097/FJC.0b013e318279ba42; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Guler AD, 2002, J NEUROSCI, V22, P6408; Hamanaka K, 2010, AM J PHYSIOL-LUNG C, V299, pL353, DOI 10.1152/ajplung.00315.2009; Haraguchi K, 2012, J NEUROSCI, V32, P3931, DOI 10.1523/JNEUROSCI.4703-11.2012; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Hechler B, 2006, J PHARMACOL EXP THER, V316, P556, DOI 10.1124/jpet.105.094037; Huang TJ, 2002, DIABETOLOGIA, V45, P560, DOI 10.1007/s00125-002-0785-x; Jarvis MF, 2010, TRENDS NEUROSCI, V33, P48, DOI 10.1016/j.tins.2009.10.003; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Katagiri A, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-23; Konno M, 2012, GLIA, V60, P761, DOI 10.1002/glia.22306; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Magni G, 2015, GLIA, V63, P1256, DOI 10.1002/glia.22819; Magni G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/495789; Mamenko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022824; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mercado J, 2014, J GEN PHYSIOL, V143, P559, DOI 10.1085/jgp.201311050; Mundell SJ, 2006, MOL PHARMACOL, V70, P1132, DOI 10.1124/mol.106.023549; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Ohara PT, 2009, NEUROSCIENTIST, V15, P450, DOI 10.1177/1073858409336094; Ohsawa K, 2007, GLIA, V55, P604, DOI 10.1002/glia.20489; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Poole DP, 2013, J BIOL CHEM, V288, P5790, DOI 10.1074/jbc.M112.438184; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; Shibasaki K, 2014, J BIOL CHEM, V289, P14470, DOI 10.1074/jbc.M114.557132; Shinozaki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04329; Sokabe T, 2010, J BIOL CHEM, V285, P18749, DOI 10.1074/jbc.M110.103606; Sonkusare SK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005052; Souza GR, 2013, P NATL ACAD SCI USA, V110, P11193, DOI 10.1073/pnas.1307445110; Suadicani SO, 2010, NEURON GLIA BIOL, V6, P43, DOI 10.1017/S1740925X09990408; Suzuki M, 2003, NEUROSCI LETT, V353, P189, DOI 10.1016/j.neulet.2003.09.041; Takeda M, 2011, PAIN, V152, P2147, DOI 10.1016/j.pain.2011.05.023; Tang X, 2010, NEUROSCIENCE, V166, P397, DOI 10.1016/j.neuroscience.2010.01.005; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; Veldhuis NA, 2015, PHARMACOL REV, V67, P36, DOI 10.1124/pr.114.009555; Veldhuis NA, 2012, J BIOL CHEM, V287, P21765, DOI 10.1074/jbc.M112.342022; Verkhratsky A, 2014, REV PHYSIOL BIOCH P, V166, P1, DOI 10.1007/112_2013_15; Vit JP, 2008, J NEUROSCI, V28, P4161, DOI 10.1523/JNEUROSCI.5053-07.2008; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wagner L, 2014, NEUROSCI LETT, V578, P143, DOI 10.1016/j.neulet.2014.06.047; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Weick M, 2003, NEUROSCIENCE, V120, P969, DOI 10.1016/S0306-4522(03)00388-9; Zeng Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119912; Zhang HJ, 2009, GLIA, V57, P1588, DOI 10.1002/glia.20872; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	80	33	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29051	29062		10.1074/jbc.M115.689729	http://dx.doi.org/10.1074/jbc.M115.689729			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26475857	Green Published, hybrid			2022-12-26	WOS:000365762300043
J	Galvan, DL; O'Neil, RT; Foster, AE; Huye, L; Bear, A; Rooney, CM; Wilson, MH				Galvan, Daniel L.; O'Neil, Richard T.; Foster, Aaron E.; Huye, Leslie; Bear, Adham; Rooney, Cliona M.; Wilson, Matthew H.			Anti-Tumor Effects after Adoptive Transfer of IL-12 Transposon-Modified Murine Splenocytes in the OT-I-Melanoma Mouse Model	PLOS ONE			English	Article							CHIMERIC ANTIGEN RECEPTORS; CELL-TRANSFER THERAPY; HUMAN T-LYMPHOCYTES; GENE-THERAPY; CANCER-IMMUNOTHERAPY; METASTATIC MELANOMA; SLEEPING-BEAUTY; PHASE-I; INTERLEUKIN-12; TUMORS	Adoptive transfer of gene modified T cells provides possible immunotherapy for patients with cancers refractory to other treatments. We have previously used the non-viral piggyBac transposon system to gene modify human T cells for potential immunotherapy. However, these previous studies utilized adoptive transfer of modified human T cells to target cancer xenografts in highly immunodeficient (NOD-SCID) mice that do not recapitulate an intact immune system. Currently, only viral vectors have shown efficacy in permanently gene-modifying mouse T cells for immunotherapy applications. Therefore, we sought to determine if piggyBac could effectively gene modify mouse T cells to target cancer cells in a mouse cancer model. We first demonstrated that we could gene modify cells to express murine interleukin-12 (p35/p40 mIL-12), a transgene with proven efficacy in melanoma immunotherapy. The OT-I melanoma mouse model provides a well-established T cell mediated immune response to ovalbumin (OVA) positive B16 melanoma cells. B16/OVA melanoma cells were implanted in wild type C57Bl6 mice. Mouse splenocytes were isolated from C57Bl6 OT-I mice and were gene modified using piggyBac to express luciferase. Adoptive transfer of luciferase-modified OT-I splenocytes demonstrated homing to B16/OVA melanoma tumors in vivo. We next gene-modified OT-I cells to express mIL-12. Adoptive transfer of mIL-12-modified mouse OT-I splenocytes delayed B16/OVA melanoma tumor growth in vivo compared to control OT-I splenocytes and improved mouse survival. Our results demonstrate that the piggyBac transposon system can be used to gene modify splenocytes and mouse T cells for evaluating adoptive immunotherapy strategies in immunocompetent mouse tumor models that may more directly mimic immunotherapy applications in humans.	[Galvan, Daniel L.; Foster, Aaron E.; Huye, Leslie; Bear, Adham; Rooney, Cliona M.; Wilson, Matthew H.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Huye, Leslie; Rooney, Cliona M.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Wilson, Matthew H.] Tennessee Valley Hlth Care, Dept Vet Affairs, Nashville, TN USA; [O'Neil, Richard T.; Wilson, Matthew H.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Wilson, MH (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	matthew.wilson@vanderbilt.edu	Galvan, Daniel L./L-2768-2019; Wilson, Matthew H/K-3193-2013; Rooney, Cliona/ABD-5475-2021	Galvan, Daniel L./0000-0001-7541-6252; ONeil, Richard/0000-0002-9734-2343	NIH [DK093660]; Vanderbilt University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007569, R01DK093660] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant DK093660 to MHW and institutional funds from Vanderbilt University.	Atkins MB, 1997, CLIN CANCER RES, V3, P409; Basile LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030434; Chinnasamy D, 2012, CLIN CANCER RES, V18, P1672, DOI 10.1158/1078-0432.CCR-11-3050; Daud AI, 2008, J CLIN ONCOL, V26, P5896, DOI 10.1200/JCO.2007.15.6794; Doherty JE, 2012, HUM GENE THER, V23, P311, DOI 10.1089/hum.2011.138; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2003, NAT REV CANCER, V3, P666, DOI 10.1038/nrc1167; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; GATELY MK, 1993, CANCER INVEST, V11, P500, DOI 10.3109/07357909309018881; Goffinet C, 2006, FASEB J, V20, P500, DOI 10.1096/fj.05-4651fje; Gollob J A, 2001, Cancer Chemother Biol Response Modif, V19, P353; Gough M, 2005, J IMMUNOL, V174, P5766, DOI 10.4049/jimmunol.174.9.5766; Hackett PB, 2013, TRANSL RES, V161, P265, DOI 10.1016/j.trsl.2012.12.005; Hackett PB, 2010, MOL THER, V18, P674, DOI 10.1038/mt.2010.2; Hudecek M, 2015, CANCER IMMUNOL RES, V3, P125, DOI 10.1158/2326-6066.CIR-14-0127; Izsvak Z, 2010, BIOESSAYS, V32, P756, DOI 10.1002/bies.201000027; Jensen MC, 2015, CURR OPIN IMMUNOL, V33, P9, DOI 10.1016/j.coi.2015.01.002; Kahlig KM, 2010, P NATL ACAD SCI USA, V107, P1343, DOI 10.1073/pnas.0910383107; Kang WK, 2001, HUM GENE THER, V12, P671, DOI 10.1089/104303401300057388; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kerkar SP, 2010, CANCER RES, V70, P6725, DOI 10.1158/0008-5472.CAN-10-0735; Leonard JP, 1997, BLOOD, V90, P2541; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Lucas ML, 2002, MOL THER, V5, P668, DOI 10.1006/mthe.2002.0601; Manuri PVR, 2010, HUM GENE THER, V21, P427, DOI 10.1089/hum.2009.114; MEHROTRA PT, 1993, J IMMUNOL, V151, P2444; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Nakazawa Y, 2013, J IMMUNOTHER, V36, P3, DOI 10.1097/CJI.0b013e3182791234; Nakazawa Y, 2011, MOL THER, V19, P2133, DOI 10.1038/mt.2011.131; Nakazawa Y, 2009, J IMMUNOTHER, V32, P826, DOI 10.1097/CJI.0b013e3181ad762b; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Singh H, 2014, IMMUNOL REV, V257, P181, DOI 10.1111/imr.12137; Song XT, 2011, MOL THER, V19, P211, DOI 10.1038/mt.2010.223; Stromnes IM, 2014, IMMUNOL REV, V257, P145, DOI 10.1111/imr.12141; Teicher B A, 1998, Radiat Oncol Investig, V6, P71, DOI 10.1002/(SICI)1520-6823(1998)6:2<71::AID-ROI2>3.3.CO;2-#; VandenDriessche T, 2009, BLOOD, V114, P1461, DOI 10.1182/blood-2009-04-210427; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zhang L, 2011, MOL THER, V19, P751, DOI 10.1038/mt.2010.313; ZITVOGEL L, 1995, J IMMUNOL, V155, P1393	43	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140744	10.1371/journal.pone.0140744	http://dx.doi.org/10.1371/journal.pone.0140744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473608	gold, Green Published, Green Submitted			2022-12-26	WOS:000363185500096
J	Ding, CZ; Shi, SN; Chen, JJ; Wei, W; Tan, ZJ				Ding, Chizhu; Shi, Shuning; Chen, Jianjun; Wei, Wei; Tan, Zuojun			Analysis of Light Transport Features in Stone Fruits Using Monte Carlo Simulation	PLOS ONE			English	Article							OPTICAL-PROPERTIES; NIR SPECTROSCOPY; TURBID MEDIA; TISSUE; REFLECTANCE; QUANTIFICATION; PENETRATION; PROPAGATION; SCATTERING; QUALITY	The propagation of light in stone fruit tissue was modeled using the Monte Carlo (MC) method. Peaches were used as the representative model of stone fruits. The effects of the fruit core and the skin on light transport features in the peaches were assessed. It is suggested that the skin, flesh and core should be separately considered with different parameters to accurately simulate light propagation in intact stone fruit. The detection efficiency was evaluated by the percentage of effective photons and the detection sensitivity of the flesh tissue. The fruit skin decreases the detection efficiency, especially in the region close to the incident point. The choices of the source-detector distance, detection angle and source intensity were discussed. Accurate MC simulations may result in better insight into light propagation in stone fruit and aid in achieving the optimal fruit quality inspection without extensive experimental measurements.	[Ding, Chizhu; Shi, Shuning; Chen, Jianjun; Wei, Wei; Tan, Zuojun] Huazhong Agr Univ, Coll Sci, Wuhan, Hubei, Peoples R China; [Ding, Chizhu; Chen, Jianjun; Wei, Wei; Tan, Zuojun] Huazhong Agr Univ, Inst Appl Phys, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Tan, ZJ (corresponding author), Huazhong Agr Univ, Coll Sci, Wuhan, Hubei, Peoples R China.	tanzuojun@163.com	Tan, Zuojun/HDM-8746-2022		Fundamental Research Funds for the Central Universities [2662015BQ046]; Hubei Provincial Natural Science Foundation of China [2015CFB479]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Fundamental Research Funds for the Central Universities (No. 2662015BQ046) and Hubei Provincial Natural Science Foundation of China (No. 2015CFB479).	Baranyai L, 2009, COMPUT ELECTRON AGR, V69, P33, DOI 10.1016/j.compag.2009.06.011; BIRTH GS, 1978, J FOOD SCI, V43, P916, DOI 10.1111/j.1365-2621.1978.tb02455.x; Cubeddu R, 2001, APPL OPTICS, V40, P538, DOI 10.1364/AO.40.000538; Fraser DG, 2003, POSTHARVEST BIOL TEC, V27, P185, DOI 10.1016/S0925-5214(02)00058-3; Fraser DG, 2001, POSTHARVEST BIOL TEC, V22, P191, DOI 10.1016/S0925-5214(01)00103-X; Guo X, 2008, OPT COMMUN, V281, P380, DOI 10.1016/j.optcom.2007.09.043; Henyey LG, 1941, ASTROPHYS J, V93, P70, DOI 10.1086/144246; Kienle A, 1996, APPL OPTICS, V35, P2304, DOI 10.1364/AO.35.002304; McGlone V. A., 1997, Journal of Near Infrared Spectroscopy, V5, P83; Nicolai BM, 2007, POSTHARVEST BIOL TEC, V46, P99, DOI 10.1016/j.postharvbio.2007.06.024; Oey ML, 2007, POSTHARVEST BIOL TEC, V44, P240, DOI 10.1016/j.postharvbio.2006.12.015; Okada E, 1997, APPL OPTICS, V36, P21, DOI 10.1364/AO.36.000021; Palmer GM, 2006, APPL OPTICS, V45, P1062, DOI 10.1364/AO.45.001062; Prahl S., 2011, EVERYTHING I THINK Y; PRAHL SA, 1993, APPL OPTICS, V32, P559, DOI 10.1364/AO.32.000559; Qin JW, 2008, POSTHARVEST BIOL TEC, V49, P355, DOI 10.1016/j.postharvbio.2008.03.010; Qin JW, 2009, COMPUT ELECTRON AGR, V68, P44, DOI 10.1016/j.compag.2009.04.002; Rowe PI, 2014, POSTHARVEST BIOL TEC, V94, P89, DOI 10.1016/j.postharvbio.2014.03.007; Scot V, 2007, NUCL INSTRUM METH B, V263, P204, DOI 10.1016/j.nimb.2007.04.205; Simpson CR, 1998, PHYS MED BIOL, V43, P2465, DOI 10.1088/0031-9155/43/9/003; Tsai CL, 2001, APPL OPTICS, V40, P5770, DOI 10.1364/AO.40.005770; Wang L., 1992, MONTE CARLO MODELING; Wang LH, 1997, COMPUT METH PROG BIO, V54, P141, DOI 10.1016/S0169-2607(97)00021-7; Wang LHV, 1999, APPL OPTICS, V38, P4951, DOI 10.1364/AO.38.004951; WILSON BC, 1990, IEEE J QUANTUM ELECT, V26, P2186, DOI 10.1109/3.64355; Zolek NS, 2006, COMPUT METH PROG BIO, V84, P50, DOI 10.1016/j.cmpb.2006.07.007	26	6	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140582	10.1371/journal.pone.0140582	http://dx.doi.org/10.1371/journal.pone.0140582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469695	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600080
J	Hao, J; Rodriguez-Monguio, R; Seoane-Vazquez, E				Hao, Jing; Rodriguez-Monguio, Rosa; Seoane-Vazquez, Enrique			Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals	PLOS ONE			English	Article							FLUTICASONE; ASTHMA; US; THERAPY; SYSTEM; IMPACT; HIV	Introduction Fixed-dose combinations (FDC) contain two or more active ingredients. The effective patent and exclusivity life of FDC compared to single active ingredient has not been assessed. Objectives Trends in FDA approved FDC in the period 1980-2012 and time lag between approval of FDC and single active ingredients in the combination were assessed, and the effective patent and exclusivity life of FDC was compared with their single active ingredients. Materials and Methods New molecular entities (NMEs), new therapeutic biologics license applications (BLAs) and FDC data were collected from the FDA Orange Book and Drugs@FDA. Analysis included FDC containing one or more NMEs or BLAs at first FDA approval (NMEs-FDC) and only already marketed drugs (Non-NMEs-FDC). Descriptive, Kruskal-Wallis and Wilcoxon Rank Sum analyses were performed. Results During the study period, the FDA approved 28 NMEs-FDC (3.5% of NMEs) and 117 non-NMEs-FDC. FDC approvals increased from 12 in the 1980s to 59 in the 2000s. Non-NMEs-FDC entered the market at a median of 5.43 years (interquartile range 1.74, 10.31) after first FDA approval of single active ingredients in the combination. The Non-NMEs-FDC entered the market at a median of 2.33 years (-7.55, 2.39) before approval of generic single active ingredient. Non-NME-FDC added a median of 9.70 (2.75, 16.24) years to the patent and exclusivity life of the single active ingredients in the combination. Conclusion FDC approvals significantly increased over the last twenty years. Pharmaceutical companies market FDC drugs shortly before the generic versions of the single ingredients enter the market extending the patent and exclusivity life of drugs included in the combination.	[Hao, Jing; Rodriguez-Monguio, Rosa] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Seoane-Vazquez, Enrique] Massachusetts Coll Pharm & Hlth Sci, Boston, MA 02115 USA; [Seoane-Vazquez, Enrique] Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Brigham & Women's Hospital	Rodriguez-Monguio, R (corresponding author), Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA.	rmonguio@schoolph.umass.edu						Aldir I, 2014, CURR MED RES OPIN, V30, P89, DOI 10.1185/03007995.2013.844685; Amin T, 2012, HEALTH AFFAIR, V31, P2286, DOI 10.1377/hlthaff.2012.0107; [Anonymous], 1971, FED REG, V36, P3126; Bangalore S, 2007, AM J MED, V120, P713, DOI 10.1016/j.amjmed.2006.08.033; Bhat V. N., 2005, Pharmaceuticals Policy and Law, V6, P109; Brixner DI, 2007, CURR MED RES OPIN, V23, P2887, DOI 10.1185/030079907X242548; Elliott G, 2007, AAPS J, V9, pE317, DOI 10.1208/aapsj0903035; FDA, DRUGS FDA DAT FIL EL; Ferrario Carlos M, 2013, Ther Adv Cardiovasc Dis, V7, P27, DOI 10.1177/1753944712470979; Friedman HS, 2007, CURR MED RES OPIN, V23, P427, DOI 10.1185/030079906X167417; Friedman HS, 2009, CLIN THER, V31, P1056, DOI 10.1016/j.clinthera.2009.05.008; Gallini NT, 2002, J ECON PERSPECT, V16, P131, DOI 10.1257/0895330027292; Griffith MM, 2012, CLIN INFECT DIS, V54, P684, DOI 10.1093/cid/cir954; Higgins MJ, 2009, SCIENCE, V326, P370, DOI 10.1126/science.1176116; Hong SH, 2013, AM J HYPERTENS, V26, P879, DOI 10.1093/ajh/hpt035; Hong Song Hee, 2005, J Manag Care Pharm, V11, P746; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kapczynski A, 2012, PLOS ONE, V12, pe4947; Kesselheim AS, 2013, CLIN PHARMACOL THER, V94, P336, DOI 10.1038/clpt.2013.115; Kesselheim AS, 2007, AAPS J, V9, pE306, DOI 10.1208/aapsj0903033; LEVIN RC, 1987, BROOKINGS PAP ECO AC, P783; Malesker Mark A, 2010, Manag Care, V19, P36; Rabbani A, 2008, AM J HYPERTENS, V21, P509, DOI 10.1038/ajh.2008.31; Rodriguez-Monguio R, 2009, AIDS CARE, V21, P760, DOI 10.1080/09540120802511950; Seoane-Vazquez EC, 2007, J PHARM FINANCE EC P, V16, P67; Seoane-Vazquez E, 2009, FOOD DRUG LAW J, V64, P171; 't Hoen E, 2013, J PUBLIC HEALTH POL, V34, P370, DOI 10.1057/jphp.2013.21; US Food and Drug Administration (FDA), OR BOOK DAT FIL EL R; Wadman M, 2006, NATURE, V439, P390, DOI 10.1038/439390a; Walker CE, 1988, INTELLECTUAL PROPERT; WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health. ATC/DDD Index, 2015, ATC DDD IND 2015 EL; World Trade Organization, TRIPS TRAD REL ASP I	32	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140708	10.1371/journal.pone.0140708	http://dx.doi.org/10.1371/journal.pone.0140708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0CX	26469277	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600103
J	Speed, HE; Masiulis, I; Gibson, JR; Powell, CM				Speed, Haley E.; Masiulis, Irene; Gibson, Jay R.; Powell, Craig M.			Increased Cortical Inhibition in Autism-Linked Neuroligin-3R451C Mice Is Due in Part to Loss of Endocannabinoid Signaling	PLOS ONE			English	Article							DEPOLARIZED POSTSYNAPTIC NEURONS; FRAGILE-X-SYNDROME; ENDOGENOUS CANNABINOIDS; GABAERGIC INTERNEURONS; SYNAPTIC-TRANSMISSION; PRESYNAPTIC TERMINALS; VISUAL-CORTEX; SYNAPSES; NEOCORTEX; HIPPOCAMPAL	A single, maternally inherited, X-linked point mutation leading to an arginine to cysteine substitution at amino acid 451 (R451C) of Neuroligin 3 (NLGN3(R451C)) is a likely cause of autism in two brothers. Knockin mice expressing the Nlgn3(R451C) mutation in place of wild-type Nlgn3 demonstrate increased inhibitory synaptic strength in somatosensory cortex, resulting in an excitatory/inhibitory (E/I) imbalance that is potentially relevant for autism-associated behavioral deficits characteristic of these mice. We have replicated the increase in evoked inhibitory postsynaptic currents (eIPSCs) onto layer II/III cortical pyramidal neurons. We also find that increased frequency of spontaneous mIPSCs in Nlgn3(R451C) mice occurs in the absence of action potential-driven transmission. This suggests the E/I imbalance is due to changes at the synapse level, as opposed to the network level. Next, we use paired whole-cell recordings in an attempt to identify specific interneuron subtypes affected by the Nlgn3(R451C) mutation. Curiously, we observe no change in the amplitude of cell-to-cell, unitary IPSCs (uIPSCs) from parvalbumin-positive (PV) or somatostatin-positive (SOM) interneurons onto pyramidal neurons. We also observe no change in the number or density of PV and SOM interneurons in LII/III of somatosensory cortex. This effectively rules out a role for these particular interneurons in the increased inhibitory synaptic transmission, pointing to perhaps alternative interneuron subtypes. Lastly, impaired endocannabinoid signaling has been implicated in hippocampal synaptic dysfunction in Nlgn3(R451C) mice, but has not been investigated at cortical synapses. We find that bath application of the CB1 antagonist, AM 251 in WT mice eliminates the Nlgn3(R451C) increase in eIPSC amplitude and mIPSC frequency, indicating that increased inhibitory transmission in mutant mice is due, at least in part, to a loss of endocannabinoid signaling through CB1 receptors likely acting at interneurons other than PV or SOM.	[Speed, Haley E.; Powell, Craig M.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Masiulis, Irene] Univ Texas SW Med Ctr Dallas, Quantitat Morphol Core, Dallas, TX 75390 USA; [Gibson, Jay R.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Powell, Craig M.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Powell, Craig M.] Univ Texas SW Med Ctr Dallas, Neurosci Grad Program, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Powell, CM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.	craig.powell@utsouthwestern.edu		Speed, Haley/0000-0001-5562-4468; Powell, Craig/0000-0001-5451-2165	National Institute of Mental Health [R01 MH081164]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093697, R01MH081164] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Neuroligin Function in vivo: Implications for Autism and Mental Retardation awarded to CMP by the National Institute of Mental Health, Grant #R01 MH081164.	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Amitai Y, 2002, J NEUROSCI, V22, P4142, DOI 10.1523/JNEUROSCI.22-10-04142.2002; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Cauli B, 1997, J NEUROSCI, V17, P3894; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cline H, 2005, CURR BIOL, V15, pR203, DOI 10.1016/j.cub.2005.03.010; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jaramillo TC, 2014, AUTISM RES, V7, P264, DOI 10.1002/aur.1362; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Maejima T, 2001, NEUROSCI RES, V40, P205, DOI 10.1016/S0168-0102(01)00241-3; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Paluszkiewicz SM, 2011, J NEUROPHYSIOL, V106, P2264, DOI 10.1152/jn.00421.2011; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rippon G, 2007, INT J PSYCHOPHYSIOL, V63, P164, DOI 10.1016/j.ijpsycho.2006.03.012; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Szabo Gergely G, 2014, J Neurosci, V34, P7958, DOI 10.1523/JNEUROSCI.0247-14.2014; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629	35	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140638	10.1371/journal.pone.0140638	http://dx.doi.org/10.1371/journal.pone.0140638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469287	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600090
J	Takada, S; Mizuno, K; Saito, T; Asada, A; Giese, KP; Hisanaga, S				Takada, Shunsuke; Mizuno, Keiko; Saito, Taro; Asada, Akiko; Giese, Karl Peter; Hisanaga, Shin-ichi			Effects of p35 Mutations Associated with Mental Retardation on the Cellular Function of p35-CDK5	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; CDK5 ACTIVATOR P35; NEURONAL-SPECIFIC ACTIVATOR; BRAIN-DEVELOPMENT; PHOSPHORYLATION; P25; PROTEINS; CLEAVAGE; DEGRADATION; CALPAIN	p35 is an activation subunit of the cyclin-dependent kinase 5 (CDK5), which is a Ser/Thr kinase that is expressed predominantly in neurons. Disruption of the CDK5 or p35 (CDK5R1) genes induces abnormal neuronal layering in various regions of the mouse brain via impaired neuronal migration, which may be relevant for mental retardation in humans. Accordingly, mutations in the p35 gene were reported in patients with nonsyndromic mental retardation; however, their effect on the biochemical function of p35 has not been examined. Here, we studied the biochemical effect of mutant p35 on its known properties, i.e., stability, CDK5 activation, and cellular localization, using heterologous expression in cultured cells. We also examined the effect of the mutations on axon elongation in cultured primary neurons and migration of newborn neurons in embryonic brains. However, we did not detect any significant differences in the effects of the mutant forms of p35 compared with wild-type p35. Therefore, we conclude that these p35 mutations are unlikely to cause mental retardation.	[Takada, Shunsuke; Saito, Taro; Asada, Akiko; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Lab Mol Neurosci, Dept Biol Sci, Grad Sch Sci, Hachioji, Tokyo, Japan; [Mizuno, Keiko; Giese, Karl Peter] Kings Coll London, Inst Psychiat, Ctr Cellular Basis Behav, London WC2R 2LS, England	Tokyo Metropolitan University; University of London; King's College London	Hisanaga, S (corresponding author), Tokyo Metropolitan Univ, Lab Mol Neurosci, Dept Biol Sci, Grad Sch Sci, Hachioji, Tokyo, Japan.	hisanaga-shinichi@tmu.ac.jp		Giese, Karl Peter/0000-0003-4503-7344	MEXT of Japan [19057007, 25290024]	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (19057007, 25290024) from MEXT of Japan to SH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin ND, 2002, J NEUROSCI RES, V67, P354, DOI 10.1002/jnr.10116; Antalffy G, 2013, BBA-MOL CELL RES, V1833, P2561, DOI 10.1016/j.bbamcr.2013.06.021; Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; Asada A, 2012, J CELL SCI, V125, P3421, DOI 10.1242/jcs.100503; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Cheung Zelda H., 2007, Biotechnology Journal, V2, P949, DOI 10.1002/biot.200700056; Engmann O, 2011, BIOL PSYCHIAT, V70, P159, DOI 10.1016/j.biopsych.2011.04.011; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Hosokawa T, 2010, MOL CELL PROTEOMICS, V9, P1133, DOI 10.1074/mcp.M900578-MCP200; Ito Y, 2014, MOL CELL NEUROSCI, V61, P34, DOI 10.1016/j.mcn.2014.05.006; Kamei H, 2007, J BIOL CHEM, V282, P1687, DOI 10.1074/jbc.M610541200; Kawauchi T, 2013, GENES CELLS, V18, P176, DOI 10.1111/gtc.12029; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kobayashi H, 2014, J BIOL CHEM, V289, P19627, DOI 10.1074/jbc.M113.501148; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lai KO, 2012, NAT NEUROSCI, V15, P1506, DOI 10.1038/nn.3237; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Magen D, 2015, HUM GENET, V134, P305, DOI 10.1007/s00439-014-1522-5; Minegishi S, 2010, BIOCHEMISTRY-US, V49, P5482, DOI 10.1021/bi100631f; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nishimura YV, 2012, MED MOL MORPHOL, V45, P1, DOI 10.1007/s00795-011-0557-0; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Paglini G, 1998, J NEUROSCI, V18, P9858; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Poon RYC, 1997, J BIOL CHEM, V272, P5703, DOI 10.1074/jbc.272.9.5703; Saito T, 1998, BIOCHEM BIOPH RES CO, V252, P775, DOI 10.1006/bbrc.1998.9739; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Saito T, 2007, J NEUROCHEM, V102, P133, DOI 10.1111/j.1471-4159.2007.04540.x; Seo J, 2014, NAT CHEM BIOL, V10, P488, DOI 10.1038/nchembio.1557; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Takahashi S, 2003, J BIOL CHEM, V278, P10506, DOI 10.1074/jbc.M211964200; Tarricone C, 2001, MOL CELL, V8, P657, DOI 10.1016/S1097-2765(01)00343-4; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Venturin M, 2006, NEUROGENETICS, V7, P59, DOI 10.1007/s10048-005-0026-9; Zuccotti P, 2014, BBA-GENE REGUL MECH, V1839, P506, DOI 10.1016/j.bbagrm.2014.04.018	41	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140821	10.1371/journal.pone.0140821	http://dx.doi.org/10.1371/journal.pone.0140821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469698	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600119
J	Baldwin, RF; Leonard, PB				Baldwin, Robert F.; Leonard, Paul B.			Interacting Social and Environmental Predictors for the Spatial Distribution of Conservation Lands	PLOS ONE			English	Article							PROTECTED AREAS; BIODIVERSITY; VEGETATION; EASEMENTS; SCALE	Conservation decisions should be evaluated for how they meet conservation goals at multiple spatial extents. Conservation easements are land use decisions resulting from a combination of social and environmental conditions. An emerging area of research is the evaluation of spatial distribution of easements and their spatial correlates. We tested the relative influence of interacting social and environmental variables on the spatial distribution of conservation easements by ownership category and conservation status. For the Appalachian region of the United States, an area with a long history of human occupation and complex land uses including public-private conservation, we found that settlement, economic, topographic, and environmental data associated with spatial distribution of easements (N = 4813). Compared to random locations, easements were more likely to be found in lower elevations, in areas of greater agricultural productivity, farther from public protected areas, and nearer other human features. Analysis of ownership and conservation status revealed sources of variation, with important differences between local and state government ownerships relative to non-governmental organizations (NGOs), and among U.S. Geological Survey (USGS) GAP program status levels. NGOs were more likely to have easements nearer protected areas, and higher conservation status, while local governments held easements closer to settlement, and on lands of greater agricultural potential. Logistic interactions revealed environmental variables having effects modified by social correlates, and the strongest predictors overall were social (distance to urban area, median household income, housing density, distance to land trust office). Spatial distribution of conservation lands may be affected by geographic area of influence of conservation groups, suggesting that multi-scale conservation planning strategies may be necessary to satisfy local and regional needs for reserve networks. Our results support previous findings and provide an ecoregion-scale view that conservation easements may provide, at local scales, conservation functions on productive, more developable lands. Conservation easements may complement functions of public protected areas but more research should examine relative landscape-level ecological functions of both forms of protection.	[Baldwin, Robert F.; Leonard, Paul B.] Clemson Univ, Dept Forestry & Environm Conservat, Clemson, SC 29634 USA		Baldwin, RF (corresponding author), Clemson Univ, Dept Forestry & Environm Conservat, 261 Lehotsky Hall, Clemson, SC 29634 USA.	baldwi6@clemson.edu		Leonard, Paul/0000-0001-8032-7449	US Fish and Wildlife Service [201043]; Clemson University GIS Teaching Assistantship	US Fish and Wildlife Service(US Fish & Wildlife Service); Clemson University GIS Teaching Assistantship	This work was supported by the US Fish and Wildlife Service contract with RB through Wildlife Management Institute for conservation planning research for the Appalachian LCC (internal funding number 201043), and Clemson University GIS Teaching Assistantship for PBL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M., 2012, RESILIENT SITES TERR; Anderson MG, 2014, CONSERV BIOL, V28; Auld G, 2008, ANNU REV ENV RESOUR, V33, P187, DOI 10.1146/annurev.environ.33.013007.103754; Borra S, 2010, COMPUT STAT DATA AN, V54, P2976, DOI 10.1016/j.csda.2010.03.004; Brewer R., 2003, CONSERVANCY LAND TRU; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Cantu-Salazar L, 2013, BIODIVERS CONSERV, V22, P1033, DOI 10.1007/s10531-013-0467-7; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Crous CJ, 2013, J APPL ECOL, V50, P205, DOI 10.1111/1365-2664.12012; DeFries RS, 2004, FRONT ECOL ENVIRON, V2, P249, DOI 10.1890/1540-9295(2004)002[0249:LCBHNA]2.0.CO;2; Delcourt PA, 1998, ECOL APPL, V8, P921, DOI 10.1890/1051-0761(1998)008[0921:PIOCOB]2.0.CO;2; Dobos R. R., 2012, NATL COMMODITY CROP; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Franklin J, 2009, MAPPING SPECIES DIST; Gaston KJ, 2006, BIOL CONSERV, V132, P76, DOI 10.1016/j.biocon.2006.03.013; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Groves CR, 2002, BIOSCIENCE, V52, P499, DOI 10.1641/0006-3568(2002)052[0499:PFBCPC]2.0.CO;2; HARMON ME, 1984, VEGETATIO, V55, P129, DOI 10.1007/BF00045013; Hayes T, 2010, FOREST POLICY ECON, V12, P545, DOI 10.1016/j.forpol.2010.07.003; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; Honnay O, 2003, LANDSCAPE URBAN PLAN, V63, P241, DOI 10.1016/S0169-2046(02)00194-9; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Igoe, 2008, NATURE UNBOUND CONSE; Jack BK, 2009, CONSERV BIOL, V23, P359, DOI 10.1111/j.1523-1739.2008.01086.x; Jenkins CN, 2015, P NATL ACAD SCI USA, V112, P5081, DOI 10.1073/pnas.1418034112; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kerr JT, 2001, P NATL ACAD SCI USA, V98, P11365, DOI 10.1073/pnas.201398398; Kiesecker JM, 2007, FRONT ECOL ENVIRON, V5, P125, DOI 10.1890/1540-9295(2007)5[125:CEICAQ]2.0.CO;2; Kirk RW, 2012, LANDSCAPE URBAN PLAN, V104, P47, DOI 10.1016/j.landurbplan.2011.09.008; Leopold Aldo, 1949, S COUNTY ALMANAC; MAEHR DS, 1990, CONSERV BIOL, V4, P167, DOI 10.1111/j.1523-1739.1990.tb00105.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McRae BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052604; Merenlender AM, 2004, CONSERV BIOL, V18, P65, DOI 10.1111/j.1523-1739.2004.00401.x; Millard MJ, 2012, J FISH WILDL MANAG, V3, P175, DOI 10.3996/052011-JFWM-030; Moilanen A., 2009, SPATIAL CONSERVATION; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Noss R., 2011, CONSERV BIOL, V26, P1, DOI DOI 10.1111/J.1523-1739; Nunez TA, 2013, CONSERV BIOL, V27, P407, DOI 10.1111/cobi.12014; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Palmer MA, 2010, SCIENCE, V327, P148, DOI 10.1126/science.1180543; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Porter-Bolland L, 2012, FOREST ECOL MANAG, V268, P6, DOI 10.1016/j.foreco.2011.05.034; Powell RB, 2009, COAST MANAGE, V37, P633, DOI 10.1080/08920750903194272; Riitters K., 2002, SURVEY USG; Rissman AR, 2007, CONSERV BIOL, V21, P709, DOI 10.1111/j.1523-1739.2007.00660.x; Rissman AR, 2008, ECOL SOC, V13; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; SILBER JH, 1995, J AM STAT ASSOC, V90, P7, DOI 10.2307/2291124; Smith WB, 2004, FOREST RESOURCES US; Sutherland WJ, 2010, J APPL ECOL, V47, P955, DOI 10.1111/j.1365-2664.2010.01863.x; Swofford J, 2010, ENERG POLICY, V38, P2508, DOI 10.1016/j.enpol.2009.12.046; Theobald DM, 2005, ECOL APPL, V15, P1906, DOI 10.1890/03-5331; Theobald DM, 2003, CONSERV BIOL, V17, P1624, DOI 10.1111/j.1523-1739.2003.00250.x; Theobald DM, 1997, LANDSCAPE URBAN PLAN, V39, P25, DOI 10.1016/S0169-2046(97)00041-8; Trombulak SC, 2010, LANDSCAPE-SCALE CONSERVATION PLANNING, P1, DOI 10.1007/978-90-481-9575-6; Turner MG, 1989, LANDSCAPE ECOL, V3, P153, DOI 10.1007/BF00131534; Wear DN, 2002, J FOREST, V100, P6; Wear DN, 1998, ECOSYSTEMS, V1, P575, DOI 10.1007/s100219900052; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577; Wiens JA, 2010, CONSERV BIOL, V24, P51, DOI 10.1111/j.1523-1739.2009.01409.x; Yarnell S. L, 1998, SO APPALACHIANS HIST	63	22	22	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140540	10.1371/journal.pone.0140540	http://dx.doi.org/10.1371/journal.pone.0140540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465155	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100139
J	Dewaele, L; Tsogtbaatar, K; Barsbold, R; Garcia, G; Stein, K; Escuillie, F; Godefroit, P				Dewaele, Leonard; Tsogtbaatar, Khishigjav; Barsbold, Rinchen; Garcia, Geraldine; Stein, Koen; Escuillie, Francois; Godefroit, Pascal			Perinatal Specimens of Saurolophus angustirostris (Dinosauria: Hadrosauridae), from the Upper Cretaceous of Mongolia	PLOS ONE			English	Article							ORNITHISCHIA; EGGSHELLS; EMBRYOS; GROWTH; CHINA	Background The Late Cretaceous Nemegt Formation, Gobi Desert, Mongolia has already yielded abundant and complete skeletons of the hadrosaur Saurolophus angustirostris, from half-grown to adult individuals. Methodology/Principal Findings Herein we describe perinatal specimens of Saurolophus angustirostris, associated with fragmentary eggshell fragments. The skull length of these babies is around 5% that of the largest known S. angustirostris specimens, so these specimens document the earliest development stages of this giant hadrosaur and bridge a large hiatus in our knowledge of the ontogeny of S. angustirostris. Conclusions/Significance The studied specimens are likely part of a nest originally located on a riverbank point bar. The perinatal specimens were buried by sediment carried by the river current presumably during the wet summer season. Perinatal bones already displayed diagnostic characters for Saurolophus angustirostris, including premaxillae with a strongly reflected oral margin and upturned premaxillary body in lateral aspect. The absence of a supracranial crest and unfused halves of the cervical neural arches characterize the earliest stages in the ontogeny of S. angustirostris. The eggshell fragments associated with the perinatal individuals can be referred to the Spheroolithus oogenus and closely resemble those found in older formations (e.g. Barun Goyot Fm in Mongolia) or associated with more basal hadrosauroids (Bactrosaurus-Gilmoreosaurus in the Iren Dabasu Fm, Inner Mongolia, China). This observation suggests that the egg microstructure was similar in basal hadrosauroids and more advanced saurolophines.	[Dewaele, Leonard; Godefroit, Pascal] Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, B-1000 Brussels, Belgium; [Dewaele, Leonard] Univ Ghent, Dept Geol & Soil Sci, Res Unit Palaeontol, B-9000 Ghent, Belgium; [Tsogtbaatar, Khishigjav; Barsbold, Rinchen] Mongolian Acad Sci, Inst Paleontol & Geol, Ulaanbaatar 210351, Mongolia; [Garcia, Geraldine] Univ Poitiers, IPHEP, CNRS, UMR 7262, F-86073 Poitiers 9, France; [Stein, Koen] Vrije Univ Brussel, AMGC, Earth Syst Sci, B-1050 Brussels, Belgium; [Escuillie, Francois] Eldonia, F-3800 Gannat, France	Royal Belgian Institute of Natural Sciences; Ghent University; Mongolian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Vrije Universiteit Brussel	Dewaele, L (corresponding author), Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, Rue Vautier 29, B-1000 Brussels, Belgium.	leonard.dewaele@ugent.be	Stein, Koen HW/G-5731-2015	Stein, Koen/0000-0003-4246-3225; Dewaele, Leonard/0000-0003-1188-2515	Eldonia	Eldonia	The author(s) received no specific funding for this work. Eldonia provided support in the form of a salary for FE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bell PR, 2013, CRETACEOUS RES, V45, P265, DOI 10.1016/j.cretres.2013.05.003; Bell PR, 2011, ACTA PALAEONTOL POL, V56, P703, DOI 10.4202/app.2010.0061; BOND GM, 1988, ZOOL J LINN SOC-LOND, V92, P105, DOI 10.1111/j.1096-3642.1988.tb00100.x; Brink KS, 2011, HIST BIOL, V23, P63, DOI 10.1080/08912963.2010.499169; Campione NE, 2013, PALAEOBIO PALAEOENV, V93, P65, DOI 10.1007/s12549-012-0097-1; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Carpenter K., 1999, EGGS NESTS BABY DINO; Chen JM, 2013, PALAEOGEOGR PALAEOCL, V385, P190, DOI 10.1016/j.palaeo.2012.07.017; Chure Daniel, 1994, P298; Currie PJ, 2009, ANN REP 2008, P143; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; Evans DC, 2005, LIFE O PAST, P349; Farke AA, 2012, J VERTEBR PALEONTOL, V32, P92; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Godefroit P, 2004, ACTA PALAEONTOL POL, V49, P585; Godefroit P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036849; Gradzinski R., 1969, Palaeont. pol., V21, P147; Grzymislawska M, 2010, FOLIA MORPHOL, V69, P177; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hirsch K.F., 1990, Journal of Vertebrate Paleontology, V10, P491; Homer J. R., 1994, DINOSAUR EGGS BABIES, P312; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 1999, J VERTEBR PALEONTOL, V19, P607, DOI 10.1080/02724634.1999.10011174; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; HORNER JR, 1979, NATURE, V282, P296, DOI 10.1038/282296a0; Ikejiri T., 2010, THESIS U MICHIGAN AN; JERZYKIEWICZ T, 1991, CRETACEOUS RES, V12, P345, DOI 10.1016/0195-6671(91)90015-5; Jiang, 1974, SCI SINICA, V17, P73; Kundrat M, 2008, ACTA ZOOL-STOCKHOLM, V89, P231, DOI 10.1111/j.1463-6395.2007.00311.x; Liang XQ, 2009, PROG NAT SCI-MATER, V19, P1587, DOI 10.1016/j.pnsc.2009.06.012; MARYANSKA T, 1981, Acta Palaeontologica Polonica, V26, P243; MARYANSKA T, 1984, Palaeontologia Polonica, P119; MARYANSKA T, 1981, Palaeontologia Polonica, P5; MIKHAILOV K E, 1991, Acta Palaeontologica Polonica, V36, P193; Mikhailov KE, 1996, J VERTEBR PALEONTOL, V16, P763, DOI 10.1080/02724634.1996.10011364; Mikhailov KE, 1997, SPEC PAP PALAEONTOL, P56; Mikhailov KE., 1994, PALEONTOL ZH, V28, P141; Mikhailov Konstantin, 1994, P88; Mikhailov Konstantin E., 2000, P560; Prieto-Marquez A, 2015, GEOL MAG, V152, P225, DOI 10.1017/S0016756814000284; Prieto-Marquez A, 2011, J PALEONTOL, V85, P468, DOI 10.1666/10-106.1; Prondvai E, 2014, BIOL J LINN SOC, V112, P799, DOI 10.1111/bij.12323; Reisz RR, 2013, NATURE, V496, P210, DOI 10.1038/nature11978; ROZHDESTVENSKII A. K., 1952, DOKLADY AKAD NAUK SSSR, V86, P405; Rozhdestvensky AK, 1965, PALEONTOL ZH, V3, P95; Stein K, 2014, BIOL REV, V89, P24, DOI 10.1111/brv.12041; Young CC, 1954, ACTA PALAEONTOLOGICA, V2, P371; Zelenitsky DK, 1997, J VERTEBR PALEONTOL, V17, P167, DOI 10.1080/02724634.1997.10010960; Zelenitsky DK, 2000, PALEONTOLOGICAL SOC, V4, P13; Zhao ZK, 1979, MESOZOIC CENOZOIC RE, P330	51	15	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138806	10.1371/journal.pone.0138806	http://dx.doi.org/10.1371/journal.pone.0138806			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466354	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100025
J	Nayak, S; Goel, MM; Makker, A; Bhatia, V; Chandra, S; Kumar, S; Agarwal, SP				Nayak, Seema; Goel, Madhu Mati; Makker, Annu; Bhatia, Vikram; Chandra, Saumya; Kumar, Sandeep; Agarwal, S. P.			Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							SUBMUCOUS FIBROSIS; EPITHELIAL DYSPLASIA; MOLECULAR PATHWAYS; TUMOR RECURRENCE; LICHEN-PLANUS; VOIDED URINE; FACTOR-I; EXPRESSION; LEUKOPLAKIA; DISORDERS	There are several factors like angiogenesis, lymphangiogenesis, genetic alterations, mutational factors that are involved in malignant transformation of potentially malignant oral lesions (PMOLs) to oral squamous cell carcinoma (OSCC). Fibroblast growth factor-2 (FGF-2) is one of the prototypes of the large family of growth factors that bind heparin. FGF-2 induces angiogenesis and its receptors may play a role in synthesis of collagen. FGFs are involved in transmission of signals between the epithelium and connective tissue, and influence growth and differentiation of a wide variety of tissue including epithelia. The present study was undertaken to analyze expression of FGF-2 and its receptors FGFR-2 and FGFR-3 in 72 PMOLs, 108 OSCC and 52 healthy controls, and their role in risk assessment for malignant transformation of Leukoplakia (LKP) and Oral submucous fibrosis (OSMF) to OSCC. Immunohistochemistry was performed using antibodies against FGF-2, FGFR-2 and FGFR-3. IHC results were validated by Real Time PCR. Expression of FGF-2, FGFR-2 and FGFR-3 was upregulated from PMOLs to OSCC. While 90% (9/10) of PMOLs which showed malignant transformation (transformed) expressed FGF-2, only 24.19% cases (15/ 62) of PMOLs which were not transformed (untransformed) to OSCC expressed FGF-2. Similarly, FGFR-2 expression was seen in 16/62 (25.81%) of untransformed PMOLs and 8/ 10 (80%) cases of transformed PMOLs. FGFR-3 expression was observed in 23/62 (37.10%) cases of untransformed PMOLs and 6/10 (60%) cases of transformed PMOLs. A significant association of FGF-2 and FGFR-2 expression with malignant transformation from PMOLs to OSCC was observed both at phenotypic and molecular level. The results suggest that FGF-2 and FGFR-2 may be useful as biomarkers of malignant transformation in patients with OSMF and LKP.	[Nayak, Seema; Goel, Madhu Mati; Makker, Annu; Bhatia, Vikram; Chandra, Saumya] King Georges Med Univ, Dept Pathol, Lucknow 226003, Uttar Pradesh, India; [Kumar, Sandeep] All India Inst Med Sci, Bhopal 462026, MP, India; [Agarwal, S. P.] King Georges Med Univ Lucknow, Dept Otorhinolaryngol, Lucknow 226003, Uttar Pradesh, India	King George's Medical University; All India Institute of Medical Sciences (AIIMS) Bhopal; King George's Medical University	Goel, MM (corresponding author), King Georges Med Univ, Dept Pathol, Lucknow 226003, Uttar Pradesh, India.	madhukgmc@gmail.com	Kumar, Sandeep/AAG-6866-2021; kumar, sandeep/GMX-3097-2022; KUMAR, SANDEEP/GZA-7182-2022		Indian council of Medical Research, New Delhi, India [5/13/56/2008-NCDIII]; Council of Science and Technology (Uttar Pradesh), India [CST/SERPD/D-1888(ii)]	Indian council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); Council of Science and Technology (Uttar Pradesh), India	This work was supported by Indian council of Medical Research, New Delhi, India-110029 (Grant No. 5/13/56/2008-NCDIII, www.icmr.nic.in); and Council of Science and Technology (Uttar Pradesh), India (Grant No. CST/SERPD/D-1888(ii), www.cstup.gov.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY LM, 1995, ORAL SURG ORAL MED O, V80, P188, DOI 10.1016/S1079-2104(05)80201-X; Amagasa T, 2011, INT J CLIN ONCOL, V16, P5, DOI 10.1007/s10147-010-0157-3; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Bishen KA, 2008, J ORAL PATHOL MED, V37, P402, DOI 10.1111/j.1600-0714.2008.00649.x; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Brouns EREA, 2014, ORAL DIS, V20, pe19, DOI 10.1111/odi.12095; Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019; Cheng L, 2009, FUTURE ONCOL, V5, P843, DOI 10.2217/FON.09.50; Coutts JC, 1995, IMMUNOL CELL BIOL, V73, P584, DOI 10.1038/icb.1995.92; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Dellacono FR, 1997, AM J SURG, V174, P540; Fang MX, 2009, QUINTESSENCE INT, V40, P235; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Forootan SS, 2000, ORAL ONCOL, V36, P437, DOI 10.1016/S1368-8375(00)00032-4; Fukui S, 2003, CANCER, V97, P3061, DOI 10.1002/cncr.11450; Giri D, 1999, CLIN CANCER RES, V5, P1063; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; Hase T, 2006, ORAL SCI INT, V3, P1; Haugsten EM, 2010, MOL CANCER RES, V8, P1439, DOI 10.1158/1541-7786.MCR-10-0168; Hernandez S, 2006, J CLIN ONCOL, V24, P3664, DOI 10.1200/JCO.2005.05.1771; Ho PS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-260; Hsue SS, 2007, J ORAL PATHOL MED, V36, P25; JANOT F, 1995, INT J CANCER, V64, P117, DOI 10.1002/ijc.2910640208; JAYE M, 1988, EMBO J, V7, P963, DOI 10.1002/j.1460-2075.1988.tb02902.x; Jordan R C, 1997, J Can Dent Assoc, V63, P517; KARABULUT A, 1995, J ORAL PATHOL MED, V24, P198, DOI 10.1111/j.1600-0714.1995.tb01166.x; Karavasilis V, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-25; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; Knights V, 2010, PHARMACOL THERAPEUT, V125, P105, DOI 10.1016/j.pharmthera.2009.10.001; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034773; Liu W, 2011, HISTOPATHOLOGY, V59, P733, DOI 10.1111/j.1365-2559.2011.03938.x; LUMERMAN H, 1995, ORAL SURG ORAL MED O, V79, P321, DOI 10.1016/S1079-2104(05)80226-4; Marshall ME, 2011, CLIN CANCER RES, V17, P5016, DOI 10.1158/1078-0432.CCR-11-0050; Mehrotra D, 2009, ORAL SURG ORAL MED O, V107, pE1, DOI 10.1016/j.tripleo.2008.12.012; Miyake M, 2010, CANCER SCI, V101, P250, DOI 10.1111/j.1349-7006.2009.01334.x; Murakami M, 2008, CURR OPIN HEMATOL, V15, P215, DOI 10.1097/MOH.0b013e3282f97d98; MURTI PR, 1986, J ORAL PATHOL MED, V15, P71, DOI 10.1111/j.1600-0714.1986.tb00580.x; MURTI PR, 1985, COMMUNITY DENT ORAL, V13, P340, DOI 10.1111/j.1600-0528.1985.tb00468.x; MYOKEN Y, 1994, J ORAL PATHOL MED, V23, P451, DOI 10.1111/j.1600-0714.1994.tb00443.x; PINDBORG JJ, 1984, SCAND J DENT RES, V92, P224; Raimondi AR, 2006, J ORAL PATHOL MED, V35, P212, DOI 10.1111/j.1600-0714.2006.00394.x; SARANATH D, 1993, ORAL ONCOL, V29B, P107, DOI 10.1016/0964-1955(93)90031-9; SASADA R, 1988, MOL CELL BIOL, V8, P588, DOI 10.1128/MCB.8.2.588; Schepman KP, 1998, ORAL ONCOL, V34, P270, DOI 10.1016/S1368-8375(98)80007-9; Shareef KN., 2013, J BAGHDAD COLL DENT, V25, P94; Shi P, 2010, CANCER EPIDEM BIOMAR, V19, P844, DOI 10.1158/1055-9965.EPI-09-0699; SILVERMAN S, 1984, CANCER, V53, P563; Smith J, 2009, ORAL ONCOL, V45, P647, DOI 10.1016/j.oraloncology.2009.02.006; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wakulich C, 2002, ORAL SURG ORAL MED O, V93, P573, DOI 10.1067/moe.2002.124461; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; YAMANAKA Y, 1993, CANCER RES, V53, P5289; YOSHITAKE Y, 1992, IN VITRO CELL DEV-AN, V28A, P419; Zuiverloon TCM, 2010, CLIN CANCER RES, V16, P3011, DOI 10.1158/1078-0432.CCR-09-3013	54	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138801	10.1371/journal.pone.0138801	http://dx.doi.org/10.1371/journal.pone.0138801			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465941	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100023
J	Ryninks, K; Sutton, E; Thomas, E; Jago, R; Shield, JPH; Burren, CP				Ryninks, Kirsty; Sutton, Eileen; Thomas, Elizabeth; Jago, Russell; Shield, Julian P. H.; Burren, Christine P.			Attitudes to Exercise and Diabetes in Young People with Type 1 Diabetes Mellitus: A Qualitative Analysis	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CHILDREN; ADOLESCENTS; MANAGEMENT; KNOWLEDGE; PARENTS	Aims To investigate young people's attitudes to, and understanding of, physical activity on glycaemic control in Type 1 Diabetes Mellitus. Methods Four focus groups with 11-14 and 15-16 year olds were conducted with twelve young people with Type 1 Diabetes, from within a larger study investigating physical activity and fitness. Qualitative analysis of the focus group data was performed using Interpretative Phenomenological Analysis. Results Four superordinate themes were identified: Benefits of Exercise, Knowledge and Understanding, Information and Training and "You can do anything". Young people felt that exercising helped them to manage their diabetes and had a beneficial psychological and physical impact on their bodies. They reported a lack of knowledge and understanding about diabetes among school staff and other young people. The overwhelming sense from young people was that although diabetes impacts upon their lives, with preparation, physical activity can take place as normal. Conclusions Whilst young people had an awareness of the physical and psychological benefits of exercise in managing their diabetes, they experienced difficulties at school. Professional support and discussions with young people, giving tailored strategies for managing Type 1 Diabetes during exercise are needed. Healthcare teams should ensure that the support and educational needs of school staff are met. Providing more opportunities to empower young people to take on the responsibility for their Type 1 Diabetes care is merited. Young people felt diabetes did not stop them from participating in activities; it is simply a part of them that needs managing throughout life.	[Ryninks, Kirsty] Univ Hosp Bristol NHS Fdn Trust, Bristol Royal Hosp Children, Psychol Hlth Serv, Bristol BS2 8BJ, Avon, England; [Sutton, Eileen; Shield, Julian P. H.; Burren, Christine P.] Univ Hosp Bristol NHS Fdn Trust, NIHR Biomed Res Unit Nutr Diet & Lifestyle, Educ Ctr, Bristol BS2 8AE, Avon, England; [Thomas, Elizabeth; Shield, Julian P. H.; Burren, Christine P.] Univ Hosp Bristol NHS Fdn Trust, Bristol Royal Hosp Children, Dept Paediat Endocrinol & Diabet, Bristol BS2 8BJ, Avon, England; [Jago, Russell] Univ Bristol, Sch Policy Studies, Ctr Exercise Nutr & Hlth Sci, Bristol BS8 1TZ, Avon, England; [Shield, Julian P. H.; Burren, Christine P.] Univ Bristol, Sch Clin Sci, Bristol BS2 8DZ, Avon, England	Bristol Royal Hospital For Children; University of Bristol; University of Bristol; Bristol Royal Hospital For Children; University of Bristol; University of Bristol; University of Bristol	Burren, CP (corresponding author), Univ Hosp Bristol NHS Fdn Trust, NIHR Biomed Res Unit Nutr Diet & Lifestyle, Educ Ctr, Upper Maudlin St, Bristol BS2 8AE, Avon, England.	Christine.Burren@UHBristol.nhs.uk	Shield, Julian PH/D-6297-2014; Jago, Russell/ABD-6271-2021; Burren, Christine/AAE-5845-2019	Shield, Julian PH/0000-0003-2601-7575; Jago, Russell/0000-0002-3394-0176; Burren, Christine/0000-0002-3778-2945	Diabetes UK [06/0003396]; David Telling Charitable Trust	Diabetes UK(Diabetes UK); David Telling Charitable Trust	This study received financial support from Diabetes UK (Research Grant 06/0003396), http://www.diabetes.org.uk/ and the David Telling Charitable Trust, http://www.uhbristol.nhs.uk/research-innovation/information-for-researchers/research-funding-and-applying-for-grants/local-and-national-funding-opportunities/local-funding/. The funders had no role in study design but they did review the study design in the application process for funding. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Aycan Z, 2012, J CLIN RES PEDIATR E, V4, P199, DOI [10.4274/jcrpe.756, 10.4274/Jcrpe.756]; Baranowski T, 2005, EXERC SPORT SCI REV, V33, P163, DOI 10.1097/00003677-200510000-00003; Bernardini Anna Lucia, 2004, Acta Biomed, V75, P153; Biddle S.J.H., 2021, PSYCHOL PHYS ACTIVIT, V4th; Cuenca-Garci a M, 2012, DIABETIC MED, V29, P369; Department for Education, 2014, DFE003932014 DEP ED; Edge JA, 2012, PRACT DIABETES, V29, P320, DOI 10.1002/pdi.1715; Ekeland E, 2005, BRIT J SPORT MED, V39, P792, DOI 10.1136/bjsm.2004.017707; Graue M, 2003, ACTA PAEDIATR, V92, P1190, DOI 10.1080/08035250310005657; Greenhalgh S, 1997, Prof Nurse, V13, P150; HORTON ES, 1988, DIABETES CARE, V11, P201, DOI 10.2337/diacare.11.2.201; Kennedy A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058861; Krueger R. A., 2000, FOCUS GROUPS PRACTIC, V3rd; Lascar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108019; Liamputtong P., 2005, QUALITATIVE RES METH; Michaliszyn SF, 2010, RES NURS HEALTH, V33, P441, DOI 10.1002/nur.20393; MORGAN DL, 1988, FOCUS GROUPS QUALITA; Nabors L, 2003, J SCHOOL HEALTH, V73, P216, DOI 10.1111/j.1746-1561.2003.tb06563.x; National Paediatric Diabetes Audit Project Board Royal College of Paediatrics and Child Health, 2013, NAT PAED DIAB AUD RE; Pendley JS, 2002, J PEDIATR PSYCHOL, V27, P429, DOI 10.1093/jpepsy/27.5.429; Pivovarov JA, 2015, PEDIATR DIABETES, V16, P242, DOI 10.1111/pedi.12272; Rickabaugh TE, 1999, RES Q EXERCISE SPORT, V70, P389, DOI 10.1080/02701367.1999.10608059; Robertson K, 2009, PEDIATR DIABETES, V10, P154, DOI 10.1111/j.1399-5448.2009.00567.x; Samson J., 2006, DIABETES NURSING, V10, P351; SELAM JL, 1992, ACTA DIABETOL, V29, P11, DOI 10.1007/BF00572822; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Smith J.A., 2003, QUALITATIVE PSYCHOL, P51; Spencer JE, 2013, DIABETIC MED, V30, pE17, DOI 10.1111/dme.12021; Tahirovic H, 2007, Minerva Pediatr, V59, P767; WIELICZKO MC, 1991, ANN PEDIATR-PARIS, V38, P84	30	14	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0137562	10.1371/journal.pone.0137562	http://dx.doi.org/10.1371/journal.pone.0137562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0CK	26465770	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100006
J	Hahn, J; Kohler, S; Glatzel, S; Jurasinski, G				Hahn, Juliane; Koehler, Stefan; Glatzel, Stephan; Jurasinski, Gerald			Methane Exchange in a Coastal Fen in the First Year after Flooding - A Systems Shift	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; FRESH-WATER WETLANDS; LAND-USE; PHRAGMITES-AUSTRALIS; PEATLAND ECOSYSTEMS; SULFATE REDUCTION; CARBON TURNOVER; CO2 EXCHANGE; RESTORATION; BALANCE	Background Peatland restoration can have several objectives, for example re-establishing the natural habitat, supporting unique biodiversity attributes or re-initiating key biogeochemical processes, which can ultimately lead to a reduction in greenhouse gas (GHG) emissions. Every restoration measure, however, is itself a disturbance to the ecosystem. Methods Here, we examine an ecosystem shift in a coastal fen at the southern Baltic Sea which was rewetted by flooding. The analyses are based on one year of bi-weekly closed chamber measurements of methane fluxes gathered at spots located in different vegetation stands. During measurement campaigns, we recorded data on water levels, peat temperatures, and chemical properties of peat water. In addition we analyzed the first 20 cm of peat before and after flooding for dry bulk density (DBD), content of organic matter and total amounts of carbon (C), nitrogen (N), sulfur (S), and other nutrients. Results Rewetting turned the site from a summer dry fen into a shallow lake with water levels up to 0.60 m. We observed a substantial die-back of vegetation, especially in stands of sedges (Carex acutiformis Ehrh). Concentrations of total organic carbon and nitrogen in the peat water, as well as dry bulk density and concentrations of C, N and S in the peat increased. In the first year after rewetting, the average annual exchange of methane amounted to 0.26 +/- 0.06 kg m(-2). This is equivalent to a 190-times increase in methane compared to pre-flooding conditions. Highest methane fluxes occurred in sedge stands which suffered from the heaviest die-back. None of the recorded environmental variables showed consistent relationships with the amounts of methane exchanged. Conclusions Our results suggest that rewetting projects should be monitored not only with regard to vegetation development but also with respect to biogeochemical conditions. Further, high methane emissions that likely occur directly after rewetting by flooding should be considered when forecasting the overall effect of rewetting on GHG exchange.	[Hahn, Juliane; Koehler, Stefan; Jurasinski, Gerald] Univ Rostock, Fac Agr & Environm Sci, Landscape Ecol, D-18055 Rostock, Germany; [Glatzel, Stephan] Univ Vienna, Dept Geog & Reg Res, Vienna, Austria	University of Rostock; University of Vienna	Hahn, J (corresponding author), Univ Rostock, Fac Agr & Environm Sci, Landscape Ecol, D-18055 Rostock, Germany.	to.juliane.hahn@web.de	Glatzel, Stephan/AAE-8189-2019; Jurasinski, Gerald/AAH-6376-2021	Glatzel, Stephan/0000-0002-2572-5484; Jurasinski, Gerald/0000-0002-6248-9388	PhD scholarship of the Faculty of Interdisciplinary Research, Department Maritime Systems, of the University of Rostock	PhD scholarship of the Faculty of Interdisciplinary Research, Department Maritime Systems, of the University of Rostock	JH was funded by a PhD scholarship of the Faculty of Interdisciplinary Research, Department Maritime Systems, of the University of Rostock. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm J, 2007, BOREAL ENVIRON RES, V12, P191; [Anonymous], 2014, 2013 SUPPLEMENT 2006; ARMENTANO TV, 1986, J ECOL, V74, P755, DOI 10.2307/2260396; Audet J, 2013, ECOL ENG, V57, P170, DOI 10.1016/j.ecoleng.2013.04.021; Augustin J, 2008, PHOSPHORUND KOHLENST, P50; BARNES H, 1954, J EXP BIOL, V31, P582; BARTLETT KB, 1987, BIOGEOCHEMISTRY, V4, P183, DOI 10.1007/BF02187365; Beetz S, 2013, BIOGEOSCIENCES, V10, P1067, DOI 10.5194/bg-10-1067-2013; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Bhullar GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089588; Blanch SJ, 1999, REGUL RIVER, V15, P43, DOI 10.1002/(SICI)1099-1646(199901/06)15:1/3&lt;43::AID-RRR535&gt;3.0.CO;2-Q; Blume HP., 2011, BODENKUNDLICHES PRAK; Bohne B, 2008, ASPEKTE GEOOKOLOGIE; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; Clevering OA, 1998, AQUAT BOT, V62, P1, DOI 10.1016/S0304-3770(98)00081-3; CLYMO RS, 1984, PHILOS T R SOC B, V303, P605, DOI 10.1098/rstb.1984.0002; Conen F, 1998, EUR J SOIL SCI, V49, P701, DOI 10.1046/j.1365-2389.1998.4940701.x; Cooper MDA, 2014, ECOSYSTEMS, V17, P1227, DOI 10.1007/s10021-014-9791-3; Couwenberg J, 2012, MIRES PEAT, V10; Couwenberg J, 2011, HYDROBIOLOGIA, V674, P67, DOI 10.1007/s10750-011-0729-x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; DELAUNE RD, 1983, TELLUS B, V35, P8, DOI 10.1111/j.1600-0889.1983.tb00002.x; Deutsches Institut fur Normen, 1977, BEST GLUHV 3; Dias ATC, 2010, ECOSYSTEMS, V13, P526, DOI 10.1007/s10021-010-9338-1; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Frolking S, 2011, ENVIRON REV, V19, P371, DOI [10.1139/A11-014, 10.1139/a11-014]; Hahn-Schofl M, 2011, BIOGEOSCIENCES, V8, P1539, DOI 10.5194/bg-8-1539-2011; Hendriks DMD, 2007, BIOGEOSCIENCES, V4, P411, DOI 10.5194/bg-4-411-2007; Heyer J, 2000, ESTUAR COAST SHELF S, V51, P13, DOI 10.1006/ecss.2000.0616; Hidding B, 2014, AQUAT BOT, V113, P83, DOI 10.1016/j.aquabot.2013.11.003; Hoggart SPG, 2014, COAST ENG, V87, P169, DOI 10.1016/j.coastaleng.2013.12.001; Hoper H., 2008, PEATLANDS CLIMATE CH, P182; HOWARTH RW, 1979, LIMNOL OCEANOGR, V24, P999, DOI 10.4319/lo.1979.24.6.0999; HOWES BL, 1985, ECOLOGY, V66, P595, DOI 10.2307/1940408; Huth V, 2013, MIRES PEAT, V13; Joosten H, 2009, IMCG NEWSLETTER, V2, P20; Jurasinski G, 2014, R PACKAGE FLUX FLUX; Kaat A., 2009, FACTBOOK UNFCCC POLI; Kalbitz K, 2001, GEODERMA, V104, P203, DOI 10.1016/S0016-7061(01)00081-7; Kasimir-Klemedtsson A, 1997, SOIL USE MANAGE, V13, P245, DOI 10.1111/j.1475-2743.1997.tb00595.x; Kayranli B, 2010, WETLANDS, V30, P111, DOI 10.1007/s13157-009-0003-4; Kimmel K, 2010, PROG PHYS GEOG, V34, P491, DOI 10.1177/0309133310365595; Klotzli F, 2001, RESTOR ECOL, V9, P209, DOI 10.1046/j.1526-100x.2001.009002209.x; Koch S, 2014, WETLANDS, V34, P593, DOI 10.1007/s13157-014-0528-z; Koebsch F, 2015, AGR FOREST METEOROL, V204, P94, DOI 10.1016/j.agrformet.2015.02.002; Koebsch F, 2013, J GEOPHYS RES-BIOGEO, V118, P940, DOI 10.1002/jgrg.20069; Koebsch F, 2013, WETL ECOL MANAG, V21, P323, DOI 10.1007/s11273-013-9304-8; Krischer H, 1977, NATURSCHUTZARBEIT ME, V20, P3; Laiho R, 2006, SOIL BIOL BIOCHEM, V38, P2011, DOI 10.1016/j.soilbio.2006.02.017; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Lindroth A, 2007, TELLUS B, V59, P812, DOI 10.1111/j.1600-0889.2007.00310.x; Livingston G., 1995, BIOGENIC TRACE GASES, P14; Maljanen M, 2010, BIOGEOSCIENCES, V7, P2711, DOI 10.5194/bg-7-2711-2010; Mueller-Dombois D, 1974, AIMS METHODS VEGETAT, Vxx; Nahlik AM, 2011, GLOBAL CHANGE BIOL, V17, P1321, DOI 10.1111/j.1365-2486.2010.02190.x; Oksanen J., 2012, R PACKAGE VEGAN COMM; OREMLAND RS, 1982, NATURE, V296, P143, DOI 10.1038/296143a0; Pagter M, 2005, AQUAT BOT, V81, P285, DOI 10.1016/j.aquabot.2005.01.002; Parish F., 2008, ASSESSMENT PEATLANDS; Poffenbarger HJ, 2011, WETLANDS, V31, P831, DOI 10.1007/s13157-011-0197-0; R Development Core Team, 2012, R LANG ENV STAT COMP; Regina K, 2015, MITIG ADAPT STRAT GL, V20, P1529, DOI 10.1007/s11027-014-9559-2; ROCHETTE P, 1992, CAN J SOIL SCI, V72, P605, DOI 10.4141/cjss92-050; Rydin H, 2013, BIOL PEATLANDS, Vxii; Saarnio S, 2009, ATMOS ENVIRON, V43, P1421, DOI 10.1016/j.atmosenv.2008.04.007; Schrier-Uijl AP, 2011, BIOGEOCHEMISTRY, V102, P265, DOI 10.1007/s10533-010-9440-7; Schulz K, 2011, HYDROBIOLOGIA, V674, P25, DOI 10.1007/s10750-011-0782-5; Schwerdtfeger B, 2007, SALZWASSERPROBLEME M; Sponagel H., 2005, BODENKUNDLICHE KARTI, V5; Stocker TF, 2013, CONTRIBUTION WORKING; Strack M, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002715; Strack M., 2008, PEATLANDS CLIMATE CH; Strom L, 2003, GLOBAL CHANGE BIOL, V9, P1185, DOI 10.1046/j.1365-2486.2003.00655.x; Strom L, 2007, SOIL BIOL BIOCHEM, V39, P1689, DOI 10.1016/j.soilbio.2007.01.019; Succow M, 2001, LANDSCHAFTSOKOLOGISC, VXIV; Szajdak L., 2010, MIRES PEAT, P158; Timmermann T, 2006, APPL VEG SCI, V9, P241; Toogood SE, 2009, APPL VEG SCI, V12, P283, DOI 10.1111/j.1654-109X.2009.01028.x; Tuittila ES, 2000, GLOBAL CHANGE BIOL, V6, P569, DOI 10.1046/j.1365-2486.2000.00341.x; Waddington JM, 2000, PHYS GEOGR, V21, P433, DOI 10.1080/02723646.2000.10642719; Whalen SC, 2005, ENVIRON ENG SCI, V22, P73, DOI 10.1089/ees.2005.22.73; Wilson D, 2009, RESTOR ECOL, V17, P796, DOI 10.1111/j.1526-100X.2008.00416.x; Yavitt JB, 1997, GEOMICROBIOL J, V14, P299, DOI 10.1080/01490459709378054; Zak D, 2007, BIOGEOCHEMISTRY, V85, P141, DOI 10.1007/s10533-007-9122-2; Zak D, 2010, ECOL APPL, V20, P1336, DOI 10.1890/08-2053.1	85	37	37	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140657	10.1371/journal.pone.0140657	http://dx.doi.org/10.1371/journal.pone.0140657			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461916	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300112
J	Sgourakis, NG; May, NA; Boyd, LF; Ying, JF; Bax, A; Margulies, DH				Sgourakis, Nikolaos G.; May, Nathan A.; Boyd, Lisa F.; Ying, Jinfa; Bax, Ad; Margulies, David H.			A Novel MHC-I Surface Targeted for Binding by the MCMV m06 Immunoevasin Revealed by Solution NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antigen presentation; herpesvirus; major histocompatibility complex (MHC); nuclear magnetic resonance (NMR); protein-protein interaction; surface plasmon resonance (SPR); MCMV; immunoevasin; m06; gp48	MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE CYTOMEGALOVIRUS GLYCOPROTEIN; RESIDUAL DIPOLAR COUPLINGS; IMMUNE EVASION PROTEINS; MURINE CYTOMEGALOVIRUS; ANTIGEN PRESENTATION; CRYSTAL-STRUCTURE; PERDEUTERATED PROTEINS; HETERONUCLEAR NMR; PEPTIDE BINDING	As part of its strategy to evade detection by the host immune system, murine cytomegalovirus (MCMV) encodes three proteins that modulate cell surface expression of major histocompatibility complex class I (MHC-I) molecules: the MHC-I homolog m152/gp40 as well as the m02-m16 family members m04/gp34 and m06/gp48. Previous studies of the m04 protein revealed a divergent Ig-like fold that is unique to immunoevasins of the m02-m16 family. Here, we engineer and characterize recombinant m06 and investigate its interactions with full-length and truncated forms of the MHC-I molecule H2-L-d by several techniques. Furthermore, we employ solution NMR to map the interaction footprint of the m06 protein on MHC-I, taking advantage of a truncated H2-L-d, mini-H2-L-d, consisting of only the 12 platform domain. Mini-H2-L-d refolded in vitro with a high affinity peptide yields a molecule that shows outstanding NMR spectral features, permitting complete backbone assignments. These NMR-based studies reveal that m06 binds tightly to a discrete site located under the peptide-binding platform that partially overlaps with the (2)-microglobulin interface on the MHC-I heavy chain, consistent with in vitro binding experiments showing significantly reduced complex formation between m06 and (2)-microglobulin-associated MHC-I. Moreover, we carry out NMR relaxation experiments to characterize the picosecond-nanosecond dynamics of the free mini-H2-L-d MHC-I molecule, revealing that the site of interaction is highly ordered. This study provides insight into the mechanism of the interaction of m06 with MHC-I, suggesting a structural manipulation of the target MHC-I molecule at an early stage of the peptide-loading pathway.	[Sgourakis, Nikolaos G.; Ying, Jinfa; Bax, Ad] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [May, Nathan A.; Boyd, Lisa F.; Margulies, David H.] NIAID, Mol Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bax, A (corresponding author), NIDDK, Chem Phys Lab, NIH, Bldg 5,Rm 126,5 Mem Dr, Bethesda, MD 20892 USA.	bax@nih.gov; dhm@nih.gov		Margulies, David/0000-0001-8530-7375	NIDDK; NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI112573, ZIAAI001028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075095] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the intramural research programs of the NIDDK and NIAID, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Babic M, 2010, J EXP MED, V207, P2663, DOI 10.1084/jem.20100921; Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; Beerbaum M, 2013, J BIOMOL NMR, V57, P167, DOI 10.1007/s10858-013-9777-z; Berry R, 2014, J BIOL CHEM, V289, P23753, DOI 10.1074/jbc.M114.584128; Bouvier M, 1998, NAT STRUCT BIOL, V5, P377, DOI 10.1038/nsb0598-377; Bubeck A, 2002, J BIOL CHEM, V277, P2216, DOI 10.1074/jbc.M104178200; CARRENO BM, 1995, J IMMUNOL, V155, P4726; Chen JZ, 2003, MICROBES INFECT, V5, P233, DOI 10.1016/S1286-4579(03)00016-9; COLLINS EJ, 1995, P NATL ACAD SCI USA, V92, P1218, DOI 10.1073/pnas.92.4.1218; Corbett AJ, 2007, J GEN VIROL, V88, P758, DOI 10.1099/vir.0.82623-0; CORR M, 1992, J EXP MED, V176, P1681, DOI 10.1084/jem.176.6.1681; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fitzkee NC, 2010, J BIOMOL NMR, V48, P65, DOI 10.1007/s10858-010-9441-9; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Gewurz BE, 2001, J VIROL, V75, P5197, DOI 10.1128/JVI.75.11.5197-5204.2001; Goddard T. D., 2008, SPARKY3; Hawse WF, 2014, J IMMUNOL, V192, P2885, DOI 10.4049/jimmunol.1302953; Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952; Hebert AM, 2001, BIOCHEMISTRY-US, V40, P5233, DOI 10.1021/bi002392s; Hee CS, 2013, IMMUNOGENETICS, V65, P157, DOI 10.1007/s00251-012-0667-4; HOCHMAN JH, 1988, J IMMUNOL, V140, P2322; Holtappels R, 2006, J VIROL, V80, P7613, DOI 10.1128/JVI.00723-06; Jones LL, 2006, J BIOL CHEM, V281, P25734, DOI 10.1074/jbc.M604343200; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kimpler LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099139; Kleijnen MF, 1997, EMBO J, V16, P685, DOI 10.1093/emboj/16.4.685; Lakomek NA, 2012, J BIOMOL NMR, V53, P209, DOI 10.1007/s10858-012-9626-5; Lemmermann NAW, 2012, MED MICROBIOL IMMUN, V201, P497, DOI 10.1007/s00430-012-0257-y; Li LN, 2012, NAT STRUCT MOL BIOL, V19, P1176, DOI 10.1038/nsmb.2396; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; Lu XJ, 2006, J VIROL, V80, P6048, DOI 10.1128/JVI.00534-06; Mage MG, 2012, J IMMUNOL, V189, P1391, DOI 10.4049/jimmunol.1200831; Massi F, 2004, J AM CHEM SOC, V126, P2247, DOI 10.1021/ja038721w; McCoy WH, 2013, MOL IMMUNOL, V55, P156, DOI 10.1016/j.molimm.2012.11.011; MURRE C, 1984, J EXP MED, V160, P167, DOI 10.1084/jem.160.1.167; Natarajan K, 1999, IMMUNITY, V11, P591, DOI 10.1016/S1074-7613(00)80134-X; OZATO K, 1980, J IMMUNOL, V125, P2473; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; PEDERSEN LO, 1995, EUR J IMMUNOL, V25, P1609, DOI 10.1002/eji.1830250621; Pinto AK, 2006, J IMMUNOL, V177, P3225, DOI 10.4049/jimmunol.177.5.3225; POWERS R, 1991, J MAGN RESON, V94, P209, DOI 10.1016/0022-2364(91)90312-H; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rossi P, 2015, PROTEINS, V83, P309, DOI 10.1002/prot.24719; Sahu D, 2007, J AM CHEM SOC, V129, P13232, DOI 10.1021/ja074604f; Sgourakis NG, 2014, STRUCTURE, V22, P1263, DOI 10.1016/j.str.2014.05.018; SMITH JD, 1992, J EXP MED, V175, P191, DOI 10.1084/jem.175.1.191; Smith LM, 2013, VIROLOGY, V435, P258, DOI 10.1016/j.virol.2012.08.041; Smith LM, 2006, VIROLOGY, V352, P450, DOI 10.1016/j.virol.2006.04.031; Trinh CH, 2002, P NATL ACAD SCI USA, V99, P9771, DOI 10.1073/pnas.152337399; van de Weijer ML, 2015, SEMIN IMMUNOL, V27, P125, DOI 10.1016/j.smim.2015.03.010; Varani L, 2007, P NATL ACAD SCI USA, V104, P13080, DOI 10.1073/pnas.0703702104; Wang R, 2012, P NATL ACAD SCI USA, V109, pE3578, DOI 10.1073/pnas.1214088109; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P117; Ying JF, 2007, J BIOMOL NMR, V37, P195, DOI 10.1007/s10858-006-9120-z; Yu YYL, 1999, J IMMUNOL, V163, P4427; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Ziegler H, 2000, EMBO J, V19, P870, DOI 10.1093/emboj/19.5.870; Zweckstetter M, 2002, J BIOMOL NMR, V23, P127, DOI 10.1023/A:1016316415261; Zweckstetter M, 2001, J BIOMOL NMR, V20, P365, DOI 10.1023/A:1011263920003	66	4	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28857	28868		10.1074/jbc.M115.689661	http://dx.doi.org/10.1074/jbc.M115.689661			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26463211	Green Published, hybrid			2022-12-26	WOS:000365762300027
J	Wollstadt, P; Meyer, U; Wibral, M				Wollstadt, Patricia; Meyer, Ulrich; Wibral, Michael			A Graph Algorithmic Approach to Separate Direct from Indirect Neural Interactions	PLOS ONE			English	Article							COMPLEX BRAIN NETWORKS; GRANGER CAUSALITY; INFORMATION-FLOW; EVOKED-RESPONSES; TIME-SERIES; MEG; EEG	Network graphs have become a popular tool to represent complex systems composed of many interacting subunits; especially in neuroscience, network graphs are increasingly used to represent and analyze functional interactions between multiple neural sources. Interactions are often reconstructed using pairwise bivariate analyses, overlooking the multivariate nature of interactions: it is neglected that investigating the effect of one source on a target necessitates to take all other sources as potential nuisance variables into account; also combinations of sources may act jointly on a given target. Bivariate analyses produce networks that may contain spurious interactions, which reduce the interpretability of the network and its graph metrics. A truly multivariate reconstruction, however, is computationally intractable because of the combinatorial explosion in the number of potential interactions. Thus, we have to resort to approximative methods to handle the intractability of multivariate interaction reconstruction, and thereby enable the use of networks in neuroscience. Here, we suggest such an approximative approach in the form of an algorithm that extends fast bivariate interaction reconstruction by identifying potentially spurious interactions post-hoc: the algorithm uses interaction delays reconstructed for directed bivariate interactions to tag potentially spurious edges on the basis of their timing signatures in the context of the surrounding network. Such tagged interactions may then be pruned, which produces a statistically conservative network approximation that is guaranteed to contain non-spurious interactions only. We describe the algorithm and present a reference implementation in MATLAB to test the algorithm's performance on simulated networks as well as networks derived from magnetoencephalographic data. We discuss the algorithm in relation to other approximative multivariate methods and highlight suitable application scenarios. Our approach is a tractable and data-efficient way of reconstructing approximative networks of multivariate interactions. It is preferable if available data are limited or if fully multivariate approaches are computationally infeasible.	[Wollstadt, Patricia; Wibral, Michael] Goethe Univ Frankfurt, Brain Imaging Ctr, MEG Unit, D-60054 Frankfurt, Germany; [Meyer, Ulrich] Goethe Univ Frankfurt, Inst Comp Sci, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Wollstadt, P (corresponding author), Goethe Univ Frankfurt, Brain Imaging Ctr, MEG Unit, D-60054 Frankfurt, Germany.	patricia.wollstadt@stud.uni-frankfurt.de	Wibral, Michael/H-5255-2019	Wibral, Michael/0000-0001-8010-5862; Wollstadt, Patricia/0000-0002-7105-5207	LOEWE "Neuronale Koordination Forschungsschwerpunkt Frankfurt (NeFF)" - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of the Land Hessen (LOEWE)	LOEWE "Neuronale Koordination Forschungsschwerpunkt Frankfurt (NeFF)" - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of the Land Hessen (LOEWE)	MW and PW received financial support from the grant LOEWE "Neuronale Koordination Forschungsschwerpunkt Frankfurt (NeFF)" awarded by the Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of the Land Hessen (LOEWE), https://wissenschaft.hessen.de/loewe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2004, EUR PHYS J B, V38, P147, DOI 10.1140/epjb/e2004-00110-5; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Batagelj V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036113; Beer, 2010, ARXIV10042515, DOI DOI 10.HTTPS://ARXIV.0RG/ABS/1004.2515; Bertschinger N, 2014, ENTROPY-SWITZ, V16, P2161, DOI 10.3390/e16042161; Blinowska KJ, 2011, MED BIOL ENG COMPUT, V49, P521, DOI 10.1007/s11517-011-0739-x; Blinowska KJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.050902; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bollobas B, 2004, COMBINATORICA, V24, P5, DOI 10.1007/s00493-004-0002-2; Bollobas B, 2001, RANDOM STRUCT ALGOR, V18, P279, DOI 10.1002/rsa.1009; Borner K, 2007, ANNU REV INFORM SCI, V41, P537, DOI 10.1002/aris.2007.1440410119; Brookes MJ, 2008, NEUROIMAGE, V39, P1788, DOI 10.1016/j.neuroimage.2007.09.050; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen YH, 2004, PHYS LETT A, V324, P26, DOI 10.1016/j.physleta.2004.02.032; CHERNIAK C, 1995, TRENDS NEUROSCI, V18, P522, DOI 10.1016/0166-2236(95)98373-7; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Cormen Thomas H., 2009, INTRO ALGORITHMS; Das A, 2008, ACM S THEORY COMPUT, P45; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; Diestel Reinhard, 2010, GRAPH THEORY; Faes L, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051112; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garey M. R., 1979, Computers and intractability. A guide to the theory of NP-completeness; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Griffith V, 2014, EMERGENCE COMPLEX CO, V9, P159, DOI 10.1007/978-3-642-53734-9_6; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Grutzner C, 2010, J NEUROSCI, V30, P8342, DOI 10.1523/JNEUROSCI.5434-09.2010; Harder M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012130; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kiebel SJ, 2006, NEUROIMAGE, V30, P1273, DOI 10.1016/j.neuroimage.2005.12.055; Kotter R, 2000, PHILOS T ROY SOC B, V355, P127, DOI 10.1098/rstb.2000.0553; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kulesa A, 2015, NAT METHODS, V12, P477, DOI 10.1038/nmeth.3414; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lindner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-119; Lizier J., 2012, 252012 M PLANCK I MA; Marinazzo D, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/303601; Mooney CM, 1951, CAN J PSYCHOLOGY, V5, P129, DOI 10.1037/h0083540; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2012, NEUROIMAGE, V62, P881, DOI 10.1016/j.neuroimage.2011.08.085; Stam CJ, 2014, INT J PSYCHOPHYSIOL, V92, P129, DOI 10.1016/j.ijpsycho.2014.04.001; Stam CJ, 2010, INT J PSYCHOPHYSIOL, V77, P186, DOI 10.1016/j.ijpsycho.2010.06.024; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stramaglia S, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/105003; Tewarie P, 2015, NEUROIMAGE, V104, P177, DOI 10.1016/j.neuroimage.2014.10.015; Vakorin VA, 2009, J NEUROSCI METH, V184, P152, DOI 10.1016/j.jneumeth.2009.07.014; Wasserman S, 1994, SOCIAL NETWORK ANALY, V8; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WELCH WJ, 1982, J STAT COMPUT SIM, V15, P17, DOI 10.1080/00949658208810560; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Wibral M, 2012, IEEE ENG MED BIO, P3676, DOI 10.1109/EMBC.2012.6346764; Williams P.L., 2011, ARXIV11021507; Wollstadt P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102833	61	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140530	10.1371/journal.pone.0140530	http://dx.doi.org/10.1371/journal.pone.0140530			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479713	Green Published, gold			2022-12-26	WOS:000363026600012
J	Bernardi, D; Salmeron, E; Horikoshi, RJ; Bernardi, O; Dourado, PM; Carvalho, RA; Martinelli, S; Head, GP; Omoto, C				Bernardi, Daniel; Salmeron, Eloisa; Horikoshi, Renato Jun; Bernardi, Oderlei; Dourado, Patrick Marques; Carvalho, Renato Assis; Martinelli, Samuel; Head, Graham P.; Omoto, Celso			Cross-Resistance between Cry1 Proteins in Fall Armyworm (Spodoptera frugiperda) May Affect the Durability of Current Pyramided Bt Maize Hybrids in Brazil	PLOS ONE			English	Article							FIELD-EVOLVED RESISTANCE; LEPIDOPTERA-NOCTUIDAE; BACILLUS-THURINGIENSIS; INSECT RESISTANCE; PUERTO-RICO; SUSCEPTIBILITY; CORN; POPULATIONS; CROPS; MANAGEMENT	Genetically modified plants expressing insecticidal proteins from Bacillus thuringiensis (Bt) offer valuable options for managing insect pests with considerable environmental and economic benefits. Despite the benefits provided by Bt crops, the continuous expression of these insecticidal proteins imposes strong selection for resistance in target pest populations. Bt maize (Zeamays) hybrids have been successful in controlling fall armyworm(Spodoptera frugiperda), the mainmaize pest in Brazil since 2008; however, field-evolved resistance to the protein Cry1F has recently been reported. Therefore it is important to assess the possibility of cross-resistance between Cry1F and other Cry proteins expressed in Bt maize hybrids. In this study, an F-2 screen followed by subsequent selection on MON 89034 maize was used to select an S. frugiperda strain (RR) able to survive on the Bt maize event MON 89034, which expresses the Cry1A.105 and Cry2Ab2 proteins. Field-collected insects from maize expressing the Cry1F protein (event TC1507) represented most of the positive (resistance allele-containing) (iso)families found. The RR strain showed high levels of resistance to Cry1F, which apparently also conferred high levels of cross resistance to Cry1A.105 and Cry1Ab, but had only low-level (10-fold) resistance to Cry2Ab2. Life history studies to investigate fitness costs associated with the resistance in RR strain revealed only small reductions in reproductive rate when compared to susceptible and heterozygous strains, but the RR strain produced 32.2% and 28.4% fewer females from each female relative to the SS and RS (pooled) strains, respectively. Consistent with the lack of significant resistance to Cry2Ab2, MON 89034 maize in combination with appropriate management practices continues to provide effective control of S. frugiperda in Brazil. Nevertheless, the occurrence of Cry1F resistance in S. frugiperda across Brazil, and the cross-resistance to Cry1Ab and Cry1A.105, indicates that current Cry1-based maize hybrids face a challenge in managing S. frugiperda in Brazil and highlights the importance of effective insect resistance management for these technologies.	[Bernardi, Daniel; Salmeron, Eloisa; Horikoshi, Renato Jun; Bernardi, Oderlei; Omoto, Celso] Escola Super Agr Luiz de Queiroz ESALQ USP, Dept Entomol & Acarol, Sao Paulo, Brazil; [Dourado, Patrick Marques; Carvalho, Renato Assis] Monsanto Brasil Ltda, Sao Paulo, Brazil; [Martinelli, Samuel; Head, Graham P.] Monsanto LLC, St Louis, MO USA	Monsanto; Monsanto	Omoto, C (corresponding author), Escola Super Agr Luiz de Queiroz ESALQ USP, Dept Entomol & Acarol, Sao Paulo, Brazil.	celso.omoto@usp.br	Bernardi, Oderlei/D-3580-2013; /N-6433-2019; Omoto, Celso/D-9794-2012	Bernardi, Oderlei/0000-0001-9320-1642; /0000-0001-9320-1642; Omoto, Celso/0000-0002-6432-830X; Head, Graham/0000-0003-0521-0616	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [312086/2013-0, 459398/2014-8]; Monsanto	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Monsanto	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (www.cnpq.br) granted a doctoral scholarship to DB and research fellowship to CO (Grants # 312086/2013-0 and 459398/2014-8). Monsanto provided support in the form of salaries for PMD, RAC, SM and GPH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andow DA, 1998, J ECON ENTOMOL, V91, P572, DOI 10.1093/jee/91.3.572; Bernardi O, 2014, CROP PROT, V58, P33, DOI 10.1016/j.cropro.2014.01.001; Biosafety Clearing-House, 2015, GEN DNA SEQ CRY1A 10; Bourguet D, 2000, J ECON ENTOMOL, V93, P1588, DOI 10.1603/0022-0493-93.6.1588; Brookes G., 2014, GM CROPS GLOBAL SOCI; Carpenter JE, 2010, NAT BIOTECHNOL, V28, P319, DOI 10.1038/nbt0410-319; Carvalho RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062268; Celeres, 2014, INF BIOT IB14 03; Comas C, 2014, TRANSGENIC RES, V23, P135, DOI 10.1007/s11248-013-9737-0; Cruz I, 2012, INT J PEST MANAGE, V58, P83, DOI 10.1080/09670874.2012.655702; CTNBio Comissao Tecnica Nacional de Biosseguranca, 2007, TECHN OP 1 100 2007; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Diez-Rodriguez Gabriela I., 2001, Neotropical Entomology, V30, P311, DOI 10.1590/S1519-566X2001000200016; Farias JR, 2014, J ECON ENTOMOL, V107, P2182, DOI 10.1603/EC14190; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Hill DS, 1983, AGR INSECT PESTS TRO; Hollingsworth RG, 2011, ACTA HORTIC, V894, P45, DOI 10.17660/ActaHortic.2011.894.3; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112958; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Jakka SRK, 2014, J ECON ENTOMOL, V107, P342, DOI 10.1603/EC13326; Kasten J. P., 1978, REV AGR, V53, P68; Kathage J, 2012, P NATL ACAD SCI USA, V109, P11652, DOI 10.1073/pnas.1203647109; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Lewinsohn TM, 2005, CONSERV BIOL, V19, P619, DOI 10.1111/j.1523-1739.2005.00680.x; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Maia AHN, 2000, J ECON ENTOMOL, V93, P511, DOI 10.1603/0022-0493-93.2.511; MCGAUGHEY WH, 1992, SCIENCE, V258, P1451, DOI 10.1126/science.258.5087.1451; Mendes SM, 2009, 128 EMBR; Monnerat R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119544; Naranjo S. E., 2014, PLANT BIOTECHNOLOGY, P129, DOI DOI 10.1007/978-3-319-06892-3_11; Niu Y, 2014, CROP PROT, V59, P22, DOI 10.1016/j.cropro.2014.01.005; Niu Y, 2013, FLA ENTOMOL, V96, P701, DOI 10.1653/024.096.0302; Okumura R. S., 2013, African Journal of Agricultural Research, V8, P2232; Omoto C, 2005, BIOTECNOLOGIA CIENCI, V34, P67; PATERNIANI E, 2000, TRANSITION GLOBAL SU, P181; Pereira P. A. A., 2012, Agriculture and Food Security, V1; Robertson J. L., 1992, PESTICIDE BIOASSAYS; Hernandez-Rodriguez CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068164; SAS Institute, 2010, JMP SOFTW INTR GUID; SAS Institute, 2000, STAT AN SYST GETT ST; Storer Nicholas P, 2012, GM Crops Food, V3, P154, DOI 10.4161/gmcr.20945; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Velez AM, 2013, B ENTOMOL RES, V103, P700, DOI 10.1017/S0007485313000448; Waquil JM, 2013, PESQUI AGROPECU BRAS, V48, P1529, DOI 10.1590/S0100-204X2013001200001; Yang F, 2013, FLA ENTOMOL, V96, P714, DOI 10.1653/024.096.0303	49	90	92	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140130	10.1371/journal.pone.0140130	http://dx.doi.org/10.1371/journal.pone.0140130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473961	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500028
J	Duquette, JF; Belant, JL; Svoboda, NJ; Beyer, DE; Lederle, PE				Duquette, Jared F.; Belant, Jerrold L.; Svoboda, Nathan J.; Beyer, Dean E., Jr.; Lederle, Patrick E.			Scale Dependence of Female Ungulate Reproductive Success in Relation to Nutritional Condition, Resource Selection and Multi-Predator Avoidance	PLOS ONE			English	Article							WHITE-TAILED DEER; CAUSE-SPECIFIC MORTALITY; HABITAT SELECTION; ANTIPREDATOR RESPONSE; NEONATAL-MORTALITY; TEMPORAL VARIATION; WOODLAND CARIBOU; SITE SELECTION; SURVIVAL; RISK	Female ungulate reproductive success is dependent on the survival of their young, and affected by maternal resource selection, predator avoidance, and nutritional condition. However, potential hierarchical effects of these factors on reproductive success are largely unknown, especially in multi-predator landscapes. We expanded on previous research of neonatal white-tailed deer (Odocoileus virginianus) daily survival within home ranges to assess if resource use, integrated risk of 4 mammalian predators, maternal nutrition, winter severity, hiding cover, or interactions among these variables best explained landscape scale variation in daily or seasonal survival during the post-partum period. We hypothesized that reproductive success would be limited greater by predation risk at coarser spatiotemporal scales, but habitat use at finer scales. An additive model of daily non-ideal resource use and maternal nutrition explained the most (69%) variation in survival; though 65% of this variation was related to maternal nutrition. Strong support of maternal nutrition across spatiotemporal scales did not fully support our hypothesis, but suggested reproductive success was related to dam behaviors directed at increasing nutritional condition. These behaviors were especially important following severe winters, when dams produced smaller fawns with less probability of survival. To increase nutritional condition and decrease wolf (Canis lupus) predation risk, dams appeared to place fawns in isolated deciduous forest patches near roads. However, this resource selection represented non-ideal resources for fawns, which had greater predation risk that led to additive mortalities beyond those related to resources alone. Although the reproductive strategy of dams resulted in greater predation of fawns from alternative predators, it likely improved the life-long reproductive success of dams, as many were late-aged (> 10 years old) and could have produced multiple litters of fawns. Our study emphasizes understanding the scale-dependent hierarchy of factors limiting reproductive success is essential to providing reliable knowledge for ungulate management.	[Duquette, Jared F.; Belant, Jerrold L.; Svoboda, Nathan J.] Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA; [Beyer, Dean E., Jr.] Michigan Dept Nat Resources, Wildlife Div, Marquette, MI USA; [Lederle, Patrick E.] Michigan Dept Nat Resources, Wildlife Div, Lansing, MI USA	Mississippi State University	Duquette, JF (corresponding author), Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA.	jared.f.duquette@gmail.com	Belant, Jerrold/HDM-7749-2022		Federal Aid in Wildlife Restoration Act under Pittman-Robertson project [W-147-R]; Michigan Department of Natural Resources; Safari Club International Foundation; Safari Club International-Michigan Involvement Committee; Mississippi State University	Federal Aid in Wildlife Restoration Act under Pittman-Robertson project; Michigan Department of Natural Resources; Safari Club International Foundation; Safari Club International-Michigan Involvement Committee; Mississippi State University	This project was supported by the Federal Aid in Wildlife Restoration Act under Pittman-Robertson project W-147-R. The authors thank Michigan Department of Natural Resources, Safari Club International Foundation, Safari Club International-Michigan Involvement Committee, and Mississippi State University for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt D, 2007, ECOLOGY, V88, P792, DOI 10.1890/06-0574; Atwood TC, 2009, J WILDLIFE MANAGE, V73, P876, DOI 10.2193/2008-325; Ballard WB, 2001, WILDLIFE SOC B, V29, P99; Barbknecht AE, 2011, J WILDLIFE MANAGE, V75, P646, DOI 10.1002/jwmg.100; Basille M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065493; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Berger KM, 2008, ECOLOGY, V89, P818, DOI 10.1890/07-0193.1; Beyer H. L, 2012, GEOSPATIAL MODELLING; Bongi P, 2008, J ZOOL, V276, P242, DOI 10.1111/j.1469-7998.2008.00481.x; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Brodie J, 2013, J APPL ECOL, V50, P295, DOI 10.1111/1365-2664.12044; Broekhuis F, 2013, J ANIM ECOL, V82, P1097, DOI 10.1111/1365-2656.12077; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Carstensen M, 2003, WILDLIFE SOC B, V31, P634; Carstensen M, 2009, J WILDLIFE MANAGE, V73, P175, DOI 10.2193/2006-107; Christianson D, 2010, ECOLOGY, V91, P1184, DOI 10.1890/09-0221.1; Ciarniello LM, 2007, ECOL APPL, V17, P1424, DOI 10.1890/06-1100.1; COOK RS, 1971, J WILDLIFE MANAGE, V35, P47, DOI 10.2307/3799870; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2008, ANIM BEHAV, V76, P1139, DOI 10.1016/j.anbehav.2008.07.006; DeCesare NJ, 2014, J ANIM ECOL, V83, P343, DOI 10.1111/1365-2656.12144; DelGiudice GD, 2002, J WILDLIFE MANAGE, V66, P698, DOI 10.2307/3803136; Delgiudice GD, 2006, J WILDLIFE MANAGE, V70, P1556, DOI 10.2193/0022-541X(2006)70[1556:ALASAO]2.0.CO;2; Duquette JF, 2012, WILDLIFE SOC B, V36, P115, DOI 10.1002/wsb.115; Duquette JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100841; Duquette JF, 2014, POPUL ECOL, V56, P481, DOI 10.1007/s10144-014-0432-7; Environmental Systems Research Institute, 2011, ARCGIS DESKT REL 10; Farmer CJ, 2006, J WILDLIFE MANAGE, V70, P1403, DOI 10.2193/0022-541X(2006)70[1403:RFAMOB]2.0.CO;2; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fox J., 2002, R S PLUS COMPANION A; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gervasi V, 2014, J ZOOL, V292, P175, DOI 10.1111/jzo.12088; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Griffin KA, 2011, J ANIM ECOL, V80, P1246, DOI 10.1111/j.1365-2656.2011.01856.x; Grovenburg TW, 2012, J WILDLIFE MANAGE, V76, P944, DOI 10.1002/jwmg.339; Grovenburg TW, 2012, ANIM BEHAV, V84, P59, DOI 10.1016/j.anbehav.2012.04.005; Grovenburg TW, 2010, J WILDLIFE MANAGE, V74, P1250, DOI 10.2193/2009-399; Gurarie E, 2011, OECOLOGIA, V165, P891, DOI 10.1007/s00442-010-1883-y; Gustine DD, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)165[1:CSOWCI]2.0.CO;2; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; Kittle AM, 2008, OECOLOGIA, V157, P163, DOI 10.1007/s00442-008-1051-9; Kjellander P, 2004, P ROY SOC LOND B BIO, V271, P338; KUNKEL KE, 1994, CAN J ZOOL, V72, P1557, DOI 10.1139/z94-207; Latif QS, 2011, OIKOS, V120, P1139, DOI 10.1111/j.1600-0706.2010.18835.x; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Manly B.F.J., 2002, RESOURCE SELECTION A; MAUTZ W W, 1978, Wildlife Society Bulletin, V6, P88; McLoughlin PD, 2005, J ANIM ECOL, V74, P701, DOI 10.1111/j.1365-2656.2005.00967.x; MECH LD, 1991, J MAMMAL, V72, P146, DOI 10.2307/1381989; *MI DEP NAT RES, 2008, MICH WOLF MAN PLAN; Michigan Department of Natural Resources, 2010, W UP DEER CAMP SURV; Michigan Department of Natural Resources, 2010, 3507 MICH DEP NAT RE; Millspaugh JJ., 2001, RADIO TRACKING ANIMA; Monteith KL, 2009, J MAMMAL, V90, P651, DOI 10.1644/08-MAMM-A-191R1.1; Nelson ME, 2006, AM MIDL NAT, V155, P373, DOI 10.1674/0003-0031(2006)155[373:ADDODO]2.0.CO;2; Nelson ME, 1981, WILDLIFE MONOGR, V77, P3; NELSON TA, 1987, J WILDLIFE MANAGE, V51, P326, DOI 10.2307/3801010; OZOGA JJ, 1982, J WILDLIFE MANAGE, V46, P281, DOI 10.2307/3808640; Panzacchi M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1267, DOI 10.1007/s00265-010-0941-0; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Petroelje TR, 2013, WILDLIFE BIOL, V19, P41, DOI 10.2981/12-022; Pettorelli N, 2006, OIKOS, V112, P565, DOI 10.1111/j.0030-1299.2006.14447.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANGUAGE ENV STAT; Relyea Rick A., 2005, P189; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Sams MG, 1996, J MAMMAL, V77, P179, DOI 10.2307/1382719; Stricker HK, 2012, WILDLIFE SOC B, V36, P257, DOI 10.1002/wsb.137; Sutherland WJ, 1983, J ANIM ECOL, V828; Therneau T., 2013, PACKAGE SURVIVAL ANA, P37; Therneau T, 2015, MIXED EFFECTS COX MO; Therrien JF, 2007, BEHAV ECOL SOCIOBIOL, V62, P193, DOI 10.1007/s00265-007-0453-8; Theuerkauf J, 2008, FOREST ECOL MANAG, V256, P1325, DOI 10.1016/j.foreco.2008.06.030; Thomson RL, 2006, ECOGRAPHY, V29, P507; Tollefson TN, 2011, J WILDLIFE MANAGE, V75, P919, DOI 10.1002/jwmg.113; United States Bureau of the Census, 2010, TOP INT GEOGR ENC RE; United States Geological Survey, 2013, 250M MODIS NORM DIFF; United States Geological Survey, 2011, NAT LANDC DAT 2006; Van Moorter B, 2009, OECOLOGIA, V159, P669, DOI 10.1007/s00442-008-1245-1; Webb Stephen L., 2012, Ecological Processes, V1; WHITE M, 1973, J MAMMAL, V54, P291, DOI 10.2307/1378900; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	88	5	5	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140433	10.1371/journal.pone.0140433	http://dx.doi.org/10.1371/journal.pone.0140433			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473968	Green Published, gold			2022-12-26	WOS:000363185500048
J	Oliver, JAC; Forman, OP; Pettitt, L; Mellersh, CS				Oliver, James A. C.; Forman, Oliver P.; Pettitt, Louise; Mellersh, Cathryn S.			Two Independent Mutations in ADAMTS17 Are Associated with Primary Open Angle Glaucoma in the Basset Hound and Basset Fauve de Bretagne Breeds of Dog	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; SITE MUTATION; GENE; IDENTIFICATION; POAG	Purpose Mutations in ADAMTS10 (CFA20) have previously been associated with primary open angle glaucoma (POAG) in the Beagle and Norwegian Elkhound. The closely related gene, ADAMTS17, has also been associated with several different ocular phenotypes in multiple breeds of dog, including primary lens luxation and POAG. We investigated ADAMTS17 as a candidate gene for POAG in the Basset Hound and Basset Fauve de Bretagne dog breeds. Methods We performed ADAMTS17 exon resequencing in three Basset Hounds and three Basset Fauve de Bretagne dogs with POAG. Identified variants were genotyped in additional sample cohorts of both breeds and dogs of other breeds to confirm their association with disease. Results All affected Basset Hounds were homozygous for a 19 bp deletion in exon 2 that alters the reading frame and is predicted to lead to a truncated protein. Fifty clinically unaffected Basset Hounds were genotyped for this mutation and all were either heterozygous or homozygous for the wild type allele. Genotyping of 223 Basset Hounds recruited for a different study revealed a mutation frequency of 0.081 and predicted frequency of affected dogs in the population to be 0.007. Based on the entire genotyping dataset the association statistic for the POAG-associated deletion was p = 1.26 x 10(-10). All affected Basset Fauve de Bretagne dogs were homozygous for a missense mutation in exon 11 causing a glycine to serine amino acid substitution (G519S) in the disintegrin-like domain of ADAMTS17 which is predicted to alter protein function. Unaffected Basset Fauve de Bretagne dogs were either heterozygous for the mutation (5/24) or homozygous for the wild type allele (19/24). Based on the entire genotyping dataset the association statistic for the POAG-associated deletion was p = 2.80 x 10(-7). Genotyping of 85 dogs of unrelated breeds and 90 dogs of related breeds for this variant was negative. Conclusion This report documents strong associations between two independent ADAMTS17 mutations and POAG in two different dog breeds.	[Oliver, James A. C.; Forman, Oliver P.; Pettitt, Louise; Mellersh, Cathryn S.] Anim Hlth Trust, Ctr Prevent Med, Dept Canine Genet Res, Newmarket, Suffolk, England	Animal Health Trust	Oliver, JAC (corresponding author), Anim Hlth Trust, Ctr Prevent Med, Dept Canine Genet Res, Newmarket, Suffolk, England.	James.Oliver@aht.org.uk		Oliver, James/0000-0002-2540-2183				Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Ahonen SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111941; Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; ALEXANDER JP, 1991, INVEST OPHTH VIS SCI, V32, P172; Apte SS, 2015, MATRIX BIOL; Apte SS, 2015, MATRIX BIOL; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Baird PN, 2005, HUM GENET, V117, P249, DOI 10.1007/s00439-005-1296-x; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; Chandra A, 2012, INVEST OPHTH VIS SCI, V53, P4889, DOI 10.1167/iovs.12-9874; Fan BJ, 2006, CLIN BIOCHEM, V39, P249, DOI 10.1016/j.clinbiochem.2005.11.001; Farias FHG, 2010, INVEST OPHTH VIS SCI, V51, P4716, DOI 10.1167/iovs.09-5142; Forman O, 2015, 8 INT C ADV CAN FEL; GELATT KN, 1976, T AM ACAD OPHTHALMOL, V81, pO636; Gould D, 2011, VET OPHTHALMOL, V14, P378, DOI 10.1111/j.1463-5224.2011.00892.x; Greene VB, 2010, OPHTHALMIC GENET, V31, P47, DOI 10.3109/13816810903567604; Grimm DG, 2015, HUM MUTAT, V36, P513, DOI 10.1002/humu.22768; Kato K, 2009, GRAEF ARCH CLIN EXP, V247, P1435, DOI 10.1007/s00417-009-1053-2; Keller KE, 2009, INVEST OPHTH VIS SCI, V50, P5769, DOI 10.1167/iovs.09-3673; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Khan AO, 2012, OPHTHALMIC GENET, V33, P235, DOI 10.3109/13816810.2012.666708; Kuchtey J, 2013, INVEST OPHTH VIS SCI, V54, P1881, DOI 10.1167/iovs.12-10796; Kuchtey J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001306; Li J, 2014, MOL VIS, V20, P1017; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Palko JR, 2013, INVEST OPHTH VIS SCI, V54, P2685, DOI 10.1167/iovs.12-10621; Peng XQ, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S5-S8; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Racette L, 2003, SURV OPHTHALMOL, V48, P295, DOI 10.1016/S0039-6257(03)00028-6; Radner FPW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003536; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Shah MH, 2014, MOL VIS, V20, P790; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Takamoto M, 2014, JPN J OPHTHALMOL, V58, P1, DOI 10.1007/s10384-013-0286-0; TEIKARI JM, 1987, ACTA OPHTHALMOL, V65, P715; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Wiggs JL, 2000, HUM MOL GENET, V9, P1109, DOI 10.1093/hmg/9.7.1109; Wolfs RCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1640, DOI 10.1001/archopht.116.12.1640	42	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140436	10.1371/journal.pone.0140436	http://dx.doi.org/10.1371/journal.pone.0140436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474315	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500051
J	Varga, Z; Noske, A				Varga, Zsuzsanna; Noske, Aurelia			Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; AMERICAN-SOCIETY; CLINICAL-ONCOLOGY; RECOMMENDATIONS; IMMUNOHISTOCHEMISTRY; ACCURACY	Introduction The latest guidelines of the American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) to test Human Epidermal Growth Factor Receptor 2 (HER2) in breast cancer after being revised in 2008 underwent a second modification in October 2013. The modification includes changes in cut-offs: 10% strong membranous staining for score 3+ on immunohistochemistry (IHC) (previously 30%) and using the ratio of >2 or absolute gene-copy-number (6 or more) alone or in combination with each other by in-situ-hybridisation technology (previously >2.2 and average copy-number of 6 or more). Hereby we addressed the question, which impact the modified cut-offs had on overall HER2-positivity in a single institution. Methods We prospectively analysed 617 consecutive diagnostic breast-cancer cases which underwent double HER2 testing by immunohistochemistry and fluorescent in-situ hybridisation (FISH), using the modified 2013 ASCO/CAP-guidelines for one year (October 2013-October 2014). Results were compared with HER2-test results on 1,528 consecutive diagnostic breast-cancer cases from two previous years (2011-2012), using the 2008 ASCO/CAP guidelines, also tested with IHC and FISH in each case. Results Between October 2013 and October 2014, overall HER2-positivity was 15.8%(98 of 617 cases were either IHC 3+ or FISH amplified). 79 of 617 cases (13%) were IHC 3+, 96 of 617 cases (15.5%) were FISH amplified. Equivocal cases were seen in 25 of 617 cases (4.1%). 22 of 25 equivocal cases (88%) in 2013-2014 were IHC 1+ or 2+. In 13 equivocal cases, there was a repeated IHC/FISH testing: 2 of 13 cases (15%) became FISH amplified, 1 of 13 cases (7.5%) became IHC 3+. In 2011-2012, overall HER2-positivity (IHC/FISH) was 13.8% (211 of 1,528 cases). 185 of 1,528 cases (12%) were 3+ on IHC, 181 of 1,522 cases (12%) were amplified by FISH. Six of 1,528 cases were equivocal by FISH, and interpreted as non-amplified (0.3%). Conclusions Applying the modified ASCO/CAP guidelines from 2013 resulted in an increase (2%) in overall HER2-positivity rate compared to overall-HER2-positivity rate using the 2008 ASCO/CAP guidelines. The increased positivity rate was mainly due to more FISH-positive cases (3.5% more than until 2013). The high rate of equivocal cases (4.1%) did not contribute to increase in overall HER2-positivity, but resulted in delay in definitive HER2-status.	[Varga, Zsuzsanna; Noske, Aurelia] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Varga, Z (corresponding author), Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland.	zsuzsanna.varga@usz.ch						Bethune GC, 2015, HISTOPATHOLOGY, V67, P880, DOI 10.1111/his.12723; Bianchi S, 2015, PATHOL ONCOL RES, V21, P477, DOI 10.1007/s12253-014-9852-0; Calhoun BC, 2015, SEMIN DIAGN PATHOL, V32, P362, DOI 10.1053/j.semdp.2015.02.011; Garbar Christian, 2014, ISRN Oncol, V2014, P793695, DOI 10.1155/2014/793695; Hicks DG, 2005, HUM PATHOL, V36, P250, DOI 10.1016/j.humpath.2004.11.010; Lebeau A, 2001, J CLIN ONCOL, V19, P354, DOI 10.1200/JCO.2001.19.2.354; Lebeau A, 2010, J CLIN ONCOL, V28, P3264, DOI 10.1200/JCO.2009.25.9366; Moelans CB, 2011, CRIT REV ONCOL HEMAT, V80, P380, DOI 10.1016/j.critrevonc.2010.12.005; Pennacchia I, 2015, BREAST, V24, P285, DOI 10.1016/j.breast.2015.01.014; Perez EA, 2014, CANCER TREAT REV, V40, P276, DOI 10.1016/j.ctrv.2013.09.001; Pu XH, 2015, PATHOL RES PRACT, V211, P421, DOI 10.1016/j.prp.2014.09.010; Rakha EA, 2015, J CLIN ONCOL, V33, DOI 10.1200/JCO.2014.59.7211; Rakha EA, 2014, HISTOPATHOLOGY, V64, P609, DOI 10.1111/his.12357; Rakha EA, 2014, NAT REV CLIN ONCOL, V11, P8, DOI 10.1038/nrclinonc.2013.230; Sapino A, 2014, ONCOLOGIST, V19, P1118, DOI 10.1634/theoncologist.2014-0195; Varga Z, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-615; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wolff AC, 2015, J CLIN ONCOL, V33, P1302, DOI 10.1200/JCO.2014.59.7559; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Zhang H., 2013, INT J INTEGRATIVE ME, V1, P1, DOI DOI 10.1049/J0E.2013.0116	20	47	47	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140652	10.1371/journal.pone.0140652	http://dx.doi.org/10.1371/journal.pone.0140652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473483	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000363185500075
J	Yang, RM; Rossiter, DG; Liu, F; Lu, YY; Yang, F; Yang, F; Zhao, YG; Li, DC; Zhang, GL				Yang, Renmin; Rossiter, David G.; Liu, Feng; Lu, Yuanyuan; Yang, Fan; Yang, Fei; Zhao, Yuguo; Li, Decheng; Zhang, Ganlin			Predictive Mapping of Topsoil Organic Carbon in an Alpine Environment Aided by Landsat TM	PLOS ONE			English	Article							REGRESSION TREES; INORGANIC CARBON; SOIL; VEGETATION; IMAGERY; STORAGE; CLASSIFICATION; GRASSLAND; MATTER; STOCKS	The objective of this study was to examine the reflectance of Landsat TM imagery for mapping soil organic Carbon (SOC) content in an Alpine environment. The studied area (ca. 3*10(4) km(2)) is the upper reaches of the Heihe River at the northeast edge of the Tibetan plateau, China. A set (105) of topsoil samples were analyzed for SOC. Boosted regression tree (BRT) models using Landsat TM imagery were built to predict SOC content, alone or with topography and climate covariates (temperature and precipitation). The best model, combining all covariates, was only marginally better than using only imagery. Imagery alone was sufficient to build a reasonable model; this was a bit better than only using topography and climate covariates. The Lin's concordance correlation coefficient values of the imagery only model and the full model are very close, larger than the topography and climate variables based model. In the full model, SOC was mainly explained by Landsat TM imagery (65% relative importance), followed by climate variables (20%) and topography (15% of relative importance). The good results from imagery are likely due to (1) the strong dependence of SOC on native vegetation intensity in this Alpine environment; (2) the strong correlation in this environment between imagery and environmental covariables, especially elevation (corresponding to temperature), precipitation, and slope aspect. We conclude that multispectral satellite data from Landsat TM images may be used to predict topsoil SOC with reasonable accuracy in Alpine regions, and perhaps other regions covered with natural vegetation, and that adding topography and climate covariables to the satellite data can improve the predictive accuracy.	[Yang, Renmin; Rossiter, David G.; Liu, Feng; Lu, Yuanyuan; Yang, Fan; Yang, Fei; Zhao, Yuguo; Li, Decheng; Zhang, Ganlin] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing 210008, Jiangsu, Peoples R China; [Yang, Renmin; Lu, Yuanyuan; Yang, Fan; Yang, Fei; Zhang, Ganlin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Rossiter, David G.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Cornell University	Zhang, GL (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing 210008, Jiangsu, Peoples R China.	glzhang@issas.ac.cn	Li, Decheng/L-7383-2019; Rossiter, David G/D-3842-2009; meersmans, jeroen/T-2186-2017; Zhang, Gan-Lin/V-9261-2017	Rossiter, David G/0000-0003-4558-1286; meersmans, jeroen/0000-0001-6614-1453; Zhang, Gan-Lin/0000-0002-6189-5018	National Natural Science Foundation of China [41130530, 91325301, 41201207, 41571212, 41371224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos: 41130530, 91325301, 41201207, 41571212, 41371224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L, 1984, WADSWORTH STAT PROBA; Bui E, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003506; Carslaw DC, 2009, ATMOS ENVIRON, V43, P3563, DOI 10.1016/j.atmosenv.2009.04.001; COLEMAN TL, 1993, SOIL SCI, V155, P283, DOI 10.1097/00010694-199304000-00007; Dare PM, 2005, PHOTOGRAMM ENG REM S, V71, P169, DOI 10.14358/PERS.71.2.169; Data Center of the Heihe Project, 2011, LANDS TM MOS IM HEIH; Dematte JAM, 2007, INT J REMOTE SENS, V28, P3813, DOI 10.1080/01431160601121469; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Froeschke JT, 2011, FISH RES, V111, P131, DOI 10.1016/j.fishres.2011.07.008; Geerken R, 2005, INT J REMOTE SENS, V26, P5535, DOI 10.1080/01431160500300297; Giles PT, 2001, PHOTOGRAMM ENG REM S, V67, P833; Grimm R, 2008, GEODERMA, V146, P102, DOI 10.1016/j.geoderma.2008.05.008; Huang XW, 2007, GEODERMA, V141, P34, DOI 10.1016/j.geoderma.2007.04.023; Jaber SM, 2011, PHOTOGRAMM ENG REM S, V77, P709, DOI 10.14358/PERS.77.7.709; Jafari A, 2014, GEODERMA, V232, P148, DOI 10.1016/j.geoderma.2014.04.029; Jalabert SSM, 2010, SOIL USE MANAGE, V26, P516, DOI 10.1111/j.1475-2743.2010.00305.x; Jin XM, 2009, INT J REMOTE SENS, V30, P5751, DOI 10.1080/01431160902736635; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kheir RB, 2010, J ENVIRON MANAGE, V91, P1150, DOI 10.1016/j.jenvman.2010.01.001; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Krishnan P, 2007, CURR SCI INDIA, V93, P706; Lawrence R, 2004, REMOTE SENS ENVIRON, V90, P331, DOI 10.1016/j.rse.2004.01.007; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Liu F, 2013, SOIL SCI SOC AM J, V77, P1241, DOI 10.2136/sssaj2012.0317; Ma WH, 2010, GLOBAL ECOL BIOGEOGR, V19, P233, DOI 10.1111/j.1466-8238.2009.00508.x; Malone BP, 2009, GEODERMA, V154, P138, DOI 10.1016/j.geoderma.2009.10.007; Martin MP, 2009, SOIL SCI SOC AM J, V73, P485, DOI 10.2136/sssaj2007.0241; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; Minasny B, 2006, AUST J SOIL RES, V44, P233, DOI 10.1071/SR05136; Minasny B, 2013, ADV AGRON, V118, P1, DOI 10.1016/B978-0-12-405942-9.00001-3; Nanni MR, 2006, SOIL SCI SOC AM J, V70, P393, DOI 10.2136/sssaj2003.0285; Olaya V., 2004, GENTLE INTRO SAGA GI; Pouteau R, 2011, REMOTE SENS ENVIRON, V115, P117, DOI 10.1016/j.rse.2010.08.011; R Core Team, 2020, R LANG ENV STAT COMP; Razakamanarivo RH, 2011, GEODERMA, V162, P335, DOI 10.1016/j.geoderma.2011.03.006; Riano D, 2003, IEEE T GEOSCI REMOTE, V41, P1056, DOI 10.1109/TGRS.2003.811693; Ryan MG, 2005, BIOGEOCHEMISTRY, V73, P3, DOI 10.1007/s10533-004-5167-7; Shi Y, 2012, BIOGEOSCIENCES, V9, P2287, DOI 10.5194/bg-9-2287-2012; Soil Survey Staff, 2014, KEYS SOIL TAX; Sullivan DG, 2005, SOIL SCI SOC AM J, V69, P1789, DOI 10.2136/sssaj2005.0071; Turner DP, 1999, REMOTE SENS ENVIRON, V70, P52, DOI 10.1016/S0034-4257(99)00057-7; Vasques GM, 2010, GEODERMA, V156, P326, DOI 10.1016/j.geoderma.2010.03.002; Vaudour E, 2013, SOIL SCI SOC AM J, V77, P2122, DOI 10.2136/sssaj2013.02.0062; Wang GX, 2002, SCI TOTAL ENVIRON, V291, P207, DOI 10.1016/S0048-9697(01)01100-7; Wang YG, 2010, SCI TOTAL ENVIRON, V408, P1925, DOI 10.1016/j.scitotenv.2010.01.015; Wang ZP, 2013, CATENA, V109, P110, DOI 10.1016/j.catena.2013.04.008; Wilson PA, 1997, PHOTOGRAMM ENG REM S, V63, P485; Xie ZB, 2007, GLOBAL CHANGE BIOL, V13, P1989, DOI 10.1111/j.1365-2486.2007.01409.x; Yang F, 2014, J HYDROL, V519, P3086, DOI 10.1016/j.jhydrol.2014.10.054; Yang YH, 2008, GLOBAL CHANGE BIOL, V14, P1592, DOI 10.1111/j.1365-2486.2008.01591.x; Zhang G., 2012, SOIL SURVEY LAB METH	54	26	27	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0139042	10.1371/journal.pone.0139042	http://dx.doi.org/10.1371/journal.pone.0139042			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473739	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500007
J	Bonnyaud, C; Pradon, D; Bensmail, D; Roche, N				Bonnyaud, Celine; Pradon, Didier; Bensmail, Djamel; Roche, Nicolas			Dynamic Stability and Risk of Tripping during the Timed Up and Go Test in Hemiparetic and Healthy Subjects	PLOS ONE			English	Article							CENTER-OF-MASS; MINIMUM FOOT CLEARANCE; SIT-TO-STAND; CHRONIC STROKE; ELDERLY INDIVIDUALS; BODY REORIENTATION; GAIT STABILITY; LEVEL WALKING; BRAIN-INJURY; FALLS	Background The Timed Up and Go (TUG) test is often used to estimate risk of falls. Foot clearance and displacement of the center of mass (COM), which are related to risk of tripping and dynamic stability have never been evaluated during the TUG. Accurate assessment of these parameters using instrumented measurements would provide a comprehensive assessment of risk of falls in hemiparetic patients. The aims of this study were to analyze correlations between TUG performance time and displacement of the COM and foot clearance in patients with stroke-related hemiparesis and healthy subjects during the walking and turning sub-tasks of the TUG and to compare these parameters between fallers and non-fallers. Methods 29 hemiparetic patients and 25 healthy subjects underwent three-dimensional gait analysis during the TUG test. COM and foot clearance were analyzed during the walking and turning sub-tasks of the TUG. Results Lateral displacement of the COM was greater and faster during the walking sub-tasks and vertical displacement of the COM was greater during the turn in the patients compared to the healthy subjects (respectively p<0.01 and p<0.05). Paretic foot clearance was greater during walking and displacement of the COM was slower during the turn in the patients (p<0.01). COM displacement and velocity during the turn were correlated with TUG performance in the patients, however, vertical COM displacement was not. These correlations were significant in the healthy subjects. There were no differences between COM parameters or foot clearance in fallers and non-fallers. Discussion and Conclusion Hemiparetic patients are less stable than healthy subjects, but compensate with a cautious gait to avoid tripping. Instrumented analysis of the TUG test appears relevant for the assessment of dynamic stability in hemiparetic patients, providing more information than straight-line gait.	[Bonnyaud, Celine; Pradon, Didier; Roche, Nicolas] Hop Raymond Poincare, Serv Physiol & Explorat Fonctionnelle, UVSQ CIC 1429,APHP Lab Analyse Mouvement, INSERM Unit 1179,Team 3 Technol & Innovat Therapi, F-92380 Garches, France; [Bensmail, Djamel] Hop Raymond Poincare, APHP Serv Med Phys & Readaptat, INSERM Unit 1179,UVSQ CIC 1429, Team 3 Technol & Innovat Therapies Appl Neuromusc, F-92380 Garches, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Bonnyaud, C (corresponding author), Hop Raymond Poincare, Serv Physiol & Explorat Fonctionnelle, UVSQ CIC 1429,APHP Lab Analyse Mouvement, INSERM Unit 1179,Team 3 Technol & Innovat Therapi, F-92380 Garches, France.	celine.bonnyaud@rpc.aphp.fr	Bensmail, Djamel/R-6035-2018; Bonnyaud, Celine/AGK-7246-2022; roche, nicolas/R-6080-2018	Bensmail, Djamel/0000-0001-9360-9330; 				Andersson AG, 2006, J REHABIL MED, V38, P186, DOI 10.1080/16501970500478023; Barre A, 2014, COMPUT METH PROG BIO, V114, DOI 10.1016/j.cmpb.2014.01.012; Barrett RS, 2010, GAIT POSTURE, V32, P429, DOI 10.1016/j.gaitpost.2010.07.010; Barry E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-14; Begg R, 2007, GAIT POSTURE, V25, P191, DOI 10.1016/j.gaitpost.2006.03.008; Bonnyaud C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129821; Brunt D, 2002, ARCH PHYS MED REHAB, V83, P924, DOI 10.1053/apmr.2002.3324; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Cheng PT, 1998, ARCH PHYS MED REHAB, V79, P1043, DOI 10.1016/S0003-9993(98)90168-X; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Chou LS, 2003, GAIT POSTURE, V18, P125, DOI 10.1016/S0966-6362(02)00067-X; Clark RA, 2012, ARCH PHYS MED REHAB, V93, P636, DOI 10.1016/j.apmr.2011.11.002; Faria CDCD, 2009, TOP STROKE REHABIL, V16, P196, DOI 10.1310/tsr1603-196; Cruz TH, 2009, J BIOMECH, V42, P1673, DOI 10.1016/j.jbiomech.2009.04.015; Dempster W.T., 1955, SPACE REQUIREMENTS S; Detrembleur C, 2003, GAIT POSTURE, V18, P47, DOI 10.1016/S0966-6362(02)00193-5; Domholdt E., 2000, PHYS THERAPY RES PRI, V2nd ed.; Faria CD, 2012, ARCH PHYS MED REHAB, V93, P1034, DOI 10.1016/j.apmr.2011.11.025; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FORSTER A, 1995, BRIT MED J, V311, P83, DOI 10.1136/bmj.311.6997.83; Frykberg GE, 2009, ARCH PHYS MED REHAB, V90, P1009, DOI 10.1016/j.apmr.2008.12.023; Gates DH, 2012, GAIT POSTURE, V35, P36, DOI 10.1016/j.gaitpost.2011.08.001; Gilleard W, 2008, GAIT POSTURE, V27, P8, DOI 10.1016/j.gaitpost.2006.11.002; Hahn ME, 2003, CLIN BIOMECH, V18, P737, DOI 10.1016/S0268-0033(03)00139-6; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Harris JE, 2005, PHYS THER, V85, P150, DOI 10.1093/ptj/85.2.150; Hasan S. S., 1996, GAIT POSTURE, V4, P1; Heasley K, 2004, INVEST OPHTH VIS SCI, V45, P2122, DOI 10.1167/iovs.03-1199; Hollands MA, 2001, EXP BRAIN RES, V140, P223, DOI 10.1007/s002210100811; Hurt CP, 2015, J BIOMECH, V48, P592, DOI 10.1016/j.jbiomech.2015.01.003; Hyndman D, 2002, ARCH PHYS MED REHAB, V83, P165, DOI 10.1053/apmr.2002.28030; Jorgensen L, 2002, STROKE, V33, P542, DOI 10.1161/hs0202.102375; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kao PC, 2014, GAIT POSTURE, V40, P457, DOI 10.1016/j.gaitpost.2014.05.014; Little VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110140; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Menant JC, 2009, GAIT POSTURE, V29, P392, DOI 10.1016/j.gaitpost.2008.10.057; Mills PM, 2001, HUM MOVEMENT SCI, V20, P427, DOI 10.1016/S0167-9457(01)00061-6; Ng SS, 2005, ARCH PHYS MED REHAB, V86, P1641, DOI 10.1016/j.apmr.2005.01.011; Orendurff MS, 2004, J REHABIL RES DEV, V41, P829, DOI 10.1682/JRRD.2003.10.0150; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; Perry J, 1992, GAIT ANAL NORMAL PAT, P9; Persson CU, 2011, J REHABIL MED, V43, P348, DOI 10.2340/16501977-0677; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Roy G, 2006, CLIN BIOMECH, V21, P585, DOI 10.1016/j.clinbiomech.2006.01.007; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Simpson SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020039; Staszkiewicz R, 2010, ACTA BIOENG BIOMECH, V12, P13; Thigpen MT, 2000, PHYS THER, V80, P1174, DOI 10.1093/ptj/80.12.1174; Tucker CA, 1998, GAIT POSTURE, V8, P117, DOI 10.1016/S0966-6362(98)00030-7; Vallis LA, 2004, EXP BRAIN RES, V157, P94, DOI 10.1007/s00221-003-1824-7; WINTER DA, 1974, J BIOMECH, V7, P157, DOI 10.1016/0021-9290(74)90056-6; WINTER DA, 1992, PHYS THER, V72, P55, DOI 10.1093/ptj/72.1.55; Winter DA., 1987, BIOMECHANICS MOTOR C; Zampieri C, 2010, J NEUROL NEUROSUR PS, V81, P171, DOI 10.1136/jnnp.2009.173740	57	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140317	10.1371/journal.pone.0140317	http://dx.doi.org/10.1371/journal.pone.0140317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469345	Green Submitted, Green Published, gold			2022-12-26	WOS:000363184600039
J	Byrareddy, SN; Little, D; Mayne, AE; Villinger, F; Ansari, AA				Byrareddy, Siddappa N.; Little, Dawn; Mayne, Ann E.; Villinger, Francois; Ansari, Aftab A.			Phenotypic and Functional Characterization of Monoclonal Antibodies with Specificity for Rhesus Macaque CD200, CD200R and Mincle	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; LECTIN-LIKE RECEPTORS; MUCOSAL TRANSMISSION; ENVELOPE; GLYCOSYLATION; INFECTION; TISSUE; IDENTIFICATION; MONOCYTE; TYPE-1	Lectin-like molecules and their receptors are cell surface molecules that have been shown to play a role in either facilitating infection or serving as transporters of HIV/SIV in vivo. The role of these lectin-like molecules in the pathogenesis of HIV/SIV infection continues to be defined. In efforts to gain further insight on the potential role of these lectin-like molecules, our laboratory generated monoclonal antibodies (mAb) against the human analogs of rhesus macaque CD200, CD200R and Mincle, since the rhesus macaques are accepted as the most reliable animal model to study human HIV infection. The characterization of the cell lineages from the blood and various tissues of rhesus macaques that express these lectin-like molecules are described herein. Among the mononuclear cells, the cells of the myeloid lineage of rhesus macaques are the predominant cell lineages that express readily detectable levels of CD200, CD200R and Mincle that is similar to the expression of Siglec-1 and Siglec-3 reported by our laboratory earlier. Subset analysis revealed that a higher frequency of the CD14(+)/CD16(-) subset from normal rhesus macaques express CD200, CD200R and Mincle. Differences in the frequencies and density of expression of these molecules by the gated population of CD14(+) cells from various tissues are noted with PBMC and bone marrow expressing the highest and the mononuclear cells isolated from the colon and ileum expressing the lowest levels. While a significant frequency of pDCs and mDCs express Siglec-1/Siglec-3, a much lower frequency expresses CD200, CD200R and Mincle in PBMCs from rhesus macaques. The mAb against CD200 and CD200R but not Mincle appear to inhibit the infection of macrophage tropic SIV/SHIV in vitro. We conclude that these mAbs may have potential to be used as adjunctive therapeutic agents to control/inhibit SIV/HIV infection.	[Byrareddy, Siddappa N.; Little, Dawn; Mayne, Ann E.; Villinger, Francois; Ansari, Aftab A.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Villinger, Francois] Emory Univ, Dept Microbiol & Immunol, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Emory University; University of Nebraska System; University of Nebraska Medical Center; Emory University	Ansari, AA (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	pathaaa@emory.edu			Yerkes National Primate Research Center of Emory University [NIH-ORIP-OD-51OD-11132];  [NIH-RO1 AI 98628];  [NIH-RO1 AI113883]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113883, R01AI098628] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Yerkes National Primate Research Center of Emory University; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH-RO1 AI 98628 to AAA, and NIH-RO1 AI113883 to SNB and the base grant to the Yerkes National Primate Research Center of Emory University NIH-ORIP-OD-51OD-11132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari AA, 2014, NATURAL HOSTS OF SIV: IMPLICATION IN AIDS, P1, DOI 10.1016/B978-0-12-404734-1.00001-2; Bloch N, 2014, AIDS RES HUM RETROV, V30, P195, DOI [10.1089/aid.2013.0119, 10.1089/AID.2013.0119]; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Byrareddy S, 2013, J NEUROVIROL, V19, pS17; Byrareddy SN, 2014, NAT MED, V20, P1397, DOI 10.1038/nm.3715; Cai YH, 2015, J LEUKOCYTE BIOL, V97, P1147, DOI 10.1189/jlb.4A0914-441R; Cantin R, 2005, J VIROL, V79, P6577, DOI 10.1128/JVI.79.11.6577-6587.2005; Cavrois M, 2014, J VIROL, V88, P2083, DOI 10.1128/JVI.02308-13; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Chohan B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005; Chow J, 2015, VIROLOGY, V479, P104, DOI 10.1016/j.virol.2015.02.051; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; Coles SJ, 2015, LEUKEMIA, V29, P1952, DOI 10.1038/leu.2015.62; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Davies LC, 2015, IMMUNOLOGY, V144, P541, DOI 10.1111/imm.12451; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Durand M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00129; Eligini S, 2015, J PROTEOMICS, V124, P112, DOI 10.1016/j.jprot.2015.03.026; Estep RD, 2014, J VIROL, V88, P10635, DOI 10.1128/JVI.01276-14; Gorczynski R, 2014, TRANSPLANTATION, V98, P1271, DOI 10.1097/TP.0000000000000456; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Jaroenpool J, 2007, CELL IMMUNOL, V250, P91, DOI 10.1016/j.cellimm.2008.01.009; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Miller E, 2013, IMMUNOL REV, V254, P170, DOI 10.1111/imr.12082; Miyake Yasunobu, 2010, Self Nonself, V1, P310, DOI 10.4161/self.1.4.13736; MOREMEN KW, 1994, GLYCOBIOLOGY, V4, P113, DOI 10.1093/glycob/4.2.113; Mori K, 2005, J VIROL, V79, P10386, DOI 10.1128/JVI.79.16.10386-10396.2005; O'Rourke SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119608; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Pino M, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0160-x; Pyz E, 2006, ANN MED, V38, P242, DOI 10.1080/07853890600608985; Rahim MMA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00145; Richardson MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00288; Sato S, 2012, ANN NY ACAD SCI, V1253, P133, DOI 10.1111/j.1749-6632.2012.06475.x; Siddappa NB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011689; Soberman RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047740; Stack G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004641; Stansell Elizabeth, 2010, Yale Journal of Biology and Medicine, V83, P201; Sugimoto C, 2008, J GEN VIROL, V89, P554, DOI 10.1099/vir.0.83186-0; Sugimoto C, 2012, J VIROL, V86, P9323, DOI 10.1128/JVI.00948-12; Tremblay MJ, 1998, IMMUNOL TODAY, V19, P346, DOI 10.1016/S0167-5699(98)01286-9; Van Breedam W, 2014, FEMS MICROBIOL REV, V38, P598, DOI 10.1111/1574-6976.12052; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yen PJ, 2014, VIROLOGY, V458, P53, DOI 10.1016/j.virol.2014.03.024; Zhang XL, 2008, ADV EXP MED BIOL, V632, P105, DOI 10.1007/978-0-387-78952-1_9	50	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140689	10.1371/journal.pone.0140689	http://dx.doi.org/10.1371/journal.pone.0140689			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468886	Green Submitted, Green Published, gold			2022-12-26	WOS:000363184600099
J	Kim, MG; Ryoo, JH; Chang, SJ; Kim, CB; Park, JK; Koh, SB; Ahn, YS				Kim, Min-Gi; Ryoo, Jae-Hong; Chang, Se-Jin; Kim, Chun-Bae; Park, Jong-Ku; Koh, Sang-Baek; Ahn, Yeon-Soon			Blood Lead Levels and Cause-Specific Mortality of Inorganic Lead-Exposed Workers in South Korea	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CANCER-MORTALITY; SOCIOECONOMIC-STATUS; HEART-DISEASE; UNITED-STATES; RISK; ASSOCIATION; MECHANISMS; PRESSURE; ALCOHOL	The objective of this study was to identify the association of blood lead level (BLL) with mortality in inorganic lead-exposed workers of South Korea. A cohort was compiled comprising 81,067 inorganic lead exposed workers working between January 1, 2000, and December 31, 2004. This cohort was merged with the Korean National Statistical Office to follow-up for mortality between 2000 and 2008. After adjusting for age and other carcinogenic metal exposure, all-cause mortality (Relative risk [RR] 1.36, 95% confidence interval [CI] 1.03-1.79), digestive disease (RR 3.23, 95% CI 1.33-7.86), and intentional self-harm (RR 2.92, 95% CI 1.07-7.81) were statistically significantly higher in males with BLL >20 mu g/dl than of those with BLL <= 10 mu g/dl. The RR of males with BLL of 10-20 mu g/dl was statistically higher than of those with BLL <= 10 mu g/dl in infection (RR 3.73. 95% CI, 1.06-13.06). The RRs of females with 10-20 mu g/dl BLL was statistically significantly greater than those with BLL <10 mu g/dl in all-cause mortality (RR 1.93, 95% CI 1.16-3.20) and colon and rectal cancer (RR 13.42, 95% CI 1.21-149.4). The RRs of females with BLL 10-20 mu g/dl (RR 10.45, 95% CI 1.74-62.93) and BLL >= 20 mu g/dl (RR 12.68, 95% CI 1.69-147.86) was statistically significantly increased in bronchus and lung cancer. The increased suicide of males with >= 20 mu g/dl BLLs, which might be caused by major depression, might be associated with higher lead exposure. Also, increased bronchus and lung cancer mortality in female workers with higher BLL might be related to lead exposure considering low smoking rate in females. The kinds of BLL-associated mortality differed by gender.	[Kim, Min-Gi; Chang, Se-Jin; Kim, Chun-Bae; Park, Jong-Ku; Koh, Sang-Baek] Yonsei Univ, Wonju Coll Med, Grad Sch Med, Wonju, South Korea; [Kim, Min-Gi] Dongguk Univ, Gyeongju Hosp, Dept Occupat Med, Gyeongju, South Korea; [Ryoo, Jae-Hong] Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea; [Ahn, Yeon-Soon] Dongguk Univ, Dept Occupat Med, Ilsan Hosp, Goyang Si, South Korea	Yonsei University; Dongguk University; Kyung Hee University; Dongguk University; NHIS Ilsan Hospital	Ahn, YS (corresponding author), Dongguk Univ, Dept Occupat Med, Ilsan Hosp, Goyang Si, South Korea.	kohhj@yonsei.ac.kr; ysahn@dongguk.ac.kr		Ryoo, Jae-Hong/0000-0002-5232-1426				[Anonymous], 1992, MAN INT STAT CLASS D; Anttila A, 1995, SCAND J WORK ENV HEA, V21, P460, DOI 10.5271/sjweh.62; BAKER EL, 1985, BRIT J IND MED, V42, P507; Bener A, 2001, INT ARCH OCC ENV HEA, V74, P375, DOI 10.1007/s004200100231; Bouchard MF, 2009, ARCH GEN PSYCHIAT, V66, P1313, DOI 10.1001/archgenpsychiatry.2009.164; Chae Hee Bok, 2009, Korean J Hepatol, V15 Suppl 6, pS13, DOI 10.3350/kjhep.2009.15.S6.S13; Chen YW, 2009, ISLETS, V1, P169, DOI 10.4161/isl.1.3.9262; Chowdhury R, 2014, ENVIRON RES, V132, P100, DOI 10.1016/j.envres.2014.03.008; GERHARDSSON L, 1986, BRIT J IND MED, V43, P707; Goodman E, 1999, AM J PUBLIC HEALTH, V89, P1522, DOI 10.2105/AJPH.89.10.1522; Gwini S, 2012, ANN EPIDEMIOL, V22, P270, DOI 10.1016/j.annepidem.2012.01.003; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Huang WH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/742545; Ilychova SA, 2012, OCCUP ENVIRON MED, V69, P87, DOI 10.1136/oem.2011.065201; International Agency for Research on Cancer, 2006, IARC MON EV CARC S7, V87; Jemal A, 2002, ENVIRON HEALTH PERSP, V110, P325, DOI 10.1289/ehp.02110325; Kim JH, 2014, ANN OCCUP ENVIRON ME, V26, DOI 10.1186/s40557-014-0030-3; Kim KR, 2006, IND HEALTH, V44, P318, DOI 10.2486/indhealth.44.318; Korean Ministry of Labor(KMOL), 2004, 2003 WORK HLTH SURV; Kosnett MJ, 2007, ENVIRON HEALTH PERSP, V115, P463, DOI 10.1289/ehp.9784; KROMHOUT D, 1988, ENVIRON HEALTH PERSP, V78, P43, DOI 10.2307/3430497; Liao LM, 2015, ENV HLTH PE IN PRESS; Lim Young Suk, 2009, Korean J Hepatol, V15 Suppl 6, pS25, DOI 10.3350/kjhep.2009.15.S6.S25; Lustberg M, 2002, ARCH INTERN MED, V162, P2443, DOI 10.1001/archinte.162.21.2443; Mazumdar I, 2014, INDIAN J CLIN BIOCHE, V29, P89, DOI 10.1007/s12291-013-0337-9; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; MOLLER L, 1992, AM J EPIDEMIOL, V136, P1091, DOI 10.1093/oxfordjournals.aje.a116574; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Occupational Safety and Health Research Institute, 2008, HLTH EFF MAN HAZ SUB; POCOCK SJ, 1988, ENVIRON HEALTH PERSP, V78, P23, DOI 10.2307/3430494; Qin P, 2003, AM J PSYCHIAT, V160, P765, DOI 10.1176/appi.ajp.160.4.765; Rhodes D, 2003, J OCCUP ENVIRON MED, V45, P1144, DOI 10.1097/01.jom.0000094995.23808.7b; Said S, 2015, ADV CHRONIC KIDNEY D, V22, P39, DOI 10.1053/j.ackd.2014.09.003; Schober SE, 2006, ENVIRON HEALTH PERSP, V114, P1538, DOI 10.1289/ehp.9123; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Schwartz BS, 2007, ENVIRON HEALTH PERSP, V115, P451, DOI 10.1289/ehp.9782; Silbergeld EK, 2003, MUTAT RES-FUND MOL M, V533, P121, DOI 10.1016/j.mrfmmm.2003.07.010; Steenland K, 2000, AM J IND MED, V38, P295, DOI 10.1002/1097-0274(200009)38:3<295::AID-AJIM8>3.3.CO;2-C; Vainio H, 1997, SCAND J WORK ENV HEA, V23, P1; van Bemmel DM, 2011, EPIDEMIOLOGY, V22, P273, DOI 10.1097/EDE.0b013e3182093f75; van Oers JAM, 1999, ALCOHOL ALCOHOLISM, V34, P78, DOI 10.1093/alcalc/34.1.78; Vaziri ND, 2008, INDIAN J MED RES, V128, P426; Vaziri ND, 2008, AM J PHYSIOL-HEART C, V295, pH454, DOI 10.1152/ajpheart.00158.2008; WINGREN G, 1985, BRIT J IND MED, V42, P411; Wong O, 2000, AM J IND MED, V38, P255, DOI 10.1002/1097-0274(200009)38:3<255::AID-AJIM4>3.0.CO;2-8	45	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140360	10.1371/journal.pone.0140360	http://dx.doi.org/10.1371/journal.pone.0140360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469177	gold, Green Published, Green Submitted			2022-12-26	WOS:000363184600050
J	Lanhers, C; Duclos, M; Guttmann, A; Coudeyre, E; Pereira, B; Ouchchane, L				Lanhers, Charlotte; Duclos, Martine; Guttmann, Aline; Coudeyre, Emmanuel; Pereira, Bruno; Ouchchane, Lemlih			General Practitioners' Barriers to Prescribe Physical Activity: The Dark Side of the Cluster Effects on the Physical Activity of Their Type 2 Diabetes Patients	PLOS ONE			English	Article							PRIMARY-CARE; EXERCISE; INTERVENTION; VALIDATION; QUALITY; GPS	Aims/hypothesis To describe barriers to physical activity (PA) in type 2 diabetes patients and their general practitioners (GPs), looking for practitioner's influence on PA practice of their patients. Methods We conducted a cross-sectional study on GPs (n = 48) and their type 2 diabetes patients (n = 369) measuring respectively barriers to prescribe and practice PA using a self-assessment questionnaire: barriers to physical activity in diabetes (BAPAD). Statistical analysis was performed accounting hierarchical data structure. Similar practitioner's patients were considered a cluster sharing common patterns. Results The higher the patient's BAPAD score, the higher the barriers to PA, the higher the risk to declare practicing no PA (p<0.001), low frequency and low duration of PA (p<0.001). A high patient's BAPAD score was also associated with a higher risk to have HbA(1c) >= 7% (53 mmol/mol) (p = 0.001). The intra-class correlation coefficient between type 2 diabetes patients and GPs was 34%, indicating a high cluster effect. A high GP's BAPAD score, regarding the PA prescription, is predictive of a high BAPAD score with their patients, regarding their practice (p = 0.03). Conclusion/interpretation Type 2 diabetes patients with lower BAPAD score, thus lower barriers to physical activity, have a higher PA level and a better glycemic control. An important and deleterious cluster effect between GPs and their patients is demonstrated: the higher the GP's BAPAD score, the higher the type 2 diabetes patients' BAPAD score. This important cluster effect might designate GPs as a relevant lever for future interventions regarding patient's education towards PA and type 2 diabetes management.	[Lanhers, Charlotte; Duclos, Martine] Clermont Ferrand Univ Hosp CHU, Dept Sport Med & Funct Explorat, F-63001 Clermont Ferrand 1, France; [Duclos, Martine] INRA, UMR 1019, Human Nutr Lab, Clermont Ferrand, France; [Guttmann, Aline; Ouchchane, Lemlih] Clermont Ferrand Univ Hosp, Dept Publ Hlth, Biostat Unit, Clermont Ferrand, France; [Guttmann, Aline; Pereira, Bruno; Ouchchane, Lemlih] Auvergne Univ, Lab Image Sci Intervent Tech, CNRS, UMR 6284,ISIT,UdA, F-63001 Clermont Ferrand, France; [Lanhers, Charlotte; Duclos, Martine; Coudeyre, Emmanuel] Univ Auvergne, Clermont Univ, Clermont Ferrand, France; [Coudeyre, Emmanuel] Clermont Ferrand Univ Hosp, Dept Phys Med & Rehabil, Clermont Ferrand, France; [Pereira, Bruno] Clermont Ferrand Univ Hosp, Innovat & Clin Res, Clermont Ferrand, France	CHU Clermont Ferrand; INRAE; CHU Clermont Ferrand; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; CHU Clermont Ferrand	Lanhers, C (corresponding author), Clermont Ferrand Univ Hosp CHU, Dept Sport Med & Funct Explorat, BP 68, F-63001 Clermont Ferrand 1, France.	lanhers.charlotte@gmail.com	Duclos, Martine/AAI-5684-2020; Guttmann, Aline/G-1879-2014	Pereira, Bruno/0000-0003-3778-7161; Guttmann, Aline/0000-0003-0162-837X				Allison KR, 1999, PREV MED, V28, P608, DOI 10.1006/pmed.1999.0489; [Anonymous], 2015, DIABETES CARE, V38; Campbell Marion K, 2004, BMC Med Res Methodol, V4, P9, DOI 10.1186/1471-2288-4-9; Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c; Di Loreto C, 2003, DIABETES CARE, V26, P404, DOI 10.2337/diacare.26.2.404; Dube MC, 2006, DIABETES RES CLIN PR, V72, P20, DOI 10.1016/j.diabres.2005.08.008; Duclos Martine, 2011, Diabetes Care, V34, pe122, DOI 10.2337/dc11-0140; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hays LM, 1999, DIABETES CARE, V22, P706, DOI 10.2337/diacare.22.5.706; Kim C, 2005, DIABETES CARE, V28, P1594, DOI 10.2337/diacare.28.7.1594; Kinmonth AL, 2008, LANCET, V371, P41, DOI 10.1016/S0140-6736(08)60070-7; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI [DOI 10.1056/NEJMoa020194, DOI 10.1056/NEJMOA020194, 10.1056/NEJMoa020194]; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Pate RR, 2005, AM J PUBLIC HEALTH, V95, P1582, DOI 10.2105/AJPH.2004.045807; Roter DL, 2002, JAMA-J AM MED ASSOC, V288, P756, DOI 10.1001/jama.288.6.756; Shojaee-Moradie F, 2007, DIABETOLOGIA, V50, P404, DOI 10.1007/s00125-006-0498-7; Snowling NJ, 2006, DIABETES CARE, V29, P2518, DOI 10.2337/dc06-1317; Supper I, 2011, FAM PRACT, V28, P226, DOI 10.1093/fampra/cmq073; Tabenkin H, 2010, ANN FAM MED, V8, P25, DOI 10.1370/afm.1071; Tan MY, 2004, DIABETES RES CLIN PR, V66, P71, DOI 10.1016/j.diabres.2004.02.021; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Williamson MK, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-42	22	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140429	10.1371/journal.pone.0140429	http://dx.doi.org/10.1371/journal.pone.0140429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468874	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600060
J	Yan, CG; Wang, X; Liu, YL; Abdulnour, RE; Wu, M; Gao, HW				Yan, Chunguang; Wang, Ximo; Liu, Yanlan; Abdulnour, Raja-Elie; Wu, Min; Gao, Hongwei			Protective Role of Rho Guanosine Diphosphate Dissociation Inhibitor, Ly-GDI, in Pulmonary Alveolitis	PLOS ONE			English	Article							ACUTE LUNG INJURY; IMMUNE-COMPLEX ALVEOLITIS; GTP-BINDING PROTEINS; NF-KAPPA-B; CHEMOKINE GENERATION; TNF-ALPHA; ACTIVATION; GTPASES; RESPONSES; MODEL	Growing evidences indicate that Ly-GDI, an inhibitory protein of Rho GTPases, plays an essential role in regulating actin cytoskeletal alteration which is indispensible for the process such as phagocytosis. However, the role of Ly-GDI in inflammation remains largely unknown. In the current study, we found that Ly-GDI expression was significantly decreased in the IgG immune complex-injured lungs. To determine if Ly-GDI might regulate the lung inflammatory response, we constructed adenovirus vectors that could mediate ectopic expression of Ly-GDI (Adeno-Ly-GDI). In vivo mouse lung expression of Ly-GDI resulted in a significant attenuation of IgG immune complex-induced lung injury, which was due to the decreased pulmonary permeability and lung inflammatory cells, especially neutrophil accumulation. Upon IgG immune complex deposition, mice with Ly-GDI over-expression in the lungs produced significant less inflammatory mediators (TNF-alpha, IL-6, MCP-1, and MIP-1 alpha) in bronchoalveolar lavage fluid when compared control mice receiving airway injection of Adeno-GFP. Mechanically, IgG immune complex-induced NF-kappa B activity was markedly suppressed by Ly-GDI in both alveolar macrophages and lungs as measured by luciferase assay and electrophoretic mobility shift assay. These findings suggest that Ly-GDI is a critical regulator of inflammatory injury after deposition of IgG immune complexes and that it negatively regulates the lung NF-kappa B activity.	[Yan, Chunguang; Liu, Yanlan; Gao, Hongwei] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Yan, Chunguang; Wu, Min] Univ N Dakota, Dept Basic Sci, Grand Forks, ND 58201 USA; [Wang, Ximo; Gao, Hongwei] Tianjin Nankai Hosp, Dept Surg, Tianjin, Peoples R China; [Abdulnour, Raja-Elie] Harvard Univ, Brigham & Womens Hosp, Sch Med, Pulm & Crit Care Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of North Dakota Grand Forks; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gao, HW (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.	hgao@zeus.bwh.harvard.edu	Yan, Chunguang/ABE-5021-2021	Wu, Min/0000-0003-1205-982X	National Institutes of Health [5R01HL092905]; National Natural Science Foundation of China [81470263]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103329] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by National Institutes of Health (http://www.nih.gov/) Grants 5R01HL092905 (H.G.) and National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/)Grant 81470263 (H.G. and X.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Chouchakova N, 2001, J IMMUNOL, V166, P5193, DOI 10.4049/jimmunol.166.8.5193; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Czermak BJ, 1999, J IMMUNOL, V162, P2321; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Gao HW, 2006, ANNU REV PATHOL-MECH, V1, P215, DOI 10.1146/annurev.pathol.1.110304.100155; Gao HW, 2006, J IMMUNOL, V177, P612, DOI 10.4049/jimmunol.177.1.612; Gao HW, 2004, J IMMUNOL, V172, P7703, DOI 10.4049/jimmunol.172.12.7703; Groysman M, 2002, J BIOL CHEM, V277, P50121, DOI 10.1074/jbc.M204299200; Guo RF, 2002, FREE RADICAL BIO MED, V33, P303, DOI 10.1016/S0891-5849(02)00823-7; Hoffmann JJ., BIOCH MED ZAGREB, V21, P282; Hsu KH, 2011, RESPIROLOGY, V16, P152, DOI 10.1111/j.1440-1843.2010.01876.x; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; LEFFERS H, 1993, EXP CELL RES, V209, P165, DOI 10.1006/excr.1993.1298; LELIAS JM, 1993, P NATL ACAD SCI USA, V90, P1479, DOI 10.1073/pnas.90.4.1479; Lentsch AB, 1998, AM J PATHOL, V152, P1327; Lentsch AB, 1999, AM J RESP CELL MOL, V20, P692, DOI 10.1165/ajrcmb.20.4.3414; Mehta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021175; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Rittirsch D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000464; Robles-Carrillo L, 2010, J IMMUNOL, V185, P1577, DOI 10.4049/jimmunol.0903888; Said N, 2012, J CLIN INVEST, V122, P1503, DOI 10.1172/JCI61392; Said N, 2009, CANCER METAST REV, V28, P327, DOI 10.1007/s10555-009-9197-4; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; SCHERLE P, 1993, P NATL ACAD SCI USA, V90, P7568, DOI 10.1073/pnas.90.16.7568; Schuyler M, 2004, LUNG, V182, P135, DOI 10.1007/s00408-004-0311-7; Shalova IN, 2012, J IMMUNOL, V188, P3584, DOI 10.4049/jimmunol.1100244; SHANLEY TP, 1995, J IMMUNOL, V154, P4793; Smith KGC, 2010, NAT REV IMMUNOL, V10, P674, DOI 10.1038/nri2762; Sun DW, 2012, J IMMUNOL, V189, P2423, DOI 10.4049/jimmunol.1201302; Tang HF, 2011, FASEB J, V25, P4292, DOI 10.1096/fj.11-187955; WARREN JS, 1989, J CLIN INVEST, V84, P1873, DOI 10.1172/JCI114374; Wu WH, 2009, NAT IMMUNOL, V10, P1208, DOI 10.1038/ni.1788; Yan C, AM J PATHOL; Yan CG, 2012, J IMMUNOL, V189, P1480, DOI 10.4049/jimmunol.1200877; Yin L, 1997, MOL IMMUNOL, V34, P481, DOI 10.1016/S0161-5890(97)00053-9	39	1	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140804	10.1371/journal.pone.0140804	http://dx.doi.org/10.1371/journal.pone.0140804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469087	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600114
J	Coffey, S; Costacou, T; Orchard, T; Erkan, E				Coffey, Sam; Costacou, Tina; Orchard, Trevor; Erkan, Elif			Akt Links Insulin Signaling to Albumin Endocytosis in Proximal Tubule Epithelial Cells	PLOS ONE			English	Article							SODIUM-CHANNEL; AS160; DAB2; RECEPTORS; MEGALIN; PHOSPHORYLATION; SUBSTRATE; CUBILIN; SURFACE	Diabetes mellitus (DM) has become an epidemic, causing a significant decline in quality of life of individuals due to its multisystem involvement. Kidney is an important target organ in DM accounting for the majority of patients requiring renal replacement therapy at dialysis units. Microalbuminuria (MA) has been a valuable tool to predict end-organ damage in DM but its low sensitivity has driven research efforts to seek other alternatives. Albumin is taken up by albumin receptors, megalin and cubilin in the proximal tubule epithelial cells. We demonstrated that insulin at physiological concentrations induce albumin endocytosis through activation of protein kinase B (Akt) in proximal tubule epithelial cells. Inhibition of Akt by a phosphorylation deficient construct abrogated insulin induced albumin endocytosis suggesting a role for Akt in insulin-induced albumin endocytosis. Furthermore we demonstrated a novel interaction between Akt substrate 160kDa (AS160) and cytoplasmic tail of megalin. Mice with type 1 DM (T1D) displayed decreased Akt, megalin, cubilin and AS160 expression in their kidneys in association with urinary cubilin shedding preceding significant MA. Patients with T1D who have developed MA in the EDC (The Pittsburgh Epidemiology of Diabetes Complications) study demonstrated urinary cubilin shedding prior to development of MA. We hypothesize that perturbed insulin-Akt cascade in DM leads to alterations in trafficking of megalin and cubilin, which results in urinary cubilin shedding as a prelude to MA in early diabetic nephropathy. We propose that utilization of urinary cubilin shedding, as a urinary biomarker, will allow us to detect and intervene in diabetic nephropathy (DN) at an earlier stage.	[Coffey, Sam; Erkan, Elif] Cincinnati Childrens Hosp Med Ctr, Div Nephrol, Cincinnati, OH 45229 USA; [Costacou, Tina; Orchard, Trevor] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA	Cincinnati Children's Hospital Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Erkan, E (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Nephrol, Cincinnati, OH 45229 USA.	Elif.Erkan@cchmc.org	Erkan, Elif/AAM-7972-2021	orchard, trevor/0000-0001-9552-3215	National Institutes of Health [K08 DK083510]; NIH [P50 DK096418]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK083510, P50DK096418, R37DK034818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health K08 DK083510 (EE) and NIH (P50 DK096418) pilot grant (EE).	Abdelhafiz AH, 2011, NEPHRON EXP NEPHROL, V119, pE6, DOI 10.1159/000328015; Alves DS, 2010, MOL BIOL CELL, V21, P4400, DOI 10.1091/mbc.E10-06-0507; Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Barzilay JI, 2011, ARCH INTERN MED, V171, P142, DOI 10.1001/archinternmed.2010.502; Boger CA, 2011, J AM SOC NEPHROL, V22, P555, DOI 10.1681/ASN.2010060598; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399; Chasman DI, 2012, HUM MOL GENET, V21, P5329, DOI 10.1093/hmg/dds369; Christensen EI, 2001, AM J PHYSIOL-RENAL, V280, pF562, DOI 10.1152/ajprenal.2001.280.4.F562; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Dahlquist G, 2000, ACTA PAEDIATR, V89, P1231, DOI 10.1080/080352500750027628; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Kim HY, 2011, AM J PHYSIOL-RENAL, V301, pF151, DOI 10.1152/ajprenal.00519.2010; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Koral K, 2014, AM J PHYSIOL-RENAL, V307, pF1380, DOI 10.1152/ajprenal.00454.2014; Koral K, 2012, AM J PHYSIOL-RENAL, V302, pF1013, DOI 10.1152/ajprenal.00289.2011; Liang XB, 2010, MOL BIOL CELL, V21, P2024, DOI 10.1091/mbc.E10-01-0042; Lu B, 2006, J IMMUNOL, V176, P6785, DOI 10.4049/jimmunol.176.11.6785; Maurer ME, 2005, J CELL SCI, V118, P5345, DOI 10.1242/jcs.02650; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Nagai J, 2005, AM J PHYSIOL-RENAL, V289, pF569, DOI 10.1152/ajprenal.00292.2004; Nakamura M, 2015, KIDNEY INT, V87, P535, DOI 10.1038/ki.2014.351; Perwad F, 2007, AM J PHYSIOL-RENAL, V293, pF1577, DOI 10.1152/ajprenal.00463.2006; Quinkler M, 2005, HYPERTENSION, V46, P787, DOI 10.1161/01.HYP.0000184362.61744.c1; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Reznichenko A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036512; Rodman JS, 2000, J CELL SCI, V113, P183; Samovski D, 2012, J LIPID RES, V53, P709, DOI 10.1194/jlr.M023424; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; STONE RA, 1990, DIABETES, V39, P858; Tabaei BP, 2001, DIABETES CARE, V24, P1560, DOI 10.2337/diacare.24.9.1560; Takeda T, 2003, AM J PHYSIOL-CELL PH, V284, pC1105, DOI 10.1152/ajpcell.00514.2002; Terryn S, 2007, AM J PHYSIOL-RENAL, V293, pF476, DOI 10.1152/ajprenal.00363.2006; Thongboonkerd V, 2002, KIDNEY INT, V62, P1461, DOI 10.1046/j.1523-1755.2002.00565.x; Tiwari S, 2013, J AM SOC NEPHROL, V24, P1209, DOI 10.1681/ASN.2012060628; Tolouian Ramin, 2013, J Nephropathol, V2, P4, DOI 10.5812/nephropathol.8966; Verroust PJ, 2002, NEPHROL DIAL TRANSPL, V17, P1867, DOI 10.1093/ndt/17.11.1867; Whitin JC, 2002, AM J PHYSIOL-RENAL, V283, pF20, DOI 10.1152/ajprenal.00014.2001; Williams ME, 2010, SEMIN DIALYSIS, V23, P129, DOI 10.1111/j.1525-139X.2009.00698.x; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Yuseff MI, 2007, TRAFFIC, V8, P1215, DOI 10.1111/j.1600-0854.2007.00601.x	45	18	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140417	10.1371/journal.pone.0140417	http://dx.doi.org/10.1371/journal.pone.0140417			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465605	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000363183100117
J	Muhlenbeck, C; Liebal, K; Pritsch, C; Jacobsen, T				Muehlenbeck, Cordelia; Liebal, Katja; Pritsch, Carla; Jacobsen, Thomas			Gaze Duration Biases for Colours in Combination with Dissonant and Consonant Sounds: A Comparative Eye-Tracking Study with Orangutans	PLOS ONE			English	Article							NEW-WORLD; TRICHROMATIC VISION; SEXUAL SWELLINGS; EVOLUTION; MUSIC; PREFERENCES; PRIMATE; PERCEPTION; CATEGORIZATION; POLYMORPHISM	Research on colour preferences in humans and non-human primates suggests similar patterns of biases for and avoidance of specific colours, indicating that these colours are connected to a psychological reaction. Similarly, in the acoustic domain, approach reactions to consonant sounds (considered as positive) and avoidance reactions to dissonant sounds (considered as negative) have been found in human adults and children, and it has been demonstrated that non-human primates are able to discriminate between consonant and dissonant sounds. Yet it remains unclear whether the visual and acoustic approach-avoidance patterns remain consistent when both types of stimuli are combined, how they relate to and influence each other, and whether these are similar for humans and other primates. Therefore, to investigate whether gaze duration biases for colours are similar across primates and whether reactions to consonant and dissonant sounds cumulate with reactions to specific colours, we conducted an eye-tracking study in which we compared humans with one species of great apes, the orangutans. We presented four different colours either in isolation or in combination with consonant and dissonant sounds. We hypothesised that the viewing time for specific colours should be influenced by dissonant sounds and that previously existing avoidance behaviours with regard to colours should be intensified, reflecting their association with negative acoustic information. The results showed that the humans had constant gaze durations which were independent of the auditory stimulus, with a clear avoidance of yellow. In contrast, the orangutans did not show any clear gaze duration bias or avoidance of colours, and they were also not influenced by the auditory stimuli. In conclusion, our findings only partially support the previously identified pattern of biases for and avoidance of specific colours in humans and do not confirm such a pattern for orangutans.	[Muehlenbeck, Cordelia] Free Univ Berlin, Dept Educ & Psychol, Evolutionary Psychol, Berlin, Germany; [Liebal, Katja] Free Univ Berlin, Dept Educ & Psychol, Comparat Dev Psychol, Berlin, Germany; [Pritsch, Carla] Free Univ Berlin, Grad Sch Languages Emot, Berlin, Germany; [Jacobsen, Thomas] Univ Fed Armed Forces Hamburg, Helmut Schmidt Univ, Expt Psychol Unit, Hamburg, Germany	Free University of Berlin; Free University of Berlin; Free University of Berlin; Helmut Schmidt University	Muhlenbeck, C (corresponding author), Free Univ Berlin, Dept Educ & Psychol, Evolutionary Psychol, Berlin, Germany.	cordelia.muehlenbeck@fu-berlin.de	Jacobsen, Thomas/B-5796-2011; Liebal, Katja/AAQ-7910-2020	Jacobsen, Thomas/0000-0002-1523-3996; Liebal, Katja/0000-0003-2447-8327	Excellence Cluster Languages of Emotion/DFG [EXC 302]; Berlin Funding for Graduates (Elsa-Neumann Stipendium des Landes Berlin)	Excellence Cluster Languages of Emotion/DFG; Berlin Funding for Graduates (Elsa-Neumann Stipendium des Landes Berlin)	This work was funded by the Excellence Cluster Languages of Emotion/DFG (EXC 302) and by Berlin Funding for Graduates (Elsa-Neumann Stipendium des Landes Berlin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS FM, 1973, J CROSS CULT PSYCHOL, V4, P135, DOI 10.1177/002202217300400201; ADAMS RJ, 1987, INFANT BEHAV DEV, V10, P143, DOI 10.1016/0163-6383(87)90029-4; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; [Anonymous], 1976, COLOUR ARCHITECTURE; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen R. H., 2008, ANAL LINGUISTIC DATA; BARBIERS RB, 1985, ZOO BIOL, V4, P287, DOI 10.1002/zoo.1430040309; BIELERT C, 1989, J ZOOL, V219, P569, DOI 10.1111/j.1469-7998.1989.tb02601.x; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bradley BJ, 2008, EVOL ANTHROPOL, V17, P97, DOI 10.1002/evan.20164; Brattico E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00206; Brattico E, 2009, MUSIC SCI, P15, DOI 10.1177/1029864909013002031; Buchanan-Smith HM, 2005, AM J PRIMATOL, V67, P393, DOI 10.1002/ajp.20194; BUTLER JW, 1968, J GEN PSYCHOL, V79, P129, DOI 10.1080/00221309.1968.9710460; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Cooper VJ, 2003, INT J PRIMATOL, V24, P1177, DOI 10.1023/B:IJOP.0000005986.21477.ad; Crozier WR, 1997, JOCCA-SURF COAT INT, V80, P577; Davidoff J, 1999, NATURE, V398, P203, DOI 10.1038/18335; Domb LG, 2001, NATURE, V410, P204, DOI 10.1038/35065597; Dubuc C, 2009, INT J PRIMATOL, V30, P777, DOI 10.1007/s10764-009-9369-7; Dulai KS, 1999, GENOME RES, V9, P629; EAZA. European Association of Zoos and Aquaria, 2008, MIN STAND ACC CAR AN; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Eysenck HJ, 1941, AM J PSYCHOL, V54, P385, DOI 10.2307/1417683; Field A., 2013, DISCOVERING STAT USI; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Fox J., 2019, R COMPANION APPL REG, V.; Garth TR, 1931, J SOC PSYCHOL, V2, P397, DOI 10.1080/00224545.1931.9918981; Garth TR, 1924, J EXP PSYCHOL, V7, P233, DOI 10.1037/h0071899; Gerald MS, 2010, NATURWISSENSCHAFTEN, V97, P89, DOI 10.1007/s00114-009-0619-5; Gerald MS, 2001, ANIM BEHAV, V61, P559, DOI 10.1006/anbe.2000.1648; Gesche I, 1927, J COMP PSYCHOL, V7, P297, DOI 10.1037/h0072520; Granger GW, 1955, J GEN PSYCHOL, V52, P3, DOI 10.1080/00221309.1955.9918340; GUILFORD JP, 1959, AM J PSYCHOL, V72, P487, DOI 10.2307/1419491; Hauser MD, 2003, NAT NEUROSCI, V6, P663, DOI 10.1038/nn1080; Higham JP, 2008, HORM BEHAV, V53, P452, DOI 10.1016/j.yhbeh.2007.11.019; HOGG J, 1969, J GEN PSYCHOL, V80, P129, DOI 10.1080/00221309.1969.9711279; Humphrey N K, 1972, Perception, V1, P395, DOI 10.1068/p010395; Jacobsen T, 2006, LEONARDO, V39, P155, DOI 10.1162/leon.2006.39.2.155; Jacobsen T, 2002, PERCEPT MOTOR SKILL, V95, P903, DOI 10.2466/PMS.95.7.903-913; Just M.A., 2018, NEW METHODS READING, V1st ed, P151; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Kano F, 2014, ANIM BEHAV, V91, P137, DOI 10.1016/j.anbehav.2014.03.011; Kano F, 2011, VISION RES, V51, P2348, DOI 10.1016/j.visres.2011.09.006; Katz SE, 1922, J APPL PSYCHOL, V6, P255, DOI 10.1037/h0075274; Kobayashi H, 2001, J HUM EVOL, V40, P419, DOI 10.1006/jhev.2001.0468; Kreitler H., 1972, PSYCHOL ARTS, P333; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lucas PW, 2003, EVOLUTION, V57, P2636, DOI 10.1554/03-168; MAHER TF, 1976, J CROSS CULT PSYCHOL, V7, P259, DOI 10.1177/002202217673001; McDermott J, 2005, MUSIC PERCEPT, V23, P29, DOI 10.1525/mp.2005.23.1.29; McDermott J, 2004, COGNITION, V94, pB11, DOI 10.1016/j.cognition.2004.04.004; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; Nieuwenhuis R, 2012, R J, V4, P38; Osorio D, 2008, VISION RES, V48, P2042, DOI 10.1016/j.visres.2008.06.018; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Pollick AS, 2007, P NATL ACAD SCI USA, V104, P8184, DOI 10.1073/pnas.0702624104; R Core Team, 2021, R LANGUAGE ENV STAT; Rowe C, 1999, EVOL ECOL, V13, P655, DOI 10.1023/A:1011021630244; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Setchell JM, 2005, INT J PRIMATOL, V26, P715, DOI 10.1007/s10764-005-5305-7; Slocombe KE, 2011, ANIM BEHAV, V81, P919, DOI 10.1016/j.anbehav.2011.02.002; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; Taglialatela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018852; TERWOGT MM, 1995, J GEN PSYCHOL, V122, P5, DOI 10.1080/00221309.1995.9921217; Trainor LJ, 1998, INFANT BEHAV DEV, V21, P77, DOI 10.1016/S0163-6383(98)90055-8; Trainor LJ, 2002, MUSIC PERCEPT, V20, P187, DOI 10.1525/mp.2002.20.2.187; VALDEZ P, 1994, J EXP PSYCHOL GEN, V123, P394, DOI 10.1037/0096-3445.123.4.394; Veilleux CC, 2009, AM J PRIMATOL, V71, P86, DOI 10.1002/ajp.20621; Waitt C, 2003, P ROY SOC B-BIOL SCI, V270, pS144, DOI 10.1098/rsbl.2003.0065; WAZA, 2005, ETH GUID COND RES AN; Weatherall, 2006, USE NONHUMAN PRIMATE; Wells DL, 2008, J COMP PSYCHOL, V122, P213, DOI 10.1037/0735-7036.122.2.213; WHITFIELD A, 1984, PERCEPT MOTOR SKILL, V59, P183, DOI 10.2466/pms.1984.59.1.183; WICKLER W, 1995, ANTHROPOS, V90, P391; Yoshioka T, 1996, BEHAV BRAIN RES, V76, P51, DOI 10.1016/0166-4328(95)00183-2; ZEKI S, 1983, NEUROSCIENCE, V9, P741, DOI 10.1016/0306-4522(83)90265-8; Zentner MR, 1998, INFANT BEHAV DEV, V21, P483, DOI 10.1016/S0163-6383(98)90021-2; Zentner MR, 1996, NATURE, V383, P29, DOI 10.1038/383029a0	84	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139894	10.1371/journal.pone.0139894	http://dx.doi.org/10.1371/journal.pone.0139894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466351	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100065
J	Peng, H; Zhuang, YG; Chen, YZ; Rizzo, AN; Chen, WG				Peng, Hu; Zhuang, Yugang; Chen, Yuanzhuo; Rizzo, Alicia N.; Chen, Weiguo			The Characteristics and Regulatory Mechanisms of Superoxide Generation from eNOS Reductase Domain	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OXYGENASE DOMAIN; MICE LACKING; L-ARGININE; TETRAHYDROBIOPTERIN; PHOSPHORYLATION; ENZYME; INHIBITION; ACTIVATION; CELLS	In addition to superoxide (O2.-) generation from nitric oxide synthase (NOS) oxygenase domain, a new O-2(.-) generation site has been identified in the reductase domain of inducible NOS (iNOS) and neuronal NOS (nNOS). Cysteine S-glutathionylation in eNOS reductase domain also induces O-2(.-) generation from eNOS reductase domain. However, the characteristics and regulatory mechanism of the O-2(.-) generation from NOS reductase domain remain unclear. We cloned and purified the wild type bovine eNOS (WT eNOS), a mutant of Serine 1179 replaced with aspartic acid eNOS (S1179D eNOS), which mimics the negative charge caused by phosphorylationand truncated eNOS reductase domain (eNOS RD). Both WT eNOS and S1179D eNOS generated significant amount of O-2(.-) in the absence of BH4 and L-arginine. The capacity of O-2(.-) generation from S1179D eNOS was significantly higher than that of WT eNOS (1.74:1). O-2(.-) generation from both WT eNOS and S1179D eNOS were not completely inhibited by 100nM tetrahydrobiopterin(BH4). This BH4 uninhibited O-2(.-) generation from eNOS was blocked by 10mM flavoprotein inhibitor, diphenyleneiodonium (DPI). Purified eNOS reductase domain protein confirmed that this BH4 uninhibited O-2(.-) generation originates at the FMN or FAD/NADPH binding site of eNOS reductase domain. DEPMPO-OOH adduct EPR signals and NADPH consumptions analyses showed that O-2(.-) generation from eNOS reductase domain was regulated by Serine 1179 phosphorylation and DPI, but not by L-arginine, BH4 or calmodulin (CaM). In addition to the heme center of eNOS oxygenase domain, we confirmed another O-2(.-) generation site in the eNOS reductase domain and characterized its regulatory properties.	[Peng, Hu; Zhuang, Yugang; Chen, Yuanzhuo; Chen, Weiguo] Tongji Univ, Shanghai Peoples Hosp 10, Dept Emergency Med, Shanghai 200092, Peoples R China; [Peng, Hu; Zhuang, Yugang; Rizzo, Alicia N.; Chen, Weiguo] Univ Illinois, Coll Med, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL USA	Tongji University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chen, WG (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Emergency Med, Shanghai 200092, Peoples R China.	weiguo@uic.edu		Rizzo, Alicia/0000-0001-9289-4635; Zhuang, Yu-Gang/0000-0002-6304-6765				Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Berka V, 2004, J BIOL CHEM, V279, P32243, DOI 10.1074/jbc.M404044200; Berka V, 2008, BIOCHEMISTRY-US, V47, P405, DOI 10.1021/bi701677r; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Chen WG, 2010, BIOCHEMISTRY-US, V49, P3129, DOI 10.1021/bi9016632; Cortes-Gonzalez C, 2010, CELL PHYSIOL BIOCHEM, V26, P657, DOI 10.1159/000322333; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Du M, 2003, J BIOL CHEM, V278, P6002, DOI 10.1074/jbc.M209606200; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Giraldez RR, 1997, J BIOL CHEM, V272, P21420, DOI 10.1074/jbc.272.34.21420; Goligorsky MS, 2009, KIDNEY INT, V75, P255, DOI 10.1038/ki.2008.605; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Jia ZQ, 2008, MOL CELL BIOCHEM, V313, P187, DOI 10.1007/s11010-008-9756-y; LAMAS S, 1992, P NATL ACAD SCI USA, V89, P6348, DOI 10.1073/pnas.89.14.6348; Liu KJ, 1999, FREE RADICAL BIO MED, V26, P714, DOI 10.1016/S0891-5849(98)00251-2; Maia AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105851; Martasek P, 1996, BIOCHEM BIOPH RES CO, V219, P359, DOI 10.1006/bbrc.1996.0238; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Miller RT, 1997, BIOCHEMISTRY-US, V36, P15277, DOI 10.1021/bi972022c; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Shi Y, 2002, CIRC RES, V91, P300, DOI 10.1161/01.RES.0000031799.12850.1E; Song Y, 2002, BIOCHEMISTRY-US, V41, P10616, DOI 10.1021/bi026060u; Song Y, 2001, AM J PHYSIOL-CELL PH, V281, pC1819, DOI 10.1152/ajpcell.2001.281.6.C1819; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vasquez-Vivar J, 2001, FREE RADICAL BIO MED, V31, P975, DOI 10.1016/S0891-5849(01)00680-3; VasquezVivar J, 1997, BIOCHEMISTRY-US, V36, P11293, DOI 10.1021/bi971475e; Whitsett J, 2006, FREE RADICAL BIO MED, V40, P2056, DOI 10.1016/j.freeradbiomed.2006.02.001; Wu KK, 2002, ANN NY ACAD SCI, V962, P122, DOI 10.1111/j.1749-6632.2002.tb04062.x; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Xia Y, 1998, J BIOL CHEM, V273, P22635, DOI 10.1074/jbc.273.35.22635	36	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140365	10.1371/journal.pone.0140365	http://dx.doi.org/10.1371/journal.pone.0140365			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465144	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100107
J	Sanders, H; Norheim, G; Chan, H; Dold, C; Vipond, C; Derrick, JP; Pollard, AJ; Maiden, MCJ; Feavers, IM				Sanders, Holly; Norheim, Gunnstein; Chan, Hannah; Dold, Christina; Vipond, Caroline; Derrick, Jeremy P.; Pollard, Andrew J.; Maiden, Martin C. J.; Feavers, Ian M.			FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression	PLOS ONE			English	Article							SYNERGISTIC BACTERICIDAL ACTIVITY; NEISSERIA-MENINGITIDIS; NEW-ZEALAND; DISEASE; PROTEIN; IMMUNOGENICITY; RESPONSES; ANTIGENS; FRPB; CRYSTALLIZATION	Invasive meningococcal disease causes over 3500 cases each year in Europe, with particularly high incidence among young children. Among serogroup B meningococci, which cause most of the cases, high diversity in the outer membrane proteins (OMPs) is observed in endemic situations; however, comprehensive molecular epidemiological data are available for the diversity and distribution of the OMPs PorA and FetA and these can be used to rationally design a vaccine with high coverage of the case isolates. The aim of this study was to determine whether outer membrane vesicles (OMVs) derived from an isolate with constitutive FetA expression (MenPF-1 vaccine) could be used to induce antibodies against both the PorA and FetA antigens. The immunogenicity of various dose levels and number of doses was evaluated in mice and rabbits, and IgG antibody responses tested against OMVs and recombinant PorA and FetA proteins. A panel of four isogenic mutants was generated and used to evaluate the relative ability of the vaccine to induce serum bactericidal activity (SBA) against FetA and PorA. Sera from mice were tested in SBA against the four target strains. Results demonstrated that the MenPF-1 OMVs were immunogenic against PorA and FetA in both animal models. Furthermore, the murine antibodies induced were bactericidal against isogenic mutant strains, suggesting that antibodies to both PorA and FetA were functional. The data presented indicate that the MenPF-1 vaccine is a suitable formulation for presenting PorA and FetA OMPs in order to induce bactericidal antibodies, and that proceeding to a Phase I clinical trial with this vaccine candidate is justified.	[Sanders, Holly; Chan, Hannah; Vipond, Caroline; Feavers, Ian M.] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Norheim, Gunnstein; Dold, Christina; Pollard, Andrew J.] Univ Oxford, Oxford Vaccine Grp, Dept Paediat, Oxford, England; [Norheim, Gunnstein; Dold, Christina; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Norheim, Gunnstein] Norwegian Inst Publ Hlth, Div Infect Dis Control, Oslo, Norway; [Norheim, Gunnstein] Univ Oslo, Fac Med, Oslo, Norway; [Derrick, Jeremy P.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford, England	National Institute for Biological Standards & Control; University of Oxford; University of Oxford; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Manchester; University of Oxford	Chan, H (corresponding author), Natl Inst Biol Stand & Controls, Potters Bar, Herts, England.	hannah.chan@nibsc.org	Maiden, Martin C J/C-5055-2014; Maiden, Martin/N-6805-2019; Dold, Christina/ABA-4237-2021	Maiden, Martin C J/0000-0001-6321-5138; Maiden, Martin/0000-0001-6321-5138; dold, christina/0000-0003-2314-507X	Wellcome Trust Strategic Translation Award [082102/Z/07/A]; National Institute for Health Research Oxford Biomedical Research Centres	Wellcome Trust Strategic Translation Award; National Institute for Health Research Oxford Biomedical Research Centres	This work was funded by a Wellcome Trust Strategic Translation Award [Award number: 082102/Z/07/A]. MM is a Wellcome Trust Senior Fellow in Basic Biomedical Sciences and a Jenner Investigator at the University of Oxford. AP receives funding support from the National Institute for Health Research Oxford Biomedical Research Centres and is a Jenner Institute Investigator at the University of Oxford.	ALAALDEEN DA, 1994, VACCINE, V12, P535, DOI 10.1016/0264-410X(94)90314-X; ALAALDEEN DA, 1990, J MED MICROBIOL, V32, P275, DOI 10.1099/00222615-32-4-275; Arnold R, 2011, VACCINE, V29, P7100, DOI 10.1016/j.vaccine.2011.06.120; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; Borrow R, 2005, CLIN DIAGN LAB IMMUN, V12, P970, DOI 10.1128/CDLI.12.8.970-976.2005; Brehony C, 2007, FEMS MICROBIOL REV, V31, P15, DOI 10.1111/j.1574-6976.2006.00056.x; Buckee CO, 2008, P NATL ACAD SCI USA, V105, P15082, DOI 10.1073/pnas.0712019105; Caron F, 2012, VACCINE, V30, P5059, DOI 10.1016/j.vaccine.2012.05.051; Cartwright K, 1999, VACCINE, V17, P2612, DOI 10.1016/S0264-410X(99)00044-4; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; DEMORAES JC, 1992, LANCET, V340, P1074; ECDC, 2013, ANN EP REP 2012 REP; Feavers IM, 2009, VACCINE, V27, pB42, DOI 10.1016/j.vaccine.2009.05.001; FINNE J, 1983, LANCET, V2, P355; Frasch CE, 2009, VACCINE, V27, pB112, DOI 10.1016/j.vaccine.2009.04.065; Frasch CE, 2001, METH MOLEC MED, V66, P81, DOI 10.1385/1-59259-148-5:81; Holst J, 2003, VACCINE, V21, P734, DOI 10.1016/S0264-410X(02)00591-1; Holst J, 2007, HUM VACCINES, V3, P290, DOI 10.4161/hv.4513; Kortekaas J, 2007, VACCINE, V25, P72, DOI 10.1016/j.vaccine.2006.07.016; Norheim G, 2012, SCAND J IMMUNOL, V76, P99, DOI 10.1111/j.1365-3083.2012.02709.x; ROSENQVIST E, 1995, INFECT IMMUN, V63, P4642, DOI 10.1128/IAI.63.12.4642-4652.1995; Saleem M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056746; Saleem M, 2012, ACTA CRYSTALLOGR F, V68, P231, DOI 10.1107/S1744309111056028; Saleem M, 2012, METHODS MOL BIOL, V799, P91, DOI 10.1007/978-1-61779-346-2_6; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; Tanabe M, 2010, P NATL ACAD SCI USA, V107, P6811, DOI 10.1073/pnas.0912115107; Thompson EA, 2001, THESIS U OXFORD OXFO; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; van den Dobbelsteen GPJM, 2007, VACCINE, V25, P2491, DOI 10.1016/j.vaccine.2006.09.025; VanDerVoort ER, 1996, INFECT IMMUN, V64, P2745, DOI 10.1128/IAI.64.7.2745-2751.1996; Vipond C, 2005, HUM VACCINES, V1, P80, DOI 10.4161/hv.1.2.1651; Vipond C, 2012, VACCINE, V30, pB10, DOI 10.1016/j.vaccine.2011.12.060; Watkins ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045349; Wedege E, 2000, J IMMUNOL METHODS, V244, P9, DOI 10.1016/S0022-1759(00)00245-3; Wedege E, 2007, CLIN VACCINE IMMUNOL, V14, P830, DOI 10.1128/CVI.00039-07; Wedege E, 1998, INFECT IMMUN, V66, P3223, DOI 10.1128/IAI.66.7.3223-3231.1998; Welsch JA, 2008, J INFECT DIS, V197, P1053, DOI 10.1086/528994; Weynants VE, 2007, INFECT IMMUN, V75, P5434, DOI 10.1128/IAI.00411-07; Yongye AB, 2008, BIOCHEMISTRY-US, V47, P12493, DOI 10.1021/bi800431c	40	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140345	10.1371/journal.pone.0140345	http://dx.doi.org/10.1371/journal.pone.0140345			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466091	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100104
J	van der Kant, R; Jonker, CTH; Wijdeven, RH; Bakker, J; Janssen, L; Klumperman, J; Neefjes, J				van der Kant, Rik; Jonker, Caspar T. H.; Wijdeven, Ruud H.; Bakker, Jeroen; Janssen, Lennert; Klumperman, Judith; Neefjes, Jacques			Characterization of the Mammalian CORVET and HOPS Complexes and Their Modular Restructuring for Endosome Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOPHAGOSOME-LYSOSOME FUSION; C-VPS COMPLEX; TETHERING COMPLEX; ENDOCYTIC TRAFFICKING; RENAL DYSFUNCTION; MEMBRANE-FUSION; PROTEIN COMPLEX; GTPASE ARL8B; ARC SYNDROME; BIOGENESIS	Trafficking of cargo through the endosomal system depends on endosomal fusion events mediated by SNARE proteins, Rab-GTPases, and multisubunit tethering complexes. The CORVET and HOPS tethering complexes, respectively, regulate early and late endosomal tethering and have been characterized in detail in yeast where their sequential membrane targeting and assembly is well understood. Mammalian CORVET and HOPS subunits significantly differ from their yeast homologues, and novel proteins with high homology to CORVET/HOPS subunits have evolved. However, an analysis of the molecular interactions between these subunits in mammals is lacking. Here, we provide a detailed analysis of interactions within the mammalian CORVET and HOPS as well as an additional endosomal-targeting complex (VIPAS39-VPS33B) that does not exist in yeast. We show that core interactions within CORVET and HOPS are largely conserved but that the membrane-targeting module in HOPS has significantly changed to accommodate binding to mammalian-specific RAB7 interacting lysosomal protein (RILP). Arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome-associated mutations in VPS33B selectively disrupt recruitment to late endosomes by RILP or binding to its partner VIPAS39. Within the shared core of CORVET/HOPS, we find that VPS11 acts as a molecular switch that binds either CORVET-specific TGFBRAP1 or HOPS-specific VPS39/RILP thereby allowing selective targeting of these tethering complexes to early or late endosomes to time fusion events in the endo/lysosomal pathway.	[van der Kant, Rik; Wijdeven, Ruud H.; Bakker, Jeroen; Janssen, Lennert; Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Jonker, Caspar T. H.; Klumperman, Judith] Ctr Mol Med, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Netherlands Cancer Institute	van der Kant, R (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	Rikkant@gmail.com; j.neefjes@nki.nl	Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; Janssen, Lennert/0000-0001-9705-0204; van der Kant, Rik/0000-0002-7023-0106	European Research Council; TOP grant from The Netherlands Organization for Scientific Research, Chemical Sciences	European Research Council(European Research Council (ERC)European Commission); TOP grant from The Netherlands Organization for Scientific Research, Chemical Sciences	This work was supported by a European Research Council Advanced Grant and a TOP grant from The Netherlands Organization for Scientific Research, Chemical Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Akbar MA, 2009, MOL BIOL CELL, V20, P1705, DOI 10.1091/mbc.E08-03-0282; Bem D, 2015, BLOOD, V126, P133, DOI 10.1182/blood-2014-12-614677; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chirivino D, 2011, MOL BIOL CELL, V22, P375, DOI 10.1091/mbc.E10-09-0796; Cullinane AR, 2010, NAT GENET, V42, P303, DOI 10.1038/ng.538; Felici A, 2003, EMBO J, V22, P4465, DOI 10.1093/emboj/cdg428; Garg S, 2011, IMMUNITY, V35, P182, DOI 10.1016/j.immuni.2011.06.009; Gissen P, 2005, HUM MOL GENET, V14, P1261, DOI 10.1093/hmg/ddi137; Gissen P, 2004, NAT GENET, V36, P400, DOI 10.1038/ng1325; Graham SC, 2013, P NATL ACAD SCI USA, V110, P13345, DOI 10.1073/pnas.1307074110; Jiang P, 2014, MOL BIOL CELL, V25, P1327, DOI 10.1091/mbc.E13-08-0447; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Khatter D, 2015, J CELL SCI, V128, P1746, DOI 10.1242/jcs.162651; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; Lachmann J., 2014, CELL LOGIST, V4, DOI DOI 10.4161/21592780.2014.970840; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Lin XS, 2014, SCI REP-UK, V4, DOI 10.1038/srep07282; Lo B, 2005, BLOOD, V106, P4159, DOI 10.1182/blood-2005-04-1356; Lobingier BT, 2012, MOL BIOL CELL, V23, P4611, DOI 10.1091/mbc.E12-05-0343; McEwan DG, 2015, CELL HOST MICROBE, V17, P58, DOI 10.1016/j.chom.2014.11.011; McEwan DG, 2015, MOL CELL, V57, P39, DOI 10.1016/j.molcel.2014.11.006; Messller S, 2011, IMMUNOBIOLOGY, V216, P343, DOI 10.1016/j.imbio.2010.07.006; Nakamura N, 1997, J BIOL CHEM, V272, P11344; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x; Perini ED, 2014, TRAFFIC, V15, P1366, DOI 10.1111/tra.12232; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; Pols MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2360; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Schindler C, 2015, NAT CELL BIOL, V17, P639, DOI 10.1038/ncb3129; Smith H, 2012, HUM MUTAT, V33, P1656, DOI 10.1002/humu.22155; Solinger JA, 2014, MOL BIOL CELL, V25, P3909, DOI 10.1091/mbc.E13-12-0710; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Suzuki T, 2003, P NATL ACAD SCI USA, V100, P1146, DOI 10.1073/pnas.0237292100; Tornieri K, 2013, HUM MOL GENET, V22, P5215, DOI 10.1093/hmg/ddt378; van der Kant R, 2013, J CELL SCI, V126, P3462, DOI 10.1242/jcs.129270; van Luijn MM, 2015, BRAIN, V138, P1531, DOI 10.1093/brain/awv080; VENNEGOOR C, 1985, INT J CANCER, V35, P287, DOI 10.1002/ijc.2910350302; Wartosch L, 2015, TRAFFIC, V16, P727, DOI 10.1111/tra.12283; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Wurthner JU, 2001, J BIOL CHEM, V276, P19495, DOI 10.1074/jbc.M006473200; Zhu GD, 2009, MOL BIOL CELL, V20, P1223, DOI 10.1091/mbc.E08-07-0728	48	61	61	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30280	30290		10.1074/jbc.M115.688440	http://dx.doi.org/10.1074/jbc.M115.688440			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26463206	hybrid, Green Published			2022-12-26	WOS:000366738200009
J	Silverstein, N; Ewers, D; Forrest, LR; Fahlke, C; Kanner, BI				Silverstein, Nechama; Ewers, David; Forrest, Lucy R.; Fahlke, Christoph; Kanner, Baruch I.			Molecular Determinants of Substrate Specificity in Sodium-coupled Glutamate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glutamate; membrane transporter reconstitution; neurotransmitter transport; site-directed mutagenesis; sodium transport	DEPENDENT ASPARTATE TRANSPORTER; RAT-BRAIN; ACID TRANSPORTER; FUNCTIONAL-CHARACTERIZATION; PYROCOCCUS-HORIKOSHII; INDIVIDUAL SUBUNITS; MEMBRANE-VESICLES; CRYSTAL-STRUCTURE; CHLORIDE CHANNEL; BINDING	Crystal structures of the archaeal homologue Glt(Ph) have provided important insights into the molecular mechanism of transport of the excitatory neurotransmitter glutamate. Whereas mammalian glutamate transporters can translocate both glutamate and aspartate, Glt(Ph) is only one capable of aspartate transport. Most of the amino acid residues that surround the aspartate substrate in the binding pocket of Glt(Ph) are highly conserved. However, in the brain transporters, Thr-352 and Met-362 of the reentrant hairpin loop 2 are replaced by the smaller Ala and Thr, respectively. Therefore, we have studied the effects of T352A and M362T on binding and transport of aspartate and glutamate by Glt(Ph). Substrate-dependent intrinsic fluorescence changes were monitored in transporter constructs containing the L130W mutation. Glt(Ph)-L130W/T352A exhibited an approximate to 15-fold higher apparent affinity for l-glutamate than the wild type transporter, and the M362T mutation resulted in an increased affinity of approximate to 40-fold. An even larger increase of the apparent affinity for l-glutamate, around 130-fold higher than that of wild type, was observed with the T352A/M362T double mutant. Radioactive uptake experiments show that Glt(Ph)-T352A not only transports aspartate but also l-glutamate. Remarkably, Glt(Ph)-M362T exhibited l-aspartate but not l-glutamate transport. The double mutant retained the ability to transport l-glutamate, but its kinetic parameters were very similar to those of Glt(Ph)-T352A alone. The differential impact of mutation on binding and transport of glutamate suggests that hairpin loop 2 not only plays a role in the selection of the substrate but also in its translocation.	[Silverstein, Nechama; Kanner, Baruch I.] Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel; [Ewers, David; Fahlke, Christoph] Forschungszentrum Julich, Inst Complex Syst, D-52425 Julich, Germany; [Ewers, David] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Forrest, Lucy R.] NINDS, Computat Struct Biol Sect, NIH, Bethesda, MD 20894 USA	Hebrew University of Jerusalem; Helmholtz Association; Research Center Julich; Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Biochem & Mol Biol, POB 12272, IL-91120 Jerusalem, Israel.	baruch.kanner@mail.huji.ac.il	Ewers, David/AAG-8478-2021; Fahlke, Christoph/G-3635-2013; Forrest, Lucy/E-8113-2016	Ewers, David/0000-0003-1037-1027; Fahlke, Christoph/0000-0001-8602-9952; Forrest, Lucy/0000-0003-1855-7985	National Institutes of Health from NINDS [NS 16708]; Division of Intramural Research of the National Institutes of Health, NINDS; Deutsche Forschungsgemeinschaft [FA301/9]; United States-Israel Binational Science Foundation [2011268]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016708, ZIANS003139, R56NS016708] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; Division of Intramural Research of the National Institutes of Health, NINDS; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS 16708 from NINDS (to B. I. K.), the Division of Intramural Research of the National Institutes of Health, NINDS (to L. R. F.), Deutsche Forschungsgemeinschaft Grant FA301/9 (to C. F.), and United States-Israel Binational Science Foundation Grant 2011268 (to B. I. K.). The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Ewers D, 2013, P NATL ACAD SCI USA, V110, P12486, DOI 10.1073/pnas.1300772110; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Focke PJ, 2011, J NEUROSCI, V31, P6255, DOI 10.1523/JNEUROSCI.6096-10.2011; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Hanelt I, 2015, J BIOL CHEM, V290, P15962, DOI 10.1074/jbc.M115.656876; Jensen S, 2013, NAT STRUCT MOL BIOL, V20, P1224, DOI 10.1038/nsmb.2663; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Machtens JP, 2015, CELL, V160, P542, DOI 10.1016/j.cell.2014.12.035; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2012, J BIOL CHEM, V287, P17198, DOI 10.1074/jbc.M112.355040; Verdon G, 2014, ELIFE, V3, DOI 10.7554/eLife.02283; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	41	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28988	28996		10.1074/jbc.M115.682666	http://dx.doi.org/10.1074/jbc.M115.682666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26475859	Green Published, hybrid			2022-12-26	WOS:000365762300037
J	Benso, B; Rosalen, PL; Alencar, SM; Murata, RM				Benso, Bruna; Rosalen, Pedro Luiz; Alencar, Severino Matias; Murata, Ramiro Mendonca			Malva sylvestris Inhibits Inflammatory Response in Oral Human Cells. An In Vitro Infection Model	PLOS ONE			English	Article							PERIODONTAL-DISEASE; NATURAL-PRODUCTS; PORPHYROMONAS-GINGIVALIS; PLANT-EXTRACTS; ACTINOMYCETEMCOMITANS; GROWTH; L.	The aim of this study was to investigate the in vitro anti-inflammatory activity of Malva sylvestris extract (MSE) and fractions in a co-culture model of cells infected by Aggregatibacter actinomycetemcomitans. In addition, we evaluated the phytochemical content in the extract and fractions of M. sylvestris and demonstrated that polyphenols were the most frequent group in all samples studied. An in vitro dual-chamber model to mimic the periodontal structure was developed using a monolayer of epithelial keratinocytes (OBA-9) and a subepithelial layer of fibroblasts (HGF-1). The invasive periodontopathogen A. actinomycetemcomitans (D7S-1) was applied to migrate through the cell layers and induce the synthesis of immune factors and cytokines in the host cells. In an attempt to analyze the antimicrobial properties of MSE and fractions, a susceptibility test was carried out. The extract (MIC 175 mu g/mL, MBC 500 mu g/mL) and chloroform fraction (MIC 150 mu g/mL, MBC 250 mu g/mL) were found to have inhibitory activity. The extract and all fractions were assessed using a cytotoxicity test and results showed that concentrations under 100 mu g/mL did not significantly reduce cell viability compared to the control group (p > 0.05, viability > 90%). In order to analyze the inflammatory response, transcriptional factors and cytokines were quantified in the supernatant released from the cells. The chloroform fraction was the most effective in reducing the bacterial colonization (p < 0.05) and controlling inflammatory mediators, and promoted the down-regulation of genes including IL-1beta, IL-6, IL-10, CD14, PTGS, MMP-1 and FOS as well as the reduction of the IL-1beta, IL-6, IL-8 and GM-CSF protein levels (p < 0.05). Malva sylvestris and its chloroform fraction minimized the A. actinomycetemcomitans infection and inflammation processes in oral human cells by a putative pathway that involves important cytokines and receptors. Therefore, this natural product may be considered as a successful dual anti-inflammatory-antimicrobial candidate.	[Benso, Bruna; Rosalen, Pedro Luiz] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Sao Paulo, Brazil; [Alencar, Severino Matias] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Agrifood Ind Food & Nutr, Sao Paulo, Brazil; [Murata, Ramiro Mendonca] Univ So Calif, Herman Ostrow Sch Dent, Div Periodontol Diagnost Sci & Dent Hyg, Los Angeles, CA 90089 USA; [Murata, Ramiro Mendonca] Univ So Calif, Herman Ostrow Sch Dent, Div Biomed Sci, Los Angeles, CA USA	Universidade Estadual de Campinas; Universidade de Sao Paulo; University of Southern California; University of Southern California	Murata, RM (corresponding author), Univ So Calif, Herman Ostrow Sch Dent, Div Periodontol Diagnost Sci & Dent Hyg, Los Angeles, CA 90089 USA.	ramiro.murata@usc.edu	Benso, Bruna/L-1010-2015; Rosalen, Pedro Luiz/I-3718-2012; Murata, Ramiro M/P-9052-2014; Alencar, Severino Matias/B-7743-2012	Benso, Bruna/0000-0002-4425-5174; Rosalen, Pedro Luiz/0000-0003-0812-4027; Murata, Ramiro M/0000-0002-8478-6981; Alencar, Severino Matias/0000-0002-6637-7973	National Center for Complementary and Integrative Health of the National Institutes of Health [R00AT006507]; Sao Paulo Research Foundation [FAPESP - 2011/23980-5]; Brazilian Federal Agency for the Support and Evaluation of Graduate Education [CAPES - 2317/2014-01]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R00AT006507] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health of the National Institutes of Health; Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Federal Agency for the Support and Evaluation of Graduate Education; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Research reported in this publication was supported by: National Center for Complementary and Integrative Health of the National Institutes of Health under award number R00AT006507, Sao Paulo Research Foundation (FAPESP - 2011/23980-5), and Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES - 2317/2014-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros L, 2010, FOOD CHEM TOXICOL, V48, P1466, DOI 10.1016/j.fct.2010.03.012; Chen C, 2010, J BACTERIOL, V192, P2643, DOI 10.1128/JB.00157-10; *CLIN LAB STAND I, 2009, M100S19 CLIN LAB STA; Cogo LL, 2010, BRAZ J MICROBIOL, V41, P304, DOI 10.1590/S1517-83822010000200007; Cragg GM, 2014, J NAT PROD, V77, P703, DOI 10.1021/np5000796; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Cutillo F, 2006, PHYTOCHEMISTRY, V67, P481, DOI 10.1016/j.phytochem.2005.11.023; da Cunha MG, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-23; Darveau RP, 1997, PERIODONTOL 2000, V14, P12, DOI 10.1111/j.1600-0757.1997.tb00190.x; DellaGreca M, 2009, NAT PROD COMMUN, V4, P893; El Ghaoui WBJ, 2008, PHYTOTHER RES, V22, P1599, DOI 10.1002/ptr.2530; Folin O, 1912, J BIOL CHEM, V12, P239; Freires IA, 2015, MOLECULES, V20, P7329, DOI 10.3390/molecules20047329; Freires ID, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099086; Gasparetto JC, 2012, J PHARM PHARMACOL, V64, P172, DOI 10.1111/j.2042-7158.2011.01383.x; Graves DT, 2011, J DENT RES, V90, P143, DOI 10.1177/0022034510385236; Irwin CR, 1998, J ORAL PATHOL MED, V27, P255; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Jeon JG, 2011, CARIES RES, V45, P243, DOI 10.1159/000327250; Johansson A., 2011, TOXINS, V3, P2459; Kang JH, 2014, J DENT RES, V93, P1116, DOI 10.1177/0022034514552677; Koeberle A, 2014, DRUG DISCOV TODAY, V19, P1871, DOI 10.1016/j.drudis.2014.08.006; Kornman KS, 1997, J CLIN PERIODONTOL, V24, P72, DOI 10.1111/j.1600-051X.1997.tb01187.x; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; Magro Ana, 2006, Revista Iberoamericana de Micologia, V23, P176; Negrato CA, 2013, J APPL ORAL SCI, V21, P1, DOI 10.1590/1678-7757201302106; Offenbacher S, 2007, J PERIODONTOL, V78, P1911, DOI 10.1902/jop.2007.060465; Pasetto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115323; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Prudente AS, 2013, FOOD CHEM TOXICOL, V58, P324, DOI 10.1016/j.fct.2013.04.042; Quave CL, 2008, J ETHNOPHARMACOL, V118, P418, DOI 10.1016/j.jep.2008.05.005; Rautemaa R, 2007, CLIN MICROBIOL INFEC, V13, P1041, DOI 10.1111/j.1469-0691.2007.01802.x; Reynier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024828; Scapoli Luca, 2012, Dent Res J (Isfahan), V9, pS197, DOI 10.4103/1735-3327.109754; SEIBERG M, 2006, Patent No. 1811955; SEIBERG M, 2006, Patent No. 2006047470; SIEBERG M, 2006, Patent No. 2006088616; SLOTS J, 1980, INFECT IMMUN, V29, P1013; SOCRANSKY SS, 1977, J PERIODONTOL, V48, P497, DOI 10.1902/jop.1977.48.9.497; Stathopoulou PG, 2010, J CLIN PERIODONTOL, V37, P24, DOI 10.1111/j.1600-051X.2009.01505.x; Susin C, 2014, PERIODONTOL 2000, V65, P27, DOI 10.1111/prd.12019; Van Dyke TE, 2003, J DENT RES, V82, P82, DOI 10.1177/154405910308200202; Wang PL, 2002, CRIT REV ORAL BIOL M, V13, P132, DOI 10.1177/154411130201300204; Zhao LX, 2013, J PERIODONTOL, V84, P1847, DOI 10.1902/jop.2013.120548	44	28	30	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140331	10.1371/journal.pone.0140331	http://dx.doi.org/10.1371/journal.pone.0140331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479870	Green Published, gold, Green Submitted			2022-12-26	WOS:000363026600005
J	Ahmad, AF; Abbas, Z; Obaiys, SJ; Ibrahim, N; Hashim, M; Khaleel, H				Ahmad, Ahmad F.; Abbas, Zulkifly; Obaiys, Suzan J.; Ibrahim, Norazowa; Hashim, Mansor; Khaleel, Haider			Theoretical and Numerical Approaches for Determining the Reflection and Transmission Coefficients of OPEFB-PCL Composites at X-Band Frequencies	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; NATURAL FIBERS	Bio-composites of oil palm empty fruit bunch (OPEFB) fibres and polycaprolactones (PCL) with a thickness of 1 mm were prepared and characterized. The composites produced from these materials are low in density, inexpensive, environmentally friendly, and possess good dielectric characteristics. The magnitudes of the reflection and transmission coefficients of OPEFB fibre-reinforced PCL composites with different percentages of filler were measured using a rectangular waveguide in conjunction with a microwave vector network analyzer (VNA) in the X-band frequency range. In contrast to the effective medium theory, which states that polymer-based composites with a high dielectric constant can be obtained by doping a filler with a high dielectric constant into a host material with a low dielectric constant, this paper demonstrates that the use of a low filler percentage (12.2% OPEFB) and a high matrix percentage (87.8% PCL) provides excellent results for the dielectric constant and loss factor, whereas 63.8% filler material with 36.2% host material results in lower values for both the dielectric constant and loss factor. The open-ended probe technique (OEC), connected with the Agilent vector network analyzer (VNA), is used to determine the dielectric properties of the materials under investigation. The comparative approach indicates that the mean relative error of FEM is smaller than that of NRW in terms of the corresponding S-21 magnitude. The present calculation of the matrix/filler percentages endorses the exact amounts of substrate utilized in various physics applications.	[Ahmad, Ahmad F.; Abbas, Zulkifly] Univ Putra Malaysia, Inst Math Res, Serdang 43400, Selangor Darul, Malaysia; [Abbas, Zulkifly; Obaiys, Suzan J.; Hashim, Mansor] Univ Putra Malaysia, Fac Sci, Dept Phys, Serdang 43400, Selangor Darul, Malaysia; [Ibrahim, Norazowa] Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang 43400, Selangor Darul, Malaysia; [Khaleel, Haider] Sonoma State Univ, Dept Engn Sci, Rohnert Pk, CA 94928 USA	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; California State University System; Sonoma State University	Ahmad, AF (corresponding author), Univ Putra Malaysia, Inst Math Res, Serdang 43400, Selangor Darul, Malaysia.	ahmad_al67@yahoo.com; suzan_ye@yahoo.com	OBAIYS, SUZAN J./AAK-1117-2021; AHMAD, AHMAD/AAW-3699-2021; ahmad, ahmad/GVT-1790-2022; Ahmad, Ahmad Fahad/M-1094-2019	OBAIYS, SUZAN J./0000-0003-4523-2385; 				AL-Oqla FM, SYNTHETIC METALS, V206, P42; Andersons J, 2006, POLYM COMPOSITE, V27, P221, DOI 10.1002/pc.20184; Coccioli R, 1999, IEEE T MICROW THEORY, V47, P1106, DOI 10.1109/22.775443; Dang ZM, 2005, CERAM INT, V31, P349, DOI 10.1016/j.ceramint.2004.05.008; Deshpande MD, 1995, APPL FEM ESTIMATE CO; Fahma F, 2010, CELLULOSE, V17, P977, DOI 10.1007/s10570-010-9436-4; Fratticcioli E, 2004, IEEE T INSTRUM MEAS, V53, P1071, DOI 10.1109/TIM.2004.830753; George J., 1997, COMPOSITE INTERFACES, V5, P201; Hasar UC, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/5/055706; Herrera-Franco PJ, 2004, COMPOS PART A-APPL S, V35, P339, DOI 10.1016/j.compositesa.2003.09.012; Khalid M, 2008, MATER DESIGN, V29, P173, DOI 10.1016/j.matdes.2006.11.002; Mohanty JR, 2013, POLYM COMPOSITE, V34, P959, DOI 10.1002/pc.22502; NICOLSON AM, 1970, IEEE T INSTRUM MEAS, VIM19, P377, DOI 10.1109/TIM.1970.4313932; Phang SW, 2005, THIN SOLID FILMS, V477, P125, DOI 10.1016/j.tsf.2004.08.120; Pozar D. M., 2009, MICROWAVE ENG; Rozman HD, 2005, NATURAL FIBERS, BIOPOLYMERS, AND BIOCOMPOSITES, P407; Singh D, 2009, INT J THEO APPL SCI, V1, P34; Soleimani H, 2009, SOLID STATE SCI TECH, V17, P32; The Comsol Multi physics, 2006, QUICK START QUICK RE; WEIR WB, 1974, P IEEE, V62, P33, DOI 10.1109/PROC.1974.9382; Wollerdorfer M, 1998, IND CROP PROD, V8, P105, DOI 10.1016/S0926-6690(97)10015-2; Yao F, 2008, POLYM DEGRAD STABIL, V93, P90, DOI 10.1016/j.polymdegradstab.2007.10.012; Zak AK, 2011, CERAM INT, V37, P1653, DOI 10.1016/j.ceramint.2011.01.037	23	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140505	10.1371/journal.pone.0140505	http://dx.doi.org/10.1371/journal.pone.0140505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474301	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000363185500061
J	Fabiansen, C; Lykke, M; Hother, AL; Koch, J; Nielsen, OB; Hunter, I; Goetze, JP; Friis, H; Thymann, T				Fabiansen, Christian; Lykke, Mikkel; Hother, Anne-Louise; Koch, Jorgen; Nielsen, Ole Baekgaard; Hunter, Ingrid; Goetze, Jens P.; Friis, Henrik; Thymann, Thomas			Cardiac Dysfunction in a Porcine Model of Pediatric Malnutrition	PLOS ONE			English	Article							MYOCARDIAL PERFORMANCE INDEX; DOPPLER-DERIVED INDEX; PROTEIN-CALORIE MALNUTRITION; LEFT-VENTRICULAR FUNCTION; CONGESTIVE-HEART-FAILURE; ELDERLY-MEN; TEI-INDEX; QUANTIFICATION; KWASHIORKOR; ECHOCARDIOGRAPHY	Background Half a million children die annually of severe acute malnutrition and cardiac dysfunction may contribute to the mortality. However, cardiac function remains poorly examined in cases of severe acute malnutrition. Objective To determine malnutrition-induced echocardiographic disturbances and longitudinal changes in plasma pro-atrial natriuretic peptide and cardiac troponin-T in a pediatric porcine model. Methods and Results Five-week old piglets (Duroc-x-Danish Landrace-x-Yorkshire) were fed a nutritionally inadequate maize-flour diet to induce malnutrition (MAIZE, n = 12) or a reference diet (AGE-REF, n = 12) for 7 weeks. Outcomes were compared to a weight-matched reference group (WEIGHT-REF, n = 8). Pro-atrial natriuretic peptide and cardiac troponin-T were measured weekly. Plasma pro-atrial natriuretic peptide decreased in both MAIZE and AGE-REF during the first 3 weeks but increased markedly in MAIZE relative to AGE-REF during week 5-7 (p <= 0.001). There was overall no difference in plasma cardiac troponin-T between groups. However, further analysis revealed that release of cardiac troponin-T in plasma was more frequent in AGE-REF compared with MAIZE (OR: 4.8; 95%CI: 1.2-19.7; p = 0.03). However, when release occurred, cardiac troponin-T concentration was 6.9-fold higher (95%CI: 3.0-15.9; p<0.001) in MAIZE compared to AGE-REF. At week 7, the mean body weight in MAIZE was lower than AGE-REF (8.3 vs 32.4 kg, p<0.001), whereas heart-weight relative to body-weight was similar across the three groups. The myocardial performance index was 86% higher in MAIZE vs AGE-REF (p<0.001) and 27% higher in MAIZE vs WEIGHT-REF (p = 0.025). Conclusions Malnutrition associates with cardiac dysfunction in a pediatric porcine model by increased myocardial performance index and pro-atrial natriuretic peptide and it associates with cardiac injury by elevated cardiac troponin-T. Clinical studies are needed to see if the same applies for children suffering from malnutrition.	[Fabiansen, Christian; Lykke, Mikkel; Hother, Anne-Louise; Friis, Henrik; Thymann, Thomas] Univ Copenhagen, Dept Nutr Exercise & Sports, Frederiksberg, Denmark; [Koch, Jorgen; Thymann, Thomas] Univ Copenhagen, Dept Clin Vet & Anim Sci, Frederiksberg, Denmark; [Nielsen, Ole Baekgaard] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Hunter, Ingrid; Goetze, Jens P.] Rigshosp Copenhagen, Dept Clin Biochem, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Aarhus University; Rigshospitalet; University of Copenhagen	Thymann, T (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sports, Frederiksberg, Denmark.	thomas.thymann@sund.ku.dk	Fabiansen, Christian/D-4273-2015; Friis, Henrik/P-2891-2019; Friis, Henrik/N-2047-2014	Fabiansen, Christian/0000-0002-1987-781X; Friis, Henrik/0000-0002-2848-2940; Friis, Henrik/0000-0002-2848-2940; Thymann, Thomas/0000-0001-7480-6064; Koch, Jorgen/0000-0001-8616-7888	Nutriset; University of Copenhagen	Nutriset; University of Copenhagen	TT received grants from Nutriset (www.nutriset.fr) and the University of Copenhagen (www.ku.dk).	Aase SA, 2008, EUR J ECHOCARDIOGR, V9, P555, DOI 10.1093/ejechocard/jen120; ABEL RM, 1979, AM HEART J, V97, P733, DOI 10.1016/0002-8703(79)90008-5; Abu Faddan NH, 2010, ANN PEDIAT CARDIOL, V3, P113, DOI 10.4103/0974-2069.74036; ALDEN PB, 1987, AM J PHYSIOL, V253, pH380, DOI 10.1152/ajpheart.1987.253.2.H380; Arnlov J, 2005, AM HEART J, V149, P902, DOI 10.1016/j.ahj.2004.07.022; Arnlov J, 2004, EUR HEART J, V25, P2220, DOI 10.1016/j.ehj.2004.10.021; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brent B, 2014, CARDIOL YOUNG, V24, pS46; Brent B, 2012, PATHOG GLOB HEALTH, V106, P197, DOI 10.1179/2047772412Z.00000000061; Bruch C, 2000, EUR HEART J, V21, P1888, DOI 10.1053/euhj.2000.2246; Bundgaard H, 1996, MOL CELL BIOCHEM, V164, P277, DOI 10.1007/BF00408668; Cheung MMH, 2004, EUR HEART J, V25, P2238, DOI 10.1016/j.ehj.2004.07.034; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Droogmans S, 2008, ULTRASOUND MED BIOL, V34, P1564, DOI 10.1016/j.ultrasmedbio.2008.02.017; EDOZIEN JC, 1968, CLIN SCI, V34, P315; El-Sayed HL, 2006, EUR J CLIN NUTR, V60, P502, DOI 10.1038/sj.ejcn.1602344; Fioretto JR, 2002, AM J PHYSIOL-HEART C, V282, pH1327, DOI 10.1152/ajpheart.00431.2001; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Grellety Y., 2000, THESIS U ABERDEEN; Gruber C, 2012, J ANAT, V220, P179, DOI 10.1111/j.1469-7580.2011.01453.x; Hunter I, 2011, CLIN CHEM, V57, P1327, DOI 10.1373/clinchem.2011.166330; Hunter I, 2011, J IMMUNOL METHODS, V370, P104, DOI 10.1016/j.jim.2011.06.005; Kjaergaard J, 2005, J AM SOC ECHOCARDIOG, V18, P1058, DOI 10.1016/j.echo.2005.03.043; KOTHARI SS, 1992, INT J CARDIOL, V35, P19, DOI 10.1016/0167-5273(92)90050-D; LaCorte JC, 2003, J AM SOC ECHOCARDIOG, V16, P442, DOI 10.1016/S0894-7317(03)00110-X; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; Lykke M, 2013, AM J TRANSL RES, V5, P543; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; Maitland K, 2009, P NUTR SOC, V68, P274, DOI 10.1017/S0029665109001359; Manary MJ, 1998, AM J CLIN NUTR, V67, P1205, DOI 10.1093/ajcn/67.6.1205; Moller JE, 1999, J AM SOC ECHOCARDIOG, V12, P1065, DOI 10.1016/S0894-7317(99)70103-3; Nielsen KL, 2014, AM J CLIN NUTR, V99, P941, DOI 10.3945/ajcn.113.074724; NORGAARD A, 1986, CARDIOVASC RES, V20, P428, DOI 10.1093/cvr/20.6.428; NUTTER DO, 1979, CIRC RES, V45, P144, DOI 10.1161/01.RES.45.1.144; OLOWONYO MT, 1995, J TROP PEDIATRICS, V41, P74, DOI 10.1093/tropej/41.2.74; Peltier M, 2002, AM J CARDIOL, V90, P1261, DOI 10.1016/S0002-9149(02)02849-7; PHORNPHATKUL C, 1994, CLIN PEDIATR, V33, P147, DOI 10.1177/000992289403300304; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Pieske B, 2003, CARDIOVASC RES, V57, P874, DOI 10.1016/S0008-6363(02)00841-6; PIZA J, 1971, AM J TROP MED HYG, V20, P343, DOI 10.4269/ajtmh.1971.20.343; Poulsen SH, 2000, J AM SOC ECHOCARDIOG, V13, P379, DOI 10.1016/S0894-7317(00)70007-1; Poulsen SH, 2000, AM J CARDIOL, V85, P19, DOI 10.1016/S0002-9149(99)00599-8; Poulsen SH, 2000, J AM SOC ECHOCARDIOG, V13, P723, DOI 10.1067/mje.2000.105174; Saito Y, 2010, J CARDIOL, V56, P262, DOI 10.1016/j.jjcc.2010.08.001; Schmidt TA, 1998, CARDIOVASC RES, V37, P335, DOI 10.1016/S0008-6363(97)00261-7; Shoukry I, 1986, PEDIAT CARDIOLOGY, P1169; SINGH G R, 1989, Indian Pediatrics, V26, P875; SMYTHE PM, 1962, BMJ-BRIT MED J, P67; Suzuki Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/195483; Tei C, 1995, J Cardiol, V26, P135; Tei C, 1995, J Cardiol, V26, P357; Tobias Joseph D, 2011, J Intensive Care Med, V26, P183, DOI 10.1177/0885066610387993; Waterlow JC, 1992, PROTEIN ENERGY MALNU, P26; WHARTON BA, 1967, LANCET, V2, P384; WHO, 2013, GUID UPD MAN SEV AC; World Health Organization, 1999, MAN SEV MALN MAN PHY; World Health Organization, 2013, POCK BOOK HOSP CAR C; Yang TS, 1997, ANIM SCI, V64, P523, DOI 10.1017/S1357729800016155; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	61	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140472	10.1371/journal.pone.0140472	http://dx.doi.org/10.1371/journal.pone.0140472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473958	gold, Green Submitted, Green Published			2022-12-26	WOS:000363185500058
J	Meyer, B; Nguyen, CBT; Moen, A; Fagermoen, E; Sulheim, D; Nilsen, H; Wyller, VB; Gjerstad, J				Meyer, Benedicte; Chinh Bkrong Thuy Nguyen; Moen, Aurora; Fagermoen, Even; Sulheim, Dag; Nilsen, Hilde; Wyller, Vegard Bruun; Gjerstad, Johannes			Maintenance of Chronic Fatigue Syndrome (CFS) in Young CFS Patients Is Associated with the 5-HTTLPR and SNP rs25531 A > G Genotype	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; FUNCTIONAL POLYMORPHISM; DISORDER; ADOLESCENTS; STRESS; METAANALYSIS; POPULATIONS; PROMOTER	Earlier studies have shown that genetic variability in the SLC6A4 gene encoding the serotonin transporter (5-HTT) may be important for the re-uptake of serotonin (5-HT) in the central nervous system. In the present study we investigated how the 5-HTT genotype i.e. the short (S) versus long (L) 5-HTTLPR allele and the SNP rs25531 A > G affect the physical and psychosocial functioning in patients with chronic fatigue syndrome (CFS). All 120 patients were recruited from The Department of Paediatrics at Oslo University Hospital, Norway, a national referral center for young CFS patients (12-18 years). Main outcomes were number of steps per day obtained by an accelerometer and disability scored by the Functional Disability Inventory (FDI). Patients with the 5-HTT SS or SLG genotype had a significantly lower number of steps per day than patients with the 5-HTT LALG, SLA or LALA genotype. Patients with the 5-HTT SS or SLG genotype also had a significantly higher FDI score than patients with the 5-HTT LALG, SLA or LALA genotype. Thus, CFS patients with the 5-HTT SS or SLG genotype had worse 30 weeks outcome than CFS patients with the 5-HTT LALG, SLA or LALA genotype. The present study suggests that the 5-HTT genotype may be a factor that contributes to maintenance of CFS.	[Meyer, Benedicte; Chinh Bkrong Thuy Nguyen; Wyller, Vegard Bruun] Akershus Univ Hosp, Dept Paediat, Oslo, Norway; [Moen, Aurora; Gjerstad, Johannes] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Fagermoen, Even] Oslo Univ Hosp, Dept Anaesthesiol & Crit Care, Oslo, Norway; [Sulheim, Dag] Lillehammer Cty Hosp, Dept Paediat, Lillehammer, Norway; [Sulheim, Dag] Oslo Univ Hosp, Dept Paediat, Oslo, Norway; [Fagermoen, Even; Nilsen, Hilde; Wyller, Vegard Bruun] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Moen, Aurora; Gjerstad, Johannes] Natl Inst Occupat Hlth, Oslo, Norway; [Nilsen, Hilde] Akershus Univ Hosp, Sect Clin Mol Biol, Oslo, Norway; [Moen, Aurora; Gjerstad, Johannes] Univ Oslo, Dept Biosci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Gjerstad, J (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.	johannes.gjerstad@stami.no		BKRONG NGUYEN, CHINH/0000-0003-4588-0016	Health Authority South-East Norway	Health Authority South-East Norway	The study was supported by the Health Authority South-East Norway.	Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Crofford LJ, 2004, BRAIN BEHAV IMMUN, V18, P314, DOI 10.1016/j.bbi.2003.12.011; Farmer A, 2004, BRIT J PSYCHIAT, V184, P477, DOI 10.1192/bjp.184.6.477; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Goertzel BN, 2006, PHARMACOGENOMICS, V7, P475, DOI 10.2217/14622416.7.3.475; Heils A, 1996, J NEUROCHEM, V66, P2621; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Jiang HY, 2013, NEUROSCI LETT, V549, P191, DOI 10.1016/j.neulet.2013.05.065; Jiang JG, 2000, BIOCHEM BIOPH RES CO, V272, P882, DOI 10.1006/bbrc.2000.2848; Kalska Hely, 2013, Psychiatry J, V2013, P849346, DOI 10.1155/2013/849346; Kiyohara C, 2010, PSYCHIAT GENET, V20, P49, DOI 10.1097/YPG.0b013e328335112b; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lonsdorf TB, 2009, PROG NEURO-PSYCHOPH, V33, P1479, DOI 10.1016/j.pnpbp.2009.08.004; Lonsdorf TB, 2009, PSYCHOL SCI, V20, P198, DOI 10.1111/j.1467-9280.2009.02280.x; Macko RF, 2002, MED SCI SPORT EXER, V34, P394, DOI 10.1097/00005768-200203000-00002; Matre D, 2013, BRAIN RES, V1491, P54, DOI 10.1016/j.brainres.2012.10.045; Nakamura M, 2000, MOL PSYCHIATR, V5, P32, DOI 10.1038/sj.mp.4000698; Olsen MB, 2012, J NEUROSCI, V32, P9831, DOI 10.1523/JNEUROSCI.1742-12.2012; Osinsky R, 2008, EMOTION, V8, P584, DOI 10.1037/a0012826; Reimold M, 2007, J NEURAL TRANSM, V114, P635, DOI 10.1007/s00702-006-0609-0; Segal TY, 2005, J PEDIATR ENDOCR MET, V18, P295; Smith AK, 2008, PSYCHONEUROENDOCRINO, V33, P188, DOI 10.1016/j.psyneuen.2007.11.001; Sulheim D, 2014, JAMA PEDIAT; Sulheim D, 2012, BIOPSYCHOSOC MED, V6, DOI 10.1186/1751-0759-6-10; van der Doelen RHA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.57; WALKER LS, 1991, J PEDIATR PSYCHOL, V16, P39, DOI 10.1093/jpepsy/16.1.39; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Wyller VB, 2007, CLIN PHYSIOL FUNCT I, V27, P231, DOI 10.1111/j.1475-097X.2007.00743.x; Wyller VB, 2010, ACTA PAEDIATR, V99, P770, DOI 10.1111/j.1651-2227.2010.01701.x; Xie PX, 2009, ARCH GEN PSYCHIAT, V66, P1201, DOI 10.1001/archgenpsychiatry.2009.153	31	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140883	10.1371/journal.pone.0140883	http://dx.doi.org/10.1371/journal.pone.0140883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473596	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500126
J	Edson, D; Field, H; McMichael, L; Vidgen, M; Goldspink, L; Broos, A; Melville, D; Kristoffersen, J; de Jong, C; McLaughlin, A; Davis, R; Kung, N; Jordan, D; Kirkland, P; Smith, C				Edson, Daniel; Field, Hume; McMichael, Lee; Vidgen, Miranda; Goldspink, Lauren; Broos, Alice; Melville, Deb; Kristoffersen, Joanna; de Jong, Carol; McLaughlin, Amanda; Davis, Rodney; Kung, Nina; Jordan, David; Kirkland, Peter; Smith, Craig			Routes of Hendra Virus Excretion in Naturally-Infected Flying-Foxes: Implications for Viral Transmission and Spillover Risk	PLOS ONE			English	Article							PTEROPID BATS; EQUINE MORBILLIVIRUS; RESERVOIR; PATTERNS; DISEASE; HOSTS	Pteropid bats or flying-foxes (Chiroptera: Pteropodidae) are the natural host of Hendra virus (HeV) which sporadically causes fatal disease in horses and humans in eastern Australia. While there is strong evidence that urine is an important infectious medium that likely drives bat to bat transmission and bat to horse transmission, there is uncertainty about the relative importance of alternative routes of excretion such as nasal and oral secretions, and faeces. Identifying the potential routes of HeV excretion in flying-foxes is important to effectively mitigate equine exposure risk at the bat-horse interface, and in determining transmission rates in host-pathogen models. The aim of this study was to identify the major routes of HeV excretion in naturally infected flying-foxes, and secondarily, to identify between-species variation in excretion prevalence. A total of 2840 flying-foxes from three of the four Australian mainland species (Pteropus alecto, P. poliocephalus and P. scapulatus) were captured and sampled at multiple roost locations in the eastern states of Queensland and New South Wales between 2012 and 2014. A range of biological samples (urine and serum, and urogenital, nasal, oral and rectal swabs) were collected from anaesthetized bats, and tested for HeV RNA using a qRT-PCR assay targeting the M gene. Forty-two P. alecto (n = 1410) had HeV RNA detected in at least one sample, and yielded a total of 78 positive samples, at an overall detection rate of 1.76% across all samples tested in this species (78/4436). The rate of detection, and the amount of viral RNA, was highest in urine samples (>serum, packed haemocytes >faecal >nasal >oral), identifying urine as the most plausible source of infection for flying-foxes and for horses. Detection in a urine sample was more efficient than detection in urogenital swabs, identifying the former as the preferred diagnostic sample. The detection of HeV RNA in serum is consistent with haematogenous spread, and with hypothesised latency and recrudesence in flying-foxes. There were no detections in P. poliocephalus (n = 1168 animals; n = 2958 samples) or P. scapulatus (n = 262 animals; n = 985 samples), suggesting (consistent with other recent studies) that these species are epidemiologically less important than P. alecto in HeV infection dynamics. The study is unprecedented in terms of the individual animal approach, the large sample size, and the use of a molecular assay to directly determine infection status. These features provide a high level of confidence in the veracity of our findings, and a sound basis from which to more precisely target equine risk mitigation strategies.	[Edson, Daniel; Field, Hume; McMichael, Lee; Vidgen, Miranda; Goldspink, Lauren; Broos, Alice; Melville, Deb; Kristoffersen, Joanna; de Jong, Carol; McLaughlin, Amanda; Kung, Nina; Smith, Craig] Queensland Ctr Emerging Infect Dis, Dept Agr & Fisheries, Coopers Plains, Qld, Australia; [Field, Hume] EcoHlth Alliance, New York, NY USA; [Davis, Rodney; Kirkland, Peter] Elizabeth Macarthur Agr Inst, New South Wales Dept Primary Ind, Menangle, NSW, Australia; [Jordan, David] Wollongbar Primary Ind Inst, New South Wales Dept Primary Ind, Wollongbar, NSW, Australia	EcoHealth Alliance; NSW Department of Primary Industries; NSW Department of Primary Industries	Edson, D (corresponding author), Queensland Ctr Emerging Infect Dis, Dept Agr & Fisheries, Coopers Plains, Qld, Australia.	Daniel.Edson@agriculture.gov.au	McMichael, Lee UQ/C-7948-2018; Kirkland, Peter/AAC-6731-2019; Jordan, David/P-7281-2019; Kung, Nina Y/H-1260-2012	McMichael, Lee UQ/0000-0002-7675-4859; Vidgen, Miranda/0000-0003-4131-0390; Broos, Alice/0000-0001-7593-1000	State of Queensland; State of New South Wales; Commonwealth of Australia under the National Hendra Virus Research Program; Queensland through the Queensland Centre for Emerging Infectious Diseases; New South Wales Department of Primary Industries	State of Queensland; State of New South Wales; Commonwealth of Australia under the National Hendra Virus Research Program; Queensland through the Queensland Centre for Emerging Infectious Diseases; New South Wales Department of Primary Industries	The research was funded by the State of Queensland, the State of New South Wales and the Commonwealth of Australia under the National Hendra Virus Research Program. Logistic support and base funding for HF, CdJ and CS was provided by Biosecurity Queensland through the Queensland Centre for Emerging Infectious Diseases. Base funding for DJ and PK was provided by the New South Wales Department of Primary Industries.	Allworth T., 1995, Communicable Diseases Intelligence, V19, P575; [Anonymous], 2015, WHAT IS HENDRA VIRUS; Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Barr J, 2015, J GEN VIROL, V96, P24, DOI 10.1099/vir.0.068106-0; Barr JA, 2012, J GEN VIROL, V93, P2590, DOI 10.1099/vir.0.045385-0; Bassiouni A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123216; Berger A, 1999, APPL ANIM BEHAV SCI, V64, P1, DOI 10.1016/S0168-1591(99)00026-X; Berhane Y, 2008, TRANSBOUND EMERG DIS, V55, P165, DOI 10.1111/j.1865-1682.2008.01021.x; Breed AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061316; Breed AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028816; Churchill S., 1998, AUSTRALIAN BATS; Daley P, 2006, J CLIN MICROBIOL, V44, P2265, DOI 10.1128/JCM.02055-05; Daniels PW, 2007, CURR TOP MICROBIOL, V315, P113; Dietrich M, 2015, ENVIRON MICROBIOL, V17, P4280, DOI 10.1111/1462-2920.12766; Edson DW, 2015, PLOS ONE; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Field H, 2015, PLOS ONE SUBMITTED; Field HE, 2016, ECOHEALTH, V13, P26, DOI 10.1007/s10393-015-1066-8; Field H, 2012, CURR TOP MICROBIOL, V359, P11, DOI 10.1007/82_2012_214; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Goldspink LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128835; Hall L, 2000, FLYING FOXES FRUIT A; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Hernes SS, 2011, EUR J CLIN MICROBIOL, V30, P159, DOI 10.1007/s10096-010-1064-2; Jonsson NN, 2004, VET REC, V154, P664, DOI 10.1136/vr.154.21.664; KEIPER RR, 1980, J MAMMAL, V61, P116, DOI 10.2307/1379963; Little TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001006; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; Martin G, 2015, J GEN VIROL, V96, P1229, DOI 10.1099/vir.0.000073; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2124; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Rahman SA, 2013, EMERG INFECT DIS, V19, P51, DOI 10.3201/eid1901.120221; Rogers RJ, 1996, AUST VET J, V74, P243, DOI 10.1111/j.1751-0813.1996.tb15413.x; Smith CS, 2014, PLOS ONE, V9, P1; Smith IL, 2001, J VIROL METHODS, V98, P33, DOI 10.1016/S0166-0934(01)00354-8; Smith I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025275; Sohayati AR, 2011, EPIDEMIOL INFECT, V139, P1570, DOI 10.1017/S0950268811000550; van Dijk JGB, 2015, ECOL EVOL, V5, P436, DOI 10.1002/ece3.1359; Vidgen ME, 2015, J GEN VIROL, V96, P1619, DOI 10.1099/vir.0.000099; Wang HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080430; Weaver GV, 2013, J WILDLIFE DIS, V49, P759, DOI 10.7589/2012-11-276; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364; Young P, 1997, RECENT ADVANCES IN M; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315	48	54	55	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140670	10.1371/journal.pone.0140670	http://dx.doi.org/10.1371/journal.pone.0140670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469523	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000363184600092
J	He, JB; Gao, CY; Lin, QX; Zhang, SQ; Zhao, WT; Lu, XG; Wang, GP				He, Jiabao; Gao, Chuanyu; Lin, Qianxin; Zhang, Shaoqing; Zhao, Winston; Lu, Xianguo; Wang, Guoping			Temporal and Spatial Changes in Black Carbon Sedimentary Processes in Wetlands of Songnen Plain, Northeast of China	PLOS ONE			English	Article							ORGANIC-CARBON; HISTORICAL TRENDS; ELEMENTAL CARBON; SOIL-PHOSPHORUS; TIBETAN PLATEAU; SANJIANG PLAIN; MIXING STATE; DESERTIFICATION; STORAGE; RECORD	Black carbon (BC), an important component of organic carbon (OC) produced from incomplete combustion of carbon compounds, is widespread and affects the global carbon storage. The objectives of this study were to analyze the BC contents and fluxes in the last 150 years to determine the causes of differences in the three profiles of the Songnen Plain of Northeast China and to estimate the BC storage in the wetlands of the Songnen Plain. In the three sampling sites, BC fluxes in the period between 1950 and the present time increased by the ratios of 1.3, 31.1 and 1.4, respectively, compared to their own baseline between 1850 and 1900. Furthermore, the BC fluxes varying from 0.76 to 5.63 g m(-2) y(-1) in the three profiles had an opposite trend with the sand percentages with mean values changing from 78.9% to 19.6%, suggesting that sand desertification might additionally affect the BC processes in the region.	[He, Jiabao; Gao, Chuanyu; Lin, Qianxin; Zhang, Shaoqing; Lu, Xianguo; Wang, Guoping] Chinese Acad Sci, Key Lab Wetland Ecol & Environm, Northeast Inst Geog & Agroecol, Changchun, Peoples R China; [He, Jiabao; Gao, Chuanyu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lin, Qianxin] Louisiana State Univ, Dept Oceanog & Coastal Sci, Sch Coast & Environm, Baton Rouge, LA 70803 USA; [Zhao, Winston] Penn State Univ, Smeal Coll, University Pk, PA 16802 USA	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Louisiana State University System; Louisiana State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wang, GP (corresponding author), Chinese Acad Sci, Key Lab Wetland Ecol & Environm, Northeast Inst Geog & Agroecol, Changchun, Peoples R China.	wangguoping@neigae.ac.cn	Gao, Chuanyu/O-3946-2019; Wang, Guoping/A-8140-2008	lu, xian guo/0000-0001-7638-2787; Gao, Chuanyu/0000-0003-2792-5022; Wang, Guoping/0000-0002-8350-812X	National Natural Science Foundation of China [41271209, 41571191]; National Basic Research Program [2012CB956100]; CAS/SAFEA International Partnership Program for Creative Research Teams [KZZD-EW-TZ-07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	Financial support was provided by the National Natural Science Foundation of China (No. 41271209, 41571191), the National Basic Research Program (No. 2012CB956100), and the CAS/SAFEA International Partnership Program for Creative Research Teams (No. KZZD-EW-TZ-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldock JA, 2000, ORG GEOCHEM, V31, P697, DOI 10.1016/S0146-6380(00)00049-8; Begy R, 2009, J ENVIRON RADIOACTIV, V100, P644, DOI 10.1016/j.jenvrad.2009.05.005; Binford, 1990, J PALEOLIMNOL, V3, P253, DOI DOI 10.1007/BF00219461; Bond TC, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002840; Cappa CD, 2012, SCIENCE, V337, P1078, DOI 10.1126/science.1223447; [柴社立 Chai Sheli], 2013, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V43, P134; Cheng L., 2008, HEILONGJIANG SHIZHI, P5; Cong ZY, 2013, ENVIRON SCI TECHNOL, V47, P2579, DOI 10.1021/es3048202; Diao CD, 2011, EARTH SCI FRONTIERS, V18, P27; Flores-Cervantes DX, 2009, MAR CHEM, V113, P172, DOI 10.1016/j.marchem.2009.01.012; Forestry Department of Jilin Province, 2010, 2 NAT WETL RES INV W; Gao C, 2014, OPTIMISATION PROTOCO, P87; Gao CA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05723; Goldberg E. D., 1985, Black carbon in the environment. Properties and distribution; Guggenberger G, 2008, GLOBAL CHANGE BIOL, V14, P1367, DOI 10.1111/j.1365-2486.2008.01568.x; Hamer U, 2004, ORG GEOCHEM, V35, P823, DOI 10.1016/j.orggeochem.2004.03.003; Han YM, 2015, ENVIRON SCI TECHNOL, V49, P4176, DOI 10.1021/es504568m; Han YM, 2011, ENVIRON SCI TECHNOL, V45, P5287, DOI 10.1021/es103518c; Hartnett HE, 1998, NATURE, V391, P572, DOI 10.1038/35351; Hassink J, 1997, PLANT SOIL, V191, P77, DOI 10.1023/A:1004213929699; Hobbie SE, 2000, GLOBAL CHANGE BIOL, V6, P196, DOI 10.1046/j.1365-2486.2000.06021.x; Hockaday WC, 2007, GEOCHIM COSMOCHIM AC, V71, P3432, DOI 10.1016/j.gca.2007.02.023; Hong G, 2007, STUDIES TEMPORAL SPA; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Kaspari SD, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046096; Lehmann J, 2008, NAT GEOSCI, V1, P832, DOI 10.1038/ngeo358; Lehndorff E, 2015, QUATERNARY SCI REV, V110, P15, DOI 10.1016/j.quascirev.2014.12.014; Lehndorff E, 2015, HOLOCENE, V25, P398, DOI 10.1177/0959683614558651; Leorri E, 2014, SCI TOTAL ENVIRON, V470, P240, DOI 10.1016/j.scitotenv.2013.09.064; Li X.J., 2000, SCI GEOGR SIN, V20, P51; Li XR, 2006, J ARID ENVIRON, V64, P505, DOI 10.1016/j.jaridenv.2005.06.011; Liu XD, 2011, MAR POLLUT BULL, V62, P2205, DOI 10.1016/j.marpolbul.2011.06.027; Ma W, 2014, J FORESTRY RES, V25, P749, DOI 10.1007/s11676-014-0523-5; Masiello CA, 2004, MAR CHEM, V92, P201, DOI 10.1016/j.marchem.2004.06.043; Meehl GA, 2008, J CLIMATE, V21, P2869, DOI 10.1175/2007JCLI1777.1; Menon S, 2002, SCIENCE, V297, P2250, DOI 10.1126/science.1075159; Morisada K, 2004, GEODERMA, V119, P21, DOI 10.1016/S0016-7061(03)00220-9; Muri G, 2003, ENVIRON TOXICOL CHEM, V22, P1009; National Bureau of Statistics, 1986, CHIN EN STAT YB; Nguyen BT, 2009, ORG GEOCHEM, V40, P846, DOI 10.1016/j.orggeochem.2009.05.004; Qiu SW, 2008, SAND DESERTIFICATION; Rasmussen K, 2001, GLOBAL ENVIRON CHANG, V11, P271, DOI 10.1016/S0959-3780(01)00005-X; Rodionov A, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003669; Schmidt MWI, 2001, GLOBAL BIOGEOCHEM CY, V15, P163, DOI 10.1029/2000GB001284; Schmidt MWI, 2000, GLOBAL BIOGEOCHEM CY, V14, P777, DOI 10.1029/1999GB001208; Shen YH, 1999, CHEMOSPHERE, V38, P1505, DOI 10.1016/S0045-6535(98)00371-3; Shrestha Gyami, 2010, Sustainability, V2, P294, DOI 10.3390/su2010294; Song JZ, 2002, ENVIRON SCI TECHNOL, V36, P3960, DOI 10.1021/es025502m; Soucemarianadin LN, 2014, GEODERMA, V217, P118, DOI 10.1016/j.geoderma.2013.11.010; Su Y, 2003, ACTA ECOLOGICA SINIC, V24, P71; Su YZ, 2003, SCI AGR SINICA, V2; Thevenon F, 2010, GLOBAL PLANET CHANGE, V72, P381, DOI 10.1016/j.gloplacha.2010.01.014; Wang G, 2008, SCI GEOGRAPHICA SINI, V3; Wang GP, 2006, GEODERMA, V132, P59, DOI 10.1016/j.geoderma.2005.04.021; Wang GP, 2004, WETLANDS, V24, P608, DOI 10.1672/0277-5212(2004)024[0608:HVOHMW]2.0.CO;2; Wang GP, 2008, GEODERMA, V145, P50, DOI 10.1016/j.geoderma.2008.02.004; Wang T, 2002, SCI CHINA SER D, V45, P23, DOI 10.1007/BF02878385; Wang ZM, 2009, AGR ECOSYST ENVIRON, V129, P315, DOI 10.1016/j.agee.2008.10.009; Wulan T.Y., 2001, SCI GEOGRAPHICA SINI, V21, P230; Xiao R, 1995, SAND DESERTIFICATION; Yu XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099715; Zhai ZL., 2006, DESERTIFICATION INFO; Zhan CL, 2013, SCI TOTAL ENVIRON, V465, P255, DOI 10.1016/j.scitotenv.2012.10.113	63	8	9	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140834	10.1371/journal.pone.0140834	http://dx.doi.org/10.1371/journal.pone.0140834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469981	gold, Green Published, Green Submitted			2022-12-26	WOS:000363184600122
J	McClanahan, TR; Muthiga, NA; Abunge, C; Kamukuru, AT; Mwakalapa, E; Kalombo, H				McClanahan, Timothy R.; Muthiga, Nyawira A.; Abunge, Caroline; Kamukuru, Albogast T.; Mwakalapa, Eliezer; Kalombo, Hassan			What Happens after Conservation and Management Donors Leave? A Before and After Study of Coral Reef Ecology and Stakeholder Perceptions of Management Benefits	PLOS ONE			English	Article							TROPHIC RELATIONSHIPS; MARINE PARKS; RECOVERY; FISHERIES; FISH; VULNERABILITY; COMANAGEMENT; HERBIVORES; TARGETS; BIOMASS	The coral reefs of Tanga, Tanzania were recognized as a national conservation priority in the early 1970s, but the lack of a management response led to damage by dynamite, beach seines, and high numbers of fishers until themid 1990s. Subsequently, an Irish Aid funded IUCN Eastern Africa program operated from 1994 to mid 2007 to implement increasedmanagement aimed at reducing these impacts. Themain effects of this management were to establish collaborative management areas, reduce dynamite and seine net fishing, and establish small community fisheries closures beginning in 1996. The ecology of the coral reefs was studied just prior to the initiation of this management in 1996, during, 2004, and a few years after the project ended in 2010. The perceptions of resource users towards management options were evaluated in 2010. The ecological studies indicated that the biomass of fish rose continuously during this period from 260 to 770 kg/ ha but the small closures were no different from the non-closure areas. The benthic community studies indicate stability in the coral cover and community composition and an increase in coralline algae and topographic complexity over time. The lack of change in the coral community suggests resilience to various disturbances including fisheries management and the warm temperature anomaly of 1998. These results indicate that some aspects of the management program had been ecologically successful even after the donor program ended. Moreover, the increased compliance with seine net use and dynamite restrictions were the most likely factors causing this increase in fish biomass and not the closures. Resource users interviewed in 2010 were supportive of gear restrictions but there was considerable between-community disagreement over the value of specific restrictions. The social-ecological results suggest that increased compliance with gear restrictions is largely responsible for the improvements in reef ecology and is a high priority for future management programs.	[McClanahan, Timothy R.; Muthiga, Nyawira A.] Marine Program, Wildlife Conservat Soc, Bronx, NY 10465 USA; [McClanahan, Timothy R.; Muthiga, Nyawira A.] Wildlife Conservat Soc, Marine Program, Mombasa, Kenya; [Kamukuru, Albogast T.] Univ Dar Es Salaam, Dept Aquat Sci & Fisheries, Dar Es Salaam, Tanzania; [Mwakalapa, Eliezer] Minist Livestock & Fisheries Dev, Mtwara, Tanzania; [Kalombo, Hassan] Reg Commissioners Off, Tanga, Tanzania	Wildlife Conservation Society; University of Dar es Salaam	Muthiga, NA (corresponding author), Marine Program, Wildlife Conservat Soc, Bronx, NY 10465 USA.	nmuthiga@wcs.org			Western Indian Ocean Marine Science Association through the Marine Science for Management Program [MASMA/CC/2010/03]	Western Indian Ocean Marine Science Association through the Marine Science for Management Program	The Western Indian Ocean Marine Science Association (www.wiomsa.org) through the Marine Science for Management Program provided funding to TRM (grant no. MASMA/CC/2010/03).	Abesamis RA, 2014, REV FISH BIOL FISHER, V24, P1033, DOI 10.1007/s11160-014-9362-x; Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Ateweberhan M, 2010, MAR POLLUT BULL, V60, P964, DOI 10.1016/j.marpolbul.2010.03.033; Barrett CB, 2006, J DEV STUD, V42, P248, DOI 10.1080/00220380500405394; Bene C, 2009, WORLD DEV, V37, P1935, DOI 10.1016/j.worlddev.2009.05.003; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Bohnsack JA, 1998, AUST J ECOL, V23, P298, DOI 10.1111/j.1442-9993.1998.tb00734.x; Burke Lauretta, 2011, REEFS AT RISK; Cinner JE, 2011, GLOBAL ENVIRON CHANG, V21, P835, DOI 10.1016/j.gloenvcha.2011.04.012; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Darling ES, 2013, GLOBAL CHANGE BIOL, V19, P1930, DOI 10.1111/gcb.12191; Daw TM, 2015, P NATL ACAD SCI USA, V112, P6949, DOI 10.1073/pnas.1414900112; Evans L, 2011, J ENVIRON MANAGE, V92, P1938, DOI 10.1016/j.jenvman.2011.03.010; Fox HE, 2006, ECOL APPL, V16, P1631, DOI 10.1890/1051-0761(2006)016[1631:RFBFOC]2.0.CO;2; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; HAY ME, 1981, AQUAT BOT, V11, P97, DOI 10.1016/0304-3770(81)90051-6; Hicks CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036022; Horrill C, 2000, CORAL REEFS OF THE I; Humphries AT, 2014, MAR ECOL PROG SER, V504, P119, DOI 10.3354/meps10744; Kaunda-Arara Boaz, 2006, Western Indian Ocean Journal of Marine Science, V5, P17; Macneil MA, 2008, ENVIRON CONSERV, V35, P193, DOI 10.1017/S0376892908004888; McClanahan TR, 2015, CONSERV BIOL, V29, P409, DOI 10.1111/cobi.12430; McClanahan TR, 2008, ENVIRON CONSERV, V35, P340, DOI 10.1017/S0376892908005250; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2016, FISH FISH, V17, P417, DOI 10.1111/faf.12118; McClanahan TR, 2014, ECOL SOC, V19, DOI 10.5751/ES-06080-190105; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McClanahan TR, 2011, GLOBAL CHANGE BIOL, V17, P2023, DOI 10.1111/j.1365-2486.2011.02395.x; McClanahan TR, 2012, ENVIRON CONSERV, V39, P357, DOI 10.1017/S0376892912000197; McClanahan TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093385; McClanahan TR, 2014, MAR ECOL PROG SER, V497, P13, DOI 10.3354/meps10605; McClanahan TR, 2009, REV FISH BIOL FISHER, V19, P33, DOI 10.1007/s11160-008-9088-8; McClanahan TR, 2002, MAR FRESHWATER RES, V53, P223, DOI 10.1071/MF01112; McClanahan TR, 2000, BIOL CONSERV, V94, P191, DOI 10.1016/S0006-3207(99)00176-7; McClanahan TR, 2001, CORAL REEFS, V19, P380, DOI 10.1007/s003380000133; MCCLANAHAN TR, 1994, J EXP MAR BIOL ECOL, V184, P237, DOI 10.1016/0022-0981(94)90007-8; MCCLANAHAN TR, 1994, CORAL REEFS, V13, P231, DOI 10.1007/BF00303637; McClanahan TR, 1999, BIOL CONSERV, V89, P161, DOI 10.1016/S0006-3207(98)00123-2; McClanahan TR, 1996, CONSERV BIOL, V10, P1187, DOI 10.1046/j.1523-1739.1996.10041187.x; McClanahan TR, 1998, J EXP MAR BIOL ECOL, V221, P231, DOI 10.1016/S0022-0981(97)00130-5; McClanahan TR, 1999, CORAL REEFS, V18, P321, DOI 10.1007/s003380050205; O'Leary JK, 2010, ECOLOGY, V91, P3584, DOI 10.1890/09-2059.1; Obura D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045013; Taylor BM, 2014, CORAL REEFS, V33, P869, DOI 10.1007/s00338-014-1187-5; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Wamukota AW, 2012, MAR POLICY, V36, P481, DOI 10.1016/j.marpol.2011.09.001; Wells S., 2007, PUTTING ADAPTIVE MAN; Wells S, 2010, OCEAN COAST MANAGE, V53, P161, DOI 10.1016/j.ocecoaman.2010.01.007; Wells S, 2009, MAR POLLUT BULL, V58, P20, DOI 10.1016/j.marpolbul.2008.09.019; Youngs R., 2001, THE EUROPEAN UNION A	52	7	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0138769	10.1371/journal.pone.0138769	http://dx.doi.org/10.1371/journal.pone.0138769			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0CX	26469979	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600005
J	Lee, YC; Lin, SW; Chen, MY; Chang, SY; Kuo, CH; Sheng, WH; Hsieh, SM; Sun, HY; Chang, HY; Wu, MR; Liu, WC; Wu, PY; Yang, SP; Zhang, JY; Su, YC; Luo, YZ; Hung, CC; Chang, SC				Lee, Yi-Chieh; Lin, Shu-Wen; Chen, Mao-Yuan; Chang, Sui-Yuan; Kuo, Ching-Hua; Sheng, Wang-Huei; Hsieh, Szu-Min; Sun, Hsin-Yun; Chang, Hsi-Yen; Wu, Mon-Ro; Liu, Wen-Chun; Wu, Pei-Ying; Yang, Shang-Ping; Zhang, Jun-Yu; Su, Yi-Ching; Luo, Yi-Zhen; Hung, Chien-Ching; Chang, Shan-Chwen			Presence of Tablet Remnants of Nevirapine Extended-Release in Stools and Its Impact on Virological Outcome in HIV-1-Infected Patients: A Prospective Cohort Study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PHARMACOKINETICS; PLASMA; EFAVIRENZ; EFFICACY; SAFETY; HIV-1	Background Nevirapine extended-release (NVP-XR) taken once daily remains an effective antiretroviral agent for patients infected with HIV-1 strains that do not harbor resistance mutations. Presence of tablet remnants of NVP XR in stools was reported in 1.19% and 3.05% of subjects in two clinical trials. However, the prevalence may have been underestimated because the information was retrospectively collected in the studies. Methods Between April and December 2014, we prospectively inquired about the frequency of noticing tablet remnants of NVP XR in stools in HIV-1-infected patients who switched to antiretroviral regimens containing NVP XR plus 2 nucleos(t)ide reverse-transcriptase inhibitors. Patients were invited to participate in therapeutic drug monitoring of plasma concentrations of NVP 12 or 24 hours after taking the previous dose (C12 and C24, respectively) of NVP XR using high-performance liquid chromatography. The information on clinical characteristics, including plasma HIV RNA load and CD4 lymphocyte count, at baseline and during follow-up was recorded. Results During the 9-month study period, 272 patients switched to NVP XR-based regimens and 60 (22.1%) noticed tablet remnants of NVP XR in stools, in whom 54.2% reported noticing the tablet remnants at least once weekly. Compared with patients who did not notice tablet remnants, those who noticed tablet remnants had a higher mean CD4 lymphocyte count (629 vs 495 cells/mm(3), P = 0.0002) and a similar mean plasma HIV RNA load (1.57 vs 1.61 log(10) copies/mL, P = 0.76) on switch. At about 12 and 24 weeks after switch, patients who noticed tablet remnants continued to have a similar mean plasma HIV RNA load (1.39 vs 1.43 log(10) copies/mL, P = 0.43; and 1.30 vs 1.37 log(10) copies/mL, P = 0.26, respectively), but had a lower median NVP C12 (3640 vs 4730 ng/mL, P = 0.06), and a similar median NVP C24 (3220 vs 3330 ng/ml, P = 0.95) when compared with those who did not notice tablet remnants. Conclusions The presence of tablet remnants of NVP XR in stools is not uncommon in HIV-1-infected Taiwanese patients receiving NVP XR-based antiretroviral regimens, which does not have an adverse impact on the virological and immunological outcomes.	[Lee, Yi-Chieh] Lo Hsu Fdn Inc, Lotung Poh Ai Hosp, Dept Internal Med, Ilan, Taiwan; [Lin, Shu-Wen; Kuo, Ching-Hua] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan; [Lin, Shu-Wen; Chen, Mao-Yuan; Chang, Sui-Yuan; Kuo, Ching-Hua; Sheng, Wang-Huei; Hsieh, Szu-Min; Sun, Hsin-Yun; Wu, Mon-Ro; Liu, Wen-Chun; Hung, Chien-Ching; Chang, Shan-Chwen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Lin, Shu-Wen] Natl Taiwan Univ, Coll Med, Grad Inst Clin Pharm, Taipei 10764, Taiwan; [Chen, Mao-Yuan; Sheng, Wang-Huei; Hsieh, Szu-Min; Sun, Hsin-Yun; Wu, Mon-Ro; Liu, Wen-Chun; Hung, Chien-Ching; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chang, Sui-Yuan] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Hsieh, Szu-Min] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei 10764, Taiwan; [Kuo, Ching-Hua] Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan; [Sheng, Wang-Huei; Chang, Hsi-Yen; Wu, Pei-Ying; Yang, Shang-Ping; Zhang, Jun-Yu; Su, Yi-Ching; Luo, Yi-Zhen] Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei 100, Taiwan; [Hung, Chien-Ching] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hung, Chien-Ching] China Med Univ, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Hung, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	hcc0401@ntu.edu.tw		Hung, Chien-Ching/0000-0001-7345-0836; CHANG, SHAN-CHWEN/0000-0001-6505-4139; LIN, SHU-WEN/0000-0002-9940-0850; KUO, CHING-HUA/0000-0001-5722-0360; HSIEH, SZU-MIN/0000-0002-1879-4086; SUN, HSIN-YUN/0000-0003-0074-7721; SHENG, WANG-HUEI/0000-0002-5605-7853; CHANG, SUI-YUAN/0000-0002-6009-6724	Centers for Disease Control, Taiwan [DOH102-DC-1401]; National Taiwan University Hospital [NTUH101S-1917]	Centers for Disease Control, Taiwan; National Taiwan University Hospital(National Taiwan University)	This study was supported by grants from the Centers for Disease Control, Taiwan (grant number DOH102-DC-1401 to C-CH) and National Taiwan University Hospital (grant number NTUH101S-1917 to C-CH). The funding source played no role in study design and conduct, data collection, analysis or interpretation, writing of the manuscript, or the decision to submit it for publication.	Arasteh K, 2012, HIV MED, V13, P236, DOI 10.1111/j.1468-1293.2011.00969.x; Battegay M, 2011, CLIN THER, V33, P1308, DOI 10.1016/j.clinthera.2011.08.003; Dahri K, 2007, CLIN PHARMACOKINET, V46, P109, DOI 10.2165/00003088-200746020-00002; de Vries-Sluijs TEMS, 2003, CLIN PHARMACOKINET, V42, P599, DOI 10.2165/00003088-200342060-00009; Fan-Havard P, 2013, ANTIMICROB AGENTS CH, V57, P2154, DOI 10.1128/AAC.02294-12; Gathe J, 2011, ANTIVIR THER, V16, P759, DOI 10.3851/IMP1803; Kappelhoff BS, 2005, HIV CLIN TRIALS, V6, P254, DOI 10.1310/B5VU-FU5F-QNWC-UDCK; Lee KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088497; Lepik KJ, 2015, ANTIVIR THER, V20, P721, DOI 10.3851/IMP2908; Micheli JE, 2013, PHARMACOGENET GENOM, V23, P591, DOI 10.1097/FPC.0b013e32836533a5; Schuerch LV, 1999, SCHWEIZ MED WSCHR, V129, P670; Stephan C, 2014, HIV MED, V15, P124, DOI 10.1111/hiv.12090; Tseng YT, 2014, INT J INFECT DIS, V29, P12, DOI 10.1016/j.ijid.2014.08.012; van Heeswijk RPG, 1998, J CHROMATOGR B, V713, P395, DOI 10.1016/S0378-4347(98)00217-5; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Veldkamp AI, 2001, AIDS, V15, P1089, DOI 10.1097/00002030-200106150-00003; Viramune XR, MEDICATION GUIDE	17	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140574	10.1371/journal.pone.0140574	http://dx.doi.org/10.1371/journal.pone.0140574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465325	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100148
J	Pendar, H; Socha, JJ				Pendar, Hodjat; Socha, John J.			Estimation of Instantaneous Gas Exchange in Flow-Through Respirometry Systems: A Modern Revision of Bartholomew's Z-Transform Method	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; INDIRECT CALORIMETER; AYTHYA-FULIGULA; HEART-RATE; DECONVOLUTION; RESPIRATION; ANIMALS; VO2; SECRETION; PRESSURE	Flow-through respirometry systems provide accurate measurement of gas exchange over long periods of time. However, these systems have limitations in tracking rapid changes. When an animal infuses a metabolic gas into the respirometry chamber in a short burst, diffusion and airflow in the chamber gradually alter the original signal before it arrives at the gas analyzer. For single or multiple bursts, the recorded signal is smeared or mixed, which may result in dramatically altered recordings compared to the emitted signal. Recovering the original metabolic signal is a difficult task because of the inherent ill conditioning problem. Here, we present two new methods to recover the fast dynamics of metabolic patterns from recorded data. We first re-derive the equations of the well-known Z-transform method (ZT method) to show the source of imprecision in this method. Then, we develop a new model of analysis for respirometry systems based on the experimentally determined impulse response, which is the response of the system to a very short unit input. As a result, we present a major modification of the ZT method (dubbed the 'EZT method') by using a new model for the impulse response, enhancing its precision to recover the true metabolic signals. The second method, the generalized Z-transform (GZT) method, was then developed by generalizing the EZT method; it can be applied to any flow-through respirometry system with any arbitrary impulse response. Experiments verified that the accuracy of recovering the true metabolic signals is significantly improved by the new methods. These new methods can be used more broadly for input estimation in variety of physiological systems.	[Pendar, Hodjat; Socha, John J.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Pendar, H (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.	hpendar@vt.edu			National Science Foundation [0938047]; Virginia Tech Institute for Critical Technology and Applied Science; Directorate For Engineering [0938047] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Virginia Tech Institute for Critical Technology and Applied Science; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by a National Science Foundation grant to JJS (0938047), and the Virginia Tech Institute for Critical Technology and Applied Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHOLOMEW GA, 1986, J EXP BIOL, V123, P191; BARTHOLOMEW GA, 1984, J EXP BIOL, V111, P131; BARTHOLOMEW GA, 1981, J EXP BIOL, V90, P17; Brychta RJ, 2009, ENG MED BIOL SOC 200; Chartrand R., 2011, ISRN APPL MATH, V2011; Contreras HL, 2010, J INSECT PHYSIOL, V56, P522, DOI 10.1016/j.jinsphys.2009.05.018; Daley MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070752; DeNicolao G, 1997, AUTOMATICA, V33, P851, DOI 10.1016/S0005-1098(96)00254-3; DENICOLAO G, 1995, IEEE T BIO-MED ENG, V42, P678, DOI 10.1109/10.391166; DEPOCAS F, 1957, J APPL PHYSIOL, V10, P388, DOI 10.1152/jappl.1957.10.3.388; FEDAK MA, 1981, J APPL PHYSIOL, V51, P772, DOI 10.1152/jappl.1981.51.3.772; FRAPPELL PB, 1989, J THEOR BIOL, V138, P479, DOI 10.1016/S0022-5193(89)80046-3; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; Granato L, 2004, J APPL PHYSIOL, V96, P1045, DOI 10.1152/japplphysiol.00788.2003; Gray EM, 2006, J EXP BIOL, V209, P1603, DOI 10.1242/jeb.02181; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Henning B, 1996, MED BIOL ENG COMPUT, V34, P207, DOI 10.1007/BF02520075; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Lighton JRB, 2011, COMP BIOCHEM PHYS A, V158, P265, DOI 10.1016/j.cbpa.2010.11.026; Lighton JRB, 2012, J EXP BIOL, V215, P1605, DOI 10.1242/jeb.068288; Mault JR, 2003, U.S. Patent, Patent No. 6629934; MILLER PL, 1960, J EXP BIOL, V37, P224; MOON JK, 1995, J NUTR, V125, P220; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; Ortigues I, 1997, J THEOR BIOL, V185, P489, DOI 10.1006/jtbi.1996.0338; Parkes R, 2002, J EXP BIOL, V205, P3945; Pendar H., 2015, INPUT ESTIMATION LIN; Porat B., 1997, COURSE DIGITAL SIGNA; SLAMA K, 1988, BIOL BULL-US, V175, P289, DOI 10.2307/1541570; Socha JJ, 2008, J EXP BIOL, V211, P3409, DOI 10.1242/jeb.019877; Sparacino G, 1996, IEEE T BIO-MED ENG, V43, P512, DOI 10.1109/10.488799; SUN M, 1994, J APPL PHYSIOL, V76, P2686, DOI 10.1152/jappl.1994.76.6.2686; Swallow JG, 1998, J APPL PHYSIOL, V84, P69, DOI 10.1152/jappl.1998.84.1.69; Tartes U, 2002, COMP BIOCHEM PHYS A, V133, P611, DOI 10.1016/S1095-6433(02)00173-3; Tokuyama K, 2009, J APPL PHYSIOL, V106, P640, DOI 10.1152/japplphysiol.90718.2008; VELDHUIS JD, 1987, P NATL ACAD SCI USA, V84, P7686, DOI 10.1073/pnas.84.21.7686; Vicini P, 1997, COMPUT METH PROG BIO, V52, P147, DOI 10.1016/S0169-2607(96)01784-1; Westneat MW, 2003, SCIENCE, V299, P558, DOI 10.1126/science.1078008; Williams TD, 2000, AM J PHYSIOL-REG I, V278, pR255, DOI 10.1152/ajpregu.2000.278.1.R255; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; WOAKES AJ, 1983, J EXP BIOL, V107, P311	42	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139508	10.1371/journal.pone.0139508	http://dx.doi.org/10.1371/journal.pone.0139508			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466361	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100050
J	Ramo, C; Amat, JA; Nilsson, L; Schricke, V; Rodriguez-Alonso, M; Gomez-Crespo, E; Jubete, F; Navedo, JG; Masero, JA; Palacios, J; Boos, M; Green, AJ				Ramo, Cristina; Amat, Juan A.; Nilsson, Leif; Schricke, Vincent; Rodriguez-Alonso, Mariano; Gomez-Crespo, Enrique; Jubete, Fernando; Navedo, Juan G.; Masero, Jose A.; Palacios, Jesus; Boos, Mathieu; Green, Andy J.			Latitudinal-Related Variation in Wintering Population Trends of Greylag Geese (Anser Anser) along the Atlantic Flyway: A Response to Climate Change?	PLOS ONE			English	Article							BREEDING PERFORMANCE; GOOSE POPULATIONS; LAND-USE; MIGRATION; BIRDS; CONSEQUENCES; TERRESTRIAL; EARLIER; SPRINGS; DONANA	The unusually high quality of census data for large waterbirds in Europe facilitates the study of how population change varies across a broad geographical range and relates to global change. The wintering population of the greylag goose Anser anser in the Atlantic flyway spanning between Sweden and Spain has increased from 120 000 to 610 000 individuals over the past three decades, and expanded its wintering range northwards. Although population sizes recorded in January have increased in all seven countries in the wintering range, we found a pronounced northwards latitudinal effect in which the rate of increase is higher at greater latitudes, causing a constant shift in the centre of gravity for the spatial distribution of wintering geese. Local winter temperatures have a strong influence on goose numbers but in a manner that is also dependent on latitude, with the partial effect of temperature (while controlling for the increasing population trend between years) being negative at the south end and positive at the north end of the flyway. Contrary to assumptions in the literature, the expansion of crops exploited by greylag geese has made little contribution to the increases in population size. Only in one case (expansion of winter cereals in Denmark) did we find evidence of an effect of changing land use. The expanding and shifting greylag population is likely to have increasing impacts on habitats in northern Europe during the course of this century.	[Ramo, Cristina; Amat, Juan A.; Green, Andy J.] CSIC, Wetland Ecol Dept, EBD, E-41080 Seville, Spain; [Nilsson, Leif] Lund Univ, Dept Biol, Lund, Sweden; [Schricke, Vincent] Off Natl Chasse & Faune Sauvage, Nantes, France; [Rodriguez-Alonso, Mariano; Palacios, Jesus] Serv Terr Medio Ambiente Zamora, Junta De Castilla Leon, Zamora, Spain; [Gomez-Crespo, Enrique] Consejeria Fomento & Medio Ambiente, Secc Espacios Nat & Especies Protegidas, Palencia, Spain; [Jubete, Fernando] Avespalencia Org, Palencia, Spain; [Navedo, Juan G.] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Masero, Jose A.] Univ Extremadura, Grp Biol Conservac, Badajoz, Spain; [Boos, Mathieu] Naturaconst, Res Agcy Appl Ecol, Wilshausen, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Lund University; Universidad Austral de Chile; Universidad de Extremadura	Ramo, C (corresponding author), CSIC, Wetland Ecol Dept, EBD, E-41080 Seville, Spain.	cristina@ebd.csic.es	Nilsson, Leif/AAF-4436-2020; Masero, Jose A./A-9478-2008; Masero, Jose A./P-3418-2019; Green, Andy J/A-5189-2008; Ramo, Cristina/B-9958-2013	Masero, Jose A./0000-0001-5318-4833; Masero, Jose A./0000-0001-5318-4833; Green, Andy J/0000-0002-1268-4951; Ramo, Cristina/0000-0002-0897-4294; Amat, Juan A./0000-0003-1685-1056				Adriaens T, 2014, P 8 INT NEOB C BIOL, P26; Alves JA, 2013, ECOLOGY, V94, P11, DOI 10.1890/12-0737.1; Alves JA, 2012, OIKOS, V121, P464, DOI 10.1111/j.1600-0706.2011.19678.x; AMAT J A, 1986, Wildfowl, V37, P35; Andersson Ake, 2001, Ornis Svecica, V11, P19; Arzel C, 2014, IBIS, V156, P288, DOI 10.1111/ibi.12134; Bernis F, 1964, ARDEOLA, V9, P67; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Clausen KK, 2013, OECOLOGIA, V173, P1101, DOI 10.1007/s00442-013-2681-0; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Deceuninck B, 2013, SYNTHESE DENOMBREMEN; Devos K, 2012, GOOSE B, V15, P18; Drent R, 2003, OIKOS, V103, P274, DOI 10.1034/j.1600-0706.2003.12274.x; Edenhofer O., 2014, CONTRIBUTION WORKING; Fouquet Michel, 2009, Wildfowl, V59, P143; Fox AD, 2005, GLOBAL CHANGE BIOL, V11, P881, DOI 10.1111/j.1365-2486.2005.00941.x; Fox Anthony D., 2010, Ornis Svecica, V20, P115; Gauthier G, 2005, GLOBAL CHANGE BIOL, V11, P856, DOI 10.1111/j.1365-2486.2005.00944.x; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; Gonzalez R, 2011, AVES ACUATICAS ESPAN; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; Guillemain M, 2013, WILDLIFE BIOL, V19, P404, DOI 10.2981/12-118; Gunnarsson TG, 2005, J ANIM ECOL, V74, P965, DOI 10.1111/j.1365-2656.2005.00994.x; Hirschfeld Axel, 2005, Berichte zum Vogelschutz, V42, P47; Hornman M, 2012, 201202 SOV; Hornman M, 2013, GOOSE B, V17, P19; Jefferies RL, 2006, J ECOL, V94, P234, DOI 10.1111/j.1365-2745.2005.01086.x; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; Koffijberg K, 2011, GOOSE B, V13, P20; Kruckenberg Helmut, 2011, Naturschutz und Landschaftsplanung, V43, P334; Lehikoinen A, 2013, GLOBAL CHANGE BIOL, V19, P2071, DOI 10.1111/gcb.12200; Lehikoinen A, 2012, J ORNITHOL, V153, P563, DOI 10.1007/s10336-011-0777-z; Lehikoinen Esa, 2010, P89; Lok T, 2013, AM NAT, V181, P520, DOI 10.1086/669679; Lok T, 2011, ANIM BEHAV, V82, P837, DOI 10.1016/j.anbehav.2011.07.019; MADSEN J, 1987, Danish Review of Game Biology, V12, P1; MADSEN J, 1991, ARDEA, V79, P113; Madsen J, 1999, WETLANDS INT PUBL, V48; Masero JA, 2011, BIRD CONSERV INT, V21, P12, DOI 10.1017/S0959270910000092; Navedo JG, 2015, SCI TOTAL ENVIRON, V511, P288, DOI 10.1016/j.scitotenv.2014.12.068; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nilsson L., 1996, Gibier Faune Sauvage, V13, P557; Nilsson Leif, 2013, Ornis Svecica, V23, P46; Nilsson Leif, 2013, Wildfowl, V63, P24; Nilsson Leif, 2012, Ornis Svecica, V22, P39; Nilsson Leif, 2006, P514; Nilsson Leif, 1997, Wildfowl, V48, P72; Nilsson Leif, 1994, Wildfowl, V45, P33; ONCFS, 2014, AM CONN OIE CENDR FR; Palacios J, 2009, ACT 5 C FOR ESP MONT, P1; Pannekoek J., 2001, 0102 STAT NETH; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Petersen IK, 2010, LANDSDAEKKENDE OPTAE; Pistorius Pierre A., 2006, Wildfowl, V56, P23; Ramo C, 2013, ARDEOLA, V60, P305, DOI 10.13157/arla.60.2.2013.305; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; Sarneel JM, 2014, ECOSYSTEMS, V17, P1426, DOI 10.1007/s10021-014-9805-1; Stainforth DA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034031; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Tombre IM, 2008, J AVIAN BIOL, V39, P691, DOI 10.1111/j.1600-048X.2008.04440.x; Van Eerden MR, 2005, GLOBAL CHANGE BIOL, V11, P894, DOI 10.1111/j.1365-2486.2005.00940.x; Voslamber Berend, 2010, Ornis Svecica, V20, P207; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Ydenberg RC, 2004, P ROY SOC B-BIOL SCI, V271, P1263, DOI 10.1098/rspb.2004.2713	64	30	35	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140181	10.1371/journal.pone.0140181	http://dx.doi.org/10.1371/journal.pone.0140181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465601	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100085
J	Yang, JF; Xu, ZZ; Sui, MS; Han, JH; Sun, LJ; Jia, XZ; Zhang, HY; Han, CS; Jin, XM; Gao, F; Liu, YH; Li, Y; Cao, JB; Ling, H; Zhang, FM; Ren, H				Yang, Jinfeng; Xu, Zhaozhen; Sui, Manshu; Han, Jihua; Sun, Lijie; Jia, Xiuzhi; Zhang, Haiyu; Han, Changsong; Jin, Xiaoming; Gao, Fei; Liu, Yanhong; Li, Yang; Cao, Jianbin; Ling, Hong; Zhang, Fengmin; Ren, Huan			Co-Positivity for Anti-dsDNA, -Nucleosome and -Histone Antibodies in Lupus Nephritis Is Indicative of High Serum Levels and Severe Nephropathy	PLOS ONE			English	Article							DNA ANTIBODIES; ALPHA-ACTININ; RENAL-DISEASE; SLE PATIENTS; ERYTHEMATOSUS; AUTOANTIBODIES; GLOMERULONEPHRITIS; MECHANISMS; CELLS	Objective To characterize the significance of correlated autoantibodies in systemic lupus erythematosus (SLE) and its complication lupus nephritis (LN) in a large cohort of patients. Methods Clinical data were statistically analyzed in 1699 SLE patients with or without nephritis who were diagnosed and treated during 2002-2013 in the northeast region of China. Reactivity to a list of 16 autoantibodies was detected by the serum test Euroline ANA profile (IgG). Serum titers of the anti-nucleosome autoantibodies were measured by ELISA assays. Kidney biopsies were examined by pathologists. Immune complex deposition was identified by immunohistochemistry stain. Results Simultaneous positivity of anti-dsDNA, -nucleosome and -histone antibodies (3-pos) was prevalent in SLE patients with LN compared to Non-renal SLE patients (41% vs 11%, p<0.001). Significant correlations were found between any two of the above three anti-nucleosome antibodies in LN patients. In comparison to non-3-pos cohorts, 3-pos patients with LN had significantly higher serum levels of the three antibodies and more active disease; was associated with type IV disease; suffered from more severe renal damages; received more intensive treatment and had worse disease outcome. The serum levels of these three autoantibodies in 3-pos LN patients were significantly decreased when they underwent clinical recovery. Conclusions Simultaneous reactivity to anti-dsDNA, -nucleosome and -histone antibodies by Euroline ANA profile (IgG) may indicate severe nephropathy in patients with SLE.	[Yang, Jinfeng; Sun, Lijie; Jia, Xiuzhi; Ren, Huan] Harbin Med Univ, Dept Immunol, Harbin 150081, Peoples R China; [Yang, Jinfeng; Sun, Lijie; Jia, Xiuzhi; Ren, Huan] Immun & Infect Key Lab Heilongjiang Prov, Harbin 150081, Peoples R China; [Xu, Zhaozhen] Harbin Med Univ, Dept Clin Lab Med, Hosp 1, Harbin 150001, Peoples R China; [Sui, Manshu] Harbin Med Univ, Dept Nephrol, Hosp 1, Harbin 150001, Peoples R China; [Han, Jihua] Harbin Med Univ, Dept Gen Surg, Hosp 1, Harbin 150001, Peoples R China; [Zhang, Haiyu] Harbin Med Univ, Dept Epidemiol & Biostat, Harbin 150081, Peoples R China; [Han, Changsong; Jin, Xiaoming] Harbin Med Univ, Dept Pathol, Harbin 150081, Peoples R China; [Gao, Fei; Liu, Yanhong] Harbin Med Univ, Dept Clin Lab Med, Hosp 2, Harbin 150001, Peoples R China; [Li, Yang] Harbin Med Univ, Dept Rheumatol, Hosp 2, Harbin 150001, Peoples R China; [Cao, Jianbin] Harbin Ctr Dis Control & Prevent, Harbin 150081, Peoples R China; [Ling, Hong; Zhang, Fengmin] Harbin Med Univ, Dept Microbiol, Harbin 150081, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Ren, H (corresponding author), Harbin Med Univ, Dept Immunol, Harbin 150081, Peoples R China.	fengminzhang@ems.hrbmu.edu.cn; huanren2009@126.com	Yang, Jinfeng/GSN-6506-2022; Jin, Xiaoming/AAH-3555-2020; Ren, Huan/O-5727-2017	ling, hong/0000-0002-1886-1242; Ren, Huan/0000-0001-7114-2012	Fund of China Postdoctoral Project [2014M561371, 2013M541411]; Fund of Heilongjiang Provincial Education Department [12541364, 12521180]; Fund of "Spring Sunshine Program" [Z2010003]; Fund of Harbin Science and Technology Bureau [RC2011XK003008]; Open Topic of Key Laboratory of Neurobiology, General Colleges and Universities in Heilongjiang Province of China [2012HLJKLNT-10]	Fund of China Postdoctoral Project; Fund of Heilongjiang Provincial Education Department; Fund of "Spring Sunshine Program"; Fund of Harbin Science and Technology Bureau; Open Topic of Key Laboratory of Neurobiology, General Colleges and Universities in Heilongjiang Province of China	The Fund of China Postdoctoral Project (2014M561371); the Fund of Heilongjiang Provincial Education Department (12541364); the Fund of Heilongjiang Provincial Education Department (12521180); the Fund of "Spring Sunshine Program" (Z2010003); the Fund of Harbin Science and Technology Bureau (RC2011XK003008); the Fund of China Postdoctoral Project (2013M541411); Open Topic of Key Laboratory of Neurobiology, General Colleges and Universities in Heilongjiang Province of China (2012HLJKLNT-10).	[Anonymous], 2008, MED BIOL SCI, P61; Becker-Merok A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2070; Bertsias G, 2008, NAT CLIN PRACT RHEUM, V4, P464, DOI 10.1038/ncprheum0896; Cervera R, 2003, ANN RHEUM DIS, V62, P431, DOI 10.1136/ard.62.5.431; Chan TM, 2002, J AM SOC NEPHROL, V13, P1219, DOI 10.1097/01.ASN.0000014223.71109.13; Cortes-Hernandez J, 2004, AM J MED, V116, P165, DOI 10.1016/j.amjmed.2003.08.034; Duarte-Garcia A, 2012, J RHEUMATOL, V39, P1392, DOI 10.3899/jrheum.111196; Fanouriakis A, 2012, MOD RHEUMATOL, V22, P803, DOI 10.1007/s10165-012-0655-4; Fransen JH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2966; Gilliam BE, 2012, SEMIN ARTHRITIS RHEU, V41, P840, DOI 10.1016/j.semarthrit.2011.09.009; Grootscholten C, 2003, ARTHRITIS RHEUM, V48, P1355, DOI 10.1002/art.10974; Huang S Y, 2014, AM J TROP MED HYG; Hung WT, 2011, LUPUS, V20, P1404, DOI 10.1177/0961203311417033; Jakes RW, 2012, ARTHRIT CARE RES, V64, P159, DOI 10.1002/acr.20683; Katsumata Y, 2011, ARTHRITIS RHEUM-US, V63, P2436, DOI 10.1002/art.30401; Kiss E, 2009, AUTOIMMUNITY, V42, P393, DOI 10.1080/08916930903002446; Licht R, 2001, ARTHRITIS RHEUM-US, V44, P1320, DOI 10.1002/1529-0131(200106)44:6<1320::AID-ART224>3.0.CO;2-X; Linnik MD, 2005, ARTHRITIS RHEUM, V52, P1129, DOI 10.1002/art.20980; Mason LJ, 2004, ARTHRITIS RHEUM-US, V50, P866, DOI 10.1002/art.20103; Meyer OC, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2725; Mjelle JE, 2011, AUTOIMMUNITY, V44, P373, DOI 10.3109/08916934.2010.541170; Moroni G, 2009, ANN RHEUM DIS, V68, P234, DOI 10.1136/ard.2008.094508; Mosca M, 2002, KIDNEY INT, V61, P1502, DOI 10.1046/j.1523-1755.2002.00280.x; Nowling TK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3528; O'Flynn J, 2011, MOL IMMUNOL, V49, P75, DOI 10.1016/j.molimm.2011.07.020; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Riemekasten G, 2005, RHEUMATOLOGY, V44, P975, DOI 10.1093/rheumatology/keh688; Shabana AA, 2009, CLIN RHEUMATOL, V28, P673, DOI 10.1007/s10067-009-1130-2; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Sui MS, 2013, J CLIN IMMUNOL, V33, P378, DOI 10.1007/s10875-012-9825-6; van Bavel CC, 2011, ANN RHEUM DIS, V70, P201, DOI 10.1136/ard.2010.129320; van Bavel CC, 2010, MOL IMMUNOL, V48, P248, DOI 10.1016/j.molimm.2010.08.003; van der Vlag J, 2011, SEMIN NEPHROL, V31, P376, DOI 10.1016/j.semnephrol.2011.06.009; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Yang J, 2012, RHEUMATOL INT, V32, P2393, DOI 10.1007/s00296-011-1971-2; Zhao ZG, 2005, ARTHRITIS RHEUM-US, V52, P522, DOI 10.1002/art.20862	36	17	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140441	10.1371/journal.pone.0140441	http://dx.doi.org/10.1371/journal.pone.0140441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465327	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100124
J	Zhang, H; Wang, DX				Zhang, Hong; Wang, Dong-Xin			Noninvasive Measurement of Carbon Dioxide during One-Lung Ventilation with Low Tidal Volume for Two Hours: End-Tidal versus Transcutaneous Techniques	PLOS ONE			English	Article							PRESSURE; ARTERIAL; INFANTS; SENSOR	Background There may be significant difference between measurement of end-tidal carbon dioxide partial pressure (PetCO(2)) and arterial carbon dioxide partial pressure (PaCO2) during one-lung ventilation with low tidal volume for thoracic surgeries. Transcutaneous carbon dioxide partial pressure (PtcCO(2)) monitoring can be used continuously to evaluate PaCO2 in a noninvasive fashion. In this study, we compared the accuracy between PetCO(2) and PtcCO(2) in predicting PaCO2 during prolonged one-lung ventilation with low tidal volume for thoracic surgeries. Methods Eighteen adult patients who underwent thoracic surgeries with one-lung ventilation longer than two hours were included in this study. Their PetCO(2), PtcCO(2), and PaCO2 values were collected at five time points before and during one-lung ventilation. Agreement among measures was evaluated by Bland-Altman analysis. Results Ninety sample sets were obtained. The bias and precision when PtcCO(2) and PaCO2 were compared were 4.1 +/- 6.5 mmHg during two-lung ventilation and 2.9 +/- 6.1 mmHg during one-lung ventilation. Those when PetCO(2) and PaCO2 were compared were -11.8 +/- 6.4 mmHg during two-lung ventilation and -11.8 +/- 4.9 mmHg during one-lung ventilation. The differences between PtcCO(2) and PaCO2 were significantly lower than those between PetCO(2) and PaCO2 at all five time-points (p < 0.05). Conclusions PtcCO(2) monitoring was more accurate for predicting PaCO2 levels during prolonged one-lung ventilation with low tidal volume for patients undergoing thoracic surgeries.	[Zhang, Hong; Wang, Dong-Xin] Peking Univ, Hosp 1, Dept Anesthesiol & Crit Care Med, Beijing 100871, Peoples R China	Peking University	Wang, DX (corresponding author), Peking Univ, Hosp 1, Dept Anesthesiol & Crit Care Med, Beijing 100871, Peoples R China.	wangdongxin@vip.sina.com		Zhang, Hong/0000-0003-1690-033X				Aliwalas Lucia Liz D, 2005, J Perinatol, V25, P26, DOI 10.1038/sj.jp.7211202; Bernet V, 2008, PEDIATR ANESTH, V18, P872, DOI 10.1111/j.1460-9592.2008.02661.x; Bhavani-Shankar K, 1998, CAN J ANAESTH, V45, P164, DOI 10.1007/BF03013257; BINDER N, 1994, AM J PERINAT, V11, P237, DOI 10.1055/s-2008-1040754; Brassard CL, 2014, CAN J ANESTH, V61, P1103, DOI 10.1007/s12630-014-0246-2; De Oliveira GS, 2010, BRIT J ANAESTH, V104, P774, DOI 10.1093/bja/aeq092; Dullenkopf A, 2003, PAEDIATR ANAESTH, V13, P777, DOI 10.1046/j.1460-9592.2003.01146.x; Eberhard P, 2007, ANESTH ANALG, V105, pS48, DOI 10.1213/01.ane.0000278642.16117.f8; Hirabayashi M, 2009, J ANESTH, V23, P198, DOI 10.1007/s00540-008-0734-z; Huttmann Sophie E, 2014, Ann Am Thorac Soc, V11, P645, DOI 10.1513/AnnalsATS.201311-387FR; Janssens JP, 2005, GERONTOLOGY, V51, P174, DOI 10.1159/000083990; Kelly AM, 2011, RESP MED, V105, P226, DOI 10.1016/j.rmed.2010.11.010; Kilpatrick B, 2010, BRIT J ANAESTH, V105, pI108, DOI 10.1093/bja/aeq299; Liu SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091563; Nishiyama T, 2007, J ANESTH, V21, P317, DOI 10.1007/s00540-006-0525-3; Oshibuchi M, 2003, ANESTH ANALG, V97, P776, DOI 10.1213/01.ANE.0000074793.12070.1E; Roediger R, 2011, J CARDIOTHOR VASC AN, V25, P243, DOI 10.1053/j.jvca.2010.06.021; Storre JH, 2007, CHEST, V132, P1810, DOI 10.1378/chest.07-1173; Tobias JD, 2003, J CARDIOTHOR VASC AN, V17, P306, DOI 10.1016/S1053-0770(03)00054-5; Tobias JD, 2009, PEDIATR ANESTH, V19, P434, DOI 10.1111/j.1460-9592.2009.02930.x; WHITESELL R, 1981, ANESTH ANALG, V60, P508; Xue QS, 2010, ANESTH ANALG, V111, P417, DOI 10.1213/ANE.0b013e3181e30b54	22	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138912	10.1371/journal.pone.0138912	http://dx.doi.org/10.1371/journal.pone.0138912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466140	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100032
J	Wu, QL; Cao, XO; Yan, D; Wang, DY; Aballay, A				Wu, Qiuli; Cao, Xiou; Yan, Dong; Wang, Dayong; Aballay, Alejandro			Genetic Screen Reveals Link between the Maternal Effect Sterile Gene mes-1 and Pseudomonas aeruginosa-induced Neurodegeneration in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE NEURON DEGENERATION; UNFOLDED PROTEIN RESPONSE; C-ELEGANS; INNATE IMMUNITY; LIFE-SPAN; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; DAF-16; CHEMOTAXIS; ACTIVATION	Increasing evidence indicates that immune responses to microbial infections may contribute to neurodegenerative diseases. Here, we show that Pseudomonas aeruginosa infection of Caenorhabditis elegans causes a number of neural changes that are hallmarks of neurodegeneration. Using an unbiased genetic screen to identify genes involved in the control of P. aeruginosa-induced neurodegeneration, we identified mes-1, which encodes a receptor tyrosine kinase-like protein that is required for unequal cell divisions in the early embryonic germ line. We showed that sterile but not fertile mes-1 animals were resistant to neurodegeneration induced by P. aeruginosa infection. Similar results were observed using animals carrying a mutation in the maternal effect gene pgl-1, which is required for postembryonic germ line development, and the germ line-deficient strains glp-1 and glp-4. Additional studies indicated that the FOXO transcription factor DAF-16 is required for resistance to P. aeruginosa-induced neurodegeneration in germ line-deficient strains. Thus, our results demonstrate that P. aeruginosa infection results in neurodegeneration phenotypes in C. elegans that are controlled by the germ line in a cell-nonautonomous manner.	[Wu, Qiuli; Cao, Xiou; Yan, Dong; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Wu, Qiuli; Wang, Dayong] Southeast Univ, Sch Med, Nanjing 210009, Jiangsu, Peoples R China	Duke University; Southeast University - China	Aballay, A (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	a.aballay@duke.edu	Cao, Xiou/K-4619-2019; Yan, Dong/AAA-6559-2020; Regan, Clinton/E-6250-2012	Yan, Dong/0000-0002-7542-1251; Cao, Xiou/0000-0001-7202-6582	National Institutes of Health [GM070977]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant GM070977. To whom correspondence should be addressed. Tel.: 919-668-1783; Fax: 919-684-2790; E-mail: a.aballay@duke.edu.	Alper S, 2010, J BIOL CHEM, V285, P1822, DOI 10.1074/jbc.M109.057323; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Bargmann C. I., 2006, WORMBOOK; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Benedetto A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001084; Berkowitz LA, 2000, DEVELOPMENT, V127, P4419; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; BRENNER S, 1974, GENETICS, V77, P71; Brody AH, 2013, NEUROTOXICOLOGY, V34, P74, DOI 10.1016/j.neuro.2012.10.007; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Chen L, 2011, NEURON, V70, P51, DOI 10.1016/j.neuron.2011.02.039; Chen P, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00018; Chew Yee Lian, 2013, Commun Integr Biol, V6, pe25288, DOI 10.4161/cib.25288; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Du M, 2009, ENVIRON TOXICOL PHAR, V27, P314, DOI 10.1016/j.etap.2008.11.011; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Hobert O, 2010, WORMBOOK; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Meisel JD, 2014, CELL, V159, P267, DOI 10.1016/j.cell.2014.09.011; Mocko JB, 2010, NEUROBIOL DIS, V40, P120, DOI 10.1016/j.nbd.2010.03.019; Negga R, 2012, NEUROTOX RES, V21, P281, DOI 10.1007/s12640-011-9274-7; O'Meara MM, 2009, GENETICS, V181, P1679, DOI 10.1534/genetics.108.097832; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pan CL, 2011, P NATL ACAD SCI USA, V108, P9274, DOI 10.1073/pnas.1011711108; Peng Chiu-Ying, 2011, Commun Integr Biol, V4, P696; Pepper ASR, 2003, GENETICS, V163, P115; Saeki S, 2001, J EXP BIOL, V204, P1757; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Singh V, 2006, CELL CYCLE, V5, P2443, DOI 10.4161/cc.5.21.3434; Singh V, 2012, J BIOL CHEM, V287, P33191, DOI 10.1074/jbc.M112.398362; Singh V, 2009, J BIOL CHEM, V284, P35580, DOI 10.1074/jbc.M109.060905; Sinha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101970; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Sun JR, 2012, EMBO REP, V13, P855, DOI 10.1038/embor.2012.100; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; TeKippe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011777; Toth ML, 2012, J NEUROSCI, V32, P8778, DOI 10.1523/JNEUROSCI.1494-11.2012; VanDuyn N, 2013, J NEUROCHEM, V124, P147, DOI 10.1111/jnc.12072; VanDuyn N, 2010, TOXICOL SCI, V118, P613, DOI 10.1093/toxsci/kfq285; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zheng GH, 2011, ACS CHEM BIOL, V6, P1332, DOI 10.1021/cb200290e	45	19	20	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29231	29239		10.1074/jbc.M115.674259	http://dx.doi.org/10.1074/jbc.M115.674259			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26475858	Green Published, hybrid			2022-12-26	WOS:000366613400010
J	Haapasalo, K; van Kessel, K; Nissila, E; Metso, J; Johansson, T; Miettinen, S; Varjosalo, M; Kirveskari, J; Kuusela, P; Chroni, A; Jauhiainen, M; van Strijp, J; Jokiranta, TS				Haapasalo, Karita; van Kessel, Kok; Nissila, Eija; Metso, Jari; Johansson, Tiira; Miettinen, Sini; Varjosalo, Markku; Kirveskari, Juha; Kuusela, Pentti; Chroni, Angelika; Jauhiainen, Matti; van Strijp, Jos; Jokiranta, T. Sakari			Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein E (ApoE); complement; complement system; high density lipoprotein (HDL); inflammation; factor H	HEMOLYTIC-UREMIC SYNDROME; MACULAR DEGENERATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; STREPTOCOCCUS-PYOGENES; ALZHEIMERS-DISEASE; PROTEIN BETA-1H; DEPOSIT DISEASE; HUMAN PLASMA; ASSOCIATION; ACTIVATION	The alternative pathway of complement is an important part of the innate immunity response against foreign particles invading the human body. To avoid damage to host cells, it needs to be efficiently down-regulated by plasma factor H (FH) as exemplified by various diseases caused by mutations in its domains 19-20 (FH19-20) and 5-7 (FH5-7). These regions are also the main interaction sites for microbial pathogens that bind host FH to evade complement attack. We previously showed that inhibition of FH binding by a recombinant FH5-7 construct impairs survival of FH binding pathogens in human blood. In this study we found that upon exposure to full blood, the addition of FH5-7 reduces survival of, surprisingly, also those microbes that are not able to bind FH. This effect was mediated by inhibition of complement regulation and subsequently enhanced neutrophil phagocytosis by FH5-7. We found that although FH5-7 does not reduce complement regulation in the actual fluid phase of plasma, it reduces regulation on HDL particles in plasma. Using affinity chromatography and mass spectrometry we revealed that FH interacts with serum apolipoprotein E (apoE) via FH5-7 domains. Furthermore, binding of FH5-7 to HDL was dependent on the concentration of apoE on the HDL particles. These findings explain why the addition of FH5-7 to plasma leads to excessive complement activation and phagocytosis of microbes in full anticoagulated blood. In conclusion, our data show how FH interacts with apoE molecules via domains 5-7 and regulates alternative pathway activation on plasma HDL particles.	[Haapasalo, Karita; Nissila, Eija; Johansson, Tiira; Jokiranta, T. Sakari] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Haapasalo, Karita; Nissila, Eija; Johansson, Tiira; Jokiranta, T. Sakari] Univ Helsinki, Res Programs Unit, Immunobiol, FIN-00014 Helsinki, Finland; [Haapasalo, Karita; van Kessel, Kok; van Strijp, Jos] Univ Med Ctr Utrecht, Med Microbiol, NL-3584 CX Utrecht, Netherlands; [Metso, Jari; Jauhiainen, Matti] Natl Inst Hlth & Welf, Biomedicum, Dept Mol Med, FI-00290 Helsinki, Finland; [Miettinen, Sini; Varjosalo, Markku] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Kirveskari, Juha; Kuusela, Pentti] Univ Helsinki, Cent Hosp Lab, HUSLAB, FIN-00290 Helsinki, Finland; [Chroni, Angelika] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens 15310, Greece	University of Helsinki; University of Helsinki; Utrecht University; Utrecht University Medical Center; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; National Centre of Scientific Research "Demokritos"	Haapasalo, K (corresponding author), Univ Med Ctr Utrecht, HP G02-628,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	K.J.Haapasalo-Tuomainen@umcutrecht.nl	Nissila, Eija/AEQ-3909-2022; van Strijp, Jos A.G./J-9549-2014; Varjosalo, Markku/K-6424-2015	Nissila, Eija/0000-0002-8089-1266; van Strijp, Jos A.G./0000-0001-6253-0830; Haapasalo, Karita/0000-0002-9619-625X; Varjosalo, Markku/0000-0002-1340-9732; Chroni, Angeliki/0000-0003-3107-1189	Finnish Cultural Foundation [00131060]; Academy of Finland [255922, 259793]; Sigrid Juselius Foundation [ERC 250172]; European Research Council; Center of Excellence in Microbial Food Safety Research (CoE-MiFoSa)	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Research Council(European Research Council (ERC)European Commission); Center of Excellence in Microbial Food Safety Research (CoE-MiFoSa)	This work was supported by Finnish Cultural Foundation Grant 00131060, Academy of Finland Grants 255922 and 259793, Sigrid Juselius Foundation Grant ERC 250172 (Microbes Inside from the European Research Council, the Center of Excellence in Microbial Food Safety Research (CoE-MiFoSa)). The authors declare that they have no conflicts of interest with the contents of this article.	Abrera-Abeleda MA, 2006, J MED GENET, V43, P582, DOI 10.1136/jmg.2005.038315; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Chroni A, 2008, BIOCHEMISTRY-US, V47, P9071, DOI 10.1021/bi800469r; Clark SJ, 2014, J IMMUNOL, V193, P4962, DOI 10.4049/jimmunol.1401613; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; Haapasalo K, 2012, J IMMUNOL, V188, P426, DOI 10.4049/jimmunol.1102545; Haapasalo K, 2008, MOL MICROBIOL, V70, P583, DOI 10.1111/j.1365-2958.2008.06347.x; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Johnson LV, 2011, P NATL ACAD SCI USA, V108, P18277, DOI 10.1073/pnas.1109703108; Jokiranta TS, 1999, J IMMUNOL, V163, P4590; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Li XP, 2003, BIOCHEMISTRY-US, V42, P10406, DOI 10.1021/bi027093c; MERI S, 1992, J EXP MED, V175, P939, DOI 10.1084/jem.175.4.939; Meri T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003308; Morrow JA, 1999, PROTEIN EXPRES PURIF, V16, P224, DOI 10.1006/prep.1999.1069; PACKMAN CH, 1985, BIOCHIM BIOPHYS ACTA, V812, P107, DOI 10.1016/0005-2736(85)90527-9; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; Pangburn MK, 2002, J IMMUNOL, V169, P4702, DOI 10.4049/jimmunol.169.9.4702; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; RALL SC, 1986, METHOD ENZYMOL, V128, P273; Ramadass M, 2014, J IMMUNOL, V192, P1220, DOI 10.4049/jimmunol.1302288; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; SALACINSKI PRP, 1981, ANAL BIOCHEM, V117, P136, DOI 10.1016/0003-2697(81)90703-X; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Sethi S, 2009, KIDNEY INT, V75, P952, DOI 10.1038/ki.2008.657; Siggins S, 2003, J LIPID RES, V44, P1698, DOI 10.1194/jlr.M300059-JLR200; Surewaard BGJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002606; Troelstra A, 1997, J LEUKOCYTE BIOL, V61, P173, DOI 10.1002/jlb.61.2.173; VAKEVA A, 1994, IMMUNOLOGY, V82, P28; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; Yu JM, 2007, BIOCHEMISTRY-US, V46, P8451, DOI 10.1021/bi700459a; Zetterberg M, 2008, AM J MED GENET B, V147B, P720, DOI 10.1002/ajmg.b.30668	38	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28977	28987		10.1074/jbc.M115.669226	http://dx.doi.org/10.1074/jbc.M115.669226			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26468283	Green Published, hybrid			2022-12-26	WOS:000365762300036
J	Kurasin, M; Kuusk, S; Kuusk, P; Sorlie, M; Valjamae, P				Kurasin, Mihhail; Kuusk, Silja; Kuusk, Piret; Sorlie, Morten; Vaeljamaee, Priit			Slow Off-rates and Strong Product Binding Are Required for Processivity and Efficient Degradation of Recalcitrant Chitin by Family 18 Chitinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellobiohydrolase; cellulose; chitin; chitinase; processivity; off-rate; product binding	TRICHODERMA-REESEI CELLOBIOHYDROLASE; LYTIC POLYSACCHARIDE MONOOXYGENASE; MODELING ENZYMATIC-HYDROLYSIS; SERRATIA-MARCESCENS; THERMOBIFIDA-FUSCA; CELLULOSE HYDROLYSIS; THERMOMONOSPORA-FUSCA; CRYSTALLINE CELLULOSE; MICROCRYSTALLINE CELLULOSE; CEL7A CELLOBIOHYDROLASES	Processive glycoside hydrolases are the key components of enzymatic machineries that decompose recalcitrant polysaccharides, such as chitin and cellulose. The intrinsic processivity (P-Intr) of cellulases has been shown to be governed by the rate constant of dissociation from polymer chain (k(off)). However, the reported k(off) values of cellulases are strongly dependent on the method used for their measurement. Here, we developed a new method for determining k(off), based on measuring the exchange rate of the enzyme between a non-labeled and a C-14-labeled polymeric substrate. The method was applied to the study of the processive chitinase ChiA from Serratia marcescens. In parallel, ChiA variants with weaker binding of the N-acetylglucosamine unit either in substrate-binding site -3 (ChiA-W167A) or the product-binding site +1 (ChiA-W275A) were studied. Both ChiA variants showed increased off-rates and lower apparent processivity on -chitin. The rate of the production of insoluble reducing groups on the reduced -chitin was an order of magnitude higher than k(off), suggesting that the enzyme can initiate several processive runs without leaving the substrate. On crystalline chitin, the general activity of the wild type enzyme was higher, and the difference was magnifying with hydrolysis time. On amorphous chitin, the variants clearly outperformed the wild type. A model is proposed whereby strong interactions with polymer in the substrate-binding sites (low off-rates) and strong binding of the product in the product-binding sites (high pushing potential) are required for the removal of obstacles, like disintegration of chitin microfibrils.	[Kurasin, Mihhail; Kuusk, Silja; Vaeljamaee, Priit] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Kuusk, Piret] Univ Tartu, Inst Phys, EE-51010 Tartu, Estonia; [Sorlie, Morten] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	University of Tartu; University of Tartu; University of Tartu Institute of Physics; Norwegian University of Life Sciences	Valjamae, P (corresponding author), Riia 23b-202, EE-51010 Tartu, Estonia.	priit.valjamae@ut.ee	Väljamäe, Priit/O-6468-2018	Väljamäe, Priit/0000-0002-1035-9493	Norwegian Financial Mechanism Grant [EMP171]; Danish Agency for Science, Technology, and Innovation; Programme Commission on Sustainable Energy and Environment [2104-07-0028]; Estonian Science Foundation [9227]	Norwegian Financial Mechanism Grant; Danish Agency for Science, Technology, and Innovation; Programme Commission on Sustainable Energy and Environment; Estonian Science Foundation	This work was supported by Norwegian Financial Mechanism Grant EMP171, Danish Agency for Science, Technology, and Innovation, Programme Commission on Sustainable Energy and Environment Grant 2104-07-0028, and Estonian Science Foundation Grant 9227. The authors declare that they have no conflict of interests with the contents of this article.	Aronson NN, 2003, BIOCHEM J, V376, P87, DOI 10.1042/bj20030273; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; BRURBERG MB, 1994, FEMS MICROBIOL LETT, V124, P399, DOI 10.1016/0378-1097(94)00462-5; CHANZY H, 1983, FEBS LETT, V153, P113, DOI 10.1016/0014-5793(83)80129-X; Colussi F, 2015, J BIOL CHEM, V290, P2444, DOI 10.1074/jbc.M114.624163; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Cruys-Bagger N, 2013, FEBS J, V280, P3952, DOI 10.1111/febs.12397; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; Hamre AG, 2015, FEBS LETT, V589, P1807, DOI 10.1016/j.febslet.2015.05.034; Hamre AG, 2014, FEBS LETT, V588, P4620, DOI 10.1016/j.febslet.2014.10.034; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Horn SJ, 2004, CARBOHYD POLYM, V56, P35, DOI 10.1016/j.carbpol.2003.11.011; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Igarashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4975; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Imai T, 1998, FEBS LETT, V432, P113, DOI 10.1016/S0014-5793(98)00845-X; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jeoh T, 2013, CARBOHYD POLYM, V97, P581, DOI 10.1016/j.carbpol.2013.05.027; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; Jung J, 2013, J BIOL CHEM, V288, P24164, DOI 10.1074/jbc.M113.455758; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Kostylev M, 2014, BIOTECHNOL BIOENG, V111, P664, DOI 10.1002/bit.25139; Kostylev M, 2014, APPL ENVIRON MICROB, V80, P339, DOI 10.1128/AEM.02706-13; Kostylev M, 2013, BIOCHEMISTRY-US, V52, P5656, DOI 10.1021/bi400358v; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Kuttiyawong K, 2008, CARBOHYD RES, V343, P2754, DOI 10.1016/j.carres.2008.05.020; Kuusk S, 2015, J BIOL CHEM, V290, P11678, DOI 10.1074/jbc.M114.635631; Li YC, 2007, APPL ENVIRON MICROB, V73, P3165, DOI 10.1128/AEM.02960-06; Luterbacher JS, 2015, BIOTECHNOL BIOENG, V112, P21, DOI 10.1002/bit.25329; Luterbacher JS, 2015, BIOTECHNOL BIOENG, V112, P32, DOI 10.1002/bit.25328; Luterbacher JS, 2013, BIOTECHNOL BIOENG, V110, P108, DOI 10.1002/bit.24597; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; Moran-Mirabal JM, 2013, BIOTECHNOL BIOENG, V110, P47, DOI 10.1002/bit.24604; Moran-Mirabal JM, 2011, BIOPHYS CHEM, V155, P20, DOI 10.1016/j.bpc.2011.02.003; Nakagawa YS, 2015, FEBS J, V282, P1065, DOI 10.1111/febs.13203; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; Norberg AL, 2011, FEBS LETT, V585, P2339, DOI 10.1016/j.febslet.2011.06.002; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; ReverbelLeroy C, 1997, J BACTERIOL, V179, P46, DOI 10.1128/jb.179.1.46-52.1997; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Santa-Maria M, 2010, BIOMACROMOLECULES, V11, P2000, DOI 10.1021/bm100366h; Shang BZ, 2014, ACS CATAL, V4, P2216, DOI 10.1021/cs500126q; Shang BZ, 2013, J BIOL CHEM, V288, P29081, DOI 10.1074/jbc.M113.497412; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; Shu ZY, 2014, BIOCHEMISTRY-US, V53, P7650, DOI 10.1021/bi501059n; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; Sorensen TH, 2015, J BIOL CHEM, V290, P22193, DOI 10.1074/jbc.M115.658930; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; Valjamae P, 1998, EUR J BIOCHEM, V253, P469, DOI 10.1046/j.1432-1327.1998.2530469.x; Valjamae P, 1999, EUR J BIOCHEM, V266, P327, DOI 10.1046/j.1432-1327.1999.00853.x; Velleste R, 2010, CELLULOSE, V17, P125, DOI 10.1007/s10570-009-9356-3; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; WALKER LP, 1990, ENZYME MICROB TECH, V12, P378, DOI 10.1016/0141-0229(90)90168-P; WALKER LP, 1992, BIOTECHNOL BIOENG, V40, P1019, DOI 10.1002/bit.260400905; WHITE AR, 1981, P NATL ACAD SCI-BIOL, V78, P1047, DOI 10.1073/pnas.78.2.1047; Wilson David B, 2012, Methods Mol Biol, V908, P93, DOI 10.1007/978-1-61779-956-3_9; WOODWARD J, 1992, ENZYME MICROB TECH, V14, P625, DOI 10.1016/0141-0229(92)90037-O; Zakariassen H, 2010, CARBOHYD POLYM, V82, P779, DOI 10.1016/j.carbpol.2010.05.051; Zakariassen H, 2010, CARBOHYD POLYM, V81, P14, DOI 10.1016/j.carbpol.2010.01.048; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x	78	28	28	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29074	29085		10.1074/jbc.M115.684977	http://dx.doi.org/10.1074/jbc.M115.684977			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26468285	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000365762300045
J	Mathur, MR; Watt, RG; Millett, CJ; Parmar, P; Tsakos, G				Mathur, Manu Raj; Watt, Richard G.; Millett, Christopher J.; Parmar, Priyanka; Tsakos, Georgios			Determinants of Socioeconomic Inequalities in Traumatic Dental Injuries among Urban Indian Adolescents	PLOS ONE			English	Article							SOCIAL NETWORKS; HEALTH; SCHOOLCHILDREN; POPULATION; MULTILEVEL; MORTALITY; PREVALENCE; AREA	Objectives To assess socioeconomic inequalities in traumatic dental injuries (TDIs) in adolescents in New Delhi and examine the role of material, psychosocial and behavioural factors in explaining these inequalities. Methods We conducted a cross sectional study of 1386 adolescents aged between 12-15 years residing in three diverse areas of New Delhi. A non-invasive clinical examination was used to estimate the prevalence of TDIs, and an interviewer-administered questionnaire was used to gather relevant behavioural and socio-demographic data. Multiple logistic regression models were used to assess the association between area based socioeconomic position and TDIs. Results The overall prevalence of TDIs was 10.9%. Social inequalities in the prevalence of TDIs were observed across the adolescent population according to their area of residence. Socio-economic group differences in the prevalence of TDIs remained statistically significant after adjusting for demographic factors, material resources, social capital, social support and health affecting behaviours (OR 3.36, 95% CI 1.75-6.46 and OR 3.99, 95% CI 1.86-8.56 for adolescents from resettlement areas and urban slums respectively in comparison to middle class adolescents). Different psychosocial, material and socio-demographic variables did not attenuate the estimates for the relationship between area socioeconomic position and TDIs. Conclusion Area of residence was a strong predictor of TDIs in adolescents with a higher prevalence in more deprived areas. Social inequalities in TDIs were not explained by psychosocial and behavioural variables. Health promoting policies aimed at improving the physical environment in which adolescents reside might be instrumental in reducing the prevalence of TDIs and associated inequalities.	[Mathur, Manu Raj; Parmar, Priyanka] Publ Hlth Fdn India, Dept Dent Publ Hlth, Gurgaon, Haryana, India; [Watt, Richard G.; Tsakos, Georgios] UCL, Dept Epidemiol & Publ Hlth, London, England; [Millett, Christopher J.] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England	Public Health Foundation of India; University of London; University College London; Imperial College London	Mathur, MR (corresponding author), Publ Hlth Fdn India, Dept Dent Publ Hlth, Gurgaon, Haryana, India.	manu.mathur@phfi.org	Choudhary, Priyanka/ABD-7169-2021	Tsakos, Georgios/0000-0002-5086-235X; Watt, Richard/0000-0001-6229-8584; Mathur, Manu/0000-0001-5518-1935; Choudhary, Priyanka/0000-0002-2420-4118; Millett, Christopher/0000-0002-0793-9884	Wellcome Trust Capacity Strengthening Award; NIHR Research Professorship award; consortium of UK universities	Wellcome Trust Capacity Strengthening Award; NIHR Research Professorship award; consortium of UK universities	This work was supported by a Wellcome Trust Capacity Strengthening Award to the Public Health Foundation of India and a consortium of UK universities. CM is funded by a NIHR Research Professorship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bajjali TT, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-101; [Anonymous], 2010, FAIR SOC HLTH LIV ST; Bendo CB, 2012, INT J ENV RES PUB HE, V9, P4278, DOI 10.3390/ijerph9124278; Bendo CB, 2009, DENT TRAUMATOL, V25, P420, DOI 10.1111/j.1600-9657.2009.00803.x; Berkman L., 2000, SOCIAL EPIDEMIOLOGY; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Carvalho ML, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-203; Coleman JS, 1990, FDN SOCIAL THEORY SO, V69, P993; Correa-faria P., 2015, INFLUENCE CLIN SOCIO, V29, P1; Cortes MIS, 2001, DENT TRAUMATOL, V17, P22, DOI 10.1034/j.1600-9657.2001.170105.x; Gage Julia C, 2005, J Adolesc Health, V37, P517, DOI 10.1016/j.jadohealth.2004.12.012; George L. K., 1986, ELDER ABUSE CONFLICT, P67; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; Hamilton FA, 1997, BRIT DENT J, V182, P91, DOI 10.1038/sj.bdj.4809313; HENDERSON S, 1980, PSYCHOL MED, V10, P723, DOI 10.1017/S003329170005501X; Jung SH, 2011, COMMUNITY DENT ORAL, V39, P221, DOI 10.1111/j.1600-0528.2010.00595.x; Kahn RL., 1980, LIFE SPAN DEV BEHAV, P253, DOI DOI 10.1038/NATURE12518; Kawachi I, 1999, AM J PUBLIC HEALTH, V89, P1187, DOI 10.2105/AJPH.89.8.1187; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kawachi I, 1996, J EPIDEMIOL COMMUN H, V50, P245, DOI 10.1136/jech.50.3.245; Kundu A, 1999, 4 MOST CIT WORDS PRO; MACINTYRE S, 1993, J SOC POLICY, V22, P213, DOI 10.1017/S0047279400019310; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Marcenes W, 2001, DENT TRAUMATOL, V17, P17, DOI 10.1034/j.1600-9657.2001.170104.x; Masiga M A, 2004, East Afr Med J, V81, P577; Mathur MR, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006391; Mitchell R, 2000, HEALTH PLACE, V6, P67, DOI 10.1016/S1353-8292(00)00004-6; OBrien M, 1994, MOD BAS CONSTR AN MO; ORTHGOMER K, 1987, J CHRON DIS, V40, P949, DOI 10.1016/0021-9681(87)90145-7; Pattussi MP, 2008, INJURY, V39, P561, DOI 10.1016/j.injury.2007.11.013; Pattussi MP, 2006, AM J PUBLIC HEALTH, V96, P1462, DOI 10.2105/AJPH.2005.066159; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Roberts C, 2009, INT J PUBLIC HEALTH, V54, P140, DOI 10.1007/s00038-009-5405-9; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; SEIDMAN E, 1995, AM J COMMUN PSYCHOL, V23, P355, DOI 10.1007/BF02506949; Singh N., 2004, IF I WERE RAIN CELEB; Thelen DS, 2010, DENT TRAUMATOL, V26, P284, DOI 10.1111/j.1600-9657.2010.00918.x; UN-HABITAT, 2012, SOLID WASTE MANAGEME; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organisation, 2002, AD FRIENDL HLTH SERV	43	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140860	10.1371/journal.pone.0140860	http://dx.doi.org/10.1371/journal.pone.0140860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7WW	26479873	Green Published, gold			2022-12-26	WOS:000363026600022
J	Tooth, L; Mishra, GD				Tooth, Leigh; Mishra, Gita D.			Does Further Education in Adulthood Improve Physical and Mental Health among Australian Women? A Longitudinal Study	PLOS ONE			English	Article							LIFE-COURSE; OLDER-ADULTS; DEPRESSION; INEQUALITIES; TRAJECTORIES; SELECTION; ANXIETY; MIDLIFE; COHORT; EXPLANATIONS	Objective We analyzed whether further education in young adult and mid-life [adult educational mobility] influences physical functioning and depressive symptoms in women. Methods 14247 women born 1973-78 (younger cohort) and 13715 women born 1946-51 (mid-aged cohort) from the Australian Longitudinal Study on Women's Health were followed for 14-16 years. Measures were the Short-Form 36 Health Survey physical functioning subscale (SF-36 PF) and Centre for Epidemiologic Studies 10-item Depression Scale (CESD-10). Linear mixed modelling, accounting for time varying covariates, assessed the influence of further education on physical functioning and depressive symptoms over time. Sensitivity analysis to assess the impact of missing data was conducted using multiple imputation. Results Compared to younger women with a pre-existing high level of education, women gaining further education (up to age 39 years) from low levels had lower SF-36 PF scores (poorer physical functioning) (fully adjusted beta estimates (95% CIs) -1.52 (-2.59, -0.44)) while those gaining further education from middle to high levels showed equivalent SF-36 PF scores (-0.08 (-0.61, 0.44)). A similar pattern was shown for CESD-10 scores (0.78 (0.29, 1.25); -0.02 (-0.26, 0.21), respectively) where higher scores represented more depressive symptoms. For mid-age women, further education from a middle to high level resulted in equivalent SF-36 PF scores (-0.61 (-1.93,0.71)) but higher CESD-10 scores (0.49 (0.11, 0.86)), compared to highly educated women. Conclusion Women who delay further education until they are aged between their 40s and 60s can improve or maintain their physical functioning but may have missed the critical time to minimise depressive symptomatology. Public health policy should focus on encouraging women to upgrade their educational qualifications earlier in life in order to potentially offset the negative associations between their initial lower socio-economic position class of origin and their mental health.	[Tooth, Leigh; Mishra, Gita D.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia	University of Queensland	Tooth, L (corresponding author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.	l.tooth@uq.edu.au	Tooth, Leigh/F-2769-2010	Tooth, Leigh/0000-0002-1569-934X	Australian Government Department of Health; Australian Research Council Future Fellowship [FT120100812]	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); Australian Research Council Future Fellowship(Australian Research Council)	The Australian Longitudinal Study on Women's Health, including A/Professor Tooth's salary, is funded by the Australian Government Department of Health. Professor Gita Mishra is funded by an Australian Research Council Future Fellowship (FT120100812). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Armstrong T, 2000, PHYS ACTIVITY PATTER; Australian Bureau of Statistics, 1997, NAT HLTH SURV SF 36; Beebe-Dimmer J, 2004, AM J EPIDEMIOL, V159, P481, DOI 10.1093/aje/kwh057; Bell A, 2014, SOC SCI MED, V120, P21, DOI 10.1016/j.socscimed.2014.09.008; Bjelland I, 2008, SOC SCI MED, V66, P1334, DOI 10.1016/j.socscimed.2007.12.019; Butterworth P, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-44; Chandola T, 2011, INT J EPIDEMIOL, V40, P1499, DOI 10.1093/ije/dyr087; Chazelle E, 2011, J AFFECT DISORDERS, V134, P304, DOI 10.1016/j.jad.2011.05.049; Claussen B, 2005, SOC SCI MED, V61, P2513, DOI 10.1016/j.socscimed.2005.04.045; Cohen J.E., 1988, STAT POWER ANAL BEHA; Commonwealth Department of Health and Aged Care, 2001, COMM DEP HLTH AG CAR, V14; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Houle JN, 2011, SOC SCI RES, V40, P757, DOI 10.1016/j.ssresearch.2010.11.008; Johansson G, 2007, SOC SCI MED, V65, P685, DOI 10.1016/j.socscimed.2007.04.001; Johnson-Lawrence V, 2013, ANN EPIDEMIOL, V23, P167, DOI 10.1016/j.annepidem.2013.02.004; Jokela M, 2010, EPIDEMIOLOGY, V21, P284, DOI 10.1097/EDE.0b013e3181d61f53; Ki M, 2011, J EPIDEMIOL COMMUN H, V65, P1132, DOI 10.1136/jech.2009.107995; Koster A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-244; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lynch SM, 2006, J HEALTH SOC BEHAV, V47, P324, DOI 10.1177/002214650604700402; Miech R, 2007, ANN EPIDEMIOL, V17, P289, DOI 10.1016/j.annepidem.2006.07.015; Mishra GD, 2014, QUAL LIFE RES, V23, P1515, DOI 10.1007/s11136-013-0586-3; National Health and Medical Research Council Commonwealth of Australia, 2001, AUSTR ALC GUID HLTH; Nicholson A, 2008, J AFFECT DISORDERS, V105, P125, DOI 10.1016/j.jad.2007.04.026; Peeters G, 2013, B WORLD HEALTH ORGAN, V91, P661, DOI 10.2471/BLT.13.123075; Plewis I, 2014, RES SOC STRAT MOBIL, V36, P1, DOI 10.1016/j.rssm.2013.10.001; ROBERTS RE, 1983, AM J PSYCHIAT, V140, P41; Ross CE, 2006, SOC SCI MED, V63, P1400, DOI 10.1016/j.socscimed.2006.03.013; Rubin DB., 2004, MULTIPLE IMPUTATION; SAS/Stat, 2011, SAS STAT US GUID VER; Singh-Manoux A, 2004, INT J EPIDEMIOL, V33, P1072, DOI 10.1093/ije/dyh224; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; Stansfeld SA, 2011, SOC PSYCH PSYCH EPID, V46, P549, DOI 10.1007/s00127-010-0221-3; Turrell G, 2000, J EPIDEMIOL COMMUN H, V54, P207, DOI 10.1136/jech.54.3.207; Ware J.E., 2000, SF 36 HLTH SURVEY MA; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454	38	2	2	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140334	10.1371/journal.pone.0140334	http://dx.doi.org/10.1371/journal.pone.0140334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7WW	26480313	Green Published, Green Submitted, gold			2022-12-26	WOS:000363026600007
J	Asaduzzaman, K; Mannan, F; Khandaker, MU; Farook, MS; Elkezza, A; Amin, YB; Sharma, S; Bin Abu Kassim, H				Asaduzzaman, Khandoker; Mannan, Farhana; Khandaker, Mayeen Uddin; Farook, Mohideen Salihu; Elkezza, Aeman; Amin, Yusoff Bin Mohd; Sharma, Sailesh; Bin Abu Kassim, Hasan			Assessment of Natural Radioactivity Levels and Potential Radiological Risks of Common Building Materials Used in Bangladeshi Dwellings	PLOS ONE			English	Article							RADON EXHALATION RATE; RADIONUCLIDE CONTENT; CONSTRUCTION; HAZARDS; EXPOSURE; SAMPLES; RATES; LIME; CITY; SOIL	The concentrations of primordial radionuclides (Ra-226, Th-232 and K-40) in commonly used building materials (brick, cement and sand), the raw materials of cement and the by-products of coal-fired power plants (fly ash) collected from various manufacturers and suppliers in Bangladesh were determined via gamma-ray spectrometry using an HPGe detector. The results showed that the mean concentrations of Ra-226, Th-232 and K-40 in all studied samples slightly exceeded the typical world average values of 50 Bq kg(-1), 50 Bq kg(-1) and 500 Bq kg(-1), respectively. The activity concentrations (especially Ra-226) of fly-ash-containing cement in this study were found to be higher than those of fly-ash-free cement. To evaluate the potential radiological risk to individuals associated with these building materials, various radiological hazard indicators were calculated. The radium equivalent activity values for all samples were found to be lower than the recommended limit for building materials of 370 Bq kg(-1), with the exception of the fly ash. For most samples, the values of the alpha index and the radiological hazard (external and internal) indices were found to be within the safe limit of 1. The mean indoor absorbed dose rate was observed to be higher than the population-weighted world average of 84 nGy h(-1), and the corresponding annual effective dose for most samples fell below the recommended upper dose limit of 1 mSv y(-1). For all investigated materials, the values of the gamma index were found to be greater than 0.5 but less than 1, indicating that the gamma dose contribution from the studied building materials exceeds the exemption dose criterion of 0.3 mSv y(-1) but complies with the upper dose principle of 1 mSv y(-1).	[Asaduzzaman, Khandoker; Khandaker, Mayeen Uddin; Amin, Yusoff Bin Mohd; Bin Abu Kassim, Hasan] Univ Malaya, Fac Sci, Dept Phys, Kuala Lumpur, Malaysia; [Mannan, Farhana; Sharma, Sailesh] Univ Malaya, Inst Educ Leadership, Kuala Lumpur, Malaysia; [Farook, Mohideen Salihu] Univ Malaya, Fac Dent, Dept Restorat Dent, Kuala Lumpur, Malaysia; [Elkezza, Aeman] Univ Malaya, Fac Dent, Dept Prosthet Dent, Kuala Lumpur, Malaysia; [Asaduzzaman, Khandoker] Bangladesh Atom Energy Commiss, Dhaka 1207, Bangladesh	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Khandaker, MU (corresponding author), Univ Malaya, Fac Sci, Dept Phys, Kuala Lumpur, Malaysia.	mu_khandaker@yahoo.com	Farook, Mohideen Salihu/L-7025-2016; Khandaker, Mayeen Uddin/F-5376-2011; Elkezza, Aeman/L-8675-2016; Sharma, Sailesh/AAA-2591-2019; Elkezza, Aeman/K-7325-2016; MOHD AMIN, YUSOFF/B-5339-2010; Khandoker, Asaduzzaman/J-9209-2013	Farook, Mohideen Salihu/0000-0001-7244-0273; Khandaker, Mayeen Uddin/0000-0003-3772-294X; Sharma, Sailesh/0000-0002-8797-7951; Elkezza, Aeman/0000-0002-5507-0503; Khandoker, Asaduzzaman/0000-0003-2420-6743	University of Malaya Research [RP006D-13AFR, RG530-13HTM]	University of Malaya Research(Universiti Malaya)	This work was supported by University of Malaya Research Grants: RP006D-13AFR and RG530-13HTM. MUK and MSF received the funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademola JA, 2008, J RADIOL PROT, V28, P581, DOI 10.1088/0952-4746/28/4/010; Ahmed NK, 2005, J ENVIRON RADIOACTIV, V83, P91, DOI 10.1016/j.jenvrad.2005.03.002; Al-Sulaiti H, 2011, NUCL INSTRUM METH A, V652, P915, DOI 10.1016/j.nima.2011.01.020; Alam MN, 1999, J ENVIRON RADIOACTIV, V42, P77, DOI 10.1016/S0265-931X(98)00027-7; Alharbi WR, 2011, AUST J BASIC APPL SC, V5, P672; Amin YM, 2013, APPL RADIAT ISOTOPES, V80, P109, DOI 10.1016/j.apradiso.2013.06.014; [Anonymous], 1994, Ann ICRP, V24, P1; [Anonymous], 1991, Ann ICRP, V21, P1; [Anonymous], 1999, RAD PROT PRINC CONC; [Anonymous], 1989, IAEA TECHNICAL REPOR; Asaduzzaman K, 2015, ANN NUCL ENERGY, V76, P85, DOI 10.1016/j.anucene.2014.09.036; Asaduzzaman K, 2014, J ENVIRON RADIOACTIV, V135, P120, DOI 10.1016/j.jenvrad.2014.04.009; Asaduzzaman Kh, 2014, INDOOR BUILT ENVIRON, V0, P1; Asgharizadeh F, 2012, RADIAT PROT DOSIM, V149, P321, DOI 10.1093/rpd/ncr233; Ben BS, 2012, ASIAN J PHYS SCI, V1, P38; BERETKA J, 1985, HEALTH PHYS, V48, P87, DOI 10.1097/00004032-198501000-00007; Flores O, 2008, J ENVIRON RADIOACTIV, V99, P1834, DOI 10.1016/j.jenvrad.2008.08.001; Chowdhury MI, 1998, J RADIOANAL NUCL CH, V231, P117, DOI 10.1007/BF02388016; Ding X, 2013, ROCK MECH ROCK ENG, P1; El Arabi AM, 2008, RADIAT PROT DOSIM, V128, P382, DOI 10.1093/rpd/ncm367; Erees FS, 2006, INDOOR BUILT ENVIRON, V15, P495, DOI 10.1177/1420326X06069059; Ghose S, 2012, RADIOPROTECTION, V47, P105, DOI 10.1051/radiopro/2011158; Gupta M, 2011, IRAN J RADIAT RES, V9, P187; Gupta M, 2013, RADIAT MEAS, V50, P160, DOI 10.1016/j.radmeas.2012.03.015; Gupta M, 2012, INDOOR BUILT ENVIRON, V21, P465, DOI 10.1177/1420326X11414283; Hvistendahl M., 2007, SCI AM          1213; Khandaker MU, 2012, RADIAT PROT DOSIM, V152, P33, DOI 10.1093/rpd/ncs145; Kobeissi MA, 2013, RADIAT PROT DOSIM, V153, P342, DOI 10.1093/rpd/ncs110; Kovler K, 2002, BUILD ENVIRON, V37, P531, DOI 10.1016/S0360-1323(01)00048-8; Krstic D, 2007, RADIAT MEAS, V42, P1731, DOI 10.1016/j.radmeas.2007.09.001; Le NS, 2011, 11255 WM 2011 C FEB; Lee SC, 2001, RADIAT PROT DOSIM, V94, P269, DOI 10.1093/oxfordjournals.rpd.a006499; Llope WJ, 2011, J ENVIRON RADIOACTIV, V102, P620, DOI 10.1016/j.jenvrad.2011.03.012; Lu XW, 2007, IEEE T NUCL SCI, V54, P327, DOI 10.1109/TNS.2007.892335; Lu XW, 2005, RADIAT MEAS, V40, P94, DOI 10.1016/j.radmeas.2005.01.003; Malain D, 2012, APPL RADIAT ISOTOPES, V70, P1467, DOI 10.1016/j.apradiso.2012.04.017; Molla MAR, 1980, DOC228 IAEATEC; MOLLAH AS, 1986, HEALTH PHYS, V50, P849; Chau ND, 2011, ISOT ENVIRON HEALT S, V47, P415, DOI 10.1080/10256016.2011.628123; OECD, 1979, EXP RAD NAT RAD BUIL; Pandit GG, 2011, RADIOPROTECTION, V46, pS173, DOI 10.1051/radiopro/20116982s; Pavlidou S, 2006, J ENVIRON RADIOACTIV, V89, P48, DOI 10.1016/j.jenvrad.2006.03.005; Petropoulos NP, 2002, J ENVIRON RADIOACTIV, V61, P257, DOI 10.1016/S0265-931X(01)00132-1; Rahman SU, 2013, RADIAT PROT DOSIM, V153, P352, DOI 10.1093/rpd/ncs109; Ramasamy V, 2005, INDIAN J PURE AP PHY, V43, P815; Ravisankar R, 2012, APPL RADIAT ISOTOPES, V70, P699, DOI 10.1016/j.apradiso.2011.12.001; Righi S, 2006, J ENVIRON RADIOACTIV, V88, P158, DOI 10.1016/j.jenvrad.2006.01.009; Roy S, 2005, RADIAT PROT DOSIM, V114, P527, DOI 10.1093/rpd/nch471; Solak S, 2014, INDOOR BUILT ENVIRON, V23, P594, DOI 10.1177/1420326X12448075; Stoulos S, 2003, J ENVIRON RADIOACTIV, V69, P225, DOI 10.1016/S0265-931X(03)00081-X; Ulbak K., 1984, Radiation Protection Dosimetry, V7, P45; United Nations Scientific Committee on the Effects of Atomic Radiations (UNSCEAR), 1988, SOURC EFF RISKS LON; United States Geological Survey, 1997, RAD EL COAL FLY ASH; UNSCEAR, 2008, SOURC EFF LON RAD; UNSCEAR, 1993, EXP NAT SOURC RAD; UNSCEAR, 2000, EX NAT RAD SOURC; Xinwei L, 2004, RADIAT PROT DOSIM, V112, P323, DOI 10.1093/rpd/nch396; ZIKOVSKY L, 1992, HEALTH PHYS, V63, P449, DOI 10.1097/00004032-199210000-00009	58	45	46	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140667	10.1371/journal.pone.0140667	http://dx.doi.org/10.1371/journal.pone.0140667			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473957	Green Submitted, gold, Green Published			2022-12-26	WOS:000363185500078
J	Brown, VR; Adney, DR; Olea-Popelka, F; Bowen, RA				Brown, Vienna R.; Adney, Danielle R.; Olea-Popelka, Francisco; Bowen, Richard A.			Prior Inoculation with Type B Strains of Francisella tularensis Provides Partial Protection against Virulent Type A Strains in Cottontail Rabbits	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; TULAREMIA; CLADES	Francisella tularensis is a highly virulent bacterium that is capable of causing severe disease (tularemia) in a wide range of species. This organism is characterized into two distinct subspecies: tularensis (type A) and holarctica (type B) which vary in several crucial ways, with some type A strains having been found to be considerably more virulent in humans and laboratory animals. Cottontail rabbits have been widely implicated as a reservoir species for this subspecies; however, experimental inoculation in our laboratory revealed type A organisms to be highly virulent, resulting in 100% mortality following challenge with 50-100 organisms. Inoculation of cottontail rabbits with the same number of organisms from type B strains of bacteria was found to be rarely lethal and to result in a robust humoral immune response. The objective of this study was to characterize the protection afforded by a prior challenge with type B strains against a later inoculation with a type A strain in North American cottontail rabbits (Sylvilagus spp). Previous infection with a type B strain of organism was found to lengthen survival time and in some cases prevent death following inoculation with a type A2 strain of F. tularensis. In contrast, inoculation of a type A1b strain was uniformly lethal in cottontail rabbits irrespective of a prior type B inoculation. These findings provide important insight about the role cottontail rabbits may play in environmental maintenance and transmission of this organism.	[Brown, Vienna R.; Adney, Danielle R.; Bowen, Richard A.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Olea-Popelka, Francisco] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Bowen, RA (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	rbowen@colostate.edu			United States Department of Agriculture [11-7100-0331-CA]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was funded through cooperative agreement 11-7100-0331-CA from the United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimana C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00034; BAKER CN, 1985, J CLIN MICROBIOL, V22, P212, DOI 10.1128/JCM.22.2.212-215.1985; BELL J F, 1975, Journal of Wildlife Diseases, V11, P421; Brown VR, 2015, J WILDLIFE DIS, V51, P564, DOI 10.7589/2015-02-030; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Foley JE, 2010, VET MICROBIOL, V140, P332, DOI 10.1016/j.vetmic.2009.07.017; Johansson A, 2000, J CLIN MICROBIOL, V38, P4180, DOI 10.1128/JCM.38.11.4180-4185.2000; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; LONG GW, 1993, J CLIN MICROBIOL, V31, P152, DOI 10.1128/JCM.31.1.152-154.1993; Molins CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010205; Nakazawa Y, 2010, AM J TROP MED HYG, V82, P912, DOI 10.4269/ajtmh.2010.09-0354; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Petersen JM, 2010, FUTURE MICROBIOL, V5, P649, DOI 10.2217/FMB.10.17; Reed DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024654; Reese SM, 2011, J MED ENTOMOL, V48, P884, DOI 10.1603/ME11005; Reese SM, 2010, AM J TROP MED HYG, V83, P645, DOI 10.4269/ajtmh.2010.10-0127; Rossow H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108864; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Tarnvik A., 2007, WHO GUIDELINES TULAR; Telford SR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00150	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140723	10.1371/journal.pone.0140723	http://dx.doi.org/10.1371/journal.pone.0140723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474413	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500092
J	Huang, L; Zhao, SD; Lu, W; Guan, SD; Zhu, Y; Wang, JH				Huang, Li; Zhao, Shidi; Lu, Wei; Guan, Sudong; Zhu, Yan; Wang, Jin-Hui			Acidosis-Induced Dysfunction of Cortical GABAergic Neurons through Astrocyte-Related Excitotoxicity	PLOS ONE			English	Article							INTERNEURON DIVERSITY SERIES; CENTRAL-NERVOUS-SYSTEM; SENSING ION CHANNELS; PYRAMIDAL NEURONS; GLUTAMATE TRANSPORT; SYNAPTIC-TRANSMISSION; THRESHOLD POTENTIALS; SEIZURE TERMINATION; METABOLIC-ACIDOSIS; REFRACTORY PERIODS	Background Acidosis impairs cognitions and behaviors presumably by acidification-induced changes in neuronal metabolism. Cortical GABAergic neurons are vulnerable to pathological factors and their injury leads to brain dysfunction. How acidosis induces GABAergic neuron injury remains elusive. As the glia cells and neurons interact each other, we intend to examine the role of the astrocytes in acidosis-induced GABAergic neuron injury. Results Experiments were done at GABAergic cells and astrocytes in mouse cortical slices. To identify astrocytic involvement in acidosis-induced impairment, we induced the acidification in single GABAergic neuron by infusing proton intracellularly or in both neurons and astrocytes by using proton extracellularly. Compared the effects of intracellular acidification and extracellular acidification on GABAergic neurons, we found that their active intrinsic properties and synaptic outputs appeared more severely impaired in extracellular acidosis than intracellular acidosis. Meanwhile, extracellular acidosis deteriorated glutamate transporter currents on the astrocytes and upregulated excitatory synaptic transmission on the GABAergic neurons. Moreover, the antagonists of glutamate NMDA-/AMPA-receptors partially reverse extracellular acidosis-induced injury in the GABAergic neurons. Conclusion Our studies suggest that acidosis leads to the dysfunction of cortical GABAergic neurons by astrocyte-mediated excitotoxicity, in addition to their metabolic changes as indicated previously.	[Huang, Li; Zhao, Shidi; Guan, Sudong; Zhu, Yan] Bengbu Med Coll, Dept Pathophysiol, Bengbu 233000, Anhui, Peoples R China; [Wang, Jin-Hui] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Lu, Wei] Qingdao Univ, Coll Med, Ctr Neurodegenerat Disorders Shandong, Qingdao 266021, Shandong, Peoples R China	Bengbu Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS; Qingdao University	Wang, JH (corresponding author), Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China.	jhw@sun5.ibp.ac.cn			National Basic Research Program [2013CB531304, 2011CB504405]; Natural Science Foundation China [30990261, 81171033, 81471123]; Anhui Natural Science Foundation [1308085QH147, 1408085MH185]	National Basic Research Program(National Basic Research Program of China); Natural Science Foundation China(National Natural Science Foundation of China (NSFC)); Anhui Natural Science Foundation(Natural Science Foundation of Anhui Province)	This study is supported by National Basic Research Program (2013CB531304 and 2011CB504405) and Natural Science Foundation China (30990261, 81171033 and 81471123) to JHW, as well as Anhui Natural Science Foundation (1308085QH147) to LH and (1408085MH185) to SDZ.	Akaike N, 1995, OBES RES, V3, pS769, DOI 10.1002/j.1550-8528.1995.tb00498.x; Anderson CM, 2000, GLIA, V32, P1; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Beller JA, 2011, RESTOR NEUROL NEUROS, V29, P331, DOI 10.3233/RNN-2011-603; Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Bezzi P, 2001, Prog Brain Res, V132, P255; Bridges RJ, 2005, PHARMACOL THERAPEUT, V107, P271, DOI 10.1016/j.pharmthera.2005.01.002; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Chen N, 2006, BIOCHEM BIOPH RES CO, V340, P151, DOI 10.1016/j.bbrc.2005.11.170; Chen N, 2008, J CELL SCI, V121, P2961, DOI 10.1242/jcs.022368; Chen N, 2006, BIOCHEM BIOPH RES CO, V346, P938, DOI 10.1016/j.bbrc.2006.06.003; Chen N, 2006, BIOCHEM BIOPH RES CO, V346, P281, DOI 10.1016/j.bbrc.2006.05.120; Chen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011868; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Corty Megan M, 2013, J Cell Biol, V203, P395, DOI 10.1083/jcb.201306099; Coryell MW, 2009, J NEUROSCI, V29, P5381, DOI 10.1523/JNEUROSCI.0360-09.2009; de Lanerolle NC, 2010, NEUROTHERAPEUTICS, V7, P424, DOI 10.1016/j.nurt.2010.08.002; Fauci AS, 1997, ACIDOSIS ALKALOSIS; Florian C, 2011, J NEUROSCI, V31, P6956, DOI 10.1523/JNEUROSCI.5761-10.2011; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Ge RJ, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-26; Ge RJ, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-19; Huang L, 2010, BIOCHEM BIOPH RES CO, V394, P709, DOI 10.1016/j.bbrc.2010.03.056; KEMPSKI OS, 1994, ACTA NEUROCHIR, P7; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Klee CB, 2002, EMBO REP, V3, P823, DOI 10.1093/embo-reports/kvf182; Li F, 2011, BIOCHEM BIOPH RES CO, V410, P775, DOI 10.1016/j.bbrc.2011.06.053; Liu B, 2014, CNS NEUROSCI THER, V20, P982, DOI 10.1111/cns.12313; Lu W, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-38; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; MURPHY VA, 1990, AM J PHYSIOL, V258, pF1528, DOI 10.1152/ajprenal.1990.258.6.F1528; Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Ni H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013736; Nowak T.J., 2004, PATHOPHYSIOLOGY, P422; Okuda T., 1998, CURRENT MED DIAGNOSI, P824; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; PASTERNACK M, 1993, ACTA PHYSIOL SCAND, V148, P229, DOI 10.1111/j.1748-1716.1993.tb09553.x; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Ransom B, 2003, TRENDS NEUROSCI, V26, P520, DOI 10.1016/j.tins.2003.08.006; REHNCRONA S, 1985, ANN EMERG MED, V14, P770, DOI 10.1016/S0196-0644(85)80055-X; SCHACHNER M, 1991, ANN NY ACAD SCI, V633, P105; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Simon R, 2006, BIOCHEM SOC T, V34, P1356, DOI 10.1042/BST0341356; Song RR, 2011, J NEUROL SCI, V304, P122, DOI 10.1016/j.jns.2011.01.024; Sonnewald U, 2002, J PHARMACOL EXP THER, V301, P1, DOI 10.1124/jpet.301.1.1; Stevens CF, 2004, CURR OPIN NEUROBIOL, V14, P341, DOI 10.1016/j.conb.2004.04.004; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; TIZIANELLO A, 1977, CLIN SCI MOL MED, V52, P125, DOI 10.1042/cs0520125; Wang DG, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00320; Wang JH, 2004, BRAIN RES, V1004, P125, DOI 10.1016/j.brainres.2004.01.025; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; WANG JH, 1995, NEURON, V15, P443, DOI 10.1016/0896-6273(95)90048-9; Wang JH, 2001, J PHYSIOL-LONDON, V533, P407, DOI 10.1111/j.1469-7793.2001.0407a.x; Wang JH, 2015, MOL CELLULAR EPILEPS, V2, pe716, DOI [10.14800/mce.716, DOI 10.14800/MCE.716]; Wang JH, 2008, J CELL SCI, V121, P2951, DOI 10.1242/jcs.025684; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Wei J, 2004, NEUROSCIENCE, V127, P637, DOI 10.1016/j.neuroscience.2004.05.056; Wen B, 2015, CNS NEUROSCI THER, V21, P204, DOI 10.1111/cns.12336; Xiong ZG, 2006, J MEMBRANE BIOL, V209, P59, DOI 10.1007/s00232-005-0840-x; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Yu JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025219; Zhang FY, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-20; Zhao J, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-12; Zhou CY, 2007, BRAIN RES, V1145, P213, DOI 10.1016/j.brainres.2007.01.121; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Zoli M, 1996, PROG NEUROBIOL, V49, P363, DOI 10.1016/0301-0082(96)00020-2; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	72	19	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140324	10.1371/journal.pone.0140324	http://dx.doi.org/10.1371/journal.pone.0140324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474076	Green Submitted, gold, Green Published			2022-12-26	WOS:000363185500039
J	Liu, D; Wu, DL; Zhao, LH; Yang, Y; Ding, J; Dong, LG; Hu, LH; Wang, F; Zhao, XM; Cai, Y; Jin, JJ				Liu, Da; Wu, Donglu; Zhao, Linhong; Yang, Yang; Ding, Jian; Dong, Liguo; Hu, Lianghai; Wang, Fei; Zhao, Xiaoming; Cai, Yong; Jin, Jingji			Arsenic Trioxide Reduces Global Histone H4 Acetylation at Lysine 16 through Direct Binding to Histone Acetyltransferase hMOF in Human Cells	PLOS ONE			English	Article							GENE-EXPRESSION; DOSAGE COMPENSATION; MALES ABSENT; MOF; CANCER; CHROMATIN; EXPOSURE; COMPLEX; EPIGENETICS; CARCINOMA	Histone post-translational modification heritably regulates gene expression involved in most cellular biological processes. Experimental studies suggest that alteration of histone modifications affects gene expression by changing chromatin structure, causing various cellular responses to environmental influences. Arsenic (As), a naturally occurring element and environmental pollutant, is an established human carcinogen. Recently, increasing evidence suggests that As-mediated epigenetic mechanisms may be involved in its toxicity and carcinogenicity, but how this occurs is still unclear. Here we present evidence that suggests As-induced global histone H4K16 acetylation (H4K16ac) partly due to the direct physical interaction between As and histone acetyltransferase (HAT) hMOF (human male absent on first) protein, leading to the loss of hMOF HAT activity. Our data show that decreased global H4K16ac and increased deacetyltransferase HDAC4 expression occurred in arsenic trioxide (As2O3)-exposed HeLa or HEK293T cells. However, depletion of HDAC4 did not affect global H4K16ac, and it could not raise H4K16ac in cells exposed to As2O3, suggesting that HDAC4 might not directly be involved in histone H4K16 de-acetylation. Using As-immobilized agarose, we confirmed that As binds directly to hMOF, and that this interaction was competitively inhibited by free As2O3. Also, the direct interaction of As and C2CH zinc finger peptide was verified by MAIDI-TOF mass and UV absorption. In an in vitro HAT assay, As2O3 directly inhibited hMOF activity. hMOF over-expression not only increased resistance to As and caused less toxicity, but also effectively reversed reduced H4K16ac caused by As exposure. These data suggest a theoretical basis for elucidating the mechanism of As toxicity.	[Liu, Da; Wu, Donglu; Zhao, Linhong; Yang, Yang; Ding, Jian; Dong, Liguo; Hu, Lianghai; Wang, Fei; Zhao, Xiaoming; Cai, Yong; Jin, Jingji] Jilin Univ, Sch Life Sci, Changchun 130012, Jilin, Peoples R China; [Cai, Yong; Jin, Jingji] Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130012, Jilin, Peoples R China; [Cai, Yong; Jin, Jingji] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130012, Jilin, Peoples R China; [Hu, Lianghai] Jilin Univ, Sch Life Sci, Res Ctr Drug Metab, Changchun 130012, Jilin, Peoples R China; [Liu, Da] Changchun Univ Tradit Chinese Med, Sch Pharm, Changchun 130117, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University; Changchun University of Chinese Medicine	Cai, Y (corresponding author), Jilin Univ, Sch Life Sci, Changchun 130012, Jilin, Peoples R China.	caiyong62@jlu.edu.cn; jjjin@jlu.edu.cn		Dong, Liguo/0000-0002-8805-7487	National Natural Science Foundation of China [31171245, 31371311, 31571316, 31100999]; Research Fund for the Doctoral Program of Higher Education of China [20110061110020]; Key Scientific and Technological Project of Jilin Province Science and Technology Development Program [20130206005YY]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Scientific and Technological Project of Jilin Province Science and Technology Development Program	This work was supported by National Natural Science Foundation of China (No. 31171245& 31371311, YC No. 31571316, JJ and No. 31100999, FW), Research Fund for the Doctoral Program of Higher Education of China (No. 20110061110020, JJ) and Key Scientific and Technological Project of Jilin Province Science and Technology Development Program (20130206005YY, JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita A, 2012, J TRACE ELEM MED BIO, V26, P174, DOI 10.1016/j.jtemb.2012.03.012; ARRIGO AP, 1983, NUCLEIC ACIDS RES, V11, P1389, DOI 10.1093/nar/11.5.1389; Cai Y, 2005, J BIOL CHEM, V280, P13665, DOI 10.1074/jbc.M500001200; Cai Y, 2006, METHODS, V40, P312, DOI 10.1016/j.ymeth.2006.06.023; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Cao LL, 2014, INT J ONCOL, V44, P1207, DOI 10.3892/ijo.2014.2266; Chang YY, 2012, ARCH TOXICOL, V86, P911, DOI 10.1007/s00204-012-0828-0; Chen HB, 2010, CARCINOGENESIS, V31, P2136, DOI 10.1093/carcin/bgq197; Chouchane S, 2001, CHEM RES TOXICOL, V14, P517, DOI 10.1021/tx000123x; Cronican AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053478; Doherty Leo F., 2010, Hormones & Cancer, V1, P146, DOI 10.1007/s12672-010-0015-9; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; Fang L, 2014, J CARCINOG MUTAGEN, V5; Feller C, 2015, MOL CELL, V57, P559, DOI 10.1016/j.molcel.2014.12.008; Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313; Guo WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019351; Gupta A, 2008, MOL CELL BIOL, V28, P397, DOI 10.1128/MCB.01045-07; Gupta A, 2014, CELL REP, V8, P177, DOI 10.1016/j.celrep.2014.05.044; Gupta A, 2013, MUTAGENESIS, V28, P263, DOI 10.1093/mutage/ges080; Herbert KJ, 2014, TOXICOL APPL PHARM, V281, P136, DOI 10.1016/j.taap.2014.09.012; Jadhav SV, 2015, J ENVIRON MANAGE, V162, P306, DOI 10.1016/j.jenvman.2015.07.020; Jensen TJ, 2008, CARCINOGENESIS, V29, P1500, DOI 10.1093/carcin/bgn102; Jo WJ, 2009, TOXICOL APPL PHARM, V241, P294, DOI 10.1016/j.taap.2009.08.027; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Kumar R, 2011, P NATL ACAD SCI USA, V108, P3636, DOI 10.1073/pnas.1016524108; Li J, 2003, J BIOL CHEM, V278, P13183, DOI 10.1074/jbc.M300269200; Ma PP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003377; Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Mulligan P, 2011, MOL CELL, V42, P689, DOI 10.1016/j.molcel.2011.04.020; Thang ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096945; Pfister S, 2008, INT J CANCER, V122, P1207, DOI 10.1002/ijc.23283; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Sadri-Vakili G, 2010, J NEUROSCI, V30, P11735, DOI 10.1523/JNEUROSCI.2328-10.2010; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shi WP, 1996, J BIOL CHEM, V271, P9291, DOI 10.1074/jbc.271.16.9291; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Song JS, 2011, KOREAN J PATHOL, V45, P386, DOI 10.4132/KoreanJPathol.2011.45.4.386; Steinmaus C, 2014, AM J EPIDEMIOL, V180, P1082, DOI 10.1093/aje/kwu238; STEVENSON KJ, 1978, BIOCHEMISTRY-US, V17, P2189, DOI 10.1021/bi00604a026; Stoica A, 2000, ENDOCRINOLOGY, V141, P3595, DOI 10.1210/en.141.10.3595; Tsuji JS, 2014, TOXICOLOGY, V317, P17, DOI 10.1016/j.tox.2014.01.004; Veazey KJ, 2013, ALCOHOL CLIN EXP RES, V37, P1111, DOI 10.1111/acer.12080; Wang Y, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-8; Wu H, 2006, CRYSTAL STRUCTURE HU; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhao XM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003940; Zhou X, 2008, CARCINOGENESIS, V29, P1831, DOI 10.1093/carcin/bgn063	49	31	33	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0141014	10.1371/journal.pone.0141014	http://dx.doi.org/10.1371/journal.pone.0141014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473953	gold, Green Published, Green Submitted			2022-12-26	WOS:000363185500138
J	Ma, JH; Kan, YJ; Zhang, AX; Lei, Y; Yang, B; Li, P; Pan, LJ				Ma, Jiehua; Kan, Yanjing; Zhang, Aixia; Lei, Yu; Yang, Bin; Li, Ping; Pan, Lianjun			Female Sexual Dysfunction in Women with Non-Malignant Cervical Diseases: A Study from an Urban Chinese Sample	PLOS ONE			English	Article							FUNCTION INDEX; UNKNOWN ETIOLOGY; CUTOFF SCORES; VERSION; CANCER; POPULATION; PREVALENCE; VALIDATION	Non-malignant cervical diseases are common causes of disease among women worldwide. Although many studies have focused on sexual function in women with cervical cancer, little is known about the prevalence of female sexual dysfunction and its risk factors in women with non-malignant cervical diseases. The present study aims to assess sexual function in Chinese women with non-malignant cervical diseases and to identify potential risk factors for these diseases. A cross-sectional hospital-based survey was conducted in Nanjing, China. The Chinese version of the Female Sexual Function Index (CVFSFI) was used to evaluate sexual function. Three hundred three women who had been diagnosed with at least one non-malignant cervical disease and 293 healthy women were recruited from Nanjing Maternity and Child Health Hospital of Nanjing Medical University. We found that women with non-malignant cervical diseases had a significantly higher prevalence of female sexual dysfunction (FSD) (51.8% vs. 34.8%), low desire (43.2% vs. 26.3%), arousal disorder (41.6% vs. 28.3%), and lubrication disorder (51.2% vs. 36.9%) compared with the control group. Cervicitis and cervical intraepithelial neoplasia (CIN) were found to be independent risk factors for FSD. Our study indicates that women with cervicitis and CIN are at a high risk for FSD and deserve focused initial and follow-up management.	[Ma, Jiehua; Pan, Lianjun] Nanjing Med Univ, State Key Lab Reprod Med, Dept Reprod Hlth, Nanjing Matern & Child Hlth Care Hosp, Nanjing, Jiangsu, Peoples R China; [Kan, Yanjing; Lei, Yu] Nanjing Med Univ, State Key Lab Reprod Med, Dept Cerv Care, Nanjing Matern & Child Hlth Care Hosp, Nanjing, Jiangsu, Peoples R China; [Zhang, Aixia] Nanjing Med Univ, State Key Lab Reprod Med, Dept Nursing, Nanjing Matern & Child Hlth Care Hosp, Nanjing, Jiangsu, Peoples R China; [Yang, Bin] Fourth Peoples Hosp, Dept Reprod Genet, Zhenjiang 212001, Peoples R China; [Li, Ping] Nanjing Med Univ, State Key Lab Reprod Med, Dept Gynecol Endocrinol, Nanjing Matern & Child Hlth Care Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Li, P (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Dept Gynecol Endocrinol, Nanjing Matern & Child Hlth Care Hosp, Nanjing, Jiangsu, Peoples R China.	liping0099@126.com; plj_androl@163.com			National Natural Science Foundation of China [30972995, 81370679, 81501239]; Science and Technology Development Fund of Nanjing Medical University [2013NJMU127]; Scientific Research Project of the health department of Jiangsu Province [Z201022]; Science and technology project of Zhenjiang City [SH2011042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Fund of Nanjing Medical University; Scientific Research Project of the health department of Jiangsu Province; Science and technology project of Zhenjiang City	This study was funded by the National Natural Science Foundation of China (30972995, 81370679 and 81501239) and was supported by the Science and Technology Development Fund of Nanjing Medical University (2013NJMU127). It was also supported by Scientific Research Project of the health department of Jiangsu Province (Z201022) and Science and technology project of Zhenjiang City (SH2011042).	Chang SR, 2009, J SEX MED, V6, P1609, DOI 10.1111/j.1743-6109.2009.01247.x; Cheng Na, 2013, CHIN MATERN CHILD HL, V28, P3491; Ertunc D, 2009, J SEX MED, V6, P1032, DOI 10.1111/j.1743-6109.2008.01086.x; Gillet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045201; Gungor ANC, 2014, INT J GYNECOL OBSTET, V124, P27, DOI 10.1016/j.ijgo.2013.07.012; Herzog TJ, 2007, GYNECOL ONCOL, V107, P572, DOI 10.1016/j.ygyno.2007.09.019; Jia SZ, 2013, OBSTET GYNECOL, V121, P601, DOI 10.1097/AOG.0b013e3182835777; Lammerink EAG, 2012, MATURITAS, V72, P296, DOI 10.1016/j.maturitas.2012.05.006; Liao QP, 2008, J SEX MED, V5, P1923, DOI 10.1111/j.1743-6109.2008.00876.x; Ma JH, 2014, J SEX MED, V11, P909, DOI 10.1111/jsm.12451; Pan LJ, 2011, J SEX MED, V8, P2299, DOI 10.1111/j.1743-6109.2011.02313.x; Sun XG, 2011, J SEX MED, V8, P1101, DOI 10.1111/j.1743-6109.2010.02171.x; Tao LX, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-1185, 10.1186/1471-2458-14-353]; Taylor SN, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0409-x; Tsai TY, 2011, J SEX MED, V8, P1789, DOI 10.1111/j.1743-6109.2010.01745.x; Tsai Tzung-Yi, 2009, Hu Li Za Zhi, V56, P37; Wang J, 2013, INT J GYNECOL CANCER, V23, P393, DOI 10.1097/IGC.0b013e31828080ee; Wiegel M, 2005, J SEX MARITAL THER, V31, P1, DOI 10.1080/00926230590475206; Wiesenfeld HC, 2013, SEX TRANSM DIS, V40, P386, DOI 10.1097/OLQ.0b013e3182917baa; Yue-e GUI, 2012, CHINA NATL MED FRONT, V7, P85	20	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0141004	10.1371/journal.pone.0141004	http://dx.doi.org/10.1371/journal.pone.0141004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473480	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500135
J	Vajravelu, BN; Hong, KU; Al-Maqtari, T; Cao, PX; Keith, MCL; Wysoczynski, M; Zhao, J; Moore, JB; Bolli, R				Vajravelu, Bathri N.; Hong, Kyung U.; Al-Maqtari, Tareq; Cao, Pengxiao; Keith, Matthew C. L.; Wysoczynski, Marcin; Zhao, John; Moore, Joseph B.; Bolli, Roberto			C-Kit Promotes Growth and Migration of Human Cardiac Progenitor Cells via the PI3K-AKT and MEK-ERK Pathways	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; SIDE POPULATION CELLS; STEM-CELLS; MAST-CELLS; KINASE DOMAIN; MURINE MODEL; PI 3-KINASE; RECEPTOR; SURVIVAL; ACTIVATION	A recent phase I clinical trial (SCIPIO) has shown that autologous c-kit+ cardiac progenitor cells (CPCs) improve cardiac function and quality of life when transplanted into patients with ischemic heart disease. Although c-kit is widely used as a marker of resident CPCs, its role in the regulation of the cellular characteristics of CPCs remains unknown. We hypothesized that c-kit plays a role in the survival, growth, and migration of CPCs. To test this hypothesis, human CPCs were grown under stress conditions in the presence or absence of SCF, and the effects of SCF-mediated activation of c-kit on CPC survival/growth and migration were measured. SCF treatment led to a significant increase in cell survival and a reduction in cell death under serum depletion conditions. In addition, SCF significantly promoted CPC migration in vitro. Furthermore, the pro-survival and pro-migratory effects of SCF were augmented by c-kit overexpression and abrogated by c-kit inhibition with imatinib. Mechanistically, c-kit activation in CPCs led to activation of the PI3K and the MAPK pathways. With the use of specific inhibitors, we confirmed that the SCF/c-kit-dependent survival and chemotaxis of CPCs are dependent on both pathways. Taken together, our findings suggest that c-kit promotes the survival/growth and migration of human CPCs cultured ex vivo via the activation of PI3K and MAPK pathways. These results imply that the efficiency of CPC homing to the injury site as well as their survival after transplantation may be improved by modulating the activity of c-kit.	[Vajravelu, Bathri N.; Hong, Kyung U.; Al-Maqtari, Tareq; Cao, Pengxiao; Keith, Matthew C. L.; Wysoczynski, Marcin; Zhao, John; Moore, Joseph B.; Bolli, Roberto] Univ Louisville, Dept Med, Inst Mol Cardiol, Louisville, KY 40202 USA	University of Louisville	Bolli, R (corresponding author), Univ Louisville, Dept Med, Inst Mol Cardiol, Louisville, KY 40202 USA.	rbolli@louisville.edu	Vajravelu, Bathri/K-5504-2019; Al-Maqtari, Tareq/AAO-7951-2021; Hong, Kyung Uk/G-7145-2011	Hong, Kyung Uk/0000-0001-6700-9470	National Institutes of Health [P01 HL078825, P20 GM103492, UM1 HL113530]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL113530, P01HL078825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The following National Institutes of Health grants, awarded to RB, supported the authors' work: P01 HL078825, P20 GM103492, and UM1 HL113530. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bone-Larson CL, 2000, AM J PATHOL, V157, P1177, DOI 10.1016/S0002-9440(10)64633-0; Botchkareva NV, 2001, FASEB J, V15, P645, DOI 10.1096/fj.00-0368com; Cosgun KN, 2014, CELL STEM CELL, V15, P227, DOI 10.1016/j.stem.2014.06.001; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Fazel SS, 2008, FASEB J, V22, P930, DOI 10.1096/fj.07-8636com; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gommerman JL, 2000, BLOOD, V96, P3734, DOI 10.1182/blood.V96.12.3734.h8003734_3734_3742; He JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027719; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hong KU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096725; Hong Kyung U, 2014, Curr Treat Options Cardiovasc Med, V16, P324, DOI 10.1007/s11936-014-0324-3; Hong KU, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0346-0; Hoyer PE, 2005, MOL CELL ENDOCRINOL, V234, P1, DOI 10.1016/j.mce.2004.09.012; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Kent D, 2008, CLIN CANCER RES, V14, P1926, DOI 10.1158/1078-0432.CCR-07-5134; Kimura Y, 2004, P NATL ACAD SCI USA, V101, P6015, DOI 10.1073/pnas.0305363101; Kimura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026918; Lennartsson J, 2003, EXP CELL RES, V288, P110, DOI 10.1016/S0014-4827(03)00206-4; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; LEV S, 1992, P NATL ACAD SCI USA, V89, P678, DOI 10.1073/pnas.89.2.678; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Longley BJ, 2001, LEUKEMIA RES, V25, P571, DOI 10.1016/S0145-2126(01)00028-5; Lutz M, 2008, CARDIOVASC RES, V77, P143, DOI 10.1093/cvr/cvm027; Lux ML, 2000, AM J PATHOL, V156, P791, DOI 10.1016/S0002-9440(10)64946-2; Matsui J, 2004, J BIOL CHEM, V279, P18600, DOI 10.1074/jbc.M311643200; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; McDaniel AS, 2008, BLOOD, V112, P4646, DOI 10.1182/blood-2008-04-155085; MEKORI YA, 1995, INT ARCH ALLERGY IMM, V107, P136, DOI 10.1159/000236955; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Orth JM, 1997, BIOL REPROD, V57, P676, DOI 10.1095/biolreprod57.3.676; Oyama T, 2007, J CELL BIOL, V176, P329, DOI 10.1083/jcb.200603014; Pesce M, 1997, MECH DEVELOP, V68, P37, DOI 10.1016/S0925-4773(97)00120-2; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; ROTTAPEL R, 1991, MOL CELL BIOL, V11, P3043, DOI 10.1128/MCB.11.6.3043; Samayawardhena LA, 2006, CELL SIGNAL, V18, P1447, DOI 10.1016/j.cellsig.2005.11.005; Sanada F, 2014, CIRC RES, V114, P41, DOI 10.1161/CIRCRESAHA.114.302500; Schachinger V, 2008, CIRCULATION, V118, P1425, DOI 10.1161/CIRCULATIONAHA.108.777102; SERVE H, 1994, J BIOL CHEM, V269, P6026; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; Simpson K, 2003, LAB INVEST, V83, P199, DOI 10.1097/01.LAB.0000057002.16935.84; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Sun LX, 2004, J CLIN INVEST, V113, P1364, DOI 10.1172/JCI200420001; Tang JM, 2009, EXP CELL RES, V315, P3521, DOI 10.1016/j.yexcr.2009.09.026; Thommes K, 1999, BIOCHEM J, V341, P211, DOI 10.1042/0264-6021:3410211; Thoren LA, 2008, J IMMUNOL, V180, P2045, DOI 10.4049/jimmunol.180.4.2045; Todd JR, 2014, ONCOGENE, V33, P236, DOI 10.1038/onc.2012.562; Trieselmann NZ, 2003, CELL MOL LIFE SCI, V60, P759, DOI 10.1007/s00018-003-2349-8; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Wang CH, 2006, CIRC RES, V99, P617, DOI 10.1161/01.RES.0000243210.79654.fd; Wang XH, 2006, STEM CELLS, V24, P1779, DOI 10.1634/stemcells.2005-0386; WEHRLEHALLER B, 1995, DEVELOPMENT, V121, P731; WILSON I, 1986, J MED CHEM, V29, P1381, DOI 10.1021/jm00158a010; Yaniz-Galende E, 2012, CIRC RES, V111, P1434, DOI 10.1161/CIRCRESAHA.111.263830; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; YEE NS, 1994, J EXP MED, V179, P1777, DOI 10.1084/jem.179.6.1777; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055	72	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140798	10.1371/journal.pone.0140798	http://dx.doi.org/10.1371/journal.pone.0140798			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474484	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500113
J	Xu, XW; Ectors, F; Davis, EE; Pirottin, D; Cheng, HJ; Farnir, F; Hadfield, T; Cockett, N; Charlier, C; Georges, M; Takeda, H				Xu, Xuewen; Ectors, Fabien; Davis, Erica E.; Pirottin, Dimitri; Cheng, Huijun; Farnir, Frederic; Hadfield, Tracy; Cockett, Noelle; Charlier, Carole; Georges, Michel; Takeda, Haruko			Ectopic Expression of Retrotransposon-Derived PEG11/RTL1 Contributes to the Callipyge Muscular Hypertrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; POLAR OVERDOMINANCE; TRANS-INTERACTION; IMPRINTED GENE; DLK1; IDENTIFICATION; MICRORNA; LOCUS; TRANSCRIPTS; PHENOTYPE	The callipyge phenotype is an ovine muscular hypertrophy characterized by polar overdominance: only heterozygous +(Mat)/CLPG(Pat) animals receiving the CLPG mutation from their father express the phenotype. +(Mat)/CLPG(Pat) animals are characterized by postnatal, ectopic expression of Delta-like 1 homologue (DLK1) and Paternally expressed gene 11/Retrotransposon-like 1 (PEG11/RTL1) proteins in skeletal muscle. We showed previously in transgenic mice that ectopic expression of DLK1 alone induces a muscular hypertrophy, hence demonstrating a role for DLK1 in determining the callipyge hypertrophy. We herein describe newly generated transgenic mice that ectopically express PEG11 in skeletal muscle, and show that they also exhibit a muscular hypertrophy phenotype. Our data suggest that both DLK1 and PEG11 act together in causing the muscular hypertrophy of callipyge sheep.	[Xu, Xuewen; Davis, Erica E.; Pirottin, Dimitri; Cheng, Huijun; Charlier, Carole; Georges, Michel; Takeda, Haruko] Univ Liege, GIGA Res Ctr, Unit Anim Genom, Liege, Belgium; [Xu, Xuewen; Davis, Erica E.; Pirottin, Dimitri; Cheng, Huijun; Farnir, Frederic; Charlier, Carole; Georges, Michel; Takeda, Haruko] Univ Liege, Fac Vet Med, Liege, Belgium; [Ectors, Fabien] Univ Liege, FARAH, Transgen Platform, Liege, Belgium; [Ectors, Fabien] Univ Liege, GIGA Res Ctr, Liege, Belgium; [Farnir, Frederic] Univ Liege, FARAH, Unit Biostat, Liege, Belgium; [Hadfield, Tracy; Cockett, Noelle] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; Utah System of Higher Education; Utah State University	Takeda, H (corresponding author), Univ Liege, GIGA Res Ctr, Unit Anim Genom, 1 Ave Hop, Liege, Belgium.	htakeda@ulg.ac.be		Davis, Erica/0000-0002-2412-8397; Georges, Michel/0000-0003-4124-2375; Charlier, Carole/0000-0002-9694-094X	Fonds de la Recherche Scientifique [2.4544.11]; Communaute Francaise de Belgique (ARC Mirage); European Union (FP7 Callimir project); China state; Belgian Federal Science Policy Office	Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Communaute Francaise de Belgique (ARC Mirage); European Union (FP7 Callimir project); China state; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office)	This work was supported by the Fonds de la Recherche Scientifique (project 2.4544.11), the Communaute Francaise de Belgique (ARC Mirage), the European Union (FP7 Callimir project), the China state-sponsored post-graduate study abroad program (to HC), and the Belgian Federal Science Policy Office (postdoctoral fellowship to XX).	Agbulut O, 2003, BIOL CELL, V95, P399, DOI 10.1016/S0248-4900(03)00087-X; [Anonymous], 2014, R LANG ENV STAT COMP; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Byrne K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008638; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Carpenter E, 1996, J ANIM SCI, V74, P388; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Cheng HJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-944; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; Georges M, 2003, TRENDS GENET, V19, P248, DOI 10.1016/S0168-9525(03)00082-9; Georges M, 2013, EPIGENETICS COMPLEX, P89; Georgiades P, 2000, DEVELOPMENT, V127, P4719; Green MR, 2012, MOL CLONING LAB MANU, V1; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jackson SP, 1997, J ANIM SCI, V75, P133; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; Koohmaraie M, 1995, J ANIM SCI, V73, P3596; Kuznetsova A., 2014, IMERTEST TESTS RANDO; Lin SP, 2007, DEVELOPMENT, V134, P417, DOI 10.1242/dev.02726; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lynch C, 2003, CURR BIOL, V13, P1518, DOI 10.1016/S0960-9822(03)00618-3; Potter CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010168; R Core Team, 2021, R LANGUAGE ENV STAT; Riordan JD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003441; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Segers K, 2000, ANIM GENET, V31, P352, DOI 10.1046/j.1365-2052.2000.00676.x; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Smit M, 2003, GENETICS, V163, P453; Smit MA, 2005, MAMM GENOME, V16, P801, DOI 10.1007/s00335-004-2415-z; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vuocolo T, 2007, PHYSIOL GENOMICS, V28, P253, DOI 10.1152/physiolgenomics.00121.2006; White JD, 2008, DIFFERENTIATION, V76, P283, DOI 10.1111/j.1432-0436.2007.00208.x	39	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140594	10.1371/journal.pone.0140594	http://dx.doi.org/10.1371/journal.pone.0140594			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474044	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500069
J	Zhao, J; Mou, YS; Bernstock, JD; Klimanis, D; Wang, SX; Spatz, M; Maric, D; Johnson, K; Klinman, DM; Li, XH; Li, XH; Hallenbeck, JM				Zhao, Jing; Mou, Yongshan; Bernstock, Joshua D.; Klimanis, Dace; Wang, Sixian; Spatz, Maria; Maric, Dragan; Johnson, Kory; Klinman, Dennis M.; Li, Xiaohong; Li, Xinhui; Hallenbeck, John M.			Synthetic Oligodeoxynucleotides Containing Multiple Telemeric TTAGGG Motifs Suppress Inflammasome Activity in Macrophages Subjected to Oxygen and Glucose Deprivation and Reduce Ischemic Brain Injury in Stroke-Prone Spontaneously Hypertensive Rats	PLOS ONE			English	Article							REGULATORY T-CELLS; TISSUE DISTRIBUTION; IMMUNE-SYSTEM; ACTIVATION; DEATH; DNA; PHARMACOKINETICS; IL-1-BETA; INFECTION; MICE	The immune system plays a fundamental role in both the development and pathobiology of stroke. Inflammasomes are multiprotein complexes that have come to be recognized as critical players in the inflammation that ultimately contributes to stroke severity. Inflammasomes recognize microbial and host-derived danger signals and activate caspase-1, which in turn controls the production of the pro-inflammatory cytokine IL-1 beta. We have shown that A151, a synthetic oligodeoxynucleotide containing multiple telemeric TTAGGG motifs, reduces IL-1 beta production by activated bone marrow derived macrophages that have been subjected to oxygen-glucose deprivation and LPS stimulation. Further, we demonstrate that A151 reduces the maturation of caspase-1 and IL-1 beta, the levels of both the iNOS and NLRP3 proteins, and the depolarization of mitochondrial membrane potential within such cells. In addition, we have demonstrated that A151 reduces ischemic brain damage and NLRP3 mRNA levels in SHR-SP rats that have undergone permanent middle cerebral artery occlusion. These findings clearly suggest that the modulation of inflammasome activity via A151 may contribute to a reduction in pro-inflammatory cytokine production by macrophages subjected to conditions that model brain ischemia and modulate ischemic brain damage in an animal model of stroke. Therefore, modulation of ischemic pathobiology by A151 may have a role in the development of novel stroke prevention and therapeutic strategies.	[Zhao, Jing; Li, Xiaohong] Shandong Univ, Jinan Cent Hosp, Dept Neurol, Jinan 250013, Shandong, Peoples R China; [Zhao, Jing; Mou, Yongshan; Bernstock, Joshua D.; Klimanis, Dace; Spatz, Maria; Li, Xinhui; Hallenbeck, John M.] NINDS, Stroke Branch, NIH, Bethesda, MD 20892 USA; [Wang, Sixian] Cornell Univ, Coll Arts & Sci, Ithaca, NY USA; [Maric, Dragan] NINDS, Flow Cytometry Core Facil, Bethesda, MD 20892 USA; [Johnson, Kory] NINDS, Informat Technol & Bioinformat Program, NIH, Bethesda, MD 20892 USA; [Klinman, Dennis M.] NCI, Canc & Inflammat Program, NIH, Bethesda, MD 20892 USA	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Li, XH (corresponding author), Shandong Univ, Jinan Cent Hosp, Dept Neurol, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China.	xiaohong-li@sdu.edu.cn; lixinh@mail.nih.gov; hallenbj@ninds.nih.gov	zhao, jing/B-3868-2019	Bernstock, Joshua/0000-0002-7814-3867	Intramural Research Program of the National Institute of Neurological Disorders and Stroke/National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002924, ZIANS002856] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Neurological Disorders and Stroke/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke/National Institutes of Health.	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Bahjat FR, 2011, J CEREBR BLOOD F MET, V31, P1229, DOI 10.1038/jcbfm.2011.6; Bedikian AY, 2014, MELANOMA RES, V24, P237, DOI 10.1097/CMR.0000000000000056; Benchoua A, 2004, J CEREBR BLOOD F MET, V24, P1272, DOI 10.1097/01.WCB.0000140272.54583.FB; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bijsterbosch MK, 1997, NUCLEIC ACIDS RES, V25, P3290, DOI 10.1093/nar/25.16.3290; Bode C, 2014, INT IMMUNOPHARMACOL, V23, P516, DOI 10.1016/j.intimp.2014.09.027; Bode C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067991; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Chang YP, 2015, J CELL PHYSIOL, V230, P1567, DOI 10.1002/jcp.24903; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15107, DOI 10.1073/pnas.2436538100; Cheng X, 2008, J MOL CELL CARDIOL, V45, P168, DOI 10.1016/j.yjmcc.2008.04.003; Chiba T, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/759103; Courties G, 2014, JAMA NEUROL, V71, P233, DOI 10.1001/jamaneurol.2013.5026; Davis Beckley K, 2013, Methods Mol Biol, V1031, P27, DOI 10.1007/978-1-62703-481-4_3; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Denes A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.86; Denes A, 2015, P NATL ACAD SCI USA, V112, P4050, DOI 10.1073/pnas.1419090112; Deroide N, 2013, J CLIN INVEST, V123, P1176, DOI 10.1172/JCI65167; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dong L, 2005, ARTHRITIS RHEUM-US, V52, P651, DOI 10.1002/art.20810; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Emsley HCA, 2002, J CEREBR BLOOD F MET, V22, P1399, DOI 10.1097/01.WCB.0000037880.62590.28; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Fang H, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-27; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Fann DYW, 2014, EXP NEUROL, V257, P114, DOI 10.1016/j.expneurol.2014.04.017; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Fugate JE, 2014, LANCET INFECT DIS, V14, P869, DOI 10.1016/S1473-3099(14)70755-8; Fujimoto C, 2009, CLIN EXP IMMUNOL, V156, P528, DOI 10.1111/j.1365-2249.2009.03918.x; Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063; Gursel I, 2003, J IMMUNOL, V171, P1393, DOI 10.4049/jimmunol.171.3.1393; Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Iadecola C, 1996, STROKE, V27, P1373, DOI 10.1161/01.STR.27.8.1373; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jahrsdorfer Bernd, 2008, Update Cancer Ther, V3, P27, DOI 10.1016/j.uct.2007.11.003; Kaminski JJ, 2013, J IMMUNOL, V191, P3876, DOI 10.4049/jimmunol.1300530; Kastbom A, 2015, J RHEUMATOL; Kim YJ, 2006, J NEUROSCI RES, V84, P1037, DOI 10.1002/jnr.21011; Klinman DM, 2015, MOL THER, V23, P222, DOI 10.1038/mt.2014.251; Klinman DM, 2009, ANN NY ACAD SCI, V1175, P80, DOI 10.1111/j.1749-6632.2009.04970.x; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Koo T, 2013, HUM GENE THER, V24, P479, DOI 10.1089/hum.2012.234; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Li N, 2013, IMMUNOL LETT, V151, P54, DOI 10.1016/j.imlet.2013.02.004; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lim SY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00027; Mazzone P, 2010, INT J ENV RES PUB HE, V7, P4111, DOI 10.3390/ijerph7124111; Mazzotta G, 2004, EUR J NEUROL, V11, P377, DOI 10.1111/j.1468-1331.2004.00798.x; McColl BW, 2009, NEUROSCIENCE, V158, P1049, DOI 10.1016/j.neuroscience.2008.08.019; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; Peng B, 2001, ANTISENSE NUCLEIC A, V11, P15, DOI 10.1089/108729001750072092; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; SAIJO Y, 1994, ONCOL RES, V6, P243; Sato T, 2008, J IMMUNOL, V180, P7648, DOI 10.4049/jimmunol.180.11.7648; Satoh T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.169; Saver JL, 2011, J THROMB HAEMOST, V9, P333, DOI 10.1111/j.1538-7836.2011.04371.x; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seijkens T, 2014, DIABETES, V63, P3982, DOI 10.2337/db14-0272; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Shirota H, 2005, J IMMUNOL, V174, P4579, DOI 10.4049/jimmunol.174.8.4579; Shirota H, 2004, J IMMUNOL, V173, P5002, DOI 10.4049/jimmunol.173.8.5002; Shirota H, 2014, EXPERT REV VACCINES, V13, P299, DOI 10.1586/14760584.2014.863715; Sotgiu S, 2006, EUR J NEUROL, V13, P505, DOI 10.1111/j.1468-1331.2006.01280.x; Stevens SL, 2008, J CEREBR BLOOD F MET, V28, P1040, DOI 10.1038/sj.jcbfm.9600606; Takahashi M, 2011, TRENDS CARDIOVAS MED, V21, P37, DOI 10.1016/j.tcm.2012.02.002; Tannahill GM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00106; TARKOWSKI E, 1995, STROKE, V26, P1393, DOI 10.1161/01.STR.26.8.1393; Trott DW, 2014, ADV PHYSIOL EDUC, V38, P20, DOI 10.1152/advan.00063.2013; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Westwell-Roper Clara, 2013, Methods Mol Biol, V1040, P9, DOI 10.1007/978-1-62703-523-1_2; Wilson A, 2005, MOL THER, V12, P510, DOI 10.1016/j.ymthe.2005.04.005; Yamada H, 2004, CRIT CARE MED, V32, P2045, DOI 10.1097/01.CCM.0000142397.38134.EF; Zeuner RA, 2003, ARTHRITIS RHEUM, V48, P1701, DOI 10.1002/art.11035; Zhang N, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/370530; ZHANG RW, 1995, BIOCHEM PHARMACOL, V49, P929, DOI 10.1016/0006-2952(95)00010-W; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	85	20	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140772	10.1371/journal.pone.0140772	http://dx.doi.org/10.1371/journal.pone.0140772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473731	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500107
J	Kay, EI; Botha, R; Montgomery, JM; Mountjoy, KG				Kay, Emma I.; Botha, Rikus; Montgomery, Johanna M.; Mountjoy, Kathleen G.			hMRAP alpha, but Not hMRAP2, Enhances hMC4R Constitutive Activity in HEK293 Cells and This Is Not Dependent on hMRAP alpha Induced Changes in hMC4R Complex N-linked Glycosylation	PLOS ONE			English	Article							GLUCOCORTICOID DEFICIENCY TYPE-2; MELANOCORTIN-4 RECEPTOR; PROTEIN; MUTATIONS; OBESITY; LOCALIZATION; ACTIVATION; CHAPERONE; SURFACE; MRAP2	MRAP1 but not MRAP2, is essential for melanocortin receptor 2 functional expression. Human MRAP1 splice variant (hMRAP alpha) and human MRAP2 (hMRAP2) also interact with the other melanocortin receptor subtypes in vitro, although the physiological significance of these interactions is unknown. Previously we showed that HA-hMC4R co-expression with hMRAP alpha, but not hMRAP2, specifically alters HA-hMC4R complex N-linked glycosylation. hMRAP alpha-FLAG also enhances hMC4R constitutive activity in vitro. Here we directly compare hMRAP alpha and hMRAP2 effects on hMC4R constitutive activity in HEK293 cells. In contrast to hMRAP alpha, co-expression with hMRAP2 had no effect on HA-hMC4R or untagged hMC4R constitutive coupling to adenylyl cyclase. We used fixed and live cell imaging of HA-hMC4R and hMC4R-eGFP respectively, to further characterise effects of hMRAP alpha on hMC4R subcellular trafficking. hMRAP alpha-FLAG co-expression did not alter the partitioning of either HA-hMC4R or hMC4R-eGFP into either the ER or the Golgi apparatus, therefore the hMRAP alpha effect on hMC4R complex N-linked glycosylation is probably not due to hMC4R retention in the ER. We also observed that unlike HA-hMC4R, hMC4R-eGFP lacks complex glycosylation both in the presence and absence of hMRAP alpha, although both HAhMC4R and hMC4R-eGFP exhibited increased constitutive coupling to adenylyl cyclase following co-expression with hMRAP alpha. We conclude that hMRAP alpha and not hMRAP2 modulates hMC4R constitutive activity. Furthermore, hMRAP alpha does not increase hMC4R constitutive activity by altering hMC4R complex N-linked glycosylation. Instead we hypothesise that hMRAP alpha alters hMC4R conformational states leading to increased hMC4R constitutive activity.	[Kay, Emma I.; Botha, Rikus; Montgomery, Johanna M.; Mountjoy, Kathleen G.] Univ Auckland, Dept Physiol, Auckland 1142, New Zealand; [Mountjoy, Kathleen G.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1142, New Zealand; [Kay, Emma I.; Montgomery, Johanna M.; Mountjoy, Kathleen G.] Univ Auckland, Ctr Brain Res, Fac Med & Hlth Sci, Auckland 1142, New Zealand; [Mountjoy, Kathleen G.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland	Mountjoy, KG (corresponding author), Univ Auckland, Dept Physiol, Private Bag 92019, Auckland 1142, New Zealand.	k.mountjoy@auckland.ac.nz	Mountjoy, Kathy/L-4473-2019	Kay, Emma/0000-0001-9668-6753				Asai M, 2013, SCIENCE, V341, P275, DOI 10.1126/science.1233000; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chan LF, 2009, P NATL ACAD SCI USA, V106, P6146, DOI 10.1073/pnas.0809918106; Daly CJ, 2003, PHARMACOL THERAPEUT, V100, P101, DOI 10.1016/j.pharmthera.2003.08.001; Fan ZC, 2009, J CELL MOL MED, V13, P3268, DOI 10.1111/j.1582-4934.2009.00726.x; Ghamari-Langroudi M, 2011, P NATL ACAD SCI USA, V108, P355, DOI 10.1073/pnas.1016785108; Granell S, 2010, MOL ENDOCRINOL, V24, P1805, DOI 10.1210/me.2010-0071; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; Kay EI, 2013, J MOL ENDOCRINOL, V50, P217, DOI 10.1530/JME-12-0220; Kay EI, 2013, J MOL ENDOCRINOL, V50, P203, DOI 10.1530/JME-12-0221; Kim DH, 2008, BIOCHEM BIOPH RES CO, V365, P439, DOI 10.1016/j.bbrc.2007.10.170; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Lubrano-Berthelier C, 2003, HUM MOL GENET, V12, P145, DOI 10.1093/hmg/ddg016; Meimaridou E, 2011, MOL ENDOCRINOL, V25, P1650, DOI 10.1210/me.2011-1020; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Pantel J, 2011, EUR J PHARMACOL, V660, P139, DOI 10.1016/j.ejphar.2011.01.031; Proneth B, 2006, CHEM BIOL DRUG DES, V67, P215, DOI 10.1111/j.1747-0285.2006.00362.x; Rasband W.S., 1997, IMAGE J; Rumie H, 2007, EUR J ENDOCRINOL, V157, P539, DOI 10.1530/EJE-07-0242; Sebag JA, 2013, SCIENCE, V341, P278, DOI 10.1126/science.1232995; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Tao YX, 2010, METHOD ENZYMOL, V484, P267, DOI [10.1016/S0076-6879(10)84014-5, 10.1016/B978-0-12-381298-8.00014-9]; Whistler JL, 2002, TRAFFIC, V3, P866, DOI 10.1034/j.1600-0854.2002.31203.x; Zurn A, 2010, BIOCONJUGATE CHEM, V21, P853, DOI 10.1021/bc900394j	27	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140320	10.1371/journal.pone.0140320	http://dx.doi.org/10.1371/journal.pone.0140320			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469516	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600040
J	Lu, XD; Wang, WX; Ren, W; Chai, ZG; Guo, WZ; Chen, RM; Wang, L; Zhao, J; Lang, ZH; Fan, YL; Zhao, JR; Zhang, CY				Lu, Xiaoduo; Wang, Weixuan; Ren, Wen; Chai, Zhenguang; Guo, Wenzhu; Chen, Rumei; Wang, Lei; Zhao, Jun; Lang, Zhihong; Fan, Yunliu; Zhao, Jiuran; Zhang, Chunyi			Genome-Wide Epigenetic Regulation of Gene Transcription in Maize Seeds	PLOS ONE			English	Article							DIRECTED DNA METHYLATION; ARABIDOPSIS-THALIANA; RICE ENDOSPERM; HUMAN CANCER; SMALL RNA; PSEUDOGENES; PLANTS; METHYLTRANSFERASES; HYPOMETHYLATION; ELEMENTS	Background Epigenetic regulation is well recognized for its importance in gene expression in organisms. DNA methylation, an important epigenetic mark, has received enormous attention in recent years as it's a key player in many biological processes. It remains unclear how DNA methylation contributes to gene transcription regulation in maize seeds. Here, we take advantage of recent technologies to examine the genome-wide association of DNA methylation with transcription of four types of DNA sequences, including protein-coding genes, pseudogenes, transposable elements, and repeats in maize embryo and endosperm, respectively. Results The methylation in CG, CHG and CHH contexts plays different roles in the control of gene expression. Methylation around the transcription start sites and transcription stop regions of protein-coding genes is negatively correlated, but in gene bodies positively correlated, to gene expression level. The upstream regions of protein-coding genes are enriched with 24-nt siRNAs and contain high levels of CHH methylation, which is correlated to gene expression level. The analysis of sequence content within CG, CHG, or CHH contexts reveals that only CHH methylation is affected by its local sequences, which is different from Arabidopsis. Conclusions In summary, we conclude that methylation-regulated transcription varies with the types of DNA sequences, sequence contexts or parts of a specific gene in maize seeds and differs from that in other plant species. Our study helps people better understand from a genome-wide viewpoint that how transcriptional expression is controlled by DNA methylation, one of the important factors influencing transcription, and how the methylation is associated with small RNAs.	[Lu, Xiaoduo; Chai, Zhenguang] Qilu Normal Univ, Sch Life Sci, Jinan 250200, Peoples R China; [Lu, Xiaoduo; Wang, Weixuan; Guo, Wenzhu; Chen, Rumei; Wang, Lei; Zhao, Jun; Lang, Zhihong; Fan, Yunliu; Zhang, Chunyi] Chinese Acad Agr Sci, Biotechnol Res Inst, Dept Crop Genom & Genet Improvement, Beijing 100081, Peoples R China; [Wang, Weixuan; Guo, Wenzhu; Chen, Rumei; Wang, Lei; Zhao, Jun; Lang, Zhihong; Fan, Yunliu; Zhang, Chunyi] Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China; [Ren, Wen; Zhao, Jiuran] Beijing Acad Agr & Forestry Sci, Maize Res Ctr, Beijing 100097, Peoples R China	Qilu Normal University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Beijing Academy of Agriculture & Forestry	Zhao, JR (corresponding author), Beijing Acad Agr & Forestry Sci, Maize Res Ctr, Beijing 100097, Peoples R China.	maizezhao@126.com; zhangchunyi@caas.cn	Ren, Wen/HCI-0284-2022	Ren, Wen/0000-0003-1698-6161	 [ZR2013CM016];  [2013CB127003]	; 	This work was supported by grant number ZR2013CM016 (URL: http://www.sdnsf.gov.cn/portal/) with a role in study design, data colletion and analysis, and grant number 2013CB127003 (URL: http://www.973.gov.cn/English/Index.aspx) with a role in the decision to publish and preparation of the manuscript.	Bennetzen JL, 2009, HANDBOOK OF MAIZE GE; Berger F, 2009, TRENDS PLANT SCI, V14, P550, DOI 10.1016/j.tplants.2009.08.003; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; D'Errico Ilenia, 2004, Briefings in Functional Genomics & Proteomics, V3, P157, DOI 10.1093/bfgp/3.2.157; Danilevskaya ON, 2003, PLANT CELL, V15, P425, DOI 10.1105/tpc.006759; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Gent JI, 2013, GENOME RES, V23, P628, DOI 10.1101/gr.146985.112; Goettel W, 2013, GENE, V516, P8, DOI 10.1016/j.gene.2012.12.034; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gutierrez-Marcos JF, 2003, PHILOS T ROY SOC B, V358, P1105, DOI 10.1098/rstb.2003.1292; Gutierrez-Marcos JF, 2006, NAT GENET, V38, P876, DOI 10.1038/ng1828; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Ito H, 2013, GENES GENET SYST, V88, P3, DOI 10.1266/ggs.88.3; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Law JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002195; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lu XD, 2013, PLANT PHYSIOL, V162, P440, DOI 10.1104/pp.113.214874; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mueller Wolf C, 2009, Recent Results Cancer Res, V171, P217, DOI 10.1007/978-3-540-31206-2_13; Muro EM, 2011, BIOCHIMIE, V93, P1916, DOI 10.1016/j.biochi.2011.07.024; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Poliseno L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002858; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Ramachandran V, 2008, TRENDS PLANT SCI, V13, P368, DOI 10.1016/j.tplants.2008.03.008; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rodrigues JA, 2013, P NATL ACAD SCI USA, V110, P7934, DOI 10.1073/pnas.1306164110; Schaefer CB, 2007, SCIENCE, V316, P398, DOI 10.1126/science.1137544; Schwartz D, 1965, GENETICS TODAY, P131; Shi JL, 2013, ONCOL REP, V30, P201, DOI 10.3892/or.2013.2456; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; VENOLIA L, 1983, NATURE, V302, P82, DOI 10.1038/302082a0; Volpe T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003731; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107; Zhang HM, 2011, CURR OPIN PLANT BIOL, V14, P142, DOI 10.1016/j.pbi.2011.02.003; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang ZD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r26; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	61	46	49	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0139582	10.1371/journal.pone.0139582	http://dx.doi.org/10.1371/journal.pone.0139582			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469520	gold, Green Published, Green Submitted			2022-12-26	WOS:000363184600014
J	Al Harun, MAY; Johnson, J; Uddin, MN; Robinson, RW				Al Harun, Md Abdullah Yousuf; Johnson, Joshua; Uddin, Md Nazim; Robinson, Randall W.			Identification and Phytotoxicity Assessment of Phenolic Compounds in Chrysanthemoides monilifera subsp monilifera (Boneseed)	PLOS ONE			English	Article							EXOTIC PLANT INVASION; ALLELOPATHIC INTERACTIONS; SEEDLING GROWTH; SSP ROTUNDATA; WATER-CONTENT; SOIL; ACIDS; GERMINATION; EXTRACTS; STRESS	Chrysanthemoides monilifera subsp. monilifera (boneseed), a weed of national significance in Australia, threatens indigenous species and crop production through allelopathy. We aimed to identify phenolic compounds produced by boneseed and to assess their phytotoxicity on native species. Phenolic compounds in water and methanol extracts, and in decomposed litter-mediated soil leachate were identified using HPLC, and phytotoxicity of identified phenolics was assessed (repeatedly) through a standard germination bioassay on native Isotoma axillaris. The impact of boneseed litter on native Xerochrysum bracteatum was evaluated using field soil in a greenhouse. Collectively, we found the highest quantity of phenolic compounds in boneseed litter followed by leaf, root and stem. Quantity varied with extraction media. The rank of phenolics concentration in boneseed was in the order of ferulic acid > phloridzin > catechin > p-coumaric acid and they inhibited germination of I. axillaris with the rank of ferulic acid > catechin > phloridzin > p-coumaric acid. Synergistic effects were more severe compared to individual phenolics. The litter-mediated soil leachate (collected after 15 days) exhibited strong phytotoxicity to I. axillaris despite the level of phenolic compounds in the decomposed leachate being decreased significantly compared with their initial level. This suggests the presence of other unidentified allelochemicals that individually or synergistically contributed to the phytotoxicity. Further, the dose response phytotoxic impacts exhibited by the boneseed litter-mediated soil to native X. bracteatum in a more naturalistic greenhouse experiment might ensure the potential allelopathy of other chemical compounds in the boneseed invasion. The reduction of leaf relative water content and chlorophyll level in X. bracteatum suggest possible mechanisms underpinning plant growth inhibition caused by boneseed litter allelopathy. The presence of a substantial quantity of free proline in the target species also suggests that the plant was in a stressed condition due to litter allelopathy. These findings are important for better understanding the invasive potential of boneseed and in devising control strategies.	[Al Harun, Md Abdullah Yousuf; Johnson, Joshua; Uddin, Md Nazim; Robinson, Randall W.] Victoria Univ, Coll Engn & Sci, Inst Sustainabil & Innovat, Melbourne, Vic 8001, Australia	Victoria University	Al Harun, MAY (corresponding author), Victoria Univ, Coll Engn & Sci, Inst Sustainabil & Innovat, Melbourne, Vic 8001, Australia.	mdabdullah.harun@live.vu.edu.au	Uddin, Nazim/AAX-1718-2020	Robinson, Randall/0000-0001-8425-0709; Johnson, Joshua/0000-0003-0000-5226; Uddin, Md. Nazim/0000-0002-7904-4115	Victoria University	Victoria University	There is no external funding source for this research, however, it is supported by the Victoria University internal research funds for postgraduate research students. The authors have duly acknowledged Victoria University in Acknowledgments section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins Stephen W., 1996, Plant Protection Quarterly, V11, P20; Al Harun MAY, 2015, J ENVIRON SCI, V33, P1, DOI 10.1016/j.jes.2014.12.017; Al Harun MAY, 2014, S AFR J BOT, V93, P157, DOI 10.1016/j.sajb.2014.04.008; Aranda E, 2006, INT BIODETER BIODEGR, V58, P176, DOI 10.1016/j.ibiod.2006.06.006; Bais HP, 2003, SCIENCE, V301, P1377, DOI 10.1126/science.1083245; Balasundram N, 2006, FOOD CHEM, V99, P191, DOI 10.1016/j.foodchem.2005.07.042; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Batish DR, 2006, PLANT PHYSIOL BIOCH, V44, P819, DOI 10.1016/j.plaphy.2006.10.014; Baziramakenga R, 1997, CAN J BOT, V75, P445, DOI 10.1139/b97-047; Bertin C, 2009, J CHEM ECOL, V35, P1288, DOI 10.1007/s10886-009-9707-4; Blum U, 1999, CRIT REV PLANT SCI, V18, P673, DOI 10.1016/S0735-2689(99)00396-2; BLUM U, 1988, SOIL BIOL BIOCHEM, V20, P793, DOI 10.1016/0038-0717(88)90084-3; Blum U, 2011, PLANT-PLANT ALLELOPATHI INTERACTIONS: PHENOLIC ACIDS, COVER CROPS AND WEED EMERGENCE, P1, DOI 10.1007/978-94-007-0683-5; Blum U., 2014, PLANT PLANT ALLELOPA, V1st; Blum U, 2006, J CHEM ECOL, V32, P1817, DOI 10.1007/s10886-006-9111-2; Brougham K.J., 2006, BONESEED MANAGEMENT; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Delfine S, 2005, AGR ECOSYST ENVIRON, V106, P243, DOI 10.1016/j.agee.2004.10.012; Department of Environment Conservation, 2006, NSW THREAT AB PLAN I; DUKE SO, 1987, WEED TECHNOL, V1, P122, DOI 10.1017/S0890037X00029304; Ens EJ, 2009, BIOL INVASIONS, V11, P275, DOI 10.1007/s10530-008-9232-3; Fu YZ, 2002, ADV ENVIRON RES, V7, P239, DOI 10.1016/S1093-0191(01)00123-X; Gallardo-Williams MT, 2002, PHYTOCHEMISTRY, V59, P305, DOI 10.1016/S0031-9422(01)00449-6; Hierro JL, 2003, PLANT SOIL, V256, P29, DOI 10.1023/A:1026208327014; Hossain MB, 2010, J AGR FOOD CHEM, V58, P10576, DOI 10.1021/jf102042g; INDERJIT, 1995, BOT REV, V61, P28, DOI 10.1007/BF02897150; INDERJIT, 1994, AM J BOT, V81, P799, DOI 10.2307/2445760; Inderjit, 2003, PLANTA, V217, P529, DOI 10.1007/s00425-003-1054-z; Inderjit, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002536; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Janas KM, 2000, PLANT PHYSIOL BIOCH, V38, P587, DOI 10.1016/S0981-9428(00)00778-6; Jefferson LV, 2003, J ARID ENVIRON, V55, P275, DOI 10.1016/S0140-1963(03)00028-4; Jiang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062315; Ju ZY, 2003, J AGR FOOD CHEM, V51, P5207, DOI 10.1021/jf0302106; Koitabashi R, 1997, J PLANT RES, V110, P1, DOI 10.1007/BF02506836; Lane D, 1978, P 1 C COUNC AUSTR WE; Li ZH, 2010, MOLECULES, V15, P8933, DOI 10.3390/molecules15128933; Lin YC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054466, 10.1371/journal.pone.0069722]; Lindsay EA, 2005, J APPL ECOL, V42, P556, DOI 10.1111/j.1365-2664.2005.01036.x; McAlpine KG, 2009, NEW ZEAL J ECOL, V33, P72; Melland R.L., 2009, THESIS U ADELAIDE; MICHELSEN A, 1995, OECOLOGIA, V103, P407, DOI 10.1007/BF00328678; Northup RR, 1998, BIOGEOCHEMISTRY, V42, P189, DOI 10.1023/A:1005991908504; Parsons W.T., 1973, NOXIOUS WEEDS VICTOR; Rashid MH, 2010, WEED SCI, V58, P47, DOI 10.1614/WS-09-106.1; RASMUSSEN JA, 1977, J CHEM ECOL, V3, P197, DOI 10.1007/BF00994146; Reigosa MJ, 1999, PLANT GROWTH REGUL, V28, P83, DOI 10.1023/A:1006269716762; Rice EL, 1984, ALLELOPATHY; Roberts David, 2008, Plant Protection Quarterly, V23, P51; Romeo JT, 1998, METHODS CHEM ECOLOGY, V2, P179; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Saura-Mas S, 2007, ANN BOT-LONDON, V99, P545, DOI 10.1093/aob/mcl284; Sharif N., 2014, International Journal of Agricultural Technology, V10, P1231; Simoes K, 2008, J CHEM ECOL, V34, P681, DOI 10.1007/s10886-008-9443-1; Singh HP, 2002, ANN APPL BIOL, V141, P111, DOI 10.1111/j.1744-7348.2002.tb00202.x; Souto XC, 2000, J CHEM ECOL, V26, P2025, DOI 10.1023/A:1005504029243; Uddin MN, 2014, J PLANT INTERACT, V9, P338, DOI 10.1080/17429145.2013.835879; Uddin MN, 2012, MAR FRESHWATER RES, V63, P777, DOI 10.1071/MF12071; VERNENGHI A, 1986, CAN J BOT, V64, P973, DOI 10.1139/b86-131; Vranjic JA, 2000, AUSTRAL ECOL, V25, P445, DOI 10.1046/j.1442-9993.2000.01086.x; Wang CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085162; Weidenhamer J, 2005, J CHEM ECOL, V31, P221, DOI 10.1007/s10886-005-1337-x; Weidenhamer JD, 2014, J CHEM ECOL, V40, P940, DOI 10.1007/s10886-014-0483-4; Grass MAY, 2012, J PLANT INTERACT, V7, P175, DOI 10.1080/17429145.2011.591504; Yang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094198; Yang WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067339; Yuan Y., 2012, J PLANT ECOL; Zhang JiangHong, 2007, Scientia Agricultura Sinica, V40, P492; Zhang JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093189; Zhou XG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048288; Zhu XZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025393	71	10	10	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139992	10.1371/journal.pone.0139992	http://dx.doi.org/10.1371/journal.pone.0139992			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465595	Green Published, Green Accepted, gold			2022-12-26	WOS:000363183100069
J	Lopez, MC; Leon, CM; Fonseca, J; Reyes, P; Moncada, L; Olivera, MJ; Ramirez, JD				Consuelo Lopez, Myriam; Leon, Cielo M.; Fonseca, Jairo; Reyes, Patricia; Moncada, Ligia; Olivera, Mario J.; David Ramirez, Juan			Molecular Epidemiology of Entamoeba: First Description of Entamoeba moshkovskii in a Rural Area from Central Colombia	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ANTIGEN-DETECTION; DISPAR; HISTOLYTICA; DIAGNOSIS; PCR; DIFFERENTIATION; INFECTIONS; AMEBIASIS; SPP.	Background Entamoeba histolytica, E. dispar and E. moshkovskii are the most frequent species described in human infection where E. histolytica is the only true pathogen. The epidemiology of this infection is complex due to the absence of a routine exam that allows a correct discrimination of the Entamoeba species complex. Therefore, molecular methods appear as the unique epidemiological tool to accomplish the species discrimination. Herein, we conducted a cross-sectional study to determine the frequency of Entamoeba species infections in a group of asymptomatic individuals from a rural area in central Colombia. Methodology/Principal Findings A total of 181 fecal samples from asymptomatic children under 16 years old from the hamlet La Virgen, Cundinamarca (Colombia) that voluntarily accepted to participate in the study were collected. The fecal samples were examined by light microscopy and DNA-extracted, subsequently submitted to molecular discrimination of E. dispar/E. histolytica/E. moshkovskii infection based on a multiplex PCR assay targeting the 18S rRNA fragment. To confirm the species description, twenty samples were randomly submitted to DNA sequencing of the aforementioned fragment. By direct microscopic examination, frequency of the complex E. histolytica/E. dispar/E. moshkovskii was 18.8%(34/181). PCR showed a frequency of 49.1% (89/181), discriminated as 23.2%(42/181) that were positive for E. dispar, 25.4% (46/181) for E. moshkovskii and 0.55% (1/181) for E. histolytica. Also, mixed infections were detected between E. dispar and E. moshkovskii at 4.42% (8/181) of the samples. Molecular barcoding confirmed the diagnosis depicted by the multiplex PCR assay. Conclusions/Significance This is the first description of E. moshkovskii in Colombia and the second report in South-America to our knowledge. Our results suggest the need to unravel the true epidemiology of Entamoeba infections around the world, including the real pathogenic role that E. moshkovskii may have.	[Consuelo Lopez, Myriam; Fonseca, Jairo; Reyes, Patricia; Moncada, Ligia] Univ Nacl Colombia, Fac Med, Dept Salud Publ, Bogota, Colombia; [Leon, Cielo M.; Olivera, Mario J.; David Ramirez, Juan] Univ Rosario, Fac Ciencias Nat & Matemat, Grp Invest Microbiol UR GIMUR, Bogota, Colombia	Universidad Nacional de Colombia; Universidad del Rosario	Ramirez, JD (corresponding author), Univ Rosario, Fac Ciencias Nat & Matemat, Grp Invest Microbiol UR GIMUR, Bogota, Colombia.	juand.ramirez@urosario.edu.co	Ramírez, Juan David/F-3524-2016	Ramírez, Juan David/0000-0002-1344-9312	Research Division Headquarters Bogota (DIB) from Universidad Nacional de Colombia [16395]	Research Division Headquarters Bogota (DIB) from Universidad Nacional de Colombia	This work was funded by the Research Division Headquarters Bogota (DIB) from Universidad Nacional de Colombia (code 16395).	ACUNASOTO R, 1993, AM J TROP MED HYG, V48, P58, DOI 10.4269/ajtmh.1993.48.58; Ali IKM, 2003, EMERG INFECT DIS, V9, P580, DOI 10.3201/eid0905.020548; Altman D.G., 2000, STAT CONFIDENCE, Vsecond; Anuar TS, 2013, J MICROBIOL METH, V92, P344, DOI 10.1016/j.mimet.2013.01.010; Bansal D, 2006, INDIAN J MED RES, V123, P115; BECK J. W., 1965, REV FAC MED BOGOTA, V33, P33; Beltramino JC, 2009, ARCH ARGENT PEDIATR, V107, P510, DOI 10.1590/S0325-00752009000600007; Benetton MLFN, 2005, T ROY SOC TROP MED H, V99, P532, DOI 10.1016/j.trstmh.2004.11.015; Mora AB, 2013, INVEST CLIN, V54, P373; Santos HLC, 2007, BRAZ J INFECT DIS, V11, P365, DOI 10.1590/S1413-86702007000300013; Santos HLC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-69; Santos HLC, 2010, PARASITOL RES, V106, P883, DOI 10.1007/s00436-010-1728-y; CLARK CG, 1991, MOL BIOCHEM PARASIT, V46, P11, DOI 10.1016/0166-6851(91)90194-B; Heredia RD, 2012, ACTA TROP, V123, P139, DOI 10.1016/j.actatropica.2012.05.012; DOOLEY CP, 1988, J CLIN GASTROENTEROL, V10, P339, DOI 10.1097/00004836-198806000-00022; Fontecha GA, 2015, EXP PARASITOL, V151, P80, DOI 10.1016/j.exppara.2015.02.003; Fotedar R, 2008, EUR J CLIN MICROBIOL, V27, P133, DOI 10.1007/s10096-007-0399-9; Fotedar R, 2007, CLIN MICROBIOL REV, V20, P511, DOI 10.1128/CMR.00004-07; Guzman C. E., 2001, Biomedica, V21, P167; Hamzah Z, 2006, J CLIN MICROBIOL, V44, P3196, DOI 10.1128/JCM.00778-06; Hanna RM, 2000, TROP MED INT HEALTH, V5, P578, DOI 10.1046/j.1365-3156.2000.00586.x; Haque Rashidul, 1998, Parasitology International, V47, P201, DOI 10.1016/S1383-5769(98)00020-8; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Khairnar K, 2007, J GASTROENTEROL, V42, P631, DOI 10.1007/s00535-007-2080-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau YL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-250; Leiva B, 2006, ARCH MED RES, V37, P529, DOI 10.1016/j.arcmed.2005.10.009; Levecke B, 2011, T ROY SOC TROP MED H, V105, P737, DOI 10.1016/j.trstmh.2011.08.010; Lopez OY, 2012, REV MED CHILE, V140, P476, DOI 10.4067/S0034-98872012000400008; Nair G, 2015, AM J TROP M IN PRESS; Parija SC, 2005, J HEALTH POPUL NUTR, V23, P292; Porras A, 2011, PERFIL EPIDEMIOLOGIC; Pritt BS, 2008, MAYO CLIN PROC, V83, P1154, DOI 10.4065/83.10.1154; Ramos F, 2005, EXP PARASITOL, V110, P327, DOI 10.1016/j.exppara.2005.03.015; Rivero Z, 2009, CAD SAUDE PUBLICA, V25, P151, DOI 10.1590/S0102-311X2009000100016; Samie A, 2006, AM J TROP MED HYG, V75, P565, DOI 10.4269/ajtmh.2006.75.565; Sharbatkhori Mitra, 2014, Gastroenterol Hepatol Bed Bench, V7, P164; Shimokawa C, 2012, J INFECT DIS, V206, P744, DOI 10.1093/infdis/jis414; Sierra C, 2012, PLAN DESARROLLO MUNI; Solaymani-Mohammadi S, 2006, J CLIN MICROBIOL, V44, P2258, DOI 10.1128/JCM.00530-06; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Stark D, 2008, J CLIN MICROBIOL, V46, P1678, DOI 10.1128/JCM.02261-07; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanyuksel M, 2007, AM J TROP MED HYG, V76, P723, DOI 10.4269/ajtmh.2007.76.723; WHO/PAHO/UNESCO, 1997, EPIDEMIOLOGICAL B, V18, P13; Ximenez C, 2009, INFECT GENET EVOL, V9, P1023, DOI 10.1016/j.meegid.2009.06.008	46	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140302	10.1371/journal.pone.0140302	http://dx.doi.org/10.1371/journal.pone.0140302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465744	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100102
J	Han, PK; Barker, JW; Kim, KH; Choi, SH; Bae, KT; Park, SH				Han, Paul Kyu; Barker, Jeffrey W.; Kim, Ki Hwan; Choi, Seung Hong; Bae, Kyongtae Ty; Park, Sung-Hong			Inter-Slice Blood Flow and Magnetization Transfer Effects as A New Simultaneous Imaging Strategy	PLOS ONE			English	Article							STATE FREE PRECESSION; WATER RESONANCE; MULTISLICE; BRAIN; COMPENSATION; ASYMMETRY; INVERSION	The recent blood flow and magnetization transfer (MT) technique termed alternate ascending/descending directional navigation (ALADDIN) achieves the contrast using interslice blood flow and MT effects with no separate preparation RF pulse, thereby potentially overcoming limitations of conventional methods. In this study, we examined the signal characteristics of ALADDIN as a simultaneous blood flow and MT imaging strategy, by comparing it with pseudo-continuous ASL (pCASL) and conventional MT asymmetry (MTA) methods, all of which had the same bSSFP readout. Bloch-equation simulations and experiments showed ALADDIN perfusion signals increased with flip angle, whereas MTA signals peaked at flip angle around 45 degrees-60 degrees. ALADDIN provided signals comparable to those of pCASL and conventional MTA methods emulating the first, second, and third prior slices of ALADDIN under the same scan conditions, suggesting ALADDIN signals to be superposition of signals from multiple labeling planes. The quantitative cerebral blood flow signals from a modified continuous ASL model overestimated the perfusion signals compared to those measured with a pulsed ASL method. Simultaneous mapping of blood flow, MTA, and MT ratio in the whole brain is feasible with ALADDIN within a clinically reasonable time, which can potentially help diagnosis of various diseases.	[Han, Paul Kyu; Kim, Ki Hwan; Park, Sung-Hong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Magnet Resonance Imaging Lab, Daejeon, South Korea; [Barker, Jeffrey W.; Bae, Kyongtae Ty; Park, Sung-Hong] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Barker, Jeffrey W.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Kim, Ki Hwan] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU)	Park, SH (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Magnet Resonance Imaging Lab, Daejeon, South Korea.	sunghongpark@kaist.ac.kr	Park, Sung-Hong/B-3393-2012	Park, Sung-Hong/0000-0002-1731-0668	National Research Foundation of Korea [NRF-2013R1A1A1061759, NRF-2013M3A9B2076548]; Competitive Medical Research Fund of the UPMC (University of Pittsburgh Medical Center) Health System	National Research Foundation of Korea(National Research Foundation of Korea); Competitive Medical Research Fund of the UPMC (University of Pittsburgh Medical Center) Health System	This work was supported by a grant from National Research Foundation of Korea (NRF-2013R1A1A1061759 and NRF-2013M3A9B2076548) and Competitive Medical Research Fund of the UPMC (University of Pittsburgh Medical Center) Health System.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Alsop DC, 1998, RADIOLOGY, V208, P410, DOI 10.1148/radiology.208.2.9680569; Barker JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117101; Bieri O, 2005, MAGNET RESON MED, V54, P129, DOI 10.1002/mrm.20527; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; DIXON WT, 1990, MAGN RESON IMAGING, V8, P417, DOI 10.1016/0730-725X(90)90050-C; EDELMAN RR, 1994, RADIOLOGY, V192, P513, DOI 10.1148/radiology.192.2.8029425; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Golay X, 1999, JMRI-J MAGN RESON IM, V9, P454, DOI 10.1002/(SICI)1522-2586(199903)9:3<454::AID-JMRI14>3.0.CO;2-B; Graham SJ, 1997, JMRI-J MAGN RESON IM, V7, P903, DOI 10.1002/jmri.1880070520; Hua J., 2007, P INT SOC MAGN RESON, P882; Hua J, 2007, MAGN RESON MED, V58, P786, DOI 10.1002/mrm.21387; Kim JW, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/565391; Kim JW, 2015, P ISMRM 23 ANN M TOR; Lee SL, 2015, P ISMRM 23 ANN M TOR, P1743; Luh WM, 1999, MAGNET RESON MED, V41, P1246, DOI 10.1002/(SICI)1522-2594(199906)41:6<1246::AID-MRM22>3.0.CO;2-N; Markl M, 2004, J MAGN RESON IMAGING, V20, P697, DOI 10.1002/jmri.20163; Markl M, 2003, MAGNET RESON MED, V50, P892, DOI 10.1002/mrm.10631; Martirosian P, 2004, MAGNET RESON MED, V51, P353, DOI 10.1002/mrm.10709; MELKI PS, 1992, MAGNET RESON MED, V24, P189, DOI 10.1002/mrm.1910240122; Ng MC, 2009, J MAGN RESON IMAGING, V29, P523, DOI 10.1002/jmri.21610; Park SH, 2012, P ISMRM 20 ANN M MEL, P1994; Park SH, 2015, KOREAN J RADIOL, V16, P550, DOI 10.3348/kjr.2015.16.3.550; Park SH, 2013, MAGN RESON IMAGING, V31, P1044, DOI 10.1016/j.mri.2013.03.024; Park SH, 2012, MAGN RESON MED, V68, P1600, DOI 10.1002/mrm.24169; Park SH, 2011, MAGN RESON MED, V65, P1578, DOI 10.1002/mrm.22580; Park SH, 2011, MAGN RESON MED, V65, P1702, DOI 10.1002/mrm.22568; Pekar J, 1996, MAGNET RESON MED, V35, P70, DOI 10.1002/mrm.1910350110; Sanders JA, 1995, FUNCTIONAL BRAIN IMA, P239; SANTYR GE, 1993, MAGN RESON IMAGING, V11, P521, DOI 10.1016/0730-725X(93)90471-O; Scheffler K, 2003, EUR RADIOL, V13, P2409, DOI 10.1007/s00330-003-1957-x; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Weigel M, 2010, MAGN RESON MED, V63, P230, DOI 10.1002/mrm.22145; WILLIAMS DM, 1987, INVEST RADIOL, V22, P642, DOI 10.1097/00004424-198708000-00005; Williams Donald S, 2006, Methods Mol Med, V124, P151; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wong EC, 1997, NMR BIOMED, V10, P237, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<237::AID-NBM475>3.0.CO;2-X; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403	39	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140560	10.1371/journal.pone.0140560	http://dx.doi.org/10.1371/journal.pone.0140560			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466316	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000363183100145
J	Taniguchi, DAA; Gagnon, Y; Wheeler, BR; Johnsen, S; Jaffe, JS				Taniguchi, Darcy A. A.; Gagnon, Yakir; Wheeler, Benjamin R.; Johnsen, Soenke; Jaffe, Jules S.			Cuttlefish Sepia officinalis Preferentially Respond to Bottom Rather than Side Stimuli When Not Allowed Adjacent to Tank Walls	PLOS ONE			English	Article							DISRUPTIVE COLORATION; VISUAL-PERCEPTION; CAMOUFLAGE; SUBSTRATE; CONTRAST; OBJECTS; SIZE	Cuttlefish are cephalopods capable of rapid camouflage responses to visual stimuli. However, it is not always clear to what these animals are responding. Previous studies have found cuttlefish to be more responsive to lateral stimuli rather than substrate. However, in previous works, the cuttlefish were allowed to settle next to the lateral stimuli. In this study, we examine whether juvenile cuttlefish (Sepia officinalis) respond more strongly to visual stimuli seen on the sides versus the bottom of an experimental aquarium, specifically when the animals are not allowed to be adjacent to the tank walls. We used the Sub Sea Holodeck, a novel aquarium that employs plasma display screens to create a variety of artificial visual environments without disturbing the animals. Once the cuttlefish were acclimated, we compared the variability of camouflage patterns that were elicited from displaying various stimuli on the bottom versus the sides of the Holodeck. To characterize the camouflage patterns, we classified them in terms of uniform, disruptive, and mottled patterning. The elicited camouflage patterns from different bottom stimuli were more variable than those elicited by different side stimuli, suggesting that S. officinalis responds more strongly to the patterns displayed on the bottom than the sides of the tank. We argue that the cuttlefish pay more attention to the bottom of the Holodeck because it is closer and thus more relevant for camouflage.	[Taniguchi, Darcy A. A.; Jaffe, Jules S.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Gagnon, Yakir; Wheeler, Benjamin R.; Johnsen, Soenke] Duke Univ, Dept Biol, Durham, NC 27708 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Duke University	Taniguchi, DAA (corresponding author), MIT, Earth Atmospher & Planetary Sci, Cambridge, MA 02142 USA.	datanigu@mit.edu	Gagnon, Yakir/C-2665-2008	Gagnon, Yakir/0000-0003-2512-4520	Office of Naval Research [N00014-09-1-1053]	Office of Naval Research(Office of Naval Research)	The funding for this work came from the Office of Naval Research, grant number N00014-09-1- 1053. The URL for the Office of Naval Research is (http://www.onr.navy.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JJ, 2010, P R SOC B, V277, P1031, DOI 10.1098/rspb.2009.1694; Barbosa A, 2004, BIOL BULL-US, V207, P154, DOI 10.1086/BBLv207n2p154; Barbosa A, 2008, VISION RES, V48, P1242, DOI 10.1016/j.visres.2008.02.011; Barbosa A, 2008, J COMP PHYSIOL A, V194, P405, DOI 10.1007/s00359-007-0311-1; Barbosa A, 2007, J EXP BIOL, V210, P1139, DOI 10.1242/jeb.02741; Barbosa A, 2012, P ROY SOC B-BIOL SCI, V279, P84, DOI 10.1098/rspb.2011.0196; BULLOCK TH, 1991, J COMP PHYSIOL A, V168, P141, DOI 10.1007/BF00217112; Buresch KC, 2011, VISION RES, V51, P2362, DOI 10.1016/j.visres.2011.09.009; Chiao CC, 2005, BIOL BULL-US, V208, P7, DOI 10.2307/3593095; Chiao CC, 2001, BIOL BULL, V201, P269, DOI 10.2307/1543359; Chiao CC, 2001, J EXP BIOL, V204, P2119; Chiao CC, 2009, VISION RES, V49, P1647, DOI 10.1016/j.visres.2009.04.002; Chlao CC, 2007, VISION RES, V47, P2223, DOI 10.1016/j.visres.2007.05.001; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; HANLON RT, 1988, PHILOS T ROY SOC B, V320, P437, DOI 10.1098/rstb.1988.0087; Hanlon RT, 1996, CEPHALOPOD BEHAV; Jaffe JS, 2011, OCEANS, V6; Kelman EJ, 2008, J EXP BIOL, V211, P1757, DOI 10.1242/jeb.015149; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mathger LM, 2007, J EXP BIOL, V210, P2657, DOI 10.1242/jeb.004382; Mathger LM, 2006, VISION RES, V46, P1746, DOI 10.1016/j.visres.2005.09.035; MUNTZ WRA, 1989, J EXP BIOL, V142, P461; Shohet AJ, 2006, J EXP BIOL, V209, P4717, DOI 10.1242/jeb.02580; Shohet A, 2007, BIOL J LINN SOC, V92, P335, DOI 10.1111/j.1095-8312.2007.00842.x; Ulmer KM, 2013, BIOL BULL-US, V224, P110, DOI 10.1086/BBLv224n2p110	25	1	1	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138690	10.1371/journal.pone.0138690	http://dx.doi.org/10.1371/journal.pone.0138690			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465786	Green Published, gold			2022-12-26	WOS:000363183100022
J	Close, H; Mason, JM; Wilson, DW; Hungin, APS; Jones, R; Rubin, G				Close, Helen; Mason, James M.; Wilson, Douglas W.; Hungin, A. Pali S.; Jones, Roger; Rubin, Greg			Risk of Ischaemic Heart Disease in Patients with Inflammatory Bowel Disease: Cohort Study Using the General Practice Research Database	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; ULCERATIVE-COLITIS; MANAGEMENT; CYTOKINES	Objective Patients with inflammatory bowel disease (IBD) demonstrate an inflammatory response which bears some similarities to that seen in ischaemic heart disease (IHD). The nature of the association of IBD with IHD is uncertain. We aimed to define the extent and direction of that association. Design This retrospective cohort study examined records from patients aged >= 15 years with IBD from 1987-2009 (n = 19163) who were age and gender matched with patients without IBD (n = 75735) using the General Practice Research Database. The primary outcome was the hazard ratio for IHD. Results A higher proportion of IBD patients had a recorded diagnosis of IHD ever, 2220 (11.6%) compared with 6504 (8.6%) of controls. However, the majority (4494, 51.5%) developed IHD prior to IBD diagnosis (1404 (63.2%) of IBD cases and 3090 (47.5%) of controls). There was increased IHD incidence in the first year after IBD diagnosis. Mean age at IHD diagnosis was statistically similar across all IBD groups apart from for those with Ulcerative Colitis (UC) who were slightly younger at diagnosis of angina compared to controls (64.5y vs. 67.0y, p = 0.008) and coronary heart disease (65.7y vs. 67.9y, p = 0.015). Of those developing IHD following IBD diagnosis, UC patients were at higher risk of IHD (unadjusted HR 1.3 (95% CI 1.1-1.5), p<0.001) or MI (unadjusted HR 1.4 (95% CI 1.1-1.6), p = 0.004). Conclusion Although IHD prevalence was higher in IBD patients, most IHD diagnoses predated the diagnosis of IBD. This implies a more complex relationship than previously proposed between the inflammatory responses associated with IHD and IBD, and alternative models should be considered.	[Close, Helen; Mason, James M.; Wilson, Douglas W.; Hungin, A. Pali S.; Rubin, Greg] Univ Durham, Sch Med Pharm & Hlth, Stockton On Tees, England; [Jones, Roger] Kings Coll London, Dept Gen Practice & Primary Care, London WC2R 2LS, England	Durham University; University of London; King's College London	Rubin, G (corresponding author), Univ Durham, Sch Med Pharm & Hlth, Stockton On Tees, England.	g.p.rubin@durham.ac.uk	Mason, James M/D-9904-2011	Mason, James M/0000-0001-9210-4082; hungin, amritpal Pali/0000-0001-7275-8927	Northern and Yorkshire Research Network [108]	Northern and Yorkshire Research Network	This study was funded by the Northern and Yorkshire Research Network (grant no. 108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cassinotti A, 2014, AUTOIMMUN REV, V13, P1, DOI 10.1016/j.autrev.2013.06.007; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Daly C, 2006, CIRCULATION, V113, P490, DOI 10.1161/CIRCULATIONAHA.105.561647; Konno S, 2004, J GASTROENTEROL, V39, P931, DOI 10.1007/s00535-004-1423-9; Krueger JG, 2005, ANN RHEUM DIS, V64, P30, DOI 10.1136/ard.2004.031120; Lewis JD, 2002, PHARMACOEPIDEM DR S, V11, P211, DOI 10.1002/pds.698; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Osterman MT, 2011, CLIN GASTROENTEROL H, V9, P875, DOI 10.1016/j.cgh.2011.06.032; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Rubin GP, 2000, ALIMENT PHARM THER, V14, P1553, DOI 10.1046/j.1365-2036.2000.00886.x; Rungoe C, 2013, GUT, V62, P689, DOI 10.1136/gutjnl-2012-303285; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Sodergren A, 2007, ANN RHEUM DIS, V66, P263, DOI 10.1136/ard.2006.052456; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Tannen RL, 2007, J CLIN EPIDEMIOL, V60, P686, DOI 10.1016/j.jclinepi.2006.10.012; Vavricka SR, 2012, INFLAMM BOWEL DIS, V18, P496, DOI 10.1002/ibd.21719; Zezos P, 2005, WORLD J GASTROENTERO, V11, P7639, DOI 10.3748/wjg.v11.i48.7639	20	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139745	10.1371/journal.pone.0139745	http://dx.doi.org/10.1371/journal.pone.0139745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461954	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000362962300024
J	Thys, RG; Wang, YH				Thys, Ryan Griffin; Wang, Yuh-Hwa			DNA Replication Dynamics of the GGGGCC Repeat of the C9orf72 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); DNA; DNA replication; DNA structure; genomic instability	ORIENTATION-DEPENDENT INSTABILITY; TRINUCLEOTIDE REPEATS; HEXANUCLEOTIDE REPEAT; LEADING-STRAND; CGG REPEATS; EXPANSION; STABILITY; FRAGILITY; DELETION; EXHIBIT	DNA has the ability to form a variety of secondary structures in addition to the normal B-form DNA, including hairpins and quadruplexes. These structures are implicated in a number of neurological diseases and cancer. Expansion of a GGGGCC repeat located at C9orf72 is associated with familial amyotrophic lateral sclerosis and frontotemporal dementia. This repeat expands from two to 24 copies in normal individuals to several hundreds or thousands of repeats in individuals with the disease. Biochemical studies have demonstrated that as little as four repeats have the ability to form a stable DNA secondary structure known as a G-quadruplex. Quadruplex structures have the ability to disrupt normal DNA processes such as DNA replication and transcription. Here we examine the role of GGGGCC repeat length and orientation on DNA replication using an SV40 replication system in human cells. Replication through GGGGCC repeats leads to a decrease in overall replication efficiency and an increase in instability in a length-dependent manner. Both repeat expansions and contractions are observed, and replication orientation is found to influence the propensity for expansions or contractions. The presence of replication stress, such as low-dose aphidicolin, diminishes replication efficiency but has no effect on instability. Two-dimensional gel electrophoresis analysis demonstrates a replication stall with as few as 20 GGGGCC repeats. These results suggest that replication of the GGGGCC repeat at C9orf72 is perturbed by the presence of expanded repeats, which has the potential to result in further expansion, leading to disease.	[Thys, Ryan Griffin; Wang, Yuh-Hwa] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Wang, YH (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, 1340 Jefferson Pk Ave, Charlottesville, VA USA.	yw4b@virginia.edu	Regan, Clinton/E-6250-2012	Thys, Ryan/0000-0003-2030-1946	National Institutes of Health [R01GM101192]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R01GM101192 (to Y. H. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Balakumaran BS, 2000, HUM MOL GENET, V9, P93, DOI 10.1093/hmg/9.1.93; Burrow AA, 2010, NUCLEIC ACIDS RES, V38, P2865, DOI 10.1093/nar/gkp1245; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Cleary JD, 2002, NAT GENET, V31, P37, DOI 10.1038/ng870; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Edamura KN, 2005, AM J HUM GENET, V76, P302, DOI 10.1086/427928; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; GACY AM, 1995, CELL, V81, P533; Gerhardt J, 2014, J CELL BIOL, V206, P599, DOI 10.1083/jcb.201404157; Gerhardt J, 2014, MOL CELL, V53, P19, DOI 10.1016/j.molcel.2013.10.029; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hirst MC, 1998, NUCLEIC ACIDS RES, V26, P2353, DOI 10.1093/nar/26.10.2353; Iyer RR, 1999, J BIOL CHEM, V274, P3865, DOI 10.1074/jbc.274.6.3865; Kim JC, 2013, CURR OPIN GENET DEV, V23, P280, DOI 10.1016/j.gde.2013.04.009; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Metzgar D, 2002, GENOME RES, V12, P408, DOI 10.1101/gr.198602; Mirkin SM, 2002, NAT GENET, V31, P5, DOI 10.1038/ng0502-5; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Pearson CE, 1998, NUCLEIC ACIDS RES, V26, P816, DOI 10.1093/nar/26.3.816; Pelletier R, 2003, MOL CELL BIOL, V23, P1349, DOI 10.1128/MCB.23.4.1349-1357.2003; Petruska J, 1996, NUCLEIC ACIDS RES, V24, P1992, DOI 10.1093/nar/24.11.1992; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Rajeswari MR, 2012, J BIOSCIENCES, V37, P519, DOI 10.1007/s12038-012-9219-1; Reddy K, 2014, NUCLEIC ACIDS RES, V42, P10473, DOI 10.1093/nar/gku658; Reddy K, 2013, J BIOL CHEM, V288, P9860, DOI 10.1074/jbc.C113.452532; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rutherford NJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.005; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; Schiavone D, 2014, EMBO J, V33, P2507, DOI 10.15252/embj.201488398; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; Voineagu I, 2009, NAT STRUCT MOL BIOL, V16, P226, DOI 10.1038/nsmb.1527; White PJ, 1999, MOL CELL BIOL, V19, P5675	34	19	21	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28953	28962		10.1074/jbc.M115.660324	http://dx.doi.org/10.1074/jbc.M115.660324			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26463209	Green Published, hybrid			2022-12-26	WOS:000365762300034
J	Gabdoulline, R; Kaisers, W; Gaspar, A; Meganathan, K; Doss, MX; Jagtap, S; Hescheler, J; Sachinidis, A; Schwender, H				Gabdoulline, R.; Kaisers, W.; Gaspar, A.; Meganathan, K.; Doss, M. X.; Jagtap, S.; Hescheler, J.; Sachinidis, A.; Schwender, H.			Differences in the Early Development of Human and Mouse Embryonic Stem Cells	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; DATABASE; PLURIPOTENT; PROFILES	We performed a systematic analysis of gene expression features in early (10-21 days) development of human vs mouse embryonic cells (hESCs vs mESCs). Many development features were found to be conserved, and a majority of differentially regulated genes have similar expression change in both organisms. The similarity is especially evident, when gene expression profiles are clustered together and properties of clustered groups of genes are compared. First 10 days of mESC development match the features of hESC development within 21 days, in accordance with the differences in population doubling time in human and mouse ESCs. At the same time, several important differences are seen. There is a clear difference in initial expression change of transcription factors and stimulus responsive genes, which may be caused by the difference in experimental procedures. However, we also found that some biological processes develop differently; this can clearly be shown, for example, for neuron and sensory organ development. Some groups of genes show peaks of the expression levels during the development and these peaks cannot be claimed to happen at the same time points in the two organisms, as well as for the same groups of (orthologous) genes. We also detected a larger number of upregulated genes during development of mESCs as compared to hESCs. The differences were quantified by comparing promoters of related genes. Most of gene groups behave similarly and have similar transcription factor (TF) binding sites on their promoters. A few groups of genes have similar promoters, but are expressed differently in two species. Interestingly, there are groups of genes expressed similarly, although they have different promoters, which can be shown by comparing their TF binding sites. Namely, a large group of similarly expressed cell cycle-related genes is found to have discrepant TF binding properties in mouse vs human.	[Gabdoulline, R.; Kaisers, W.; Schwender, H.] Univ Dusseldorf, Biol Med Res Ctr, Ctr Bioinformat & Biostat, D-40225 Dusseldorf, Germany; [Gaspar, A.; Meganathan, K.; Doss, M. X.; Jagtap, S.; Hescheler, J.; Sachinidis, A.] Univ Cologne, Ctr Physiol & Pathophysiol, Inst Neurophysiol, D-50931 Cologne, Germany; [Gaspar, A.; Meganathan, K.; Doss, M. X.; Jagtap, S.; Hescheler, J.; Sachinidis, A.] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Schwender, H.] Univ Dusseldorf, Math Inst, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; University of Cologne; University of Cologne; Heinrich Heine University Dusseldorf	Gabdoulline, R (corresponding author), Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Carl Neuberg Str 1, D-30625 Hannover, Germany.	razif.gabdoulline@gmail.com	Sachinidis, Agapios/AAM-7988-2020; Sachinidis, Agapios/AAD-4178-2020; Jesudoss, Michael Xavier Doss/D-1983-2015	Gabdoulline, Razif/0000-0002-4780-1134; Jesudoss, Michael Xavier Doss/0000-0001-6339-9782	Deutsche Forschungsgemeinschaft [SCHW 1508/3-1]; SysDT, Bundesministerium fur Bildung und Forschung; "Fit for Excellence" initiative, Heinrich Heine University Dusseldorf	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SysDT, Bundesministerium fur Bildung und Forschung; "Fit for Excellence" initiative, Heinrich Heine University Dusseldorf	This work was supported by SCHW 1508/3-1 to HS, Deutsche Forschungsgemeinschaft, http://www.dfg.de/; SysDT to AS, Bundesministerium fur Bildung und Forschung, http://www.bmbf.de/; "Fit for Excellence" initiative to RG, Heinrich Heine University Dusseldorf, http://www.hhu.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Cai J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000707; Fisher R. A., 1915, BIOMETRIKA, P507, DOI DOI 10.2307/2331838; Gaspar JA, 2012, STEM CELLS DEV, V21, P2471, DOI 10.1089/scd.2011.0637; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Grskovic M, 2007, PLOS GENET, V3, P1524, DOI 10.1371/journal.pgen.0030145; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUANG XQ, 1992, COMPUT APPL BIOSCI, V8, P155; Hunt RW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-472; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kel A, 2008, SAR QSAR ENVIRON RES, V19, P481, DOI 10.1080/10629360802083806; Lee KC, 2013, BIOMEDICINES, V1, P49, DOI 10.3390/biomedicines1010049; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Meganathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044228; Qin ZS, 2006, BIOINFORMATICS, V22, P1988, DOI 10.1093/bioinformatics/btl284; Robasky K, 2011, NUCLEIC ACIDS RES, V39, pD124, DOI 10.1093/nar/gkq992; Roider HG, 2009, NUCLEIC ACIDS RES, V37, P6305, DOI 10.1093/nar/gkp682; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Schnerch A, 2010, STEM CELLS, V28, P419, DOI 10.1002/stem.298; Stegmaier P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017738; Sun Y, 2007, GENOMICS, V89, P22, DOI 10.1016/j.ygeno.2006.09.010; Sun Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003406; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wingender E, 2013, NUCLEIC ACIDS RES, V41, pD165, DOI 10.1093/nar/gks1123; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Xie D, 2010, GENOME RES, V20, P804, DOI 10.1101/gr.100594.109; Xing Y, 2007, MOL BIOL EVOL, V24, P1283, DOI 10.1093/molbev/msm061	29	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140803	10.1371/journal.pone.0140803	http://dx.doi.org/10.1371/journal.pone.0140803			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473594	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500116
J	Guma, M; Wang, Y; Viollet, B; Ru, LB				Guma, Monica; Wang, Yun; Viollet, Benoit; Ru Liu-Bryan			AMPK Activation by A-769662 Controls IL-6 Expression in Inflammatory Arthritis	PLOS ONE			English	Article							NF-KAPPA-B; INSULIN-RESISTANCE; TNF; INHIBITION; RELEVANCE; CANCER; CELLS	Objective AMP-activated protein kinase (AMPK) is a serine/threonine protein kinase critically involved in the regulation of cellular energy homeostasis. It is a central regulator of both lipid and glucose metabolism. Many studies have suggested that AMPK activation exert significant anti-inflammatory and immunosuppressive effects. In this study, we assessed whether targeted activation of AMPK inhibits inflammatory arthritis in vivo. Methods We tested the effect of A-769662, a specific AMPK agonist (60mg/kg/bid) in mouse models of antigen-induced arthritis (AIA) and passive K/BxN serum-induced arthritis. The passive K/BxN serum-induced arthritis model was also applied to AMPK alpha 1-deficient mice. Joints were harvested and subjected to histological analysis. IL-6 expression was measured in both joint tissues and sera by ELISA. The effect of A-769662 on bone marrow derived macrophage (BMDM) response to stimulation with TLR2 and TLR4 agonists was tested in vitro. Results AMPK activation by A-769662 reduced inflammatory infiltration and joint damage in both mouse models. IL-6 expression in serum and arthritic joints was significantly decreased in A-769662-treated mice. AMPK alpha 1 deficient mice mildly elicited an increase of clinical arthritis. IL-6 expression at both mRNA and protein levels, phosphorylation of p65 NF-kappa B and MAPK phosphorylation were inhibited by A-769662 in BMDMs stimulated with either TLR2 or TLR4 agonists. Conclusions AMPK activation by specific AMPK agonist A-769662 suppressed inflammatory arthritis in mice as well as IL-6 expression in serum and arthritic joints. These data suggest that targeted activation of AMPK has a potential to be an effective therapeutic strategy for IL-6 dependent inflammatory arthritis.	[Guma, Monica; Wang, Yun; Ru Liu-Bryan] Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA; [Viollet, Benoit] INSERM, Inst Cochin, U1016, Paris, France; [Viollet, Benoit] CNRS, UMR8104, Paris, France; [Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Ru Liu-Bryan] VA San Diego Healthcare Syst, La Jolla, CA USA	University of California System; University of California San Diego; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Guma, M (corresponding author), Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA.	mguma@ucsd.edu; ruliu@ucsd.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; guma, monica/0000-0003-1951-9411; wang, yun/0000-0002-4346-0096	National Institutes of Health [K08AR064834, T32AR06419, AR106796]; Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR064834, T32AR064194] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institutes of Health [K08AR064834 (MG); T32AR06419 (YW); AR106796 (RLB)] and Arthritis Foundation [http://www.arthritis.org (RLB)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai AP, 2010, J PHARMACOL EXP THER, V333, P717, DOI 10.1124/jpet.109.164954; Benziane B, 2009, AM J PHYSIOL-CELL PH, V297, pC1554, DOI 10.1152/ajpcell.00010.2009; Christianson CA, 2012, METHODS MOL BIOL, V851, P249, DOI 10.1007/978-1-61779-561-9_19; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Ding CH, 2009, EXPERT OPIN INV DRUG, V18, P1457, DOI 10.1517/13543780903203789; Ferraz-Amaro I, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/710928; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Geyer M, 2010, CURR OPIN RHEUMATOL, V22, P246, DOI 10.1097/BOR.0b013e3283373fa0; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Green CJ, 2011, BIOCHEM J, V435, P463, DOI 10.1042/BJ20101517; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Hammaker D, 2003, ANN RHEUM DIS, V62, P86; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Kang KY, 2013, INT IMMUNOPHARMACOL, V16, P85, DOI 10.1016/j.intimp.2013.03.020; Kim YD, 2012, DIABETOLOGIA, V55, P1482, DOI 10.1007/s00125-012-2494-4; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Muller-Ladner Ulf, 2002, Curr Rheumatol Rep, V4, P201, DOI 10.1007/s11926-002-0066-1; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Prasad R, 2006, J NEUROSCI RES, V84, P614, DOI 10.1002/jnr.20953; Richards PJ, 1999, RHEUMATOLOGY, V38, P818, DOI 10.1093/rheumatology/38.9.818; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Salt IP, 2012, EXPERT OPIN INV DRUG, V21, P1155, DOI 10.1517/13543784.2012.696609; Sethi G, 2009, ADV EXP MED BIOL, V647, P37, DOI 10.1007/978-0-387-89520-8_3; Simmonds RE, 2008, RHEUMATOLOGY, V47, P584, DOI 10.1093/rheumatology/kem298; Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Treebak JT, 2009, AM J PHYSIOL-CELL PH, V297, pC1041, DOI 10.1152/ajpcell.00051.2009; Vincent EE, 2014, ONCOGENE; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yusof MYM, 2013, DRUGS, V73, P341, DOI 10.1007/s40265-013-0018-2; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008	37	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140452	10.1371/journal.pone.0140452	http://dx.doi.org/10.1371/journal.pone.0140452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474486	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500053
J	Singh, B; Owens, KM; Bajpai, P; Desouki, MM; Srinivasasainagendra, V; Tiwari, HK; Singh, KK				Singh, Bhupendra; Owens, Kjerstin M.; Bajpai, Prachi; Desouki, Mohamed Mokhtar; Srinivasasainagendra, Vinodh; Tiwari, Hemant K.; Singh, Keshav K.			Mitochondrial DNA Polymerase POLG1 Disease Mutations and Germline Variants Promote Tumorigenic Properties	PLOS ONE			English	Article							COPY-NUMBER; HUMAN CANCERS; SYNONYMOUS MUTATIONS; DRIVER MUTATIONS; MTDNA DEPLETION; ALPERS-SYNDROME; BREAST-CANCER; KINASE GENE; CROSS-TALK; GAMMA	Germline mutations in mitochondrial DNA polymerase gamma (POLG1) induce mitochondrial DNA (mtDNA) mutations, depletion, and decrease oxidative phosphorylation. Earlier, we identified somatic mutations in POLG1 and the contribution of these mutations in human cancer. However, a role for germline variations in POLG1 in human cancers is unknown. In this study, we examined a role for disease associated germline variants of POLG1, POLG1 gene expression, copy number variation and regulation in human cancers. We analyzed the mutations, expression and copy number variation in POLG1 in several cancer databases and validated the analyses in primary breast tumors and breast cancer cell lines. We discovered 5-aza-2'-deoxycytidine led epigenetic regulation of POLG1, mtDNA-encoded genes and increased mitochondrial respiration. We conducted comprehensive race based bioinformatics analyses of POLG1 gene in more than 33,000 European-Americans and 5,000 African-Americans. We identified a mitochondrial disease causing missense variation in polymerase domain of POLG1 protein at amino acid 1143 (E1143G) to be 25 times more prevalent in European-Americans (allele frequency 0.03777) when compared to African-American (allele frequency 0.00151) population. We identified T251I and P587L missense variations in exonuclease and linker region of POLG1 also to be more prevalent in European-Americans. Expression of these variants increased glucose consumption, decreased ATP production and increased matrigel invasion. Interestingly, conditional expression of these variants revealed that matrigel invasion properties conferred by these germline variants were reversible suggesting a role of epigenetic regulators. Indeed, we identified a set of miRNA whose expression was reversible after variant expression was turned off. Together, our studies demonstrate altered genetic and epigenetic regulation of POLG1 in human cancers and suggest a role for POLG1 germline variants in promoting tumorigenic properties.	[Singh, Bhupendra; Bajpai, Prachi; Singh, Keshav K.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Owens, Kjerstin M.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Desouki, Mohamed Mokhtar] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Srinivasasainagendra, Vinodh; Tiwari, Hemant K.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Dept Environm Hlth, Birmingham, AL USA; [Singh, Keshav K.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL USA; [Singh, Keshav K.] Univ Alabama Birmingham, Ctr Aging, Birmingham, AL USA; [Singh, Keshav K.] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL USA; [Singh, Keshav K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Roswell Park Cancer Institute; Vanderbilt University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Singh, KK (corresponding author), Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA.	kksingh@uab.edu		Owens, Kjerstin/0000-0001-5210-319X	Veterans Administration [1I01BX001716]; NIH [R21 5R21CA176054]; NATIONAL CANCER INSTITUTE [R21CA176054] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001716] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by grants from Veterans Administration 1I01BX001716 and NIH R21 5R21CA176054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2005, ARCH PATHOL LAB MED, V129, P1295; Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007; Chornokur G, 2011, PROSTATE, V71, P985, DOI 10.1002/pros.21314; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Copeland WC, 2010, SUBCELL BIOCHEM, V50, P211, DOI 10.1007/978-90-481-3471-7_11; Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; DeSantis C, 2013, CA-CANCER J CLIN, V63, P151, DOI 10.3322/caac.21173; Desouki MM, 2005, CANCER BIOL THER, V4, P1367, DOI 10.4161/cbt.4.12.2233; Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548; Hosnijeh FS, 2014, BLOOD, V124, P530, DOI 10.1182/blood-2013-10-532085; Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233; Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913; Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770; Koochekpour S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074688; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee W, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.34; Linkowska K, 2015, ANN HUM GENET; Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029; Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196; Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Mito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055789; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; MORAES CT, 1991, AM J HUM GENET, V48, P492; Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079; Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70; Osella M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00345; Owens KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023846; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Posada IJ, 2010, MED CLIN-BARCELONA, V135, P452, DOI 10.1016/j.medcli.2010.03.031; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207; Selvanayagam P, 1996, LAB INVEST, V74, P592; Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71; Singh KK, 2005, GENE, V354, P140, DOI 10.1016/j.gene.2005.03.027; Singh KK, 2001, NUCLEIC ACIDS RES, V29, P1381, DOI 10.1093/nar/29.6.1381; Smiraglia DJ, 2008, CANCER BIOL THER, V7, P1182, DOI 10.4161/cbt.7.8.6215; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222; Tewari S, 2012, INVEST OPHTH VIS SCI, V53, P4881, DOI 10.1167/iovs.12-9732; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tsao J, 2010, METHODS MOL BIOL, V632, P73, DOI 10.1007/978-1-60761-663-4_5; Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83; WARBURG O, 1956, SCIENCE, V124, P269; Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	67	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0139846	10.1371/journal.pone.0139846	http://dx.doi.org/10.1371/journal.pone.0139846			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468652	Green Submitted, gold, Green Published			2022-12-26	WOS:000363184600020
J	Cho, EH; Hur, J; Lee, KJ				Cho, Eun-Hee; Hur, Junguk; Lee, Kyung-Ju			Early Gestational Weight Gain Rate and Adverse Pregnancy Outcomes in Korean Women	PLOS ONE			English	Article							BODY-MASS INDEX; RISK	During pregnancy, many women gain excessive weight, which is related to adverse maternal and neonatal outcomes. In this study, we evaluated whether rate of gestational weight gain (RGWG) in early, mid, and late pregnancy is strongly associated with adverse pregnancy outcomes. A retrospective chart review of 2,789 pregnant Korean women was performed. Weights were recorded at the first clinic visit, during the screening test for fetal anomaly, and during the 50g oral glucose challenge test and delivery, to represent early, mid, and late pregnancy, respectively. A multivariate logistic regression analysis was performed to examine the relationship between RGWG and adverse pregnancy outcomes. At early pregnancy, the RGWG was significantly associated with high risk of developing gestational diabetes mellitus (GDM), pregnancy-induced hypertension (PIH), large for gestational age (LGA) infants, macrosomia, and primary cesarean section (P-CS). The RGWG of mid pregnancy was not significantly associated with any adverse pregnancy outcomes. The RGWG at late pregnancy was significantly associated with a lower risk of developing GDM, preterm birth and P-CS, but with a higher risk of developing LGA infants and macrosomia. When the subjects were divided into three groups (Underweight, Normal, and Obese), based on pre-pregnancy body mass index (BMI), the relationship between early RGWG and adverse pregnancy outcomes was significantly different across the three BMI groups. At early pregnancy, RGWG was not significantly associated to adverse pregnancy outcomes for subjects in the Underweight group. In the Normal group, however, early RGWG was significantly associated with GDM, PIH, LGA infants, macrosomia, P-CS, and small for gestational weight (SGA) infants, whereas early RGWG was significantly associated with only a high risk of PIH in the Obese group. The results of our study suggest that early RGWG is significantly associated with various adverse pregnancy outcomes and that proper preemptive management of early weight gain, particularly in pregnant women with a normal or obese pre-pregnancy BMI, is necessary to reduce the risk of developing adverse pregnancy outcomes.	[Cho, Eun-Hee] Kangwon Natl Univ, Dept Internal Med, Kangwon Do, South Korea; [Hur, Junguk] Univ N Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA; [Lee, Kyung-Ju] CHA Univ, Kangnam CHA Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Kyung-Ju] Korea Univ, Coll Med, Integrat Med Ctr, Seoul 136705, South Korea	Kangwon National University; University of North Dakota Grand Forks; Pochon Cha University; Korea University; Korea University Medicine (KU Medicine)	Lee, KJ (corresponding author), CHA Univ, Kangnam CHA Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea.	drlkj52551@korea.ac.kr	Lee, Kyung Ju/AAH-1823-2022; Hur, Junguk/J-6229-2019; Lee, Kyung Ju/AFL-9687-2022	Hur, Junguk/0000-0002-0736-2149; Lee, Kyung Ju/0000-0003-4655-1521				Brown JE, 2002, AM J CLIN NUTR, V76, P205, DOI 10.1093/ajcn/76.1.205; Brunner S, 2015, DIABETOLOGIA, V58, P2229, DOI 10.1007/s00125-015-3686-5; Carreno CA, 2012, OBSTET GYNECOL, V119, P1227, DOI 10.1097/AOG.0b013e318256cf1a; Catov JM, 2015, OBESITY, V23, P1071, DOI 10.1002/oby.21006; Cedergren M, 2006, INT J GYNECOL OBSTET, V93, P269, DOI 10.1016/j.ijgo.2006.03.002; Faucher MA, 2015, WOMEN BIRTH, V28, pE70, DOI 10.1016/j.wombi.2015.03.006; Gesche J, 2015, INT J GYNECOL OBSTET, DOI [10.1016/j.ijgo.2014.12.013, DOI 10.1016/J.IJGO.2014.12.013]; Hedderson MM, 2010, OBSTET GYNECOL, V115, P597, DOI 10.1097/AOG.0b013e3181cfce4f; Herring SJ, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.01.039; Macdonald-Wallis C, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.042; Mourtakos SP, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0498-z; Schubring C, 1998, HORM RES, V50, P276, DOI 10.1159/000023290; Siega-Riz AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.002; Sommer C, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0512-5; Tsochandaridis M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/294954; VANRAAIJ JMA, 1988, AM J CLIN NUTR, V48, P24, DOI 10.1093/ajcn/48.1.24; Viswanathan M, 2008, EDUC ASIA PAC REG-IS, V12, P1, DOI 10.1007/978-1-4020-5769-4; Wen TY, 2015, INT J CLIN EXP MED, V8, P2881; Williams MA, 2004, J CLIN ENDOCR METAB, V89, P2306, DOI 10.1210/jc.2003-031201; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624; Zilko CEM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.007	21	37	44	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140376	10.1371/journal.pone.0140376	http://dx.doi.org/10.1371/journal.pone.0140376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465322	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100108
J	Jang, EJ; Jeong, HO; Park, D; Kim, DH; Choi, YJ; Chung, KW; Park, MH; Yu, BP; Chung, HY				Jang, Eun Ji; Jeong, Hyoung Oh; Park, Daeui; Kim, Dae Hyun; Choi, Yeon Ja; Chung, Ki Wung; Park, Min Hi; Yu, Byung Pal; Chung, Hae Young			Src Tyrosine Kinase Activation by 4-Hydroxynonenal Upregulates p38, ERK/AP-1 Signaling and COX-2 Expression in YPEN-1 Cells	PLOS ONE			English	Article							NF-KAPPA-B; VEIN ENDOTHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE; MAP KINASE; C-JUN; OXIDATIVE STRESS; FAMILY KINASES; EGF RECEPTOR; OXIDIZED LDL	4-Hydroxynonenal (4-HNE), a major end product of lipid peroxidation, is highly reactive and involved in various cellular processes, such as inflammatory signaling. However, to date, the mechanistic roles of 4-HNE in inflammatory signaling related to protein tyrosine kinases have not been elucidated. In the present study, we investigated the interaction between 4-HNE and Src (a non-receptor tyrosine kinase) for its involvement in the molecular modulation of the inflammatory signaling pathway utilizing the YPEN-1 cell system. Immunoprecipitation experiments showed that 4-HNE phosphorylates (activates) Src at Tyr416 via adduct formation. In addition, LC-MS/MS and a docking simulation model revealed an addiction site at the Cys248 residue of Src, resulting in the stimulation of downstream p38, ERK/AP-1 and cyclooxygenase-2 (COX-2) signaling in YPEN-1 cells. The role of 4-HNE-activated Src in downstream inflammatory signaling was further investigated using dasatinib (a Src inhibitor) and by siRNA knockdown of Src. p38 and ERK were directly regulated by Src, as revealed by immunoblotting of the phosphorylated forms of mitogen-activated protein kinases (MAPKs), which are key elements in the signaling transduction pathway initiated by Src. The study also shows that Src modulates the HNE-enhanced activation of AP-1 and the expression of COX-2 (a target gene of AP-1). Together, the results of this study show that 4-HNE stimulates Src tyrosine kinase in activation of the inflammation process.	[Jang, Eun Ji; Jeong, Hyoung Oh; Park, Daeui; Kim, Dae Hyun; Choi, Yeon Ja; Chung, Ki Wung; Park, Min Hi; Chung, Hae Young] Pusan Natl Univ, Dept Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Busan, South Korea; [Jeong, Hyoung Oh; Park, Daeui] Pusan Natl Univ, Interdisciplinary Res Program Bioinformat & Longe, Busan 609735, South Korea; [Yu, Byung Pal] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	Pusan National University; Pusan National University; University of Texas System; University of Texas Health San Antonio	Chung, HY (corresponding author), Pusan Natl Univ, Dept Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Busan, South Korea.	hyjung@pusan.ac.kr	Park, Min Hi/AAL-9880-2020	Park, Daeui/0000-0002-9452-5849	National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology [2009-0083538]	National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (No. 2009-0083538).	Bahk YY, 2004, PROTEOMICS, V4, P3299, DOI 10.1002/pmic.200400980; Borbiev T, 2004, AM J PHYSIOL-LUNG C, V287, pL911, DOI 10.1152/ajplung.00372.2003; Burleigh ME, 2005, J MOL CELL CARDIOL, V39, P443, DOI 10.1016/j.yjmcc.2005.06.011; Chenevard R, 2003, CIRCULATION, V107, P405, DOI 10.1161/01.CIR.0000051361.69808.3A; Deng L, 2001, J BIOL CHEM, V276, P413, DOI 10.1074/jbc.M004551200; Deo DD, 2002, J BIOL CHEM, V277, P21237, DOI 10.1074/jbc.M110955200; Dong ZG, 1997, J BIOL CHEM, V272, P9962; Escargueil-Blanc I, 2001, CIRCULATION, V104, P1814, DOI 10.1161/hc4001.097179; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fujisawa T, 2012, INT J CANCER, V131, P344, DOI 10.1002/ijc.26366; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Guan ZH, 1998, J BIOL CHEM, V273, P12901, DOI 10.1074/jbc.273.21.12901; Hoefen RJ, 2002, VASC PHARMACOL, V38, P271, DOI 10.1016/S1537-1891(02)00251-3; Hsieh HL, 2008, BBA-MOL CELL RES, V1783, P1563, DOI 10.1016/j.bbamcr.2008.03.016; Hu XH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-74; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hwang YP, 2011, MOL NUTR FOOD RES, V55, P594, DOI 10.1002/mnfr.201000292; Jin YJ, 2012, CELL SIGNAL, V24, P1485, DOI 10.1016/j.cellsig.2012.03.014; Jung YD, 2002, CYTOKINE, V18, P206, DOI 10.1006/cyto.2002.1034; Khadaroo RG, 2003, SURGERY, V134, P242, DOI 10.1067/msy.2003.228; Kim CH, 2006, J GERONTOL A-BIOL, V61, P332, DOI 10.1093/gerona/61.4.332; Kim JM, 2010, AGE, V32, P197, DOI 10.1007/s11357-009-9124-1; Kim MJ, 2008, MOL CANCER RES, V6, P1872, DOI 10.1158/1541-7786.MCR-08-0084; Kim SR, 2014, ARCH PHARM RES, V37, P539, DOI 10.1007/s12272-013-0211-6; Kimura H, 2013, CELL PHYSIOL BIOCHEM, V32, P899, DOI 10.1159/000354493; Kuldo Joanna M., 2005, Current Vascular Pharmacology, V3, P11, DOI 10.2174/1570161052773898; Kutuk O, 2007, REDOX REP, V12, P30, DOI 10.1179/135100007X162329; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonarduzzi G, 2005, MOL NUTR FOOD RES, V49, P1044, DOI 10.1002/mnfr.200500090; Leonarduzzi G, 2004, FREE RADICAL BIO MED, V37, P1694, DOI 10.1016/j.freeradbiomed.2004.08.027; Li MH, 2005, FREE RADICAL BIO MED, V39, P890, DOI 10.1016/j.freeradbiomed.2005.05.015; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Looby E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-190; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Madamanchi NR, 2005, J THROMB HAEMOST, V3, P254, DOI 10.1111/j.1538-7836.2004.01085.x; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; Mattson MP, 2009, EXP GERONTOL, V44, P625, DOI 10.1016/j.exger.2009.07.003; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Negre-Salvayre Anne, 2003, Molecular Aspects of Medicine, V24, P251, DOI 10.1016/S0098-2997(03)00020-7; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; Pfundt R, 2001, J PATHOL, V193, P248; Rohr-Udilova NV, 2008, MOL NUTR FOOD RES, V52, P352, DOI 10.1002/mnfr.200700149; Sampey BP, 2007, MOL PHARMACOL, V71, P871, DOI 10.1124/mol.106.029686; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Singer CA, 2003, AM J PHYSIOL-LUNG C, V285, pL1087, DOI 10.1152/ajplung.00409.2002; Singh S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-73; Suc I, 1998, FASEB J, V12, P665, DOI 10.1096/fasebj.12.9.665; Syeda F, 2006, J BIOL CHEM, V281, P11792, DOI 10.1074/jbc.M509292200; Thobe BM, 2006, AM J PHYSIOL-CELL PH, V291, pC476, DOI 10.1152/ajpcell.00076.2006; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Wu WD, 2002, J BIOL CHEM, V277, P24252, DOI 10.1074/jbc.M200437200; Yamagishi S, 2001, J BIOL CHEM, V276, P5129, DOI 10.1074/jbc.M007258200; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; Yu JQ, 2004, J BIOL CHEM, V279, P50446, DOI 10.1074/jbc.M409221200; Zarrouki B, 2007, FEBS LETT, V581, P2394, DOI 10.1016/j.febslet.2007.04.048; Zhong X, 2012, BIOCHEM BIOPH RES CO, V425, P401, DOI 10.1016/j.bbrc.2012.07.110; Zhou L, 2011, NEOPLASIA, V13, P1101, DOI 10.1593/neo.111060; Zuo X, 2001, ELECTROPHORESIS, V22, P1603, DOI 10.1002/1522-2683(200105)22:9<1603::AID-ELPS1603>3.0.CO;2-I	59	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0129244	10.1371/journal.pone.0129244	http://dx.doi.org/10.1371/journal.pone.0129244			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466383	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100002
J	Karnik, R; Beer, MA				Karnik, Rahul; Beer, Michael A.			Identification of Predictive Cis-Regulatory Elements Using a Discriminative Objective Function and a Dynamic Search Space	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; MOTIF DISCOVERY; C-ELEGANS; CHIP-SEQ; TRANSCRIPTION-FACTOR; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; GENOME; SEQUENCE	The generation of genomic binding or accessibility data from massively parallel sequencing technologies such as ChIP-seq and DNase-seq continues to accelerate. Yet state-of-theart computational approaches for the identification of DNA binding motifs often yield motifs of weak predictive power. Here we present a novel computational algorithm called Motif-Spec, designed to find predictive motifs, in contrast to over-represented sequence elements. The key distinguishing feature of this algorithm is that it uses a dynamic search space and a learned threshold to find discriminative motifs in combination with the modeling of motifs using a full PWM (position weight matrix) rather than k-mer words or regular expressions. We demonstrate that our approach finds motifs corresponding to known binding specificities in several mammalian ChIP-seq datasets, and that our PWMs classify the ChIP-seq signals with accuracy comparable to, or marginally better than motifs from the best existing algorithms. In other datasets, our algorithm identifies novel motifs where other methods fail. Finally, we apply this algorithm to detect motifs from expression datasets in C. elegans using a dynamic expression similarity metric rather than fixed expression clusters, and find novel predictive motifs.	[Karnik, Rahul; Beer, Michael A.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Beer, Michael A.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Beer, MA (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	mbeer@jhu.edu	Beer, Michael/AFV-4282-2022	Karnik, Rahul/0000-0002-0400-635X; Beer, Michael A/0000-0001-9955-3809	Searle Scholars program; NIH [HG007348]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007348] Funding Source: NIH RePORTER	Searle Scholars program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	M. Beer was supported by the Searle Scholars program and NIH grant HG007348. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Boxem M, 2002, CURR BIOL, V12, P906, DOI 10.1016/S0960-9822(02)00844-8; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Fauteux F, 2008, BIOINFORMATICS, V24, P2303, DOI 10.1093/bioinformatics/btn444; Fletez-Brant C, 2013, NUCLEIC ACIDS RES, V41, pW544, DOI 10.1093/nar/gkt519; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Ghandi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003711; Gorkin DU, 2012, GENOME RES, V22, P2290, DOI 10.1101/gr.139360.112; Grau J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt831; GuhaThakurta D, 2004, GENOME RES, V14, P2457, DOI 10.1101/gr.2961104; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Huggins P, 2011, BIOINFORMATICS, V27, P2361, DOI 10.1093/bioinformatics/btr412; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Lee D, 2011, GENOME RES, V21, P2167, DOI 10.1101/gr.121905.111; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Linhart C, 2012, GENOME RES, V22, P76, DOI 10.1101/gr.115626.110; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Patel RY, 2014, BIOINFORMATICS, V30, P941, DOI 10.1093/bioinformatics/btt748; Pervouchine DD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6903; Redhead E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-385; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Schwartz HT, 2007, GENE DEV, V21, P3181, DOI 10.1101/gad.1607007; Simcha D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047836; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Yao ZZ, 2014, BIOINFORMATICS, V30, P775, DOI 10.1093/bioinformatics/btt615; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	48	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140557	10.1371/journal.pone.0140557	http://dx.doi.org/10.1371/journal.pone.0140557			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465884	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100143
J	Little, MP; Kwon, D; Zablotska, LB; Brenner, AV; Cahoon, EK; Rozhko, AV; Polyanskaya, ON; Minenko, VF; Golovanov, I; Bouville, A; Drozdovitch, V				Little, Mark P.; Kwon, Deukwoo; Zablotska, Lydia B.; Brenner, Alina V.; Cahoon, Elizabeth K.; Rozhko, Alexander V.; Polyanskaya, Olga N.; Minenko, Victor F.; Golovanov, Ivan; Bouville, Andre; Drozdovitch, Vladimir			Impact of Uncertainties in Exposure Assessment on Thyroid Cancer Risk among Persons in Belarus Exposed as Children or Adolescents Due to the Chernobyl Accident	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; INCIDENCE DOSE-RESPONSE; MEASUREMENT ERROR; REGRESSION CALIBRATION; POOLED ANALYSIS; MONTE-CARLO; RADIATION; COHORT; RECONSTRUCTION; CURVILINEARITY	Background The excess incidence of thyroid cancer in Ukraine and Belarus observed a few years after the Chernobyl accident is considered to be largely the result of I-131 released from the reactor. Although the Belarus thyroid cancer prevalence data has been previously analyzed, no account was taken of dose measurement error. Methods We examined dose-response patterns in a thyroid screening prevalence cohort of 11,732 persons aged under 18 at the time of the accident, diagnosed during 1996-2004, who had direct thyroid 131I activity measurement, and were resident in the most radio-actively contaminated regions of Belarus. Three methods of dose-error correction (regression calibration, Monte Carlo maximum likelihood, Bayesian Markov Chain Monte Carlo) were applied. Results There was a statistically significant (p<0.001) increasing dose-response for prevalent thyroid cancer, irrespective of regression-adjustment method used. Without adjustment for dose errors the excess odds ratio was 1.51 Gy(-) (95% CI 0.53, 3.86), which was reduced by 13% when regression-calibration adjustment was used, 1.31 Gy(-) (95% CI 0.47, 3.31). A Monte Carlo maximum likelihood method yielded an excess odds ratio of 1.48 Gy(-) (95% CI 0.53, 3.87), about 2% lower than the unadjusted analysis. The Bayesian method yielded a maximum posterior excess odds ratio of 1.16 Gy(-) (95% BCI 0.20, 4.32), 23% lower than the unadjusted analysis. There were borderline significant (p = 0.053-0.078) indications of downward curvature in the dose response, depending on the adjustment methods used. There were also borderline significant (p = 0.102) modifying effects of gender on the radiation dose trend, but no significant modifying effects of age at time of accident, or age at screening as modifiers of dose response (p>0.2). Conclusions In summary, the relatively small contribution of unshared classical dose error in the current study results in comparatively modest effects on the regression parameters.	[Little, Mark P.; Brenner, Alina V.; Cahoon, Elizabeth K.; Bouville, Andre; Drozdovitch, Vladimir] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept HHS, Bethesda, MD 20892 USA; [Kwon, Deukwoo] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Zablotska, Lydia B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Rozhko, Alexander V.; Polyanskaya, Olga N.] Republican Res Ctr Radiat Med & Human Ecol, Gomel 246040, BELARUS; [Minenko, Victor F.] Res Inst Nucl Problems, Minsk, BELARUS; [Golovanov, Ivan] Burnasyan Fed Med Biophys Ctr, Moscow, Russia	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Miami; University of California System; University of California San Francisco; Republican Research Centre for Radiation Medicine & Human Ecology; Belarusian State University; Burnazyan Federal Medical Biophysical Center	Little, MP (corresponding author), NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept HHS, Bethesda, MD 20892 USA.	mark.little@nih.gov		Little, Mark/0000-0003-0980-7567; Razhko, Alexandr/0000-0001-9965-8424; Drozdovitch, Vladimir/0000-0002-7952-379X	Intramural Research Program of the National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics; NCI [NO1-CP-21178, 5K07CA132918]; NATIONAL CANCER INSTITUTE [K07CA132918, ZIACP010132] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics. Dr Zablotska's work is supported by NCI contract NO1-CP-21178 and NCI grant 5K07CA132918.	Annex A, 2008, UNSCEAR 2006 REP, P13; Bateson TF, 2010, AM J EPIDEMIOL, V172, P344, DOI 10.1093/aje/kwq123; Bennett J, 2004, RADIAT ENVIRON BIOPH, V43, P233, DOI 10.1007/s00411-004-0258-3; Brenner AV, 2011, ENVIRON HEALTH PERSP, V119, P933, DOI 10.1289/ehp.1002674; Cardis E, 2005, JNCI-J NATL CANCER I, V97, P724, DOI 10.1093/jnci/dji129; Carroll RJ, 2006, MODERN PERSPECTIVE, P1; Drozdovitch V, 2007, RADIAT PROT DOSIM, V127, P540, DOI 10.1093/rpd/ncm360; Drozdovitch V, 2015, RADIAT RES, V184, P203, DOI 10.1667/RR13791.1; Drozdovitch V, 2013, RADIAT RES, V179, P597, DOI 10.1667/RR3153.1; Drozdovitch V, 2010, HEALTH PHYS, V99, P1, DOI 10.1097/HP.0b013e3181c910dd; Fearn T, 2008, STAT MED, V27, P2159, DOI 10.1002/sim.3163; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Kesminiene A, 2012, RADIAT RES, V178, P425, DOI 10.1667/RR2975.1; Kwon D, 2016, STAT MED, V35, P399, DOI 10.1002/sim.6635; Land CE, 2015, RADIAT RES, V183, P159, DOI 10.1667/RR13794.1; Little MP, 2008, RADIAT RES, V169, P660, DOI 10.1667/RR1091.1; Little MP, 2014, RADIAT RES, V182, P1, DOI 10.1667/RR13413.1; Little MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085723; Little MP, 1997, ENVIRON HEALTH PERSP, V105, P1505, DOI 10.2307/3433661; Little MP, 1998, INT J RADIAT BIOL, V74, P471, DOI 10.1080/095530098141348; Little MP, 2000, INT J RADIAT BIOL, V76, P939, DOI 10.1080/09553000050050954; Little MP, 1996, INT J RADIAT BIOL, V70, P83, DOI 10.1080/095530096145364; Little MP, 2000, RADIAT ENVIRON BIOPH, V39, P241, DOI 10.1007/s004110000070; LUNDELL M, 1994, RADIAT RES, V140, P334, DOI 10.2307/3579110; McCullagh P, 1989, MONOGRAPHS STAT APPL, V37, P1, DOI DOI 10.1007/978-1-4899-3242-6; Pierce DA, 2004, BIOMETRIKA, V91, P863, DOI 10.1093/biomet/91.4.863; PIERCE DA, 1992, J AM STAT ASSOC, V87, P351; PIERCE DA, 1990, RADIAT RES, V123, P275, DOI 10.2307/3577733; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Schafer DW, 2001, BIOMETRICS, V57, P689, DOI 10.1111/j.0006-341X.2001.00689.x; SHORE RE, 1993, AM J EPIDEMIOL, V137, P1068, DOI 10.1093/oxfordjournals.aje.a116610; Sigurdson AJ, 2005, LANCET, V365, P2014, DOI 10.1016/S0140-6736(05)66695-0; Simon SL, 2015, RADIAT RES, V183, P27, DOI 10.1667/RR13729.1; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stayner L, 2007, RADIAT RES, V168, P757, DOI 10.1667/RR0677.1; Stram DO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119418; Stram DO, 2003, RADIAT RES, V160, P408, DOI 10.1667/3046; THOMAS D, 1993, ANNU REV PUBL HEALTH, V14, P69, DOI 10.1146/annurev.pu.14.050193.000441; Tronko MD, 2006, JNCI-J NATL CANCER I, V98, P897, DOI 10.1093/jnci/djj244; Veiga LHS, 2012, RADIAT RES, V178, P365, DOI 10.1667/RR2889.1; Williams D, 2008, Oncogene, V27 Suppl 2, pS9, DOI 10.1038/onc.2009.349; Zablotska LB, 2011, BRIT J CANCER, V104, P181, DOI 10.1038/sj.bjc.6605967	43	14	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139826	10.1371/journal.pone.0139826	http://dx.doi.org/10.1371/journal.pone.0139826			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465339	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100060
J	Namgung, B; Ng, YC; Nam, J; Leo, HL; Kim, S				Namgung, Bumseok; Ng, Yan Cheng; Nam, Jeonghun; Leo, Hwa Liang; Kim, Sangho			Alteration of Blood Flow in a Venular Network by Infusion of Dextran 500: Evaluation with a Laser Speckle Contrast Imaging System	PLOS ONE			English	Article							DEPENDENT RHEOLOGICAL BEHAVIOR; SKELETAL-MUSCLE VENULES; ERYTHROCYTE AGGREGATION; CELL AGGREGATION; SHEAR RATE; RESISTANCE; ARTERIAL; DIAMETER; DENSITY; TUBES	This study examined the effect of dextran-induced RBC aggregation on the venular flow in microvasculature. We utilized the laser speckle contrast imaging (LSCI) as a wide-field imaging technique to visualize the flow distribution in venules influenced by abnormally elevated levels of RBC aggregation at a network-scale level, which was unprecedented in previous studies. RBC aggregation in rats was induced by infusing Dextran 500. To elucidate the impact of RBC aggregation on microvascular perfusion, blood flow in the venular network of a rat cremaster muscle was analyzed with a stepwise reduction of the arterial pressure (100 -> 30 mmHg). The LSCI analysis revealed a substantial decrease in the functional vascular density after the infusion of dextran. The relative decrease in flow velocity after dextran infusion was notably pronounced at low arterial pressures. Whole blood viscosity measurements implied that the reduction in venular flow with dextran infusion could be due to the elevation of medium viscosity in high shear conditions (> 45 s(-1)). In contrast, further augmentation to the flow reduction at low arterial pressures could be attributed to the formation of RBC aggregates (< 45 s(-1)). This study confirmed that RBC aggregation could play a dominant role in modulating microvascular perfusion, particularly in the venular networks.	[Namgung, Bumseok; Ng, Yan Cheng; Nam, Jeonghun; Leo, Hwa Liang; Kim, Sangho] Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore; [Ng, Yan Cheng; Leo, Hwa Liang; Kim, Sangho] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Kim, Sangho] Natl Univ Singapore, Dept Surg, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Kim, S (corresponding author), Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore.	bieks@nus.edu.sg	Kim, Sangho/I-7032-2012; Leo, Hwa Liang/B-6946-2011	Kim, Sangho/0000-0002-1045-5928; Leo, Hwa Liang/0000-0003-0592-6470; Nam, Jeonghun/0000-0002-0591-7745	National Medical Research Council (NMRC)/Cooperative Basic Research Grant (CBRG) [0019/2012]	National Medical Research Council (NMRC)/Cooperative Basic Research Grant (CBRG)	The authors wish to thank Ms. Yacincha S Liem for her expert technical assistance. This work was supported by National Medical Research Council (NMRC)/Cooperative Basic Research Grant (CBRG)/0019/2012.	ALONSO C, 1989, BIORHEOLOGY, V26, P229; ALONSO C, 1993, AM J PHYSIOL, V265, pH553, DOI 10.1152/ajpheart.1993.265.2.H553; Baskurt OK, 2007, INDIAN J EXP BIOL, V45, P25; Ben Ami R, 2001, AM J PHYSIOL-HEART C, V280, pH1982, DOI 10.1152/ajpheart.2001.280.5.H1982; Bishop JJ, 2002, AM J PHYSIOL-HEART C, V283, pH1985, DOI 10.1152/ajpheart.00888.2001; Bishop JJ, 2001, AM J PHYSIOL-HEART C, V281, pH939, DOI 10.1152/ajpheart.2001.281.2.H939; Bishop JJ, 2001, AM J PHYSIOL-HEART C, V280, pH222, DOI 10.1152/ajpheart.2001.280.1.H222; Bishop JJ, 2000, AM J PHYSIOL-HEART C, V279, pH47, DOI 10.1152/ajpheart.2000.279.1.H47; Boas D. A., 2010, J BIOMEDICAL OPTICS, V15; Cabel M, 1997, AM J PHYSIOL-HEART C, V272, pH1020; Cheng HY, 2008, OPT EXPRESS, V16, P10214, DOI 10.1364/OE.16.010214; Cheng HY, 2007, OPT LETT, V32, P2188, DOI 10.1364/OL.32.002188; COKELET GR, 1991, CIRC RES, V68, P1, DOI 10.1161/01.RES.68.1.1; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Dunn AK, 2012, ANN BIOMED ENG, V40, P367, DOI 10.1007/s10439-011-0469-0; Durussel JJ, 1998, ACTA PHYSIOL SCAND, V163, P25, DOI 10.1046/j.1365-201x.1998.00342.x; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; HOUSE SD, 1986, AM J PHYSIOL, V250, pH828, DOI 10.1152/ajpheart.1986.250.5.H828; Kim S, 2006, AM J PHYSIOL-HEART C, V290, pH941, DOI 10.1152/ajpheart.00645.2005; Kirkpatrick SJ, 2008, OPT LETT, V33, P2886, DOI 10.1364/OL.33.002886; Le TM, 2009, APPL BIOINF BIOSTAT, P243, DOI 10.1007/978-1-4419-0811-7_11; Lominadze D, 1998, AM J HYPERTENS, V11, P784, DOI 10.1016/S0895-7061(98)00056-9; Luquita A, 2009, CLIN HEMORHEOL MICRO, V41, P49, DOI 10.3233/CH-2009-1154; Meisner JK, 2012, MICROCIRCULATION, V19, P619, DOI 10.1111/j.1549-8719.2012.00197.x; Mokken FC, 1996, ANN HEMATOL, V73, P135, DOI 10.1007/s002770050214; Ong PK, 2011, MICROCIRCULATION, V18, P541, DOI 10.1111/j.1549-8719.2011.00114.x; OZANNE P, 1983, KIDNEY INT, V23, P519, DOI 10.1038/ki.1983.50; Parthasarathy AB, 2008, OPT EXPRESS, V16, P1975, DOI 10.1364/OE.16.001975; Ramirez-San-Juan JC, 2008, OPT EXPRESS, V16, P3197, DOI 10.1364/OE.16.003197; Rege A, 2012, ANGIOGENESIS, V15, P87, DOI 10.1007/s10456-011-9245-x; Rege A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3582334; Rege A, 2010, IEEE ENG MED BIO, P1978, DOI 10.1109/IEMBS.2010.5627543; REINKE W, 1986, CIRC RES, V59, P124, DOI 10.1161/01.RES.59.2.124; Sturesson C, 2013, MICROVASC RES, V87, P34, DOI 10.1016/j.mvr.2013.01.004; Tom WJ, 2008, IEEE T MED IMAGING, V27, P1728, DOI 10.1109/TMI.2008.925081; VICAUT E, 1995, J CARDIOVASC SURG, V36, P361; White SM, 2011, MICROVASC RES, V82, P92, DOI 10.1016/j.mvr.2011.03.006; Yalcin O, 2004, AM J PHYSIOL-HEART C, V287, pH2644, DOI 10.1152/ajpheart.00534.2004	38	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140038	10.1371/journal.pone.0140038	http://dx.doi.org/10.1371/journal.pone.0140038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466371	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100074
J	Sawada, G; Niida, A; Hirata, H; Komatsu, H; Uchi, R; Shimamura, T; Takahashi, Y; Kurashige, J; Matsumura, T; Ueo, H; Takano, Y; Ueda, M; Sakimura, S; Shinden, Y; Eguchi, H; Sudo, T; Sugimachi, K; Yamasaki, M; Tanaka, F; Tachimori, Y; Kajiyama, Y; Natsugoe, S; Fujita, H; Tanaka, Y; Calin, G; Miyano, S; Doki, Y; Mori, M; Mimori, K				Sawada, Genta; Niida, Atsushi; Hirata, Hidenari; Komatsu, Hisateru; Uchi, Ryutaro; Shimamura, Teppei; Takahashi, Yusuke; Kurashige, Junji; Matsumura, Tae; Ueo, Hiroki; Takano, Yuki; Ueda, Masami; Sakimura, Shotaro; Shinden, Yoshiaki; Eguchi, Hidetoshi; Sudo, Tomoya; Sugimachi, Keishi; Yamasaki, Makoto; Tanaka, Fumiaki; Tachimori, Yuji; Kajiyama, Yoshiaki; Natsugoe, Shoji; Fujita, Hiromasa; Tanaka, Yoichi; Calin, George; Miyano, Satoru; Doki, Yuichiro; Mori, Masaki; Mimori, Koshi			An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							CIRCULAR BINARY SEGMENTATION; COPY-NUMBER ALTERATIONS; GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; GRB7 FAMILY; ABERRATIONS; EXPRESSION; MIGRATION; SURVIVAL; HER2	Background Few driver genes have been well established in esophageal squamous cell carcinoma (ESCC). Identification of the genomic aberrations that contribute to changes in gene expression profiles can be used to predict driver genes. Methods We searched for driver genes in ESCC by integrative analysis of gene expression microarray profiles and copy number data. To narrow down candidate genes, we performed survival analysis on expression data and tested the genetic vulnerability of each genes using public RNAi screening data. We confirmed the results by performing RNAi experiments and evaluating the clinical relevance of candidate genes in an independent ESCC cohort. Results We found 10 significantly recurrent copy number alterations accompanying gene expression changes, including loci 11q13.2, 7p11.2, 3q26.33, and 17q12, which harbored CCND1, EGFR, SOX2, and ERBB2, respectively. Analysis of survival data and RNAi screening data suggested that GRB7, located on 17q12, was a driver gene in ESCC. In ESCC cell lines harboring 17q12 amplification, knockdown of GRB7 reduced the proliferation, migration, and invasion capacities of cells. Moreover, siRNA targeting GRB7 had a synergistic inhibitory effect when combined with trastuzumab, an anti-ERBB2 antibody. Survival analysis of the independent cohort also showed that high GRB7 expression was associated with poor prognosis in ESCC. Conclusion Our integrative analysis provided important insights into ESCC pathogenesis. We identified GRB7 as a novel ESCC driver gene and potential new therapeutic target.	[Sawada, Genta; Hirata, Hidenari; Komatsu, Hisateru; Uchi, Ryutaro; Takahashi, Yusuke; Kurashige, Junji; Matsumura, Tae; Ueo, Hiroki; Takano, Yuki; Ueda, Masami; Sakimura, Shotaro; Shinden, Yoshiaki; Eguchi, Hidetoshi; Sudo, Tomoya; Sugimachi, Keishi; Tanaka, Fumiaki; Mimori, Koshi] Kyushu Univ, Beppu Hosp, Dept Surg, Beppu, Oita 8740838, Japan; [Sawada, Genta; Komatsu, Hisateru; Takahashi, Yusuke; Matsumura, Tae; Ueda, Masami; Yamasaki, Makoto; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan; [Niida, Atsushi; Shimamura, Teppei; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal,Minato Ku, Tokyo 1088639, Japan; [Tachimori, Yuji] Natl Canc Ctr, Dept Surg, Tokyo, Japan; [Kajiyama, Yoshiaki] Juntendo Univ, Sch Med, Dept Esophageal & Gastroenterol Surg, Tokyo 113, Japan; [Natsugoe, Shoji] Kagoshima Univ, Sch Med, Dept Surg Oncol & Digest Surg, Kagoshima 890, Japan; [Fujita, Hiromasa] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 830, Japan; [Tanaka, Yoichi] Saitama Canc Ctr, Div Gastroenterol Surg, Saitama, Japan; [Calin, George] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Calin, George] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA	Kyushu University; Osaka University; University of Tokyo; National Cancer Center - Japan; Juntendo University; Kagoshima University; Kurume University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Mimori, K (corresponding author), Kyushu Univ, Beppu Hosp, Dept Surg, 4546 Tsurumihara, Beppu, Oita 8740838, Japan.	kmimori@tsurumi.beppu.kyushu-u.ac.jp	Sudo, Tomoya/M-4341-2019; Calin, George/E-9390-2011	Mimori, Koshi/0000-0003-3897-9974; Calin, George/0000-0001-6704-5615; Shimamura, Teppei/0000-0003-2994-872X; Calin, George/0000-0002-7427-0578; Miyano, Satoru/0000-0002-1753-6616	Funding Program for Next Generation World-Leading Researchers [LS094];  [21229015]; Grants-in-Aid for Scientific Research [26861003] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by Grants-in-Aid for Scientific Research (grant number 21229015) and the Funding Program for Next Generation World-Leading Researchers (LS094).	Ambaye ND, 2011, J MOL BIOL, V412, P397, DOI 10.1016/j.jmb.2011.07.030; Ambaye ND, 2011, BIOORGAN MED CHEM, V19, P693, DOI 10.1016/j.bmc.2010.10.030; Ando N, 1997, J THORAC CARDIOV SUR, V114, P205, DOI 10.1016/S0022-5223(97)70146-6; Bancewicz J, 2002, LANCET, V359, P1727; Bandla S, 2012, ANN THORAC SURG, V93, P1101, DOI 10.1016/j.athoracsur.2012.01.064; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chu PY, 2010, J BIOL CHEM, V285, P29279, DOI 10.1074/jbc.C110.114124; Daly RJ, 1998, CELL SIGNAL, V10, P613, DOI 10.1016/S0898-6568(98)00022-9; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Feng J, 2012, AM J CLIN PATHOL, V138, P230, DOI 10.1309/AJCPDHQFNYJZ01YG; Han DC, 2002, J BIOL CHEM, V277, P45655, DOI 10.1074/jbc.M203165200; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Hu N, 2009, CANCER RES, V69, P5908, DOI 10.1158/0008-5472.CAN-08-4622; Huang JX, 2013, ONCOL LETT, V6, P13, DOI 10.3892/ol.2013.1348; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Kato H, 2013, INT J ONCOL, V42, P1151, DOI 10.3892/ijo.2013.1830; Kleinberg L, 2007, J CLIN ONCOL, V25, P4110, DOI 10.1200/JCO.2007.12.0881; Kuroki T, 2003, CANCER RES, V63, P3724; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Li HB, 2005, ONCOGENE, V24, P4206, DOI 10.1038/sj.onc.1208591; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mimura K, 2005, BRIT J CANCER, V92, P1253, DOI 10.1038/sj.bjc.6602499; Miyawaki Y, 2012, CANCER SCI, V103, P1558, DOI 10.1111/j.1349-7006.2012.02329.x; Nakamura T, 2008, ANN SURG ONCOL, V15, P2451, DOI 10.1245/s10434-008-0016-x; Natrajan R, 2010, BREAST CANCER RES TR, V121, P575, DOI 10.1007/s10549-009-0501-3; Nishida K, 2005, CANCER RES, V65, P401; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Porter CJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-58; Pradip D, 2013, AM J CANCER RES, V3, P173; Reid JF, 2009, GENE CHROMOSOME CANC, V48, P953, DOI 10.1002/gcc.20697; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Sahlberg KK, 2013, MOL ONCOL, V7, P392, DOI 10.1016/j.molonc.2012.10.012; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Schafer M, 2009, BIOINFORMATICS, V25, P3228, DOI 10.1093/bioinformatics/btp592; Shen TL, 2002, J BIOL CHEM, V277, P29069, DOI 10.1074/jbc.M203085200; Shi ZZ, 2013, CLIN CANCER RES, V19, P5867, DOI 10.1158/1078-0432.CCR-12-3753; Shimada H, 2003, SURGERY, V133, P24, DOI 10.1067/msy.2003.31; Sintupisut N, 2013, NUCLEIC ACIDS RES, V41, P8803, DOI 10.1093/nar/gkt656; SOLOMON E, 1991, SCIENCE, V254, P1153, DOI 10.1126/science.1957167; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Tanaka S, 2000, J CELL PHYSIOL, V183, P411, DOI 10.1002/(SICI)1097-4652(200006)183:3<411::AID-JCP14>3.0.CO;2-Z; Tanaka S, 1997, CANCER RES, V57, P28; Tanaka S, 1998, J CLIN INVEST, V102, P821, DOI 10.1172/JCI2921; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wu XH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-180; Yokote K, 1996, J BIOL CHEM, V271, P30942, DOI 10.1074/jbc.271.48.30942; Zhan N, 2012, MED ONCOL, V29, P933, DOI 10.1007/s12032-011-9850-y; Zhang J., 2012, J CANC THER RES, V1, P19, DOI [10.7243/2049-7962-1-19, DOI 10.7243/2049-7962-1-19, DOI 10.1371/J0URNAL.P0NE.0029902]	51	14	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139808	10.1371/journal.pone.0139808	http://dx.doi.org/10.1371/journal.pone.0139808			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465158	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100059
J	Carter, TE; Malloy, H; Existe, A; Memnon, G; St Victor, Y; Okech, BA; Mulligan, CJ				Carter, Tamar E.; Malloy, Halley; Existe, Alexandre; Memnon, Gladys; St Victor, Yves; Okech, Bernard A.; Mulligan, Connie J.			Genetic Diversity of Plasmodium falciparum in Haiti: Insights from Microsatellite Markers	PLOS ONE			English	Article							MALARIA ELIMINATION; POPULATION-STRUCTURE; CHLOROQUINE; TRANSMISSION; RESISTANCE; FREQUENCY; REVEAL; REGION; TESTS; RATES	Hispaniola, comprising Haiti and the Dominican Republic, has been identified as a candidate for malaria elimination. However, incomplete surveillance data in Haiti hamper efforts to assess the impact of ongoing malaria control interventions. Characteristics of the genetic diversity of Plasmodium falciparum populations can be used to assess parasite transmission, which is information vital to evaluating malaria elimination efforts. Here we characterize the genetic diversity of P. falciparum samples collected from patients at seven sites in Haiti using 12 microsatellite markers previously employed in population genetic analyses of global P. falciparum populations. We measured multiplicity of infections, level of genetic diversity, degree of population geographic substructure, and linkage disequilibrium (defined as non-random association of alleles from different loci). For low transmission populations like Haiti, we expect to see few multiple infections, low levels of genetic diversity, high degree of population structure, and high linkage disequilibrium. In Haiti, we found low levels of multiple infections (12.9%), moderate to high levels of genetic diversity (mean number of alleles per locus = 4.9, heterozygosity = 0.61), low levels of population structure (highest pairwise F-st = 0.09 and no clustering in principal components analysis), and moderate linkage disequilibrium (ISA = 0.05, P<0.0001). In addition, population bottleneck analysis revealed no evidence for a reduction in the P. falciparum population size in Haiti. We conclude that the high level of genetic diversity and lack of evidence for a population bottleneck may suggest that Haiti's P. falciparum population has been stable and discuss the implications of our results for understanding the impact of malaria control interventions. We also discuss the relevance of parasite population history and other host and vector factors when assessing transmission intensity from genetic diversity data.	[Carter, Tamar E.] Univ Florida, Genet & Genom Program, Gainesville, FL 32611 USA; [Carter, Tamar E.; Mulligan, Connie J.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Carter, Tamar E.; Malloy, Halley; Mulligan, Connie J.] Univ Florida, Genet Inst, Gainesville, FL USA; [Malloy, Halley] Univ Florida, Dept Med Chem, Gainesville, FL USA; [Existe, Alexandre] Natl Publ Hlth Lab, Port Au Prince, Haiti; [Memnon, Gladys] Hosp St Croix, Leogane, Haiti; [St Victor, Yves] Blanchard Clin, Terre Noire, Haiti; [Okech, Bernard A.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Okech, Bernard A.] Univ Florida, Dept Environm & Global Hlth, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Carter, TE (corresponding author), Univ Florida, Genet & Genom Program, Gainesville, FL 32611 USA.	tamarec@ufl.edu			Department of Defense Global Emerging Infections Surveillance & Response System (DoD-GEIS) [C0607_12_UN]; UNCF/Merck Graduate Science Research Dissertation Fellowship	Department of Defense Global Emerging Infections Surveillance & Response System (DoD-GEIS); UNCF/Merck Graduate Science Research Dissertation Fellowship	This material is based upon work supported by the Department of Defense Global Emerging Infections Surveillance & Response System (DoD-GEIS), Grant No. C0607_12_UN (http://forcereadiness.dhhq.health.mil/resources/afhsc.aspx) awarded to BAO and a UNCF/Merck Graduate Science Research Dissertation Fellowship awarded to TEC (http://umsi.uncf.org/).	Al-Hamidhi S, 2014, INFECT GENET EVOL, V27, P25, DOI 10.1016/j.meegid.2014.06.015; Anderson TJC, 2000, MOL ECOL, V9, P1599, DOI 10.1046/j.1365-294x.2000.01057.x; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; [Anonymous], 2010, SCIENCE, V328, P850, DOI 10.1126/science.328.5980.850; Arnold BF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093684; Bogreau H, 2006, AM J TROP MED HYG, V74, P953; Boncy PJ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0753-9; Bonizzoni M, 2009, INFECT GENET EVOL, V9, P806, DOI 10.1016/j.meegid.2009.04.015; Branch OH, 2011, MOL BIOL EVOL, V28, P1973, DOI 10.1093/molbev/msq311; Carter TE, 2015, AM J TROP MED HYG, V92, P552, DOI 10.4269/ajtmh.14-0664; Carter TE, 2014, AM J TROP MED HYG, V91, P412, DOI 10.4269/ajtmh.14-0053; Carter TE, 2014, AM J TROP MED HYG, V91, P406, DOI 10.4269/ajtmh.13-0572; Carter TE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-275; Cornuet JM, 1996, GENETICS, V144, P2001; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; DUVERSEAU YT, 1986, AM J TROP MED HYG, V35, P459, DOI 10.4269/ajtmh.1986.35.459; ElBadry MA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-426; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Griffing SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058984; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Keating J, 2010, LANCET INFECT DIS, V10, P291, DOI 10.1016/S1473-3099(10)70075-X; Larranaga N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-354; Londono BL, 2009, EMERG INFECT DIS, V15, P735, DOI 10.3201/eid1505.081063; Londono-Renteria B, 2012, ACTA TROP, V121, P6, DOI 10.1016/j.actatropica.2011.09.005; MAGLOIRE R, 1983, B WORLD HEALTH ORGAN, V61, P1017; Mobegi VA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-223; Neuberger A, 2012, EMERG INFECT DIS, V18, P1487, DOI 10.3201/eid1809.120605; Nkhoma SC, 2013, MOL ECOL, V22, P273, DOI 10.1111/mec.12099; Okech BA, 2015, AM J TROP MED HYG, V92, P541, DOI 10.4269/ajtmh.14-0302; PHUC ND, 1984, B WORLD HEALTH ORGAN, V62, P623; Pumpaibool T, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-155; Raccurt C P, 2015, Bull Soc Pathol Exot, V108, P14, DOI 10.1007/s13149-014-0367-4; Schug MD, 1997, NAT GENET, V15, P99, DOI 10.1038/ng0197-99; Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336; Sisya TJ, 2015, ACTA TROP, V142, P108, DOI 10.1016/j.actatropica.2014.11.008; Su XZ, 1996, GENOMICS, V33, P430, DOI 10.1006/geno.1996.0218; Townes D, 2012, AM J TROP MED HYG, V86, P29, DOI 10.4269/ajtmh.2012.11-0431; Volkman SK, 2012, NAT REV GENET, V13, P315, DOI 10.1038/nrg3187; von Fricken ME, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-361; Weppelmann TA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-30; WHO, 2013, WORLD MALARIA REPORT 2013, P1	42	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140416	10.1371/journal.pone.0140416	http://dx.doi.org/10.1371/journal.pone.0140416			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462203	gold, Green Submitted, Green Published			2022-12-26	WOS:000362962300092
J	Sacramento, CQ; Marttorelli, A; Fintelman-Rodrigues, N; de Freitas, CS; de Melo, GR; Rocha, MEN; Kaiser, CR; Rodrigues, KF; da Costa, GL; Alves, CM; Santos, O; Barbosa, JP; Souza, TML				Sacramento, Carolina Q.; Marttorelli, Andressa; Fintelman-Rodrigues, Natalia; de Freitas, Caroline S.; de Melo, Gabrielle R.; Rocha, Marco E. N.; Kaiser, Carlos R.; Rodrigues, Katia F.; da Costa, Gisela L.; Alves, Cristiane M.; Santos-Filho, Osvaldo; Barbosa, Jussara P.; Souza, Thiago Moreno L.			Aureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein Hemagglutinin	PLOS ONE			English	Article							ALGA DICTYOTA-PFAFFII; CHAETOMIUM-GLOBOSUM; NEURAMINIDASE INHIBITORS; DOLABELLANE DITERPENE; VIRUS-INFECTION; HIV-1 PROTEASE; ACTIVE-SITE; DRUG; RESISTANT; ARBIDOL	The influenza virus causes acute respiratory infections, leading to high morbidity and mortality in groups of patients at higher risk. Antiviral drugs represent the first line of defense against influenza, both for seasonal infections and pandemic outbreaks. Two main classes of drugs against influenza are in clinical use: M2-channel blockers and neuraminidase inhibitors. Nevertheless, because influenza strains that are resistant to these antivirals have been described, the search for novel compounds with different mechanisms of action is necessary. Here, we investigated the anti-influenza activity of a fungi-derived natural product, aureonitol. This compound inhibited influenza A and B virus replication. This compound was more effective against influenza A(H3N2), with an EC50 of 100 nM. Aureonitol cytoxicity was also very low, with a CC50 value of 1426 mu M. Aureonitol inhibited influenza hemagglutination and, consequently, significantly impaired virus adsorption. Molecular modeling studies revealed that aureonitol docked in the sialic acid binding site of hemagglutinin, forming hydrogen bonds with highly conserved residues. Altogether, our results indicate that the chemical structure of aureonitol is promising for future anti-influenza drug design.	[Sacramento, Carolina Q.; Marttorelli, Andressa; Fintelman-Rodrigues, Natalia; de Freitas, Caroline S.; de Melo, Gabrielle R.; Rocha, Marco E. N.; Alves, Cristiane M.; Santos-Filho, Osvaldo; Souza, Thiago Moreno L.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Virus Resp, Rio De Janeiro, Brazil; [Sacramento, Carolina Q.; Marttorelli, Andressa; Fintelman-Rodrigues, Natalia; de Freitas, Caroline S.; de Melo, Gabrielle R.; Rocha, Marco E. N.; Souza, Thiago Moreno L.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, Brazil; [Sacramento, Carolina Q.; Marttorelli, Andressa; Fintelman-Rodrigues, Natalia; de Freitas, Caroline S.; de Melo, Gabrielle R.; Rocha, Marco E. N.; Souza, Thiago Moreno L.] Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, Rio De Janeiro, Brazil; [Rocha, Marco E. N.] Fundacao Oswaldo Cruz, Farmanguinhos, Lab Quim Prod Nat 5, Rio De Janeiro, Brazil; [Kaiser, Carlos R.] Univ Fed Rio de Janeiro, Inst Quim, Rio De Janeiro, Brazil; [Rodrigues, Katia F.; da Costa, Gisela L.; Barbosa, Jussara P.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Taxon Bioquim & Bioprospeccao Fungos, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Souza, TML (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Virus Resp, Rio De Janeiro, Brazil.	tmoreno@ioc.fiocruz.br	Santos-Filho, Osvaldo/H-2246-2018; Santos-Filho, Osvaldo Andrade/AAQ-8522-2020; Souza, Thiago Moreno L./G-2900-2012; Kaiser, Carlos R/D-1049-2015	Santos-Filho, Osvaldo Andrade/0000-0001-7407-158X; Souza, Thiago Moreno L./0000-0003-2212-3899; Kaiser, Carlos R/0000-0002-2132-1351	CNPq; Faperj	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by grants from CNPq (www.cnpq.br), and Faperj (www.faperj.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes JL, 2010, PLANTA MED, V76, P339, DOI 10.1055/s-0029-1186144; Al-Majhdi FN, 2007, J BIOL SCI, P113, DOI DOI 10.3923/JBS; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P437; AUSTIN FJ, 1990, J GEN VIROL, V71, P2471, DOI 10.1099/0022-1317-71-10-2471; Auwerx J, 2004, J VIROL, V78, P7427, DOI 10.1128/JVI.78.14.7427-7437.2004; Balicer RD, 2005, EMERG INFECT DIS, V11, P1280; Barbosa JP, 2004, PLANTA MED, V70, P856, DOI 10.1055/s-2004-827235; Barbosa JP, 2003, BIOCHEM SYST ECOL, V31, P1451, DOI 10.1016/S0305-1978(03)00120-0; Bedard J, 1999, ANTIMICROB AGENTS CH, V43, P557, DOI 10.1128/AAC.43.3.557; Bergmann JH, 2014, CURR OPIN CELL BIOL, V26, P10, DOI 10.1016/j.ceb.2013.08.005; BERNSTEIN FC, 1978, ARCH BIOCHEM BIOPHYS, V185, P584, DOI 10.1016/0003-9861(78)90204-7; Brooks MJ, 2012, J MED VIROL, V84, P170, DOI 10.1002/jmv.22234; Cirne-Santos CC, 2008, ANTIVIR RES, V77, P64, DOI 10.1016/j.antiviral.2007.08.006; Damjanovic D, 2012, CLIN IMMUNOL, V144, P57, DOI 10.1016/j.clim.2012.05.005; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Ding G, 2006, J NAT PROD, V69, P302, DOI 10.1021/np050515+; Ellis D, 2007, DESCRIPTION MED FUNG, P41; Fry AM, 2012, J INFECT DIS, V206, P145, DOI 10.1093/infdis/jis338; Hopkins S., 2012, SAFETY STUDY FLUFIRV; Hurt AC, 2012, J INFECT DIS, V206, P148, DOI 10.1093/infdis/jis337; Hurt AC, 2014, CURR OPIN VIROL, V8, P22, DOI 10.1016/j.coviro.2014.04.009; Hussain Basha Syed, 2012, BMC Res Notes, V5, P105, DOI 10.1186/1756-0500-5-105; Jervis PJ, 2008, J ORG CHEM, V73, P7616, DOI 10.1021/jo801338t; Jiao RH, 2006, ORG LETT, V8, P5709, DOI 10.1021/ol062257t; Joy Saju, 2006, In Silico Biology, V6, P601; Kollerova E, 2006, ACTA VIROL, V50, P7; Leneva IA, 2009, ANTIVIR RES, V81, P132, DOI 10.1016/j.antiviral.2008.10.009; Li J, 2011, MAR DRUGS, V9, P1887, DOI 10.3390/md9101887; Liu MY, 2009, CLIN THER, V31, P784, DOI 10.1016/j.clinthera.2009.04.016; Manz B, 2013, J VIROL, V87, P7200, DOI 10.1128/JVI.00980-13; Marwah RG, 2007, TETRAHEDRON, V63, P8174, DOI 10.1016/j.tet.2007.05.119; Mesquita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101056; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Murphy B. R., 1996, ORTHOMYXOVIRUSES; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Nakazawa T, 2013, J AM CHEM SOC, V135, P13446, DOI 10.1021/ja405128k; Nishihara Y, 2000, J ANTIBIOT, V53, P1333, DOI 10.7164/antibiotics.53.1333; Palese P, 2007, ORTHOMYXOVIRIDAE VIR; Park JH, 2005, FEMS MICROBIOL LETT, V252, P309, DOI 10.1016/j.femsle.2005.09.013; Patel A, 2009, CLIN PHARMACOL THER, V86, P241, DOI 10.1038/clpt.2009.142; Pereira HDS, 2005, PLANTA MED, V71, P1019, DOI 10.1055/s-2005-873113; Gutierrez RMP, 2008, J ETHNOPHARMACOL, V117, P1, DOI 10.1016/j.jep.2008.01.025; Phonkerd N, 2008, TETRAHEDRON, V64, P9636, DOI 10.1016/j.tet.2008.07.040; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rodrigues KF, 1999, J BASIC MICROB, V39, P131, DOI 10.1002/(SICI)1521-4028(199905)39:2&lt;131::AID-JOBM131&gt;3.0.CO;2-9; Rodriguez K, 2002, MYCOLOGIA, V94, P116, DOI 10.2307/3761851; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Schinazi RF, 2006, ANTIVIR RES, V71, P322, DOI 10.1016/j.antiviral.2006.03.012; Schlorke O, 2006, EUR J ORG CHEM, V2006, P1043, DOI 10.1002/ejoc.200500793; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Soares AR, 2007, PLANTA MED, V73, P1221, DOI 10.1055/s-2007-981589; Souza TML, 2007, PLANTA MED, V73, P200, DOI 10.1055/s-2007-967109; Souza TML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014158; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Tang JW, 2010, INFECT DIS CLIN N AM, V24, P603, DOI 10.1016/j.idc.2010.04.001; Wang GT, 2005, BIOORG MED CHEM LETT, V15, P125, DOI 10.1016/j.bmcl.2004.10.022; Wang YH, 2012, PHYTOMEDICINE, V19, P364, DOI 10.1016/j.phymed.2011.10.011; World Health Organization, 2010, SER DIAGN INFL MICR; Yedidi RS, 2014, ANTIMICROB AGENTS CH, V58, P3679, DOI 10.1128/AAC.00107-14; Zhang HM, 2013, J MED CHEM, V56, P1074, DOI 10.1021/jm301519z; Zhang Q, 2012, MINI-REV MED CHEM, V12, P127, DOI 10.2174/138955712798995066	62	14	15	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139236	10.1371/journal.pone.0139236	http://dx.doi.org/10.1371/journal.pone.0139236			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462111	Green Published, gold			2022-12-26	WOS:000362962300014
J	Li, SJ; Liang, YH; Mariano, J; Metzger, MB; Stringer, DK; Hristova, VA; Li, J; Randazzo, PA; Tsai, YC; Ji, XH; Weissman, AM				Li, Shengjian; Liang, Yu-He; Mariano, Jennifer; Metzger, Meredith B.; Stringer, Daniel K.; Hristova, Ventzislava A.; Li, Jess; Randazzo, Paul A.; Tsai, Yien Che; Ji, Xinhua; Weissman, Allan M.			Insights into Ubiquitination from the Unique Clamp-like Binding of the RING E3 AO7 to the E2 UbcH5B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYME; ALLOSTERIC ACTIVATION; STRUCTURAL BASIS; SUMO CHAIN; LIGASE; COMPLEX; DOMAIN; MECHANISM; UBIQUITYLATION; REVEALS	RING proteins constitute the largest class of E3 ubiquitin ligases. Unlike most RINGs, AO7 (RNF25) binds the E2 ubiquitin-conjugating enzyme, UbcH5B (UBE2D2), with strikingly high affinity. We have defined, by co-crystallization, the distinctive means by which AO7 binds UbcH5B. AO7 contains a structurally unique UbcH5B binding region (U5BR) that is connected by an 11-amino acid linker to its RING domain, forming a clamp surrounding the E2. The U5BR interacts extensively with a region of UbcH5B that is distinct from both the active site and the RING-interacting region, referred to as the backside of the E2. An apparent paradox is that the high-affinity binding of the AO7 clamp to UbcH5B, which is dependent on the U5BR, decreases the rate of ubiquitination. We establish that this is a consequence of blocking the stimulatory, non-covalent, binding of ubiquitin to the backside of UbcH5B. Interestingly, when non-covalent backside ubiquitin binding cannot occur, the AO7 clamp now enhances the rate of ubiquitination. The high-affinity binding of the AO7 clamp to UbcH5B has also allowed for the co-crystallization of previously described and functionally important RING mutants at the RING-E2 interface. We show that mutations having marked effects on function only minimally affect the intermolecular interactions between the AO7 RING and UbcH5B, establishing a high degree of complexity in activation through the RING-E2 interface.	[Li, Shengjian; Mariano, Jennifer; Metzger, Meredith B.; Stringer, Daniel K.; Hristova, Ventzislava A.; Tsai, Yien Che; Weissman, Allan M.] NCI, Lab Prot Dynam & Signaling, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Liang, Yu-He; Ji, Xinhua] NCI, Macromol Crystallog Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Li, Jess] NCI, Struct Biophys Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Randazzo, Paul A.] NCI, Lab Cell & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ji, XH (corresponding author), NCI, Macromol Crystallog Lab, Ctr Canc Res, 1050 Boyles St, Frederick, MD 21702 USA.	jix@mail.nih.gov; weissmaa@mail.nih.gov	Ji, Xinhua/C-9664-2012	Ji, Xinhua/0000-0001-6942-1514; Metzger, Meredith/0000-0002-6248-0009; Tsai, Yien Che/0000-0001-9624-1092	Werner H. Kristen Student Internship Program; NATIONAL CANCER INSTITUTE [ZIABC010326] Funding Source: NIH RePORTER	Werner H. Kristen Student Internship Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Marzena Dyba and Sergey Tarasov of the Biophysics Resource, Structural Biophysics Laboratory, Center for Cancer Research for assistance with MST and Mei Yang for providing reagents. Some experiments were carried out with assistance from Erin Marshall and Alex Roumeliotis (both supported by the Werner H. Kristen Student Internship Program). We thank R. Andrew Byrd, Ranabir Das, and Stanley Lipkowitz for invaluable discussions and critical reading of this manuscript. Wealso thank Ranabir Das and R. Andrew Byrd for NMR analyses and Gary Pauly for FlAsH-EDT2.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Berndsen CE, 2013, NAT CHEM BIOL, V9, P154, DOI [10.1038/NCHEMBIO.1159, 10.1038/nchembio.1159]; Brown NG, 2015, P NATL ACAD SCI USA, V112, P5272, DOI 10.1073/pnas.1504161112; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Buetow L, 2015, MOL CELL, V58, P297, DOI 10.1016/j.molcel.2015.02.017; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Cenciarelli C, 1996, J BIOL CHEM, V271, P8709, DOI 10.1074/jbc.271.15.8709; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dowil RT, 2011, J BIOL CHEM, V286, P14913, DOI 10.1074/jbc.M110.158808; Downes BP, 2006, J BIOL CHEM, V281, P27145, DOI 10.1074/jbc.M602283200; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HAAS AL, 1985, J BIOL CHEM, V260, P2464; Haririnia A, 2007, J MOL BIOL, V368, P753, DOI 10.1016/j.jmb.2007.02.037; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Metzger MB, 2013, MOL CELL, V50, P516, DOI 10.1016/j.molcel.2013.04.004; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nakatani Y, 2013, BIOCHEM J, V450, P629, DOI 10.1042/BJ20121702; Nguyen L, 2014, BIOCHEMISTRY-US, V53, P4004, DOI 10.1021/bi500072v; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Prudden J, 2009, NAT STRUCT MOL BIOL, V16, P509, DOI 10.1038/nsmb.1582; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Sekiyama N, 2010, PROTEINS, V78, P1491, DOI 10.1002/prot.22667; Soss SE, 2013, BIOCHEMISTRY-US, V52, P2991, DOI 10.1021/bi3015949; Tsai YC, 2012, MOL BIOL CELL, V23, P4484, DOI 10.1091/mbc.E12-08-0631; Turco E, 2015, J BIOL CHEM, V290, P5298, DOI 10.1074/jbc.M114.626788; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Williams C, 2012, EMBO J, V31, P391, DOI 10.1038/emboj.2011.411; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	66	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30225	30239		10.1074/jbc.M115.685867	http://dx.doi.org/10.1074/jbc.M115.685867			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26475854	Green Published, hybrid			2022-12-26	WOS:000366738200003
J	Ramkumar, P; Lee, CM; Moradian, A; Sweredoski, MJ; Hess, S; Sharrocks, AD; Haines, DS; Reddy, EP				Ramkumar, Poornima; Lee, Clement M.; Moradian, Annie; Sweredoski, Michael J.; Hess, Sonja; Sharrocks, Andrew D.; Haines, Dale S.; Reddy, E. Premkumar			JNK-associated Leucine Zipper Protein Functions as a Docking Platform for Polo-like Kinase 1 and Regulation of the Associating Transcription Factor Forkhead Box Protein K1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE-KINASE-1 PLK1; PLK1-PBIP1 INTERACTION; SCAFFOLDING PROTEIN; CELL-MIGRATION; DOMAIN; FOXK1; PHOSPHORYLATION; IDENTIFICATION; LOCALIZATION; KINETOCHORES	JLP (JNK-associated leucine zipper protein) is a scaffolding protein that interacts with various signaling proteins associated with coordinated regulation of cellular process such as endocytosis, motility, neurite outgrowth, cell proliferation, and apoptosis. Here we identified PLK1 (Polo-like kinase 1) as a novel interaction partner of JLP through mass spectrometric approaches. Our results indicate that JLP is phospho-primed by PLK1 on Thr-351, which is recognized by the Polo box domain of PLK1 leading to phosphorylation of JLP at additional sites. Stable isotope labeling by amino acids in cell culture and quantitative LC-MS/MS analysis was performed to identify PLK1-dependent JLP-interacting proteins. Treatment of cells with the PLK1 kinase inhibitor BI2536 suppressed binding of the Forkhead box protein K1 (FOXK1) transcriptional repressor to JLP. JLP was found to interact with PLK1 and FOXK1 during mitosis. Moreover, knockdown of PLK1 affected the interaction between JLP and FOXK1. FOXK1 is a known transcriptional repressor of the CDK inhibitor p21/WAF1, and knockdown of JLP resulted in increased FOXK1 protein levels and a reduction of p21 transcript levels. Our results suggest a novel mechanism by which FOXK1 protein levels and activity are regulated by associating with JLP and PLK1.	[Ramkumar, Poornima; Lee, Clement M.; Reddy, E. Premkumar] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Haines, Dale S.] Temple Univ, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19122 USA; [Moradian, Annie; Sweredoski, Michael J.; Hess, Sonja] CALTECH, Beckman Inst, Proteome Explorat Lab, Pasadena, CA 91125 USA; [Sharrocks, Andrew D.] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England	Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; California Institute of Technology; University of Manchester	Reddy, EP (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, 1425 Madison Ave,Rm 15-20C, New York, NY 10029 USA.	ep.reddy@mssm.edu	Lee, Clement M./E-7104-2012; Regan, Clinton/E-6250-2012; Reddy, E. Premkumar/F-6233-2011	Lee, Clement M./0000-0003-3486-8492; 	National Institutes of Health [RO1CA158209]; Gordon and Betty Moore Foundation [GBMF775]; Beckman Institute; Wellcome Trust; NATIONAL CANCER INSTITUTE [R01CA158209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health RO1CA158209 (to E. P. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Gordon and Betty Moore Foundation Grant GBMF775 and the Beckman Institute.; Supported by a grant from the Wellcome Trust.	Bucur Octavian, 2014, Discoveries (Craiova), V2; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Carcer G, 2011, CELL CYCLE, V10, P2255, DOI 10.4161/cc.10.14.16494; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Freddie CT, 2007, NUCLEIC ACIDS RES, V35, P5203, DOI 10.1093/nar/gkm528; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Gantulga D, 2008, J BIOCHEM, V144, P693, DOI 10.1093/jb/mvn123; Haines DS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016444; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hawke TJ, 2003, J BIOL CHEM, V278, P4015, DOI 10.1074/jbc.M209200200; Jatiani Shashidhar S, 2010, Genes Cancer, V1, P331, DOI 10.1177/1947601910371337; Ji Zongling, 2015, Mol Syst Biol, V11, P782, DOI 10.15252/msb.20145936; Kalli A, 2013, J PROTEOME RES, V12, P3071, DOI 10.1021/pr3011588; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kang YH, 2011, J BIOL CHEM, V286, P19744, DOI 10.1074/jbc.M111.224105; Katoh M, 2004, INT J ONCOL, V25, P1495; Katoh M, 2004, INT J MOL MED, V14, P127; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Kothe M, 2007, BIOCHEMISTRY-US, V46, P5960, DOI 10.1021/bi602474j; Laszlo B, 2010, FEBS J, V277, P4348, DOI 10.1111/j.1742-4658.2010.07864.x; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Lee JE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006460; Lee KS, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-4; Lee KS, 2008, CELL CYCLE, V7, P141, DOI 10.4161/cc.7.2.5272; Li X, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145504; Marais A, 2010, J BIOL CHEM, V285, P35728, DOI 10.1074/jbc.M110.154005; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nguyen Q, 2005, J BIOL CHEM, V280, P30185, DOI 10.1074/jbc.M505499200; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Shi XZ, 2012, J CELL SCI, V125, P5329, DOI 10.1242/jcs.105239; Shi XZ, 2012, MOL CELL BIOCHEM, V366, P251, DOI 10.1007/s11010-012-1302-2; Takahashi T, 2003, CANCER SCI, V94, P148, DOI 10.1111/j.1349-7006.2003.tb01411.x; Takino T, 2005, J BIOL CHEM, V280, P37772, DOI 10.1074/jbc.M505241200; Tuvshintugs B, 2014, GENES CELLS, V19, P692, DOI 10.1111/gtc.12170; Wang WQ, 2015, DEV CELL, V32, P707, DOI 10.1016/j.devcel.2015.01.031; Weichert W, 2005, WORLD J GASTROENTERO, V11, P5644, DOI 10.3748/wjg.v11.i36.5644; Xu H, 2010, J BIOL CHEM, V285, P3548, DOI 10.1074/jbc.M109.064113; Yuan CF, 2014, CELL CYCLE, V13, P807, DOI 10.4161/cc.27727	48	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29617	29628		10.1074/jbc.M115.664649	http://dx.doi.org/10.1074/jbc.M115.664649			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468278	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000366613400042
J	Perusek, L; Sahu, B; Parmar, T; Maeno, H; Arai, E; Le, YZ; Subauste, CS; Chen, Y; Palczewski, K; Maeda, A				Perusek, Lindsay; Sahu, Bhubanananda; Parmar, Tanu; Maeno, Hiroshi; Arai, Eisuke; Le, Yun-Zheng; Subauste, Carlos S.; Chen, Yu; Palczewski, Krzysztof; Maeda, Akiko			Di-retinoid-pyridinium-ethanolamine (A2E) Accumulation and the Maintenance of the Visual Cycle Are Independent of Atg7-mediated Autophagy in the Retinal Pigmented Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aging; autophagy; autophagy-related protein 7 (ATG7); retina; retinal degeneration; A2E; ABCA4; Stargardt disease	CHAPERONE-MEDIATED AUTOPHAGY; LIPOFUSCIN FLUOROPHORE A2E; PLURIPOTENT STEM-CELLS; HUMAN RPE CELLS; MACULAR DEGENERATION; OUTER SEGMENTS; MICROGLIAL ACTIVATION; OXIDATIVE STRESS; IN-VIVO; MICE	Autophagy is an evolutionarily conserved catabolic mechanism that relieves cellular stress by removing/recycling damaged organelles and debris through the action of lysosomes. Compromised autophagy has been implicated in many neurodegenerative diseases, including retinal degeneration. Here we examined retinal phenotypes resulting from RPE-specific deletion of the autophagy regulatory gene Atg7 by generating Atg7(flox/flox);VMD2-rtTA-cre+ mice to determine whether autophagy is essential for RPE functions including retinoid recycling. Atg7-deficient RPE displayed abnormal morphology with increased RPE thickness, cellular debris and vacuole formation indicating that autophagy is important in maintaining RPE homeostasis. In contrast, 11-cis-retinal content, ERGs and retinal histology were normal in mice with Atg7-deficient RPE in both fasted and fed states. Because A2E accumulation in the RPE is associated with pathogenesis of both Stargardt disease and age-related macular degeneration (AMD) in humans, deletion of Abca4 was introduced into Atg7(flox/flox);VMD2-rtTA-cre+ mice to investigate the role of autophagy during A2E accumulation. Comparable A2E concentrations were detected in the eyes of 6-month-old mice with and without Atg7 from both Abca4(-/-) and Abca4(+/+) backgrounds. To identify other autophagy-related molecules involved in A2E accumulation, we performed gene expression array analysis on A2E-treated human RPE cells and found up-regulation of four autophagy related genes; DRAM1, NPC1, CASP3, and EIF2AK3/PERK. These observations indicate that Atg7-mediated autophagy is dispensable for retinoid recycling and A2E deposition; however, autophagy plays a role in coping with stress caused by A2E accumulation.	[Perusek, Lindsay; Sahu, Bhubanananda; Parmar, Tanu; Maeno, Hiroshi; Arai, Eisuke; Maeda, Akiko] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Chen, Yu; Palczewski, Krzysztof; Maeda, Akiko] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Chen, Yu; Palczewski, Krzysztof; Maeda, Akiko] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Subauste, Carlos S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Med Endocrinol, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Oklahoma City, OK 73104 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Maeda, A (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.	aam19@case.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [5P30AR039750]; Ohio Department of Development - Center for Innovative Immunosuppressive Therapeutics [TECH 09-023];  [P30 EY11373]; NATIONAL EYE INSTITUTE [R24EY021126, R01EY022658, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR039750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Department of Development - Center for Innovative Immunosuppressive Therapeutics; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Dr. Leslie T. Webster, Jr, Vipulkumar Parmar (Case Western Reserve University) for helpful comments on the manuscript, the Visual Sciences Research Center Core Facility (supported by P30 EY11373), in particular Scott Howell and Sarah Lindstrom for their help with microscopy, and the flow cytometry facility in the Department of Dermatology's Skin Diseases Research Center (SDRC) for assistance with confocal microscopy. The Department of Dermatology's Skin Diseases Research Center (SDRC) is supported in part by the National Institutes of Health Grant (5P30AR039750) and the Ohio Department of Development - Center for Innovative Immunosuppressive Therapeutics (TECH 09-023).	Basu S, 2014, AUTOPHAGY, V10, P1193, DOI 10.4161/auto.28768; Besirli CG, 2011, INVEST OPHTH VIS SCI, V52, P4193, DOI 10.1167/iovs.10-7090; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Claudepierre T, 2010, MOL CELL NEUROSCI, V43, P164, DOI 10.1016/j.mcn.2009.10.007; Diemer T, 2008, ADV EXP MED BIOL, V613, P321, DOI 10.1007/978-0-387-74904-4_37; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Guha S, 2014, ADV EXP MED BIOL, V801, P105, DOI 10.1007/978-1-4614-3209-8_14; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; Holz FG, 1999, OPHTHALMOLOGE, V96, P781, DOI 10.1007/s003470050496; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Iriyama A, 2008, J BIOL CHEM, V283, P11947, DOI 10.1074/jbc.M708989200; Jo C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4496; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kohno H, 2013, J BIOL CHEM, V288, P15326, DOI 10.1074/jbc.M112.448712; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Lakkaraju A, 2007, P NATL ACAD SCI USA, V104, P11026, DOI 10.1073/pnas.0702504104; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; Lee SY, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.266; Ma WX, 2013, NEUROBIOL AGING, V34, P943, DOI 10.1016/j.neurobiolaging.2012.06.010; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda T, 2013, J BIOL CHEM, V288, P34484, DOI 10.1074/jbc.M113.518571; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mitter SK, 2014, AUTOPHAGY, V10, P1989, DOI 10.4161/auto.36184; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Morishita H, 2013, J BIOL CHEM, V288, P11436, DOI 10.1074/jbc.M112.437103; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Saadat KASM, 2014, FEBS OPEN BIO, V4, P1007, DOI 10.1016/j.fob.2014.11.003; Schutt F, 2000, INVEST OPHTH VIS SCI, V41, P2303; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Taneike M, 2010, AUTOPHAGY, V6, P600, DOI 10.4161/auto.6.5.11947; Toops KA, 2015, MOL BIOL CELL, V26, P1, DOI 10.1091/mbc.E14-05-1028; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Wu HJ, 2014, INT J BIOL SCI, V10, P1072, DOI 10.7150/ijbs.9719; Yannuzzi LA, 2004, AM J OPHTHALMOL, V137, P511, DOI 10.1016/j.ajo.2003.12.035; Yao JY, 2014, INVEST OPHTH VIS SCI, V55, P3237, DOI 10.1167/iovs.13-13336; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	61	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29035	29044		10.1074/jbc.M115.682310	http://dx.doi.org/10.1074/jbc.M115.682310			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26468292	hybrid, Green Published			2022-12-26	WOS:000365762300041
J	Sasset, L; Petris, G; Cesaratto, F; Burrone, OR				Sasset, Linda; Petris, Gianluca; Cesaratto, Francesca; Burrone, Oscar R.			The VCP/p97 and YOD1 Proteins Have Different Substrate-dependent Activities in Endoplasmic Reticulum-associated Degradation (ERAD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P97 AAA-ATPASE; I HEAVY-CHAINS; MEMBRANE-PROTEIN; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; DEUBIQUITINATING ENZYME; SECRETORY PATHWAY; CHOLERA-TOXIN; DISLOCATION; UBIQUITIN	Endoplasmic reticulum-associated degradation (ERAD) is an essential quality control mechanism of the folding state of proteins in the secretory pathway that targets unfolded/misfolded polypeptides for proteasomal degradation. The cytosolic p97/valosin-containing protein is an essential ATPase for degradation of ERAD substrates. It has been considered necessary during retro-translocation to extract proteins from the endoplasmic reticulum that are otherwise supposed to accumulate in the endoplasmic reticulum lumen. The activity of the p97-associated deubiquitinylase YOD1 is also required for substrate disposal. We used the in vivo biotinylation retro-translocation assay in mammalian cells under conditions of impaired p97 or YOD1 activity to directly discriminate their requirements and diverse functions in ERAD. Using different ERAD substrates, we found that both proteins participate in two distinct retro-translocation steps. For CD4 and MHC-I alpha, which are induced to degradation by the HIV-1 protein Vpu and by the CMV immunoevasins US2 and US11, respectively, p97 and YOD1 have a retro-translocation-triggering role. In contrast, for three other spontaneous ERAD model substrates (NS1, NHK-alpha 1AT, and BST-2/Tetherin), p97 and YOD1 are required in the downstream events of substrate deglycosylation and proteasomal degradation.	[Sasset, Linda; Cesaratto, Francesca; Burrone, Oscar R.] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy; [Petris, Gianluca] Univ Trento, CIBIO, I-38123 Mattarello, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trento	Petris, G (corresponding author), Univ Trento, CIBIO, Via Regole 101, I-38123 Mattarello, Italy.	gianluca.petris@unitn.it; burrone@icgeb.org	Sasset, Linda/AAC-3131-2020; Petris, Gianluca/N-9754-2018	Sasset, Linda/0000-0001-5298-2374; Petris, Gianluca/0000-0002-2420-6359	ICGEB predoctoral fellowships	ICGEB predoctoral fellowships	Supported by ICGEB predoctoral fellowships.	Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; Baker BM, 2007, J BIOL CHEM, V282, P26845, DOI 10.1074/jbc.M704315200; Ballar P, 2008, BIOCHEM SOC T, V36, P818, DOI 10.1042/BST0360818; Bernardi KM, 2013, MOL BIOL CELL, V24, P3545, DOI 10.1091/mbc.E13-06-0332; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chou TF, 2011, AUTOPHAGY, V7, P1091, DOI 10.4161/auto.7.9.16489; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Claessen JHL, 2010, J BIOL CHEM, V285, P20732, DOI 10.1074/jbc.M110.120766; Dantuma NP, 2012, TRENDS CELL BIOL, V22, P483, DOI 10.1016/j.tcb.2012.06.003; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Hendershot L, 1996, P NATL ACAD SCI USA, V93, P5269, DOI 10.1073/pnas.93.11.5269; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Leitzgen K, 1997, J BIOL CHEM, V272, P3117, DOI 10.1074/jbc.272.5.3117; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Omura T, 2008, J PHARMACOL SCI, V106, P512, DOI 10.1254/jphs.08005FP; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Petris G, 2014, J BIOL CHEM, V289, P1, DOI 10.1074/jbc.M113.512368; Petris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023712; Predonzani A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-41; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Rutledge AC, 2009, ARTERIOSCL THROM VAS, V29, P579, DOI 10.1161/ATVBAHA.108.181859; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Story CM, 1999, P NATL ACAD SCI USA, V96, P8516, DOI 10.1073/pnas.96.15.8516; Vecchi L, 2012, J BIOL CHEM, V287, P20007, DOI 10.1074/jbc.M112.355107; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	68	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28175	28188		10.1074/jbc.M115.656660	http://dx.doi.org/10.1074/jbc.M115.656660			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26463207	Green Published, hybrid			2022-12-26	WOS:000365761900013
J	Chung, FH; Jin, ZH; Hsu, TT; Hsu, CL; Liu, HC; Lee, HC				Chung, Feng-Hsiang; Jin, Zhen-Hua; Hsu, Tzu-Ting; Hsu, Chueh-Lin; Liu, Hsueh-Chuan; Lee, Hoong-Chien			Gene-Set Local Hierarchical Clustering (GSLHC)-A Gene Set-Based Approach for Characterizing Bioactive Compounds in Terms of Biological Functional Groups	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; CANCER-CELLS; KINASE INHIBITOR; EXPRESSION DATA; DISCOVERY; MICROARRAY; TOOL; INVOLVEMENT; MECHANISM; APOPTOSIS	Gene-set-based analysis (GSA), which uses the relative importance of functional gene-sets, or molecular signatures, as units for analysis of genome-wide gene expression data, has exhibited major advantages with respect to greater accuracy, robustness, and biological relevance, over individual gene analysis (IGA), which uses log-ratios of individual genes for analysis. Yet IGA remains the dominant mode of analysis of gene expression data. The Connectivity Map (CMap), an extensive database on genomic profiles of effects of drugs and small molecules and widely used for studies related to repurposed drug discovery, has been mostly employed in IGA mode. Here, we constructed a GSA-based version of CMap, Gene-Set Connectivity Map (GSCMap), in which all the genomic profiles in CMap are converted, using gene-sets from the Molecular Signatures Database, to functional profiles. We showed that GSCMap essentially eliminated cell-type dependence, a weakness of CMap in IGA mode, and yielded significantly better performance on sample clustering and drug-target association. As a first application of GSCMap we constructed the platform Gene-Set Local Hierarchical Clustering (GSLHC) for discovering insights on coordinated actions of biological functions and facilitating classification of heterogeneous subtypes on drug-driven responses. GSLHC was shown to tightly clustered drugs of known similar properties. We used GSLHC to identify the therapeutic properties and putative targets of 18 compounds of previously unknown characteristics listed in CMap, eight of which suggest anti-cancer activities. The GSLHC website http://cloudr.ncu.edu.tw/gslhc/contains 1,857 local hierarchical clusters accessible by querying 555 of the 1,309 drugs and small molecules listed in CMap. We expect GSCMap and GSLHC to be widely useful in providing new insights in the biological effect of bioactive compounds, in drug repurposing, and in function-based classification of complex diseases.	[Chung, Feng-Hsiang; Jin, Zhen-Hua; Hsu, Tzu-Ting; Hsu, Chueh-Lin; Liu, Hsueh-Chuan; Lee, Hoong-Chien] Natl Cent Univ, Inst Syst Biol & Bioinformat, Zhongli 32001, Taiwan; [Chung, Feng-Hsiang; Lee, Hoong-Chien] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Zhongli 32001, Taiwan; [Lee, Hoong-Chien] Chung Yuan Christian Univ, Dept Phys, Zhongli 32023, Taiwan; [Lee, Hoong-Chien] Natl Ctr Theoret Sci, Div Phys, Hsinchu 30043, Taiwan	National Central University; National Central University; Chung Yuan Christian University	Lee, HC (corresponding author), Natl Cent Univ, Inst Syst Biol & Bioinformat, Zhongli 32001, Taiwan.	hclee12345@gmail.com			Ministry of Science and Technology (Republic of China) [NSC-102-2911-I-008-001, NSC-100-2911-I-008-001, NSC-100-2627-M-008-004]; Ministry of Education (Republic of China) [100CGH-NCU-A5, 101CGH-NCU-A5]; National Central University [10110021-5, 10210061-5]; Cathay General Hospital	Ministry of Science and Technology (Republic of China); Ministry of Education (Republic of China)(Ministry of Education, Taiwan); National Central University; Cathay General Hospital	This work was supported by grants NSC-102-2911-I-008-001, NSC-100-2911-I-008-001, NSC-100-2627-M-008-004, Ministry of Science and Technology (Republic of China) http://www.most.gov.tw/; Grants 100CGH-NCU-A5, 101CGH-NCU-A5, Ministry of Education (Republic of China) http://english.moe.gov.tw/; Grants 10110021-5, 10210061-5, National Central University http://www.ncu.edu.tw/?hl=en; and Cathay General Hospital http://www.cgh.org.tw/en/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramadhaka LR, 2013, TOXICON, V69, P160, DOI 10.1016/j.toxicon.2013.03.018; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balakin KV, 2007, ANTI-CANCER AGENT ME, V7, P576, DOI 10.2174/187152007781668698; Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; Ben-Dor A, 2003, J COMPUT BIOL, V10, P373, DOI 10.1089/10665270360688075; Breslin T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-193; Chen F, 2013, AM J ALZHEIMERS DIS, V28, P693, DOI 10.1177/1533317513500838; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Damian D, 2004, NAT GENET, V36, P663, DOI 10.1038/ng0704-663a; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Garcia P, 1999, MOL MICROBIOL, V31, P1275, DOI 10.1046/j.1365-2958.1999.01238.x; Garman KS, 2008, P NATL ACAD SCI USA, V105, P19432, DOI 10.1073/pnas.0806674105; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; HOLTJE JV, 1995, ARCH MICROBIOL, V164, P243, DOI 10.1007/s002030050261; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022274; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Iskar M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000925; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Keen JC, 2003, BREAST CANCER RES TR, V81, P177, DOI 10.1023/A:1026146524737; KELLER HU, 1989, INT J CANCER, V44, P934, DOI 10.1002/ijc.2910440531; Kemp MG, 2005, NUCLEIC ACIDS RES, V33, P325, DOI 10.1093/nar/gki177; Khan SA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-112; Kim JY, 2011, TOXICOLOGY, V289, P91, DOI 10.1016/j.tox.2011.07.014; Ko MW, 2008, J NEUROL SCI, V273, P144, DOI 10.1016/j.jns.2008.06.028; Lahusen T, 2003, MOL CARCINOGEN, V36, P183, DOI 10.1002/mc.10114; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Li QL, 2010, DRUG DISCOV TODAY, V15, P1052, DOI 10.1016/j.drudis.2010.10.003; Lottaz C, 2007, BIOINFORMATICS, V23, P2256, DOI 10.1093/bioinformatics/btm322; Manning CD, INTRO INFORM RETRIEV; Meng FL, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1057; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Mootha VK, 2004, NAT GENET, V36, P663, DOI 10.1038/ng0704-663b; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Pacini C, 2013, BIOINFORMATICS, V29, P132, DOI 10.1093/bioinformatics/bts656; Parkkinen JA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-113; Pavlidis P, 2003, METHODS, V31, P282, DOI 10.1016/S1046-2023(03)00157-9; Perez-Diez A, 2007, ADV EXP MED BIOL, V593, P74; Prifti E, 2008, BIOINFORMATICS, V24, P2636, DOI 10.1093/bioinformatics/btn492; Richon VM, 2006, BRIT J CANCER, V95, pS2, DOI 10.1038/sj.bjc.6603463; Rose MG, 2009, NAT REV CLIN ONCOL, V6, P502, DOI 10.1038/nrclinonc.2009.125; Sanders W E Jr, 1968, Int Anesthesiol Clin, V6, P211, DOI 10.1097/00004311-196806010-00019; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun CH, 2009, NUCLEIC ACIDS RES, V37, pW350, DOI 10.1093/nar/gkp331; Tamaoki J, 2005, ANTIBIOTICS ANTIINFL, Vxiii; TAN C, 1967, CANCER-AM CANCER SOC, V20, P333, DOI 10.1002/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulukan H, 2002, DRUGS, V62, P2039, DOI 10.2165/00003495-200262140-00004; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wang GP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014573; Wong DJ, 2008, CANCER RES, V68, P369, DOI 10.1158/0008-5472.CAN-07-0382; Wood ER, 2004, BIOORG MED CHEM LETT, V14, P953, DOI 10.1016/j.bmcl.2003.12.002; Yadav B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05193; Zaravinos A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018135; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	64	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0139889	10.1371/journal.pone.0139889	http://dx.doi.org/10.1371/journal.pone.0139889			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473729	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500017
J	Fan, SJ; Jiang, LY; Wu, JJ; Dong, LD; Cheng, Q; Xu, PF; Zhang, SZ				Fan, Sujie; Jiang, Liangyu; Wu, Junjiang; Dong, Lidong; Cheng, Qun; Xu, Pengfei; Zhang, Shuzhen			A Novel Pathogenesis-Related Class 10 Protein Gly m 4l, Increases Resistance upon Phytophthora sojae Infection in Soybean (Glycine max [L.] Merr.)	PLOS ONE			English	Article							BET V 1; GLY M 4; BARCELONA ASTHMA OUTBREAKS; BIRCH POLLEN ALLERGEN; APPLE MALUS-DOMESTICA; MOLECULAR-CLONING; JASMONIC ACID; YELLOW LUPINE; VITIS-PSEUDORETICULATA; PLASMOPARA-VITICOLA	Phytophthora root and stem rot of soybean, caused by Phytophthora sojae (P. sojae), is a destructive disease in many soybean planting regions worldwide. In a previous study, an expressed sequence tag (EST) homolog of the major allergen Pru ar 1 in apricot (Prunus armeniaca) was identified up-regulated in the highly resistant soybean 'Suinong 10' infected with P. sojae. Here, the full length of the EST was isolated using rapid amplification of cDNA ends (RACE). It showed the highest homolgy of 53.46% with Gly m 4 after comparison with the eight soybean allergen families reported and was named Gly m 4-like (Gly m 4l, GenBank accession no. HQ913577.1). The cDNA full length of Gly m 4l was 707 bp containing a 474 bp open reading frame encoding a polypeptide of 157 amino acids. Sequence analysis suggests that Gly m 4l contains a conserved 'P-loop' (phosphate-binding loop) motif at residues 47-55 aa and a Bet v 1 domain at residues 87-120 aa. The transcript abundance of Gly m 4l was significantly induced by P. sojae, salicylic acid (SA), NaCl, and also responded to methyl jasmonic acid (MeJA) and ethylene (ET). The recombinant Gly m 4l protein showed RNase activity and displayed directly antimicrobial activity that inhibited hyphal growth and reduced zoospore release in P. sojae. Further analyses showed that the RNase activity of the recombinant protein to degrading tRNA was significantly affected in the presence of zeatin. Over-expression of Gly m 4l in susceptible 'Dongnong 50' soybean showed enhanced resistance to P. sojae. These results indicated that Gly m 4l protein played an important role in the defense of soybean against P. sojae infection.	[Fan, Sujie; Jiang, Liangyu; Dong, Lidong; Cheng, Qun; Xu, Pengfei; Zhang, Shuzhen] Northeast Agr Univ, Soybean Res Inst, Chinese Educ Minist, Key Lab Soybean Biol, Harbin 150030, Heilongjiang, Peoples R China; [Wu, Junjiang] Heilongjiang Acad Agr Sci, Collaborat Innovat Ctr Grain Prod Capac Improveme, Soybean Res Inst, Harbin 150086, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Heilongjiang Academy of Agricultural Sciences	Xu, PF (corresponding author), Northeast Agr Univ, Soybean Res Inst, Chinese Educ Minist, Key Lab Soybean Biol, Harbin 150030, Heilongjiang, Peoples R China.	xupengfei@neau.edu.cn; zhangshuzhen@neau.edu.cn			Heilongjiang Province outstanding youth fund [JC201308]; NSFC [31071439, 31171577, 31101167]; Natural Science Foundation of Heilongjiang Province [C2015010]; Specialized Research Fund for the Doctoral Program of Higher Education [20112325120005]; Science and Technology Innovation Project in Harbin [2012RFQXN011, 2012RFXXN019]; Research Fund for Young Teachers through NEAU [2012 RCB 08]	Heilongjiang Province outstanding youth fund; NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science and Technology Innovation Project in Harbin; Research Fund for Young Teachers through NEAU	The research was supported through funding from the Heilongjiang Province outstanding youth fund (JC201308), NSFC Projects (31071439, 31171577, 31101167), Natural Science Foundation of Heilongjiang Province (C2015010), the Specialized Research Fund for the Doctoral Program of Higher Education (20112325120005), the Science and Technology Innovation Project in Harbin (2012RFQXN011, 2012RFXXN019), and the Research Fund for Young Teachers through NEAU (2012 RCB 08).	Agarwal GK, 2002, PROTEOMICS, V2, P947, DOI 10.1002/1615-9861(200208)2:8<947::AID-PROT947>3.0.CO;2-J; Agarwal P, 2014, MOL BIOL REP, V41, P599, DOI 10.1007/s11033-013-2897-4; Bahramnejad B, 2010, PLANT CELL REP, V29, P1235, DOI 10.1007/s00299-010-0909-6; Bantignies B, 2000, PLANT MOL BIOL, V42, P871, DOI 10.1023/A:1006475303115; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Berkner H, 2009, BIOSCIENCE REP, V29, P183, DOI 10.1042/BSR20080117; Biesiadka J, 2002, J MOL BIOL, V319, P1223, DOI 10.1016/S0022-2836(02)00385-6; Borsics T, 2002, J EXP BOT, V53, P1831, DOI 10.1093/jxb/erf039; Breiteneder H, 2000, J ALLERGY CLIN IMMUN, V106, P27, DOI 10.1067/mai.2000.106929; Chacon O, 2010, GENE, V452, P54, DOI 10.1016/j.gene.2009.11.011; Christensen AB, 2002, MOL PLANT PATHOL, V3, P135, DOI 10.1046/j.1364-3703.2002.00105.x; Codina R, 1999, INT ARCH ALLERGY IMM, V119, P69, DOI 10.1159/000024178; Codina R, 1997, CLIN EXP ALLERGY, V27, P424, DOI 10.1046/j.1365-2222.1997.d01-514.x; Colditz F, 2007, PLANTA, V226, P57, DOI 10.1007/s00425-006-0466-y; CROWELL DN, 1992, PLANT MOL BIOL, V18, P459, DOI 10.1007/BF00040662; Enkerli K, 1997, CAN J BOT, V75, P1493, DOI 10.1139/b97-864; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fernandes H, 2013, FEBS J, V280, P1169, DOI 10.1111/febs.12114; Fujimoto Y, 1998, EUR J BIOCHEM, V258, P794, DOI 10.1046/j.1432-1327.1998.2580794.x; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gao ZS, 2005, THEOR APPL GENET, V111, P171, DOI 10.1007/s00122-005-2018-4; Geng T, 2015, J AGR FOOD CHEM, V63, P4947, DOI 10.1021/acs.jafc.5b00792; Hadjiivanova C, 2001, BULG J PLANT PHYSL, V27, P101; Hashimoto M, 2004, PLANT CELL PHYSIOL, V45, P550, DOI 10.1093/pcp/pch063; He MY, 2013, PROTOPLASMA, V250, P129, DOI 10.1007/s00709-012-0384-8; HoffmannSommergruber K, 1997, GENE, V197, P91, DOI 10.1016/S0378-1119(97)00246-1; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Holzhauser T, 2009, J ALLERGY CLIN IMMUN, V123, P452, DOI 10.1016/j.jaci.2008.09.034; Ito K, 2015, CHEM IMMUNOL ALLERGY, V101, P145, DOI 10.1159/000375468; Jellouli N, 2008, J PLANT PHYSIOL, V165, P471, DOI 10.1016/j.jplph.2007.02.009; Julka S, 2012, ANAL CHEM, V84, P10019, DOI 10.1021/ac3024685; Jwa NS, 2001, BIOCHEM BIOPH RES CO, V286, P973, DOI 10.1006/bbrc.2001.5507; Kim SG, 2011, MOL CELLS, V31, P25, DOI 10.1007/s10059-011-0004-z; Kim ST, 2004, PROTEOMICS, V4, P3569, DOI 10.1002/pmic.200400999; Kim ST, 2008, PLANT CELL REP, V27, P593, DOI 10.1007/s00299-007-0485-6; Kim YJ, 2014, PLANT CELL TISS ORG, V118, P531, DOI 10.1007/s11240-014-0505-5; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; Koistinen KM, 2005, PHYTOCHEMISTRY, V66, P2524, DOI 10.1016/j.phytochem.2005.09.007; Lee OR, 2012, MOL BIOL REP, V39, P2365, DOI 10.1007/s11033-011-0987-8; Liu JJ, 2003, PHYSIOL PLANTARUM, V119, P544, DOI 10.1046/j.1399-3054.2003.00200.x; Liu XJ, 2006, J PLANT PHYSIOL, V163, P546, DOI 10.1016/j.jplph.2005.04.031; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Maillot P, 2009, PLANT PHYSIOL BIOCH, V47, P743, DOI 10.1016/j.plaphy.2009.03.016; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; Mellersh DG, 2002, PLANT J, V29, P257, DOI 10.1046/j.0960-7412.2001.01215.x; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Park CJ, 2004, PLANT J, V37, P186, DOI 10.1046/j.1365-313X.2003.01951.x; Pasternak O, 2006, PLANT CELL, V18, P2622, DOI 10.1105/tpc.105.037119; Paz MM, 2004, EUPHYTICA, V136, P167, DOI 10.1023/B:EUPH.0000030670.36730.a4; Peters S, 2011, TRANSGENIC RES, V20, P547, DOI 10.1007/s11248-010-9435-0; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Poupard P, 2001, AUST J PLANT PHYSIOL, V28, P57; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Rakwal R, 1999, ELECTROPHORESIS, V20, P3472, DOI 10.1002/(SICI)1522-2683(19991101)20:17<3472::AID-ELPS3472>3.0.CO;2-0; Rakwal R, 2001, PLANT SCI, V161, P469, DOI 10.1016/S0168-9452(01)00433-2; Rihs HP, 1999, J ALLERGY CLIN IMMUN, V104, P1293, DOI 10.1016/S0091-6749(99)70027-8; Robert N, 2001, EUR J PLANT PATHOL, V107, P249, DOI 10.1023/A:1011241001383; Samanani N, 2004, PLANT J, V40, P302, DOI 10.1111/j.1365-313X.2004.02210.x; Sampson HA, 2015, SOY REACTIVITY MAY B; Scheurer S, 1997, MOL IMMUNOL, V34, P619, DOI 10.1016/S0161-5890(97)00072-2; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Sikorski MM, 1999, PLANT SCI, V149, P125, DOI 10.1016/S0168-9452(99)00148-X; SOMSSICH IE, 1986, P NATL ACAD SCI USA, V83, P2427, DOI 10.1073/pnas.83.8.2427; Utriainen M, 1998, PLANT CELL ENVIRON, V21, P821, DOI 10.1046/j.1365-3040.1998.00326.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; VANEKKREBITZ M, 1995, BIOCHEM BIOPH RES CO, V214, P538, DOI 10.1006/bbrc.1995.2320; Walter MH, 1996, EUR J BIOCHEM, V239, P281, DOI 10.1111/j.1432-1033.1996.0281u.x; WALTER MH, 1990, MOL GEN GENET, V222, P353, DOI 10.1007/BF00633840; Wang HX, 2001, INT J BIOCHEM CELL B, V33, P483, DOI 10.1016/S1357-2725(01)00038-3; Wang L, 2014, INT J MOL SCI, V15, P19162, DOI 10.3390/ijms151019162; WARD EWB, 1979, PHYTOPATHOLOGY, V69, P951, DOI 10.1094/Phyto-69-951; Wen J, 1997, MOL PHYLOGENET EVOL, V8, P317, DOI 10.1006/mpev.1997.0447; Wisniewski M, 2004, TREE PHYSIOL, V24, P339, DOI 10.1093/treephys/24.3.339; Wood NT, 2000, PLANT J, V24, P335, DOI 10.1046/j.1365-313x.2000.00881.x; Xu PF, 2012, J INTEGR AGR, V11, P368, DOI 10.1016/S2095-3119(12)60021-5; Xu PF, 2014, MOL BIOL REP, V41, P4899, DOI 10.1007/s11033-014-3356-6; Xu TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095102; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang SZ, 2010, PLANT DIS, V94, P87, DOI 10.1094/PDIS-94-1-0087; Zubini P, 2009, PLANT PHYSIOL, V150, P1235, DOI 10.1104/pp.109.139543	82	18	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140364	10.1371/journal.pone.0140364	http://dx.doi.org/10.1371/journal.pone.0140364			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474489	gold, Green Submitted, Green Published			2022-12-26	WOS:000363185500043
J	Forlim, CG; Pinto, RD; Varona, P; Rodriguez, FB				Forlim, Caroline Garcia; Pinto, Reynaldo Daniel; Varona, Pablo; Rodriguez, Francisco B.			Delay-Dependent Response in Weakly Electric Fish under Closed-Loop Pulse Stimulation	PLOS ONE			English	Article							ORGAN DISCHARGE PATTERNS; MORMYRID FISH; GNATHONEMUS-PETERSII; AGONISTIC BEHAVIOR; JAMMING AVOIDANCE; ECHO RESPONSE; COMMUNICATION; MECHANISMS; ELECTROLOCATION; SIGNALS	In this paper, we apply a real time activity-dependent protocol to study how freely swimming weakly electric fish produce and process the timing of their own electric signals. Specifically, we address this study in the elephant fish, Gnathonemus petersii, an animal that uses weak discharges to locate obstacles or food while navigating, as well as for electro-communication with conspecifics. To investigate how the inter pulse intervals vary in response to external stimuli, we compare the response to a simple closed-loop stimulation protocol and the signals generated without electrical stimulation. The activity-dependent stimulation protocol explores different stimulus delivery delays relative to the fish's own electric discharges. We show that there is a critical time delay in this closed-loop interaction, as the largest changes in inter pulse intervals occur when the stimulation delay is below 100 ms. We also discuss the implications of these findings in the context of information processing in weakly electric fish.	[Forlim, Caroline Garcia] Univ Sao Paulo, Inst Fis, Lab Fenomenos Naolineares, BR-01498 Sao Paulo, Brazil; [Pinto, Reynaldo Daniel] Univ Sao Paulo, Inst Fis Sao Carlos, Lab Neurodinam Neurobiofis, Sao Carlos, SP, Brazil; [Varona, Pablo; Rodriguez, Francisco B.] Univ Autonoma Madrid, Escuela Politecn Super, Dept Ingn Informat, Grp Neurocomputac Biol, Madrid, Spain	Universidade de Sao Paulo; Universidade de Sao Paulo; Autonomous University of Madrid	Forlim, CG (corresponding author), Univ Ghent, Dept Data Anal, Fac Psychol & Educ Sci, B-9000 Ghent, Belgium.	Caroline.GarciaForlim@ugent.be	de Borja Rodriguez, Francisco/F-7812-2013; Varona, Pablo/B-5583-2012; Forlim, Caroline G/GLU-9139-2022	de Borja Rodriguez, Francisco/0000-0003-4053-099X; Varona, Pablo/0000-0002-1754-8991; Forlim, Caroline G/0000-0003-4709-7797	Sao Paulo Research Foundation; Coordenacao de Aperfeicoamento de Pessoal de nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Ministerio de Economia y Competitividad [TIN-2010-19607, TIN-2012-30883]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio de Economia y Competitividad(Spanish Government)	This work was funded by Sao Paulo Research Foundation (http://www.fapesp.br.443/en/) (CGF, RDP), Coordenacao de Aperfeicoamento de Pessoal de nivel Superior (http://www.capes.gov.br/) (CGF, RDP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) (RDP), Ministerio de Economia y Competitividad TIN-2010-19607 (http://www.mineco.gob.es/) (FBR), and Ministerio de Economia y Competitividad TIN-2012-30883 (http://www.mineco.gob.es/) (PV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar P, 2007, J NEUROSCI METH, V166, P66, DOI 10.1016/j.jneumeth.2007.06.020; Arnegard ME, 2006, J EXP BIOL, V209, P2182, DOI 10.1242/jeb.02239; Arnegard ME, 2005, P ROY SOC B-BIOL SCI, V272, P1305, DOI 10.1098/rspb.2005.3101; Baker CA, 2013, J EXP BIOL, V216, P2365, DOI 10.1242/jeb.082289; BELL CC, 1974, J COMP PHYSIOL, V92, P201, DOI 10.1007/BF00694506; BULLOCK TH, 1969, BRAIN BEHAV EVOLUT, V2, P85, DOI 10.1159/000125815; Bullock TH, 2005, ELECTRORECEPTION; Caputi AA, 2002, J PHYSIOLOGY-PARIS, V96, P493, DOI 10.1016/S0928-4257(03)00005-6; Carlson BA, 2002, J PHYSIOLOGY-PARIS, V96, P405, DOI 10.1016/S0928-4257(03)00019-6; Carlson BA, 2013, J NEUROGENET, V27, P106, DOI 10.3109/01677063.2013.799670; Chamorro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040887; Cleveland WS., 1993, VISUALIZING DATA; Cowan NJ, 2007, J NEUROSCI, V27, P1123, DOI 10.1523/JNEUROSCI.4198-06.2007; Fernandez-Vargas J, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00027; Forlim C, 2013, BMC NEUROSCI S1, V14, P405; Forlim CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084885; HEILIGENBERG W, 1976, J COMP PHYSIOL, V109, P357, DOI 10.1007/BF00663615; HOPKINS CD, 1986, BRAIN BEHAV EVOLUT, V29, P77, DOI 10.1159/000118673; KRAMER B, 1979, BEHAV ECOL SOCIOBIOL, V6, P67, DOI 10.1007/BF00293246; KRAMER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P45, DOI 10.1007/BF00299952; KRAMER B, 1974, J COMP PHYSIOL, V93, P203, DOI 10.1007/BF00607000; KRAMER B, 1994, ADV STUD BEHAV, V23, P233, DOI 10.1016/S0065-3454(08)60355-1; Lebastard V, 2013, INT J ROBOT RES, V32, P172, DOI 10.1177/0278364912470181; Madhav MS, 2013, J EXP BIOL, V216, P4272, DOI 10.1242/jeb.088922; Mileva G, 2008, J PHYSIOL-PARIS, V102, P173, DOI 10.1016/j.jphysparis.2008.10.012; MOLLER P, 1970, ANIM BEHAV, V18, P768, DOI 10.1016/0003-3472(70)90026-6; Muniz C, 2009, BMC NEUROSCI S1, V10, pP49, DOI DOI 10.1186/1471-2202-10-S1-P49; Nogueira J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022159; Post N, 1999, PHYSIOL BEHAV, V68, P115, DOI 10.1016/S0031-9384(99)00153-5; Roth E, 2014, CURR OPIN NEUROBIOL, V25, P54, DOI 10.1016/j.conb.2013.11.005; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Ruiz S, 2014, BIOL PSYCHOL, V95, P4, DOI 10.1016/j.biopsycho.2013.04.010; RUSSELL CJ, 1974, J COMP PHYSIOL, V92, P181, DOI 10.1007/BF00694505; Schalk Gerwin, 2011, IEEE Rev Biomed Eng, V4, P140, DOI 10.1109/RBME.2011.2172408; Schuster S, 2001, J EXP BIOL, V204, P1401; TEYSSEDRE C, 1986, BEHAV PROCESS, V12, P77, DOI 10.1016/0376-6357(86)90073-2; Varona P., 2011, BMC NEUROSCI S1, V12, pP358, DOI [DOI 10.1186/1471-2202-12-S1-P358, 10.1186/1471-2202-12-S1-P358]; von der Emde G, 1998, NATURE, V395, P890, DOI 10.1038/27655; von der Emde G, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00026	39	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0141007	10.1371/journal.pone.0141007	http://dx.doi.org/10.1371/journal.pone.0141007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473597	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500136
J	Lauhkonen, E; Koponen, P; Terasjarvi, J; Grondahl-Yli-Hannuksela, K; Vuononvirta, J; Nuolivirta, K; Toikka, JO; Helminen, M; He, QS; Korppi, M				Lauhkonen, Eero; Koponen, Petri; Terasjarvi, Johanna; Grondahl-Yli-Hannuksela, Kirsi; Vuononvirta, Juho; Nuolivirta, Kirsi; Toikka, Jyri O.; Helminen, Merja; He, Qiushui; Korppi, Matti			IL-10 Gene Polymorphisms Are Associated with Post-Bronchiolitis Lung Function Abnormalities at Six Years of Age	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RESPIRATORY SYNCYTIAL VIRUS; RHINOVIRUS BRONCHIOLITIS; IMPULSE OSCILLOMETRY; PRESCHOOL-CHILDREN; PROMOTER; ASTHMA; HAPLOTYPES; PHENOTYPES	Aim Interleukin-10 (IL-10) has been associated with wheezing and asthma in children and the genetic variation of the IL-10 cytokine production may be linked to post-bronchiolitis lung function. We used impulse oscillometry (IOS) to evaluate the associations of IL10 polymorphisms with lung function at a median age of 6.3 years in children hospitalised for bronchiolitis before six months of age. Methods We performed baseline and post-exercise IOS on 103 former bronchiolitis patients. Data on single nucleotide polymorphisms (SNP) of IL10 rs1800896 (-1082G/A), rs1800871 (-819C/T), rs1800872 (-592C/A) were available for 99 children and of IL10 rs1800890 (-3575T/A) for 98 children. Results IL10 rs1800896, rs1800871 and rs1800872 combined genotype AA+CT+CA and carriage of haplotype ATA, respectively, were associated with higher resistance and lower reactance in baseline IOS in adjusted analyses. At IL10 rs1800890, the A/A-genotype and carriers of A-allele were associated with lower reactance in baseline IOS. There were no significant associations between the studied SNPs and airway hyper-reactivity to exercise. Conclusion Low-IL-10-producing polymorphisms in the IL-10 encoding gene were associated with obstructive lung function parameters, suggesting an important role for IL-10 in development of lung function deficit in early bronchiolitis patients.	[Lauhkonen, Eero; Koponen, Petri; Helminen, Merja; Korppi, Matti] Tampere Univ, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland; [Lauhkonen, Eero; Koponen, Petri; Helminen, Merja; Korppi, Matti] Tampere Univ Hosp, Tampere, Finland; [Terasjarvi, Johanna; Grondahl-Yli-Hannuksela, Kirsi; Vuononvirta, Juho; He, Qiushui] Turku Univ, Dept Med Microbiol & Immunol, Turku, Finland; [Terasjarvi, Johanna; Grondahl-Yli-Hannuksela, Kirsi; Vuononvirta, Juho; He, Qiushui] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Turku, Finland; [Nuolivirta, Kirsi] Seinajoki Cent Hosp, Seinajoki, Finland; [Toikka, Jyri O.] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland; [Toikka, Jyri O.] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Turku; Finland National Institute for Health & Welfare; Seinajoki Central Hospital; Tampere University; Tampere University Hospital; University of Turku	Lauhkonen, E (corresponding author), Tampere Univ, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland.	eero.lauhkonen@fimnet.fi		Lauhkonen, Eero/0000-0003-4654-7602				Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Bont L, 2000, AM J RESP CRIT CARE, V161, P1518, DOI 10.1164/ajrccm.161.5.9904078; Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; DUBOIS AB, 1956, J APPL PHYSIOL, V8, P587, DOI 10.1152/jappl.1956.8.6.587; Eskdale J, 1999, GENES IMMUN, V1, P151, DOI 10.1038/sj.gene.6363656; Garcia C, 2012, PEDIATR INFECT DIS J, V31, P86, DOI 10.1097/INF.0b013e31822dc8c1; Gibson AW, 2001, J IMMUNOL, V166, P3915, DOI 10.4049/jimmunol.166.6.3915; Helminen M, 2008, PEDIATR PULM, V43, P391, DOI 10.1002/ppul.20793; Hyun MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053758; Koponen P, 2012, EUR RESPIR J, V39, P76, DOI 10.1183/09031936.00040211; Koponen P, 2014, PEDIATR PULM, V49, P800, DOI 10.1002/ppul.22909; Lauhkonen E, 2015, PEDIATR PULM, V50, P908, DOI 10.1002/ppul.23085; Lauhkonen E, 2015, PEDIATR PULM, V50, P389, DOI 10.1002/ppul.23039; Lyon H, 2004, GENET EPIDEMIOL, V26, P155, DOI 10.1002/gepi.10298; Makela MJ, 2000, P NATL ACAD SCI USA, V97, P6007, DOI 10.1073/pnas.100118997; Malmberg LP, 2008, PEDIATR PULM, V43, P538, DOI 10.1002/ppul.20805; Malmberg LP, 2002, CLIN PHYSIOL FUNCT I, V22, P64, DOI 10.1046/j.1365-2281.2002.00396.x; Mok CC, 1998, ARTHRITIS RHEUM, V41, P1090, DOI 10.1002/1529-0131(199806)41:6<1090::AID-ART16>3.0.CO;2-6; Nuolivirta K, 2009, PEDIATR INFECT DIS J, V28, P1121, DOI 10.1097/INF.0b013e3181af37ee; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Smith H, 2005, EUR RESP SOC MONOGR, V31, P75; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Vuononvirta J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026198	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140799	10.1371/journal.pone.0140799	http://dx.doi.org/10.1371/journal.pone.0140799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473365	gold, Green Published, Green Submitted			2022-12-26	WOS:000363185500114
J	Martincic, R; Mravljak, J; Svajger, U; Perdih, A; Anderluh, M; Novic, M				Martincic, Rok; Mravljak, Janez; Svajger, Urban; Perdih, Andrej; Anderluh, Marko; Novic, Marjana			In Silico Discovery of Novel Potent Antioxidants on the Basis of Pulvinic Acid and Coumarine Derivatives and Their Experimental Evaluation	PLOS ONE			English	Article							CENTER-DOT ASSAY; SCAVENGING ACTIVITY; PROOXIDANT ACTIVITIES; PHENOLIC-COMPOUNDS; VALIDATION; CAPACITY; QSAR; CURCUMIN; PHARMACOPHORE; POLYPHENOLS	A pigment from the edible mushroom Xerocomus badius norbadione A, which is a natural derivative of pulvinic acid, was found to possess antioxidant properties. Since the pulvinic acid represents a novel antioxidant scaffold, several other derivatives were recently synthetized and evaluated experimentally, along with some structurally related coumarine derivatives. The obtained data formed the basis for the construction of several quantitative structure-activity and pharmacophore models, which were employed in the virtual screening experiments of compound libraries and for the prediction of their antioxidant activity, with the goal of discovering novel compounds possessing antioxidant properties. A final prioritization list of 21 novel compounds alongside 8 established antioxidant compounds was created for their experimental evaluation, consisting of the DPPH assay, 2-deoxyribose assay, beta-carotene bleaching assay and the cellular antioxidant activity assay. Ten novel compounds from the tetronic acid and barbituric acid chemical classes displayed promising antioxidant activity in at least one of the used assays, that is comparable to or even better than some standard antioxidants. Compounds 5, 7 and 9 displayed good activity in all the assays, and were furthermore effective preventers of oxidative stress in human peripheral blood mononuclear cells, which are promising features for the potential therapeutic use of such compounds.	[Martincic, Rok; Novic, Marjana] Natl Inst Chem Slovenia, Lab Chemometr, Ljubljana 1000, Slovenia; [Mravljak, Janez; Anderluh, Marko] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia; [Svajger, Urban] Blood Transfus Ctr Slovenia, Ljubljana 1000, Slovenia; [Perdih, Andrej] Natl Inst Chem Slovenia, Lab Biocomp & Bioinformat, Ljubljana 1000, Slovenia	National Institute of Chemistry - Slovenia; University of Ljubljana; National Institute of Chemistry - Slovenia	Martincic, R (corresponding author), Natl Inst Chem Slovenia, Lab Chemometr, Hajdrihova 19, Ljubljana 1000, Slovenia.	rok.martincic@ki.si	Mravljak, Janez/ABC-8040-2020; Anderluh, Marko/B-7170-2008; Perdih, Andrej/T-7029-2018; Švajger, Urban/AAQ-1756-2020; Mravljak, Janez/GRX-7308-2022; Švajger, Urban/ABD-8035-2021	Mravljak, Janez/0000-0003-4591-3455; Anderluh, Marko/0000-0003-1768-8246; Perdih, Andrej/0000-0002-6645-9231; Švajger, Urban/0000-0002-1908-4254	Slovenian Research Agency (ARRS) through the ARRS Research Program [P1-0017, P1-0012]; PhD grant for Rok Martincic	Slovenian Research Agency (ARRS) through the ARRS Research Program; PhD grant for Rok Martincic	The study was funded by the Slovenian Research Agency (ARRS) (url: https://www.arrs.gov.si/en/novo.asp) through the ARRS Research Program Grants P1-0017, P1-0012, and a PhD grant for Rok Martincic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abas F, 2006, Z NATURFORSCH C, V61, P625; Anuj Malik, 2011, Journal of Chemical and Pharmaceutical Research, V3, P659; Ao GZ, 2014, INT J MOL SCI, V15, P3970, DOI 10.3390/ijms15033970; ARUOMA OI, 1994, METHOD ENZYMOL, V233, P57; Biljali Sefedin, 2012, Folia Med (Plovdiv), V54, P42; Bortolomeazzi R, 2007, FOOD CHEM, V100, P1481, DOI 10.1016/j.foodchem.2005.11.039; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Burda S, 2001, J AGR FOOD CHEM, V49, P2774, DOI 10.1021/jf001413m; Burits M, 2000, PHYTOTHER RES, V14, P323, DOI 10.1002/1099-1573(200008)14:5&lt;323::AID-PTR621&gt;3.0.CO;2-Q; Carocho M, 2013, FOOD CHEM TOXICOL, V51, P15, DOI 10.1016/j.fct.2012.09.021; Chaillou LL, 2006, J AGR FOOD CHEM, V54, P8397, DOI 10.1021/jf061729f; Chen Z, 2013, FOOD CHEM, V138, P414, DOI 10.1016/j.foodchem.2012.11.001; Cheng ZH, 2006, J AGR FOOD CHEM, V54, P7429, DOI 10.1021/jf0611668; Cheng ZY, 2003, ANAL CHIM ACTA, V478, P129, DOI 10.1016/S0003-2670(02)01435-6; Dawidowicz A, 2010, EUR FOOD RES TECHNOL, V231, P835, DOI 10.1007/s00217-010-1333-4; Dror O, 2009, J CHEM INF MODEL, V49, P2333, DOI 10.1021/ci900263d; El Bakkali M, 2011, INT J MED CHEM, V2011, DOI 10.1155/2011/592879; Frankel EN, 2000, J SCI FOOD AGR, V80, P1925, DOI 10.1002/1097-0010(200010)80:13&lt;1925::AID-JSFA714&gt;3.0.CO;2-4; Genaro-Mattos TC, 2009, BBA-GEN SUBJECTS, V1790, P1636, DOI 10.1016/j.bbagen.2009.09.003; Gu BB, 2013, MOLECULES, V18, P7486, DOI 10.3390/molecules18077486; Habrant D, 2009, J MED CHEM, V52, P2454, DOI 10.1021/jm801500h; Hagerman AE, 1998, J AGR FOOD CHEM, V46, P1887, DOI 10.1021/jf970975b; HALLIWELL B, 1995, FREE RADICAL BIO MED, V18, P125, DOI 10.1016/0891-5849(95)91457-3; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hoffman R.D., 2006, PHARMACOPHORES PHARM; Hossain SU, 2007, BIOORG MED CHEM LETT, V17, P1149, DOI 10.1016/j.bmcl.2006.12.040; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Jaworska J, 2005, ATLA-ALTERN LAB ANIM, V33, P445, DOI 10.1177/026119290503300508; Jayaprakasha GK, 2004, BIOORGAN MED CHEM, V12, P5141, DOI 10.1016/j.bmc.2004.07.028; Jing P, 2012, MOLECULES, V17, P12910, DOI 10.3390/molecules171112910; Kerns EH, 2008, DRUG-LIKE PROPERTIES: CONCEPTS, STRUCTURE DESIGN AND METHODS, P1; Khanduja KL, 2003, INDIAN J BIOCHEM BIO, V40, P416; Kim JK, 2002, B KOREAN CHEM SOC, V23, P661; Kirchmair J, 2008, J COMPUT AID MOL DES, V22, P213, DOI 10.1007/s10822-007-9163-6; Langer T, 2008, PRACTICE OF MEDICINAL CHEMISTRY, 3RD EDITION, P210, DOI 10.1016/B978-0-12-374194-3.00010-X; Le Roux A, 2012, LETT DRUG DES DISCOV, V9, P48, DOI 10.2174/157018012798192900; Le Roux A, 2011, J CHEM INF MODEL, V51, P3050, DOI 10.1021/ci200205d; Li XC, 2011, FUNCT FOODS HEALTH D, V1, P232; LIN JK, 1994, CARCINOGENESIS, V15, P1717, DOI 10.1093/carcin/15.8.1717; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lu Y., 2014, Pharmacology and Pharmacy, V5, P395, DOI 10.4236/pp.2014.54047; Lu YR, 2000, FOOD CHEM, V68, P81, DOI 10.1016/S0308-8146(99)00167-3; Macrides TA, 1997, BIOCHEM MOL BIOL INT, V42, P1249; Martincic R, 2015, ANAL CHIM ACTA, V868, P23, DOI 10.1016/j.aca.2015.01.050; Meunier S, 2005, CHEMBIOCHEM, V6, P1234, DOI 10.1002/cbic.200400421; Meunier S, 2004, CHEMBIOCHEM, V5, P832, DOI 10.1002/cbic.200300787; Mishra K, 2012, FOOD CHEM, V130, P1036, DOI 10.1016/j.foodchem.2011.07.127; Mitra Indrani, 2013, Sci Pharm, V81, P57, DOI 10.3797/scipharm.1208-01; Mogana R, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/734824; Mogana R, 2013, ISRN Biotechnol, V2013, P986361, DOI 10.5402/2013/986361; Ndhlala AR, 2010, MOLECULES, V15, P6905, DOI 10.3390/molecules15106905; OECD, 2007, GUID DOC VAL QUANT S; Otajagic S., 2012, B CHEM TECHNOL BOSNI, V38, P35; Prieto MA, 2012, J AGR FOOD CHEM, V60, P8983, DOI 10.1021/jf302218g; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Queiroz AN, 2009, EUR J MED CHEM, V44, P1644, DOI 10.1016/j.ejmech.2008.09.023; Radice M., 2011, THESIS U FERRARA; Rebelo MM, 2009, REV BRAS FARMACOGN, V19, P230, DOI 10.1590/S0102-695X2009000200009; Roy K, 2012, J CHEM INF MODEL, V52, P396, DOI 10.1021/ci200520g; Rufino MSM, 2009, FOOD CHEM, V114, P693, DOI 10.1016/j.foodchem.2008.09.098; Sabudak T, 2013, PHYTOCHEMISTRY, V96, P305, DOI [10.1016/j.phytochem.2013.08.014, 1]; Sewell JC, 2006, ANESTH ANALG, V102, P764, DOI 10.1213/01.ane.0000195421.46107.d0; Shen M, 2004, J MED CHEM, V47, P2356, DOI 10.1021/jm030584q; Siatka T, 2010, MOLECULES, V15, P9450, DOI 10.3390/molecules15129450; Skedelj V, 2013, EUR J MED CHEM, V67, P208, DOI 10.1016/j.ejmech.2013.06.017; Song W, 2010, J AGR FOOD CHEM, V58, P6621, DOI 10.1021/jf9035832; Sykes MJ, 2006, J CHEM INF MODEL, V46, P2661, DOI 10.1021/ci600221h; Szelag M, 2015, OPEN CHEM, V13, P17, DOI 10.1515/chem-2015-0001; Traore K, 2005, LEUKEMIA RES, V29, P863, DOI 10.1016/j.leukres.2004.12.011; Triballeau N, 2005, J MED CHEM, V48, P2534, DOI 10.1021/jm049092j; Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061; van Reyk DM, 2001, FREE RADICAL BIO MED, V30, P82, DOI 10.1016/S0891-5849(00)00449-4; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Wang X., 2011, ASIAN J PHARM BIOL R, V1, P186; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Wolfe KL, 2007, J AGR FOOD CHEM, V55, P8896, DOI 10.1021/jf0715166; Wu CR, 2007, FOOD CHEM, V104, P1464, DOI 10.1016/j.foodchem.2007.02.023; Zhu LC, 2009, CHEM BIODIVERS, V6, P1716, DOI 10.1002/cbdv.200800248	80	8	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140602	10.1371/journal.pone.0140602	http://dx.doi.org/10.1371/journal.pone.0140602			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474393	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500072
J	Moriwaki, Y; Takada, K; Nagasaki, T; Kubo, N; Ishii, T; Kose, K; Kageyama, T; Tsuji, S; Kawashima, K; Misawa, H				Moriwaki, Yasuhiro; Takada, Kiyoko; Nagasaki, Toshinori; Kubo, Natsuki; Ishii, Tomohiro; Kose, Kazuaki; Kageyama, Taihei; Tsuji, Shoutaro; Kawashima, Koichiro; Misawa, Hidemi			IL-22/STAT3-Induced Increases in SLURP1 Expression within Psoriatic Lesions Exerts Antimicrobial Effects against Staphylococcus aureus	PLOS ONE			English	Article							SKIN INFLAMMATION; IL-22; DIFFERENTIATION; KERATINOCYTES; PEPTIDES; PROTEIN; MELEDA; CELLS; CYTOKINES; VULGARIS	Background SLURP1 is the causal gene for Mal de Meleda (MDM), an autosomal recessive skin disorder characterized by diffuse palmoplantar keratoderma and transgressive keratosis. Moreover, although SLURP1 likely serves as an important proliferation/differentiation factor in keratinocytes, the possible relation between SLURP1 and other skin diseases, such as psoriasis and atopic dermatitis, has not been studied, and the pathophysiological control of SLURP1 expression in keratinocytes is largely unknown. Objectives Our aim was to examine the involvement of SLURP1 in the pathophysiology of psoriasis using an imiquimod (IMQ)-induced psoriasis model mice and normal human epidermal keratinocytes (NHEKs). Results SLURP1 expression was up-regulated in the skin of IMQ-induced psoriasis model mice. In NHEKs stimulated with the inflammatory cytokines IL-17, IL-22 and TNF-alpha, which are reportedly expressed in psoriatic lesions, SLURP1 mRNA expression was significantly up-regulated by IL-22 but not the other two cytokines. The stimulatory effect of IL-22 was completely suppressed in NHEKs treated with a STAT3 inhibitor or transfected with siRNA targeting STAT3. Because IL-22 induces production of antimicrobial proteins in epithelial cells, the antibacterial activity of SLURP1 was assessed against Staphylococcus aureus (S. aureus), which is known to be associated with disease severity in psoriasis. SLURP1 significantly suppressed the growth of S. aureus. Conclusions These results indicate SLURP1 participates in pathophysiology of psoriasis by regulating keratinocyte proliferation and differentiation, and by suppressing the growth of S. aureus.	[Moriwaki, Yasuhiro; Takada, Kiyoko; Nagasaki, Toshinori; Kubo, Natsuki; Ishii, Tomohiro; Kose, Kazuaki; Misawa, Hidemi] Keio Univ, Dept Pharmacol, Fac Pharm, Minato Ku, Tokyo 1058512, Japan; [Kageyama, Taihei; Tsuji, Shoutaro] Kanagawa Canc Ctr, Res Inst, Mol Diagnost Project, Yokohama, Kanagawa 2410815, Japan; [Kawashima, Koichiro] Kitasato Univ, Sch Pharm, Dept Mol Pharmacol, Minato Ku, Tokyo, Japan	Keio University; Kanagawa Prefectural Cancer Center; Kitasato University	Moriwaki, Y (corresponding author), Keio Univ, Dept Pharmacol, Fac Pharm, Minato Ku, Tokyo 1058512, Japan.	moriwaki-ys@pha.keio.ac.jp; misawa-hd@pha.keio.ac.jp		Ishii, Tomohiro/0000-0003-3092-1401; Moriwaki, Yasuhiro/0000-0001-9533-0421	JSPS KAKENHI [15K21370, 23111006, 26460692]; MEXT KAKENHI [25293020, 24590120]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1411004]; Smoking Research Foundation; Naito Foundation; Hoansha Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation; Naito Foundation(Naito Memorial Foundation); Hoansha Foundation(Hoansha Foundation)	This work was supported in part by JSPS KAKENHI Grant Numbers 15K21370 (Y.M.), 23111006 (H.M.) and 26460692 (S.T.); MEXT KAKENHI Grant Numbers 25293020 (H.M.) and 24590120 (K.K.); MEXT-Supported Program (Grant Number S1411004) for the Strategic Research Foundation at Private Universities 2014-2016 (H.M.); the Smoking Research Foundation (K.K. and H.M.); The Naito Foundation (H.M.); and the Hoansha Foundation (H.M.).	Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; Adeyo O, 2014, J INVEST DERMATOL, V134, P1589, DOI 10.1038/jid.2014.19; Arredondo J, 2002, J CELL BIOL, V159, P325, DOI 10.1083/jcb.200206096; Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; Balci DD, 2009, EUR J DERMATOL, V19, P238, DOI 10.1684/ejd.2009.0663; Barker JN, 2007, LANCET, V370, P263; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Chernyavsky AI, 2012, WOUND REPAIR REGEN, V20, P103, DOI 10.1111/j.1524-475X.2011.00753.x; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fischer J, 2001, HUM MOL GENET, V10, P875, DOI 10.1093/hmg/10.8.875; Fujii T, 2014, J NEUROIMMUNOL, V267, P43, DOI 10.1016/j.jneuroim.2013.12.003; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1420, DOI 10.1016/j.jaci.2011.01.054; Kormeili T, 2004, BRIT J DERMATOL, V151, P3, DOI 10.1111/j.1365-2133.2004.06009.x; Li BS, 2014, J INVEST DERMATOL, V134, P1828, DOI 10.1038/jid.2014.28; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu HJ, 2006, EUR J DERMATOL, V16, P205; MARPLES RR, 1973, ARCH DERMATOL, V107, P568, DOI 10.1001/archderm.107.4.568; Mastrangeli R, 2003, EUR J DERMATOL, V13, P560; Moriwaki Y, 2009, NEUROSCI RES, V64, P403, DOI 10.1016/j.neures.2009.04.014; Niebuhr M, 2010, J ALLERGY CLIN IMMUN, V126, P1176, DOI 10.1016/j.jaci.2010.07.041; Nizri E, 2009, J IMMUNOL, V183, P6681, DOI 10.4049/jimmunol.0902212; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Rajesh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032633; Sakabe J, 2014, ACTA DERM-VENEREOL, V94, P512, DOI 10.2340/00015555-1775; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Tjiu JW, 2011, BRIT J DERMATOL, V164, P47, DOI 10.1111/j.1365-2133.2010.10059.x; Tomi NS, 2005, J AM ACAD DERMATOL, V53, P67, DOI 10.1016/j.jaad.2005.02.034; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; ZASLOFF M, 1988, P NATL ACAD SCI USA, V85, P910, DOI 10.1073/pnas.85.3.910	34	16	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140750	10.1371/journal.pone.0140750	http://dx.doi.org/10.1371/journal.pone.0140750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474319	gold, Green Submitted, Green Published			2022-12-26	WOS:000363185500101
J	Croome, KP; Lee, DD; Burns, JM; Perry, DK; Keaveny, AP; Taner, CB				Croome, Kristopher P.; Lee, David D.; Burns, Justin M.; Perry, Dana K.; Keaveny, Andrew P.; Taner, C. Burcin			Patterns and Outcomes Associated with Patient Migration for Liver Transplantation in the United States	PLOS ONE			English	Article							SURVIVAL; DISTANCE; ACCESS; IMPACT; TRAVEL; MELD	Background Traveling to seek specialized care such as liver transplantation (LT) is a reality in the United States. Patient migration has been attributed to organ availability. The aims of this study were to delineate patterns of patient migration and outcomes after LT. Study Design All deceased donor LT between 2008-2013 were extracted from UNOS data. Migrated patients were defined as those patients who underwent LT at a center in a different UNOS region from the region in which they resided and traveled a distance > 100 miles. Results Migrated patients comprised 8.2% of 28,700 LT performed. Efflux and influx of patients were observed in all 11 UNOS regions. Regions 1, 5, 6, and 9 had a net efflux, while regions 2, 3, 4, 7, 10, and 11 had a net influx of patients. After multivariate adjustment for donor and recipient factors, graft (p = 0.68) and patient survival (p = 0.52) were similar between migrated and non-migrated patients. Conclusion A significant number of patients migrated in patterns that could not be explained alone by regional variations in MELD score and wait time. Migration may be a complex interplay of factors including referral patterns, specialized services at centers of excellence and patient preference.	[Croome, Kristopher P.; Lee, David D.; Burns, Justin M.; Perry, Dana K.; Keaveny, Andrew P.; Taner, C. Burcin] Mayo Clin, Dept Transplant, Mayo Clin Collaborat Transplant Res & Outcomes, Jacksonville, FL 32224 USA	Mayo Clinic	Taner, CB (corresponding author), Mayo Clin, Dept Transplant, Mayo Clin Collaborat Transplant Res & Outcomes, Jacksonville, FL 32224 USA.	taner.burcin@mayo.edu	Keaveny, Andrew Paul/K-2599-2019; Croome, Kristopher/ABB-3908-2020; Lee, David/ABH-1406-2021	Keaveny, Andrew Paul/0000-0003-2355-2433; Croome, Kristopher/0000-0001-7725-703X; Lee, David/0000-0002-2086-0150	Mayo Clinic Collaborative in Transplant Research and Outcomes	Mayo Clinic Collaborative in Transplant Research and Outcomes	Funding provided internally by Mayo Clinic Collaborative in Transplant Research and Outcomes. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod DA, 2005, AM J TRANSPLANT, V5, P2297, DOI 10.1111/j.1600-6143.2005.01025.x; Croome KP, 2013, TRANSPL P, V45, P259, DOI 10.1016/j.transproceed.2012.07.147; Dzebisashvili N, 2013, TRANSPLANTATION, V95, P361, DOI 10.1097/TP.0b013e3182737cfb; EVANS RW, 1992, TRANSPLANTATION, V53, P1041, DOI 10.1097/00007890-199205000-00014; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Goldberg DS, 2014, JAMA-J AM MED ASSOC, V311, P1234, DOI 10.1001/jama.2014.2520; Kohn R, 2014, J AM COLL SURGEONS, V218, P1113, DOI 10.1016/j.jamcollsurg.2013.12.056; Lamont EB, 2003, JNCI-J NATL CANCER I, V95, P1370, DOI 10.1093/jnci/djg035; Longworth L, 2003, LIVER TRANSPLANT, V9, P1295, DOI 10.1016/j.lts.2003.09.012; Lucey MR, 2013, LIVER TRANSPLANT, V19, P3, DOI 10.1002/lt.23566; Merion RM, 2004, AM J TRANSPLANT, V4, P94, DOI 10.1046/j.1600-6135.2003.00282.x; Northup PG, 2015, HEPATOLOGY, V61, P285, DOI 10.1002/hep.27283; Ozhathil DK, 2011, LIVER TRANSPLANT, V17, P1191, DOI 10.1002/lt.22343; Rana A, 2014, CLIN TRANSPLANT; Rana A, 2015, TRANSPLANTATION, V99, P515, DOI 10.1097/TP.0000000000000372; Salvalaggio PR, 2011, LIVER TRANSPLANT, V17, P233, DOI 10.1002/lt.22230; Schuetz C, 2013, AM J TRANSPLANT, V13, P2989, DOI 10.1111/ajt.12441; Vagefi PA, 2014, J AM COLL SURGEONS, V219, P496, DOI 10.1016/j.jamcollsurg.2014.03.048; Washburn K, 2011, LIVER TRANSPLANT, V17, P1005, DOI 10.1002/lt.22349; Yeh HD, 2011, TRANSPLANTATION, V91, P479, DOI 10.1097/TP.0b013e3182066275	20	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140295	10.1371/journal.pone.0140295	http://dx.doi.org/10.1371/journal.pone.0140295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469071	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600036
J	Zhang, F; Yu, JL; Johnston, CR; Wang, YQ; Zhu, K; Lu, F; Zhang, ZP; Zou, JQ				Zhang, Fei; Yu, Jialin; Johnston, Christopher R.; Wang, Yanqiu; Zhu, Kai; Lu, Feng; Zhang, Zhipeng; Zou, Jianqiu			Seed Priming with Polyethylene Glycol Induces Physiological Changes in Sorghum (Sorghum bicolor L. Moench) Seedlings under Suboptimal Soil Moisture Environments	PLOS ONE			English	Article							HELIANTHUS-ANNUUS L.; PROLINE METABOLISM; OSMOTIC COMPONENTS; DROUGHT STRESS; TOLERANCE; GERMINATION; SALT; OSMOREGULATION; ESTABLISHMENT; ANTIOXIDANTS	Osmopriming with PEG has potential to improve seed germination, seedling emergence, and establishment, especially under stress conditions. This research investigated germination performance, seedling establishment, and effects of osmopriming with PEG on physiology in sorghum seedlings and their association with post-priming stress tolerance under various soil moisture stress conditions. Results showed that seed priming increased the environmental range suitable for sorghum germination and has potential to provide more uniform and synchronous emergence. Physiologically, seed priming strengthened the antioxidant activities of APX, CAT, POD, and SOD, as well as compatible solutes including free amino acid, reducing sugar, proline, soluble sugar, and soluble protein contents. As a result, seed priming reduced lipid peroxidation and stabilized the cell membrane, resulting in increased stress tolerance under drought or excessive soil moisture environments. Overall, results suggested that seed priming with PEG was effective in improving seed germination and seedling establishment of sorghum under adverse soil moisture conditions. Osmopriming effectively strengthened the antioxidant system and increased osmotic adjustment, likely resulting in increased stress tolerance.	[Zhang, Fei; Wang, Yanqiu; Zhu, Kai; Lu, Feng; Zhang, Zhipeng; Zou, Jianqiu] Liaoning Acad Agr Sci, Dept Innovat Ctr, Shenyang, Liaoning, Peoples R China; [Yu, Jialin; Johnston, Christopher R.] Univ Georgia, Dept Crop & Soil Sci, Griffin, GA 30223 USA	University System of Georgia; University of Georgia	Yu, JL (corresponding author), Univ Georgia, Dept Crop & Soil Sci, Griffin, GA 30223 USA.	yu3577@uga.edu; jianqiuzou@126.com	Wang, Yanbo/HFZ-8018-2022; wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022		Sorghum Research and Development Program, Ministry of Agriculture of the People's Republic of China [CARS-06]	Sorghum Research and Development Program, Ministry of Agriculture of the People's Republic of China	Financial assistance received from Sorghum Research and Development Program, Ministry of Agriculture of the People's Republic of China (CARS-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bai LP, 2006, PEDOSPHERE, V16, P326, DOI 10.1016/S1002-0160(06)60059-3; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen KT, 2011, PLANT SCI, V180, P212, DOI 10.1016/j.plantsci.2010.08.007; DAVISON EM, 1985, NEW PHYTOL, V101, P743, DOI 10.1111/j.1469-8137.1985.tb02879.x; Demir AO, 2006, IRRIGATION SCI, V24, P279, DOI 10.1007/s00271-006-0028-x; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P345, DOI 10.1016/0048-4059(83)90019-X; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Edge R, 1997, J PHOTOCH PHOTOBIO B, V41, P189, DOI 10.1016/S1011-1344(97)00092-4; Foyer C H, 2001, Biologist (London), V48, P115; Gao YP, 1999, PLANT MOL BIOL, V40, P635, DOI 10.1023/A:1006212216876; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; HANSON AD, 1982, ANNU REV PLANT PHYS, V33, P163, DOI 10.1146/annurev.pp.33.060182.001115; Hattori T, 2005, PHYSIOL PLANTARUM, V123, P459, DOI 10.1111/j.1399-3054.2005.00481.x; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hur S, 1991, KOREAN J ANIMAL SCI; HURNG WP, 1994, PLANT GROWTH REGUL, V14, P37, DOI 10.1007/BF00024139; Jisha KC, 2013, ACTA PHYSIOL PLANT, V35, P1381, DOI 10.1007/s11738-012-1186-5; Kaya MD, 2006, EUR J AGRON, V24, P291, DOI 10.1016/j.eja.2005.08.001; Kumar SG, 2003, PLANT SCI, V165, P1245, DOI 10.1016/S0168-9452(03)00332-7; Lin KHR, 2004, PLANT SCI, V167, P355, DOI 10.1016/j.plantsci.2004.04.004; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Manivannan P, 2007, COLLOID SURFACE B, V59, P141, DOI 10.1016/j.colsurfb.2007.05.002; MOORE S, 1948, J BIOL CHEM, V176, P367; MORGAN JM, 1992, AUST J PLANT PHYSIOL, V19, P67, DOI 10.1071/PP9920067; MORGAN JM, 1984, ANNU REV PLANT PHYS, V35, P299, DOI 10.1146/annurev.pp.35.060184.001503; NAKANO Y, 1980, PLANT CELL PHYSIOL, V21, P1295, DOI 10.1093/oxfordjournals.pcp.a076128; Noreen Z, 2010, J AGRON CROP SCI, V196, P273, DOI 10.1111/j.1439-037X.2010.00420.x; Parera C. A., 1994, Horticultural Reviews, V16, P109, DOI 10.1002/9780470650561.ch4; Parida AK, 2007, PLANT BIOTECHNOL REP, V1, P37, DOI 10.1007/s11816-006-0004-1; Ramanjulu S, 2002, PLANT CELL ENVIRON, V25, P141, DOI 10.1046/j.0016-8025.2001.00764.x; Ritchie G, 2006, FOREST NURSERY NOTES; Santos HP, 2004, ANN BOT-LONDON, V94, P819, DOI 10.1093/aob/mch209; SCANDALIOS JG, 1993, PLANT PHYSIOL, V101, P7, DOI 10.1104/pp.101.1.7; SINGH M, 1981, PLANT SOIL, V59, P349, DOI 10.1007/BF02184206; Smirnoff N., 1995, ENV PLANT METABOLISM; Sun Lu, 2012, Scientia Agricultura Sinica, V45, P1714; Sun YuanYuan, 2010, Acta Agronomica Sinica, V36, P1931, DOI 10.1016/S1875-2780(09)60085-7; Sundaravalli V. M., 2005, Journal of Plant Biology, V32, P13; VANHANDEL E, 1968, ANAL BIOCHEM, V22, P280, DOI 10.1016/0003-2697(68)90317-5; Yiu JC, 2009, PLANT PHYSIOL BIOCH, V47, P710, DOI 10.1016/j.plaphy.2009.03.007; Zaidi PH, 2007, FIELD CROP RES, V101, P117, DOI 10.1016/j.fcr.2006.10.002; Zhang Chunping, 2010, Zhongguo Zhong Yao Za Zhi, V35, P2372; Zhang JX, 1996, PLANT SCI, V113, P139, DOI 10.1016/0168-9452(95)04295-4	47	41	44	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140620	10.1371/journal.pone.0140620	http://dx.doi.org/10.1371/journal.pone.0140620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469084	Green Submitted, gold, Green Published			2022-12-26	WOS:000363184600088
J	Chorell, E; Andersson, E; Evans, ML; Jain, N; Gotheson, A; Aden, J; Chapman, MR; Almqvist, F; Wittung-Stafshede, P				Chorell, Erik; Andersson, Emma; Evans, Margery L.; Jain, Neha; Gotheson, Anna; Aden, Jorgen; Chapman, Matthew R.; Almqvist, Fredrik; Wittung-Stafshede, Pernilla			Bacterial Chaperones CsgE and CsgC Differentially Modulate Human alpha-Synuclein Amyloid Formation via Transient Contacts	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOFILM FORMATION; FIELD GRADIENT; IN-VITRO; AGGREGATION; PROTEIN; OLIGOMERS; FIBRILLATION; BIOGENESIS; POLYMERIZATION	Amyloid formation is historically associated with cytotoxicity, but many organisms produce functional amyloid fibers (e.g., curli) as a normal part of cell biology. Two E. coli genes in the curli operon encode the chaperone-like proteins CsgC and CsgE that both can reduce in vitro amyloid formation by CsgA. CsgC was also found to arrest amyloid formation of the human amyloidogenic protein alpha-synuclein, which is involved in Parkinson's disease. Here, we report that the inhibitory effects of CsgC arise due to transient interactions that promote the formation of spherical alpha-synuclein oligomers. We find that CsgE also modulates alpha-synuclein amyloid formation through transient contacts but, in contrast to CsgC, CsgE accelerates alpha-synuclein amyloid formation. Our results demonstrate the significance of transient protein interactions in amyloid regulation and emphasize that the same protein may inhibit one type of amyloid while accelerating another.	[Chorell, Erik; Andersson, Emma; Gotheson, Anna; Aden, Jorgen; Almqvist, Fredrik; Wittung-Stafshede, Pernilla] Umea Univ, Dept Chem, Umea, Sweden; [Evans, Margery L.; Jain, Neha; Chapman, Matthew R.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Almqvist, Fredrik] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden	Umea University; University of Michigan System; University of Michigan; Umea University	Almqvist, F (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	fredrik.almqvist@chem.umu.se; Pernilla.wittung@chalmers.se	wittung-stafshede, pernilla/AAV-4392-2021	wittung-stafshede, pernilla/0000-0003-1058-1964; Gardner, Margery/0000-0003-0227-7743; Almqvist, Fredrik/0000-0002-0504-4446; Chapman, Matthew/0000-0002-2645-1294	Swedish Research Council; Knut and Alice Wallenberg foundation; Goran Gustafsson foundation; National Institutes of Health [AI073847-6]; Swedish Foundation for Strategic Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI073847, R01AI073847] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Goran Gustafsson foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by Swedish Research Council (PWS, FA); Knut and Alice Wallenberg foundation (PWS, FA); Goran Gustafsson foundation (PWS, FA); National Institutes of Health AI073847-6 (MRC); Swedish Foundation for Strategic Research (FA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2010, INT J BIOL MACROMOL, V46, P275, DOI 10.1016/j.ijbiomac.2009.12.017; Andersson EK, 2013, CHEM BIOL, V20, P1245, DOI 10.1016/j.chembiol.2013.07.017; [Anonymous], [No title captured]; Berger S., 2004, 200 MORE NMR EXPT PR; Braga CA, 2011, J MOL BIOL, V405, P254, DOI 10.1016/j.jmb.2010.10.027; Breydo L., 2015, MOL NEUROBIOL; Cegelski L, 2009, NAT CHEM BIOL, V5, P913, DOI 10.1038/nchembio.242; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chi YC, 2014, J BIOL CHEM, V289, P15474, DOI 10.1074/jbc.M113.544049; Daturpalli S, 2013, J MOL BIOL, V425, P4614, DOI 10.1016/j.jmb.2013.08.006; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DePas WH, 2013, P NATL ACAD SCI USA, V110, P2629, DOI 10.1073/pnas.1218703110; Dueholm MS, 2011, BIOCHEMISTRY-US, V50, P8281, DOI 10.1021/bi200967c; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Evans M.L., 2015, MOL CELL; Evans ML, 2014, BBA-MOL CELL RES, V1843, P1551, DOI 10.1016/j.bbamcr.2013.09.010; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Galvin J E, 1999, Adv Neurol, V80, P313; Gerard M, 2006, FASEB J, V20, P524, DOI 10.1096/fj.05-5126fje; Goyal P, 2014, NATURE, V516, P250, DOI 10.1038/nature13768; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Hammer ND, 2012, J MOL BIOL, V422, P376, DOI 10.1016/j.jmb.2012.05.043; Helgstrand M, 2000, J BIOMOL NMR, V18, P329, DOI 10.1023/A:1026729404698; Hong DP, 2008, J MOL BIOL, V383, P214, DOI 10.1016/j.jmb.2008.08.039; Horvath I, 2013, ARCH BIOCHEM BIOPHYS, V532, P84, DOI 10.1016/j.abb.2013.01.012; Horvath I, 2012, J AM CHEM SOC, V134, P3439, DOI 10.1021/ja209829m; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Karamanos TK, 2014, MOL CELL, V55, P214, DOI 10.1016/j.molcel.2014.05.026; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KESTIN J, 1978, J PHYS CHEM REF DATA, V7, P941, DOI 10.1063/1.555581; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Li J, 2004, CHEM BIOL, V11, P1513, DOI 10.1016/j.chembiol.2004.08.025; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nenninger AA, 2011, MOL MICROBIOL, V81, P486, DOI 10.1111/j.1365-2958.2011.07706.x; Price WS, 1998, CONCEPT MAGNETIC RES, V10, P197, DOI 10.1002/(SICI)1099-0534(1998)10:4<197::AID-CMR1>3.0.CO;2-S; Salgado PS, 2011, ACTA CRYSTALLOGR D, V67, P8, DOI 10.1107/S0907444910042022; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Taylor JD, 2011, STRUCTURE, V19, P1307, DOI 10.1016/j.str.2011.05.015; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Visanji Naomi P, 2013, Acta Neuropathol Commun, V1, P2, DOI 10.1186/2051-5960-1-2; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wu KP, 2011, BIOMOL NMR ASSIGN, V5, P43, DOI 10.1007/s12104-010-9263-4	44	47	47	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140194	10.1371/journal.pone.0140194	http://dx.doi.org/10.1371/journal.pone.0140194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465894	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100087
J	Gopalakrishnapillai, A; Kolb, EA; Dhanan, P; Mason, RW; Napper, A; Barwe, SP				Gopalakrishnapillai, Anilkumar; Kolb, E. Anders; Dhanan, Priyanka; Mason, Robert W.; Napper, Andrew; Barwe, Sonali P.			Disruption of Annexin II /p11 Interaction Suppresses Leukemia Cell Binding, Homing and Engraftment, and Sensitizes the Leukemia Cells to Chemotherapy	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ENDOTHELIAL-CELLS; STROMAL CELLS; CANCER CELLS; EXPRESSION; ADHESION; S100A10; OSTEOBLASTS; RECEPTOR; A2	The bone marrow microenvironment plays an important role in acute lymphoblastic leukemia (ALL) cell proliferation, maintenance, and resistance to chemotherapy. Annexin II (ANX2) is abundantly expressed on bone marrow cells and complexes with p11 to form ANX2/p11-hetero-tetramer (ANX2T). We present evidence that p11 is upregulated in refractory ALL cell lines and patient samples. A small molecule inhibitor that disrupts ANX2/p11 interaction (ANX2T inhibitor), an anti-ANX2 antibody, and knockdown of p11, abrogated ALL cell adhesion to osteoblasts, indicating that ANX2/p11 interaction facilitates binding and retention of ALL cells in the bone marrow. Furthermore, ANX2T inhibitor increased the sensitivity of primary ALL cells co-cultured with osteoblasts to dexamethasone and vincristine induced cell death. Finally, in an orthotopic leukemia xenograft mouse model, the number of ALL cells homing to the bone marrow was reduced by 40-50% in mice injected with anti-ANX2 antibody, anti-p11 antibody or ANX2T inhibitor compared to respective controls. In a long-term engraftment assay, the percentage of ALL cells in mouse blood, bone marrow and spleen was reduced in mice treated with agents that disrupt ANX2/p11 interaction. These data show that disruption of ANX2/p11 interaction results in reduced ALL cell adhesion to osteoblasts, increased ALL cell sensitization to chemotherapy, and suppression of ALL cell homing and engraftment.	[Gopalakrishnapillai, Anilkumar; Kolb, E. Anders; Dhanan, Priyanka; Mason, Robert W.; Napper, Andrew; Barwe, Sonali P.] Alfred I duPont Hosp Children, Nemours Ctr Childhood Canc Res, Wilmington, DE 19803 USA	Nemours Alfred I. duPont Hospital for Children	Barwe, SP (corresponding author), Alfred I duPont Hosp Children, Nemours Ctr Childhood Canc Res, Wilmington, DE 19803 USA.	barwe@medsci.udel.edu	gopala, Anilkumar/AAG-2713-2021	Kolb, E. Anders/0000-0003-2854-9014; Barwe, Sonali/0000-0003-4162-3004; Gopalakrishnapillai, Anilkumar/0000-0002-0465-578X	Delaware INBRE program; National Institute of General Medical Sciences - NIGMS of the National Institutes of Health [8 P20 GM103446-13]; Delaware-CTR ACCEL [U54GM104941]; Nemours Foundation; Delaware INBRE [P20GM103446]; Leukemia Research Foundation of Delaware; Cell Science Core of the Center for Pediatric Research [P20GM103464]; Nemours BioBank; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464, U54GM104941, P20GM103446, P30GM114736] Funding Source: NIH RePORTER	Delaware INBRE program; National Institute of General Medical Sciences - NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Delaware-CTR ACCEL; Nemours Foundation; Delaware INBRE; Leukemia Research Foundation of Delaware; Cell Science Core of the Center for Pediatric Research; Nemours BioBank; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Delaware INBRE program, with a grant from the National Institute of General Medical Sciences - NIGMS (8 P20 GM103446-13) of the National Institutes of Health; Delaware-CTR ACCEL (U54GM104941); and Nemours Foundation to SPB. This project was also supported by the Delaware INBRE (P20GM103446) to AG, Leukemia Research Foundation of Delaware to EAK, Cell Science Core of the Center for Pediatric Research (P20GM103464) to RWM, and Nemours BioBank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhojwani D, 2008, J CLIN ONCOL, V26, P4376, DOI 10.1200/JCO.2007.14.4519; Brown VI, 2008, IMMUNOL RES, V42, P84, DOI 10.1007/s12026-008-8038-9; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Choi KS, 2003, FASEB J, V17, P235, DOI 10.1096/fj.02-0697com; D'Souza S, 2012, BLOOD, V119, P1888, DOI 10.1182/blood-2011-11-393348; Garcia T, 2002, BONE, V31, P205, DOI 10.1016/S8756-3282(02)00781-0; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; Jung Y, 2005, CYTOKINE, V32, P155, DOI 10.1016/j.cyto.2005.09.001; Jung YH, 2007, BLOOD, V110, P82, DOI 10.1182/blood-2006-05-021352; Kremer KN, 2014, J CELL BIOCHEM, V115, P1128, DOI 10.1002/jcb.24755; Liu L, 1997, CELL SIGNAL, V9, P299, DOI 10.1016/S0898-6568(97)89891-9; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; Lu GW, 2006, J BIOL CHEM, V281, P30542, DOI 10.1074/jbc.M607072200; Menaa C, 1999, J CLIN INVEST, V103, P1605, DOI 10.1172/JCI6374; Meucci MA, 2005, PHARMACOGENOMICS, V6, P59, DOI 10.1517/14622416.6.1.59; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; Myrvang HK, 2013, FEBS LETT, V587, P3210, DOI 10.1016/j.febslet.2013.08.012; Rand V, 2008, BRIT J CANCER, V99, P1136, DOI 10.1038/sj.bjc.6604651; Reddy TRK, 2011, J MED CHEM, V54, P2080, DOI 10.1021/jm101212e; Remmelink M, 2005, INT J ONCOL, V26, P247; Rust R, 2005, BRIT J HAEMATOL, V131, P596, DOI 10.1111/j.1365-2141.2005.05816.x; Shiozawa Y, 2008, J CELL BIOCHEM, V105, P370, DOI 10.1002/jcb.21835; Spijkers-Hagelstein JAP, 2013, LEUKEMIA, V27, P1063, DOI 10.1038/leu.2012.372; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Teratani T, 2002, CANCER LETT, V175, P71, DOI 10.1016/S0304-3835(01)00724-8; TRESSLER RJ, 1993, J CELL BIOCHEM, V53, P265, DOI 10.1002/jcb.240530311; Zhang LB, 2004, J BIOL CHEM, V279, P2053, DOI 10.1074/jbc.M310357200	27	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140564	10.1371/journal.pone.0140564	http://dx.doi.org/10.1371/journal.pone.0140564			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465153	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100147
J	Kluba, M; Engelborghs, Y; Hofkens, J; Mizuno, H				Kluba, Malgorzata; Engelborghs, Yves; Hofkens, Johan; Mizuno, Hideaki			Inhibition of Receptor Dimerization as a Novel Negative Feedback Mechanism of EGFR Signaling	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-D; LASER-SCANNING MICROSCOPE; D-DEPENDENT ACTIVATION; LIVING CELLS; TYROSINE PHOSPHATASES; CATALYTIC DOMAIN; LUNG-CANCER; SH2 DOMAINS; KAPPA-B	Dimerization of the epidermal growth factor receptor (EGFR) is crucial for initiating signal transduction. We employed raster image correlation spectroscopy to continuously monitor the EGFR monomer-dimer equilibrium in living cells. EGFR dimer formation upon addition of EGF showed oscillatory behavior with a periodicity of about 2.5 min, suggesting the presence of a negative feedback loop to monomerize the receptor. We demonstrated that monomerization of EGFR relies on phospholipase C gamma, protein kinase C, and protein kinase D (PKD), while being independent of Ca2+ signaling and endocytosis. Phosphorylation of the juxtamembrane threonine residues of EGFR (T654/T669) by PKD was identified as the factor that shifts the monomer-dimer equilibrium of ligand bound EGFR towards the monomeric state. The dimerization state of the receptor correlated with the activity of an extracellular signal-regulated kinase, downstream of the EGFR. Based on these observations, we propose a novel, negative feedback mechanism that regulates EGFR signaling via receptor monomerization.	[Kluba, Malgorzata; Engelborghs, Yves; Mizuno, Hideaki] Katholieke Univ Leuven, Dept Chem, Biochem Mol & Struct Biol Sect, Lab Biomol Network Dynam, Celestijnenlaan 200G Box 2403, B-3001 Heverlee, Belgium; [Hofkens, Johan] Katholieke Univ Leuven, Mol Imaging & Photon, Dept Chem, B-3001 Heverlee, Belgium	KU Leuven; KU Leuven	Mizuno, H (corresponding author), Katholieke Univ Leuven, Dept Chem, Biochem Mol & Struct Biol Sect, Lab Biomol Network Dynam, Celestijnenlaan 200G Box 2403, B-3001 Heverlee, Belgium.	hideaki.mizuno@chem.kuleuven.be	Hofkens, Johan/AAL-4204-2020; Hofkens, Johan/AAP-9255-2020; Mizuno, Hideaki/AAH-5737-2021; LARIJANI, Professor Banafshe/H-3909-2015; Hofkens, Johan/D-4284-2017	Mizuno, Hideaki/0000-0002-6983-5255; LARIJANI, Professor Banafshe/0000-0003-4735-1169; Hofkens, Johan/0000-0002-9101-0567	Interdisciplinaire Onderzoeksprogramma (IDO) KU Leuven [IDO/12/020]; Research Foundation-Flanders (FWO Onderzoeksproject) [G0B5514N]; European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC Grant [291593 FLUOROCODE]; Flemish government [METH/08/04 CASAS]	Interdisciplinaire Onderzoeksprogramma (IDO) KU Leuven; Research Foundation-Flanders (FWO Onderzoeksproject)(FWO); European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC Grant(European Research Council (ERC)); Flemish government(European Commission)	This work was partly supported by "Interdisciplinaire Onderzoeksprogramma (IDO) KU Leuven" (IDO/12/020) and the Research Foundation-Flanders (FWO Onderzoeksproject G0B5514N). J. H. gratefully acknowledges the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement no. 291593 FLUOROCODE) and the Flemish government for long-term structural funding "Methusalem" grant METH/08/04 CASAS.	Arndt-Jovin DJ, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a008961; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bagowski CP, 1999, EMBO J, V18, P5567, DOI 10.1093/emboj/18.20.5567; BENVENISTE M, 1988, J CELL BIOL, V106, P1903, DOI 10.1083/jcb.106.6.1903; Bogdan S, 2001, CURR BIOL, V11, pR292, DOI 10.1016/S0960-9822(01)00167-1; Chattopadhyay A, 1999, J BIOL CHEM, V274, P26091, DOI 10.1074/jbc.274.37.26091; Choi CK, 2011, BIOPHYS J, V100, P583, DOI 10.1016/j.bpj.2010.12.3719; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Coban O, 2015, BIOPHYS J, V108, P1013, DOI 10.1016/j.bpj.2015.01.005; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; De Keersmaecker H., 2013, Biophysical Reviews and Letters, V8, P229, DOI 10.1142/S1793048013500070; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Digman MA, 2009, MICROSC RES TECHNIQ, V72, P323, DOI 10.1002/jemt.20655; Digman MA, 2009, BIOPHYS J, V96, P707, DOI 10.1016/j.bpj.2008.09.051; Digman MA, 2009, P NATL ACAD SCI USA, V106, P2170, DOI 10.1073/pnas.0806036106; Fry WHD, 2009, EXP CELL RES, V315, P697, DOI 10.1016/j.yexcr.2008.07.022; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; HERBST JJ, 1994, J BIOL CHEM, V269, P12865; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Hsieh MY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-57; Hurley JH, 1997, PROTEIN SCI, V6, P477; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kaszuba K, 2015, P NATL ACAD SCI USA, V112, P4334, DOI 10.1073/pnas.1503262112; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; Kloth MT, 2002, J BIOL CHEM, V277, P8693, DOI 10.1074/jbc.M111884200; Koese M, 2013, ONCOGENE, V32, P2858, DOI 10.1038/onc.2012.303; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Kral J., 2011, Proceedings 2011 IEEE International Instrumentation and Measurement Technology Conference (I2MTC 2011), DOI 10.1109/IMTC.2011.5944293; Kunkel MT, 2007, J BIOL CHEM, V282, P6733, DOI 10.1074/jbc.M608086200; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Lewis RS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003970; Li X, 2008, CELL SIGNAL, V20, P2145, DOI 10.1016/j.cellsig.2008.08.006; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Santiskulvong C, 2007, CELL SIGNAL, V19, P1348, DOI 10.1016/j.cellsig.2007.01.006; Sato K, 2013, CANCER SCI, V104, P1315, DOI 10.1111/cas.12225; Schaapveld R, 1997, MOL BIOL REP, V24, P247, DOI 10.1023/A:1006870016238; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Singhai A, 2014, BIOPHYS J, V107, P2639, DOI 10.1016/j.bpj.2014.09.048; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Storz P, 2004, MOL PHARMACOL, V66, P870, DOI 10.1124/mol.104.000687; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, J BIOL CHEM, V278, P17969, DOI 10.1074/jbc.M213224200; Tiganis T, 2002, IUBMB LIFE, V53, P3, DOI 10.1080/15216540210811; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Valley CC, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020735; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Van Slyke P, 2005, MOL CELL BIOL, V25, P3831, DOI 10.1128/MCB.25.9.3831-3841.2005; Wang Q, 2007, EXP CELL RES, V313, P3349, DOI 10.1016/j.yexcr.2007.06.014; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zwaenepoel K, 2010, FASEB J, V24, P538, DOI 10.1096/fj.09-140228; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	74	19	19	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139971	10.1371/journal.pone.0139971	http://dx.doi.org/10.1371/journal.pone.0139971			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465157	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000363183100067
J	Portegies, JM; Fick, RHJ; Sanguinetti, GR; Meesters, SPL; Girard, G; Duits, R				Portegies, J. M.; Fick, R. H. J.; Sanguinetti, G. R.; Meesters, S. P. L.; Girard, G.; Duits, R.			Improving Fiber Alignment in HARDI by Combining Contextual PDE Flow with Constrained Spherical Deconvolution	PLOS ONE			English	Article							DIFFUSION MRI; SCALE SPACES; TRACTOGRAPHY; FIELD; REGULARIZATION; ENHANCEMENT; VALIDATION; COMPLETION; EQUATIONS; TRACKING	We propose two strategies to improve the quality of tractography results computed from diffusion weighted magnetic resonance imaging (DW-MRI) data. Both methods are based on the same PDE framework, defined in the coupled space of positions and orientations, associated with a stochastic process describing the enhancement of elongated structures while preserving crossing structures. In the first method we use the enhancement PDE for contextual regularization of a fiber orientation distribution (FOD) that is obtained on individual voxels from high angular resolution diffusion imaging (HARDI) data via constrained spherical deconvolution (CSD). Thereby we improve the FOD as input for subsequent tractography. Secondly, we introduce the fiber to bundle coherence (FBC), a measure for quantification of fiber alignment. The FBC is computed from a tractography result using the same PDE framework and provides a criterion for removing the spurious fibers. We validate the proposed combination of CSD and enhancement on phantom data and on human data, acquired with different scanning protocols. On the phantom data we find that PDE enhancements improve both local metrics and global metrics of tractography results, compared to CSD without enhancements. On the human data we show that the enhancements allow for a better reconstruction of crossing fiber bundles and they reduce the variability of the tractography output with respect to the acquisition parameters. Finally, we show that both the enhancement of the FODs and the use of the FBC measure on the tractography improve the stability with respect to different stochastic realizations of probabilistic tractography. This is shown in a clinical application: the reconstruction of the optic radiation for epilepsy surgery planning.	[Portegies, J. M.; Sanguinetti, G. R.; Meesters, S. P. L.; Duits, R.] Eindhoven Univ Technol, Dept Math & Comp Sci, NL-5600 MB Eindhoven, Netherlands; [Fick, R. H. J.; Girard, G.] INRIA Sophia Antipolis Mediterranee, Athena Project Team, Valbonne, France; [Meesters, S. P. L.] Acad Ctr Epileptol Kempenhaeghe, Heeze, Netherlands; [Meesters, S. P. L.] Maastricht UMC, Heeze, Netherlands; [Girard, G.] Univ Sherbrooke, Dept Comp Sci, Sherbrooke Connect Imaging Lab SCIL, Sherbrooke, PQ J1K 2R1, Canada; [Duits, R.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology; Maastricht University; University of Sherbrooke; Eindhoven University of Technology	Portegies, JM (corresponding author), Eindhoven Univ Technol, Dept Math & Comp Sci, POB 513, NL-5600 MB Eindhoven, Netherlands.	j.m.portegies@tue.nl			European Research Council under the European Community's 7th Framework Programme (FP7)/ERC [335555]	European Research Council under the European Community's 7th Framework Programme (FP7)/ERC	The research leading to the results of this paper has received funding from the European Research Council under the European Community's 7th Framework Programme (FP7/2007-2014)/ERC grant agreement No. 335555 (http://erc.europa.eu/lie-group-analysis-medical-image-processing, author who received the funding: RD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganj I, 2011, MED IMAGE ANAL, V15, P414, DOI 10.1016/j.media.2011.01.003; Agrachev A, 2009, J FUNCT ANAL, V256, P2621, DOI 10.1016/j.jfa.2009.01.006; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; August J, 2003, IEEE T PATTERN ANAL, V25, P387, DOI 10.1109/TPAMI.2003.1190567; Barmpoutis A, 2008, LECT NOTES COMPUT SC, V5241, P9, DOI 10.1007/978-3-540-85988-8_2; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Burgeth B, 2009, LECT NOTES COMPUT SC, V5567, P247, DOI 10.1007/978-3-642-02256-2_21; Burgeth B, 2009, MATH VIS, P305, DOI 10.1007/978-3-540-88378-4_15; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Caruyer E., 2014, P ISMRM; Chamberland M, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00059; Citti G, 2006, J MATH IMAGING VIS, V24, P307, DOI 10.1007/s10851-005-3630-2; Close TG, 2009, NEUROIMAGE, V47, P1288, DOI 10.1016/j.neuroimage.2009.03.077; Cote MA, 2013, MED IMAGE ANAL, V17, P844, DOI 10.1016/j.media.2013.03.009; Cote MA, 2012, LECT NOTES COMPUT SC, V7510, P699, DOI 10.1007/978-3-642-33415-3_86; Coulon O., 2001, Information Processing in Medical Imaging. 17th International Conference, IPMI 2001. Proceedings (Lecture Notes in Computer Science Vol.2082), P92; Coupe P, 2008, IEEE T MED IMAGING, V27, P425, DOI 10.1109/TMI.2007.906087; Creusen E, 2013, NUMERICAL MATH THEOR, V6, P326; Creusen EJ, 2011, NUMERICAL SCHEMES LI, P14; Daducci A, 2013, I S BIOMED IMAGING, P524; Descoteaux M, 2012, COMPREHENSIVE BIOMED, V3, P81; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Descoteaux M, 2011, MED IMAGE ANAL, V15, P603, DOI 10.1016/j.media.2010.07.001; Descoteaux M, 2008, LECT NOTES COMPUT SC, V5242, P122, DOI 10.1007/978-3-540-85990-1_15; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Dhollander T, 2014, NEUROIMAGE, V94, P312, DOI 10.1016/j.neuroimage.2013.12.047; Duits R, 2015, ARXIV150208002V4; Duits R, 2008, Q APPL MATH, V66, P27; Duits R, 2007, LECT NOTES COMPUT SC, V4485, P300; Duits R, 2013, J MATH IMAGING VIS, V46, P326, DOI 10.1007/s10851-012-0387-2; Duits R, 2011, INT J COMPUT VISION, V92, P231, DOI 10.1007/s11263-010-0332-z; Duits R, 2010, Q APPL MATH, V68, P255, DOI 10.1090/S0033-569X-10-01172-0; FALCONER MA, 1963, J NEUROL NEUROSUR PS, V26, P154, DOI 10.1136/jnnp.26.2.154; Franken E, 2008, THESIS EINDHOVEN U T; Franken E, 2009, INT J COMPUT VISION, V85, P253, DOI 10.1007/s11263-009-0213-5; Garyfallidis E, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00008; Girard G, 2014, NEUROIMAGE, V98, P266, DOI 10.1016/j.neuroimage.2014.04.074; Goh A, 2009, LECT NOTES COMPUT SC, V5761, P877, DOI 10.1007/978-3-642-04268-3_108; Haije T.C.D., 2014, VISUALIZATION PROCES, P97; HORMANDE.L, 1967, ACTA MATH-UPPSALA, V119, P147, DOI 10.1007/BF02392081; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Meesters S, 2013, THESIS EINDHOVEN U T; MomayyezSiahkal P, 2013, IEEE T PATTERN ANAL, V35, P983, DOI 10.1109/TPAMI.2012.184; Mumford D., 1994, ALGEBRAIC GEOMETRY I, P491, DOI DOI 10.1007/978-1-4612-2628-4_31; Nilsson D, 2007, EPILEPSY RES, V77, P11, DOI 10.1016/j.eplepsyres.2007.07.012; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; Powell HWR, 2005, NEUROLOGY, V65, P596, DOI 10.1212/01.wnl.0000172858.20354.73; Prckovska V, 2010, MICCAI WORKSH COMP D; Prckovska V, 2015, MATH VIS, P353, DOI 10.1007/978-3-319-15090-1_18; Reisert M, 2012, ARXIV12025414; Reisert M, 2013, LECT NOTES COMPUT SC, V8151, P493, DOI 10.1007/978-3-642-40760-4_62; Reisert M, 2011, IEEE T MED IMAGING, V30, P1274, DOI 10.1109/TMI.2011.2112769; Rodrigues P, 2010, EUR WORKSH VIS COMP, P49; Roine T, 2015, MED IMAGE ANAL, V24, P269, DOI 10.1016/j.media.2015.01.001; Roine T, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00028; Sanguinetti G, 2010, J VISION, V10, DOI 10.1167/10.14.37; Schultz T., 2012, NEW DEV VISUALIZATIO, P253; Schultz T, 2013, LECT NOTES COMPUT SC, V8149, P663, DOI 10.1007/978-3-642-40811-3_83; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.9.15; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; SODERMAN O, 1995, J MAGN RESON SER A, V117, P94, DOI 10.1006/jmra.1995.0014; Tax CMW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101524; Tax CMW, 2014, NEUROIMAGE, V86, P67, DOI 10.1016/j.neuroimage.2013.07.067; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2013, NMR BIOMED, V26, P1775, DOI 10.1002/nbm.3017; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tschumperle D, 2001, PROC CVPR IEEE, P948; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wiest-Daessle N, 2007, LECT NOTES COMPUT SC, V4792, P344; Wolfram Research Inc, 2014, MATHEMATICA; Zweck J, 2004, J MATH IMAGING VIS, V21, P135, DOI 10.1023/B:JMIV.0000035179.47895.bc	80	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138122	10.1371/journal.pone.0138122	http://dx.doi.org/10.1371/journal.pone.0138122			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465600	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100013
J	Rousseau-Gagnon, M; Agharazii, M; De Serres, SA; Desmeules, S				Rousseau-Gagnon, Mathieu; Agharazii, Mohsen; De Serres, Sacha A.; Desmeules, Simon			Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy	PLOS ONE			English	Article							HIGH CUTOFF HEMODIALYSIS; ACUTE-RENAL-FAILURE; ALL-CAUSE MORTALITY; ONLINE HEMODIAFILTRATION; MULTIPLE-MYELOMA; PLASMA-EXCHANGE; KIDNEY; SERUM; REMOVAL; IMMUNOGLOBULIN	Introduction In cases of myeloma cast nephropathy in need of haemodialysis (HD), reduction of free light chains using HD with High-Cut-Off filters (HCO-HD), in combination with chemotherapy, may be associated with better renal recovery. The aim of the present study is to evaluate the effectiveness of haemodiafiltration (HDF) in reducing free light chain levels using a less expensive heat sterilized high-flux polyphenylene HF dialyzer (HF-HDF). Methods In a single-centre prospective cohort study, 327 dialysis sessions were performed using a 2.2 m(2) heat sterilized high-flux polyphenylene HF dialyzer (Phylther HF22SD), a small (1.1m(2)) or large (2.1 m(2)) high-cut-off (HCO) dialyzer (HCOS and HCOL) in a cohort of 16 patients presenting with dialysis-dependent acute cast nephropathy and elevated free light chains (10 kappa, 6 lambda). The outcomes of the study were the mean reduction ratio (RR) of kappa and lambda, the proportion of treatments with an RR of at least 0.65, albumin loss and the description of patient outcomes. Statistical analysis was performed using linear and logistic regression through generalized estimating equation analysis so as to take into account repeated observation within subjects and adjust for session duration. Results There were no significant differences in the estimated marginal mean of kappa RR, which were respectively 0.67, 0.69 and 0.70 with HCOL-HD, HCOS-HDF and HF-HDF (P = 0.950). The estimated marginal mean of the proportions of treatments with a kappa RR >= 0.65 were 68%, 63% and 71% with HCOL-HD, HCOS-HDF and HF-HDF, respectively (P = 0.913). The estimated marginal mean of lambda RR were higher with HCOL-HDF (0.78), compared to HCOL-HD and HF-HDF (0.62, and 0.61 respectively). The estimated marginal mean proportion of treatments with a lambda RR >= 0.65 were higher with HCOL-HDF (81%), compared to 57% in HF-HDF (P = 0.042). The median albumin loss were 7, 21 and 63 g/session with HF-HDF, HCOL-HD and HCOL-HDF respectively (P = 0.044). Among survivors, 9 out of 10 episodes of acute kidney injuries became dialysis-independent following a median time of renal replacement therapy of 40 days (range 7-181). Conclusion Therefore, in patients with acute dialysis-dependent myeloma cast nephropathy, in addition to chemotherapy, HDF with a heat sterilized high-flux polyphenylene HF dialyzer could offer an alternative to HCO dialysis for extracorporeal kappa reduction with lower albumin loss.	[Rousseau-Gagnon, Mathieu; Agharazii, Mohsen; De Serres, Sacha A.; Desmeules, Simon] CHU Quebec, Hotel Dieu Quebec, Dept Med, Div Nephrol, Quebec City, PQ, Canada; [Rousseau-Gagnon, Mathieu; Agharazii, Mohsen; De Serres, Sacha A.; Desmeules, Simon] Univ Laval, Fac Med, Dept Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Desmeules, S (corresponding author), CHU Quebec, Hotel Dieu Quebec, Dept Med, Div Nephrol, Quebec City, PQ, Canada.	mohsen.agharazii@crhdq.ulaval.ca; simon.desmeules@mail.chuq.qc.ca	Agharazii, Mohsen/Q-2968-2019	Agharazii, Mohsen/0000-0002-7628-5757	Canadian Institute of Health Research; Canadian Society of Nephrology; Fonds de Recherche du Qubec-Sante (FRQ-S); FRQ-S; Kidney Foundation of Canada	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Society of Nephrology; Fonds de Recherche du Qubec-Sante (FRQ-S); FRQ-S; Kidney Foundation of Canada	SDS holds a Kidney Research Scientist Core Education and National Training Program (KRESCENT) scholarship supported by Canadian Institute of Health Research, Kidney Foundation of Canada and Canadian Society of Nephrology, and from Fonds de Recherche du Qubec-Sante (FRQ-S). MA holds a scholarship from FRQ-S, and a research chair in nephrology from Universite Laval.	Boschetti-de-Fierro A, 2013, INT J ARTIF ORGANS, V36, P455, DOI 10.5301/ijao.5000220; Bradwell AR, 2001, CLIN CHEM, V47, P673; Bridoux F, 2012, ADV CHRONIC KIDNEY D, V19, P333, DOI 10.1053/j.ackd.2012.07.003; Burnette BL, 2011, NEW ENGL J MED, V364, P2365, DOI 10.1056/NEJMc1101834; Canaud B, 2006, KIDNEY INT, V69, P2087, DOI 10.1038/sj.ki.5000447; Clark WF, 2005, ANN INTERN MED, V143, P777, DOI 10.7326/0003-4819-143-11-200512060-00005; Gakhar B, 2011, SEMIN DIALYSIS, V24, P9, DOI 10.1111/j.1525-139X.2010.00814.x; Grooteman MPC, 2012, J AM SOC NEPHROL, V23, P1087, DOI 10.1681/ASN.2011121140; Gupta D, 2010, HEMODIAL INT, V14, P355, DOI 10.1111/j.1542-4758.2010.00481.x; Harding S, 2011, NEPHROL DIAL TRANSPL, V26, P1438, DOI 10.1093/ndt/gfr019; Hutchison CA, 2012, NEPHROL DIAL TRANSPL, V27, P3823, DOI 10.1093/ndt/gfr773; Hutchison CA, 2011, J AM SOC NEPHROL, V22, P1129, DOI 10.1681/ASN.2010080857; Hutchison CA, 2009, CLIN J AM SOC NEPHRO, V4, P745, DOI 10.2215/CJN.04590908; Hutchison CA, 2008, ARTIF ORGANS, V32, P910, DOI 10.1111/j.1525-1594.2008.00653.x; Kiaii M, 2011, JAMA-J AM MED ASSOC, V306, P1679, DOI 10.1001/jama.2011.1499; LEBOULLEUX M, 1995, KIDNEY INT, V48, P72, DOI 10.1038/ki.1995.269; Maduell F, 2013, J AM SOC NEPHROL, V24, P487, DOI 10.1681/ASN.2012080875; Nistor I, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006258.pub2; Ok E, 2013, NEPHROL DIAL TRANSPL, V28, P192, DOI 10.1093/ndt/gfs407; Pasquali S, 2015, J NEPHROL, V28, P251, DOI 10.1007/s40620-014-0130-8; Susantitaphong P, 2012, ARTIF ORGANS, V36, P845, DOI 10.1111/j.1525-1594.2012.01442.x; Tsakiris DJ, 2010, NEPHROL DIAL TRANSPL, V25, P1200, DOI 10.1093/ndt/gfp679; Vallee AG, 2011, NEPHROL DIAL TRANSPL, V26, P3627, DOI 10.1093/ndt/gfr180; Wang AY, 2014, AM J KIDNEY DIS, V63, P968, DOI 10.1053/j.ajkd.2014.01.435; Ying WZ, 2012, J CLIN INVEST, V122, P1777, DOI 10.1172/JCI46490	25	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140463	10.1371/journal.pone.0140463	http://dx.doi.org/10.1371/journal.pone.0140463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466100	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100128
J	Schirmer, B; Wedekind, D; Glage, S; Neumann, D				Schirmer, Bastian; Wedekind, Dirk; Glage, Silke; Neumann, Detlef			Deletion of IL-18 Expression Ameliorates Spontaneous Kidney Failure in MRLlpr Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; IFN-GAMMA; DISEASE-ACTIVITY; INTERFERON-GAMMA; AUTOANTIBODY PRODUCTION; RHEUMATOID-ARTHRITIS; INTERLEUKIN-18; RECEPTOR; ASSOCIATION; LYMPHOCYTES	The role of IL-18 in the pathogenesis of systemic lupus erythematosus is still not definitively solved. In this study, we generated MRLlpr mice, which develop a disease resembling systemic lupus erythematosus, genetically devoid of IL-18 expression. These mice in comparison to IL-18-competent MRLlpr mice show reduced signs of renal pathogenesis, while other parameters such as mean survival time, lymphadenopathy, constitutive interferon-gamma. production, and frequency of CD3(+) B220(+) abnormal T cells were without differences. We conclude that in the systemic lupus erythematosus syndrom IL-18 is involved specifically in the renal pathogenesis.	[Schirmer, Bastian; Neumann, Detlef] Hannover Med Sch, Inst Pharmacol, Hannover, Germany; [Wedekind, Dirk; Glage, Silke] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany	Hannover Medical School; Hannover Medical School	Neumann, D (corresponding author), Hannover Med Sch, Inst Pharmacol, Hannover, Germany.	neumann.detlef@mh-hannover.de	Schirmer, Bastian/H-6729-2019; Neumann, Detlef/F-6182-2011	Schirmer, Bastian/0000-0002-4074-3584; Neumann, Detlef/0000-0003-0145-7507	Hannover Medical School by MHH-HiLF	Hannover Medical School by MHH-HiLF	This study was supported by the Hannover Medical School by means of MHH-HiLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerio P, 2002, CLIN EXP RHEUMATOL, V20, P535; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750; BOSSU P, 1993, J IMMUNOL, V151, P7233; Bossu P, 2003, P NATL ACAD SCI USA, V100, P14181, DOI 10.1073/pnas.2336094100; Chen SL, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-107; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Clark DN, 2013, CLIN IMMUNOL, V148, P335, DOI 10.1016/j.clim.2012.11.001; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Esfandiari E, 2001, J IMMUNOL, V167, P5338, DOI 10.4049/jimmunol.167.9.5338; Faust J, 2002, ARTHRITIS RHEUM-US, V46, P3083, DOI 10.1002/art.10563; Ghoreishi M, 2010, LUPUS, V19, P1029, DOI 10.1177/0961203310370045; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Haas C, 1997, J IMMUNOL, V158, P5484; He ZB, 2008, AM J PHYSIOL-RENAL, V295, pF1414, DOI 10.1152/ajprenal.90288.2008; Kahlenberg JM, 2014, CURR OPIN RHEUMATOL, V26, P475, DOI 10.1097/BOR.0000000000000088; Kinoshita K, 2004, J IMMUNOL, V173, P5312, DOI 10.4049/jimmunol.173.8.5312; Lech M, 2015, ANN RHEUM DIS, V74, P2224, DOI 10.1136/annrheumdis-2014-205496; Lin L, 2005, ARTHRITIS RHEUM, V52, P984, DOI 10.1002/art.20961; Menke J, 2011, KIDNEY INT, V79, P452, DOI 10.1038/ki.2010.438; MONTGOMERY CA, 1987, J AM VET MED ASSOC, V191, P1277; Neumann D, 2001, J IMMUNOL, V166, P3757, DOI 10.4049/jimmunol.166.6.3757; Neumann D, 2001, J INTERF CYTOK RES, V21, P635, DOI 10.1089/10799900152547902; Neumann D, 2006, INT IMMUNOL, V18, P1779, DOI 10.1093/intimm/dxl112; Nicoletti F, 2000, EUR J IMMUNOL, V30, P438; Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014; OHTEKI T, 1990, J EXP MED, V172, P7, DOI 10.1084/jem.172.1.7; Park MC, 2004, CLIN RHEUMATOL, V23, P225, DOI 10.1007/s10067-004-0867-x; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Schwarting A, 1998, J IMMUNOL, V161, P494; Sedimbi SK, 2013, CELL MOL LIFE SCI, V70, P4795, DOI 10.1007/s00018-013-1425-y; Shimizu C, 2012, MOD RHEUMATOL, V22, P73, DOI 10.1007/s10165-011-0471-2; Song GG, 2013, MOL BIOL REP, V40, P2581, DOI 10.1007/s11033-012-2344-y; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Tomura M, 1998, J IMMUNOL, V160, P3759; Tomura M, 1998, J IMMUNOL, V160, P4738; Tsao BP, 2003, TRENDS IMMUNOL, V24, P595, DOI 10.1016/j.it.2003.09.006; Wen D, 2014, INT REV IMMUNOL, V33, P34, DOI 10.3109/08830185.2013.816699; Wong CK, 2000, RHEUMATOLOGY, V39, P1078, DOI 10.1093/rheumatology/39.10.1078; Yang YB, 2015, KIDNEY INT, V87, P396, DOI 10.1038/ki.2014.295; Yap DYH, 2013, NEPHROLOGY, V18, P243, DOI 10.1111/nep.12047; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385	45	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140173	10.1371/journal.pone.0140173	http://dx.doi.org/10.1371/journal.pone.0140173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465326	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100084
J	Turlo, A; Cywinska, A; Czopowicz, M; Witkowski, L; Niedzwiedz, A; Slowikowska, M; Borowicz, H; Jaskiewicz, A; Winnicka, A				Turlo, Agnieszka; Cywinska, Anna; Czopowicz, Michal; Witkowski, Lucjan; Niedzwiedz, Artur; Slowikowska, Malwina; Borowicz, Hieronim; Jaskiewicz, Anna; Winnicka, Anna			The Effect of Different Types of Musculoskeletal Injuries on Blood Concentration of Serum Amyloid A in Thoroughbred Racehorses	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; PRO-INFLAMMATORY CYTOKINES; TUMOR-NECROSIS-FACTOR; SYNOVIAL-FLUID; BIOCHEMICAL INDICATORS; EQUINE RHABDOMYOLYSIS; SKELETAL-MUSCLES; FLEXOR TENDON; A SAA; HORSES	Background Training-induced muscle, skeletal and joint trauma may result in acute phase response reflected by the changes in the blood concentration of serum amyloid A (SAA) in racehorses. It remains yet unclear if such systemic reaction could be triggered by sport injuries and what is the impact of different types of musculoskeletal trauma on SAA concentrations in racehorses. This study aimed to determine changes in the SAA blood concentration in racehorses with different types of injuries of musculoskeletal system. Materials and Methods The study involved 28 racehorses diagnosed after the race with bone fractures (n = 7), dorsal metacarpal disease (n = 11), joint trauma (n = 4) or tendon and muscle trauma (n = 6) and 28 healthy control racehorses. Serum samples were collected twice, between 1 and 4 days of the injury or succesful completion of the race. SAA concentration was measured using the commercial ELISA kit. Differences between mean SAA concentration in respective groups were analyzed using ANOVA and Tukey post-hoc test. Results Mean SAA concentration within the first 4 days of the injury of muscle and tendon was significantly higher than in bone fractures, dorsal metacarpal disease, joint trauma or in the healthy horses (p<0,001). There were no significant differences between the other groups. Conclusions Strain injuries of muscle and tendons can cause a moderate increase in SAA blood concentration in racehorses, reflecting the occurrence of the acute phase response. Similar reaction is not observed in the stress-related bone injuries.	[Turlo, Agnieszka; Cywinska, Anna; Jaskiewicz, Anna; Winnicka, Anna] Warsaw Univ Life Sci SGGW, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland; [Czopowicz, Michal; Witkowski, Lucjan] Warsaw Univ Life Sci SGGW, Fac Vet Med, Lab Vet Epidemiol & Econ, Warsaw, Poland; [Niedzwiedz, Artur; Slowikowska, Malwina; Borowicz, Hieronim] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Internal Dis, Clin Horses Dogs & Cats, Wroclaw, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences; Wroclaw University of Environmental & Life Sciences	Turlo, A (corresponding author), Warsaw Univ Life Sci SGGW, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland.	agnieszka_turlo@sggw.pl	Cywinska, Anna/AAD-2890-2020; Slowikowska, Malwina/AAE-2834-2020; Słowikowska, Malwina Anna/V-5150-2018; Czopowicz, Michał/U-5452-2018; Witkowski, Lucjan Adam/AAE-9239-2019	Cywinska, Anna/0000-0002-5365-9218; Slowikowska, Malwina/0000-0002-7014-956X; Słowikowska, Malwina Anna/0000-0002-7014-956X; Czopowicz, Michał/0000-0002-4238-8360; Witkowski, Lucjan Adam/0000-0003-1069-3384; Winnicka, Anna/0000-0001-9918-3430				Bauza G, 2011, J TRAUMA, V70, P948, DOI 10.1097/TA.0b013e3181e1d27b; Belgrave RL, 2013, JAVMA-J AM VET MED A, V243, P113, DOI 10.2460/javma.243.1.113; Berglund M, 2007, J HAND SURG-EUR VOL, V32E, P581, DOI 10.1016/j.jhse.2007.05.017; BILLINGHURST RC, 1995, EQUINE VET J, V27, P208, DOI 10.1111/j.2042-3306.1995.tb03064.x; Buttenschoen K, 2000, J TRAUMA, V48, P241, DOI 10.1097/00005373-200002000-00008; CAMPBELL MD, 1981, AM J VET RES, V42, P100; Canisso IF, 2014, AM J REPROD IMMUNOL, V72, P376, DOI 10.1111/aji.12278; Cray C., 2012, PROGR MOL BIOL TRANS; Cywinska A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-91; Cywinska A, 2012, RES VET SCI, V93, P1402, DOI 10.1016/j.rvsc.2012.02.008; Donovan DC, 2007, VET IMMUNOL IMMUNOP, V118, P263, DOI 10.1016/j.vetimm.2007.05.015; Dyson PK, 2008, EQUINE VET J, V40, P650, DOI 10.2746/042516408X363242; EL-Deeb WM, 2014, J EQUINE VET SCI, V34, P484, DOI 10.1016/j.jevs.2013.09.012; El-Deeb WM, 2010, VET RES COMMUN, V34, P677, DOI 10.1007/s11259-010-9439-5; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Hobo S, 2007, J VET MED SCI, V69, P827, DOI 10.1292/jvms.69.827; Horohov DW, 2012, J EQUINE VET SCI, V32, P805, DOI 10.1016/j.jevs.2012.03.017; Hosaka Y, 2002, J VET MED SCI, V64, P945, DOI 10.1292/jvms.64.945; Hulten C, 2002, EQUINE VET J, V34, P699, DOI 10.2746/042516402776250405; Jackson BF, 2009, EQUINE VET J, V41, P410, DOI 10.2746/042516409X416206; Jackson BF, 2005, EQUINE VET J, V37, P87, DOI 10.2746/0425164054406775; Jacobsen S, 2007, EQUINE VET EDUC, V19, P38, DOI [10.1111/j.2042-3292.2007.tb00550.x, 10.2746/095777307X177235]; Jacobsen S, 2006, VET IMMUNOL IMMUNOP, V110, P325, DOI 10.1016/j.vetimm.2005.10.012; Jacobsen S, 2005, EQUINE VET J, V37, P552, DOI 10.2746/042516405775314853; Jacobsen S, 2006, AM J VET RES, V67, P1738, DOI 10.2460/ajvr.67.10.1738; Jacobsen S, 2009, VET SURG, V38, P762, DOI 10.1111/j.1532-950X.2009.00564.x; John T, 2010, J ORTHOP RES, V28, P1071, DOI 10.1002/jor.21079; Jonsdottir IH, 2000, J PHYSIOL-LONDON, V528, P157, DOI 10.1111/j.1469-7793.2000.00157.x; Kramer J., 2004, EQUINE SPORTS MED SU; Lamprecht ED, 2008, COMP EXERC PHYSIOL, V5, P115, DOI 10.1017/S1478061509294448; Langberg H, 2002, J PHYSIOL-LONDON, V542, P985, DOI 10.1113/jphysiol.2002.019141; Ley C, 2007, J VET MED A, V54, P346, DOI 10.1111/j.1439-0442.2007.00956.x; Liburt NR, 2010, EQUINE VET J, V42, P280, DOI 10.1111/j.2042-3306.2010.00275.x; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; Millar NL, 2009, J BONE JOINT SURG BR, V91B, P417, DOI 10.1302/0301-620X.91B3.21652; Millar NL, 2012, ANN RHEUM DIS, V71, P302, DOI 10.1136/ard.2011.154229; Nieman DC, 2005, BRAIN BEHAV IMMUN, V19, P398, DOI 10.1016/j.bbi.2005.03.008; Nieman DC, 2001, J APPL PHYSIOL, V91, P109, DOI 10.1152/jappl.2001.91.1.109; Pedersen BK, 2001, EXERC IMMUNOL REV, V7, P18; Pihl TH, 2015, J VET INTERN MED, V29, P651, DOI 10.1111/jvim.12542; Pollock PJ, 2005, VET REC, V156, P538, DOI 10.1136/vr.156.17.538; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Turlo A, 2015, RES VET SCI, V100, P223, DOI 10.1016/j.rvsc.2015.04.008; Vandenplas ML, 2005, AM J VET RES, V66, P1509, DOI 10.2460/ajvr.2005.66.1509; Verwilghen D, 2009, RES VET SCI, V87, P319, DOI 10.1016/j.rvsc.2009.02.002; Wilsher S, 2006, EQUINE VET J, V38, P113, DOI 10.2746/042516406776563305; YOON SI, 1993, INT ORTHOP, V17, P198; Zar JH., 2010, BIOSTAT ANAL, V5th	48	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140673	10.1371/journal.pone.0140673	http://dx.doi.org/10.1371/journal.pone.0140673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466121	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100160
J	Xiao, QG; Zhu, Y; Luo, WB				Xiao, Qianguo; Zhu, Yi; Luo, Wen-bo			Experiencing Physical Pain Leads to More Sympathetic Moral Judgments	PLOS ONE			English	Article							EVOKED POTENTIALS; SOCIAL COGNITION; RATING-SCALES; NEURAL BASES; EMPATHY; OTHERS; VALIDATION; PERCEPTION; ALTRUISM; SYSTEMS	Previous studies have shown that observing another's pain can evoke other-oriented emotions, which instigate empathic concern for another's needs. It is not clear whether experiencing first-hand physical pain may also evoke other-oriented emotion and thus influence people's moral judgment. Based on the embodied simulation literature and neuroimaging evidence, the present research tested the idea that participants who experienced physical pain would be more sympathetic in their moral judgments. Study 1 showed that ice-induced physical pain facilitated higher self-assessments of empathy, which motivated participants to be more sympathetic in their moral judgments. Study 2 confirmed findings in study 1 and also showed that State Perspective Taking subscale of the State Empathy Scale mediated the effects of physical pain on moral judgment. These results provide support for embodied view of morality and for the view that pain can serve a positive psychosocial function.	[Xiao, Qianguo] Inner Mongolia Normal Univ, Coll Educ & Sci, Hohhot, Peoples R China; [Xiao, Qianguo] Chongqing Univ Arts & Sci, Lab Cognit & Mental Hlth, Chongqing, Peoples R China; [Zhu, Yi] Southwestern Univ Finance & Econ, Int Business Sch, Chengdu, Peoples R China; [Luo, Wen-bo] Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China	Inner Mongolia Normal University; Chongqing University of Arts & Sciences; Southwestern University of Finance & Economics - China; Liaoning Normal University	Zhu, Y (corresponding author), Southwestern Univ Finance & Econ, Int Business Sch, Chengdu, Peoples R China.	soc.zhuyi@gmail.com; wenbo9390@sina.com	Xiao, Qianguo/AAL-5131-2020		Chongqing University of Arts and Sciences [Z2013JY21]; National Natural Science Foundation of China [31000503, 31170984]	Chongqing University of Arts and Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Chongqing University of Arts and Sciences (Z2013JY21) and the National Natural Science Foundation of China (Grant Nos. 31000503, 31170984).	Ackerman JM, 2010, SCIENCE, V328, P1712, DOI 10.1126/science.1189993; Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Avenanti A, 2006, NEUROIMAGE, V32, P316, DOI 10.1016/j.neuroimage.2006.03.010; Aziz-Zadeh L, 2012, CEREB CORTEX, V22, P811, DOI 10.1093/cercor/bhr139; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; Bastian B, 2014, PSYCHOL SCI, V25, P2079, DOI 10.1177/0956797614545886; Bastian B, 2014, PERS SOC PSYCHOL REV, V18, P256, DOI 10.1177/1088868314527831; Bastian B, 2011, PSYCHOL SCI, V22, P334, DOI 10.1177/0956797610397058; Batson C.D., 2011, ALTRUISM HUMANS; Batson CD, 1996, PERS SOC PSYCHOL B, V22, P474, DOI 10.1177/0146167296225005; Batson CD, 1997, PERS SOC PSYCHOL B, V23, P751, DOI 10.1177/0146167297237008; Benuzzi F, 2008, J NEUROSCI, V28, P923, DOI 10.1523/JNEUROSCI.4012-07.2008; Bolognini N, 2013, J NEUROSCI, V33, P4201, DOI 10.1523/JNEUROSCI.4498-12.2013; Burke DM, 2001, J INTERPERS VIOLENCE, V16, P222, DOI 10.1177/088626001016003003; Cheng Y, 2008, NEUROIMAGE, V40, P1833, DOI 10.1016/j.neuroimage.2008.01.064; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; Costantini M, 2008, EUR J NEUROSCI, V28, P1222, DOI 10.1111/j.1460-9568.2008.06406.x; Crockett MJ, 2014, P NATL ACAD SCI USA, V111, P17320, DOI 10.1073/pnas.1408988111; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety Jean, 2015, AJOB Neurosci, V6, P3; Decety Jean, 2011, SOC NEUROSCI-UK; Dovidio JF., 2006, SOCIAL PSYCHOL PROSO; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Eisenberg N., 2010, PROSOCIAL MOTIVES EM, P129, DOI DOI 10.1037/12061-007; Eisenberg N., 1987, PSYCHOL BULL, V94, P101; Fehr R, 2010, PSYCHOL BULL, V136, P894, DOI 10.1037/a0019993; Galinsky AD, 2006, PSYCHOL SCI, V17, P1068, DOI 10.1111/j.1467-9280.2006.01824.x; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Gini G, 2007, AGGRESSIVE BEHAV, V33, P467, DOI 10.1002/ab.20204; Goldman A, 2009, TRENDS COGN SCI, V13, P154, DOI 10.1016/j.tics.2009.01.007; Goubert L, 2005, PAIN, V118, P285, DOI 10.1016/j.pain.2005.10.025; Jackson PL, 2006, PAIN, V125, P5, DOI 10.1016/j.pain.2006.09.013; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Jolliffe D, 2006, J ADOLESCENCE, V29, P589, DOI 10.1016/j.adolescence.2005.08.010; Jostmann NB, 2009, PSYCHOL SCI, V20, P1169, DOI 10.1111/j.1467-9280.2009.02426.x; Lamm C, J COGN NEUROSCI, V19, P42; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lawrence EJ, 2006, NEUROIMAGE, V29, P1173, DOI 10.1016/j.neuroimage.2005.09.001; Lin Q, 2009, CHN J APPL PSYCHOL, V14, P249; Mancini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026008; Mason MG, 1993, J ADOLESCENT RES, V8, P109, DOI DOI 10.1177/074355489381008; Merksey H., 1994, CLASSIFICATION CHRON; Moriarty N, 2001, J ADOLESCENCE, V24, P743, DOI 10.1006/jado.2001.0441; Pavey L, 2012, PERS SOC PSYCHOL B, V38, P681, DOI 10.1177/0146167211435940; PILIAVIN JA, 1990, ANNU REV SOCIOL, V16, P27, DOI 10.1146/annurev.so.16.080190.000331; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Preis MA, 2012, EUR J PAIN, V16, P1311, DOI 10.1002/j.1532-2149.2012.00119.x; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Reynolds W J, 1988, Nurse Educ Today, V8, P123, DOI 10.1016/0260-6917(88)90029-9; Riecansky I, 2015, SOC COGN AFFECT NEUR, V10, P893, DOI 10.1093/scan/nsu139; [戎幸 Rong Xing], 2010, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V18, P158; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; SCOTT J, 1976, PAIN, V2, P175, DOI 10.1016/0304-3959(76)90113-5; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Taylor SE, 2006, PSYCHOSOM MED, V68, P238, DOI 10.1097/01.psy.0000203242.95990.74; TROBST KK, 1994, J SOC PERS RELAT, V11, P45, DOI 10.1177/0265407594111003; Valeriani M, 2008, NEUROIMAGE, V40, P1419, DOI 10.1016/j.neuroimage.2007.12.056; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whitmarsh S, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00091; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Xia D, 2011, STUDY RELIABILITY VA, P1; Zhong CB, 2010, J EXP SOC PSYCHOL, V46, P859, DOI 10.1016/j.jesp.2010.04.003	69	4	4	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140580	10.1371/journal.pone.0140580	http://dx.doi.org/10.1371/journal.pone.0140580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0CK	26465603	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100149
J	Yuan, HB; Ding, YX; Gu, SH; Sun, L; Zhu, XQ; Liu, HW; Dhiloo, KH; Zhang, YJ; Guo, YY				Yuan, Hai-Bin; Ding, Yu-Xiao; Gu, Shao-Hua; Sun, Liang; Zhu, Xiao-Qiang; Liu, Hang-Wei; Dhiloo, Khalid Hussain; Zhang, Yong-Jun; Guo, Yu-Yuan			Molecular Characterization and Expression Profiling of Odorant-Binding Proteins in Apolygus lucorum	PLOS ONE			English	Article							BUG ADELPHOCORIS-LINEOLATUS; PLANT BUG; CHEMOSENSORY PROTEINS; PHEROMONE-BINDING; MEYER-DUR; HEMIPTERA-MIRIDAE; GENOME ANNOTATION; OLFACTORY GENES; MULTIPLE CROPS; FINE-STRUCTURE	Apolygus lucorum (Meyer-Dur) (Hemiptera: Miridae) is one of the most important agricultural pests, with broad host range and cryptic feeding habits in China. Chemosensory behavior plays an important role in many crucial stages in the life of A. lucorum, such as the detection of sex pheromone cues during mate pursuit and fragrant odorants during flowering host plant localization. Odorant-binding proteins (OBPs) are involved in the initial biochemical recognition steps in semiochemical perception. In the present study, a transcriptomics-based approach was used to identify potential OBPs in A. lucorum. In total, 38 putative OBP genes were identified, corresponding to 26 'classic' OBPs and 12 'Plus-C' OBPs. Phylogenetic analysis revealed that A. lucorum OBP proteins are more closely related to the OBP proteins of other mirid bugs as the same family OBP clustering together. Quantitative real-time PCR analysis for the first reported 23 AlucOBPs revealed that the expression level of 11 AlucOBP genes were significantly higher in antennae of both sexes than in other tissues. Three of them were male antennae-biased and six were female antennae-biased, suggesting their putative roles in the detection of female sex pheromones and host plant volatiles. In addition, three, four, two and one AlucOBPs had the highest degree of enrichment in the stylet, head, leg, and in abdomen tissues, respectively. Two other OBPs were ubiquitously expressed in the main tissues, including antennae, stylets, heads, legs and wings. Most orthologs had similar expression patterns, strongly indicating that these genes have the same function in olfaction and gustation.	[Yuan, Hai-Bin; Ding, Yu-Xiao] Jilin Agr Univ, Coll Agron, Changchun 130118, Jilin, Peoples R China; [Yuan, Hai-Bin; Ding, Yu-Xiao; Gu, Shao-Hua; Zhu, Xiao-Qiang; Liu, Hang-Wei; Dhiloo, Khalid Hussain; Zhang, Yong-Jun; Guo, Yu-Yuan] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Sun, Liang] Chinese Acad Agr Sci, Tea Res Inst, Key Lab Tea Plants Biol & Resources Utilizat, Minist Agr, Hangzhou 310008, Zhejiang, Peoples R China; [Dhiloo, Khalid Hussain] Sindh Agr Univ Tandojam, Fac Crop Protect, Dept Entomol, Tandojam, Pakistan	Jilin Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Sindh Agricultural University	Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yjzhang@ippcaas.cn			China National "973" Basic Research Program [2012CB114104]; National Natural Science Foundation of China [31272048, 31321004, 31471778]	China National "973" Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China National "973" Basic Research Program (2012CB114104) and the National Natural Science Foundation of China (31272048, 31321004 and 31471778).	Allmann S, 2010, SCIENCE, V329, P1075, DOI 10.1126/science.1191634; Asahina K, 2008, CURR BIOL, V18, P1153, DOI 10.1016/j.cub.2008.06.075; Buchel K, 2011, BASIC APPL ECOL, V12, P403, DOI 10.1016/j.baae.2011.06.002; Contreras E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055330; Cui XJ, 2011, ARCH INSECT BIOCHEM, V77, P45, DOI 10.1002/arch.20420; Dickens JC, 1998, J EXP BIOL, V201, P33; DICKENS JC, 1995, J INSECT PHYSIOL, V41, P857, DOI 10.1016/0022-1910(95)00038-V; Fu XW, 2014, J ECON ENTOMOL, V107, P1399, DOI 10.1603/EC13380; Galindo K, 2001, GENETICS, V159, P1059; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073524; Gu SH, 2013, INSECT BIOCHEM MOLEC, V43, P237, DOI 10.1016/j.ibmb.2012.12.009; Gu SH, 2011, ARCH INSECT BIOCHEM, V77, P81, DOI 10.1002/arch.20427; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He M, 2014, COMP BIOCHEM PHYS B, V174, P1, DOI 10.1016/j.cbpb.2014.04.008; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hua JF, 2013, J INSECT PHYSIOL, V59, P690, DOI 10.1016/j.jinsphys.2013.04.013; Hua JF, 2012, J CHEM ECOL, V38, P1163, DOI 10.1007/s10886-012-0178-7; Jeong YT, 2013, NEURON, V79, P725, DOI 10.1016/j.neuron.2013.06.025; Ji Ping, 2013, Acta Entomologica Sinica, V56, P575; Ji P, 2013, APPL ENTOMOL ZOOL, V48, P301, DOI 10.1007/s13355-013-0188-0; Leal WS, 2013, P NATL ACAD SCI USA, V110, P18704, DOI 10.1073/pnas.1316059110; Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064; Liu F, 2013, J INSECT PHYSIOL, V59, P1169, DOI 10.1016/j.jinsphys.2013.08.016; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes O, 2002, ARTHROPOD STRUCT DEV, V31, P1, DOI 10.1016/S1467-8039(02)00011-7; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Lu YH, 2007, ENVIRON ENTOMOL, V36, P1007, DOI 10.1603/0046-225X(2007)36[1007:FPOLLM]2.0.CO;2; Lu YanHui, 2011, Outlooks on Pest Management, V22, P248, DOI 10.1564/22dec02; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; McBrien HL, 1996, CAN ENTOMOL, V128, P1057, DOI 10.4039/Ent1281057-6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pan HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117153; Pan HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068980; Pan HS, 2013, CHEM COMMUNICATION M; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Rose USR, 2004, PLANTA, V218, P824, DOI 10.1007/s00425-003-1162-9; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Steinbrecht R.A., 1987, P353; STEINBRECHT RA, 1995, CELL TISSUE RES, V282, P203, DOI 10.1007/BF00319112; Sun L, 2014, INSECT MOL BIOL, V23, P417, DOI 10.1111/imb.12089; Sun L, 2013, J CHEM ECOL, V39, P1221, DOI 10.1007/s10886-013-0333-9; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Sun YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032759; Takanashi T, 2006, J EXP BIOL, V209, P4946, DOI 10.1242/jeb.02587; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 1999, CHEM SENSES, V24, P481, DOI 10.1093/chemse/24.5.481; VOGT RG, 1991, J NEUROSCI, V11, P2972; Wang Gui-rong, 2002, Scientia Agricultura Sinica, V35, P1479; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117054; Zhang QH, 2008, J CHEM ECOL, V34, P719, DOI 10.1007/s10886-008-9479-2; Zhang SG, 2001, CHEM SENSES, V26, P885, DOI 10.1093/chemse/26.7.885; Zhang SF, 2014, INSECT BIOCHEM MOLEC, V52, P69, DOI 10.1016/j.ibmb.2014.06.006; Zhang T, 2011, STUDY EXTRACTION IDE; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou JingJiang, 2010, Outlooks on Pest Management, V21, P31, DOI 10.1564/21feb08; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007; Zhou SS, 2014, COMP BIOCHEM PHYS D, V9, P31, DOI 10.1016/j.cbd.2013.12.002	68	49	62	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140562	10.1371/journal.pone.0140562	http://dx.doi.org/10.1371/journal.pone.0140562			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466366	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100146
J	Young, JG; Allard, A; Hebert-Dufresne, L; Dube, LJ				Young, Jean-Gabriel; Allard, Antoine; Hebert-Dufresne, Laurent; Dube, Louis J.			A Shadowing Problem in the Detection of Overlapping Communities: Lifting the Resolution Limit through a Cascading Procedure	PLOS ONE			English	Article							COMPLEX NETWORKS	Community detection is the process of assigning nodes and links in significant communities (e.g. clusters, function modules) and its development has led to a better understanding of complex networks. When applied to sizable networks, we argue that most detection algorithms correctly identify prominent communities, but fail to do so across multiple scales. As a result, a significant fraction of the network is left uncharted. We show that this problem stems from larger or denser communities overshadowing smaller or sparser ones, and that this effect accounts for most of the undetected communities and unassigned links. We propose a generic cascading approach to community detection that circumvents the problem. Using real and artificial network datasets with three widely used community detection algorithms, we show how a simple cascading procedure allows for the detection of the missing communities. This work highlights a new detection limit of community structure, and we hope that our approach can inspire better community detection algorithms.	[Young, Jean-Gabriel; Allard, Antoine; Hebert-Dufresne, Laurent; Dube, Louis J.] Univ Laval, Dept Phys Genie Phys & Opt, Quebec City, PQ G1V 0A6, Canada	Laval University	Dube, LJ (corresponding author), Univ Laval, Dept Phys Genie Phys & Opt, Quebec City, PQ G1V 0A6, Canada.	Louis.Dube@phy.ulaval.ca	Allard, Antoine/H-3168-2011; Young, Jean-Gabriel/K-1365-2019	Allard, Antoine/0000-0002-8208-9920; Young, Jean-Gabriel/0000-0002-4464-2692	Fonds de recherche du Quebec-Nature et technologies; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council	Fonds de recherche du Quebec-Nature et technologies; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors are grateful for the support of the Fonds de recherche du Quebec-Nature et technologies (JGY), of the Canadian Institutes of Health Research (AA), and of the Natural Sciences and Engineering Research Council (LHD, LJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Allard A, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/40/405005; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Boguna M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056122; Chen PY, 2015, IEEE T SIGNAL PROCES, V63, P5706, DOI 10.1109/TSP.2015.2458782; Chien-Cheng Lee, 2010, 2010 International Computer Symposium (ICS 2010), P1, DOI 10.1109/COMPSYM.2010.5685519; Derenyi I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160202; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Farkas IJ, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/180; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; He K, 2015, ARXIV50105700; Hebert-Dufresne L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.158702; Hebert-Dufresne L, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036115; Hric D, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062805; Karrer B, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066118; Kawamoto T, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.012809; Kumpula JM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026109; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Peixoto TP, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.148701; Ripeanu M, 2002, LECT NOTES COMPUT SC, V2429, P85; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Traag VA, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016114; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wen HR, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016114; Xie JR, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2501654.2501657; Yang J, 2015, KNOWL INF SYST, V42, P181, DOI 10.1007/s10115-013-0693-z	33	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140133	10.1371/journal.pone.0140133	http://dx.doi.org/10.1371/journal.pone.0140133			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461919	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300057
J	Shi, J; Miralles, F; Birnbaumer, L; Large, WA; Albert, AP				Shi, Jian; Miralles, Francesc; Birnbaumer, Lutz; Large, William A.; Albert, Anthony P.			Store depletion induces Gaq-mediated PLCb1 activity to stimulate TRPC1 channels in vascular smooth muscle cells	FASEB JOURNAL			English	Article						electrophysiology; PLC activity; Ca2+ signaling; phosphoinositol signaling	PROTEIN-KINASE-C; OPERATED CA2+ CHANNELS; PORTAL-VEIN MYOCYTES; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CALCIUM-CHANNELS; ARTERY MYOCYTES; ANGIOTENSIN-II; ACTIVATION; ENTRY; STIM1	Depletion of sarcoplasmic reticulum (SR) Ca2+ stores activates store-operated channels (SOCs) composed of canonical transient receptor potential (TRPC) 1 proteins in vascular smooth muscle cells (VSMCs), which contribute to important cellular functions. We have previously shown that PKC is obligatory for activation of TRPC1 SOCs in VSMCs, and the present study investigates if the classic phosphoinositol signaling pathway involving Gaq-mediated PLC activity is responsible for driving PKC-dependent channel gating. The G-protein inhibitor GDP beta-S, anti-Gaq antibodies, the PLC inhibitor U73122, and the PKC inhibitor GF109203X all inhibited activation of TRPC1 SOCs, and U73122 and GF109203X also reduced storeoperated PKC-dependent phosphorylation of TRPC1 proteins. Three distinct SR Ca2+ store-depleting agents, 1,2-bis(2-aminophenoxy) ethane-N, N, N', N'-tetraacetic acid acetoxymethyl ester, cyclopiazonic acid, and N, N, N', N'-tetrakis(2-pyridylmethyl) ethane-1,2-diamineed, induced-translocations of the fluorescent biosensor GFP-PLCd1-PH from the cell membrane to the cytosol, which were inhibited by U73122. Knockdown of PLC beta 1 with small hairpin RNA reduced both store-operated PLC activity and stimulation of TRPC1 SOCs. Immunoprecipitation studies and proximity ligation assays revealed that store depletion induced interactions between TRPC1 and Gaq, and TRPC1 and PLC beta 1. We propose a novel activation mechanism for TRPC1 SOCs in VSMCs, in which store depletion induces formation of TRPC1-Gaq-PLC beta 1 complexes that lead to PKC stimulation and channel gating.	[Shi, Jian; Miralles, Francesc; Large, William A.; Albert, Anthony P.] Univ London, Inst Cardiovasc & Cell Sci, Vasc Biol Res Ctr, Cranmer Terrace, London SW17 0RE, England; [Miralles, Francesc] Univ London, Inst Med & Biomed Educ, London, England; [Birnbaumer, Lutz] Natl Inst Environm Hlth Sci, Neurobiol Lab, Res Triangle Pk, NC USA	St Georges University London; University of London; University of London; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Shi, J (corresponding author), Univ London, Inst Cardiovasc & Cell Sci, Vasc Biol Res Ctr, Cranmer Terrace, London SW17 0RE, England.	jshi@sgul.ac.uk		Miralles, Francesc/0000-0003-3069-2725; Albert, Anthony/0000-0002-3596-9634	Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom) [BB/J007226/1, BB/M018350/1]; U.S. National Institutes of Health Intramural Research Program [Z01-ES-101684]; Biotechnology and Biological Sciences Research Council [BB/M018350/1, BB/J007226/1] Funding Source: researchfish; BBSRC [BB/M018350/1, BB/J007226/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101684] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. Elena Sviderskaya for assistance with electroporation. This work was supported by the Biotechnology and Biological Sciences Research Council (Swindon, United Kingdom) (BB/J007226/1 and BB/M018350/1 to A.P.A.) and was also supported in part by the U.S. National Institutes of Health Intramural Research Program (Project Z01-ES-101684 to L.B.).	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Ahmmed GU, 2004, J BIOL CHEM, V279, P20941, DOI 10.1074/jbc.M313975200; Albert AP, 2006, BRIT J PHARMACOL, V148, P1001, DOI 10.1038/sj.bjp.0706797; Albert AP, 2011, ADV EXP MED BIOL, V704, P391, DOI 10.1007/978-94-007-0265-3_22; Albert AP, 2009, CURR MED CHEM, V16, P1158, DOI 10.2174/092986709787581815; Albert AP, 2002, J PHYSIOL-LONDON, V544, P113, DOI 10.1113/jphysiol.2002.022574; Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Asanov A, 2015, CELL CALCIUM, V57, P1, DOI 10.1016/j.ceca.2014.10.011; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Balla Tamas, 2009, Curr Protoc Cell Biol, VChapter 24, DOI 10.1002/0471143030.cb2404s42; Beech DJ, 2013, CIRC J, V77, P570, DOI 10.1253/circj.CJ-13-0154; Beech DJ, 2012, PFLUG ARCH EUR J PHY, V463, P635, DOI 10.1007/s00424-012-1090-2; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; Cheng KT, 2013, CURR TOP MEMBR, V71, P149, DOI 10.1016/B978-0-12-407870-3.00007-X; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Cooley N, 2014, MOL PHARMACOL, V86, P399, DOI 10.1124/mol.114.093690; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Earley S, 2015, PHYSIOL REV, V95, P645, DOI 10.1152/physrev.00026.2014; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Large WA, 2009, CELL CALCIUM, V45, P574, DOI 10.1016/j.ceca.2009.02.007; Lee KP, 2014, J BIOL CHEM, V289, P6372, DOI 10.1074/jbc.M113.546556; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Lewis RS, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003970; Li J, 2008, CIRC RES, V103, pE97, DOI 10.1161/CIRCRESAHA.108.182931; Litjens T, 2007, BIOCHEM J, V405, P269, DOI 10.1042/BJ20061762; Ng LC, 2009, J PHYSIOL-LONDON, V587, P2429, DOI 10.1113/jphysiol.2009.172254; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Quinn KV, 2008, J PHYSIOL-LONDON, V586, P2855, DOI 10.1113/jphysiol.2008.153791; Ritchie MF, 2012, EMBO J, V31, P1123, DOI 10.1038/emboj.2011.495; Saleh SN, 2006, J PHYSIOL-LONDON, V577, P479, DOI 10.1113/jphysiol.2006.119305; Saleh SN, 2008, J PHYSIOL-LONDON, V586, P2463, DOI 10.1113/jphysiol.2008.152157; Saleh SN, 2009, J PHYSIOL-LONDON, V587, P5361, DOI 10.1113/jphysiol.2009.180331; Saleh SN, 2009, J PHYSIOL-LONDON, V587, P531, DOI 10.1113/jphysiol.2008.166678; Shi J, 2010, J PHYSIOL-LONDON, V588, P3671, DOI 10.1113/jphysiol.2010.194621; Shi J, 2014, FASEB J, V28, P244, DOI 10.1096/fj.13-238022; Shi J, 2012, FASEB J, V26, P409, DOI 10.1096/fj.11-185611; Shim AHR, 2015, J MOL BIOL, V427, P77, DOI 10.1016/j.jmb.2014.09.021; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Trebak M, 2012, J PHYSIOL-LONDON, V590, P4201, DOI 10.1113/jphysiol.2012.233353; Tu CL, 2005, J INVEST DERMATOL, V124, P187, DOI 10.1111/j.0022-202X.2004.23544.x; Wang M, 2007, J NEUROCHEM, V101, P411, DOI 10.1111/j.1471-4159.2006.04377.x; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Xu SZ, 2006, AM J PHYSIOL-HEART C, V291, pH2653, DOI 10.1152/ajpheart.00495.2006; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Xu SZ, 2001, CIRC RES, V88, P84, DOI 10.1161/01.RES.88.1.84; Yan HD, 2009, J NEUROSCI, V29, P10038, DOI 10.1523/JNEUROSCI.1042-09.2009; Yang B, 2012, AM J PHYSIOL-CELL PH, V302, pC748, DOI 10.1152/ajpcell.00312.2011; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198	53	22	23	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					702	715		10.1096/fj.15-280271	http://dx.doi.org/10.1096/fj.15-280271			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26467792	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000369391900021
J	Mandal, CC; Das, F; Ganapathy, S; Harris, SE; Choudhury, GG; Ghosh-Choudhury, N				Mandal, Chandi C.; Das, Falguni; Ganapathy, Suthakar; Harris, Stephen E.; Choudhury, Goutam Ghosh; Ghosh-Choudhury, Nandini			Bone Morphogenetic Protein-2 ( BMP-2) Activates NFATc1 Transcription Factor via an Autoregulatory Loop Involving Smad/Akt/Ca2+ Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; PHOSPHATIDYLINOSITOL 3-KINASE; RECEPTOR ACTIVATOR; NF-ATC; OSTEOBLASTIC CELLS; CALCIUM; EXPRESSION; KINASE; DIFFERENTIATION; RANKL	Background: Mutations in NFATc1 and BMP-2 genes result in bone abnormalities in mice. Results: BMP-2 activates intracellular Ca2+ release, thus activating calcineurin phosphatase to induce NFATc1 expression involving canonical Smad and noncanonical PI 3-kinase in osteoblasts. Conclusion: BMP-2-stimulated Ca-2 -calcineurin-NFATc1 axis potentiates osteoblast differentiation. Significance: NFATc1 autoregulates its expression in response to BMP-2 in osteoblasts.	[Choudhury, Goutam Ghosh; Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Vet Affairs Res, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Mandal, Chandi C.; Ganapathy, Suthakar; Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Das, Falguni; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Harris, Stephen E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Ghosh-Choudhury, N (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA.	choudhury@uthscsa.edu		Mandal, Chandi/0000-0002-2292-6635	Veterans Affairs Merit Review grants; National Institutes of Health [RO1 AR52425, RO1 DK50190]; Cancer Prevention Research Institute of Texas fellowship; Veterans Affairs Senior Research Career Scientist Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190] Funding Source: NIH RePORTER	Veterans Affairs Merit Review grants(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas fellowship; Veterans Affairs Senior Research Career Scientist Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Veterans Affairs Merit Review grants and National Institutes of Health Grant RO1 AR52425 (to N.G.-C.)and National Institutes of Health Grant RO1 DK50190 and Veterans Affairs Merit Review grants (to G.G.C.). The authors do not have any conflict of interests. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipient of a Cancer Prevention Research Institute of Texas fellowship. Present address: Dept. of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer 305801, India.r Recipient of a Veterans Affairs Senior Research Career Scientist Award.	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Blair HC, 2011, BIOFACTORS, V37, P159, DOI 10.1002/biof.143; BODEN SD, 1990, ORTHOP CLIN N AM, V21, P31; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Capulli M, 2014, ARCH BIOCHEM BIOPHYS, V561, P3, DOI 10.1016/j.abb.2014.05.003; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dvorak MM, 2004, CELL CALCIUM, V35, P249, DOI 10.1016/j.ceca.2003.10.014; Eapen A, 2010, J BIOL CHEM, V285, P36339, DOI 10.1074/jbc.M110.145607; Fruman David A., 1996, Methods (Orlando), V9, P146, DOI 10.1006/meth.1996.0020; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Ghosh-Choudhury N, 2007, J BIOL CHEM, V282, P4983, DOI 10.1074/jbc.M606706200; Ghosh-Choudhury N, 2006, J BIOL CHEM, V281, P20160, DOI 10.1074/jbc.M511071200; Ghosh-Choudhury N, 2013, J BIOL CHEM, V288, P24503, DOI 10.1074/jbc.M113.455733; GhoshChoudhury N, 1996, ENDOCRINOLOGY, V137, P331, DOI 10.1210/en.137.1.331; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Itoh K, 2001, ENDOCRINOLOGY, V142, P3656, DOI 10.1210/en.142.8.3656; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lee HL, 2011, BONE, V49, P242, DOI 10.1016/j.bone.2011.04.006; Lu WJ, 2010, AM J PHYSIOL-CELL PH, V299, pC1370, DOI 10.1152/ajpcell.00040.2010; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Mandal CC, 2011, BIOCHEM J, V433, P393, DOI 10.1042/BJ20100357; Mandal CC, 2009, ENDOCRINOLOGY, V150, P4989, DOI 10.1210/en.2009-0026; Mandal CC, 2012, CARCINOGENESIS, V33, P1897, DOI 10.1093/carcin/bgs198; Mandal CC, 2011, J BIOL CHEM, V286, P11314, DOI 10.1074/jbc.M110.193714; Mandal CC, 2010, CALCIFIED TISSUE INT, V87, P533, DOI 10.1007/s00223-010-9419-3; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Massague J, 2000, GENE DEV, V14, P627; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Nesti LJ, 2007, J CELL BIOCHEM, V101, P348, DOI 10.1002/jcb.21180; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Shah AK, 1999, BIOL CELL, V91, P131, DOI 10.1016/S0248-4900(99)80037-9; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takami M, 2000, ENDOCRINOLOGY, V141, P4711, DOI 10.1210/en.141.12.4711; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Yang WC, 2013, J CELL SCI, V126, P4085, DOI 10.1242/jcs.118596; Zhang GH, 1997, P SOC EXP BIOL MED, V216, P117; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134	49	34	36	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1148	1161		10.1074/jbc.M115.668939	http://dx.doi.org/10.1074/jbc.M115.668939			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26472929	Green Published, hybrid			2022-12-26	WOS:000368068300011
J	Lackey, L; McArthur, E; Laederach, A				Lackey, Lela; McArthur, Evonne; Laederach, Alain			Increased Transcript Complexity in Genes Associated with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GLYCATION END-PRODUCTS; RNA SECONDARY STRUCTURES; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CYSTIC-FIBROSIS; LUNG-DISEASE; GLUCOCORTICOID-RECEPTOR; EMERGING GENETICS; INDUCED EMPHYSEMA	Genome-wide association studies aim to correlate genotype with phenotype. Many common diseases including Type II diabetes, Alzheimer's, Parkinson's and Chronic Obstructive Pulmonary Disease (COPD) are complex genetic traits with hundreds of different loci that are associated with varied disease risk. Identifying common features in the genes associated with each disease remains a challenge. Furthermore, the role of post-transcriptional regulation, and in particular alternative splicing, is still poorly understood in most multigenic diseases. We therefore compiled comprehensive lists of genes associated with Type II diabetes, Alzheimer's, Parkinson's and COPD in an attempt to identify common features of their corresponding mRNA transcripts within each gene set. The SERPINA1 gene is a well-recognized genetic risk factor of COPD and it produces 11 transcript variants, which is exceptional for a human gene. This led us to hypothesize that other genes associated with COPD, and complex disorders in general, are highly transcriptionally diverse. We found that COPD-associated genes have a statistically significant enrichment in transcript complexity stemming from a disproportionately high level of alternative splicing, however, Type II Diabetes, Alzheimer's and Parkinson's disease genes were not significantly enriched. We also identified a subset of transcriptionally complex COPD-associated genes (similar to 40%) that are differentially expressed between mild, moderate and severe COPD. Although the genes associated with other lung diseases are not extensively documented, we found preliminary data that idiopathic pulmonary disease genes, but not cystic fibrosis modulators, are also more transcriptionally complex. Interestingly, complex COPD transcripts are more often the product of alternative acceptor site usage. To verify the biological importance of these alternative transcripts, we used RNA-sequencing analyses to determine that COPD-associated genes are frequently expressed in lung and liver tissues and are regulated in a tissue-specific manner. Additionally, many complex COPD-associated genes are spliced differently between COPD and non-COPD patients. Our analysis therefore suggests that post-transcriptional regulation, particularly alternative splicing, is an important feature specific to COPD disease etiology that warrants further investigation.	[Lackey, Lela; McArthur, Evonne; Laederach, Alain] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Laederach, A (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	alain@unc.edu		Lackey, Lela/0000-0003-2163-4005; McArthur, Evonne/0000-0003-4566-4321	National Institutes of Health/National Heart Lung and Blood Institute [RO1 HL111527-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111527] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101237] Funding Source: NIH RePORTER	National Institutes of Health/National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health/National Heart Lung and Blood Institute: RO1 HL111527-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Arif E, 2008, CLIN CHIM ACTA, V397, P46, DOI 10.1016/j.cca.2008.07.010; Artigas MS, 2011, AM J RESP CRIT CARE, V184, P786, DOI 10.1164/rccm.201102-0192OC; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Berndt A, 2012, EMBO MOL MED, V4, P1144, DOI 10.1002/emmm.201100627; Bettens K, 2013, LANCET NEUROL, V12, P92, DOI 10.1016/S1474-4422(12)70259-4; Bonnefond A, 2010, TRENDS MOL MED, V16, P407, DOI 10.1016/j.molmed.2010.06.004; Bosse Y, 2012, INT J CHRONIC OBSTR, V7, P607, DOI 10.2147/COPD.S35294; Bosse Y, 2009, PHARMACOGENOMICS, V10, P655, DOI 10.2217/PGS.09.10; Brebner JA, 2013, EXPERT REV RESP MED, V7, P213, DOI [10.1586/ERS.13.20, 10.1586/ers.13.20]; CARRELL RW, 1982, NATURE, V298, P329, DOI 10.1038/298329a0; Castaldi PJ, 2015, HUM MOL GENET, V24, P1200, DOI 10.1093/hmg/ddu525; Chang CQ, 2014, EUR J HUM GENET, V22, P402, DOI 10.1038/ejhg.2013.161; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chen L, 2014, MOL BIOL EVOL, V31, P1402, DOI 10.1093/molbev/msu083; Chen W, 2015, ANN AM THORAC SOC, V12, P340, DOI 10.1513/AnnalsATS.201408-380OC; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Corvol H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-88; Corvol H, 2014, J MED GENET, V51, P646, DOI 10.1136/jmedgenet-2014-102525; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; D'Anna C, 2015, LIFE SCI, V126, P10, DOI 10.1016/j.lfs.2015.01.017; Damico R, 2011, AM J RESP CELL MOL, V44, P323, DOI 10.1165/rcmb.2009-0379OC; de Jong K, 2015, J ALLERGY CLIN IMMUN, V136, P1664, DOI 10.1016/j.jaci.2015.03.042; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; DUMUR V, 1990, LANCET, V335, P1340, DOI 10.1016/0140-6736(90)91216-W; Elbein SC, 2012, AM J HUM GENET, V91, P466, DOI 10.1016/j.ajhg.2012.08.002; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Florea Liliana, 2013, F1000Res, V2, P188, DOI 10.12688/f1000research.2-188.v1; Foissac S, 2007, NUCLEIC ACIDS RES, V35, pW297, DOI 10.1093/nar/gkm311; Gao CX, 2012, J BIOL CHEM, V287, P16699, DOI 10.1074/jbc.M111.315333; Gebauer F, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012245; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghouse R, 2014, DIS MODEL MECH, V7, P411, DOI 10.1242/dmm.014092; Gooptu B, 2009, EUR RESPIR J, V34, P475, DOI 10.1183/09031936.00096508; Guo WA, 2012, INTENS CARE MED, V38, P1588, DOI 10.1007/s00134-012-2624-y; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Hambly N, 2015, RESPIROLOGY, V20, P1010, DOI 10.1111/resp.12569; Hancock DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003098; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hancox RJ, 2009, HUM GENET, V126, P559, DOI 10.1007/s00439-009-0704-z; Hao LL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-316; He JQ, 2008, EUR RESPIR J, V32, P25, DOI 10.1183/09031936.00040307; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hindorff LA, CATALOG PUBLISHED GE; Homma S, 2006, INT J MOL MED, V18, P933; Houlden H, 2012, ACTA NEUROPATHOL, V124, P325, DOI 10.1007/s00401-012-1013-5; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Jin ZG, 2015, MOL BIOL CELL, V26, P1160, DOI 10.1091/mbc.E14-08-1276; Jourquin J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S20; Kamio K, 2012, BIOCHEM BIOPH RES CO, V424, P112, DOI 10.1016/j.bbrc.2012.06.081; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kim S, 2015, J HUM GENET, V60, P139, DOI 10.1038/jhg.2014.118; Kim WJ, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/206937; Knowles MR, 2006, CURR OPIN PULM MED, V12, P416, DOI 10.1097/01.mcp.0000245707.59138.40; Konrad FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121725; Kropski JA, 2015, EUR RESPIR J, V45, P1717, DOI 10.1183/09031936.00163814; Lajoie M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-231; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JH, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0113-2; Lee YL, 2006, J LAB CLIN MED, V147, P228, DOI 10.1016/j.lab.2005.12.008; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Lin WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116229; Loy CT, 2014, LANCET, V383, P828, DOI 10.1016/S0140-6736(13)60630-3; Lu ZX, 2012, WIRES RNA, V3, P581, DOI 10.1002/wrna.120; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Marciniak SJ, 2014, CLIN CHEST MED, V35, P29, DOI 10.1016/j.ccm.2013.10.008; Matamala N, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0585-y; Mathers C, 2008, GLOB BURD DIS 2004 U, pvii; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Miniati M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-37; Murray J. F., 2010, MURRAY NADELS TXB RE; Nakamura Hidetoshi, 2011, Allergology International, V60, P253, DOI 10.2332/allergolint.11-RAI-0326; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Obeidat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019382; Perrotti D, 2002, NAT GENET, V30, P48, DOI 10.1038/ng791; Petrie JR, 2011, BIOCHEM PHARMACOL, V81, P471, DOI 10.1016/j.bcp.2010.11.010; Pillai SG, 2010, AM J RESP CRIT CARE, V182, P1498, DOI 10.1164/rccm.201002-0151OC; Puschmann A, 2013, PARKINSONISM RELAT D, V19, P407, DOI 10.1016/j.parkreldis.2013.01.020; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Research MPIfHaL, 2014, SNP4DISEASE; Rider CF, 2011, J PHARMACOL EXP THER, V338, P860, DOI 10.1124/jpet.111.181016; Ridge PG, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/254954; Ringman John M, 2013, Continuum (Minneap Minn), V19, P358, DOI 10.1212/01.CON.0000429179.21977.a1; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Schafer SA, 2011, DIABETES RES CLIN PR, V93, pS9, DOI 10.1016/S0168-8227(11)70008-0; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Sessa L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086903; Sharma S, 2009, EUR RESPIR J, V33, P1287, DOI 10.1183/09031936.00113008; Shepard PJ, 2008, RNA, V14, P1463, DOI 10.1261/rna.1069408; Shetty SK, 2012, AM J RESP CELL MOL, V47, P474, DOI 10.1165/rcmb.2011-0390OC; Silverman EK, 2002, AM J HUM GENET, V70, P1229, DOI 10.1086/340316; Simm A, 2004, ANN NY ACAD SCI, V1019, P228, DOI 10.1196/annals.1297.038; Singh D, 2011, THORAX, V66, P489, DOI 10.1136/thx.2010.153767; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Smith DJ, 2011, EUR RESPIR J, V37, P516, DOI 10.1183/09031936.00029310; Spagnolo P, 2014, LANCET RESP MED, V2, P416, DOI 10.1016/S2213-2600(14)70047-5; Stoller JK, 1993, ALPHA 1 ANTITRYPSIN; Tanzi RE, 2013, J ALZHEIMERS DIS, V33, pS5, DOI 10.3233/JAD-2012-129044; Thun GA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003585; Tosto G, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0381-0; Tsui LC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009472; Xie JG, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0209-3; Yamada M, 2011, J HUM GENET, V56, P857, DOI 10.1038/jhg.2011.118; Yoon HK, 2014, COPD, V11, P652, DOI 10.3109/15412555.2014.898045; Zanini A, 2014, RESPIRATION, V87, P234, DOI 10.1159/000356749; Zhang F, 2011, RESPIRATION, V82, P358, DOI 10.1159/000328762; Zhang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-90	112	12	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140885	10.1371/journal.pone.0140885	http://dx.doi.org/10.1371/journal.pone.0140885			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26480348	Green Published, Green Submitted, gold			2022-12-26	WOS:000363026600024
J	Mohrbeck, I; Raupach, MJ; Arbizu, PM; Knebelsberger, T; Laakmann, S				Mohrbeck, Inga; Raupach, Michael J.; Arbizu, Pedro Martinez; Knebelsberger, Thomas; Laakmann, Silke			High-Throughput Sequencing-The Key to Rapid Biodiversity Assessment of Marine Metazoa?	PLOS ONE			English	Article							18S RIBOSOMAL-RNA; OCEAN DEEP-SEA; SMALL-SUBUNIT; SPECIES IDENTIFICATION; MICROBIAL DIVERSITY; CONCERTED EVOLUTION; MITOCHONDRIAL-DNA; RDNA; GENE; EXPANSION	The applications of traditional morphological and molecular methods for species identification are greatly restricted by processing speed and on a regional or greater scale are generally considered unfeasible. In this context, high-throughput sequencing, or metagenetics, has been proposed as an efficient tool to document biodiversity. Here we evaluated the effectiveness of 454 pyrosequencing in marine metazoan community analysis using the 18S rDNA: V1-V2 region. Multiplex pyrosequencing of the V1-V2 region was used to analyze two pooled samples of DNA, one comprising 118 and the other 37 morphologically identified species, and one natural sample taken directly from a North Sea zooplankton community. A DNA reference library comprising all species represented in the pooled samples was created by Sanger sequencing, and this was then used to determine the optimal similarity threshold for species delineation. The optimal threshold was found at 99% species similarity, with 85% identification success. Pyrosequencing was able to identify between fewer species: 67% and 78% of the species in the two pooled samples. Also, a large number of sequences for three species that were not included in the pooled samples were amplified by pyrosequencing, suggesting preferential amplification of some genotypes and the sensitivity of this approach to even low levels of contamination. Conversely, metagenetic analysis of the natural zooplankton sample identified many more species (particularly gelatinous zooplankton and meroplankton) than morphological analysis of a formalin-fixed sample from the same sampling site, suggesting an increased level of taxonomic resolution with pyrosequencing. The study demonstrated that, based on the V1-V2 region, 454 sequencing does not provide accurate species differentiation and reliable taxonomic classification, as it is required in most biodiversity monitoring. The analysis of artificially prepared samples indicated that species detection in pyrosequencing datasets is complicated by potential PCR-based biases and that the V1-V2 marker is poorly resolved for some taxa.	[Mohrbeck, Inga; Raupach, Michael J.; Arbizu, Pedro Martinez; Knebelsberger, Thomas; Laakmann, Silke] Senckenberg Meer, Dept German Ctr Marine Biodivers Res, Wilhelmshaven, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN)	Mohrbeck, I (corresponding author), Senckenberg Meer, Dept German Ctr Marine Biodivers Res, Wilhelmshaven, Germany.	imohrbeck@senckenberg.de	Raupach, Michael J./AAF-7566-2020	Raupach, Michael J./0000-0001-8299-6697; Laakmann, Silke/0000-0003-3273-7907	Federal Ministry for Education and Research; State of Lower Saxony [03F0499A, 03F0664A]	Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); State of Lower Saxony(European Commission)	This work was funded by the Federal Ministry for Education and Research (www.bmbf.de) and the State of Lower Saxony (grant no. 03F0499A, 03F0664A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Balzer S, 2011, BIOINFORMATICS, V27, pI304, DOI 10.1093/bioinformatics/btr251; Benita Y, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng101; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bik HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038550; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Brokeland W, 2008, ZOOL J LINN SOC-LOND, V152, P655, DOI 10.1111/j.1096-3642.2008.00362.x; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; Carranza S, 1996, MOL BIOL EVOL, V13, P824, DOI 10.1093/oxfordjournals.molbev.a025643; Cepeda GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035861; Chen HN, 2013, BIOFOULING, V29, P133, DOI 10.1080/08927014.2012.753061; Crease TJ, 1998, MOL BIOL EVOL, V15, P1430, DOI 10.1093/oxfordjournals.molbev.a025871; CREASE TJ, 1991, MOL BIOL EVOL, V8, P620; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Edwards Robert A, 2006, BMC Genomics, V7, P57; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fonseca VG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks002; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666, DOI 10.1073/pnas.82.22.7666; Greve W, 2001, SENCK MARIT, V31, P263, DOI 10.1007/BF03043035; Hajibabaei M, 2012, TRENDS GENET, V28, P535, DOI 10.1016/j.tig.2012.08.001; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hancock JM, 2000, MOL PHYLOGENET EVOL, V14, P366, DOI 10.1006/mpev.1999.0709; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; HILLIS DM, 1991, SCIENCE, V251, P308, DOI 10.1126/science.1987647; HOEH WR, 1991, SCIENCE, V251, P1488, DOI 10.1126/science.1672472; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Hwang UW, 2000, ZOOL SCI, V17, P111, DOI 10.2108/zsj.17.111; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keller I, 2008, EVOLUTION, V62, P833, DOI 10.1111/j.1558-5646.2008.00320.x; Kemppainen P, 2009, J EVOLUTION BIOL, V22, P2000, DOI 10.1111/j.1420-9101.2009.01810.x; Ko HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053451; Krieger J, 2004, J APPL ICHTHYOL, V20, P433, DOI 10.1111/j.1439-0426.2004.00610.x; Krieger J, 2006, J HERED, V97, P218, DOI 10.1093/jhered/esj035; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Laakmann S, 2012, MOL PHYLOGENET EVOL, V65, P535, DOI 10.1016/j.ympev.2012.07.007; Lecroq B, 2011, P NATL ACAD SCI USA, V108, P13177, DOI 10.1073/pnas.1018426108; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Lindeque PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081327; Luddington IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045664; Machida RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046180; Machida RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035887; Machida RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010278; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markmann M, 2005, PHILOS T R SOC B, V360, P1917, DOI 10.1098/rstb.2005.1723; McTaggart SJ, 2005, MOL BIOL EVOL, V22, P1309, DOI 10.1093/molbev/msi119; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Mohrbeck I, 2010, SYST PARASITOL, V77, P131, DOI 10.1007/s11230-010-9260-0; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Pawlowski J, 2010, J EUKARYOT MICROBIOL, V57, P197, DOI 10.1111/j.1550-7408.2009.00468.x; Pereira Filipe, 2008, Recent Pat DNA Gene Seq, V2, P187, DOI 10.2174/187221508786241738; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pfenninger M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-100; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Prinja S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043093, 10.1371/journal.pone.0030362]; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Radulovici Adriana E., 2010, Diversity, V2, P450; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Raupach MJ, 2006, ANTARCT SCI, V18, P191, DOI 10.1017/S0954102006000228; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Santos SR, 2003, J EUKARYOT MICROBIOL, V50, P417, DOI 10.1111/j.1550-7408.2003.tb00264.x; Schaechter M, 2004, DESK ENCY MICROBIOLO; Shinoda N, 2009, NUCLEOS NUCLEOT NUCL, V28, P324, DOI 10.1080/15257770902963400; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Shokralla S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021252; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; Stoeckle M, 2003, BIOSCIENCE, V53, P796, DOI 10.1641/0006-3568(2003)053[0796:TDATBC]2.0.CO;2; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taberlet P, 2012, MOL ECOL, V21, P1816, DOI 10.1111/j.1365-294X.2011.05317.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang CQ, 2012, P NATL ACAD SCI USA, V109, P16208, DOI 10.1073/pnas.1209160109; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tsaousis AD, 2005, MOL BIOL EVOL, V22, P925, DOI 10.1093/molbev/msi084; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; White KN, 2011, J CRUSTACEAN BIOL, V31, P710, DOI 10.1651/11-3489.1; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; Wu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131498; Xie Q, 2009, MOL PHYLOGENET EVOL, V50, P310, DOI 10.1016/j.ympev.2008.10.025; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zhan AB, 2013, METHODS ECOL EVOL, V4, P558, DOI 10.1111/2041-210X.12037; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6	110	41	43	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140342	10.1371/journal.pone.0140342	http://dx.doi.org/10.1371/journal.pone.0140342			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479071	gold, Green Published, Green Submitted			2022-12-26	WOS:000363026600008
J	Nomura, R; Liang, YZ; Okada, T				Nomura, Ryota; Liang, Yingzong; Okada, Takeshi			Interactions among Collective Spectators Facilitate Eyeblink Synchronization	PLOS ONE			English	Article							SELF-ADAPTIVE SYSTEMS	Whereas the entrainment of movements and aspirations among audience members has been known as a basis of collective excitement in the theater, the role of the entrainment of cognitive processes among audience members is still unclear. In the current study, temporal patterns of the audience's attention were observed using eyeblink responses. To determine the effect of interactions among audience members on cognitive entrainment, as well as its direction (attractive or repulsive), the eyeblink synchronization of the following two groups were compared: (1) the experimental condition, where the audience members (seven frequent viewers and seven first-time viewers) viewed live performances in situ, and (2) the control condition, where the audience members (15 frequent viewers and 15 first-time viewers) viewed videotaped performances in individual experimental settings (results reported in previous study.) The results of this study demonstrated that the mean values of a measure of asynchrony (i.e., D-interval) were much lower for the experimental condition than for the control condition. Frequent viewers had a moderate attractive effect that increased as the story progressed, while a strong attractive effect was observed throughout the story for first-time viewers. The attractive effect of interactions among a group of spectators was discussed from the viewpoint of cognitive and somatic entrainment in live performances.	[Nomura, Ryota; Okada, Takeshi] Univ Tokyo, Dept Educ, Bunkyo Ward, Tokyo, Japan; [Liang, Yingzong] Univ Tokyo, Grad Sch Engn, Bunkyo Ward, Tokyo, Japan	University of Tokyo; University of Tokyo	Nomura, R (corresponding author), Univ Tokyo, Dept Educ, Bunkyo Ward, 7-3-1 Hongo, Tokyo, Japan.	nomuraryota@gmail.com			Japan Society for the Promotion of Science [2408089, 24243062]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Support was provided by the Japan Society for the Promotion of Science, Grant-in-Aid for Japan Society for the Promotion of Science Fellows #2408089 to RN [https://kaken.nii.ac.jp/d/p/12J08089.en.html] and the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research(A) #24243062 to TO [https://kaken.nii.ac.jp/d/p/ 24243062.en.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brun Y, 2009, LECT NOTES COMPUT SC, V5525, P48, DOI 10.1007/978-3-642-02161-9_3; HOLLAND MK, 1975, PERCEPT MOTOR SKILL, V41, P403, DOI 10.2466/pms.1975.41.2.403; Latif N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105036; Louzada VHP, 2013, SCI REP, P3; Macias-Escriva FD, 2013, EXPERT SYST APPL, V40, P7267, DOI 10.1016/j.eswa.2013.07.033; Nakano T, 2009, P ROY SOC B-BIOL SCI, V276, P3635, DOI 10.1098/rspb.2009.0828; Nomura R., 2014, COGN STUD, V21, P226, DOI 10.11225/jcss.21.226; Nomura R., 2008, JAPANESE PSYCHOL REV, V51, P500; Nomura R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00447; Oh J, 2012, HUM MOVEMENT SCI, V31, P1353, DOI 10.1016/j.humov.2012.06.003; Oh J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034871; Strogatz S.H., 2014, NONLINEAR DYNAMICS C; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; von Scheve C., 2014, COLLECTIVE EMOTIONS; Wang RQ, 2006, BIOINFORMATICS, V22, P1775, DOI 10.1093/bioinformatics/btl182; WYER RS, 1992, PSYCHOL REV, V99, P663, DOI 10.1037/0033-295X.99.4.663	16	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140774	10.1371/journal.pone.0140774	http://dx.doi.org/10.1371/journal.pone.0140774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479405	Green Submitted, Green Published, gold			2022-12-26	WOS:000363026600019
J	Geurts, M; van der Worp, HB; Horsch, AD; Kappelle, LJ; Biessels, GJ; Velthuis, BK				Geurts, Marjolein; van der Worp, H. Bart; Horsch, Alexander D.; Kappelle, L. Jaap; Biessels, Geert J.; Velthuis, Birgitta K.		DUST Investigators	No Relation between Body Temperature and Arterial Recanalization at Three Days in Patients with Acute Ischaemic Stroke	PLOS ONE			English	Article							THERAPEUTIC HYPOTHERMIA; ASSOCIATION; GUIDELINES; MANAGEMENT; BENEFIT	Background Recanalization of an occluded intracranial artery is influenced by temperature-dependent enzymes, including alteplase. We assessed the relation between body temperature on admission and recanalization. Methods We included 278 patients with acute ischaemic stroke within nine hours after symptom onset, who had an intracranial arterial occlusion on admission CT angiography, in 13 participating centres. We calculated the relation per every 0.1 degrees Celsius increase in admission body temperature and recanalization at three days. Results Recanalization occurred in 80% of occluded arteries. There was no relation between body temperature and recanalization at three days after adjustments for age, NIHSS score on admission and treatment with alteplase (adjusted odds ratio per 0.1 degrees Celsius, 0.99; 95% confidence interval, 0.94-1.05; p = 0.70). Results for patients treated or not treated with alteplase were essentially the same. Conclusions Our findings suggest that in patients with acute ischaemic stroke there is no relation between body temperature on admission and recanalization of an occluded intracranial artery three days later, irrespective of treatment with alteplase.	[Geurts, Marjolein; van der Worp, H. Bart; Kappelle, L. Jaap; Biessels, Geert J.] Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Horsch, Alexander D.; Velthuis, Birgitta K.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Geurts, M (corresponding author), Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	m.geurts-2@umcutrecht.nl	Horsch, Alexander D./U-3330-2019; Geurts, Marjolein/AAP-4148-2020	Horsch, Alexander/0000-0001-8213-2784	Dutch Heart Foundation [2010B239, 2010T075, 2010T073, 2008T034]; NutsOhra Foundation [0903-012]	Dutch Heart Foundation(Netherlands Heart Foundation); NutsOhra Foundation	M. Geurts, H. B. van der Worp, and G. J. Biessels are supported by the Dutch Heart Foundation (2010B239, 2010T075, and 2010T073 respectively). The DUST study was supported by the Dutch Heart Foundation (2008T034) and the NutsOhra Foundation (0903-012).	de Ridder I, 2013, CEREBROVASC DIS, V35, P60, DOI 10.1159/000345335; den Hertog HM, 2011, J NEUROL, V258, P302, DOI 10.1007/s00415-010-5756-4; Ernon L, 2006, ACTA NEUROL SCAND, V114, P23, DOI 10.1111/j.1600-0404.2006.00596.x; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kim SH, 2015, STROKE, V46, P132, DOI 10.1161/STROKEAHA.114.006107; Kvistad CE, 2014, ACTA NEUROL SCAND, V129, P325, DOI 10.1111/ane.12184; Lyden PD, 2014, INT J STROKE, V9, P117, DOI 10.1111/ijs.12151; Millan M, 2008, EUR J NEUROL, V15, P1384, DOI 10.1111/j.1468-1331.2008.02321.x; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Saini M, 2009, STROKE, V40, P3051, DOI 10.1161/STROKEAHA.109.556134; van der Worp HB, 2014, INT J STROKE, V9, P642, DOI 10.1111/ijs.12294; van der Worp HB, 2010, J CEREBR BLOOD F MET, V30, P1079, DOI 10.1038/jcbfm.2010.44; van Seeters T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-37; Yenari MA, 2010, STROKE, V41, pS72, DOI 10.1161/STROKEAHA.110.595371	15	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140777	10.1371/journal.pone.0140777	http://dx.doi.org/10.1371/journal.pone.0140777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473959	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500108
J	Huang, LF; Tan, CC; Yeh, JF; Liu, HY; Liu, YK; Ho, SL; Lu, CA				Huang, Li-Fen; Tan, Chia-Chun; Yeh, Ju-Fang; Liu, Hsin-Yi; Liu, Yu-Kuo; Ho, Shin-Lon; Lu, Chung-An			Efficient Secretion of Recombinant Proteins from Rice Suspension-Cultured Cells Modulated by the Choice of Signal Peptide	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TRANSGENIC RICE; ENDOPLASMIC-RETICULUM; PLANT-CELLS; RECOGNITION PARTICLE; WALL INVERTASE; A-AMYLASE; EXPRESSION; GENE; CSF	Plant-based expression systems have emerged as a competitive platform in the large-scale production of recombinant proteins. By adding a signal peptide, alpha Amy3sp, the desired recombinant proteins can be secreted outside transgenic rice cells, making them easy to harvest. In this work, to improve the secretion efficiency of recombinant proteins in rice expression systems, various signal peptides including alpha Amy3sp, CIN1sp, and 33KDsp have been fused to the N-terminus of green fluorescent protein (GFP) and introduced into rice cells to explore the efficiency of secretion of foreign proteins. 33KDsp had better efficiency than alpha Amy3sp and CIN1sp for the secretion of GFP from calli and suspension-cultured cells. 33KDsp was further applied for the secretion of mouse granulocyte-macrophage colony-stimulating factor (mGM-CSF) from transgenic rice suspension-cultured cells; approximately 76%-92% of total rice-derived mGM-CSF (rmGM-CSF) was detected in the culture medium. The rmGM-CSF was bioactive and could stimulate the proliferation of a murine myeloblastic leukemia cell line, NSF-60. The extracellular yield of rmGM-CSF reached 31.7 mg/L. Our study indicates that 33KDsp is better at promoting the secretion of recombinant proteins in rice suspension-cultured cell systems than the commonly used alpha Amy3sp.	[Huang, Li-Fen; Tan, Chia-Chun] Yuan Ze Univ, Grad Sch Biotechnol & Bioengn, Taoyuan, Taiwan; [Yeh, Ju-Fang; Liu, Hsin-Yi; Lu, Chung-An] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan; [Liu, Yu-Kuo] Chang Gung Univ, Grad Inst Biochem & Biomed Engn, Taoyuan, Taiwan; [Ho, Shin-Lon] Natl Chiayi Univ, Dept Agron, Chiayi 60004, Taiwan	Yuan Ze University; National Central University; Chang Gung University; National Chiayi University	Huang, LF (corresponding author), Yuan Ze Univ, Grad Sch Biotechnol & Bioengn, 135 Yuan Tung Rd, Taoyuan, Taiwan.	hlf326@saturn.yzu.edu.tw; chungan@cc.ncu.edu.tw	Huang, Li-Fen/AAB-8041-2022		Ministry of Science and Technology of the Republic of China [102-2313-B-155-001, 103-2321-B-008-002]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	The work was supported by Ministry of Science and Technology of the Republic of China (http://www.most.gov.tw/mp.aspx?mp=7), 102-2313-B-155-001 to Li-Fen Huang and 103-2321-B-008-002 to Chung-An Lu.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Borisjuk NV, 1999, NAT BIOTECHNOL, V17, P466, DOI 10.1038/8643; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; CARPITA N, 1979, SCIENCE, V205, P1144, DOI 10.1126/science.205.4411.1144; CHAN MT, 1993, PLANT MOL BIOL, V22, P491, DOI 10.1007/BF00015978; Chen MH, 2004, PLANT PHYSIOL, V135, P1367, DOI 10.1104/pp.104.042184; Chen PW, 2002, J BIOL CHEM, V277, P13641, DOI 10.1074/jbc.M109722200; Chen TL, 2004, TRANSGENIC RES, V13, P499, DOI 10.1007/s11248-004-2376-8; DALE DC, 1995, J INFECT DIS, V172, P1061, DOI 10.1093/infdis/172.4.1061; Daniell H, 2009, TRENDS PLANT SCI, V14, P669, DOI 10.1016/j.tplants.2009.09.009; Eiden-Plach A, 2004, APPL ENVIRON MICROB, V70, P961, DOI 10.1128/AEM.70.2.961-966.2004; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Everly JJ, 2005, EXPERT OPIN BIOL TH, V5, P293, DOI 10.1517/14712598.5.3.293; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; Gleba D, 1999, P NATL ACAD SCI USA, V96, P5973, DOI 10.1073/pnas.96.11.5973; Hamilton JA, 2004, GROWTH FACTORS, V22, P225, DOI 10.1080/08977190412331279881; Hellwig S, 2004, NAT BIOTECHNOL, V22, P1415, DOI 10.1038/nbt1027; HILTON MG, 1990, APPL MICROBIOL BIOT, V33, P132, DOI 10.1007/BF00176513; Hirose T, 2002, PLANT CELL PHYSIOL, V43, P452, DOI 10.1093/pcp/pcf055; Hong SY, 2006, PROTEIN EXPRES PURIF, V47, P68, DOI 10.1016/j.pep.2005.09.028; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Huang CK, 2010, PLANT MOL BIOL, V74, P119, DOI 10.1007/s11103-010-9659-7; Huang JM, 2002, TRANSGENIC RES, V11, P229, DOI 10.1023/A:1015663706259; Huang LF, 2005, TRANSGENIC RES, V14, P569, DOI 10.1007/s11248-004-6481-5; James EA, 2000, PROTEIN EXPRES PURIF, V19, P131, DOI 10.1006/prep.2000.1232; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Kim NS, 2011, PROTEIN EXPRES PURIF, V76, P121, DOI 10.1016/j.pep.2010.10.007; Kim ST, 2009, PROTEOMICS, V9, P1302, DOI 10.1002/pmic.200800589; Kim TG, 2008, PLANT CELL REP, V27, P885, DOI 10.1007/s00299-008-0514-0; Kitajima A, 2009, PLANT CELL, V21, P2844, DOI 10.1105/tpc.109.068288; Knappskog S, 2007, J BIOTECHNOL, V128, P705, DOI 10.1016/j.jbiotec.2006.11.026; Kober L, 2013, BIOTECHNOL BIOENG, V110, P1164, DOI 10.1002/bit.24776; Lee ST, 2014, PLANT GROWTH REGUL, V73, P193, DOI 10.1007/s10725-013-9880-x; Lee SJ, 2007, PROTEIN EXPRES PURIF, V51, P293, DOI 10.1016/j.pep.2006.08.019; Liu YK, 2012, BIOTECHNOL BIOENG, V109, P1239, DOI 10.1002/bit.24394; Lu CA, 2002, PLANT CELL, V14, P1963, DOI 10.1105/tpc.001735; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; METCALF D, 1991, SCIENCE, V254, P529, DOI 10.1126/science.1948028; Ng DTW, 2013, APPL ENVIRON MICROB, V79, P347, DOI 10.1128/AEM.02667-12; Paul M, 2011, BIOTECHNOL APPL BIOC, V58, P58, DOI 10.1002/bab.6; Remans T, 1999, PLANT MOL BIOL REP, V17, P385, DOI 10.1023/A:1007654318401; Schaaf A, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-30; Sharp JM, 2001, BIOTECHNOL PROGR, V17, P979, DOI 10.1021/bp010104t; Stern B., 2007, TRENDS CELL MOL BIOL, V2, P1; Vitale A, 1999, PLANT CELL, V11, P615, DOI 10.1105/tpc.11.4.615; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; Wang ET, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-108; Zhang L, 2005, J GENE MED, V7, P354, DOI 10.1002/jgm.677	53	15	15	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140812	10.1371/journal.pone.0140812	http://dx.doi.org/10.1371/journal.pone.0140812			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473722	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500117
J	Mobuchon, L; Marthey, S; Le Guillou, S; Laloe, D; Le Provost, F; Leroux, C				Mobuchon, Lenha; Marthey, Sylvain; Le Guillou, Sandrine; Laloe, Denis; Le Provost, Fabienne; Leroux, Christine			Food Deprivation Affects the miRNome in the Lactating Goat Mammary Gland	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION; AMINO-ACID; MICRORNAS; BOVINE; IDENTIFICATION; TRANSPORT; TISSUES; PCR; INTEGRATION	Background Nutrition affects milk composition thus influencing its nutritional properties. Nutrition also modifies the expression of mammary genes, whose regulation is not fully understood. MicroRNAs (miRNA) are small non coding RNA which are important post-transcriptional regulators of gene expression by targeting messenger RNAs. Our goal was to characterize miRNA whose expression is regulated by nutrition in the lactating goat mammary gland, which may provide clues to deciphering regulations of the biosynthesis and secretion of milk components. Methodology/principal findings Using high-throughput sequencing technology, miRNomes of the lactating mammary gland were established from lactating goats fed ad libitum or deprived of food for 48h affecting milk production and composition. High throughput miRNA sequencing revealed 30 miRNA with an expression potentially modulated by food deprivation; 16 were down-regulated and 14 were up-regulated. Diana-microT predictive tools suggested a potential role for several nutriregulated miRNA in lipid metabolism. Among the putative targets, 19 were previously identified as differently expressed genes (DEG). The functions of these 19 DEG revealed, notably, their involvement in tissue remodelling. Conclusion/significance In conclusion, this study offers the first evidence of nutriregulated miRNA in the ruminant mammary gland. Characterization of these 30 miRNA could contribute to a clearer understanding of gene regulation in the mammary gland in response to nutrition.	[Mobuchon, Lenha; Marthey, Sylvain; Le Guillou, Sandrine; Laloe, Denis; Le Provost, Fabienne] INRA, Genet Anim & Biol Integrat UMR1313, F-78350 Jouy En Josas, France; [Mobuchon, Lenha; Leroux, Christine] INRA, Herbivores UMR1213, F-63122 St Genes Champanelle, France; [Mobuchon, Lenha; Leroux, Christine] Clermont Univ, VetAgro Sup, Herbivores UMR1213, F-63000 Clermont Ferrand, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; VetAgro Sup; VetAgro Sup	Leroux, C (corresponding author), INRA, Herbivores UMR1213, F-63122 St Genes Champanelle, France.	Christine.Leroux@clermont.inra.fr	Laloe, Denis/O-7045-2019	Leroux, Christine/0000-0001-6835-3978; Laloe, Denis/0000-0001-8359-0760	ApisGene (France); INRA; ApisGene	ApisGene (France); INRA; ApisGene	This study was supported by the ApisGene (France) and INRA. Lenha Mobuchon's grant was financially supported by INRA and ApisGene. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashwell MS, 2004, J DAIRY SCI, V87, P468, DOI 10.3168/jds.S0022-0302(04)73186-0; Baik M, 2009, ASIAN AUSTRAL J ANIM, V22, P871, DOI 10.5713/ajas.2009.90061; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BAUMRUCKER CR, 1984, J DAIRY SCI, V67, P2500, DOI 10.3168/jds.S0022-0302(84)81606-9; Baylin A, 2013, EUR J CLIN NUTR, V67, P101, DOI 10.1038/ejcn.2012.124; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard L, 2008, ADV EXP MED BIOL, V606, P67, DOI 10.1007/978-0-387-74087-4_2; Bionaz M, 2012, GENE REGUL SYST BIO, V6, P109, DOI 10.4137/GRSB.S9852; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chilliard Y, 2004, REPROD NUTR DEV, V44, P467, DOI 10.1051/rnd:2004052; Cui W, 2011, MOL CELL BIOCHEM, V355, P17, DOI 10.1007/s11010-011-0834-1; Dessauge F, 2011, J DAIRY SCI, V94, P4623, DOI 10.3168/jds.2010-4012; Dhahbi JM, 2013, AGING-US, V5, P130, DOI 10.18632/aging.100540; Ding J, 2011, BMC BIOINFORMATICS, V12, P1471; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaj S, 2008, GENES NUTR, V3, P153, DOI 10.1007/s12263-008-0094-1; Garcia-Segura L, 2013, J NUTRIGENET NUTRIGE, V6, P16, DOI 10.1159/000345826; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Gu ZL, 2007, FEBS LETT, V581, P981, DOI 10.1016/j.febslet.2007.01.081; Han LQ, 2010, GENET MOL RES, V9, P1250, DOI 10.4238/vol9-2gmr814; Harris J, 2006, MOL ENDOCRINOL, V20, P1177, DOI 10.1210/me.2005-0473; Hu YS, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093310, 10.1371/journal.pone.0093425, 10.1371/journal.pone.0092099]; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Kansal Vinod K., 2000, Indian Journal of Experimental Biology, V38, P1097; Komatsu T, 2005, J ANIM SCI, V83, P557; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Le Guillou S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091938; Le Guillou S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045727; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li DW, 2014, MOL BIOL REP, V41, P6475, DOI 10.1007/s11033-014-3530-x; Li HM, 2012, MOLECULES, V17, P12037, DOI 10.3390/molecules171012037; Li Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-731; Li ZM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041658, 10.1371/journal.pone.0053176]; Lin XZ, 2013, GENE, V521, P15, DOI 10.1016/j.gene.2013.03.050; Lin XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079258; Liu LH, 2010, LIFE SCI, V86, P192, DOI 10.1016/j.lfs.2009.12.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llobet-Navas D, 2014, GENE DEV, V28, P765, DOI 10.1101/gad.237404.114; MADON RJ, 1990, BIOCHEM J, V272, P99, DOI 10.1042/bj2720099; Mani O, 2010, AM J PHYSIOL-REG I, V299, pR642, DOI 10.1152/ajpregu.00723.2009; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Masotti A, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/659028; Mercken EM, 2013, AGING-US, V5, P692, DOI 10.18632/aging.100598; Ollier S, 2007, J NUTR, V137, P560, DOI 10.1093/jn/137.3.560; Orom UA, 2012, CELL CYCLE, V11, P1291, DOI 10.4161/cc.19704; Pando R, 2012, J NUTR BIOCHEM, V23, P1474, DOI 10.1016/j.jnutbio.2011.09.010; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Shah Manasvi S., 2012, Frontiers in Genetics, V3, P305, DOI 10.3389/fgene.2012.00305; Shennan DB, 2014, J MAMMARY GLAND BIOL, V19, P19, DOI 10.1007/s10911-013-9305-5; Shennan DB, 2000, PHYSIOL REV, V80, P925, DOI 10.1152/physrev.2000.80.3.925; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wang ZR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102118; Watson CJ, 2011, INT J DEV BIOL, V55, P757, DOI 10.1387/ijdb.113414cw; Yoo KH, 2014, DEV BIOL, V395, P245, DOI 10.1016/j.ydbio.2014.09.012; Zarzynska J, 2008, J PHYSIOL PHARMACOL, V59, P275; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zhao JJ, 2008, CHILD NERV SYST, V24, P485, DOI 10.1007/s00381-007-0520-5; Zhou MM, 2011, J ANIM PHYSIOL AN N, V95, P781, DOI 10.1111/j.1439-0396.2010.01110.x	69	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140111	10.1371/journal.pone.0140111	http://dx.doi.org/10.1371/journal.pone.0140111			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473604	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500026
J	Scheuplein, F; Lamont, DJ; Poynter, ME; Boyson, JE; Serreze, D; Lundblad, LKA; Mashal, R; Schaub, R				Scheuplein, Felix; Lamont, Deanna J.; Poynter, Matthew E.; Boyson, Jonathan E.; Serreze, David; Lundblad, Lennart K. A.; Mashal, Robert; Schaub, Robert			Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo	PLOS ONE			English	Article							KILLER T-CELLS; PULMONARY INFLAMMATION; MICE	Invariant Natural Killer T (iNKT) cells are a T cell subset expressing an invariant T Cell Receptor (TCR) that recognizes glycolipid antigens rather than peptides. The cells have both innate-like rapid cytokine release, and adaptive-like thymic positive selection. iNKT cell activation has been implicated in the pathogenesis of allergic asthma and inflammatory diseases, while reduced iNKT cell activation promotes infectious disease, cancer and certain autoimmune diseases such as Type 1 diabetes (T1D). Therapeutic means to reduce or deplete iNKT cells could treat inflammatory diseases, while approaches to promote their activation may have potential in certain infectious diseases, cancer or autoimmunity. Thus, we developed invariant TCR-specific monoclonal antibodies to better understand the role of iNKT cells in disease. We report here the first monoclonal antibodies specific for the mouse invariant TCR that by modifying the Fc construct can specifically deplete or activate iNKT cells in vivo in otherwise fully immuno-competent animals. We have used both the depleting and activating version of the antibody in the NOD model of T1D. As demonstrated previously using genetically iNKT cell deficient NOD mice, and in studies of glycolipid antigen activated iNKT cells in standard NOD mice, we found that antibody mediated depletion or activation of iNKT cells respectively accelerated and retarded T1D onset. In BALB/c mice, ovalbumin (OVA) mediated airway hyper-reactivity (AHR) was abrogated with iNKT cell depletion prior to OVA sensitization, confirming studies in knockout mice. Depletion of iNKT cells after sensitization had no effect on AHR in the conducting airways but did reduce AHR in the lung periphery. This result raises caution in the interpretation of studies that use animals that are genetically iNKT cell deficient from birth. These activating and depleting antibodies provide a novel tool to assess the therapeutic potential of iNKT cell manipulation.	[Scheuplein, Felix; Mashal, Robert; Schaub, Robert] NKT Therapeut Inc, Waltham, MA 02451 USA; [Lamont, Deanna J.; Serreze, David] Jackson Lab, Bar Harbor, ME 04609 USA; [Poynter, Matthew E.; Boyson, Jonathan E.; Lundblad, Lennart K. A.] Univ Vermont, Dept Med, Burlington, VT USA	Jackson Laboratory; University of Vermont	Schaub, R (corresponding author), NKT Therapeut Inc, Waltham, MA 02451 USA.	rschaub@nktrx.com		Lundblad, Lennart/0000-0002-1749-8242; Poynter, Matthew/0000-0002-7578-4570	NKT Therapeutics Inc.; NIH/NIAID grant [1R21AI112804-01, P30 RR 031158]; University of Vermont College of Medicine; NKT Therapeutics Inc; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI112804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046266, R01DK095735] Funding Source: NIH RePORTER	NKT Therapeutics Inc.; NIH/NIAID grant; University of Vermont College of Medicine; NKT Therapeutics Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by NKT Therapeutics Inc., NIH/NIAID grant 1R21AI112804-01, P30 RR 031158 and the University of Vermont College of Medicine internal grant program. NKT Therapeutics Inc provided support in the form of salaries for authors Felix Scheuplein, Robert Mashal and Robert Schaub but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section.	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Bate JHT, 2008, RESP PHYSIOL NEUROBI, V163, P54, DOI 10.1016/j.resp.2008.03.012; Bedel R, 2012, NAT IMMUNOL, V13, P705, DOI 10.1038/ni.2347; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Chen YG, 2012, GENES IMMUN, V13, P164, DOI 10.1038/gene.2011.68; Chen YG, 2005, J IMMUNOL, V174, P1196, DOI 10.4049/jimmunol.174.3.1196; Driver JP, 2010, DIABETES, V59, P423, DOI 10.2337/db09-1116; Farrow CE, 2012, J APPL PHYSIOL, V113, P958, DOI 10.1152/japplphysiol.01618.2011; Field JJ, 2011, CLIN IMMUNOL, V140, P177, DOI 10.1016/j.clim.2011.03.002; Hamid Q, 1997, J ALLERGY CLIN IMMUN, V100, P44, DOI 10.1016/S0091-6749(97)70193-3; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Kaminsky DA, 2004, J APPL PHYSIOL, V97, P1849, DOI 10.1152/japplphysiol.00300.2004; Li S, 2014, AM J PHYSIOL-LUNG C, V306, pL196, DOI 10.1152/ajplung.00055.2013; Lundblad LKA, 2007, AM J RESP CRIT CARE, V175, P768, DOI 10.1164/rccm.200610-1410OC; Lundblad LKA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-27; Lundblad LKA, 2002, J APPL PHYSIOL, V93, P1198, DOI 10.1152/japplphysiol.00080.2002; Matangkasombut P, 2008, J ALLERGY CLIN IMMUN, V121, P1287, DOI 10.1016/j.jaci.2008.02.006; Matangkasombut P, 2009, J ALLERGY CLIN IMMUN, V123, P1181, DOI 10.1016/j.jaci.2009.02.013; Renukaradhya GJ, 2008, BLOOD, V111, P5637, DOI 10.1182/blood-2007-05-092866; Riesenfeld Erik, 2012, J Allergy Ther, V1, P1; Scheuplein F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076692; Scheuplein F, 2010, J AUTOIMMUN, V34, P145, DOI 10.1016/j.jaut.2009.08.012; SCHUESSLER TF, 1995, IEEE T BIO-MED ENG, V42, P860, DOI 10.1109/10.412653; Shi FD, 2001, P NATL ACAD SCI USA, V98, P6777, DOI 10.1073/pnas.121169698; STEURER W, 1995, J IMMUNOL, V155, P1165; Van Kaer L, 2011, CELL TISSUE RES, V343, P43, DOI 10.1007/s00441-010-1023-3; Wallace KL, 2010, BLOOD, V116, P5010, DOI 10.1182/blood-2010-06-290643; Wallace KL, 2009, BLOOD, V114, P667, DOI 10.1182/blood-2009-02-205492; Yamasaki K, 2011, CLIN IMMUNOL, V138, P255, DOI 10.1016/j.clim.2010.11.014	30	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140729	10.1371/journal.pone.0140729	http://dx.doi.org/10.1371/journal.pone.0140729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474487	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500093
J	Tsuchiya, H; Sakata, N; Yoshimatsu, G; Fukase, M; Aoki, T; Ishida, M; Katayose, Y; Egawa, S; Unno, M				Tsuchiya, Haruyuki; Sakata, Naoaki; Yoshimatsu, Gumpei; Fukase, Masahiko; Aoki, Takeshi; Ishida, Masaharu; Katayose, Yu; Egawa, Shinichi; Unno, Michiaki			Extracellular Matrix and Growth Factors Improve the Efficacy of Intramuscular Islet Transplantation	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; INSULIN-SECRETION; RECEPTOR EXPRESSION; SIGNALING PATHWAY; SKELETAL-MUSCLE; DOWN-REGULATION; COLLAGEN-IV; BONE-MARROW; ANGIOGENESIS; SURVIVAL	Background The efficacy of intramuscular islet transplantation is poor despite being technically simple, safe, and associated with reduced rates of severe complications. We evaluated the efficacy of combined treatment with extracellular matrix (ECM) and growth factors in intramuscular islet transplantation. Methods Male BALB/C mice were used for the in vitro and transplantation studies. The following three groups were evaluated: islets without treatment (islets-only group), islets embedded in ECM with growth factors (Matrigel group), and islets embedded in ECM without growth factors [growth factor-reduced (GFR) Matrigel group]. The viability and insulin-releasing function of islets cultured for 96 h were significantly improved in Matrigel and GFR Matrigel groups compared with the islets-only group. Results Blood glucose and serum insulin levels immediately following transplantation were significantly improved in the Matrigel and GFR Matrigel groups and remained significantly improved in the Matrigel group at postoperative day (POD) 28. On histological examination, significantly decreased numbers of TdT-mediated deoxyuridine triphosphate-biotin nick end labeling-positive islet cells and significantly increased numbers of Ki67-positive cells were observed in the Matrigel and GFR Matrigel groups at POD 3. Peri-islet revascularization was most prominent in the Matrigel group at POD 14. Conclusions The efficacy of intramuscular islet transplantation was improved by combination treatment with ECM and growth factors through the inhibition of apoptosis, increased proliferation of islet cells, and promotion of revascularization.	[Tsuchiya, Haruyuki; Sakata, Naoaki; Yoshimatsu, Gumpei; Fukase, Masahiko; Aoki, Takeshi; Ishida, Masaharu; Katayose, Yu; Unno, Michiaki] Tohoku Univ, Dept Surg, Sendai, Miyagi 980, Japan; [Katayose, Yu] Tohoku Univ, Grad Sch Med, Div Integrated Surg & Oncol, Sendai, Miyagi 980, Japan; [Egawa, Shinichi] Tohoku Univ, Int Res Inst Disaster Sci, Div Int Cooperat Disaster Mediscine, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Sakata, N (corresponding author), Tohoku Univ, Dept Surg, Sendai, Miyagi 980, Japan.	n-sakata@surg1.med.tohoku.ac.jp	Unno, Michiaki/A-8633-2010; Unno, Michiaki/AAX-5246-2020; Egawa, Shinichi/S-4055-2019; Sakata, Naoaki/H-4738-2019	Unno, Michiaki/0000-0002-2145-6416; Unno, Michiaki/0000-0002-2145-6416; Egawa, Shinichi/0000-0002-1115-4932; Sakata, Naoaki/0000-0002-3495-4270	Japanese Society for the Promotion of Science [20302151, 22390253, 26462053]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research from the Japanese Society for the Promotion of Science, Challenging Exploratory Research (YK: 20302151), and Scientific Research B (SE: 22390253) and C (NS: 26462053). URL:https://www.jsps.go.jp/j-grantsinaid/.	Avram D, 2008, CELL PHYSIOL BIOCHEM, V21, P455, DOI 10.1159/000129638; Barzelay A, 2010, THROMB HAEMOSTASIS, V103, P188, DOI 10.1160/TH09-07-0433; Bharat A, 2005, TRANSPLANTATION, V79, P1627, DOI 10.1097/01.TP.0000159145.86990.44; Brady AC, 2013, TISSUE ENG PT A, V19, P2544, DOI [10.1089/ten.tea.2012.0686, 10.1089/ten.TEA.2012.0686]; Cahuana GM, 2008, CELL SIGNAL, V20, P301, DOI 10.1016/j.cellsig.2007.10.001; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Christoffersson G, 2010, DIABETES, V59, P2569, DOI 10.2337/db10-0205; Desai NM, 2003, TRANSPLANTATION, V76, P1623, DOI 10.1097/01.TP.0000081043.23751.81; Edamura K, 2001, CELL TRANSPLANT, V10, P493; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GOTOH M, 1986, TRANSPLANTATION, V42, P387, DOI 10.1097/00007890-198610000-00011; Graiani G, 2004, DIABETOLOGIA, V47, P1047, DOI 10.1007/s00125-004-1414-7; Hata T, 2015, TRANSPLANTATION, V99, P1132, DOI 10.1097/TP.0000000000000655; Hata T, 2013, TRANSPLANTATION, V96, pE40, DOI 10.1097/TP.0b013e3182a049bb; Hirata A, 2002, CANCER RES, V62, P2554; Hou M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085808; Imai K, 2000, INFECT IMMUN, V68, P2418, DOI 10.1128/IAI.68.5.2418-2423.2000; Kaido T, 2004, J BIOL CHEM, V279, P53762, DOI 10.1074/jbc.M411202200; Kaido T, 2006, DIABETES, V55, P2723, DOI 10.2337/db06-0120; Kawahara T, 2011, AM J TRANSPLANT, V11, P2700, DOI 10.1111/j.1600-6143.2011.03717.x; Khanna O, 2013, MICROVASC RES, V90, P23, DOI 10.1016/j.mvr.2013.08.006; Kin T, 2003, AM J TRANSPLANT, V3, P281, DOI 10.1034/j.1600-6143.2003.00049.x; Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65; Lan F, 2014, DIABETES, V63, P1649, DOI 10.2337/db13-0728; Lee Y, 2007, DIABETES, V56, P2295, DOI 10.2337/db07-0460; LEROITH D, 1992, ANN INTERN MED, V116, P854, DOI 10.7326/0003-4819-116-10-854; Lund T, 2010, J SURG RES, V160, P145, DOI 10.1016/j.jss.2008.11.009; Maeda H, 2004, TRANSPL P, V36, P1163, DOI 10.1016/j.transproceed.2004.04.018; Maffi P, 2013, DIABETES, V62, P3523, DOI 10.2337/db13-0465; Maillard E, 2011, BIOMATERIALS, V32, P9282, DOI 10.1016/j.biomaterials.2011.08.044; McCartney-Francis N, 2004, J IMMUNOL, V172, P3814, DOI 10.4049/jimmunol.172.6.3814; Miettinen PJ, 2006, DIABETES, V55, P3299, DOI 10.2337/db06-0413; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Nagata N, 2001, CELL TRANSPLANT, V10, P447; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Oberg-Welsh C, 2001, PANCREAS, V22, P157; Perrella MA, 1996, P NATL ACAD SCI USA, V93, P2054, DOI 10.1073/pnas.93.5.2054; Qiao JB, 2012, BIOCHEM BIOPH RES CO, V424, P421, DOI 10.1016/j.bbrc.2012.06.125; Rackham CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057844; Rajab A, 2010, CURR DIABETES REP, V10, P332, DOI 10.1007/s11892-010-0130-6; Rivas-Carrillo JD, 2006, CELL TRANSPLANT, V15, P939, DOI 10.3727/000000006783981323; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Sakata N, 2009, TRANSPL P, V41, P346, DOI 10.1016/j.transproceed.2008.08.155; Sakata N, 2013, TRANSPLANTATION, V96, pE38, DOI 10.1097/TP.0b013e3182a01333; Sakata N, 2010, TRANSPLANTATION, V89, P686, DOI 10.1097/TP.0b013e3181cb3e8d; Sakata N, 2010, WORLD J GASTROENTERO, V16, P1215, DOI 10.3748/wjg.v16.i10.1215; Samikannu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082639; Shah P, 2014, J ORAL IMPLANTOL, V40, P330, DOI 10.1563/AAID-JOI-D-11-00173; Stagner JI, 2007, J PANCREAS, V8, P628; Stegall MD, 1996, TRANSPLANTATION, V61, P1272, DOI 10.1097/00007890-199604270-00027; Sterkers A, 2013, AM J TRANSPLANT, V13, P891, DOI 10.1111/ajt.12136; Svensson J, 2011, CELL TRANSPLANT, V20, P783, DOI 10.3727/096368910X536527; WEBER CJ, 1978, SURGERY, V84, P166; Yap WT, 2013, TISSUE ENG PT A, V19, P2361, DOI [10.1089/ten.tea.2013.0033, 10.1089/ten.TEA.2013.0033]; Yoshimatsu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117561; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	59	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140910	10.1371/journal.pone.0140910	http://dx.doi.org/10.1371/journal.pone.0140910			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473955	gold, Green Published, Green Submitted			2022-12-26	WOS:000363185500128
J	Riley, BT; Broendum, SS; Reboul, CF; Cowieson, NP; Costa, MGS; Kass, I; Jackson, C; Perahia, D; Buckle, AM; McGowan, S				Riley, Blake T.; Broendum, Sebastian S.; Reboul, Cyril F.; Cowieson, Nathan P.; Costa, Mauricio G. S.; Kass, Itamar; Jackson, Colin; Perahia, David; Buckle, Ashley M.; McGowan, Sheena			Dynamic Motion and Communication in the Streptococcal C1 Phage Lysin, PlyC	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; BACTERIOPHAGE; SCATTERING; LANDSCAPE	The growing problem of antibiotic resistance underlies the critical need to develop new treatments to prevent and control resistant bacterial infection. Exogenous application of bacteriophage lysins results in rapid and specific destruction of Gram-positive bacteria and therefore lysins represent novel antibacterial agents. The PlyC phage lysin is the most potent lysin characterized to date and can rapidly lyse Group A, C and E streptococci. Previously, we have determined the X-ray crystal structure of PlyC, revealing a complicated and unique arrangement of nine proteins. The scaffold features a multimeric cell-wall docking assembly bound to two catalytic domains that communicate and work synergistically. However, the crystal structure appeared to be auto-inhibited and raised important questions as to the mechanism underlying its extreme potency. Here we use small angle X-ray scattering (SAXS) and reveal that the conformational ensemble of PlyC in solution is different to that in the crystal structure. We also investigated the flexibility of the enzyme using both normal mode (NM) analysis and molecular dynamics (MD) simulations. Consistent with our SAXS data, MD simulations show rotational dynamics of both catalytic domains, and implicate inter-domain communication in achieving a substrate-ready conformation required for enzyme function. Our studies therefore provide insights into how the domains in the PlyC holoenzyme may act together to achieve its extraordinary potency.	[Riley, Blake T.; Broendum, Sebastian S.; Reboul, Cyril F.; Kass, Itamar; Buckle, Ashley M.; McGowan, Sheena] Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia; [Riley, Blake T.; Broendum, Sebastian S.; Reboul, Cyril F.; Kass, Itamar; Buckle, Ashley M.; McGowan, Sheena] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Reboul, Cyril F.] Monash Univ, Australian Res Council, Ctr Excellence Adv Mol Imaging, Clayton, Vic, Australia; [Cowieson, Nathan P.] Australian Synchrotron, Clayton, Vic, Australia; [Costa, Mauricio G. S.] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil; [Kass, Itamar] Monash Univ, Victorian Life Sci Computat Initiat, Life Sci Computat Ctr, Clayton, Vic, Australia; [Jackson, Colin] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia; [Perahia, David] CNRS, Ecole Normale Super Cachan, Lab Biol & Pharmacol Appl, Cachan, France; [McGowan, Sheena] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Monash University; Monash University; Monash University; Fundacao Oswaldo Cruz; Monash University; Australian National University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Monash University	Buckle, AM (corresponding author), Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia.	ashley.buckle@monash.edu; sheena.mcgowan@monash.edu	Perahia, David/A-4277-2016; Riley, Blake T./ABD-8129-2020; Jackson, Colin J/C-1500-2008; Kass, Itamar/P-5724-2014; McGowan, Sheena/C-4797-2014; Buckle, Ashley/P-8366-2016; Costa, Mauricio G.S/N-4464-2013	Perahia, David/0000-0001-7480-3349; Riley, Blake T./0000-0003-2176-0503; Jackson, Colin J/0000-0001-6150-3822; Kass, Itamar/0000-0002-5368-937X; McGowan, Sheena/0000-0001-6863-1106; Buckle, Ashley/0000-0003-2943-9044; Costa, Mauricio G.S/0000-0001-5443-286X; Reboul, Cyril/0000-0002-6258-2697	French-Brazilian CAPES/COFECUB collaboration project; Australian Research Council [FT100100690]; Victorian Life Sciences Computation Initiative (VLSCI); Victorian Government, Australia	French-Brazilian CAPES/COFECUB collaboration project; Australian Research Council(Australian Research Council); Victorian Life Sciences Computation Initiative (VLSCI); Victorian Government, Australia	The authors received no specific funding for this work. MGSC was financially supported by a French-Brazilian CAPES/COFECUB collaboration project. AMB is a National Health and Medical Research Senior Research Fellow (1022688). SM acknowledges fellowship support from the Australian Research Council (FT100100690). This work was supported by the Victorian Life Sciences Computation Initiative (VLSCI), an initiative of the Victorian Government, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cava F, 2014, CURR OPIN MICROBIOL, V18, P46, DOI 10.1016/j.mib.2014.01.004; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; ECDC/EMEA, 2009, BACT CHALL TIM REACT; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Gravitz L, 2012, NAT MED, V18, P1318, DOI 10.1038/nm0912-1318; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Heselpoth RD, 2015, PROTEIN ENG DES SEL; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kerns SJ, 2015, NAT STRUCT MOL BIOL, V22, P124, DOI 10.1038/nsmb.2941; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KRAUSE RM, 1957, J EXP MED, V106, P365, DOI 10.1084/jem.106.3.365; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Marsh JA, 2012, CURR OPIN STRUC BIOL, V22, P643, DOI 10.1016/j.sbi.2012.08.008; Matsuzaki Shigenobu, 2005, Journal of Infection and Chemotherapy, V11, P211, DOI 10.1007/s10156-005-0408-9; McGowan S, 2012, P NATL ACAD SCI USA, V109, P12752, DOI 10.1073/pnas.1208424109; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Wilson C, 2015, SCIENCE, V347, P882, DOI 10.1126/science.aaa1823	28	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140219	10.1371/journal.pone.0140219	http://dx.doi.org/10.1371/journal.pone.0140219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26470022	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600032
J	El-Najjar, N; Orso, E; Wallner, S; Liebisch, G; Schmitz, G				El-Najjar, Nahed; Orso, Evelyn; Wallner, Stefan; Liebisch, Gerhard; Schmitz, Gerd			Increased Levels of Sphingosylphosphorylcholine (SPC) in Plasma of Metabolic Syndrome Patients	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; LYSOPHOSPHATIDIC ACID; SMOOTH-MUSCLE; SOLUBLE CD163; LYSOPHOSPHOLIPASE-D; LIPID EXTRACTION; BLOOD-PLASMA; SPHINGOMYELIN; AUTOTAXIN	Recent developments in lipid mass spectrometry enable extensive lipid class and species analysis in metabolic disorders such as diabesity and metabolic syndrome. The minor plasma lipid class sphingosylphosphorylcholine (SPC) was identified as a ligand for lipid sensitive G-protein coupled receptors playing a key role in cell growth, differentiation, motility, calcium signaling, tissue remodeling, vascular diseases and cancer. However, information about its role in diabesity patients is sparse. In this study, we analyzed plasma lipid species in patients at risk for diabesity and the metabolic syndrome and compared them with healthy controls. Our data show that SPC is significantly increased in plasma samples from metabolic syndrome patients but not in plasma from patients at risk for diabesity. Detailed SPC species analysis showed that the observed increase is due to a significant increase in all detected SPC subspecies. Moreover, a strong positive correlation is observed between total SPC and individual SPC species with both body mass index and the acute phase low grade inflammation marker soluble CD163 (sCD163). Collectively, our study provides new information on SPC plasma levels in metabolic syndrome and suggests new avenues for investigation.	[El-Najjar, Nahed; Orso, Evelyn; Wallner, Stefan; Liebisch, Gerhard; Schmitz, Gerd] Univ Hosp Regensburg, Inst Clin Chem & Lab Med, Regensburg, Germany	University of Regensburg	Schmitz, G (corresponding author), Univ Hosp Regensburg, Inst Clin Chem & Lab Med, Regensburg, Germany.	gerd.schmitz@klinik.uni-regensburg.de	El-Najjar, Nahed/I-2755-2019; Liebisch, Gerhard/G-6130-2010	El-Najjar, Nahed/0000-0002-2278-8586; Liebisch, Gerhard/0000-0003-4886-0811; Schmitz, Gerd/0000-0002-1325-1007	European Community's Seventh Framework Programme (FP7) under IP-Project 'LipidomicNet' [202272]	European Community's Seventh Framework Programme (FP7) under IP-Project 'LipidomicNet'	The work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 202272, IP-Project 'LipidomicNet'.	Aristoteli LP, 2006, ATHEROSCLEROSIS, V184, P342, DOI 10.1016/j.atherosclerosis.2005.05.004; Barber MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041456; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Byun HJ, 2013, BIOMOL THER, V21, P338, DOI 10.4062/biomolther.2013.066; Chuang WL, 2014, MOL GENET METAB, V111, P209, DOI 10.1016/j.ymgme.2013.11.012; Clair T, 2003, CANCER RES, V63, P5446; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ge D, 2012, ACTA PHARMACOL SIN, V33, P57, DOI 10.1038/aps.2011.142; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Heimerl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111348; Heringdorf DMZ, 2002, BBA-MOL CELL BIOL L, V1582, P178, DOI 10.1016/S1388-1981(02)00154-3; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Jove M, 2014, FASEB J, V28, P5163, DOI 10.1096/fj.14-253187; Kim KH, 2012, EXP MOL MED, V44, P159, DOI 10.3858/emm.2012.44.2.011; Kleger A, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/916180; Kovacs E, 2008, BIOCHEM J, V410, P427, DOI 10.1042/BJ20071019; Kulkarni H, 2013, HYPERTENSION, V62, P621, DOI 10.1161/HYPERTENSIONAHA.113.01396; Lee JY, 2011, ANAL BIOANAL CHEM, V400, P2953, DOI 10.1007/s00216-011-4958-7; Liebisch G, 1999, J LIPID RES, V40, P1539; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2002, CLIN CHEM, V48, P2217; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Liliom K, 2001, BIOCHEM J, V355, P189, DOI 10.1042/0264-6021:3550189; Lopez X, 2013, J PEDIATR ENDOCR MET, V26, P995, DOI 10.1515/jpem-2012-0407; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moller HJ, 2011, CLIN CHEM, V57, P291, DOI 10.1373/clinchem.2010.154724; Nishimura S, 2014, DIABETES, V63, P4154, DOI 10.2337/db13-1694; Nixon GF, 2008, PROG LIPID RES, V47, P62, DOI 10.1016/j.plipres.2007.11.001; Parkner T, 2012, DIABETOLOGIA, V55, P1856, DOI 10.1007/s00125-012-2533-1; Scherer M, 2011, BBA-MOL CELL BIOL L, V1811, P68, DOI 10.1016/j.bbalip.2010.11.003; Scherer M, 2010, ANAL CHEM, V82, P8794, DOI 10.1021/ac1021826; Scherer M, 2009, CLIN CHEM, V55, P1218, DOI 10.1373/clinchem.2008.113779; Shirao S, 2002, CIRC RES, V91, P112, DOI 10.1161/01.RES.0000026057.13161.42; Shirao S, 2015, J CEREB BLOOD FLOW M; Sigruener A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085724; SUBBAIAH PV, 1992, BIOCHIM BIOPHYS ACTA, V1128, P83, DOI 10.1016/0005-2760(92)90261-S; Tolle M, 2008, ARTERIOSCL THROM VAS, V28, P1542, DOI 10.1161/ATVBAHA.107.161042; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Wang XQ, 2014, PROSTAG OTH LIPID M, V108, P23, DOI 10.1016/j.prostaglandins.2014.02.002; Welford RWD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114669; Wirrig C, 2011, J CEREBR BLOOD F MET, V31, P212, DOI 10.1038/jcbfm.2010.79; Wright MM, 2004, BIOCHEM CELL BIOL, V82, P18, DOI 10.1139/o03-092; Yea K, 2008, J MOL MED-JMM, V86, P211, DOI 10.1007/s00109-007-0269-z; Yeboah J, 2010, ARTERIOSCL THROM VAS, V30, P628, DOI 10.1161/ATVBAHA.109.199281; Yue HW, 2014, BIOCHEM BIOPH RES CO, V453, P502, DOI 10.1016/j.bbrc.2014.09.120; Zhu C, 2011, TALANTA, V85, P1711, DOI 10.1016/j.talanta.2011.05.036	55	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140683	10.1371/journal.pone.0140683	http://dx.doi.org/10.1371/journal.pone.0140683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466367	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100162
J	Hubenthal, M; Hemmrich-Stanisak, G; Degenhardt, F; Szymczak, S; Du, ZP; Elsharawy, A; Keller, A; Schreiber, S; Franke, A				Huebenthal, Matthias; Hemmrich-Stanisak, Georg; Degenhardt, Frauke; Szymczak, Silke; Du, Zhipei; Elsharawy, Abdou; Keller, Andreas; Schreiber, Stefan; Franke, Andre			Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease	PLOS ONE			English	Article							ULCERATIVE-COLITIS; EXPRESSION PROFILES; CROHNS-DISEASE; INCREASED SUSCEPTIBILITY; NEOPLASTIC PROGRESSION; CIRCULATING MICRORNA; MULTIPLE-SCLEROSIS; PERIPHERAL-BLOOD; MURINE MODEL; GENE	The diagnosis of inflammatory bowel disease (IBD) still remains a clinical challenge and the most accurate diagnostic procedure is a combination of clinical tests including invasive endoscopy. In this study we evaluated whether systematic miRNA expression profiling, in conjunction with machine learning techniques, is suitable as a non-invasive test for the major IBD phenotypes (Crohn's disease (CD) and ulcerative colitis (UC)). Based on microarray technology, expression levels of 863 miRNAs were determined for whole blood samples from 40 CD and 36 UC patients and compared to data from 38 healthy controls (HC). To further discriminate between disease-specific and general inflammation we included miRNA expression data from other inflammatory diseases (inflammation controls (IC): 24 chronic obstructive pulmonary disease (COPD), 23 multiple sclerosis, 38 pancreatitis and 45 sarcoidosis cases) as well as 70 healthy controls from previous studies. Classification problems considering 2, 3 or 4 groups were solved using different types of penalized support vector machines (SVMs). The resulting models were assessed regarding sparsity and performance and a subset was selected for further investigation. Measured by the area under the ROC curve (AUC) the corresponding median holdout-validated accuracy was estimated as ranging from 0.75 to 1.00 (including IC) and 0.89 to 0.98 (excluding IC), respectively. In combination, the corresponding models provide tools for the distinction of CD and UC as well as CD, UC and HC with expected classification error rates of 3.1 and 3.3%, respectively. These results were obtained by incorporating not more than 16 distinct miRNAs. Validated target genes of these miRNAs have been previously described as being related to IBD. For others we observed significant enrichment for IBD susceptibility loci identified in earlier GWAS. These results suggest that the proposed miRNA signature is of relevance for the etiology of IBD. Its diagnostic value, however, should be further evaluated in large, independent, clinically well characterized cohorts.	[Huebenthal, Matthias; Hemmrich-Stanisak, Georg; Degenhardt, Frauke; Szymczak, Silke; Du, Zhipei; Elsharawy, Abdou; Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Elsharawy, Abdou] Damietta Univ, Div Biochem, Dept Chem, Fac Sci, New Damietta, Egypt; [Keller, Andreas] Univ Saarland, Chair Clin Bioinformat, D-66123 Saarbrucken, Germany; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Internal Med 1, Kiel, Germany	University of Kiel; Egyptian Knowledge Bank (EKB); Damietta University; Saarland University; University of Kiel; Schleswig Holstein University Hospital	Hemmrich-Stanisak, G (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.	g.hemmrich-stanisak@ikmb.uni-kiel.de	Szymczak, Silke/C-6625-2013; Hübenthal, Matthias/M-8149-2015; Keller, Andreas/ABB-6412-2021; Franke, Andre/B-2151-2010; Szymczak, Silke/HGT-8202-2022	Hübenthal, Matthias/0000-0002-5956-3006; Keller, Andreas/0000-0002-5361-0895; Franke, Andre/0000-0003-1530-5811; Degenhardt, Frauke/0000-0001-7516-3179; Elsharawy, Abdou/0000-0002-5089-9435; Szymczak, Silke/0000-0002-8897-9035	German Ministry of Education and Research (BMBF) program e:Med sysINFLAME [01ZX1306A]	German Ministry of Education and Research (BMBF) program e:Med sysINFLAME(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Ministry of Education and Research (BMBF) program e:Med sysINFLAME (http://www.gesundheitsforschung-bmbf.de/de/5111.php, no.: 01ZX1306A) and received infrastructure support from the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 'Inflammation at Interfaces' (http://www.inflammation-at-interfaces.de, no.: XC306/2). Andre Franke receives an endowment professorship (Peter Hans Hofschneider Professorship) of the "Stiftung Experimentelle Biomedizin" located in Zuerich, Switzerland.	Abu-Halima M, 2014, FERTIL STERIL, V102, P989, DOI 10.1016/j.fertnstert.2014.07.001; Andoh A, 2001, INFLAMM BOWEL DIS, V7, P210, DOI 10.1097/00054725-200108000-00005; Balzola F, 2012, INFLAMM BOWEL DIS, P126; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Becker N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-138; Becker N, 2009, BIOINFORMATICS, V25, P1711, DOI 10.1093/bioinformatics/btp286; Bhonde MR, 2008, AM J PHYSIOL-GASTR L, V295, pG1237, DOI 10.1152/ajpgi.90537.2008; Bian Z, 2011, J PATHOL, V225, P544, DOI 10.1002/path.2907; Blunt MD, 2012, CURR OPIN PHARMACOL, V12, P444, DOI 10.1016/j.coph.2012.02.015; Bouzid D, 2012, HUM IMMUNOL, V73, P732, DOI 10.1016/j.humimm.2012.04.018; Bradley P. S., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P82; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Chen Wei-Xu, 2014, World J Gastrointest Pathophysiol, V5, P63, DOI 10.4291/wjgp.v5.i2.63; Chen Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.22; Chen Y, 2013, BIOCHEM BIOPH RES CO, V438, P133, DOI 10.1016/j.bbrc.2013.07.040; Chuang AY, 2014, INFLAMM BOWEL DIS, V20, P126, DOI 10.1097/01.MIB.0000436954.70596.9b; Clark PM, 2012, INFLAMM BOWEL DIS, V18, P2315, DOI 10.1002/ibd.22958; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dahan S, 2011, GASTROENTEROLOGY, V140, P550, DOI 10.1053/j.gastro.2010.10.057; Deng H, 2012, GENE SELECTION GUIDE; Diegelmann J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077773; Dotan I, 2006, GASTROENTEROLOGY, V131, P366, DOI 10.1053/j.gastro.2006.04.030; Duttagupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031241; Fasseu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013160; Feng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052782; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frey MR, 2014, PEDIATR RES, V75, P127, DOI 10.1038/pr.2013.210; Friedman J.H., 1996, ANOTHER APPROACH POL; Gerlach K, 2014, NAT IMMUNOL, V15, P676, DOI 10.1038/ni.2920; Ghorpade DS, 2013, J BIOL CHEM, V288, P33037, DOI 10.1074/jbc.M113.492496; Gologan S, 2013, J CROHNS COLITIS, V7, P622, DOI 10.1016/j.crohns.2012.08.015; Granlund AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056818; Guimil R, 2003, NUCLEOS NUCLEOT NUCL, V22, P1721, DOI 10.1081/NCN-120023122; Nguyen HTT, 2014, GASTROENTEROLOGY, V146, P508, DOI 10.1053/j.gastro.2013.10.021; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huber W., 2003, STAT APPL GENET MOL, V2, pARTICL, DOI [10.2202/1544-6115.1008, DOI 10.2202/1544-6115.1008]; Iborra M, 2013, CLIN EXP IMMUNOL, V173, P250, DOI 10.1111/cei.12104; Iskandar HN, 2012, TRANSL RES, V159, P313, DOI 10.1016/j.trsl.2012.01.001; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Kanaan Z, 2012, HUM MUTAT, V33, P551, DOI 10.1002/humu.22021; Keller A, 2014, MULT SCLER J, V20, P295, DOI 10.1177/1352458513496343; Keller A, 2011, MOL BIOSYST, V7, P3187, DOI 10.1039/c1mb05353a; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Keller A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007440; Keutgen XM, 2012, CLIN CANCER RES, V18, P2032, DOI 10.1158/1078-0432.CCR-11-2487; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001; Lajer CB, 2011, BRIT J CANCER, V104, P830, DOI 10.1038/bjc.2011.29; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Li ZX, 2011, J IMMUNOL, V186, P6182, DOI 10.4049/jimmunol.1000917; Liu JZ, 2014, BEST PRACT RES CL GA, V28, P373, DOI 10.1016/j.bpg.2014.04.009; Ludwig K, 2013, VIRCHOWS ARCH, V462, P57, DOI 10.1007/s00428-012-1345-5; Marcil V, 2012, GENES IMMUN, V13, P556, DOI 10.1038/gene.2012.37; Miotto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080149; Montero-Melendez T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076235; Moum B, 1997, GUT, V40, P328, DOI 10.1136/gut.40.3.328; Olaru AV, 2013, INFLAMM BOWEL DIS, V19, P471, DOI 10.1097/MIB.0b013e31827e78eb; Olaru AV, 2011, INFLAMM BOWEL DIS, V17, P221, DOI 10.1002/ibd.21359; Paraskevi A, 2012, J CROHNS COLITIS, V6, P900, DOI 10.1016/j.crohns.2012.02.006; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046045; Schulmann K, 2005, GASTROENTEROLOGY, V129, P74, DOI 10.1053/j.gastro.2005.04.011; Shi CZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066814; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sipos F, 2008, SCAND J GASTROENTERO, V43, P289, DOI 10.1080/00365520701714434; Sobajima J, 1997, CLIN EXP IMMUNOL, V107, P135, DOI 10.1046/j.1365-2249.1997.d01-907.x; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Szymczak S, R2VIM NEW VARI UNPUB; van Lierop PPE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079549; Vorwerk S, 2008, NEW BIOTECHNOL, V25, P142, DOI 10.1016/j.nbt.2008.08.005; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu F, 2011, INFLAMM BOWEL DIS, V17, P241, DOI 10.1002/ibd.21450; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Yang YZ, 2013, BIOCHEM BIOPH RES CO, V434, P746, DOI 10.1016/j.bbrc.2013.03.122; Ying L, 2005, CANCER RES, V65, P9132, DOI 10.1158/0008-5472.CAN-05-1358; Zahm AM, 2014, J CROHNS COLITIS, V8, P1108, DOI 10.1016/j.crohns.2014.02.012; Zahm AM, 2011, J PEDIATR GASTR NUTR, V53, P26, DOI 10.1097/MPG.0b013e31822200cc; Zhai Z, 2013, INFLAMM BOWEL DIS, V19, P2295, DOI 10.1097/MIB.0b013e31829e71cf; Zhang HH, 2006, BIOINFORMATICS, V22, P88, DOI 10.1093/bioinformatics/bti736; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	83	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140155	10.1371/journal.pone.0140155	http://dx.doi.org/10.1371/journal.pone.0140155			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466382	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100082
J	Maidment, SCR; Brassey, C; Barrett, PM				Maidment, Susannah Catherine Rose; Brassey, Charlotte; Barrett, Paul Michael			The Postcranial Skeleton of an Exceptionally Complete Individual of the Plated Dinosaur Stegosaurus stenops (Dinosauria: Thyreophora) from the Upper Jurassic Morrison Formation of Wyoming, USA	PLOS ONE			English	Article							ORNITHISCHIA; GROWTH; LONG	Although Stegosaurus is one of the most iconic dinosaurs, well-preserved fossils are rare and as a consequence there is still much that remains unknown about the taxon. A new, exceptionally complete individual affords the opportunity to describe the anatomy of Stegosaurus in detail for the first time in over a century, and enables additional comparisons with other stegosaurian dinosaurs. The new specimen is from the Red Canyon Ranch Quarry, near Shell Wyoming, and appears to have been so well preserved because it was buried rapidly in a pond or body of standing water immediately after death. The quarry is probably located in the middle part of the Morrison Formation, which is believed to be Tithonian in age in this area. The specimen is referable to Stegosaurus stenops based on the possession of an edentulous anterior portion of the dentary and elevated postzygapophyses on the cervical vertebrae. New information provided by the specimen concerns the morphology of the vertebrae, the iliosacral block and dermal armor. Several aspects of its morphology indicate the individual was not fully skeletally mature at the time of death, corroborating a previous histological study.	[Maidment, Susannah Catherine Rose] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Brassey, Charlotte; Barrett, Paul Michael] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	Imperial College London; Natural History Museum London	Maidment, SCR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, South Kensington Campus, London SW7 2AZ, England.	s.maidment@imperial.ac.uk	Brassey, Charlotte A/R-2029-2017; Barrett, Paul M/A-2648-2010	Brassey, Charlotte A/0000-0002-6552-541X; Barrett, Paul M/0000-0003-0412-3000	Imperial College Junior Research Fellowship	Imperial College Junior Research Fellowship	SCRM was funded by an Imperial College Junior Research Fellowship during the course of this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barden HE, 2011, J VERTEBR PALEONTOL, V31, P641, DOI 10.1080/02724634.2011.557112; Carpenter K, 2001, LIFE O PAST, P55; Carpenter K, 2005, LIFE O PAST, P325; Carpenter Kenneth, 1998, Modern Geology, V23, P127; CASANOVASCLADEL.L, 1999, REV ESPANOLA PALEONT, P57; Christiansen NA, 2010, SWISS J GEOSCI, V103, P163, DOI 10.1007/s00015-010-0026-0; COOMBS WP, 1979, J PALEONTOL, V53, P666; Cope ED, 1878, AM NAT, V12, P181; DONG Z.M., 1973, MEM I VERTEBR PALEON, V11, P45; Escaso F, 2007, NATURWISSENSCHAFTEN, V94, P367, DOI 10.1007/s00114-006-0209-8; Galton P.M., 1985, Journal of Vertebrate Paleontology, V5, P211; Galton P.M., 1982, Geologica et Palaeontologica, V15, P139; Galton P.M., 1990, Geologica et Palaeontologica, V24, P185; Galton P.M., 1991, Geologica et Palaeontologica, V25, P299; GALTON P M, 1982, Journal of Vertebrate Paleontology, V2, P47; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P343; Galton PM, 2010, SWISS J GEOSCI, V103, P187, DOI 10.1007/s00015-010-0022-4; Gao R, 1986, VERTEBRAT PALASIATIC, V24, P1; Gilmore C.W., 1914, US NATL MUSEUM B, V89, P1136, DOI DOI 10.5962/BHL.TITLE.63658; Hayashi S, 2009, J VERTEBR PALEONTOL, V29, P123, DOI 10.1080/02724634.2009.10010366; HENNIG E, 1924, PALAEONTOGRAPHICA ST, V7, P101; International Commission on Zoological Nomenclature, 2013, BULL ZOOL NOMENCL, V70, P129; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Jia CK, 2007, ACTA GEOL SIN-ENGL, V81, P351; Kvale EP, 2001, PALAIOS, V16, P233, DOI 10.2307/3515602; Lockley Martin, 1998, Modern Geology, V23, P309; Maidment SCR, 2006, GEOL MAG, V143, P621, DOI 10.1017/S0016756806002500; Maidment SCR, 2006, J VERTEBR PALEONTOL, V26, P944, DOI 10.1671/0272-4634(2006)26[944:ROTPSO]2.0.CO;2; Maidment SCR, 2008, J SYST PALAEONTOL, V6, P367, DOI 10.1017/S1477201908002459; Mallison H, 2010, SWISS J GEOSCI, V103, P211, DOI 10.1007/s00015-010-0024-2; Marsh O. C., 1887, American Journal of Science (3), Vxxxiv, P413; Marsh O. C., 1877, AM J SCI, V14, P34; Marsh O.C., 1879, AM J SCI, V3, P501; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Marsh O. C, 1880, AM J SCI, V19, P253; Mateus O, 2009, P ROY SOC B-BIOL SCI, V276, P1815, DOI 10.1098/rspb.2008.1909; McIntosh J. S., 1999, MARSHS DINOSAURS COL; McWhinney LA, 2001, LIFE O PAST, P141; NOPCSA F., 1915, MITTEILUNGEN JB KONI, V23, P1; NOPCSA F, 1911, B SOC GEOLOGIQUE NOR, V30, P23; Norman D.B., 1984, 3 S MESOZOIC TERREST, P157; Ostrom JH., 1970, PEABODY MUSEUM B, V35, P1; Ouyang H., 1992, DISCOVERY G IGANTSPI, P47; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Peng G.-Z., 2005, JURASSIC DINOSAUR FA; Piechowski R, 2014, J VERTEBR PALEONTOL, V34, P1383, DOI 10.1080/02724634.2014.873045; Redelstorff R, 2015, LETHAIA, V48, P47, DOI 10.1111/let.12086; Redelstorff R, 2009, J VERTEBR PALEONTOL, V29, P1087, DOI 10.1671/039.029.0420; Saitta ET, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123503; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Siber H.-J., 2009, STEGOSAURS SAURIERMU; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Yen T-C, 1950, GEOLOGICAL SURVEY A, V233, P1; Zhang Y, 1983, PALAEONTOLOGICA SI C, V162, P1; Zhou S.W, 1984, MIDDLE JURASSIC DINO	55	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138352	10.1371/journal.pone.0138352	http://dx.doi.org/10.1371/journal.pone.0138352			107	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466098	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100016
J	Stalmans, S; Bracke, N; Wynendaele, E; Gevaert, B; Peremans, K; Burvenich, C; Polis, I; De Spiegeleer, B				Stalmans, Sofie; Bracke, Nathalie; Wynendaele, Evelien; Gevaert, Bert; Peremans, Kathelijne; Burvenich, Christian; Polis, Ingeborgh; De Spiegeleer, Bart			Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo	PLOS ONE			English	Article							PLASMA-MEMBRANE; CAPSID PROTEIN; TRANSPORTAN 10; BASIC DOMAIN; DELIVERY; INTERNALIZATION; MECHANISM; ANALOGS; DESIGN; PVEC	Cell-penetrating peptides (CPPs) are a group of peptides, which have the ability to cross cell membrane bilayers. CPPs themselves can exert biological activity and can be formed endogenously. Fragmentary studies demonstrate their ability to enhance transport of different cargoes across the blood-brain barrier (BBB). However, comparative, quantitative data on the BBB permeability of different CPPs are currently lacking. Therefore, the in vivo BBB transport characteristics of five chemically diverse CPPs, i.e. pVEC, SynB3, Tat 47-57, transportan 10 (TP10) and TP10-2, were determined. The results of the multiple time regression (MTR) analysis revealed that CPPs show divergent BBB influx properties: Tat 47-57, SynB3, and especially pVEC showed very high unidirectional influx rates of 4.73 mu l/(g x min), 5.63 mu l/(g x min) and 6.02 mu l/(g x min), respectively, while the transportan analogs showed a negligible to low brain influx. Using capillary depletion, it was found that 80% of the influxed peptides effectively reached the brain parenchyma. Except for pVEC, all peptides showed a significant efflux out of the brain. Co-injection of pVEC with radioiodinated bovine serum albumin (BSA) did not enhance the brain influx of radiodionated BSA, indicating that pVEC does not itself significantly alter the BBB properties. A saturable mechanism could not be demonstrated by co-injecting an excess dose of non-radiolabeled CPP. No significant regional differences in brain influx were observed, with the exception for pVEC, for which the regional variations were only marginal. The observed BBB influx transport properties cannot be correlated with their cell-penetrating ability, and therefore, good CPP properties do not imply efficient brain influx.	[Stalmans, Sofie; Bracke, Nathalie; Wynendaele, Evelien; Gevaert, Bert; De Spiegeleer, Bart] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium; [Peremans, Kathelijne] Univ Ghent, Dept Vet Med Imaging & Small Anim Orthopaed, Fac Vet Med, Merelbeke, Belgium; [Burvenich, Christian] Univ Ghent, Dept Comparat Physiol & Biometr, Fac Vet Med, Merelbeke, Belgium; [Polis, Ingeborgh] Univ Ghent, Dept Med & Clin Biol Small Anim, Fac Vet Med, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	De Spiegeleer, B (corresponding author), Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium.	Bart.DeSpiegeleer@UGent.be	De Spiegeleer, Bart/A-2001-2008	De Spiegeleer, Bart/0000-0001-6794-3108	Special Research Fund (BOF) of Ghent University [01D38811]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT) [121512]	Special Research Fund (BOF) of Ghent University(Ghent University); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by the Special Research Fund (BOF) of Ghent University (no. 01D38811 to SS): (http://www.ugent.be/nl/onderzoek/financiering/bof) and the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT, no. 121512 to BG): (http://www.iwt.be/english/funding/subsidy/sb). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Akdag IO, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/851915; BANKS WA, 1989, METHOD ENZYMOL, V168, P652; Banks WA, 1997, PEPTIDES, V18, P1423, DOI 10.1016/S0196-9781(97)00231-3; Banks WA, 1998, PEPTIDES, V19, P883, DOI 10.1016/S0196-9781(98)00018-7; Banks William A., 1997, V73, P353; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Brock R, 2014, BIOCONJUGATE CHEM, V25, P863, DOI 10.1021/bc500017t; Brugnano Jamie, 2010, Biomol Concepts, V1, P109, DOI 10.1515/bmc.2010.016; Brugnano JL, 2011, J CONTROL RELEASE, V155, P128, DOI 10.1016/j.jconrel.2011.05.007; Copolovici DM, 2014, ACS NANO, V8, P1972, DOI 10.1021/nn4057269; Czihal P, 2012, ACS CHEM BIOL, V7, P1281, DOI 10.1021/cb300063v; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Duchardt F, 2009, J BIOL CHEM, V284, P36099, DOI 10.1074/jbc.M109.036426; Eiriksdottir E, 2010, BBA-BIOMEMBRANES, V1798, P1119, DOI 10.1016/j.bbamem.2010.03.005; Elmquist A, 2003, BIOL CHEM, V384, P387, DOI 10.1515/BC.2003.044; Elmquist A, 2001, EXP CELL RES, V269, P237, DOI 10.1006/excr.2001.5316; Elmquist A, 2006, BBA-BIOMEMBRANES, V1758, P721, DOI 10.1016/j.bbamem.2006.05.013; Freire JM, 2014, FEBS J, V281, P191, DOI 10.1111/febs.12587; Futaki S, 2007, BIOCHEM SOC T, V35, P784, DOI 10.1042/BST0350784; GJEDDE A, 1981, J NEUROCHEM, V36, P1463, DOI 10.1111/j.1471-4159.1981.tb00587.x; GJEDDE A, 1982, BRAIN RES REV, V4, P237, DOI 10.1016/0165-0173(82)90018-2; Gjedde A, 2011, NEUROKINETICS DYNAMI, DOI [10.1007/978-1-4419-7409-9, DOI 10.1007/978-1-4419-7409-9]; Grunwald J, 2009, BIOCONJUGATE CHEM, V20, P1531, DOI 10.1021/bc900081e; GUTIERREZ EG, 1993, J NEUROIMMUNOL, V47, P169, DOI 10.1016/0165-5728(93)90027-V; Herbig ME, 2006, BIOCHEMISTRY-US, V45, P3598, DOI 10.1021/bi050923c; Herve F, 2008, AAPS J, V10, P455, DOI 10.1208/s12248-008-9055-2; Howl J, 2012, CELL MOL LIFE SCI, V69, P2951, DOI 10.1007/s00018-012-0979-4; Islam MZ, 2014, BIOCHEMISTRY-US, V53, P386, DOI 10.1021/bi401406p; JAY TM, 1988, J CEREBR BLOOD F MET, V8, P121, DOI 10.1038/jcbfm.1988.16; Johansson HJ, 2008, MOL THER, V16, P115, DOI 10.1038/sj.mt.6300346; Jones S, 2008, BBA-MOL CELL RES, V1783, P849, DOI 10.1016/j.bbamcr.2008.01.009; Jones S, 2010, CHEM BIOL, V17, P735, DOI 10.1016/j.chembiol.2010.05.018; Kastin AJ, 2003, PROG DRUG RES, V61, P79; Kastin AJ, 2001, PEPTIDES, V22, P2127, DOI 10.1016/S0196-9781(01)00569-1; Langedijk JPM, 2002, J BIOL CHEM, V277, P5308, DOI 10.1074/jbc.M104147200; Lee JE, 2012, MOL BIOL REP, V39, P1079, DOI 10.1007/s11033-011-0834-y; Li Y, 2007, CELL DEATH DIFFER, V14, P2058, DOI 10.1038/sj.cdd.4402219; Lindgren M, 2011, METHODS MOL BIOL, V683, P3, DOI 10.1007/978-1-60761-919-2_1; Lindgren ME, 2004, BIOCHEM J, V377, P69, DOI 10.1042/BJ20030760; Lofgren K, 2008, FASEB J, V22, P2177, DOI 10.1096/fj.07-099549; Lu SW, 2006, ANAL BIOCHEM, V353, P7, DOI 10.1016/j.ab.2006.01.044; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Manosroi J, 2012, DRUG DELIV, V19, P21, DOI 10.3109/10717544.2011.621991; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Montrose K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01661; Nakase I, 2009, MOL THER, V17, P1868, DOI 10.1038/mt.2009.192; Doan ND, 2012, J CONTROL RELEASE, V163, P256, DOI 10.1016/j.jconrel.2012.08.021; Niarchos DK, 2006, PEPTIDES, V27, P2661, DOI 10.1016/j.peptides.2006.05.021; Novoa A, 2012, J MED CHEM, V55, P9549, DOI 10.1021/jm3008079; Oess S, 2000, GENE THER, V7, P750, DOI 10.1038/sj.gt.3301154; Ostlund P, 2005, INT J PEPT RES THER, V11, P237, DOI 10.1007/s10989-005-9329-9; Padari K, 2005, BIOCONJUGATE CHEM, V16, P1399, DOI 10.1021/bc050125z; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; PARDRIDGE WM, 1985, AM J PHYSIOL, V249, pE264, DOI 10.1152/ajpendo.1985.249.3.E264; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Rousselle C, 2001, J PHARMACOL EXP THER, V296, P124; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Sarko D, 2010, MOL PHARMACEUT, V7, P2224, DOI 10.1021/mp100223d; Simon MJ, 2011, ANN BIOMED ENG, V39, P394, DOI 10.1007/s10439-010-0144-x; Song JJ, 2011, PEPTIDES, V32, P1934, DOI 10.1016/j.peptides.2011.07.018; Stalmans S, 2016, J PHARM BIOMED, V117, P289; Stalmans S, 2015, PROTEIN PEPTIDE LETT, V22, P768, DOI 10.2174/0929866522666150622101223; Stalmans S, 2014, PROTEIN PEPTIDE LETT, V21, P399, DOI 10.2174/09298665113206660110; Stalmans S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071752; Suhorutsenko J, 2012, INT J PEPT RES THER, V18, P291, DOI 10.1007/s10989-012-9302-3; Svenson J, 2010, J PHARMACOL EXP THER, V332, P1032, DOI 10.1124/jpet.109.162826; Taylor BN, 2009, CANCER RES, V69, P537, DOI 10.1158/0008-5472.CAN-08-2932; Trehin R, 2004, PHARM RES-DORDR, V21, P1248, DOI 10.1023/B:PHAM.0000033013.45204.c3; TRIGUERO D, 1990, J NEUROCHEM, V54, P1882, DOI 10.1111/j.1471-4159.1990.tb04886.x; Verbeken M, 2015, PEPTIDES, V63, P10, DOI 10.1016/j.peptides.2014.10.010; Verdurmen WPR, 2011, TRENDS PHARMACOL SCI, V32, P116, DOI 10.1016/j.tips.2010.11.005; Vergote V, 2008, PEPTIDES, V29, P1740, DOI 10.1016/j.peptides.2008.05.018; Vergote V, 2008, J PHARMACEUT BIOMED, V46, P127, DOI 10.1016/j.jpba.2007.10.005; Violini S, 2002, BIOCHEMISTRY-US, V41, P12652, DOI 10.1021/bi026097e; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; WONG DF, 1986, J CEREBR BLOOD F MET, V6, P137, DOI 10.1038/jcbfm.1986.27; Yandek LE, 2007, BIOPHYS J, V92, P2434, DOI 10.1529/biophysj.106.100198; Zou LL, 2013, CURR NEUROPHARMACOL, V11, P197, DOI 10.2174/1570159X11311020006	79	119	120	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139652	10.1371/journal.pone.0139652	http://dx.doi.org/10.1371/journal.pone.0139652			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465925	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100055
J	Twidwell, D; Wonkka, CL; Sindelar, MT; Weir, JR				Twidwell, Dirac; Wonkka, Carissa L.; Sindelar, Michael T.; Weir, John R.			First Approximations of Prescribed Fire Risks Relative to Other Management Techniques Used on Private Lands	PLOS ONE			English	Article							WILDLAND; PERSPECTIVES; INJURIES; BURN	Fire is widely recognized as a critical ecological and evolutionary driver that needs to be at the forefront of land management actions if conservation targets are to be met. However, the prevailing view is that prescribed fire is riskier than other land management techniques. Perceived risks associated with the application of fire limits its use and reduces agency support for prescribed burning in the private sector. As a result, considerably less cost-share support is given for prescribed fire compared to mechanical techniques. This study tests the general perception that fire is a riskier technique relative to other land management options. Due to the lack of data available to directly test this notion, we use a combination of approaches including 1) a comparison of fatalities resulting from different occupations that are proxies for techniques employed in land management, 2) a comparison of fatalities resulting from wildland fire versus prescribed fire, and 3) an exploration of causal factors responsible for wildland fire-related fatalities. This approach establishes a first approximation of the relative risk of fatality to private citizens using prescribed fire compared to other management techniques that are readily used in ecosystem management. Our data do not support using risks of landowner fatalities as justification for the use of alternative land management techniques, such as mechanical (machine-related) equipment, over prescribed fire. Vehicles and heavy machinery are consistently leading reasons for fatalities within occupations selected as proxies for management techniques employed by ranchers and agricultural producers, and also constitute a large proportion of fatalities among firefighters. Our study provides the foundation for agencies to establish data-driven decisions regarding the degree of support they provide for prescribed burning on private lands.	[Twidwell, Dirac; Wonkka, Carissa L.; Sindelar, Michael T.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA; [Weir, John R.] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA	University of Nebraska System; University of Nebraska Lincoln; Oklahoma State University System; Oklahoma State University - Stillwater	Twidwell, D (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA.	dirac.twidwell@unl.edu	Wonkka, Carissa/AAZ-4199-2020	Twidwell, Dirac/0000-0002-0280-3339				[Anonymous], 2014, NEBRASKA B; Bowman DMJS, 2011, J BIOGEOGR, V38, P2223, DOI 10.1111/j.1365-2699.2011.02595.x; Britton C, 2013, AM J EMERG MED, V31, P339, DOI 10.1016/j.ajem.2012.08.032; Brunson MW, 2005, J FOREST, V103, P134; Calkin DE, 2013, INT J WILDLAND FIRE, V22, P212, DOI 10.1071/WF11075; Christensen N., 1988, ECOSYSTEM MANAGEMENT, P62; Crow TR, 2004, LANDSCAPE ECOL, V19, P231, DOI 10.1023/B:LAND.0000030762.86156.5d; Dill K, 2014, FORBES          0925; Flannigan MD, 2009, INT J WILDLAND FIRE, V18, P483, DOI 10.1071/WF08187; Hard David L, 2006, J Agromedicine, V11, P57, DOI 10.1300/J096v11n02_09; Liew D. van, 2012, The Open Agriculture Journal, V6, P17, DOI 10.2174/1874331501206010017; Maguire LA, 2005, FOREST ECOL MANAG, V211, P47, DOI 10.1016/j.foreco.2005.01.027; Myers JR, 2009, AM J IND MED, V52, P185, DOI 10.1002/ajim.20661; Rautiainen R H, 2002, J Agric Saf Health, V8, P259; Russell-Smith J, 2013, FRONT ECOL ENVIRON, V11, pE3, DOI 10.1890/1540-9295-11.s1.e3; Smith MJ, 1977, C OCC STRESS LOS ANG; Sorice MG, 2012, J ARID ENVIRON, V80, P56, DOI 10.1016/j.jaridenv.2012.01.004; Stankey GH, 2003, MANAG FOR ECOSYST, V8, P453; Toledo D, 2014, J ENVIRON MANAGE, V132, P323, DOI 10.1016/j.jenvman.2013.11.014; Twidwell D, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00124.1; Twidwell D, 2013, FRONT ECOL ENVIRON, V11, pE64, DOI 10.1890/130015; US Bureau of Labor Statistics, 2014, 2014 CENS FAT OCC IN; Vasiljevic M., 2013, REASONING EXTREME EV; Weir J. R., 2015, GPE PUBLICATION, V2015-6; WFA NIFC, 2014, WILDL FIR FAT TYP AC; WFLLC, 2012, 2012 ESC PRESCR FIR; Winter G, 2000, SOC NATUR RESOUR, V13, P33, DOI 10.1080/089419200279225; Wong C, 2004, J ECOSYSTEMS MANAGEM, V4, P1; Yoder J, 2008, J LAW ECON, V51, P297, DOI 10.1086/589661	29	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140410	10.1371/journal.pone.0140410	http://dx.doi.org/10.1371/journal.pone.0140410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465329	Green Published, gold			2022-12-26	WOS:000363183100116
J	Zhang, YY; Huai, DX; Yang, QY; Cheng, Y; Ma, M; Kliebenstein, DJ; Zhou, YM				Zhang, Yuanyuan; Huai, Dongxin; Yang, Qingyong; Cheng, Yan; Ma, Ming; Kliebenstein, Daniel J.; Zhou, Yongming			Overexpression of Three Glucosinolate Biosynthesis Genes in Brassica napus Identifies Enhanced Resistance to Sclerotinia sclerotiorum and Botrytis cinerea	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; ARABIDOPSIS-THALIANA; INDOLE-GLUCOSINOLATE; INSECT RESISTANCE; SECONDARY METABOLITES; NONHOST RESISTANCE; AUXIN HOMEOSTASIS; DEFENSE COMPOUNDS; OILSEED RAPE; CYP83B1	Sclerotinia sclerotiorum and Botrytis cinerea are notorious plant pathogenic fungi with an extensive host range including Brassica crops. Glucosinolates (GSLs) are an important group of secondary metabolites characteristic of the Brassicales order, whose degradation products are proving to be increasingly important in plant protection. Enhancing the defense effect of GSL and their associated degradation products is an attractive strategy to strengthen the resistance of plants by transgenic approaches. We generated the lines of Brassica napus with three biosynthesis genes involved in GSL metabolic pathway (BnMAM1, BnCYP83A1 and BnUGT74B1), respectively. We then measured the foliar GSLs of each transgenic lines and inoculated them with S. sclerotiorum and B. cinerea. Compared with the wild type control, over-expressing BnUGT74B1 in B. napus increased the aliphatic and indolic GSL levels by 1.7 and 1.5 folds in leaves respectively; while over-expressing BnMAM1 or BnCYP83A1 resulted in an approximate 1.5-fold higher only in the aliphatic GSL level in leaves. The results of plant inoculation demonstrated that BnUGT74B1-overexpressing lines showed less severe disease symptoms and tissue damage compared with the wild type control, but BnMAM1 or BnCYP83A1-overexpressing lines showed no significant difference in comparison to the controls. These results suggest that the resistance to S. sclerotiorum and B. cinerea in B. napus could be enhanced through tailoring the GSL profiles by transgenic approaches or molecular breeding, which provides useful information to assist plant breeders to design improved breeding strategies.	[Zhang, Yuanyuan; Huai, Dongxin; Yang, Qingyong; Cheng, Yan; Ma, Ming; Zhou, Yongming] Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Zhang, Yuanyuan; Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kliebenstein, Daniel J.] Univ Copenhagen, Copenhagen Plant Sci Ctr, DynaMo Ctr Excellence, DK-1871 Frederiksberg C, Denmark	Huazhong Agricultural University; University of California System; University of California Davis; University of Copenhagen	Kliebenstein, DJ (corresponding author), Univ Calif Davis, Dept Plant Sci, One Shield Ave, Davis, CA 95616 USA.	kliebenstein@ucdavis.edu; ymzhou@mail.hzau.edu.cn	zhang, yuanyuan/GYA-4428-2022	ma, ma ming/0000-0002-4785-3225; Yang, Qing-Yong/0000-0002-3510-8906	China Scholarship Council [2010676009]; Ministry of Agriculture of China [nycytx-00503]; National Science Foundation-Integrative Organismal Systems [1021861, 1339125]; USDA National Institute of Food and Agriculture, Hatch project [CA-D-PLS-7033-H]; Danish National Research Foundation [DNRF99]	China Scholarship Council(China Scholarship Council); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Science Foundation-Integrative Organismal Systems; USDA National Institute of Food and Agriculture, Hatch project; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by the China Scholarship Council (http://en.csc.edu.cn/) grant 2010676009 to Y. Zhang, Ministry of Agriculture of China (http://www.kjs.moa.gov.cn/) grant nycytx-00503 to Y. Zhou, the National Science Foundation-Integrative Organismal Systems (http://www.nsf.gov/div/index.jsp?org=IOS) grant 1021861 to DJK, the National Science Foundation-Integrative Organismal Systems (http://www.nsf.gov/div/index.jsp?org=IOS) grant 1339125 to DJK, the USDA National Institute of Food and Agriculture (http://nifa.usda.gov/#), Hatch project number CA-D-PLS-7033-H to DJK and by the Danish National Research Foundation (http://dg.dk/en/) (DNRF99) grant to DJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; Bak S, 2001, PLANT PHYSIOL, V127, P108, DOI 10.1104/pp.127.1.108; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bednarek P, 2011, NEW PHYTOL, V192, P713, DOI 10.1111/j.1469-8137.2011.03824.x; Beekwilder J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002068; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Cheng Y, 2013, PLANT J, V75, P642, DOI 10.1111/tpj.12228; Clarke DB, 2010, ANAL METHODS-UK, V2, P310, DOI 10.1039/b9ay00280d; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Cui JP, 2002, PLANT PHYSIOL, V129, P551, DOI 10.1104/pp.010815; de Vos M, 2008, PLANT PHYSIOL, V146, P916, DOI 10.1104/pp.107.112185; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fan J, 2011, SCIENCE, V331, P1185, DOI 10.1126/science.1199707; Fan ZX, 2008, J PLANT PATHOL, V90, P43; Feng J, 2012, NEW PHYTOL, V193, P96, DOI 10.1111/j.1469-8137.2011.03890.x; Gachon CMM, 2005, PLANT MOL BIOL, V58, P229, DOI 10.1007/s11103-005-5346-5; Gao MQ, 2006, PLANT CELL REP, V25, P592, DOI 10.1007/s00299-005-0078-1; Grubb CD, 2014, PLANT J, V79, P92, DOI 10.1111/tpj.12541; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Grubb CD, 2004, PLANT J, V40, P893, DOI 10.1111/j.1365-313X.2004.02261.x; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen BG, 2008, PLANT PHYSIOL, V148, P2096, DOI 10.1104/pp.108.129981; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; Hemm MR, 2003, PLANT CELL, V15, P179, DOI 10.1105/tpc.006544; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; Hirani AH, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00055; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; Kliebenstein D, 2002, GENETICS, V161, P325; Kliebenstein DJ, 2012, ANNU REV PHYTOPATHOL, V50, P155, DOI 10.1146/annurev-phyto-081211-172950; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kliebenstein DJ, 2002, GENETICS, V161, P1685; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Li G, 2003, THEOR APPL GENET, V106, P1116, DOI 10.1007/s00122-002-1161-4; Li G, 2001, J AM SOC HORTIC SCI, V126, P427, DOI 10.21273/JASHS.126.4.427; Li GY, 2002, GENETICS, V162, P1937; Li Q, 2015, J EXPT BOT; Li Y, 1999, ANN APPL BIOL, V134, P45, DOI 10.1111/j.1744-7348.1999.tb05234.x; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Liu Z, 2012, PLANT MOL BIOL, V79, P179, DOI 10.1007/s11103-012-9905-2; Liu Z, 2011, MOL BREEDING, V27, P467, DOI 10.1007/s11032-010-9444-y; Mikkelsen MD, 2003, PLANT PHYSIOL, V131, P298, DOI 10.1104/pp.011015; MITHEN R, 1992, EUPHYTICA, V63, P71, DOI 10.1007/BF00023913; Muller R, 2010, J CHEM ECOL, V36, P905, DOI 10.1007/s10886-010-9825-z; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagaharu U., 1935, JPN J BOT, V7, P389, DOI DOI 10.1038/35036519; Naur P, 2003, PLANT PHYSIOL, V133, P63, DOI 10.1104/pp.102.019240; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Oliver RP, 2010, CURR OPIN PLANT BIOL, V13, P415, DOI 10.1016/j.pbi.2010.05.003; Pfalz M, 2009, PLANT CELL, V21, P985, DOI 10.1105/tpc.108.063115; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rowe HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000861; Sanchez-Vallet A, 2010, PLANT J, V63, P115, DOI 10.1111/j.1365-313X.2010.04224.x; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Stotz HU, 2011, PLANT J, V67, P81, DOI 10.1111/j.1365-313X.2011.04578.x; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tierens KFMJ, 2001, PLANT PHYSIOL, V125, P1688, DOI 10.1104/pp.125.4.1688; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Weis C, 2014, NEW PHYTOL, V202, P1310, DOI 10.1111/nph.12759; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; Wu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067740; Zang YX, 2009, FEBS J, V276, P3559, DOI 10.1111/j.1742-4658.2009.07076.x; Zhang YY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00343; Zhao J, 2003, PLANT BREEDING, V122, P19, DOI 10.1046/j.1439-0523.2003.00784.x; Zhou YM, 2002, PLANTA, V215, P248, DOI 10.1007/s00425-002-0752-2; Zhu B, 2012, INT J MOL SCI, V13, P5832, DOI 10.3390/ijms13055832; Zust T, 2012, SCIENCE, V338, P116, DOI 10.1126/science.1226397	73	31	35	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140491	10.1371/journal.pone.0140491	http://dx.doi.org/10.1371/journal.pone.0140491			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465156	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100131
J	Gibert, A; Magda, D; Hazard, L				Gibert, Anais; Magda, Daniele; Hazard, Laurent			Interplay between Endophyte Prevalence, Effects and Transmission: Insights from a Natural Grass Population	PLOS ONE			English	Article							VERTICAL TRANSMISSION; ENVIRONMENTAL-STRESSES; FUNGAL ENDOPHYTES; EVOLUTION; INFECTION; FREQUENCY; SYMBIOSIS; CONSERVATION; MUTUALISM; ULM	Two main mechanisms are thought to affect the prevalence of endophyte-grass symbiosis in host populations: the mode of endophyte transmission, and the fitness differential between symbiotic and non-symbiotic plants. These mechanisms have mostly been studied in synthetic grass populations. If we are to improve our understanding of the ecological and evolutionary dynamics of such symbioses, we now need to determine the combinations of mechanisms actually operating in the wild, in populations shaped by evolutionary history. We used a demographic population modeling approach to identify the mechanisms operating in a natural stand of an intermediate population (i.e. 50% of plants symbiotic) of the native grass Festuca eskia. We recorded demographic data in the wild over a period of three years, with manipulation of the soil resources for half the population. We developed two stage-structured matrix population models. The first model concerned either symbiotic or non-symbiotic plants. The second model included both symbiotic and non-symbiotic plants and took endophyte transmission rates into account. According to our models, symbiotic had a significantly higher population growth rate than non-symbiotic plants, and endophyte prevalence was about 58%. Endophyte transmission rates were about 0.67 or 0.87, depending on the growth stage considered. In the presence of nutrient supplementation, population growth rates were still significantly higher for symbiotic than for non-symbiotic plants, but endophyte prevalence fell to 0%. At vertical transmission rates below 0.10-0.20, no symbiosis was observed. Our models showed that a positive benefit of the endophyte and vertical transmission rates of about 0.6 could lead to the coexistence of symbiotic and non-symbiotic F. eskia plants. The positive effect of the symbiont on host is not systematically associated with high transmission rates of the symbiont over short time scales, in particular following an environmental change.	[Gibert, Anais; Magda, Daniele; Hazard, Laurent] INRA, UMR AGIR, F-31320 Castanet Tolosan, France; [Gibert, Anais] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	INRAE; Macquarie University	Gibert, A (corresponding author), INRA, UMR AGIR, F-31320 Castanet Tolosan, France.	anais.gibert@gmail.com	Gibert, Anais/E-5005-2018	Gibert, Anais/0000-0003-2924-2380; Hazard, Laurent/0000-0002-0538-8214	French government (Fond Unique Interministeriel); state of Midi-Pyrenees	French government (Fond Unique Interministeriel); state of Midi-Pyrenees	The French government (Fond Unique Interministeriel) and the state of Midi-Pyrenees supported this work.	Afkhami ME, 2008, AM NAT, V172, P405, DOI 10.1086/589893; [Anonymous], 2014, R LANG ENV STAT COMP; Bacon C.W., 1994, BIOTECHNOLOGY ENDOPH, P47; BAUDIERE A, 1973, Acta Botanica Academiae Scientiarum Hungaricae, V19, P23; Caswell H, 2001, MATRIX POPULATION MO, P1; Cheplick G. P., 2009, ECOLOGY EVOLUTION GR, P1; CLAY K, 1989, MYCOL RES, V92, P1, DOI 10.1016/S0953-7562(89)80088-7; Clay K., 1993, AGR ECOSYST ENVIRON, P44; Colbry VL, 1961, SEEDS YB AGR; Douglas A.E., 2010, SYMBIOTIC HABIT, Vfirst, P1; Ebert D, 2013, ANNU REV ECOL EVOL S, V44, P623, DOI 10.1146/annurev-ecolsys-032513-100555; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; EWALD PW, 1987, ANN NY ACAD SCI, V503, P295, DOI 10.1111/j.1749-6632.1987.tb40616.x; Ferriere R, 1996, ACTA OECOL, V17, P629; FINE PEM, 1975, ANN NY ACAD SCI, V266, P173, DOI 10.1111/j.1749-6632.1975.tb35099.x; Gibert A, 2013, J ECOL, V101, P743, DOI 10.1111/1365-2745.12073; Gibert A, 2013, OIKOS, V122, P367, DOI 10.1111/j.1600-0706.2012.19976.x; Gibert A, 2012, NEW PHYTOL, V194, P561, DOI 10.1111/j.1469-8137.2012.04073.x; Gonzalo-Turpin H, 2010, CONSERV GENET, V11, P877, DOI 10.1007/s10592-009-9927-8; Gundel PE, 2011, OIKOS, V120, P1121, DOI 10.1111/j.1600-0706.2011.19299.x; Gundel PE, 2008, P ROY SOC B-BIOL SCI, V275, P897, DOI 10.1098/rspb.2007.1494; Gundel PE, 2006, AUSTRAL ECOL, V31, P767, DOI 10.1111/j.1442-9993.2006.01638.x; Hiatt EE, 1999, CROP SCI, V39, P796, DOI 10.2135/cropsci1999.0011183X003900030030x; Horvitz C., 1997, STRUCTURED POPULATIO, P247, DOI DOI 10.1007/978-1-4615-5973-3; Kannadan S, 2008, FUNCT ECOL, V22, P706, DOI 10.1111/j.1365-2435.2008.01395.x; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Legendre S, 1995, J APPL STAT, V22, P817, DOI 10.1080/02664769524649; Lewis GC, 1997, ANN APPL BIOL, V130, P227, DOI 10.1111/j.1744-7348.1997.tb06828.x; Malinowski DP, 2000, CROP SCI, V40, P923, DOI 10.2135/cropsci2000.404923x; Rasmussen S, 2007, NEW PHYTOL, V173, P787, DOI 10.1111/j.1469-8137.2006.01960.x; Ravel C, 1997, OIKOS, V80, P18, DOI 10.2307/3546511; Ravel C, 1997, BENEFICIAL EFFECTS N; Rudgers JA, 2009, ECOLOGY, V90, P1531, DOI 10.1890/08-0116.1; Saikkonen K, 2002, P ROY SOC B-BIOL SCI, V269, P1397, DOI 10.1098/rspb.2002.2006; Saikkonen K, 2013, J CHEM ECOL, V39, P962, DOI 10.1007/s10886-013-0310-3; Saona NM, 2010, J ECOL, V98, P470, DOI 10.1111/j.1365-2745.2009.01613.x; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Yule KM, 2013, OIKOS, V122, P1512, DOI 10.1111/j.1600-0706.2012.00229.x; Zabal-Aguirre M, 2010, HEREDITY, V104, P174, DOI 10.1038/hdy.2009.106	39	7	7	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139919	10.1371/journal.pone.0139919	http://dx.doi.org/10.1371/journal.pone.0139919			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462113	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300036
J	Mukhopadhyay, P; Ferguson, B; Muller, HK; Handoko, HY; Walker, GJ				Mukhopadhyay, P.; Ferguson, B.; Muller, H. K.; Handoko, H. Y.; Walker, G. J.			Murine melanomas accelerated by a single UVR exposure carry photoproduct footprints but lack UV signature C > T mutations in critical genes	ONCOGENE			English	Article							ULTRAVIOLET-RADIATION; SOMATIC MUTATIONS; NORMAL SKIN; DNA; REPAIR; MECHANISMS; MUTAGENESIS; DRIVEN; CANCER; RISK	Ultraviolet radiation (UVR) exposure increases malignant melanoma (MM) risk, but in the context of acute, not cumulative exposure. C > T and CC > TT changes make up the overwhelming majority of single base substitutions (SBS) in MM DNA, as both precursor melanocytes and melanocytic lesions have incurred incidental exposures to sunlight. To study the mutagenic mechanisms by which acute sunburn accelerates MM, we sequenced the exomes of spontaneous and neonatal UVB-induced Cdk4-R24C::Tyr-NRASQ61K mouse MMs. UVR-induced MMs carried more SBSs than spontaneous MMs, but the levels of genomic instability, reflected by translocations and copy number changes, were not different. C > T/G > A was the most common SBS in spontaneous and UVR-induced MMs, only modestly increased in the latter. However, they tended to occur at the motif A/GpCpG (reflecting C > T transition due to spontaneous deamination of cytosine at CpG) in spontaneous MMs, and T/CpCpC/T (reflecting the effects of pyrimidine dimers on either side of the mutated C) in UVR-induced MMs. Unlike MMs associated with repetitive exposures, we observed no CC > TT changes. In addition, we also found UVR `footprints' at T > A/A > Ts (at NpTpT) and T > C/A > G (at CpTpC). These footprints are also present in MMs from a chronic UVR mouse model, and in some human MMs, suggesting that they may be minor UVR signature changes. We found few significantly somatically mutated genes (similar to 6 per spontaneous and 15 per UVR-induced melanoma) in addition to the Cdk4 and NRAS mutations already present. Trp53 was the most convincing recurrently mutated gene; however, in the UVR-induced MMs no Trp53 mutations were at C > T/G > A, suggesting that it was probably mutated during tumour progression, not directly induced by UVR photoproducts. The very low load of recurrent mutations convincingly induced by classical UVB-induced dimer photoproducts may support a role for cell extrinsic mechanisms, such as photoimmunosuppression and inflammation in driving MM after acute UVB exposure.	[Mukhopadhyay, P.; Ferguson, B.; Handoko, H. Y.; Walker, G. J.] QIMR Berghofer Med Res Inst, 300 Herston Rd, Herston, Qld 4006, Australia; [Muller, H. K.] Univ Tasmania, Sch Med, Hobart, Tas, Australia	QIMR Berghofer Medical Research Institute; University of Tasmania	Walker, GJ (corresponding author), QIMR Berghofer Med Res Inst, 300 Herston Rd, Herston, Qld 4006, Australia.	Graeme.Walker@qimrberghofer.edu.au	, Herlina/F-4193-2015	, Herlina/0000-0003-3153-2248; Ferguson, Blake/0000-0002-5643-6976	Cancer Council of Queensland; National Health and Medical Research Council of Australia	Cancer Council of Queensland(Cancer Council Queensland); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by The Cancer Council of Queensland, and the National Health and Medical Research Council of Australia. We thank Nick Hayward and Peter Johansson for helpful discussions, and Grant Morahan for prompting us to consider the influence of genetic background on cancer incidence.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Besaratinia A, 2004, BIOCHEMISTRY-US, V43, P8169, DOI 10.1021/bi049761v; Besaratinia A, 2008, FASEB J, V22, P2379, DOI 10.1096/fj.07-105437; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; Bryan DS, 2014, GENOME RES, V24, P1534, DOI 10.1101/gr.174052.114; Carstens MJ, 2004, J BIOL CHEM, V279, P35984, DOI 10.1074/jbc.M400408200; Ferguson B, 2015, ONCOGENE, V34, P2879, DOI 10.1038/onc.2014.227; Fulci G, 2002, CANCER RES, V62, P2897; Furney SJ, 2013, J PATHOL, V230, P261, DOI 10.1002/path.4204; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Giglia-Mari G, 2003, HUM MUTAT, V21, P217, DOI 10.1002/humu.10179; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Ikehata H, 2013, J INVEST DERMATOL, V133, P1850, DOI 10.1038/jid.2012.504; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; Jans J, 2006, MOL CELL BIOL, V26, P8515, DOI 10.1128/MCB.00807-06; Jia PL, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-11; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Malcikova J, 2009, BLOOD, V114, P5307, DOI 10.1182/blood-2009-07-234708; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Matin RN, 2013, J EXP MED, V210, P581, DOI 10.1084/jem.20121439; Metz CHD, 2013, CANCER MED-US, V2, P208, DOI 10.1002/cam4.61; Mitchell DL, 2009, PHOTOCHEM PHOTOBIOL, V85, P1384, DOI 10.1111/j.1751-1097.2009.00591.x; MITCHELL DL, 1989, PHOTOCHEM PHOTOBIOL, V49, P805, DOI 10.1111/j.1751-1097.1989.tb05578.x; NAKAZAWA H, 1994, P NATL ACAD SCI USA, V91, P360, DOI 10.1073/pnas.91.1.360; Otoshi E, 2000, CANCER RES, V60, P1729; Ouhtit A, 1998, J NATL CANCER I, V90, P523, DOI 10.1093/jnci/90.7.523; Pattison DI, 2006, EXP SUPPL, V96, P131; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Robert C, 1996, J INVEST DERMATOL, V106, P721, DOI 10.1111/1523-1747.ep12345616; SELVANAYAGAM CS, 1995, CANCER RES, V55, P3310; Sheppard KE, 2013, CLIN CANCER RES, V19, P5320, DOI 10.1158/1078-0432.CCR-13-0259; Slovackova J, 2010, CELL CYCLE, V9, P2141, DOI 10.4161/cc.9.11.11808; Song Q, 2014, NUCLEIC ACIDS RES, V42, P13122, DOI 10.1093/nar/gku1049; Su DGT, 2010, CHEM RES TOXICOL, V23, P474, DOI 10.1021/tx9003962; Viros A, 2014, NATURE, V511, P478, DOI 10.1038/nature13298; Wolnicka-Glubisz A, 2006, PHOTOCH PHOTOBIO SCI, V5, P254, DOI 10.1039/b506974b; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666	41	15	15	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 23	2016	35	25					3342	3350		10.1038/onc.2015.386	http://dx.doi.org/10.1038/onc.2015.386			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP2GN	26477315				2022-12-26	WOS:000378306400013
J	Qiang, L; Shah, P; Barcellos-Hoff, MH; He, YY				Qiang, L.; Shah, P.; Barcellos-Hoff, M. H.; He, Y. Y.			TGF-beta signaling links E-cadherin loss to suppression of nucleotide excision repair	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL CARCINOMA PROGRESSION; GROWTH-FACTOR-BETA; XERODERMA-PIGMENTOSUM; DOWN-REGULATION; ADHESION MOLECULE; DNA-BINDING; C-MYC; SKIN; INDUCTION	E-cadherin is a cell adhesion molecule best known for its function in suppressing tumor progression and metastasis. Here we show that E-cadherin promotes nucleotide excision repair through positively regulating the expression of xeroderma pigmentosum complementation group C (XPC) and DNA damage-binding protein 1 (DDB1). Loss of E-cadherin activates the E2F4 and p130/107 transcription repressor complexes to suppress the transcription of both XPC and DDB1 through activating the transforming growth factor-beta (TGF-beta) pathway. Adding XPC or DDB1, or inhibiting the TGF-beta pathway, increases the repair of ultraviolet (UV)-induced DNA damage in E-cadherin-inhibited cells. In the mouse skin and skin tumors, UVB radiation downregulates E-cadherin. In sunassociated premalignant and malignant skin neoplasia, E-cadherin is downregulated in association with reduced XPC and DDB1 levels. These findings demonstrate a crucial role of E-cadherin in efficient DNA repair of UV-induced DNA damage, identify a new link between epithelial adhesion and DNA repair and suggest a mechanistic link of early E-cadherin loss in tumor initiation.	[Qiang, L.; Shah, P.; He, Y. Y.] Univ Chicago, Dept Med, Dermatol Sect, Chicago, IL 60637 USA; [Barcellos-Hoff, M. H.] NYU, Sch Med, Dept Radiat Oncol & Cell Biol, New York, NY USA	University of Chicago; New York University	He, YY (corresponding author), Univ Chicago, Dept Med, Dermatol Sect, Chicago, IL 60637 USA.	yyhe@medicine.bsd.uchicago.edu	Qiang, Lei/B-2763-2012	Qiang, Lei/0000-0002-7164-3164; Barcellos-Hoff, Mary Helen/0000-0002-5994-9558	NIH/NIEHS [ES016936, ES024373]; American Cancer Society (ACS) [RSG-13-078-01]; University of Chicago Cancer Research Center [P30 CA014599]; CTSA [UL1 TR000430]; University of Chicago Friends of Dermatology Endowment Fund; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016936, R01ES024373] Funding Source: NIH RePORTER	NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Cancer Society (ACS)(American Cancer Society); University of Chicago Cancer Research Center; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Chicago Friends of Dermatology Endowment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We are grateful to Dr Altaf Wani for his helpful suggestions. We thank Terri Li for immunohistochemistry and Dr Ann Motten for a critical reading of the manuscript. This work was supported by the NIH/NIEHS grants ES016936 and ES024373 (to YYH), the American Cancer Society (ACS) grant RSG-13-078-01 (to YYH), the University of Chicago Cancer Research Center (P30 CA014599), the CTSA (UL1 TR000430) and the University of Chicago Friends of Dermatology Endowment Fund.	Boyle J, 2008, HUM MUTAT, V29, P1194, DOI 10.1002/humu.20768; Bradford PT, 2011, J MED GENET, V48, P168, DOI 10.1136/jmg.2010.083022; Braithwaite E, 1998, CARCINOGENESIS, V19, P1239, DOI 10.1093/carcin/19.7.1239; Brouxhon S, 2007, CANCER RES, V67, P7654, DOI 10.1158/0008-5472.CAN-06-4415; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Cho IJ, 2010, HEPATOLOGY, V52, P2053, DOI 10.1002/hep.23931; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Cui TT, 2015, ONCOTARGET, V6, P10060, DOI 10.18632/oncotarget.3542; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Dominguez-Brauer C, 2009, EMBO REP, V10, P1036, DOI 10.1038/embor.2009.139; Dubrovska A, 2005, ONCOGENE, V24, P2289, DOI 10.1038/sj.onc.1208443; Fei J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001183; Fleisch MC, 2006, ENDOCR-RELAT CANCER, V13, P379, DOI 10.1677/erc.1.01112; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Glick AB, 2012, J SKIN CANCER, V2012, DOI 10.1155/2012/249063; Gu CN, 2006, BIOCHEMISTRY-US, V45, P10739, DOI 10.1021/bi060423z; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hoot KE, 2008, J CLIN INVEST, V118, P2722, DOI 10.1172/JCI33713; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Imoto K, 2002, J INVEST DERMATOL, V119, P1177, DOI 10.1046/j.1523-1747.2002.19514.x; Jamal S, 2002, J CLIN INVEST, V110, P443, DOI 10.1172/JCI200213729; Jans J, 2005, CURR BIOL, V15, P105, DOI 10.1016/j.cub.2005.01.001; Kad NM, 2010, MOL CELL, V37, P702, DOI 10.1016/j.molcel.2010.02.003; Kao YC, 2010, MOL CELL BIOL, V30, P4767, DOI 10.1128/MCB.01021-09; Katsumi S, 2001, J INVEST DERMATOL, V117, P1156, DOI 10.1046/j.0022-202x.2001.01540.x; Kim I, 2014, GENES DIS, V1, P188, DOI 10.1016/j.gendis.2014.08.005; Kim MR, 2015, MOL CANCER RES, V13, P319, DOI 10.1158/1541-7786.MCR-14-0098-T; Kobayashi N, 2001, PIGM CELL RES, V14, P94, DOI 10.1034/j.1600-0749.2001.140204.x; Li AG, 2004, CANCER RES, V64, P7836, DOI 10.1158/0008-5472.CAN-04-1331; Li JY, 2006, CANCER RES, V66, P8590, DOI 10.1158/0008-5472.CAN-06-1115; Margulis A, 2005, CANCER RES, V65, P1783, DOI 10.1158/0008-5472.CAN-04-3399; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108; Mitra D, 2013, J INVEST DERMATOL, V133, P2609, DOI 10.1038/jid.2013.213; Nakagawa H, 2014, P NATL ACAD SCI USA, V111, P1090, DOI 10.1073/pnas.1322731111; NAVARRO P, 1991, J CELL BIOL, V115, P517, DOI 10.1083/jcb.115.2.517; Nichols AF, 2003, NUCLEIC ACIDS RES, V31, P562, DOI 10.1093/nar/gkg152; NIGGLI HJ, 1988, J INVEST DERMATOL, V91, P579, DOI 10.1111/1523-1747.ep12477095; Oh KS, 2011, PHOTOCHEM PHOTOBIOL, V87, P729, DOI 10.1111/j.1751-1097.2011.00909.x; Orsulic S, 1999, J CELL SCI, V112, P1237; Perez-Lorenzo R, 2010, CARCINOGENESIS, V31, P1116, DOI 10.1093/carcin/bgq041; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Qiang L, 2014, P NATL ACAD SCI USA, V111, P9241, DOI 10.1073/pnas.1322913111; Ravindran A, 2014, CARCINOGENESIS, V35, P959, DOI 10.1093/carcin/bgt486; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shah P, 2015, PHOTOCHEM PHOTOBIOL, V91, P254, DOI 10.1111/php.12406; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sugasawa K, 2008, CARCINOGENESIS, V29, P455, DOI 10.1093/carcin/bgm282; Sugasawa K, 2009, DNA REPAIR, V8, P969, DOI 10.1016/j.dnarep.2009.05.001; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; VINK AA, 1991, CARCINOGENESIS, V12, P861, DOI 10.1093/carcin/12.5.861; Vogelmann R, 2005, J CELL SCI, V118, P4901, DOI 10.1242/jcs.02594; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang HJ, 2005, FREE RADICAL BIO MED, V38, P890, DOI 10.1016/j.freeradbiomed.2004.12.005; Wang QE, 2013, NUCLEIC ACIDS RES, V41, P1722, DOI 10.1093/nar/gks1312; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	64	19	20	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 23	2016	35	25					3293	3302		10.1038/onc.2015.390	http://dx.doi.org/10.1038/onc.2015.390			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP2GN	26477308	Green Accepted, Green Submitted			2022-12-26	WOS:000378306400008
J	Borcherding, DC; Tong, W; Hugo, ER; Barnard, DF; Fox, S; LaSance, K; Shaughnessy, E; Ben-Jonathan, N				Borcherding, D. C.; Tong, W.; Hugo, E. R.; Barnard, D. F.; Fox, S.; LaSance, K.; Shaughnessy, E.; Ben-Jonathan, N.			Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PERIPHERAL DOPAMINE; GUANYLATE-CYCLASE; NITRIC-OXIDE; TUMOR-GROWTH; AGONIST; CELLS; ANGIOGENESIS; FENOLDOPAM; NEURONS	Patients with advanced breast cancer often fail to respond to treatment, creating a need to develop novel biomarkers and effective therapeutics. Dopamine (DA) is a catecholamine that binds to five G protein-coupled receptors. We discovered expression of DA type-1 receptors (D1Rs) in breast cancer, thereby identifying these receptors as novel therapeutic targets in this disease. Strong to moderate immunoreactive D1R expression was found in 30% of 751 primary breast carcinomas, and was associated with larger tumors, higher tumor grades, node metastasis and shorter patient survival. DA and D1R agonists, signaling through the cGMP/protein kinase G (PKG) pathway, suppressed cell viability, inhibited invasion and induced apoptosis in multiple breast cancer cell lines. Fenoldopam, a peripheral D1R agonist that does not penetrate the brain, dramatically suppressed tumor growth in two mouse models with D1R-expressing xenografts by increasing both necrosis and apoptosis. D1R-expressing primary tumors and metastases in mice were detected by fluorescence imaging. In conclusion, D1R overexpression is associated with advanced breast cancer and poor prognosis. Activation of the D1R/cGMP/PKG pathway induces apoptosis in vitro and causes tumor shrinkage in vivo. Fenoldopam, which is FDA (Food and Drug Administration) approved to treat renal hypertension, could be repurposed as a novel therapeutic agent for patients with D1R-expressing tumors.	[Borcherding, D. C.; Hugo, E. R.; Barnard, D. F.; Fox, S.; Ben-Jonathan, N.] Univ Cincinnati, Dept Canc Biol, Cincinnati, OH 45267 USA; [Tong, W.] Univ Cincinnati, Dept Pathol, Cincinnati, OH 45267 USA; [LaSance, K.] Univ Cincinnati, Dept Radiol, Cincinnati, OH 45267 USA; [Shaughnessy, E.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Ben-Jonathan, N (corresponding author), Univ Cincinnati, Dept Canc Biol, Coll Med, 3125 Eden Ave, Cincinnati, OH 45267 USA.	Nira.Ben-Jonathan@uc.edu	Hugo, Eric/ADA-3523-2022	Borcherding, Dana/0000-0002-8849-2139	NIH [CA096613, ES020909]; DOD [AR110050, BC122992]; University of Cincinnati Center for Clinical and Translational Science and Training (CCTST); Marlene Harris-Ride Cincinnati; NATIONAL CANCER INSTITUTE [R01CA096613, T32CA117846] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES020909, R01ES012212] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); University of Cincinnati Center for Clinical and Translational Science and Training (CCTST); Marlene Harris-Ride Cincinnati; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We dedicate this manuscript to Wilson Tong, M.D., whose untimely death was a major loss to all who knew him. We thank Dean Quaranta for technical assistance, and Drs Susan Waltz and Peter Stambrook for critical reviews of this manuscript. This investigation was funded by NIH grants CA096613 and ES020909, DOD grants AR110050 and BC122992, and pilot grants from Marlene Harris-Ride Cincinnati, and the University of Cincinnati Center for Clinical and Translational Science and Training (CCTST).	Almubarak M, 2009, ONCOLOGY-NY, V23, P255; Amenta F., 2002, Italian Journal of Anatomy and Embryology, V107, P145; Arcangeli S, 2013, J CEREBR BLOOD F MET, V33, P278, DOI 10.1038/jcbfm.2012.167; Azevedo MF, 2014, ENDOCR REV, V35, P195, DOI 10.1210/er.2013-1053; Basu S, 2004, CANCER RES, V64, P5551, DOI 10.1158/0008-5472.CAN-04-1600; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bodei S, 2009, N-S ARCH PHARMACOL, V379, P413, DOI 10.1007/s00210-008-0384-6; Borcherding DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025537; Carlo RD, 1986, ANN NY ACAD SCI, V464, P559, DOI DOI 10.1111/J.1749-6632.1986.TB16068.X; Chakroborty D, 2009, CANCER RES, V69, P3727, DOI 10.1158/0008-5472.CAN-08-4289; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Conole D, 2013, DRUGS, V73, P1967, DOI 10.1007/s40265-013-0149-5; Contreras F, 2002, J HUM HYPERTENS, V16, pS13, DOI 10.1038/sj.jhh.1001334; Dajani R, 1999, J BIOL CHEM, V274, P37862, DOI 10.1074/jbc.274.53.37862; Eisenhofer G, 1999, CLIN EXP PHARMACOL P, V26, pS41; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; FLAIM KE, 1985, LIFE SCI, V36, P1427, DOI 10.1016/0024-3205(85)90049-9; Ghosh D, 2007, CELL MOL LIFE SCI, V64, P2013, DOI 10.1007/s00018-007-7175-y; Goldstein DS, 1999, J CLIN ENDOCR METAB, V84, P2523, DOI 10.1210/jc.84.7.2523; GRANADOSPRINCIP.S, 2015, BREAST CANCER RES, V17, P527; Hoque KE, 2010, PSYCHOPHARMACOLOGY, V207, P571, DOI 10.1007/s00213-009-1687-0; JOHNSON DE, 1995, ANTI-CANCER DRUG, V6, P471, DOI 10.1097/00001813-199506000-00017; Li ZS, 2006, J NEUROSCI, V26, P2798, DOI 10.1523/JNEUROSCI.4720-05.2006; Lin DTS, 2010, SYNAPSE, V64, P460, DOI 10.1002/syn.20750; Maggio R, 2009, PARKINSONISM RELAT D, V15, pS2, DOI 10.1016/S1353-8020(09)70826-0; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moreno-Smith M, 2011, CLIN CANCER RES, V17, P3649, DOI 10.1158/1078-0432.CCR-10-2441; Murphy MB, 2001, NEW ENGL J MED, V345, P1548, DOI 10.1056/NEJMra010253; Natarajan A, 2010, J PHARMACOL EXP THER, V332, P640, DOI 10.1124/jpet.109.159871; Ng SSW, 2000, BRIT J PHARMACOL, V129, P853, DOI 10.1038/sj.bjp.0703119; Proskuryakov SY, 2010, CURR PHARM DESIGN, V16, P56, DOI 10.2174/138161210789941793; Rubi B, 2010, ENDOCRINOLOGY, V151, P5570, DOI 10.1210/en.2010-0745; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Sammut S, 2006, NEUROPSYCHOPHARMACOL, V31, P493, DOI 10.1038/sj.npp.1300826; Sarkar C, 2004, AM J PHYSIOL-HEART C, V287, pH1554, DOI 10.1152/ajpheart.00272.2004; Sarkar C, 2008, CLIN CANCER RES, V14, P2502, DOI 10.1158/1078-0432.CCR-07-1778; Sharma RK, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00056; Shen LH, J BIOMED BIOTECHNOL; Sidhu A, 2000, INT J DEV NEUROSCI, V18, P669, DOI 10.1016/S0736-5748(00)00033-2; Supuran CT, 2006, CURR PHARM DESIGN, V12, P3459, DOI 10.2174/138161206778343118; Wang PS, 2002, ARCH GEN PSYCHIAT, V59, P1147, DOI 10.1001/archpsyc.59.12.1147; WEBER RR, 1988, BRIT J CLIN PHARMACO, V25, P17, DOI 10.1111/j.1365-2125.1988.tb03276.x; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zhang L, 2006, BRAIN RES, V1118, P192, DOI 10.1016/j.brainres.2006.08.028; Zhao DL, 2007, NEUROPHARMACOLOGY, V53, P724, DOI 10.1016/j.neuropharm.2007.07.017; Zhu B, 2007, CURR TOP MED CHEM, V7, P437, DOI 10.2174/156802607779941198	48	57	68	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 16	2016	35	24					3103	3113		10.1038/onc.2015.369	http://dx.doi.org/10.1038/onc.2015.369			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO9GI	26477316	Green Accepted			2022-12-26	WOS:000378092700003
J	Roy, A; Dakroub, M; Tezini, GCSV; Liu, Y; Guatimosim, S; Feng, QP; Salgado, HC; Prado, VF; Prado, MAM; Gros, R				Roy, Ashbeel; Dakroub, Mouhamed; Tezini, Geisa C. S. V.; Liu, Yin; Guatimosim, Silvia; Feng, Qingping; Salgado, Helio C.; Prado, Vania F.; Prado, Marco A. M.; Gros, Robert			Cardiac acetylcholine inhibits ventricular remodeling and dysfunction under pathologic conditions	FASEB JOURNAL			English	Article						heart disease; choline acetyltransferase; heart failure; nonneuronal acetylcholine; VAChT	CONGESTIVE-HEART-FAILURE; RECEPTOR-DEFICIENT MICE; LONG-TERM SURVIVAL; ANGIOTENSIN-II; SYMPATHETIC CONTROL; INDUCED HYPERTROPHY; ACTIVATION; RESPONSES; VAGAL; STIMULATION	Autonomic dysfunction is a characteristic of cardiac disease and decreased vagal activity is observed in heart failure. Rodent cardiomyocytes produce de novo ACh, which is critical in maintaining cardiac homeostasis. We report that this nonneuronal cholinergic system is also found in human cardiomyocytes, which expressed choline acetyltransferase (ChAT) and the vesicular acetylcholine transporter (VAChT). Furthermore, VAChT expression was increased 3-and 1.5-fold at the mRNA and protein level, respectively, in ventricular tissue from patients with heart failure, suggesting increased ACh secretion in disease. We used mice with genetic deletion of cardiomyocyte specific VAChT or ChAT and mice overexpressing VAChT to test the functional significance of cholinergic signaling. Mice deficient for VAChT displayed an 8% decrease in fractional shortening and 13% decrease in ejection fraction compared with angiotensin II (Ang II)-treated control animals, suggesting enhanced ventricular dysfunction and pathologic remodeling in response to Ang II. Similar results were observed in ChAT-deficient mice. Conversely, no decline in ventricular function was observed in Ang II-treated VAChT overexpressors. Furthermore, the fibrotic area was significantly greater (P < 0.05) in Ang II-treated VAChT-deficient mice (3.61 6 0.64%) compared with wild-type animals (2.24 +/- 0.11%). In contrast, VAChT overexpressing mice did not display an increase in collagen deposition. Our results provide new insight into cholinergic regulation of cardiac function, suggesting that a compensatory increase in cardiomyocyte VAChT levels may help offset cardiac remodeling in heart failure.	[Roy, Ashbeel; Dakroub, Mouhamed; Prado, Vania F.; Prado, Marco A. M.; Gros, Robert] Univ Western Ontario, Robarts Res Inst, 1151 Richmond St N, London, ON N6A 5B7, Canada; [Roy, Ashbeel; Dakroub, Mouhamed; Liu, Yin; Feng, Qingping; Prado, Vania F.; Prado, Marco A. M.; Gros, Robert] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Feng, Qingping; Gros, Robert] Univ Western Ontario, Dept Med, London, ON, Canada; [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Tezini, Geisa C. S. V.; Salgado, Helio C.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Physiol, BR-14049 Ribeirao Preto, Brazil; [Guatimosim, Silvia] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Universidade de Sao Paulo; Universidade Federal de Minas Gerais	Prado, MAM; Gros, R (corresponding author), Univ Western Ontario, Robarts Res Inst, 1151 Richmond St N, London, ON N6A 5B7, Canada.	mprado@robarts.ca; rgros@robarts.ca	Guatimosim, Silvia/AAN-7441-2021; Prado, Marco Antonio Maximo/K-7638-2013; Gros, Robert/A-3010-2009; Gros, Robert/AAV-2237-2020; Prado, Vania/K-7630-2013	Guatimosim, Silvia/0000-0001-8386-3722; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Gros, Robert/0000-0002-3667-8011; Gros, Robert/0000-0002-3667-8011; Prado, Vania/0000-0003-4994-6393; Feng, Qingping/0000-0001-9739-2765	Heart and Stroke Foundation of Ontario [NA6656, G-13-0002843]; Canadian Institutes for Health Research [MOP-82756, MOP-89919]; Canadian Foundation for Innovation; Ontario Research Fund; U.S. National Institutes for Health Fogarty International Center [R03TW008425]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); Heart and Stroke Foundation of Canada; Ontario Graduate Scholarship; FAPESP; FOGARTY INTERNATIONAL CENTER [R03TW008425] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research Fund; U.S. National Institutes for Health Fogarty International Center; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Ontario Graduate Scholarship(Ontario Graduate Scholarship); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors thank M. Watson (Duke Human Heart Repository) for assistance in obtaining human HF samples. This work was supported by the Heart and Stroke Foundation of Ontario (NA6656 and G-13-0002843), Canadian Institutes for Health Research (MOP-82756 and MOP-89919), Canadian Foundation for Innovation, the Ontario Research Fund, and the U.S. National Institutes for Health Fogarty International Center Grant R03TW008425 to S.G. S.G. was supported by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais), and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). H.C.S. was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). R.G. was supported by a New Investigator Award from the Heart and Stroke Foundation of Canada. A.R. was supported by an Ontario Graduate Scholarship. G.C.S.V.T. received a FAPESP postdoctoral fellowship.	Beraldo FH, 2013, FASEB J, V27, P3594, DOI 10.1096/fj.13-232280; BINKLEY PF, 1991, J AM COLL CARDIOL, V18, P464, DOI 10.1016/0735-1097(91)90602-6; Braunwald E, 2000, CIRCULATION, V102, P14; Bravo DT, 2005, NEUROCHEM INT, V47, P243, DOI 10.1016/j.neuint.2005.05.002; Bravo DT, 2004, J NEUROCHEM, V91, P766, DOI 10.1111/j.1471-4159.2004.02746.x; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Coso OA, 1996, J BIOL CHEM, V271, P3963; Crittenden JR, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00057; DiPiro J., 2008, PHARMACOTHERAPY PATH, V1; Epelman S, 2015, NAT REV IMMUNOL, V15, P117, DOI 10.1038/nri3800; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Fujii T, 1996, J NEUROSCI RES, V44, P66, DOI 10.1002/(SICI)1097-4547(19960401)44:1<66::AID-JNR9>3.0.CO;2-G; Gavioli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100179; Goldenberg I, 2001, J HYPERTENS, V19, P1681, DOI 10.1097/00004872-200109000-00022; GRASSI G, 1995, CIRCULATION, V92, P3206, DOI 10.1161/01.CIR.92.11.3206; Grassi G, 2001, CLIN SCI, V101, P141, DOI 10.1042/CS20000326; Gutkind JS, 1997, LIFE SCI, V60, P999; Handa T, 2009, J CARD FAIL, V15, P805, DOI 10.1016/j.cardfail.2009.05.008; HASKING GJ, 1986, CIRCULATION, V73, P615, DOI 10.1161/01.CIR.73.4.615; Kakinuma Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004887; Kakinuma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050761; Kanazawa H, 2010, J CLIN INVEST, V120, P408, DOI 10.1172/JCI39778; KENT KM, 1974, CIRCULATION, V50, P948, DOI 10.1161/01.CIR.50.5.948; KINUGAWA T, 1995, AM J PHYSIOL-REG I, V268, pR310, DOI 10.1152/ajpregu.1995.268.2.R310; Kleinbongard P, 2011, HEART FAIL REV, V16, P49, DOI 10.1007/s10741-010-9180-8; Kolisnyk B, 2013, J NEUROSCI, V33, P10427, DOI 10.1523/JNEUROSCI.0395-13.2013; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Lataro RM, 2013, AM J PHYSIOL-REG I, V305, pR908, DOI 10.1152/ajpregu.00102.2013; Lau JK, 2013, CANCER RES, V73, P1328, DOI 10.1158/0008-5472.CAN-12-3190; Laursen JB, 1997, CIRCULATION, V95, P588, DOI 10.1161/01.CIR.95.3.588; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Li MH, 2013, CIRC J, V77, P2519, DOI 10.1253/circj.CJ-13-0476; Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999; Mann DL, 2015, CIRC RES, V116, P1254, DOI 10.1161/CIRCRESAHA.116.302317; Marano G, 1997, J HYPERTENS, V15, P1019, DOI 10.1097/00004872-199715090-00013; Marti CN, 2014, CIRC-HEART FAIL, V7, P5, DOI 10.1161/CIRCHEARTFAILURE.113.000344; MASSIE BM, 1988, J AM COLL CARDIOL, V12, P547, DOI 10.1016/0735-1097(88)90433-0; Nishiyama A, 2001, HYPERTENSION, V37, P77, DOI 10.1161/01.HYP.37.1.77; Nordstrom P, 2013, EUR HEART J, V34, P2585, DOI 10.1093/eurheartj/eht182; Oliverio MI, 1997, AM J PHYSIOL-RENAL, V272, pF515, DOI 10.1152/ajprenal.1997.272.4.F515; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Ren J, 2011, NEURON, V69, P445, DOI 10.1016/j.neuron.2010.12.038; RINNER I, 1993, J NEUROSCI RES, V35, P188, DOI 10.1002/jnr.490350209; Rocha-Resende C, 2012, J MOL CELL CARDIOL, V53, P206, DOI 10.1016/j.yjmcc.2012.05.003; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Roy A, 2014, MOL MED, V20, P527, DOI 10.2119/molmed.2014.00125; Roy A, 2013, FASEB J, V27, P5072, DOI 10.1096/fj.13-238279; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039997; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Schwartz PJ, 2008, EUR J HEART FAIL, V10, P884, DOI 10.1016/j.ejheart.2008.07.016; Shanmugam P, 2011, J MOL CELL CARDIOL, V50, P928, DOI 10.1016/j.yjmcc.2011.02.012; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Westermann D, 2011, CIRC-HEART FAIL, V4, P44, DOI 10.1161/CIRCHEARTFAILURE.109.931451; Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	57	23	23	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					688	701		10.1096/fj.15-277046	http://dx.doi.org/10.1096/fj.15-277046			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26481308	Green Published, Green Submitted			2022-12-26	WOS:000369391900020
J	Inada, M; Takita, M; Yokoyama, S; Watanabe, K; Tominari, T; Matsumoto, C; Hirata, M; Maru, Y; Maruyama, T; Sugimoto, Y; Narumiya, S; Uematsu, S; Akira, S; Murphy, G; Nagase, H; Miyaura, C				Inada, Masaki; Takita, Morichika; Yokoyama, Satoshi; Watanabe, Kenta; Tominari, Tsukasa; Matsumoto, Chiho; Hirata, Michiko; Maru, Yoshiro; Maruyama, Takayuki; Sugimoto, Yukihiko; Narumiya, Shuh; Uematsu, Satoshi; Akira, Shizuo; Murphy, Gillian; Nagase, Hideaki; Miyaura, Chisato			Direct Melanoma Cell Contact Induces Stromal Cell Autocrine Prostaglandin E2-EP4 Receptor Signaling That Drives Tumor Growth, Angiogenesis, and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; OSTEOCLAST DIFFERENTIATION; GENETIC DELETION; BONE-RESORPTION; E-2 PRODUCTION; EXPRESSION; EP4; LIGAND; FIBROBLASTS; OSTEOLYSIS	The stromal cells associated with tumors such as melanoma are significant determinants of tumor growth and metastasis. Using membrane-bound prostaglandin E synthase 1 (mPges1(-/-)) mice, we show that prostaglandin E-2 (PGE(2)) production by host tissues is critical for B16 melanoma growth, angiogenesis, and metastasis to both bone and soft tissues. Concomitant studies in vitro showed that PGE(2) production by fibroblasts is regulated by direct interaction with B16 cells. Autocrine activity of PGE(2) further regulates the production of angiogenic factors by fibroblasts, which are key to the vascularization of both primary and metastatic tumor growth. Similarly, cell-cell interactions between B16 cells and host osteoblasts modulate mPGES-1 activity and PGE(2) production by the osteoblasts. PGE(2), in turn, acts to stimulate receptor activator of NF-kappa B ligand expression, leading to osteoclast differentiation and bone erosion. Using eicosanoid receptor antagonists, we show that PGE(2) acts on osteoblasts and fibroblasts in the tumor microenvironment through the EP4 receptor. Metastatic tumor growth and vascularization in soft tissues was abrogated by an EP4 receptor antagonist. EP4-null Ptger4(-/-) mice do not support B16 melanoma growth. In vitro, an EP4 receptor antagonist modulated PGE(2) effects on fibroblast production of angiogenic factors. Our data show that B16 melanoma cells directly influence host stromal cells to generate PGE(2) signals governing neoangiogenesis and metastatic growth in bone via osteoclast erosive activity as well as angiogenesis in soft tissue tumors.	[Inada, Masaki; Takita, Morichika; Yokoyama, Satoshi; Watanabe, Kenta; Tominari, Tsukasa; Matsumoto, Chiho; Hirata, Michiko; Miyaura, Chisato] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Inada, Masaki; Tominari, Tsukasa; Murphy, Gillian; Nagase, Hideaki; Miyaura, Chisato] Tokyo Univ Agr & Technol, Global Innovat Res Org, Koganei, Tokyo 1848588, Japan; [Takita, Morichika; Maru, Yoshiro] Tokyo Womens Med Univ, Dept Pharmacol, Tokyo 1628666, Japan; [Maruyama, Takayuki] Ono Pharmaceut Co Ltd, Minase Res Inst, Osaka 6188585, Japan; [Sugimoto, Yukihiko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Chem, Kumamoto 8620973, Japan; [Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan; [Uematsu, Satoshi; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan; [Uematsu, Satoshi] Chiba Univ, Sch Med, Dept Mucosal Immunol, Chiba 2608670, Japan; [Uematsu, Satoshi] Univ Tokyo, Inst Med Sci, Ctr Mucosal Vaccines, Div Innate Immune Regulat Int Res & Dev, Tokyo 1088639, Japan; [Murphy, Gillian] Univ Cambridge, Li Ka Shing Ctr, Cambridge Inst, Dept Oncol,Canc Res UK, Cambridge CB2 0RE, England; [Nagase, Hideaki] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7FY, England	Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology; Tokyo Women's Medical University; Ono Pharmaceutical Co Ltd; Kumamoto University; Kyoto University; Osaka University; Chiba University; University of Tokyo; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Oxford	Miyaura, C (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Nakamachi, Koganei, Tokyo 1848588, Japan.	miyaura@cc.tuat.ac.jp	miyaura, chisato/D-1864-2013; Hirata, Michiko/D-2351-2013; Takita, Morichika/I-2927-2019; inada, masaki/D-1581-2013; Akira, Shizuo/C-3134-2009; Sugimoto, Yukihiko/AAV-6470-2021; Tominari, Tsukasa/B-6054-2015	miyaura, chisato/0000-0002-2548-8191; Hirata, Michiko/0000-0002-5291-6112; inada, masaki/0000-0002-5066-8506; Sugimoto, Yukihiko/0000-0001-6973-932X; Tominari, Tsukasa/0000-0001-5683-8951	National Institute of Health [AR40994]; Arthritis Research UK; Cancer Research UK; Global Innovation Research Organization in Tokyo University of Agriculture and Technology;  [25460062];  [23590069]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Research UK(Versus Arthritis); Cancer Research UK(Cancer Research UK); Global Innovation Research Organization in Tokyo University of Agriculture and Technology; ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research 25460062 (to C. M.) and 23590069 (to M. I.), National Institute of Health Grant AR40994 (to H. N.), Arthritis Research UK (to H. N.), Cancer Research UK (to G. M.), and the Global Innovation Research Organization in Tokyo University of Agriculture and Technology (to M. I. and H. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcolea S, 2012, J LIPID RES, V53, P630, DOI 10.1194/jlr.M019695; Amano H, 2003, J EXP MED, V197, P221, DOI 10.1084/jem.20021408; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Berger W, 1999, INT J CANCER, V83, P415, DOI 10.1002/(SICI)1097-0215(19991029)83:3<415::AID-IJC19>3.0.CO;2-Y; Brandner JM, 2013, PATHOLOGY, V45, P443, DOI 10.1097/PAT.0b013e328363b3bd; Brown JE, 2012, NAT REV CLIN ONCOL, V9, P110, DOI 10.1038/nrclinonc.2011.197; Elander N, 2008, BIOCHEM BIOPH RES CO, V372, P249, DOI 10.1016/j.bbrc.2008.05.026; Elder DJE, 1998, NAT MED, V4, P392, DOI 10.1038/nm0498-392; Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200; Giri D, 1999, CLIN CANCER RES, V5, P1063; Guo XY, 2008, J BIOL CHEM, V283, P19864, DOI 10.1074/jbc.M800798200; Hatazawa R., 2007, Inflammopharmacology, V15, P214, DOI 10.1007/s10787-007-1595-z; Holt DM, 2012, J IMMUNOTHER, V35, P179, DOI 10.1097/CJI.0b013e318247a5e9; Inada M, 2006, J IMMUNOL, V177, P1879, DOI 10.4049/jimmunol.177.3.1879; Jain S, 2008, CANCER RES, V68, P7750, DOI 10.1158/0008-5472.CAN-07-6689; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li HJ, 2012, CANCER DISCOV, V2, P840, DOI 10.1158/2159-8290.CD-12-0101; Lipton A, 2011, BONE, V48, P96, DOI 10.1016/j.bone.2010.10.161; Ma XR, 2006, CANCER RES, V66, P2923, DOI 10.1158/0008-5472.CAN-05-4348; MIYAURA C, 1995, J BONE MINER RES, V10, P1365; Miyaura C, 2000, J BIOL CHEM, V275, P19819, DOI 10.1074/jbc.M002079200; Morony S, 2001, CANCER RES, V61, P4432; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nakanishi M, 2008, CANCER RES, V68, P3251, DOI 10.1158/0008-5472.CAN-07-6100; Ohshiba T, 2003, BRIT J CANCER, V88, P1318, DOI 10.1038/sj.bjc.6600858; Ohshiba T, 2003, BIOCHEM BIOPH RES CO, V300, P957, DOI 10.1016/S0006-291X(02)02937-6; Plotkin LI, 2015, CURR OSTEOPOROS REP, V13, P67, DOI 10.1007/s11914-015-0255-2; Polnaszek N, 2003, CANCER RES, V63, P5754; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Relf M, 1997, CANCER RES, V57, P963; Ristimaki A, 2002, CANCER RES, V62, P632; Rundhaug JE, 2011, CANCER METAST REV, V30, P465, DOI 10.1007/s10555-011-9317-9; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Suzawa T, 2000, ENDOCRINOLOGY, V141, P1554, DOI 10.1210/en.141.4.1554; Takita M, 2007, FEBS LETT, V581, P565, DOI 10.1016/j.febslet.2007.01.005; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wicki A, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13550; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wu JJ, 2011, J BIOL CHEM, V286, P33954, DOI 10.1074/jbc.M110.187344; Yang L, 2006, CANCER RES, V66, P9665, DOI 10.1158/0008-5472.CAN-06-1271; Yang SF, 2010, J BIOL CHEM, V285, P29808, DOI 10.1074/jbc.M110.108183; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhang J, 2003, CANCER RES, V63, P7883	46	27	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29781	29793		10.1074/jbc.M115.669481	http://dx.doi.org/10.1074/jbc.M115.669481			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26475855	hybrid, Green Published			2022-12-26	WOS:000366614700013
J	Goto, H; Ishihara, Y; Kikuchi, T; Izawa, A; Ozeki, N; Okabe, E; Kamiya, Y; Ozawa, Y; Mizutani, H; Yamamoto, G; Mogi, M; Nakata, K; Maeda, H; Noguchi, T; Mitani, A				Goto, Hisashi; Ishihara, Yuichi; Kikuchi, Takeshi; Izawa, Ario; Ozeki, Nobuaki; Okabe, Eijiro; Kamiya, Yosuke; Ozawa, Yusuke; Mizutani, Hiroki; Yamamoto, Genta; Mogi, Makio; Nakata, Kazuhiko; Maeda, Hatsuhiko; Noguchi, Toshihide; Mitani, Akio			Interleukin-1 Receptor Antagonist Has a Novel Function in the Regulation of Matrix Metalloproteinase-13 Expression	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; DEFICIENT MICE; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; RHEUMATOID-ARTHRITIS; LAMININ-5; MIGRATION; PERIODONTITIS; IL-1-BETA; IL-1RA	Interleukin-1 receptor antagonist (IL-1Ra) is an IL-1 family member, which binds to IL-1 receptors but does not induce any intracellular signaling. We addressed whether IL-1Ra has a novel function in regulation of the extracellular matrix or adhesion molecules. Polymerase chain reaction array analysis demonstrated a similar to 5-fold increase in matrix metalloproteinase 13 (MMP-13) mRNA expression of IL-1Ra siRNA-transfected Ca9-22 human oral squamous epithelial carcinoma cells compared with the control. In fact, MMP-13 mRNA and protein expression as well as its activity in IL-1Ra siRNA-transfected Ca9-22 cell lines were significantly higher than those in the control. IL-1Ra siRNA treatment resulted in strong elevation of MMP-13 expression, whereas addition of rhIL-1Ra (40 ng/ml) suppressed MMP-13 expression, suggesting that IL-1Ra had a specific effect on MMP-13 induction. IL-1Ra siRNA could potently suppress IL-1 alpha. No significant difference was found between the MMP-13 mRNA expression of IL-1Ra siRNA-transfected cells and those treated with antiI-L-1 alpha or anti-IL-1 beta antibodies. These results suggested that continuous supply of IL-1 had no effect on the induction of MMP-13 by IL-1Ra siRNA. Histopathological investigation of MMP-13 in periodontal tissue showed specific localization in the junctional epithelial cells of IL-1Ra knockout (KO) mice. Furthermore, infection with Aggregatibacter actinomycetemcomitans to establish an experimental periodontitis model resulted in predominant localization of MMP-13 along apical junctional epithelial cells. Laminin-5, which is degraded by MMP-13, was found in the internal basal lamina of wild-type mice, whereas the internal basal lamina of IL-1Ra KO mice did not show obvious laminin-5 localization. In particular, laminin-5 localization almost disappeared in the internal basal lamina of IL-1Ra KO mice infected with A. actinomycetemcomitans, suggesting that the suppression of IL-1Ra resulted in strong induction of MMP-13 that degraded laminin-5. In conclusion, IL-1Ra is associated with MMP-13 expression and has a novel function in such regulation without interference of the IL-1 signaling cascade.	[Goto, Hisashi; Kikuchi, Takeshi; Izawa, Ario; Okabe, Eijiro; Kamiya, Yosuke; Ozawa, Yusuke; Mizutani, Hiroki; Yamamoto, Genta; Noguchi, Toshihide; Mitani, Akio] Aichi Gakuin Univ, Dept Periodontol, Sch Dent, Chikusa Ku, Nagoya, Aichi 464, Japan; [Ishihara, Yuichi] Matsumoto Dent Univ, Dept Operat Dent Endodontol & Periodontol, Sch Dent, Nagano, Japan; [Ozeki, Nobuaki; Nakata, Kazuhiko] Aichi Gakuin Univ, Dept Endodont, Sch Dent, Chikusa Ku, Nagoya, Aichi 464, Japan; [Mogi, Makio] Aichi Gakuin Univ, Dept Med Biochem, Sch Pharm, Chikusa Ku, Nagoya, Aichi 464, Japan; [Maeda, Hatsuhiko] Aichi Gakuin Univ, Dept Pathol, Sch Dent, Chikusa Ku, Nagoya, Aichi 464, Japan	Aichi Gakuin University; Matsumoto Dental University; Aichi Gakuin University; Aichi Gakuin University; Aichi Gakuin University	Kikuchi, T (corresponding author), Aichi Gakuin Univ, Dept Periodontol, Sch Dent, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	tkikuchi@dpc.aichi-gakuin.ac.jp		Kikuchi, Takeshi/0000-0003-0310-5302	Japan Society for the Promotion of Science KAKENHI [24593137, 15K11402]; Grants-in-Aid for Scientific Research [15K11402, 26463149] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science KAKENHI (grant number: 24593137, 15K11402), http:/www.jsps.go.jp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Assirelli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096925; Atsuta I, 2005, BIOMATERIALS, V26, P6280, DOI 10.1016/j.biomaterials.2005.03.046; BRENNAN FM, 1989, LANCET, V2, P244; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Horikoshi M, 1974, Nihon Koku Geka Gakkai Zasshi, V20, P100; Hormia M, 1998, J DENT RES, V77, P1479, DOI 10.1177/00220345980770070201; Ilgenli T, 2006, ORAL DIS, V12, P573, DOI 10.1111/j.1601-0825.2006.01244.x; Ishihara Y, 1997, J PERIODONTAL RES, V32, P524, DOI 10.1111/j.1600-0765.1997.tb00568.x; Izawa A, 2014, INFECT IMMUN, V82, P1904, DOI 10.1128/IAI.01618-13; Kinumatsu T, 2009, J PERIODONTAL RES, V44, P13, DOI 10.1111/j.1600-0765.2007.01036.x; Kothapalli R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012494; Kriebel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078226; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; MARSH CB, 1994, AM J PHYSIOL, V267, pL39, DOI 10.1152/ajplung.1994.267.1.L39; Mizutani H, 2013, J PERIODONTAL RES, V48, P748, DOI 10.1111/jre.12065; Oksanen J, 2001, J DENT RES, V80, P2093, DOI 10.1177/00220345010800121401; Pirila E, 2003, BIOCHEM BIOPH RES CO, V303, P1012, DOI 10.1016/S0006-291X(03)00452-2; Rawlinson A, 2000, J CLIN PERIODONTOL, V27, P738, DOI 10.1034/j.1600-051x.2000.027010738.x; Somm E, 2005, DIABETES, V54, P3503, DOI 10.2337/diabetes.54.12.3503; Toker H, 2008, J CLIN PERIODONTOL, V35, P507, DOI 10.1111/j.1600-051X.2008.01213.x; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Zijnge V, 2012, FRONT ORAL BIOL, V15, P1, DOI 10.1159/000329667	25	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140942	10.1371/journal.pone.0140942	http://dx.doi.org/10.1371/journal.pone.0140942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474296	Green Published, gold			2022-12-26	WOS:000363185500131
J	Janssen, S; Wieten, RW; Stolp, S; Cremers, AL; Rossatanga, EG; Klipstein-Grobusch, K; Belard, S; Grobusch, MP				Janssen, Saskia; Wieten, Rosanne Willemijn; Stolp, Sebastiaan; Cremers, Anne Lia; Rossatanga, Elie Gide; Klipstein-Grobusch, Kerstin; Belard, Sabine; Grobusch, Martin Peter			Factors Associated with Retention to Care in an HIV Clinic in Gabon, Central Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; FOLLOW-UP; EARLY INITIATION; ADHERENCE; INFECTION; BARRIERS; UGANDA; TRIAL; INTERVENTIONS	Background Retention to HIV care is vital for patients' survival, to prevent onward transmission and emergence of drug resistance. Travelling to receive care might influence adherence. Data on the functioning of and retention to HIV care in the Central African region are limited. Methods This retrospective study reports outcomes and factors associated with retention to HIV care at a primary HIV clinic in Lambarene, Gabon. Adult patients who presented to this clinic between January 2010 and January 2012 were included. Outcomes were retention in care (defined as documented show-up for clinical visits, regardless of delay) or LTFU (defined as a patient not retained in care; on ART or ART naive, not returning to care during the study period with a patient delay for scheduled visits of more than 6 months), and mortality. Cox regression analysis was used to assess factors associated with respective outcomes. Qualitative data on reasons for LTFU were obtained from focus-group discussions. Results Of 223 patients included, 67.3% were female. The mean age was 40.5 (standard deviation 11.4) years and the median CD4 count 275 (interquartile range 100.5-449.5) cells/mu L. In total, 34.1% were lost to follow up and 8.1% died. Documented tuberculosis was associated with increased risk of being LTFU (adjusted hazard ratio (aHR) 1.80, 95% confidence interval (95% CI) 1.05-3.11, P = 0.03), whereas early starting anti-retroviral therapy (ART) was associated with a decreased risk of LTFU (aHR 0.43, 95% CI 0.24-0.76, P = 0.004), as was confirmed by qualitative data. Conclusions Retention to HIV care in a primary clinic in Gabon is relatively poor and interventions to address this should be prioritized in the HIV program. Early initiation of ART might improve retention in care.	[Janssen, Saskia; Wieten, Rosanne Willemijn; Stolp, Sebastiaan; Cremers, Anne Lia; Belard, Sabine; Grobusch, Martin Peter] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis,Div Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Janssen, Saskia; Rossatanga, Elie Gide] Ctr Traitement Ambulatoire, Lambarene, Gabon; [Janssen, Saskia; Stolp, Sebastiaan; Cremers, Anne Lia; Belard, Sabine; Grobusch, Martin Peter] Ctr Rech Med Lambarene CERMEL, Lambarene, Gabon; [Janssen, Saskia; Belard, Sabine; Grobusch, Martin Peter] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Janssen, Saskia; Grobusch, Martin Peter] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa; [Klipstein-Grobusch, Kerstin] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Div Epidemiol, Johannesburg, South Africa; [Belard, Sabine] Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Eberhard Karls University of Tubingen; University of Cape Town; Utrecht University; Utrecht University Medical Center; University of Witwatersrand; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Janssen, S (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis,Div Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.janssen@amc.uva.nl	Klipstein-Grobusch, Kerstin/F-5555-2016; Bélard, Sabine/J-9557-2019	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Bélard, Sabine/0000-0002-2008-418X; Janssen, Saskia/0000-0003-0966-3233				Adane AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078791; Adegnika AA, 2014, ANTIMICROB AGENTS CH, V58, P2535, DOI 10.1128/AAC.01317-13; Anglemyer A, 2014, AIDS, V28, pS105, DOI 10.1097/QAD.0000000000000232; Bekolo Cavin Epie, 2013, BMC Res Notes, V6, P512, DOI 10.1186/1756-0500-6-512; Berheto TM, 2014, N AM J MED SCI, V6, P453, DOI 10.4103/1947-2714.141636; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cremers AL, 2013, PUBLIC HLTH ACTION, V3; Curran K, 2014, AIDS, V28, P227, DOI 10.1097/QAD.0000000000000025; DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, 2015, GUIDELINES USE ANTIR; Fleishman JA, 2012, JAIDS-J ACQ IMM DEF, V60, P249, DOI 10.1097/QAI.0b013e318258c696; Ghidei L, 2013, DRUG AGING, V30, P809, DOI 10.1007/s40266-013-0107-7; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; Govindasamy D, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19032; Kalichman SC, 2013, JAIDS-J ACQ IMM DEF, V63, P42, DOI 10.1097/QAI.0b013e318286ce49; Kisambu J, 2014, INT J TUBERC LUNG D, V18, P799, DOI 10.5588/ijtld.13.0753; Lankowski AJ, 2014, AIDS BEHAV, V18, P1199, DOI 10.1007/s10461-014-0729-8; Lanoy E, 2006, J CLIN EPIDEMIOL, V59, P829, DOI 10.1016/j.jclinepi.2005.11.024; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Mills EJ, 2012, LANCET INFECT DIS, V12, P97, DOI 10.1016/S1473-3099(11)70354-1; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Mutasa-Apollo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086305; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Olupot-Olupot P, 2008, AIDS, V22, P1882, DOI 10.1097/QAD.0b013e3283112ba6; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Scanlon ML, 2013, HIV AIDS-RES PALLIAT, V5, P1, DOI 10.2147/HIV.S28912; Scott CA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-296; Senkomago V, 2011, AIDS CARE, V23, P1246, DOI 10.1080/09540121.2011.564112; Spaar A, 2010, AIDS CARE, V22, P775, DOI 10.1080/09540120903349102; Taylor BS, 2011, MT SINAI J MED, V78, P342, DOI 10.1002/msj.20255; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; UNAIDS, 2013, REP GLOB AIDS EP; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2013, CONGUID UANT DRU	36	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140746	10.1371/journal.pone.0140746	http://dx.doi.org/10.1371/journal.pone.0140746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473965	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500098
J	Sommer, G; Gianinazzi, ME; Kuonen, R; Bohlius, J; l'Allemand, D; Hauschild, M; Mullis, PE; Kuehni, CE				Sommer, Grit; Gianinazzi, Micol E.; Kuonen, Rahel; Bohlius, Julia; l'Allemand, Dagmar; Hauschild, Michael; Mullis, Primus-Eugen; Kuehni, Claudia E.		Swiss Soc Paediat Endocrinology	Health-Related Quality of Life of Young Adults Treated with Recombinant Human Growth Hormone during Childhood	PLOS ONE			English	Article							IDIOPATHIC SHORT STATURE; ONSET CRANIOPHARYNGIOMA; DEFICIENT PATIENTS; CANCER SURVIVORS; GH REPLACEMENT; THERAPY; DISCONTINUATION; ADOLESCENTS; TRANSITION; STANDARDS	Background Since recombinant human growth hormone (rhGH) became available in 1985, the spectrum of indications has broadened and the number of treated patients increased. However, long-term health-related quality of life (HRQoL) after childhood rhGH treatment has rarely been documented. We assessed HRQoL and its determinants in young adults treated with rhGH during childhood. Methodology/Principal Findings For this study, we retrospectively identified former rhGH patients in 11 centers of paediatric endocrinology, including university hospitals and private practices. We sent a questionnaire to all patients treated with rhGH for any diagnosis, who were older than 18 years, and who resided in Switzerland at time of the survey. Three hundred participants (58% of 514 eligible) returned the questionnaire. Mean age was 23 years; 56% were women; 43% had isolated growth hormone deficiency, or idiopathic short stature; 43% had associated diseases or syndromes, and 14% had growth hormone deficiency after childhood cancer. Swiss siblings of childhood cancer survivors and the German norm population served as comparison groups. HRQoL was assessed using the Short Form-36. We found that the Physical Component Summary of healthy patients with isolated growth hormone deficiency or idiopathic short stature resembled that of the control group (53.8 vs. 54.9). Patients with associated diseases or syndromes scored slightly lower (52.5), and former cancer patients scored lowest (42.6). The Mental Component Summary was similar for all groups. Lower Physical Component Summary was associated with lower educational level (coeff. -1.9). Final height was not associated with HRQoL. Conclusions/Significance In conclusion, HRQoL after treatment with rhGH in childhood depended mainly on the underlying indication for rhGH treatment. Patients with isolated growth hormone deficiency/idiopathic short stature or patients with associated diseases or syndromes had HRQoL comparable to peers. Patients with growth hormone deficiency after childhood cancer were at high risk for lower HRQoL. This reflects the general impaired health of this vulnerable group, which needs long-term follow-up.	[Sommer, Grit; Gianinazzi, Micol E.; Kuonen, Rahel; Bohlius, Julia; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [l'Allemand, Dagmar] Ostschweizer Sauglings & Kinderspital, Div Paediat Endocrinol & Diabetol, Clin Adolescent Med, CH-9007 St Gallen, Switzerland; [Hauschild, Michael] Univ Hosp, Dept Paediat, Div Paediat Endocrinol Diabetol & Obes, Lausanne, Switzerland; [Mullis, Primus-Eugen] Univ Childrens Hosp Bern, Div Paediat Endocrinol Diabetol & Metab, Inselspital, Bern, Switzerland	University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern	Kuehni, CE (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	claudia.kuehni@ispm.unibe.ch	Hauschild, Michael/AAZ-6990-2021	Hauschild, Michael/0000-0002-1940-8730; Bohlius, Julia/0000-0003-1955-1585; Kuehni, Claudia E./0000-0001-8957-2002	Swiss Cancer League [KLS-02586-02-2010, KLS-2948-02-2012]; 7th framework program of the European Union [HEALTH-F2-2009-223497]; Pfizer AG [WI172069]; Novo Nordisk Pharma AG; Sandoz Pharmaceuticals AG	Swiss Cancer League; 7th framework program of the European Union(European Commission); Pfizer AG; Novo Nordisk Pharma AG(Novo Nordisk); Sandoz Pharmaceuticals AG	This study was supported by the Swiss Cancer League (http://www.krebsliga.ch; KLS-02586-02-2010; KLS-2948-02-2012), the 7th framework program of the European Union (http://ec.europa.eu/research/fp7/index_en.cfm; Grant Agreement Number HEALTH-F2-2009-223497 (SAGhE)), Pfizer AG (www.pfizer.com; WI172069), Novo Nordisk Pharma AG (http://www.novonordisk.com), and Sandoz Pharmaceuticals AG (http://www.sandoz.com). All funding was granted to PEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson E, 2010, J CLIN ENDOCR METAB, V95, P1355, DOI 10.1210/jc.2009-1754; Armstrong GT, 2010, EUR J PAEDIATR NEURO, V14, P298, DOI 10.1016/j.ejpn.2009.12.006; Attanasio AF, 2005, J CLIN ENDOCR METAB, V90, P4525, DOI 10.1210/jc.2005-0439; Bannink EMN, 2006, J PEDIATR-US, V148, P95, DOI 10.1016/j.jpeds.2005.08.043; Bowling A, 1999, J PUBLIC HEALTH MED, V21, P255, DOI 10.1093/pubmed/21.3.255; Brutt AL, 2009, HORM RES, V72, P65, DOI 10.1159/000232158; Bullinger M, 2009, HORM RES, V72, P74, DOI 10.1159/000232159; Carel JC, 2005, J CLIN ENDOCR METAB, V90, P1992, DOI 10.1210/jc.2004-1395; Christensen TL, 2007, CLIN ENDOCRINOL, V67, P407, DOI 10.1111/j.1365-2265.2007.02901.x; Coste J, 2012, J CLIN ENDOCR METAB, V97, P3231, DOI 10.1210/jc.2012-1543; Ellert U, 1999, Gesundheitswesen, V61 Spec No, pS184; Furnee CA, 2008, EUR J PUBLIC HEALTH, V18, P417, DOI 10.1093/eurpub/ckn028; Hazem A, 2012, EUR J ENDOCRINOL, V166, P13, DOI 10.1530/EJE-11-0558; Hoybye C, 2015, BEST PRACT RES CL EN, V29, P115, DOI 10.1016/j.beem.2014.09.006; Kendall-Taylor P, 2005, EUR J ENDOCRINOL, V152, P557, DOI 10.1530/eje.1.01877; Kuehni CE, 2012, INT J EPIDEMIOL, V41, P1553, DOI 10.1093/ije/dyr142; Kuehni CE, 2012, CANCER-AM CANCER SOC, V118, P1439, DOI 10.1002/cncr.26418; Lagrou K, 2001, J Pediatr Endocrinol Metab, V14 Suppl 5, P1249; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Rekers-Mombarg LTM, 1998, ACTA PAEDIATR, V87, P865, DOI 10.1080/080352598750013653; ROBINSON LD, 1991, BIOMETRICS, V47, P342; Rueegg CS, 2013, J CANCER SURVIV, V7, P511, DOI 10.1007/s11764-013-0288-4; Sandberg DE, 1998, J CLIN ENDOCR METAB, V83, P1134, DOI 10.1210/jc.83.4.1134; Sommer R, 2015, EUR J PEDIATR, V174, P875, DOI 10.1007/s00431-014-2480-6; Stabler B, 2001, HORM RES, V56, P55, DOI 10.1159/000048136; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Stouthart PJHM, 2003, PSYCHONEUROENDOCRINO, V28, P612, DOI 10.1016/S0306-4530(02)00045-8; STRACK F, 1990, BRIT J SOC PSYCHOL, V29, P303, DOI 10.1111/j.2044-8309.1990.tb00912.x; Taback SP, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-49; Vahl N, 2000, J CLIN ENDOCR METAB, V85, P1874, DOI 10.1210/jc.85.5.1874; Visser-van Balen H, 2008, HORM RES, V69, P172, DOI 10.1159/000112591; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Wengenroth L, 2014, PEDIATR BLOOD CANCER, V61, P538, DOI 10.1002/pbc.24821; Wiren L, 2001, J CLIN ENDOCR METAB, V86, P3494, DOI 10.1210/jc.86.8.3494; Wit JM, 2007, HORM RES, V68, pVII; Yuen KCJ, 2013, EUR J ENDOCRINOL, V169, P511, DOI 10.1530/EJE-13-0280	37	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140944	10.1371/journal.pone.0140944	http://dx.doi.org/10.1371/journal.pone.0140944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0DF	26474398	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500132
J	Wang, XH; Li, LH; Xu, T; Ding, ZX				Wang, Xun-Heng; Li, Lihua; Xu, Tao; Ding, Zhongxiang			Investigating the Temporal Patterns within and between Intrinsic Connectivity Networks under Eyes-Open and Eyes-Closed Resting States: A Dynamical Functional Connectivity Study Based on Phase Synchronization	PLOS ONE			English	Article							DEFAULT MODE NETWORK; HUMAN BRAIN; ACTIVATION; CHARACTERIZE; RELIABILITY; COHERENCE; IMPACT; HUBS	The brain active patterns were organized differently under resting states of eyes open (EO) and eyes closed (EC). The altered voxel-wise and regional-wise resting state active patterns under EO/EC were found by static analysis. More importantly, dynamical spontaneous functional connectivity has been observed in the resting brain. To the best of our knowledge, the dynamical mechanisms of intrinsic connectivity networks (ICNs) under EO/EC remain largely unexplored. The goals of this paper were twofold: 1) investigating the dynamical intra-ICN and inter-ICN temporal patterns during resting state; 2) analyzing the altered dynamical temporal patterns of ICNs under EO/EC. To this end, a cohort of healthy subjects with scan conditions of EO/EC were recruited from 1000 Functional Connectomes Project. Through Hilbert transform, time-varying phase synchronization (PS) was applied to evaluate the inter-ICN synchrony. Meanwhile, time-varying amplitude was analyzed as dynamical intra-ICN temporal patterns. The results found six micro-states of inter-ICN synchrony. The medial visual network (MVN) showed decreased intra-ICN amplitude during EC relative to EO. The sensory-motor network (SMN) and auditory network (AN) exhibited enhanced intra-ICN amplitude during EC relative to EO. Altered inter-ICN PS was found between certain ICNs. Particularly, the SMN and AN exhibited enhanced PS to other ICNs during EC relative to EO. In addition, the intra-ICN amplitude might influence the inter-ICN synchrony. Moreover, default mode network (DMN) might play an important role in information processing during EO/EC. Together, the dynamical temporal patterns within and between ICNs were altered during different scan conditions of EO/EC. Overall, the dynamical intra-ICN and inter-ICN temporal patterns could benefit resting state fMRI-related research, and could be potential biomarkers for human functional connectome.	[Wang, Xun-Heng; Li, Lihua; Xu, Tao] Hangzhou Dianzi Univ, Coll Life Informat Sci & Instrument Engn, Hangzhou 310018, Zhejiang, Peoples R China; [Ding, Zhongxiang] Zhejiang Prov Peoples Hosp, Dept Radiol, Hangzhou 310014, Zhejiang, Peoples R China	Hangzhou Dianzi University; Zhejiang Provincial People's Hospital	Wang, XH (corresponding author), Hangzhou Dianzi Univ, Coll Life Informat Sci & Instrument Engn, Hangzhou 310018, Zhejiang, Peoples R China.	xhwang@hdu.edu.cn; lilh@hdu.edu.cn			973 Program [2013CB329502]; National Natural Science Foundation of China [61271063, 61402142, 30770594]; National Distinguished Young Research Scientist Award [60788101]; Zhejiang Provincial Natural Science Foundation of China [LZ15F010001]; Science Foundation from Health Commission of Zhejiang Province [2013RCA001]; National High Technology Program of China [2008AA02Z405]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Distinguished Young Research Scientist Award; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Science Foundation from Health Commission of Zhejiang Province; National High Technology Program of China(National High Technology Research and Development Program of China)	XHW is supported by 973 Program (2013CB329502). LL is supported by the grants from 973 Program (2013CB329502), National Natural Science Foundation of China (61271063), National Distinguished Young Research Scientist Award (60788101), Zhejiang Provincial Natural Science Foundation of China (LZ15F010001). TX is supported by National Natural Science Foundation of China (61402142). ZD is supported by The Science Foundation from Health Commission of Zhejiang Province (2013RCA001). Financial support for the data used in this project was provided by a grant from the National Natural Science Foundation of China: 30770594 and a grant from the National High Technology Program of China (863): 2008AA02Z405.	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Beckmann C., 2009, NEUROIMAGE, V47, pS148, DOI [10.1016/S1053-8119(09)71511-3, DOI 10.1016/S1053-8119(09)71511-3, 10.1016/s1053-8119(09)71511-3]; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Di X, 2015, BRAIN STRUCT FUNCT, V220, P37, DOI 10.1007/s00429-013-0634-3; Diedenhofen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121945; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Florin E, 2015, NEUROIMAGE, V111, P26, DOI 10.1016/j.neuroimage.2015.01.054; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fraley C, 2003, J CLASSIF, V20, P263, DOI 10.1007/s00357-003-0015-3; Ganzetti M, 2013, NEUROSCIENCE, V240, P297, DOI 10.1016/j.neuroscience.2013.02.032; Glerean E, 2012, BRAIN CONNECT, V2, P91, DOI 10.1089/brain.2011.0068; Hutchison RM, 2013, HUM BRAIN MAPP, V34, P2154, DOI 10.1002/hbm.22058; Jao T, 2013, NEUROIMAGE, V69, P21, DOI 10.1016/j.neuroimage.2012.12.007; Jin SH, 2014, J NEUROPHYSIOL, V111, P1455, DOI 10.1152/jn.00585.2013; Kucyi A, 2014, NEUROIMAGE, V100, P471, DOI 10.1016/j.neuroimage.2014.06.044; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Laird AR, 2002, HUM BRAIN MAPP, V16, P71, DOI 10.1002/hbm.10027; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Lei X, 2013, NEUROIMAGE, V74, P52, DOI 10.1016/j.neuroimage.2013.02.020; Liang BS, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00645; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Liu DQ, 2013, NEUROINFORMATICS, V11, P469, DOI 10.1007/s12021-013-9187-0; Liu DQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00024; Liu ZM, 2010, NEUROIMAGE, V51, P102, DOI 10.1016/j.neuroimage.2010.01.092; Marx E, 2004, NEUROIMAGE, V21, P1818, DOI 10.1016/j.neuroimage.2003.12.026; McDonough IM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00409; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Niso G, 2013, NEUROINFORMATICS, V11, P405, DOI 10.1007/s12021-013-9186-1; Patriat R, 2013, NEUROIMAGE, V78, P463, DOI 10.1016/j.neuroimage.2013.04.013; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rangaprakash D, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065713500032; Riedl V, 2014, J NEUROSCI, V34, P6260, DOI 10.1523/JNEUROSCI.0492-14.2014; Rokach L, 2005, DATA MINING AND KNOW, P321; Sadaghiani S, 2012, J NEUROSCI, V32, P14305, DOI 10.1523/JNEUROSCI.1358-12.2012; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sun JF, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046219; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Tong YJ, 2013, NEUROIMAGE, V76, P202, DOI 10.1016/j.neuroimage.2013.03.019; Wang X, 2013, NEUROSCIENCE, V254, P404, DOI 10.1016/j.neuroscience.2013.09.009; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wu WC, 2014, NMR BIOMED, V27, P444, DOI 10.1002/nbm.3080; Xu PF, 2014, NEUROIMAGE, V90, P246, DOI 10.1016/j.neuroimage.2013.12.060; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Yang Z, 2014, NEUROIMAGE, V93, P124, DOI 10.1016/j.neuroimage.2014.02.014; Yuan BK, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00503; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang DL, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/Inhum.2015.00081, 10.3389/fnhum.2015.00081]; Zou QH, 2015, NEUROIMAGE, V121, P91, DOI 10.1016/j.neuroimage.2015.07.044; Zou QH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121757; Zuo XN, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.49; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	56	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140300	10.1371/journal.pone.0140300	http://dx.doi.org/10.1371/journal.pone.0140300			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469182	gold, Green Published, Green Submitted			2022-12-26	WOS:000363184600037
J	Sundby, S; Kristiansen, T				Sundby, Svein; Kristiansen, Trond			The Principles of Buoyancy in Marine Fish Eggs and Their Vertical Distributions across the World Oceans	PLOS ONE			English	Article							COD GADUS-MORHUA; ANCHOVY ENGRAULIS-ENCRASICOLUS; PLEURONECTES-PLATESSA L; ONE-DIMENSIONAL MODEL; NORTHERN BENGUELA; EMBRYONIC-DEVELOPMENT; GREENLAND HALIBUT; THERMAL-EXPANSION; SALT BALANCE; ST-LAWRENCE	Buoyancy acting on plankton, i.e. the difference in specific gravity between plankton and the ambient water, is a function of salinity and temperature. From specific gravity measurements of marine fish eggs salinity appears to be the only determinant of the buoyancy indicating that the thermal expansions of the fish egg and the ambient seawater are equal. We analyze the mechanisms behind thermal expansion in fish eggs in order to determine to what extent it can be justified to neglect the effects of temperature on buoyancy. Our results confirm the earlier assumptions that salinity is the basic determinant on buoyancy in marine fish eggs that, in turn, influence the vertical distributions and, consequently, the dispersal of fish eggs from the spawning areas. Fish populations have adapted accordingly by producing egg specific gravities that tune the egg buoyancy to create specific vertical distributions for each local population. A wide variety of buoyancy adaptations are found among fish populations. The ambient physical conditions at the spawning sites form a basic constraint for adaptation. In coastal regions where salinity increases with depth, and where the major fraction of the fish stocks spawns, pelagic and mesopelagic egg distributions dominate. However, in the larger part of worlds' oceans salinity decreases with depth resulting in different egg distributions. Here, the principles of vertical distributions of fish eggs in the world oceans are presented in an overarching framework presenting the basic differences between regions, mainly coastal, where salinity increases with depth and the major part of the world oceans where salinity decreases with depth. We show that under these latter conditions, steady-state vertical distribution of mesopelagic fish eggs cannot exist as it does in most coastal regions. In fact, a critical spawning depth must exist where spawning below this depth threshold results in eggs sinking out of the water column and become lost for recruitment to the population. An example of adaptation to such conditions is Cape hake spawning above the critical layer in the Northern Benguela upwelling ecosystem. The eggs rise slowly in the onshore subsurface current below the Ekman layer, hence being advected inshore where the hatched larvae concentrate with optimal feeding conditions.	[Sundby, Svein] Inst Marine Res, N-5817 Bergen, Norway; Hjort Ctr Marine Ecosyst Dynam, N-5817 Bergen, Norway	Institute of Marine Research - Norway	Sundby, S (corresponding author), Inst Marine Res, POB 1870 Nordnes, N-5817 Bergen, Norway.	svein.sundby@imr.no		Sundby, Svein/0000-0002-0815-9740; Kristiansen, Trond/0000-0001-6121-297X	Research Council of Norway; Statoil	Research Council of Norway(Research Council of Norway); Statoil	This work was supported by the Research Council of Norway (http://www.forskningsradet.no/en/Home_page/1177315753906): SS and Statoil (http://www.statoil.com/en/Pages/default.aspx): SS TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlandsvik B, 2001, FISH RES, V50, P59, DOI 10.1016/S0165-7836(00)00242-3; Ahlstrom E. H., 1959, Fishery Bulletin United States, V60, P107; ALDERDICE DF, 1971, J FISH RES BOARD CAN, V28, P727, DOI 10.1139/f71-101; ANDERSON JT, 1995, CAN J FISH AQUAT SCI, V52, P1978, DOI 10.1139/f95-789; Antonov J.I., 2010, NOAA ATLAS NESDIS; Bakke S., 1973, Fiskeridirektoratets Skr (Havundersok), V16, P140; BERGSTAD OA, 1987, FISH RES, V5, P119, DOI 10.1016/0165-7836(87)90037-3; Boyra G, 2003, FISH OCEANOGR, V12, P381, DOI 10.1046/j.1365-2419.2003.00260.x; Checkley DM, 1997, FISH OCEANOGR, V6, P58, DOI 10.1046/j.1365-2419.1997.00030.x; CHECKLEY DM, 1988, NATURE, V335, P346, DOI 10.1038/335346a0; COOMBS S H, 1981, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V178, P188; COOMBS SH, 1981, MAR BIOL, V63, P101, DOI 10.1007/BF00394667; Coombs SH, 2004, MAR BIOL, V145, P959, DOI 10.1007/s00227-004-1389-4; COOMBS SH, 1985, J MAR BIOL ASSOC UK, V65, P461, DOI 10.1017/S0025315400050542; COOMBS SH, 1990, J CONSEIL, V47, P133; Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446; Coupland JN, 1997, J AM OIL CHEM SOC, V74, P1559, DOI 10.1007/s11746-997-0077-1; CRAIK JCA, 1987, J MAR BIOL ASSOC UK, V67, P169, DOI 10.1017/S0025315400026436; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; Dellarole M, 2013, J PHYS CHEM B, V117, P12742, DOI 10.1021/jp401113p; Dominguez-Petit R, 2013, ICES J MAR SCI, V70, P342, DOI 10.1093/icesjms/fss180; ELLERTSEN B, 1989, RAP PROCES, V191, P209; Fiksen O, 2007, MAR ECOL PROG SER, V347, P195, DOI 10.3354/meps06978; Fofonoff N. P., 1983, UNESCO TECH PAP MAR, V44, P1; FORRESTER CR, 1964, J FISH RES BOARD CAN, V21, P9, DOI 10.1139/f64-002; FRAUENFELDER H, 1987, BIOCHEMISTRY-US, V26, P254, DOI 10.1021/bi00375a035; Goarant A, 2007, MAR BIOL, V151, P1907, DOI 10.1007/s00227-007-0624-1; Grote B, 2012, AFR J MAR SCI, V34, P195, DOI 10.2989/1814232X.2012.675040; GUGGINO WB, 1980, AM J PHYSIOL, V238, pR42, DOI 10.1152/ajpregu.1980.238.1.R42; HAEGELE CW, 1985, CAN J FISH AQUAT SCI, V42, P39, DOI 10.1139/f85-261; Hansen P. M., 1949, Rapport Conseil Exploration Mer Copenhague, V123, P1; HAUG T, 1986, MAR ECOL PROG SER, V33, P207, DOI 10.3354/meps033207; HAUG T, 1984, CAN J FISH AQUAT SCI, V41, P798, DOI 10.1139/f84-092; Hjort J., 1914, RAPPORTS PROCES VERB, V20, P1; Hoegh-Guldberg O, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1655; Huang JQ, 2008, J FOOD ENG, V89, P105, DOI 10.1016/j.jfoodeng.2008.03.007; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Iversen SA, 1973, THESIS U BERGEN; Jung KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104089; Jung KM, 2012, MAR BIOL, V159, P1969, DOI 10.1007/s00227-012-1984-8; KENDALL AW, 1994, FISH B-NOAA, V92, P540; KJESBU OS, 1992, J FISH BIOL, V41, P581, DOI 10.1111/j.1095-8649.1992.tb02685.x; Kristiansen T, 2009, BEHAV ECOL, V20, P490, DOI 10.1093/beheco/arp023; Liverseege JF, 1904, ANALYST, V29, P210; Loaning S., 1972, Fiskeridirektoratets Skr (Havundersok), V16, P77; Locarnini R.A., 2010, TEMPERATURE NOAA ATL, V1, P184; MacKenzie BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039998; MANGORJENSEN A, 1991, J FISH BIOL, V39, P133, DOI 10.1111/j.1095-8649.1991.tb04349.x; Mohrholz V, 2014, J MARINE SYST, V140, P92, DOI 10.1016/j.jmarsys.2014.04.019; Monteiro PMS, 2005, CONT SHELF RES, V25, P1864, DOI 10.1016/j.csr.2005.06.012; Myksvoll MS, 2014, ICES J MAR SCI, V71, P943, DOI 10.1093/icesjms/fst113; Myksvoll MS, 2011, MAR COAST FISH, V3, P279, DOI 10.1080/19425120.2011.595258; Navarro-Garcia G, 2010, FOOD CHEM, V119, P1578, DOI 10.1016/j.foodchem.2009.09.045; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; NISSLING A, 1991, MAR BIOL, V111, P33, DOI 10.1007/BF01986342; Nissling A, 1996, J FISH BIOL, V48, P217; NISSLING A, 1994, MAR ECOL PROG SER, V110, P67, DOI 10.3354/meps110067; OLIVAR MP, 1990, MAR BIOL, V106, P39, DOI 10.1007/BF02114672; Ospina-Alvarez A, 2012, FISH RES, V117, P86, DOI 10.1016/j.fishres.2011.01.030; Ouellet P, 1997, CAN J FISH AQUAT SCI, V54, P198, DOI 10.1139/cjfas-54-1-198; Ouellet P, 1997, CAN J FISH AQUAT SCI, V54, P211, DOI 10.1139/cjfas-54-1-211; PAGE FH, 1989, CAN J FISH AQUAT SCI, V46, P55; Parada C, 2003, FISH OCEANOGR, V12, P170, DOI 10.1046/j.1365-2419.2003.00235.x; Petereit C, 2014, PROG OCEANOGR, V122, P131, DOI 10.1016/j.pocean.2014.01.001; Petitgas P, 2006, FISH OCEANOGR, V15, P413, DOI 10.1111/j.1365-2419.2006.00409.x; POMMERANZ T, 1973, BER DEUT WISS KOMM, V22, P427; Remotti E., 1921, MEMORIE R COM TALASS, V80, P1; Rhein M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P255; Riis-Vestergaard J, 2002, J FISH BIOL, V60, P1511, DOI 10.1006/jfbi.2002.2004; Riis-Vestergaard J., 1984, Flodevigen Rapportserie, V1, P87; RIISVESTERGAARD J, 1982, MAR BIOL, V70, P135, DOI 10.1007/BF00397677; Rohrs J, 2014, LIMNOL OCEANOGR, V59, P1213, DOI 10.4319/lo.2014.59.4.1213; Salam K. A., 2005, Pakistan Journal of Biological Sciences, V8, P810, DOI 10.3923/pjbs.2005.810.815; Sars GO, 1879, INNBERETNINGER DEP I; Serebryakov V. P., 1992, Journal of Northwest Atlantic Fishery Science, V14, P107; Smith HW, 1930, AM J PHYSIOL, V93, P480, DOI 10.1152/ajplegacy.1930.93.2.480; Solemdal P., 1967, Sarsia, VNo. 29, P431; Solemdal P, 1981, VERTICAL DISTRIBUTIO, V77, P1; Stenevik EK, 2001, S AFR J MARINE SCI, V23, P85; Stenevik EK, 2008, ICES J MAR SCI, V65, P1198, DOI 10.1093/icesjms/fsn101; Sundby S, 1997, SCI MAR, V61, P159; SUNDBY S, 1983, DEEP-SEA RES, V30, P645, DOI 10.1016/0198-0149(83)90042-0; Sundby S, 2001, S AFR J MARINE SCI, V23, P317; SUNDBY S, 1991, ICES MAR SC, V192, P33; SUNDNES G., 1965, J CONS CONS PERMA INT EXPLOR MER, V29, P249; Tanaka Y, 2008, FISH OCEANOGR, V17, P89, DOI 10.1111/j.1365-2419.2008.00466.x; TEMPLEMAN W, 1970, J FISH RES BOARD CAN, V27, P1549, DOI 10.1139/f70-176; Thorsen A, 1996, J FISH BIOL, V48, P457, DOI 10.1111/j.1095-8649.1996.tb01440.x; TRISTRAMNAGLE S, 1986, BIOCHIM BIOPHYS ACTA, V854, P58, DOI 10.1016/0005-2736(86)90064-7; Yamamoto Jun, 2009, PICES Scientific Report, V36, P289; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yin HX, 2010, J FOOD SCI, V75, pE163, DOI 10.1111/j.1750-3841.2010.01532.x	92	54	54	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138821	10.1371/journal.pone.0138821	http://dx.doi.org/10.1371/journal.pone.0138821			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465149	Green Submitted, gold, Green Published			2022-12-26	WOS:000363183100027
J	Friedman, AA; Amzallag, A; Pruteanu-Malinici, I; Baniya, S; Cooper, ZA; Piris, A; Hargreaves, L; Igras, V; Frederick, DT; Lawrence, DP; Haber, DA; Flaherty, KT; Wargo, JA; Ramaswamy, S; Benes, CH; Fisher, DE				Friedman, Adam A.; Amzallag, Arnaud; Pruteanu-Malinici, Iulian; Baniya, Subash; Cooper, Zachary A.; Piris, Adriano; Hargreaves, Leeza; Igras, Vivien; Frederick, Dennie T.; Lawrence, Donald P.; Haber, Daniel A.; Flaherty, Keith T.; Wargo, Jennifer A.; Ramaswamy, Sridhar; Benes, Cyril H.; Fisher, David E.			Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; RAF INHIBITION; ACQUIRED-RESISTANCE; CONFERS RESISTANCE; CANCER; PATHWAY; MEK; GROWTH	A newer generation of anti-cancer drugs targeting underlying somatic genetic driver events have resulted in high single-agent or single-pathway response rates in selected patients, but few patients achieve complete responses and a sizeable fraction of patients relapse within a year. Thus, there is a pressing need for identification of combinations of targeted agents which induce more complete responses and prevent disease progression. We describe the results of a combination screen of an unprecedented scale in mammalian cells performed using a collection of targeted, clinically tractable agents across a large panel of melanoma cell lines. We find that even the most synergistic drug pairs are effective only in a discrete number of cell lines, underlying a strong context dependency for synergy, with strong, widespread synergies often corresponding to non-specific or off-target drug effects such as multidrug resistance protein 1 (MDR1) transporter inhibition. We identified drugs sensitizing cell lines that are BRAF(V600E) mutant but intrinsically resistant to BRAF inhibitor PLX4720, including the vascular endothelial growth factor receptor/kinase insert domain receptor (VEGFR/KDR) and platelet derived growth factor receptor (PDGFR) family inhibitor cediranib. The combination of cediranib and PLX4720 induced apoptosis in vitro and tumor regression in animal models. This synergistic interaction is likely due to engagement of multiple receptor tyrosine kinases (RTKs), demonstrating the potential of drug-rather than gene-specific combination discovery approaches. Patients with elevated biopsy KDR expression showed decreased progression free survival in trials of mitogen-activated protein kinase (MAPK) kinase pathway inhibitors. Thus, high-throughput unbiased screening of targeted drug combinations, with appropriate library selection and mechanistic follow-up, can yield clinically-actionable drug combinations.	[Friedman, Adam A.; Amzallag, Arnaud; Pruteanu-Malinici, Iulian; Baniya, Subash; Hargreaves, Leeza; Igras, Vivien; Frederick, Dennie T.; Lawrence, Donald P.; Haber, Daniel A.; Flaherty, Keith T.; Ramaswamy, Sridhar; Benes, Cyril H.; Fisher, David E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02163 USA; [Friedman, Adam A.; Baniya, Subash; Hargreaves, Leeza; Igras, Vivien; Fisher, David E.] Massachusetts Gen Hosp, Dermatol & Cutaneous Biol Res Ctr, Charlestown, MA USA; [Cooper, Zachary A.; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Cooper, Zachary A.; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Piris, Adriano] Massachusetts Gen Hosp, Div Dermatopathol, Boston, MA 02114 USA; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Friedman, AA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02163 USA.	aafriedman@partners.org; cbenes@partners.org; dfisher3@partners.org	Fisher, David/AAH-2878-2019	Amzallag, Arnaud/0000-0001-7467-1227; Birdwell, Leeza/0000-0002-0137-3939; Cooper, Zachary/0000-0003-1059-0940	National Institutes of Health [P01CA163222, R21CA175907, 1K08CA160692-01A1, U54CA163125, 1U54HG006097-01]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Doris Duke Medical Foundation; Elsa U. Pardee Foundation grant; Fred Lovejoy Resident Research and Education Award; Brigham and Women's Hospital Department of Dermatology NIH Training Grant [T32AR007098-38]; Wellcome Trust [086357, 102696]; NATIONAL CANCER INSTITUTE [P30CA016672, K08CA160692, R21CA175907, U54CA163125, P01CA163222] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007098, R01AR043369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Doris Duke Medical Foundation(Doris Duke Charitable Foundation (DDCF)); Elsa U. Pardee Foundation grant; Fred Lovejoy Resident Research and Education Award; Brigham and Women's Hospital Department of Dermatology NIH Training Grant; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (P01CA163222 and R21CA175907 to D.E.F.; 1K08CA160692-01A1 and U54CA163125 to J.A.W., 1U54HG006097-01 to C.H.B.), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (D.E.F.), the Doris Duke Medical Foundation (D.E.F.), an Elsa U. Pardee Foundation grant (D.E.F.), a Fred Lovejoy Resident Research and Education Award (A.A.F.), a Brigham and Women's Hospital Department of Dermatology NIH Training Grant T32AR007098-38 (A.A.F.), and grants from the Wellcome Trust (086357 and 102696; C.H.B., D.A.H.).	Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; Corcoran RB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005753; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Erlichman C, 2001, CANCER RES, V61, P739; Fallahi-Sichani M, 2013, NAT CHEM BIOL, V9, P708, DOI [10.1038/nchembio.1337, 10.1038/NCHEMBIO.1337]; Flaherty K, 2014, ASCO M, V32, P9010; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; GRECO WR, 1995, PHARMACOL REV, V47, P331; Guertin AD, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-45; Gujral TS, 2014, P NATL ACAD SCI USA, V111, P5048, DOI 10.1073/pnas.1403080111; Haq R, 2013, P NATL ACAD SCI USA, V110, P4321, DOI 10.1073/pnas.1205575110; Held MA, 2013, CANCER DISCOV, V3, P52, DOI 10.1158/2159-8290.CD-12-0408; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kendrew J, 2013, CANCER CHEMOTH PHARM, V71, P1021, DOI 10.1007/s00280-013-2097-x; Kim KB, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.8519; Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Noguchi K, 2009, CANCER SCI, V100, P1701, DOI 10.1111/j.1349-7006.2009.01213.x; Roller DG, 2012, MOL CANCER THER, V11, P2505, DOI 10.1158/1535-7163.MCT-12-0461; Sabbatino F, 2014, ONCOTARGET; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Takahashi O, 2012, CLIN CANCER RES, V18, P1641, DOI 10.1158/1078-0432.CCR-11-2324; Turajlic S, 2014, ANN ONCOL, V25, P959, DOI 10.1093/annonc/mdu049; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wedge SR, 2005, CANCER RES, V65, P4389, DOI 10.1158/0008-5472.CAN-04-4409	45	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140310	10.1371/journal.pone.0140310	http://dx.doi.org/10.1371/journal.pone.0140310			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461489	gold, Green Published, Green Submitted			2022-12-26	WOS:000362962300078
J	Kim, NH; Lee, J; Kim, TJ; Kim, NH; Choi, KM; Baik, SH; Choi, DS; Pop-Busui, R; Park, Y; Kim, SG				Kim, Nam Hoon; Lee, Juneyoung; Kim, Tae Joon; Kim, Nan Hee; Choi, Kyung Mook; Baik, Sei Hyun; Choi, Dong Seop; Pop-Busui, Rodica; Park, Yousung; Kim, Sin Gon			Body Mass Index and Mortality in the General Population and in Subjects with Chronic Disease in Korea: A Nationwide Cohort Study (2002-2010)	PLOS ONE			English	Article							OBESITY PARADOX; SOCIOECONOMIC-STATUS; CARDIOVASCULAR RISK; OVERWEIGHT; ASSOCIATION; WEIGHT; WOMEN; MEN; INTERVENTION; UNDERWEIGHT	Background The association between body mass index (BMI) and mortality is not conclusive, especially in East Asian populations. Furthermore, the association has been neither supported by recent data, nor assessed after controlling for weight changes. Methods We evaluated the relationship between BMI and all-cause or cause-specific mortality, using prospective cohort data by the National Health Insurance Service in Korea, which consisted of more than one million subjects. A total of 153,484 Korean adults over 30 years of age without pre-existing cardiovascular disease or cancer at baseline were followed-up until 2010 (mean follow-up period = 7.91 +/- 0.59 years). Study subjects repeatedly measured body weight 3.99 times, on average. Results During follow-up, 3,937 total deaths occurred; 557 deaths from cardiovascular disease, and 1,224 from cancer. In multiple-adjusted analyses, U-shaped associations were found between BMI and mortality from any cause, cardiovascular disease, and cancer after adjustment for age, sex, smoking status, alcohol consumption, physical activity, socioeconomic status, and weight change. Subjects with a BMI < 23 kg/m(2) and >= 30 kg/m(2) had higher risks of all-cause and cause-specific mortality compared with the reference group (BMI 23-24.9 kg/m(2)). The lowest risk of all-cause mortality was observed in subjects with a BMI of 25-26.4 kg/m(2) (adjusted hazard ratio [HR] 0.86; 95% CI 0.77 to 0.97). In subgroup analyses, including the elderly and those with chronic diseases (diabetes mellitus, hypertension, and chronic kidney disease), subjects with a BMI of 25-29.9 kg/m(2) (moderate obesity) had a lower risk of mortality compared with the reference. However, this association has been attenuated in younger individuals, in those with higher socioeconomic status, and those without chronic diseases. Conclusion Moderate obesity was associated more strongly with a lower risk of mortality than with normal, underweight, and overweight groups in the general population of South Korea. This obesity paradox was prominent in not only the elderly but also individuals with chronic disease.	[Kim, Nam Hoon; Kim, Nan Hee; Choi, Kyung Mook; Baik, Sei Hyun; Choi, Dong Seop; Kim, Sin Gon] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea; [Lee, Juneyoung] Korea Univ, Coll Med, Dept Biostat, Seoul 136705, South Korea; [Kim, Tae Joon; Park, Yousung] Korea Univ, Dept Stat, Seoul, South Korea; [Pop-Busui, Rodica] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; University of Michigan System; University of Michigan	Kim, SG (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea.	k50367@korea.ac.kr	Choi, Kyung Mook/C-4195-2018; Kim, Nan Hee/T-8627-2019	Choi, Kyung Mook/0000-0001-6175-0225; Kim, Nam Hoon/0000-0002-9926-1344; Kim, Sin Gon/0000-0002-7430-3675; Lee, Juneyoung/0000-0001-8073-9304; Kim, Nan Hee/0000-0003-4378-520X; Pop-Busui, Rodica/0000-0002-2042-1350	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C1731]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by a grant of the Korean Health Technology R&D Project (HI14C1731), Ministry of Health & Welfare, Republic of Korea. The views expressed in this article are those of the authors and do not necessarily represent the official position of the department of Korean National Health Insurance Service.	Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Atkins JL, 2014, J AM GERIATR SOC, V62, P253, DOI 10.1111/jgs.12652; B-Y Kim, 2005, J KOREAN OFIICIAL ST, V10; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Chen Y, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5446; Choo J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003954; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; Doehner W, 2012, INT J CARDIOL, V162, P20, DOI 10.1016/j.ijcard.2011.09.039; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Hainer V, 2013, DIABETES CARE, V36, pS276, DOI 10.2337/dcS13-2023; Howard G, 2000, ANN EPIDEMIOL, V10, P214, DOI 10.1016/S1047-2797(00)00038-7; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kalantar-Zadeh K, 2004, J AM COLL CARDIOL, V43, P1439, DOI 10.1016/j.jacc.2003.11.039; Kalantar-Zadeh K, 2012, AM J EPIDEMIOL, V175, P793, DOI 10.1093/aje/kwr384; Kim Tae Nyun, 2013, J Bone Metab, V20, P1, DOI 10.11005/jbm.2013.20.1.1; Lainscak M, 2012, J CACHEXIA SARCOPENI, V3, P1, DOI 10.1007/s13539-012-0059-5; Lee CMY, 2007, OBES REV, V8, P191, DOI 10.1111/j.1467-789X.2006.00292.x; Logue J, 2013, DIABETES CARE, V36, P887, DOI 10.2337/dc12-0944; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Schenkeveld L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000535; Standl E, 2013, DIABETES CARE, V36, pS282, DOI 10.2337/dcS13-2040; The Korean National Statistical Office, 2012, KOR POP 50 MILL; Tobias DK, 2014, NEW ENGL J MED, V370, P233, DOI 10.1056/NEJMoa1304501; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; World Health Organization Western Pacific Region, 2000, AS PAC PERSP RED OB; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	34	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139924	10.1371/journal.pone.0139924	http://dx.doi.org/10.1371/journal.pone.0139924			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462235	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300037
J	Stahl, BA; Gross, JB; Speiser, DI; Oakley, TH; Patel, NH; Gould, DB; Protas, ME				Stahl, Bethany A.; Gross, Joshua B.; Speiser, Daniel I.; Oakley, Todd H.; Patel, Nipam H.; Gould, Douglas B.; Protas, Meredith E.			A Transcriptomic Analysis of Cave, Surface, and Hybrid Isopod Crustaceans of the Species Asellus aquaticus	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; ASTYANAX CAVEFISH; GENE-EXPRESSION; RNA-SEQ; EVOLUTION; GENOME; MODEL; EYE; PIGMENTATION; INVOLVEMENT	Cave animals, compared to surface-dwelling relatives, tend to have reduced eyes and pigment, longer appendages, and enhanced mechanosensory structures. Pressing questions include how certain cave-related traits are gained and lost, and if they originate through the same or different genetic programs in independent lineages. An excellent system for exploring these questions is the isopod, Asellus aquaticus. This species includes multiple cave and surface populations that have numerous morphological differences between them. A key feature is that hybrids between cave and surface individuals are viable, which enables genetic crosses and linkage analyses. Here, we advance this system by analyzing single animal transcriptomes of Asellus aquaticus. We use high throughput sequencing of nonnormalized cDNA derived from the head of a surface-dwelling male, the head of a cavedwelling male, the head of a hybrid male (produced by crossing a surface individual with a cave individual), and a pooled sample of surface embryos and hatchlings. Assembling reads from surface and cave head RNA pools yielded an integrated transcriptome comprised of 23,984 contigs. Using this integrated assembly as a reference transcriptome, we aligned reads from surface-, cave- and hybrid-head tissue and pooled surface embryos and hatchlings. Our approach identified 742 SNPs and placed four new candidate genes to an existing linkage map for A. aquaticus. In addition, we examined SNPs for allele-specific expression differences in the hybrid individual. All of these resources will facilitate identification of genes and associated changes responsible for cave adaptation in A. aquaticus and, in concert with analyses of other species, will inform our understanding of the evolutionary processes accompanying adaptation to the subterranean environment.	[Stahl, Bethany A.; Gross, Joshua B.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH USA; [Stahl, Bethany A.] Florida Atlantic Univ, Dept Biol Sci, Jupiter, FL 33458 USA; [Speiser, Daniel I.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Oakley, Todd H.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Patel, Nipam H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Patel, Nipam H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Gould, Douglas B.] UCSF Sch Med, Inst Human Genet, Dept Ophthalmol, San Francisco, CA USA; [Gould, Douglas B.] UCSF Sch Med, Inst Human Genet, Dept Anat, San Francisco, CA USA; [Protas, Meredith E.] Dominican Univ Calif, Dept Nat Sci & Math, San Rafael, CA 94901 USA	University System of Ohio; University of Cincinnati; State University System of Florida; Florida Atlantic University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Protas, ME (corresponding author), Dominican Univ Calif, Dept Nat Sci & Math, San Rafael, CA 94901 USA.	meredith.protas@dominican.edu	Speiser, Daniel Isaac/AGL-4870-2022	Speiser, Daniel Isaac/0000-0001-6662-3583; Patel, Nipam/0000-0003-4328-654X; Oakley, Todd/0000-0002-4478-915X	National Science Foundation [IOS-1045257, DEB-1146337, DEB-1354831, DEB-1457630]	National Science Foundation(National Science Foundation (NSF))	This work was funded by National Science Foundation grants IOS-1045257 and DEB-1146337 to THO and DEB-1354831 to THO and DIS. This work was supported in part by a grant from the National Science Foundation to JBG (DEB-1457630).	Austin JD, 2011, MOL ECOL RESOUR, V11, P757, DOI 10.1111/j.1755-0998.2011.03028.x; Baldwin E, 1941, J EXP BIOL, V18, P136; Bilandzija H, 2012, EVOL DEV, V14, P196, DOI 10.1111/j.1525-142X.2012.00535.x; Carlson BM, 2015, G3-GENES GENOM GENET, V5, P241, DOI 10.1534/g3.114.015438; Christie AE, 2014, GEN COMP ENDOCR, V201, P74, DOI 10.1016/j.ygcen.2014.01.017; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cooley AM, 2012, EVOL DEV, V14, P317, DOI 10.1111/j.1525-142X.2012.00550.x; Coolon JD, 2012, CELL REP, V2, P69, DOI 10.1016/j.celrep.2012.06.013; Culver D. C., 1982, CAVE LIFE; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Ferguson LC, 2009, EVOL DEV, V11, P498, DOI 10.1111/j.1525-142X.2009.00358.x; Fraser HB, 2011, BIOESSAYS, V33, P469, DOI 10.1002/bies.201000094; Friedrich M, 2011, J EXP BIOL, V214, P3532, DOI 10.1242/jeb.060368; Gross JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055659; Gross JB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-105; Hasegawa Y, 1999, ADV EXP MED BIOL, V467, P645; HEIMANN P, 1984, CELL TISSUE RES, V235, P117; Hinaux H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053553; Jaramillo AM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-3; Jeffery WR, 2009, ANNU REV GENET, V43, P25, DOI 10.1146/annurev-genet-102108-134216; Kenny NJ, 2014, MAR DRUGS, V12, P1419, DOI 10.3390/md12031419; Korir PK, 2014, METHODS MOL BIOL, V1112, P49, DOI 10.1007/978-1-62703-773-0_4; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; McGaugh SE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6307; Meng FW, 2013, MOL BIOL EVOL, V30, P1527, DOI 10.1093/molbev/mst079; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullins C, 2000, MOL GEN GENET, V263, P1003, DOI 10.1007/PL00008688; NECKAMEYER WS, 1993, J NEUROGENET, V8, P189, DOI 10.3109/01677069309083448; Negishi S, 1999, ADV EXP MED BIOL, V467, P649; OETINGER DF, 1982, J PARASITOL, V68, P270, DOI 10.2307/3281186; Orr WC, 2013, ANTIOXID REDOX SIGN, V19, P788, DOI 10.1089/ars.2012.5002; Protas M, 2012, WIRES DEV BIOL, V1, P823, DOI 10.1002/wdev.61; Protas ME, 2011, P NATL ACAD SCI USA, V108, P5702, DOI 10.1073/pnas.1013850108; Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917; Speiser DI, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0350-x; Tatematsu K, 2011, GENES CELLS, V16, P331, DOI 10.1111/j.1365-2443.2011.01490.x; Turk S, 1996, HYDROBIOLOGIA, V337, P161, DOI 10.1007/BF00028517; Wang X, 2014, HEREDITY, V113, P156, DOI 10.1038/hdy.2014.18; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698	41	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140484	10.1371/journal.pone.0140484	http://dx.doi.org/10.1371/journal.pone.0140484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462237	Green Published, gold			2022-12-26	WOS:000362962300103
J	Bockus, LB; Humphries, KM				Bockus, Lee B.; Humphries, Kenneth M.			cAMP-dependent Protein Kinase (PKA) Signaling Is Impaired in the Diabetic Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVOUS-SYSTEM; FATTY-ACIDS; FAILURE; CARDIOMYOPATHY; HYPERTROPHY; GLYCOLYSIS; PATHOPHYSIOLOGY; EXPRESSION; RESPONSES; PRESSURE	Diabetes mellitus causes cardiac dysfunction and heart failure that is associated with metabolic abnormalities and autonomic impairment. Autonomic control of ventricular function occurs through regulation of cAMP-dependent protein kinase (PKA). The diabetic heart has suppressed beta-adrenergic responsiveness, partly attributable to receptor changes, yet little is known about how PKA signaling is directly affected. Control and streptozotocin-induced diabetic mice were therefore administered 8-bromo-cAMP (8Br-cAMP) acutely to activate PKA in a receptor-independent manner, and cardiac hemodynamic function and PKA signaling were evaluated. In response to 8Br-cAMP treatment, diabetic mice had impaired inotropic and lusitropic responses, thus demonstrating postreceptor defects. This impaired signaling was mediated by reduced PKA activity and PKA catalytic subunit content in the cytoplasm and myofilaments. Compartment-specific loss of PKA was reflected by reduced phosphorylation of discrete substrates. In response to 8Br-cAMP treatment, the glycolytic activator PFK-2 was robustly phosphorylated in control animals but not diabetics. Control adult cardiomyocytes cultured in lipid-supplemented media developed similar changes in PKA signaling, suggesting that lipotoxicity is a contributor to diabetes-induced beta-adrenergic signaling dysfunction. This work demonstrates that PKA signaling is impaired in diabetes and suggests that treating hyper-lipidemia is vital for proper cardiac signaling and function.	Oklahoma Med Res Fdn, Aging & Metab Res Program, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Humphries, KM (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	kenneth-humphries@omrf.org		Humphries, Kenneth/0000-0002-6167-3175	National Institute of General Medical Sciences of the National Institutes of Health [P20GM104934]; Oklahoma Center for the Advancement of Science and Technology Grant [HR13-183]; American Heart Association [14GRNT20510031]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104934] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Oklahoma Center for the Advancement of Science and Technology Grant; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by an Institutional Development Award from the National Institute of General Medical Sciences of the National Institutes of Health through Grant P20GM104934, by Oklahoma Center for the Advancement of Science and Technology Grant HR13-183, and by American Heart Association Grant 14GRNT20510031. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Asrih M, 2012, AM J PHYSIOL-ENDOC M, V302, pE872, DOI 10.1152/ajpendo.00427.2011; Bugger H, 2014, DIABETOLOGIA, V57, P660, DOI 10.1007/s00125-014-3171-6; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; Depre C, 1998, J CLIN INVEST, V101, P390, DOI 10.1172/JCI1168; Dincer UD, 2001, DIABETES, V50, P455, DOI 10.2337/diabetes.50.2.455; Donthi RV, 2004, J BIOL CHEM, V279, P48085, DOI 10.1074/jbc.M405510200; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589; Gilbert RE, 2015, LANCET, V385, P2107, DOI 10.1016/S0140-6736(14)61402-1; Hausken ZE, 1998, METH MOL B, V88, P47; Hicks KK, 1998, J AUTONOM NERV SYST, V69, P21, DOI 10.1016/S0165-1838(98)00004-6; Hoit BD, 1999, J CARD FAIL, V5, P324, DOI 10.1016/S1071-9164(99)91337-4; Humphries KM, 2007, J BIOL CHEM, V282, P22072, DOI 10.1074/jbc.M702582200; Hwang Sun-Ii, 2013, Methods Mol Biol, V1002, P25, DOI 10.1007/978-1-62703-360-2_3; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; MCFARLAND BH, 1971, ARCH BIOCHEM BIOPHYS, V145, P456, DOI 10.1016/S0003-9861(71)80005-X; McMurray JJV, 2014, LANCET DIABETES ENDO, V2, P843, DOI 10.1016/S2213-8587(14)70031-2; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Pappachan JM, 2013, WORLD J DIABETES, V4, P177, DOI 10.4239/wjd.v4.i5.177; PAULSON DJ, 1981, RES COMMUN CHEM PATH, V33, P559; Pop-Busui R, 2010, DIABETES CARE, V33, P434, DOI 10.2337/dc09-1294; Ros S, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-8; SANDBERG M, 1991, BIOCHEM J, V279, P521, DOI 10.1042/bj2790521; Tamada A, 1998, AM J PHYSIOL-HEART C, V274, pH1849, DOI 10.1152/ajpheart.1998.274.6.H1849; Tillquist MN, 2012, CURR DIABETES REP, V12, P305, DOI 10.1007/s11892-012-0274-7; Vadvalkar SS, 2013, BIOCHEM J, V449, P253, DOI 10.1042/BJ20121038; VANDENENDE R, 1994, FUNDAM CLIN PHARM, V8, P408; Wang QW, 2008, AM J PHYSIOL-HEART C, V294, pH2889, DOI 10.1152/ajpheart.91501.2007; Watt MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1, DOI 10.1152/ajpendo.00418.2011; Yang JH, 2014, J MOL CELL CARDIOL, V66, P83, DOI 10.1016/j.yjmcc.2013.11.001; YU Z, 1994, AM J PHYSIOL, V266, pH2334, DOI 10.1152/ajpheart.1994.266.6.H2334	37	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29250	29258		10.1074/jbc.M115.681767	http://dx.doi.org/10.1074/jbc.M115.681767			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468277	hybrid, Green Published			2022-12-26	WOS:000366613400013
J	Cai, LH; Wu, HL; Li, DF; Zhou, K; Zou, FH				Cai, Lihua; Wu, Honglong; Li, Dongfang; Zhou, Ke; Zou, Fuhao			Type 2 Diabetes Biomarkers of Human Gut Microbiota Selected via Iterative Sure Independent Screening Method	PLOS ONE			English	Article							VARIABLE SELECTION; REGRESSION; REGULARIZATION; METAGENOME; OBESITY	Type 2 diabetes, which is a complex metabolic disease influenced by genetic and environment, has become a worldwide problem. Previous published results focused on genetic components through genome-wide association studies that just interpret this disease to some extent. Recently, two research groups published metagenome-wide association studies (MGWAS) result that found meta-biomarkers related with type 2 diabetes. However, One key problem of analyzing genomic data is that how to deal with the ultra-high dimensionality of features. From a statistical viewpoint it is challenging to filter true factors in high dimensional data. Various methods and techniques have been proposed on this issue, which can only achieve limited prediction performance and poor interpretability. New statistical procedure with higher performance and clear interpretability is appealing in analyzing high dimensional data. To address this problem, we apply an excellent statistical variable selection procedure called iterative sure independence screening to gene profiles that obtained from metagenome sequencing, and 48/24 meta-markers were selected in Chinese/European cohorts as predictors with 0.97/0.99 accuracy in AUC (area under the curve), which showed a better performance than other model selection methods, respectively. These results demonstrate the power and utility of data mining technologies within the large-scale and ultra-high dimensional genomic-related dataset for diagnostic and predictive markers identifying.	[Cai, Lihua; Wu, Honglong; Li, Dongfang; Zhou, Ke; Zou, Fuhao] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China; [Cai, Lihua] Guangdong Ocean Univ, Sch Informat Sci, Zhanjiang, Guangdong, Peoples R China; [Wu, Honglong; Li, Dongfang] BGI Shenzhen, BGI Tianjin, Binhia Genom Inst, Tianjin, Peoples R China	Huazhong University of Science & Technology; Guangdong Ocean University; Beijing Genomics Institute (BGI)	Zhou, K (corresponding author), Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China.	k.zhou@hust.edu.cn		Li, Dongfang/0000-0002-6587-2892				Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Das UN, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-35; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Fan JQ, 2010, STAT SINICA, V20, P101; Fan JQ, 2009, J MACH LEARN RES, V10, P2013; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Li CY, 2008, BIOINFORMATICS, V24, P1175, DOI 10.1093/bioinformatics/btn081; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Liu J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P547; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Strittmatter WJ, 2001, BIOCHEM SOC SYMP, V67, P101; Sun H, 2012, BIOINFORMATICS, V28, P1368, DOI 10.1093/bioinformatics/bts145; Tibshirani R, 2005, J R STAT SOC B, V67, P91, DOI 10.1111/j.1467-9868.2005.00490.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Z., 2014, REGULARIZATION OPTIM, P131; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	24	20	23	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140827	10.1371/journal.pone.0140827	http://dx.doi.org/10.1371/journal.pone.0140827			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479726	Green Submitted, Green Published, gold			2022-12-26	WOS:000363026600021
J	Salinas-Almaguer, S; Angulo-Sherman, A; Sierra-Valdez, FJ; Mercado-Uribe, H				Salinas-Almaguer, Samuel; Angulo-Sherman, Abril; Javier Sierra-Valdez, Francisco; Mercado-Uribe, Hilda			Sterilization by Cooling in Isochoric Conditions: The Case of Escherichia coli	PLOS ONE			English	Article							HIGH HYDROSTATIC-PRESSURE; STATIONARY-PHASE CELLS; MEMBRANE DAMAGE; WATER; INACTIVATION; PRESERVATION; INTEGRITY; PROTEIN; DEATH	High hydrostatic pressure (HHP) affects the structure, metabolism and survival of microorganisms including bacteria. For this reason HHP is a promising treatment in the food industry. The aim of this work is to evaluate the effect of high pressure, under isochoric cooling conditions, on Escherichia coli, where such high pressure develops due to the fact water cannot expand. We combine survival curves obtained by spectrophotometry and images of atomic force microscopy in this study. Our results show that cooling at -20 and -30 degrees C leads to a partial destruction of a Escherichia coli population. However, cooling at -15 degrees C causes a total extermination of bacteria. This intriguing result is explained by the phase diagram of water. In the first case, the simultaneous formation of ice III and ice Ih crystals provides a safe environment for bacteria. In the second case (-15 degrees C) Escherichia coli remains in a metastable and amorphous free-of-crystals liquid subjected to high pressure. Our work is the first experimental study carried out to inactivate Escherichia coli under isochoric cooling conditions. Unlike HHP, which is based on the application of an external load to augment the pressure, this technique only requires cooling. The method could be used for annihilation of other Escherichia coli strains and perhaps other micro-organisms.	[Salinas-Almaguer, Samuel; Angulo-Sherman, Abril; Javier Sierra-Valdez, Francisco; Mercado-Uribe, Hilda] CINVESTAV Monterrey, Apodaca, Nuevo Leon, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Mercado-Uribe, H (corresponding author), CINVESTAV Monterrey, Apodaca, Nuevo Leon, Mexico.	hmercado@cinvestav.mx		Sierra-Valdez, Francisco J/0000-0002-7803-9701	Consejo Nacional de Ciencia y Tecnologia [154202]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research work was supported by Consejo Nacional de Ciencia y Tecnologia (Grant 154202), HMU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2013, HIGH PRESSURE RES, V33, P278, DOI 10.1080/08957959.2013.769533; Angulo-Sherman A, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022406; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Black SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073995; Byrne RT, 2014, J BACTERIOL, V196, P3534, DOI 10.1128/JB.01589-14; Casadei MA, 2002, APPL ENVIRON MICROB, V68, P5965, DOI 10.1128/AEM.68.12.5965-5972.2002; Chaplin M., 2000, WATER STRUCTURE SCI; Chua B, 2014, BIOMED MICRODEVICES, V16, P355, DOI 10.1007/s10544-014-9838-4; GROSS M, 1993, EUR J BIOCHEM, V218, P463, DOI 10.1111/j.1432-1033.1993.tb18397.x; Hong YC, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3418371; Hsu H, 2014, FOOD MICROBIOL, V40, P25, DOI 10.1016/j.fm.2013.11.019; Kaletunc G, 2004, APPL ENVIRON MICROB, V70, P1116, DOI 10.1128/AEM.70.2.1116-1122.2004; KALICHEVSKY MT, 1995, TRENDS FOOD SCI TECH, V6, P253, DOI 10.1016/S0924-2244(00)89109-8; Kim HS, 2013, SEP PURIF TECHNOL, V120, P423, DOI 10.1016/j.seppur.2013.09.041; Klotz B, 2010, INT J FOOD MICROBIOL, V137, P214, DOI 10.1016/j.ijfoodmicro.2009.11.020; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; LeBail A, 2002, INT J REFRIG, V25, P504, DOI 10.1016/S0140-7007(01)00030-5; MACKEY BM, 2008, HIGHPR MICR, P53; Manas P, 2005, J APPL MICROBIOL, V98, P1387, DOI 10.1111/j.1365-2672.2005.02561.x; Manas P, 2004, APPL ENVIRON MICROB, V70, P1545, DOI 10.1128/AEM.70.3.1545-1554.2004; Moussa M, 2007, APPL ENVIRON MICROB, V73, P6508, DOI 10.1128/AEM.01212-07; Niven GW, 1999, MICROBIOL-SGM, V145, P419, DOI 10.1099/13500872-145-2-419; Ohshima S, 2013, HIGH PRESSURE RES, V33, P308, DOI 10.1080/08957959.2013.773429; Pagan R, 2000, APPL ENVIRON MICROB, V66, P2829, DOI 10.1128/AEM.66.7.2829-2834.2000; Pena-Eguiluz R, 2010, EUR PHYS J-APPL PHYS, V49, DOI 10.1051/epjap/2009197; Preciado JA, 2010, CRYOBIOLOGY, V60, P23, DOI 10.1016/j.cryobiol.2009.06.010; Prieto-Calvo M, 2014, MOLECULES, V19, P21310, DOI 10.3390/molecules191221310; Rubinsky B, 2005, CRYOBIOLOGY, V50, P121, DOI 10.1016/j.cryobiol.2004.12.002; Suppes GJ, 2003, CRYOBIOLOGY, V47, P93, DOI 10.1016/S0011-2240(03)00072-5; Szobota SA, 2006, CRYOBIOLOGY, V53, P139, DOI 10.1016/j.cryobiol.2006.04.001; Takahashi T, 2000, TRANSPL P, V32, P1634, DOI 10.1016/S0041-1345(00)01440-8; Velegol SB, 2002, LANGMUIR, V18, P5256, DOI 10.1021/la011818g; WELCH TJ, 1993, J BACTERIOL, V175, P7170, DOI 10.1128/JB.175.22.7170-7177.1993; Zhao F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062388	34	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140882	10.1371/journal.pone.0140882	http://dx.doi.org/10.1371/journal.pone.0140882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26480032	Green Published, gold, Green Submitted			2022-12-26	WOS:000363026600023
J	Baldan, E; Nigris, S; Romualdi, C; D'Alessandro, S; Clocchiatti, A; Zottini, M; Stevanato, P; Squartini, A; Baldan, B				Baldan, Enrico; Nigris, Sebastiano; Romualdi, Chiara; D'Alessandro, Stefano; Clocchiatti, Anna; Zottini, Michela; Stevanato, Piergiorgio; Squartini, Andrea; Baldan, Barbara			Beneficial Bacteria Isolated from Grapevine Inner Tissues Shape Arabidopsis thaliana Roots	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; VITIS-VINIFERA L.; PHYTOFIRMANS STRAIN PSJN; PLANT-GROWTH; ENDOPHYTIC COLONIZATION; DEFENSE RESPONSES; BOTRYTIS-CINEREA; AZOARCUS SP; RESISTANCE; BACILLUS	We investigated the potential plant growth-promoting traits of 377 culturable endophytic bacteria, isolated from Vitis vinifera cv. Glera, as good biofertilizer candidates in vineyard management. Endophyte ability in promoting plant growth was assessed in vitro by testing ammonia production, phosphate solubilization, indole-3-acetic acid (IAA) and IAA-like molecule biosynthesis, siderophore and lytic enzyme secretion. Many of the isolates were able to mobilize phosphate (33%), release ammonium (39%), secrete siderophores (38%) and a limited part of them synthetized IAA and IAA-like molecules (5%). Effects of each of the 377 grapevine beneficial bacteria on Arabidopsis thaliana root development were also analyzed to discern plant growth-promoting abilities (PGP) of the different strains, that often exhibit more than one PGP trait. A supervised model-based clustering analysis highlighted six different classes of PGP effects on root architecture. A. thaliana DR5::GUS plantlets, inoculated with IAA-producing endophytes, resulted in altered root growth and enhanced auxin response. Overall, the results indicate that the Glera PGP endospheric culturable microbiome could contribute, by structural root changes, to obtain water and nutrients increasing plant adaptation and survival. From the complete cultivable collection, twelve promising endophytes mainly belonging to the Bacillus but also to Micrococcus and Pantoea genera, were selected for further investigations in the grapevine host plants towards future application in sustainable management of vineyards.	[Baldan, Enrico; Nigris, Sebastiano; Romualdi, Chiara; D'Alessandro, Stefano; Clocchiatti, Anna; Zottini, Michela; Baldan, Barbara] Univ Padua, Dept Biol, Padua, Italy; [Stevanato, Piergiorgio; Squartini, Andrea] Dept Agron Food Nat Resources Anim & Environm, Dipartimento DAFNAE, Legnaro, PD, Italy	University of Padua	Baldan, B (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	barbara.baldan@unipd.it	D'Alessandro, Stefano/F-9647-2017; Clocchiatti, Anna/C-1268-2016; Romualdi, Chiara/K-1132-2016; Baldan, Barbara/AGX-8602-2022; Zottini, Michela/Y-3763-2019; Squartini, Andrea/AAX-9942-2020; D'Alessandro, Stefano/AAH-8326-2019; Clocchiatti, Anna/AAK-1182-2020	D'Alessandro, Stefano/0000-0002-0464-5549; Clocchiatti, Anna/0000-0003-3944-3039; Romualdi, Chiara/0000-0003-4792-9047; Baldan, Barbara/0000-0002-5564-1214; Squartini, Andrea/0000-0002-1961-1165; D'Alessandro, Stefano/0000-0002-0464-5549; Clocchiatti, Anna/0000-0003-3944-3039; zottini, michela/0000-0001-8930-2969	Misura 124 Project ENDOFLORVIT (DGR "Regione del Veneto") By "Progetto di Ricerca di Ateneo [CE 1698/2005, 1604, 2307732, 2013-CPDA139795]; Assegno di Ricerca Junior of Padova University [CPDR114442]	Misura 124 Project ENDOFLORVIT (DGR "Regione del Veneto") By "Progetto di Ricerca di Ateneo; Assegno di Ricerca Junior of Padova University	This work was funded by the Misura 124 Project ENDOFLORVIT (Reg. CE 1698/2005, DGR "Regione del Veneto" n. 1604 del 31/07/2012, request 2307732) By "Progetto di Ricerca di Ateneo 2013-CPDA139795". E.B. is the recipient of Assegno di Ricerca Junior of Padova University (Project 2011-prot. CPDR114442). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali B, 2009, LETT APPL MICROBIOL, V48, P542, DOI 10.1111/j.1472-765X.2009.02565.x; Baldan E, 2014, PLANT BIOSYST, V148, P508, DOI 10.1080/11263504.2014.916364; Barka EA, 2002, BIOL CONTROL, V24, P135, DOI 10.1016/S1049-9644(02)00034-8; Barka EA, 2006, APPL ENVIRON MICROB, V72, P7246, DOI 10.1128/AEM.01047-06; Bashan Y, 1998, SOIL BIOL BIOCHEM, V30, P1225, DOI 10.1016/S0038-0717(97)00187-9; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Bhattacharyya PN, 2012, WORLD J MICROB BIOT, V28, P1327, DOI 10.1007/s11274-011-0979-9; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Bordiec S, 2011, J EXP BOT, V62, P595, DOI 10.1093/jxb/erq291; BRIC JM, 1991, APPL ENVIRON MICROB, V57, P535, DOI 10.1128/AEM.57.2.535-538.1991; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Bulgari D, 2009, J MICROBIOL, V47, P393, DOI 10.1007/s12275-009-0082-1; Campbell AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084106; Cappuccino J. C., 1992, MICROBIOLOGY LAB MAN, Vthird, P125, DOI DOI 10.2307/1309615; Compant S, 2005, APPL ENVIRON MICROB, V71, P1685, DOI 10.1128/AEM.71.4.1685-1693.2005; Compant S, 2008, FEMS MICROBIOL ECOL, V63, P84, DOI 10.1111/j.1574-6941.2007.00410.x; Compant S, 2012, PLANT SOIL, V356, P299, DOI 10.1007/s11104-012-1204-9; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Coombs JT, 2003, APPL ENVIRON MICROB, V69, P4260, DOI 10.1128/AEM.69.7.4260-4262.2003; COSTACURTA A, 1995, CRIT REV MICROBIOL, V21, P1, DOI 10.3109/10408419509113531; Dobbelaere S, 1999, PLANT SOIL, V212, P155, DOI 10.1023/A:1004658000815; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Gaiero JR, 2013, AM J BOT, V100, P1738, DOI 10.3732/ajb.1200572; Glick BR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/963401; Goldstein A., 1986, American Journal of Alternative Agriculture, V1, P51; Gutierrez-Manero FJ, 2001, PHYSIOL PLANTARUM, V111, P206, DOI 10.1034/j.1399-3054.2001.1110211.x; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Jourdan E, 2009, MOL PLANT MICROBE IN, V22, P456, DOI 10.1094/MPMI-22-4-0456; Kazan K, 2013, ANN BOT-LONDON, V112, P1655, DOI 10.1093/aob/mct229; Kpomblekou-A K, 2003, AGR ECOSYST ENVIRON, V100, P275, DOI 10.1016/S0167-8809(03)00185-3; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Magnin-Robert M, 2014, PHYTOPATHOL MEDITERR, V53, P168; Maksimov IV, 2011, APPL BIOCHEM MICRO+, V47, P333, DOI 10.1134/S0003683811040090; Marasco R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/491091; Mitter B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00120; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Persello-Cartieaux F, 2003, PLANT CELL ENVIRON, V26, P189, DOI 10.1046/j.1365-3040.2003.00956.x; PIKOVSKAIA R. I., 1948, Mikrobiologiya, V17, P362; Rashid S, 2012, APPL SOIL ECOL, V61, P217, DOI 10.1016/j.apsoil.2011.09.011; Reinhold-Hurek B, 2006, MOL PLANT MICROBE IN, V19, P181, DOI 10.1094/MPMI-19-0181; REINHOLDHUREK B, 1993, J BACTERIOL, V175, P7056, DOI 10.1128/jb.175.21.7056-7065.1993; Reissinger A, 2001, MYCOL RES, V105, P563, DOI 10.1017/S0953756201003823; Richardson AE, 2011, PLANT SOIL, V349, P121, DOI 10.1007/s11104-011-0950-4; Rodriguez H, 2006, PLANT SOIL, V287, P15, DOI 10.1007/s11104-006-9056-9; Rolli E, 2015, ENVIRON MICROBIOL, V17, P316, DOI 10.1111/1462-2920.12439; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Spaepen Stijn, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001438; Spaepen S, 2014, NEW PHYTOL, V201, P850, DOI 10.1111/nph.12590; Sukumar P, 2013, PLANT CELL ENVIRON, V36, P909, DOI 10.1111/pce.12036; Timmusk S, 1999, SOIL BIOL BIOCHEM, V31, P1847, DOI 10.1016/S0038-0717(99)00113-3; Trotel-Aziz P, 2008, ENVIRON EXP BOT, V64, P21, DOI 10.1016/j.envexpbot.2007.12.009; Tsavkelova EA, 2006, APPL BIOCHEM MICRO+, V42, P117, DOI 10.1134/S0003683806020013; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Verhagen BWM, 2010, J EXP BOT, V61, P249, DOI 10.1093/jxb/erp295; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Welbaum GE, 2004, CRIT REV PLANT SCI, V23, P175, DOI 10.1080/07352680490433295; West ER, 2010, CAN J MICROBIOL, V56, P209, DOI [10.1139/w10-004, 10.1139/W10-004]; WILSON D, 1995, OIKOS, V73, P274, DOI 10.2307/3545919; Yandell BS, 1997, PRACTICAL DATA ANAL	68	29	29	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140252	10.1371/journal.pone.0140252	http://dx.doi.org/10.1371/journal.pone.0140252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473358	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500034
J	Plog, S; Klymiuk, N; Binder, S; Van Hook, MJ; Thoreson, WB; Gruber, AD; Mundhenk, L				Plog, Stephanie; Klymiuk, Nikolai; Binder, Stefanie; Van Hook, Matthew J.; Thoreson, Wallace B.; Gruber, Achim D.; Mundhenk, Lars			Naturally Occurring Deletion Mutants of the Pig-Specific, Intestinal Crypt Epithelial Cell Protein CLCA4b without Apparent Phenotype	PLOS ONE			English	Article							CA2+-ACTIVATED CL-CHANNELS; MESSENGER-RNA DECAY; CYSTIC-FIBROSIS; CHLORIDE CURRENTS; APICAL MEMBRANE; BASIC DEFECT; CALCIUM; FAMILY; MCLCA3; GENE	The human CLCA4 (chloride channel regulator, calcium-activated) modulates the intestinal phenotype of cystic fibrosis (CF) patients via an as yet unknown pathway. With the generation of new porcine CF models, species-specific differences between human modifiers of CF and their porcine orthologs are considered critical for the translation of experimental data. Specifically, the porcine ortholog to the human CF modulator gene CLCA4 has recently been shown to be duplicated into two separate genes, CLCA4a and CLCA4b. Here, we characterize the duplication product, CLCA4b, in terms of its genomic structure, tissue and cellular expression patterns as well as its in vitro electrophysiological properties. The CLCA4b gene is a pig-specific duplication product of the CLCA4 ancestor and its protein is exclusively expressed in small and large intestinal crypt epithelial cells, a niche specifically occupied by no other porcine CLCA family member. Surprisingly, a unique deleterious mutation of the CLCA4b gene is spread among modern and ancient breeds in the pig population, but this mutation did not result in an apparent phenotype in homozygously affected animals. Electrophysiologically, neither the products of the wild type nor of the mutated CLCA4b genes were able to evoke a calcium-activated anion conductance, a consensus feature of other CLCA proteins. The apparently pig-specific duplication of the CLCA4 gene with unique expression of the CLCA4b protein variant in intestinal crypt epithelial cells where the porcine CFTR is also present raises the question of whether it may modulate the porcine CF phenotype. Moreover, the naturally occurring null variant of CLCA4b will be valuable for the understanding of CLCA protein function and their relevance in modulating the CF phenotype.	[Plog, Stephanie; Binder, Stefanie; Gruber, Achim D.; Mundhenk, Lars] Free Univ Berlin, Fac Vet Med, Dept Vet Pathol, Berlin, Germany; [Klymiuk, Nikolai] Univ Munich, Inst Mol Anim Breeding & Biotechnol, Oberschleissheim, Germany; [Van Hook, Matthew J.; Thoreson, Wallace B.] Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE USA	Free University of Berlin; University of Munich; University of Nebraska System; University of Nebraska Medical Center	Mundhenk, L (corresponding author), Free Univ Berlin, Fac Vet Med, Dept Vet Pathol, Berlin, Germany.	lars.mundhenk@fu-berlin.de	Thoreson, Wallace B./F-6172-2010; Klymiuk, Nikolai/AAB-8345-2022; Gruber, Achim D./ABA-4514-2021	Thoreson, Wallace B./0000-0001-7104-042X; Klymiuk, Nikolai/0000-0003-3532-1659; 	German Research Foundation [DFG MU 3015/1-1]; U.S. National Institutes of Health [EY10542, F32EY23864]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY010542, R55EY010542, F32EY023864, R29EY010542] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Financial support by the German Research Foundation (DFG MU 3015/1-1), U.S. National Institutes of Health (EY10542, WBT; F32EY23864, MJH), and a Senior Scientific Investigator Award from Research to Prevent Blindness (WBT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnel M, 1999, FEBS LETT, V455, P295, DOI 10.1016/S0014-5793(99)00891-1; ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; Anton F, 2005, J HISTOCHEM CYTOCHEM, V53, P1011, DOI 10.1369/jhc.4A6599.2005; Behm-Ansmant I, 2007, FEBS LETT, V581, P2845, DOI 10.1016/j.febslet.2007.05.027; Bothe MK, 2008, J HISTOCHEM CYTOCHEM, V56, P495, DOI 10.1369/jhc.2008.950592; Bothe M, 2011, MOL CELLS, V32, P535, DOI 10.1007/s10059-011-0158-8; Ching JCH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083130; Dietert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102606; Evans SR, 2004, J BIOL CHEM, V279, P41792, DOI 10.1074/jbc.M408354200; Fuller CM, 2000, NEWS PHYSIOL SCI, V15, P165; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; GRAY MA, 1994, AM J PHYSIOL, V266, pC213, DOI 10.1152/ajpcell.1994.266.1.C213; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Gruber AD, 1999, BBA-GENE STRUCT EXPR, V1444, P418, DOI 10.1016/S0167-4781(99)00008-1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamann M, 2009, J PHYSIOL-LONDON, V587, P2255, DOI 10.1113/jphysiol.2009.170159; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; Klymiuk N, 2012, J MOL MED, V90, P597, DOI 10.1007/s00109-011-0839-y; Kolbe EW, 2013, EUR J HUM GENET, V21, P691, DOI 10.1038/ejhg.2012.234; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Meyerholz DK, 2010, AM J RESP CRIT CARE, V182, P1251, DOI 10.1164/rccm.201004-0643OC; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Mundhenk L, 2006, J BIOL CHEM, V281, P30072, DOI 10.1074/jbc.M606489200; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Plog S, 2012, CELL TISSUE RES, V350, P445, DOI 10.1007/s00441-012-1482-9; Plog S, 2012, J HISTOCHEM CYTOCHEM, V60, P45, DOI 10.1369/0022155411426455; Plog S, 2010, J HISTOCHEM CYTOCHEM, V58, P785, DOI 10.1369/jhc.2010.955377; Plog S, 2009, J HISTOCHEM CYTOCHEM, V57, P1169, DOI 10.1369/jhc.2009.954594; RIORDAN JR, 1989, SCIENCE, V245, P1066; Ritzka M, 2004, HUM GENET, V115, P483, DOI 10.1007/s00439-004-1190-y; RODMAN DM, 1991, MED HYPOTHESES, V36, P253, DOI 10.1016/0306-9877(91)90144-N; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; Salvatore F, 2002, AM J MED GENET, V111, P88, DOI 10.1002/ajmg.10461; Scholte Bob J, 2004, J Cyst Fibros, V3 Suppl 2, P183, DOI 10.1016/j.jcf.2004.05.039; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; van der Doef HPJ, 2010, J PEDIATR GASTR NUTR, V50, P347, DOI 10.1097/MPG.0b013e3181afce6c; WAGNER JA, 1991, NATURE, V349, P793, DOI 10.1038/349793a0; Walia V, 2012, ONCOGENE, V31, P2237, DOI 10.1038/onc.2011.392; Wuensch A, 2014, TRANSPLANTATION, V97, P138, DOI 10.1097/TP.0b013e3182a95cbc; Young FD, 2007, GASTROENTEROLOGY, V133, P1928, DOI 10.1053/j.gastro.2007.10.007; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083943; Zetoune AB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-83	44	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140050	10.1371/journal.pone.0140050	http://dx.doi.org/10.1371/journal.pone.0140050			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474299	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500021
J	Zatulovskaia, YA; Ilyechova, EY; Puchkova, LV				Zatulovskaia, Yulia A.; Ilyechova, Ekaterina Y.; Puchkova, Ludmila V.			The Features of Copper Metabolism in the Rat Liver during Development	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; SUPEROXIDE-DISMUTASE; WILSONS-DISEASE; CERULOPLASMIN-GENE; MITOCHONDRIAL MATRIX; MILK CERULOPLASMIN; HEPATIC COPPER; GUINEA-PIG; CHAPERONE; PROTEIN	Strong interest in copper homeostasis is due to the fact that copper is simultaneously a catalytic co-factor of the vital enzymes, a participant in signaling, and a toxic agent provoking oxidative stress. In mammals, during development copper metabolism is conformed to two types. In embryonic type copper metabolism (ETCM), newborns accumulate copper to high level in the liver because its excretion via bile is blocked; and serum copper concentration is low because ceruloplasmin (the main copper-containing protein of plasma) gene expression is repressed. In the late weaning, the ETCM switches to the adult type coppermetabolism (ATCM), which is manifested by the unlocking of copper excretion and the induction of ceruloplasmin gene activity. The considerable progress has been made in the understanding of the molecular basis of copper metabolic turnover in the ATCM, but many aspects of the copper homeostasis in the ETCM remain unclear. The aim of this study was to investigate the copper metabolism during transition from the ETCM (up to 12-days-old) to the ATCM in the rats. It was shown that in the liver, copper was accumulated in the nuclei during the first 5 days of life, and then it was re-located to the mitochondria. In parallel with the mitochondria, copper bulk bound with cytosolic metallothionein was increased. All compartments of the liver cells rapidly lost most of their copper on the 13th day of life. In newborns, serum copper concentration was low, and its major fraction was associated with holo-Cp, however, a small portion of copper was bound to extracellular metallothionein and a substance that was slowly eluted during gel-filtration. In adults, serum copper concentration increased by about a factor of 3, while metallothionein-bound copper level decreased by a factor of 2. During development, the expression level of Cp, Sod1, Cox4i1, Atp7b, Ctr1, Ctr2, Cox17, and Ccs genes was significantly increased, and metallothionein was decreased. Atp7a gene's activity was fully repressed. The copper routes in newborns are discussed.	[Zatulovskaia, Yulia A.; Ilyechova, Ekaterina Y.; Puchkova, Ludmila V.] Peter Great St Petersburg Polytech Univ, Dept Biophys, Inst Phys Nanotechnol & Telecommun, St Petersburg, Russia; [Ilyechova, Ekaterina Y.; Puchkova, Ludmila V.] Russian Acad Med Sci, Inst Expt Med, Dept Mol Genet, St Petersburg P-22, Russia; [Ilyechova, Ekaterina Y.; Puchkova, Ludmila V.] ITMO Univ, Lab Trace Element Metab, St Petersburg, Russia	Peter the Great St. Petersburg Polytechnic University; Institute of Experimental Medicine; Russian Academy of Medical Sciences; ITMO University	Ilyechova, EY (corresponding author), Peter Great St Petersburg Polytech Univ, Dept Biophys, Inst Phys Nanotechnol & Telecommun, St Petersburg, Russia.	ilichevaey@gmail.com			Russian Foundation for Basic Research (RU) [N15-04-06770]	Russian Foundation for Basic Research (RU)	Support was provided by the Russian Foundation for Basic Research (RU) N15-04-06770.	Adam V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011441; Airede AKI, 1997, E AFR MED J, V74, P221; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; BINGLE CD, 1991, BIOCHEM J, V276, P771, DOI 10.1042/bj2760771; Bogaard HJ, 2012, AM J RESP CELL MOL, V46, P582, DOI 10.1165/rcmb.2011-0296OC; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Bruckmann G, 1939, BIOCHEM J, V33, P1845; Buiakova OI, 1999, HUM MOL GENET, V8, P1665, DOI 10.1093/hmg/8.9.1665; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Cerveza PJ, 2000, ARCH BIOCHEM BIOPHYS, V373, P451, DOI 10.1006/abbi.1999.1572; Chen HJ, 2004, BLOOD, V103, P3933, DOI 10.1182/blood-2003-09-3139; Chu YL, 2012, BIOMETALS, V25, P373, DOI 10.1007/s10534-011-9509-3; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; CZAJA MJ, 1987, J CLIN INVEST, V80, P1200, DOI 10.1172/JCI113180; De Bie P, 2005, J HERED, V96, P803, DOI 10.1093/jhered/esi110; Dodani SC, 2011, J AM CHEM SOC, V133, P8606, DOI 10.1021/ja2004158; Fieten H, 2012, MAMM GENOME, V23, P62, DOI 10.1007/s00335-011-9378-7; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Gerard C, 2010, BIOMATERIALS, V31, P824, DOI 10.1016/j.biomaterials.2009.10.009; GOLDFISCHER S, 1980, AM J PATHOL, V99, P715; GOLDFISCHER S, 1968, AM J PATHOL, V53, P883; Gray LW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038327; GREGORIA.G, 1970, J BIOL CHEM, V245, P5833; Gulec S, 2014, ANNU REV NUTR, V34, P95, DOI 10.1146/annurev-nutr-071812-161215; Gupta A, 2009, FUTURE MED CHEM, V1, P1125, DOI 10.4155/FMC.09.84; Gyulikhandanova NE, 2004, B EXP BIOL MED+, V137, P485, DOI 10.1023/B:BEBM.0000038160.60211.6f; Han H, 2009, BIOL TRACE ELEM RES, V129, P130, DOI 10.1007/s12011-008-8293-6; Healy J, 2007, J NEURAL TRANSM, V114, P777, DOI 10.1007/s00702-007-0687-7; Hiromura M, 2000, BIOCHEM BIOPH RES CO, V275, P394, DOI 10.1006/bbrc.2000.3328; Hurley L S, 1980, Ciba Found Symp, V79, P227; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Kang YJ, 2006, EXP BIOL MED, V231, P1459, DOI 10.1177/153537020623100903; KATAOKA M, 1984, EXP CELL RES, V155, P232, DOI 10.1016/0014-4827(84)90784-5; Kawamata H, 2010, ANTIOXID REDOX SIGN, V13, P1375, DOI 10.1089/ars.2010.3212; Kenney GE, 2012, ACS CHEM BIOL, V7, pA, DOI 10.1021/cb2003913; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Kim H, 2009, AM J PHYSIOL-GASTR L, V296, pG356, DOI 10.1152/ajpgi.90632.2008; Knutson MD, 2007, NUTR REV, V65, P335, DOI 10.1301/nr.2007.jul.335-340; Kodama H, 2012, CURR DRUG METAB, V13, P237, DOI 10.2174/138920012799320455; Kozlowski H, 2014, CURR MED CHEM, V21, P3721, DOI 10.2174/0929867321666140716093838; Lenartowicz M, 2010, J EXP ZOOL PART A, V313A, P209, DOI 10.1002/jez.586; Levy AR, 2014, J PHYS CHEM B, V118, P5832, DOI 10.1021/jp412589b; Liang ZD, 2012, MOL PHARMACOL, V81, P455, DOI 10.1124/mol.111.076422; loannoni R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036338, DOI 10.1371/J0URNAL.P0NE.0036338]; Lutsenko S, 1998, P NATL ACAD SCI USA, V95, P6004, DOI 10.1073/pnas.95.11.6004; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Lynes MA, 2006, EXP BIOL MED, V231, P1548, DOI 10.1177/153537020623100915; Mufti AR, 2007, ARCH BIOCHEM BIOPHYS, V463, P168, DOI 10.1016/j.abb.2007.01.033; Nakazato K, J TOXICOL SCI; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Opazo CM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00143; OWEN JA, 1961, CLIN CHIM ACTA, V6, P441, DOI 10.1016/0009-8981(61)90074-2; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; Platonova N A, 2004, Ontogenez, V35, P171; Platonova NA, 2005, BIOPHYS CHEM, V115, P247, DOI 10.1016/j.bpc.2004.12.014; PLATONOVA NA, 2005, IZV AKAD NAUK BIOL+, V2, P141; Platonova N, 2007, J TRACE ELEM MED BIO, V21, P184, DOI 10.1016/j.jtemb.2007.04.003; Pope CR, 2013, P NATL ACAD SCI USA, V110, P20491, DOI 10.1073/pnas.1309820110; Prudovsky I., 2013, ANGIOL OPEN ACCESS, V1, DOI [10.4172/2329-9495.1000101, DOI 10.4172/2329-9495.1000101]; Puchkova L. V., 1994, Biokhimiya, V59, P296; Ralle M, 2010, J BIOL CHEM, V285, P30875, DOI 10.1074/jbc.M110.114447; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rezk NA, 2015, GENE; Richter OMH, 2003, REV PHYSIOL BIOCH P, V147, P47, DOI 10.1007/s10254-003-0006-0; Rubino JT, 2012, J INORG BIOCHEM, V107, P129, DOI 10.1016/j.jinorgbio.2011.11.024; SRAI SKS, 1986, HEPATOLOGY, V6, P427, DOI 10.1002/hep.1840060318; Summer KH, 2011, J TRACE ELEM MED BIO, V25, P36, DOI 10.1016/j.jtemb.2010.12.002; Suter A, 2001, DEVELOPMENT, V128, P4899; Takahashi Y, 2002, MOL CELL BIOL, V22, P7614, DOI 10.1128/MCB.22.21.7614-7621.2002; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P386, DOI 10.1016/S0753-3322(03)00012-X; Tariba B, 2015, CANCER CHEMOTH PHARM, V75, P813, DOI 10.1007/s00280-015-2702-2; Thirumoorthy N, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-54; Turski ML, 2012, MOL CELL BIOL, V32, P1284, DOI 10.1128/MCB.05722-11; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; Vasak M, 2011, J BIOL INORG CHEM, V16, P1067, DOI 10.1007/s00775-011-0799-2; Vest KE, 2013, J BIOL CHEM, V288, P23884, DOI 10.1074/jbc.M113.470674; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P379, DOI 10.1016/S0091-679X(06)80019-1; Vonk WIM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092408; Vonk WIM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029183; Wee NKY, 2013, INT J BIOCHEM CELL B, V45, P960, DOI 10.1016/j.biocel.2013.01.018; Wissler JH, 2004, ANN NY ACAD SCI, V1022, P163, DOI 10.1196/annals.1318.027; Wissler JH, 2008, ANN NY ACAD SCI, V1137, P316, DOI 10.1196/annals.1448.047; Zatulovskiy EA, 2012, J INORG BIOCHEM, V116, P88, DOI 10.1016/j.jinorgbio.2012.07.003; Zhang SP, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-100; Zischka H, 2011, J CLIN INVEST, V121, P1508, DOI 10.1172/JCI45401	86	26	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140797	10.1371/journal.pone.0140797	http://dx.doi.org/10.1371/journal.pone.0140797			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474410	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500112
J	Allender, MC; Baker, S; Wylie, D; Loper, D; Dreslik, MJ; Phillips, CA; Maddox, C; Driskell, EA				Allender, Matthew C.; Baker, Sarah; Wylie, Daniel; Loper, Daniel; Dreslik, Michael J.; Phillips, Christopher A.; Maddox, Carol; Driskell, Elizabeth A.			Development of Snake Fungal Disease after Experimental Challenge with Ophidiomyces ophiodiicola in Cottonmouths (Agkistrodon piscivorous)	PLOS ONE			English	Article							CROTALUS-HORRIDUS; INFECTION; DERMATITIS	Snake fungal disease (SFD) is a clinical syndrome associated with dermatitis, myositis, osteomyelitis, and pneumonia in several species of free-ranging snakes in the US. The causative agent has been suggested as Ophidiomyces ophiodiicola, but other agents may contribute to the syndrome and the pathogenesis is not understood. To understand the role of O. ophiodiicola in SFD, a cottonmouth snake model of SFD was designed. Five cottonmouths (Agkistrodon piscivorous) were experimentally challenged by nasolabial pit inoculation with a pure culture of O. ophiodiicola. Development of skin lesions or facial swelling at the site of inoculation was observed in all snakes. Twice weekly swabs of the inoculation site revealed variable presence of O. ophiodiicola DNA by qPCR in all five inoculated snakes for 3 to 58 days post-inoculation; nasolabial flushes were not a useful sampling method for detection. Inoculated snakes had a 40% mortality rate. All inoculated snakes had microscopic lesions unilaterally on the side of the swabbed nasolabial pit, including erosions to ulcerations and heterophilic dermatitis. All signs were consistent with SFD; however, the severity of lesions varied in individual snakes, and fungal hyphae were only observed in 3 of 5 inoculated snakes. These three snakes correlated with post-mortem tissue qPCR evidence of O. ophiodiicola. The findings of this study conclude that O. ophiodiicola inoculation in a cottonmouth snake model leads to disease similar to SFD, although lesion severity and the fungal load are quite variable within the model. Future studies may utilize this model to further understand the pathogenesis of this disease and develop management strategies that mitigate disease effects, but investigation of other models with less variability may be warranted.	[Allender, Matthew C.; Loper, Daniel; Dreslik, Michael J.; Phillips, Christopher A.] Univ Illinois, Coll Vet Med, Wildlife Epidemiol Lab, Dept Comparat Biosci, Urbana, IL 61801 USA; [Allender, Matthew C.; Baker, Sarah; Wylie, Daniel] Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA; [Maddox, Carol; Driskell, Elizabeth A.] Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Allender, MC (corresponding author), Univ Illinois, Coll Vet Med, Wildlife Epidemiol Lab, Dept Comparat Biosci, Urbana, IL 61801 USA.	mcallend@illinois.edu	Dreslik, Michael J/G-5325-2012		Illinois Department of Natural Resources [E-57R-1]	Illinois Department of Natural Resources	Funding for the project was provided by the Illinois Department of Natural Resources, grant E-57R-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender MC, 2015, FUNGAL ECOL, V17, P187, DOI 10.1016/j.funeco.2015.05.003; Allender MC, 2015, J VET DIAGN INVEST, V27, P217, DOI 10.1177/1040638715573983; Allender MC, 2013, COPEIA, P97, DOI 10.1643/OT-12-004; Allender MC, 2011, EMERG INFECT DIS, V17, P2383, DOI 10.3201/eid1712.110240; Bohuski E, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0407-8; Cheatwood JL, 2003, J WILDLIFE DIS, V39, P329, DOI 10.7589/0090-3558-39.2.329; Clark RW, 2011, BIOL CONSERV, V144, P886, DOI 10.1016/j.biocon.2010.12.001; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dolinski Amanda C., 2014, Journal of Herpetological Medicine and Surgery, V24, P7, DOI 10.5818/1529-9651-24.1.7; Johnson AJ, 2007, VET PATHOL, V44, P285, DOI 10.1354/vp.44-3-285; McBride MP, 2015, J ZOO WILDLIFE MED, V46, P86, DOI 10.1638/2012-0248R2.1; Rajeev S, 2009, J CLIN MICROBIOL, V47, P1264, DOI 10.1128/JCM.01751-08; Sigler L, 2013, J CLIN MICROBIOL, V51, P3338, DOI 10.1128/JCM.01465-13; Sleeman JM., 2013, NATL WILDLIFE HLTH C; Smith Christopher E., 2013, Herpetological Review, V44, P519; Tetzlaff Sasha, 2015, Herpetology Notes, V8, P31; Vissiennon T, 1999, MYCOSES, V42, P107, DOI 10.1046/j.1439-0507.1999.00409.x	17	38	40	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140193	10.1371/journal.pone.0140193	http://dx.doi.org/10.1371/journal.pone.0140193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469977	gold, Green Published, Green Submitted			2022-12-26	WOS:000363184600031
J	Rodier, M; Quirie, A; Prigent-Tessier, A; Bejot, Y; Jacquin, A; Mossiat, C; Marie, C; Garnier, P				Rodier, Marion; Quirie, Aurore; Prigent-Tessier, Anne; Bejot, Yannick; Jacquin, Agnses; Mossiat, Claude; Marie, Christine; Garnier, Philippe			Relevance of Post-Stroke Circulating BDNF Levels as a Prognostic Biomarker of Stroke Outcome. Impact of rt-PA Treatment	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; NEUROTROPHIC FACTOR BDNF; BLOOD-BRAIN-BARRIER; ISCHEMIC-STROKE; HUMAN PLATELETS; PLASMA-LEVELS; LATE-PHASE; SERUM; PLASTICITY; HYPERTENSION	The recombinant form of tissue plasminogen activator (rt-PA) is the only curative treatment for ischemic stroke. Recently, t-PA has been linked to the metabolism of brain-derived neurotrophic factor (BDNF), a major neurotrophin involved in post-stroke neuroplasticity. Thus, the objective of our study was to investigate the impact of rt-PA treatment on post-stroke circulating BDNF levels in humans and in animals. Serum BDNF levels and t-PA/plasmin activity were measured at hospital admission and at up to 90 days in stroke patients receiving (n = 24) or not (n = 14) rt-PA perfusion. We investigated the relationships between serum BDNF with concurrent t-PA/plasmin activity, neurological outcomes and cardiovascular scores at admission. In parallel, serum BDNF levels and t-PA/plasmin activity were assessed before and after (1, 4 and 24h) the induction of ischemic stroke in rats. Our study revealed higher serum BDNF levels and better neurological outcome in rt-PA-treated than non-treated patients. However, serum BDNF levels did not predict stroke outcome when the whole cohort of stroke patients was analyzed. By contrast, serum BDNF levels when measured at admission and at day 90 correlated with cardiovascular scores, and those at day 1 correlated with serum t-PA/plasmin activity in the whole cohort of patients whereas no association could be found in the rt-PA-treated group. In rats devoid of cardiovascular risk, no difference in post-stroke serum BDNF levels was detected between rt-PA- and vehicle-treated animals and no correlation was found between serum BDNF levels and t-PA/plasmin activity. Overall, the data suggest that serum BDNF levels may not be useful as a prognostic biomarker of stroke outcome and that endothelial dysfunction could be a confounding factor when serum BDNF levels after stroke are used to reflect of brain BDNF levels.	[Rodier, Marion; Quirie, Aurore; Prigent-Tessier, Anne; Mossiat, Claude; Marie, Christine; Garnier, Philippe] Unite INSERM U1093 Cognit Action & Plasticite Sen, F-21078 Dijon, France; [Rodier, Marion; Quirie, Aurore; Prigent-Tessier, Anne; Mossiat, Claude; Marie, Christine; Garnier, Philippe] Univ Bourgogne Franche Comte, F-21079 Dijon, France; [Quirie, Aurore; Garnier, Philippe] IUT, Dept Genie Biol, F-21078 Dijon, France; [Rodier, Marion; Bejot, Yannick; Jacquin, Agnses] Univ Hosp, Dept Neurol, F-21000 Dijon, France; [Bejot, Yannick; Jacquin, Agnses] Ctr Epidemiol Populat, EA4184, F-21000 Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne	Garnier, P (corresponding author), Unite INSERM U1093 Cognit Action & Plasticite Sen, F-21078 Dijon, France.	pgarnier@u-bourgogne.fr	Béjot, Yannick/D-3942-2019; QUIRIE, Aurore/AAZ-4875-2021	Béjot, Yannick/0000-0001-7848-7072; QUIRIE, Aurore/0000-0002-8926-1834; tessier, anne/0000-0001-6655-5074; Garnier, Philippe/0000-0002-7877-3113; marie, christine/0000-0003-3724-0713				Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Begliuomini S, 2007, HUM REPROD, V22, P995, DOI 10.1093/humrep/del479; Bejot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029405; Bejot Y, 2011, NEUROCHEM INT, V58, P102, DOI 10.1016/j.neuint.2010.10.019; Benchenane K, 2005, CIRCULATION, V111, P2241, DOI 10.1161/01.CIR.0000163542.48611.A2; Bus BAA, 2011, PSYCHONEUROENDOCRINO, V36, P228, DOI 10.1016/j.psyneuen.2010.07.013; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Chaldakov GN, 2004, PROG BRAIN RES, V146, P279, DOI 10.1016/S0079-6123(03)46018-4; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; Di Lazzaro V, 2007, NEUROSCI LETT, V422, P128, DOI 10.1016/j.neulet.2007.06.001; Dwivedi Y, 2013, AM J GERIAT PSYCHIAT, V21, P433, DOI 10.1016/j.jagp.2012.10.026; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Ghiadoni L, 2012, CURR VASC PHARMACOL, V10, P42, DOI 10.2174/157016112798829823; Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Jiang H, 2011, BIOCHEM BIOPH RES CO, V415, P99, DOI 10.1016/j.bbrc.2011.10.020; Kaess BM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001544; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Lemarchant S, 2012, NEUROPHARMACOLOGY, V62, P749, DOI 10.1016/j.neuropharm.2011.10.020; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Lorgis L, 2010, FUND CLIN PHARMACOL, V24, P525, DOI 10.1111/j.1472-8206.2009.00790.x; Madinier A, 2013, NEUROSCIENCE, V231, P169, DOI 10.1016/j.neuroscience.2012.11.054; Manni L, 2005, INT J CARDIOL, V102, P169, DOI 10.1016/j.ijcard.2004.10.041; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Millerot-Serrurot E, 2007, NEUROCHEM INT, V50, P328, DOI 10.1016/j.neuint.2006.08.016; Munkholm K, 2014, PSYCHONEUROENDOCRINO, V47, P199, DOI 10.1016/j.psyneuen.2014.05.011; Nagappan G, 2009, P NATL ACAD SCI USA, V106, P1267, DOI 10.1073/pnas.0807322106; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Navaratna D, 2011, DIABETES, V60, P1789, DOI 10.2337/db10-1371; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Pikula A, 2013, STROKE, V44, P2768, DOI 10.1161/STROKEAHA.113.001447; Prigent-Tessier A, 2013, CARDIOVASC RES, V100, P374, DOI 10.1093/cvr/cvt219; Quirie A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044218; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Rodier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092416; ROSENFELD RD, 1995, PROTEIN EXPRES PURIF, V6, P465, DOI 10.1006/prep.1995.1062; Trajkovska V, 2007, BRAIN RES BULL, V73, P143, DOI 10.1016/j.brainresbull.2007.03.009; van Donkelaar EL, 2009, EUR NEUROPSYCHOPHARM, V19, P812, DOI 10.1016/j.euroneuro.2009.06.012; Vivien D, 2011, J CEREBR BLOOD F MET, V31, P2119, DOI 10.1038/jcbfm.2011.127; Yang LL, 2011, INT J GERIATR PSYCH, V26, P495, DOI 10.1002/gps.2552; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Zhou ZM, 2011, CLIN CHEM LAB MED, V49, P185, DOI 10.1515/CCLM.2011.039	46	23	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140668	10.1371/journal.pone.0140668	http://dx.doi.org/10.1371/journal.pone.0140668			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469350	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600091
J	Xiang, Y; Lu, YH; Song, M; Wang, Y; Xu, WQ; Wu, LT; Wang, HC; Ma, ZQ				Xiang, Yang; Lu, Yun Hai; Song, Min; Wang, Yun; Xu, Wenqi; Wu, Lintao; Wang, Hancheng; Ma, Zhengqiang			Overexpression of a Triticum aestivum Calreticulin gene (TaCRT1) Improves Salinity Tolerance in Tobacco	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; DROUGHT TOLERANCE; CHAPERONE CALRETICULIN; CA2+-BINDING CHAPERONE; ESCHERICHIA-COLI; QUALITY-CONTROL; EXPRESSION; IDENTIFICATION	Calreticulin (CRT) is a highly conserved and abundant multifunctional protein that is encoded by a small gene family and is often associated with abiotic/biotic stress responses in plants. However, the roles played by this protein in salt stress responses in wheat (Triticum aestivum) remain obscure. In this study, three TaCRT genes were identified in wheat and named TaCRT1, TaCRT2 and TaCRT3-1 based on their sequence characteristics and their high homology to other known CRT genes. Quantitative real-time PCR expression data revealed that these three genes exhibit different expression patterns in different tissues and are strongly induced under salt stress in wheat. The calcium-binding properties of the purified recombinant TaCRT1 protein were determined using a PIPES/Arsenazo III analysis. TaCRT1 gene overexpression in Nicotiana tabacum decreased salt stress damage in transgenic tobacco plants. Physiological measurements indicated that transgenic tobacco plants showed higher activities of superoxide dismutase (SOD), peroxidase (POD) and catalase (CAT) than non-transgenic tobacco under normal growth conditions. Interestingly, overexpression of the entire TaCRT1 gene or of partial TaCRT1 segments resulted in significantly higher tolerance to salt stress in transgenic plants compared with their WT counterparts, thus revealing the essential role of the C-domain of TaCRT1 in countering salt stress in plants.	[Xiang, Yang; Wu, Lintao] Guizhou Acad Agr Sci, Guizhou Rapeseed Inst, Guiyang, Peoples R China; [Lu, Yun Hai] Fujian Agr & Forestry Univ, Coll Crop Sci, Fuzhou, Peoples R China; [Xiang, Yang; Song, Min; Wang, Yun; Xu, Wenqi; Wang, Hancheng; Ma, Zhengqiang] Nanjing Agr Univ, Crop Genom & Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China; [Xiang, Yang; Song, Min; Wang, Yun; Xu, Wenqi; Wang, Hancheng; Ma, Zhengqiang] Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Song, Min] Qufu Normal Univ, Coll Life Sci, Qufu, Peoples R China	Guizhou Academy of Agricultural Sciences; Fujian Agriculture & Forestry University; Nanjing Agricultural University; Nanjing Agricultural University; Qufu Normal University	Ma, ZQ (corresponding author), Nanjing Agr Univ, Crop Genom & Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China.	zqm2@njau.edu.cn	Ma, Zhengqiang/AAQ-9160-2021; Ma, Zhengqiang/AAI-9876-2020	Ma, Zhengqiang/0000-0003-4950-5387; Xiang, Yang/0000-0003-2393-9216	NFSC program [31360344]; Agricultural Scientific and Technological Research Projects of Guizhou province [NY[2013]3009]; Science & technology special project of Guizhou Academy of Agricultural Sciences [[2014]014]; Engineering Technology Research Center Fund of Guizhou Province [[2012]4006]; Grand Science and Technology Special Project of Guizhou [[2013]6005]	NFSC program; Agricultural Scientific and Technological Research Projects of Guizhou province; Science & technology special project of Guizhou Academy of Agricultural Sciences; Engineering Technology Research Center Fund of Guizhou Province; Grand Science and Technology Special Project of Guizhou	This study was partially supported by NFSC program (31360344), Agricultural Scientific and Technological Research Projects of Guizhou province (No. NY[2013]3009), Science & technology special project of Guizhou Academy of Agricultural Sciences (no. [2014]014), Engineering Technology Research Center Fund of Guizhou Province (No. [2012]4006), and Grand Science and Technology Special Project of Guizhou (no. [2013]6005).	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; An YQ, 2011, GENET MOL RES, V10, P3576, DOI 10.4238/2011.November.10.1; Arnaudeau S, 2002, J BIOL CHEM, V277, P46696, DOI 10.1074/jbc.M202395200; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Borisjuk N, 1998, PLANTA, V206, P504, DOI 10.1007/s004250050427; Boudsocq M, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P75, DOI 10.1007/978-90-481-3112-9_4; Brunagel G, 2003, J CELL BIOCHEM, V89, P238, DOI 10.1002/jcb.10502; CAMACHO P, 1995, CELL, V82, P765, DOI 10.1016/0092-8674(95)90473-5; Chapman JA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0582-8; Chen DQ, 2005, J BIOL CHEM, V280, P22425, DOI 10.1074/jbc.M413380200; CHEN FQ, 1994, PLANT CELL, V6, P835, DOI 10.1105/tpc.6.6.835; Christensen A, 2008, PLANT CELL PHYSIOL, V49, P912, DOI 10.1093/pcp/pcn065; Christensen A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011342; CORBISIER P, 1987, ANAL BIOCHEM, V164, P240, DOI 10.1016/0003-2697(87)90392-7; Coughlan SJ, 1997, PLANT MOL BIOL, V34, P897, DOI 10.1023/A:1005822327479; Dar MA, 2014, APPL BIOCHEM BIOTECH, V174, P1771, DOI 10.1007/s12010-014-1150-5; DENECKE J, 1995, PLANT CELL, V7, P391, DOI 10.1105/tpc.7.4.391; Deng XM, 2013, PHYSIOL PLANTARUM, V149, P367, DOI 10.1111/ppl.12046; Deng Xinyang, 2013, ScientificWorldJournal, V2013, P123731, DOI 10.1155/2013/123731; Ding H, 2014, CLIN EXP IMMUNOL, V178, P236, DOI 10.1111/cei.12411; Ding MQ, 2010, PLANT MOL BIOL, V73, P251, DOI 10.1007/s11103-010-9612-9; Dizaji NB, 2014, GENE, V550, P245, DOI 10.1016/j.gene.2014.08.036; Dresselhaus T, 1996, PLANT MOL BIOL, V31, P23, DOI 10.1007/BF00020603; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; Gao WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067462; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Heilmann I, 2001, PLANT PHYSIOL, V127, P1193, DOI 10.1104/pp.010538; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Jia XY, 2008, J EXP BOT, V59, P739, DOI 10.1093/jxb/erm369; Jia XY, 2009, PHYSIOL PLANTARUM, V136, P127, DOI [10.1111/j.1399-3054.2009.1223.x, 10.1111/j.1399-3054.2009.01223.x]; Jiang YM, 2015, THEOR APPL GENET, V128, P131, DOI 10.1007/s00122-014-2417-5; Jiang Y, 2014, MEMBRANES-BASEL, V4, P630, DOI 10.3390/membranes4030630; Jin H, 2009, P NATL ACAD SCI USA, V106, P13612, DOI 10.1073/pnas.0906144106; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Komatsu S, 2009, AMINO ACIDS, V36, P115, DOI 10.1007/s00726-008-0039-4; Konishi S, 2010, GENES GENET SYST, V85, P167, DOI 10.1266/ggs.85.167; KWIATKOWSKI BA, 1995, GENE, V165, P219, DOI 10.1016/0378-1119(95)00537-G; Laporte C, 2003, PLANT CELL, V15, P2058, DOI 10.1105/tpc.013896; LEARY NO, 1992, CLIN CHEM, V38, P904; Lenartowska M, 2002, PROTOPLASMA, V219, P23, DOI 10.1007/s007090200002; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Li ZJ, 2003, BIOL PHARM BULL, V26, P256, DOI 10.1248/bpb.26.256; Li ZJ, 2000, EUR J BIOCHEM, V267, P737, DOI 10.1046/j.1432-1327.2000.01052.x; Liang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083056; Lim CO, 1996, PLANT PHYSIOL, V111, P577, DOI 10.1104/pp.111.2.577; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MA ZQ, 1995, CROP SCI, V35, P1137, DOI 10.2135/cropsci1995.0011183X003500040037x; Ruiz-Lozano JM, 2012, J EXP BOT, V63, P4033, DOI 10.1093/jxb/ers126; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; MCCAULIFFE DP, 1990, J CLIN INVEST, V85, P1379, DOI 10.1172/JCI114582; MENEGAZZI P, 1993, BIOCHEM BIOPH RES CO, V190, P1130, DOI 10.1006/bbrc.1993.1167; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; NAPIER RM, 1995, J EXP BOT, V46, P1603, DOI 10.1093/jxb/46.10.1603; Nardi MC, 2006, PLANTA, V223, P1263, DOI 10.1007/s00425-005-0175-y; NAUSEEF WM, 1995, J BIOL CHEM, V270, P4741, DOI 10.1074/jbc.270.9.4741; NAVAZIO L, 1995, PLANT PHYSIOL, V109, P983, DOI 10.1104/pp.109.3.983; Negi NP, 2015, PLANT CELL REP, V34, P1109, DOI 10.1007/s00299-015-1770-4; Nelson DE, 1997, PLANT PHYSIOL, V114, P29, DOI 10.1104/pp.114.1.29; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; Opas M, 1996, J CELL BIOL, V135, P1913, DOI 10.1083/jcb.135.6.1913; OSTWALD TJ, 1974, J BIOL CHEM, V249, P974; Persson S, 2003, PLANT PHYSIOL, V133, P1385, DOI 10.1104/pp.103.024943; Persson S, 2002, GENE, V297, P151, DOI 10.1016/S0378-1119(02)00880-6; Persson S, 2001, PLANT PHYSIOL, V126, P1092, DOI 10.1104/pp.126.3.1092; Pinto RD, 2013, FISH SHELLFISH IMMUN, V34, P1611, DOI 10.1016/j.fsi.2013.03.004; POLLE A, 1994, PLANT PHYSIOL, V106, P53, DOI 10.1104/pp.106.1.53; Qiu YJ, 2012, PLANT J, V69, P489, DOI 10.1111/j.1365-313X.2011.04807.x; Qiu YY, 2009, INT J BIOCHEM CELL B, V41, P531, DOI 10.1016/j.biocel.2008.06.020; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Sakono M, 2014, BIOCHEM BIOPH RES CO, V452, P27, DOI 10.1016/j.bbrc.2014.08.041; Sewelam N, 2014, PLANT CELL ENVIRON, V37, P2024, DOI 10.1111/pce.12274; Shan H, 2014, MOL CELL BIOCHEM, V397, P125, DOI 10.1007/s11010-014-2179-z; Sharma A, 2004, PLANT CELL PHYSIOL, V45, P684, DOI 10.1093/pcp/pch077; Sheveleva E, 1997, PLANT PHYSIOL, V115, P1211, DOI 10.1104/pp.115.3.1211; Smith M J, 1992, DNA Seq, V3, P247, DOI 10.3109/10425179209034025; Smith M.J., 1992, DNA Sequence, V2, P235, DOI 10.3109/10425179209020808; SMITH MJ, 1989, EMBO J, V8, P3581, DOI 10.1002/j.1460-2075.1989.tb08530.x; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsou PL, 2012, PLANTA, V235, P539, DOI 10.1007/s00425-011-1522-9; Turkan I, 2009, ENVIRON EXP BOT, V67, P2, DOI 10.1016/j.envexpbot.2009.05.008; Wang WA, 2012, INT J BIOCHEM CELL B, V44, P842, DOI 10.1016/j.biocel.2012.02.009; Waterhouse NJ, 2007, APOPTOSIS, V12, P631, DOI 10.1007/s10495-007-0057-9; Wu YC, 2014, PROTOPLASMA, V251, P1191, DOI 10.1007/s00709-014-0626-z; Wyatt SE, 2002, TRANSGENIC RES, V11, P1, DOI 10.1023/A:1013917701701; Zhang X, 2014, PLANT MOL BIOL, V85, P333, DOI 10.1007/s11103-014-0192-y	95	26	29	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140591	10.1371/journal.pone.0140591	http://dx.doi.org/10.1371/journal.pone.0140591			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469859	Green Submitted, Green Published, gold			2022-12-26	WOS:000363184600082
J	Chen, H; Dou, YG; Tang, Y; Zhang, ZJ; Zheng, XQ; Niu, XY; Yang, J; Yu, XL; Diao, YX				Chen, Hao; Dou, Yanguo; Tang, Yi; Zhang, Zhenjie; Zheng, Xiaoqiang; Niu, Xiaoyu; Yang, Jing; Yu, Xianglong; Diao, Youxiang			Isolation and Genomic Characterization of a Duck-Origin GPV-Related Parvovirus from Cherry Valley Ducklings in China	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS TYPE-2; MUSCOVY DUCKS; PHYLOGENETIC ANALYSIS; CAPSID PROTEINS; MINUTE VIRUS; GOOSE; IDENTIFICATION; STRAINS	A newly emerged duck parvovirus, which causes beak atrophy and dwarfism syndrome (BADS) in Cherry Valley ducks, has appeared in Northern China since March 2015. To explore the genetic diversity among waterfowl parvovirus isolates, the complete genome of an identified isolate designated SDLC01 was sequenced and analyzed in the present study. Genomic sequence analysis showed that SDLC01 shared 90.8%-94.6% of nucleotide identity with goose parvovirus (GPV) isolates and 78.6%-81.6% of nucleotide identity with classical Muscovy duck parvovirus (MDPV) isolates. Phylogenetic analysis of 443 nucleotides (nt) of the fragment A showed that SDLC01 was highly similar to a mule duck isolate (strain D146/02) and close to European GPV isolates but separate from Asian GPV isolates. Analysis of the left inverted terminal repeat regions revealed that SDLC01 had two major segments deleted between positions 160-176 and 306-322 nt compared with field GPV and MDPV isolates. Phylogenetic analysis of Rep and VP1 encoded by two major open reading frames of parvoviruses revealed that SDLC01 was distinct from all GPV and MDPV isolates. The viral pathogenicity and genome characterization of SDLC01 suggest that the novel GPV (N-GPV) is the causative agent of BADS and belongs to a distinct GPV-related subgroup. Furthermore, N-GPV sequences were detected in diseased ducks by polymerase chain reaction and viral proliferation was demonstrated in duck embryos and duck embryo fibroblast cells.	[Chen, Hao; Dou, Yanguo; Tang, Yi; Zheng, Xiaoqiang; Niu, Xiaoyu; Yang, Jing; Yu, Xianglong; Diao, Youxiang] Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China; [Zhang, Zhenjie] Taishan Med Univ, Coll Basic Med, Tai An 271000, Shandong, Peoples R China	Shandong Agricultural University; Shandong First Medical University & Shandong Academy of Medical Sciences	Diao, YX (corresponding author), Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China.	yxdiao@126.com	Niu, Xiaoyu/GPW-8895-2022; Tang, Yi/AAS-3979-2020	Niu, Xiaoyu/0000-0002-6412-7348; 	China Agriculture Research System [CARS-43-10]; National Natural Science Foundation of China [31272583, 31472199]; Science and Technology Development Plan of Shandong Province [2014GNC111023]; Natural Science Foundation of Shandong Province [ZR2014HP068]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Plan of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by the China Agriculture Research System (CARS-43-10) (Youxiang Diao, samples collection); National Natural Science Foundation of China (31272583, 31472199) (Youxiang Diao, nucleotides sequencing); Science and Technology Development Plan of Shandong Province (2014GNC111023) (Youxiang Diao, virus isolation); and Natural Science Foundation of Shandong Province (ZR2014HP068) (Zhenjie Zhang, data analysis).	BERNS KI, 1990, MICROBIOL REV, V54, P316, DOI 10.1128/MMBR.54.3.316-329.1990; Bleker S, 2005, J VIROL, V79, P2528, DOI 10.1128/JVI.79.4.2528-2540.2005; Chang PC, 2000, AVIAN PATHOL, V29, P45, DOI 10.1080/03079450094270; Cotmore SF, 2007, ADV VIRUS RES, V70, P183, DOI 10.1016/S0065-3527(07)70005-2; Girod A, 2002, J GEN VIROL, V83, P973, DOI 10.1099/0022-1317-83-5-973; Glavits R, 2005, ACTA VET HUNG, V53, P73, DOI 10.1556/AVet.53.2005.1.8; Grifman M, 2001, MOL THER, V3, P964, DOI 10.1006/mthe.2001.0345; Kisary J., 1986, Acute virus infections of poultry, P239; KISARY J, 1974, ACTA VET ACAD SCI H, V24, P329; Kontou M, 2005, J VIROL, V79, P10931, DOI 10.1128/JVI.79.17.10931-10943.2005; Kronenberg S, 2005, J VIROL, V79, P5296, DOI 10.1128/JVI.79.9.5296-5303.2005; LEGALLRECULE G, 1994, ARCH VIROL, V139, P121, DOI 10.1007/BF01309459; Lombardo E, 2002, J VIROL, V76, P7049, DOI 10.1128/JVI.76.14.7049-7059.2002; LU YS, 1993, AVIAN DIS, V37, P591, DOI 10.2307/1591694; Lukashov VV, 2001, J VIROL, V75, P2729, DOI 10.1128/JVI.75.6.2729-2740.2001; Opie SR, 2003, J VIROL, V77, P6995, DOI 10.1128/JVI.77.12.6995-7006.2003; Palya V, 2009, AVIAN PATHOL, V38, P175, DOI 10.1080/03079450902737839; Poonia B, 2006, AVIAN PATHOL, V35, P435, DOI 10.1080/03079450601009563; Samorek-Salamonowicz E, 1995, ZYCIE WETERYNARYJNE, V2, P56; Shien JH, 2008, AVIAN PATHOL, V37, P499, DOI 10.1080/03079450802356979; Smith DH, 1999, J VIROL, V73, P2930, DOI 10.1128/JVI.73.4.2930-2937.1999; TAKEHARA K, 1994, AVIAN DIS, V38, P810, DOI 10.2307/1592118; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatar-Kis T, 2004, AVIAN PATHOL, V33, P438, DOI 10.1080/03079450410001724067; ZADORI Z, 1994, AVIAN PATHOL, V23, P359, DOI 10.1080/03079459408419004; ZADORI Z, 1995, VIROLOGY, V212, P562, DOI 10.1006/viro.1995.1514; Zhu YM, 2014, VET MICROBIOL, V174, P560, DOI 10.1016/j.vetmic.2014.10.032; Zsak L, 2008, AVIAN PATHOL, V37, P435, DOI 10.1080/03079450802210648	28	45	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140284	10.1371/journal.pone.0140284	http://dx.doi.org/10.1371/journal.pone.0140284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465143	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100099
J	Escobedo-Cousin, M; Jackson, N; Laza-Briviesca, R; Ariza-McNaughton, L; Luevano, M; Derniame, S; Querol, S; Blundell, M; Thrasher, A; Soria, B; Cooper, N; Bonnet, D; Madrigal, A; Saudemont, A				Escobedo-Cousin, Michelle; Jackson, Nicola; Laza-Briviesca, Raquel; Ariza-McNaughton, Linda; Luevano, Martha; Derniame, Sophie; Querol, Sergio; Blundell, Michael; Thrasher, Adrian; Soria, Bernat; Cooper, Nichola; Bonnet, Dominique; Madrigal, Alejandro; Saudemont, Aurore			Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse Model	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; BONE-MARROW-TRANSPLANTATION; NOD/SCID MICE; T-CELLS; HEMATOLOGIC MALIGNANCY; UNRELATED DONORS; PROGENITOR CELLS; CHEMOKINE SDF-1; CD34(+) CELLS; MIGRATION	Cord blood (CB) is increasingly used as a source of hematopoietic stem cells (HSC) for transplantation. Low incidence and severity of graft-versus-host disease (GvHD) and a robust graft-versus-leukemia (GvL) effect are observed following CB transplantation (CBT). However, its main disadvantages are a limited number of HSC per unit, delayed immune reconstitution and a higher incidence of infection. Unmanipulated grafts contain accessory cells that may facilitate HSC engraftment. Therefore, the effects of accessory cells, particularly natural killer (NK) cells, on human CB HSC (CBSC) functions were assessed in vitro and in vivo. CBSC cultured with autologous CB NK cells showed higher levels of CXCR4 expression, a higher migration index and a higher number of colony forming units (CFU) after short-term and long-term cultures. We found that CBSC secreted CXCL9 following interaction with CB NK cells. In addition, recombinant CXCL9 increased CBSC clonogenicity, recapitulating the effect observed of CB NK cells on CBSC. Moreover, the co-infusion of CBSC with CB NK cells led to a higher level of CBSC engraftment in NSG mouse model. The results presented in this work offer the basis for an alternative approach to enhance HSC engraftment that could improve the outcome of CBT.	[Escobedo-Cousin, Michelle; Luevano, Martha; Derniame, Sophie; Madrigal, Alejandro; Saudemont, Aurore] UCL, Inst Canc, London, England; [Escobedo-Cousin, Michelle; Jackson, Nicola; Laza-Briviesca, Raquel; Luevano, Martha; Derniame, Sophie; Madrigal, Alejandro; Saudemont, Aurore] Anthony Nolan Res Inst, London, England; [Ariza-McNaughton, Linda; Bonnet, Dominique] Canc Res UK, London Res Inst, London, England; [Querol, Sergio] Programa Concordia Banc Sang & Teixits, Barcelona, Spain; [Blundell, Michael; Thrasher, Adrian] UCL, Inst Child Hlth, London, England; [Soria, Bernat] Fdn Progreso & Salud, Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Seville, Spain; [Soria, Bernat] Inst Salud Carlos III, Biomed Res Network Diabet & Related Metab Dis CIB, Madrid, Spain; [Cooper, Nichola] Hammersmith Hosp, Dept Haematol, London, England	University of London; University College London; Cancer Research UK; University of London; University College London; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Instituto de Salud Carlos III; Imperial College London	Saudemont, A (corresponding author), UCL, Inst Canc, London, England.	aurore.saudemont@anthonynolan.org	Blundell, Michael P/M-1276-2015; , Bernat/AAL-6470-2021	Saudemont, Aurore/0000-0002-9376-8339; Bonnet, Dominique/0000-0002-4735-5226; Soria, Bernat/0000-0002-2356-0380; Blundell, Michael/0000-0002-9179-6870; Laza Briviesca, Raquel/0000-0003-2369-567X; Madrigal, Alejandro/0000-0001-8359-9917	Anthony Nolan; CONACyT fellowship; SEP fellowship; Cancer Research UK [15692] Funding Source: researchfish; The Francis Crick Institute [10045] Funding Source: researchfish	Anthony Nolan; CONACyT fellowship(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); SEP fellowship; Cancer Research UK(Cancer Research UK); The Francis Crick Institute	Anthony Nolan funded this work. Michelle Escobedo-Cousin and Martha Luevano are recipients of CONACyT and SEP fellowships.	Adams GB, 2003, BLOOD, V101, P45, DOI 10.1182/blood-2002-02-0486; Adhesion C JA., 2011, METHOD MOL BIOL, V750, P187, DOI [10.1007/978-1-61779-145-1_13, DOI 10.1007/978-1-61779-145-1_13]; Alnabhan R, 2015, CYTOTHERAPY, V17, P73, DOI 10.1016/j.jcyt.2014.08.003; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Barker JN, 2005, BLOOD, V105, P1343, DOI 10.1182/blood-2004-07-2717; Bonig H, 2006, BLOOD, V107, P79, DOI 10.1182/blood-2005-05-2023; Bonnet D, 1999, BONE MARROW TRANSPL, V23, P203, DOI 10.1038/sj.bmt.1701564; Broxmeyer HE, 2006, METHOD ENZYMOL, V419, P439, DOI 10.1016/S0076-6879(06)19018-7; Brunstein CG, 2007, BLOOD, V110, P3064, DOI 10.1182/blood-2007-04-067215; Brunstein CG, 2010, BLOOD, V116, P4693, DOI 10.1182/blood-2010-05-285304; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; Christopherson KW, 2002, J IMMUNOL, V169, P7000, DOI 10.4049/jimmunol.169.12.7000; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Eldjerou LK, 2010, BLOOD, V116, P3999, DOI 10.1182/blood-2010-03-276212; Gluckman E, 1997, NEW ENGL J MED, V337, P373, DOI 10.1056/NEJM199708073370602; Hexner EO, 2007, BIOL BLOOD MARROW TR, V13, P1135, DOI 10.1016/j.bbmt.2007.06.010; Hu B, 2012, J IMMUNOL, V189, P1661, DOI 10.4049/jimmunol.1103199; Jaatinen Taina, 2007, Curr Protoc Stem Cell Biol, VChapter 2, DOI [10.1002/9780470151808.sc02a02s1, 10.1002/9780470151808.sc02a01s1]; Jiang Z, 2002, BIOL BLOOD MARROW TR, V8, P588, DOI 10.1053/bbmt.2002.v8.abbmt080588; Kang HJ, 2006, BONE MARROW TRANSPL, V38, P197, DOI 10.1038/sj.bmt.1705423; Kim DH, 2006, BIOL BLOOD MARROW TR, V12, P719, DOI 10.1016/j.bbmt.2006.03.005; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Luevano M, 2012, HUM IMMUNOL, V73, P248, DOI 10.1016/j.humimm.2011.12.015; Park CY, 2008, NAT PROTOC, V3, P1932, DOI 10.1038/nprot.2008.194; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Pfeiffer MM, 2012, LEUKEMIA, V26, P2435, DOI 10.1038/leu.2012.167; Popat U, 2015, BLOOD, V125, P2885, DOI 10.1182/blood-2015-01-607366; Robinson SN, 2012, EXP HEMATOL, V40, P445, DOI 10.1016/j.exphem.2012.01.015; Rocha V, 2000, NEW ENGL J MED, V342, P1846, DOI 10.1056/NEJM200006223422501; Rubinstein P, 1998, NEW ENGL J MED, V339, P1565, DOI 10.1056/NEJM199811263392201; Tarnowski M, 2010, EUR J HAEMATOL, V85, P472, DOI 10.1111/j.1600-0609.2010.01531.x; Terakura S, 2007, BIOL BLOOD MARROW TR, V13, P822, DOI 10.1016/j.bbmt.2007.03.006; van Heeckeren WJ, 2007, BRIT J HAEMATOL, V139, P464, DOI 10.1111/j.1365-2141.2007.06824.x; Verstegen MMA, 1998, BLOOD, V91, P1966, DOI 10.1182/blood.V91.6.1966.1966_1966_1976; Voermans C, 2001, BLOOD, V97, P799, DOI 10.1182/blood.V97.3.799; Wu KH, 2013, TRANSPLANTATION, V95, P773, DOI 10.1097/TP.0b013e31827a93dd	38	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138623	10.1371/journal.pone.0138623	http://dx.doi.org/10.1371/journal.pone.0138623			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465138	Green Published, gold			2022-12-26	WOS:000363183100019
J	Magron, A; Elowe, S; Carreau, M				Magron, Audrey; Elowe, Sabine; Carreau, Madeleine			The Fanconi Anemia C Protein Binds to and Regulates Stathmin-1 Phosphorylation	PLOS ONE			English	Article							REPLICATION STRESS; CELL-CYCLE; IN-VITRO; KINASE; IDENTIFICATION; PATHWAY; SITES; CENTROSOME; EXPRESSION; MUTATIONS	The Fanconi anemia (FA) proteins are involved in a signaling network that assures the safeguard of chromosomes. To understand the function of FA proteins in cellular division events, we investigated the interaction between Stathmin-1 (STMN1) and the FA group C (FANCC) protein. STMN1 is a ubiquitous cytosolic protein that regulates microtubule dynamics. STMN1 activities are regulated through phosphorylation-dephosphorylation mechanisms that control assembly of the mitotic spindle, and dysregulation of STMN1 phosphorylation is associated with mitotic aberrancies leading to chromosome instability and cancer progression. Using different biochemical approaches, we showed that FANCC interacts and co-localizes with STMN1 at centrosomes during mitosis. We also showed that FANCC is required for STMN1 phosphorylation, as mutations in FANCC reduced serine 16- and 38-phosphorylated forms of STMN1. Phosphorylation of STMN1 at serine 16 is likely an event dependent on a functional FA pathway, as it is reduced in FANCA- and FANCD2-mutant cells. Furthermore, FA-mutant cells exhibited mitotic spindle anomalies such as supernumerary centrosomes and shorter mitotic spindles. These results suggest that FA proteins participate in the regulation of cellular division via the microtubule-associated protein STMN1.	[Elowe, Sabine; Carreau, Madeleine] Univ Laval, Dept Pediat, Quebec City, PQ, Canada; [Magron, Audrey; Elowe, Sabine; Carreau, Madeleine] CHU Quebec, CHUL Res Ctr, Quebec City, PQ, Canada	Laval University; Laval University	Carreau, M (corresponding author), Univ Laval, Dept Pediat, Quebec City, PQ, Canada.	madeleine.carreau@crchul.ulaval.ca		Carreau, Madeleine/0000-0002-0582-6114	Fanconi Anemia Research Fund Inc.; Fanconi Canada (the Canadian Fanconi Anemia Research Fund/La Fondation Canadienne de Recherche de l'Anemie de Fanconi); Canadian Leukemia Lymphoma Society; Foundation of Stars	Fanconi Anemia Research Fund Inc.; Fanconi Canada (the Canadian Fanconi Anemia Research Fund/La Fondation Canadienne de Recherche de l'Anemie de Fanconi); Canadian Leukemia Lymphoma Society; Foundation of Stars	This work was supported in part by grants from the Fanconi Anemia Research Fund Inc., Fanconi Canada (the Canadian Fanconi Anemia Research Fund/La Fondation Canadienne de Recherche de l'Anemie de Fanconi) and the Canadian Leukemia Lymphoma Society. S.E. is a Young Investigator of the Canadian Institutes of Health Research. Additional support was provided by the Foundation of Stars (training award to A.M.).	Alter Blanche P, 2007, Hematology Am Soc Hematol Educ Program, P29, DOI 10.1182/asheducation-2007.1.29; Alter BP, 2003, CANCER-AM CANCER SOC, V97, P425, DOI 10.1002/cncr.11046; Andersen SSL, 1997, NATURE, V389, P640, DOI 10.1038/39382; Antonsson B, 1998, J BIOL CHEM, V273, P8439, DOI 10.1074/jbc.273.14.8439; Belletti B, 2011, EXPERT OPIN THER TAR, V15, P1249, DOI 10.1517/14728222.2011.620951; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1995, EUR J BIOCHEM, V227, P388, DOI 10.1111/j.1432-1033.1995.tb20401.x; BERETTA L, 1993, J BIOL CHEM, V268, P20076; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Brodeur I, 2004, J BIOL CHEM, V279, P4713, DOI 10.1074/jbc.M301291200; Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chen M, 1996, NAT GENET, V12, P448, DOI 10.1038/ng0496-448; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; DiPaolo G, 1997, FEBS LETT, V416, P149, DOI 10.1016/S0014-5793(97)01188-5; Du J, 2009, ACTA BIOCH BIOPH SIN, V41, P816, DOI 10.1093/abbs/gmp074; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Gavet O, 1998, J CELL SCI, V111, P3333; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Guervilly JH, 2015, MOL CELL, V57, P123, DOI 10.1016/j.molcel.2014.11.014; Gupta KK, 2013, P NATL ACAD SCI USA, V110, P20449, DOI 10.1073/pnas.1309958110; Hira A, 2015, AM J HUM GENET, V96, P1001, DOI 10.1016/j.ajhg.2015.04.022; Huang FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092811; Huard CC, 2014, P NATL ACAD SCI USA, V111, P2152, DOI 10.1073/pnas.1314226111; Huard CC, 2013, BLOOD, V121, P1729, DOI 10.1182/blood-2012-02-408997; Iancu C, 2000, CANCER RES, V60, P3537; Iancu-Rubin C, 2005, CELL CYCLE, V4, P1774, DOI 10.4161/cc.4.12.2171; Kaddar T, 2012, ANEMIA, V2012, DOI 10.1155/2012/425814; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Kim S, 2013, INT J BIOCHEM CELL B, V45, P1953, DOI 10.1016/j.biocel.2013.06.012; Kupfer GM, 1997, BLOOD, V90, P1047, DOI 10.1182/blood.V90.3.1047.1047_1047_1054; LARSSON N, 1995, J BIOL CHEM, V270, P14175, DOI 10.1074/jbc.270.23.14175; Longerich S, 2014, BLOOD, V124, P2812, DOI 10.1182/blood-2014-04-526293; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Miceli C, 2013, CANCER GENE THER, V20, P298, DOI 10.1038/cgt.2013.21; Mistry SJ, 1998, BIOCHEM J, V334, P23, DOI 10.1042/bj3340023; Mistry SJ, 2002, MT SINAI J MED, V69, P299; Mistry SJ, 2001, ANTISENSE NUCLEIC A, V11, P41, DOI 10.1089/108729001750072119; Naim V, 2013, NAT CELL BIOL, V15, P1008, DOI 10.1038/ncb2793; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Nakanishi A, 2007, BIOCHEM BIOPH RES CO, V355, P34, DOI 10.1016/j.bbrc.2007.01.100; Nalepa Grzegorz, 2014, F1000Prime Rep, V6, P23, DOI 10.12703/P6-23; Nalepa G, 2013, J CLIN INVEST, V123, P3839, DOI 10.1172/JCI67364; Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108; Ozon S, 1998, J NEUROCHEM, V70, P2386; Pawlikowska P, 2014, BLOOD, V124, P3613, DOI 10.1182/blood-2014-01-551457; Ringhoff DN, 2009, MOL BIOL CELL, V20, P3451, DOI 10.1091/mbc.E09-02-0140; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Rubin CI, 2003, EXP HEMATOL, V31, P389, DOI 10.1016/S0301-472X(03)00043-2; Sawyer SL, 2015, CANCER DISCOV, V5, P135, DOI 10.1158/2159-8290.CD-14-1156; Schneider M, 2015, CLIN GENET, V88, P13, DOI 10.1111/cge.12517; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Tremblay CS, 2008, BLOOD, V112, P2062, DOI 10.1182/blood-2008-04-152710; Vinciguerra P, 2010, J CLIN INVEST, V120, P3834, DOI 10.1172/JCI43391; Yamashita T, 1996, BLOOD, V87, P4424, DOI 10.1182/blood.V87.10.4424.bloodjournal87104424; Zou JQ, 2013, BIOL OPEN, V2, P1022, DOI 10.1242/bio.20135801	60	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140612	10.1371/journal.pone.0140612	http://dx.doi.org/10.1371/journal.pone.0140612			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466335	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100153
J	Moreno, LO; Lamacchia, O; Copetti, M; Salvemini, L; De Bonis, C; De Cosmo, S; Cignarelli, M; Trischitta, V; Menzaghi, C				Moreno, Lorena Ortega; Lamacchia, Olga; Copetti, Massimiliano; Salvemini, Lucia; De Bonis, Concetta; De Cosmo, Salvatore; Cignarelli, Mauro; Trischitta, Vincenzo; Menzaghi, Claudia			Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes	PLOS ONE			English	Article							INSULIN-RESISTANCE; KIDNEY-DISEASE; RENAL-FUNCTION; METAANALYSIS; NEPHROPATHY; DYSFUNCTION; ADIPOKINES; RECEPTOR; TISSUE	High serum adiponectin has been increased in several conditions of kidney disease. Only sparse and conflicting results have been reported in patients with type 2 diabetes (T2D), a subgroup of individuals who are at high risk for renal dysfunction. The aim of this study was to fill up this gap of knowledge by investigating such association in a large sample of Italian diabetic patients. The association between serum adiponectin levels and estimated glomerular filtration rate (eGFR by Chronic Kidney Disease-Epidemiology Collaboration CKD-EPI equation) was investigated in 1,243 patients with T2D from two cross-sectional Italian studies: 878 from San Giovanni Rotondo (SGR) and 365 from Foggia (FG). Serum adiponectin was inversely associated with eGFR in SGR [beta (standard error, SE) for 1 standard deviation (SD) of adiponectin = -3.26 (0.64)] and in FG [beta(SE)=-5.70(1.28)] sample, as well as in the two studies combined [beta(SE)=-3.99(0.59)];(p<0.0001 for all). In this combined analysis, the association was still significant after adjusting for sex, smoking habits, body mass index (BMI), waist circumference, diabetes duration, glycated hemoglobin (HbA1c), albumin creatinine ratio (ACR) and anti-hyperglycemic, anti-hypertensive and anti-dyslipidemic treatments [beta (SE)= -2.19 (0.59), p = 0.0001]. A stronger association between each SD adiponectin increment and low eGFR was observed among patients with micro-/macro-albuminuria, as compared to those with normo-albuminuria [adjusted beta(SE)=-4.42(1.16) ml/min/ 1.73m(2) vs. -1.50 (0.67) ml/min/1.73m(2), respectively; p for adiponectin-by-albuminuric status = 0.022]. For each adiponectin SD increment, the odds of having eGFR <60 ml/min/1.73m2 increased by 41% (odds ratio, OR = 1.41; 95% confidence interval, CI 1.21-1.64) in SGR sample, 53% (OR = 1.53; 95% CI 1.21-1.94) in FG sample, and 44% (OR = 1.44; 95% CI 1.27-1.64) in the two studies considered together (p<0.0001 for all). In the combined sample, further adjustment for the above mentioned covariates did not change the observed association (OR = 1.36; 95% CI 1.16-1.60; p<0.0001). Our study, so far the largest addressing the relationship between serum adiponectin and GFR in T2D, strongly suggests that the paradoxical inverse association, previously reported in different clinical sets, is also observed in diabetic patients. Further studies are needed to unravel the biology underlying this counterintuitive relationship.	[Moreno, Lorena Ortega; Salvemini, Lucia; De Bonis, Concetta; Trischitta, Vincenzo; Menzaghi, Claudia] IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy; [Lamacchia, Olga; Cignarelli, Mauro] Univ Foggia, Dept Med & Surg Sci, Unit Endocrinol, Foggia, Italy; [Copetti, Massimiliano] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, Italy; [De Cosmo, Salvatore] IRCCS Casa Sollievo Sofferenza, Div Internal Med, San Giovanni Rotondo, Italy; [Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	IRCCS Casa Sollievo Della Sofferenza; University of Foggia; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Sapienza University Rome	Trischitta, V (corresponding author), IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy.	vincenzo.trischitta@uniroma1.it; c.menzaghi@operapadrepio.it	COPETTI, MASSIMILIANO/AAG-1473-2021; Salvemini, Lucia/K-2121-2016; DE BONIS, CONCETTA/AAM-8146-2020; Ortega Moreno, Lorena/ABI-5355-2020; De Cosmo, Salvatore/J-7420-2016; Menzaghi, Claudia/J-7210-2016; TRISCHITTA, Vincenzo/K-1487-2016	COPETTI, MASSIMILIANO/0000-0002-7960-5947; Salvemini, Lucia/0000-0001-8776-9477; Ortega Moreno, Lorena/0000-0001-6008-8559; De Cosmo, Salvatore/0000-0001-8787-8286; Menzaghi, Claudia/0000-0002-7438-8955; TRISCHITTA, Vincenzo/0000-0003-1174-127X	Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST; Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PO Puglia FESR; Italian Ministry of Health; European Foundation for the Study of Diabetes/Pfizer grant; Societa Italiana di Diabetologia-Fondazione Diabete Ricerca; Italian Ministry of Health Ricerca Finalizzata	Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST; Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PO Puglia FESR; Italian Ministry of Health(Ministry of Health, Italy); European Foundation for the Study of Diabetes/Pfizer grant; Societa Italiana di Diabetologia-Fondazione Diabete Ricerca; Italian Ministry of Health Ricerca Finalizzata(Ministry of Health, Italy)	This study was supported by Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST 2006 and PO Puglia FESR 2007-2013, Italian Ministry of Health grants RC2014 and RC2015, European Foundation for the Study of Diabetes/Pfizer grant, Societa Italiana di Diabetologia-Fondazione Diabete Ricerca and Italian Ministry of Health Ricerca Finalizzata 2013. Dr. Ortega Moreno is supported by a grant from Societa Italiana di Diabetologia-Fondazione Diabete Ricerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso Y, 2009, TRANSL RES, V154, P175, DOI 10.1016/j.trsl.2009.07.005; Barlovic DP, 2009, CYTOKINE, V46, P142, DOI 10.1016/j.cyto.2009.01.001; Beige J, 2009, EXPERT OPIN THER TAR, V13, P163, DOI [10.1517/14728220802658481 , 10.1517/14728220802658481]; Cantarin MPM, 2014, NEPHROL DIAL TRANSPL, V29, P2268, DOI 10.1093/ndt/gfu249; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Christou GA, 2014, J ENDOCRINOL, V221, pR49, DOI 10.1530/JOE-13-0578; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; De Cosmo S, 2013, NEPHROL DIAL TRANSPL, V28, P3031, DOI 10.1093/ndt/gft325; De Cosmo S, 2012, NEPHROL DIAL TRANSPL, V27, P4411, DOI 10.1093/ndt/gfs148; Doumatey AP, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/730920; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Fang F, 2015, DIABETOLOGIA, V58, P1668, DOI 10.1007/s00125-015-3605-9; Guo LL, 2009, NEPHROL DIAL TRANSPL, V24, P1876, DOI 10.1093/ndt/gfn770; Guo XH, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.230; Kacso IM, 2012, SCAND J CLIN LAB INV, V72, P333, DOI 10.3109/00365513.2012.668928; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kato K, 2008, CLIN ENDOCRINOL, V68, P442, DOI 10.1111/j.1365-2265.2007.03063.x; Kawamoto R, 2011, ENDOCR RES, V36, P53, DOI 10.3109/07435800.2010.534754; Komaba H, 2006, AM J NEPHROL, V26, P476, DOI 10.1159/000096870; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lim S, 2014, ATHEROSCLEROSIS, V233, P721, DOI 10.1016/j.atherosclerosis.2014.01.051; Lin J, 2007, DIABETES CARE, V30, P239, DOI 10.2337/dc06-1296; Looker HC, 2004, J CLIN ENDOCR METAB, V89, P4010, DOI 10.1210/jc.2003-031916; Maahs DM, 2007, AM J EPIDEMIOL, V166, P731, DOI 10.1093/aje/kwm125; Matsuda M, 2014, REV ENDOCR METAB DIS, V15, P1, DOI 10.1007/s11154-013-9271-7; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Menzaghi C, 2011, DIABETOLOGIA, V54, P812, DOI 10.1007/s00125-010-2037-9; Menzaghi C, 2010, J INTERN MED, V267, P287, DOI 10.1111/j.1365-2796.2009.02141.x; Moreno LO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119529; Olkin I, 1998, BIOMETRICS, V54, P317, DOI 10.2307/2534018; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Risch L, 2007, CLIN CHIM ACTA, V376, P108, DOI 10.1016/j.cca.2006.07.026; Saraheimo M, 2005, DIABETES CARE, V28, P1410, DOI 10.2337/diacare.28.6.1410; Schalkwijk CG, 2006, J CLIN ENDOCR METAB, V91, P129, DOI 10.1210/jc.2005-1117; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Sharma K, 2014, KIDNEY INT SUPPL, V4, P113, DOI 10.1038/kisup.2014.21; Shen YY, 2007, NEPHROL DIAL TRANSPL, V22, P171, DOI 10.1093/ndt/gfl552; Sweiss N, 2014, BEST PRACT RES CL EN, V28, P71, DOI 10.1016/j.beem.2013.08.002; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Yenicesu M, 2005, CLIN NEPHROL, V64, P12; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134	43	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140631	10.1371/journal.pone.0140631	http://dx.doi.org/10.1371/journal.pone.0140631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465607	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100157
J	Tao, J; Liang, J; Zhang, H; Pei, LJ; Qian, HZ; Chambers, MC; Jiang, Y; Xiao, Y				Tao, Jun; Liang, Jun; Zhang, Hui; Pei, Lijian; Qian, Han-zhu; Chambers, Matthew C.; Jiang, Yan; Xiao, Yao			The Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in China	PLOS ONE			English	Article							HEPATITIS-C VIRUS; PEGYLATED INTERFERON; VIROLOGICAL RESPONSE; RISK FACTOR; HIV; THERAPY; SEROCONVERSION; TRANSMISSION; COMBINATION; PREVALENCE	Background More than half of intravenous drug users (IDUs) in China suffer from the Hepatitis C virus (HCV). The virus is also more prevalent in non-injection drug users (NIDUs) than in the general population. However, not much is known about HCV subtype distribution in these populations. Methods Our research team conducted a cross-sectional study in four provinces in China. We sampled 825 IDUs and 244 NIDUs (1162 total), genotyped each DU's virus, and performed a phylogenetic analysis to differentiate HCV subtypes. Results Nucleic acid testing (NAT) determined that 82% percent (952/1162) of samples were HCV positive; we subtyped 90% (859/952) of these. We found multiple HCV subtypes: 3b (249, 29.0%), 3a (225, 26.2%), 6a (156, 18.2%), 1b (137, 15.9%), 6n (50, 5.9%), 1a (27, 3.1%), and 2a (15, 1.7%). An analysis of subtype distributions adjusted for province found statistically significant differences between HCV subtypes in IDUs and NIDUs. Discussion HCV subtypes 3b, 3a, 6a, and 1b were the most common in our study, together accounting for 89% of infections. The subtype distribution differences we found between IDUs and NIDUs suggested that sharing syringes was not the most likely pathway for HCV transmission in NIDUs. However, further studies are needed to elucidate how NIDUs were infected.	[Tao, Jun; Qian, Han-zhu] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA; [Liang, Jun; Zhang, Hui; Pei, Lijian; Jiang, Yan; Xiao, Yao] Chinese Ctr Dis Control & Prevent China CDC, Natl AIDS Reference Lab NARL, Natl Ctr AIDS STD Control & Prevent NCAIDS, Beijing, Peoples R China; [Qian, Han-zhu] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Chambers, Matthew C.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA	Vanderbilt University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Vanderbilt University; Vanderbilt University	Jiang, Y (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl AIDS Reference Lab NARL, Natl Ctr AIDS STD Control & Prevent NCAIDS, Beijing, Peoples R China.	jiangyan03@263.net; xiaoyao@chinaaids.cn		Tao, Jun/0000-0002-1940-8634				Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Bowden DS, 2006, FUTURE MICROBIOL, V1, P103, DOI 10.2217/17460913.1.1.103; Bruno S, 1997, HEPATOLOGY, V25, P754, DOI 10.1002/hep.510250344; Derbala M, 2005, J VIRAL HEPATITIS, V12, P380, DOI 10.1111/j.1365-2893.2005.00604.x; Di Bisceglie AM, 2002, HEPATOLOGY, V36, pS121, DOI 10.1053/jhep.2002.36228; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Fuller CM, 2003, JAIDS, V32, P86, DOI 10.1097/00126334-200301010-00013; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hagan H, 2004, EPIDEMIOLOGY, V15, P543, DOI 10.1097/01.ede.0000135170.54913.9d; Hagan H, 2001, AM J PUBLIC HEALTH, V91, P42, DOI 10.2105/AJPH.91.1.42; Hahn JA, 2002, J INFECT DIS, V186, P1558, DOI 10.1086/345554; Legrand-Abravanel F, 2009, J MED VIROL, V81, P2029, DOI 10.1002/jmv.21583; Min JA, 2013, J MED VIROL, V85, P575, DOI 10.1002/jmv.23523; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Nguyen Mindie H, 2005, Clin Gastroenterol Hepatol, V3, pS97, DOI 10.1016/S1542-3565(05)00711-1; Pellicelli AM, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-162; Rezza G, 1996, SCAND J INFECT DIS, V28, P27, DOI 10.3109/00365549609027145; Roulot D, 2007, J VIRAL HEPATITIS, V14, P460, DOI 10.1111/j.1365-2893.2006.00823.x; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Scheinmann R, 2007, DRUG ALCOHOL DEPEN, V89, P1, DOI 10.1016/j.drugalcdep.2006.11.014; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Tanimoto T, 2010, J MED VIROL, V82, P1355, DOI 10.1002/jmv.21787; Tao Jun, 2012, Chinese Journal of Viral Diseases, V2, P117; Terrault NA, 2002, HEPATOLOGY, V36, pS99, DOI 10.1053/jhep.2002.36797; van den Berg CHSB, 2009, J VIRAL HEPATITIS, V16, P568, DOI 10.1111/j.1365-2893.2009.01105.x; Wejstal R, 1999, J HEPATOL, V31, P92, DOI 10.1016/S0168-8278(99)80382-1; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhuang X, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-130	30	7	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140263	10.1371/journal.pone.0140263	http://dx.doi.org/10.1371/journal.pone.0140263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466103	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100096
J	Olsvik, HL; Lamark, T; Takagi, K; Larsen, KB; Evjen, G; Overvatn, A; Mizushima, T; Johansen, T				Olsvik, Hallvard L.; Lamark, Trond; Takagi, Kenji; Larsen, Kenneth Bowitz; Evjen, Gry; Overvatn, Aud; Mizushima, Tsunehiro; Johansen, Terje			FYCO1 Contains a C-terminally Extended, LC3A/B-preferring LC3-interacting Region (LIR) Motif Required for Efficient Maturation of Autophagosomes during Basal Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE AUTOPHAGY; STRUCTURAL BASIS; PROTEIN; LC3; DEGRADATION; GABARAP; COMPLEX; ATG8; P62; RECRUITMENT	FYCO1 (FYVE and coiled-coil protein 1) is a transport adaptor that binds to phosphatidylinositol 3-phosphate, to Rab7, and to LC3 (microtubule-associated protein 1 light chain 3) to mediate transport of late endosomes and autophagosomes along microtubules in the plus end direction. We have previously shown that FYCO1 binds to LC3B via a 19-amino acid sequence containing a putative core LC3-interacting region (LIR) motif. Here, we show that FYCO1 preferentially binds to LC3A and -B. By peptide array-based two-dimensional mutational scans of the binding to LC3B, we found FYCO1 to contain a C-terminally extended LIR domain. We determined the crystal structure of a complex between a 13-amino acid LIR peptide from FYCO1 and LC3B at 1.53 angstrom resolution. By combining the structural information with mutational analyses, both the basis for the C-terminally extended LIR and the specificity for LC3A/B binding were revealed. FYCO1 contains a 9-amino acid-long F-type LIR motif. In addition to the canonical aromatic residue at position 1 and the hydrophobic residue at position 3, an acidic residue and a hydrophobic residue at positions 8 and 9, respectively, are important for efficient binding to LC3B explaining the C-terminal extension. The specificity for binding to LC3A/B is due to the interaction between Asp1285 in FYCO1 and His(57) in LC3B. To address the functional significance of the LIR motif of FYCO1, we generated FYCO1 knock-out cells that subsequently were reconstituted with GFP-FYCO1 WT and LIR mutant constructs. Our data show that FYCO1 requires a functional LIR motif to facilitate efficient maturation of autophagosomes under basal conditions, whereas starvation-induced autophagy was unaffected.	[Olsvik, Hallvard L.; Lamark, Trond; Larsen, Kenneth Bowitz; Evjen, Gry; Overvatn, Aud; Johansen, Terje] UiT Arctic Univ Norway, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway; [Takagi, Kenji; Mizushima, Tsunehiro] Univ Hyogo, Grad Sch Life Sci, Picobiol Inst, Kobe, Hyogo 6512197, Japan	UiT The Arctic University of Tromso; University of Hyogo	Johansen, T (corresponding author), UiT Arctic Univ Norway, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway.	terje.johansen@uit.no	Johansen, Terje/N-2971-2015; Johansen, Terje/AAY-1753-2021; Larsen, Kenneth/HDO-5510-2022	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Evjen, Gry/0000-0002-8313-0593; Lamark, Trond/0000-0001-6338-3342; Olsvik, Hallvard/0000-0003-3489-7461; Mizushima, Tsunehiro/0000-0002-6631-2889	FRIBIO of the Norwegian Research Council [196898, 214448]; FRIBIOMED of the Norwegian Research Council [196898, 214448]; Norwegian Cancer Society [71043-PR-2006-0320]	FRIBIO of the Norwegian Research Council; FRIBIOMED of the Norwegian Research Council; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from the FRIBIO and FRIBIOMED programs of the Norwegian Research Council (Grants 196898 and 214448) and by the Norwegian Cancer Society (Grant 71043-PR-2006-0320) (to T. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Chen JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/j.ajhg.2011.05.008; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fu MM, 2014, DEV CELL, V29, P577, DOI 10.1016/j.devcel.2014.04.015; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Geeraert C, 2010, J BIOL CHEM, V285, P24184, DOI 10.1074/jbc.M109.091553; Genau HM, 2015, MOL CELL, V57, P995, DOI 10.1016/j.molcel.2014.12.040; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lystad AH, 2014, EMBO REP, V15, P557, DOI 10.1002/embr.201338003; Ma J, 2014, J IMMUNOL, V192, P1356, DOI 10.4049/jimmunol.1302835; Ma PX, 2013, J BIOL CHEM, V288, P37204, DOI 10.1074/jbc.M113.528067; Manil-Segalen M, 2014, DEV CELL, V28, P43, DOI 10.1016/j.devcel.2013.11.022; Maruyama Y, 2014, BIOCHEM BIOPH RES CO, V446, P309, DOI 10.1016/j.bbrc.2014.02.093; McEwan DG, 2015, MOL CELL, V57, P39, DOI 10.1016/j.molcel.2014.11.006; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mrakovic A, 2012, TRAFFIC, V13, P1667, DOI 10.1111/tra.12003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Raiborg C, 2015, NATURE, V520, P234, DOI 10.1038/nature14359; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rogov VV, 2013, BIOCHEM J, V454, P459, DOI 10.1042/BJ20121907; Rozenknop A, 2011, J MOL BIOL, V410, P477, DOI 10.1016/j.jmb.2011.05.003; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Shvets E, 2011, AUTOPHAGY, V7, P683, DOI 10.4161/auto.7.7.15279; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki H, 2014, STRUCTURE, V22, P47, DOI 10.1016/j.str.2013.09.023; Szalai P, 2015, EXP CELL RES, V333, P21, DOI 10.1016/j.yexcr.2015.02.003; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292	46	78	80	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29361	29374		10.1074/jbc.M115.686915	http://dx.doi.org/10.1074/jbc.M115.686915			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468287	hybrid, Green Published			2022-12-26	WOS:000366613400022
J	Ahmed, RH; Huri, HZ; Al-Hamodi, Z; Salem, SD; Muniandy, S				Ahmed, Radwan H.; Huri, Hasniza Zaman; Al-Hamodi, Zaid; Salem, Sameer D.; Muniandy, Sekaran			Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; DPP-4 INHIBITORS; ORAL GLUCOSE; DIPEPTIDYL; METFORMIN; CD26; INFLAMMATION	Background A soluble form of CD26/dipeptidyl peptidase-IV (sCD26/DPP-IV) induces DPP-IV enzymatic activity that degrades incretin. We investigated fasting serum levels of sCD26/DPP-IV and active glucagon-like peptide-1 (GLP-1) in Malaysian patients with type 2 diabetes mellitus (T2DM) with and without metabolic syndrome (MetS), as well as the associations between sCD26/DPP-IV levels, MetS, and antidiabetic therapy. Methods We assessed sCD26/DPP-IV levels, active GLP-1 levels, body mass index (BMI), glucose, insulin, A1c, glucose homeostasis indices, and lipid profiles in 549 Malaysian subjects (including 257 T2DM patients with MetS, 57 T2DM patients without MetS, 71 non-diabetics with MetS, and 164 control subjects without diabetes or metabolic syndrome). Results Fasting serum levels of sCD26/DPP-IV were significantly higher in T2DM patients with and without MetS than in normal subjects. Likewise, sCD26/DPP-IV levels were significantly higher in patients with T2DM and MetS than in non-diabetic patients with MetS. However, active GLP-1 levels were significantly lower in T2DM patients both with and without MetS than in normal subjects. In T2DM subjects, sCD26/DPP-IV levels were associated with significantly higher A1c levels, but were significantly lower in patients using monotherapy with metformin. In addition, no significant differences in sCD26/DPP-IV levels were found between diabetic subjects with and without MetS. Furthermore, sCD26/DPP-IV levels were negatively correlated with active GLP-1 levels in T2DM patients both with and without MetS. In normal subjects, sCD26/DPP-IV levels were associated with increased BMI, cholesterol, and LDL-cholesterol (LDL-c) levels. Conclusion Serum sCD26/DPP-IV levels increased in T2DM subjects with and without MetS. Active GLP-1 levels decreased in T2DM patients both with and without MetS. In addition, sCD26/DPP-IV levels were associated with Alc levels and negatively correlated with active GLP-1 levels. Moreover, metformin monotherapy was associated with reduced sCD26/DPP-IV levels. In normal subjects, sCD26/DPP-IV levels were associated with increased BMI, cholesterol, and LDL-c.	[Ahmed, Radwan H.; Muniandy, Sekaran] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Huri, Hasniza Zaman] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Huri, Hasniza Zaman] Univ Malaya, Med Ctr, Clin Invest Ctr, Kuala Lumpur, Malaysia; [Al-Hamodi, Zaid; Salem, Sameer D.] Sanaa Univ, Fac Med, Dept Biochem & Mol Biol, Sanaa, Yemen	Universiti Malaya; Universiti Malaya; Universiti Malaya	Ahmed, RH (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	radwanalhamody@yahoo.com; sekaran@um.edu.my	MUNIANDY, SEKARAN/B-5345-2010; Ahmed, Radwan H./O-3803-2018; HURI, HASNIZA ZAMAN/B-8612-2010	MUNIANDY, SEKARAN/0000-0003-1310-3634; Ahmed, Radwan H./0000-0003-1398-6772; HURI, HASNIZA ZAMAN/0000-0002-6423-8515	University of Malaya [HIR/420001-E000046, RP024A-14HTM, PG035-2014A]	University of Malaya(Universiti Malaya)	This study was supported by research grants HIR/420001-E000046 and RP024A-14HTM and PPP Grant PG035-2014A from the University of Malaya.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2013, DIABETES ATLAS; Aso Y, 2013, TRANSL RES, V162, P309, DOI 10.1016/j.trsl.2013.07.011; Barnett A, 2006, INT J CLIN PRACT, V60, P1454, DOI 10.1111/j.1742-1241.2006.01178.x; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Blaslov K, 2015, J DIABETES COMPLICAT, V29, P390, DOI 10.1016/j.jdiacomp.2014.12.019; Blaslov K, 2015, J DIABETES, V7, P340, DOI 10.1111/1753-0407.12194; Busso N, 2005, AM J PATHOL, V166, P433, DOI 10.1016/S0002-9440(10)62266-3; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Durinx C, 2000, EUR J BIOCHEM, V267, P5608, DOI 10.1046/j.1432-1327.2000.01634.x; Fadini GP, 2012, DIABETES OBES METAB, V14, P518, DOI 10.1111/j.1463-1326.2011.01550.x; Feron D, 2009, PEPTIDES, V30, P256, DOI 10.1016/j.peptides.2008.11.004; Firneisz G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012226; Freeman Jeffrey S, 2009, Cleve Clin J Med, V76 Suppl 5, pS12, DOI 10.3949/ccjm.76.s5.03; Green BD, 2006, EUR J PHARMACOL, V547, P192, DOI 10.1016/j.ejphar.2006.07.043; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; *INT DIAB FED, 2014, DIABETES ATLAS; Kobayashi H, 2002, J RHEUMATOL, V29, P1858; Korosi J, 2001, J GERONTOL A-BIOL, V56, pM575, DOI 10.1093/gerona/56.9.M575; Kusunoki M, 2015, DRUG RES; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Lee SA, 2013, J CLIN ENDOCR METAB, V98, P2553, DOI 10.1210/jc.2012-4288; Legakis IN, 2003, DIABETES CARE, V26, P252, DOI 10.2337/diacare.26.1.252; Lenhard JM, 2004, BIOCHEM BIOPH RES CO, V324, P92, DOI 10.1016/j.bbrc.2004.09.021; Lindsay JR, 2005, DIABETIC MED, V22, P654, DOI 10.1111/j.1464-5491.2005.01461.x; Liu Y, 2014, DIABETES OBES METAB, V16, P111, DOI 10.1111/dom.12128; Matsuzawa Y, 2008, INT J OBESITY, V32, pS83, DOI 10.1038/ijo.2008.243; Matteucci E, 2009, CURR MED CHEM, V16, P2943, DOI 10.2174/092986709788803114; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKillop AM, 2008, DIABETES RES CLIN PR, V79, P79, DOI 10.1016/j.diabres.2007.08.001; Meneilly GS, 2000, DIABETIC MED, V17, P346, DOI 10.1046/j.1464-5491.2000.00236.x; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; Pala L, 2005, DIABETOLOGIA, V48, P1168, DOI 10.1007/s00125-005-1749-8; Pala L, 2003, BIOCHEM BIOPH RES CO, V310, P28, DOI 10.1016/j.bbrc.2003.08.111; Pala L, 2010, DIABETIC MED, V27, P691, DOI 10.1111/j.1464-5491.2010.03010.x; Ryskjaer J, 2006, EUR J ENDOCRINOL, V155, P485, DOI 10.1530/eje.1.02221; Scheen AJ, 2012, DIABETES METAB, V38, P89, DOI 10.1016/j.diabet.2011.11.001; Shirakawa J, 2011, DIABETES, V60, P1246, DOI 10.2337/db10-1338; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; Yang F., 2014, PLOS ONE, V9; Zhang F, 2012, INT J MED SCI, V9, P574, DOI 10.7150/ijms.4128; Zheng T, 2014, J HUMAN HYPERTENSION	42	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140618	10.1371/journal.pone.0140618	http://dx.doi.org/10.1371/journal.pone.0140618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474470	gold, Green Published, Green Submitted			2022-12-26	WOS:000363185500073
J	Misra, A; Anoop, S; Gulati, S; Mani, K; Bhatt, SP; Pandey, RM				Misra, Anoop; Anoop, Shajith; Gulati, Seema; Mani, Kalaivani; Bhatt, Surya Prakash; Pandey, Ravindra Mohan			Body Fat Patterning, Hepatic Fat and Pancreatic Volume of Non-Obese Asian Indians with Type 2 Diabetes in North India: A Case-Control Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ABDOMINAL ADIPOSE-TISSUE; INSULIN-RESISTANCE; LIVER-DISEASE; SOUTH ASIANS; OBESITY; MEN; SENSITIVITY; MELLITUS; HEALTHY	Objective To evaluate body fat patterning and phenotype including hepatic fat and pancreatic volume of non-obese (BMI: < 25 kg/m(2)) Asian Indians with type 2 diabetes residing in North India. Methods Non-obese patients with type 2 diabetes (n = 93) and non-obese, normo-glycemic subjects (n = 40) were recruited. BMI, waist & hip circumferences, skinfold thickness at 8 sites, body fat, lean mass and detailed abdominal fat evaluation [total abdominal fat, total subcutaneous fat (superficial, deep, anterior, and posterior), total intra-abdominal fat (intra-peritoneal, retroperitoneal)], liver span, grades of fatty liver and pancreatic volume were compared. Results Waist circumference, subscapular skinfolds and total truncal fat (on DEXA) were higher whereas calf, total peripheral skinfolds and total leg fat (on DEXA) lower in patients. Specifically, the following volumes were higher in cases as compared to controls; total abdominal fat (19.4%), total intra-abdominal fat (49.7%), intra-peritoneal fat (47.7%), retroperitoneal fat (70.7%), pancreatic volume (26.6%), pancreatic volume index (21.3%) and liver span (10.8%). In cases, significant positive correlations were observed for pancreatic volume with BMI, waist and hip circumferences, W-HR, subscapular, abdominal and total truncal skinfolds, truncal, total subcutaneous, total intra-abdominal, intra-peritoneal, retroperitoneal fat depots, liver span and fatty liver. Conclusions In non-obese Asian Indians with type 2 diabetes, subcutaneous and intra-abdominal obesity, including fatty liver, and pancreatic volume were higher and peripheral subcutaneous adiposity was lower than BMI matched non-diabetic subjects. Importantly, increased pancreatic volume in patients was highly correlated with multiple measures of abdominal obesity and liver fat.	[Misra, Anoop; Anoop, Shajith; Gulati, Seema; Bhatt, Surya Prakash] Natl Diabet Obes & Cholesterol Fdn N DOC, Ctr Nutr & Metab Res C NET, SDA, New Delhi, India; [Misra, Anoop; Anoop, Shajith; Gulati, Seema; Bhatt, Surya Prakash] Diabet Fdn India, SDA, New Delhi, India; [Misra, Anoop] Fortis C DOC Ctr Excellence Diabet Metab Dis & En, New Delhi, India; [Misra, Anoop] Fortis Flt Lt Rajan Dhall Hosp, New Delhi, India; [Mani, Kalaivani; Pandey, Ravindra Mohan] All India Inst Med Sci, Dept Biostat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Misra, A (corresponding author), Natl Diabet Obes & Cholesterol Fdn N DOC, Ctr Nutr & Metab Res C NET, SDA, New Delhi, India.	anoopmisra@gmail.com	Bhatt, Surya/K-5263-2019; Bhatt, Surya Prakash/X-5941-2018	Bhatt, Surya/0000-0001-9489-9747; Bhatt, Surya Prakash/0000-0001-9489-9747	Merck Pharma Ltd, India; National Diabetes, Obesity and cholesterol foundation	Merck Pharma Ltd, India; National Diabetes, Obesity and cholesterol foundation	This study was supported by a financial grant from Merck Pharma Ltd, India. The sponsors had no role in study design, experiments, data analysis and drafting the manuscript and decision to publish. National Diabetes, Obesity and cholesterol foundation provided internal financial assistance in the form of authors' salaries and research materials.	Abate N, 2004, J CLIN ENDOCR METAB, V89, P2750, DOI 10.1210/jc.2003-031843; ABATE N, 1995, J CLIN INVEST, V96, P88, DOI DOI 10.1172/JCI118083; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Bhatt SP, 2013, METAB SYNDR RELAT D, V11, P329, DOI 10.1089/met.2012.0064; Burute N, 2014, PANCREATOLOGY, V14, P268, DOI 10.1016/j.pan.2014.04.031; Chandalia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000812; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Dudeja V, 2001, BRIT J NUTR, V86, P105, DOI 10.1079/BJN2001382; Frayling TM, 2003, DIABETES, V52, P1857, DOI 10.2337/diabetes.52.7.1857; Goda K, 2001, ACTA DIABETOL, V38, P145, DOI 10.1007/s005920170012; Goel K, 2010, HEART, V96, P579, DOI 10.1136/hrt.2009.183236; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Kruit JK, 2010, CURR OPIN LIPIDOL, V21, P178, DOI 10.1097/MOL.0b013e328339387b; Lindroos AS, 2002, J CLIN ENDOCR METAB, V87, P3023; Lingvay I, 2009, J CLIN ENDOCR METAB, V94, P4070, DOI 10.1210/jc.2009-0584; Misra A, 2011, INT J OBESITY, V35, P167, DOI 10.1038/ijo.2010.135; Misra A, 2003, NUTRITION, V19, P815, DOI 10.1016/S0899-9007(03)00141-2; Misra A, 2003, DIABETIC MED, V20, P361, DOI 10.1046/j.1464-5491.2003.00932.x; Misra A, 2008, DIABETES CARE, V31, P1282, DOI 10.2337/dc07-2316; Misra A, 2006, METABOLISM, V55, P1569, DOI 10.1016/j.metabol.2006.06.029; Misra A, 2013, NUTRIENTS, V5, P2708, DOI 10.3390/nu5072708; Misra A, 2010, METAB SYNDR RELAT D, V8, P243, DOI 10.1089/met.2009.0046; Nigam P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049286; Permutt Z, 2012, ALIMENT PHARM THER, V36, P22, DOI 10.1111/j.1365-2036.2012.05121.x; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Shen W, 2003, OBES RES, V11, P5, DOI 10.1038/oby.2003.3; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Yoon KH, 2011, DIABETES METAB J, V35, P26, DOI [10.4093/dmj.2011.35.1.26, 10.4093/dmj.2011.35.5.444]	30	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140447	10.1371/journal.pone.0140447	http://dx.doi.org/10.1371/journal.pone.0140447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474415	gold, Green Published, Green Submitted			2022-12-26	WOS:000363185500052
J	Kokkinopoulos, I; Ishida, H; Saba, R; Ruchaya, P; Cabrera, C; Struebig, M; Barnes, M; Terry, A; Kaneko, M; Shintani, Y; Coppen, S; Shiratori, H; Ameen, T; Mein, C; Hamada, H; Suzuki, K; Yashiro, K				Kokkinopoulos, Ioannis; Ishida, Hidekazu; Saba, Rie; Ruchaya, Prashant; Cabrera, Claudia; Struebig, Monika; Barnes, Michael; Terry, Anna; Kaneko, Masahiro; Shintani, Yasunori; Coppen, Steven; Shiratori, Hidetaka; Ameen, Torath; Mein, Charles; Hamada, Hiroshi; Suzuki, Ken; Yashiro, Kenta			Single-Cell Expression Profiling Reveals a Dynamic State of Cardiac Precursor Cells in the Early Mouse Embryo	PLOS ONE			English	Article							2ND HEART FIELD; HOLT-ORAM-SYNDROME; TRANSCRIPTION FACTOR TBX5; CONDUCTION SYSTEM; PHARYNGEAL MESODERM; MYOCARDIAL-CELLS; PRIMITIVE-STREAK; VERTEBRATE HEART; MAMMALIAN HEART; CRE-RECOMBINASE	In the early vertebrate embryo, cardiac progenitor/precursor cells (CPs) give rise to cardiac structures. Better understanding their biological character is critical to understand the heart development and to apply CPs for the clinical arena. However, our knowledge remains incomplete. With the use of single-cell expression profiling, we have now revealed rapid and dynamic changes in gene expression profiles of the embryonic CPs during the early phase after their segregation from the cardiac mesoderm. Progressively, the nascent mesodermal gene Mesp1 terminated, and Nkx2-5(+)/Tbx5(+) population rapidly replaced the Tbx5(low+) population as the expression of the cardiac genes Tbx5 and Nkx2-5 increased. At the Early Headfold stage, Tbx5-expressing CPs gradually showed a unique molecular signature with signs of cardiomyocyte differentiation. Lineage-tracing revealed a developmentally distinct characteristic of this population. They underwent progressive differentiation only towards the cardiomyocyte lineage corresponding to the first heart field rather than being maintained as a progenitor pool. More importantly, Tbx5 likely plays an important role in a transcriptional network to regulate the distinct character of the FHF via a positive feedback loop to activate the robust expression of Tbx5 in CPs. These data expands our knowledge on the behavior of CPs during the early phase of cardiac development, subsequently providing a platform for further study.	[Kokkinopoulos, Ioannis; Ishida, Hidekazu; Saba, Rie; Ruchaya, Prashant; Kaneko, Masahiro; Shintani, Yasunori; Coppen, Steven; Ameen, Torath; Suzuki, Ken; Yashiro, Kenta] Queen Mary Univ London, Translat Med & Therapeut, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Ruchaya, Prashant] Univ Sao Paulo State UNESP, Physiol & Pathol, Araraquara Sch Dent, Sao Paulo, Brazil; [Cabrera, Claudia] Queen Mary Univ London, Clin Pharmacol, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Cabrera, Claudia; Struebig, Monika; Barnes, Michael; Terry, Anna; Mein, Charles] Queen Mary Univ London, Genome Ctr, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Cabrera, Claudia] Queen Mary Univ London, NIHR Barts Cardiovasc Biomed Res Unit, Barts & London Sch Med & Dent, London, England; [Hamada, Hiroshi] Osaka Univ, Dept Dev Genet, Grad Sch Frontier Biosci, Suita, Osaka, Japan	University of London; Queen Mary University London; Universidade Estadual Paulista; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; Osaka University	Yashiro, K (corresponding author), Queen Mary Univ London, Translat Med & Therapeut, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.	k.yashiro@qmul.ac.uk	Hamada, Hiroshi/N-6374-2015	Hamada, Hiroshi/0000-0002-7196-5948; ruchaya, prashant/0000-0001-9580-4746; Mein, Charles/0000-0003-0811-9658; Shintani, Yasunori/0000-0001-9579-0727; Barnes, Michael/0000-0001-9097-7381; Terry, Anna/0000-0002-1946-8223	Medical Research Council (MRC) [G0900105, MR/J007625/1]; MRC [G0900105, MR/J007625/1, G1000461] Funding Source: UKRI; British Heart Foundation [RG/15/3/31236] Funding Source: researchfish; Medical Research Council [MR/J007625/1, G1000461, G0900105] Funding Source: researchfish; Grants-in-Aid for Scientific Research [24113004] Funding Source: KAKEN	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Medical Research Council (MRC) New Investigator Research Grant (G0900105) and the MRC Research Grant (MR/J007625/1 to KY) (http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker ML, 2008, CIRC RES, V102, P1340, DOI 10.1161/CIRCRESAHA.107.169565; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Brouilette S, 2012, DEV DYNAM, V241, P1584, DOI 10.1002/dvdy.23850; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cagavi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110752; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304; Devine WP, 2014, ELIFE, V3, DOI 10.7554/eLife.03848; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fijnvandraat AC, 2003, J MUSCLE RES CELL M, V24, P211, DOI 10.1023/A:1026063409656; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Hoogaars WMH, 2004, CARDIOVASC RES, V62, P489, DOI 10.1016/j.cardiores.2004.01.030; INAGAKI T, 1993, DEV DYNAM, V197, P57, DOI 10.1002/aja.1001970106; Jensen B, 2013, BBA-MOL CELL RES, V1833, P783, DOI 10.1016/j.bbamcr.2012.10.004; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kawasumi A, 2011, DEV BIOL, V353, P321, DOI 10.1016/j.ydbio.2011.03.009; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kelly RG, 2012, CURR TOP DEV BIOL, V100, P33, DOI 10.1016/B978-0-12-387786-4.00002-6; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Lescroart F, 2014, NAT CELL BIOL, V16, P829, DOI 10.1038/ncb3024; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Liang XQ, 2013, CIRC RES, V113, P399, DOI 10.1161/CIRCRESAHA.113.301588; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; Moorman AFM, 2007, PHILOS T R SOC B, V362, P1257, DOI 10.1098/rstb.2007.2113; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moskowitz IPG, 2004, DEVELOPMENT, V131, P4107, DOI 10.1242/dev.01265; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nelson DO, 2014, DEV DYNAM, V243, P381, DOI 10.1002/dvdy.24078; OBRIEN TX, 1993, P NATL ACAD SCI USA, V90, P5157, DOI 10.1073/pnas.90.11.5157; Park EJ, 2008, DEV DYNAM, V237, P447, DOI 10.1002/dvdy.21415; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Rana MS, 2013, ACTA PHYSIOL, V207, P588, DOI 10.1111/apha.12061; Saga Y, 1999, DEVELOPMENT, V126, P3437; Schoenwolf GC, 1995, CELL MOL BIOL RES, V41, P233; Shen MM, 1997, DEVELOPMENT, V124, P429; Shintani Y, 2013, P NATL ACAD SCI USA, V110, P5109, DOI 10.1073/pnas.1219243110; Smemo S, 2012, HUM MOL GENET, V21, P3255, DOI 10.1093/hmg/dds165; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spaeter D, 2013, NAT CELL BIOL, V15, P1098, DOI 10.1038/ncb2824; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stolfi A, 2010, SCIENCE, V329, P565, DOI 10.1126/science.1190181; Sun GF, 2004, J CELL BIOCHEM, V92, P189, DOI 10.1002/jcb.20039; Takaoka K, 2011, NAT CELL BIOL, V13, P743, DOI 10.1038/ncb2251; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tam PPL, 1997, DEVELOPMENT, V124, P1631; Tian Y, 2010, PEDIATR CARDIOL, V31, P342, DOI 10.1007/s00246-009-9606-z; Tzahor E, 2011, CARDIOVASC RES, V91, P196, DOI 10.1093/cvr/cvr116; Uehara M, 2009, GENE DEV, V23, P1689, DOI 10.1101/gad.1776209; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang W, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001725; Watanabe Y, 2012, P NATL ACAD SCI USA, V109, P18273, DOI 10.1073/pnas.1215360109; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Xie LL, 2012, DEV CELL, V23, P280, DOI 10.1016/j.devcel.2012.06.006; Yamahara K, 2008, BIOCHEM BIOPH RES CO, V371, P615, DOI 10.1016/j.bbrc.2008.04.021; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0	72	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140831	10.1371/journal.pone.0140831	http://dx.doi.org/10.1371/journal.pone.0140831			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469858	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600121
J	Ponnusamy, S; Haldar, S; Mulani, F; Zinjarde, S; Thulasiram, H; RaviKumar, A				Ponnusamy, Sudha; Haldar, Saikat; Mulani, Fayaj; Zinjarde, Smita; Thulasiram, Hirekodathakallu; RaviKumar, Ameeta			Gedunin and Azadiradione: Human Pancreatic Alpha-Amylase Inhibiting Limonoids from Neem (Azadirachta indica) as Anti-Diabetic Agents	PLOS ONE			English	Article							MEDICINAL-PLANTS; LEAF EXTRACT; BINDING; RESOLUTION; MECHANISM; CHLORIDE; ACARBOSE; CALCIUM	Human pancreatic alpha-amylase (HPA) inhibitors offer an effective strategy to lower postprandial hyperglycemia via control of starch breakdown. Limonoids from Azadirachta indica known for their therapeutic potential were screened for pancreatic alpha-amylase inhibition, a known anti-diabetic target. Studies were carried out to reveal their mode of action so as to justify their hypoglycemic potential. Of the nine limonoids isolated/semi-synthesized from A. indica and screened for alpha-amylase inhibition, azadiradione and exhibited potential inhibition with an IC50 value of 74.17 and 68.38 mu M, respectively against HPA under in vitro conditions. Further screening on AR42J alpha-amylase secretory cell line for cytotoxicity and bioactivity revealed that azadiradione and gedunin exhibited cytotoxicity with IC50 of 11.1 and 13.4 mu M. Maximal secreted alpha-amylase inhibition of 41.8% and 53.4% was seen at 3.5 and 3.3 mu M, respectively. Michaelis-Menten kinetics suggested a mixed mode of inhibition with maltopentaose (K-i 42.2, 18.6 mu M) and starch (K-i' 75.8, 37.4 mu M) as substrate with a stiochiometry of 1: 1 for both azadiradione and gedunin, respectively. The molecular docking simulation indicated plausible p-alkyl and alkyl-alkyl interactions between the aromatic amino acids and inhibitors. Fluorescence and CD confirmed the involvement of tryptophan and tyrosine in ligand binding to HPA. Thermodynamic parameters suggested that binding is enthalpically and entropically driven with Delta G degrees of -21.25 kJ mol(-1) and -21.16 kJ mol(-1) for azadiradione and gedunin, respectively. Thus, the limonoids azadiradione and gedunin could bind and inactivate HPA (anti-diabetic target) and may prove to be lead drug candidates to reduce/control post-prandial hyperglycemia.	[Ponnusamy, Sudha; Zinjarde, Smita; RaviKumar, Ameeta] Savitribai Phule Pune Univ, Inst Bioinformat & Biotechnol, Pune 411007, Maharashtra, India; [Haldar, Saikat; Mulani, Fayaj; Thulasiram, Hirekodathakallu] CSIR, Natl Chem Lab, Div Organ Chem, Chem Biol Unit, Pune 411008, Maharashtra, India	Savitribai Phule Pune University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Thulasiram, H (corresponding author), CSIR, Natl Chem Lab, Div Organ Chem, Chem Biol Unit, Pune 411008, Maharashtra, India.	hv.thulasiram@ncl.res.in; ameeta@unipune.ac.in			UPE-Phase-II program of University Grants Commission, New Delhi [UGC-262-A]	UPE-Phase-II program of University Grants Commission, New Delhi	The study was funded by UPE-Phase-II program of University Grants Commission, New Delhi (grant no. UGC-262-A).	Accelrys Software Inc, 2013, DISCOVERY STUDIO MOD; Alam A, 2012, J BIOL CHEM, V287, P24844, DOI 10.1074/jbc.M112.341321; Bastaki S., 2005, INT J DIABETES METAB, V13, P111; Beverley B, 2003, TXB DIABETES, P1; Bigoniya P., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS290; Biswas K, 2002, CURR SCI INDIA, V82, P1336; Brahmachari G., 2004, CHEMBIOCHEM, V5, P408, DOI DOI 10.1002/cbic.200300749; BRAYER GD, 1995, PROTEIN SCI, V4, P1730, DOI 10.1002/pro.5560040908; BUISSON G, 1987, EMBO J, V6, P3909, DOI 10.1002/j.1460-2075.1987.tb02731.x; CHAKRABORTTY T, 1989, PHYTOTHER RES, V3, P30, DOI 10.1002/ptr.2650030108; CHAMPAGNE DE, 1992, PHYTOCHEMISTRY, V31, P377, DOI 10.1016/0031-9422(92)90003-9; Cheng AYY, 2005, CAN MED ASSOC J, V172, P213, DOI 10.1503/cmaj.1031414; Chianese G, 2010, J NAT PROD, V73, P1448, DOI 10.1021/np100325q; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; CHRISTOPHE J, 1994, AM J PHYSIOL, V266, pG963, DOI 10.1152/ajpgi.1994.266.6.G963; Coman C, 2012, NOT BOT HORTI AGROBO, V40, P314; Desseaux V, 2002, BIOLOGIA, V57, P163; Dewanjee S, 2009, FITOTERAPIA, V80, P249, DOI 10.1016/j.fitote.2009.02.004; EL-HAWARY Z M, 1990, Archives of Pharmacal Research (Seoul), V13, P108, DOI 10.1007/BF02857845; Eum WS, 2003, EXP MOL MED, V35, P379, DOI 10.1038/emm.2003.50; Feller G, 1996, J BIOL CHEM, V271, P23836, DOI 10.1074/jbc.271.39.23836; Gavin JR, 1997, DIABETES CARE, V20, P1183; Ghosh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106039; GOVINDACHARI TR, 1992, CURR SCI INDIA, V63, P117; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Haldar S, 2013, ANAL METHODS-UK, V5, P5386, DOI 10.1039/c3ay41136b; Haldar S, 2013, GREEN CHEM, V15, P1311, DOI 10.1039/c3gc40193f; Hashim A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/729393; Hegde SS, 1998, BBA-PROTEIN STRUCT M, V1388, P93, DOI 10.1016/S0167-4838(98)00163-0; Kazanjian KK, 2003, J SURG RES, V114, P95, DOI 10.1016/S0022-4804(03)00218-X; Kazeem M I, 2013, Pak J Biol Sci, V16, P1358, DOI 10.3923/pjbs.2013.1358.1362; KHALID SA, 1989, J NAT PROD, V52, P922, DOI 10.1021/np50065a002; Khalil-Moghaddam S, 2012, DARU, V20, P1; Kikuchi T, 2011, J NAT PROD, V74, P866, DOI 10.1021/np100783k; Krentz AJ, 2005, DRUGS, V65, P385, DOI 10.2165/00003495-200565030-00005; Kumar DB, 2011, PHARMACOG COMMUN, V1, P78, DOI DOI 10.5530/PC.2011.1.5; Kumar P, 2002, TXB CLIN MED, V8th, P1099; Li CM, 2005, BIOCHEMISTRY-US, V44, P3347, DOI 10.1021/bi048334e; Luna B, 2001, AM FAM PHYSICIAN, V63, P1747; MARSHALL JJ, 1975, J BIOL CHEM, V250, P8030; Perez-Gutierrez RM, 2012, BIOL PHARM BULL, V35, P1516, DOI 10.1248/bpb.b12-00246; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mukherjee PK, 2006, J ETHNOPHARMACOL, V106, P1, DOI 10.1016/j.jep.2006.03.021; Najafian M, 2011, MOL BIOL REP, V38, P1617, DOI 10.1007/s11033-010-0271-3; PASERO L, 1986, BIOCHIM BIOPHYS ACTA, V869, P147, DOI 10.1016/0167-4838(86)90289-X; Patwardhan B, 2004, CURR SCI INDIA, V86, P789; Payan F, 2003, J PROTEIN CHEM, V22, P275, DOI 10.1023/A:1025072520607; Ponnusamy S, 2013, NAT PROD J, V3, P15, DOI 10.2174/2210315511303010005; Ponnusamy S, 2012, FOOD CHEM, V135, P2638, DOI 10.1016/j.foodchem.2012.06.110; Ponnusamy S, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/515647; Powers J. R., 1977, Journal of Food Biochemistry, V1, P239, DOI 10.1111/j.1745-4514.1978.tb00184.x; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Tan QG, 2011, CHEM REV, V111, P7437, DOI 10.1021/cr9004023; Tarling CA, 2008, CHEMBIOCHEM, V9, P433, DOI 10.1002/cbic.200700470; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tundis R, 2010, MINI-REV MED CHEM, V10, P315, DOI 10.2174/138955710791331007; WHITAKER JR, 1988, BIOCHIMIE, V70, P1153, DOI 10.1016/0300-9084(88)90180-0; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; WHO, 2011, GLOBAL STATUS REPORT; Wiese S, 2009, J SCI FOOD AGR, V89, P33, DOI 10.1002/jsfa.3407; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	62	47	47	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140113	10.1371/journal.pone.0140113	http://dx.doi.org/10.1371/journal.pone.0140113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469405	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600027
J	Titon, B; Gomes, FR				Titon Junior, Braz; Gomes, Fernando Ribeiro			Relation between Water Balance and Climatic Variables Associated with the Geographical Distribution of Anurans	PLOS ONE			English	Article							LOCOMOTOR PERFORMANCE; CUTANEOUS RESISTANCE; FROG; ABSORPTION; SKIN; REHYDRATION; DEHYDRATION; TEMPERATURE; AQUAPORINS; HYDRATION	Amphibian species richness increases toward the equator, particularly in humid tropical forests. This relation between amphibian species richness and environmental water availability has been proposed to be a consequence of their high rates of evaporative water loss. In this way, traits that estimate water balance are expected to covary with climate and constrain a species' geographic distribution. Furthermore, we predicted that coexisting species of anurans would have traits that are adapted to local hydric conditions. We compared the traits that describe water balance in 17 species of anurans that occur in the mesic Atlantic Forest and xeric Cerrado (savannah) habitats of Brazil. We predicted that species found in the warmer and dryer areas would show a lower sensitivity of locomotor performance to dehydration (SLPD), increased resistance to evaporative water loss (REWL) and higher rates of water uptake (RWU) than species restricted to the more mesic areas. We estimated the allometric relations between the hydric traits and body mass using phylogenetic generalized least squares. These regressions showed that REWL scaled negatively with body mass, whereas RWU scaled positively with body mass. Additionally, species inhabiting areas characterized by higher and more seasonally uniform temperatures, and lower and more seasonally concentrated precipitation, such as the Cerrado, had higher RWU and SLPD than species with geographical distributions more restricted to mesic environments, such as the Atlantic Forest. These results support the hypothesis that the interspecific variation of physiological traits shows an adaptation pattern to abiotic environmental traits.	[Titon Junior, Braz; Gomes, Fernando Ribeiro] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Titon, B (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, SP, Brazil.	titonjr.b@hotmail.com	Gomes, Fernando Ribeiro/C-5997-2012	Gomes, Fernando/0000-0003-2244-6161	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2006/54699-1, 2008/01917-7, 2010/16804-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grant 2006/54699-1, led by FRG, and grants 2008/01917-7 and 2010/16804-3, led by BTJ; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (website: http://www.fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT AF, 1973, J COMP PHYSIOL, V87, P351, DOI 10.1007/BF00695269; BENNETT AF, 1974, COMP BIOCHEM PHYSIOL, V48, P319, DOI 10.1016/0300-9629(74)90712-9; BENTLEY PJ, 1958, J EXP BIOL, V35, P677; Bertoluci J, 1998, J HERPETOL, V32, P607, DOI 10.2307/1565223; BEUCHAT CA, 1984, J COMP PHYSIOL, V154, P579, DOI 10.1007/BF00684411; Boutilier Robert G., 1992, P81; Brasileiro Cínthia Aguirre, 2005, Biota Neotrop., V5, P93, DOI 10.1590/S1676-06032005000300006; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Buttemer WA, 2003, AUST J ZOOL, V51, P111, DOI 10.1071/ZO02057; CHRISTENSEN CU, 1974, J COMP PHYSIOL, V93, P93, DOI 10.1007/BF00696264; CLAUSSEN DL, 1969, PHYSIOL ZOOL, V42, P1; Conte CE, 2006, REV BRAS ZOOL, V23, P162, DOI 10.1590/S0101-81752006000100008; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Faivovich J, 2002, CLADISTICS, V18, P367, DOI 10.1111/j.1096-0031.2002.tb00157.x; Hasegawa T, 2003, ENDOCRINOLOGY, V144, P4087, DOI 10.1210/en.2003-0418; HEATWOLE H, 1969, COMP BIOCHEM PHYSIOL, V28, P245, DOI 10.1016/0010-406X(69)91342-5; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Hillyard SD, 1998, PHYSIOL ZOOL, V71, P127, DOI 10.1086/515900; Lillywhite HB, 2006, J EXP BIOL, V209, P202, DOI 10.1242/jeb.02007; LITTLEFORD RA, 1947, ECOLOGY, V28, P440, DOI 10.2307/1931231; MCCLANAH.L, 1969, COMP BIOCHEM PHYSIOL, V28, P381, DOI 10.1016/0010-406X(69)91351-6; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; MOORE FR, 1989, HERPETOLOGICA, V45, P101; Ogushi Y, 2007, ENDOCRINOLOGY, V148, P5891, DOI 10.1210/en.2007-0613; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; PREEST MR, 1989, FUNCT ECOL, V3, P693, DOI 10.2307/2389501; Pyron RA, 2014, SYST BIOL, V63, P779, DOI 10.1093/sysbio/syu042; RAY C, 1958, ECOLOGY, V39, P75, DOI 10.2307/1929968; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Rogowitz GL, 1999, J COMP PHYSIOL B, V169, P179, DOI 10.1007/s003600050209; ROTH JJ, 1973, J MORPHOL, V140, P443, DOI 10.1002/jmor.1051400405; Santos Tiago Gomes dos, 2007, Iheringia, Sér. Zool., V97, P37, DOI 10.1590/S0073-47212007000100007; SCHMID WD, 1965, ECOLOGY, V46, P261, DOI 10.2307/1936329; SpeciesLink, 2014, SIST INF DISTR COL B; SPIGHT TM, 1968, PHYSIOL ZOOL, V41, P195, DOI 10.1086/physzool.41.2.30155450; SPOTILA JR, 1976, COMP BIOCHEM PHYS A, V55, P407, DOI 10.1016/0300-9629(76)90069-4; Suzuki M, 2007, COMP BIOCHEM PHYS A, V148, P72, DOI 10.1016/j.cbpa.2006.12.021; Tanii H, 2002, J MEMBRANE BIOL, V188, P43, DOI 10.1007/s00232-001-0172-4; The WorldClim, 2014, GLOB CLIM DAT; THORSON TB, 1955, ECOLOGY, V36, P100, DOI 10.2307/1931435; Titon B, 2010, COMP BIOCHEM PHYS A, V156, P129, DOI 10.1016/j.cbpa.2010.01.009; Tracy CR, 2014, PHYSIOL BIOCHEM ZOOL, V87, P197, DOI 10.1086/674537; VANBERKUM F, 1982, PHYSIOL ZOOL, V55, P130, DOI 10.1086/physzool.55.2.30155847; Viborg AL, 2006, J EXP BIOL, V209, P834, DOI 10.1242/jeb.02057; Viborg AL, 2005, PHYSIOL BIOCHEM ZOOL, V78, P394, DOI 10.1086/430225; Viborg AL, 2004, PHYSIOL BIOCHEM ZOOL, V77, P39, DOI 10.1086/380212; Warburg M.R., 1972, Symposia Zool Soc Lond, VNo. 31, P79; Wells K.D, 2007, ECOLOGY BEHAV AMPHIB, P82; WITHERS PC, 1984, J EXP ZOOL, V232, P11, DOI 10.1002/jez.1402320103; WITHERS PC, 1982, J EXP BIOL, V97, P335; WYGODA ML, 1984, PHYSIOL ZOOL, V57, P329, DOI 10.1086/physzool.57.3.30163722; Young JE, 2005, PHYSIOL BIOCHEM ZOOL, V78, P847, DOI 10.1086/432152; [No title captured], DOI DOI 10.1590/S1676-06032005000300010	54	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140761	10.1371/journal.pone.0140761	http://dx.doi.org/10.1371/journal.pone.0140761			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469787	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600107
J	Xing, WJ; Lin, HY; Li, Y; Yang, DZ; Wang, WJ; Zhang, QX				Xing, Weijie; Lin, Haiyan; Li, Yu; Yang, Dongzi; Wang, Wenjun; Zhang, Qingxue			Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?	PLOS ONE			English	Article							OVARIAN HYPERSTIMULATION SYNDROME; IN-VITRO FERTILIZATION; STIMULATION; AGONIST; PREDICTION; HORMONE; GANIRELIX; WOMEN	Objective To determine if the GnRH antagonist protocol is effective in preventing ovarian hyperstimulation syndrome (OHSS) in potentially high responders. Methods A total of 660 IVF-ET/ICSI cycles were retrospectively identified. The inclusion criterion was age <= 30 years. Cycles were divided into two groups: a GnRHa group and a GnRHant group. In the GnRHa group, the patients received one single injection of 1.0mg-1.3mg Triptorelin in previous mid-luteal phase. In the GnRHant group, a daily dose of 0.25 mg Cetrotide was initiated when a lead follicle obtained a mean diameter of 14 mm, continued up until the day of hCG administration. The duration of stimulation, total dose of Gn, implantation rate, pregnancy rate, and OHSS rate were compared. Results The duration of stimulation, E-2 level on hCG day, numbers of oocytes retrieved, MII oocytes, and high-quality embryos in the GnRHa group were all significantly more than those in the GnRHant group. In the GnRHa group, 83.53% of cancelled fresh-transferred cycles were cancelled because of high risk of OHSS, which was significantly higher than that in the GnRHant group (43.55%, P<0.05). The incidence of OHSS in the GnRHa group was slightly higher than that in the GnRHant group. The implantation and clinical pregnancy rates in the GnRHa group were significantly higher than those in the GnRHant group (37.36% VS 19.25%, 62.78% VS 31.06%; P<0.05). Conclusions Our study demonstrated that for potentially high responders, the GnRHant protocol can, to some extent, lower the cancellation and incidence rates of OHSS. The GnRHa protocol was superior to the GnRHant protocol in terms of implantation and clinical pregnancy rates.	[Xing, Weijie] Sun Yat Sen Univ, Affiliated Hosp 3, Ctr Reprod Med, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Haiyan; Li, Yu; Yang, Dongzi; Wang, Wenjun; Zhang, Qingxue] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Ctr Reprod Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, QX (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Ctr Reprod Med, Guangzhou 510275, Guangdong, Peoples R China.	zhangqingxue666@aliyun.com						Aboulghar M, 2003, HUM REPROD, V18, P1140, DOI 10.1093/humrep/deg208; Al-Inany H, 2002, HUM REPROD, V17, P874, DOI 10.1093/humrep/17.4.874; Al-Inany HG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001750.pub3; Borm G, 2000, HUM REPROD, V15, P1490; BRINSDEN PR, 1995, BRIT J OBSTET GYNAEC, V102, P767, DOI 10.1111/j.1471-0528.1995.tb10840.x; Copperman AB, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-20; Devroey P, 2009, HUM REPROD, V24, P764, DOI 10.1093/humrep/den468; Engmann L, 2008, FERTIL STERIL, V89, P84, DOI 10.1016/j.fertnstert.2007.02.002; Griesinger G, 2005, HUM REPROD, V20, P2373, DOI 10.1093/humrep/dei086; Klement AH, 2015, EUR J OBSTET GYN R B, V185, P170, DOI 10.1016/j.ejogrb.2014.12.021; Lambalk CB, 2006, HUM REPROD, V21, P632, DOI 10.1093/humrep/dei386; Levy MJ, 2013, REPROD BIOMED ONLINE, V26, P50, DOI 10.1016/j.rbmo.2012.09.014; Mocanu Edgar, 2007, Hum Fertil (Camb), V10, P175, DOI 10.1080/14647270701194143; Orvieto R, 2003, HUM REPROD, V18, P665, DOI 10.1093/humrep/deg166; Orvieto R, 2014, REPROD BIOMED ONLINE, V29, P647, DOI 10.1016/j.rbmo.2014.07.002; Orvieto R, 2013, REPROD BIOMED ONLINE, V26, P4, DOI 10.1016/j.rbmo.2012.11.001; Ou JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133887; Papanikolaou EG, 2006, FERTIL STERIL, V85, P112, DOI 10.1016/j.fertnstert.2005.07.1292; Tesarik Jan, 2003, Reprod Biomed Online, V7, P59; Verberg MFG, 2008, HUM REPROD, V23, P2050, DOI 10.1093/humrep/den219; Weissman A, 2003, FERTIL STERIL, V79, P886, DOI 10.1016/S0015-0282(02)04928-2	21	11	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140286	10.1371/journal.pone.0140286	http://dx.doi.org/10.1371/journal.pone.0140286			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468951	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600035
J	Zhou, C; Wang, ZW; Guo, JY; Zhang, Z; Yang, YF				Zhou, Chan; Wang, Zhengwen; Guo, Junyue; Zhang, Zhuo; Yang, Yunfei			Clonal Patch Size and Ramet Position of Leymus chinensis Affected Reproductive Allocation	PLOS ONE			English	Article							BIOMASS ALLOCATION; PHENOTYPIC PLASTICITY; POLYGONUM-PERSICARIA; PLANT; GROWTH; STRATEGIES; COSTS; POPULATIONS; COMPETITION; DEMOGRAPHY	Reproductive allocation is critically important for population maintenance and usually varies with not only environmental factors but also biotic ones. As a typical rhizome clonal plant in China's northern grasslands, Leymus chinensis usually dominates the steppe communities and grows in clonal patches. In order to clarify the sexual reproductive allocation of L. chinensis in the process of the growth and expansion, we selected L. chinensis clonal patches of a range of sizes to examine the reproductive allocation and allometric growth of the plants. Moreover, the effects of position of L. chinensis ramets within the patch on their reproductive allocation were also examined. Clonal patch size and position both significantly affected spike biomass, reproductive tiller biomass and SPIKE/TILLER biomass ratio. From the central to the marginal zone, both the spike biomass and reproductive tiller biomass displayed an increasing trend in all the five patch size categories except for reproductive tiller biomass in 15-40m(2) category. L. chinensis had significantly larger SPIKE/TILLER biomass ratio in marginal zone than in central zone of clonal patches that are larger than 15 m(2) in area. Regression analysis showed that the spike biomass and SPIKE/TILLER biomass ratio were negatively correlated with clonal patch size while patch size showed significantly positive effect on SEED/SPIKE biomass ratio, but the reproductive tiller biomass and SEED/TILLER biomass ratio were not dependent on clonal patch size. The relationships between biomass of spike and reproductive tiller, between mature seed biomass and spike biomass and between mature seed biomass and reproductive tiller biomass were significant allometric for all or some of patch size categories, respectively. The slopes of all these allometric relationships were significantly different from 1. The allometric growth of L. chinensis is patch size-dependent. This finding will be helpful for developing appropriate practices for the management of L. chinensis-dominant grasslands.	[Zhou, Chan; Guo, Junyue] Liaoning Univ, Sch Life Sci, Shenyang 110036, Peoples R China; [Zhou, Chan; Yang, Yunfei] NE Normal Univ, Inst Grassland Sci, Key Lab Vegetat Ecol, Minist Educ, Changchun 130024, Peoples R China; [Zhou, Chan; Wang, Zhengwen] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110164, Peoples R China; [Zhang, Zhuo] Shenyang Univ, Coll Biol Sci & Bioengn, Shenyang 110044, Peoples R China	Liaoning University; Northeast Normal University - China; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Shenyang University	Zhang, Z (corresponding author), Shenyang Univ, Coll Biol Sci & Bioengn, 21 Wanghua St, Shenyang 110044, Peoples R China.	zhangzhuonet@163.com	Wang, Zhengwen/A-8292-2011		National Science Foundation of China [31570332, 31472134, 31360574]; Outstanding Young Scholars Foundation of Higher University in Liaoning Province [LJQ2014004]; Open Foundation of Key Laboratory for Vegetation Ecology, Ministry of Education; Open foundation of Hulunber Grassland Ecosystem Research Station of Chinese Academy of Agricultural Sciences	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Young Scholars Foundation of Higher University in Liaoning Province; Open Foundation of Key Laboratory for Vegetation Ecology, Ministry of Education; Open foundation of Hulunber Grassland Ecosystem Research Station of Chinese Academy of Agricultural Sciences	This research is supported by National Science Foundation of China (Grant 31570332, 31472134, 31360574), Outstanding Young Scholars Foundation of Higher University in Liaoning Province (LJQ2014004), and Open Foundation of Key Laboratory for Vegetation Ecology, Ministry of Education, and Open foundation of Hulunber Grassland Ecosystem Research Station of Chinese Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; ARONSON J, 1993, OECOLOGIA, V93, P336, DOI 10.1007/BF00317875; Bai WM, 2009, PLANT ECOL, V205, P13, DOI 10.1007/s11258-009-9595-2; Bonser SP, 2009, PERSPECT PLANT ECOL, V11, P31, DOI 10.1016/j.ppees.2008.10.003; Brenchley JL, 1996, HYDROBIOLOGIA, V327, P185; Cheplick Gregory P., 2005, P94; CODY ML, 1966, EVOLUTION, V20, P174, DOI 10.1111/j.1558-5646.1966.tb03353.x; Erickson HE, 2005, FOREST SCI, V51, P211; Fabbro T, 2004, FLORA, V199, P70, DOI 10.1078/0367-2530-00128; Fortunel C, 2009, PERSPECT PLANT ECOL, V11, P267, DOI 10.1016/j.ppees.2009.04.003; HANDEL SN, 1985, AM NAT, V125, P367, DOI 10.1086/284348; Harper J. L., 1977, Population biology of plants.; Harris MS, 2008, P ROY SOC B-BIOL SCI, V275, P2595, DOI 10.1098/rspb.2008.0585; HARTNETT DC, 1990, OECOLOGIA, V84, P254, DOI 10.1007/BF00318281; Huang ZeHao, 2002, Grassland of China, V24, P55; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Huxley J., 1932, PROBLEMS RELATIVE GR; JENNERSTEN O, 1993, OIKOS, V68, P283, DOI 10.2307/3544841; Johansen L, 2009, PLANT ECOL, V201, P435, DOI 10.1007/s11258-008-9471-5; Jongejans E, 2006, OECOLOGIA, V147, P369, DOI 10.1007/s00442-005-0325-8; Li YY, 2014, PHYTON-INT J EXP BOT, V83, P283; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; MENDEZ M, 1993, CAN J BOT, V71, P309, DOI 10.1139/b93-032; Niklas K.., 1994, PLANT ALLOMETRY; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; OHLSON M, 1988, J ECOL, V76, P1007, DOI 10.2307/2260629; Pluess AR, 2005, FUNCT ECOL, V19, P228, DOI 10.1111/j.0269-8463.2005.00951.x; Reekie EG, 1998, CAN J BOT, V76, P43, DOI 10.1139/cjb-76-1-43; Ricklefs RE, 2004, ECOLOGY; SAMSON DA, 1986, AM NAT, V127, P667, DOI 10.1086/284512; SIH A, 1987, ECOLOGY, V68, P1679, DOI 10.2307/1939860; SOWIG P, 1989, OECOLOGIA, V78, P550, DOI 10.1007/BF00378747; Sugiyama S, 1998, FUNCT ECOL, V12, P280, DOI 10.1046/j.1365-2435.1998.00187.x; SULTAN SE, 1993, EVOLUTION, V47, P1009, DOI 10.1111/j.1558-5646.1993.tb02132.x; SULTAN SE, 1993, EVOLUTION, V47, P1032, DOI 10.2307/2409973; SULTAN SE, 1993, EVOLUTION, V47, P1050, DOI [10.2307/2409974, 10.1111/j.1558-5646.1993.tb02134.x]; Teng NJ, 2006, FLORA, V201, P658, DOI 10.1016/j.flora.2005.12.006; Tian DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042833; van Kleunen M, 2001, OIKOS, V94, P515, DOI 10.1034/j.1600-0706.2001.940313.x; Van Zandt PA, 2003, J ECOL, V91, P837, DOI 10.1046/j.1365-2745.2003.00806.x; VANANDEL J, 1977, J ECOL, V65, P747, DOI 10.2307/2259377; Wang JunFeng, 2008, Acta Prataculturae Sinica, V17, P53; Wang Renzhong, 2000, Yingyong Shengtai Xuebao, V11, P399; Wang RZ, 2003, J ARID ENVIRON, V54, P653, DOI 10.1006/jare.2002.1087; Wang RZ, 2001, J ARID ENVIRON, V49, P289, DOI 10.1006/jare.2000.0787; Wang Zheng-Wen, 2007, Zhiwu Shengtai Xuebao, V31, P673; WATT AS, 1947, J ECOL, V35, P1, DOI 10.2307/2256497; Weiner J., 1988, Plant reproductive ecology: patterns and strategies, P228; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; Wikberg S, 2003, J ECOL, V91, P847, DOI 10.1046/j.1365-2745.2003.00817.x; Wikberg S, 2006, PLANT ECOL, V183, P55, DOI 10.1007/s11258-005-9006-2; Worley AC, 1996, J ECOL, V84, P195, DOI 10.2307/2261355; Zhang DY, 2002, J EVOLUTION BIOL, V15, P74, DOI 10.1046/j.1420-9101.2002.00369.x; Zhang QS, 2009, AQUAT BOT, V91, P194, DOI 10.1016/j.aquabot.2009.06.003; Zhang Xiao-Na, 2010, Chinese Journal of Plant Ecology, V34, P253, DOI 10.3773/j.issn.1005-264x.2010.03.002; Zhou C, 2014, PLANT SOIL, V383, P191, DOI 10.1007/s11104-014-2169-7; Zhou Chan, 2012, Acta Agrestia Sinica, V20, P213; ZIMMERMAN M, 1980, ECOLOGY, V61, P502, DOI 10.2307/1937415	59	5	6	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140350	10.1371/journal.pone.0140350	http://dx.doi.org/10.1371/journal.pone.0140350			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468878	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600047
J	Heino, M; Kummu, M; Makkonen, M; Mulligan, M; Verburg, PH; Jalava, M; Rasanen, TA				Heino, Matias; Kummu, Matti; Makkonen, Marika; Mulligan, Mark; Verburg, Peter H.; Jalava, Mika; Rasanen, Timo A.			Forest Loss in Protected Areas and Intact Forest Landscapes: A Global Analysis	PLOS ONE			English	Article							DEFORESTATION; DRIVERS; BIODIVERSITY; POPULATION; GOVERNANCE; LOCATION; IMPACTS	In spite of the high importance of forests, global forest loss has remained alarmingly high during the last decades. Forest loss at a global scale has been unveiled with increasingly finer spatial resolution, but the forest extent and loss in protected areas (PAs) and in large intact forest landscapes (IFLs) have not so far been systematically assessed. Moreover, the impact of protection on preserving the IFLs is not well understood. In this study we conducted a consistent assessment of the global forest loss in PAs and IFLs over the period 2000-2012. We used recently published global remote sensing based spatial forest cover change data, being a uniform and consistent dataset over space and time, together with global datasets on PAs' and IFLs' locations. Our analyses revealed that on a global scale 3% of the protected forest, 2.5% of the intact forest, and 1.5% of the protected intact forest were lost during the study period. These forest loss rates are relatively high compared to global total forest loss of 5% for the same time period. The variation in forest losses and in protection effect was large among geographical regions and countries. In some regions the loss in protected forests exceeded 5% (e.g. in Australia and Oceania, and North America) and the relative forest loss was higher inside protected areas than outside those areas (e.g. in Mongolia and parts of Africa, Central Asia, and Europe). At the same time, protection was found to prevent forest loss in several countries (e.g. in South America and Southeast Asia). Globally, high area-weighted forest loss rates of protected and intact forests were associated with high gross domestic product and in the case of protected forests also with high proportions of agricultural land. Our findings reinforce the need for improved understanding of the reasons for the high forest losses in PAs and IFLs and strategies to prevent further losses.	[Heino, Matias; Kummu, Matti; Jalava, Mika; Rasanen, Timo A.] Aalto Univ, Water & Dev Res Grp, Espoo 02150, Finland; [Makkonen, Marika] Nat Resources Inst Finland Luke, Vantaa 01301, Finland; [Mulligan, Mark] Kings Coll London, Dept Geog, London WC2R 2LS, England; [Verburg, Peter H.] Vrije Univ Amsterdam, Environm Geog Grp, NL-1081 HV Amsterdam, Netherlands	Aalto University; Natural Resources Institute Finland (Luke); University of London; King's College London; Vrije Universiteit Amsterdam	Kummu, M (corresponding author), Aalto Univ, Water & Dev Res Grp, Tietotie 1E, Espoo 02150, Finland.	matti.kummu@aalto.fi	Mulligan, Mark/V-9275-2019; Kummu, Matti/C-4797-2011; Verburg, Peter H/Z-1582-2019; Verburg, Peter h./A-8469-2010	Kummu, Matti/0000-0001-5096-0163; Verburg, Peter h./0000-0002-6977-7104; Mulligan, Mark/0000-0002-0132-0888; Rasanen, Timo A./0000-0003-0839-3155	Maa- ja vesitekniikan tuki ry; Academy of Finland project SCART [267463]; Academy of Finland project Green Economy and Policies [257919]; ERC grant agreement (GLOLAND) [311819]; FP7 project LUC4C	Maa- ja vesitekniikan tuki ry; Academy of Finland project SCART; Academy of Finland project Green Economy and Policies; ERC grant agreement (GLOLAND); FP7 project LUC4C	The work was funded by Maa- ja vesitekniikan tuki ry. In addition, MK was funded by the Academy of Finland project SCART (grant no. 267463) and MMa by the Academy of Finland project Green Economy and Policies (grant no. 257919). PHV thanks the ERC grant agreement nr. 311819 (GLOLAND) and the FP7 project LUC4C for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ENCY US CENSUS; [Anonymous], 2012, METHODOLOGY NEAR REA; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Busch J., 2014, STOPPING DEFORESTATI; Damette O, 2012, ECON MODEL, V29, P2427, DOI 10.1016/j.econmod.2012.06.015; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Dudley N., 2008, GUIDELINES APPL PROT, DOI [10.2305/IUCN.CH.2008.PAPS.2.en, DOI 10.2305/IUCN.CH.2008.PAPS.2.EN]; Ewers RM, 2008, TRENDS ECOL EVOL, V23, P113, DOI 10.1016/j.tree.2007.11.008; Ewers RM, 2006, GLOBAL ENVIRON CHANG, V16, P161, DOI 10.1016/j.gloenvcha.2005.12.001; FAO, 2010, GLOBAL FOREST RESOUR; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Godar J, 2014, P NATL ACAD SCI USA, V111, P15591, DOI 10.1073/pnas.1322825111; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; IUCN & UNEP-WCMC, 2014, WORLD DAT PROT AR WD; Joppa LN, 2009, PLOS ONE, V4, pe8253; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Juffe-Bignoli D, 2014, PROTECTED PLANET REP; Koop G, 1999, J DEV ECON, V58, P231, DOI 10.1016/S0304-3878(98)00110-2; Lee PG, 2009, ECOL SOC, V14; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; Maiorano L, 2008, P ROY SOC B-BIOL SCI, V275, P1297, DOI 10.1098/rspb.2007.1756; Margono B. A., 2014, PRIMARY FOREST COVER; Marshall M., 2014, POLITY 4 REGIME TREN; Mather AS, 2000, GEOGR J, V166, P2, DOI 10.1111/j.1475-4959.2000.tb00002.x; Mather AS, 1998, HYDROL PROCESS, V12, P1983, DOI 10.1002/(SICI)1099-1085(19981030)12:13/14&lt;1983::AID-HYP713&gt;3.0.CO;2-M; Nagendra H, 2008, AMBIO, V37, P330, DOI 10.1579/06-R-184.1; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Nolte C, 2013, P NATL ACAD SCI USA, V110, P4956, DOI 10.1073/pnas.1214786110; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Pagnutti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075890; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Porter-Bolland L, 2012, FOREST ECOL MANAG, V268, P6, DOI 10.1016/j.foreco.2011.05.034; Potapov P, 2008, REMOTE SENS ENVIRON, V112, P3708, DOI 10.1016/j.rse.2008.05.006; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Radeloff VC, 2013, CONSERV LETT, V6, P58, DOI 10.1111/j.1755-263X.2012.00290.x; Rudel T., 2005, TROPICAL FORESTS REG; Rudel TK, 2007, LAND USE POLICY, V24, P35, DOI 10.1016/j.landusepol.2005.11.004; Rudel TK, 2009, CONSERV BIOL, V23, P1396, DOI 10.1111/j.1523-1739.2009.01332.x; Schmitt CB, 2009, BIOL CONSERV, V142, P2122, DOI 10.1016/j.biocon.2009.04.012; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; Tole L, 1998, ENVIRON MANAGE, V22, P19, DOI 10.1007/s002679900081; Transparency International, 2010, CORR PERC IND; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; UNDP, 2014, HUM DEV IND 2012; Verburg PH, 2006, APPL GEOGR, V26, P153, DOI 10.1016/j.apgeog.2005.11.005; World Bank, 2014, WORLD BANK DEV IND	54	83	84	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138918	10.1371/journal.pone.0138918	http://dx.doi.org/10.1371/journal.pone.0138918			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466348	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100033
J	Jiao, L; Ma, JX; Dai, HQ				Jiao, Li; Ma, Jinxia; Dai, Hongqi			Preparation and Characterization of Self-Reinforced Antibacterial and Oil-Resistant Paper Using a NaOH/Urea/ZnO Solution	PLOS ONE			English	Article							ALL-CELLULOSE COMPOSITES; SURFACE SELECTIVE DISSOLUTION; ZINC-OXIDE NANOPARTICLES; ZNO NANOPARTICLES; SODIUM-HYDROXIDE; AQUEOUS-SOLUTION; LIPID-PEROXIDATION; FTIR SPECTROSCOPY; LOW-TEMPERATURE; CARBON-DIOXIDE	This paper describes self-reinforced antibacterial and oil-resistant properties that were successfully prepared by surface selective dissolution of filter paper in a NaOH/Urea/ZnO (weight ratio of 8:12:0.25) aqueous solution. The effect of the processing time on the mechanical properties of this paper was evaluated at -12 degrees C. The paper morphologies were characterized using Scanning Electron Microscopy (SEM), X-ray Diffraction (XRD), Fourier Transform Infrared Spectroscopy (FT-IR) and X-ray photoelectron spectroscopy (XPS). The oil-resistance and antibacterial properties of the produced paper were also investigated. Excellent mechanical properties were observed for an optimized handling time. The tensile and burst strengths of the modified paper were in excess of 100% of the original. Meanwhile, the treated paper was completely oil-resistant within 24 h and demonstrated good antibacterial properties when exposed to Staphylococcus aureus. The traces of residual zinc oxide were found to be safe for food.	[Jiao, Li; Ma, Jinxia; Dai, Hongqi] Nanjing Forestry Univ, Dept Pulp & Paper Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Ma, JX (corresponding author), Nanjing Forestry Univ, Dept Pulp & Paper Sci & Technol, Nanjing, Jiangsu, Peoples R China.	jxma@njfu.edu.cn			National Natural Science Foundation of China [31470599, 31570576]; Nanjing Forestry University Innovation fund program for Doctorate Fellowship Foundation; Innovation program of Jiangsu province [KYZZ15-0254]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Forestry University Innovation fund program for Doctorate Fellowship Foundation; Innovation program of Jiangsu province	The National Natural Science Foundation of China (Grant Numbers 31470599 and 31570576) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) supported the data collection and analysis; Nanjing Forestry University Innovation fund program for Doctorate Fellowship Foundation and Innovation program KYZZ15-0254 of Jiangsu province supported preparation of manuscript. In addition, the authors got assistance from the National Natural Science Foundation of China (Grant Number 31570576) during revision such as the expenditures of TEM and Language editing.	Abidi N, 2014, CARBOHYD POLYM, V100, P9, DOI 10.1016/j.carbpol.2013.01.074; Applerot G, 2009, ADV FUNCT MATER, V19, P842, DOI 10.1002/adfm.200801081; Azam A, 2012, INT J NANOMED, V7, P6003, DOI 10.2147/IJN.S35347; Ben Brahim S, 2007, COMPOS SCI TECHNOL, V67, P140, DOI 10.1016/j.compscitech.2005.10.006; Bhuyan T, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-3093-3; Cai J, 2007, CHEMPHYSCHEM, V8, P1572, DOI 10.1002/cphc.200700229; Carrillo A, 2004, EUR POLYM J, V40, P2229, DOI 10.1016/j.eurpolmj.2004.05.003; Cetinkol OP, 2012, PLOS ONE; Chennakesavulu K, 2015, J MOL STRUCT, V1091, P49, DOI 10.1016/j.molstruc.2015.02.052; COLIPA Sn, 2003, 24 PLEN M 24 25 JUN; Dutta RK, 2012, COLLOID SURFACE B, V94, P143, DOI 10.1016/j.colsurfb.2012.01.046; Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289; Ghaderi M, 2014, CARBOHYD POLYM, V104, P59, DOI 10.1016/j.carbpol.2014.01.013; Ghule K, 2006, GREEN CHEM, V8, P1034, DOI 10.1039/b605623g; Gindl W, 2005, POLYMER, V46, P10221, DOI 10.1016/j.polymer.2005.08.040; Guo DD, 2013, TOXICOL IN VITRO, V27, P731, DOI 10.1016/j.tiv.2012.12.001; Han DL, 2010, CARBOHYD POLYM, V79, P614, DOI 10.1016/j.carbpol.2009.09.008; He LL, 2011, MICROBIOL RES, V166, P207, DOI 10.1016/j.micres.2010.03.003; Hou AQ, 2009, CARBOHYD POLYM, V75, P328, DOI 10.1016/j.carbpol.2008.07.032; Isobe N, 2013, CELLULOSE, V20, P97, DOI 10.1007/s10570-012-9800-7; Jin HJ, 2007, CARBOHYD RES, V342, P851, DOI 10.1016/j.carres.2006.12.023; Jones N, 2008, FEMS MICROBIOL LETT, V279, P71, DOI 10.1111/j.1574-6968.2007.01012.x; Kjellgren H., 2005, BARRIER PROPERTIES G, V2005, P17; Kjellgren H, 2006, CARBOHYD POLYM, V65, P453, DOI 10.1016/j.carbpol.2006.02.005; Lindman B, 2010, J MOL LIQ, V156, P76, DOI 10.1016/j.molliq.2010.04.016; Ma JX, 2014, NORD PULP PAP RES J, V29, P246, DOI 10.3183/npprj-2014-29-02-p246-252; Martins NCT, 2013, COLLOID SURFACE A, V417, P111, DOI 10.1016/j.colsurfa.2012.10.042; Medronho B, 2015, ADV COLLOID INTERFAC, V222, P502, DOI 10.1016/j.cis.2014.05.004; Medronho B, 2014, CURR OPIN COLLOID IN, V19, P32, DOI 10.1016/j.cocis.2013.12.001; Medronho B, 2012, CELLULOSE, V19, P581, DOI 10.1007/s10570-011-9644-6; Nishino T, 2007, BIOMACROMOLECULES, V8, P2712, DOI 10.1021/bm0703416; Oh SY, 2005, CARBOHYD RES, V340, P2376, DOI 10.1016/j.carres.2005.08.007; Oh SY, 2005, CARBOHYD RES, V340, P417, DOI 10.1016/j.carres.2004.11.027; Espitia PJP, 2012, FOOD BIOPROCESS TECH, V5, P1447, DOI 10.1007/s11947-012-0797-6; Prasanna VL, 2015, LANGMUIR, V31, P9155, DOI 10.1021/acs.langmuir.5b02266; Premanathan M, 2011, NANOMED-NANOTECHNOL, V7, P184, DOI 10.1016/j.nano.2010.10.001; Qin C, 2008, CARBOHYD POLYM, V71, P458, DOI 10.1016/j.carbpol.2007.06.019; Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u; Raheem D, 2013, EMIR J FOOD AGR, V25, P177, DOI 10.9755/ejfa.v25i3.11509; Rimbu C, 2013, TEXT RES J, V83, P2142, DOI 10.1177/0040517513478460; Roy D, 2008, BIOMACROMOLECULES, V9, P91, DOI 10.1021/bm700849j; Sharma D, 2010, THIN SOLID FILMS, V519, P1224, DOI 10.1016/j.tsf.2010.08.073; Sharma SK, 2015, MAT SCI ENG C-MATER, V53, P104, DOI 10.1016/j.msec.2015.04.007; Shi LE, 2014, FOOD ADDIT CONTAM A, V31, P173, DOI 10.1080/19440049.2013.865147; Song WH, 2010, TOXICOL LETT, V199, P389, DOI 10.1016/j.toxlet.2010.10.003; Soykeabkaew N, 2008, COMPOS SCI TECHNOL, V68, P2201, DOI 10.1016/j.compscitech.2008.03.023; Soykeabkaew N, 2009, COMPOS PART A-APPL S, V40, P321, DOI 10.1016/j.compositesa.2008.10.021; Wang Y, 2009, BIOTECHNOL BIOENG, V102, P1398, DOI 10.1002/bit.22160; Wei YP, 2008, REACT FUNCT POLYM, V68, P981, DOI 10.1016/j.reactfunctpolym.2008.02.004; Xie YP, 2011, APPL ENVIRON MICROB, V77, P2325, DOI 10.1128/AEM.02149-10; Xu CB, 2015, AER ADV ENG RES, V40, P10; Yang QL, 2011, CARBOHYD POLYM, V83, P1185, DOI 10.1016/j.carbpol.2010.09.020; Zhang GY, 2013, MATER LETT, V97, P184, DOI 10.1016/j.matlet.2013.01.096; Zhang L, 2005, IND ENG CHEM RES, V44, P522, DOI 10.1021/ie0491802; Zhang LL, 2007, J NANOPART RES, V9, P479, DOI 10.1007/s11051-006-9150-1; Zhang LL, 2010, J NANOPART RES, V12, P1625, DOI 10.1007/s11051-009-9711-1	56	19	20	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140603	10.1371/journal.pone.0140603	http://dx.doi.org/10.1371/journal.pone.0140603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465917	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100151
J	Lee, JE; Lee, K; Hong, YS; Kim, ER; Lee, H; Min, BH				Lee, Ji Eun; Lee, Keol; Hong, Yun Soo; Kim, Eun Ran; Lee, Hyuk; Min, Byung-Hoon			Impact of Carcinomatosis on Clinical Outcomes after Self-Expandable Metallic Stent Placement for Malignant Gastric Outlet Obstruction	PLOS ONE			English	Article							PALLIATIVE TREATMENT; EXERCISE	Background It is still unclear whether the peritoneal carcinomatosis had a negative effect on the clinical outcomes of patients who underwent self-expandable metallic stent (SEMS) placement for malignant gastric outlet obstruction (GOO). Although carcinomatosis may be associated with the development of multifocal gastrointestinal (GI) tract obstruction or decreased bowel movement, previous studies investigated the occurrence of stent failure only and thus had limitation in evaluating clinical outcomes of patients with carcinomatosis. Methods Between 2009 and 2013, 155 patients (88 patients without carcinomatosis and 67 patients with carcinomatosis) underwent endoscopic SEMS placement for malignant GOO. Factors affecting clinical success and obstructive symptom-free survival (time period between SEMS placement and the recurrence of obstructive symptoms due to multifocal GI tract obstruction or decreased bowel movement as well as stent failure) were assessed. Results Patients with carcinomatosis showed higher Eastern Cooperative Oncology Group (ECOG) scale than those without carcinomatosis. Clinical success rates were 88.1% in patients with carcinomatosis and 97.7% in patients without carcinomatosis. In multivariate analysis, only ECOG scale was identified as an independent predictor of clinical success. During followup period, patients with carcinomatosis showed significantly shorter obstructive symptom-free survival than those without carcinomatosis. In multivariate analysis, the presence of carcinomatosis, chemotherapy or radiation therapy after SEMS placement, and obstruction site were identified as independent predictors of obstructive symptom-free survival. For patient without carcinomatosis, stent failure accounted for the recurrence of obstructive symptoms in 84.6% of cases. For patients with carcinomatosis, multifocal GI tract obstruction or decreased bowel movement accounted for 37.9% of cases with obstructive symptom recurrence and stent failure accounted for 44.8% of cases. Conclusions Carcinomatosis predicts unfavorable long-term clinical outcomes in patients undergoing SEMS placement for malignant GOO. This is mainly due to the development of multifocal GI tract obstructions or decreased bowel movement as well as stent failure.	[Lee, Ji Eun; Lee, Keol; Hong, Yun Soo; Kim, Eun Ran; Lee, Hyuk; Min, Byung-Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Min, BH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.	bhmin@skku.edu	Kim, Eun Ran/AAD-8003-2022	Lee, Keol/0000-0002-0958-6373; Kim, Eun Ran/0000-0002-0495-2565				Adler DG, 2002, AM J GASTROENTEROL, V97, P72; Baron TH, 2003, GASTROINTEST ENDOSC, V58, P421, DOI 10.1067/S0016-5107(03)00023-3; Brimhall Bryan, 2011, Gastrointest Endosc Clin N Am, V21, P389, DOI 10.1016/j.giec.2011.04.002; Jeon HH, 2014, SURG ENDOSC, V28, P988, DOI 10.1007/s00464-013-3268-x; Kim CG, 2010, GASTROINTEST ENDOSC, V72, P25, DOI 10.1016/j.gie.2010.01.039; Kim JH, 2009, AM J ROENTGENOL, V193, P241, DOI 10.2214/AJR.08.1760; Kim S, 2013, GASTROINTEST ENDOSC, V78, P913, DOI 10.1016/j.gie.2013.07.015; Maetani I, 2014, DIGEST ENDOSC, V26, P192, DOI 10.1111/den.12117; Mendelsohn RB, 2011, GASTROINTEST ENDOSC, V73, P1135, DOI 10.1016/j.gie.2011.01.042; NEUFER PD, 1989, EUR J APPL PHYSIOL O, V58, P440, DOI 10.1007/BF00643522; OETTLE GJ, 1991, GUT, V32, P941, DOI 10.1136/gut.32.8.941; Park CH, 2015, GASTROINTEST ENDOSC, V81, P321, DOI 10.1016/j.gie.2014.06.024	12	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140648	10.1371/journal.pone.0140648	http://dx.doi.org/10.1371/journal.pone.0140648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465920	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100159
J	Wu, C; McMurtry, MS; Sandhu, RK; Youngson, E; Ezekowitz, JA; Kaul, P; McAlister, FA				Wu, Cynthia; McMurtry, Michael Sean; Sandhu, Roopinder K.; Youngson, Erik; Ezekowitz, Justin A.; Kaul, Padma; McAlister, Finlay A.			Impact of Rural Residence on Warfarin Use and Clinical Events in Patients with Non-Valvular Atrial Fibrillation: A Canadian Population Based Study	PLOS ONE			English	Article							RISK STRATIFICATION SCHEMES; BLEEDING RISK; CLASSIFICATION SCHEMES; NATIONAL REGISTRY; PREDICTING STROKE; HEART-FAILURE; ANTICOAGULATION; VALIDATION; HEMORRHAGE; OUTCOMES	Background and Purpose We studied whether anticoagulant use and outcomes differed between rural versus urban Canadian non-valvular atrial fibrillation (NVAF) patients prior to the introduction of direct oral anticoagulant drugs. Methods Retrospective cohort study of 25,284 adult Albertans with NVAF between April 1, 1999 and December 31, 2008. Results Compared to urban patients, rural patients were older (p = 0.0009) and had more comorbidities but lower bleeding risk at baseline. In the first year after NVAF diagnosis, urban patients were less likely to be hospitalized (aOR 0.82, 95% CI 0.77-0.89) or have an emergency department visit for any reason (aOR 0.61, 95% CI 0.56-0.66) but warfarin dispensation rates (72.2% vs 71.8% at 365 days, p = 0.98) and clinical outcomes were similar: 7.8% died in both groups, 3.2% rural vs. 2.8% urban had a stroke or systemic embolism (SSE) (aOR 0.92, 95% CI 0.77-1.11), and 6.6% vs. 5.7% (aOR 0.93, 95% CI 0.81-1.06) had a bleed. Baseline SSE risk did not impact warfarin dispensation (73.0% in those with high vs. 72.8% in those with low CHADS(2) score, p = 0.85) but patients at higher baseline bleeding risk were less likely to be using warfarin (69.2% high vs. 73.6% low HASBLED score, p<0.0001) in the first 365 days after diagnosis. In warfarin users, bleeding was more frequent (7.5% vs 6.2%, aHR 1.51 [95% CI 1.33-1.72]) but death or SSE was less frequent (7.0% vs 18.1%, aHR 0.60 [0.54-0.66]). Conclusion Warfarin use and clinical event rates did not differ between rural and urban NVAF patients in a universal access publically-funded healthcare system.	[Wu, Cynthia] Univ Alberta, Dept Med, Div Hematol, Edmonton, AB, Canada; [McMurtry, Michael Sean; Sandhu, Roopinder K.; Ezekowitz, Justin A.; Kaul, Padma] Univ Alberta, Div Cardiol, Dept Med, Edmonton, AB, Canada; [Youngson, Erik; McAlister, Finlay A.] Univ Alberta, Patient Hlth Outcomes Res & Clin Effectiveness Un, Edmonton, AB, Canada; [Ezekowitz, Justin A.] Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada; [McAlister, Finlay A.] Univ Alberta, Div Gen Internal Med, Dept Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Wu, C (corresponding author), Univ Alberta, Dept Med, Div Hematol, Edmonton, AB, Canada.	cynthia.wu@ualberta.ca	Wu, Cynthia/G-9905-2016; Ezekowitz, Justin/C-4579-2013; McAlister, Finlay/C-4151-2013	Ezekowitz, Justin/0000-0002-2724-4086; Kaul, Padma/0000-0003-2239-3944; McAlister, Finlay/0000-0001-7435-3341	Alberta Innovates: Health Solutions; Heart and Stroke Foundation of Canada	Alberta Innovates: Health Solutions; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	Drs. McAlister and Ezekowitz are supported by salary awards from Alberta Innovates: Health Solutions; Dr. McAlister holds the University of Alberta Chair in Cardiovascular Outcomes Research; Dr. McMurtry receives a salary award from the Heart and Stroke Foundation of Canada. The funding agencies did not have input into study design, data collection, interpretation of results, or write up/approval for submission.	Apostolakis S, 2012, J AM COLL CARDIOL, V60, P861, DOI 10.1016/j.jacc.2012.06.019; Arnason T, 2006, THROMB RES, V118, P253, DOI 10.1016/j.thromres.2005.06.015; Booth GL, 2005, DIABETES CARE, V28, P1045, DOI 10.2337/diacare.28.5.1045; Borzecki AM, 2004, AM J MED QUAL, V19, P201, DOI 10.1177/106286060401900504; Bungard TJ, 2000, ARCH INTERN MED, V160, P41, DOI 10.1001/archinte.160.1.41; Bungard TJ, 2001, CAN MED ASSOC J, V165, P301; Clark RA, 2007, MED J AUSTRALIA, V186, P441, DOI 10.5694/j.1326-5377.2007.tb00993.x; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Donze J, 2012, AM J MED, V125, P1095, DOI 10.1016/j.amjmed.2012.04.005; du Plessis V., 2001, RURAL SMALL TOWN CAN, V3, P1; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Friberg L, 2012, CIRCULATION, V125, P2298, DOI 10.1161/CIRCULATIONAHA.111.055079; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gamble JM, 2011, CIRC-HEART FAIL, V4, P317, DOI 10.1161/CIRCHEARTFAILURE.110.959262; Giugliano RP, 2013, NEW ENGL J MED, V369, P1406; Gomes T, 2013, CAN MED ASSOC J, V185, pE121, DOI 10.1503/cmaj.121218; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hassan A, 2009, CAN J CARDIOL, V25, P207, DOI 10.1016/S0828-282X(09)70062-5; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Loslier J, 2007, CAN J RURAL MED, V12, P93; Majumdar SR, 2004, J AM COLL CARDIOL, V43, P1738, DOI 10.1016/j.jacc.2003.12.043; Nieuwlaat R, 2012, THROMB RES, V129, P715, DOI 10.1016/j.thromres.2011.08.024; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Piccini J, 2013, CIRCULATION, V127, P223; Pilote L, 2013, CAN J CARDIOL, V29, P1241, DOI 10.1016/j.cjca.2012.09.021; Pohar SL, 2007, CLIN THER, V29, P1316, DOI 10.1016/j.clinthera.2007.07.001; Pong RW, 2009, AUST J RURAL HEALTH, V17, P58, DOI 10.1111/j.1440-1584.2008.01039.x; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Roldan V, 2013, CHEST, V143, P179, DOI 10.1378/chest.12-0608; Ronksley PE, 2012, NEPHROL DIAL TRANSPL, V27, P1826, DOI 10.1093/ndt/gfr598; Sandhu RK, 2011, HEART, V97, P2046, DOI 10.1136/heartjnl-2011-300901; Skanes AC, 2012, CAN J CARDIOL, V28, P125, DOI 10.1016/j.cjca.2012.01.021; Tsadok MA, 2015, J RURAL HEALTH, P1; Wan Y, 2008, CIRC-CARDIOVASC QUAL, V1, P84, DOI 10.1161/CIRCOUTCOMES.108.796185	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140607	10.1371/journal.pone.0140607	http://dx.doi.org/10.1371/journal.pone.0140607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466118	gold, Green Submitted, Green Published			2022-12-26	WOS:000363183100152
J	Yang, HS; Wang, F; Gu, NJ; Zhang, Y				Yang, Hongsheng; Wang, Fang; Gu, Nianjun; Zhang, Ying			Self-Advantage in the Online World	PLOS ONE			English	Article							VISUAL-SEARCH; ATTENTION; RECOGNITION; NAME; FACE; STIMULI; ERP	In the current research, screen name was employed to explore the possible cognitive advantage for self-related online material. The results showed that one's own screen name and real name were detected faster than famous names in both visual search and discrimination tasks. In comparison, there was no difference in visual search speed for the two kinds of self-related names. These findings extend self-advantage from the physical world to the virtual online environment and confirm its robustness. In addition, the present findings also suggest that familiarity might not be the determining factor for self-advantage.	[Yang, Hongsheng; Wang, Fang; Gu, Nianjun; Zhang, Ying] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Yang, Hongsheng] Southwest Univ, Res Ctr Psychol & Social Dev, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Yang, HS (corresponding author), Southwest Univ, Sch Psychol, Chongqing, Peoples R China.	yanghs@swu.edu.cn			Chongqing Key Research Base for Humanities and Social Sciences [09SKB26]; Fundamental Research Funds for the Central Universities [XDJK2009C187]; Key Discipline Fund of National 211 Project [NSKD08012]; Doctoral Research Fund of Southwest University [SWU109040]	Chongqing Key Research Base for Humanities and Social Sciences; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Discipline Fund of National 211 Project; Doctoral Research Fund of Southwest University(Southwest University - China)	This research was supported by Chongqing Key Research Base for Humanities and Social Sciences (09SKB26), Fundamental Research Funds for the Central Universities (XDJK2009C187), Key Discipline Fund of National 211 Project (NSKD08012), and Doctoral Research Fund of Southwest University (SWU109040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechar-Israeli Haya, 1995, J COMPUT-MEDIAT COMM, V1, P1, DOI [10.1111/j.1083-6101.1995.tb00325.x, DOI 10.1111/J.1083-6101.1995.TB00325.X]; Bredart S, 2006, Q J EXP PSYCHOL, V59, P46, DOI 10.1080/17470210500343678; Conway ARA, 2001, PSYCHON B REV, V8, P331, DOI 10.3758/BF03196169; Fischer C, 2008, CLIN NEUROPHYSIOL, V119, P2224, DOI 10.1016/j.clinph.2008.03.035; Gray HM, 2004, J EXP SOC PSYCHOL, V40, P216, DOI 10.1016/S0022-1031(03)00092-1; Harris CR, 2004, PSYCHOL SCI, V15, P171, DOI 10.1111/j.0956-7976.2004.01503005.x; Harris CR, 2004, Q J EXP PSYCHOL-A, V57, P1, DOI 10.1080/02724980343000107; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Miyakoshi M, 2007, BRAIN COGNITION, V63, P182, DOI 10.1016/j.bandc.2006.12.001; MORAY N, 1959, Q J EXP PSYCHOL, V11, P56, DOI 10.1080/17470215908416289; Qin PM, 2012, HUM BRAIN MAPP, V33, P154, DOI 10.1002/hbm.21201; Stommel W, 2007, J COMPUT-MEDIAT COMM, V13, P141, DOI 10.1111/j.1083-6101.2007.00390.x; Sugiura M, 2008, NEUROIMAGE, V42, P414, DOI 10.1016/j.neuroimage.2008.03.054; Tacikowski P, 2011, SOC NEUROSCI-UK, V6, P98, DOI 10.1080/17470919.2010.490665; Tacikowski P, 2010, BIOL PSYCHOL, V84, P318, DOI 10.1016/j.biopsycho.2010.03.009; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; WOOD N, 1995, J EXP PSYCHOL LEARN, V21, P255, DOI 10.1037/0278-7393.21.1.255	17	5	5	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140654	10.1371/journal.pone.0140654	http://dx.doi.org/10.1371/journal.pone.0140654			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT6ZJ	26461490	gold, Green Published, Green Submitted			2022-12-26	WOS:000362962300111
J	Zou, M; Baitei, EY; Al-Rijjal, RA; Parhar, RS; Al-Mohanna, FA; Kimura, S; Pritchard, C; Binessa, HA; Alzahrani, AS; Al-Khalaf, HH; Hawwari, A; Akhtar, M; Assiri, AM; Meyer, BF; Shi, Y				Zou, M.; Baitei, E. Y.; Al-Rijjal, R. A.; Parhar, R. S.; Al-Mohanna, F. A.; Kimura, S.; Pritchard, C.; Binessa, H. A.; Alzahrani, A. S.; Al-Khalaf, H. H.; Hawwari, A.; Akhtar, M.; Assiri, A. M.; Meyer, B. F.; Shi, Y.			TSH overcomes Braf(V600E)-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer	ONCOGENE			English	Article							ONCOGENE-INDUCED SENESCENCE; SERUM TSH; TRANSGENIC MICE; BRAF MUTATIONS; MOUSE MODEL; IN-VIVO; PTEN; CARCINOMA; CELLS; RAS	The BRAF(V600E) mutation is found in approximately 40% of papillary thyroid cancers (PTC). Mice with thyroid-specific expression of BRAF(V600E) (TPO-BRAF(V600E)) develop PTC rapidly with high levels of serum thyroid-stimulating hormone (TSH). It is unclear to what extent the elevated TSH contributes to tumor progression. To investigate the progression of BRAF(V600E)-induced PTC (BVE-PTC) under normal TSH, we transplanted BVE-PTC tumors subcutaneously into nude and TPO-Braf(WT) mice. Regression of the transplanted tumors was observed in both nude and TPO-Braf(WT) mice. They were surrounded by heavy lymphocyte infiltration and oncogene-induced senescence (OIS) was demonstrated by strong beta-gal staining and absence of Ki-67 expression. In contrast, BVE-PTC transplants continued to grow when transplanted into TPO-BRAF(V600E) mice. The expression of Trp53 was increased in tumor transplants undergoing OIS. Trp53 inactivation reversed OIS and enabled tumor transplants to grow in nude mice with characteristic cell morphology of anaplastic thyroid cancer (ATC). PTC-to-ATC transformation was also observed in primary BVE-PTC tumors. ATC cells derived from Trp53 knockout tumors had increased PI3K/AKT signaling and became resistant to BRAF(V600E) inhibitor PLX4720, which could be overcome by combined treatment of PI3K inhibitor LY294002 and PLX4720. In conclusion, BVE-PTC progression could be contained via p53-dependent OIS and TSH is a major disruptor of this balance. Simultaneous targeting of both MAPK and PI3K/AKT pathways offer a better therapeutic outcome against ATC. The current study reinforces the importance of rigorous control of serum TSH in PTC patients.	[Zou, M.; Baitei, E. Y.; Al-Rijjal, R. A.; Binessa, H. A.; Hawwari, A.; Meyer, B. F.; Shi, Y.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, MBC 3,Takhassusi St,POB 3354, Riyadh 11211, Saudi Arabia; [Parhar, R. S.; Al-Mohanna, F. A.] King Faisal Specialist Hosp & Res Ctr, Dept Cell Biol, Riyadh 11211, Saudi Arabia; [Kimura, S.] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Pritchard, C.] Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 7RH, Leics, England; [Alzahrani, A. S.] King Faisal Specialist Hosp & Res Ctr, Dept Med, POB 3354, Riyadh 11211, Saudi Arabia; [Al-Khalaf, H. H.] King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia; [Akhtar, M.] King Faisal Specialist Hosp & Res Ctr, Dept Pathol, POB 3354, Riyadh 11211, Saudi Arabia; [Assiri, A. M.] King Faisal Specialist Hosp & Res Ctr, Dept Comparat Med, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Leicester; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center	Shi, Y (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, MBC 3,Takhassusi St,POB 3354, Riyadh 11211, Saudi Arabia.	yufei@kfshrc.edu.sa	Shi, Yufei/ABG-5228-2020; Alkhalaf, Huda/Z-5701-2019; Hawwari, Abbas/L-1934-2019	Shi, Yufei/0000-0002-6999-0191; Hawwari, Abbas/0000-0001-9643-6500; Pritchard, Catrin/0000-0003-1859-4487; Assiri, Abdullah/0000-0002-2753-5238; Assiri, Abdullah/0000-0002-5605-2876	KACST [11-BIO1434-20]; NATIONAL CANCER INSTITUTE [ZIABC005522] Funding Source: NIH RePORTER; Cancer Research UK [13083] Funding Source: researchfish	KACST; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	We would like to thank Mr Wilfredo Antiquera for excellent technical support. This study is supported by KACST grant 11-BIO1434-20.	Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Arciuch VGA, 2011, ONCOTARGET, V2, P1109, DOI 10.18632/oncotarget.380; Boelaert K, 2006, J CLIN ENDOCR METAB, V91, P4295, DOI 10.1210/jc.2006-0527; Boelaert K, 2009, ENDOCR-RELAT CANCER, V16, P1065, DOI 10.1677/ERC-09-0150; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Charles RP, 2014, MOL CANCER RES, V12, P979, DOI 10.1158/1541-7786.MCR-14-0158-T; Charles RP, 2011, CANCER RES, V71, P3863, DOI 10.1158/0008-5472.CAN-10-4463; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cheng JC, 2011, ONCOGENE, V30, P1020, DOI 10.1038/onc.2010.486; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Durante C, 2007, J CLIN ENDOCR METAB, V92, P2840, DOI 10.1210/jc.2006-2707; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; Fiore E, 2010, ENDOCR-RELAT CANCER, V17, P231, DOI 10.1677/ERC-09-0251; Fiore E, 2009, ENDOCR-RELAT CANCER, V16, P1251, DOI 10.1677/ERC-09-0036; Fiore E, 2012, J CLIN ENDOCR METAB, V97, P1134, DOI 10.1210/jc.2011-2735; Franco AT, 2011, P NATL ACAD SCI USA, V108, P1615, DOI 10.1073/pnas.1015557108; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Fujisawa T, 2012, INT J CANCER, V131, P344, DOI 10.1002/ijc.26366; Hagemann T, 2007, MOL CANCER THER, V6, P1993, DOI 10.1158/1535-7163.MCT-07-0118; Haymart MR, 2009, CLIN ENDOCRINOL, V71, P434, DOI 10.1111/j.1365-2265.2008.03489.x; Hollenbeak CS, 2013, EUR J ENDOCRINOL, V168, P549, DOI 10.1530/EJE-12-0848; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Jonklaas J, 2008, THYROID, V18, P943, DOI 10.1089/thy.2008.0061; Knauf JA, 2005, CANCER RES, V65, P4238, DOI 10.1158/0008-5472.CAN-05-0047; Kollmar O, 2008, J SURG RES, V145, P295, DOI 10.1016/j.jss.2007.02.010; Kusakabe T, 2004, GENESIS, V39, P212, DOI 10.1002/gene.20043; Li XY, 2014, ONCOTARGET, V5, P788, DOI 10.18632/oncotarget.1772; Malaguarnera R, 2007, ENDOCR-RELAT CANCER, V14, P43, DOI 10.1677/erc.1.01223; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; McFadden DG, 2014, P NATL ACAD SCI USA, V111, pE1600, DOI 10.1073/pnas.1404357111; Mercer K, 2005, CANCER RES, V65, P11493, DOI 10.1158/0008-5472.CAN-05-2211; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Natori T, 2002, BIOCHEM BIOPH RES CO, V297, P1058, DOI 10.1016/S0006-291X(02)02335-5; Romei C, 2008, ENDOCR-RELAT CANCER, V15, P511, DOI 10.1677/ERC-07-0130; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shimamura M, 2013, ENDOCRINOLOGY, V154, P4423, DOI 10.1210/en.2013-1174; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vizioli MG, 2014, ONCOTARGET, V5, P8270, DOI 10.18632/oncotarget.2013; Vizioli MG, 2011, ENDOCR-RELAT CANCER, V18, P743, DOI 10.1530/ERC-11-0240; Wei S, 1999, CANCER RES, V59, P1539; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yeager N, 2007, CANCER RES, V67, P959, DOI 10.1158/0008-5472.CAN-06-3524; Yoshimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058791; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zou M, 2005, BRIT J CANCER, V93, P1277, DOI 10.1038/sj.bjc.6602856; Zou MJ, 2014, THYROID, V24, P1256, DOI 10.1089/thy.2013.0610	59	27	27	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 14	2016	35	15					1909	1918		10.1038/onc.2015.253	http://dx.doi.org/10.1038/onc.2015.253			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ2CC	26477313	Green Accepted			2022-12-26	WOS:000374010300004
J	Abdouh, M; Hanna, R; El Hajjar, J; Flamier, A; Bernier, G				Abdouh, Mohamed; Hanna, Roy; El Hajjar, Jida; Flamier, Anthony; Bernier, Gilbert			The Polycomb Repressive Complex 1 Protein BMI1 Is Required for Constitutive Heterochromatin Formation and Silencing in Mammalian Somatic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						BRCA1; heterochromatin; lamin; polycomb; ubiquitylation (ubiquitination); BMI1; histone H2A	EMBRYONIC STEM-CELLS; DNA-DAMAGE RESPONSE; GROUP GENE BMI1; PERICENTRIC HETEROCHROMATIN; H2A UBIQUITYLATION; PRC2 RECRUITMENT; UBIQUITIN LIGASE; X-INACTIVATION; SELF-RENEWAL; HISTONE H2A	Background: BMI1 silences the expression of genes located at the facultative heterochromatin. Results: BMI1 is abundant at repetitive genomic regions, including the pericentromeric heterochromatin (PCH), where it is required for compaction and silencing. Conclusion: BMI1 is essential for PCH formation. Significance: BMI1 function at PCH is important to understand how BMI1 regulates genomic stability. The polycomb repressive complex 1 (PRC1), containing the core BMI1 and RING1A/B proteins, mono-ubiquitinylates histone H2A (H2A(ub)) and is associated with silenced developmental genes at facultative heterochromatin. It is, however, assumed that the PRC1 is excluded from constitutive heterochromatin in somatic cells based on work performed on mouse embryonic stem cells and oocytes. We show here that BMI1 is required for constitutive heterochromatin formation and silencing in human and mouse somatic cells. BMI1 was highly enriched at intergenic and pericentric heterochromatin, co-immunoprecipitated with the architectural heterochromatin proteins HP1, DEK1, and ATRx, and was required for their localization. In contrast, BRCA1 localization was BMI1-independent and partially redundant with that of BMI1 for H2A(ub) deposition, constitutive heterochromatin formation, and silencing. These observations suggest a dynamic and developmentally regulated model of PRC1 occupancy at constitutive heterochromatin, and where BMI1 function in somatic cells is to stabilize the repetitive genome.	[Bernier, Gilbert] Univ Montreal, Dept Neurosci, Montreal, PQ H1T 2M4, Canada; Hop Maison Neuve Rosemont, Stem Cell & Dev Biol Lab, Montreal, PQ H1T 2M4, Canada	Universite de Montreal; Universite de Montreal	Bernier, G (corresponding author), Univ Montreal, Dept Neurosci, 5415 Boul Assomption, Montreal, PQ H1T 2M4, Canada.	gbernier.hmr@ssss.gouv.qc.ca	Hanna, Roy/E-2645-2015	Hanna, Roy/0000-0002-1284-7941; Abdouh, Mohamed/0000-0003-0702-9335	Natural Science and Engineering Research Council of Canada; University of Montreal Molecular Biology Program	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Montreal Molecular Biology Program	This work was supported in part by a grant from the Natural Science and Engineering Research Council of Canada. The authors declare that they have no conflict of interest regarding the content of this manuscript.; Supported by fellowships from the University of Montreal Molecular Biology Program.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chagraoui J, 2011, P NATL ACAD SCI USA, V108, P5284, DOI 10.1073/pnas.1014263108; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; HEWISH DR, 1973, BIOCHEM BIOPH RES CO, V52, P504, DOI 10.1016/0006-291X(73)90740-7; Huh MS, 2012, J CLIN INVEST, V122, P4412, DOI 10.1172/JCI63765; Hwang WL, 2014, NATURE, V512, P213, DOI 10.1038/nature13380; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kalb R, 2014, CELL REP, V8, P999, DOI 10.1016/j.celrep.2014.07.025; Kappes F, 2011, GENE DEV, V25, P673, DOI 10.1101/gad.2036411; Kim J, 2013, MOL CELL, V49, P1121, DOI 10.1016/j.molcel.2013.01.034; Kim M, 2004, NUCLEIC ACIDS RES, V32, P5742, DOI 10.1093/nar/gkh912; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; KORNBERG RD, 1989, METHOD ENZYMOL, V170, P3; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Larson K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002473; Lassman AB, 2004, NEURON GLIA BIOL, V1, P157, DOI 10.1017/S1740925X04000249; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Maison C, 2011, NAT GENET, V43, P220, DOI 10.1038/ng.765; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; ORIAN JM, 1992, BRIT J CANCER, V66, P106, DOI 10.1038/bjc.1992.225; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Roman-Trufero M, 2009, STEM CELLS, V27, P1559, DOI 10.1002/stem.82; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Saksouk N, 2014, MOL CELL, V56, P580, DOI 10.1016/j.molcel.2014.10.001; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Sewalt RGAB, 2002, MOL CELL BIOL, V22, P5539, DOI 10.1128/MCB.22.15.5539-5553.2002; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Smigova J, 2011, NUCLEUS-AUSTIN, V2, P219, DOI 10.4161/nucl.2.3.15737; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tadeu AMB, 2008, EMBO J, V27, P2510, DOI 10.1038/emboj.2008.175; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Thakar A, 2010, J BIOMOL STRUCT DYN, V27, P399, DOI 10.1080/07391102.2010.10507326; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Visser HPJ, 2001, BRIT J HAEMATOL, V112, P950, DOI 10.1046/j.1365-2141.2001.02641.x; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Watson LA, 2013, J CLIN INVEST, V123, P2049, DOI 10.1172/JCI65634; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Wu LP, 2013, MOL CELL, V49, P1108, DOI 10.1016/j.molcel.2013.01.033; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	78	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					182	197		10.1074/jbc.M115.662403	http://dx.doi.org/10.1074/jbc.M115.662403			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26468281	Green Published, hybrid			2022-12-26	WOS:000367589500015
J	Scioli, MG; Lo Giudice, P; Bielli, A; Tarallo, V; De Rosa, A; De Falco, S; Orlandi, A				Scioli, Maria Giovanna; Lo Giudice, Pietro; Bielli, Alessandra; Tarallo, Valeria; De Rosa, Alfonso; De Falco, Sandro; Orlandi, Augusto			Propionyl-L-Carnitine Enhances Wound Healing and Counteracts Microvascular Endothelial Cell Dysfunction	PLOS ONE			English	Article							NITRIC-OXIDE-SYNTHASE; PROTEIN-KINASE-C; MITOCHONDRIAL DYSFUNCTION; ATHEROSCLEROTIC LESIONS; EXERCISE PERFORMANCE; OXIDATIVE STRESS; REACTIVE OXYGEN; NADPH OXIDASES; GROWTH-FACTOR; ANGIOGENESIS	Background Impaired wound healing represents a high cost for health care systems. Endothelial dysfunction characterizes dermal microangiopathy and contributes to delayed wound healing and chronic ulcers. Endothelial dysfunction impairs cutaneous microvascular blood flow by inducing an imbalance between vasorelaxation and vasoconstriction as a consequence of reduced nitric oxide (NO) production and the increase of oxidative stress and inflammation. Propionyl-L-carnitine (PLC) is a natural derivative of carnitine that has been reported to ameliorate post-ischemic blood flow recovery. Methods and Results We investigated the effects of PLC in rat skin flap and cutaneous wound healing. A daily oral PLC treatment improved skin flap viability and associated with reactive oxygen species (ROS) reduction, inducible nitric oxide synthase (iNOS) and NO up-regulation, accelerated wound healing and increased capillary density, likely favoring dermal angiogenesis by up-regulation for iNOS, vascular endothelial growth factor (VEGF), placental growth factor (PlGF) and reduction of NADPH-oxidase 4 (Nox4) expression. In serum-deprived human dermal microvascular endothelial cell cultures, PLC ameliorated endothelial dysfunction by increasing iNOS, PlGF, VEGF receptors 1 and 2 expression and NO level. In addition, PLC counteracted serum deprivation-induced impairment of mitochondrial beta-oxidation, Nox4 and cellular adhesion molecule (CAM) expression, ROS generation and leukocyte adhesion. Moreover, dermal microvascular endothelial cell dysfunction was prevented by Nox4 inhibition. Interestingly, inhibition of beta-oxidation counteracted the beneficial effects of PLC on oxidative stress and endothelial dysfunction. Conclusion PLC treatment improved rat skin flap viability, accelerated wound healing and dermal angiogenesis. The beneficial effects of PLC likely derived from improvement of mitochondrial beta-oxidation and reduction of Nox4-mediated oxidative stress and endothelial dysfunction. Antioxidant therapy and pharmacological targeting of endothelial dysfunction may represent a promising tool for the treatment of delayed wound healing or chronic ulcers.	[Scioli, Maria Giovanna; Bielli, Alessandra; Orlandi, Augusto] Univ Roma Tor Vergata, Dept Biomed & Prevent, Anat Pathol, Rome, Italy; [Lo Giudice, Pietro; De Rosa, Alfonso] Sigma Tau Pharmaceut Co, Rome, Italy; [Tarallo, Valeria; De Falco, Sandro] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy; [Orlandi, Augusto] Policlin Tor Vergata, Anat Pathol, Rome, Italy	University of Rome Tor Vergata; Leadiant Biosciences; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Rome Tor Vergata; Policlin Tor Vergata	Orlandi, A (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Anat Pathol, Rome, Italy.	orlandi@uniroma2.it	Orlandi, Augusto/AHE-8753-2022; De Falco, Sandro/P-6724-2015; Scioli, Maria Giovanna/AAC-7612-2022	Scioli, Maria Giovanna/0000-0002-8458-4108; De Falco, Sandro/0000-0002-6501-1697; Tarallo, Valeria/0000-0002-6920-4402	Sigma-Tau SpA	Sigma-Tau SpA	P. Lo Giudice and A. De Rosa are employees of Sigma-Tau SpA. Sigma-Tau SpA provided support in the form of salaries for P. Lo Giudice and A. De Rosa, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Addabbo F, 2009, AM J PATHOL, V174, P34, DOI 10.2353/ajpath.2009.080650; Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; de Sotomayor MA, 2007, J VASC RES, V44, P354, DOI 10.1159/000102303; Brass EP, 2013, VASC MED, V18, P3, DOI 10.1177/1358863X12467491; BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420; Bueno R, 2005, LIFE SCI, V77, P2082, DOI 10.1016/j.lfs.2005.01.035; Bussolati B, 2001, AM J PATHOL, V159, P993, DOI 10.1016/S0002-9440(10)61775-0; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Cervelli V, 2012, STEM CELL TRANSL MED, V1, P206, DOI 10.5966/sctm.2011-0052; Chin LC, 2011, BRIT J DERMATOL, V165, P1223, DOI 10.1111/j.1365-2133.2011.10599.x; Cipolla MJ, 1999, J VASC SURG, V29, P1097, DOI 10.1016/S0741-5214(99)70251-X; Deng BQ, 2012, J VASC RES, V49, P144, DOI 10.1159/000332337; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dong J, 2014, MOL MED REP, V9, P583, DOI 10.3892/mmr.2013.1838; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Ferlosio A, 2012, ATHEROSCLEROSIS, V224, P51, DOI 10.1016/j.atherosclerosis.2012.07.016; Ferraro B, 2009, MOL THER, V17, P651, DOI 10.1038/mt.2009.12; Galley HF, 2004, BRIT J ANAESTH, V93, P105, DOI 10.1093/bja/aeh163; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; Harrington JR, 2000, STEM CELLS, V18, P65, DOI 10.1634/stemcells.18-1-65; Hiatt WR, 2001, AM J MED, V110, P616, DOI 10.1016/S0002-9343(01)00704-5; Hirase T, 2012, AM J PHYSIOL-HEART C, V302, pH499, DOI 10.1152/ajpheart.00325.2011; Huang N, 2006, AM J PHYSIOL-HEART C, V291, pH127, DOI 10.1152/ajpheart.01253.2005; Kane AJ, 2001, BRIT J PHARMACOL, V132, P1631, DOI 10.1038/sj.bjp.0703944; Konior A, 2014, ANTIOXID REDOX SIGN, V20, P2794, DOI 10.1089/ars.2013.5607; Kvietys PR, 2012, FREE RADICAL BIO MED, V52, P556, DOI 10.1016/j.freeradbiomed.2011.11.002; Laing T, 2007, MED HYPOTHESES, V69, P1029, DOI 10.1016/j.mehy.2007.02.040; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; LI P, 1995, AM J PHYSIOL-HEART C, V268, pH1702, DOI 10.1152/ajpheart.1995.268.4.H1702; Luo JD, 2005, ACTA PHARMACOL SIN, V26, P259, DOI 10.1111/j.1745-7254.2005.00058.x; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mauriello A, 1996, HYPERTENSION, V28, P177, DOI 10.1161/01.HYP.28.2.177; May JM, 2013, ANTIOXID REDOX SIGN, V19, P2068, DOI 10.1089/ars.2013.5205; Mayol L, 2014, J MATER SCI-MATER M, V25, P1483, DOI 10.1007/s10856-014-5175-7; MCFARLANE R M, 1965, Plast Reconstr Surg, V35, P177, DOI 10.1097/00006534-196502000-00007; McNeel DG, 2005, CLIN CANCER RES, V11, P7851, DOI 10.1158/1078-0432.CCR-05-0262; Michlits W, 2007, WOUND REPAIR REGEN, V15, P360, DOI 10.1111/j.1524-475X.2007.00238.x; Mohammed KA, 2007, AM J PHYSIOL-LUNG C, V292, pL559, DOI 10.1152/ajplung.00075.2006; Nagy I, 2000, PHARMACOL RES, V41, P9, DOI 10.1006/phrs.1999.0565; Nanney Lillian B., 2001, Angiogenesis, V4, P61, DOI 10.1023/A:1016752925761; Orlandi A, 2005, AM J PATHOL, V166, P1619, DOI 10.1016/S0002-9440(10)62472-8; Orlandi A, 2004, CARDIOVASC RES, V64, P544, DOI 10.1016/j.cardiores.2004.07.024; ORLANDI A, 1994, ARTERIOSCLER THROMB, V14, P982, DOI 10.1161/01.ATV.14.6.982; Orlandi A, 2000, ARTERIOSCL THROM VAS, V20, P1123, DOI 10.1161/01.ATV.20.4.1123; Orlandi A, 2010, BIOCHEM PHARMACOL, V79, P1706, DOI 10.1016/j.bcp.2010.01.027; Pisano C, 2010, CLIN CANCER RES, V16, P3944, DOI 10.1158/1078-0432.CCR-10-0964; POLA P, 1991, DRUG EXP CLIN RES, V17, P277; Quagliaro L, 2005, ATHEROSCLEROSIS, V183, P259, DOI 10.1016/j.atherosclerosis.2005.03.015; Reiber GE, 1999, DIABETES CARE, V22, P157, DOI 10.2337/diacare.22.1.157; Ribas GS, 2014, GENE, V533, P469, DOI 10.1016/j.gene.2013.10.017; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Schaffer MR, 1997, SURGERY, V121, P513, DOI 10.1016/S0039-6060(97)90105-7; Scioli MG, 2014, J VASC RES, V51, P327, DOI 10.1159/000365926; Scioli MG, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-19; Scioli MG, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.4; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; SPAGNOLI LG, 1991, ATHEROSCLEROSIS, V89, P11, DOI 10.1016/0021-9150(91)90003-L; SPAGNOLI LG, 1995, ATHEROSCLEROSIS, V114, P29, DOI 10.1016/0021-9150(94)05460-Z; Stallmeyer B, 1999, J INVEST DERMATOL, V113, P1090, DOI 10.1046/j.1523-1747.1999.00784.x; Stasi MA, 2010, ARTERIOSCL THROM VAS, V30, P426, DOI 10.1161/ATVBAHA.109.201533; Theile DRB, 1998, BRIT J PLAST SURG, V51, P243, DOI 10.1016/S0007-1226(98)80016-7; TOPALAN M, 1993, EUR J PLAST SURG, V16, P33; Whitlock E, 2014, AUST FAM PHYSICIAN, V43, P143; Zakynthinos E, 2009, J CARDIOL, V53, P317, DOI 10.1016/j.jjcc.2008.12.007	70	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140697	10.1371/journal.pone.0140697	http://dx.doi.org/10.1371/journal.pone.0140697			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473356	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500084
J	Gibson, CC; Davis, CT; Zhu, WQ; Bowman-Kirigin, JA; Walker, AE; Tai, ZF; Thomas, KR; Donato, AJ; Lesniewski, LA; Li, DY				Gibson, Christopher C.; Davis, Chadwick T.; Zhu, Weiquan; Bowman-Kirigin, Jay A.; Walker, Ashley E.; Tai, Zhengfu; Thomas, Kirk R.; Donato, Anthony J.; Lesniewski, Lisa A.; Li, Dean Y.			Dietary Vitamin D and Its Metabolites Non-Genomically Stabilize the Endothelium	PLOS ONE			English	Article							D-RECEPTOR; D DEFICIENCY; TYROSINE PHOSPHORYLATION; CARDIOVASCULAR-DISEASE; PERMEABILITY; CELLS; D-3; BINDING; IDENTIFICATION; MECHANISMS	Vitamin D is a known modulator of inflammation. Native dietary vitamin D-3 is thought to be bio-inactive, and beneficial vitamin D3 effects are thought to be largely mediated by the metabolite 1,25(OH)(2)D-3. Reduced serum levels of the most commonly measured precursor metabolite, 25(OH)D-3, is linked to an increased risk of multiple inflammatory diseases, including: cardiovascular disease, arthritis, multiple sclerosis, and sepsis. Common to all of these diseases is the disruption of endothelial stability and an enhancement of vascular leak. We previously performed an unbiased chemical suppressor screen on a genetic model of vascular instability, and identified cholecalciferol (D-3, dietary Vitamin D-3) as a factor that had profound and immediate stabilizing and therapeutic effects in that model. In this manuscript we show that the presumed inactive sterol, D-3, is actually a potent and general mediator of endothelial stability at physiologically relevant concentrations. We further demonstrate that this phenomenon is apparent in vitamin D-3 metabolites 25(OH)D-3 and 1,25 (OH)(2)D-3, and that the effects are independent of the canonical transcription-mediated vitamin D pathway. Our data suggests the presence of an alternative signaling modality by which D-3 acts directly on endothelial cells to prevent vascular leak. The finding that D-3 and its metabolites modulate endothelial stability may help explain the clinical correlations between low serum vitamin D levels and the many human diseases with well-described vascular dysfunction phenotypes.	[Gibson, Christopher C.; Davis, Chadwick T.; Zhu, Weiquan; Bowman-Kirigin, Jay A.; Thomas, Kirk R.; Li, Dean Y.] Univ Utah, Program Mol Med, Salt Lake City, UT 84112 USA; [Gibson, Christopher C.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Gibson, Christopher C.; Davis, Chadwick T.; Thomas, Kirk R.; Li, Dean Y.] Recurs Pharmaceut LLC, Salt Lake City, UT 84108 USA; [Davis, Chadwick T.; Li, Dean Y.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Walker, Ashley E.; Donato, Anthony J.; Lesniewski, Lisa A.] Univ Utah, Div Geriatr, Dept Med, Salt Lake City, UT 84112 USA; [Tai, Zhengfu; Li, Dean Y.] Sichuan Acad Med Sci, Inst Lab Med, Key Lab Human Dis Gene Study Sichuan Prov, Chengdu 610072, Sichuan, Peoples R China; [Tai, Zhengfu; Li, Dean Y.] Sichuan Prov Peoples Hosp, Chengdu 610072, Sichuan, Peoples R China; [Li, Dean Y.] Univ Utah, Div Cardiol, Dept Med, Salt Lake City, UT 84112 USA; [Li, Dean Y.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Li, Dean Y.] VA Salt Lake City Hlth Care Syst, Cardiol Sect, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs	Li, DY (corresponding author), Univ Utah, Program Mol Med, Salt Lake City, UT 84112 USA.	dean.li@u2m2.utah.edu	Lesniewski, Lisa A/B-2443-2012; Walker, Ashley/B-3791-2012	Walker, Ashley/0000-0003-1612-4545; LESNIEWSKI, LISA/0000-0002-2138-1450; Bowman-Kirigin, Jay/0000-0002-7687-3727	NIH [1R01NS080893-01A1, 2R01HL077671-09, 2R01HL084516-05A1]; Veteran's Affairs Merit Award [1IOBX002976]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG045339] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Affairs Merit Award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH Grants 1R01NS080893-01A1 (PI: Li, Dean Y.), 2R01HL077671-09 (PI: Li, Dean Y.), and 2R01HL084516-05A1 (PI: Li, Dean Y.), and Veteran's Affairs Merit Award 1IOBX002976 (PI: Li, Dean Y.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Recursion Pharmaceuticals, LLC provided support in the form of salaries for authors CCG, CTD, KRT and DYL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Amital H, 2010, ANN RHEUM DIS, V69, P1155, DOI 10.1136/ard.2009.120329; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Boyan BD, 2003, J CELL BIOCHEM, V90, P1207, DOI 10.1002/jcb.10716; Broman MT, 2006, CIRC RES, V98, P73, DOI 10.1161/01.RES.0000198387.44395.e9; Chen TC, 2000, J NUTR BIOCHEM, V11, P267, DOI 10.1016/S0955-2863(00)00077-2; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Cines DB, 1998, BLOOD, V91, P3527; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; Davis CT, 2014, J IMMUNOL, V192, P6045, DOI 10.4049/jimmunol.1400309; De Boer RA, 2011, J RENIN-ANGIO-ALDO S, V12, P123, DOI 10.1177/1470320311410923; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Dubnov-Raz G, 2015, PEDIATR EXERC SCI, V27, P113, DOI 10.1123/pes.2014-0030; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Gibson CC, 2015, CIRCULATION, V131, P289, DOI 10.1161/CIRCULATIONAHA.114.010403; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Heaney RP, 2008, AM J CLIN NUTR, V87, P1738, DOI 10.1093/ajcn/87.6.1738; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Horst RL, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P15; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Jones C, 2009, NATURE CELL BIOL; Kerr GS, 2011, J RHEUMATOL, V38, P53, DOI 10.3899/jrheum.100516; Kim DH, 2009, KIDNEY INT, V76, P1180, DOI 10.1038/ki.2009.387; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Lou YR, 2010, J STEROID BIOCHEM, V118, P162, DOI 10.1016/j.jsbmb.2009.11.011; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Meyer MB, 2010, J BIOL CHEM, V285, P15599, DOI 10.1074/jbc.M110.119958; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Moromizato T, 2014, CRIT CARE MED, V42, P97, DOI 10.1097/CCM.0b013e31829eb7af; Nambu H, 2004, GENE THER, V11, P865, DOI 10.1038/sj.gt.3302230; Ng K, 2014, CURR COLORECT CANC R, V10, P339, DOI 10.1007/s11888-014-0238-1; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; NORMAN AW, 1992, J STEROID BIOCHEM, V41, P231, DOI 10.1016/0960-0760(92)90349-N; NORMAN AW, 1971, SCIENCE, V173, P51, DOI 10.1126/science.173.3991.51; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Poole KES, 2006, STROKE, V37, P243, DOI 10.1161/01.STR.0000195184.24297.c1; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Sawada J, 2012, CANCER CELL, V22, P235, DOI 10.1016/j.ccr.2012.06.013; Shui Irene, 2014, Adv Exp Med Biol, V810, P33; Svoren BM, 2009, J PEDIATR-US, V154, P132, DOI 10.1016/j.jpeds.2008.07.015; Thacher TD, 2011, MAYO CLIN PROC, V86, P50, DOI 10.4065/mcp.2010.0567; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Yin K, 2014, J INFLAMM RES, V7, P69, DOI 10.2147/JIR.S63898; Zehnder D, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133621; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603	51	42	45	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140370	10.1371/journal.pone.0140370	http://dx.doi.org/10.1371/journal.pone.0140370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469335	Green Published, gold			2022-12-26	WOS:000363184600052
J	Lee, SW; Yu, MY; Lee, H; Ahn, SY; Kim, S; Chin, HJ; Na, KY				Lee, Sung Woo; Yu, Mi-yeon; Lee, Hajeong; Ahn, Shin Young; Kim, Sejoong; Chin, Ho Jun; Na, Ki Young			Risk Factors for Acute Kidney Injury and In-Hospital Mortality in Patients Receiving Extracorporeal Membrane Oxygenation	PLOS ONE			English	Article							CELL DISTRIBUTION WIDTH; ACUTE RESPIRATORY-FAILURE; CRITICALLY-ILL PATIENTS; PROGNOSTIC MARKER; CENTRIFUGAL-PUMP; CO2 REMOVAL; COMPLICATIONS; METAANALYSIS; VENTILATION; COHORT	Background and Objectives Although acute kidney injury (AKI) is the most frequent complication in patients receiving extracorporeal membrane oxygenation (ECMO), few studies have been conducted on the risk factors of AKI. We performed this study to identify the risk factors of AKI associated with in-hospital mortality. Methods Data from 322 adult patients receiving ECMO were analyzed. AKI and its stages were defined according to Kidney Disease Improving Global Outcomes (KDIGO) classifications. Variables within 24 h before ECMO insertion were collected and analyzed for the associations with AKI and in-hospital mortality. Results Stage 3 AKI was associated with in-hospital mortality, with a hazard ratio (HR) (95% CI) of 2.690 (1.472-4.915) compared to non-AKI (rho = 0.001). The simplified acute physiology score 2 (SAPS2) and serum sodium level were also associated with in-hospital mortality, with HRs of 1.02 (1.004-1.035) per 1 score increase (rho = 0.01) and 1.042 (1.014-1.070) per 1 mmol/L increase (rho = 0.003). The initial pump speed of ECMO was significantly related to in-hospital mortality with a HR of 1.333 (1.020-1.742) per 1,000 rpm increase (rho = 0.04). The pump speed was also associated with AKI (rho = 0.02) and stage 3 AKI (rho = 0.03) with ORs (95% CI) of 2.018 (1.129-3.609) and 1.576 (1.058-2.348), respectively. We also found that the red cell distribution width (RDW) above 14.1% was significantly related to stage 3 AKI. Conclusion The initial pump speed of ECMO was a significant risk factor of in-hospital mortality and AKI in patients receiving ECMO. The RDW was a risk factor of stage 3 AKI.	[Lee, Sung Woo; Yu, Mi-yeon; Ahn, Shin Young; Kim, Sejoong; Chin, Ho Jun; Na, Ki Young] Seoul Natl Univ, Bundang Hosp, Div Nephrol, Dept Internal Med, Seongnam, Gyeonggi Do, South Korea; [Lee, Hajeong] Seoul Natl Univ Hosp, Div Nephrol, Dept Internal Med, Seoul 110744, South Korea; [Chin, Ho Jun; Na, Ki Young] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Na, KY (corresponding author), Seoul Natl Univ, Bundang Hosp, Div Nephrol, Dept Internal Med, Seongnam, Gyeonggi Do, South Korea.	kyna@snubh.org	Yu, Mi-Yeon/ABB-7937-2021; Kim, Sejoong/J-5356-2015	Kim, Sejoong/0000-0002-7238-9962				Allen LA, 2010, J CARD FAIL, V16, P230, DOI 10.1016/j.cardfail.2009.11.003; Bazick HS, 2011, CRIT CARE MED, V39, P1913, DOI 10.1097/CCM.0b013e31821b85c6; Brodie D, 2011, NEW ENGL J MED, V365, P1905, DOI 10.1056/NEJMct1103720; Chang WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042687; Chen YC, 2014, J FORMOS MED ASSOC, V113, P778, DOI 10.1016/j.jfma.2014.04.006; Chen YC, 2011, ANN THORAC SURG, V91, P137, DOI 10.1016/j.athoracsur.2010.08.063; Cheng R, 2014, ANN THORAC SURG, V97, P610, DOI 10.1016/j.athoracsur.2013.09.008; Combes A, 2014, AM J RESP CRIT CARE, V190, P488, DOI 10.1164/rccm.201404-0630CP; Darmon M, 2013, CRIT CARE, V17, DOI 10.1186/cc11937; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; GATTINONI L, 1986, JAMA-J AM MED ASSOC, V256, P881, DOI 10.1001/jama.256.7.881; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Hu ZD, 2013, CLIN CHEM LAB MED, V51, P1403, DOI 10.1515/cclm-2012-0704; Kielstein JT, 2013, NEPHROL DIAL TRANSPL, V28, P86, DOI 10.1093/ndt/gfs398; Kress D C, 1987, ASAIO Trans, V33, P446; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lehle K, 2014, ARTIF ORGANS, V38, P391, DOI 10.1111/aor.12180; Lin CY, 2006, NEPHROL DIAL TRANSPL, V21, P2867, DOI 10.1093/ndt/gfl326; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; Lou S, 2014, CRIT CARE MED, V42, P1213, DOI 10.1097/CCM.0000000000000128; MORRIS AH, 1994, AM J RESP CRIT CARE, V149, P295, DOI 10.1164/ajrccm.149.2.8306022; Nichols EL, 2015, CORONARY ARTERY DIS, V26, P283, DOI 10.1097/MCA.0000000000000239; Noah MA, 2011, JAMA-J AM MED ASSOC, V306, P1659, DOI 10.1001/jama.2011.1471; Ozturk ZA, 2013, ARCH GERONTOL GERIAT, V56, P50, DOI 10.1016/j.archger.2012.10.002; Pedersen TH, 1997, ANN THORAC SURG, V63, P1333, DOI 10.1016/S0003-4975(97)00098-2; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Shema-Didi L, 2010, NEPHRON CLIN PRACT, V115, pC168, DOI 10.1159/000312881; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; Tsai CW, 2008, EUR J CARDIO-THORAC, V34, P1158, DOI 10.1016/j.ejcts.2008.07.025; Tulman DB, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-65; Windsant ICV, 2010, KIDNEY INT, V77, P913, DOI 10.1038/ki.2010.24; Yan XL, 2010, EUR J CARDIO-THORAC, V37, P334, DOI 10.1016/j.ejcts.2009.07.004; Zangrillo A, 2013, CRIT CARE RESUSC, V15, P172; ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193; Zwiers AJM, 2013, CRIT CARE, V17, DOI 10.1186/cc12830	37	30	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140674	10.1371/journal.pone.0140674	http://dx.doi.org/10.1371/journal.pone.0140674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469793	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600094
J	Spiesberger, K; Paulfranz, F; Egger, A; Reiser, J; Vogl, C; Rudolf-Scholik, J; Mayrhofer, C; Grosse-Hovest, L; Brem, G				Spiesberger, Katrin; Paulfranz, Florian; Egger, Anton; Reiser, Judith; Vogl, Claus; Rudolf-Scholik, Judith; Mayrhofer, Corina; Grosse-Hovest, Ludger; Brem, Gottfried			Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODY; CELLS IN-VITRO; T-CELLS; CANCER-THERAPY; FARM-ANIMALS; ACTIVATION; CD28; STIMULATION; METASTASIS; DISEASES	Background 30 years ago, the potential of bispecific antibodies to engage cytotoxic T cells for the lysis of cancer cells was discovered. Today a variety of bispecific antibodies against diverse cell surface structures have been developed, the majority of them produced in mammalian cell culture systems. Beside the r28M, described here, no such bispecific antibody is known to be expressed by transgenic livestock, although various biologicals for medical needs are already harvested-mostly from the milk-of these transgenics. In this study we investigated the large-scale purification and biological activity of the bispecific antibody r28M, expressed in the blood of transgenic cattle. This tandem single-chain variable fragment antibody is designed to target human CD28 and the melanoma/glioblastoma-associated cell surface chondroitin sulfate proteoglycan 4 (CSPG4). Results With the described optimized purification protocol an average yield of 30 mg enriched r28M fraction out of 2 liters bovine plasma could be obtained. Separation of this enriched fraction by size exclusion chromatography into monomers, dimers and aggregates and further testing regarding the biological activity revealed the monomer fraction as being the most appropriate one to continue working with. The detailed characterization of the antibody's activity confirmed its high specificity to induce the killing of CSPG4 positive cells. In addition, first insights into tumor cell death pathways mediated by r28M-activated peripheral blood mononuclear cells were gained. In consideration of possible applications in vivo we also tested the effect of the addition of different excipients to r28M. Conclusion Summing up, we managed to purify monomeric r28M from bovine plasma in a large-scale preparation and could prove that its biological activity is unaffected and still highly specific and thus, might be applicable for the treatment of melanoma.	[Spiesberger, Katrin; Vogl, Claus; Mayrhofer, Corina; Brem, Gottfried] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Dept Biomed Sci, Vienna, Austria; [Spiesberger, Katrin; Paulfranz, Florian; Egger, Anton; Reiser, Judith; Rudolf-Scholik, Judith; Brem, Gottfried] Univ Vet Med Vienna, Christian Doppler Lab Innovat Immunotherapy, Vienna, Austria; [Mayrhofer, Corina; Brem, Gottfried] Univ Bodenkultur Wien, Dept Agrobiotechnol IFA Tulln, Inst Biotechnol Anim Prod, Tulln, Austria; [Grosse-Hovest, Ludger] Univ Tubingen, Inst Cell Biol, Dept Immunol, Tubingen, Germany	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna; Eberhard Karls University of Tubingen	Spiesberger, K (corresponding author), Univ Vet Med Vienna, Inst Anim Breeding & Genet, Dept Biomed Sci, Vienna, Austria.	katrin.spiesberger@vetmeduni.ac.at			Christian Doppler Forschungsgesellschaft	Christian Doppler Forschungsgesellschaft	This work was supported by Christian Doppler Forschungsgesellschaft, https://www.cdg.ac.at/ (receiving author: Gottfried Brem). Christian Doppler Forschungsgesellschaft provided support in the form of salaries for authors KS, FP, AE, JR and JRS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arakawa T, 2006, BIOPROCESS INT, V4, P42; Arndt KM, 1998, BIOCHEMISTRY-US, V37, P12918, DOI 10.1021/bi9810407; Baeuerle PA, 2009, CURR OPIN MOL THER, V11, P22; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; BAROJA ML, 1989, CELL IMMUNOL, V120, P205, DOI 10.1016/0008-8749(89)90188-3; Beyersdorf N, 2005, ANN RHEUM DIS, V64, P91, DOI 10.1136/ard.2005.042564; Beyersdorf N, 2015, EUR J IMMUNOL, V45, P1997, DOI 10.1002/eji.201445317; Brischwein K, 2007, J IMMUNOTHER, V30, P798, DOI 10.1097/CJI.0b013e318156750c; Chi EY, 2012, FDD TECH CORNER; Chu L, 2001, CURR OPIN BIOTECH, V12, P180, DOI 10.1016/S0958-1669(00)00197-X; Cope L, 2009, THERAPEUTIC MONOCLON; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Denecker G, 2001, CELL DEATH DIFFER, V8, P829, DOI 10.1038/sj.cdd.4400883; Felo M, 2013, BIOTECHNOL PROGR, DOI [10.1021/btpr.1776, DOI 10.1021/BTPR.1776]; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fortmuller K, 2011, PROSTATE, V71, P588, DOI 10.1002/pros.21274; Gaffen SL, 2004, CYTOKINE, V28, P109, DOI 10.1016/j.cyto.2004.06.010; Grosse-Hovest L, 2005, INT J CANCER, V117, P1060, DOI 10.1002/ijc.21294; Grosse-Hovest L, 2004, P NATL ACAD SCI USA, V101, P6858, DOI 10.1073/pnas.0308487101; Grosse-Hovest L, 2003, EUR J IMMUNOL, V33, P1334, DOI 10.1002/eji.200323322; Grosse-Hovest L, 1999, INT J CANCER, V80, P138, DOI 10.1002/(SICI)1097-0215(19990105)80:1<138::AID-IJC25>3.0.CO;2-J; Hoffmann P, 2005, INT J CANCER, V115, P98, DOI 10.1002/ijc.20908; Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005; Kamerzell TJ, 2011, ADV DRUG DELIVER REV, V63, P1118, DOI 10.1016/j.addr.2011.07.006; Kanduc D, 2002, INT J ONCOL, V21, P165; Kontermann RE, 2005, ACTA PHARMACOL SIN, V26, P1, DOI 10.1111/j.1745-7254.2005.00008.x; Kues WA, 2011, PREV VET MED, V102, P146, DOI 10.1016/j.prevetmed.2011.04.009; Maggio ET, 2010, J EXCIPIENTS FOOD CH; Marco-Ramell A, 2014, J PROTEOMICS, V101, P205, DOI 10.1016/j.jprot.2014.02.018; Niemann H, 2007, REPROD FERT DEVELOP, V19, P762, DOI 10.1071/RD07040; Otz T, 2009, LEUKEMIA, V23, P71, DOI 10.1038/leu.2008.271; Price MA, 2011, PIGM CELL MELANOMA R, V24, P1148, DOI 10.1111/j.1755-148X.2011.00929.x; SCHRAPPE M, 1991, CANCER RES, V51, P4986; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Society AC, 2015, CANC FACTS FIG 2015; STAERZ UD, 1985, NATURE, V314, P628, DOI 10.1038/314628a0; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stein C, 2012, ANTIBODIES, V1, P88, DOI 10.3390/antib1010088; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tacke M, 1997, EUR J IMMUNOL, V27, P239, DOI 10.1002/eji.1830270136; Team RC, 2014, R LANG ENV STAT COMP; Topp MS, 2012, BLOOD, V120, P5185, DOI 10.1182/blood-2012-07-441030; Torisu-Itakura H, 2011, J IMMUNOTHER, V34, P597, DOI 10.1097/CJI.0b013e3182307fd8; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; YOKOTA T, 1992, CANCER RES, V52, P3402	45	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140471	10.1371/journal.pone.0140471	http://dx.doi.org/10.1371/journal.pone.0140471			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469402	gold, Green Submitted, Green Published			2022-12-26	WOS:000363184600066
J	Kokubun, N; Yamamoto, T; Kikuchi, DM; Kitaysky, A; Takahashi, A				Kokubun, Nobuo; Yamamoto, Takashi; Kikuchi, Dale M.; Kitaysky, Alexander; Takahashi, Akinori			Nocturnal Foraging by Red-Legged Kittiwakes, a Surface Feeding Seabird That Relies on Deep Water Prey During Reproduction	PLOS ONE			English	Article							VERTICAL MIGRATION; BERING-SEA; FOOD; ACCELERATION; ALBATROSSES; ABUNDANCE; TRACKING; BEHAVIOR; NORTH; DIET	Narrow foraging specialization may increase the vulnerability of marine predators to climate change. The red-legged kittiwake (Rissa brevirostris) is endemic to the Bering Sea and has experienced drastic population fluctuations in recent decades, presumably due to climate-driven changes in food resources. Red-legged kittiwakes are presumed to be a nocturnal surface-foraging seabird that feed almost entirely on deep water Myctophidae fishes. However, there is little empirical evidence confirming their nocturnal foraging activity during the breeding season. This study investigated the foraging behavior of red-legged kittiwakes by combining GPS tracking, accelerometry, and dietary analyses at the world's largest breeding colony of red-legged kittiwakes on St. George I. GPS tracking of 5 individuals revealed that 82.5% of non-flight behavior (including foraging and resting) occurred over the ocean basin (bottom depth >1,000 m). Acceleration data from 4 birds showed three types of behaviors during foraging trips: (1) flight, characterized by regular wing flapping, (2) resting on water, characterized by non-active behavior, and (3) foraging, when wing flapping was irregular. The proportions of both foraging and resting behaviors were higher at night (14.1 +/- 7.1% and 20.8 +/- 14.3%) compared to those during the day (6.5 +/- 3.0% and 1.7 +/- 2.7%). The mean duration of foraging (2.4 +/- 2.9 min) was shorter than that of flight between prey patches (24.2 +/- 53.1 min). Dietary analyses confirmed myctophids as the dominant prey (100% by occurrence and 98.4 +/- 2.4% by wet-weight). Although the sample size was limited, these results suggest that breeding red-legged kittiwakes concentrated their foraging on myctophids available at the surface during nighttime in deep water regions. We propose that the diel patterns and ephemeral nature of their foraging activity reflected the availability of myctophids. Such foraging specialization may exacerbate the vulnerability of red-legged kittiwakes to climate change in the Bering Sea.	[Kokubun, Nobuo; Yamamoto, Takashi; Takahashi, Akinori] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Kokubun, Nobuo; Kikuchi, Dale M.; Takahashi, Akinori] Grad Univ Adv Studies SOKENDAI, Dept Polar Sci, Tachikawa, Tokyo 1908518, Japan; [Yamamoto, Takashi] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Kitaysky, Alexander] Univ Alaska Fairbanks, Dept Biol & Wildlife, Inst Arct Biol, Fairbanks, AK 99503 USA	Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Graduate University for Advanced Studies - Japan; Hokkaido University; University of Alaska System; University of Alaska Fairbanks	Kokubun, N (corresponding author), Natl Inst Polar Res, 10-3 Midori Cho, Tachikawa, Tokyo 1908518, Japan.	kokubun@nipr.ac.jp		Chiaradia, Andre/0000-0002-6178-4211	Green Network of Excellence Program (GRENE), Arctic Climate Change Research Project 'Rapid Change of the Arctic Climate System and its Global Influences'; NIPR	Green Network of Excellence Program (GRENE), Arctic Climate Change Research Project 'Rapid Change of the Arctic Climate System and its Global Influences'; NIPR(National Institute of Polar Research (NIPR) - Japan)	This study was funded by the Green Network of Excellence Program (GRENE), Arctic Climate Change Research Project 'Rapid Change of the Arctic Climate System and its Global Influences'. The production of this paper was supported by an NIPR publication subsidy.	Ashmole N.P., 1971, P223; Barger CP, 2012, BIOL LETTERS, V8, P442, DOI 10.1098/rsbl.2011.1020; Benoit-Bird KJ, 2004, DEEP-SEA RES PT I, V51, P707, DOI 10.1016/j.dsr.2004.01.004; BirdLife International, 2013, RISS BREV IUCN RED L; Brodeur RD, 2003, J OCEANOGR, V59, P515, DOI 10.1023/A:1025548801541; Brodeur RD, 2001, CONT SHELF RES, V21, P207, DOI 10.1016/S0278-4343(00)00083-2; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; Byrd GV, 2008, DEEP-SEA RES PT II, V55, P1846, DOI 10.1016/j.dsr2.2008.04.004; BYRD GV, 1993, BIRDS N AM ONLINE; Chivers LS, 2012, MAR ECOL PROG SER, V456, P269, DOI 10.3354/meps09691; Coulson J.C., 2011, THE KITTIWAKE; Daunt F, 2002, MAR ECOL PROG SER, V245, P239, DOI 10.3354/meps245239; Dypvik E, 2012, MAR BIOL, V159, P1673, DOI 10.1007/s00227-012-1953-2; Edwards EWJ, 2013, DEEP-SEA RES PT II, V98, P438, DOI 10.1016/j.dsr2.2013.04.011; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Gallagher AJ, 2015, TRENDS ECOL EVOL, V30, P61, DOI 10.1016/j.tree.2014.12.001; Hunt GL, 1981, E BERING SEA SHELF O, P649; Hunt GL, 1981, E BERING SEA SHELF O, P689; Hunt GL, 1981, E BERING SEA SHELF I, P629; Iverson SJ, 2007, MAR ECOL PROG SER, V352, P235, DOI 10.3354/meps07073; Kotzerka J, 2010, J ORNITHOL, V151, P459, DOI 10.1007/s10336-009-0479-y; Lance BK, 1998, COLON WATERBIRD, V21, P375, DOI 10.2307/1521650; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Miramontes O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034317; Mizobata K, 2002, PROG OCEANOGR, V55, P65, DOI 10.1016/S0079-6611(02)00070-8; Mudge ML, 2015, BIOL MONITORING ST G; Nagasawa K, 1997, LOW WAKE FI, V97, P337; Ohizumi Hiroshi, 2001, Aquabiology (Tokyo), V23, P626; Orben RA, 2015, J BIOGEOGR, V42, P401, DOI 10.1111/jbi.12425; Paredes R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092520; Paredes R, 2012, MAR ECOL PROG SER, V471, P253, DOI 10.3354/meps10034; Peck DR, 2004, MAR ECOL PROG SER, V281, P259, DOI 10.3354/meps281259; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Prince P.A., 1987, P135; R Development Core Team, 2012, R LANG ENV STAT COMP; Regular PM, 2010, MAR ECOL PROG SER, V415, P295, DOI 10.3354/meps08752; Regular PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026763; Ricklefs R. E., 1983, STUD AVIAN BIOL, V8, P84; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Schneider D., 1984, P86; Stephensen Shawn W., 2003, Marine Ornithology, V31, P167; Thorsteinson LK, 2002, FISHES ALASKA; Wakefield ED, 2009, MAR ECOL PROG SER, V391, P165, DOI 10.3354/meps08203; Weimerskirch H, 2002, IBIS, V144, P40, DOI 10.1046/j.0019-1019.2001.00021.x; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Yoda K, 2001, J EXP BIOL, V204, P685; YOUNG RE, 1980, DEEP-SEA RES, V27, P671, DOI 10.1016/0198-0149(80)90022-9; Zavalaga CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019966	50	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138850	10.1371/journal.pone.0138850	http://dx.doi.org/10.1371/journal.pone.0138850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465335	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100028
J	Sandstrom, A; Cnattingius, S; Wikstrom, AK; Stephansson, O; Iliadou, AN				Sandstrom, Anna; Cnattingius, Sven; Wikstrom, Anna-Karin; Stephansson, Olof; Iliadou, Anastasia N.			Does Use of Low-Molecular-Weight Heparin during Pregnancy Influence the Risk of Prolonged Labor: A Population-Based Cohort Study	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; POSTPARTUM; WOMEN; 2ND-STAGE; OUTCOMES; SAFETY; BIRTH; PUERPERIUM	Background The use of low-molecular-weight heparins (LMWHs) during pregnancy is increasing. In vitro studies and small clinical studies support the hypothesis that LMWH treatment during pregnancy may reduce duration of labor. The aim of this study was to investigate if use of LMWH is associated with a reduced risk of diagnosis of prolonged labor, after taking maternal, fetal and other delivery characteristics into account. Methods and Findings A population-based cohort study from the Swedish Medical Birth Register from April 2006 through December 2011. We identified 514 875 term (>= 37 weeks) deliveries of live singleton infants in cephalic presentation with spontaneous or induced onsets of labor. The Birth Register was linked to the Prescribed Drug Register to retrieve information on dispensed LMWH during pregnancy and to the Patient Register for information on underlying diagnosis for use of LMWH. Diagnosis of prolonged labor in the Birth Register was retrieved from diagnosis at discharge from the delivery hospital. The risk of diagnosis of prolonged labor in relation to treatment with LMWH was assessed using logistic regression analysis to estimate unadjusted and adjusted odds ratios. A total of 5 275 (1.0%) of the pregnant women used LMWH. The absolute risk of diagnosis of prolonged labor for nulliparous women was 19.9% among women using LMWH in third trimester, and 21.2% in women without use of LMWH. For parous women the corresponding absolute risks were 4.3% and 4.7%, respectively. Compared to nulliparous women without use of LMWH, nulliparous women with LMWH during third trimester had an odds ratio (OR) of 0.92 (95% CI 0.81-1.05, p-value: 0.051) for diagnosis of prolonged labor in unadjusted analyses and after adjustments for maternal characteristics, gestational age and epidural analgesia the OR was 1.00 (95% CI 0.87-1.15, p-value: 0.673). Parous women treated with LMWH in third trimester presented the same pattern, unadjusted OR for diagnosis of prolonged labor was 0.92 (95% CI 0.76-1.12, p-value: 0.418) and after adjustments OR was 0.99 (95% CI 0.80-1.22, p-value: 0.892). One limitation with the study was that information on prolonged labor was based on discharge diagnoses from the delivery hospital according to the International Classification of Diseases (ICD). Conclusions Treatment with LMWH during pregnancy is not associated with a risk of diagnosis of prolonged labor after adjustments for maternal, fetal and delivery characteristics.	[Sandstrom, Anna; Cnattingius, Sven; Wikstrom, Anna-Karin; Stephansson, Olof] Karolinska Univ Hosp, Clin Epidemiol Unit, Dept Med Solna, Stockholm, Sweden; [Sandstrom, Anna; Cnattingius, Sven; Wikstrom, Anna-Karin; Stephansson, Olof] Karolinska Inst, Stockholm, Sweden; [Sandstrom, Anna; Stephansson, Olof] Karolinska Univ Hosp, Div Obstet & Gynecol, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Wikstrom, Anna-Karin] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Iliadou, Anastasia N.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Karolinska Institutet	Sandstrom, A (corresponding author), Karolinska Univ Hosp, Clin Epidemiol Unit, Dept Med Solna, Stockholm, Sweden.	anna.sandstrom@karolinska.se		Stephansson, Olof/0000-0003-1528-4563	Swedish Research Council [2013-2429, 2008-5857]; Stockholm County Council (ALF project) [20130156]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council (ALF project)(Stockholm County Council)	This study was supported by grants from the Swedish Research Council (2013-2429, Olof Stephansson and 2008-5857, Sven Cnattingius) (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html) and by grants provided by the Stockholm County Council (ALF project 20130156, Olof Stephansson and Sven Cnattingius) (https://forskningsstod.vmi.se/Ansokan/start.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen VM, 2009, OBSTET GYNECOL, V113, P1248, DOI 10.1097/AOG.0b013e3181a722d6; American College of Obstetrics and Gynecology Committee on Practice Bulletins-Obstetrics, 2003, Obstet Gynecol, V102, P1445; Andersen AS, 2010, ACTA OBSTET GYN SCAN, V89, P15, DOI 10.3109/00016340903370098; Andersen BS, 1998, ACTA OBSTET GYN SCAN, V77, P170, DOI 10.1034/j.1600-0412.1998.770207.x; [Anonymous], 2000, WHO TECH REP SER, P894; Berglund S, 2008, BJOG-INT J OBSTET GY, V115, P316, DOI 10.1111/j.1471-0528.2007.01602.x; Cluff AH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-24; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Donnelly J, 2012, Ir Med J, V105, P27; Duhl AJ, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.022; Ekman-Ordeberg G, 2010, ACTA OBSTET GYN SCAN, V89, P147, DOI 10.3109/00016340903294272; Ekman-Ordeberg G, 2009, ACTA OBSTET GYN SCAN, V88, P984, DOI 10.1080/00016340903176818; Feinstein U, 2002, INT J GYNECOL OBSTET, V77, P7, DOI 10.1016/S0020-7292(02)00007-3; Galambosi PJ, 2012, EUR J OBSTET GYN R B, V163, P154, DOI 10.1016/j.ejogrb.2012.05.010; Gherman RB, 1999, OBSTET GYNECOL, V94, P730, DOI 10.1016/S0029-7844(99)00426-3; Greer IA, 2005, BLOOD, V106, P401, DOI 10.1182/blood-2005-02-0626; Gynaecologists RCoOa, 2009, RED RISK THROMB EMB; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Hjelm AM, 2002, EUR J OBSTET GYN R B, V100, P146, DOI 10.1016/S0301-2115(01)00476-6; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Isma N, 2010, J THROMB THROMBOLYS, V30, P149, DOI 10.1007/s11239-009-0428-x; Jacobsen AF, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.041; James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008; James AH, 2005, AM J OBSTET GYNECOL, V193, P216, DOI 10.1016/j.ajog.2004.11.037; Jonsson M, 2008, ACTA OBSTET GYN SCAN, V87, P745, DOI 10.1080/00016340802220352; Kjaergaard H, 2010, J OBSTET GYNAECOL, V30, P25, DOI 10.3109/01443610903276417; Knol HM, 2012, THROMB RES, V130, P334, DOI 10.1016/j.thromres.2012.03.007; Kominiarek MA, 2007, J PERINATOL, V27, P329, DOI 10.1038/sj.jp.7211745; Laughon SK, 2014, OBSTET GYNECOL, V124, P57, DOI 10.1097/AOG.0000000000000278; Lindqvist P, 1999, OBSTET GYNECOL, V94, P595, DOI 10.1016/S0029-7844(99)00308-7; Lindqvist Pelle G, 2014, Lakartidningen, V111, P1305; Lindqvist PG, 2011, ACTA OBSTET GYN SCAN, V90, P648, DOI 10.1111/j.1600-0412.2011.01098.x; Lindqvist PG, 2008, VASC HEALTH RISK MAN, V4, P1081, DOI 10.2147/VHRM.S2831; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Mocanu EV, 2000, EUR J OBSTET GYN R B, V92, P229, DOI 10.1016/S0301-2115(99)00280-8; Pabinger I, 2005, J THROMB HAEMOST, V3, P949, DOI 10.1111/j.1538-7836.2005.01307.x; Patel JP, 2008, J THROMB HAEMOST, V6, P1461, DOI 10.1111/j.1538-7836.2008.03048.x; Patel JP, 2012, J THROMB HAEMOST, V10, P2526, DOI 10.1111/jth.12020; Ray J G, 1999, Obstet Gynecol Surv, V54, P265, DOI 10.1097/00006254-199904000-00023; Rova K, 2012, FERTIL STERIL, V97, P95, DOI 10.1016/j.fertnstert.2011.10.038; Sanson BJ, 1999, THROMB HAEMOSTASIS, V81, P668, DOI 10.1055/s-0037-1614550; Sennstrom MB, 2000, MOL HUM REPROD, V6, P375, DOI 10.1093/molehr/6.4.375; Sheiner E, 2002, ACTA OBSTET GYN SCAN, V81, P222, DOI 10.1034/j.1600-0412.2002.810306.x; Simpson EL, 2001, BRIT J OBSTET GYNAEC, V108, P56, DOI 10.1111/j.1471-0528.2001.00004.x; Sorensen HT, 2000, ACTA OBSTET GYN SCAN, V79, P655, DOI 10.1034/j.1600-0412.2000.079008655.x; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Swedish Society of Obstetrics and Gynecology (SFOG) RgfHdIS, 2012, 68 SFOG; Walsh J, 2011, J MATERN-FETAL NEO M, V24, P817, DOI 10.3109/14767058.2010.531313; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	50	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140422	10.1371/journal.pone.0140422	http://dx.doi.org/10.1371/journal.pone.0140422			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465918	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100119
J	Schmidt, L; Gortz, S; Wohlfahrt, J; Melbye, M; Munch, TN				Schmidt, Linnea; Gortz, Sanne; Wohlfahrt, Jan; Melbye, Mads; Munch, Tina Noergaard			Recurrence of Subdural Haematoma in a Population-Based Cohort - Risks and Predictive Factors	PLOS ONE			English	Article							INDEPENDENT PREDICTORS; MANAGEMENT; SURGERY; THERAPY	Objectives To estimate the risks of and identify predictors for recurrent subdural haematoma in surgically and conservatively treated patients. Methods The cohort comprised all individuals diagnosed with a first-time subdural hematoma in Denmark 1996-2011. Information on potential predictors was retrieved from the Danish health registers. Cumulative recurrence risks were estimated using the Aalen-Johansen estimator. Rate ratios (RR) were estimated using Poisson regression. Results Among 10,158 individuals with a subdural hematoma, 1,555 had a recurrent event. The cumulative risk of recurrent subdural hematoma was 9% at 4 weeks after the primary bleeding, increasing to and stabilising at 14% after one year. Predictors associated with recurrence were: Male sex (RR 1.60, 95% CI:1.43-1.80), older age (>70 years compared to 20-49 years; RR 1.41, 95% CI: 1.21-1.65), alcohol addiction (RR 1.20, 95% CI:1.04-1.37), surgical treatment (RR 1.76, 95% CI:1.58-1.96), trauma diagnoses (RR 1.14, 95% CI:1.03-1.27), and diabetes mellitus (RR 1.40, 95% CI:1.11-1.74). Out of a selected combination of risk factors, the highest cumulative 1-year recurrence risks for subdural hematoma of 25% (compared to 14% for all patients) was found in surgically treated males with diabetes mellitus. Conclusions The recurrence risk of subdural hematoma is largely limited to the first year. Patient characteristics including co-morbidities greatly influence the recurrence risk of SDH, suggesting that individualized prognostic guidance and follow-up is needed.	[Schmidt, Linnea; Gortz, Sanne; Wohlfahrt, Jan; Melbye, Mads; Munch, Tina Noergaard] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Munch, Tina Noergaard] Copenhagen Univ Hosp, Dept Neurosurg, Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen	Schmidt, L (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.	lisc@ssi.dk		melbye, mads/0000-0001-8264-6785; Schmidt, Linnea Boegeskov/0000-0001-6162-3090; Munch, Tina Norgaard/0000-0001-5938-000X				Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Aspegren OP, 2013, CLIN NEUROL NEUROSUR, V115, P981, DOI 10.1016/j.clineuro.2012.10.008; Chon KH, 2012, ACTA NEUROCHIR, V154, P1541, DOI 10.1007/s00701-012-1399-9; Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y; Forster MT, 2010, J CLIN NEUROSCI, V17, P975, DOI 10.1016/j.jocn.2009.11.023; Grant PJ, 2007, J INTERN MED, V262, P157, DOI 10.1111/j.1365-2796.2007.01824.x; Hong HJ, 2009, SURG NEUROL, V71, P161, DOI 10.1016/j.surneu.2008.01.023; Huang YH, 2014, INJURY, V45, P1327, DOI 10.1016/j.injury.2014.02.023; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; MARKWALDER TM, 1981, J NEUROSURG, V54, P637, DOI 10.3171/jns.1981.54.5.0637; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; Oh HJ, 2010, J KOREAN NEUROSURG S, V48, P518, DOI 10.3340/jkns.2010.48.6.518; Ohba S, 2013, NEUROSURG REV, V36, P145, DOI 10.1007/s10143-012-0396-z; Oishi M, 2001, NEUROL MED-CHIR, V41, P382, DOI 10.2176/nmc.41.382; Okano A, 2014, BRIT J NEUROSURG, V28, P204, DOI 10.3109/02688697.2013.829563; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Ramachandran R, 2007, SURG NEUROL, V67, P367, DOI 10.1016/j.surneu.2006.07.022; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937; Yamamoto H, 2003, J NEUROSURG, V98, P1217, DOI 10.3171/jns.2003.98.6.1217; Yang AIL, 2012, BRAIN INJURY, V26, P1731, DOI 10.3109/02699052.2012.698364	22	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140450	10.1371/journal.pone.0140450	http://dx.doi.org/10.1371/journal.pone.0140450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465602	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100125
J	Winship, A; Correia, J; Zhang, JG; Nicola, NA; Dimitriadis, E				Winship, Amy; Correia, Jeanne; Zhang, Jian-Guo; Nicola, Nicos A.; Dimitriadis, Evdokia			Leukemia Inhibitory Factor (LIF) Inhibition during Mid-Gestation Impairs Trophoblast Invasion and Spiral Artery Remodelling during Pregnancy in Mice	PLOS ONE			English	Article							BLASTOCYST IMPLANTATION; HUMAN ENDOMETRIUM; MOUSE; EXPRESSION; CELLS; RECEPTOR; UTERUS; BIOLOGY	The placenta forms the interface between the maternal and fetal circulation and is critical for the establishment of a healthy pregnancy. Trophoblast cell proliferation, migration and invasion into the endometrium are fundamental events in the initiation of placentation. Leukemia inhibitory factor (LIF) has been shown to promote trophoblast invasion in vitro, however its precise role in trophoblast invasion in vivo is unknown. We hypothesized that LIF would be required for normal trophoblast invasion and spiral artery remodeling in mice. Both LIF and its receptor (LIFR alpha) co-localized with cytokeratin-positive invasive endovascular extravillous trophoblasts (EVT) in mouse implantation sites during mid-gestation. Temporally blocking LIF action during specific periods of placental development via administration of our unique LIFR alpha antagonist, PEGLA, resulted in abnormal trophoblast invasion and impaired spiral artery remodeling compared to PEG control. PEGLA-treated mouse decidual vessels were characterized by retention of alpha-smooth muscle actin (alpha SMA)-positive vascular smooth muscle cells (VSMCs), while PEG control decidual vessels were remodelled by cytokeratin-positive trophoblasts. LIF blockade did not alter F4/80-positive decidual macrophage numbers between treatment groups, but resulted in down-regulation of decidual transcript levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-10 (IL-10), which are important immune cell activation factors that promote spiral artery remodeling during pregnancy. Our data suggest that LIF plays an important role in trophoblast invasion in vivo and may facilitate trophoblast-decidual-immune cell cross talk to enable adequate spiral artery remodeling.	[Winship, Amy; Correia, Jeanne; Dimitriadis, Evdokia] Hudson Inst, Melbourne, Vic, Australia; [Winship, Amy; Dimitriadis, Evdokia] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Zhang, Jian-Guo; Nicola, Nicos A.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Zhang, Jian-Guo; Nicola, Nicos A.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia	Hudson Institute of Medical Research; Monash University; Walter & Eliza Hall Institute; University of Melbourne	Dimitriadis, E (corresponding author), Hudson Inst, Melbourne, Vic, Australia.	evdokia.dimitriadis@hudson.org	dimitriadis, e/AAD-7601-2021	Dimitriadis, Eva/0000-0001-8698-1927; Winship, Amy/0000-0001-7848-1447; dimitriadis, eva/0000-0003-1425-950X	Victorian Government's Operational Infrastructure Support Program; Australian Government NHMRC IRIISS; NHMRC Fellowships [550905, 637300]; NHMRC Program Grant [1016647]; Australian Postgraduate Award	Victorian Government's Operational Infrastructure Support Program; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Fellowships(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	The authors acknowledge the support of the Victorian Government's Operational Infrastructure Support Program and the Australian Government NHMRC IRIISS. ED and NAN were supported by NHMRC Fellowships (#550905 and #637300, respectively). JGZ and NAN were supported by an NHMRC Program Grant (#1016647). AW was supported by an Australian Postgraduate Award.	Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Aghajanova L, 2004, ANN NY ACAD SCI, V1034, P176, DOI 10.1196/annals.1335.020; Aghajanova L, 2009, FERTIL STERIL, V91, P2602, DOI 10.1016/j.fertnstert.2008.04.010; Aplin JD, 2010, INT J DEV BIOL, V54, P323, DOI 10.1387/ijdb.082759ja; Benian A, 2008, INT J GYNECOL OBSTET, V100, P228, DOI 10.1016/j.ijgo.2007.09.023; BHATT H, 1991, P NATL ACAD SCI USA, V88, P11408, DOI 10.1073/pnas.88.24.11408; Brown MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00606; Charalambous F, 2012, BIOCHEM BIOPH RES CO, V417, P847, DOI 10.1016/j.bbrc.2011.12.057; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Cheng JG, 2001, P NATL ACAD SCI USA, V98, P8680, DOI 10.1073/pnas.151180898; Classen-Linke I, 2004, MOL HUM REPROD, V10, P495, DOI 10.1093/molehr/gah069; Cox B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.37; DE M, 1991, J LEUKOCYTE BIOL, V50, P252, DOI 10.1002/jlb.50.3.252; Dilworth M, 2012, PLACENTA, V12, P1; Dimitriadis E, 2010, PLACENTA, V31, pS99, DOI 10.1016/j.placenta.2009.12.027; Dimitriadis E, 2010, INT J DEV BIOL, V54, P313, DOI 10.1387/ijdb.082772ed; Fest S, 2007, AM J REPROD IMMUNOL, V57, P55, DOI 10.1111/j.1600-0897.2006.00446.x; Harris LK, 2010, PLACENTA, V31, pS93, DOI 10.1016/j.placenta.2009.12.012; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Jasper MJ, 2011, BIOL REPROD, V84, P179, DOI 10.1095/biolreprod.110.085399; Kimber SJ, 2005, REPRODUCTION, V130, P131, DOI 10.1530/rep.1.00304; KOJIMA K, 1994, BIOL REPROD, V50, P882, DOI 10.1095/biolreprod50.4.882; Krishnan T, 2013, PLACENTA, V34, P1014, DOI 10.1016/j.placenta.2013.09.003; Menkhorst E, 2010, J REPROD IMMUNOL, V86, P33, DOI 10.1016/j.jri.2010.06.062; Menkhorst E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019665; PIJNENBORG R, 1994, REPRODUCTIVE MED REV, V3, P53; Poehlmann TG, 2005, PLACENTA, V26, pS37, DOI 10.1016/j.placenta.2005.01.007; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Salamonsen LA, 2009, REPROD FERT DEVELOP, V21, P923, DOI 10.1071/RD09145; Schofield G, 2005, BIOL REPROD, V72, P872, DOI 10.1095/biolreprod.104.034876; Sengupta J, 2006, CONTRACEPTION, V74, P419, DOI 10.1016/j.contraception.2006.05.070; Sharkey AM, 1999, BIOL REPROD, V60, P355, DOI 10.1095/biolreprod60.2.355; Shuya LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025288; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Tapia A, 2008, HUM REPROD, V23, P1724, DOI 10.1093/humrep/den121; VINCE GS, 1990, J IMMUNOL METHODS, V132, P181, DOI 10.1016/0022-1759(90)90028-T; Wang WJ, 2011, J REPROD IMMUNOL, V92, P97, DOI 10.1016/j.jri.2011.08.004; WARE CB, 1995, DEVELOPMENT, V121, P1283; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; White CA, 2007, P NATL ACAD SCI USA, V104, P19357, DOI 10.1073/pnas.0710110104	42	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0129110	10.1371/journal.pone.0129110	http://dx.doi.org/10.1371/journal.pone.0129110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479247	Green Published, gold			2022-12-26	WOS:000363026600001
J	Campiao, KM; Ribas, ACD; Morais, DH; da Silva, RJ; Tavares, LER				Campiao, Karla Magalhaes; de Aquino Ribas, Augusto Cesar; Morais, Drausio Honorio; da Silva, Reinaldo Jose; Roland Tavares, Luiz Eduardo			How Many Parasites Species a Frog Might Have? Determinants of Parasite Diversity in South American Anurans	PLOS ONE			English	Article							RICHNESS; NESTEDNESS; HOST; IDENTIFICATION; COMMUNITIES; TREMATODES; EVOLUTION; LINNAEUS; ECOLOGY	There is an increasing interest in unveiling the dynamics of parasite infection. Understanding the interaction patterns, and determinants of host- parasite association contributes to filling knowledge gaps in both community and disease ecology. Despite being targeted as a relevant group for conservation efforts, determinants of the association of amphibians and their parasites in broad scales are poorly understood. Here we describe parasite biodiversity in South American amphibians, testing the influence of host body size and geographic range in helminth parasites species richness (PSR). We also test whether parasite diversity is related to hosts' phylogenetic diversity. Results showed that nematodes are the most common anuran parasites. Host-parasite network has a nested pattern, with specialist helminth taxa generally associated with hosts that harbour the richest parasite faunas. Host size is positively correlated with helminth fauna richness, but we found no support for the association of host geographic range and PSR. These results remained consistent after correcting for uneven study effort and hosts' phylogenic correlation. However, we found no association between host and parasite diversity, indicating that more diversified anuran clades not necessarily support higher parasite diversity. Overall, considering both the structure and the determinants of PRS in anurans, we conclude that specialist parasites are more likely to be associated with large anurans, which are the ones harbouring higher PSR, and that the lack of association of PSR with hosts' clade diversification suggests it is strongly influenced by ecological and contemporary constrains.	[Campiao, Karla Magalhaes] Univ Fed Parana, Programa Posgrad Ecol & Conservacao, BR-80060000 Curitiba, Parana, Brazil; [de Aquino Ribas, Augusto Cesar] Univ Fed Mato Grosso do Sul, Fac Comp, Campo Grande, MS, Brazil; [Morais, Drausio Honorio; da Silva, Reinaldo Jose] UNESP Univ Estadual Paulista, Inst Biociencias, Dept Parasitol, Sao Paulo, Brazil; [Roland Tavares, Luiz Eduardo] Univ Fed Mato Grosso do Sul, Dept Biol, Campo Grande, MS, Brazil	Universidade Federal do Parana; Universidade Federal de Mato Grosso do Sul; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Federal de Mato Grosso do Sul	Campiao, KM (corresponding author), Univ Fed Parana, Programa Posgrad Ecol & Conservacao, BR-80060000 Curitiba, Parana, Brazil.	karla_mcamp@yahoo.com.br	Campiao, Karla M/K-2074-2017; da Silva, Reinaldo José/C-1384-2019; Tavares, Luiz ER/H-9909-2012	Campiao, Karla M/0000-0002-2574-8045; da Silva, Reinaldo José/0000-0002-3426-6873; Tavares, Luiz ER/0000-0001-6522-3633; Honorio Morais, Drausio/0000-0002-9866-6008	Coodenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Coodenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	KMC was funded by a fellowship from Coodenacao de Aperfeicoamento de Pessoal de Nivel Superior. LERT was funded by a fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	AHO JM, 1990, PARASITE COMMUNITIES : PATTERNS AND PROCESSES, P157; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Barton DP, 1999, INT J PARASITOL, V29, P921, DOI 10.1016/S0020-7519(99)00057-0; Bolker B., 2007, ECOLOGICAL MODELS DA; Brooks DR, 2001, TRENDS PARASITOL, V17, P273, DOI 10.1016/S1471-4922(01)01894-3; Bursey CR, 2001, COMP PARASITOL, V68, P21; Campiao KM, 2014, ZOOTAXA, V3843, P1, DOI 10.11646/zootaxa.3843.1.1; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Sa RO, 1826, S AM J HERPETOL, V9, P1; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; Frost D.R., 2021, AMPHIBIAN SPECIES WO; Goater TM, 2001, ECOLOGICAL MONITORIN; Graham SP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007873; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Hechinger RF, 2005, P ROY SOC B-BIOL SCI, V272, P1059, DOI 10.1098/rspb.2005.3070; Hechinger RF, 2007, OECOLOGIA, V151, P82, DOI 10.1007/s00442-006-0568-z; Johnson PTJ, 2013, P NATL ACAD SCI USA, V110, P16916, DOI 10.1073/pnas.1310557110; Kamiya T, 2014, BIOL REV, V89, P123, DOI 10.1111/brv.12046; Lavilla EO, 2010, ZOOTAXA, P1; Locke SA, 2010, MOL ECOL, V19, P2813, DOI 10.1111/j.1365-294X.2010.04713.x; Morand S, 2015, INT J PARASITOL-PAR, V4, P80, DOI 10.1016/j.ijppaw.2015.01.001; Nunn CL, 2004, AM NAT, V164, pS90, DOI 10.1086/424608; Nunn CL, 2003, AM NAT, V162, P597, DOI 10.1086/378721; Orme D., 2018, R PACKAGE VERSION, V5, P1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E., 2012, ANAL PHYLOGENETICS E; Pik AJ, 1999, AUST J ECOL, V24, P555, DOI 10.1046/j.1442-9993.1999.01003.x; Pires MM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0649; Poulin R, 2007, PARASITOLOGY, V134, P763, DOI 10.1017/S0031182006002150; Poulin R, 1996, OECOLOGIA, V105, P545, DOI 10.1007/BF00330018; POULIN R, 1995, ECOL MONOGR, V65, P283, DOI 10.2307/2937061; Poulin R, 2010, PARASITOLOGY, V137, P1967, DOI 10.1017/S0031182010000910; Poulin R, 1997, ANNU REV ECOL SYST, V28, P341, DOI 10.1146/annurev.ecolsys.28.1.341; Poulin R., 2004, PARASITE BIODIVERSIT; Poulin R, 2012, EVOL ECOL, V26, P1169, DOI 10.1007/s10682-011-9544-0; Poulin R, 2010, TRENDS PARASITOL, V26, P492, DOI 10.1016/j.pt.2010.05.008; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; R Core Team, 2013, R LANG ENV STAT COMP; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Seed, 2001, PARASITISM DIVERSITY; Shah HB, 2013, J HELMINTHOL, V87, P1; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025	45	37	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140577	10.1371/journal.pone.0140577	http://dx.doi.org/10.1371/journal.pone.0140577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473593	gold, Green Published, Green Submitted			2022-12-26	WOS:000363185500066
J	Gondim, OS; de Camargo, VTN; Gutierrez, FA; Martins, PFD; Passos, MEP; Momesso, CM; Santos, VC; Gorjao, R; Pithon-Curi, TC; Cury-Boaventura, MF				Gondim, Olivia Santos; Nunes de Camargo, Vinicius Tadeu; Gutierrez, Fernanda Almeida; de Oliveira Martins, Patricia Fatima; Pereira Passos, Maria Elizabeth; Momesso, Cesar Miguel; Santos, Vinicius Coneglian; Gorjao, Renata; Pithon-Curi, Tania Cristina; Cury-Boaventura, Maria Fernanda			Benefits of Regular Exercise on Inflammatory and Cardiovascular Risk Markers in Normal Weight, Overweight and Obese Adults	PLOS ONE			English	Article							ADIPOSE-TISSUE; METABOLIC SYNDROME; LIPID PROFILE; LEPTIN; DIET; ADIPONECTIN; RESISTIN; ADOLESCENTS; ADIPOKINES; WALKING	Obesity is a worldwide epidemic that increases the risk of several well-known co-morbidities. There is a complicated relationship between adipokines and low-grade inflammation in obesity and cardiovascular disease (CVD). Physical activity practices have beneficial health effects on obesity and related disorders such as hypertension and dyslipidemia. We investigated the effects of 6 and 12 months of moderate physical training on the levels of adipokines and CVD markers in normal weight, overweight and obese volunteers. The 143 participants were followed up at baseline and after six and twelfth months of moderate regular exercise, 2 times a week, for 12 months. The volunteers were distributed into 3 groups: Normal Weight Group (NWG,), Overweight Group (OVG) and Obese Group (OBG). We evaluated blood pressure, resting heart rate, anthropometric parameters, body composition, fitness capacity (VO2max and isometric back strength), cardiovascular markers (CRP, total cholesterol, LDL-c, HDL-c, homocysteine) and adipokine levels (leptin, adiponectin, resistin, IL-6 and TNF-alpha). There were no significant changes in anthropometric parameters and body composition in any of the groups following 6 and 12 months of exercise training. Leptin, IL-6 levels and systolic blood pressure were significantly elevated in OBG before the training. Regular exercise decreased HDL-c, leptin, adiponectin and resistin levels and diastolic blood pressure in OVG. In OBG, exercise diminished HDL-c, homocysteine, leptin, resistin, IL-6, adiponectin. Moderate exercise had no effect on the body composition; however, exercise did promote beneficial effects on the low-grade inflammatory state and CVD clinical markers in overweight and obese individuals.	[Gondim, Olivia Santos; Nunes de Camargo, Vinicius Tadeu; Gutierrez, Fernanda Almeida; de Oliveira Martins, Patricia Fatima; Pereira Passos, Maria Elizabeth; Momesso, Cesar Miguel; Gorjao, Renata; Pithon-Curi, Tania Cristina; Cury-Boaventura, Maria Fernanda] Cruzeiro do Sul Univ, Inst Phys Act & Sports Sci, Postgrad Program Human Movement Sci, Sao Paulo, SP, Brazil; [Santos, Vinicius Coneglian] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, BR-05508 Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Cury-Boaventura, MF (corresponding author), Cruzeiro do Sul Univ, Inst Phys Act & Sports Sci, Postgrad Program Human Movement Sci, Sao Paulo, SP, Brazil.	maria.boaventura@cruzeirodosul.edu.br	Cury-Boaventura, Maria Fernanda MF/B-3945-2012; Gorjão, Renata/D-4130-2013; Momesso, Cesar Miguel/D-3281-2012; Pithon-Curi, Tania Cristina/AAB-9436-2021	Cury-Boaventura, Maria Fernanda MF/0000-0002-1596-0624; Momesso, Cesar Miguel/0000-0001-6448-6028; PITHON-CURI, TANIA CRISTINA/0000-0002-9714-9105; Gorjao, Renata/0000-0002-9655-1477				Ahmadi N, 2011, AM J MED, V124, P978, DOI 10.1016/j.amjmed.2011.02.032; Bai Youping, 2013, Wei Sheng Yan Jiu, V42, P538; Chaudhary Sarika, 2010, Asian J Sports Med, V1, P177; Choi Sung Hee, 2013, Front Endocrinol (Lausanne), V4, P97, DOI 10.3389/fendo.2013.00097; COOPER KH, 1968, JAMA-J AM MED ASSOC, V203, P135, DOI [10.1001/jama.1968.03140030033008, DOI 10.1001/JAMA.1968.03140030033008]; Desgorces FD, 2015, HORM METAB RES, V47, P473, DOI 10.1055/s-0034-1387704; Eder K, 2009, INFLAMM RES, V58, P727, DOI 10.1007/s00011-009-0060-4; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Golbidi S, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/726861; Hong Hye-Ryun, 2014, J Exerc Nutrition Biochem, V18, P277, DOI 10.5717/jenb.2014.18.3.277; Huang CJ, 2014, BRAIN BEHAV IMMUN, V35, P163, DOI 10.1016/j.bbi.2013.10.004; Izadpanah A, 2012, AM J PHYSIOL-ENDOC M, V303, pE542, DOI 10.1152/ajpendo.00190.2012; Jain SH, 2009, DIABETES CARE, V32, P903, DOI 10.2337/dc08-1733; Kannan U, 2014, J CLIN DIAGN RES, V8, pBC8, DOI 10.7860/JCDR/2014/8519.4611; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Kelley GA, 2004, PREV MED, V38, P651, DOI 10.1016/j.ypmed.2003.12.012; Khadir A, 2015, AM J PHYSIOL-ENDOC M, V308, pE71, DOI 10.1152/ajpendo.00577.2013; Khan M, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/328592; Kim DY, 2014, J PHYS THER SCI, V26, P1723, DOI 10.1589/jpts.26.1723; Knuth ND, 2014, OBESITY, V22, P2563, DOI 10.1002/oby.20900; Lakhdar N, 2014, NEUROENDOCRINOL LETT, V35, P373; Lambert E, 2010, HYPERTENSION, V56, P351, DOI 10.1161/HYPERTENSIONAHA.110.155663; Landeros-Olvera Erick, 2014, Arch. Cardiol. Méx., V84, P177, DOI 10.1016/j.acmx.2013.11.007; Leal VD, 2013, CLIN CHIM ACTA, V419, P87, DOI 10.1016/j.cca.2013.02.003; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Makni E, 2013, OBESITY FACTS, V6, P393, DOI 10.1159/000354574; Malo E, 2011, METAB SYNDR RELAT D, V9, P203, DOI 10.1089/met.2010.0106; Mazurek K, 2014, ANN AGR ENV MED, V21, P844, DOI 10.5604/12321966.1129949; Mendham AE, 2015, J SCI MED SPORT, V18, P438, DOI 10.1016/j.jsams.2014.06.013; Nelson JK, 1979, PRACTICAL MEASUREMEN, P78; Northcott JM, 2012, CAN J PHYSIOL PHARM, V90, P1029, DOI [10.1139/Y2012-053, 10.1139/y2012-053]; Owecki M, 2011, EXP CLIN ENDOCR DIAB, V119, P117, DOI 10.1055/s-0030-1263111; Rezaeipour M, 2014, TURK J MED SCI, V44, P792, DOI 10.3906/sag-1303-10; Sainz N, 2015, METABOLISM, V64, P35, DOI 10.1016/j.metabol.2014.10.015; Salvadori A, 2015, HORM METAB RES, V47, P225, DOI 10.1055/s-0034-1395637; Samjoo IA, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.30; Sanches PL, 2014, INFLAMMATION, V37, P35, DOI 10.1007/s10753-013-9709-9; Smith MM, 2012, J PHYSIOL-LONDON, V590, P1787, DOI 10.1113/jphysiol.2011.221036; Swart KMA, 2013, J NUTR HEALTH AGING, V17, P578, DOI 10.1007/s12603-013-0047-2; Tiss A, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-106; Touati S, 2015, CLIN EXP PHARMACOL P, V42, P179, DOI 10.1111/1440-1681.12338; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P6; Zhang C, 2015, ACTA DIABETOL, V52, P625, DOI 10.1007/s00592-014-0655-2	43	54	55	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140596	10.1371/journal.pone.0140596	http://dx.doi.org/10.1371/journal.pone.0140596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474157	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500070
J	Bonsall, DR; Kim, H; Tocci, C; Ndiaye, A; Petronzio, A; McKay-Corkum, G; Molyneux, PC; Scammell, TE; Harrington, ME				Bonsall, David R.; Kim, Hyunji; Tocci, Catherine; Ndiaye, Awa; Petronzio, Abbey; McKay-Corkum, Grace; Molyneux, Penny C.; Scammell, Thomas E.; Harrington, Mary E.			Suppression of Locomotor Activity in Female C57Bl/6J Mice Treated with Interleukin-1 beta: Investigating a Method for the Study of Fatigue in Laboratory Animals	PLOS ONE			English	Article							MESSENGER-RNA; DOUBLE-BLIND; BEHAVIORAL DEPRESSION; INFLAMMATORY MARKERS; BRAIN IL-1-BETA; CANCER PATIENTS; BASAL GANGLIA; MOUSE MODEL; SLEEP; METHYLPHENIDATE	Fatigue is a disabling symptom in patients with multiple sclerosis and Parkinson's Disease, and is also common in patients with traumatic brain injury, cancer, and inflammatory disorders. Little is known about the neurobiology of fatigue, in part due to the lack of an approach to induce fatigue in laboratory animals. Fatigue is a common response to systemic challenge by pathogens, a response in part mediated through action of the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta). We investigated the behavioral responses of mice to IL-1 beta. Female C57Bl/6J mice of 3 ages were administered IL-1 beta at various doses i.p. Interleukin-1 beta reduced locomotor activity, and sensitivity increased with age. Further experiments were conducted with middle-aged females. Centrally administered IL-1 beta dose-dependently reduced locomotor activity. Using doses of IL-1 beta that caused suppression of locomotor activity, we measured minimal signs of sickness, such as hyperthermia, pain or anhedonia (as measured with abdominal temperature probes, pre-treatment with the analgesic buprenorphine and through sucrose preference, respectively), all of which are responses commonly reported with higher doses. We found that middle-aged orexin(-/-) mice showed equivalent effects of IL-1 beta on locomotor activity as seen in wild-type controls, suggesting that orexins are not necessary for IL-1 beta-induced reductions in wheel-running. Given that the availability and success of therapeutic treatments for fatigue is currently limited, we examined the effectiveness of two potential clinical treatments, modafinil and methylphenidate. We found that these treatments were variably successful in restoring locomotor activity after IL-1 beta administration. This provides one step toward development of a satisfactory animal model of the multidimensional experience of fatigue, a model that could allow us to determine possible pathways through which inflammation induces fatigue, and could lead to novel treatments for reversal of fatigue.	[Bonsall, David R.; Kim, Hyunji; Tocci, Catherine; Ndiaye, Awa; Petronzio, Abbey; McKay-Corkum, Grace; Molyneux, Penny C.; Harrington, Mary E.] Smith Coll, Neurosci Program, Northampton, MA 01063 USA; [Scammell, Thomas E.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	Smith College; Harvard University; Beth Israel Deaconess Medical Center	Harrington, ME (corresponding author), Smith Coll, Neurosci Program, Northampton, MA 01063 USA.	mharring@smith.edu		Bonsall, David/0000-0002-2542-7559	National Institutes of Health [R21NR012845-01A1]; NATIONAL INSTITUTE OF NURSING RESEARCH [R21NR012845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by the National Institutes of Health grant to MEH R21NR012845-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anforth HR, 1998, EUR CYTOKINE NETW, V9, P279; Anisman H, 2008, PSYCHOPHARMACOLOGY, V199, P231, DOI 10.1007/s00213-008-1166-z; Antle MC, 2012, NEUROPSYCHOPHARMACOL, V37, P2446, DOI 10.1038/npp.2012.103; Baker FC, 2005, AM J PHYSIOL-REG I, V288, pR998, DOI 10.1152/ajpregu.00615.2004; BARRETT J, 1993, SLEEP, V16, P93; Bluthe RM, 1997, PSYCHONEUROENDOCRINO, V22, P1, DOI 10.1016/S0306-4530(96)00042-X; Bower JE, 2015, ADV EXP MED BIOL, V862, P53, DOI 10.1007/978-3-319-16366-6_5; Bower JE, 2011, BRAIN BEHAV IMMUN, V25, P147, DOI 10.1016/j.bbi.2010.09.010; Bower JE, 2009, CLIN CANCER RES, V15, P5534, DOI 10.1158/1078-0432.CCR-08-2584; Cambras T, 2007, P NATL ACAD SCI USA, V104, P7634, DOI 10.1073/pnas.0702424104; Capuron L, 2012, ARCH GEN PSYCHIAT, V69, P1044, DOI 10.1001/archgenpsychiatry.2011.2094; Carmichael MD, 2006, AM J PHYSIOL-REG I, V291, pR1344, DOI 10.1152/ajpregu.00141.2006; CHAO CC, 1992, CLIN IMMUNOL IMMUNOP, V64, P161, DOI 10.1016/0090-1229(92)90194-S; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Ching S, 2007, J NEUROSCI, V27, P10476, DOI 10.1523/JNEUROSCI.3357-07.2007; Chou TC, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-19-j0003.2001; Clevenger L, 2012, BRAIN BEHAV IMMUN, V26, P1037, DOI 10.1016/j.bbi.2012.04.003; Dobryakova E, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00052; Donohue KD, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-14; DUNN AJ, 1991, BRAIN RES BULL, V26, P539, DOI 10.1016/0361-9230(91)90092-X; Eldadah BA, 2010, PM&R, V2, P406, DOI 10.1016/j.pmrj.2010.03.022; Espana RA, 2007, SLEEP, V30, P1417, DOI 10.1093/sleep/30.11.1417; Felger JC, 2013, BRAIN BEHAV IMMUN, V31, P153, DOI 10.1016/j.bbi.2012.10.010; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; Finsterer J, 2014, AM J HOSP PALLIAT ME, V31, P562, DOI 10.1177/1049909113494748; Fletcher MA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-96; Franceschi C, 2003, BIOCHEM SOC T, V31, P457, DOI 10.1042/BST0310457; Gaykema RPA, 2008, NEUROSCIENCE, V152, P273, DOI 10.1016/j.neuroscience.2007.10.042; Gaykema RPA, 2009, BRAIN BEHAV IMMUN, V23, P926, DOI 10.1016/j.bbi.2009.03.005; Gong S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084391; Grossberg AJ, 2011, J NEUROSCI, V31, P11376, DOI 10.1523/JNEUROSCI.2311-11.2011; Harden LM, 2011, PSYCHONEUROENDOCRINO, V36, P608, DOI 10.1016/j.psyneuen.2010.09.003; Harrington ME, 2012, PROG NEUROBIOL, V99, P93, DOI 10.1016/j.pneurobio.2012.07.004; Ifuku M, 2014, EUR J NEUROSCI, V40, P3253, DOI 10.1111/ejn.12668; Ishizuka T, 2008, EUR J PHARMACOL, V578, P209, DOI 10.1016/j.ejphar.2007.09.009; Jean-Pierre P, 2010, CANCER-AM CANCER SOC, V116, P3513, DOI 10.1002/cncr.25083; Katafuchi T, 2003, NEUROSCIENCE, V120, P837, DOI 10.1016/S0306-4522(03)00365-8; Katafuchi T, 2006, ANN NY ACAD SCI, V1088, P230, DOI 10.1196/annals.1366.020; KENT S, 1992, P NATL ACAD SCI USA, V89, P9117, DOI 10.1073/pnas.89.19.9117; Kerr CW, 2012, J PAIN SYMPTOM MANAG, V43, P68, DOI 10.1016/j.jpainsymman.2011.03.026; Konsman JP, 2008, EUR J NEUROSCI, V28, P2499, DOI 10.1111/j.1460-9568.2008.06549.x; Konsman JP, 2000, EUR J NEUROSCI, V12, P4434, DOI 10.1046/j.0953-816X.2000.01319.x; Lattie EG, 2012, BRAIN BEHAV IMMUN, V26, P849, DOI 10.1016/j.bbi.2012.02.008; LAYE S, 1995, AM J PHYSIOL-REG I, V268, pR1327, DOI 10.1152/ajpregu.1995.268.5.R1327; Lindqvist D, 2013, BRAIN BEHAV IMMUN, V33, P183, DOI 10.1016/j.bbi.2013.07.007; Liu LQ, 2012, BRAIN BEHAV IMMUN, V26, P706, DOI 10.1016/j.bbi.2012.02.001; MASOTTO C, 1992, BRAIN RES BULL, V28, P161, DOI 10.1016/0361-9230(92)90175-W; Matsuwaki T, 2014, BRAIN BEHAV IMMUN, V40, P166, DOI 10.1016/j.bbi.2014.03.015; McCusker RH, 2013, J EXP BIOL, V216, P84, DOI 10.1242/jeb.073411; Mendonca DA, 2007, MOVEMENT DISORD, V22, P2070, DOI 10.1002/mds.21656; Minton O, 2011, J PAIN SYMPTOM MANAG, V41, P761, DOI 10.1016/j.jpainsymman.2010.06.020; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Nunes EJ, 2014, PSYCHOPHARMACOLOGY, V231, P727, DOI 10.1007/s00213-013-3285-4; Opp MR, 1998, LIFE SCI, V62, P923, DOI 10.1016/S0024-3205(98)00010-1; Ottenweller JE, 1998, PHYSIOL BEHAV, V63, P795, DOI 10.1016/S0031-9384(97)00539-8; Prommer E, 2012, AM J HOSP PALLIAT ME, V29, P483, DOI 10.1177/1049909111427029; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Ricci JA, 2007, J OCCUP ENVIRON MED, V49, P1, DOI 10.1097/01.jom.0000249782.60321.2a; Ridder DA, 2011, J EXP MED, V208, P2615, DOI 10.1084/jem.20110398; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Schoene C, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00081; Schrepf A, 2013, BRAIN BEHAV IMMUN, V30, pS126, DOI 10.1016/j.bbi.2012.07.022; Schwartz N, 2014, SCIENCE, V345, P535, DOI 10.1126/science.1253994; Sheng P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081802; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123; Smith LB, 2014, BRAIN BEHAV IMMUN, V38, P66, DOI 10.1016/j.bbi.2013.12.022; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; SPADARO F, 1990, BRAIN BEHAV IMMUN, V4, P308, DOI 10.1016/0889-1591(90)90034-N; Spath-Schwalbe E, 1998, J CLIN ENDOCR METAB, V83, P1573, DOI 10.1210/jc.83.5.1573; Spathis A, 2014, J CLIN ONCOL, V32, P1882, DOI 10.1200/JCO.2013.54.4346; Stringer EA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-93; Trotti LM, 2014, NEUROTHERAPEUTICS, V11, P68, DOI 10.1007/s13311-013-0236-z; Volkow N D, 2001, J Neurosci, V21, pRC121; Wang XS, 2008, CANCER, V113, P2102, DOI 10.1002/cncr.23820; Wang XS, 2015, GYNECOL ONCOL, V136, P446, DOI 10.1016/j.ygyno.2014.10.013; Weymann KB, 2014, BRAIN BEHAV IMMUN, V37, P84, DOI 10.1016/j.bbi.2013.11.003; Wood LJ, 2006, BIOL RES NURS, V8, P157, DOI 10.1177/1099800406290932; Worden LT, 2009, PSYCHOPHARMACOLOGY, V203, P489, DOI 10.1007/s00213-008-1396-0; Yamato M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090950; Zolkowska D, 2009, J PHARMACOL EXP THER, V329, P738, DOI 10.1124/jpet.108.146142; Zombeck JA, 2013, COMPARATIVE MED, V63, P491	82	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140678	10.1371/journal.pone.0140678	http://dx.doi.org/10.1371/journal.pone.0140678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469939	gold, Green Submitted, Green Published			2022-12-26	WOS:000363184600095
J	Devarayan, K; Sathishkumar, Y; Lee, YS; Kim, BS				Devarayan, Kesavan; Sathishkumar, Yesupatham; Lee, Yang Soo; Kim, Byoung-Suhk			Effect of Microgravity on Fungistatic Activity of an alpha-Aminophosphonate Chitosan Derivative against Aspergillus niger	PLOS ONE			English	Article							ANTIFUNGAL PROPERTIES; GERMINATION	Biocontamination within the international space station is ever increasing mainly due to human activity. Control of microorganisms such as fungi and bacteria are important to maintain the well-being of the astronauts during long-term stay in space since the immune functions of astronauts are compromised under microgravity. For the first time control of the growth of an opportunistic pathogen, Aspergillus niger, under microgravity is studied in the presence of alpha-aminophosphonate chitosan. A low-shear modelled microgravity was used to mimic the conditions similar to space. The results indicated that the alpha-aminophosphonate chitosan inhibited the fungal growth significantly under microgravity. In addition, the inhibition mechanism of the modified chitosan was studied by UV-Visible spectroscopy and cyclic voltammetry. This work highlighted the role of a bio-based chitosan derivative to act as a disinfectant in space stations to remove fungal contaminants.	[Kim, Byoung-Suhk] Chonbuk Natl Univ, Dept Organ Mat & Fiber Engn, Jeonju Si 54896, Jeollabuk Do, South Korea; [Devarayan, Kesavan; Kim, Byoung-Suhk] Chonbuk Natl Univ, Dept BIN Convergence Technol, Jeonju Si 54896, Jeollabuk Do, South Korea; [Sathishkumar, Yesupatham; Lee, Yang Soo] Chonbuk Natl Univ, Dept Forest Sci & Technol, Coll Agr & Life Sci, Jeonju Si 54896, Jeollabuk Do, South Korea; [Devarayan, Kesavan] Tamil Nadu Fisheries Univ, Dept Basic Sci, Coll Fisheries Engn, Nagapattinam, India	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University	Lee, YS (corresponding author), Chonbuk Natl Univ, Dept Forest Sci & Technol, Coll Agr & Life Sci, 567 Baekje Daero, Jeonju Si 54896, Jeollabuk Do, South Korea.	ysoolee@jbnu.ac.kr; kbsuhk@jbnu.ac.kr	Kim, Byoung-Suhk/K-1573-2015; Devarayan, Kesavan/AAN-6687-2020	Kim, Byoung-Suhk/0000-0001-8070-3424; Devarayan, Kesavan/0000-0002-2940-0388	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [1301001076, 1401001209]; Brain Korea 21 PLUS Project, NRF; Basic Research Laboratory Program through the Ministry of Science, ICT& Future Planning [2014R1A4A1008140]; Robot industrial cluster construction program through the Ministry of Trade, Industry Energy (MOTIE); National Research Foundation of Korea (NRF) Grant - Korean Government [1201002578]; university research grants from Chonbuk National University	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Brain Korea 21 PLUS Project, NRF; Basic Research Laboratory Program through the Ministry of Science, ICT& Future Planning; Robot industrial cluster construction program through the Ministry of Trade, Industry Energy (MOTIE); National Research Foundation of Korea (NRF) Grant - Korean Government; university research grants from Chonbuk National University	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (1301001076 and 1401001209) and financially supported by the Brain Korea 21 PLUS Project, NRF. This work was also supported by the Basic Research Laboratory Program (2014R1A4A1008140) through the Ministry of Science, ICT& Future Planning and by the Robot industrial cluster construction program through the Ministry of Trade, Industry & Energy (MOTIE). This research was also supported by the National Research Foundation of Korea (NRF) Grant No. 1201002578 funded by the Korean Government and Sathish Kumar was supported by university research grants from Chonbuk National University.	Ce N, 2012, CYTA-J FOOD, V10, P21, DOI 10.1080/19476337.2010.537371; Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x; Gomoiu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062130; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hu DY, 2008, J AGR FOOD CHEM, V56, P998, DOI 10.1021/jf072394k; Jin LH, 2006, BIOORG MED CHEM LETT, V16, P1537, DOI 10.1016/j.bmcl.2005.12.041; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; Kraicheva I, 1998, PHOSPHORUS SULFUR, V134, P287; Martinez-Camacho AP, 2010, CARBOHYD POLYM, V82, P305, DOI 10.1016/j.carbpol.2010.04.069; Mourya VK, 2008, REACT FUNCT POLYM, V68, P1013, DOI 10.1016/j.reactfunctpolym.2008.03.002; Nickerson CA, 2004, MICROBIOL MOL BIOL R, V68, P345, DOI 10.1128/MMBR.68.2.345-361.2004; Nickerson CA, 2000, INFECT IMMUN, V68, P3147, DOI 10.1128/IAI.68.6.3147-3152.2000; Nielsen KF, 2009, ANAL BIOANAL CHEM, V395, P1225, DOI 10.1007/s00216-009-3081-5; OUIMETTE DG, 1989, PHYTOPATHOLOGY, V79, P761, DOI 10.1094/Phyto-79-761; PAUL GC, 1993, BIOTECHNOL BIOENG, V42, P11, DOI 10.1002/bit.260420103; Plascencia-Jatomea M, 2003, MACROMOL BIOSCI, V3, P582, DOI 10.1002/mabi.200350024; Prashanth KVH, 2007, TRENDS FOOD SCI TECH, V18, P117, DOI 10.1016/j.tifs.2006.10.022; Qin YK, 2014, INT J BIOL MACROMOL, V63, P83, DOI 10.1016/j.ijbiomac.2013.10.023; Rhoades J, 2000, APPL ENVIRON MICROB, V66, P80, DOI 10.1128/AEM.66.1.80-86.2000; Roller S, 1999, INT J FOOD MICROBIOL, V47, P67, DOI 10.1016/S0168-1605(99)00006-9; Rykova M. P., 2013, Human Physiology, V39, P557, DOI 10.1134/S0362119713050137; Sathishkumar Y, 2014, ANTON LEEUW INT J G, V106, P197, DOI 10.1007/s10482-014-0181-9; Sonar SS, 2010, PHOSPHORUS SULFUR, V185, P65, DOI 10.1080/10426500802713259; Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901; Van Houdt R, 2012, PLANET SPACE SCI, V60, P115, DOI 10.1016/j.pss.2011.09.001; Vesper SJ, 2007, J OCCUP ENVIRON MED, V49, P987; Vesper SJ, 2008, RES MICROBIOL, V159, P432, DOI 10.1016/j.resmic.2008.06.001; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Zakrzewska A, 2005, EUKARYOT CELL, V4, P703, DOI 10.1128/EC.4.4.703-715.2005; Zhang GP, 2006, J FLUORINE CHEM, V127, P48, DOI 10.1016/j.jfluchem.2005.09.014	30	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0139303	10.1371/journal.pone.0139303	http://dx.doi.org/10.1371/journal.pone.0139303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468641	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600007
J	Kiel, S; Hansen, BT				Kiel, Steffen; Hansen, Bent T.			Cenozoic Methane-Seep Faunas of the Caribbean Region	PLOS ONE			English	Article								We report new examples of Cenozoic cold-seep communities from Colombia, Cuba, the Dominican Republic, Trinidad, and Venezuela, and attempt to improve the stratigraphic dating of Cenozoic Caribbean seep communities using strontium isotope stratigraphy. Two seep faunas are distinguished in Barbados: the late Eocene mudstone-hosted 'Joes River fauna' consists mainly of large lucinid bivalves and tall abyssochrysoid gastropods, and the early Miocene carbonate-hosted 'Bath Cliffs fauna' containing the vesicomyid Pleurophopsis, the mytilid Bathymodiolus and small gastropods. Two new Oligocene seep communities from the Sinu River basin in Colombia consist of lucinid bivalves including Elongatolucina, thyasirid and solemyid bivalves, and Pleurophopsis. A new early Miocene seep community from Cuba includes Pleurophopsis and the large lucinid Meganodontia. Strontium isotope stratigraphy suggests an Eocene age for the Cuban Elmira asphalt mine seep community, making it the oldest in the Caribbean region. A new basal Pliocene seep fauna from the Dominican Republic is characterized by the large lucinid Anodontia (Pegophysema). In Trinidad we distinguish two types of seep faunas: the mudstone-hosted Godineau River fauna consisting mainly of lucinid bivalves, and the limestone-hosted Freeman's Bay fauna consisting chiefly of Pleurophopsis, Bathymodiolus, and small gastropods; they are all dated as late Miocene. Four new seep communities of Oligocene to Miocene age are reported from Venezuela. They consist mainly of large globular lucinid bivalves including Meganodontia, and moderately sized vesicomyid bivalves. After the late Miocene many large and typical 'Cenozoic' lucinid genera disappeared from the Caribbean seeps and are today known only from the central Indo-Pacific Ocean. We speculate that the increasingly oligotrophic conditions in the Caribbean Sea after the closure of the Isthmus of Panama in the Pliocene may have been unfavorable for such large lucinids because they are only facultative chemosymbiotic and need to derive a significant proportion of their nutrition from suspended organic matter.	[Kiel, Steffen] Univ Gottingen, Geosci Ctr, Geobiol Grp, D-37077 Gottingen, Germany; [Kiel, Steffen] Nat Hist Riksmuseet, Dept Palaeobiol, S-10405 Stockholm, Sweden; [Hansen, Bent T.] Univ Gottingen, Geosci Ctr, Dept Isotope Geol, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen	Kiel, S (corresponding author), Univ Gottingen, Geosci Ctr, Geobiol Grp, Goldschmidtstr 3, D-37077 Gottingen, Germany.	steffen.kiel@nrm.se	Kiel, Steffen/C-3150-2009	Kiel, Steffen/0000-0001-6281-100X	Deutsche Forschungsgemeinschaft [Ha1166/17-1, Ki802/6-1]; Open Access Publication Funds of the Georg-August-University Gottingen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Funds of the Georg-August-University Gottingen	Financial support was provided by the Deutsche Forschungsgemeinschaft through grants Ha1166/17-1 and Ki802/6-1, and by the Open Access Publication Funds of the Georg-August-University Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140788	10.1371/journal.pone.0140788	http://dx.doi.org/10.1371/journal.pone.0140788			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468887	Green Published, gold			2022-12-26	WOS:000363184600112
J	Herber-Gast, GCM; Hulsegge, G; Hartman, L; Verschuren, WMM; Stehouwer, CDA; Gansevoort, RT; Bakker, SJL; Spijkerman, AMW				Herber-Gast, Gerrie-Cor M.; Hulsegge, Gerben; Hartman, Linda; Verschuren, W. M. Monique; Stehouwer, Coen D. A.; Gansevoort, Ron T.; Bakker, Stephan J. L.; Spijkerman, Annemieke M. W.			Physical Activity Is not Associated with Estimated Glomerular Filtration Rate among Young and Middle-Aged Adults: Results from the Population-Based Longitudinal Doetinchem Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; FOOD FREQUENCY QUESTIONNAIRE; CARDIOVASCULAR EVENTS; AUSTRALIAN ADULTS; RELATIVE VALIDITY; COCKCROFT-GAULT; RENAL-DISEASE; PREVALENCE; RISK	There is debate as to whether physical inactivity is associated with reduced kidney function. We studied the prospective association of (changes in) physical activity with estimated glomerular filtration rate (eGFR) in adult men and women. We included 3,935 participants aged 26 to 65 years from the Doetinchem Cohort study, examined every 5 years for 15 years. Physical activity was assessed at each round using the Cambridge Physical Activity Index. Using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation, GFR was estimated from routinely measured cystatin C concentrations, examining all available samples per participant in one assay run. We determined the association between 1) physical activity and eGFR and 2) 5-year changes in physical activity (becoming inactive, staying inactive, staying active, becoming active) and eGFR, using time-lagged generalized estimating equation analyses. At baseline, 3.6% of the participants were inactive, 18.5% moderately inactive, 26.0% moderately active, and 51.9% active. The mean (+/- SD) eGFR was 107.9 (+/- 14.5) mL/min per 1.73 m(2). Neither physical activity nor 5-year changes in physical activity were associated with eGFR at the subsequent round. The multivariate adjusted beta eGFR was 0.57 mL/min per 1.73 m(2) (95% Confidence Interval (CI) -1.70, 0.56) for inactive compared to active participants. Studying changes in physical activity between rounds, the adjusted beta eGFR was -1.10 mL/min per 1.73 m(2) (95% CI -4.50, 2.30) for those who stayed inactive compared with participants who became active. Physical activity was not associated with eGFR in this population-based study of adults.	[Herber-Gast, Gerrie-Cor M.; Hulsegge, Gerben; Hartman, Linda; Verschuren, W. M. Monique; Spijkerman, Annemieke M. W.] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands; [Herber-Gast, Gerrie-Cor M.; Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Dept Internal Med, NL-6200 MD Maastricht, Netherlands; [Herber-Gast, Gerrie-Cor M.; Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst, NL-6200 MD Maastricht, Netherlands; [Hulsegge, Gerben; Verschuren, W. M. Monique] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Gansevoort, Ron T.; Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands	Netherlands National Institute for Public Health & the Environment; Maastricht University; Maastricht University; Utrecht University; Utrecht University Medical Center; University of Groningen	Herber-Gast, GCM (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands.	Gerrie-Cor.Herber@rivm.nl	Stehouwer, Coen/AAB-3435-2021	Stehouwer, Coen/0000-0001-8752-3223; Hulsegge, Gerben/0000-0003-4649-9436	Dutch Kidney Foundation [PV42]	Dutch Kidney Foundation	This work was supported by a grant from the Dutch Kidney Foundation (PV42). The supporting agency had no role in the design or conduct of the study, collection, analysis, or interpretation of the data, or the preparation and approval of the manuscript.	Bharakhada N, 2012, AM J KIDNEY DIS, V60, P583, DOI 10.1053/j.ajkd.2012.04.024; Botev R, 2009, CLIN J AM SOC NEPHRO, V4, P899, DOI 10.2215/CJN.05371008; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Finkelstein J, 2006, AM J KIDNEY DIS, V48, P372, DOI 10.1053/j.ajkd.2006.05.013; Hallan S, 2006, AM J KIDNEY DIS, V47, P396, DOI 10.1053/j.ajkd.2005.11.027; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Khaw KT, 2006, INT J EPIDEMIOL, V35, P1034, DOI 10.1093/ije/dyl079; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Lin J, 2003, J AM SOC NEPHROL, V14, P2573, DOI 10.1097/01.ASN.0000088721.98173.4B; May AM, 2010, AM J CLIN NUTR, V92, P491, DOI 10.3945/ajcn.2010.29404; NEVO Foundation, 1996, DUTCH FOOD COMP DAT; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Parsons TJ, 2005, EUR J CLIN NUTR, V59, P49, DOI 10.1038/sj.ejcn.1602032; Picavet HSJ, 2011, MED SCI SPORT EXER, V43, P74, DOI 10.1249/MSS.0b013e3181e57a6a; Poggio ED, 2005, J AM SOC NEPHROL, V16, P459, DOI 10.1681/ASN.2004060447; Robinson-Cohen C, 2009, ARCH INTERN MED, V169, P2116, DOI 10.1001/archinternmed.2009.438; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Stengel B, 2003, EPIDEMIOLOGY, V14, P479, DOI 10.1097/01.EDE.0000071413.55296.c4; US Department of Health and Human Services and US Department of Agriculture, 2005, DIET GUID AM; Vart P, 2015, CLIN CHEM LAB MED, V53, P1381, DOI 10.1515/cclm-2014-0894; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; White SL, 2011, NUTR METAB CARDIOVAS, V21, P104, DOI 10.1016/j.numecd.2009.08.010; White SL, 2009, NUTRMETAB CARDIOVASC; Willis BL, 2012, ARCH INTERN MED, V172, P1333, DOI 10.1001/archinternmed.2012.3400; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865	32	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0133864	10.1371/journal.pone.0133864	http://dx.doi.org/10.1371/journal.pone.0133864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465150	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100003
J	Porter, WR; Witmer, LM				Porter, William Ruger; Witmer, Lawrence M.			Vascular Patterns in Iguanas and Other Squamates: Blood Vessels and Sites of Thermal Exchange	PLOS ONE			English	Article							BODY TEMPERATURE DIFFERENCES; BRAIN TEMPERATURE; WATER ECONOMY; LIZARD; HEAD; THERMOREGULATION; VARANUS; SYSTEM; VARIABILITY; MECHANISM	Squamates use the circulatory system to regulate body and head temperatures during both heating and cooling. The flexibility of this system, which possibly exceeds that of endotherms, offers a number of physiological mechanisms to gain or retain heat (e.g., increase peripheral blood flow and heart rate, cooling the head to prolong basking time for the body) as well as to shed heat (modulate peripheral blood flow, expose sites of thermal exchange). Squamates also have the ability to establish and maintain the same head-to-body temperature differential that birds, crocodilians, and mammals demonstrate, but without a discrete rete or other vascular physiological device. Squamates offer important anatomical and phylogenetic evidence for the inference of the blood vessels of dinosaurs and other extinct archosaurs in that they shed light on the basal diapsid condition. Given this basal positioning, squamates likewise inform and constrain the range of physiological thermoregulatory mechanisms that may have been found in Dinosauria. Unfortunately, the literature on squamate vascular anatomy is limited. Cephalic vascular anatomy of green iguanas (Iguana iguana) was investigated using a differential-contrast, dual-vascular injection (DCDVI) technique and high-resolution X-ray microcomputed tomography (mu CT). Blood vessels were digitally segmented to create a surface representation of vascular pathways. Known sites of thermal exchange, consisting of the oral, nasal, and orbital regions, were given special attention due to their role in brain and cephalic thermoregulation. Blood vessels to and from sites of thermal exchange were investigated to detect conserved vascular patterns and to assess their ability to deliver cooled blood to the dural venous sinuses. Arteries within sites of thermal exchange were found to deliver blood directly and through collateral pathways. The venous drainage was found to have multiple pathways that could influence neurosensory tissue temperature, as well as pathways that would bypass neurosensory tissues. The orbital region houses a large venous sinus that receives cooled blood from the nasal region. Blood vessels from the nasal region and orbital sinus show anastomotic connections to the dural sinus system, allowing for the direct modulation of brain temperatures. The generality of the vascular patterns discovered in iguanas were assessed by firsthand comparison with other squamates taxa (e.g., via dissection and osteological study) as well as the literature. Similar to extant archosaurs, iguanas and other squamates have highly vascularized sites of thermal exchange that likely support physiological thermoregulation that "fine tunes" temperatures attained through behavioral thermoregulation.	[Porter, William Ruger; Witmer, Lawrence M.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA	University System of Ohio; Ohio University	Porter, WR (corresponding author), Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA.	porterw1@ohio.edu		Porter, William Ruger/0000-0001-9421-5384; Witmer, Lawrence/0000-0002-7610-0118	Ohio University Student Enhancement Award; Ohio Center for Ecological and Evolutionary Studies Research Fellowship; Ohio University; Sigma Xi; University of California Welles Fund; United States National Science Foundation [IOB-0517257, IOS-1050154]; Ohio University Heritage College of Osteopathic Medicine; Ohio Supercomputer Center; Jurassic Foundation; Direct For Biological Sciences [1050154, 1456503] Funding Source: National Science Foundation	Ohio University Student Enhancement Award; Ohio Center for Ecological and Evolutionary Studies Research Fellowship; Ohio University; Sigma Xi; University of California Welles Fund; United States National Science Foundation(National Science Foundation (NSF)); Ohio University Heritage College of Osteopathic Medicine; Ohio Supercomputer Center; Jurassic Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Ohio University Student Enhancement Award, Jurassic Foundation Grant-in-aid of Research, Ohio Center for Ecological and Evolutionary Studies Research Fellowship, Ohio University Graduate Student Senate Grant-in-aid of Research, Sigma Xi Grant-in-aid of Research, and the University of California Welles Fund (to WRP). LMW acknowledges support from the United States National Science Foundation (IOB-0517257, IOS-1050154), Ohio University Heritage College of Osteopathic Medicine, and the Ohio Supercomputer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPH SC, 1993, AM NAT, V142, P273, DOI 10.1086/285538; AHO AC, 1993, J PHYSIOL-LONDON, V463, P501, DOI 10.1113/jphysiol.1993.sp019608; BARTHOLOMEW GEORGE A., 1963, PHYSIOL ZOOL, V36, P199; BELLAIRS AD, 1949, J ANAT, V83, P116; Borrell BJ, 2005, COMP BIOCHEM PHYS A, V140, P471, DOI 10.1016/j.cbpb.2005.02.012; Bruner HL, 1907, AM J ANAT, V7, P1, DOI 10.1002/aja.1000070102; BURDA DJ, 1966, AM J ANAT, V118, P743, DOI 10.1002/aja.1001180305; Cadena V, 1993, J COMP PHYSIOL A, V199, P1093; CRAWFORD EC, 1977, COMP BIOCHEM PHYS A, V56, P161, DOI 10.1016/0300-9629(77)90178-5; CRAWFORD EC, 1972, SCIENCE, V177, P431, DOI 10.1126/science.177.4047.431; DAWSON WR, 1966, ECOLOGY, V47, P589, DOI 10.2307/1933936; Dendy A, 1909, PHILOS T R SOC LON B, V200, P403, DOI 10.1098/rstb.1909.0010; DEWITT CB, 1967, PHYSIOL ZOOL, V40, P49, DOI 10.1086/physzool.40.1.30152438; Dorcas ME, 1997, J HERPETOL, V31, P87, DOI 10.2307/1565333; Dzialowski EM, 1999, J THERM BIOL, V24, P21, DOI 10.1016/S0306-4565(98)00034-5; Fuller A, 2003, J EXP BIOL, V206, P1171, DOI 10.1242/jeb.00230; GREGORY PT, 1990, J HERPETOL, V24, P241, DOI 10.2307/1564389; HEATH JAMES EDWARD, 1964, PHYSIOL ZOOL, V37, P273; HEATH JE, 1966, PHYSIOL ZOOL, V39, P30, DOI 10.1086/physzool.39.1.30152764; Herczeg G, 2006, BEHAV ECOL SOCIOBIOL, V60, P405, DOI 10.1007/s00265-006-0180-6; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Holliday CM, 2006, ANAT REC PART A, V288A, P1031, DOI 10.1002/ar.a.20374; HUEY RB, 1976, Q REV BIOL, V51, P363, DOI 10.1086/409470; JOHNSON CR, 1972, COMP BIOCHEM PHYSIOL, V43, P1025, DOI 10.1016/0300-9629(72)90174-0; KILGORE DL, 1973, AM J PHYSIOL, V225, P739; KLEINHAUS S, 1985, PHYSIOL ZOOL, V58, P105, DOI 10.1086/physzool.58.1.30161224; Kuhnen G, 1997, COMP BIOCHEM PHYS A, V118, P891, DOI 10.1016/S0300-9629(97)00235-1; Maloney SK, 2007, AM J PHYSIOL-REG I, V292, pR1298, DOI 10.1152/ajpregu.00275.2006; MAUTZ WJ, 1980, COMP BIOCHEM PHYS A, V67, P429, DOI 10.1016/S0300-9629(80)80019-3; MIDTGARD U, 1983, J EXP ZOOL, V225, P197, DOI 10.1002/jez.1402250204; Mitchel D, 2002, COMP BIOCH PHYSL B, P571; MURRISH DE, 1970, RESP PHYSIOL, V10, P151, DOI 10.1016/0034-5687(70)90079-4; O'Donoghue CH, 1921, PHILOS T R SOC LON B, V210, P175, DOI 10.1098/rstb.1921.0006; Oelrich T. M., 1956, Miscellaneous Publications Museum of Zoology University of Michigan, V94, P1; Ostrowski S, 2003, J EXP BIOL, V206, P1471, DOI 10.1242/jeb.00275; Porter WR., 2015, THESIS OHIO U; POUGH FH, 1980, AM ZOOL, V20, P173; RIEPPEL O, 1979, ZOOL J LINN SOC-LOND, V65, P161, DOI 10.1111/j.1096-3642.1979.tb01088.x; Rieppel O, 2000, ZOOL J LINN SOC-LOND, V129, P489, DOI 10.1006/zjls.1999.0215; Sannolo M, 2014, J ZOOL, V293, P71, DOI 10.1111/jzo.12121; Sedlmayr JC, 2015, THESIS OHIO U; Seebacher F, 2000, J THEOR BIOL, V203, P97, DOI 10.1006/jtbi.1999.1067; Seebacher F, 2005, J EXP ZOOL PART B, V175, P553; Sherbrooke WC, 2001, COPEIA, P1114, DOI 10.1643/0045-8511(2001)001[1114:BSVIHL]2.0.CO;2; SMITH EN, 1975, PHYSIOL ZOOL, V48, P177, DOI 10.1086/physzool.48.2.30155651; SPOTILA JR, 1977, NATURE, V265, P235, DOI 10.1038/265235a0; SPRAY DC, 1973, COMP BIOCHEM PHYSIOL, V44, P881, DOI 10.1016/0300-9629(73)90151-5; STEBBINS RC, 1948, AM J ANAT, V83, P183, DOI 10.1002/aja.1000830202; Tattersall GJ, 2005, J EXP BIOL, V208, P3321, DOI 10.1242/jeb.01773; Tattersall GJ, 2006, RESP PHYSIOL NEUROBI, V154, P302, DOI 10.1016/j.resp.2006.02.011; TEMPLETON JAMES R., 1960, PHYSIOL ZOOL, V33, P136; Tieleman BI, 1999, PHYSIOL BIOCHEM ZOOL, V72, P87, DOI 10.1086/316640; TRAUTWEIN SN, 1985, COMP BIOCHEM PHYS A, V80, P199, DOI 10.1016/0300-9629(85)90541-9; Vidal MA, 2008, REV CHIL HIST NAT, V81, P171; WEATHERS WW, 1971, COMP BIOCHEM PHYSIOL, V40, P503, DOI 10.1016/0300-9629(71)90042-9; WEATHERS WW, 1970, COPEIA, P549; WEBB GJW, 1972, PHYSIOL ZOOL, V45, P130, DOI 10.1086/physzool.45.2.30155577; WHITFIELD CL, 1973, PHYSIOL ZOOL, V46, P285, DOI 10.1086/physzool.46.4.30155611; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; WITMER LM, 1995, J MORPHOL, V225, P269, DOI 10.1002/jmor.1052250304	60	34	35	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139215	10.1371/journal.pone.0139215	http://dx.doi.org/10.1371/journal.pone.0139215			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466378	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100042
J	Dhondup, Y; Sjaastad, I; Scott, H; Sandanger, O; Zhang, LL; Haugstad, SB; Aronsen, JM; Ranheim, T; Holmen, SD; Alfsnes, K; Ahmed, MS; Attramadal, H; Gullestad, L; Aukrust, P; Christensen, G; Yndestad, A; Vinge, LE				Dhondup, Yangchen; Sjaastad, Ivar; Scott, Helge; Sandanger, Oystein; Zhang, Lili; Haugstad, Solveig Bjaerum; Aronsen, Jan Magnus; Ranheim, Trine; Holmen, Sigve Dhondup; Alfsnes, Katrine; Ahmed, Muhammad Shakil; Attramadal, Havard; Gullestad, Lars; Aukrust, Pal; Christensen, Geir; Yndestad, Arne; Vinge, Leif Erik			Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice	PLOS ONE			English	Article							PRESERVED SYSTOLIC FUNCTION; BACTERIAL-DNA; MITOCHONDRIAL-DNA; INNATE IMMUNITY; CELL-DEATH; DYSFUNCTION; DAMPS; CONTRACTILITY; STIMULATION; RECOGNITION	Aim Cardiac inflammation is important in the pathogenesis of heart failure. However, the consequence of systemic inflammation on concomitant established heart failure, and in particular diastolic heart failure, is less explored. Here we investigated the impact of systemic inflammation, caused by sustained Toll-like receptor 9 activation, on established diastolic heart failure. Methods and Results Diastolic heart failure was established in 8-10 week old cardiomyocyte specific, inducible SERCA2a knock out (i.e., SERCA2a KO) C57Bl/6J mice. Four weeks after conditional KO, mice were randomized to receive Toll-like receptor 9 agonist (CpG B; 2 mu g/g body weight) or PBS every third day. After additional four weeks, echocardiography, phase contrast magnetic resonance imaging, histology, flow cytometry, and cardiac RNA analyses were performed. A subgroup was followed, registering morbidity and death. Non-heart failure control groups treated with CpG B or PBS served as controls. Our main findings were: (i) Toll-like receptor 9 activation (CpG B) reduced life expectancy in SERCA2a KO mice compared to PBS treated SERCA2a KO mice. (ii) Diastolic function was lower in SERCA2a KO mice with Toll-like receptor 9 activation. (iii) Toll-like receptor 9 stimulated SERCA2a KO mice also had increased cardiac and systemic inflammation. Conclusion Sustained activation of Toll-like receptor 9 causes cardiac and systemic inflammation, and deterioration of SERCA2a depletion-mediated diastolic heart failure.	[Dhondup, Yangchen; Sandanger, Oystein; Ranheim, Trine; Alfsnes, Katrine; Aukrust, Pal; Yndestad, Arne; Vinge, Leif Erik] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Dhondup, Yangchen; Sjaastad, Ivar; Sandanger, Oystein; Zhang, Lili; Haugstad, Solveig Bjaerum; Gullestad, Lars; Christensen, Geir; Yndestad, Arne; Vinge, Leif Erik] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Dhondup, Yangchen; Scott, Helge; Sandanger, Oystein; Ranheim, Trine; Alfsnes, Katrine; Ahmed, Muhammad Shakil; Attramadal, Havard; Aukrust, Pal; Yndestad, Arne] Univ Oslo, KG Jebsen Inflammat Res Ctr, Oslo, Norway; [Sjaastad, Ivar; Zhang, Lili; Haugstad, Solveig Bjaerum; Aronsen, Jan Magnus; Christensen, Geir] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Scott, Helge] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pathol, N-0027 Oslo, Norway; [Scott, Helge; Holmen, Sigve Dhondup; Attramadal, Havard; Gullestad, Lars; Aukrust, Pal; Yndestad, Arne] Univ Oslo, Inst Clin Med, Oslo, Norway; [Aronsen, Jan Magnus] Bjorknes Coll, Oslo, Norway; [Holmen, Sigve Dhondup] Oslo Univ Hosp, Dept Infect Dis, Ctr Imported & Trop Dis, Oslo, Norway; [Ahmed, Muhammad Shakil; Attramadal, Havard] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Surg Res, N-0027 Oslo, Norway; [Gullestad, Lars] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Cardiol, N-0027 Oslo, Norway; [Aukrust, Pal; Vinge, Leif Erik] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway; [Vinge, Leif Erik] Diakonhjemmet Hosp, Dept Internal Med, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Diakonhjemmet Hospital	Dhondup, Y (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway.	yangched@gmail.com		Sandanger, Oystein/0000-0001-7475-7362; Attramadal, Havard/0000-0001-9506-0687	Norwegian Health Association, Helse Sor-Ost Regional Health Authority [6680]	Norwegian Health Association, Helse Sor-Ost Regional Health Authority	Funding was provided by the Norwegian Health Association, Helse Sor-Ost Regional Health Authority (http://www.nasjonalforeningen.no/), grant number 6680, to YD and LEV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157; Berkowitz D, 2013, HUM IMMUNOL, V74, P1519, DOI 10.1016/j.humimm.2013.08.285; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Espe EKS, 2013, MAGN RESON MED, V69, P48, DOI 10.1002/mrm.24226; Finsen AV, 2005, J APPL PHYSIOL, V98, P680, DOI 10.1152/japplphysiol.00924.2004; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Glezeva N, 2014, HEART FAIL REV, V19, P681, DOI 10.1007/s10741-013-9405-8; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hougen K, 2010, AM J PHYSIOL-HEART C, V299, pH1671, DOI 10.1152/ajpheart.01155.2009; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Knuefermann P, 2008, CARDIOVASC RES, V78, P26, DOI 10.1093/cvr/cvn011; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Leong DP, 2010, JACC-CARDIOVASC IMAG, V3, P409, DOI 10.1016/j.jcmg.2009.12.011; Liu HJ, 1998, J CHROMATOGR A, V828, P383, DOI 10.1016/S0021-9673(98)00836-X; Louch WE, 2010, J PHYSIOL-LONDON, V588, P465, DOI 10.1113/jphysiol.2009.183517; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; McCarthy CG, 2015, CARDIOVASC RES, V107, P119, DOI 10.1093/cvr/cvv137; Nie QH, 2010, MOL BIOL REP, V37, P3487, DOI 10.1007/s11033-009-9941-4; Ohm IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104407; Ohm IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104398; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Shintani Y, 2014, EMBO REP, V15, P438, DOI 10.1002/embr.201337945; Velten M, 2012, CARDIOVASC RES, V96, P422, DOI 10.1093/cvr/cvs280; Wenceslau CF, 2014, EUR HEART J, V35, P1172, DOI 10.1093/eurheartj/ehu047; Yancy CW, 2006, J AM COLL CARDIOL, V47, P76, DOI 10.1016/j.jacc.2005.09.022; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062373; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang QH, 2013, AUTOPHAGY, V9, P451, DOI 10.4161/auto.23691; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	34	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139715	10.1371/journal.pone.0139715	http://dx.doi.org/10.1371/journal.pone.0139715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461521	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300023
J	Singh, B; Li, XR; Owens, KM; Vanniarajan, A; Liang, P; Singh, KK				Singh, Bhupendra; Li, Xiurong; Owens, Kjerstin M.; Vanniarajan, Ayyasamy; Liang, Ping; Singh, Keshav K.			Human REV3 DNA Polymerase Zeta Localizes to Mitochondria and Protects the Mitochondrial Genome	PLOS ONE			English	Article							CATALYTIC SUBUNIT; POL-ZETA; CANCER-CELLS; EMBRYONIC LETHALITY; INDUCED MUTAGENESIS; MAMMALIAN-CELLS; BREAST-CANCER; ERROR-FREE; DAMAGE; GENE	To date, mitochondrial DNA polymerase. (POLG) is the only polymerase known to be present in mammalian mitochondria. A dogma in the mitochondria field is that there is no other polymerase present in the mitochondria of mammalian cells. Here we demonstrate localization of REV3 DNA polymerase in the mammalian mitochondria. We demonstrate localization of REV3 in the mitochondria of mammalian tissue as well as cell lines. REV3 associates with POLG and mitochondrial DNA and protects the mitochondrial genome from DNA damage. Inactivation of Rev3 leads to reduced mitochondrial membrane potential, reduced OXPHOS activity, and increased glucose consumption. Conversely, inhibition of the OXPHOS increases expression of Rev3. Rev3 expression is increased in human primary breast tumors and breast cancer cell lines. Inactivation of Rev3 decreases cell migration and invasion, and localization of Rev3 in mitochondria increases survival and the invasive potential of cancer cells. Taken together, we demonstrate that REV3 functions in mammalian mitochondria and that mitochondrial REV3 is associated with the tumorigenic potential of cells.	[Singh, Bhupendra] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Li, Xiurong; Owens, Kjerstin M.; Vanniarajan, Ayyasamy] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Liang, Ping] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Singh, Keshav K.] Univ Alabama Birmingham, Dept Genet Pathol, Ctr Free Rad Biol, Environm Hlth,Ctr Aging, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL USA; [Singh, Keshav K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; Roswell Park Cancer Institute; Brock University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Singh, KK (corresponding author), Univ Alabama Birmingham, Dept Genet Pathol, Ctr Free Rad Biol, Environm Hlth,Ctr Aging, Birmingham, AL 35294 USA.	kksingh@uab.edu	Liang, Ping/S-3790-2018; Vanniarajan, A./AAB-4896-2022	Liang, Ping/0000-0003-4423-0636; Owens, Kjerstin/0000-0001-5210-319X	Veterans Administration [1I01BX001716]	Veterans Administration(US Department of Veterans Affairs)	This study was supported by grant from Veterans Administration (1I01BX001716) to KKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baruffini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034322; Bemark M, 2000, CURR BIOL, V10, P1213, DOI 10.1016/S0960-9822(00)00724-7; Bhat A, 2013, NUCLEIC ACIDS RES, V41, P2328, DOI 10.1093/nar/gks1442; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Brondello JM, 2008, ONCOGENE, V27, P6093, DOI 10.1038/onc.2008.212; Chatterjee A, 2001, NUCLEIC ACIDS RES, V29, P4935, DOI 10.1093/nar/29.24.4935; Copeland WC, 2003, ACTA BIOCHIM POL, V50, P155; Copeland William C, 2003, ScientificWorldJournal, V3, P34; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; FOURY F, 1989, J BIOL CHEM, V264, P20552; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Gibbs PEM, 1998, P NATL ACAD SCI USA, V95, P6876, DOI 10.1073/pnas.95.12.6876; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Gueranger Q, 2008, DNA REPAIR, V7, P1551, DOI 10.1016/j.dnarep.2008.05.012; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659; Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940; Kazak L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062340; Knobel PA, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-39; Knobel PA, 2011, NEOPLASIA, V13, P961, DOI 10.1593/neo.11828; Kozmin SG, 2003, NUCLEIC ACIDS RES, V31, P4541, DOI 10.1093/nar/gkg489; Kulawiec M, 2008, CANCER BIOL THER, V7, P1732, DOI 10.4161/cbt.7.11.6729; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Lange SS, 2013, P NATL ACAD SCI USA, V110, pE687, DOI 10.1073/pnas.1217425110; Lange SS, 2012, NUCLEIC ACIDS RES, V40, P4473, DOI 10.1093/nar/gks054; Li ZQ, 2002, MUTAT RES-FUND MOL M, V510, P71, DOI 10.1016/S0027-5107(02)00253-1; Lin XJ, 2006, CLIN CANCER RES, V12, P563, DOI 10.1158/1078-0432.CCR-05-1380; Meyer JN, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r70; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rajpal DK, 2000, MUTAT RES-DNA REPAIR, V461, P133, DOI 10.1016/S0921-8777(00)00047-1; Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Singh B, 2012, CARCINOGENESIS, V33, P2601, DOI 10.1093/carcin/bgs300; Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71; Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10; Van Sloun PPH, 2002, MOL CELL BIOL, V22, P2159, DOI 10.1128/MCB.22.7.2159-2169.2002; Varadi V, 2011, BREAST CANCER RES TR, V129, P235, DOI 10.1007/s10549-011-1460-z; Wang HB, 2009, NEURO-ONCOLOGY, V11, P790, DOI 10.1215/15228517-2009-015; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; Wittschieben JP, 2010, CANCER RES, V70, P2770, DOI 10.1158/0008-5472.CAN-09-4267; Wittschieben JP, 2006, CANCER RES, V66, P134, DOI 10.1158/0008-5472.CAN-05-2982; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810; Zhang HS, 2006, GENETICS, V172, P2683, DOI 10.1534/genetics.105.051029	53	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140409	10.1371/journal.pone.0140409	http://dx.doi.org/10.1371/journal.pone.0140409			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462070	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300091
J	Desmarais, SM; Tropini, C; Miguel, A; Cava, F; Monds, RD; de Pedro, MA; Huang, KC				Desmarais, Samantha M.; Tropini, Carolina; Miguel, Amanda; Cava, Felipe; Monds, Russell D.; de Pedro, Miguel A.; Huang, Kerwyn Casey			High-throughput, Highly Sensitive Analyses of Bacterial Morphogenesis Using Ultra Performance Liquid Chromatography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING-PROTEINS; CELL-WALL; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PEPTIDOGLYCAN STRUCTURE; CHEMICAL-COMPOSITION; MUREIN STRUCTURE; L-FORMS; RESISTANCE; SHAPE	The bacterial cell wall is a network of glycan strands crosslinked by short peptides (peptidoglycan); it is responsible for the mechanical integrity of the cell and shape determination. Liquid chromatography can be used to measure the abundance of the muropeptide subunits composing the cell wall. Characteristics such as the degree of cross-linking and average glycan strand length are known to vary across species. However, a systematic comparison among strains of a given species has yet to be undertaken, making it difficult to assess the origins of variability in peptidoglycan composition. We present a protocol for muropeptide analysis using ultra performance liquid chromatography (UPLC) and demonstrate that UPLC achieves resolution comparable with that of HPLC while requiring orders of magnitude less injection volume and a fraction of the elution time. We also developed a software platform to automate the identification and quantification of chromatographic peaks, which we demonstrate has improved accuracy relative to other software. This combined experimental and computational methodology revealed that peptidoglycan composition was approximately maintained across strains from three Gram-negative species despite taxonomical and morphological differences. Peptidoglycan composition and density were maintained after we systematically altered cell size in Escherichia coli using the antibiotic A22, indicating that cell shape is largely decoupled from the biochemistry of peptidoglycan synthesis. High-throughput, sensitive UPLC combined with our automated software for chromatographic analysis will accelerate the discovery of peptidoglycan composition and the molecular mechanisms of cell wall structure determination.	[Desmarais, Samantha M.; Tropini, Carolina; Miguel, Amanda; Monds, Russell D.; Huang, Kerwyn Casey] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Huang, Kerwyn Casey] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Tropini, Carolina; Huang, Kerwyn Casey] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Cava, Felipe] Umea Univ, Umea Ctr Microbial Res, Dept Mol Biol, S-90187 Umea, Sweden; [Cava, Felipe] Umea Univ, Umea Ctr Microbial Res, Lab Mol Infect Med Sweden, S-90187 Umea, Sweden; [Monds, Russell D.; Huang, Kerwyn Casey] Stanford Univ, Bio X Program, Stanford, CA 94305 USA; [de Pedro, Miguel A.] Univ Autonoma Madrid, E-28049 Madrid, Spain	Stanford University; Stanford University; Stanford University; Umea University; Umea University; Stanford University; Autonomous University of Madrid	Huang, KC (corresponding author), Dept Bioengn, 443 Via Ortega,Shriram Bldg,Rm 007, Stanford, CA 94305 USA.	kchuang@stanford.edu	Tropini, Carolina/H-2992-2019; Cava, Felipe/L-2082-2017	Tropini, Carolina/0000-0002-7542-1577; Cava, Felipe/0000-0001-5995-718X	Stanford Interdisciplinary Graduate Fellowship; National Science Foundation; Laboratory for Infection Medicine Sweden; Knut and Alice Wallenberg Foundation; Swedish Research Council; Bio-X Senior Postdoctoral Fellowship; National Institutes of Health Director's New Innovator Award [DP2OD006466]; National Science Foundation [MCB-1149328]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006466] Funding Source: NIH RePORTER	Stanford Interdisciplinary Graduate Fellowship; National Science Foundation(National Science Foundation (NSF)); Laboratory for Infection Medicine Sweden; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Bio-X Senior Postdoctoral Fellowship; National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Stanford Interdisciplinary Graduate Fellowship (to C. T.), a National Science Foundation Graduate Research Fellowship (to A. M.), the Laboratory for Infection Medicine Sweden, the Knut and Alice Wallenberg Foundation, the Swedish Research Council (to F. C.), a Bio-X Senior Postdoctoral Fellowship (to R. D. M.), and National Institutes of Health Director's New Innovator Award DP2OD006466 and National Science Foundation CAREER Award MCB-1149328 (to K. C. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Barreteau H, 2009, J BACTERIOL, V191, P3657, DOI 10.1128/JB.01824-08; Barsanti L, 2011, NAT PROD REP, V28, P457, DOI 10.1039/c0np00018c; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Billings G, 2014, MOL MICROBIOL, V93, P883, DOI 10.1111/mmi.12703; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; BOYLEN CW, 1968, J BACTERIOL, V96, P421, DOI 10.1128/JB.96.2.421-427.1968; Bruck S, 2011, J BACTERIOL, V193, P4425, DOI 10.1128/JB.01154-10; Bush K, 2012, REV SCI TECH OIE, V31, P43; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Czechowska K, 2014, P NATL ACAD SCI USA, V111, P7801, DOI 10.1073/pnas.1400782111; DELAROSA EJ, 1985, P NATL ACAD SCI USA, V82, P5632; Desmarais SM, 2014, JOVE-J VIS EXP, DOI 10.3791/51183; Desmarais SM, 2013, MOL MICROBIOL, V89, P1, DOI 10.1111/mmi.12266; DUCHENE M, 1989, J BACTERIOL, V171, P4130; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Evans KL, 2013, J BACTERIOL, V195, P4415, DOI 10.1128/JB.00596-13; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; GARCIABUSTOS J, 1990, P NATL ACAD SCI USA, V87, P5415, DOI 10.1073/pnas.87.14.5415; GARCIABUSTOS JF, 1988, J BACTERIOL, V170, P2143, DOI 10.1128/jb.170.5.2143-2147.1988; Garimella R, 2009, BIOCHEMISTRY-US, V48, P9242, DOI 10.1021/bi900503k; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; GOODELL EW, 1977, EUR J BIOCHEM, V81, P205, DOI 10.1111/j.1432-1033.1977.tb11942.x; Hakenbeck R., 1983, TARGET PENICILLIN MU; HEILMANN HD, 1974, EUR J BIOCHEM, V43, P35, DOI 10.1111/j.1432-1033.1974.tb03381.x; HEILMANN HD, 1972, EUR J BIOCHEM, V31, P456, DOI 10.1111/j.1432-1033.1972.tb02552.x; Huang KC, 2008, P NATL ACAD SCI USA, V105, P19282, DOI 10.1073/pnas.0805309105; Joseleau-Petit D, 2007, J BACTERIOL, V189, P6512, DOI 10.1128/JB.00273-07; KANDLER O, 1968, J BACTERIOL, V96, P1935, DOI 10.1128/JB.96.6.1935-1939.1968; KITANO K, 1986, J BACTERIOL, V167, P759, DOI 10.1128/jb.167.3.759-765.1986; Koch AL, 2000, CRIT REV MICROBIOL, V26, P1, DOI 10.1080/10408410091154165; Koyama N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048981; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Lee TK, 2014, P NATL ACAD SCI USA, V111, P4554, DOI 10.1073/pnas.1313826111; Legaree BA, 2007, J ANTIMICROB CHEMOTH, V59, P411, DOI 10.1093/jac/dkl536; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; MARKIEWICZ Z, 1983, J BACTERIOL, V156, P649, DOI 10.1128/JB.156.2.649-655.1983; MIRELMAN D, 1981, ANTIMICROB AGENTS CH, V19, P687, DOI 10.1128/AAC.19.5.687; Moll A, 2014, J BACTERIOL, V196, P3937, DOI 10.1128/JB.02094-14; Monds RD, 2014, CELL REP, V9, P1528, DOI 10.1016/j.celrep.2014.10.040; OBERMANN W, 1994, MICROBIOL-UK, V140, P79, DOI 10.1099/13500872-140-1-79; Philippe N, 2009, J BACTERIOL, V191, P909, DOI 10.1128/JB.01419-08; Remans K, 2010, MICROBIOL-SGM, V156, P2597, DOI 10.1099/mic.0.040659-0; Ronholm J, 2012, GLYCOBIOLOGY, V22, P1311, DOI 10.1093/glycob/cws100; Schaberle TF, 2011, ANTIMICROB AGENTS CH, V55, P4283, DOI 10.1128/AAC.01372-10; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Scheurwater EM, 2007, PROTEIN EXPRES PURIF, V56, P128, DOI 10.1016/j.pep.2007.06.009; Skurnik D, 2013, P NATL ACAD SCI USA, V110, P20747, DOI 10.1073/pnas.1221552110; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; SUTOW AB, 1967, J BACTERIOL, V93, P1452, DOI 10.1128/JB.93.4.1452-1457.1967; TOUCHSTONE JC, 1993, J LIQ CHROMATOGR, V16, P1647, DOI 10.1080/10826079308021679; Tropini C, 2014, CELL REP, V9, P1520, DOI 10.1016/j.celrep.2014.10.027; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Uehara T, 2008, J BACTERIOL, V190, P3914, DOI 10.1128/JB.00207-08; Ursell TS, 2014, P NATL ACAD SCI USA, V111, pE1025, DOI 10.1073/pnas.1317174111; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Vollmer W, 1997, J BACTERIOL, V179, P1580, DOI 10.1128/jb.179.5.1580-1583.1997; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; WANG WS, 1968, J BACTERIOL, V95, P1851, DOI 10.1128/JB.95.5.1851-1856.1968; WEIDEL W, 1960, J GEN MICROBIOL, V22, P158, DOI 10.1099/00221287-22-1-158; Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4; Wolter DJ, 2013, CURR PHARM DESIGN, V19, P209, DOI 10.2174/138161213804070311; Wu Z, 2013, CARBOHYD POLYM, V96, P466, DOI 10.1016/j.carbpol.2013.04.028; Yang ZY, 2012, METHOD ENZYMOL, V516, P153, DOI 10.1016/B978-0-12-394291-3.00031-9; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Young KD, 2010, ANNU REV MICROBIOL, V64, P223, DOI 10.1146/annurev.micro.112408.134102; Yount NY, 2013, ANN NY ACAD SCI, V1277, P127, DOI 10.1111/nyas.12005; Zegans ME, 2012, ANTIMICROB AGENTS CH, V56, P4112, DOI 10.1128/AAC.00373-12	71	22	22	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31090	31100		10.1074/jbc.M115.661660	http://dx.doi.org/10.1074/jbc.M115.661660			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26468288	Green Published, hybrid			2022-12-26	WOS:000367199000037
J	Yagishita, S; Murayama, M; Ebihara, T; Maruyama, K; Takashima, A				Yagishita, Sosuke; Murayama, Miyuki; Ebihara, Tomoe; Maruyama, Kei; Takashima, Akihiko			Glycogen Synthase Kinase 3 beta-mediated Phosphorylation in the Most C-terminal Region of Protein Interacting with C Kinase 1 (PICK1) Regulates the Binding of PICK1 to Glutamate Receptor Subunit GluA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC PLASTICITY; PDZ DOMAIN; TAU; KINASE-3-BETA; TRAFFICKING; DEPRESSION; GSK-3-BETA; SUBSTRATE; GLUR2/3; DISEASE	Protein interacting with C kinase 1 (PICK1) is a synaptic protein interacting with the AMPA receptor subunits GluA2/3. The interaction between GluA2 and PICK1 is required for the removal of GluA2 from the synaptic plasma membrane during long-term depression (LTD). It has been suggested that glycogen synthase kinase 3 beta (GSK-3 beta) is activated during LTD, but the relationships between GluA2, PICK1, and GSK-3 beta are not well understood. In particular, the substrate(s) of GSK-3 beta have not yet been determined. Here we showed that PICK1 is a substrate of GSK-3 beta. We found that Ser(339), Ser(342), Ser(412), and Ser(416) of PICK1 were putative GSK-3 beta-mediated phosphorylation sites. Among these sites, Ser(416) played a crucial role in regulating the interaction between GluA2 and PICK1. We showed that replacing Ser(416) with Ala disrupted the GluA2-PICK1 interaction, whereas substituting Ser(416) with Glu or Asp retained this interaction. However, deletion of Ser(416) did not affect the GluA2-PICK1 interaction, and substitution of Ser(416) with Ala did not alter the PICK1-PICK1 interaction. Using image analysis in COS-7 cells with AcGFP1-fused PICK1, we showed that substitution of Ser(416) with Ala increased the formation of AcGFP1-positive clusters, suggesting an increase in the association of PICK1 with the membrane. This may have resulted in the dissociation of the GluA2-PICK1 complexes. Our results indicated that GSK-3 beta-mediated phosphorylation of PICK1 at Ser(416) was required for its association with the AMPA receptor subunit. Therefore, the GSK-3 beta-mediated phosphorylation of PICK1 may be a regulating factor during LTD induction.	[Yagishita, Sosuke; Murayama, Miyuki; Takashima, Akihiko] RIKEN Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama 3510198, Japan; [Yagishita, Sosuke; Ebihara, Tomoe; Maruyama, Kei] Saitama Med Univ, Fac Med, Dept Pharmacol, Moroyama, Saitama 3500495, Japan; [Takashima, Akihiko] Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Aging Neurobiol, Obu, Aichi 4748522, Japan	RIKEN; Saitama Medical University; National Center for Geriatrics & Gerontology	Yagishita, S (corresponding author), Saitama Med Univ, Fac Med, Dept Pharmacol, 38 Moro Hongo, Moroyama, Saitama 3500495, Japan.	syagi@saitama-med.ac.jp; kenneth@ncgg.go.jp			Ochiai Memorial Award; Kurata Memorial Hitachi Science and Technology Foundation;  [23700429];  [25460341]	Ochiai Memorial Award; Kurata Memorial Hitachi Science and Technology Foundation; ; 	This study was supported by Grant-in-Aid for Young Scientists (B) 23700429 (to S. Y.), a grant from Ochiai Memorial Award 2013 (to S. Y.), a Kurata Grant awarded by the Kurata Memorial Hitachi Science and Technology Foundation (to S. Y.), and Grant-in-Aid for Scientific Research (C) 25460341 (to K. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ammendrup-Johnsen I, 2012, BIOCHEMISTRY-US, V51, P586, DOI 10.1021/bi2014689; Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kimura T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0144; Llorens-Martin M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00046; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Takashima A, 1996, NEUROSCI LETT, V203, P33, DOI 10.1016/0304-3940(95)12257-5; Takashima A, 1998, P NATL ACAD SCI USA, V95, P9637, DOI 10.1073/pnas.95.16.9637; Takashima A, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P309; Takashima A, 2009, J PHARMACOL SCI, V109, P174, DOI 10.1254/jphs.08R29FM; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Volk L, 2010, P NATL ACAD SCI USA, V107, P21784, DOI 10.1073/pnas.1016103107; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xu JY, 2006, NEUROSIGNALS, V15, P190, DOI 10.1159/000098482	29	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29438	29448		10.1074/jbc.M114.619668	http://dx.doi.org/10.1074/jbc.M114.619668			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26472923	Green Published, hybrid			2022-12-26	WOS:000366613400028
J	Bastianini, S; Silvani, A; Berteotti, C; Lo Martire, V; Cohen, G; Ohtsu, H; Lin, JS; Zoccoli, G				Bastianini, Stefano; Silvani, Alessandro; Berteotti, Chiara; Lo Martire, Viviana; Cohen, Gary; Ohtsu, Hiroshi; Lin, Jian-Sheng; Zoccoli, Giovanna			Histamine Transmission Modulates the Phenotype of Murine Narcolepsy Caused by Orexin Neuron Deficiency	PLOS ONE			English	Article							CEREBROSPINAL-FLUID HISTAMINE; BLOOD-PRESSURE; KNOCKOUT MICE; SLEEP-APNEA; HEART-RATE; HYPOCRETIN; CATAPLEXY; OREXIN/HYPOCRETIN; REM; WAKEFULNESS	Narcolepsy type 1 is associated with loss of orexin neurons, sleep-wake derangements, cataplexy, and a wide spectrum of alterations in other physiological functions, including energy balance, cardiovascular, and respiratory control. It is unclear which narcolepsy signs are directly related to the lack of orexin neurons or are instead modulated by dysfunction of other neurotransmitter systems physiologically controlled by orexin neurons, such as the histamine system. To address this question, we tested whether some of narcolepsy signs would be detected in mice lacking histamine signaling (HDC-KO). Moreover, we studied double-mutant mice lacking both histamine signaling and orexin neurons (DM) to evaluate whether the absence of histamine signaling would modulate narcolepsy symptoms produced by orexin deficiency. Mice were instrumented with electrodes for recording the electroencephalogram and electromyogram and a telemetric arterial pressure transducer. Sleep attacks fragmenting wakefulness, cataplexy, excess rapid-eye-movement sleep (R) during the activity period, and enhanced increase of arterial pressure during R, which are hallmarks of narcolepsy in mice, did not occur in HDC-KO, whereas they were observed in DM mice. Thus, these narcolepsy signs are neither caused nor abrogated by the absence of histamine. Conversely, the lack of histamine produced obesity in HDC-KO and to a greater extent also in DM. Moreover, the regularity of breath duration during R was significantly increased in either HDC-KO or DM relative to that in congenic wild-type mice. Defects of histamine transmission may thus modulate the metabolic and respiratory phenotype of murine narcolepsy.	[Bastianini, Stefano; Silvani, Alessandro; Berteotti, Chiara; Lo Martire, Viviana; Zoccoli, Giovanna] Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci, PRISM Lab, Bologna, Italy; [Cohen, Gary] Karolinska Inst, Dept Women & Child Hlth, Stockholm, Sweden; [Ohtsu, Hiroshi] Tohoku Univ, Grad Sch Engn, Appl Quantum Med Engn, Sendai, Miyagi 980, Japan; [Lin, Jian-Sheng] Univ Lyon 1, Physiol Integree Syst Eveil, Ctr Rech Neurosci Lyon, INSERM,CNRS,Fac Med,U1028,UMR 5292, F-69365 Lyon, France	University of Bologna; Karolinska Institutet; Tohoku University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet	Zoccoli, G (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci, PRISM Lab, Bologna, Italy.	giovanna.zoccoli@unibo.it	berteotti, chiara/AAK-9065-2020; Lin, Jian-Sheng/G-4395-2013; Zoccoli, Giovanna/CAH-3382-2022; Bastianini, Stefano/AAO-7982-2020; Silvani, Alessandro/A-1027-2015	Lin, Jian-Sheng/0000-0002-2004-6079; Bastianini, Stefano/0000-0003-2468-1704; Silvani, Alessandro/0000-0003-3992-3892; Cohen, Gary/0000-0001-9677-2870; Zoccoli, Giovanna/0000-0002-9670-9959; BERTEOTTI, CHIARA/0000-0002-4143-9445; Lo Martire, Viviana/0000-0001-8696-0835				Anaclet C, 2010, J SLEEP RES S2, V19, P154; Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; [Anonymous], 2014, INT CLASSIFICATION S; Bassetti CL, 2010, J SLEEP RES, V19, P620, DOI 10.1111/j.1365-2869.2010.00819.x; Bastianini S, 2011, SLEEP, V34, P213, DOI 10.1093/sleep/34.2.213; Bhuiyan ME, 2011, AM J PHYSIOL-HEART C, V301, pH523, DOI 10.1152/ajpheart.00263.2011; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Chabas D, 2007, SLEEP, V30, P1267, DOI 10.1093/sleep/30.10.1267; Chapuis C, 2014, J PHYSIOL-LONDON, V592, P2169, DOI 10.1113/jphysiol.2013.268730; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; CHOKROVERTY S, 1986, SLEEP, V9, P250, DOI 10.1093/sleep/9.1.250; Dahmen N, 2009, SLEEP, V32, P962; DANTZ B, 1994, ELECTROEN CLIN NEURO, V90, P24, DOI 10.1016/0013-4694(94)90110-4; Dauvilliers Y, 2013, LANCET NEUROL, V12, P1068, DOI 10.1016/S1474-4422(13)70225-4; Dauvilliers Y, 2012, SLEEP, V35, P1359, DOI 10.5665/sleep.2114; Dauvilliers Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038977; Donadio V, 2014, NEUROLOGY, V83, P1080, DOI 10.1212/WNL.0000000000000793; Donadio V, 2014, SLEEP MED, V15, P315, DOI 10.1016/j.sleep.2013.12.005; Dutschmann M, 2003, PFLUG ARCH EUR J PHY, V445, P570, DOI 10.1007/s00424-002-0904-z; Eriksson KS, 2004, EUR J NEUROSCI, V19, P1278, DOI 10.1111/j.1460-9568.2004.03243.x; Eriksson KS, 2001, J NEUROSCI, V21, P9273, DOI 10.1523/JNEUROSCI.21-23-09273.2001; Fujiki N, 2006, PEPTIDES, V27, P2326, DOI 10.1016/j.peptides.2006.03.011; Fujiki N, 2009, EXP NEUROL, V217, P46, DOI 10.1016/j.expneurol.2009.01.015; Grimaldi D, 2014, NEUROLOGY, V82, P271, DOI 10.1212/WNL.0000000000000045; Grimaldi D, 2012, SLEEP, V35, P519, DOI 10.5665/sleep.1738; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hara J, 2005, NEUROSCI LETT, V380, P239, DOI 10.1016/j.neulet.2005.01.046; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Hermida RC, 2013, CHRONOBIOL INT, V30, P87, DOI 10.3109/07420528.2012.701127; Huang ZL, 2006, P NATL ACAD SCI USA, V103, P4687, DOI 10.1073/pnas.0600451103; Inocente CO, 2013, CNS NEUROSCI THER, V19, P521, DOI 10.1111/cns.12105; John J, 2013, ANN NEUROL, V74, P786, DOI 10.1002/ana.23968; Kantor S, 2009, SLEEP, V32, P1127, DOI 10.1093/sleep/32.9.1127; Khatami R, 2008, SLEEP, V31, P859, DOI 10.1093/sleep/31.6.859; Kukkonen JP, 2013, AM J PHYSIOL-CELL PH, V304, pC2, DOI 10.1152/ajpcell.00227.2012; Lin JS, 2008, NEUROBIOL DIS, V30, P74, DOI 10.1016/j.nbd.2007.12.003; Lo Martire V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047032; Lubkin M, 1998, BIOCHEM BIOPH RES CO, V253, P241, DOI 10.1006/bbrc.1998.9750; Meister B, 2007, PHYSIOL BEHAV, V92, P263, DOI 10.1016/j.physbeh.2007.05.021; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Miyamoto K, 2004, RESP PHYSIOL NEUROBI, V144, P25, DOI 10.1016/j.resp.2004.07.016; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; Nakamura A, 2007, J APPL PHYSIOL, V102, P241, DOI 10.1152/japplphysiol.00679.2006; Nanduri J, 2012, P NATL ACAD SCI USA, V109, P2515, DOI 10.1073/pnas.1120600109; Nishino S, 2009, SLEEP, V32, P175, DOI 10.1093/sleep/32.2.175; Ohayon MM, 2014, SLEEP, V37, P439, DOI 10.5665/sleep.3470; Ohayon MM, 2013, SLEEP MED, V14, P488, DOI 10.1016/j.sleep.2013.03.002; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Parmentier R, 2002, J NEUROSCI, V22, P7695; Pataka AD, 2012, EUR J NEUROL, V19, P696, DOI 10.1111/j.1468-1331.2011.03610.x; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Pizza F, 2013, EUR NEUROL, V70, P22, DOI 10.1159/000348719; Poli F, 2009, SLEEP, V32, P1491, DOI 10.1093/sleep/32.11.1491; Raghuraman S, 2014, P NATL ACAD SCI USA, V111, P6449, DOI 10.1073/pnas.1404421111; Rocca FL, 2015, NEUROPEDIATRICS, V46, P181, DOI 10.1055/s-0035-1550152; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sansa G, 2010, SLEEP MED, V11, P93, DOI 10.1016/j.sleep.2009.02.009; Scammell TE, 2009, SLEEP, V32, P111; Schone C, 2012, J NEUROSCI, V32, P12437, DOI 10.1523/JNEUROSCI.0706-12.2012; Silvani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100536; Silvani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089432; Silvani A, 2014, J SLEEP RES, V23, P98, DOI 10.1111/jsr.12081; Silvani A, 2013, AM J PHYSIOL-HEART C, V305, pH1683, DOI 10.1152/ajpheart.00554.2013; Silvani A, 2009, HYPERTENSION, V53, P251, DOI 10.1161/HYPERTENSIONAHA.108.125542; Takahashi K, 2006, J NEUROSCI, V26, P10292, DOI 10.1523/JNEUROSCI.2341-06.2006; Terada J, 2008, J APPL PHYSIOL, V104, P499, DOI 10.1152/japplphysiol.00919.2007; Valko PO, 2013, ANN NEUROL, V74, P794, DOI 10.1002/ana.24019; Vu MH, 2011, J SLEEP RES, V20, P50, DOI 10.1111/j.1365-2869.2010.00851.x; Young JK, 2005, J APPL PHYSIOL, V98, P1387, DOI 10.1152/japplphysiol.00914.2004; Zhang SW, 2007, J PHYSIOL-LONDON, V581, P649, DOI 10.1113/jphysiol.2007.129510	70	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140520	10.1371/journal.pone.0140520	http://dx.doi.org/10.1371/journal.pone.0140520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474479	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500063
J	Slagter, SN; van Vliet-Ostaptchouk, JV; van Beek, AP; Keers, JC; Lutgers, HL; van der Klauw, MM; Wolffenbuttel, BHR				Slagter, Sandra N.; van Vliet-Ostaptchouk, Jana V.; van Beek, Andre P.; Keers, Joost C.; Lutgers, Helen L.; van der Klauw, Melanie M.; Wolffenbuttel, Bruce H. R.			Health-Related Quality of Life in Relation to Obesity Grade, Type 2 Diabetes, Metabolic Syndrome and Inflammation	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BODY-MASS INDEX; CHRONIC KIDNEY-DISEASE; FUNCTIONAL-CAPACITY; INDIVIDUALS; SF-36; MEN; ASSOCIATION; OVERWEIGHT; WEIGHT	Background Health-related quality of life (HR-QoL) may be compromised in obese individuals, depending on the presence of other complications. The aim of this study is to assess the effect of obesity-related conditions on HR-QoL. These conditions are i) grade of obesity with and without type 2 diabetes (T2D), ii) metabolic syndrome (MetS), and iii) level of inflammation. Methods From the Dutch LifeLines Cohort Study we included 13,686 obese individuals, aged 18-80 years. HR-QoL was measured with the RAND 36-Item Health Survey which encompasses eight health domains. We calculated the percentage of obese individuals with poor HR-QoL, i.e. those scoring below the domain and sex specific cut-off value derived from the normal weight population. Logistic regression analysis was used to calculate the probability of having poor domain scores according to the conditions under study. Results Higher grades of obesity and the additional presence of T2D were associated with lower HR-QoL, particularly in the domains physical functioning (men: odds ratios (ORs) 1.48-11.34, P<0.005, and women: ORs 1.66-5.05, P<0.001) and general health (men: ORs 1.44-3.07, P<0.005, and women: ORs 1.36-3.73, P<0.001). A higher percentage of obese individuals with MetS had a poor HR-QoL than those without MetS. Furthermore, we observed a linear trend between inflammation and the percentage of obese individuals with poor scores on the HR-QoL domains. Individuals with MetS were more likely to have poor scores in the domains general health, vitality, social functioning and role limitations due to emotional problems. Obese women with increased inflammation levels were more likely to have poor scores on all domains except role limitations due to emotional problems and mental health. Conclusions The impact of obesity on an individual's quality of life is enhanced by grade of obesity, T2D, MetS and inflammation and are mainly related to reduced physical health. The mental wellbeing is less often impaired.	[Slagter, Sandra N.; van Vliet-Ostaptchouk, Jana V.; van Beek, Andre P.; Keers, Joost C.; Lutgers, Helen L.; van der Klauw, Melanie M.; Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Keers, Joost C.] Martini Hosp, Van Swieten Res Inst, Groningen, Netherlands	University of Groningen; Martini Hospital	Wolffenbuttel, BHR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands.	bwo@umcg.nl	van Beek, Andre/O-3753-2014; van der Klauw, Melanie/A-2138-2014	van Beek, Andre/0000-0002-0335-8177; van der Klauw, Melanie/0000-0001-7178-009X; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153	Netherlands Organization of Scientific Research (NWO) [175.010.2007.006]; Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces (SNN); Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; National Consortium for Healthy Ageing; European Union's Seventh Framework programme (FP7) through the BioSHaRE-EU (Biobank Standardisation and Harmonisation for Research Excellence in the European Union) [261433]	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces (SNN); Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; National Consortium for Healthy Ageing; European Union's Seventh Framework programme (FP7) through the BioSHaRE-EU (Biobank Standardisation and Harmonisation for Research Excellence in the European Union)	The LifeLines Cohort Study was supported by the Netherlands Organization of Scientific Research (NWO) [grant 175.010.2007.006]; the Economic Structure Enhancing Fund (FES) of the Dutch government; the Ministry of Economic Affairs; the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the Northern Netherlands Collaboration of Provinces (SNN); the Province of Groningen; University Medical Center Groningen; the University of Groningen; the Dutch Kidney Foundation; and the Dutch Diabetes Research Foundation. This work was supported by the National Consortium for Healthy Ageing, and the European Union's Seventh Framework programme (FP7/2007-2013) through the BioSHaRE-EU (Biobank Standardisation and Harmonisation for Research Excellence in the European Union) project, grant agreement 261433.	Amiri P, 2010, J WOMENS HEALTH, V19, P1201, DOI 10.1089/jwh.2009.1710; Baiano M, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-165; Bentley TGK, 2011, QUAL LIFE RES, V20, P665, DOI 10.1007/s11136-011-9878-7; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cameron AJ, 2012, INT J OBESITY, V36, P295, DOI 10.1038/ijo.2011.103; Choo J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003954; Cummings DM, 2003, ANN PHARMACOTHER, V37, P1593, DOI 10.1345/aph.1D029; de Zwaan M, 2009, PSYCHOSOMATICS, V50, P474, DOI 10.1176/appi.psy.50.5.474; Doll HA, 2000, OBES RES, V8, P160, DOI 10.1038/oby.2000.17; Farag YMK, 2011, CLIN NEPHROL, V75, P524, DOI 10.5414/CNP75524; Farivar SS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-54; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Ford ES, 1999, DIABETES CARE, V22, P1971, DOI 10.2337/diacare.22.12.1971; Formiguera X, 2004, BEST PRACT RES CL GA, V18, P1125, DOI [10.1016/S1521-6918(04)00091-5, 10.1016/j.bpg.2004.06.030]; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Jagielski AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092859; Jia HM, 2005, J PUBLIC HEALTH-UK, V27, P156, DOI 10.1093/pubmed/fdi025; Kalender B, 2007, INT J CLIN PRACT, V61, P569, DOI 10.1111/j.1742-1241.2006.01251.x; Kolotkin RL, 2002, OBES RES, V10, P748, DOI 10.1038/oby.2002.102; Korhonen PE, 2014, QUAL LIFE RES, V23, P67, DOI 10.1007/s11136-013-0433-6; Lakoski SG, 2006, AM HEART J, V152, P593, DOI 10.1016/j.ahj.2006.02.015; Levinger I, 2007, DIABETES CARE, V30, P2205, DOI 10.2337/dc07-0841; Levinger I, 2009, INT J CARDIOL, V133, P281, DOI 10.1016/j.ijcard.2007.11.046; Mommersteeg PMC, 2012, BRAIN BEHAV IMMUN, V26, P301, DOI 10.1016/j.bbi.2011.09.010; Motie M, 2014, EXP THER MED, V8, P181, DOI 10.3892/etm.2014.1673; Renzaho A, 2010, QUAL LIFE RES, V19, P515, DOI 10.1007/s11136-010-9610-z; Ridker PM, 2003, CIRCULATION, V108, pE81, DOI 10.1161/01.CIR.0000093381.57779.67; Rieger E, 2005, INT J EAT DISORDER, V37, P234, DOI 10.1002/eat.20101; Serrano-Aguilar P, 2009, QUAL LIFE RES, V18, P171, DOI 10.1007/s11136-008-9427-1; Soltoft F, 2009, QUAL LIFE RES, V18, P1293, DOI 10.1007/s11136-009-9541-8; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; Taft C, 2001, QUAL LIFE RES, V10, P395, DOI 10.1023/A:1012552211996; Tapp RJ, 2006, DIABETES RES CLIN PR, V74, P154, DOI 10.1016/j.diabres.2006.03.012; Tsai AG, 2008, OBESITY, V16, P59, DOI 10.1038/oby.2007.8; van der Zee KI, 1996, INT J BEHAV MED, V3, P104, DOI 10.1207/s15327558ijbm0302_2; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Vetter ML, 2011, INT J OBESITY, V35, P1087, DOI 10.1038/ijo.2010.230; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wong YYE, 2012, MATURITAS, V73, P158, DOI 10.1016/j.maturitas.2012.06.007	40	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140599	10.1371/journal.pone.0140599	http://dx.doi.org/10.1371/journal.pone.0140599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0DF	26474291	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500071
J	Wang, LN; Nissi, MJ; Toth, F; Shaver, J; Johnson, CP; Zhang, JJ; Garwood, M; Carlson, CS; Ellermann, JM				Wang, Luning; Nissi, Mikko J.; Toth, Ferenc; Shaver, Jonah; Johnson, Casey P.; Zhang, Jinjin; Garwood, Michael; Carlson, Cathy S.; Ellermann, Jutta M.			Multiparametric MRI of Epiphyseal Cartilage Necrosis (Osteochondrosis) with Histological Validation in a Goat Model	PLOS ONE			English	Article							ROTATING-FRAME RELAXATION; ARTICULAR-CARTILAGE; T-2 RELAXATION; QUANTITATIVE MRI; II COLLAGEN; SAFRANIN-O; DISSECANS; GLYCOSAMINOGLYCANS; PROTEOGLYCAN; DEGRADATION	Purpose To evaluate multiple MRI parameters in a surgical model of osteochondrosis (OC) in goats. Methods Focal ischemic lesions of two different sizes were induced in the epiphyseal cartilage of the medial femoral condyles of goats at 4 days of age by surgical transection of cartilage canal blood vessels. Goats were euthanized and specimens harvested 3, 4, 5, 6, 9 and 10 weeks post-op. Ex vivo MRI scans were conducted at 9.4 Tesla for mapping the T-1, T-2, T-1 rho, adiabatic T-1 rho and T-RAFF relaxation times of articular cartilage, unaffected epiphyseal cartilage, and epiphyseal cartilage within the area of the induced lesion. After MRI scans, safranin O staining was conducted to validate areas of ischemic necrosis induced in the medial femoral condyles of six goats, and to allow comparison of MRI findings with the semi-quantitative proteoglycan assessment in corresponding safranin O-stained histological sections. Results All relaxation time constants differentiated normal epiphyseal cartilage from lesions of ischemic cartilage necrosis, and the histological staining results confirmed the proteoglycan (PG) loss in the areas of ischemia. In the scanned specimens, all of the measured relaxation time constants were higher in the articular than in the normal epiphyseal cartilage, consistently allowing differentiation between these two tissues. Conclusions Multiparametric MRI provided a sensitive approach to discriminate between necrotic and viable epiphyseal cartilage and between articular and epiphyseal cartilage, which may be useful for diagnosing and monitoring OC lesions and, potentially, for assessing effectiveness of treatment interventions.	[Wang, Luning; Nissi, Mikko J.; Johnson, Casey P.; Zhang, Jinjin; Garwood, Michael; Ellermann, Jutta M.] Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Wang, Luning; Nissi, Mikko J.] Univ Minnesota, Dept Orthopaed Surg, Minneapolis, MN 55455 USA; [Nissi, Mikko J.] Univ Oulu, Fac Med, Res Grp Med Imaging Phys & Technol, Oulu, Finland; [Nissi, Mikko J.] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Nissi, Mikko J.] Univ Oulu, Oulu, Finland; [Nissi, Mikko J.] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Toth, Ferenc; Carlson, Cathy S.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Shaver, Jonah] Univ Minnesota, Dept Elect & Comp Engn, Lab Nanostruct & Biosensing, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Oulu; University of Oulu; University of Oulu; University of Eastern Finland; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wang, LN (corresponding author), Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.	wang5517@umn.edu	Johnson, Casey P./AAG-1005-2021; zhang, jin/GXV-9154-2022; Wang, Luning/B-2780-2016	Nissi, Mikko/0000-0002-5678-0689; Toth, Ferenc/0000-0002-6615-389X; Garwood, Michael/0000-0003-1578-9166; Johnson, Casey/0000-0001-9826-7296; Ellermann, Jutta/0000-0002-7109-9656	National Institutes of Health (NIH) [NIH/NIAMS R21AR065385, NIH T32OD10993, NIH/NCRR K18RR033297]; academy of Finland [260321, 285909]; University of Minnesota; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR065385] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD021293, T32OD010993] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); academy of Finland(Academy of Finland); University of Minnesota(University of Minnesota System); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by National Institutes of Health (NIH) (http://www.nih.gov/) NIH/NIAMS R21AR065385, NIH T32OD10993, and NIH/NCRR K18RR033297 to CSC, the academy of Finland (http://www.aka.fi/en) Grant #260321, Grant #285909 to MJN, and the University of Minnesota (http://www.umn.edu) comparative medicine signature program.	Akella SVS, 2001, MAGNET RESON MED, V46, P419, DOI 10.1002/mrm.1208; Bates JT, 2014, CLIN SPORT MED, V33, P199, DOI 10.1016/j.csm.2013.11.004; Bolbos RI, 2009, OSTEOARTHR CARTILAGE, V17, P12, DOI 10.1016/j.joca.2008.05.016; Borthakur A, 2006, NMR BIOMED, V19, P781, DOI 10.1002/nbm.1102; Breuer FA, 2006, MAGN RESON MED, V55, P549, DOI 10.1002/mrm.20787; Breuer FA, 2005, MAGNET RESON MED, V53, P684, DOI 10.1002/mrm.20401; CARLSON CS, 1989, VET PATHOL, V26, P47, DOI 10.1177/030098588902600108; CARLSON CS, 1986, CALCIFIED TISSUE INT, V38, P44, DOI 10.1007/BF02556594; Duvvuri U, 1997, MAGN RESON MED, V38, P863, DOI 10.1002/mrm.1910380602; Edmonds EW, 2013, CLIN ORTHOP RELAT R, V471, P1118, DOI 10.1007/s11999-012-2290-y; EKMAN S, 1992, VET PATHOL, V29, P514, DOI 10.1177/030098589202900605; Ellermann J, 2013, MAGN RESON IMAGING, V31, P1537, DOI 10.1016/j.mri.2013.06.004; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Gold GE, 2009, AM J ROENTGENOL, V193, P628, DOI 10.2214/AJR.09.3042; Goodwin DW, 1998, ACAD RADIOL, V5, P790, DOI 10.1016/S1076-6332(98)80264-X; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Grunder W, 1998, MAGN RESON MED, V39, P376, DOI 10.1002/mrm.1910390307; Kiraly K, 1996, HISTOCHEM J, V28, P577, DOI 10.1007/BF02331378; Kiraly K, 1996, HISTOCHEM J, V28, P99, DOI 10.1007/BF02331414; KIVIRANTA I, 1985, HISTOCHEMISTRY, V82, P249, DOI 10.1007/BF00501401; Laverty S, 2002, J ORTHOP RES, V20, P1282, DOI 10.1016/S0736-0266(02)00053-0; Li XJ, 2013, J MAGN RESON IMAGING, V38, P991, DOI 10.1002/jmri.24313; Liimatainen T, 2014, MAGN RESON MED; Liimatainen T, 2010, MAGN RESON MED, V64, P983, DOI 10.1002/mrm.22372; Mccoy AM, 2013, OSTEOARTHR CARTILAGE, V21, P1638, DOI 10.1016/j.joca.2013.08.011; Menezes NM, 2004, MAGN RESON MED, V51, P503, DOI 10.1002/mrm.10710; Michaeli S, 2006, J MAGN RESON, V181, P135, DOI 10.1016/j.jmr.2006.04.002; Mosher TJ, 2004, SEMIN MUSCULOSKEL R, V8, P355, DOI 10.1055/s-2004-861764; Mwale F, 2002, J BONE MINER RES, V17, P275, DOI 10.1359/jbmr.2002.17.2.275; NAKANO T, 1985, CAN J COMP MED, V49, P219; Nieminen MT, 2001, MAGN RESON MED, V46, P487, DOI 10.1002/mrm.1218; Nissi MJ, 2006, OSTEOARTHR CARTILAGE, V14, P1265, DOI 10.1016/j.joca.2006.06.002; Pascual-Garrido C, 2013, CURR OPIN PEDIATR, V25, P46, DOI 10.1097/MOP.0b013e32835adbf5; Poole AR, 2002, ANN RHEUM DIS, V61, P78, DOI 10.1136/ard.61.suppl_2.ii78; Rautiainen J, 2014, OSTEOARTHR CARTILAGE, V22, P1444, DOI 10.1016/j.joca.2014.04.023; Rautiainen J, 2014, MAGN RESON MED; Regatte RR, 2002, ACAD RADIOL, V9, P1388, DOI 10.1016/S1076-6332(03)80666-9; Shea KG, 2013, KNEE SURG SPORT TR A, V21, P403, DOI 10.1007/s00167-012-1983-9; Toth F, 2015, OSTEOARTHR CARTILAGE, V23, P300, DOI 10.1016/j.joca.2014.11.009; Weiger M, 2002, MAGN RESON MATER PHY, V14, P10, DOI 10.1016/S1352-8661(01)00152-1; Wheaton AJ, 2004, J MAGN RESON IMAGING, V20, P519, DOI 10.1002/jmri.20148; Xia Y, 2002, MAGNET RESON MED, V48, P460, DOI 10.1002/mrm.10216	42	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140400	10.1371/journal.pone.0140400	http://dx.doi.org/10.1371/journal.pone.0140400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473611	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500046
J	Ferreira, LD; Pereira, MH; Guarneri, AA				Ferreira, Luciana de Lima; Pereira, Marcos Horacio; Guarneri, Alessandra Aparecida			Revisiting Trypanosoma rangeli Transmission Involving Susceptible and Non-Susceptible Hosts	PLOS ONE			English	Article							RHODNIUS-PROLIXUS; HEMIPTERA REDUVIIDAE; IN-VITRO; TEJERA; CRUZI; COMPLEMENT; INFECTION; SALIVARY; VIRUS; MICE	Trypanosoma rangeli infects several triatomine and mammal species in South America. Its transmission is known to occur when a healthy insect feeds on an infected mammal or when an infected insect bites a healthy mammal. In the present study we evaluated the classic way of T. rangeli transmission started by the bite of a single infected triatomine, as well as alternative ways of circulation of this parasite among invertebrate hosts. The number of metacyclic trypomastigotes eliminated from salivary glands during a blood meal was quantified for unfed and recently fed nymphs. The quantification showed that similar to 50,000 parasites can be liberated during a single blood meal. The transmission of T. rangeli from mice to R. prolixus was evaluated using infections started through the bite of a single infected nymph. The mice that served as the blood source for single infected nymphs showed a high percentage of infection and efficiently transmitted the infection to new insects. Parasites were recovered by xenodiagnosis in insects fed on mice with infections that lasted approximately four months. Hemolymphagy and co-feeding were tested to evaluate insect-insect T. rangeli transmission. T. rangeli was not transmitted during hemolymphagy. However, insects that had co-fed on mice with infected conspecifics exhibited infection rates of approximately 80%. Surprisingly, 16% of the recipient nymphs became infected when pigeons were used as hosts. Our results show that T. rangeli is efficiently transmitted between the evaluated hosts. Not only are the insect-mouse-insect transmission rates high, but parasites can also be transmitted between insects while co-feeding on a living host. We show for the first time that birds can be part of the T. rangeli transmission cycle as we proved that insect-insect transmission is feasible during a co-feeding on these hosts.	[Ferreira, Luciana de Lima; Guarneri, Alessandra Aparecida] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Vector Behav & Pathogen Interact Grp, Belo Horizonte, MG, Brazil; [Pereira, Marcos Horacio] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Guarneri, AA (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Vector Behav & Pathogen Interact Grp, Belo Horizonte, MG, Brazil.	guarneri@cpqrr.fiocruz.br	Pereira, Marcos Horácio/AAE-7076-2021; Pereira, Marcos H/A-3774-2012; guarneri, Alessandra A/I-4124-2012	Pereira, Marcos Horácio/0000-0003-4843-0088; Pereira, Marcos H/0000-0003-4843-0088; Guarneri, Alessandra Aparecida/0000-0002-9162-2731	INCT-EM/CNPq (Institutos Nacionais de Ciencia e Tecnologia-Entomologia Molecular/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [573959/2008-0]; PAPES VI/FIOCRUZ (Programa Institucional de Inducao a Ciencia, Tecnologia e Inovacao em Saude/Fundacao Oswaldo Cruz) [407614/2012-5]; PROEP/FIOCRUZ (Programa de Excelencia em Pesquisa/Fundacao Oswaldo Cruz) [401973/20123]; FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)	INCT-EM/CNPq (Institutos Nacionais de Ciencia e Tecnologia-Entomologia Molecular/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); PAPES VI/FIOCRUZ (Programa Institucional de Inducao a Ciencia, Tecnologia e Inovacao em Saude/Fundacao Oswaldo Cruz)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROEP/FIOCRUZ (Programa de Excelencia em Pesquisa/Fundacao Oswaldo Cruz); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by INCT-EM/CNPq (Institutos Nacionais de Ciencia e Tecnologia-Entomologia Molecular/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)-(573959/2008-0), PAPES VI/FIOCRUZ (Programa Institucional de Inducao a Ciencia, Tecnologia e Inovacao em Saude/Fundacao Oswaldo Cruz)-(407614/2012-5), PROEP/FIOCRUZ (Programa de Excelencia em Pesquisa/Fundacao Oswaldo Cruz)-(401973/20123) and FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais).	ACOSTA L, 1991, AM J TROP MED HYG, V44, P676, DOI 10.4269/ajtmh.1991.44.676; Vallejo GA, 2003, INFECT GENET EVOL, V3, P39, DOI 10.1016/S1567-1348(02)00150-8; Alves CL, 2011, J MED ENTOMOL, V48, P372, DOI 10.1603/ME10151; ANEZ N, 1982, ANN TROP MED PARASIT, V76, P641, DOI 10.1080/00034983.1982.11687595; Barreto-Santana D, 2014, BIOMEDICA, V35, P1; Barros VC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006047; Barrozo RB, 2004, BIOL RHYTHM RES, V35, P79, DOI 10.1080/09291010412331313250; Brecher G., 1944, PARASITOLOGY, V35, P220, DOI 10.1017/S0031182000021648; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; Brumpt E., 1914, Bulletin de la Societe de Pathologie Exotique Paris, V7; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; D'Alessandro-Bacigalupo Antonio, 1992, P1; Da Silva FM, 2007, MOL ECOL, V16, P3361, DOI 10.1111/j.1365-294X.2007.03371.x; Da Silva FM, 2004, PARASITOLOGY, V128, P283, DOI 10.1017/S0031182003004554; DESCORZA C, 1986, REV I MED TROP, V28, P371, DOI 10.1590/S0036-46651986000500014; Eger-Mangrich I, 2001, PARASITOL RES, V87, P505, DOI 10.1007/s004360000356; Fellet MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105255; Ferreira LL, 2010, J INVERTEBR PATHOL, V105, P91, DOI 10.1016/j.jip.2010.05.013; Friend WG, 1985, FACTORES BIOL ECOLOG, P55; Gomes SAO, 2002, J INVERTEBR PATHOL, V79, P86, DOI 10.1016/S0022-2011(02)00011-3; Grewal MS, 1957, EXP PARASITOL; KIERSZENBAUM F, 1976, IMMUNOLOGY, V30, P1; Labuda M, 1997, VIROLOGY, V235, P138, DOI 10.1006/viro.1997.8622; LAKE P, 1967, P ENTOMOL SOC ONT, V98, P53; Lawrie CH, 2004, EMERG INFECT DIS, V10, P653, DOI 10.3201/eid1004.030517; Mansfield J.M., 1977, P297; MARINKEL.CJ, 1968, J MED ENTOMOL, V5, P497, DOI 10.1093/jmedent/5.4.497; MARINKELLE C. J., 1965, REV BIOL TROP, V13, P55; Mead DG, 2000, SCIENCE, V287, P485, DOI 10.1126/science.287.5452.485; Mendes-Sousa AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079787; MILES MA, 1983, AM J TROP MED HYG, V32, P1251, DOI 10.4269/ajtmh.1983.32.1251; MINTERGOEDBLOED E, 1981, T ROY SOC TROP MED H, V75, P350, DOI 10.1016/0035-9203(81)90090-0; Molyneux D. H., 1987, MORPHOLOGY ULTRASTRU, P121; Morales L, 2002, EXP PARASITOL, V102, P72, DOI 10.1016/S0014-4894(03)00027-4; NUSSENZVEIG RH, 1995, J EXP BIOL, V198, P1093; Ormerod W.E., 1979, P339; OSORIO Y, 1995, J PARASITOL, V81, P687, DOI 10.2307/3283955; Paim RMM, 2013, INSECT BIOCHEM MOLEC, V43, P229, DOI 10.1016/j.ibmb.2012.12.011; Ramirez LE, 2002, ACTA TROP, V84, P189, DOI 10.1016/S0001-706X(02)00185-7; Randolph SE, 1996, PARASITOL TODAY, V12, P472, DOI 10.1016/S0169-4758(96)10072-7; RYCKMAN RE, 1951, J PARASITOL, V37, P433, DOI 10.2307/3273249; SCHOTTELIUS J, 1987, TROP MED PARASITOL, V38, P323; SCHOTTELIUS J, 1986, TROP MED PARASITOL, V37, P54; Soares AC, 2006, J INSECT PHYSIOL, V52, P468, DOI 10.1016/j.jinsphys.2006.01.003; Dias FBS, 2008, MEM I OSWALDO CRUZ, V103, P824, DOI 10.1590/S0074-02762008000800014; STEINDEL M, 1991, MEM I OSWALDO CRUZ, V86, P73, DOI 10.1590/S0074-02761991000100012; Tanoura K, 1999, J EUKARYOT MICROBIOL, V46, P43, DOI 10.1111/j.1550-7408.1999.tb04582.x; Teixeira ARL, 2001, EMERG INFECT DIS, V7, P100, DOI 10.3201/eid0701.010115; Tejera E., 1920, Bulletin de la Societe de Pathologie Exotique Paris, V13; TOBIE EJ, 1965, J PARASITOL, V51, P837, DOI 10.2307/3276172; TOBIE EJ, 1970, J INVERTEBR PATHOL, V15, P118, DOI 10.1016/0022-2011(70)90106-0; TOBIE EJ, 1961, EXP PARASITOL, V11, P1, DOI 10.1016/0014-4894(61)90002-9; URDANETAMORALES S, 1986, REV I MED TROP, V28, P166, DOI 10.1590/S0036-46651986000300005; VALLEJO GA, 1986, REV BIOL TROP, V34, P75; Zar JH, 1999, BIOSTAT ANAL, P209	55	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140575	10.1371/journal.pone.0140575	http://dx.doi.org/10.1371/journal.pone.0140575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469403	gold, Green Published, Green Submitted			2022-12-26	WOS:000363184600079
J	Liu, Y; Pan, XZ; Wang, CK; Li, YL; Shi, RJ				Liu, Ya; Pan, Xianzhang; Wang, Changkun; Li, Yanli; Shi, Rongjie			Predicting Soil Salinity with Vis-NIR Spectra after Removing the Effects of Soil Moisture Using External Parameter Orthogonalization	PLOS ONE			English	Article							NEAR-INFRARED-SPECTROSCOPY; REFLECTANCE; VEGETATION; SALT	Robust models for predicting soil salinity that use visible and near-infrared (vis-NIR) reflectance spectroscopy are needed to better quantify soil salinity in agricultural fields. Currently available models are not sufficiently robust for variable soil moisture contents. Thus, we used external parameter orthogonalization (EPO), which effectively projects spectra onto the subspace orthogonal to unwanted variation, to remove the variations caused by an external factor, e.g., the influences of soil moisture on spectral reflectance. In this study, 570 spectra between 380 and 2400 nm were obtained from soils with various soil moisture contents and salt concentrations in the laboratory; 3 soil types x 10 salt concentrations x 19 soil moisture levels were used. To examine the effectiveness of EPO, we compared the partial least squares regression (PLSR) results established from spectra with and without EPO correction. The EPO method effectively removed the effects of moisture, and the accuracy and robustness of the soil salt contents (SSCs) prediction model, which was built using the EPO-corrected spectra under various soil moisture conditions, were significantly improved relative to the spectra without EPO correction. This study contributes to the removal of soil moisture effects from soil salinity estimations when using vis-NIR reflectance spectroscopy and can assist others in quantifying soil salinity in the future.	[Liu, Ya; Pan, Xianzhang; Wang, Changkun; Li, Yanli; Shi, Rongjie] Chinese Acad Sci, Key Lab Soil Environm & Pollut Remediat, Inst Soil Sci, Nanjing 210008, Peoples R China; [Liu, Ya; Li, Yanli; Shi, Rongjie] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Pan, XZ (corresponding author), Chinese Acad Sci, Key Lab Soil Environm & Pollut Remediat, Inst Soil Sci, Nanjing 210008, Peoples R China.	panxz@issas.ac.cn	Pan, Xianzhang/F-1623-2016	Pan, Xianzhang/0000-0001-5713-9132	National Natural Science Foundation of China [41071140]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA05050509]; Institute of Soil Science [Y112000016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Institute of Soil Science(Chinese Academy of Sciences)	This study was financially supported by the National Natural Science Foundation of China (No. 41071140), the Strategic Priority Research Program of the Chinese Academy of Sciences (No. XDA05050509), and the fund from the Institute of Soil Science (No. Y112000016).	Amat-Tosello S, 2009, ANAL CHIM ACTA, V642, P6, DOI 10.1016/j.aca.2009.01.003; [Anonymous], 2014, 106 FAO; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; Ben-Dor E, 2002, ADV AGRON, V75, P173, DOI 10.1016/S0065-2113(02)75005-0; Boulet JC, 2007, CHEMOMETR INTELL LAB, V87, P295, DOI 10.1016/j.chemolab.2007.03.008; Bricklemyer RS, 2010, COMPUT ELECTRON AGR, V70, P209, DOI 10.1016/j.compag.2009.10.006; Corwin DL, 2003, AGRON J, V95, P352, DOI 10.2134/agronj2003.0455; CSILLAG F, 1993, REMOTE SENS ENVIRON, V43, P231, DOI 10.1016/0034-4257(93)90068-9; Dehaan RL, 2002, REMOTE SENS ENVIRON, V80, P406, DOI 10.1016/S0034-4257(01)00321-2; FAO, 1988, SOILS B, V39; Hansen CL, 2010, CHEMOMETR INTELL LAB, V104, P243, DOI 10.1016/j.chemolab.2010.08.014; HICK PT, 1990, AUST J SOIL RES, V28, P417, DOI 10.1071/SR9900417; Hunt G. R., 1972, Modern Geology, V3, P121; Hunt G. R., 1982, HDB PHYS PROPERTIES, P295; Igne B, 2009, CHEMOMETR INTELL LAB, V99, P57, DOI 10.1016/j.chemolab.2009.07.007; Jin PB, 2015, ECOL INDIC, V54, P116, DOI 10.1016/j.ecolind.2015.02.028; Li D, 2012, SOIL TILL RES, V123, P78, DOI 10.1016/j.still.2012.03.013; Liu HJ, 2009, PEDOSPHERE, V19, P532, DOI 10.1016/S1002-0160(09)60146-6; Liu Ya, 2012, Acta Pedologica Sinica, V49, P824; Lobell DB, 2002, SOIL SCI SOC AM J, V66, P722, DOI 10.2136/sssaj2002.0722; Metternicht G, 1997, INT J REMOTE SENS, V18, P2571, DOI 10.1080/014311697217486; Metternicht GI, 2003, REMOTE SENS ENVIRON, V85, P1, DOI 10.1016/S0034-4257(02)00188-8; Minasny B, 2011, GEODERMA, V167-68, P118, DOI 10.1016/j.geoderma.2011.09.008; Minasny B, 2009, AUST J SOIL RES, V47, P664, DOI 10.1071/SR09005; Nanni MR, 2006, SOIL SCI SOC AM J, V70, P393, DOI 10.2136/sssaj2003.0285; Nocita M, 2015, GLOBAL CHANGE BIOL, V21, P10, DOI 10.1111/gcb.12632; Nocita M, 2013, GEODERMA, V199, P37, DOI 10.1016/j.geoderma.2012.07.020; Rienzi EA, 2014, SOIL SCI SOC AM J, V78, P958, DOI 10.2136/sssaj2013.09.0408; Roger JM, 2003, CHEMOMETR INTELL LAB, V66, P191, DOI 10.1016/S0169-7439(03)00051-0; Shepherd KD, 2002, SOIL SCI SOC AM J, V66, P988, DOI 10.2136/sssaj2002.0988; Summers D, 2011, ECOL INDIC, V11, P123, DOI 10.1016/j.ecolind.2009.05.001; Szilagyi A., 1991, Technical papers 1991, ACSM-ASPRS Annual Convention, Baltimore, Maryland, USA, March 25-28 1991, Volume 3: remote sensing., P430; Wang CK, 2013, AGRON J, V105, P967, DOI 10.2134/agronj2012.0460; Wang Q, 2012, GEODERMA, V170, P103, DOI 10.1016/j.geoderma.2011.10.015; Weng YL, 2010, PEDOSPHERE, V20, P378, DOI 10.1016/S1002-0160(10)60027-6; Zhang TT, 2011, ECOL INDIC, V11, P1552, DOI 10.1016/j.ecolind.2011.03.025	36	12	16	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140688	10.1371/journal.pone.0140688	http://dx.doi.org/10.1371/journal.pone.0140688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468645	gold, Green Published, Green Submitted			2022-12-26	WOS:000363184600098
J	Piccini, LE; Castilla, V; Damonte, EB				Piccini, Luana E.; Castilla, Viviana; Damonte, Elsa B.			Dengue-3 Virus Entry into Vero Cells: Role of Clathrin-Mediated Endocytosis in the Outcome of Infection	PLOS ONE			English	Article							DEPENDENT ENDOCYTOSIS; PLASMA-MEMBRANE; CHOLESTEROL; REVEALS; DYNAMIN; INTERFERENCE; MICRODOMAINS; INHIBITION; MECHANISMS; PATHWAYS	The endocytic uptake and intracellular trafficking for penetration of DENV-3 strain H-87 into Vero cells was analyzed by using several biochemical inhibitors and dominant negative mutants of cellular proteins. The results presented show that the infective entry of DENV-3 into Vero cells occurs through a non-classical endocytosis pathway dependent on low pH and dynamin, but non-mediated by clathrin. After uptake, DENV-3 transits through early endosomes to reach Rab 7-regulated late endosomes, and according with the half-time for ammonium chloride resistance viral nucleocapsid is released into the cytosol approximately at 12 min post-infection. Furthermore, the influence of the clathrin pathway in DENV-3 infective entry in other mammalian cell lines of human origin, such as A549, HepG2 and U937 cells, was evaluated demonstrating that variable entry pathways are employed depending on the host cell. Results show for the first time the simultaneous coexistence of infective and non-infective routes for DENV entry into the host cell, depending on the usage of clathrin-mediated endocytosis.	[Piccini, Luana E.; Castilla, Viviana; Damonte, Elsa B.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Virol, Buenos Aires, DF, Argentina; [Piccini, Luana E.; Damonte, Elsa B.] Consejo Nacl Invest Cient & Tecn CONICET, IQUIBICEN, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Damonte, EB (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Virol, Buenos Aires, DF, Argentina.	edamonte@qb.fcen.uba.ar		Piccini, Luana/0000-0002-8239-9419	Universidad de Buenos Aires (Argentina) [UBACyT 00404]; Agencia Nacional para la Promocion Cientifica y Tecnologica (Argentina) [PICT 2011 0506]	Universidad de Buenos Aires (Argentina)(University of Buenos Aires); Agencia Nacional para la Promocion Cientifica y Tecnologica (Argentina)(ANPCyT)	This work was supported by Grant UBACyT 00404, from Universidad de Buenos Aires (Argentina), www.uba.ar (recipient: EBD), and Grant PICT 2011 0506, from Agencia Nacional para la Promocion Cientifica y Tecnologica (Argentina), www.agencia.mincyt.gob.ar (recipient EBD).	Acosta EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044835; Acosta EG, 2011, VIRUS RES, V160, P173, DOI 10.1016/j.virusres.2011.06.008; Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x; Aleksandrowicz P, 2011, J INFECT DIS, V204, pS957, DOI 10.1093/infdis/jir326; Alen MMF, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/628475; Alhoot MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034060; Alhoot MA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001410; Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Ang F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-24; Benmerah A, 1999, J CELL SCI, V112, P1303; Carro AC, 2013, VIRUS RES, V174, P78, DOI 10.1016/j.virusres.2013.03.005; Castilla V, 2015, FUTURE VIROL, V10, P625, DOI 10.2217/FVL.15.35; Clemente R, 2009, J VIROL, V83, P10406, DOI 10.1128/JVI.00990-09; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004; de Vries E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001329; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GUINEA R, 1994, BIOCHEM BIOPH RES CO, V201, P1270, DOI 10.1006/bbrc.1994.1842; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Haqqani AA, 2013, ANTIVIR RES, V98, P158, DOI 10.1016/j.antiviral.2013.03.017; Hasebe R, 2009, VIROLOGY, V393, P198, DOI 10.1016/j.virol.2009.07.032; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Huang CYH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002243; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12; Karasneh GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-481; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lee HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025800; Lee RCH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002050; Leppert BJ, 2007, J IMMUNOL, V179, P548, DOI 10.4049/jimmunol.179.1.548; Lozach PY, 2011, CURR OPIN VIROL, V1, P35, DOI 10.1016/j.coviro.2011.05.004; Lozach PY, 2010, CELL HOST MICROBE, V7, P488, DOI 10.1016/j.chom.2010.05.007; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011; Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012; Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Pelkmans L, 2005, BBA-MOL CELL RES, V1746, P295, DOI 10.1016/j.bbamcr.2005.06.009; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Peng T, 2009, CAN J MICROBIOL, V55, P139, DOI [10.1139/W08-107, 10.1139/w08-107]; Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004; Permanyer M, 2010, TRENDS MICROBIOL, V18, P543, DOI 10.1016/j.tim.2010.09.003; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Sanchez V, 2006, VACCINE, V24, P4914, DOI 10.1016/j.vaccine.2006.03.066; Sauvonnet N, 2005, J CELL BIOL, V168, P155, DOI 10.1083/jcb.200406174; SCHLEGEL R, 1982, P NATL ACAD SCI-BIOL, V79, P2291, DOI 10.1073/pnas.79.7.2291; Schulz WL, 2012, J VIROL, V86, P12665, DOI 10.1128/JVI.01861-12; Spoden G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003313; Suksanpaisan L, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-17; Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131; Zhu YZ, 2012, J VIROL, V86, P13407, DOI 10.1128/JVI.00903-12; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	61	32	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140824	10.1371/journal.pone.0140824	http://dx.doi.org/10.1371/journal.pone.0140824			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469784	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600120
J	Wolin, KY; Steinberg, DM; Lane, IB; Askew, S; Greaney, ML; Colditz, GA; Bennett, GG				Wolin, Kathleen Y.; Steinberg, Dori M.; Lane, Ilana B.; Askew, Sandy; Greaney, Mary L.; Colditz, Graham A.; Bennett, Gary G.			Engagement with eHealth Self-Monitoring in a Primary Care-Based Weight Management Intervention	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; WEB; INTERNET; PROGRAM; WOMEN	Background While eHealth approaches hold promise for improving the reach and cost-effectiveness of behavior change interventions, they have been challenged by declining participant engagement over time, particularly for self-monitoring behaviors. These are significant concerns in the context of chronic disease prevention and management where durable effects are important for driving meaningful changes. Purpose "Be Fit, Be Well" was an eHealth weight loss intervention that allowed participants to self-select a self-monitoring modality (web or interactive voice response (IVR)). Participants could change their modality. As such, this study provides a unique opportunity to examine the effects of intervention modality choice and changing modalities on intervention engagement and outcomes. Methods Intervention participants, who were recruited from community health centers, (n = 180) were expected to self-monitor health behaviors weekly over the course of the 24-month intervention. We examined trends in intervention engagement by modality (web, IVR, or changed modality) among participants in the intervention arm. Results The majority (61%) of participants chose IVR self-monitoring, while 39% chose web. 56% of those who selected web monitoring changed to IVR during the study versus no change in those who initially selected IVR. Self-monitoring declined in both modalities, but completion rates were higher in those who selected IVR. There were no associations between self-monitoring modality and weight or blood pressure outcomes. Conclusions This is the first study to compare web and IVR self-monitoring in an eHealth intervention where participants could select and change their self-monitoring modality. IVR shows promise for achieving consistent engagement.	[Wolin, Kathleen Y.] Coeus Hlth, Chicago, IL 60622 USA; [Steinberg, Dori M.; Lane, Ilana B.; Askew, Sandy; Bennett, Gary G.] Duke Univ, Durham, NC USA; [Greaney, Mary L.] Univ Rhode Isl, Kingston, RI 02881 USA; [Colditz, Graham A.] Washington Univ, St Louis, MO USA	Duke University; University of Rhode Island; Washington University (WUSTL)	Wolin, KY (corresponding author), Coeus Hlth, Chicago, IL 60622 USA.	kate@drkatewolin.com	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291; Steinberg, Dori/0000-0001-7588-4216	National Institutes of Health (NIH) [5 U01 HL087071, K22CA126992]; NATIONAL CANCER INSTITUTE [K22CA126992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087071] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Institutes of Health (NIH) Grants 5 U01 HL087071 and K22CA126992. The funders had no role in the design, data collection and analysis, decision to publish or preparation of the manuscript.	Bennett GG, 2012, ARCH INTERN MED, V172, P565, DOI 10.1001/archinternmed.2012.1; Bennett GG, 2010, OBESITY, V18, P308, DOI 10.1038/oby.2009.242; Bennett GG, 2009, ANNU REV PUBL HEALTH, V30, P273, DOI 10.1146/annurev.publhealth.031308.100235; Bennett GG, OBES RES IN PRESS; Boutelle KN, 1998, OBES RES, V6, P219, DOI 10.1002/j.1550-8528.1998.tb00340.x; Burke LE, 2012, AM J PREV MED, V43, P20, DOI 10.1016/j.amepre.2012.03.016; Burke LE, 2011, OBESITY, V19, P338, DOI 10.1038/oby.2010.208; Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008; Chew LD, 2004, FAM MED, V36, P588; Foley P, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-305; Fox S., MOBILE HLTH 2012; Glanz K, 2006, AM J HEALTH PROMOT, V20, P165, DOI 10.4278/0890-1171-20.3.165; Gold BC, 2007, OBESITY, V15, P155, DOI 10.1038/oby.2007.520; Greaney ML, 2012, J MED INTERNET RES, V14, P76, DOI 10.2196/jmir.1981; Greaney ML, 2009, OBES WEIGHT MANAG, V5, P222, DOI DOI 10.1089/OBE.2009.0507; Helsel DL, 2007, J AM DIET ASSOC, V107, P1807, DOI 10.1016/j.jada.2007.07.014; Kim BH, 2013, AM J PREV MED, V44, P71, DOI 10.1016/j.amepre.2012.09.050; Weinstein PK, 2006, J CARDIOVASC NURS, V21, P251, DOI 10.1097/00005082-200607000-00003; Neve M, 2010, OBES REV, V11, P306, DOI 10.1111/j.1467-789X.2009.00646.x; Robroek SJW, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1402; Schriftman IB, 2012, 30TH ANNUAL SCIENTIF; Shaw R, 2012, HEALTH INFORM J, V18, P235, DOI 10.1177/1460458212442422; Smith A., SMARTPHONE OWNERSHIP; Steinberg DM, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2844; Tate DF, 2006, ARCH INTERN MED, V166, P1620, DOI 10.1001/archinte.166.15.1620	25	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140455	10.1371/journal.pone.0140455	http://dx.doi.org/10.1371/journal.pone.0140455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469065	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600062
J	Belo, H; Silva, G; Cardoso, BA; Porto, B; Minguillon, J; Barbot, J; Coutinho, J; Casado, JA; Benedito, M; Saturnino, H; Costa, E; Bueren, JA; Surralles, J; Almeida, A				Belo, Helio; Silva, Gabriela; Cardoso, Bruno A.; Porto, Beatriz; Minguillon, Jordi; Barbot, Jose; Coutinho, Jorge; Casado, Jose A.; Benedito, Manuela; Saturnino, Hema; Costa, Emilia; Bueren, Juan A.; Surralles, Jordi; Almeida, Antonio			Epigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential	PLOS ONE			English	Article							CLASS-II TRANSACTIVATOR; NF-KAPPA-B; PROMOTER HYPERMETHYLATION; HISTONE DEACETYLATION; INTERFERON-GAMMA; DNA METHYLATION; BRCA PATHWAY; CANCER; EXPRESSION; METHYLTRANSFERASE	Fanconi anaemia (FA) is an inherited disorder characterized by chromosomal instability. The phenotype is variable, which raises the possibility that it may be affected by other factors, such as epigenetic modifications. These play an important role in oncogenesis and may be pharmacologically manipulated. Our aim was to explore whether the epigenetic profiles in FA differ from non-FA individuals and whether these could be manipulated to alter the disease phenotype. We compared expression of epigenetic genes and DNA methylation profile of tumour suppressor genes between FA and normal samples. FA samples exhibited decreased expression levels of genes involved in epigenetic regulation and hypomethylation in the promoter regions of tumour suppressor genes. Treatment of FA cells with histone deacetylase inhibitor Vorinostat increased the expression of DNM3T beta and reduced the levels of CIITA and HDAC9, PAK1, USP16, all involved in different aspects of epigenetic and immune regulation. Given the ability of Vorinostat to modulate epigenetic genes in FA patients, we investigated its functional effects on the FA phenotype. This was assessed by incubating FA cells with Vorinostat and quantifying chromosomal breaks induced by DNA cross-linking agents. Treatment of FA cells with Vorinostat resulted in a significant reduction of aberrant cells (81% on average). Our results suggest that epigenetic mechanisms may play a role in oncogenesis in FA. Epigenetic agents may be helpful in improving the phenotype of FA patients, potentially reducing tumour incidence in this population.	[Belo, Helio; Silva, Gabriela; Cardoso, Bruno A.; Almeida, Antonio] EPE, Inst Portugues Oncol Lisboa Francisco Gentil, Unidade Invest Patobiol Mol, Lisbon, Portugal; [Belo, Helio; Silva, Gabriela; Cardoso, Bruno A.; Almeida, Antonio] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1200 Lisbon, Portugal; [Porto, Beatriz] Inst Ciencias Biomed Abel Salazar, Lab Citogenet, Oporto, Portugal; [Minguillon, Jordi; Surralles, Jordi] Univ Autonoma Barcelona, Ctr Biomed Network Res Rare Dis CIBERER, E-08193 Barcelona, Spain; [Minguillon, Jordi; Surralles, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain; [Barbot, Jose; Coutinho, Jorge; Costa, Emilia; Bueren, Juan A.] Ctr Hosp Porto, Unidade Hematol Pediat, Oporto, Portugal; [Casado, Jose A.] CIEMAT, Hematopoiesis & Gene Therapy Div, E-28040 Madrid, Spain; [Benedito, Manuela; Saturnino, Hema] Ctr Hosp Coimbra, Serv Hematol, Coimbra, Portugal; [Benedito, Manuela; Saturnino, Hema] Univ Coimbra, Coimbra, Portugal	Universidade Nova de Lisboa; Universidade do Porto; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Barcelona; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra	Almeida, A (corresponding author), EPE, Inst Portugues Oncol Lisboa Francisco Gentil, Unidade Invest Patobiol Mol, Lisbon, Portugal.	amalmeida@ipolisboa.min-saude.pt	Bueren, Juan/L-6112-2014; Surrallés, Jordi/AAE-7667-2020; Casado, Jose A/H-5077-2015	Bueren, Juan/0000-0002-3228-7013; Casado, Jose A/0000-0003-2479-1508; Minguillon, Jordi/0000-0003-2124-8294; Almeida, Antonio/0000-0003-4361-0928; Silva, Gabriela/0000-0002-4004-9904; Cardoso, Bruno/0000-0002-6521-7257; Surralles, Jordi/0000-0002-4041-7519; Porto, Beatriz/0000-0003-4281-5438	Associacao Portuguesa Contra a Leucemia; Liga Portuguesa contra o Cancro/Fundacao Terry Fox	Associacao Portuguesa Contra a Leucemia; Liga Portuguesa contra o Cancro/Fundacao Terry Fox	This project was funded by a project grant 2011-2012 from Associacao Portuguesa Contra a Leucemia and from a project grant from Liga Portuguesa contra o Cancro/Fundacao Terry Fox 2013-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli F, 2013, CURR PHARM DESIGN, V19, P578, DOI 10.2174/138161213804581918; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Bai XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040024; Buglio D, 2011, BLOOD, V117, P2910, DOI 10.1182/blood-2010-08-303701; Chernikova SB, 2012, CANCER RES, V72, P2111, DOI 10.1158/0008-5472.CAN-11-2209; Costello JF, 2001, J MED GENET, V38, P285, DOI 10.1136/jmg.38.5.285; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Ganesan A, 2009, CURR CANCER DRUG TAR, V9, P963, DOI 10.2174/156800909790192428; Geiselhart A, 2012, ANEMIA, V2012, DOI 10.1155/2012/265790; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Griffiths EA, 2008, SEMIN HEMATOL, V45, P23, DOI 10.1053/j.seminhematol.2007.11.007; Harakalova M, 2012, J MED GENET, V49, P539, DOI 10.1136/jmedgenet-2012-100921; Issa JP, 2010, HEMATOL ONCOL CLIN N, V24, P317, DOI 10.1016/j.hoc.2010.02.007; Jain N, 2009, INT J BIOCHEM CELL B, V41, P72, DOI 10.1016/j.biocel.2008.10.006; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jung KH, 2012, J CELL BIOCHEM, V113, P2167, DOI 10.1002/jcb.24090; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Liu GH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5330; Lucio-Eterovic AK, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-243; Milde T, 2010, CLIN CANCER RES, V16, P3240, DOI 10.1158/1078-0432.CCR-10-0395; Milde-Langosch K, 2008, BREAST CANCER RES TR, V107, P337, DOI 10.1007/s10549-007-9559-y; Morimoto Y, 2004, BRIT J CANCER, V90, P844, DOI 10.1038/sj.bjc.6601602; Narayan G, 2004, CANCER RES, V64, P2994, DOI 10.1158/0008-5472.CAN-04-0245; Noh JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028103; Nosho K, 2009, CLIN CANCER RES, V15, P3663, DOI 10.1158/1078-0432.CCR-08-2383; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; Osada H, 2004, INT J CANCER, V112, P26, DOI 10.1002/ijc.20395; Plass C, 2008, SEMIN ONCOL, V35, P378, DOI 10.1053/j.seminoncol.2008.04.008; Richon VM, 2009, CANCER LETT, V280, P201, DOI 10.1016/j.canlet.2009.01.002; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Satoh A, 2004, ONCOGENE, V23, P8876, DOI 10.1038/sj.onc.1208144; Sawyer SL, 2015, CANCER DISCOV, V5, P135, DOI 10.1158/2159-8290.CD-14-1156; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Siegel D, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-31; Silva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053766; Soulier J, 2011, HEMATOL-AM SOC HEMAT, P492, DOI 10.1182/asheducation-2011.1.492; Stintzing S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/214143; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Truax AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036013; Vanderwerf SM, 2009, BLOOD, V114, P5290, DOI 10.1182/blood-2009-05-222414; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Wang ZH, 2006, CANCER BIOL THER, V5, P256, DOI 10.4161/cbt.5.3.2380; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	50	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139740	10.1371/journal.pone.0139740	http://dx.doi.org/10.1371/journal.pone.0139740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466379	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100058
J	Carroll, C; Lawler, JJ; Roberts, DR; Hamann, A				Carroll, Carlos; Lawler, Joshua J.; Roberts, David R.; Hamann, Andreas			Biotic and Climatic Velocity Identify Contrasting Areas of Vulnerability to Climate Change	PLOS ONE			English	Article							RANGE SHIFTS; CONSERVATION; IMPACTS; CLASSIFICATION; DISTRIBUTIONS; BIODIVERSITY; PREDICTION; MARINE; FUTURE; RISK	Metrics that synthesize the complex effects of climate change are essential tools for mapping future threats to biodiversity and predicting which species are likely to adapt in place to new climatic conditions, disperse and establish in areas with newly suitable climate, or face the prospect of extirpation. The most commonly used of such metrics is the velocity of climate change, which estimates the speed at which species must migrate over the earth's surface to maintain constant climatic conditions. However, "analog-based" velocities, which represent the actual distance to where analogous climates will be found in the future, may provide contrasting results to the more common form of velocity based on local climate gradients. Additionally, whereas climatic velocity reflects the exposure of organisms to climate change, resultant biotic effects are dependent on the sensitivity of individual species as reflected in part by their climatic niche width. This has motivated development of biotic velocity, a metric which uses data on projected species range shifts to estimate the velocity at which species must move to track their climatic niche. We calculated climatic and biotic velocity for the Western Hemisphere for 1961-2100, and applied the results to example ecological and conservation planning questions, to demonstrate the potential of such analog-based metrics to provide information on broad-scale patterns of exposure and sensitivity. Geographic patterns of biotic velocity for 2954 species of birds, mammals, and amphibians differed from climatic velocity in north temperate and boreal regions. However, both biotic and climatic velocities were greatest at low latitudes, implying that threats to equatorial species arise from both the future magnitude of climatic velocities and the narrow climatic tolerances of species in these regions, which currently experience low seasonal and interannual climatic variability. Biotic and climatic velocity, by approximating lower and upper bounds on migration rates, can inform conservation of species and locally-adapted populations, respectively, and in combination with backward velocity, a function of distance to a source of colonizers adapted to a site's future climate, can facilitate conservation of diversity at multiple scales in the face of climate change.	[Carroll, Carlos] Klamath Ctr Conservat Res, Orleans, CA 95556 USA; [Lawler, Joshua J.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Roberts, David R.; Hamann, Andreas] Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2H1, Canada; [Roberts, David R.] Univ Freiburg, Dept Biometry & Environm Syst Anal, D-79106 Freiburg, Germany	University of Washington; University of Washington Seattle; University of Alberta; University of Freiburg	Carroll, C (corresponding author), Klamath Ctr Conservat Res, Orleans, CA 95556 USA.	carlos@klamathconservation.org		Roberts, David/0000-0002-3437-2422	Wilburforce Foundation	Wilburforce Foundation	This work was supported in part by a grant from the Wilburforce Foundation (www.wilburforce.org) to CC, JJL, and DRR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Arya S, 2010, LECT NOTES COMPUT SC, V6346, P374, DOI 10.1007/978-3-642-15775-2_32; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Crookston NL, 2008, J STAT SOFTW, V23, P1, DOI DOI 10.18637/jss.v023.i10; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Dobrowski SZ, 2013, GLOBAL CHANGE BIOL, V19, P241, DOI 10.1111/gcb.12026; Early R, 2011, ECOL LETT, V14, P1125, DOI 10.1111/j.1461-0248.2011.01681.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Hamann A, 2015, GLOBAL CHANGE BIOL, V21, P997, DOI 10.1111/gcb.12736; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Holmgren M, 2013, NAT CLIM CHANGE, V3, P755, DOI [10.1038/nclimate1906, 10.1038/NCLIMATE1906]; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Knutti R, 2013, GEOPHYS RES LETT, V40, P1194, DOI 10.1002/grl.50256; Knutti R, 2013, NAT CLIM CHANGE, V3, P369, DOI [10.1038/nclimate1716, 10.1038/NCLIMATE1716]; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Koven CD, 2013, NAT GEOSCI, V6, P452, DOI [10.1038/NGEO1801, 10.1038/ngeo1801]; Lawler JJ, 2013, ECOL LETT, V16, P1014, DOI 10.1111/ele.12132; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; McRae BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052604; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Morueta-Holme N, 2013, ECOL LETT, V16, P1446, DOI 10.1111/ele.12184; Nakicenovic N., 2000, SPECIAL REPORT EMISS; NOSS RF, 1986, ENVIRON MANAGE, V10, P299, DOI 10.1007/BF01867252; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Ohlemuller R, 2006, GLOBAL ECOL BIOGEOGR, V15, P395, DOI 10.1111/j.1466-822X.2006.00245.x; Ohlemuller R, 2012, GLOBAL ECOL BIOGEOGR, V21, P152, DOI 10.1111/j.1466-8238.2011.00674.x; Ordonez A, 2014, NAT CLIM CHANGE, V4, P811, DOI [10.1038/nclimate2337, 10.1038/NCLIMATE2337]; Ordonez A, 2013, CLIMATIC CHANGE, V119, P659, DOI 10.1007/s10584-013-0752-1; Ordonez A, 2013, ECOL LETT, V16, P773, DOI 10.1111/ele.12110; Patterson BD, 2003, DIGITAL DISTRIBUTION; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Ridgely R. S., 2003, DIGITAL DISTRIBUTION; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Serra-Diaz JM, 2014, DIVERS DISTRIB, V20, P169, DOI 10.1111/ddi.12131; Sunday JM, 2015, ECOL LETT, V18, P944, DOI 10.1111/ele.12474; Tingley MW, 2014, ANN NY ACAD SCI, V1322, P92, DOI 10.1111/nyas.12484; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; VanDerWal J, 2013, NAT CLIM CHANGE, V3, P239, DOI [10.1038/nclimate1688, 10.1038/NCLIMATE1688]; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Wright SJ, 2009, CONSERV BIOL, V23, P1418, DOI 10.1111/j.1523-1739.2009.01337.x	61	68	71	8	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140486	10.1371/journal.pone.0140486	http://dx.doi.org/10.1371/journal.pone.0140486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466364	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100130
J	Drew, JA; Amatangelo, KL; Hufbauer, RA				Drew, Joshua A.; Amatangelo, Kathryn L.; Hufbauer, Ruth A.			Quantifying the Human Impacts on Papua New Guinea Reef Fish Communities across Space and Time	PLOS ONE			English	Article							NULL MODEL ANALYSIS; BOOTLESS BAY; CONSERVATION; MARINE; BIODIVERSITY; NESTEDNESS; TEMPERATURE; EXTINCTION; MANAGEMENT; DIVERSITY	Describing the drivers of species loss and of community change are important goals in both conservation and ecology. However, it is difficult to determine whether exploited species decline due to direct effects of harvesting or due to other environmental perturbations brought about by proximity to human populations. Here we quantify differences in species richness of coral reef fish communities along a human population gradient in Papua New Guinea to understand the relative impacts of fishing and environmental perturbation. Using data from published species lists we categorize the reef fishes as either fished or non-fished based on their body size and reports from the published literature. Species diversity for both fished and non-fished groups decreases as the size of the local human population increases, and this relationship is stronger in species that are fished. Additionally, comparison of modern and museum collections show that modern reef communities have proportionally fewer fished species relative to 19th century ones. Together these findings show that the reef fish communities of Papua New Guinea experience multiple anthropogenic stressors and that even at low human population levels targeted species experience population declines across both time and space.	[Drew, Joshua A.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Drew, Joshua A.] Amer Museum Nat Hist, Div Vertebrate Zool, New York, NY 10024 USA; [Amatangelo, Kathryn L.] SUNY Coll Brockport, Dept Environm Sci & Biol, Brockport, NY 14420 USA; [Hufbauer, Ruth A.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Hufbauer, Ruth A.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA	Columbia University; American Museum of Natural History (AMNH); State University of New York (SUNY) System; Colorado State University; Colorado State University	Drew, JA (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	j.drew@columbia.edu	Hufbauer, Ruth/ABA-3984-2020	Hufbauer, Ruth/0000-0002-8270-0638; Drew, Joshua/0000-0001-9072-0885	Columbia University; National Science Foundation Postdoctoral Fellowship [DBI-0805458]; Marshall Field Fund of the Field Museum of Natural History; United States Department of Agriculture via the Colorado Agricultural Experiment Station; NSF RCN [0541673]	Columbia University; National Science Foundation Postdoctoral Fellowship(National Science Foundation (NSF)); Marshall Field Fund of the Field Museum of Natural History; United States Department of Agriculture via the Colorado Agricultural Experiment Station; NSF RCN	Funding for JAD provided by Columbia University, a National Science Foundation Postdoctoral Fellowship to JAD (DBI-0805458) with additional support from the Marshall Field Fund of the Field Museum of Natural History RAH acknowledges support of the United States Department of Agriculture via the Colorado Agricultural Experiment Station, and connections that led to involvement in this research made with the support of NSF RCN 0541673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G. R., 2012, REEF FISHES E INDIES, VI-III; Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Allen Gerald R., 2014, Journal of the Ocean Science Foundation, V11, P13; Allen GR, 1995, KIMBE BAY RAPID ECOL, V3, P107; Allen GR, 2009, RAPID ECOLOGICAL ASS; Allen GR, 2000, BIOL ASSESSMENT, V29; Almeida M, 2007, OIKOS, V116, P716, DOI 10.1111/j.2007.0030-1299.15803.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Barber PH, 2009, J BIOGEOGR, V36, P1845, DOI 10.1111/j.1365-2699.2009.02198.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Beger M, 2003, BIOL CONSERV, V111, P53, DOI 10.1016/S0006-3207(02)00249-5; BENNETT EL, 1993, BIODIVERS CONSERV, V2, P359, DOI 10.1007/BF00114040; Bennett S, 2011, MAR ECOL PROG SER, V426, P241, DOI 10.3354/meps09016; Burke L, 2012, REEFS RISK REVISITED; Butler JRA, 2014, MAR POLICY, V46, P1, DOI 10.1016/j.marpol.2013.12.011; Cardoso P, 2015, METHODS ECOL EVOL, V6, P232, DOI 10.1111/2041-210X.12310; Cinner JE, 2006, ENVIRON CONSERV, V33, P73, DOI 10.1017/S0376892906002748; Crooks JA, 2011, BIOL INVASIONS, V13, P165, DOI 10.1007/s10530-010-9799-3; Davies JM, 1997, MAR FRESHWATER RES, V48, P513, DOI 10.1071/MF96128; Drew J, 2011, CONSERV BIOL, V25, P1250, DOI 10.1111/j.1523-1739.2011.01725.x; Drew JA, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-15; Fricke R, 2014, ZOOTAXA, V3832, P1, DOI 10.11646/zootaxa.3832.1.1; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Graham NAJ, 2010, AQUAT CONSERV, V20, P543, DOI 10.1002/aqc.1116; Hicks CC, 2014, P NATL ACAD SCI USA, V111, P17791, DOI 10.1073/pnas.1413473111; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; McClanahan TR, 2008, AQUAT CONSERV, V18, P493, DOI 10.1002/aqc.874; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; McClenachan L, 2015, BIOSCIENCE, V65, P932, DOI 10.1093/biosci/biv100; McClenachan L, 2009, CONSERV BIOL, V23, P636, DOI 10.1111/j.1523-1739.2008.01152.x; de Mitcheson YS, 2013, FISH FISH, V14, P119, DOI 10.1111/j.1467-2979.2011.00455.x; Moore C, 2012, MEMOIRS QUEENSLAND M, V6, P39; Mumby PJ, 2012, MAR ECOL PROG SER, V445, P13, DOI 10.3354/meps09450; Oram NigelD., 1976, COLONIAL TOWN MELANE; Podani J, 2011, OIKOS, V120, P1625, DOI 10.1111/j.1600-0706.2011.19451.x; Seixas Cristiana Simao, 2001, Journal of Ethnobiology, V21, P107; Smith SDA, 2012, MAR POLLUT BULL, V64, P1880, DOI 10.1016/j.marpolbul.2012.06.013; Smith SV, 2003, BIOSCIENCE, V53, P235, DOI 10.1641/0006-3568(2003)053[0235:HHATDO]2.0.CO;2; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Wenger AS, 2015, CONSERVATIO IN PRESS; Wood PJ, 1997, ENVIRON MANAGE, V21, P203, DOI 10.1007/s002679900019; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	43	6	6	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140682	10.1371/journal.pone.0140682	http://dx.doi.org/10.1371/journal.pone.0140682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466336	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100161
J	Tompkins, G; Forrest, LF; Adams, J				Tompkins, Gerald; Forrest, Lynne F.; Adams, Jean			Socio-Economic Differences in the Association between Self-Reported and Clinically Present Diabetes and Hypertension: Secondary Analysis of a Population-Based Cross-Sectional Study	PLOS ONE			English	Article							HEALTH OUTCOMES; RISK-FACTORS; PREVALENCE; AWARENESS; LITERACY; DYSLIPIDEMIA; MANAGEMENT; POSITION; DISEASES	Background Diabetes and hypertension are key risk factors for coronary heart disease. Prevalence of both conditions is socio-economically patterned. Awareness of presence of the conditions may influence risk behaviour and use of preventative services. Our aim was to examine whether there were socio-economic differences in awareness of hypertension and diabetes in a UK population. Method Data from the Scottish Health Survey was used to compare self-reported awareness of hypertension and diabetes amongst those found on examination to have these conditions, by socioeconomic position (SEP) (measured by occupation, education and income). Odds ratios of self-reported awareness against presence, and the sensitivity, specificity and predictive value of self-reporting as a measure of the presence of the condition, were calculated. Results Presence and self-reported awareness of both conditions increased as SEP decreased, on most measures. There was only one significant difference in awareness by SEP once other factors had been taken into account. Sensitivity showed that those in the most disadvantaged groups were most likely to self-report awareness of their hypertension, and specificity showed that those in the least disadvantaged groups were most likely to self-report awareness of its absence. There were few differences of note for diabetes. Conclusion We found no consistent pattern in the associations between SEP and the presence and self-reported awareness of hypertension and diabetes amongst those with these conditions. Without evidence of differences, it is important that universal approaches continue to be applied to the identification and management of those at risk of these and other conditions that underpin cardiovascular disease.	[Tompkins, Gerald] Hlth Educ North East, Newcastle Upon Tyne, Tyne & Wear, England; [Tompkins, Gerald; Forrest, Lynne F.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Adams, Jean] Univ Cambridge, MRC Epidemiol Unit, Ctr Diet & Act Res, Cambridge, England	Newcastle University - UK; University of Cambridge	Adams, J (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Ctr Diet & Act Res, Cambridge, England.	jma79@medschl.cam.ac.uk	Forrest, Lynne/U-6426-2019; Adams, Jean/G-2402-2010	Adams, Jean/0000-0002-5733-7830; Forrest, Lynne/0000-0002-3740-5541	Health Education North East; ESRC PhD studentship via Fuse: the Centre for Translational Research in Public Health; National Institute for Health Research (NIHR) School for Public Health Research (SPHR) via Fuse; Fuse; Centre for Diet and Activity Research (CEDAR); British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1] Funding Source: researchfish	Health Education North East; ESRC PhD studentship via Fuse: the Centre for Translational Research in Public Health(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research (NIHR) School for Public Health Research (SPHR) via Fuse(National Institute for Health Research (NIHR)); Fuse; Centre for Diet and Activity Research (CEDAR); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was not supported by direct funding. When the work was conducted, Gerald Tompkins was working as a Registrar in Public Health Medicine, funded by Health Education North East; Lynne Forrest was funded by an ESRC PhD studentship via Fuse: the Centre for Translational Research in Public Health, and is now funded by the National Institute for Health Research (NIHR) School for Public Health Research (SPHR) via Fuse; and Jean Adams was partly funded by Fuse. JA is now funded by the Centre for Diet and Activity Research (CEDAR). Both Fuse and CEDAR are UKCRC Public Health Research Centres of Excellence. Funding for Fuse and CEDAR from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2006, PUBLIC HEALTH, V120, P70, DOI 10.1016/j.puhe.2005.05.005; Adams J, 2014, J EPIDEMIOL COMMUN H, V68, P818, DOI 10.1136/jech-2014-203872; Annandale E, 2003, SOCIOLOGY HLTH HLTH; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Cai L, 2011, TROP MED INT HEALTH, V16, P1070, DOI 10.1111/j.1365-3156.2011.02805.x; Campbell SM, 1996, FAM PRACT, V13, P75, DOI 10.1093/fampra/13.1.75; Chanfreau J., 2008, EQUIVALENCE SCALES R; Dalstra JAA, 2005, INT J EPIDEMIOL, V34, P316, DOI 10.1093/ije/dyh386; Delpierre C, 2009, AM J PUBLIC HEALTH, V99, P1278, DOI 10.2105/AJPH.2008.147934; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Drieskens S, 2010, EUR J PUBLIC HEALTH, V20, P634, DOI 10.1093/eurpub/ckp185; Fine LJ, 2004, AM J PREV MED, V27, P18, DOI 10.1016/j.amepre.2004.04.017; Forde I, 2011, ATHEROSCLEROSIS, V215, P223, DOI 10.1016/j.atherosclerosis.2010.12.012; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Hertz RP, 2006, AM J PREV MED, V30, P103, DOI 10.1016/j.amepre.2005.10.015; Howard G, 2006, STROKE, V37, P1171, DOI 10.1161/01.STR.0000217222.09978.ce; Kirkwood E, 2003, EVALUATION DIAGNOSTI; Marmot M, 2010, FAIR SOC HLTH LIVES; McDonald M, 2009, J GERONTOL A-BIOL, V64, P256, DOI 10.1093/gerona/gln016; Molenaar EA, 2007, EUR J PUBLIC HEALTH, V17, P199, DOI 10.1093/eurpub/ckl113; Moreira Gisela C, 2009, J Hypertens, V27, P1900, DOI 10.1097/HJH.0b013e32832dd10f; *NAT COLL CTR CHRO, 2008, TYP 2 DIAB NAT CLIN; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Institute for Health and Care Excellence, 2011, HYP CLIN MAN PRIM HY; National Institute of Health and Care Excellence, 2010, PH 25 PREV CARD DIS; Nguyen QC, 2011, PREV CHRONIC DIS, V8; NICE-National Institute for Health + Care Excellence, 2011, PREV TYP 2 DIAB POP; Nutbeam D, 1998, HEALTH PROMOT INT, V13, P349, DOI 10.1093/heapro/13.4.349; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Porapakkham Y, 2008, SINGAPORE MED J, V49; Protheroe J, 2009, BRIT J GEN PRACT, V59, P721, DOI 10.3399/bjgp09X472584; Public Health England, 2013, CARD DIS KEY FACTS 7; Ramsay LE, 1999, J HUM HYPERTENS, V13, P569, DOI 10.1038/sj.jhh.1000917; Rose David., 2005, NATL STAT SOCIO EC C; Rutherford L, 2011, SCOTTISH HLTH SURVEY; Rutherford L, 2012, SCOTTISH HLTH SURVEY, V3, P56; Smith KB, 2008, AUST J RURAL HEALTH, V16, P56, DOI 10.1111/j.1440-1584.2008.00953.x; The Scottish Government, 2014, SCOTT HLTH SURV DES; van Rossum CTM, 2000, HYPERTENSION, V35, P814, DOI 10.1161/01.HYP.35.3.814; Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440; Wu SC, 2000, PUBLIC HEALTH, V114, P137, DOI 10.1016/S0033-3506(00)00323-1; Wyatt SB, 2008, HYPERTENSION, V51, P650, DOI 10.1161/HYPERTENSIONAHA.107.100081	43	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139928	10.1371/journal.pone.0139928	http://dx.doi.org/10.1371/journal.pone.0139928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0CK	26466384	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100066
J	Lee, S; Lee, S; Kim, K; Kim, YH				Lee, Seungseob; Lee, SuKyoung; Kim, Kyungsoo; Kim, Yoon Hyuk			Base Station Placement Algorithm for Large-Scale LTE Heterogeneous Networks	PLOS ONE			English	Article							MULTIOBJECTIVE EVOLUTIONARY ALGORITHMS; DIFFERENTIAL EVOLUTION; TRANSMITTER PLACEMENT; OPTIMIZATION MODELS; LOCATION	Data traffic demands in cellular networks today are increasing at an exponential rate, giving rise to the development of heterogeneous networks (HetNets), in which small cells complement traditional macro cells by extending coverage to indoor areas. However, the deployment of small cells as parts of HetNets creates a key challenge for operators' careful network planning. In particular, massive and unplanned deployment of base stations can cause high interference, resulting in highly degrading network performance. Although different mathematical modeling and optimization methods have been used to approach various problems related to this issue, most traditional network planning models are ill-equipped to deal with HetNet-specific characteristics due to their focus on classical cellular network designs. Furthermore, increased wireless data demands have driven mobile operators to roll out large-scale networks of small long term evolution (LTE) cells. Therefore, in this paper, we aim to derive an optimum network planning algorithm for large-scale LTE HetNets. Recently, attempts have been made to apply evolutionary algorithms (EAs) to the field of radio network planning, since they are characterized as global optimization methods. Yet, EA performance often deteriorates rapidly with the growth of search space dimensionality. To overcome this limitation when designing optimum network deployments for large-scale LTE HetNets, we attempt to decompose the problem and tackle its subcomponents individually. Particularly noting that some HetNet cells have strong correlations due to inter-cell interference, we propose a correlation grouping approach in which cells are grouped together according to their mutual interference. Both the simulation and analytical results indicate that the proposed solution outperforms the random-grouping based EA as well as an EA that detects interacting variables by monitoring the changes in the objective function algorithm in terms of system throughput performance.	[Lee, Seungseob; Lee, SuKyoung] Yonsei Univ, Dept Comp Sci, Seoul 120749, South Korea; [Kim, Kyungsoo] Kyung Hee Univ, Dept Appl Math, Yongin, South Korea; [Kim, Yoon Hyuk] Kyung Hee Univ, Dept Mech Engn, Yongin, South Korea	Yonsei University; Kyung Hee University; Kyung Hee University	Lee, S (corresponding author), Yonsei Univ, Dept Comp Sci, Seoul 120749, South Korea.	sklee@yonsei.ac.kr	Kim, Kyungsoo/AAK-1711-2020		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT AMP; Future Planning [NRF-2013R1A1A3005914]; MSIP (Ministry of Science, ICT and Future Planning), Korea, under the ITRC (Information Technology Research Center) [NIPA-2014-H0301-14-1042]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT AMP; Future Planning; MSIP (Ministry of Science, ICT and Future Planning), Korea, under the ITRC (Information Technology Research Center)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013R1A1A3005914) and by the MSIP (Ministry of Science, ICT and Future Planning), Korea, under the ITRC (Information Technology Research Center) support program (NIPA-2014-H0301-14-1042) supervised by the NIPA (National IT Industry Promotion Agency).	Amaldi E, 2003, IEEE T WIREL COMMUN, V2, P939, DOI 10.1109/TWC.2003.817438; Amaldi E, 2003, IEEE WCNC, P827; Amaldi E, 2008, WIREL NETW, V14, P435, DOI 10.1007/s11276-006-0729-3; [Anonymous], 2009, 25816 3GPP TR; [Anonymous], 2012, 3GPP TR 36 931; [Anonymous], 2013, 3GPP TS 36 104; Auer G, 2011, 2011 IEEE 73 VEH TEC, P1; Baldemair R, 2013, IEEE VEH TECHNOL MAG, V8, P24, DOI 10.1109/MVT.2012.2234051; Chen JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103429; Das S, 2011, IEEE T EVOLUT COMPUT, V15, P4, DOI 10.1109/TEVC.2010.2059031; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Eisenblatter A, 2006, IEEE WIREL COMMUN, V13, P8, DOI 10.1109/MWC.2006.275193; Eisenblatter A, 2004, PROC OF WIOPT; Fitchard K, SPRINT HAS BIG PLANS; Guan XM, 2016, INT J SYST SCI, V47, P1995, DOI 10.1080/00207721.2014.966282; Han JK, 2001, IEEE VTS VEH TECHNOL, P2703, DOI 10.1109/VTC.2001.957251; Kalvenes J, 2006, INFORMS J COMPUT, V18, P366, DOI 10.1287/ijoc.1040.0129; Khalek AA, 2011, IEEE T VEH TECHNOL, V60, P1612, DOI 10.1109/TVT.2011.2132745; Li XD, 2012, IEEE T EVOLUT COMPUT, V16, P210, DOI 10.1109/TEVC.2011.2112662; Li XD, 2009, IEEE C EVOL COMPUTAT, P1546, DOI 10.1109/CEC.2009.4983126; Li ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083739; Liu Y, 2001, IEEE C EVOL COMPUTAT, P1101, DOI 10.1109/CEC.2001.934314; Logenthiran T, 2012, IEEE T SMART GRID, V3, P1244, DOI 10.1109/TSG.2012.2195686; Mukhopadhyay A, 2014, IEEE T EVOLUT COMPUT, V18, P4, DOI 10.1109/TEVC.2013.2290086; Omidvar MN, 2014, IEEE T EVOLUT COMPUT, V18, P378, DOI 10.1109/TEVC.2013.2281543; Ponsich A, 2013, IEEE T EVOLUT COMPUT, V17, P321, DOI 10.1109/TEVC.2012.2196800; Sherali HD, 1996, IEEE J SEL AREA COMM, V14, P662, DOI 10.1109/49.490417; Ting CK, 2009, IEEE T SYST MAN CY B, V39, P945, DOI 10.1109/TSMCB.2008.2010951; Weicker N, 2003, IEEE T EVOLUT COMPUT, V7, P189, DOI 10.1109/TEVC.2003.810760; Yang ZY, 2008, INFORM SCIENCES, V178, P2985, DOI 10.1016/j.ins.2008.02.017; Yang ZY, 2008, IEEE C EVOL COMPUTAT, P1110, DOI 10.1109/CEC.2008.4630935; Zhang XJ, 2013, SCI CHINA INFORM SCI, V56, DOI 10.1007/s11432-013-4836-3	32	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139190	10.1371/journal.pone.0139190	http://dx.doi.org/10.1371/journal.pone.0139190			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461933	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300013
J	Cho, HY; Maeng, SJ; Cho, HJ; Choi, YS; Chung, JM; Lee, S; Kim, HK; Kim, JH; Eom, CY; Kim, YG; Guo, M; Jung, HS; Kang, BS; Kim, S				Cho, Ha Yeon; Maeng, Seo Jin; Cho, Hyo Je; Choi, Yoon Seo; Chung, Jeong Min; Lee, Sangmin; Kim, Hoi Kyoung; Kim, Jong Hyun; Eom, Chi-Yong; Kim, Yeon-Gil; Guo, Min; Jung, Hyun Suk; Kang, Beom Sik; Kim, Sunghoon			Assembly of Multi-tRNA Synthetase Complex via Heterotetrameric Glutathione Transferase-homology Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; 3-DIMENSIONAL STRUCTURE; STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE; TRANSLATION; REVEALS; BINDING; MOTIF	Many multicomponent protein complexes mediating diverse cellular processes are assembled through scaffolds with specialized protein interaction modules. The multi-tRNA synthetase complex (MSC), consisting of nine different aminoacyl-tRNA synthetases and three non-enzymatic factors (AIMP1-3), serves as a hub for many signaling pathways in addition to its role in protein synthesis. However, the assembly process and structural arrangement of the MSC components are not well understood. Here we show the heterotetrameric complex structure of the glutathione transferase (GST) domains shared among the four MSCcomponents, methionyl-tRNA synthetase (MRS), glutaminyl-prolyl-tRNA synthetase (EPRS), AIMP2 and AIMP3. The MRS-AIMP3 and EPRS-AIMP2 using interface 1 are bridged via interface 2 of AIMP3 and EPRS to generate a unique linear complex of MRS-AIMP3: EPRS-AIMP2 at the molar ratio of (1: 1):(1: 1). Interestingly, the affinity at interface 2 of AIMP3: EPRS can be varied depending on the occupancy of interface 1, suggesting the dynamic nature of the linear GST tetramer. The four components are optimally arranged for maximal accommodation of additional domains and proteins. These characteristics suggest the GST tetramer as a unique and dynamic structural platform from which the MSC components are assembled. Considering prevalence of the GST-like domains, this tetramer can also provide a tool for the communication of the MSC with other GST-containing cellular factors.	[Cho, Ha Yeon; Maeng, Seo Jin; Cho, Hyo Je; Choi, Yoon Seo; Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, KNU Creat BioRes Grp, Taegu 702701, South Korea; [Chung, Jeong Min; Lee, Sangmin; Jung, Hyun Suk] Kangwon Natl Univ, Coll Nat Sci, Dept Biochem, Chunchon 200701, South Korea; [Kim, Hoi Kyoung; Kim, Jong Hyun; Kim, Sunghoon] Seoul Natl Univ, Grad Sch Convergence Technol, Med Bioconvergence Res Ctr, Dept Mol Med & Biopharmaceut Sci, Seoul 151742, South Korea; [Eom, Chi-Yong] Korea Basic Sci Inst, Western Seoul Ctr, NanoBio Convergence Res Team, Seoul 120750, South Korea; [Kim, Yeon-Gil] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790834, South Korea; [Guo, Min] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Kim, Sunghoon] Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China	Kyungpook National University; Kangwon National University; Seoul National University (SNU); Korea Basic Science Institute (KBSI); Pohang University of Science & Technology (POSTECH); Scripps Research Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Kang, BS (corresponding author), 80 Daehak Ro, Daegu 702701, South Korea.	bskang2@knu.ac.kr; sungkim@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020	kim, sunghoon/0000-0002-1570-3230	Global Frontier Project Grant of the National Research Foundation - Ministry of Science, ICT & Future Planning (MSIP) of Korea [NRF-2014M3A6A4062857]; NATIONAL CANCER INSTITUTE [R01CA178315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100136] Funding Source: NIH RePORTER	Global Frontier Project Grant of the National Research Foundation - Ministry of Science, ICT & Future Planning (MSIP) of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Global Frontier Project Grant NRF-2014M3A6A4062857 of the National Research Foundation funded by the Ministry of Science, ICT & Future Planning (MSIP) of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ahn HC, 2003, FEBS LETT, V542, P119, DOI 10.1016/S0014-5793(03)00362-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266; Crepin T, 2004, BIOCHEMISTRY-US, V43, P2635, DOI 10.1021/bi0356247; Dias J, 2013, J BIOL CHEM, V288, P23979, DOI 10.1074/jbc.M113.489922; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu YY, 2014, P NATL ACAD SCI USA, V111, P15084, DOI 10.1073/pnas.1408836111; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Guo M, 2014, TOP CURR CHEM, V344, P89, DOI 10.1007/128_2013_424; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; Kim JE, 2000, NUCLEIC ACIDS RES, V28, P2866, DOI 10.1093/nar/28.15.2866; Kim JH, 2014, TOP CURR CHEM, V344, P119, DOI 10.1007/128_2013_479; Kim KR, 2013, PROTEINS, V81, P1840, DOI 10.1002/prot.24306; Kim KJ, 2008, J BIOL CHEM, V283, P14032, DOI 10.1074/jbc.M800859200; Kim SO, 2012, J MOL CELL BIOL, V4, P258, DOI 10.1093/jmcb/mjs026; KOONIN EV, 1994, PROTEIN SCI, V3, P2045, DOI 10.1002/pro.5560031117; Kwon NH, 2011, P NATL ACAD SCI USA, V108, P19635, DOI 10.1073/pnas.1103922108; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; Nureki O, 2010, NUCLEIC ACIDS RES, V38, P7286, DOI 10.1093/nar/gkq605; Oakley AJ, 2005, CURR OPIN STRUC BIOL, V15, P716, DOI 10.1016/j.sbi.2005.10.005; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Renault L, 2001, EMBO J, V20, P570, DOI 10.1093/emboj/20.3.570; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Rossjohn J, 1998, STRUCTURE, V6, P309, DOI 10.1016/S0969-2126(98)00034-3; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Wu BJ, 2012, TRENDS PHARMACOL SCI, V33, P656, DOI 10.1016/j.tips.2012.09.007; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774	39	45	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29313	29328		10.1074/jbc.M115.690867	http://dx.doi.org/10.1074/jbc.M115.690867			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26472928	Green Published, hybrid			2022-12-26	WOS:000366613400019
J	Chen, YL; Zhang, ZQ; Cheng, LL; Fan, L; Wang, CS; Shu, XH				Chen, Yongle; Zhang, Zhiqi; Cheng, Leilei; Fan, Li; Wang, Chunsheng; Shu, Xianhong			The Early Variation of Left Ventricular Strain after Aortic Valve Replacement by Three-Dimensional Echocardiography	PLOS ONE			English	Article							SPECKLE-TRACKING; LONGITUDINAL STRAIN; STENOSIS	Aortic stenosis (AS) and aortic incompetence (AI) are common aortic valve diseases. Both may deteriorate into irreversible myocardial dysfunction and will increase the risk of sudden death. In this study, we aimed to investigate the early variation trend of left ventricular function by three-dimensional speckle tracking echocardiography (3D-STE) in the patients who underwent cardiac surgeries for aortic valve disease. Twenty patients with severe aortic AS and 16 patients with severe AI were enrolled. All of them underwent the aortic valve replacement (AVR) procedures. The patients' global longitudinal strain (GLS) and global circumferential strain (GCS) were evaluated by 3D-STE before surgery and at 1 week after surgery. In addition, GLS and GCS were followed at 1 month as well as 3 months after AVR. In AS patients, the GCS after AVR altered little both at 1 week (p = 0.562) and at 1 month (p = 0.953) compared with the data before the surgery. And it increased significantly at 3 months of follow-up observation compared to that before AVR (p<0.05). Meanwhile, GLS increased progressively after AVR and improved significantly at 3 months after surgery (p<0.05). For the AI patients, GLS as well as GCS decreased at 1 week after AVR compared to those data at baseline (p<0.05). However, these two parameters recovered at 1 month after AVR. Furthermore, GLS and GCS improved significantly at 3 months after the surgery (p<0.05). Therefore, both GLS and GCS were influenced by AVR and would be improved at 3 months after surgery both in AS patients or AI patients. GLS and GCS can be finely evaluated by 3D-STE, and they are helpful to determine the variation tendency of left ventricular function in patients with AVR.	[Chen, Yongle; Cheng, Leilei; Shu, Xianhong] Fudan Univ, Shanghai Inst Cardiovasc Dis, Shanghai Inst Med Imaging, Dept Echocardiog,Zhongshan Hosp, Shanghai 200433, Peoples R China; [Zhang, Zhiqi; Fan, Li; Wang, Chunsheng] Fudan Univ, Shanghai Inst Cardiovasc Dis, Dept Cardiac Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Cheng, LL (corresponding author), Fudan Univ, Shanghai Inst Cardiovasc Dis, Shanghai Inst Med Imaging, Dept Echocardiog,Zhongshan Hosp, Shanghai 200433, Peoples R China.	cheng.leilei@zs-hospital.sh.cn	Zhang, Zhiqi/AAL-9346-2020	Zhang, Zhiqi/0000-0001-7565-5456	Shanghai Institute of Medical Imaging Scientific Fund [SHIMI-GJ-2013-005]; Chinese National Scientific Fund [81201095]	Shanghai Institute of Medical Imaging Scientific Fund; Chinese National Scientific Fund	The study was supported by the Shanghai Institute of Medical Imaging Scientific Fund (SHIMI-GJ-2013-005) www.zs-hospital.sh.cn and Chinese National Scientific Fund (No. 81201095) www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate E, 2012, AM J CARDIOL, V110, P961, DOI 10.1016/j.amjcard.2012.05.023; Baumgartner H, 2005, HEART, V91, P1483, DOI 10.1136/hrt.2004.056176; Carasso S, 2011, AM J CARDIOL, V107, P1052, DOI 10.1016/j.amjcard.2010.11.032; Carasso S, 2009, AM HEART J, V158, P540, DOI 10.1016/j.ahj.2009.07.008; Dahl JS, 2012, CIRC-CARDIOVASC IMAG, V5, P613, DOI 10.1161/CIRCIMAGING.112.973834; Dandel M, 2009, INT J CARDIOL, V132, P11, DOI 10.1016/j.ijcard.2008.06.091; Delgado V, 2009, EUR HEART J, V30, P3037, DOI 10.1093/eurheartj/ehp351; Gelsomino S, 2013, HEART VESSELS, V28, P775, DOI 10.1007/s00380-012-0308-8; Gorcsan J, 2011, J AM COLL CARDIOL, V58, P1401, DOI 10.1016/j.jacc.2011.06.038; Gorcsan J, 2008, EUROPACE, V10, P80, DOI 10.1093/europace/eun222; Hoit BD, 2011, CIRC-CARDIOVASC IMAG, V4, P179, DOI 10.1161/CIRCIMAGING.110.959817; Juhl-Olsen P, 2012, INTERACT CARDIOV TH, V15, P395, DOI 10.1093/icvts/ivs253; Lindqvist P, 2010, EUR J ECHOCARDIOGR, V11, P608, DOI 10.1093/ejechocard/jeq026; Madriago E, 2010, EUROPACE, V12, P1341, DOI 10.1093/europace/euq169; Morbach C, 2014, PROG CARDIOVASC DIS, V57, P19, DOI 10.1016/j.pcad.2014.05.005; Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031; Pellikka PA, 2005, CIRCULATION, V111, P3290, DOI 10.1161/CIRCULATIONAHA.104.495903; Rost C, 2010, EUR J ECHOCARDIOGR, V11, P584, DOI 10.1093/ejechocard/jeq017; Shirali GS, 2012, ECHOCARDIOGR-J CARD, V29, P242, DOI 10.1111/j.1540-8175.2011.01612.x; Smedsrud MK, 2011, J AM SOC ECHOCARDIOG, V24, P1253, DOI 10.1016/j.echo.2011.08.003; Staron A, 2013, INT J CARDIOVAS IMAG, V29, P797, DOI 10.1007/s10554-012-0160-z; Veress G, 2013, HEART FAIL REV, V18, P267, DOI 10.1007/s10741-012-9325-z	22	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140469	10.1371/journal.pone.0140469	http://dx.doi.org/10.1371/journal.pone.0140469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473730	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500057
J	Al-Hamidhi, S; Tageldin, MH; Weir, W; Al-Fahdi, A; Johnson, EH; Bobade, P; Alqamashoui, B; Beja-Pereira, A; Thompson, J; Kinnaird, J; Shiels, B; Tait, A; Babiker, H				Al-Hamidhi, Salama; Tageldin, Mohammed. H.; Weir, William; Al-Fahdi, Amira; Johnson, Eugene H.; Bobade, Patrick; Alqamashoui, Badar; Beja-Pereira, Albano; Thompson, Joanne; Kinnaird, Jane; Shiels, Brian; Tait, Andy; Babiker, Hamza			Genetic Diversity and Population Structure of Theileria annulata in Oman	PLOS ONE			English	Article							MOLECULAR-DETECTION; CLONAL THEORY; PLASMODIUM; EVOLUTION; PARVA	Background Theileriosis, caused by a number of species within the genus Theileria, is a common disease of livestock in Oman. It is a major constraint to the development of the livestock industry due to a high rate of morbidity and mortality in both cattle and sheep. Since little is currently known about the genetic diversity of the parasites causing theileriosis in Oman, the present study was designed to address this issue with specific regard to T. annulata in cattle. Methods Blood samples were collected from cattle from four geographically distinct regions in Oman for genetic analysis of the Theileria annulata population. Ten genetic markers (micro- and mini-satellites) representing all four chromosomes of T. annulata were applied to these samples using a combination of PCR amplification and fragment analysis. The resultant genetic data was analysed to provide a first insight into the structure of the T. annulata population in Oman. Results We applied ten micro-and mini-satellite markers to a total of 310 samples obtained from different regions (174 [56%] from Dhofar, 68 [22%] from Dhira, 44 [14.5%] from Batinah and 24 [8%] from Sharqia). A high degree of allelic diversity was observed among the four parasite populations. Expected heterozygosity for each site ranged from 0.816 to 0.854. A high multiplicity of infection was observed in individual hosts, with an average of 3.3 to 3.4 alleles per locus, in samples derived from Batinah, Dhofar and Sharqia regions. In samples from Dhira region, an average of 2.9 alleles per locus was observed. Mild but statistically significant linkage disequilibrium between pairs of markers was observed in populations from three of the four regions. In contrast, when the analysis was performed at farm level, no significant linkage disequilibrium was observed. Finally, no significant genetic differentiation was seen between the four populations, with most pair-wise F-ST values being less than 0.03. Slightly higher FST values (G(ST)' = 0.075, theta=0.07) were detected when the data for T. annulata parasites in Oman was compared with that previously generated for Turkey and Tunisia. Conclusion Genetic analyses of T. annulata samples representing four geographical regions in Oman revealed a high level of genetic diversity in the parasite population. There was little evidence of genetic differentiation between parasites from different regions, and a high level of genetic diversity was maintained within each sub-population. These findings are consistent with a high parasite transmission rate and frequent movement of animals between different regions in Oman.	[Al-Hamidhi, Salama; Al-Fahdi, Amira; Babiker, Hamza] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Biochem, Al Khoud, Oman; [Tageldin, Mohammed. H.; Johnson, Eugene H.; Bobade, Patrick] Sultan Qaboos Univ, Dept Anim & Vet Sci, Coll Agr & Marine Sci, Al Khoud, Oman; [Weir, William; Kinnaird, Jane; Shiels, Brian; Tait, Andy] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Alqamashoui, Badar] Minist Agr & Fisheries, Muscat, Oman; [Beja-Pereira, Albano] Univ Porto, Res Ctr Biodivers & Genet Resources CIBIO, P-4485661 Vairao, Portugal; [Thompson, Joanne; Babiker, Hamza] Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Inst Evolut Immunol & Infect Res,Ashworth Labs, Edinburgh, Midlothian, Scotland	Sultan Qaboos University; Sultan Qaboos University; University of Glasgow; Universidade do Porto; University of Edinburgh	Babiker, H (corresponding author), Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Biochem, POB 35,Postal Code 123, Al Khoud, Oman.	hbabiker@squ.edu.om	Beja-Pereira, Albano/B-3681-2008; AL-HAMIDHI, SALAMA/HDN-6457-2022	Beja-Pereira, Albano/0000-0002-1607-7382; Shiels, Brian/0000-0001-7595-2514; JOHNSON, EUGENE/0000-0003-2237-9675; Thompson, joanne/0000-0002-3343-2278; Weir, William/0000-0001-8648-666X	Research Council Oman [RC/MED/BIOC/13/01]; PiroVac	Research Council Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman); PiroVac	This work was supported by the Research Council Oman, (https://home.trc.gov.om/tabid/40/language/en-US/Default.aspx), Grant Number RC/MED/BIOC/13/01. SA received a training fellowship from PiroVac (http://www.theileria.org/pirovac/index.htm). WW, BS and JK were all funded by PIROVAC.	Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; [Anonymous], 1996, EVALUATION FORENSIC; Awadalla P, 2001, TRENDS PARASITOL, V17, P351, DOI 10.1016/S1471-4922(01)02034-7; Beck HP, 2009, INT J PARASITOL, V39, P175, DOI 10.1016/j.ijpara.2008.10.001; Belotindos LP, 2014, ACTA PARASITOL, V59, P448, DOI 10.2478/s11686-014-0256-9; Bobade Pa A-RS, 2015, BRIT SOC ANIMAL SCI, V6, P74; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; CONWAY DJ, 1991, PARASITOLOGY, V103, P1, DOI 10.1017/S0031182000059217; Conway DJ, 1999, P NATL ACAD SCI USA, V96, P4506, DOI 10.1073/pnas.96.8.4506; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Dobbelaere D, 1999, ANNU REV MICROBIOL, V53, P1, DOI 10.1146/annurev.micro.53.1.1; DOLIVEIRA C, 1995, J CLIN MICROBIOL, V33, P2665, DOI 10.1128/JCM.33.10.2665-2669.1995; Durand P, 2003, AM J TROP MED HYG, V68, P345, DOI 10.4269/ajtmh.2003.68.345; EXCOFFIER L, 1992, GENETICS, V131, P479; GAUER M, 1995, PARASITOL RES, V81, P565, DOI 10.1007/BF00932023; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; HILL WG, 1995, GENET RES, V65, P53, DOI 10.1017/S0016672300033000; Hill WG, 1995, P ROY SOC B-BIOL SCI, V262, P249, DOI 10.1098/rspb.1995.0203; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Inci A, 2007, PARASITOL RES, V101, pS171, DOI 10.1007/s00436-007-0693-6; Katzer F, 2006, INFECT IMMUN, V74, P5456, DOI 10.1128/IAI.00472-06; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Muleya W, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-255; NEI M, 1974, GENETICS, V76, P379; Nei M., 1987, MOL EVOLUTIONARY GEN; Oura CAL, 2005, MOL BIOCHEM PARASIT, V140, P229, DOI 10.1016/j.molbiopara.2004.12.015; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Santos M, 2013, TICKS TICK-BORNE DIS, V4, P72, DOI 10.1016/j.ttbdis.2012.07.006; Sivakumar T, 2014, INFECT GENET EVOL, V27, P250, DOI 10.1016/j.meegid.2014.07.013; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; TIBAYRENC M, 1991, PARASITOL TODAY, V7, P228, DOI 10.1016/0169-4758(91)90234-F; UILENBERG G, 1995, VET PARASITOL, V57, P19, DOI 10.1016/0304-4017(94)03107-8; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Weir W, 2007, MOL BIOCHEM PARASIT, V154, P170, DOI 10.1016/j.molbiopara.2007.04.015; Weir W, 2011, INT J PARASITOL, V41, P193, DOI 10.1016/j.ijpara.2010.08.004	40	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0139581	10.1371/journal.pone.0139581	http://dx.doi.org/10.1371/journal.pone.0139581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469349	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000363184600013
J	Gaynes, BN; Pence, BW; Atashili, J; O'Donnell, JK; Njamnshi, AK; Tabenyang, ME; Arrey, CK; Whetten, R; Whetten, K; Ndumbe, P				Gaynes, Bradley N.; Pence, Brian W.; Atashili, Julius; O'Donnell, Julie K.; Njamnshi, Alfred K.; Tabenyang, Mbu Eyongetah; Arrey, Charles Kefie; Whetten, Rachel; Whetten, Kathryn; Ndumbe, Peter			Changes in HIV Outcomes Following Depression Care in a Resource-Limited Setting: Results from a Pilot Study in Bamenda, Cameroon	PLOS ONE			English	Article							IDENTIFICATION TEST AUDIT; SELF-REPORTED ADHERENCE; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; MENTAL-HEALTH; PSYCHIATRIC-DISORDERS; RISK BEHAVIORS; HIV/AIDS; VALIDITY; POPULATION	Background Little is known about how improved depression care affects HIV-related outcomes in Africa. In a sample of depressed HIV patients in a low income, sub-Saharan country, we explored how implementing measurement-based antidepressant care (MBC) affected HIV outcomes over 4 months of antidepressant treatment. Methods As part of a project adapting MBC for use in Cameroon, we enrolled 41 depressed HIV patients on antiretroviral therapy in a pilot study in which a depression care manager (DCM) provided an outpatient HIV clinician with evidence-based decision support for antidepressant treatment. Acute depression management was provided for the first 12 weeks, with DCM contact every 2 weeks and HIV clinician appointments every 4 weeks. We measured HIV clinical and psychiatric outcomes at 4 months. Results Participants were moderately depressed at baseline (mean Patient Health Questionnaire [PHQ] score = 14.4, range 13.1, 15.6). All HIV clinical outcomes improved by four month follow-up: mean (range) CD4 count improved from 436 (2, 860) to 452 (132, 876), mean (range) log-viral load decreased from 4.02 (3.86, 4.17) to 3.15 (2.81, 3.49), the proportion with virologic suppression improved from 0% to 18%, mean (range) HIV symptoms decreased from 6.4 (5.5, 7.3) to 3.1 (2.5, 3.7), the proportion reporting good or excellent health improved from 18% to 70%, and the proportion reporting any missed ARV doses in the past month decreased from 73% to 55%. Concurrently, psychiatric measures improved. The mean (range) PHQ score decreased from 14.4 (13.1, 15.6) to 1.6 (0.8, 2.4) and 90% achieved depression remission, while mean maladaptive coping style scores decreased and mean adaptive coping scores and self-efficacy scores improved. Conclusion In this pilot study of an evidence-based depression treatment intervention for HIV-infected patients in Cameroon, a number of HIV behavioral and non-behavioral health outcomes improved over 4 months of effective depression treatment. These data are consistent with the hypothesis that better depression care can lead to improved HIV outcomes.	[Gaynes, Bradley N.] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27599 USA; [Pence, Brian W.; O'Donnell, Julie K.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Atashili, Julius] Univ Buea, Buea, Cameroon; [Njamnshi, Alfred K.] Univ Yaounde I, Dept Internal Med, Neurol Unit, Yaounde, Cameroon; [Tabenyang, Mbu Eyongetah] Bamenda Hosp, HIV AIDS Treatment Ctr, Bamenda, Cameroon; [Arrey, Charles Kefie] Bamenda Hosp, Reg Tech Grp Fight HIV North West Reg, Bamenda, Cameroon; [Whetten, Rachel; Whetten, Kathryn] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Ndumbe, Peter] Univ Buea, Dept Biomed Sci, Buea, Cameroon; [Ndumbe, Peter] Univ Yaounde I, Dept Microbiol & Immunol, Yaounde, Cameroon	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Yaounde I; Duke University; University of Yaounde I	Gaynes, BN (corresponding author), Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27599 USA.	Bradley_gaynes@med.unc.edu		NJAMNSHI, Alfred K./0000-0003-0052-1511	National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA [R34 MH084673]; NC TRACS Institute; NIH National Center for Research Resources [UL1RR025747, KL2RR025746, TLRR025745]; National Center for Advancing Translational Sciences, National Institutes of Health; NIH [P30 AI064518]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025746, UL1RR025747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, T32AI070114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH084673] Funding Source: NIH RePORTER	National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA; NC TRACS Institute; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by grant R34 MH084673 of the National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. BNG receives funding from the NC TRACS Institute, which is supported by grants UL1RR025747, KL2RR025746, and TLRR025745 from the NIH National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health. This publication was made possible with help from the Duke University Center for AIDS Research (CFAR), an NIH funded program (P30 AI064518). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIMH or the NIH. The funders had no role in study design, data collection and analysis, preparation of the manuscript, or decision to publish.	Adams JL, 2012, AIDS PATIENT CARE ST, V26, P647, DOI 10.1089/apc.2012.0113; Adewuya AO, 2007, J PSYCHOSOM RES, V63, P203, DOI 10.1016/j.jpsychores.2007.03.006; Amico KR, 2006, JAIDS-J ACQ IMM DEF, V42, P455, DOI 10.1097/01.qai.0000225020.73760.c2; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Blashill AJ, 2012, J BEHAV MED; Breuer E, 2011, AJAR-AFR J AIDS RES, V10, P101, DOI 10.2989/16085906.2011.593373; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Collins PY, 2006, AIDS, V20, P1571, DOI 10.1097/01.aids.0000238402.70379.d4; Dybek I, 2006, J STUD ALCOHOL, V67, P473, DOI 10.15288/jsa.2006.67.473; Freeman MC, 2005, BRIT J PSYCHIAT, V187, P1, DOI 10.1192/bjp.187.1.1; Freeman M, 2008, S AFR J PSYCHOL, V38, P489, DOI 10.1177/008124630803800304; Gaynes BN, 2008, J GEN INTERN MED, V23, P551, DOI 10.1007/s11606-008-0522-3; Gaynes BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041699; Gonzalez JS, 2011, ANN BEHAV MED, V42, P120, DOI 10.1007/s12160-011-9268-y; Horberg MA, 2008, JAIDS-J ACQ IMM DEF, V47, P384, DOI 10.1097/QAI.0b013e318160d53e; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Landis SE, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-7; Layous K, 2011, J ALTERN COMPLEM MED, V17, P675, DOI 10.1089/acm.2011.0139; Pence BW, 2012, J AFFECT DISORDERS, V143, P208, DOI 10.1016/j.jad.2012.05.056; Pence BW, 2014, AIDS BEHAV IN PRESS; Primeau MM, 2013, PSYCHOSOMATICS; Pyne JM, 2011, ARCH INTERN MED, V171, P23, DOI 10.1001/archinternmed.2010.395; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sebit M B, 2003, East Afr Med J, V80, P503; Stein MD, 2003, AM J PSYCHIAT, V160, P1659, DOI 10.1176/appi.ajp.160.9.1659; Tsai AC, 2010, ARCH GEN PSYCHIAT, V67, P1282, DOI 10.1001/archgenpsychiatry.2010.160; Wagner GJ, 2012, AIDS BEHAV, V16, P1862, DOI 10.1007/s10461-011-0051-7; Watt MH, 2010, AIDS CARE, V22, P381, DOI 10.1080/09540120903193708; WHO, 2008, MHGAP MENTAL HLTH GA; Wisniewski Stephen R, 2006, J Psychiatr Pract, V12, P71, DOI 10.1097/00131746-200603000-00002; World Health Organization, 2007, ESSENTIAL PREVENTION; Yang XS, 2006, AIDS BEHAV, V10, P71, DOI 10.1007/s10461-005-9028-8; Yun LWH, 2005, JAIDS-J ACQ IMM DEF, V38, P432, DOI 10.1097/01.qai.0000147524.19122.fd	34	31	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140001	10.1371/journal.pone.0140001	http://dx.doi.org/10.1371/journal.pone.0140001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0CX	26469186	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600024
J	Li, XH; Wang, XP; Gu, WS; Lin, JH; Huang, H; Kang, T; Zhang, L; Chen, H; Zheng, X				Li, Xiao-Hui; Wang, Xue-Ping; Gu, Wen-Shen; Lin, Jian-Hua; Huang, Hao; Kang, Ting; Zhang, Lin; Chen, Hao; Zheng, Xin			Clinical Significance of Preoperative Thrombin Time in Patients with Esophageal Squamous Cell Carcinoma following Surgical Resection	PLOS ONE			English	Article							D-DIMER; PROGNOSTIC-SIGNIFICANCE; PROTHROMBOTIC STATE; THROMBOPHILIC STATE; CANCER; COAGULATION; RISK; THROMBOEMBOLISM; ABNORMALITIES; MALIGNANCY	Background Noninvasive tools for the prognosis of ESCC are urgently needed. To this end, serum coagulation tests have been researched in some cancers, but the prognostic value of the TT in ESCC has not been described. Methods The levels of pre-treatment serum coagulation markers (including the PT, APTT, PTA, INR, fibrinogen level, TT and PLT) were retrospectively analyzed in 204 patients with ESCC who underwent surgical resection at our department and in 200 healthy controls, and the two groups were compared. The prognostic significance of the coagulation tests was then determined with univariate and multivariate cox hazard analyses in patients with ESCC. Results Compared with those in normal controls, the PT, APTT, and fibrinogen levels were significantly increased, whereas the TT values significantly decreased in the 204 ESCC patients. The TT directly correlated with the 5-year survival rate, not only in the entire ESCC cohort (p = 0.023) but also in the subgroups stratified according to the T and N classifications and metastasis. Conversely, the other tests were not independent prognostic factors for ESCC. Of the clotting markers, the TT inversely correlated with the fibrinogen level (p = 0.005). Conclusions The 5-year survival was shorter in ESCC patients exhibiting decreased pre-treatment TT values. Thus, the serum TT may be a clinical prognostic factor for ESCC patients.	[Li, Xiao-Hui; Wang, Xue-Ping; Lin, Jian-Hua; Kang, Ting; Zhang, Lin; Chen, Hao; Zheng, Xin] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Li, Xiao-Hui; Wang, Xue-Ping; Lin, Jian-Hua; Kang, Ting; Zhang, Lin; Chen, Hao; Zheng, Xin] Sun Yat Sen Univ, Dept Clin Lab Med, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Gu, Wen-Shen] Sun Yat Sen Mem Hosp, Dept Clin Lab Med, Guangzhou, Guangdong, Peoples R China; [Huang, Hao] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Clin Lab Med, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Lin] Guangdong Esophageal Canc Inst, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Chen, H (corresponding author), Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	chenhao@sysucc.org.cn; zhengxin@sysucc.org.cn	zhan, lin/AAP-5149-2020; ZHANG, LIN/GYD-9123-2022		Guangdong Esophageal Cancer Institute, Guangdong, China [02250301]	Guangdong Esophageal Cancer Institute, Guangdong, China	This study was financially supported by Guangdong Esophageal Cancer Institute, Guangdong, China (No. 02250301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirkhosravi A, 2007, SEMIN THROMB HEMOST, V33, P643, DOI 10.1055/s-2007-991531; BICK RL, 1992, SEMIN THROMB HEMOST, V18, P353, DOI 10.1055/s-2007-1002575; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; Bottasso B, 1996, THROMB RES, V81, P345, DOI 10.1016/0049-3848(96)00006-0; De Cicco M, 2004, CRIT REV ONCOL HEMAT, V50, P187, DOI 10.1016/j.critrevonc.2003.10.003; Dirix LY, 2002, BRIT J CANCER, V86, P389, DOI 10.1038/sj.bjc.6600069; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Falanga A, 1999, SEMIN THROMB HEMOST, V25, P173, DOI 10.1055/s-2007-994919; Falanga A, 2001, INT J HEMATOL, V73, P137, DOI 10.1007/BF02981929; Falanga Anna, 2003, Clin Adv Hematol Oncol, V1, P673; GOODNIGHT SH, 1974, ANN NY ACAD SCI, V230, P271, DOI 10.1111/j.1749-6632.1974.tb14459.x; Gouin-Thibault I, 2001, ACTA HAEMATOL-BASEL, V106, P33, DOI 10.1159/000046587; Hefler-Frischmuth K, 2015, GYNECOL ONCOL, V136, P567, DOI 10.1016/j.ygyno.2014.12.041; Ilson DH, 2007, ANN ONCOL, V18, P898, DOI 10.1093/annonc/mdm004; Iversen LH, 2002, THROMB HAEMOSTASIS, V87, P402; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khorana AA, 2006, J CLIN ONCOL, V24, P484, DOI 10.1200/JCO.2005.03.8877; Kuderer NM, 2009, J CLIN ONCOL, V27, P4902, DOI 10.1200/JCO.2009.22.4584; Li K, 2002, INT J CANCER, V102, P271, DOI [10.1002/ijc.10706, 10.1002/jhc.10706]; Longer E, 2008, HAMOSTASEOLOGIE, V28, P472; Loreto M. F., 2000, Pathology and Oncology Research, V6, P301; Matsuda S, 2014, DIS ESOPHAGUS, V27, P654, DOI 10.1111/dote.12115; Mytnik M, 2011, NEOPLASMA, V58, P235, DOI 10.4149/neo_2011_03_235; Oberhoff C, 2000, EUR J GYNAECOL ONCOL, V21, P560; Oya M, 2001, JPN J CLIN ONCOL, V31, P388, DOI 10.1093/jjco/hye075; RICKLES FR, 1983, BLOOD, V62, P14; Rickles FR, 2001, THROMB RES, V102, pV215, DOI 10.1016/S0049-3848(01)00285-7; Shimada H, 2004, J AM COLL SURGEONS, V198, P737, DOI 10.1016/j.jamcollsurg.2004.01.022; Shu YJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-566; Sun W, 2015, AM J CLIN ONCOLOGY, V1; Tas F, 2013, RESP MED, V107, P451, DOI 10.1016/j.rmed.2012.11.007; Thodiyil PA, 2002, THROMB HAEMOSTASIS, V87, P1076, DOI 10.1055/s-0037-1613136; Thurner EM, 2014, WORLD J UROL; Wang Jian-qiang, 2015, ScientificWorldJournal, V2015, P806983, DOI 10.1155/2015/806983; Zheng S, 2009, CANCER SCI, V100, P859, DOI 10.1111/j.1349-7006.2009.01115.x	35	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140323	10.1371/journal.pone.0140323	http://dx.doi.org/10.1371/journal.pone.0140323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469700	Green Submitted, Green Published, gold			2022-12-26	WOS:000363184600041
J	McKinnon, AD; Doyle, J; Duggan, S; Logan, M; Lonborg, C; Brinkman, R				McKinnon, A. David; Doyle, Jason; Duggan, Samantha; Logan, Murray; Lonborg, Christian; Brinkman, Richard			Zooplankton Growth, Respiration and Grazing on the Australian Margins of the Tropical Indian and Pacific Oceans	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SUBTROPICAL WATERS ADJACENT; TRANSPORT-SYSTEM ACTIVITY; COPEPOD EGG-PRODUCTION; COMMUNITY STRUCTURE; WESTERN-AUSTRALIA; NORTH QUEENSLAND; COASTAL WATERS; PHYTOPLANKTON; MICROZOOPLANKTON	The specific activity of aminoacyl-tRNA synthetases (spAARS), an index of growth rate, and of the electron transport system (spETS), an index of respiration, was measured in three size fractions (73-150 mu m, > 150 mu m and > 350 mu m) of zooplankton during five cruises to tropical coastal waters of the Kimberley coast (North West Australia) and four cruises to waters of the Great Barrier Reef (GBR; North East Australia). The N-specific biomass of plankton was 3-4-fold higher in the Kimberley than on the GBR in all 3 size classes: Kimberley 1.27, 3.63, 1.94 mg m(-3); GBR 0.36, 0.88 and 0.58 mg m-3 in the 73-150 mu m, > 150 mu m and > 350 mu m size classes, respectively. Similarly, spAARS activity in the Kimberley was greater than that of the GBR: 88.4, 132.2, and 147.6 nmol PPi hr(-1) mg protein(-1) in the Kimberley compared with 71.7, 82.0 and 83.8 nmol PPi hr(-1) mg protein(-1) in the GBR, for the 73-150 mu m, > 150 mu m and > 350 mu m size classes, respectively. Specific ETS activity showed similar differences in scale between the two coasts: 184.6, 148.8 and 92.2 mu L O-2 hr(-1) mg protein-1 in the Kimberley, against 86.5, 88.3 and 71.3 mu L O2 hr(-1) mg protein(-1) in the GBR. On the basis of these measurements, we calculated that > 150 mu m zooplankton grazing accounted for 7% of primary production in the Kimberley and 8% in GBR waters. Area-specific respiration by > 73 mu m zooplankton was 7-fold higher in the Kimberley than on the GBR and production by > 150 mu m zooplankton was of the order of 278 mg C m(-2) d(-1) in the Kimberley and 42 mg C m(-2) d(-1) on the GBR. We hypothesize that the much stronger physical forcing on the North West shelf is the principal driver of higher rates in the west than in the east of the continent.	[McKinnon, A. David; Doyle, Jason; Duggan, Samantha; Logan, Murray; Lonborg, Christian; Brinkman, Richard] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [McKinnon, A. David; Brinkman, Richard] Western Australian Marine Sci Inst, Perth, WA, Australia; [McKinnon, A. David] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4810, Australia	Australian Institute of Marine Science; James Cook University	McKinnon, AD (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	d.mckinnon@aims.gov.au	Brinkman, Ryan/B-1108-2008; Lønborg, Christian/M-4456-2013	Brinkman, Ryan/0000-0002-9765-2990; Lønborg, Christian/0000-0001-8380-0238; McKinnon, David/0000-0002-6983-2126; Logan, Murray/0000-0001-5102-3972	Australian Institute of Marine Science (AIMS); Australian Research Council [DP1095294]; Great Barrier Reef Foundation; Bureau of Meteorology, Commonwealth Scientific and Industrial Research Organization	Australian Institute of Marine Science (AIMS); Australian Research Council(Australian Research Council); Great Barrier Reef Foundation; Bureau of Meteorology, Commonwealth Scientific and Industrial Research Organization	Core funding for this project was provided by the Australian Institute of Marine Science (AIMS). The Kimberley component was enabled by collaboration and opportunities developed by AIMS' partnership in the Western Australian Marine Science Institution. The 2011 Kimberley cruises were partially supported by Australian Research Council grant DP1095294 to Greg Ivey (University of Western Australia). The GBR component of this project received support from eReefs, a collaboration between the Great Barrier Reef Foundation, Bureau of Meteorology, Commonwealth Scientific and Industrial Research Organization, AIMS and the Queensland Government, supported by funding from the Australian and Queensland Governments, the BHP Billiton Mitsubishi Alliance and the Science and Industry Endowment Fund.	Alongi DM, 2005, MAR POLLUT BULL, V51, P239, DOI 10.1016/j.marpolbul.2004.10.033; Arrhenius S., 1889, Z PHYS CHEM, V4, P96, DOI [DOI 10.1515/ZPCH-1889-0408, 10.1515/zpch-1889-0408]; Bamstedt U., 2000, P297; Behrenfeld MJ, 2014, ANNU REV MAR SCI, V6, P167, DOI 10.1146/annurev-marine-052913-021325; BIDIGARE RR, 1982, J PLANKTON RES, V4, P895, DOI 10.1093/plankt/4.4.895; Brinkman R, 2002, ESTUAR COAST SHELF S, V54, P655, DOI 10.1006/ecss.2001.0850; Brodie JE, 2012, MAR POLLUT BULL, V65, P81, DOI 10.1016/j.marpolbul.2011.12.012; Calbet A, 1999, LIMNOL OCEANOGR, V44, P1370, DOI 10.4319/lo.1999.44.6.1370; Calbet A, 2001, LIMNOL OCEANOGR, V46, P1824, DOI 10.4319/lo.2001.46.7.1824; Calbet A, 2008, ICES J MAR SCI, V65, P325, DOI 10.1093/icesjms/fsn013; CHANG GG, 1984, ANAL BIOCHEM, V142, P369, DOI 10.1016/0003-2697(84)90478-0; Condie SA, 2008, CONT SHELF RES, V28, P1724, DOI 10.1016/j.csr.2008.04.003; Condie SA, 2006, MAR FRESHWATER RES, V57, P569, DOI 10.1071/MF06009; Darnis G, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007374; Devlin M, 2009, MAR FRESHWATER RES, V60, P1109, DOI 10.1071/MF08343; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Fernandez-Urruzola I, 2014, J MARINE SYST, V140, P138, DOI 10.1016/j.jmarsys.2014.05.009; Fletcher WJ, 2015, ECOL APPL, V25, P1187, DOI 10.1890/14-1427.1; Friedland KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028945; Furnas M, 2005, MAR POLLUT BULL, V51, P253, DOI 10.1016/j.marpolbul.2004.11.010; Furnas M, 2011, CONT SHELF RES, V31, P1967, DOI 10.1016/j.csr.2011.09.007; Furnas M, 2007, CONT SHELF RES, V27, P958, DOI 10.1016/j.csr.2007.01.002; FURNAS MJ, 1987, CONT SHELF RES, V7, P1049, DOI 10.1016/0278-4343(87)90098-7; Gehringer JW, 1974, ZOOPLANKTON SAMPLI 1, P87; Gelman A., 2007, DATA ANAL USING REGR; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Goswami SC, 1996, INDIAN J MAR SCI, V25, P91; Great Barrier Reef Marine Park Authority, FACTS GREAT BARR REE; Hernandez-Leon S, 2005, J PLANKTON RES, V27, P153, DOI 10.1093/plankt/fbh166; Hernandez-Leon Santiago, 2005, P57; Herrera A, 2014, J MARINE SYST, V131, P54, DOI 10.1016/j.jmarsys.2013.11.004; Herrera I, 2012, J EXP MAR BIOL ECOL, V416, P101, DOI 10.1016/j.jembe.2012.02.019; Hopcroft RR, 1998, J PLANKTON RES, V20, P539, DOI 10.1093/plankt/20.3.539; IKEDA T, 1978, FISH B-NOAA, V76, P357; Ikeda T., 2000, P455, DOI 10.1016/B978-012327645-2/50011-6; KENNER RA, 1975, MAR BIOL, V33, P119, DOI 10.1007/BF00390716; Kiorboe T, 2014, AM NAT, V183, pE118, DOI 10.1086/675241; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McKinnon AD, 2015, ESTUAR COAST SHELF S, V153, P156, DOI 10.1016/j.ecss.2014.11.006; McKinnon AD, 2013, LIMNOL OCEANOGR, V58, P1227, DOI 10.4319/lo.2013.58.4.1227; Mckinnon A.D., 2014, COPEPODS DIVERSITY H, P25; McKinnon AD, 2014, ANNU REV MAR SCI, V6, P415, DOI 10.1146/annurev-marine-010213-135042; McKinnon AD, 2005, ESTUAR COAST SHELF S, V63, P497, DOI 10.1016/j.ecss.2004.12.011; McKinnon AD, 2003, MAR BIOL, V143, P897, DOI 10.1007/s00227-003-1153-1; MCKINNON AD, 1993, J PLANKTON RES, V15, P1387, DOI 10.1093/plankt/15.12.1387; McKinnon AD, 2001, HYDROBIOLOGIA, V453, P121, DOI 10.1023/A:1013115900841; McKinnon AD, 1998, HYDROBIOLOGIA, V362, P145; Meekan MG, 2003, MAR ECOL PROG SER, V256, P193, DOI 10.3354/meps256193; Molony B. W., 2011, Journal of the Royal Society of Western Australia, V94, P323; Moritz CM, 2006, MAR BIOL RES, V2, P1, DOI 10.1080/17451000500497159; NEWBURY TK, 1976, PAC SCI, V30, P373; Omori M., 1984, METHODS MARINE ZOOPL; OWENS TG, 1975, MAR BIOL, V30, P27, DOI 10.1007/BF00393750; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Paterson HL, 2008, J PLANKTON RES, V30, P379, DOI 10.1093/plankt/fbn004; Paterson HL, 2007, DEEP-SEA RES PT II, V54, P1076, DOI 10.1016/j.dsr2.2006.12.011; Peterson WT, 1995, J PLANKTON RES, V17, P2275, DOI 10.1093/plankt/17.12.2275; Plummer M., 2003, P 3 INT WORKSH DISTR; R Core Team, 2011, R LANG ENV STAT COMP; Richardson TL, 2007, SCIENCE, V315, P838, DOI 10.1126/science.1133471; Robinson C, 2005, RESPIRATION IN AQUATIC ECOSYSTEMS, P147, DOI 10.1093/acprof:oso/9780198527084.003.0009; Roman M, 2000, DEEP-SEA RES PT II, V47, P1423, DOI 10.1016/S0967-0645(99)00149-6; ROMAN MR, 1990, MAR BIOL, V105, P73, DOI 10.1007/BF01344272; Runge J.A., 2000, P401, DOI 10.1016/B978-012327645-2/50010-4; Sampey A, 2007, MAR ECOL PROG SER, V339, P243, DOI 10.3354/meps339243; Sorokin YI, 2010, J MAR BIOL ASSOC UK, V90, P1173, DOI 10.1017/S0025315410000597; Su Y-S, R2JAGS PACKAGE RUNNI; Thompson P. A., 2011, Journal of the Royal Society of Western Australia, V94, P161; Thompson PA, 2011, DEEP-SEA RES PT II, V58, P645, DOI 10.1016/j.dsr2.2010.10.003; Tranter DJ, 1962, ZOOPLANKTON ABUNDANC, V32, P106; Verdugo P, 2004, MAR CHEM, V92, P67, DOI 10.1016/j.marchem.2004.06.017; Yebra L, 2005, MAR BIOL, V147, P1367, DOI 10.1007/s00227-005-0039-9; Yebra L, 2004, J PLANKTON RES, V26, P351, DOI 10.1093/plankt/fbh028; Yebra L, 2011, J EXP MAR BIOL ECOL, V406, P87, DOI 10.1016/j.jembe.2011.06.019; Zamora-Terol S, 2014, J PLANKTON RES, V36, P1047, DOI 10.1093/plankt/fbu039	75	18	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140012	10.1371/journal.pone.0140012	http://dx.doi.org/10.1371/journal.pone.0140012			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469275	Green Published, Green Accepted, gold			2022-12-26	WOS:000363184600025
J	Rohrbach, TD; Shah, N; Jackson, WP; Feeney, EV; Scanlon, S; Gish, R; Khodadadi, R; Hyde, SO; Hicks, PH; Anderson, JC; Jarboe, JS; Willey, CD				Rohrbach, Timothy D.; Shah, Nishi; Jackson, William P.; Feeney, Erin V.; Scanlon, Samantha; Gish, Robert; Khodadadi, Ryan; Hyde, Stephen O.; Hicks, Patricia H.; Anderson, Joshua C.; Jarboe, John S.; Willey, Christopher D.			The Effector Domain of MARCKS Is a Nuclear Localization Signal that Regulates Cellular PIP2 Levels and Nuclear PIP2 Localization	PLOS ONE			English	Article							C-KINASE-SUBSTRATE; EXPRESSION	Translocation to the nucleus of diacylglycerol kinase (DGK)-zeta is dependent on a sequence homologous to the effector domain of Myristoylated Alanine Rich C-Kinase Substrate (MARCKS). These data would suggest that MARCKS could also localize to the nucleus. A single report demonstrated immunofluorescence staining of MARCKS in the nucleus; however, further experimental evidence confirming the specific domain responsible for this localization has not been reported. Here, we report that MARCKS is present in the nucleus in GBM cell lines. We then over-expressed wild-type MARCKS (WT) and MARCKS with the effector domain deleted (Delta ED), both tagged with V5-epitope in a GBM cell line with low endogenous MARCKS expression (U87). We found that MARCKS-WT localized to the nucleus, while the MARCKS construct without the effector domain remained in the cytoplasm. We also found that over-expression of MARCKS-WT resulted in a significant increase in total cellular phosphatidyl-inositol (4,5) bisphosphate (PIP2) levels, consistent with prior evidence that MARCKS can regulate PIP2 levels. We also found increased staining for PIP2 in the nucleus with MARCKS-WT over-expression compared to MARCKS.ED by immunofluorescence. Interestingly, we observed MARCKS and PIP2 co-localization in the nucleus. Lastly, we found changes in gene expression when MARCKS was not present in the nucleus (MARCKS Delta ED). These data indicate that the MARCKS effector domain can function as a nuclear localization signal and that this sequence is critical for the ability of MARCKS to regulate PIP2 levels, nuclear localization, and gene expression. These data suggests a novel role for MARCKS in regulating nuclear functions such as gene expression.	[Rohrbach, Timothy D.; Shah, Nishi; Jackson, William P.; Feeney, Erin V.; Scanlon, Samantha; Gish, Robert; Khodadadi, Ryan; Hyde, Stephen O.; Hicks, Patricia H.; Anderson, Joshua C.; Jarboe, John S.; Willey, Christopher D.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Willey, CD (corresponding author), Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA.	cwilley@uab.edu	Shah, Nishi/V-5971-2019; Gish, Robert/B-3605-2018	Shah, Nishi/0000-0002-4723-6745; Gish, Robert/0000-0001-6306-3189; Anderson, Joshua/0000-0002-6977-9054	American Cancer Society [RSG-14-071-01-TBG]; National Cancer Institute of the National Institutes of Health [P20 CA151129-02]; NATIONAL CANCER INSTITUTE [P30CA013148, P20CA151129] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by RSG-14-071-01-TBG (to CDW) from The American Cancer Society (cancer.org), and a pilot grant from P20 CA151129-02 (to CDW) from the National Cancer Institute of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Arques O, 2012, STANDARDIZED RELATIV; Bickeboller M, 2015, ONCOGENE, V34, P1150, DOI 10.1038/onc.2014.40; Dove A, 2006, NAT METHODS, V3, P223, DOI 10.1038/nmeth0306-223; Fiume Roberta, 2012, Subcell Biochem, V59, P335, DOI 10.1007/978-94-007-3015-1_11; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Hartl M, 2009, P NATL ACAD SCI USA, V106, P5604, DOI 10.1073/pnas.0812101106; Isayeva T, 2015, MODERN PATHOL, V28, P631, DOI 10.1038/modpathol.2014.149; Jarboe JS, 2012, CLIN CANCER RES, V18, P3030, DOI 10.1158/1078-0432.CCR-11-3091; Kalwa H, 2011, J BIOL CHEM, V286, P2320, DOI 10.1074/jbc.M110.196022; Kopitar-Jerala N, 2007, BIOL CHEM, V388, P847, DOI 10.1515/BC.2007.092; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Michaut MA, 2005, DEV BIOL, V280, P26, DOI 10.1016/j.ydbio.2005.01.006; Neufeld KL, 1997, P NATL ACAD SCI USA, V94, P3034, DOI 10.1073/pnas.94.7.3034; Pena MJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064551; Rohrbach TD, 2015, INT J ONCOL, V46, P1079, DOI 10.3892/ijo.2014.2799; Rombouts K, 2012, AM J PHYSIOL-CELL PH, V303, pC357, DOI 10.1152/ajpcell.00093.2012; Shah ZH, 2013, FEBS J, V280, P6295, DOI 10.1111/febs.12543; Spizz G, 2001, J BIOL CHEM, V276, P32264, DOI 10.1074/jbc.M103960200; Streb JW, 2005, J BIOL CHEM, V280, P28007, DOI 10.1074/jbc.M414017200; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Toska E, 2012, CELL REP, V2, P462, DOI 10.1016/j.celrep.2012.08.005; Trovo L, 2013, NAT NEUROSCI, V16, P449, DOI 10.1038/nn.3342	25	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140870	10.1371/journal.pone.0140870	http://dx.doi.org/10.1371/journal.pone.0140870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26470026	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600123
J	Schreiber, K; Csaba, G; Haslbeck, M; Zimmer, R				Schreiber, Konrad; Csaba, Gergely; Haslbeck, Martin; Zimmer, Ralf			Alternative Splicing in Next Generation Sequencing Data of Saccharomyces cerevisiae	PLOS ONE			English	Article							RNA-SEQ; GENE-EXPRESSION; MESSENGER-RNA; BUDDING YEAST; TRANSCRIPTOME; INTRONS; GENOME; DEGRADATION; ULTRAFAST; JUNCTIONS	mRNA splicing is required in about 4% of protein coding genes in Saccharomyces cerevisiae. The gene structure of those genes is simple, generally comprising two exons and one intron. In order to characterize the impact of alternative splicing on the S. cerevisiae transcriptome, we perform a systematic analysis of mRNA sequencing data. We find evidence of a pervasive use of alternative splice sites and detect several novel introns both within and outside protein coding regions. We also find a predominance of alternative splicing on the 3' side of introns, a finding which is consistent with existing knowledge on conservation of exon-intron boundaries in S. cerevisiae. Some of the alternatively spliced transcripts allow for a translation into different protein products.	[Schreiber, Konrad; Csaba, Gergely; Zimmer, Ralf] Univ Munich, Inst Informat, D-80539 Munich, Germany; [Haslbeck, Martin] Tech Univ Munich, Dept Chem, Garching, Germany	University of Munich; Technical University of Munich	Schreiber, K (corresponding author), Univ Munich, Inst Informat, D-80539 Munich, Germany.	schreiber@bio.ifi.lmu.de	Haslbeck, Martin/A-4413-2013; Zimmer, Ralf/L-9295-2019		Ludwig-Maximilians-Universitat Munich; Deutsche Forschungsgesgemeinschaft [SFB1035]	Ludwig-Maximilians-Universitat Munich; Deutsche Forschungsgesgemeinschaft	This work was funded by Ludwig-Maximilians-Universitat Munich and in part by the collaborative research centre SFB1035, project B08 of the Deutsche Forschungsgesgemeinschaft.	Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Bonfert T, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0557-5; Bradley RK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001229; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Crotti LB, 2009, P NATL ACAD SCI USA, V106, P18954, DOI 10.1073/pnas.0907948106; Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Egecioglu DE, 2012, NUCLEIC ACIDS RES, V40, P1787, DOI 10.1093/nar/gkr864; ENGEBRECHT J, 1991, CELL, V66, P1257, DOI 10.1016/0092-8674(91)90047-3; FRANK D, 1992, GENE DEV, V6, P2112, DOI 10.1101/gad.6.11.2112; Grund SE, 2008, J CELL BIOL, V182, P897, DOI 10.1083/jcb.200803098; Guan QN, 2006, PLOS GENET, V2, P1924, DOI 10.1371/journal.pgen.0020203; Hossain MA, 2011, NUCLEIC ACIDS RES, V39, P8612, DOI 10.1093/nar/gkr497; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Juneau K, 2009, GENETICS, V183, P185, DOI 10.1534/genetics.109.105155; Kawashima T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004249; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; PATTERSON B, 1991, CELL, V64, P181, DOI 10.1016/0092-8674(91)90219-O; Pelechano V, 2013, NATURE, V497, P127, DOI 10.1038/nature12121; Plass M, 2012, RNA, V18, P1103, DOI 10.1261/rna.030767.111; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Preker PJ, 2006, RNA, V12, P994, DOI 10.1261/rna.6706; Sayani S, 2008, MOL CELL, V31, P360, DOI 10.1016/j.molcel.2008.07.005; Schwartz SH, 2008, GENOME RES, V18, P88, DOI 10.1101/gr.6818908; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Tadokoro K, 2005, J HUM GENET, V50, P382, DOI 10.1007/s10038-005-0261-9; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vilardell J, 1997, MOL CELL BIOL, V17, P1959, DOI 10.1128/MCB.17.4.1959; Volanakis A, 2013, GENE DEV, V27, P2025, DOI 10.1101/gad.221960.113; Waern K, 2013, G3-GENES GENOM GENET, V3, P343, DOI 10.1534/g3.112.003640; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106	36	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140487	10.1371/journal.pone.0140487	http://dx.doi.org/10.1371/journal.pone.0140487			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469855	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600069
J	Webby, RJ; Weaver, EA				Webby, Richard J.; Weaver, Eric A.			Centralized Consensus Hemagglutinin Genes Induce Protective Immunity against H1, H3 and H5 Influenza Viruses	PLOS ONE			English	Article							INHIBITING ANTIBODY; A VIRUSES; INFECTION; RESPONSES; VACCINES; IMMUNOGENICITY; TITERS; MODEL; MICE; NP	With the exception of the live attenuated influenza vaccine there have been no substantial changes in influenza vaccine strategies since the 1940' s. Here we report an alternative vaccine approach that uses Adenovirus-vectored centralized hemagglutinin ( HA) genes as vaccine antigens. Consensus H1-Con, H3-Con and H5-Con HA genes were computationally derived. Mice were immunized with Ad vaccines expressing the centralized genes individually. Groups of mice were vaccinated with 1 x 10(10), 5 x 10(7) and 1 x 10(7) virus particles per mouse to represent high, intermediate and low doses, respectively. 100% of the mice that were vaccinated with the high dose vaccine were protected from heterologous lethal challenges within each subtype. In addition to 100% survival, there were no signs of weight loss and disease in 7 out of 8 groups of high dose vaccinated mice. Lower doses of vaccine showed a reduction of protection in a dose-dependent manner. However, even the lowest dose of vaccine provided significant levels of protection against the divergent influenza strains, especially considering the stringency of the challenge virus. In addition, we found that all doses of H5-Con vaccine were capable of providing complete protection against mortality when challenged with lethal doses of all 3 H5N1 influenza strains. This data demonstrates that centralized H1-Con, H3-Con and H5-Con genes can be effectively used to completely protect mice against many diverse strains of influenza. Therefore, we believe that these Ad-vectored centralized genes could be easily translated into new human vaccines.	[Webby, Richard J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Weaver, Eric A.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Weaver, Eric A.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA	St Jude Children's Research Hospital; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Weaver, EA (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	eweaver2@unl.edu	Webby, Richard J/N-5657-2018		NIH NIAID grant [AI097241]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097241] Funding Source: NIH RePORTER	NIH NIAID grant(CGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH NIAID grant AI097241. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baden LR, 2013, J INFECT DIS, V207, P240, DOI 10.1093/infdis/jis670; Bart PA, 2014, J CLIN INVEST, V124, P4843, DOI 10.1172/JCI75894; Black S, 2011, PEDIATR INFECT DIS J, V30, P1081, DOI 10.1097/INF.0b013e3182367662; CDC, KEY FACTS SEAS FLU V; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Ducatez MF, 2011, P NATL ACAD SCI USA, V108, P349, DOI 10.1073/pnas.1012457108; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Gao Feng, 2004, Expert Rev Vaccines, V3, pS161, DOI 10.1586/14760584.3.4.S161; Giles BM, 2012, J INFECT DIS, V205, P1562, DOI 10.1093/infdis/jis232; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Kamlangdee A, 2014, J VIROL, V88, P13300, DOI 10.1128/JVI.01532-14; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; Li Z, 2013, J VIROL, V87, P5985, DOI 10.1128/JVI.00120-13; Margine I, 2013, J VIROL, V87, P4728, DOI 10.1128/JVI.03509-12; Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Ouedraogo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078679; Price GE, 2014, J VIROL, V88, P6019, DOI 10.1128/JVI.03101-13; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Taubenberger JK, 2011, VIRUS RES, V162, P2, DOI 10.1016/j.virusres.2011.09.003; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; van Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P872, DOI DOI 10.1111/IRV.12074; Wang W, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044883, 10.1371/journal.pone.0052488]; Weaver EA, 2010, AIDS RES HUM RETROV, V26, P577, DOI 10.1089/aid.2009.0258; Weaver EA, 2006, J VIROL, V80, P6745, DOI 10.1128/JVI.02484-05; Weaver EA, 2014, HUM VACC IMMUNOTHER, V10, P544, DOI 10.4161/hv.27238; Weaver EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018314; Zheng M, 2014, INFECTION, V42, P251, DOI 10.1007/s15010-013-0546-4	32	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140702	10.1371/journal.pone.0140702	http://dx.doi.org/10.1371/journal.pone.0140702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469190	Green Published, gold			2022-12-26	WOS:000363184600102
J	Dempsey, SJ; Gese, EM; Kluever, BM; Lonsinger, RC; Waits, LP				Dempsey, Steven J.; Gese, Eric M.; Kluever, Bryan M.; Lonsinger, Robert C.; Waits, Lisette P.			Evaluation of Scat Deposition Transects versus Radio Telemetry for Developing a Species Distribution Model for a Rare Desert Carnivore, the Kit Fox	PLOS ONE			English	Article							GREAT-BASIN DESERT; RESOURCE SELECTION; VULPES-VELOX; ACCURACY; COYOTES; ECOLOGY; PREDICTION; MAXENT; DOGS	Development and evaluation of noninvasive methods for monitoring species distribution and abundance is a growing area of ecological research. While noninvasive methods have the advantage of reduced risk of negative factors associated with capture, comparisons to methods using more traditional invasive sampling is lacking. Historically kit foxes (Vulpes macrotis) occupied the desert and semi-arid regions of southwestern North America. Once the most abundant carnivore in the Great Basin Desert of Utah, the species is now considered rare. In recent decades, attempts have been made to model the environmental variables influencing kit fox distribution. Using noninvasive scat deposition surveys for determination of kit fox presence, we modeled resource selection functions to predict kit fox distribution using three popular techniques (Maxent, fixed-effects, and mixed-effects generalized linear models) and compared these with similar models developed from invasive sampling (telemetry locations from radio-collared foxes). Resource selection functions were developed using a combination of landscape variables including elevation, slope, aspect, vegetation height, and soil type. All models were tested against subsequent scat collections as a method of model validation. We demonstrate the importance of comparing multiple model types for development of resource selection functions used to predict a species distribution, and evaluating the importance of environmental variables on species distribution. All models we examined showed a large effect of elevation on kit fox presence, followed by slope and vegetation height. However, the invasive sampling method (i.e., radio-telemetry) appeared to be better at determining resource selection, and therefore may be more robust in predicting kit fox distribution. In contrast, the distribution maps created from the noninvasive sampling (i.e., scat transects) were significantly different than the invasive method, thus scat transects may be appropriate when used in an occupancy framework to predict species distribution. We concluded that while scat deposition transects may be useful for monitoring kit fox abundance and possibly occupancy, they do not appear to be appropriate for determining resource selection. On our study area, scat transects were biased to road-ways, while data collected using radio-telemetry was dictated by movements of the kit foxes themselves. We recommend that future studies applying noninvasive scat sampling should consider a more robust random sampling design across the landscape (e.g., random transects or more complete road coverage) that would then provide a more accurate and unbiased depiction of resource selection useful to predict kit fox distribution.	[Dempsey, Steven J.; Kluever, Bryan M.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Gese, Eric M.] Utah State Univ, USDA, Wildlife Serv, Natl Wildlife Res Ctr,Dept Wildland Resources, Logan, UT 84322 USA; [Lonsinger, Robert C.; Waits, Lisette P.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA	Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University; Idaho; University of Idaho	Gese, EM (corresponding author), Utah State Univ, USDA, Wildlife Serv, Natl Wildlife Res Ctr,Dept Wildland Resources, Logan, UT 84322 USA.	eric.gese@usu.edu		Waits, Lisette/0000-0002-1323-0812; Lonsinger, Robert/0000-0002-1040-7299	Quinney College of Natural Resources, Utah State University, Logan, Utah; Endangered Species Mitigation Fund of the Utah Department of Natural Resources, Division of Wildlife Resources, Salt Lake City, Utah; U.S. Department of Defense Environmental Security Technology Certification Program; Legacy Resource Management Program; U.S. Army Dugway Proving Ground, Environmental Programs, Dugway, Utah; U.S. Department of Agriculture, Wildlife Services, National Wildlife Research Center; U.S. Department of Defense	Quinney College of Natural Resources, Utah State University, Logan, Utah; Endangered Species Mitigation Fund of the Utah Department of Natural Resources, Division of Wildlife Resources, Salt Lake City, Utah; U.S. Department of Defense Environmental Security Technology Certification Program(United States Department of Defense); Legacy Resource Management Program; U.S. Army Dugway Proving Ground, Environmental Programs, Dugway, Utah; U.S. Department of Agriculture, Wildlife Services, National Wildlife Research Center; U.S. Department of Defense(United States Department of Defense)	Funding and logistical support provided by the U.S. Department of Defense, U.S. Army Dugway Proving Ground, Environmental Programs, Dugway, Utah, and the U.S. Department of Agriculture, Wildlife Services, National Wildlife Research Center. Additional funding provided by the Quinney College of Natural Resources, Utah State University, Logan, Utah, the Endangered Species Mitigation Fund of the Utah Department of Natural Resources, Division of Wildlife Resources, Salt Lake City, Utah, and the U.S. Department of Defense Environmental Security Technology Certification Program, and the Legacy Resource Management Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Arjo WM, 2007, WEST N AM NATURALIST, V67, P389, DOI 10.3398/1527-0904(2007)67[389:CIKFRI]2.0.CO;2; Arjo WM, 2003, CAN J ZOOL, V81, P96, DOI 10.1139/Z02-232; Baasch DM, 2010, ECOL MODEL, V221, P565, DOI 10.1016/j.ecolmodel.2009.10.033; Beauvais GP, 2006, KIT FOX VULPES MACRO; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cao Y, 2013, ECOL MODEL, V259, P30, DOI 10.1016/j.ecolmodel.2013.03.012; Dempsey SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105873; EBERHARDT LE, 1982, J WILDLIFE MANAGE, V46, P183, DOI 10.2307/3808421; EGOSCUE H. J., 1956, JOUR MAMMAL, V37, P351, DOI 10.2307/1376734; EGOSCUE HJ, 1962, ECOLOGY, V43, P481, DOI 10.2307/1933376; Elbroch M., 2003, MAMMAL TRACKS SIGN G; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzgerald JP, 1996, FINAL REPORT U NO CO; Gerrard R, 2001, LANDSCAPE URBAN PLAN, V52, P239, DOI 10.1016/S0169-2046(00)00119-5; Gese E.M., 2004, P273; GESE EM, 1990, J WILDLIFE MANAGE, V54, P501, DOI 10.2307/3809665; Gese EM, 2001, CONSERV BIOL SER, V5, P372; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Gompper ME, 2006, WILDLIFE SOC B, V34, P1142, DOI 10.2193/0091-7648(2006)34[1142:ACONTT]2.0.CO;2; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harrison RL, 2002, AM MIDL NAT, V148, P320, DOI 10.1674/0003-0031(2002)148[0320:ACOPST]2.0.CO;2; Kelly MJ, 2012, TECH ECOL CONSERVAT, P47; Kluever BM, 2015, WILDLIFE RES, V42, P75, DOI 10.1071/WR14244; Knowlton FF, 1984, FINAL REPORT DENVER; Koopman ME, 2000, J MAMMAL, V81, P213, DOI 10.1644/1545-1542(2000)081<0213:DPOSJK>2.0.CO;2; Kozlowski AJ, 2008, AM MIDL NAT, V160, P191, DOI 10.1674/0003-0031(2008)160[191:NOARPB]2.0.CO;2; Kozlowski Adam J., 2012, International Journal of Ecology, P1; Long RA, 2008, NONINVASIVE SURVEY M; Long RA, 2007, J WILDLIFE MANAGE, V71, P2018, DOI 10.2193/2006-292; Lonsinger RC, 2015, WILD SOC B IN PRESS, P39; Lonsinger RC, 2015, MOL ECOL RESOUR, V15, P831, DOI 10.1111/1755-0998.12356; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Manly B.F.J., 2002, RESOURCE SELECTION A; McGrew JC, 1976, MAMMALIAN SPECIES, V123, P1; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Proulx G, 2012, TECH ECOL CONSERVAT, P70; Purvis A, 2001, CONSERV BIOL SER, V5, P11; R Development Core Team, 2012, R LANG ENV STAT COMP; Ralls K, 2004, WEST N AM NATURALIST, V64, P544; Schaller G.B., 1996, CARNIVORE BEHAV ECOL, P1; Schauster ER, 2002, WILDLIFE SOC B, V30, P464; Schauster ER, 2002, CAN J ZOOL, V80, P307, DOI 10.1139/Z02-009; Smith DA, 2005, WILDLIFE SOC B, V33, P897, DOI 10.2193/0091-7648(2005)33[897:AOSDST]2.0.CO;2; Smith DA, 2003, ANIM CONSERV, V6, P339, DOI 10.1017/S136794300300341X; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; SWIHART RK, 1985, ECOLOGY, V66, P1176, DOI 10.2307/1939170; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Thacker R. K., 1995, COMP USE 4 TECHNIQUE; Utah Department of Natural Resources, 2011, UT SENS SPEC LIST; Vynne C, 2011, CONSERV BIOL, V25, P154, DOI 10.1111/j.1523-1739.2010.01581.x; Warrick GD, 1998, J WILDLIFE MANAGE, V62, P707, DOI 10.2307/3802347; WHITE PJ, 1994, CAN J ZOOL, V72, P1831, DOI 10.1139/z94-247; ZOELLICK BW, 1989, J WILDLIFE MANAGE, V53, P955, DOI 10.2307/3809595	65	15	15	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138995	10.1371/journal.pone.0138995	http://dx.doi.org/10.1371/journal.pone.0138995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465332	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100036
J	Shin, JH; Kim, IY; Kim, YN; Shin, SM; Roh, KJ; Lee, SH; Sohn, M; Cho, SY; Lee, SH; Ko, CY; Kim, HS; Choi, CS; Bae, YS; Seong, JK				Shin, Jae Hoon; Kim, Il Yong; Kim, Yo Na; Shin, Sun Mee; Roh, Kyung Jin; Lee, Seo Hyun; Sohn, Mira; Cho, Soo Young; Lee, Sang Hyuk; Ko, Chang-Yong; Kim, Han-Sung; Choi, Cheol Soo; Bae, Yun Soo; Seong, Je Kyung			Obesity Resistance and Enhanced Insulin Sensitivity in Ahnak(-/-) Mice Fed a High Fat Diet Are Related to Impaired Adipogenesis and Increased Energy Expenditure	PLOS ONE			English	Article							PROTEIN-KINASE-C; PLURIPOTENT STEM-CELLS; ADIPOCYTE DIFFERENTIATION; ADIPOSE-TISSUE; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; PLASMA-MEMBRANE; TRANSGENIC MICE; GLUCOSE-UPTAKE; GENE	Objective Recent evidence has suggested that AHNAK expression is altered in obesity, although its role in adipose tissue development remains unclear. The objective of this study was to determine the molecular mechanism by which Ahnak influences adipogenesis and glucose homeostasis. Design We investigated the in vitro role of AHNAK in adipogenesis using adipose-derived mesenchymal stem cells (ADSCs) and C3H10T1/2 cells. AHNAK-KO male mice were fed a high-fat diet (HFD; 60% calories from fat) and examined for glucose and insulin tolerances, for body fat compositions, and by hyperinsulinemic-euglycemic clamping. Energy expenditures were assessed using metabolic cages and by measuring the expression levels of genes involved in thermogenesis in white or brown adipose tissues. Results Adipogenesis in ADSCs was impaired in AHNAK-KO mice. The loss of AHNAK led to decreased BMP4/SMAD1 signaling, resulting in the downregulation of key regulators of adipocyte differentiation (P<0.05). AHNAK directly interacted with SMAD1 on the Ppar gamma 2 promoter. Concomitantly, HFD-fed AHNAK-KO mice displayed reduced hepatosteatosis and improved metabolic profiles, including improved glucose tolerance (P<0.001), enhanced insulin sensitivity (P<0.001), and increased energy expenditure (P<0.05), without undergoing alterations in food intake and physical activity. Conclusion AHNAK plays a crucial role in body fat accumulation by regulating adipose tissue development via interaction with the SMAD1 protein and can be involved in metabolic homeostasis.	[Shin, Jae Hoon; Kim, Il Yong; Kim, Yo Na; Lee, Seo Hyun; Cho, Soo Young; Kim, Han-Sung; Seong, Je Kyung] Seoul Natl Univ, Coll Vet Med, Lab Dev Biol & Genom, Seoul, South Korea; [Shin, Jae Hoon; Kim, Il Yong; Kim, Yo Na; Lee, Seo Hyun; Cho, Soo Young; Kim, Han-Sung; Seong, Je Kyung] Seoul Natl Univ, BK21 Program Vet Sci, Seoul, South Korea; [Shin, Jae Hoon; Kim, Il Yong; Kim, Yo Na; Lee, Seo Hyun; Cho, Soo Young; Kim, Han-Sung; Seong, Je Kyung] Seoul Natl Univ, KMPC, Seoul, South Korea; [Shin, Sun Mee; Sohn, Mira] Ewha Womans Univ, Div Life Sci, Seoul, South Korea; [Roh, Kyung Jin; Choi, Cheol Soo] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Roh, Kyung Jin; Choi, Cheol Soo] Gachon Univ Med & Sci, Div Endocrinol, Gil Med Ctr, Inchon, South Korea; [Lee, Sang Hyuk] Ewha Womans Univ, Ewha Res Ctr Syst Biol, Seoul, South Korea; [Ko, Chang-Yong] Yonsei Univ, Inst Med Engn, Dept Biomed Engn, Coll Hlth Sci, Wonju, South Korea; [Seong, Je Kyung] Seoul Natl Univ, Program Canc Biol, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Seong, Je Kyung] Seoul Natl Univ, BIOMAX Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Ewha Womans University; Gachon University; Gachon University; Ewha Womans University; Yonsei University; Seoul National University (SNU); Seoul National University (SNU)	Bae, YS (corresponding author), Ewha Womans Univ, Div Life Sci, Seoul, South Korea.	baeys@ewha.ac.kr; snumouse@snu.ac.kr		Seong, Je Kyung/0000-0003-1177-6958	Korean Ministry of Science, ICT and Future Planning [KMPC:2013M3A9D5072550, 20110031224]; Brain Korea 21 Program for Veterinary Science; Research Institute for Veterinary Science of Seoul National University	Korean Ministry of Science, ICT and Future Planning; Brain Korea 21 Program for Veterinary Science(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Research Institute for Veterinary Science of Seoul National University	This work was supported by grants from the Korean Ministry of Science, ICT and Future Planning to JKS (KMPC:2013M3A9D5072550) and YSB (20110031224). This study was also partially supported by the Brain Korea 21 Program for Veterinary Science and the Research Institute for Veterinary Science of Seoul National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Alli AA, 2009, AM J PHYSIOL-CELL PH, V297, pC1157, DOI 10.1152/ajpcell.00219.2009; Atkinson BJ, 2013, DIABETES, V62, P2249, DOI 10.2337/db12-1146; Blitz IL, 2009, DEV DYNAM, V238, P1321, DOI 10.1002/dvdy.21984; Bowers RR, 2006, P NATL ACAD SCI USA, V103, P13022, DOI 10.1073/pnas.0605789103; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Fajas L, 2003, ANN MED, V35, P79, DOI 10.1080/07853890310009999; FREYTAG SO, 1988, MOL CELL BIOL, V8, P1614, DOI 10.1128/MCB.8.4.1614; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Griffith ML, 2010, AM J LIFESTYLE MED, V4, P230, DOI 10.1177/1559827609360959; Guerre-Millo M, 2004, DIABETES METAB, V30, P13, DOI 10.1016/S1262-3636(07)70084-8; HASHIMOTO T, 1995, EXP CELL RES, V217, P258, DOI 10.1006/excr.1995.1085; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356; Hohaus A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0855com; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Karasawa H, 2011, OBESITY, V19, P514, DOI 10.1038/oby.2010.171; Kim IY, 2010, BIOCHEM BIOPH RES CO, V403, P428, DOI 10.1016/j.bbrc.2010.11.048; Lee H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052474; Lee IH, 2014, ONCOGENE, V33, P4675, DOI 10.1038/onc.2014.69; Lee IH, 2004, J BIOL CHEM, V279, P26645, DOI 10.1074/jbc.M311525200; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; Li JP, 2002, AM J PHYSIOL-ENDOC M, V282, pE1334, DOI 10.1152/ajpendo.00516.2001; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Pan QH, 2008, J CELL PHYSIOL, V217, P228, DOI 10.1002/jcp.21496; Parikh H, 2008, AM J PHYSIOL-ENDOC M, V294, pE1152, DOI 10.1152/ajpendo.90255.2008; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Rajkumar K, 1999, J ENDOCRINOL, V162, P457, DOI 10.1677/joe.0.1620457; Ramdas M, 2015, HORM METAB RES, V47, P265, DOI 10.1055/s-0034-1387736; Reichert M, 1999, ONCOGENE, V18, P459, DOI 10.1038/sj.onc.1202308; Reshef R, 1998, GENE DEV, V12, P290, DOI 10.1101/gad.12.3.290; Riordan NH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-29; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; ROSSETTI L, 1990, J CLIN INVEST, V85, P1785, DOI 10.1172/JCI114636; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; Takahashi A, 2012, MOL CELL BIOL, V32, P5067, DOI 10.1128/MCB.00610-12; Tan CK, 2011, DIABETES, V60, P464, DOI 10.2337/db10-0801; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Vaillant F, 2014, AM J PHYSIOL-HEART C, V306, pH78, DOI 10.1152/ajpheart.00465.2013; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yamamoto N, 2007, J DERMATOL SCI, V48, P43, DOI 10.1016/j.jdermsci.2007.05.015; YOUN JH, 1993, DIABETES, V42, P757, DOI 10.2337/diabetes.42.5.757; Zamani N, 2011, ENDOCR REV, V32, P387, DOI 10.1210/er.2010-0018; Zehentner BK, 1999, J BONE MINER RES, V14, P1734, DOI 10.1359/jbmr.1999.14.10.1734; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167	51	15	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139720	10.1371/journal.pone.0139720	http://dx.doi.org/10.1371/journal.pone.0139720			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466345	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100057
J	Borrelli, S; Leonardis, D; Minutolo, R; Chiodini, P; De Nicola, L; Esposito, C; Mallamaci, F; Zoccali, C; Conte, G				Borrelli, Silvio; Leonardis, Daniela; Minutolo, Roberto; Chiodini, Paolo; De Nicola, Luca; Esposito, Ciro; Mallamaci, Francesca; Zoccali, Carmine; Conte, Giuseppe			Epidemiology of CKD Regression in Patients under Nephrology Care	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; DOMINANT POLYCYSTIC KIDNEY; GLOMERULAR-FILTRATION-RATE; CHRONIC NEPHROPATHIES; RENAL-FUNCTION; DECLINE; RISK; GFR; PROGRESSION; PROGNOSIS	Chronic Kidney Disease (CKD) regression is considered as an infrequent renal outcome, limited to early stages, and associated with higher mortality. However, prevalence, prognosis and the clinical correlates of CKD regression remain undefined in the setting of nephrology care. This is a multicenter prospective study in 1418 patients with established CKD (eGFR: 60-15 ml/min/1.73m(2)) under nephrology care in 47 outpatient clinics in Italy from a least one year. We defined CKD regressors as a Delta GFR >= 0 ml/min/1.73 m(2)/year. Delta GFR was estimated as the absolute difference between eGFR measured at baseline and at follow up visit after 18-24 months, respectively. Outcomes were End Stage Renal Disease (ESRD) and overall-causes Mortality. 391 patients (27.6%) were identified as regressors as they showed an eGFR increase between the baseline visit in the renal clinic and the follow up visit. In multivariate regression analyses the regressor status was not associated with CKD stage. Low proteinuria was the main factor associated with CKD regression, accounting per se for 48% of the likelihood of this outcome. Lower systolic blood pressure, higher BMI and absence of autosomal polycystic disease (PKD) were additional predictors of CKD regression. In regressors, ESRD risk was 72% lower (HR: 0.28; 95% CI 0.14-0.57; p<0.0001) while mortality risk did not differ from that in non-regressors (HR: 1.16; 95% CI 0.73-1.83; p = 0.540). Spline models showed that the reduction of ESRD risk associated with positive Delta GFR was attenuated in advanced CKD stage. CKD regression occurs in about one-fourth patients receiving renal care in nephrology units and correlates with low proteinuria, BP and the absence of PKD. This condition portends better renal prognosis, mostly in earlier CKD stages, with no excess risk for mortality.	[Borrelli, Silvio; Minutolo, Roberto; De Nicola, Luca; Conte, Giuseppe] Univ Naples 2, Div Nephrol, Naples, Italy; [Leonardis, Daniela; Mallamaci, Francesca; Zoccali, Carmine] Inst Biomed & Mol Immunol Hosp, Ctr Natl Res, Nephrol Diis, Reggio Di Calabria, Italy; [Chiodini, Paolo] Univ Naples 2, Div Med Stat, Naples, Italy; [Esposito, Ciro] IRCCS Maugeri Inst Pavia, Div Nephrol, Pavia, Italy	Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Universita della Campania Vanvitelli	Conte, G (corresponding author), Univ Naples 2, Div Nephrol, Naples, Italy.	giuseppe.conte@unina2.it	De Nicola, Luca/AAB-7682-2019; esposito, ciro/AAC-8023-2020; Borrelli, Silvio/AAH-8549-2019; Zoccali, Carmine/B-9445-2009; Zoccali, Carmine/AAR-4473-2020; Chiodini, Paolo/E-7290-2014	esposito, ciro/0000-0002-7906-1097; Borrelli, Silvio/0000-0002-4414-4597; Zoccali, Carmine/0000-0002-6616-1996; Chiodini, Paolo/0000-0003-0139-2264; Minutolo, Roberto/0000-0001-5686-2089				Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210; Cianciaruso B, 2003, G Ital Nefrol, V20 Suppl 24, pS48; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; De Nicola L, 2012, KIDNEY INT, V82, P482, DOI 10.1038/ki.2012.174; De Nicola L, 2011, CLIN J AM SOC NEPHRO, V6, P2421, DOI 10.2215/CJN.01180211; Dwyer J., 1993, NUTR KIDNEY, V2nd ed., P61; Ecder T, 2000, AM J KIDNEY DIS, V35, P427, DOI 10.1016/S0272-6386(00)70195-8; Eriksen BO, 2007, KIDNEY INT, V72, P1242, DOI 10.1038/sj.ki.5002472; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Hogan MC, 2010, J AM SOC NEPHROL, V21, P1052, DOI 10.1681/ASN.2009121291; Hu B, 2012, J AM SOC NEPHROL, V23, P706, DOI 10.1681/ASN.2011050456; Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198; *K DOQI, 2004, AM J KIDNEY DIS S, V43, pS1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leonardis D, 2012, J NEPHROL, V25, P1081, DOI 10.5301/jn.5000239; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Mallamaci F, 2013, KIDNEY INT, V84, P381, DOI 10.1038/ki.2013.132; Mancia G, 2007, J HYPERTENS, V25, P1105, DOI DOI 10.1097/HJH.0B013E3281FC975A; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; Minutolo R, 2014, CLIN J AM SOC NEPHRO, V9, P1586, DOI 10.2215/CJN.10481013; Murthy K, 2005, KIDNEY INT, V68, P1884, DOI 10.1111/j.1523-1755.2005.00608.x; Perkins RM, 2011, CLIN J AM SOC NEPHRO, V6, P1879, DOI 10.2215/CJN.00470111; Poggio ED, 2009, KIDNEY INT, V75, P1079, DOI 10.1038/ki.2009.11; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Ruggenenti P, 1999, J AM SOC NEPHROL, V10, P997; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Stevens LA, 2007, AM J KIDNEY DIS, V50, P21, DOI 10.1053/j.ajkd.2007.04.004; Tjur T, 2009, AM STAT, V63, P366, DOI 10.1198/tast.2009.08210; Tseng CL, 2008, ARCH INTERN MED, V168, P55, DOI 10.1001/archinternmed.2007.9; Turin TC, 2013, KIDNEY INT, V83, P684, DOI 10.1038/ki.2012.443; Weis L, 2013, PLOS ONE, V8; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374	39	24	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140138	10.1371/journal.pone.0140138	http://dx.doi.org/10.1371/journal.pone.0140138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462071	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300058
J	Manda, KR; Tripathi, P; Hsi, AC; Ning, J; Ruzinova, MB; Liapis, H; Bailey, M; Zhang, H; Maher, CA; Humphrey, PA; Andriole, GL; Ding, L; You, Z; Chen, F				Manda, K. R.; Tripathi, P.; Hsi, A. C.; Ning, J.; Ruzinova, M. B.; Liapis, H.; Bailey, M.; Zhang, H.; Maher, C. A.; Humphrey, P. A.; Andriole, G. L.; Ding, L.; You, Z.; Chen, F.			NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence	ONCOGENE			English	Article							CELL-PROLIFERATION; CANCER PROGRESSION; C-MYC; ACTIVATION; EXPRESSION; INVASION; STAT3; OSTEOCLASTOGENESIS; INTERLEUKIN-6; INFLAMMATION	Despite recent insights into prostate cancer (PCa)-associated genetic changes, full understanding of prostate tumorigenesis remains elusive owing to complexity of interactions among various cell types and soluble factors present in prostate tissue. We found the upregulation of nuclear factor of activated T cells c1 (NFATc1) in human PCa and cultured PCa cells, but not in normal prostates and non-tumorigenic prostate cells. To understand the role of NFATc1 in prostate tumorigenesis in situ, we temporally and spatially controlled the activation of NFATc1 in mouse prostate and showed that such activation resulted in prostatic adenocarcinoma with features similar to those seen in human PCa. Our results indicate that the activation of a single transcription factor, NFATc1 in prostatic luminal epithelium to PCa can affect expression of diverse factors in both cells harboring the genetic changes and in neighboring cells through microenvironmental alterations. In addition to the activation of oncogenes c-MYC and STAT3 in tumor cells, a number of cytokines and growth factors, such as IL1 beta, IL6 and SPP1 ( osteopontin, a key biomarker for PCa), were upregulated in NFATc1-induced PCa, establishing a tumorigenic microenvironment involving both NFATc1 positive and negative cells for prostate tumorigenesis. To further characterize interactions between genes involved in prostate tumorigenesis, we generated mice with both NFATc1 activation and Pten inactivation in prostate. We showed that NFATc1 activation led to acceleration of Pten null-driven prostate tumorigenesis by overcoming the PTEN loss-induced cellular senescence through inhibition of p21 activation. This study provides direct in vivo evidence of an oncogenic role of NFATc1 in prostate tumorigenesis and reveals multiple functions of NFATc1 in activating oncogenes, in inducing proinflammatory cytokines, in oncogene addiction, and in overcoming cellular senescence, which suggests calcineurin-NFAT signaling as a potential target in preventing PCa.	[Manda, K. R.; Ning, J.; Maher, C. A.; Ding, L.; Chen, F.] Washington Univ, Sch Med, Dept Med, Campus Box 8126,660 S Euclid Ave, St Louis, MO 63110 USA; [Tripathi, P.; Ruzinova, M. B.; Liapis, H.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Hsi, A. C.; Ning, J.; Bailey, M.; Maher, C. A.; Ding, L.] Washington Univ, Genome Inst, St Louis, MO USA; [Zhang, H.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA USA; [Maher, C. A.; Andriole, G. L.; Ding, L.; Chen, F.] Washington Univ, Siteman Canc Ctr, St Louis, MO USA; [Humphrey, P. A.] Yale Univ, Dept Pathol, New Haven, CT USA; [Andriole, G. L.] Washington Univ, Dept Surg, St Louis, MO USA; [You, Z.] Tulane Univ, Dept Struct & Cellular Biol, New Orleans, LA 70118 USA; [Chen, F.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Massachusetts System; University of Massachusetts Worcester; Siteman Cancer Center; Washington University (WUSTL); Yale University; Washington University (WUSTL); Tulane University; Washington University (WUSTL)	Chen, F (corresponding author), Washington Univ, Sch Med, Dept Med, Campus Box 8126,660 S Euclid Ave, St Louis, MO 63110 USA.	fchen@dom.wustl.edu		Bailey, Matthew H./0000-0003-4526-9727	DoD [PC130118]; NIH [DK087960, R01CA174714, R01CA180006, R01CA178383, U01HG006517]; NATIONAL CANCER INSTITUTE [R01CA178383, R01CA174714, R01CA180006] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087960] Funding Source: NIH RePORTER	DoD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs Gerald Crabtree and Minggui Pan for providing the TetO-NFATc1<SUP>Nuc</SUP> mice. FC is supported in part by grants from DoD (PC130118) and NIH (DK087960). ZY is supported in part by NIH R01CA174714. LD is supported in part by grants from NIH (R01CA180006, R01CA178383 and U01HG006517).	Alberti C, 2008, EUR REV MED PHARMACO, V12, P167; Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Blagosklonny MV, 2002, CELL CYCLE, V1, P391, DOI 10.4161/cc.1.6.262; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Carnero A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00252; Culig Z, 2014, AM J CLIN EXP UROL, V2, P231; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Foldynova-Trantirkova S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2581; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Huang HH, 2012, BIOCHEM BIOPH RES CO, V418, P186, DOI 10.1016/j.bbrc.2012.01.004; JANIK P, 1975, CANCER RES, V35, P3698; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jiang JF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1015; Karlou M, 2010, NAT REV UROL, V7, P494, DOI 10.1038/nrurol.2010.134; Kavitha CV, 2014, MOL CARCINOGEN, V53, P169, DOI 10.1002/mc.21959; Kawahara T, 2015, PROSTATE, V75, P573, DOI 10.1002/pros.22937; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Lagunas L, 2009, J CELL BIOCHEM, V108, P237, DOI 10.1002/jcb.22245; Lee SJ, 2003, J MOL BIOL, V330, P749, DOI 10.1016/S0022-2836(03)00640-5; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; McCormick F, 2011, J SURG ONCOL, V103, P464, DOI 10.1002/jso.21749; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Nguyen DP, 2014, BJU INT, V113, P986, DOI 10.1111/bju.12452; Nilsson-Berglund LM, 2010, ARTERIOSCL THROM VAS, V30, P218, DOI 10.1161/ATVBAHA.109.199299; Ortega-Molina A, 2013, TRENDS ENDOCRIN MET, V24, P184, DOI 10.1016/j.tem.2012.11.002; Pan MG, 2013, CURR MOL MED, V13, P543; Pan MG, 2007, J IMMUNOL, V178, P4315, DOI 10.4049/jimmunol.178.7.4315; Phin S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00240; Rafiei S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-605; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Suzman DL, 2014, THER ADV MED ONCOL, V6, P167, DOI 10.1177/1758834014529176; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Tripathi P, 2014, ONCOGENE, V33, P1840, DOI 10.1038/onc.2013.132; Vincent AJ, 2012, FEBS LETT, V586, P3429, DOI 10.1016/j.febslet.2012.07.063; Wang YQ, 2010, J AM SOC NEPHROL, V21, P1657, DOI 10.1681/ASN.2009121253; Wei Z, 2013, CELL SIGNAL, V25, P931, DOI 10.1016/j.cellsig.2013.01.011; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yiu GK, 2011, BIOCHEM J, V440, P157, DOI 10.1042/BJ20110530; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zhang H, 2008, J CELL PHYSIOL, V215, P613, DOI 10.1002/jcp.21337; Zhao D, 2014, ONCOGENE, V34, P107	46	28	29	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 23	2016	35	25					3282	3292		10.1038/onc.2015.389	http://dx.doi.org/10.1038/onc.2015.389			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP2GN	26477312	Green Accepted			2022-12-26	WOS:000378306400007
J	Su, Y; Li, J; Shi, C; Hruban, RH; Radice, GL				Su, Y.; Li, J.; Shi, C.; Hruban, R. H.; Radice, G. L.			N-cadherin functions as a growth suppressor in a model of K-ras-induced PanIN	ONCOGENE			English	Article							CONTACT INHIBITION; MESENCHYMAL TRANSITION; PANCREATIC-CANCER; SIGNALING-PATHWAY; PROLIFERATION; EXPRESSION; KI-RAS(G12V); INSTABILITY; SURVIVAL	Cadherin subtype switching from E-cadherin to N-cadherin is associated with the epithelial-to-mesenchymal transition (EMT), a process required for invasion and dissemination of carcinoma cells. We found that N-cadherin is expressed in human and mouse pancreatic intraepithelial neoplasia (PanIN), suggesting that N-cadherin may also have a role in early-stage pancreatic cancer. To investigate the role of N-cadherin in mouse PanIN (mPanIN), we simultaneously activated oncogenic K-ras(G12D) and deleted the N-cadherin (Cdh2) gene in the murine pancreas. Genetic ablation of N-cadherin (N-cad KO) caused hyperproliferation, accelerated mPanIN progression, and early tumor development in K-ras(G12D) mice. Decreased E-cadherin and redistribution of beta-catenin accompanied the loss of N-cadherin in pancreatic ductal epithelial cells (PDEC). Nuclear accumulation of beta-catenin and its transcription co-activator Tcf4 led to activation of Wnt/beta-catenin target genes. Unexpectedly, loss of N-cadherin in the K-rasG12D model resulted in increased mPanIN progression and tumor incidence. These in vivo results demonstrate for the first time that N-cadherin functions as a growth suppressor in the context of oncogenic K-ras.	[Su, Y.; Li, J.; Radice, G. L.] Thomas Jefferson Univ, Ctr Translat Med, Dept Med, Suite 543E Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA; [Shi, C.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Shi, C.; Hruban, R. H.] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD USA; [Shi, C.; Hruban, R. H.] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD USA; [Su, Y.] Fox Chase Canc Ctr, Breast Canc Res Lab, 7701 Burholme Ave, Philadelphia, PA 19111 USA	Jefferson University; Vanderbilt University; Johns Hopkins University; Johns Hopkins University; Fox Chase Cancer Center	Radice, GL (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Ctr Translat Med, Dept Med, Suite 543E Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.	glenn.radice@jefferson.edu			NCI Cancer Center [P30 CA56036]; NIH [R21 CA176097]; SPORE grant [CA62924]; NATIONAL CANCER INSTITUTE [P30CA056036, P50CA062924, R21CA176097] Funding Source: NIH RePORTER	NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPORE grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Frans van Roy, Anil Rustgi and Jennifer Wilson for comments. We thank David Tuveson for the LSL-K-ras<SUP>G12D</SUP> mice, Andrew Lowy for the Pdx1/Cre mice and Michael Goggins for the PanIN microarrays. We are grateful to Mathew Thakur for assistance with PET imaging, and Han Du, Craig Riley and David Kurz for technical assistance. Research in this study includes work carried out by the Jefferson Kimmel Cancer Center Small Animal Imaging Facility, which is supported in part by NCI Cancer Center Support Grant P30 CA56036. This work was supported by NIH R21 CA176097 (GR). This study was also supported by the SPORE grant CA62924 (RH).	Agbunag C, 2004, CANCER RES, V64, P5659, DOI 10.1158/0008-5472.CAN-04-0807; Al-Aynati MM, 2004, CLIN CANCER RES, V10, P1235, DOI 10.1158/1078-0432.CCR-03-0087; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; Deramaudt TB, 2006, MOL CELL BIOL, V26, P4185, DOI 10.1128/MCB.01055-05; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Gavard J, 2004, J BIOL CHEM, V279, P36795, DOI 10.1074/jbc.M401705200; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Johansson JK, 2010, GENESIS, V48, P374, DOI 10.1002/dvg.20628; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Levenberg S, 1999, ONCOGENE, V18, P869, DOI 10.1038/sj.onc.1202396; Li JF, 2015, CIRC RES, V116, P70, DOI 10.1161/CIRCRESAHA.116.304472; Luo Y, 2005, DEV DYNAM, V232, P336, DOI 10.1002/dvdy.20241; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; Mui KL, 2015, CELL REP, V10, P1477, DOI 10.1016/j.celrep.2015.02.023; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Qian X, 2014, ONCOGENE, V33, P3411, DOI 10.1038/onc.2013.310; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Su Y, 2012, ONCOGENE, V31, P4484, DOI 10.1038/onc.2011.574; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Zhang YQ, 2013, CANCER RES, V73, P4909, DOI 10.1158/0008-5472.CAN-12-4384	33	18	18	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 23	2016	35	25					3335	3341		10.1038/onc.2015.382	http://dx.doi.org/10.1038/onc.2015.382			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP2GN	26477318	Green Accepted			2022-12-26	WOS:000378306400012
J	Landreat, MG; Rozaire, C; Guillet, JY; Vigneau, CV; Le Reste, JY; Bronnec, MG				Landreat, Morgane Guillou; Rozaire, Charles; Guillet, Jean Yves; Vigneau, Caroline Victorri; Le Reste, Jean Yves; Bronnec, Marie Grall			French Experience with Buprenorphine : Do Physicians Follow the Guidelines?	PLOS ONE			English	Article							HIGH-DOSAGE	Opiate dependence affects about 15,479,000 people worldwide. The effectiveness of opiate substitution treatments (OST) has been widely demonstrated. Buprenorphine plays a particular role in opiate dependence care provision in France. It is widely prescribed by physicians and national opiate substitution treatment guidelines have been available since 2004. In order to study the prescribing of buprenorphine, we used a questionnaire sent by email, to a large sample of physicians. These physicians were either in practice, or belonged to an addiction treatment network or a hospital. The main objective of this work was to measure the extent to which the theoretical, clinical attitude of physicians towards prescribing buprenorphine (BHD) complied with the statutory guidelines. We showed that the physicians we interviewed rarely took into account the guidelines regarding buprenorphine prescription. The actual prescribing of Buprenorphine differed from the guidelines. Only 42% of independent Family Physicians (FPs), working outside the national health care system, had prescribed buprenorphine as a first-time prescription and 40% of FPs do not follow up patients on buprenorphine. In terms of compliance with the guidelines, 55% of FPs gave theoretical answers that only partially complied with the guidelines. The variations in compliance with the guidelines was noted according to different variables and took into particular account whether the physician were affiliated to a network or in training.	[Landreat, Morgane Guillou] Univ Bretagne Occidentale, ERCR SPURBO, Dept Addict Disorders, Brest, France; [Rozaire, Charles] CHU Nantes, Addict Psychiat, F-44035 Nantes 01, France; [Guillet, Jean Yves] Addict Dept Les Apsyades, Nantes, France; [Vigneau, Caroline Victorri; Bronnec, Marie Grall] Univ Hosp Nantes, Dept Pharmacol, Nantes, France; [Vigneau, Caroline Victorri] Fac Med Nantes, EA 4275, Nantes, France; [Le Reste, Jean Yves] Univ Bretagne Occidentale, ERCR SPURBO, Dept Gen Practice, Brest, France; [Bronnec, Marie Grall] Univ Hosp Nantes, Addict Psychiat, Nantes, France	Universite de Bretagne Occidentale; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; Universite de Bretagne Occidentale; Nantes Universite; CHU de Nantes	Landreat, MG (corresponding author), Univ Bretagne Occidentale, ERCR SPURBO, Dept Addict Disorders, Brest, France.	morgane.guillou@chu-brest.fr	Grall-Bronnec, Marie/L-9036-2015; Victorri Vigneau, Caroline/L-9030-2015	Victorri-Vigneau, Caroline/0000-0002-3745-2532; grall-bronnec, marie/0000-0003-0722-7243	Arrow	Arrow	The authors received a grant from Arrow for this work. This grant was used to build the e-mail questionnaire and to manage the platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Act UP-Paris, 2004, Presse Med, V33, P41; AURIACOMBE M, 1994, ANN MED INTERNE, V145, P27; Auriacombe M, 2003, REV PRATICIEN, V53, P137; Benyamina A, 2014, INT J GEN MED, V7, P449, DOI 10.2147/IJGM.S61014; Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5; DOLE VP, 1965, J AMER MED ASSOC, V193, P646, DOI 10.1001/jama.1965.03090080008002; Feroni I, 2004, REV EPIDEMIOL SANTE, V52, P511, DOI 10.1016/S0398-7620(04)99091-8; Feroni I, 2005, ADDICT BEHAV, V30, P187, DOI 10.1016/j.addbeh.2004.04.019; Guignard R., 2011, TREATMENT CARE OPIOI, P177; Guillou Landreat M., 2013, PSYCHOTROPES, V19, P23; Ksouda K, 2013, PRESSE MED, V42, P28; Landreat MG, 2013, ANN MED-PSYCHOL, V171, P367, DOI 10.1016/j.amp.2010.11.019; Langlois E, 2012, TENDANCES, V83; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; Michael Kidd Am Prof, 2013, J Family Med Prim Care, V2, P211, DOI 10.4103/2249-4863.120712; Observatoire Francais des drogues et Toxicomanies (OFDT), 2002, OP SUBST TREATM 5 PL; OFDT, 2013, DROG CHIFFR CLES; Orman JS, 2009, DRUGS, V69, P577, DOI 10.2165/00003495-200969050-00006; Pauly V, 2012, DRUG ALCOHOL DEPEN, V126, P13, DOI 10.1016/j.drugalcdep.2012.03.009; Roux P, 2008, ADDICT BEHAV, V33, P1625, DOI 10.1016/j.addbeh.2008.07.018; Soyka M, 2011, WORLD J BIOL PSYCHIA, V12, P160, DOI 10.3109/15622975.2011.561872; Wisniewski AM, 2013, SUBST ABUS, V34, P105, DOI 10.1080/08897077.2012.677753	22	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0137708	10.1371/journal.pone.0137708	http://dx.doi.org/10.1371/journal.pone.0137708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479400	Green Published, Green Submitted, gold			2022-12-26	WOS:000363026600002
J	Goh, HF; Philip, K				Goh, Hweh Fen; Philip, Koshy			Purification and Characterization of Bacteriocin Produced by Weissella confusa A3 of Dairy Origin	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; STRAIN; MESENTEROIDES; SPECTRUM; GROWTH	A dramatic increase in bacterial resistance towards currently available antibiotics has raised worldwide concerns for public health. Therefore, antimicrobial peptides (AMPs) have emerged as a promisingly new group of therapeutic agents for managing infectious diseases. The present investigation focusses on the isolation and purification of a novel bacteriocin from an indigenous sample of cow milk and it's mode of action. The bacteriocin was isolated from Weissella confusa A3 that was isolated from the sample and was shown to have inhibitory activity towards pathogenic bacteria namely Bacillus cereus, Escherichia coli, Pseudomonas aeruginosa and Micrococcus luteus. The bacteriocin was shown to be heat stable and functioned well at low pH (2 to 6). Reduction of activity was shown after treatment with proteinase K, trypsin and peptidase that confirmed the proteinaceous nature of the compound. MALDI-TOF analysis of the sample gave a mass approximating 2.7 kDa. The membrane of the bacteria was disrupted by the bacteriocin causing SYTOX (R) green dye to enter the cell and bind to the bacterial DNA giving fluorescence signal. Bacterial cell treated with the bacteriocin also showed significant morphological changes under transmission electron microscope. No virulence and disease related genes can be detected from the genome of the strain.	[Goh, Hweh Fen; Philip, Koshy] Univ Malaya, Fac Sci, Inst Biol Sci, Div Microbiol, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Philip, K (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Div Microbiol, Kuala Lumpur 50603, Malaysia.	kphil@um.edu.my	PHILIP, Koshy/B-8803-2010	Goh, Hweh Fen/0000-0002-0566-8814	University of Malaya - Ministry of Higher Education High Impact Research Grant [UM.C/HIR/MOHE/SC/08 (F0008-21001)]	University of Malaya - Ministry of Higher Education High Impact Research Grant	The study was funded by University of Malaya - Ministry of Higher Education High Impact Research Grant number UM.C/HIR/MOHE/SC/08 (F0008-21001) awarded to the Principal Investigator Koshy Philip who is the corresponding author of the manuscript.	Ahmad V, 2014, ANAEROBE, V27, P87, DOI 10.1016/j.anaerobe.2014.04.001; Ashby G K, 1938, Science, V87, P443, DOI 10.1126/science.87.2263.443; Barbour A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077751; BHUNIA AK, 1988, J APPL BACTERIOL, V65, P261, DOI 10.1111/j.1365-2672.1988.tb01893.x; BJORKROTH J, 2006, GENERA LEUCONOSTOC O, P267, DOI DOI 10.1007/0-387-30744-3_9; Cleveland J, 2001, INT J FOOD MICROBIOL, V71, P1, DOI 10.1016/S0168-1605(01)00560-8; de Arauz LJ, 2009, TRENDS FOOD SCI TECH, V20, P146, DOI 10.1016/j.tifs.2009.01.056; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; Fedders H, 2010, INT J ANTIMICROB AG, V36, P264, DOI 10.1016/j.ijantimicag.2010.04.008; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Hajirostamloo B., 2010, WORLD ACAD SCI ENG T, V72, P162; He ZG, 2007, APPL ENVIRON MICROB, V73, P168, DOI 10.1128/AEM.02023-06; Holzapfel W.H.N., 2012, GENERA LACTIC ACID B, V2; Katina K, 2009, FOOD MICROBIOL, V26, P734, DOI 10.1016/j.fm.2009.07.008; Lebaron P, 1998, APPL ENVIRON MICROB, V64, P2697; Maina NH, 2008, CARBOHYD RES, V343, P1446, DOI 10.1016/j.carres.2008.04.012; Mataragas M, 2004, ANTON LEEUW INT J G, V85, P191, DOI 10.1023/B:ANTO.0000020291.01957.a2; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Nam H, 2002, APPL ENVIRON MICROB, V68, P4642, DOI 10.1128/AEM.68.9.4642-4645.2002; Oyston PCF, 2009, J MED MICROBIOL, V58, P977, DOI 10.1099/jmm.0.011122-0; Papagianni M, 2011, BIORESOURCE TECHNOL, V102, P6730, DOI 10.1016/j.biortech.2011.03.106; Parapouli M, 2013, APPL ENVIRON MICROB, V79, P3476, DOI 10.1128/AEM.00436-13; Pingitore E. V., 2007, COMMUNICATING CURREN, V1, P557; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; Sang Yongming, 2008, Animal Health Research Reviews, V9, P227, DOI 10.1017/S1466252308001497; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schleifer KH., 2009, BERGEYS MANUAL SYSTE, P19, DOI [DOI 10.1007/978-0-387-68489-5_3, 10.1007/978-0-387-68489-5_3]; Shukla S, 2014, CARBOHYD POLYM, V101, P554, DOI 10.1016/j.carbpol.2013.09.087; Skandamis P, 2001, ITAL J FOOD SCI, V13, P65; Srionnual S, 2007, APPL ENVIRON MICROB, V73, P2247, DOI 10.1128/AEM.02484-06; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; Stiles ME, 1997, INT J FOOD MICROBIOL, V36, P1, DOI 10.1016/S0168-1605(96)01233-0; Todorov SD, 2006, MICROBIOL RES, V161, P102, DOI 10.1016/j.micres.2005.06.006; Todorov SD, 2005, WORLD J MICROB BIOT, V21, P1585, DOI 10.1007/s11274-005-8122-4; Zamfir M, 2000, FEMS MICROBIOL LETT, V190, P305, DOI 10.1016/S0378-1097(00)00351-7	35	49	52	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140434	10.1371/journal.pone.0140434	http://dx.doi.org/10.1371/journal.pone.0140434			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474074	Green Published, gold			2022-12-26	WOS:000363185500049
J	Tavares, AC; Fernandes, PB; Carballido-Lopez, R; Pinho, MG				Tavares, Andreia C.; Fernandes, Pedro B.; Carballido-Lopez, Rut; Pinho, Mariana G.			MreC and MreD Proteins Are Not Required for Growth of Staphylococcus aureus	PLOS ONE			English	Article							CELL-WALL SYNTHESIS; PEPTIDOGLYCAN SYNTHESIS; NULL MUTANT; SHAPE; COMPLEXES; DIVISION; INACTIVATION; MICROSCOPY; VECTOR; MODE	The transmembrane proteins MreC and MreD are present in a wide variety of bacteria and are thought to be involved in cell shape determination. Together with the actin homologue MreB and other morphological elements, they play an essential role in the synthesis of the lateral cell wall in rod-shaped bacteria. In ovococcus, which lack MreB homologues, mreCD are also essential and have been implicated in peripheral cell wall synthesis. In this work we addressed the possible roles of MreC and MreD in the spherical pathogen Staphylococcus aureus. We show that MreC and MreD are not essential for cell viability and do not seem to affect cell morphology, cell volume or cell cycle control. MreC and MreD localize preferentially to the division septa, but do not appear to influence peptidoglycan composition, nor the susceptibility to different antibiotics and to oxidative and osmotic stress agents. Our results suggest that the function of MreCD in S. aureus is not critical for cell division and cell shape determination.	[Tavares, Andreia C.; Fernandes, Pedro B.; Pinho, Mariana G.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Lab Bacterial Cell Biol, P-2780156 Oeiras, Portugal; [Carballido-Lopez, Rut] INRA, UMR Micalis 1319, F-78350 Jouy En Josas, France; [Carballido-Lopez, Rut] AgroParisTech, UMR Micalis, F-78350 Jouy En Josas, France	Universidade Nova de Lisboa; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Pinho, MG (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Lab Bacterial Cell Biol, P-2780156 Oeiras, Portugal.	mgpinho@itqb.unl.pt	LOPEZ, RUT CARBALLIDO/G-2283-2015; Pinho, Mariana/B-9192-2008	LOPEZ, RUT CARBALLIDO/0000-0001-9383-8811; Pinho, Mariana/0000-0002-7132-8842; Tavares, Andreia/0000-0002-8260-0776; Fernandes, Pedro/0000-0002-4513-0736	Fundacao para a Ciencia e Tecnologia (FCT) [FCT-ANR/BEX-BCM/0150/2012]; French National Research Agency [ANR-12-ISV3-0004-01]; FCT [SFRH/BD/52204/2013]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); French National Research Agency(French National Research Agency (ANR)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by a joint international grant from the Fundacao para a Ciencia e Tecnologia (FCT, FCT-ANR/BEX-BCM/0150/2012 to M.G.P) and the French National Research Agency (ANR-12-ISV3-0004-01 to R.C.-L.). A.C.T. is the recipient of a doctoral fellowship from FCT (SFRH/BD/52204/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Barendt SM, 2009, J BACTERIOL, V191, P3024, DOI 10.1128/JB.01505-08; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Carballido-Lopez R, 2007, CURR OPIN MICROBIOL, V10, P611, DOI 10.1016/j.mib.2007.09.008; Carvalho F, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004919; Chastanet Arnaud, 2012, Front Biosci (Schol Ed), V4, P1582; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; Divakaruni AV, 2005, P NATL ACAD SCI USA, V102, P18602, DOI 10.1073/pnas.0507937102; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Dye NA, 2005, P NATL ACAD SCI USA, V102, P18608, DOI 10.1073/pnas.0507708102; El Ghachi M, 2011, MOL MICROBIOL, V82, P68, DOI 10.1111/j.1365-2958.2011.07791.x; Fisher AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002351; Formstone A, 2005, MOL MICROBIOL, V55, P1646, DOI 10.1111/j.1365-2958.2005.04506.x; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gautam S, 2015, J AM CHEM SOC, V137, P7441, DOI 10.1021/jacs.5b02972; Heintzmann R, 1999, P SOC PHOTO-OPT INS, V3568, P185, DOI 10.1117/12.336833; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Kuru E, 2015, NAT PROTOC, V10, P33, DOI 10.1038/nprot.2014.197; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; Land AD, 2011, J BACTERIOL, V193, P4166, DOI 10.1128/JB.05245-11; Leaver M, 2005, MOL MICROBIOL, V57, P1196, DOI 10.1111/j.1365-2958.2005.04736.x; Monteiro JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9055; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; OSHIDA T, 1992, J BACTERIOL, V174, P4952, DOI 10.1128/JB.174.15.4952-4959.1992; Pereira PM, 2007, ANTIMICROB AGENTS CH, V51, P3627, DOI 10.1128/AAC.00431-07; Pereira PM, 2010, APPL ENVIRON MICROB, V76, P4346, DOI 10.1128/AEM.00359-10; Pinho MG, 2013, NAT REV MICROBIOL, V11, P601, DOI 10.1038/nrmicro3088; Pinho MG, 2004, FEMS MICROBIOL LETT, V240, P145, DOI 10.1016/j.femsle.2004.09.038; Pinho MG, 2003, MOL MICROBIOL, V50, P871, DOI 10.1046/j.1365-2958.2003.03719.x; Pinho MG, 2001, J BACTERIOL, V183, P6525, DOI 10.1128/JB.183.22.6525-6531.2001; Reed P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004891; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Tsui HCT, 2014, MOL MICROBIOL, V94, P21, DOI 10.1111/mmi.12745; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; van den Ent F, 2006, MOL MICROBIOL, V62, P1631, DOI 10.1111/j.1365-2958.2006.05485.x; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x	39	16	16	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140523	10.1371/journal.pone.0140523	http://dx.doi.org/10.1371/journal.pone.0140523			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26470021	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600071
J	Zanden, RWD; de Vries, F; Lalmohamed, A; Driessen, JHM; de Boer, A; Rohde, G; Neef, C; den Heijer, C				Zanden, Rogier Wvan Der; de Vries, Frank; Lalmohamed, Arief; Driessen, Johanna H. M.; de Boer, Anthonius; Rohde, Gernot; Neef, Cees; den Heijer, Casper			Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITORS; COMMUNITY-ACQUIRED PNEUMONIA; TYPE-2 DIABETES-MELLITUS; T-CELL-ACTIVATION; FRACTURE RISK; SAFETY; SITAGLIPTIN; EFFICACY; DATABASE; IV/CD26	Background Dipeptidyl-peptidase-4 inhibitors (DPP4Is) are drugs for the treatment of type 2 diabetes mellitus (T2DM). There is increasing evidence that DPP4Is may result in suppression of the immune system and may increase the risk of infections such as pneumonia. Aim of this study was to evaluate the association between the use of DPP4Is and the risk of pneumonia in a population-based study. Methods We conducted a population-based cohort study using data from the world's largest primary care database, the UK Clinical Practice Research Datalink (CPRD). We selected all users of non-insulin antidiabetic drugs (NIADs), including DPP4Is, between 2007 and 2012. To each NIAD user, we matched randomly selected non-users. The NIAD user's first prescription defined the index date, which was then assigned to the matched non-users. Patients were followed from their first prescription until end of data collection or the first event of pneumonia, whichever came first. Cox regression analysis estimated the association between pneumonia and current use of DPP4Is versus 1) current use of other NIADs and 2) non-users. DPP4I use was then stratified to daily and cumulative dose. Analyses were statistically adjusted for age, sex, lifestyle factors and comorbidities and concomitant use of various other drugs. Results Risk of pneumonia was not increased with current DPP4I use versus use of other NIADs, adjusted Hazard Ratio (HR) 0.70; 95% Confidence Interval (CI) 0.55-0.91. Also higher cumulative doses or daily doses did not further increase risk of pneumonia. Conclusion We found no increased risk of pneumonia in T2DM patients using DPP4Is compared to T2DM patients using other NIADs. Our finding is in line with direct and indirect evidence from observational studies and RCTs. There is probably no need to avoid prescribing of DPP4Is to elderly patients who are at risk of pneumonia.	[Zanden, Rogier Wvan Der; de Vries, Frank; Driessen, Johanna H. M.; Neef, Cees] Maastricht Univ, Dept Clin Pharm & Toxicol, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Zanden, Rogier Wvan Der; de Vries, Frank; Driessen, Johanna H. M.; Neef, Cees] Care & Publ Hlth Res Inst CAPHRI, Maastricht, Netherlands; [de Vries, Frank; Lalmohamed, Arief; Driessen, Johanna H. M.; de Boer, Anthonius] Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [de Vries, Frank; Lalmohamed, Arief; Driessen, Johanna H. M.; de Boer, Anthonius] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands; [Lalmohamed, Arief] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands; [Rohde, Gernot] Maastricht Univ, Med Ctr, Dept Resp Med, NL-6200 MD Maastricht, Netherlands; [den Heijer, Casper] Publ Hlth Serv South Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [den Heijer, Casper] Maastricht Univ, Dept Microbiol, Med Ctr, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University; Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Maastricht University; Maastricht University	de Vries, F (corresponding author), Maastricht Univ, Dept Clin Pharm & Toxicol, Med Ctr, NL-6200 MD Maastricht, Netherlands.	f.devries@uu.nl	Rohde, Gernot GU/F-3060-2013; de Vries, Frank/E-4934-2011	Rohde, Gernot GU/0000-0002-5193-7755; de Vries, Frank/0000-0003-3837-8319; Driessen, Johanna/0000-0002-4503-6408; van der Zanden, Rogier/0000-0003-0222-2865				Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Cai L, 2012, J CLIN PHARM THER, V37, P386, DOI 10.1111/j.1365-2710.2011.01323.x; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; de Vries F, 2011, OSTEOPOROSIS INT, V22, P1641, DOI 10.1007/s00198-010-1323-1; de Vries F, 2006, INT J EPIDEMIOL, V35, P1301, DOI 10.1093/ije/dyl147; Driessen JHM, 2014, BONE, V68, P124, DOI 10.1016/j.bone.2014.07.030; Eddens T, 2012, CURR OPIN IMMUNOL, V24, P424, DOI 10.1016/j.coi.2012.07.005; Engel SS, 2013, DIABETES THER, V4, P119, DOI 10.1007/s13300-013-0024-0; Eppenga WL, 2014, DIABETES CARE, V37, P2218, DOI 10.2337/dc13-3023; Faillie JL, 2015, DIABETES OBES METAB, V17, P379, DOI 10.1111/dom.12431; Fan H, 2003, ADV EXP MED BIOL, V524, P165; Goossen K, 2012, DIABETES OBES METAB, V14, P1061, DOI 10.1111/j.1463-1326.2012.01610.x; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Karagiannis T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1369; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kolls JK, 2013, IMMUNOL REV, V252, P156, DOI 10.1111/imr.12030; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Lee SA, 2013, J CLIN ENDOCR METAB, V98, P2553, DOI 10.1210/jc.2012-4288; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; Peeters PJHL, 2015, DIABETES CARE, V38, P495, DOI 10.2337/dc14-1175; PETRI H, 1991, STAT MED, V10, P577, DOI 10.1002/sim.4780100409; Reinhold D, 2007, ANN NY ACAD SCI, V1110, P402, DOI 10.1196/annals.1423.042; Richter B, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006739.pub2; Rosenstock J, 2009, CURR MED RES OPIN, V25, P2401, DOI 10.1185/03007990903178735; Rosenstock J, 2006, CLIN THER, V28, P1556, DOI 10.1016/j.clinthera.2006.10.007; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Torres A, 2014, EUR J CLIN MICROBIOL, V33, P1065, DOI 10.1007/s10096-014-2067-1; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; von Bonin A, 1998, IMMUNOL REV, V161, P43; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; White PC, 2010, J DIABETES COMPLICAT, V24, P209, DOI 10.1016/j.jdiacomp.2009.09.001; Willemen MJ, 2011, DIABETES CARE, V34, P369, DOI 10.2337/dc10-1771; Zhang H, 2013, MOL CANCER RES, V11, P1487, DOI 10.1158/1541-7786.MCR-13-0272	33	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0139367	10.1371/journal.pone.0139367	http://dx.doi.org/10.1371/journal.pone.0139367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468883	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600008
J	Alpkvist, H; Athlin, S; Naucler, P; Herrmann, B; Abdeldaim, G; Slotved, HC; Hedlund, J; Stralin, K				Alpkvist, Helena; Athlin, Simon; Naucler, Pontus; Herrmann, Bjorn; Abdeldaim, Guma; Slotved, Hans-Christian; Hedlund, Jonas; Stralin, Kristoffer			Clinical and Microbiological Factors Associated with High Nasopharyngeal Pneumococcal Density in Patients with Pneumococcal Pneumonia	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; LINKED-IMMUNOSORBENT-ASSAY; STREPTOCOCCUS-PNEUMONIAE; INFECTIOUS-DISEASES; COLONIZATION; SEROTYPE; ADULTS; POLYSACCHARIDES; METAANALYSIS; ADSORPTION	Background We aimed to study if certain clinical and/or microbiological factors are associated with a high nasopharyngeal (NP) density of Streptococcus pneumoniae in pneumococcal pneumonia. In addition, we aimed to study if a high NP pneumococcal density could be useful to detect severe pneumococcal pneumonia. Methods Adult patients hospitalized for radiologically confirmed community-acquired pneumonia were included in a prospective study. NP aspirates were collected at admission and were subjected to quantitative PCR for pneumococcal DNA (Spn9802 DNA). Patients were considered to have pneumococcal etiology if S. pneumoniae was detected in blood culture and/ or culture of respiratory secretions and/or urinary antigen test. Results Of 166 included patients, 68 patients had pneumococcal DNA detected in NP aspirate. Pneumococcal etiology was noted in 57 patients (84%) with positive and 8 patients (8.2%) with negative test for pneumococcal DNA (p<0.0001). The median NP pneumococcal density of DNA positive patients with pneumococcal etiology was 6.83 log(10) DNA copies/mL (range 1.79-9.50). In a multivariate analysis of patients with pneumococcal etiology, a high pneumococcal density was independently associated with severe pneumonia (Pneumonia Severity Index risk class IV-V), symptom duration >= 2 days prior to admission, and a medium/high serum immunoglobulin titer against the patient's own pneumococcal serotype. NP pneumococcal density was not associated with sex, age, smoking, co-morbidity, viral co-infection, pneumococcal serotype, or bacteremia. Severe pneumococcal pneumonia was noted in 28 study patients. When we studied the performance of PCR with different DNA cut-off levels for detection of severe pneumococcal pneumonia, we found sensitivities of 54-82% and positive predictive values of 37-56%, indicating suboptimal performance. Conclusions Pneumonia severity, symptom duration similar to 2 days, and a medium/high serum immunoglobulin titer against the patient's own serotype were independently associated with a high NP pneumococcal density. NP pneumococcal density has limited value for detection of severe pneumococcal pneumonia.	[Alpkvist, Helena; Naucler, Pontus; Hedlund, Jonas; Stralin, Kristoffer] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Alpkvist, Helena; Stralin, Kristoffer] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden; [Athlin, Simon; Stralin, Kristoffer] Univ Orebro, Dept Infect Dis, Fac Med & Hlth, SE-70182 Orebro, Sweden; [Naucler, Pontus; Hedlund, Jonas] Karolinska Inst, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden; [Herrmann, Bjorn; Abdeldaim, Guma] Uppsala Univ, Sect Clin Bacteriol, Dept Med Sci, Uppsala, Sweden; [Abdeldaim, Guma] Benghazi Univ, Dept Med Microbiol & Parasitol, Fac Med, Benghazi, Libya; [Slotved, Hans-Christian] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Orebro University; Karolinska Institutet; Uppsala University; University of Benghazi; Statens Serum Institut	Stralin, K (corresponding author), Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden.	kristoffer.stralin@ki.se	Slotved, Hans-Christian/H-7476-2019; Abdeldaim, Guma M. K./AAT-3561-2020	Slotved, Hans-Christian/0000-0002-7294-4911; Athlin, Simon/0000-0002-8730-6955; Abdeldaim, Guma/0000-0001-5509-9093				Abdeldaim GMK, 2008, DIAGN MICR INFEC DIS, V60, P143, DOI 10.1016/j.diagmicrobio.2007.08.010; Albrich WC, 2012, CLIN INFECT DIS, V54, P601, DOI 10.1093/cid/cir859; Albrich WC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005953; Athlin S, 2014, CLIN VACCINE IMMUNOL, V21, P1541, DOI 10.1128/CVI.00259-14; Athlin S, 2013, SCAND J INFECT DIS, V45, P425, DOI 10.3109/00365548.2012.760843; Avni T, 2010, J CLIN MICROBIOL, V48, P489, DOI 10.1128/JCM.01636-09; BARON EJ, 1999, MANUAL CLIN MICROBIO, P246; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Caliendo AM, 2013, CLIN INFECT DIS, V57, pS139, DOI 10.1093/cid/cit578; Chiou CC, 2006, CLIN INFECT DIS, V42, P234, DOI 10.1086/499596; Ferreira DM, 2013, AM J RESP CRIT CARE, V187, P855, DOI 10.1164/rccm.201212-2277OC; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Habib M, 2014, JOVE-J VIS EXP, DOI 10.3791/51208; Hinge M, 2012, APMIS, V120, P935, DOI 10.1111/j.1600-0463.2012.02922.x; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; KALIN M, 1983, SCAND J INFECT DIS, V15, P153, DOI 10.3109/inf.1983.15.issue-2.05; KONRADSEN HB, 1995, CLIN INFECT DIS, V21, P616, DOI 10.1093/clinids/21.3.616; Musher DM, 1997, CLIN INFECT DIS, V24, P441, DOI 10.1093/clinids/24.3.441; Rello J, 2009, CHEST, V136, P832, DOI 10.1378/chest.09-0258; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Skovsted IC, 2007, VACCINE, V25, P6490, DOI 10.1016/j.vaccine.2007.06.034; Slotved HC, 2009, CLIN VACCINE IMMUNOL, V16, P1279, DOI 10.1128/CVI.00143-09; Spindler C, 2012, SCAND J INFECT DIS, V44, P885, DOI 10.3109/00365548.2012.700120; Stralin K, 2004, J CLIN MICROBIOL, V42, P3620, DOI 10.1128/jcm.42.8.3620-3625.2004; Stralin K, 2014, J CLIN MICROBIOL, V52, P83, DOI 10.1128/JCM.01742-13; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Wernette CM, 2003, CLIN DIAGN LAB IMMUN, V10, P514, DOI 10.1128/CDLI.10.4.514-519.2003; Werno AM, 2012, J MED MICROBIOL, V61, P1129, DOI 10.1099/jmm.0.044107-0; Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326; Woodhead M, 2002, EUR RESPIR J, V20, p20S, DOI 10.1183/09031936.02.00702002	31	15	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140112	10.1371/journal.pone.0140112	http://dx.doi.org/10.1371/journal.pone.0140112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466142	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100080
J	Caruso, M; Zhang, XM; Ma, DJ; Yang, Z; Qi, Y; Yi, ZP				Caruso, Michael; Zhang, Xiangmin; Ma, Danjun; Yang, Zhao; Qi, Yue; Yi, Zhengping			Novel Endogenous, Insulin-Stimulated Akt2 Protein Interaction Partners in L6 Myoblasts	PLOS ONE			English	Article							KINASE-B-GAMMA; QUANTITATIVE PROTEOMICS; GLUCOSE; PHOSPHORYLATION; RESISTANCE; EXPRESSION; PATHWAY; MUSCLE; B/AKT	Insulin resistance and Type 2 diabetes are marked by an aberrant response in the insulin signaling network. The phosphoinositide-dependent serine/threonine kinase, Akt2, plays a key role in insulin signaling and glucose uptake, most notably within skeletal muscle. Protein-protein interaction regulates the functional consequence of Akt2 and in turn, Akt2's role in glucose uptake. However, only few insulin-responsive Akt2 interaction partners have been identified in skeletal muscle cells. In the present work, rat L6 myoblasts, a widely used insulin sensitive skeletal muscle cell line, were used to examine endogenous, insulin-stimulated Akt2 protein interaction partners. Akt2 co-immunoprecipitation was coupled with 1D-SDS-PAGE and fractions were analyzed by HPLC-ESI-MS/MS to reveal Akt2 protein-protein interactions. The pull-down assay displayed specificity for the Akt2 isoform; Akt1 and Akt3 unique peptides were not detected. A total of 49 were detected with a significantly increased (47) or decreased (2) association with Akt2 following insulin administration (n = 4; p<0.05). Multiple pathways were identified for the novel Akt2 interaction partners, such as the EIF2 and ubiquitination pathways. These data suggest that multiple new endogenous proteins may associate with Akt2 under basal as well as insulin-stimulated conditions, providing further insight into the insulin signaling network. Data are available via ProteomeX-change with identifier PXD002557.	[Caruso, Michael; Zhang, Xiangmin; Ma, Danjun; Yang, Zhao; Qi, Yue; Yi, Zhengping] Wayne State Univ, Dept Pharmaceut Sci, Eugene Applebaum Coll Pharm Hlth Sci, Detroit, MI 48202 USA	Wayne State University	Yi, ZP (corresponding author), Wayne State Univ, Dept Pharmaceut Sci, Eugene Applebaum Coll Pharm Hlth Sci, Detroit, MI 48202 USA.	zhengping.yi@wayne.edu	Yang, Zhao/AAY-3680-2020; Qi, Yue/B-1857-2019	Yang, Zhao/0000-0002-4133-3130; Qi, Yue/0000-0003-1914-8710; MA, DANJUN/0000-0002-1555-6306; Zhang, Xiangmin/0000-0001-9285-1619	NIH/NIDDK [R01DK081750]; Wayne State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK081750] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wayne State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/NIDDK R01DK081750 (Z. Yi), Wayne State University faculty competition for post-doctoral fellow award (MC/Z. Yi), and Wayne State University faculty start-up (Z. Yi).	Altomare DA, 1998, ONCOGENE, V16, P2407, DOI 10.1038/sj.onc.1201750; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bottermann K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066045; Bouzakri K, 2006, CELL METAB, V4, P89, DOI 10.1016/j.cmet.2006.04.008; Brozinick JT, 2003, DIABETES, V52, P935, DOI 10.2337/diabetes.52.4.935; Caruso M, 2014, DIABETES, V63, P1933, DOI 10.2337/db13-1872; Caruso MA, 2011, GEN COMP ENDOCR, V173, P227, DOI 10.1016/j.ygcen.2011.06.014; Chen H, 2001, BIOCHEMISTRY-US, V40, P11851, DOI 10.1021/bi010743c; Chun KH, 2012, ENDOCRINOLOGY, V153, P1649, DOI 10.1210/en.2011-1036; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Fayard E, CURRENT TOPICS MICRO, V1, P31; FERRANNINI E, 1988, METABOLISM, V37, P79, DOI 10.1016/0026-0495(88)90033-9; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Geetha T, 2011, J AM SOC MASS SPECTR, V22, P457, DOI 10.1007/s13361-010-0051-2; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Gosmanov AR, 2004, AM J PHYSIOL-ENDOC M, V287, pE8, DOI 10.1152/ajpendo.00485.2003; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kim YB, 2000, DIABETES, V49, P847, DOI 10.2337/diabetes.49.5.847; Kong APS, 2013, NAT REV ENDOCRINOL, V9, P537, DOI 10.1038/nrendo.2013.102; Koromilas AE, 2013, FUTURE ONCOL, V9, P1005, DOI [10.2217/fon.13.49, 10.2217/FON.13.49]; Li CB, 2012, CLIN EXP PHARMACOL P, V39, P759, DOI 10.1111/j.1440-1681.2012.05730.x; Lu DM, 2006, J BIOL CHEM, V281, P22799, DOI 10.1074/jbc.M603390200; Mangialardi G, 2013, ARTERIOSCL THROM VAS, V33, P555, DOI 10.1161/ATVBAHA.112.300424; Marcilla M, 2013, IUBMB LIFE, V65, P9, DOI 10.1002/iub.1081; Martinez E, 2013, J NUTR BIOCHEM, V24, P1241, DOI 10.1016/j.jnutbio.2012.09.008; McCurdy CE, 2005, DIABETES, V54, P1349, DOI 10.2337/diabetes.54.5.1349; Neuhauser N, 2013, J PROTEOME RES, V12, P2858, DOI 10.1021/pr400181q; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Peppa M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/527850; Reaven G, 2005, PANMINERVA MED, V47, P201; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schwartz EA, 2006, ENDOCRIN METAB CLIN, V35, P525, DOI 10.1016/j.ecl.2006.06.005; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Spilka R, 2013, CANCER LETT, V340, P9, DOI 10.1016/j.canlet.2013.06.019; Tan K, 2007, DIABETES, V56, P714, DOI 10.2337/db06-0921; Tate S, 2013, J PROTEOMICS, V81, P91, DOI 10.1016/j.jprot.2012.10.027; Thomas Sterling, 2010, Human Genomics, V4, P353; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Weisser H., 2013, J PROTEOME RES; Wepf A, 2009, NAT METHODS, V6, P203, DOI [10.1038/NMETH.1302, 10.1038/nmeth.1302]; Werner T, 2008, CURR OPIN BIOTECH, V19, P50, DOI 10.1016/j.copbio.2007.11.005; Xie XT, 2010, J PROTEOME RES, V9, P4521, DOI 10.1021/pr100268f; Ye Y, 2013, J PROTEOME RES, V12, P363, DOI 10.1021/pr300611e	51	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140255	10.1371/journal.pone.0140255	http://dx.doi.org/10.1371/journal.pone.0140255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465754	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100094
J	Charlton, BD				Charlton, Benjamin D.			The Acoustic Structure and Information Content of Female Koala Vocal Signals	PLOS ONE			English	Article							NONLINEAR PHENOMENA; BODY-SIZE; REPRODUCTIVE SUCCESS; GRUNT VOCALIZATIONS; STRESS-RELAXATION; INDICATE LARGER; TRACT LENGTH; SEX; IDENTITY; CALLS	Determining the information content of animal vocalisations can give valuable insights into the potential functions of vocal signals. The source-filter theory of vocal production allows researchers to examine the information content of mammal vocalisations by linking variation in acoustic features with variation in relevant physical characteristics of the caller. Here I used a source-filter theory approach to classify female koala vocalisations into different call-types, and determine which acoustic features have the potential to convey important information about the caller to other conspecifics. A two-step cluster analysis classified female calls into bellows, snarls and tonal rejection calls. Additional results revealed that female koala vocalisations differed in their potential to provide information about a given caller's phenotype that may be of importance to receivers. Female snarls did not contain reliable acoustic cues to the caller's identity and age. In contrast, female bellows and tonal rejection calls were individually distinctive, and the tonal rejection calls of older female koalas had consistently lower mean, minimum and maximum fundamental frequency. In addition, female bellows were significantly shorter in duration and had higher fundamental frequency, formant frequencies, and formant frequency spacing than male bellows. These results indicate that female koala vocalisations have the potential to signal the caller's identity, age and sex. I go on to discuss the anatomical basis for these findings, and consider the possible functional relevance of signalling this type of information in the koala's natural habitat.	Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland	University College Dublin	Charlton, BD (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	benjamin.charlton@ucd.ie		Charlton, Benjamin/0000-0002-0218-7177	Leverhulme Early Career Fellowship	Leverhulme Early Career Fellowship(Leverhulme Trust)	The author was funded by a Leverhulme Early Career Fellowship.	Abitbol J, 1999, J VOICE, V13, P424, DOI 10.1016/S0892-1997(99)80048-4; [Anonymous], 1998, PRINCIPLES ANIMAL CO; Bachorowski JA, 1999, J ACOUST SOC AM, V106, P1054, DOI 10.1121/1.427115; BECKFORD NS, 1985, ANN OTO RHINOL LARYN, V94, P634, DOI 10.1177/000348948509400622; Bercovitch FB, 2006, J ZOOL, V270, P512, DOI 10.1111/j.1469-7998.2006.00169.x; Blumstein DT, 2009, ETHOLOGY, V115, P1074, DOI 10.1111/j.1439-0310.2009.01691.x; Blumstein DT, 2005, ANIM BEHAV, V69, P353, DOI 10.1016/j.anbehav.2004.10.001; Boersma P., 2010, PRAAT DOING PHONETIC, DOI DOI 10.1007/s10072-018-3598-5; Charlton BD, 2008, J ACOUST SOC AM, V123, P2936, DOI 10.1121/1.2896758; Charlton BD, 2013, CURR BIOL, V23, pR1035, DOI 10.1016/j.cub.2013.10.069; Charlton BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070279; Charlton BD, 2012, ANIM BEHAV, V84, P1565, DOI 10.1016/j.anbehav.2012.09.034; Charlton BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045420; Charlton BD, 2012, ANIM COGN, V15, P999, DOI 10.1007/s10071-012-0527-5; Charlton BD, 2011, J EXP BIOL, V214, P3414, DOI 10.1242/jeb.061358; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; Charlton BD, 2009, ANIM BEHAV, V78, P893, DOI 10.1016/j.anbehav.2009.06.029; Charrier I, 2003, MAR MAMMAL SCI, V19, P161, DOI 10.1111/j.1748-7692.2003.tb01099.x; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; Ellis W, 2011, BEHAV ECOL, V22, P372, DOI 10.1093/beheco/arq216; Ellis WAH, 2011, BEHAV ECOL SOCIOBIOL, V65, P1229, DOI 10.1007/s00265-010-1136-4; Ey E, 2007, INT J PRIMATOL, V28, P947, DOI 10.1007/s10764-007-9139-3; Feige S, 2007, APPL ANIM BEHAV SCI, V103, P131, DOI 10.1016/j.applanim.2006.03.014; FERRERI G, 1959, ITALIAN GENERAL REV, V1, P640; Field A., 2013, DISCOVERING STAT USI; FISCHER GM, 1980, EXP MOL PATHOL, V33, P15, DOI 10.1016/0014-4800(80)90003-9; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Fitch WT, 2000, ZOOL-ANAL COMPLEX SY, V103, P40; Fitch WTS, 2003, METH NE FRO NEUROSCI, P87; Giovanni A, 1999, J VOICE, V13, P465, DOI 10.1016/S0892-1997(99)80002-2; Handasyde, 1999, KOALA NATURAL HIST C; Harris TR, 2006, ETHOLOGY, V112, P911, DOI 10.1111/j.1439-0310.2006.01247.x; Hauser, 1996, EVOL COMMUN; HAUSER MD, 1994, BRAIN LANG, V46, P232, DOI 10.1006/brln.1994.1014; Herbst CT, 2012, SCIENCE, V337, P595, DOI 10.1126/science.1219712; Johnston SD, 2000, J REPROD FERTIL, V120, P49, DOI 10.1530/reprod/120.1.49; LEBOEUF BJ, 1974, AM ZOOL, V14, P163; Manser MB, 2002, TRENDS COGN SCI, V6, P55, DOI 10.1016/S1364-6613(00)01840-4; McLean T., 2003, ECOLOGY MANAGEMENT O; Mergell P, 1997, SPEECH COMMUN, V22, P141, DOI 10.1016/S0167-6393(97)00016-2; Mitchell P., 1990, P151; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; Pfefferle D, 2007, J ACOUST SOC AM, V121, P3947, DOI 10.1121/1.2722507; RAND AS, 1993, PHYSIOL ZOOL, V66, P793, DOI 10.1086/physzool.66.5.30163824; Reby D, 2003, ADV STUD BEHAV, V33, P231, DOI 10.1016/S0065-3454(03)33005-0; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2006, J ACOUST SOC AM, V120, P4080, DOI 10.1121/1.2358006; Reby D, 2012, ANIM COGN, V15, P265, DOI 10.1007/s10071-011-0451-0; Rendall D, 2004, J ACOUST SOC AM, V115, P411, DOI 10.1121/1.1635838; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; Riede T, 1999, J EXP BIOL, V202, P2859; Riede T, 2000, J ACOUST SOC AM, V108, P1435, DOI 10.1121/1.1289208; Riede T, 2008, J EXP BIOL, V211, P2144, DOI 10.1242/jeb.017004; Riede T, 2007, J ACOUST SOC AM, V121, P1758, DOI 10.1121/1.2427115; Riede T, 2011, J BIOMECH, V44, P1936, DOI 10.1016/j.jbiomech.2011.04.024; Riede T, 2010, J EXP BIOL, V213, P2924, DOI 10.1242/jeb.044404; Riede T, 2010, J MORPHOL, V271, P1, DOI 10.1002/jmor.10774; Rose RW, 1997, J ZOOL, V243, P523, DOI 10.1111/j.1469-7998.1997.tb02798.x; Sanvito S, 2007, ANIM BEHAV, V73, P287, DOI 10.1016/j.anbehav.2006.08.005; Searby A, 2003, P ROY SOC B-BIOL SCI, V270, P1765, DOI 10.1098/rspb.2003.2442; SMITH M, 1980, AUST WILDLIFE RES, V7, P13; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Stoeger AS, 2012, ETHOLOGY, V118, P896, DOI 10.1111/j.1439-0310.2012.02080.x; Titze IR, 1994, PRINCIPLES VOICE PRO; Torriani MVG, 2006, AM NAT, V168, P412, DOI 10.1086/506971; Townsend SW, 2014, ANIM BEHAV, V94, P143, DOI 10.1016/j.anbehav.2014.05.021; Townsend SW, 2011, BIOL LETTERS, V7, P47, DOI 10.1098/rsbl.2010.0537; Vannoni E, 2007, ETHOLOGY, V113, P223, DOI 10.1111/j.1439-0310.2006.01323.x; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; Volodina EV, 2006, ETHOLOGY, V112, P815, DOI 10.1111/j.1439-0310.2006.01231.x; Wilden I., 1998, Bioacoustics, V9, P171	75	11	11	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138670	10.1371/journal.pone.0138670	http://dx.doi.org/10.1371/journal.pone.0138670			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465340	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100020
J	Ding, ZH; Weissmann, S; Wang, MH; Du, BJ; Huang, L; Wang, L; Tu, XY; Zhong, SL; Myers, C; Brutnell, TP; Sun, Q; Li, PH				Ding, Zehong; Weissmann, Sarit; Wang, Minghui; Du, Baijuan; Huang, Lei; Wang, Lin; Tu, Xiaoyu; Zhong, Silin; Myers, Christopher; Brutnell, Thomas P.; Sun, Qi; Li, Pinghua			Identification of Photosynthesis-Associated C-4 Candidate Genes through Comparative Leaf Gradient Transcriptome in Multiple Lineages of C-3 and C-4 Species	PLOS ONE			English	Article							BUNDLE-SHEATH; FUNCTIONAL-DIFFERENTIATION; QUANTITATIVE PROTEOMICS; DEVELOPMENTAL GRADIENT; GENOME SEQUENCE; MAIZE MESOPHYLL; EXPRESSION; EVOLUTION; PLANTS; RICE	Leaves of C-4 crops usually have higher radiation, water and nitrogen use efficiencies compared to the C-3 species. Engineering C-4 traits into C-3 crops has been proposed as one of the most promising ways to repeal the biomass yield ceiling. To better understand the function of C-4 photosynthesis, and to identify candidate genes that are associated with the C-4 pathways, a comparative transcription network analysis was conducted on leaf developmental gradients of three C-4 species including maize, green foxtail and sorghum and one C-3 species, rice. By combining the methods of gene co-expression and differentially co-expression networks, we identified a total of 128 C-4 specific genes. Besides the classic C-4 shuttle genes, a new set of genes associated with light reaction, starch and sucrose metabolism, metabolites transportation, as well as transcription regulation, were identified as involved in C-4 photosynthesis. These findings will provide important insights into the differential gene regulation between C-3 and C-4 species, and a good genetic resource for establishing C-4 pathways in C-3 crops.	[Ding, Zehong] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Hainan, Haikou, Peoples R China; [Ding, Zehong; Wang, Minghui; Huang, Lei; Myers, Christopher; Sun, Qi] Cornell Univ, Life Sci Core Labs Ctr, Computat Biol Serv Unit, Ithaca, NY 14853 USA; [Weissmann, Sarit; Wang, Lin; Brutnell, Thomas P.] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Du, Baijuan; Li, Pinghua] Shandong Agr Univ, Coll Agron, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Tu, Xiaoyu; Zhong, Silin] Chinese Univ Hong Kong, Sch Life Sci, Partner State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Cornell University; Donald Danforth Plant Science Center; Shandong Agricultural University; Chinese University of Hong Kong	Sun, Q (corresponding author), Cornell Univ, Life Sci Core Labs Ctr, Computat Biol Serv Unit, Ithaca, NY 14853 USA.	qisun@cornell.edu; pinghuali@sdau.edu.cn	Brutnell, Thomas/M-2840-2013; zhong, silin/O-7029-2015; Myers, Christopher R/I-8516-2017; Tu, Xiaoyu/L-9743-2019; Li, Ping/GYV-4914-2022	Brutnell, Thomas/0000-0002-3581-8211; zhong, silin/0000-0002-0198-7383; Tu, Xiaoyu/0000-0002-0082-8989; Weissmann, Sarit/0000-0001-9608-0866	National Science Foundation of China [31271393]; National Science Foundation [IOS-1127017]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation of China (http://www.nsfc.gov.cn/) grant 31271393 to PL the National Science Foundation (www.nsf.gov) grant IOS-1127017 to TPB and QS.	Aubry S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004365; Aubry S, 2011, J EXP BOT, V62, P3049, DOI 10.1093/jxb/err012; Babu MM, 2006, TRENDS MICROBIOL, V14, P11, DOI 10.1016/j.tim.2005.11.005; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bonke M, 2003, NATURE, V426, P181, DOI 10.1038/nature02100; Brautigam A, 2008, PLANT PHYSIOL, V148, P568, DOI 10.1104/pp.108.121012; Brautigam A, 2011, PLANT PHYSIOL, V155, P142, DOI 10.1104/pp.110.159442; Chang YM, 2012, PLANT PHYSIOL, V160, P165, DOI 10.1104/pp.112.203810; Christin PA, 2013, GENOME BIOL EVOL, V5, P2174, DOI 10.1093/gbe/evt168; Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Friso G, 2010, PLANT PHYSIOL, V152, P1219, DOI 10.1104/pp.109.152694; Garfield DA, 2010, BIOSCIENCE, V60, P15, DOI 10.1525/bio.2010.60.1.6; Han XX, 2012, J INTEGR PLANT BIOL, V54, P486, DOI 10.1111/j.1744-7909.2012.01132.x; Hansen BO, 2014, FRONTIERS PLANT SCI, V5; Hibberd JM, 2008, CURR OPIN PLANT BIOL, V11, P228, DOI 10.1016/j.pbi.2007.11.002; Hibberd JM, 2010, ANNU REV PLANT BIOL, V61, P181, DOI 10.1146/annurev-arplant-042809-112238; Jiao YL, 2009, NAT GENET, V41, P258, DOI 10.1038/ng.282; John CR, 2014, PLANT PHYSIOL, V165, P62, DOI 10.1104/pp.114.238667; Kajala K, 2011, J EXP BOT, V62, P3001, DOI 10.1093/jxb/err022; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Majeran W, 2005, PLANT CELL, V17, P3111, DOI 10.1105/tpc.105.035519; Majeran W, 2009, TRENDS PLANT SCI, V14, P100, DOI 10.1016/j.tplants.2008.11.006; Majeran W, 2008, MOL CELL PROTEOMICS, V7, P1609, DOI 10.1074/mcp.M800016-MCP200; Majeran W, 2010, PLANT CELL, V22, P3509, DOI 10.1105/tpc.110.079764; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mitchell PL, 2006, NEW PHYTOL, V171, P688, DOI 10.1111/j.1469-8137.2006.01855.x; Miyao M, 2011, J EXP BOT, V62, P3021, DOI 10.1093/jxb/err023; Monson RK, 2003, INT J PLANT SCI, V164, pS43, DOI 10.1086/368400; Nelson T, 2011, J EXP BOT, V62, P3039, DOI 10.1093/jxb/err072; Niittyla T, 2006, J BIOL CHEM, V281, P11815, DOI 10.1074/jbc.M600519200; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Peterhansel C, 2011, J EXP BOT, V62, P3011, DOI 10.1093/jxb/err027; Pick TR, 2011, PLANT CELL, V23, P4208, DOI 10.1105/tpc.111.090324; Ranz JM, 2006, TRENDS ECOL EVOL, V21, P29, DOI 10.1016/j.tree.2005.09.002; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sage RF, 2011, J EXP BOT, V62, P2989, DOI 10.1093/jxb/err179; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Schnable JC, 2012, GENOME BIOL EVOL, V4, P265, DOI 10.1093/gbe/evs009; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SHEEN J, 1991, PLANT CELL, V3, P225, DOI 10.1105/tpc.3.3.225; Slewinski TL, 2009, J EXP BOT, V60, P881, DOI 10.1093/jxb/ern335; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Studer AJ, 2014, PLANT PHYSIOL, V165, P608, DOI 10.1104/pp.114.237602; Tausta SL, 2014, J EXPT BOT; Tesson BM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-497; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; Wang L, 2014, NATURE BIOTECHNOLOGY; Wang P, 2013, PLANT J, V75, P656, DOI 10.1111/tpj.12229; Wang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r68; Wang Y, 2014, J EXPT BOT; Weber APM, 2010, CURR OPIN PLANT BIOL, V13, P257, DOI 10.1016/j.pbi.2010.01.007; Yamori W, 2014, PHOTOSYNTH RES, V119, P101, DOI 10.1007/s11120-013-9874-6; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	60	26	25	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140629	10.1371/journal.pone.0140629	http://dx.doi.org/10.1371/journal.pone.0140629			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465154	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100155
J	Shao, J; Zhang, JN; Wu, X; Mao, QY; Chen, P; Zhu, FC; Xu, M; Kong, W; Liang, ZL; Wang, JZ				Shao, Jie; Zhang, Junnan; Wu, Xing; Mao, Qunying; Chen, Pan; Zhu, Fengcai; Xu, Miao; Kong, Wei; Liang, Zhenglun; Wang, Junzhi			Comparing the Primary and Recall Immune Response Induced by a New EV71 Vaccine Using Systems Biology Approaches	PLOS ONE			English	Article							ENTEROVIRUS 71 VACCINE; YELLOW-FEVER VACCINE; T-CELL; GENE-EXPRESSION; IMMUNOGENICITY; TAIWAN; SAFETY; REGULATOR; INFECTION; CHILDREN	Three inactivated EV71 whole-virus vaccines have completed Phase III clinical trials in mainland China, with high efficacy, satisfactory safety, and sustained immunogenicity. However, the molecular mechanisms how this new vaccine elicit potent immune response remain poorly understood. To characterize the primary and recall responses to EV71 vaccines, PBMC from 19 recipients before and after vaccination with EV71 vaccine are collected and their gene expression signatures after stimulation with EV71 antigen were compared. The results showed that primary and recall response to EV71 antigen have both activated an IRF7 regulating type I interferon and antiviral immune response network. However, up-regulated genes involved in T cell activation regulated by IRF1, inflammatory response, B-cell activation and humoral immune response were only observed in recall response. The specific secretion of IL-10 in primary response and IL-2, IP-10, CCL14a, CCL21 in recall response was consistent with the activation of immune response process found in genes. Furthermore, the expression of MX1 and secretion of IP-10 in recall response were strongly correlated with NTAb level at 180d after vaccination (r = 0.81 and 0.99). In summary, inflammatory response, adaptive immune response and a stronger antiviral response were indentified in recall response.	[Shao, Jie; Kong, Wei] Jilin Univ, Sch Life Sci, Changchun 130023, Jilin, Peoples R China; [Zhang, Junnan; Wu, Xing; Mao, Qunying; Chen, Pan; Xu, Miao; Liang, Zhenglun; Wang, Junzhi] Natl Inst Food & Drug Control, Div Hepatitis Virus Vaccines, Beijing, Peoples R China; [Zhu, Fengcai] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China	Jilin University; National Institute of Food & Drug Control - China; Jiangsu Provincial Center for Disease Control & Prevention	Kong, W (corresponding author), Jilin Univ, Sch Life Sci, Changchun 130023, Jilin, Peoples R China.	weikong@jlu.edu.cn; lzhenglun@126.com; wangjz@nicpbp.org.cn			National High Technology Research and Development Program ("863" program) from the Ministry of Science and Technology of the People's Republic of China [2012AA02A402]	National High Technology Research and Development Program ("863" program) from the Ministry of Science and Technology of the People's Republic of China(National High Technology Research and Development Program of China)	This Work was supported by National High Technology Research and Development Program ("863" program, No. 2012AA02A402) from the Ministry of Science and Technology of the People's Republic of China. URLs:http://www.863.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almire C, 2007, GENE CHROMOSOME CANC, V46, P1011, DOI 10.1002/gcc.20490; Bernal-Quiros M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059842; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chinese center for disease control and prevention, NAT NOT DIS REP SYST; Church SE, 2011, CANCER J, V17, P379, DOI 10.1097/PPO.0b013e3182346320; Cianciulli A, 2015, INT IMMUNOPHARMACOL, V24, P369, DOI 10.1016/j.intimp.2014.12.035; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; EBERLE F, 1995, GENE, V159, P267, DOI 10.1016/0378-1119(95)00180-E; Favole A, 2012, TRANSL ONCOL, V5, P48, DOI 10.1593/tlo.11247; Forssmann U, 2001, J LEUKOCYTE BIOL, V70, P357; Gan CS, 2015, ACTA TROP, V149, P8, DOI 10.1016/j.actatropica.2015.05.005; Garcia-Pineres AJ, 2009, J IMMUNOL, V182, P1706, DOI 10.4049/jimmunol.182.3.1706; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hong CY, 2014, SCAND J IMMUNOL, V79, P173, DOI 10.1111/sji.12145; Hu YM, 2013, CLIN VACCINE IMMUNOL, V20, P1805, DOI 10.1128/CVI.00491-13; Ikushima H, 2013, COLD SH Q B, V78, P105, DOI 10.1101/sqb.2013.78.020321; Kim D, 2011, J VIROL, V85, P200, DOI 10.1128/JVI.01624-10; Kok Chee Choy, 2015, World J Virol, V4, P78, DOI 10.5501/wjv.v4.i2.78; Liang ZL, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.24; Liang ZL, 2011, VACCINE, V29, P9668, DOI 10.1016/j.vaccine.2011.10.018; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Mao QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079599; Maruyama S, 2015, INT IMMUNOL, V27, P143, DOI 10.1093/intimm/dxu092; Moraes-Vieira PM, 2014, CELL METAB, V19, P512, DOI 10.1016/j.cmet.2014.01.018; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Penninger JM, 1997, IMMUNITY, V7, P243, DOI 10.1016/S1074-7613(00)80527-0; Pinto LA, 2003, J INFECT DIS, V188, P327, DOI 10.1086/376505; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Romero N, 2013, MOL BIOL CELL, V24, P617, DOI 10.1091/mbc.E12-07-0530; Shen FH, 2013, J GEN VIROL, V94, P1019, DOI 10.1099/vir.0.046383-0; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Thibault-Espitia A, 2012, AM J TRANSPLANT, V12, P2754, DOI 10.1111/j.1600-6143.2012.04194.x; Tylaska LA, 2002, CYTOKINE, V18, P184, DOI 10.1006/cyto.2002.1031; Villanueva JE, 2015, EUR J IMMUNOL, V45, P1820, DOI 10.1002/eji.201445416; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Youngblood Ben, 2015, F1000Prime Rep, V7, P38, DOI 10.12703/P7-38; Yuan B, 2015, ARCH VIROL, V160, P1989, DOI 10.1007/s00705-015-2473-4; Zhang JN, 2015, HUM VACC IMMUNOTHER, V11, P739, DOI 10.1080/21645515.2015.1008884; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923	48	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140515	10.1371/journal.pone.0140515	http://dx.doi.org/10.1371/journal.pone.0140515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465882	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100135
J	Statton, J; Gustin-Craig, S; Dixon, KW; Kendrick, GA				Statton, John; Gustin-Craig, Samuel; Dixon, Kingsley W.; Kendrick, Gary A.			Edge Effects along a Seagrass Margin Result in an Increased Grazing Risk on Posidonia australis Transplants	PLOS ONE			English	Article							PREDATOR-PREY RELATIONSHIPS; HABITAT FRAGMENTATION; FLORIDA BAY; SHARK BAY; THALASSIA-TESTUDINUM; WESTERN-AUSTRALIA; PATCH REEFS; HERBIVORY; RESTORATION; COMMUNITIES	A key issue in habitat restoration are the changes in ecological processes that occur when fragments of habitat are lost, resulting in the persistence of habitat-degraded margins. Margins often create or enhance opportunities for negative plant-herbivore interactions, preventing natural or assisted re-establishment of native vegetation into the degraded area. However, at some distance from the habitat margin these negative interactions may relax. Here, we posit that the intensity of species interactions in a fragmented Posidonia australis seagrass meadow may be spatially dependent on proximity to the seagrass habitat edge, whereby the risk of grazing is high and the probability of survival of seagrass transplants is low. To test this, transplants were planted 2 m within the meadow, on the meadow edge at 0m, and at 2m, 10m, 30m, 50m and 100m distance from the edge of the seagrass meadow into the unvegetated sand sheet. There was an enhanced grazing risk 0-10m from the edge, but decreased sharply with increasing distances (>30m). Yet, the risk of grazing was minimal inside the seagrass meadow, indicating that grazers may use the seagrass meadow for refuge but are not actively grazing within it. The relationship between short-term herbivory risk and long-term survival was not straightforward, suggesting that other environmental filters are also affecting survival of P. australis transplants within the study area. We found that daily probability of herbivory was predictable and operating over a small spatial scale at the edge of a large, intact seagrass meadow. These findings highlight the risk from herbivory can be high, and a potential contributing factor to seagrass establishment in restoration programs.	[Statton, John; Gustin-Craig, Samuel; Kendrick, Gary A.] Univ Western Australia, Fac Nat & Agr Sci, Sch Plant Biol, Crawley, WA, Australia; [Statton, John; Gustin-Craig, Samuel; Kendrick, Gary A.] Univ Western Australia, Fac Nat & Agr Sci, UWA Oceans Inst, Crawley, WA, Australia; [Statton, John; Gustin-Craig, Samuel] Kings Pk & Bot Gardens, Perth, WA, Australia; [Dixon, Kingsley W.] Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia	University of Western Australia; University of Western Australia; Curtin University	Statton, J (corresponding author), Univ Western Australia, Fac Nat & Agr Sci, Sch Plant Biol, Crawley, WA, Australia.	john.statton@uwa.edu.au	Kendrick, Gary Andrew/B-3460-2011; Dixon, Kingsley W/A-8133-2016	Kendrick, Gary Andrew/0000-0002-0276-6064; Dixon, Kingsley W/0000-0001-5989-2929	Australian Research Council [LP130100155]; Shark Bay Salt Pty. Ltd.	Australian Research Council(Australian Research Council); Shark Bay Salt Pty. Ltd.	JS and GAK were partly funded by the Australian Research Council (http://www.arc.gov.au/) Linkage Grant (LP130100155). This study was also funded by Shark Bay Salt Pty. Ltd. (https://www.mitsui.com/au/en/group/1197874_3954.html).	Armitage AR, 2006, J EXP MAR BIOL ECOL, V339, P65, DOI 10.1016/j.jembe.2006.07.013; Bologna PAX, 2002, ESTUARIES, V25, P1033, DOI 10.1007/BF02691350; Bourque AS, 2013, J EXP MAR BIOL ECOL, V445, P29, DOI 10.1016/j.jembe.2013.03.014; Burkholder DA, 2012, MAR FRESHWATER RES, V63, P1051, DOI 10.1071/MF12029; Dixon KW, 2011, COASTAL PLANTS A FIE; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FERRELL DJ, 1991, MAR ECOL PROG SER, V72, P15, DOI 10.3354/meps072015; Fonseca CR, 2007, RESTOR ECOL, V15, P613, DOI 10.1111/j.1526-100X.2007.00273.x; Fonseca M.S., 1998, GUIDELINES CONSERVAT; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Hallett LM, 2013, RESTOR ECOL, V21, P312, DOI 10.1111/rec.12007; HARDT RA, 1989, ECOLOGY, V70, P1252, DOI 10.2307/1938183; Hovel KA, 2001, ECOLOGY, V82, P1814; Hovel KA, 2008, LANDSCAPE ECOL, V23, P75, DOI 10.1007/s10980-007-9148-9; Hovey RK, 2012, MAR ECOL PROG SER, V446, P23, DOI 10.3354/meps09483; Kendrick GA, 2012, MAR FRESHWATER RES, V63, P941, DOI [10.1071/MF12280, 10.1071/MF12101]; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kremsater L., 1999, FOREST FRAGMENTATION, P117; Lambrinos JG, 2006, OECOLOGIA, V147, P327, DOI 10.1007/s00442-005-0259-1; Lidicker WZ, 1999, LANDSCAPE ECOL, V14, P333, DOI 10.1023/A:1008056817939; Macia S, 2005, MAR ECOL PROG SER, V303, P113, DOI 10.3354/meps303113; Moore EC, 2010, OIKOS, V119, P1299, DOI 10.1111/j.1600-0706.2009.17909.x; Morrison PF, 2009, WV02466 SINCL KNIGHT; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; OGDEN JC, 1973, SCIENCE, V182, P715, DOI 10.1126/science.182.4113.715; Ogden JC, 1977, ECOLOGICAL ASPECTS C, P377; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Ostfeld RS, 1997, ECOLOGY, V78, P1531, DOI 10.1890/0012-9658(1997)078[1531:EOROSO]2.0.CO;2; PAINE RT, 1981, ECOL MONOGR, V51, P145, DOI 10.2307/2937261; Paling E.I., 2009, COASTAL WETLANDS INT, P685; PARMENTER RR, 1985, RECLAM REVEG RES, V4, P93; Prado P, 2008, MAR ECOL PROG SER, V361, P69, DOI 10.3354/meps07405; RICHARDS JH, 1984, OECOLOGIA, V64, P21, DOI 10.1007/BF00377538; SCHUSTER JL, 1964, ECOLOGY, V45, P63, DOI 10.2307/1937107; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Sisk T. D., 1993, P57; Smith TM, 2011, J EXP MAR BIOL ECOL, V399, P8, DOI 10.1016/j.jembe.2011.01.010; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Statton J, 2012, MAR FRESHWATER RES, V63, P984, DOI 10.1071/MF12032; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Tanner JE, 2005, AUSTRAL ECOL, V30, P210, DOI 10.1111/j.1442-9993.2005.01438.x; TRIBBLE GW, 1981, MAR BIOL, V65, P277, DOI 10.1007/BF00397122; Valentine JF, 1997, OECOLOGIA, V112, P193, DOI 10.1007/s004420050300; van Katwijk MM, 2009, MAR POLLUT BULL, V58, P179, DOI 10.1016/j.marpolbul.2008.09.028; WALKER DI, 1988, AQUAT BOT, V30, P305, DOI 10.1016/0304-3770(88)90063-0; Wirsing AJ, 2007, ANIM BEHAV, V74, P93, DOI 10.1016/j.anbehav.2006.11.016; Wirth Rainer, 2008, V69, P423, DOI 10.1007/978-3-540-72954-9_17; ZIEMAN JC, 1989, B MAR SCI, V44, P292	50	5	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0137778	10.1371/journal.pone.0137778	http://dx.doi.org/10.1371/journal.pone.0137778			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465926	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100007
J	Koufaris, C; Valbuena, GN; Pomyen, Y; Tredwell, GD; Nevedomskaya, E; Lau, CHE; Yang, T; Benito, A; Ellis, JK; Keun, HC				Koufaris, C.; Valbuena, G. N.; Pomyen, Y.; Tredwell, G. D.; Nevedomskaya, E.; Lau, C-H E.; Yang, T.; Benito, A.; Ellis, J. K.; Keun, H. C.			Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells	ONCOGENE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; ATP-CITRATE LYASE; TUMOR-SUPPRESSOR; BIOCONDUCTOR PACKAGE; MICRORNA-22; CONTRIBUTES; MODEL; PROLIFERATION; TRANSCRIPTION; SIGNATURE	Dysregulated microRNA (miRNA) mediate malignant phenotypes, including metabolic reprogramming. By performing an integrative analysis of miRNA and metabolome data for the NCI-60 cell line panel, we identified an miRNA cluster strongly associated with both c-Myc expression and global metabolic variation. Within this cluster the cancer-associated and cardioprotective miR-22 was shown to repress fatty acid synthesis and elongation in tumour cells by targeting ATP citrate lyase and fatty acid elongase 6, as well as impairing mitochondrial one-carbon metabolism by suppression of methylene tetrahydrofolate dehydrogenase/cyclohydrolase. Across several data sets, expression of these target genes were associated with poorer outcomes in breast cancer patients. Importantly, a beneficial effect of miR-22 on clinical outcomes in breast cancer was shown to depend on the expression levels of the identified target genes, demonstrating the relevance of miRNA/mRNA interactions to disease progression in vivo. Our systematic analysis establishes miR-22 as a novel regulator of tumour cell metabolism, a function that could contribute to the role of this miRNA in cellular differentiation and cancer development. Moreover, we provide a paradigmatic example of effect modification in outcome analysis as a consequence of miRNA-directed gene targeting, a phenomenon that could be exploited to improve patient prognosis and treatment.	[Koufaris, C.; Valbuena, G. N.; Pomyen, Y.; Tredwell, G. D.; Lau, C-H E.; Yang, T.; Benito, A.; Ellis, J. K.; Keun, H. C.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Surg & Canc, Div Canc, London, England; [Koufaris, C.] Cyprus Inst Neurol & Genet, Dept Cytogenet & Genom, Nicosia, Cyprus; [Pomyen, Y.] Chulabhorn Res Inst, Translat Res Unit, Bangkok, Thailand; [Nevedomskaya, E.] Leiden Univ, Med Ctr, Ctr Prote & Metabol, Leiden, Netherlands; [Keun, H. C.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Syst Oncol & Canc Innovat, London, England	Imperial College London; Chulabhorn Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Imperial College London	Keun, HC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Div Canc, Inst Reprod & Dev Biol,Hammersmith Hosp, London W12 0NN, England.	h.keun@imperial.ac.uk	Koufaris, Costas/ABW-5036-2022; Tredwell, Greg/L-2294-2015; Lau, ChungHo/K-3557-2019	Koufaris, Costas/0000-0002-1222-5130; Tredwell, Greg/0000-0002-0020-5626; Lau, ChungHo/0000-0002-3602-8326; Benito, Adrian/0000-0002-8088-9537; Valbuena, Gabriel/0000-0001-6825-7214; Pomyen, Yotsawat/0000-0002-1070-3047	European Community's Seventh Framework Programme-Health project DETECTIVE [266838]; Cancer Research UK programme grant [A15115]; EC project Euro-MOTOR [259867]; UK Biotechnology and Biological Sciences Research Council (BBSRC) PhD studentship [BB/F529270/1]; Royal Thai Government Scholarship; UK MRC PhD studentship (Imperial College London Faculty of Medicine Doctoral Training Award); EC project HeCaTos [602156]; Medical Research Council [1416153] Funding Source: researchfish	European Community's Seventh Framework Programme-Health project DETECTIVE; Cancer Research UK programme grant(Cancer Research UK); EC project Euro-MOTOR; UK Biotechnology and Biological Sciences Research Council (BBSRC) PhD studentship; Royal Thai Government Scholarship; UK MRC PhD studentship (Imperial College London Faculty of Medicine Doctoral Training Award); EC project HeCaTos; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	HK, CK, GT and JE acknowledge support by the European Community's Seventh Framework Programme-Health (FP7/2007-2013) project DETECTIVE (grant agreement number 266838). HK and JE are also supported by Cancer Research UK programme grant A15115. HK and GV are supported by the EC FP7/2007-2013 project Euro-MOTOR (grant agreement number 259867). CHL is supported by a UK Biotechnology and Biological Sciences Research Council (BBSRC) PhD studentship (grant number BB/F529270/1 for the Institute of Chemical Biology (Imperial College London) Doctoral Training Centre). YP is supported by a Royal Thai Government Scholarship. TY is supported by a UK MRC PhD studentship (Imperial College London Faculty of Medicine Doctoral Training Award). AB is supported by the EC FP7/20132018 project HeCaTos (grant agreement number 602156). We also acknowledge valuable discussions with Dr Charlotte Bevan, Professor Charles Coombes, Dr Jake Bundy, Professor Nigel Gooderham and Dr Tim Ebbels.	Alvarez-Diaz S, 2012, HUM MOL GENET, V21, P2157, DOI 10.1093/hmg/dds031; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behrends V, 2011, ANAL BIOCHEM, V415, P206, DOI 10.1016/j.ab.2011.04.009; Bylesjo M, 2007, PLANT J, V52, P1181, DOI 10.1111/j.1365-313X.2007.03293.x; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Doria ML, 2014, FASEB J, V28, P4247, DOI 10.1096/fj.14-249672; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Gurha P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075882; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Helton JC, 2006, RELIAB ENG SYST SAFE, V91, P1175, DOI 10.1016/j.ress.2005.11.017; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jiang S, 2012, EMBO J, V31, P1985, DOI 10.1038/emboj.2012.45; KELLEHER JK, 1992, AM J PHYSIOL, V262, pE118, DOI 10.1152/ajpendo.1992.262.1.E118; Kirwan GM, 2012, ANAL CHEM, V84, P7064, DOI 10.1021/ac301269r; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kong LM, 2014, CANCER RES, V74, P3764, DOI 10.1158/0008-5472.CAN-13-3555; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lehtinen L, 2013, ONCOTARGET, V4, P48, DOI 10.18632/oncotarget.756; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; LligonaTrulla L, 1997, J LIPID RES, V38, P1454; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; Marzi MJ, 2012, J CELL BIOL, V199, P77, DOI 10.1083/jcb.201206033; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Meiri E, 2010, NUCLEIC ACIDS RES, V38, P6234, DOI 10.1093/nar/gkq376; Migita T, 2014, INT J CANCER, V135, P37, DOI 10.1002/ijc.28652; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Muir K, 2013, CANCER RES, V73, P4722, DOI 10.1158/0008-5472.CAN-12-3797; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; National Cancer Institute, MOL TARG DAT NCI NIH; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Polioudakis D, 2013, NUCLEIC ACIDS RES, V41, P2239, DOI 10.1093/nar/gks1452; Rantalainen M, 2006, J PROTEOME RES, V5, P2642, DOI 10.1021/pr060124w; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shin M, 2014, J BIOL CHEM, V289, P15507, DOI 10.1074/jbc.M114.555573; Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Song SJ, 2013, CELL STEM CELL, V13, P87, DOI 10.1016/j.stem.2013.06.003; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Tedeschi PM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.393; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Trygg J, 2002, J CHEMOMETR, V16, P283, DOI 10.1002/cem.724; Trygg J, 2003, J CHEMOMETR, V17, P53, DOI 10.1002/cem.775; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Vecchione A, 2013, P NATL ACAD SCI USA, V110, P9845, DOI 10.1073/pnas.1305472110; Volinia S, 2013, P NATL ACAD SCI USA, V110, P7413, DOI 10.1073/pnas.1304977110; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Xu XD, 2012, J CELL PHYSIOL, V227, P1391, DOI 10.1002/jcp.22852; Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	74	48	51	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2016	35	21					2766	2776		10.1038/onc.2015.333	http://dx.doi.org/10.1038/onc.2015.333			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MJ	26477310	Green Submitted			2022-12-26	WOS:000377472700010
J	Handali, M; Roychowdhury, H; Neupane, DP; Yukl, ET				Handali, Melody; Roychowdhury, Hridindu; Neupane, Durga P.; Yukl, Erik T.			AztD, a Periplasmic Zinc Metallochaperone to an ATP-binding Cassette (ABC) Transporter System in Paracoccus denitrificans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; METAL-BINDING; ESCHERICHIA-COLI; BACTERIAL PATHOGENS; COG0523 FAMILY; HOMEOSTASIS; REGULATOR; AFFINITY; COPPER; ZNTA	Bacterial ATP-binding cassette (ABC) transporters of transition metals are essential for acquisition of necessary elements from the environment. A large number of Gram-negative bacteria, including human pathogens, have a fourth conserved gene of unknown function adjacent to the canonical permease, ATPase, and solute-binding protein (SBP) genes of the AztABC zinc transporter system. To assess the function of this putative accessory factor (AztD) from Paracoccus denitrificans, we have analyzed its transcriptional regulation, metal binding properties, and interaction with the SBP (AztC). Transcription of the aztD gene is significantly up-regulated under conditions of zinc starvation. Recombinantly expressed AztD purifies with slightly substoichiometric zinc from the periplasm of Escherichia coli and is capable of binding up to three zinc ions with high affinity. Size exclusion chromatography and a simple intrinsic fluorescence assay were used to determine that AztD as isolated is able to transfer bound zinc nearly quantitatively to apo-AztC. Transfer occurs through a direct, associative mechanism that prevents loss of metal to the solvent. These results indicate that AztD is a zinc chaperone to AztC and likely functions to maintain zinc homeostasis through interaction with the AztABC system. This work extends our understanding of periplasmic zinc trafficking and the function of chaperones in this process.	[Handali, Melody; Roychowdhury, Hridindu; Neupane, Durga P.; Yukl, Erik T.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	New Mexico State University	Yukl, ET (corresponding author), Dept Chem & Biochem, 1175 N Horseshoe Dr, Las Cruces, NM 88003 USA.	etyukl@nmsu.edu		Yukl, Erik/0000-0001-6519-6938	National Institutes of Health from NIGMS [1SC2GM111170-01]; Discovery Scholars Program for undergraduate research at New Mexico State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM111170] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Discovery Scholars Program for undergraduate research at New Mexico State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1SC2GM111170-01 from NIGMS and the Discovery Scholars Program for undergraduate research at New Mexico State University (summer undergraduate funding). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badarau A, 2013, CHEM COMMUN, V49, P8000, DOI 10.1039/c3cc42709a; Bagai I, 2008, BIOCHEMISTRY-US, V47, P11408, DOI 10.1021/bi801638m; Berducci G, 2004, FEBS LETT, V569, P289, DOI 10.1016/j.febslet.2004.06.008; Braymer JJ, 2014, CURR OPIN CHEM BIOL, V19, P59, DOI 10.1016/j.cbpa.2013.12.021; Chacon KN, 2014, P NATL ACAD SCI USA, V111, P15373, DOI 10.1073/pnas.1411475111; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Costello LC, 2004, J INORG BIOCHEM, V98, P664, DOI 10.1016/j.jinorgbio.2004.02.005; Dainty SJ, 2010, J BIOL INORG CHEM, V15, P77, DOI 10.1007/s00775-009-0555-z; de Seny D, 2001, J BIOL CHEM, V276, P45065, DOI 10.1074/jbc.M106447200; Djoko KY, 2015, J BIOL CHEM, V290, P18954, DOI 10.1074/jbc.R115.647099; Dutta SJ, 2006, BIOCHEMISTRY-US, V45, P5923, DOI 10.1021/bi0523456; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; Gabbianelli R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-36; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Graham AI, 2009, J BIOL CHEM, V284, P18377, DOI 10.1074/jbc.M109.001503; Haas CE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-470; Handali M, 2015, J BIOL CHEM, V290, P11878, DOI 10.1074/jbc.M115.645853; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Ilari A, 2014, BBA-GEN SUBJECTS, V1840, P535, DOI 10.1016/j.bbagen.2013.10.010; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; Liu JB, 2006, BIOCHEMISTRY-US, V45, P763, DOI 10.1021/bi051836n; Liu JB, 2005, BIOCHEMISTRY-US, V44, P5159, DOI 10.1021/bi0476275; Mealman TD, 2012, BIOCHEMISTRY-US, V51, P6767, DOI 10.1021/bi300596a; Mealman TD, 2011, BIOCHEMISTRY-US, V50, P2559, DOI 10.1021/bi102012j; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Noll M, 1998, J BIOL CHEM, V273, P21393, DOI 10.1074/jbc.273.33.21393; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrarca P, 2010, J BACTERIOL, V192, P1553, DOI 10.1128/JB.01310-09; Ranieri-Raggi M, 2014, BIOMOLECULES, V4, P474, DOI 10.3390/biom4020474; Shin JH, 2007, J BACTERIOL, V189, P4070, DOI 10.1128/JB.01851-06; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Sullivan MJ, 2013, P NATL ACAD SCI USA, V110, P19926, DOI 10.1073/pnas.1314529110; Sydor AM, 2013, BIOCHEMISTRY-US, V52, P1788, DOI 10.1021/bi301600z; Wang D, 2012, J INORG BIOCHEM, V111, P173, DOI 10.1016/j.jinorgbio.2012.02.008; Wang YT, 2003, BIOCHEMISTRY-US, V42, P7318, DOI 10.1021/bi034243q; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702	44	13	13	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29984	29992		10.1074/jbc.M115.684506	http://dx.doi.org/10.1074/jbc.M115.684506			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26468286	Green Published, hybrid			2022-12-26	WOS:000366614700030
J	Alswied, A; Parekh, AB				Alswied, Abdullah; Parekh, Anant B.			Ca2+ Influx through Store-operated Calcium Channels Replenishes the Functional Phosphatidylinositol 4,5-Bisphosphate Pool Used by Cysteinyl Leukotriene Type I Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATE KINASES; INOSITOL 1,4,5-TRISPHOSPHATE; OSCILLATIONS; GENE; LITHIUM; ACTIVATION; EXPRESSION; AGONIST; IMPA2; STIM	Oscillations in cytoplasmic Ca2+ concentration are a universal mode of signaling following physiological levels of stimulation with agonists that engage the phospholipase C pathway. Sustained cytoplasmic Ca2+ oscillations require replenishment of the membrane phospholipid phosphatidylinositol 4,5-bis-phosphate (PIP2), the source of the Ca2+-releasing second messenger inositol trisphosphate. Here we show that cytoplasmic Ca2+ oscillations induced by cysteinyl leukotriene type I receptor activation run down when cells are pretreated with Li+, an inhibitor of inositol monophosphatases that prevents PIP2 resynthesis. In Li+-treated cells, cytoplasmic Ca2+ signals evoked by an agonist were rescued by addition of exogenous inositol or phosphatidylinositol 4-phosphate (PI4P). Knockdown of the phosphatidylinositol 4-phosphate 5 (PIP5) kinases alpha and gamma resulted in rapid loss of the intracellular Ca2+ oscillations and also prevented rescue by PI4P. Knockdown of talin1, a protein that helps regulate PIP5 kinases, accelerated rundown of cytoplasmic Ca2+ oscillations, and these could not be rescued by inositol or PI4P. In Li+-treated cells, recovery of the cytoplasmic Ca2+ oscillations in the presence of inositol or PI4P was suppressed when Ca2+ influx through store-operated Ca2+ channels was inhibited. After rundown of the Ca2+ signals following leukotriene receptor activation, stimulation of P2Y receptors evoked prominent inositol trisphosphate-dependent Ca2+ release. Therefore, leukotriene and P2Y receptors utilize distinct membrane PIP2 pools. Our findings show that store-operated Ca2+ entry is needed to sustain cytoplasmic Ca2+ signaling following leukotriene receptor activation both by refilling the Ca2+ stores and by helping to replenish the PIP2 pool accessible to leukotriene receptors, ostensibly through control of PIP5 kinase activity.	[Alswied, Abdullah; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Pk Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk			MRC [L01047X]; Saudi Arabian government; Medical Research Council [MR/L01047X/1] Funding Source: researchfish; MRC [MR/L01047X/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Saudi Arabian government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by MRC Program Grant L01047X (to A. B. P.). The authors declare that they have no conflict of interest with the contents of this article.; Recipient of a Saudi Arabian government studentship.	ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Amcheslavsky A, 2015, BIOPHYS J, V108, P237, DOI 10.1016/j.bpj.2014.11.3473; Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; ATACK JR, 1993, BRIT J PHARMACOL, V110, P809, DOI 10.1111/j.1476-5381.1993.tb13884.x; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bate N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034461; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; FAIN JN, 1979, BIOCHEM J, V180, P655, DOI 10.1042/bj1800655; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; JENKINSON S, 1994, MOL PHARMACOL, V46, P1138; Kunz J, 2000, MOL CELL, V5, P1, DOI 10.1016/S1097-2765(00)80398-6; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Maleth J., 2014, NAT COMMUN, V2014, P5; Ng SW, 2012, NATURE, V482, P111, DOI 10.1038/nature10731; Ohnishi T, 2007, J BIOL CHEM, V282, P637, DOI 10.1074/jbc.M604474200; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Straube S, 2001, PFLUG ARCH EUR J PHY, V442, P391, DOI 10.1007/s004240100546; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; THORN P, 1995, J PHYSIOL-LONDON, V482, P275, DOI 10.1113/jphysiol.1995.sp020516; TSE A, 1993, SCIENCE, V260, P82, DOI 10.1126/science.8385366; Walsh CM, 2010, BIOCHEM J, V425, P159, DOI 10.1042/BJ20090884; WANG SSH, 1995, J GEN PHYSIOL, V105, P149, DOI 10.1085/jgp.105.1.149; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Xie LH, 1999, P NATL ACAD SCI USA, V96, P15292, DOI 10.1073/pnas.96.26.15292; Yeh YC, 2014, J BIOL CHEM, V289, P17843, DOI 10.1074/jbc.M114.553453; Yoshikawa T, 2001, MOL PSYCHIATR, V6, P202, DOI 10.1038/sj.mp.4000835	41	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29555	29566		10.1074/jbc.M115.678292	http://dx.doi.org/10.1074/jbc.M115.678292			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468289	Green Published, hybrid			2022-12-26	WOS:000366613400037
J	Briggs, DC; Birchenough, HL; Ali, T; Rugg, MS; Waltho, JP; Ievoli, E; Jowitt, TA; Enghild, JJ; Richter, RP; Salustri, A; Milner, CM; Day, AJ				Briggs, David C.; Birchenough, Holly L.; Ali, Tariq; Rugg, Marilyn S.; Waltho, Jon P.; Ievoli, Elena; Jowitt, Thomas A.; Enghild, Jan J.; Richter, Ralf P.; Salustri, Antonietta; Milner, Caroline M.; Day, Anthony J.			Metal Ion-dependent Heavy Chain Transfer Activity of TSG-6 Mediates Assembly of the Cumulus-Oocyte Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hyaluronan; protein structure; protein-protein interaction; reproduction; site-directed mutagenesis; CUB module structure; TSG-6; cumulus-oocyte complex expansion; heavy chain-hyaluronan complex formation; inter--inhibitor	INTER-ALPHA-INHIBITOR; FACTOR-STIMULATED GENE-6; SHAP-HYALURONAN COMPLEX; COVALENTLY CROSS-LINKS; EXTRACELLULAR-MATRIX; TRYPSIN-INHIBITOR; PROTEIN TSG-6; CHROMOSOMAL LOCALIZATION; BINDING DOMAIN; MODULE	The matrix polysaccharide hyaluronan (HA) has a critical role in the expansion of the cumulus cell-oocyte complex (COC), a process that is necessary for ovulation and fertilization in most mammals. Hyaluronan is organized into a cross-linked network by the cooperative action of three proteins, inter--inhibitor (II), pentraxin-3, and TNF-stimulated gene-6 (TSG-6), driving the expansion of the COC and providing the cumulus matrix with its required viscoelastic properties. Although it is known that matrix stabilization involves the TSG-6-mediated transfer of II heavy chains (HCs) onto hyaluronan (to form covalent HCHA complexes that are cross-linked by pentraxin-3) and that this occurs via the formation of covalent HCTSG-6 intermediates, the underlying molecular mechanisms are not well understood. Here, we have determined the tertiary structure of the CUB module from human TSG-6, identifying a calcium ion-binding site and chelating glutamic acid residue that mediate the formation of HCTSG-6. This occurs via an initial metal ion-dependent, non-covalent, interaction between TSG-6 and HCs that also requires the presence of an HC-associated magnesium ion. In addition, we have found that the well characterized hyaluronan-binding site in the TSG-6 Link module is not used for recognition during transfer of HCs onto HA. Analysis of TSG-6 mutants (with impaired transferase and/or hyaluronan-binding functions) revealed that although the TSG-6-mediated formation of HCHA complexes is essential for the expansion of mouse COCs in vitro, the hyaluronan-binding function of TSG-6 does not play a major role in the stabilization of the murine cumulus matrix.	[Briggs, David C.; Birchenough, Holly L.; Ali, Tariq; Jowitt, Thomas A.; Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Briggs, David C.; Birchenough, Holly L.; Ali, Tariq; Waltho, Jon P.; Jowitt, Thomas A.; Milner, Caroline M.; Day, Anthony J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Rugg, Marilyn S.] Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England; [Ievoli, Elena; Salustri, Antonietta] Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy; [Enghild, Jan J.] Univ Aarhus, Dept Mol Chem, DK-8000 Aarhus C, Denmark; [Richter, Ralf P.] CIC BiomaGUNE, Donostia San Sebastian 20009, Spain; [Richter, Ralf P.] Univ Grenoble Alpes, Dept Mol Chem, F-38000 Grenoble, France; [Richter, Ralf P.] CNRS, F-38000 Grenoble, France; [Richter, Ralf P.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany	University of Manchester; University of Manchester; University of Oxford; University of Rome Tor Vergata; Aarhus University; CIC biomaGUNE; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Max Planck Society	Day, AJ (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Oxford Rd, Manchester M13 9PT, Lancs, England.	anthony.day@manchester.ac.uk	Milner, Caroline M/P-5526-2015; Richter, Ralf Peter/B-3343-2013; Day, Anthony/O-1658-2015; Ievoli, Elena/ABG-8920-2021; biomaGUNE, CIC/J-9136-2014	Milner, Caroline M/0000-0001-7355-9655; Richter, Ralf Peter/0000-0003-3071-2837; Day, Anthony/0000-0002-1415-3134; Jowitt, Thomas/0000-0002-4045-0933; Briggs, David/0000-0002-9793-7339; Waltho, Jonathan/0000-0002-7402-5492; SALUSTRI, ANTONIETTA/0000-0002-8731-1041; Enghild, Jan Johannes/0000-0001-9292-9172; biomaGUNE, CIC/0000-0001-7690-0660	Arthritis Research Campaign [14871, 18472, 19489]; Medical Research Council [G0701180]; Biotechnology and Biological Sciences Research Council CASE award; Biotechnology and Biological Sciences Research Council [BB/H000844/1, 957322] Funding Source: researchfish; Medical Research Council [MC_U138274352] Funding Source: researchfish; Versus Arthritis [19489, 18472] Funding Source: researchfish; BBSRC [BB/H000844/1] Funding Source: UKRI; MRC [G0701180, MC_U138274352] Funding Source: UKRI	Arthritis Research Campaign(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council CASE award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Arthritis Research Campaign Grants 14871, 18472, and 19489 and Medical Research Council Grant G0701180. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Biotechnology and Biological Sciences Research Council CASE award.	Baranova NS, 2014, J BIOL CHEM, V289, P30481, DOI 10.1074/jbc.M114.568154; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; BLOM A, 1995, J BIOL CHEM, V270, P9698, DOI 10.1074/jbc.270.17.9698; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Briggs DC, 2008, TRENDS MICROBIOL, V16, P407, DOI 10.1016/j.tim.2008.06.002; Camaioni A, 1996, ARCH BIOCHEM BIOPHYS, V325, P190, DOI 10.1006/abbi.1996.0024; CAMPBELL ID, 2011, CSH PERSPECT BIOL, V3, DOI DOI 10.1101/cshperspect.a004994; Carrette O, 2001, BIOL REPROD, V65, P301, DOI 10.1095/biolreprod65.1.301; CHEN L, 1993, MOL REPROD DEV, V34, P87, DOI 10.1002/mrd.1080340114; CHEN L, 1992, J BIOL CHEM, V267, P12380; Chen L, 1996, J BIOL CHEM, V271, P19409, DOI 10.1074/jbc.271.32.19409; Coulson-Thomas VJ, 2014, J BIOL CHEM, V289, P23465, DOI 10.1074/jbc.M114.557447; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Enghild JJ, 1999, BIOCHEMISTRY-US, V38, P11804, DOI 10.1021/bi9908540; EPPIG JJ, 1979, NATURE, V281, P483, DOI 10.1038/281483a0; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fulop C, 1997, GENE, V202, P95, DOI 10.1016/S0378-1119(97)00459-9; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; He H, 2014, INVEST OPHTH VIS SCI, V55, P1647, DOI 10.1167/iovs.13-13094; He H, 2013, J BIOL CHEM, V288, P25792, DOI 10.1074/jbc.M113.479584; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Hess KA, 1999, BIOL REPROD, V61, P436, DOI 10.1095/biolreprod61.2.436; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Higman VA, 2014, J BIOL CHEM, V289, P5619, DOI 10.1074/jbc.M113.542357; HUANG L, 1993, J BIOL CHEM, V268, P26725; Ievoli E, 2011, MATRIX BIOL, V30, P330, DOI 10.1016/j.matbio.2011.05.002; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Inforzato A, 2010, J BIOL CHEM, V285, P17681, DOI 10.1074/jbc.M109.085639; JESSEN TE, 1994, BIOL CHEM H-S, V375, P521, DOI 10.1515/bchm3.1994.375.8.521; Jessen TE, 2004, OSTEOARTHR CARTILAGE, V12, P142, DOI 10.1016/j.joca.2003.10.004; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Kaslik G, 1999, ARCH BIOCHEM BIOPHYS, V362, P254, DOI 10.1006/abbi.1998.1035; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Lam X, 2000, BIOL REPROD, V62, P579, DOI 10.1095/biolreprod62.3.579; Lamkin E, 2015, J BIOL CHEM, V290, P5156, DOI 10.1074/jbc.M114.636258; Lauer ME, 2014, J BIOL CHEM, V289, P29171, DOI 10.1074/jbc.M114.600809; Lauer ME, 2014, J BIOL CHEM, V289, P6791, DOI 10.1074/jbc.M113.512491; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lord MS, 2013, J BIOL CHEM, V288, P22930, DOI 10.1074/jbc.M112.404186; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Mahoney DJ, 2001, GLYCOBIOLOGY, V11, P1025, DOI 10.1093/glycob/11.12.1025; Mahoney DJ, 2001, J BIOL CHEM, V276, P22764, DOI 10.1074/jbc.M100666200; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; MORELLE W, 1994, EUR J BIOCHEM, V221, P881, DOI 10.1111/j.1432-1033.1994.tb18803.x; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagyova E, 2015, Endocr Regul, V49, P37; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P1008, DOI 10.1210/en.2002-220435; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Russell DL, 2006, SEMIN REPROD MED, V24, P217, DOI 10.1055/s-2006-948551; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2006, BIOCHEMISTRY-US, V45, P7661, DOI 10.1021/bi060106s; Sanggaard KW, 2010, BBA-PROTEINS PROTEOM, V1804, P1011, DOI 10.1016/j.bbapap.2010.01.013; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Shay E, 2011, INVEST OPHTH VIS SCI, V52, P2669, DOI 10.1167/iovs.10-5888; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200; Thakar D, 2014, CHEM COMMUN, V50, P15148, DOI 10.1039/c4cc06905f; Tirone E, 1997, J BIOL CHEM, V272, P4787, DOI 10.1074/jbc.272.8.4787; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	96	35	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28708	28723		10.1074/jbc.M115.669838	http://dx.doi.org/10.1074/jbc.M115.669838			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26468290	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000365762300012
J	Wojcik, S; Spodnik, JH; Dziewiatkowski, J; Spodnik, E; Morys, J				Wojcik, Slawomir; Spodnik, Jan Henryk; Dziewiatkowski, Jerzy; Spodnik, Edyta; Morys, Janusz			Morphological Changes within the Rat Lateral Ventricle after the Administration of Proteasome Inhibitors	PLOS ONE			English	Article							NEURON DEGENERATION; CELL-DEATH; EPENDYMAL REACTIONS; HEAT-SHOCK; IN-VIVO; BRAIN; HYDROCEPHALUS; ACTIVATION; SYSTEM; APOPTOSIS	The broad variety of substances that inhibit the action of the ubiquitin-proteasome system (UPS)-known as proteasome inhibitors-have been used extensively in previous studies, and they are currently frequently proposed as a novel form of cancer treatment and as a protective factor in intracerebral hemorrhage treatment. The experimental data on the safest route of proteasome inhibitor administration, their associated side effects, and the possible ways of minimizing these effects have recently become a very important topic. The aim of our present study was to determine the effects of administering of MG-132, lactacystin and epoxomicin, compounds belonging to three different classes of proteasome inhibitors, on the ependymal walls of the lateral ventricle. Observations were made 2 and 8 weeks after the intraventricular administration of the studied substances dissolved in dimethyl sulfoxide (DMSO) into the lateral ventricle of adult Wistar rats. Qualitative and quantitative analysis of brain sections stained with histochemical and inmmunofluorescence techniques showed that the administration of proteasome inhibitors caused a partial occlusion of the injected ventricle in all of the studied animals. The occlusion was due to ependymal cells damage and subsequent ependymal discontinuity, which caused direct contact between the striatum and the lateral nuclei of the septum, mononuclear cell infiltration and the formation of a glial scar between these structures (with the activation of astroglia, microglia and oligodendroglia). Morphologically, the ubiquitin-positive aggregates corresponded to aggresomes, indicating impaired activity of the UPS and the accumulation and aggregation of ubiquitinated proteins that coincided with the occurrence of glial scars. The most significant changes were observed in the wall covering the striatum in animals that were administered epoxomicin, and milder changes were observed in animals administered lactacystin and MG-132. Interestingly, DMSO administration also caused damage to some of the ependymal cells, but the aggresome-like structures were not formed. Our results indicate that all of the studied classes of proteasome inhibitors are detrimental to ependymal cells to some extent, and may cause severe changes in the ventricular system. The safety implications of their usage in therapeutic strategies to attenuate intracerebral hemorrhagic injury and in brain cancer treatment will require further studies.	[Wojcik, Slawomir; Spodnik, Jan Henryk; Dziewiatkowski, Jerzy; Spodnik, Edyta; Morys, Janusz] Med Univ Gdansk, Dept Anat & Neurobiol, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk	Wojcik, S (corresponding author), Med Univ Gdansk, Dept Anat & Neurobiol, Gdansk, Poland.	swoj@gumed.edu.pl	Janusz Morys, Professor//ABF-9423-2020; Spodnik, Jan/ABC-3195-2021; Wojcik, Slawomir/U-5266-2018	Janusz Morys, Professor//0000-0002-4048-1721; Spodnik, Jan/0000-0002-6311-9936; Wojcik, Slawomir/0000-0002-9635-2005; Morys, Janusz/0000-0001-5037-4607	Polish Ministry of Science and Higher Education [NN401 005735, ST-11, ST-0011/07/211]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by a Polish Ministry of Science and Higher Education grant - NN401 005735 (to SW) and by a statutory (ST-11) grant from the Polish Ministry of Science and Higher Education ST-0011/07/211. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; Ahn TB, 2006, BRAIN RES, V1087, P159, DOI 10.1016/j.brainres.2006.02.097; Akbari E, 2013, RES MOL MED, V1, P22; Al-Senani FM, 2012, TRANSL STROKE RES, V3, P146, DOI 10.1007/s12975-011-0108-y; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Caldeira MV, 2014, PROG NEUROBIOL, V112, P50, DOI 10.1016/j.pneurobio.2013.10.003; Carbonell WS, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-5; Carvalho PG, 2011, BRAIN RES, V1385, P107, DOI 10.1016/j.brainres.2011.02.044; Choi SC, 2015, J CELL PHYSIOL, V230, P1807, DOI 10.1002/jcp.24892; D'Cruz BJ, 2005, BRAIN RES, V1064, P108, DOI 10.1016/j.brainres.2005.09.052; Dasuri K, 2010, FREE RADICAL BIO MED, V49, P1290, DOI 10.1016/j.freeradbiomed.2010.07.014; DELBIGIO MR, 1995, J NEUROPATH EXP NEUR, V54, P405, DOI 10.1097/00005072-199505000-00014; Delli Pizzi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056501; Di Giorgio AM, 2008, RESTOR NEUROL NEUROS, V26, P501; Ding QX, 2003, J NEUROCHEM, V86, P489, DOI 10.1046/j.1471-4159.2003.01885.x; Elkharaz J, 2013, BBA-MOL BASIS DIS, V1832, P1930, DOI 10.1016/j.bbadis.2013.07.002; Fine SM, 1999, J NEUROIMMUNOL, V95, P55, DOI 10.1016/S0165-5728(98)00267-7; Galvao J, 2014, FASEB J, V28, P1317, DOI 10.1096/fj.13-235440; Gao C, 2014, J CEREBR BLOOD F MET, V34, P1070, DOI 10.1038/jcbfm.2014.56; Gao F, 2014, J CEREBR BLOOD F MET, V34, P489, DOI 10.1038/jcbfm.2013.225; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Goldbaum O, 2006, GLIA, V53, P891, DOI 10.1002/glia.20348; Goldbaum O, 2009, GLIA, V57, P1566, DOI 10.1002/glia.20870; Gomez-Roldan MDC, 2008, J COMP NEUROL, V507, P1571, DOI 10.1002/cne.21618; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Grondona JM, 1996, J NEUROPATH EXP NEUR, V55, P999, DOI 10.1097/00005072-199609000-00007; Hamano T, 2009, INT J CLIN EXP PATHO, V2, P561; Hanslick JL, 2009, NEUROBIOL DIS, V34, P1, DOI 10.1016/j.nbd.2008.11.006; Hirst RA, 2009, CHILD NERV SYST, V25, P559, DOI 10.1007/s00381-008-0768-4; Jansen AHP, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00073; Kandilis AN, 2014, EXPERT OPIN INV DRUG, V23, P67, DOI 10.1517/13543784.2013.840287; Kuhlmann T, 2007, J NEUROPATH EXP NEUR, V66, P238, DOI 10.1097/01.jnen.0000248559.83573.71; Kwon SJ, 2008, BRAIN RES, V1205, P116, DOI 10.1016/j.brainres.2008.02.030; Chala CL, 2013, COLOMB MEDICA, V44, P32; Lattke M, 2012, J NEUROSCI, V32, P11511, DOI 10.1523/JNEUROSCI.0182-12.2012; Li XP, 2007, J GERONTOL A-BIOL, V62, P943, DOI 10.1093/gerona/62.9.943; Liu J, 2001, INT IMMUNOPHARMACOL, V1, P63, DOI 10.1016/S1567-5769(00)00016-3; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Millet V, 2009, EXP NEUROL, V217, P282, DOI 10.1016/j.expneurol.2009.03.005; Miwa H, 2005, NEUROSCI LETT, V380, P93, DOI 10.1016/j.neulet.2005.01.024; Notman R, 2006, J AM CHEM SOC, V128, P13982, DOI 10.1021/ja063363t; OACU, 1996, GUID ENDP AN STUD PR; OECD, 2000, OECD GUID DOC REC AS; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Pasquini LA, 2003, J NEUROSCI, V23, P4635; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Redwine JM, 2002, CURR TOP MICROBIOL, V265, P119; Rogers N, 2010, NEUROPATH APPL NEURO, V36, P113, DOI [10.1111/j.1365-2990.2009.01063.x, 10.1111/j.1365-2990.2010.01063.x]; SARNAT HB, 1995, J NEUROPATH EXP NEUR, V54, P1, DOI 10.1097/00005072-199501000-00001; Schaeffer EL, 2015, J NEURAL TRANSM, V122, P619, DOI 10.1007/s00702-014-1305-0; Shoham S, 2003, EXP NEUROL, V184, P1043, DOI 10.1016/j.expneurol.2003.08.015; Sujashvili R, 2008, Georgian Med News, P48; SZMANT HH, 1975, ANN NY ACAD SCI, V243, P20, DOI 10.1111/j.1749-6632.1975.tb25340.x; Titler AM, 2013, CELL TISSUE RES, V352, P427, DOI 10.1007/s00441-013-1571-4; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Vernon AC, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-1; Villamar-Cruz O, 2006, BRAIN RES BULL, V69, P276, DOI 10.1016/j.brainresbull.2005.12.006; Wang HF, 2013, J INT MED RES, V41, P72, DOI 10.1177/0300060513476992; Wojcik S, 2014, FOLIA NEUROPATHOL, V52, P41, DOI 10.5114/fn.2014.41743; Wojcik S, 2013, FOLIA HISTOCHEM CYTO, V51, P249, DOI 10.5603/FHC.2013.0036; Wu WKK, 2010, CANCER LETT, V293, P15, DOI 10.1016/j.canlet.2009.12.002; Xie WJ, 2010, J NEUROCHEM, V115, P188, DOI 10.1111/j.1471-4159.2010.06914.x; Yuan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107447; Zhang LP, 2013, J CANCER RES CLIN, V139, P1105, DOI 10.1007/s00432-013-1412-6	64	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140536	10.1371/journal.pone.0140536	http://dx.doi.org/10.1371/journal.pone.0140536			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479862	Green Published, Green Submitted, gold			2022-12-26	WOS:000363026600013
J	Casado, NAR; Horcasitas, MDM; Vazquez, RR; Garcia, FJE; Vargas, JP; Castolo, AA; Ferrera-Cerrato, R; Guzman, OG; Calva, GC				Rivera Casado, Noemi Araceli; Montes Horcasitas, Maria del Carmen; Rodriguez Vazquez, Refugio; Esparza Garcia, Fernando Jose; Perez Vargas, Josefina; Ariza Castolo, Armando; Ferrera-Cerrato, Ronald; Gomez Guzman, Octavio; Calva Calva, Graciano			The Fatty Acid Profile Analysis of Cyperus laxus Used for Phytoremediation of Soils from Aged Oil Spill-Impacted Sites Revealed That This Is a C18:3 Plant Species	PLOS ONE			English	Article							PHOTOSYNTHETIC PATHWAYS; KRANZ ANATOMY; WATER DEPTH; CYPERACEAE; BIOSYNTHESIS; ACCUMULATION; EXTRACTION; RECOVERY; YELLOW; STARCH	The effect of recalcitrant hydrocarbons on the fatty acid profile from leaf, basal corm, and roots of Cyperus laxus plants cultivated in greenhouse phytoremediation systems of soils from aged oil spill-impacted sites containing from 16 to 340 g/Kg total hydrocarbons (THC) was assessed to investigate if this is a C18:3 species and if the hydrocarbon removal during the phytoremediation process has a relationship with the fatty acid profile of this plant. The fatty acid profile was specific to each vegetative organ and was strongly affected by the hydrocarbons level in the impacted sites. Leaf extracts of plants from uncontaminated soil produced palmitic acid (C16), octadecanoic acid (C18:0), unsaturated oleic acids (C18:1C18:3), and unsaturated eichosanoic (C20:2-C20:3) acids with a noticeable absence of the unsaturated hexadecatrienoic acid (C16:3); this finding demonstrates, for the first time, that C. laxus is a C18:3 plant. In plants from the phytoremediation systems, the total fatty acid contents in the leaf and the corm were negatively affected by the hydrocarbons presence; however, the effect was positive in root. Interestingly, under contaminated conditions, unusual fatty acids such as odd numbered carbons (C15, C17, C21, and C23) and uncommon unsaturated chains (C20:3n6 and C20:4) were produced together with a remarkable quantity of C22:2 and C24:0 chains in the corm and the leaf. These results demonstrate that weathered hydrocarbons may drastically affect the lipidic composition of C. laxus at the fatty acid level, suggesting that this species adjusts the cover lipid composition in its vegetative organs, mainly in roots, in response to the weathered hydrocarbon presence and uptake during the phytoremediation process.	[Rivera Casado, Noemi Araceli; Montes Horcasitas, Maria del Carmen; Rodriguez Vazquez, Refugio; Esparza Garcia, Fernando Jose; Gomez Guzman, Octavio; Calva Calva, Graciano] CINVESTAV IPN, Biotechnol & Bioengn, Mexico City, DF, Mexico; [Perez Vargas, Josefina] TESE, Biochem Engn, Postgrad Div, Valle De Anahuac, Ecatepec Estado, Mexico; [Ariza Castolo, Armando] CINVESTAV IPN, Dept Chem, Mexico City, DF, Mexico; [Ferrera-Cerrato, Ronald] Postgrad Coll, Microbiol Area, Edaphol Postgrad, Montecillo, Edo De Mexico, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Colegio de Postgraduados - Mexico	Calva, GC (corresponding author), Ave IPN 2508, Mexico City 07360, DF, Mexico.	gcalva@cinvestav.mx	Calva, Graciano Calva/M-2292-2018	Calva, Graciano Calva/0000-0002-0416-1464; Ariza-Castolo, Armando/0000-0003-2799-0764; PEREZ VARGAS, JOSEFINA/0000-0001-5574-2544	Consejo Nacional de Ciencia y Tecnologoia [CONACyT Mexico: 211085-5-29307B]; CONACyT doctoral fellowship	Consejo Nacional de Ciencia y Tecnologoia; CONACyT doctoral fellowship	This study was funded by Consejo Nacional de Ciencia y Tecnologoia (CONACyT Mexico: 211085-5-29307B), and a CONACyT doctoral fellowship to NARC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafat S. M., 2009, WORLD APPL SCI J, V7, P151; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogucka-Kocka A, 2010, GRASAS ACEITES, V61, P165, DOI 10.3989/gya.076109; Bruhl Jeremy J., 2007, Aliso, V23, P99; Bryson Charles T., 2008, V108, P15; Burja AM, 2007, J AGR FOOD CHEM, V55, P4795, DOI 10.1021/jf070412s; Daehler CC, 1998, BIOL CONSERV, V84, P167, DOI 10.1016/S0006-3207(97)00096-7; Debiane D, 2012, J HAZARD MATER, V209, P18, DOI 10.1016/j.jhazmat.2011.12.044; Deng H, 2004, ENVIRON POLLUT, V132, P29, DOI 10.1016/j.envpol.2004.03.030; Dominy NJ, 2008, EVOL BIOL, V35, P159, DOI 10.1007/s11692-008-9026-7; Eyherabide JJ, 2001, PESQUI AGROPECU BRAS, V36, P205, DOI 10.1590/S0100-204X2001000100025; Ezeh O, 2014, EUR J LIPID SCI TECH, V116, P783, DOI 10.1002/ejlt.201300446; Garcia-Lopez E., 2006, Terra, V24, P17; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Ke L, 2002, MAR POLLUT BULL, V45, P339, DOI 10.1016/S0025-326X(02)00117-0; KOLATTUKUDY PE, 1970, ANN REV PLANT PHYSIO, V21, P163, DOI 10.1146/annurev.pp.21.060170.001115; KROUMOVA AB, 1994, P NATL ACAD SCI USA, V91, P11437, DOI 10.1073/pnas.91.24.11437; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Lawer E.A., 2013, INT J ECOSYST, V3, P148, DOI DOI 10.5923/j.ije.20130305.07; LESSIRE R, 1982, PHYTOCHEMISTRY, V21, P55, DOI 10.1016/0031-9422(82)80014-9; Lin QX, 2005, ENVIRON SCI TECHNOL, V39, P1848, DOI 10.1021/es049063y; Lin QX, 2002, ENVIRON SCI TECHNOL, V36, P576, DOI 10.1021/es011075l; Lopez-Cortes I, 2013, IND CROP PROD, V51, P19, DOI 10.1016/j.indcrop.2013.08.061; Lot A., 2004, DIAGNOSTICO AMBIENTA, P521; Lovera M, 1996, MYCORRHIZA, V6, P111, DOI 10.1007/s005720050115; Lundgren MR, 2014, J EXP BOT, V65, P3357, DOI 10.1093/jxb/eru186; Malallah G, 1998, ENVIRON INT, V24, P919, DOI 10.1016/S0160-4120(98)00061-0; Martinez MG, 2000, WATER SCI TECHNOL, V42, P377, DOI 10.2166/wst.2000.0538; Martins S, 2013, AN ACAD BRAS CIENC, V85, P605, DOI 10.1590/S0001-37652013005000032; Martins S, 2009, BRITTONIA, V61, P189, DOI 10.1007/s12228-009-9073-0; Matthiesen RL, 1976, THESIS U ILLINOIDS U, P86; Mendelssohn IA, 2002, P 25 ART MAR OIL SPI, P785; Merkl N, 2004, J APPL BOT FOOD QUAL, V78, P185; Mongrand S, 1998, PHYTOCHEMISTRY, V49, P1049, DOI 10.1016/S0031-9422(98)00243-X; Palma CFJ, 2004, 1 INT M ENV BIOT ENG; Paquot C., 1987, STANDARD METHODS ANA; Pena-Castro JM, 2006, PLANT SCI, V170, P724, DOI 10.1016/j.plantsci.2005.11.004; Rivera Casado NA, 2013, 2 INT S BIOR SUST EN, pA; Rivera-Casado NA, 2010, REV CENIC CHEM SCI, V41, P1; Semple KT, 2004, ENVIRON SCI TECHNOL, V38, p228A, DOI 10.1021/es040548w; Somerville C., 2000, BIOCH MOL BIOL PLANT, P456; STOLLER EW, 1975, PLANT PHYSIOL, V55, P859, DOI 10.1104/pp.55.5.859; Turesson H, 2010, AM J BOT, V97, P1884, DOI 10.3732/ajb.1000200; UENO O, 1992, OECOLOGIA, V89, P195, DOI 10.1007/BF00317218; Voznesenskaya EV, 2001, NATURE, V414, P543, DOI 10.1038/35107073; Zunino MP, 2005, J CHEM ECOL, V31, P1269, DOI 10.1007/s10886-005-5285-2	47	4	4	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140103	10.1371/journal.pone.0140103	http://dx.doi.org/10.1371/journal.pone.0140103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473488	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500025
J	Ferriol, M; Garmendia, A; Gonzalez, A; Merle, H				Ferriol, Maria; Garmendia, Alfonso; Gonzalez, Ana; Merle, Hugo			Allogamy-Autogamy Switch Enhance Assortative Mating in the Allotetraploid Centaurea seridis L. Coexisting with the Diploid Centaurea aspera L. and Triggers the Asymmetrical Formation of Triploid Hybrids	PLOS ONE			English	Article							REPRODUCTIVE ISOLATION; SELF-INCOMPATIBILITY; TETRAPLOID CYTOTYPES; CONTACT ZONE; ASTERACEAE; DIFFERENTIATION; HYBRIDIZATION; EVOLUTION; BARRIERS; SYSTEM	Hybridization between tetraploids and their related diploids is generally unsuccessful in Centaurea, hence natural formation of triploid hybrids is rare. In contrast, the diploid Centaurea aspera and the allotetraploid C. seridis coexist in several contact zones where a high frequency of triploid hybrids is found. We analyzed the floral biology of the three taxa to identify reproductive isolation mechanisms that allow their coexistence. Flowering phenology was recorded, and controlled pollinations within and between the three taxa were performed in the field. Ploidy level and germination of progeny were also assessed. There was a 50% flowering overlap which indicated a phenological shift. Diploids were strictly allogamous and did not display mentor effects, while tetraploids were found to be highly autogamous. This breakdown of self-incompatibility by polyploids is first described in Centaurea. The asymmetrical formation of the hybrid was also found: all the triploid intact cypselae came from the diploid mothers pollinated by the pollen of tetraploids. Pollen and eggs from triploids were totally sterile, acting as a strong triploid block. These prezygotic isolation mechanisms ensured higher assortative mating in tetraploids than in diploids, improving their persistence in the contact zones. However these mechanisms can also be the cause of the low genetic diversity and high genetic structure observed in C. seridis.	[Ferriol, Maria; Garmendia, Alfonso] Univ Politecn Valencia, Inst Agroforestal Mediterraneo, E-46022 Valencia, Spain; [Gonzalez, Ana; Merle, Hugo] Univ Politecn Valencia, Dept Ecosistemas Agroforestales, E-46022 Valencia, Spain	Universitat Politecnica de Valencia; Universitat Politecnica de Valencia	Merle, H (corresponding author), Univ Politecn Valencia, Dept Ecosistemas Agroforestales, E-46022 Valencia, Spain.	humerfa@upvnet.upv.es	Garmendia, Alfonso/C-5895-2013; Ferriol, Maria/M-1370-2014; Merle, Hugo/L-4502-2017	Garmendia, Alfonso/0000-0001-6837-1818; Ferriol, Maria/0000-0002-6533-5720; Merle, Hugo/0000-0002-0004-7162				Awadalla P, 1997, MOL BIOL EVOL, V14, P1023, DOI 10.1093/oxfordjournals.molbev.a025708; Baldwin SJ, 2011, P ROY SOC B-BIOL SCI, V278, P2011, DOI 10.1098/rspb.2010.2208; Barrett S. C. H., 1988, Plant reproductive ecology: patterns and strategies, P98; Barringer BC, 2007, AM J BOT, V94, P1527, DOI 10.3732/ajb.94.9.1527; Bellanger S, 2014, FLORA, V209, P325, DOI 10.1016/j.flora.2014.04.002; Blanca G., 1984, Lazaroa, V6, P169; BOLOS O, 1995, FLORA DELS PAISOS CA; Borges LA, 2012, PLANT SYST EVOL, V298, P1371, DOI 10.1007/s00606-012-0643-3; Carputo D, 2003, GENETICS, V163, P287; Colas B, 2001, BIOL CONSERV, V99, P375, DOI 10.1016/S0006-3207(00)00229-9; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Cui C, 2012, GENETICS, V191, P725, DOI 10.1534/genetics.112.140780; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Felber F, 1997, BIOL J LINN SOC, V60, P95, DOI 10.1006/bijl.1996.0090; Ferrer MM, 2007, NEW PHYTOL, V173, P401, DOI 10.1111/j.1469-8137.2006.01905.x; Ferriol M, 2012, PLANT BIOSYST, V146, P86, DOI 10.1080/11263504.2012.727878; Ferriol M, 2014, BOT J LINN SOC, V176, P82, DOI 10.1111/boj.12194; Ferriol M, 2009, PLANT SYST EVOL, V277, P105, DOI 10.1007/s00606-008-0110-3; Font M., 2008, Collectanea Botanica (Barcelona), V27, P7; Garmendia A, 2015, PLANT BIOLOGY, V17, P746, DOI 10.1111/plb.12284; Garmendia A., 2010, BIOGEOGRAFIA CIENCIA, P463; Greiner R, 2012, FLORA, V207, P629, DOI 10.1016/j.flora.2012.07.001; Hardy OJ, 2001, HEREDITY, V87, P136, DOI 10.1046/j.1365-2540.2001.00862.x; Hardy OJ, 2000, NEW PHYTOL, V146, P281, DOI 10.1046/j.1469-8137.2000.00631.x; HARVILLE DA, 1974, BIOMETRIKA, V61, P383, DOI 10.2307/2334370; Hellwig FH, 2004, PLANT SYST EVOL, V246, P137, DOI 10.1007/s00606-004-0150-2; Hiscock SJ, 2000, HEREDITY, V85, P10, DOI 10.1046/j.1365-2540.2000.00692.x; Husband BC, 2004, BIOL J LINN SOC, V82, P537, DOI 10.1111/j.1095-8312.2004.00339.x; Husband BC, 2004, NEW PHYTOL, V161, P703, DOI 10.1046/j.1469-8137.2004.00998.x; Husband BC, 2002, P ROY SOC B-BIOL SCI, V269, P2565, DOI 10.1098/rspb.2002.2196; Husband BC, 2000, J ECOL, V88, P689, DOI 10.1046/j.1365-2745.2000.00481.x; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Koutecky P, 2012, PLANT SYST EVOL, V298, P1349, DOI 10.1007/s00606-012-0641-5; Koutecky P, 2012, PRESLIA, V84, P1; Koutecky P, 2011, BIOL J LINN SOC, V104, P93, DOI 10.1111/j.1095-8312.2011.01707.x; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; McCullagh P, 1989, GEN LINEAR MODELS; McKinnon G., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P81, DOI 10.1079/9780851999043.0081; Mraz P, 2003, FOLIA GEOBOT, V38, P345, DOI 10.1007/BF02803204; Mraz P, 2012, ANN BOT-LONDON, V110, P615, DOI 10.1093/aob/mcs120; Nielsen LR, 2003, BOT J LINN SOC, V142, P93, DOI 10.1046/j.1095-8339.2003.00168.x; Olsavska K, 2013, FOLIA GEOBOT, V48, P537, DOI 10.1007/s12224-013-9155-3; Peckert T, 2006, FOLIA GEOBOT, V41, P323, DOI 10.1007/BF02904945; Petit C, 1999, TRENDS ECOL EVOL, V14, P306, DOI 10.1016/S0169-5347(99)01608-0; R Core Team, 2021, R LANGUAGE ENV STAT; REINARTZ JA, 1994, AM J BOT, V81, P446, DOI 10.2307/2445494; Romaschenko K, 2004, BOT J LINN SOC, V145, P345, DOI 10.1111/j.1095-8339.2004.00292.x; Sonnleitner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078959; Spaniel S, 2008, FOLIA GEOBOT, V43, P131, DOI 10.1007/s12224-008-9008-7; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Sun M, 1998, HEREDITY, V80, P225, DOI 10.1046/j.1365-2540.1998.00290.x; Thorsson AETH, 2007, ANN BOT-LONDON, V99, P1183, DOI 10.1093/aob/mcm060; Tutin T. G., 1976, FLORA EUROPAEA, V4; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106	56	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140465	10.1371/journal.pone.0140465	http://dx.doi.org/10.1371/journal.pone.0140465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469271	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600064
J	Kinoshita, N; Katsukawa, F; Yamazaki, H				Kinoshita, Norimitsu; Katsukawa, Fuminori; Yamazaki, Hajime			Modeling of Longitudinal Changes in Left Ventricular Dimensions among Female Adolescent Runners	PLOS ONE			English	Article							FAT-FREE MASS; ATHLETES HEART; CARDIAC STRUCTURE; BODY-COMPOSITION; ELITE RUNNERS; ENDURANCE; ECHOCARDIOGRAPHY; METAANALYSIS; ASSOCIATION; PERFORMANCE	Purpose Left ventricular (LV) enlargement has been linked to sudden cardiac death among young athletes. This study aimed to model the effect of long-term incessant endurance training on LV dimensions in female adolescent runners. Methods Japanese female adolescent competitive distance runners (n = 36, age: 15 years, height: 158.1 +/- 4.6 cm, weight: 44.7 +/- 6.1 kg, percent body fat: 17.0 +/- 5.2%) underwent echocardiography and underwater weighing every 6 months for 3 years. Since the measurement occasions varied across subjects, multilevel analysis was used for curvilinear modeling of changes in running performance (velocities in 1500 m and 3000 m track race), maximal oxygen uptake (VO(2)max), body composition, and LV dimensions. Results Initially, LV end-diastolic dimension (LVEDd) and LV mass were 47.0 +/- 3.0mm and 122.6 +/- 15.7 g, respectively. Running performance and VO(2)max improved along with the training duration. The trends of changes in fat-free mass (FFM) and LVEDd were similarly best described by quadratic polynomials. LVEDd did not change over time in the model including FFM as a covariate. Increases in LV wall thicknesses were minimal and independent of FFM. LV mass increased according to a quadratic polynomial trend even after adjusting for FFM. Conclusions FFM was an important factor determining changes in LVEDd and LV mass. Although running performance and VO(2)max were improved by continued endurance training, further LV cavity enlargement hardly occurred beyond FFM gain in these adolescent female runners, who already demonstrated a large LVEDd.	[Kinoshita, Norimitsu] Hosei Univ, Fac Sports & Hlth Studies, Machida, Tokyo, Japan; [Katsukawa, Fuminori; Yamazaki, Hajime] Keio Univ, Sports Med Res Ctr, Yokohama, Kanagawa 223, Japan	Hosei University; Keio University	Kinoshita, N (corresponding author), Hosei Univ, Fac Sports & Hlth Studies, Machida, Tokyo, Japan.	sportsmed.kinoshita@hosei.ac.jp			Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research	Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research	This study was supported by the Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research in 2002 and 2003, and otherwise performed by using the institutional regular budget of the Sports Medicine Research Center, Keio University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel E, 2004, J AM COLL CARDIOL, V44, P144, DOI 10.1016/j.jacc.2004.02.057; ADAMS TD, 1981, CIRCULATION, V64, P958, DOI 10.1161/01.CIR.64.5.958; Arrese AL, 2005, J AM SOC ECHOCARDIOG, V18, P419, DOI 10.1016/j.echo.2005.02.002; Baggish AL, 2008, J APPL PHYSIOL, V104, P1121, DOI 10.1152/japplphysiol.01170.2007; BROZEK J, 1963, ANN NY ACAD SCI, V110, P113, DOI 10.1111/j.1749-6632.1963.tb17079.x; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558, DOI 10.1152/jappl.1983.55.5.1558; COX ML, 1986, J APPL PHYSIOL, V61, P926, DOI 10.1152/jappl.1986.61.3.926; D'Ascenzi F, 2015, EUR J PREV CARDIOL, V22, P127, DOI 10.1177/2047487313505820; DEMARIA AN, 1978, CIRCULATION, V57, P237, DOI 10.1161/01.CIR.57.2.237; DEVEREUX RB, 1984, J AM COLL CARDIOL, V4, P1222, DOI 10.1016/S0735-1097(84)80141-2; Di Paolo FM, 2012, J AM COLL CARDIOL, V59, P1029, DOI 10.1016/j.jacc.2011.12.008; DuBois D, 1913, ARCH INTERN MED, V17, P863; Fagard RH, 1996, INT J SPORTS MED, V17, pS140, DOI 10.1055/s-2007-972915; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; ISSEKUTZ B, 1962, J APPL PHYSIOL, V17, P47, DOI 10.1152/jappl.1962.17.1.47; La Gerche A, 2012, EUR J APPL PHYSIOL, V112, P2139, DOI 10.1007/s00421-011-2184-9; Legaz-Arrese A, 2006, EUR J APPL PHYSIOL, V96, P740, DOI 10.1007/s00421-005-0076-6; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; Ogden CL., 2011, NATL HLTH STAT REP, P1; Pelliccia A, 1999, ANN INTERN MED, V130, P23, DOI 10.7326/0003-4819-130-1-199901050-00005; Pelliccia A, 1996, JAMA-J AM MED ASSOC, V276, P211, DOI 10.1001/jama.276.3.211; Pelliccia A, 2010, J AM COLL CARDIOL, V55, P1619, DOI 10.1016/j.jacc.2009.10.068; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Pressler A, 2012, EUR J PREV CARDIOL, V19, P1194, DOI 10.1177/1741826711422455; Scharhag J, 2002, J AM COLL CARDIOL, V40, P1856, DOI 10.1016/S0735-1097(02)02478-6; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Sharma S, 2002, J AM COLL CARDIOL, V40, P1431, DOI 10.1016/S0735-1097(02)02270-2; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Spence AL, 2011, J PHYSIOL-LONDON, V589, P5443, DOI 10.1113/jphysiol.2011.217125; Steding K, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-8; Weiner RB, 2014, EXPERT REV CARDIOVAS, V12, P1243, DOI 10.1586/14779072.2014.970178; Whalley GA, 2004, J AM COLL CARDIOL, V44, P892, DOI 10.1016/j.jacc.2004.04.051; Yamazaki H, 2000, CLIN J SPORT MED, V10, P286, DOI 10.1097/00042752-200010000-00011	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140573	10.1371/journal.pone.0140573	http://dx.doi.org/10.1371/journal.pone.0140573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469336	Green Submitted, gold, Green Published			2022-12-26	WOS:000363184600078
J	Brumm, PJ; Monsma, S; Keough, B; Jasinovica, S; Ferguson, E; Schoenfeld, T; Lodes, M; Mead, DA				Brumm, Phillip J.; Monsma, Scott; Keough, Brendan; Jasinovica, Svetlana; Ferguson, Erin; Schoenfeld, Thomas; Lodes, Michael; Mead, David A.			Complete Genome Sequence of Thermus aquaticus Y51MC23	PLOS ONE			English	Article							SP NOV.; EXTREME THERMOPHILE; HOT-SPRINGS; BACTERIOPHAGE; DATABASE; PROTEIN; GENE; IDENTIFICATION; ENZYMES; DNA	Thermus aquaticus Y51MC23 was isolated from a boiling spring in the Lower Geyser Basin of Yellowstone National Park. Remarkably, this T. aquaticus strain is able to grow anaerobically and produces multiple morphological forms. Y51MC23 is a Gram-negative, rod-shaped organism that grows well between 50 degrees C and 80 degrees C with maximum growth rate at 65 degrees C to 70 degrees C. Growth studies suggest that Y51MC23 primarily scavenges protein from the environment, supported by the high number of secreted and intracellular proteases and peptidases as well as transporter systems for amino acids and peptides. The genome was assembled de novo using a 350 bp fragment library (paired end sequencing) and an 8 kb long span mate pair library. A closed and finished genome was obtained consisting of a single chromosome of 2.15 Mb and four plasmids of 11, 14, 70, and 79 kb. Unlike other Thermus species, functions usually found on megaplasmids were identified on the chromosome. The Y51MC23 genome contains two full and two partial prophage as well as numerous CRISPR loci. The high identity and synteny between Y51MC23 prophage 2 and that of Thermus sp. 2.9 is interesting, given the 8,800 km separation of the two hot springs from which they were isolated. The anaerobic lifestyle of Y51MC23 is complex, with multiple morphologies present in cultures. The use of fluorescence microscopy reveals new details about these unusual morphological features, including the presence of multiple types of large and small spheres, often forming a confluent layer of spheres. Many of the spheres appear to be formed not from cell envelope or outer membrane components as previously believed, but from a remodeled peptidoglycan cell wall. These complex morphological forms may serve multiple functions in the survival of the organism, including food and nucleic acid storage as well as colony attachment and organization.	[Brumm, Phillip J.] C5 6 Technol LLC, Fitchburg, WI 53711 USA; [Monsma, Scott; Keough, Brendan; Jasinovica, Svetlana; Ferguson, Erin; Schoenfeld, Thomas; Lodes, Michael; Mead, David A.] Lucigen Corp, Middleton, WI USA		Brumm, PJ (corresponding author), C5 6 Technol LLC, Fitchburg, WI 53711 USA.	pbrumm@c56technologies.com		MEAD, David/0000-0003-1982-9356	SBIR grant award from the National Human Genome Research Institute [1R43HG007797-01A1]; C5*6 Technologies LLC; Lucigen Corporation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R43HG007797] Funding Source: NIH RePORTER	SBIR grant award from the National Human Genome Research Institute; C5*6 Technologies LLC; Lucigen Corporation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was supported by an SBIR grant award (1R43HG007797-01A1) from the National Human Genome Research Institute. C5*6 Technologies LLC, and Lucigen Corporation provided support in the form of salaries for authors PB, SM, BK, SJ, EF, TS, ML & DM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2014, CUR BIOTECHNOL, DOI DOI 10.2174/2211550102999131230150918; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrett AJ, 2001, J STRUCT BIOL, V134, P95, DOI 10.1006/jsbi.2000.4332; Barth VC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084361; BEALL B, 1994, J BACTERIOL, V176, P2003, DOI 10.1128/jb.176.7.2003-2012.1994; Bender MH, 2003, J BACTERIOL, V185, P6057, DOI 10.1128/JB.185.20.6057-6066.2003; Berdygulova Z, 2011, J MOL BIOL, V405, P125, DOI 10.1016/j.jmb.2010.10.049; Bjornsdottir SH, 2009, INT J SYST EVOL MICR, V59, P2962, DOI 10.1099/ijs.0.007013-0; Bose M., 2006, In Silico Biology, V6, P223; BROCK TD, 1970, J BACTERIOL, V104, P509, DOI 10.1128/JB.104.1.509-517.1970; BROCK TD, 1969, J BACTERIOL, V98, P289, DOI 10.1128/JB.98.1.289-297.1969; BROCK TD, 1973, APPL MICROBIOL, V25, P72, DOI 10.1128/AEM.25.1.72-76.1973; Bruggemann H, 2006, J BIOTECHNOL, V124, P654, DOI 10.1016/j.jbiotec.2006.03.043; Brumm P, 2015, BIOENERG RES, V8, P1039, DOI 10.1007/s12155-015-9585-2; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; CASTON JR, 1993, MOL MICROBIOL, V9, P65, DOI 10.1111/j.1365-2958.1993.tb01669.x; Cava F, 2009, EXTREMOPHILES, V13, P213, DOI 10.1007/s00792-009-0226-6; Chandran V, 2013, BIOCHEM SOC T, V41, P17, DOI 10.1042/BST20120332; Chung AP, 2000, INT J SYST EVOL MICR, V50, P209, DOI 10.1099/00207713-50-1-209; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; Costa KC, 2009, EXTREMOPHILES, V13, P447, DOI 10.1007/s00792-009-0230-x; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; Devoid Scott, 2013, Methods Mol Biol, V985, P17, DOI 10.1007/978-1-62703-299-5_2; Dwivedi V, 2012, J BACTERIOL, V194, P3534, DOI 10.1128/JB.00604-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichenberger P, 2003, J MOL BIOL, V327, P945, DOI 10.1016/S0022-2836(03)00205-5; FERNANDEZHERRERO LA, 1995, MOL MICROBIOL, V17, P1, DOI 10.1111/j.1365-2958.1995.mmi_17010001.x; FERNANDEZHERRERO LA, 1995, J BACTERIOL, V177, P5460, DOI 10.1128/jb.177.19.5460-5466.1995; Fischer C, 1996, GENE, V168, P55, DOI 10.1016/0378-1119(95)00758-X; Fuhrman JA, 1740, PROTEORHODOPSINS ARR; GOLOVACHEVA R S, 1977, Mikrobiologiya, V46, P695; GOLOVACHEVA R S, 1977, Mikrobiologiya, V46, P506; Golovacheva R S, 1977, Mikrobiologiia, V46, P1019; Gounder K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-577; Gur E, RECOGNITION IN PRESS, P0890, DOI [10.1101/gad.1670908PST-ppublish, DOI 10.1101/GAD.1670908]; Gutierrez J, 2010, J BACTERIOL, V192, P3174, DOI 10.1128/JB.00127-10; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; Hong Wei, 2010, Weishengwu Xuebao, V50, P322; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Jiang L, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00308-13; Karpowich NK, 2013, P NATL ACAD SCI USA, V110, P2534, DOI 10.1073/pnas.1217361110; Kumwenda B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-813; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lin LB, 2010, J BASIC MICROB, V50, P452, DOI 10.1002/jobm.201000116; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Matsushita I, 2009, J BIOCHEM, V146, P775, DOI 10.1093/jb/mvp125; McCleskey C, 2004, WATER CHEM DATA SELE; Mead DA, 2012, STAND GENOMIC SCI, V6, P366, DOI 10.4056/sigs.2605792; Ming H, 2014, INT J SYST EVOL MICR, V64, P650, DOI 10.1099/ijs.0.056838-0; MUNSTER MJ, 1986, J GEN MICROBIOL, V132, P1677; Murugapiran SK, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00106-12; Murugapiran SK, 2013, STAND GENOMIC SCI, V7, P449, DOI 10.4056/sigs.3667269; Naryshkina T, 2006, J MOL BIOL, V364, P667, DOI 10.1016/j.jmb.2006.08.087; Navas LE, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01414-14; Nobre MF, 1996, INT J SYST BACTERIOL, V46, P604, DOI 10.1099/00207713-46-2-604; Ohtani N, 2010, J BACTERIOL, V192, P5499, DOI 10.1128/JB.00662-10; Overman SA, 2005, BIOCHEMISTRY-US, V44, P3091, DOI 10.1021/bi048163d; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ponting CP, 1997, PROTEIN SCI, V6, P464; Radax C, 1998, SYST APPL MICROBIOL, V21, P12, DOI 10.1016/S0723-2020(98)80003-9; Ramirez-Arcos S, 1998, J BACTERIOL, V180, P3137; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; RESNEKOV O, 1995, J BACTERIOL, V177, P5628, DOI 10.1128/jb.177.19.5628-5635.1995; SAKAKI Y, 1975, J VIROL, V15, P1449, DOI 10.1128/JVI.15.6.1449-1453.1975; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Schillinger Thomas, 2012, Mob Genet Elements, V2, P287; Tabata K, CAROTENOGEN IN PRESS; Takano H, 1465, LDRP CAMP RECEPTOR P; Tamakoshi Masatada, 2011, Bacteriophage, V1, P152; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teh BS, 2012, J BACTERIOL, V194, P1240, DOI 10.1128/JB.06589-11; Tian B, 2010, TRENDS MICROBIOL, V18, P512, DOI 10.1016/j.tim.2010.07.007; Vajna B, 2012, INT J SYST EVOL MICR, V62, P1486, DOI 10.1099/ijs.0.030866-0; Valas RE, 2008, J MOL EVOL, V66, P494, DOI 10.1007/s00239-008-9075-7; van Heesch S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-257; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; WILLIAMS RAD, 1995, INT J SYST BACTERIOL, V45, P495, DOI 10.1099/00207713-45-3-495; Williams RAD, 1996, INT J SYST BACTERIOL, V46, P403, DOI 10.1099/00207713-46-2-403; Wood TK, 2013, APPL ENVIRON MICROB, V79, P7116, DOI 10.1128/AEM.02636-13; Xie G, 2003, MICROBIOL MOL BIOL R, V67, P303, DOI 10.1128/MMBR.67.3.303-342.2003; Yan JY, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00382; Yu MX, 2006, ARCH VIROL, V151, P663, DOI 10.1007/s00705-005-0667-x; Zhang J, 2013, BIOCHEM SOC T, V41, P1422, DOI 10.1042/BST20130031; Zhang XQ, 2010, INT J SYST EVOL MICR, V60, P834, DOI 10.1099/ijs.0.007690-0; Zilla ML, 2015, J BACTERIOL, V197, P343, DOI 10.1128/JB.02364-14	91	8	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138674	10.1371/journal.pone.0138674	http://dx.doi.org/10.1371/journal.pone.0138674			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465632	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100021
J	Imsirovic, J; Wellman, TJ; Mondonedo, JR; Bartolak-Suki, E; Suki, B				Imsirovic, Jasmin; Wellman, Tyler J.; Mondonedo, Jarred R.; Bartolak-Suki, Elizabeth; Suki, Bela			Design of a Novel Equi-Biaxial Stretcher for Live Cellular and Subcellular Imaging	PLOS ONE			English	Article							CELLS IN-VITRO; MECHANICAL STRAIN; EPITHELIAL-CELLS; MITOCHONDRIAL FISSION; CHANNEL; CULTURE; INJURY	Cells in the body experience various mechanical stimuli that are often essential to proper cell function. In order to study the effects of mechanical stretch on cell function, several devices have been built to deliver cyclic stretch to cells; however, they are generally not practical for live cell imaging. We introduce a novel device that allows for live cell imaging, using either an upright or inverted microscope, during the delivery of cyclic stretch, which can vary in amplitude and frequency. The device delivers equi-biaxial strain to cells seeded on an elastic membrane via indentation of the membrane. Membrane area strain was calibrated to indenter depth and the device showed repeatable and accurate delivery of strain at the scale of individual cells. At the whole cell level, changes in intracellular calcium were measured at different membrane area strains, and showed an amplitude-dependent response. At the subcellular level, the mitochondrial network was imaged at increasing membrane area strains to demonstrate that stretch can lead to mitochondrial fission in lung fibroblasts. The device is a useful tool for studying transient as well as long-term mechanotransduction as it allows for simultaneous stretching and imaging of live cells in the presence of various chemical stimuli.	[Imsirovic, Jasmin; Wellman, Tyler J.; Mondonedo, Jarred R.; Bartolak-Suki, Elizabeth; Suki, Bela] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University	Suki, B (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	bsuki@bu.edu			NIH [HL-098976, HL-111745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098976, R01HL111745] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH HL-098976, HL-111745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arold SP, 2007, ANN BIOMED ENG, V35, P1156, DOI 10.1007/s10439-007-9262-5; Arold SP, 2009, AM J PHYSIOL-LUNG C, V296, pL574, DOI 10.1152/ajplung.90454.2008; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Bartolak-Suki E, 2015, NAT MATER, V14, P1049, DOI [10.1038/NMAT4358, 10.1038/nmat4358]; Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3; Chapman KE, 2005, AM J PHYSIOL-LUNG C, V289, pL834, DOI 10.1152/ajplung.00069.2005; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Gerstmair A, 2009, J APPL PHYSIOL, V107, P613, DOI 10.1152/japplphysiol.00012.2009; Greiner AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077328; Heidemann SR, 2003, BIOTECHNIQUES, V35, P708, DOI 10.2144/03354bi01; Huang L, 2010, ANN BIOMED ENG, V38, P1728, DOI 10.1007/s10439-010-9968-7; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Ito S, 2008, AM J RESP CELL MOL, V38, P407, DOI 10.1165/rcmb.2007-0259OC; Ito S, 2010, AM J RESP CELL MOL, V43, P26, DOI 10.1165/rcmb.2009-0073OC; Janmey PA, 2011, J CELL SCI, V124, P9, DOI 10.1242/jcs.071001; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Lau JJ, 2014, ANN BIOMED ENG, V42, P1062, DOI 10.1007/s10439-014-0976-x; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Mohanty MJ, 2002, AM J PHYSIOL-CELL PH, V283, pC456, DOI 10.1152/ajpcell.00057.2002; Quill B, 2015, BRIT J OPHTHALMOL, V99, P1009, DOI 10.1136/bjophthalmol-2014-306093; Shinmura A, 2015, ADV BIOMED ENG, V4, P60, DOI 10.14326/abe.4.60; Tschumperlin DJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1173, DOI 10.1152/ajplung.1998.275.6.L1173; Uhlig U, 2011, COMPR PHYSIOL, V1, P635, DOI 10.1002/cphy.c100004; WIRTZ HRW, 1990, SCIENCE, V250, P1266, DOI 10.1126/science.2173861; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	25	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140283	10.1371/journal.pone.0140283	http://dx.doi.org/10.1371/journal.pone.0140283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466363	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100098
J	Kolby, JE; Skerratt, LF				Kolby, Jonathan E.; Skerratt, Lee F.			Amphibian Chytrid Fungus in Madagascar neither Shows Widespread Presence nor Signs of Certain Establishment	PLOS ONE			English	Article							CHYTRIDIOMYCOSIS	The global spread of amphibian chytrid fungus (Batrachochytrium dendrobatidis, Bd) is associated with amphibian mass mortality, population decline, and extinction. Over the past decade, concern has been expressed for the potential introduction of Bd to Madagascar, a global hotspot of amphibian biodiversity. Following years without detection, widespread Bd presence in Madagascar has now been reported (Bletz et al. 2015a), raising international conservation concern. Before reacting to this finding with a significant management response, the accuracy and context of the data warrant cautious review. Re-examination of a 10-year dataset together with results from more recent surveillance (Kolby et al. 2015) does not yet demonstrate widespread Bd presence. Detection of Bd at "positive" locations in Madagascar has been inconsistent for unknown reasons. Whether Bd is established in Madagascar (i.e. populations are self-sustaining) or instead requires continued introduction to persist also remains uncertain. The deployment of emergency conservation rescue initiatives is expected to target areas where the distribution of Bd and the risk of chytridiomycosis endangering amphibians is believed to overlap. Thus, erroneous description of Bd presence would misdirect limited conservation resources. Standardized surveillance and confirmatory surveys are now imperative to reliably characterize the distribution, potential spread, virulence and overall risk of Bd to amphibians in Madagascar.	[Kolby, Jonathan E.; Skerratt, Lee F.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, One Hlth Res Grp, Townsville, Qld 4811, Australia	James Cook University	Kolby, JE (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, One Hlth Res Grp, Townsville, Qld 4811, Australia.	jonathan.kolby@my.jcu.edu.au	Kolby, Jonathan/GWV-5557-2022; Kolby, Jonathan/GWZ-3092-2022	Skerratt, Lee/0000-0003-3471-7512	James Cook University Australian Postgraduate Research Scholarship	James Cook University Australian Postgraduate Research Scholarship	JEK is supported by a James Cook University Australian Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bletz MC, 2015, DIS AQUAT ORGAN, V113, P1, DOI 10.3354/dao02822; Bletz MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08633; Chestnut T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106790; Crottini A, 2011, NORTH-WEST J ZOOL, V7, P346; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Kolby JE, 2015, PLOS ONE IN PRESS; Kolby JE., 2014, PLOS ONE; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Scheele BC, 2015, BIOL CONSERV, V182, P36, DOI 10.1016/j.biocon.2014.11.032; Shin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111091; Skerratt LF, 2011, J HERPETOL, V45, P444, DOI 10.1670/10-193.1; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Speare R, 2004, AUST VET J, V82, P300, DOI 10.1111/j.1751-0813.2004.tb12710.x; Vredenburg VT, 2012, HERPETOLOGY NOTES, V5, P507, DOI DOI 10.1186/1756-0500-5-507; Weldon C, 2013, ECOHEALTH, V10, P234, DOI 10.1007/s10393-013-0869-8; Weldon Che, 2008, Museo Regionale di Scienze Naturali Monografie (Turin), V45, P95	18	2	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139172	10.1371/journal.pone.0139172	http://dx.doi.org/10.1371/journal.pone.0139172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465924	Green Published, gold, Green Accepted			2022-12-26	WOS:000363183100039
J	Zhang, K; Zhou, YZ; Zhao, T; Wu, LY; Huang, X; Wu, KW; Xu, L; Li, DH; Liu, SH; Zhao, YQ; Fan, M; Zhu, LL				Zhang, Kuan; Zhou, Yanzhao; Zhao, Tong; Wu, Liying; Huang, Xin; Wu, Kuiwu; Xu, Lun; Li, Dahu; Liu, Shuhong; Zhao, Yongqi; Fan, Ming; Zhu, Lingling			Reduced Cerebral Oxygen Content in the DG and SVZ In Situ Promotes Neurogenesis in the Adult Rat Brain In Vivo	PLOS ONE			English	Article							NEURAL STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; INTERMITTENT HYPOXIA; MOUSE; DIFFERENTIATION; PROLIFERATION; DEPRESSION; INCREASES; DISEASE	Neurogenesis in the adult brain occurs mainly within two neurogenic structures, the dentate gyrus (DG) of the hippocampus and the sub-ventricular zone (SVZ) of the forebrain. It has been reported that mild hypoxia promoted the proliferation of Neural Stem Cells (NSCs) in vitro. Our previous study further demonstrated that an external hypoxic environment stimulated neurogenesis in the adult rat brain in vivo. However, it remains unknown how external hypoxic environments affect the oxygen content in the brain and result in neurogenesis. Here we use an optical fiber luminescent oxygen sensor to detect the oxygen content in the adult rat brain in situ under normoxia and hypoxia. We found that the distribution of oxygen in cerebral regions is spatiotemporally heterogeneous. The Po-2 values in the ventricles (45 similar to 50 Torr) and DG (approximately 10 Torr) were much higher than those of other parts of the brain, such as the cortex and thalamus (approximately 2 Torr). Interestingly, our in vivo studies showed that an external hypoxic environment could change the intrinsic oxygen content in brain tissues, notably reducing oxygen levels in both the DG and SVZ, the major sites of adult neurogenesis. Furthermore, the hypoxic environment also increased the expression of HIF-1 alpha and VEGF, two factors that have been reported to regulate neurogenesis, within the DG and SVZ. Thus, we have demonstrated that reducing the oxygen content of the external environment decreased Po-2 levels in the DG and SVZ. This reduced oxygen level in the DG and SVZ might be the main mechanism triggering neurogenesis in the adult brain. More importantly, we speculate that varying oxygen levels may be the physiological basis of the regionally restricted neurogenesis in the adult brain.	[Zhang, Kuan; Zhou, Yanzhao; Zhao, Tong; Wu, Liying; Huang, Xin; Wu, Kuiwu; Xu, Lun; Li, Dahu; Liu, Shuhong; Zhao, Yongqi; Fan, Ming; Zhu, Lingling] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Brain Protect & Plast, Beijing 100730, Peoples R China; [Fan, Ming; Zhu, Lingling] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China; [Fan, Ming] Beijing Inst Brain Disorders, Beijing, Peoples R China; [Zhang, Kuan] Third Mil Med Univ, Coll Basic Med Sci, Brain Res Ctr, Chongqing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Nantong University; Army Medical University	Fan, M (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Brain Protect & Plast, Beijing 100730, Peoples R China.	fanming@nic.bmi.ac.cn; linglingzhu@hotmail.com		Wu, Li-Ying/0000-0001-5277-2078	National Basic Research Program of China [2011CB910800, 2012CB518200]; Natural Science Foundation of China [81430044, 31271205, 90919052, 31400933]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Basic Research Program of China, No. 2011CB910800 and 2012CB518200; The Natural Science Foundation of China, No. 81430044, 31271205, 90919052 and 31400933. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerud P, 2001, J NEUROSCI, V21, P8108, DOI 10.1523/JNEUROSCI.21-20-08108.2001; Bi B, 2011, J NEUROSCI, V31, P9205, DOI 10.1523/JNEUROSCI.0518-11.2011; Boushel R, 2001, CIRCULATION, V104, P1785, DOI 10.1161/hc4001.097040; Boushel R, 2001, CIRCULATION, V104, P1785; CERVOSNAVARRO J, 1991, CRIT REV NEUROBIOL, V6, P149; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Drew Michael R., 2007, CNS & Neurological Disorders-Drug Targets, V6, P205, DOI 10.2174/187152707780619353; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gualtieri F, 2013, NEUROMOL MED, V15, P133, DOI 10.1007/s12017-012-8203-0; Hempel C, 2011, AM J PATHOL, V179, P1939, DOI 10.1016/j.ajpath.2011.06.027; Horie N, 2008, CELL MOL NEUROBIOL, V28, P833, DOI 10.1007/s10571-007-9237-y; Jablonska B, 2012, J NEUROSCI, V32, P14775, DOI 10.1523/JNEUROSCI.2060-12.2012; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; LIN CS, 1990, NEUROSCIENCE, V35, P289, DOI 10.1016/0306-4522(90)90083-G; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Nishijima T, 2006, NEUROSCI RES, V54, P186, DOI 10.1016/j.neures.2005.11.005; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; Plane JM, 2004, NEUROBIOL DIS, V16, P585, DOI 10.1016/j.nbd.2004.04.003; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Salmaso N, 2012, J NEUROSCI, V32, P8930, DOI 10.1523/JNEUROSCI.1398-12.2012; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Tsai YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024001; Yuen TJ, 2014, CELL, V158, P383, DOI 10.1016/j.cell.2014.04.052; Zhang CP, 2006, NEUROSIGNALS, V15, P259, DOI 10.1159/000103385; Zhao T, 2008, FEBS J, V275, P1824, DOI 10.1111/j.1742-4658.2008.06340.x; Zhu LL, 2005, MOL NEUROBIOL, V31, P231, DOI 10.1385/MN:31:1-3:231; Zhu LL, 2005, BRAIN RES, V1055, P1, DOI 10.1016/j.brainres.2005.04.075; Zhu XH, 2010, J NEUROSCI, V30, P12653, DOI 10.1523/JNEUROSCI.6414-09.2010; Zupet P, 2009, EUR J APPL PHYSIOL, V107, P345, DOI 10.1007/s00421-009-1123-5	33	15	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140035	10.1371/journal.pone.0140035	http://dx.doi.org/10.1371/journal.pone.0140035			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466323	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100073
J	Schaapsmeerders, P; Tuladhar, AM; Maaijwee, NAM; Rutten-Jacobs, LCA; Arntz, RM; Schoonderwaldt, HC; Dorresteijn, LDA; van Dijk, EJ; Kessels, RPC; de Leeuw, FE				Schaapsmeerders, Pauline; Tuladhar, Anil M.; Maaijwee, Noortje A. M.; Rutten-Jacobs, Loes C. A.; Arntz, Renate M.; Schoonderwaldt, Hennie C.; Dorresteijn, Lucille D. A.; van Dijk, Ewoud J.; Kessels, Roy P. C.; de Leeuw, Frank-Erik			Lower Ipsilateral Hippocampal Integrity after Ischemic Stroke in Young Adults: A Long-Term Follow-Up Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MIDDLE CEREBRAL-ARTERY; WHITE-MATTER; EPISODIC MEMORY; BRAIN; SCALE; INFARCTS; ATROPHY; PREVALENCE; DEMENTIA	Background and purpose Memory impairment after stroke is poorly understood as stroke rarely occurs in the hippocampus. Previous studies have observed smaller ipsilateral hippocampal volumes after stroke compared with controls. Possibly, these findings on macroscopic level are not the first occurrence of structural damage and are preceded by microscopic changes that may already be associated with a worse memory function. We therefore examined the relationship between hippocampal integrity, volume, and memory performance long after first-ever ischemic stroke in young adults. Methods We included all consecutive first-ever ischemic stroke patients, without hippocampal strokes or recurrent stroke/TIA, aged 18-50 years, admitted to our academic hospital between 1980 and 2010. One hundred and forty-six patients underwent T1 MPRAGE, DTI scanning and completed the Rey Auditory Verbal Learning Test and were compared with 84 stroke-free controls. After manual correction of hippocampal automatic segmentation, we calculated mean hippocampal fractional anisotropy (FA) and diffusivity (MD). Results On average 10 years after ischemic stroke, lesion volume was associated with lower ipsilateral hippocampal integrity (p<0.05), independent of hippocampal volume. In patients with a normal ipsilateral hippocampal volume (volume is less than or equal to 1.5 SD below the mean volume of controls) significant differences in ipsilateral hippocampal MD were observed (p<0.0001). However, patients with a normal hippocampal volume and high hippocampal MD did not show a worse memory performance compared with patients with a normal volume and low hippocampal MD (p>0.05). Conclusions Patients with average ipsilateral hippocampal volume could already have lower ipsilateral hippocampal integrity, although at present with no attendant worse memory performance compared with patients with high hippocampal integrity. Longitudinal studies are needed to investigate whether a low hippocampal integrity after stroke might lead to exacerbated memory decline with increasing age.	[Schaapsmeerders, Pauline; Tuladhar, Anil M.; Maaijwee, Noortje A. M.; Arntz, Renate M.; Schoonderwaldt, Hennie C.; van Dijk, Ewoud J.; de Leeuw, Frank-Erik] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Rutten-Jacobs, Loes C. A.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Dorresteijn, Lucille D. A.] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Ctr Neurosci, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Ctr Cognit, NL-6525 ED Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; University of Cambridge; Medical Spectrum Twente; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	de Leeuw, FE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands.	FrankErik.deLeeuw@radboudumc.nl	de Leeuw, Frank-Erik/E-4795-2012; van Dijk, Ewoud J/J-7951-2012; Kessels, Roy P.C./D-1902-2010; Rutten-Jacobs, Loes/C-7746-2013; Tuladhar, Anil/G-8214-2016	Kessels, Roy P.C./0000-0001-9500-9793; Rutten-Jacobs, Loes/0000-0003-3223-885X; Tuladhar, Anil/0000-0002-4815-2834	Dutch Epilepsy Fund [10-18]	Dutch Epilepsy Fund	This study was funded by the Dutch Epilepsy Fund (grant 10-18). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Jr HP, 1993, ARTERIOSCLER THROMB, V24, P35, DOI DOI 10.1161/01.STR.24.1.35; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Colliot O, 2008, RADIOLOGY, V248, P194, DOI 10.1148/radiol.2481070876; den Heijer T, 2012, NEUROIMAGE, V63, P1782, DOI 10.1016/j.neuroimage.2012.08.067; den Heijer T, 2010, BRAIN, V133, P1163, DOI 10.1093/brain/awq048; Driscoll I, 2003, CEREB CORTEX, V13, P1344, DOI 10.1093/cercor/bhg081; Duering M, 2012, NEUROLOGY, V79, P2025, DOI 10.1212/WNL.0b013e3182749f39; Exner C, 2001, NEUROLOGY, V57, P2054, DOI 10.1212/WNL.57.11.2054; Geuze E, 2005, MOL PSYCHIATR, V10, P160, DOI 10.1038/sj.mp.4001579; Grau-Olivares M, 2010, CEREBROVASC DIS, V30, P157, DOI 10.1159/000316059; HERMANN BP, 1987, EPILEPSIA, V28, P547, DOI 10.1111/j.1528-1157.1987.tb03687.x; Herve D, 2005, J NEUROL NEUROSUR PS, V76, P200, DOI 10.1136/jnnp.2004.041012; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Kasner SE, 1999, STROKE, V30, P1534, DOI 10.1161/01.STR.30.8.1534; Leifer D, 2011, STROKE, V42, P849, DOI 10.1161/STR.0b013e318208eb99; Moretti D V, 2012, Int J Alzheimers Dis, V2012, P917537, DOI 10.1155/2012/917537; Moretti D V, 2012, Int J Alzheimers Dis, V2012, P253153, DOI 10.1155/2012/253153; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Muller MJ, 2007, NEUROBIOL AGING, V28, P398, DOI 10.1016/j.neurobiolaging.2006.01.009; MUNGAS D, 1985, EPILEPSIA, V26, P340, DOI 10.1111/j.1528-1157.1985.tb05660.x; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Rutten-Jacobs LCA, 2013, ANN NEUROL, V74, P592, DOI 10.1002/ana.23953; Rutten-Jacobs LCA, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-109; Schaapsmeerders P, 2015, HUM BRAIN MAPP, V36, P2432, DOI 10.1002/hbm.22782; Schaapsmeerders P, 2013, STROKE, V44, P1621, DOI 10.1161/STROKEAHA.111.000792; Smith EE, 2012, NEUROLOGY, V79, P2016, DOI 10.1212/WNL.0b013e3182749f6e; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Snaphaan L, 2009, BRAIN, V132, P1882, DOI 10.1093/brain/awp133; TAMAMAKI N, 1991, J COMP NEUROL, V303, P435, DOI 10.1002/cne.903030309; TAMURA A, 1991, STROKE, V22, P615, DOI 10.1161/01.STR.22.5.615; Tuladhar AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066556; VAKIL E, 1993, J CLIN PSYCHOL, V49, P883, DOI 10.1002/1097-4679(199311)49:6<883::AID-JCLP2270490616>3.0.CO;2-6; van Norden AGW, 2008, NEUROLOGY, V71, P1152, DOI 10.1212/01.wnl.0000327564.44819.49; van Norden AGW, 2012, HUM BRAIN MAPP, V33, P542, DOI 10.1002/hbm.21231; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; Williams LS, 2000, STROKE, V31, P858, DOI 10.1161/01.STR.31.4.858; Wolk DA, 2011, NEUROIMAGE, V54, P1530, DOI 10.1016/j.neuroimage.2010.09.005; Xie MJ, 2011, ANN NEUROL, V70, P121, DOI 10.1002/ana.22386; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zwiers MP, 2010, NEUROIMAGE, V53, P565, DOI 10.1016/j.neuroimage.2010.06.014	44	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139772	10.1371/journal.pone.0139772	http://dx.doi.org/10.1371/journal.pone.0139772			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462115	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300025
J	Vajjhala, PR; Lu, A; Brown, DL; Pang, SW; Sagulenko, V; Sester, DP; Cridland, SO; Hill, JM; Schroder, K; Stow, JL; Wu, H; Stacey, KJ				Vajjhala, Parimala R.; Lu, Alvin; Brown, Darren L.; Pang, Siew Wai; Sagulenko, Vitaliya; Sester, David P.; Cridland, Simon O.; Hill, Justine M.; Schroder, Kate; Stow, Jennifer L.; Wu, Hao; Stacey, Katryn J.			The Inflammasome Adaptor ASC Induces Procaspase-8 Death Effector Domain Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELL-DEATH; CRYSTAL-STRUCTURE; SIGNALING COMPLEX; CD95-INDUCED APOPTOSIS; NLRP3 INFLAMMASOMES; PYRIN INFLAMMASOME; SELF-ASSOCIATION; CYTOPLASMIC DNA; MELANOMA 2; C-FLIP	Inflammasomes mediate inflammatory and cell death responses to pathogens and cellular stress signals via activation of procaspases-1 and -8. During inflammasome assembly, activated receptors of the NLR or PYHIN family recruit the adaptor protein ASC and initiate polymerization of its pyrin domain (PYD) into filaments. We show that ASC filaments in turn nucleate procaspase-8 death effector domain (DED) filaments in vitro and in vivo. Interaction between ASC PYD and procaspase-8 tandem DEDs optimally required both DEDs and represents an unusual heterotypic interaction between domains of the death fold superfamily. Analysis of ASC PYD mutants showed that interaction surfaces that mediate procaspase-8 interaction overlap with those required for ASC self-association and interaction with the PYDs of inflammasome initiators. Our data indicate that multiple types of death fold domain filaments form at inflammasomes and that PYD/DED and homotypic PYD interaction modes are similar. Interestingly, we observed condensation of procaspase-8 filaments containing the catalytic domain, suggesting that procaspase-8 interactions within and/or between filaments may be involved in caspase-8 activation. Procaspase-8 filaments may also be relevant to apoptosis induced by death receptors.	[Vajjhala, Parimala R.; Pang, Siew Wai; Sagulenko, Vitaliya; Sester, David P.; Cridland, Simon O.; Hill, Justine M.; Stacey, Katryn J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Brown, Darren L.; Schroder, Kate; Stow, Jennifer L.; Stacey, Katryn J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Lu, Alvin; Wu, Hao] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lu, Alvin; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA	University of Queensland; University of Queensland; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Wu, H (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Biol Chem & Mol Pharmacol,Program Cellular &, 3 Blackfan Circle,Rm 3099, Boston, MA 02115 USA.	hao.wu@childrens.harvard.edu; katryn.stacey@uq.edu.au	Schroder, Kate/C-6132-2008; Regan, Clinton/E-6250-2012; Pang, Siew Wai/U-5651-2019; Hill, Justine M/C-5781-2009; Sester, David/GLR-2942-2022; Stow, Jennifer/I-4723-2013	Schroder, Kate/0000-0001-9261-3805; Stow, Jennifer/0000-0002-5409-9101; Brown, Darren/0000-0003-2174-7691; Lu, Alvin/0000-0003-2353-848X; Stacey, Katryn/0000-0002-3992-7802	National Health and Medical Research Council (NHMRC) [1050651]; ACRF [FT130100361]; NHMRC [606788, 1003021, 1059729]; National Institutes of Health [AI050872]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050872] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); ACRF; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Health and Medical Research Council (NHMRC) Grant 1050651 (to K. J. S. and K. S.). The Australian Cancer Research Foundation (ACRF)/Institute for Molecular Bioscience Cancer Biology Imaging Facility was established with the support of the ACRF. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Australian Research Council Fellowship FT130100361.; Supported by NHMRC Grant 606788 and Fellowship 1003021.; Supported by National Institutes of Health RO1 Grant AI050872. To whom correspondence may be addressed: Dept. of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Program in Cellular and Molecular Medicine, Boston Children's Hospital, 3 Blackfan Circle, Rm. 3099, Boston, MA 02115. Tel.: 617-713-8160; Fax: 617-713-8161; E-mail: hao.wu@childrens.harvard.edu.; Supported by NHMRC Fellowship 1059729. To whom correspondence may be addressed: School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland 4072, Australia. Tel.: 61-7-33654640; Fax: 61-7-33654273; E-mail: katryn.stacey@uq.edu.au.	Aachoui Y, 2013, CURR OPIN MICROBIOL, V16, P319, DOI 10.1016/j.mib.2013.04.004; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Antonopoulos C, 2015, J BIOL CHEM, V290, P20167, DOI 10.1074/jbc.M115.652321; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Cresswell KS, 2005, BIOCHEM BIOPH RES CO, V326, P417, DOI 10.1016/j.bbrc.2004.11.048; Dickens LS, 2012, MOL CELL, V47, P291, DOI 10.1016/j.molcel.2012.05.004; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Fernandes-Alnemri T., 2007, CELL DEATH DIFFER, V14, P1590; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gavrilin MA, 2012, J IMMUNOL, V188, P3469, DOI 10.4049/jimmunol.1102272; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; Hauenstein AV, 2015, CURR OPIN STRUC BIOL, V31, P75, DOI 10.1016/j.sbi.2015.03.014; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kallenberger SM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004738; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lu A, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.13; Lu A, 2015, FEBS J, V282, P435, DOI 10.1111/febs.13133; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Lu A, 2014, J MOL BIOL, V426, P1420, DOI 10.1016/j.jmb.2013.12.029; Majkut J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4350; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Masumoto J, 2001, BIOCHEM BIOPH RES CO, V280, P652, DOI 10.1006/bbrc.2000.4190; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Monie TP, 2015, IMMUNOL REV, V265, P181, DOI 10.1111/imr.12284; Morrone SR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8827; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Sahillioglu AC, 2014, STRUCTURE, V22, P1722, DOI 10.1016/j.str.2014.09.011; Salvesen GS, 2014, SEMIN IMMUNOL, V26, P246, DOI 10.1016/j.smim.2014.03.005; Sandu C, 2006, CELL DEATH DIFFER, V13, P2052, DOI 10.1038/sj.cdd.4401966; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Sester DP, 2015, J IMMUNOL, V194, P455, DOI 10.4049/jimmunol.1401110; Shen C, 2015, BIOCHEM BIOPH RES CO, V463, P297, DOI 10.1016/j.bbrc.2015.05.054; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Theile CS, 2013, NAT PROTOC, V8, P1800, DOI 10.1038/nprot.2013.102; Tsao KL, 1996, GENE, V169, P59, DOI 10.1016/0378-1119(95)00762-8; Vajjhala PR, 2014, J BIOL CHEM, V289, P23504, DOI 10.1074/jbc.M114.553305; Vajjhala PR, 2012, J BIOL CHEM, V287, P41732, DOI 10.1074/jbc.M112.381228; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Wu YH, 2014, CELL DEATH DIFFER, V21, P451, DOI 10.1038/cdd.2013.165; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	67	58	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29217	29230		10.1074/jbc.M115.687731	http://dx.doi.org/10.1074/jbc.M115.687731			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468282	hybrid, Green Published			2022-12-26	WOS:000366613400009
J	Allam, SL; Bouteiller, JMC; Hu, EY; Ambert, N; Greget, R; Bischoff, S; Baudry, M; Berger, TW				Allam, Sushmita L.; Bouteiller, Jean-Marie C.; Hu, Eric Y.; Ambert, Nicolas; Greget, Renaud; Bischoff, Serge; Baudry, Michel; Berger, Theodore W.			Synaptic Efficacy as a Function of Ionotropic Receptor Distribution: A Computational Study	PLOS ONE			English	Article							GLUTAMATERGIC SYNAPSES; HIPPOCAMPAL SYNAPSES; RAT HIPPOCAMPUS; NMDA RECEPTORS; EXCITATORY SYNAPSES; QUANTAL VARIABILITY; DENDRITIC SPINES; AMPA RECEPTORS; CA1; TRANSMISSION	Glutamatergic synapses are the most prevalent functional elements of information processing in the brain. Changes in pre-synaptic activity and in the function of various post-synaptic elements contribute to generate a large variety of synaptic responses. Previous studies have explored postsynaptic factors responsible for regulating synaptic strength variations, but have given far less importance to synaptic geometry, and more specifically to the subcellular distribution of ionotropic receptors. We analyzed the functional effects resulting from changing the subsynaptic localization of ionotropic receptors by using a hippocampal synaptic computational framework. The present study was performed using the EONS (Elementary Objects of the Nervous System) synaptic modeling platform, which was specifically developed to explore the roles of subsynaptic elements as well as their interactions, and that of synaptic geometry. More specifically, we determined the effects of changing the localization of ionotropic receptors relative to the presynaptic glutamate release site, on synaptic efficacy and its variations following single pulse and paired-pulse stimulation protocols. The results indicate that changes in synaptic geometry do have consequences on synaptic efficacy and its dynamics.	[Allam, Sushmita L.; Bouteiller, Jean-Marie C.; Hu, Eric Y.; Berger, Theodore W.] Univ So Calif, Dept Biomed Engn, Ctr Neural Engn, Los Angeles, CA 90089 USA; [Bouteiller, Jean-Marie C.; Ambert, Nicolas; Greget, Renaud; Bischoff, Serge; Baudry, Michel] Rhenovia Pharma, Mulhouse, France; [Baudry, Michel] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA USA	University of Southern California; Western University of Health Sciences	Bouteiller, JMC (corresponding author), Univ So Calif, Dept Biomed Engn, Ctr Neural Engn, Los Angeles, CA 90089 USA.	jbouteil@usc.edu	bouteiller, jean-marie/L-4298-2019	bouteiller, jean-marie/0000-0003-3069-0826	National Institute of Biomedical Imaging and Bioengineering from National Institute of Neurological Disorders and Stroke [P41 EB001978-24, U01 GM104604, 1R01NS057128-01A2]; EC via Eurostars; French Association against Myopathies; Alsace Region; French Ministry of Defense; Mulhouse Area; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM104604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057128] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering from National Institute of Neurological Disorders and Stroke; EC via Eurostars; French Association against Myopathies; Alsace Region(Region Grand-Est); French Ministry of Defense; Mulhouse Area; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work supported by National Institute of Biomedical Imaging and Bioengineering - grant P41 EB001978-24 and U01 GM104604 to TWB, 1R01NS057128-01A2 to MB and TWB from National Institute of Neurological Disorders and Stroke. RHENOVIA Pharma acknowledges support from the EC via Eurostars, French Association against Myopathies, Alsace Region and Mulhouse Area, and the French Ministry of Defense.	Allam SL, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00070; Ambert Nicolas, 2010, Open Access Bioinformatics, V2, P113; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Bellingham MC, 1998, J PHYSIOL-LONDON, V511, P861, DOI 10.1111/j.1469-7793.1998.861bg.x; Bergles DE, 1998, J NEUROSCI, V18, P7709; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Boucher J, 2010, BRAIN STRUCT FUNCT, V215, P49, DOI 10.1007/s00429-010-0273-x; Bouteiller JMC, 2011, IEEE T BIO-MED ENG, V58, P3008, DOI 10.1109/TBME.2011.2158605; Bouteiller JMC, 2010, IEEE ENG MED BIO, P787, DOI 10.1109/IEMBS.2010.5626491; Bouteiller Jean-Marie C., 2008, Journal of Integrative Neuroscience, V7, P185, DOI 10.1142/S0219635208001770; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Choquet D, 2010, EUR J NEUROSCI, V32, P250, DOI 10.1111/j.1460-9568.2010.07350.x; Conti R, 2003, P NATL ACAD SCI USA, V100, P4885, DOI 10.1073/pnas.0630290100; FISHER RE, 1990, J NEUROPHYSIOL, V64, P91, DOI 10.1152/jn.1990.64.1.91; Franks KM, 2003, J NEUROSCI, V23, P3186; Hanse E, 2001, J PHYSIOL-LONDON, V531, P467, DOI 10.1111/j.1469-7793.2001.0467i.x; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Johnston D, 1992, Ion Channels, V3, P39; Jonas P, 1993, EXS, V66, P61; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Lisman J., 2006, SCI STKE, V2006, pr; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; MacGillavry HD, 2011, MOL CELL NEUROSCI, V48, P321, DOI 10.1016/j.mcn.2011.09.001; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Mayer ML, 2005, CURR OPIN NEUROBIOL, V15, P282, DOI 10.1016/j.conb.2005.05.004; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Racca C, 2000, J NEUROSCI, V20, P2512; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Robert A, 2003, J NEUROSCI, V23, P847; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Savtchenko LP, 2007, P NATL ACAD SCI USA, V104, P1823, DOI 10.1073/pnas.0606636104; Schorge S, 2005, J PHYSIOL-LONDON, V569, P395, DOI 10.1113/jphysiol.2005.095349; Singh P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002106; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Tarusawa E, 2009, J NEUROSCI, V29, P12896, DOI 10.1523/JNEUROSCI.6160-08.2009; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Vautrin J, 2003, SYNAPSE, V47, P184, DOI 10.1002/syn.10161; Wang JH, 1996, J NEUROPHYSIOL, V76, P276, DOI 10.1152/jn.1996.76.1.276; Xie XP, 1997, P NATL ACAD SCI USA, V94, P6983, DOI 10.1073/pnas.94.13.6983; Zhang W, 2008, NAT NEUROSCI, V11, P1373, DOI 10.1038/nn.2214; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	51	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140333	10.1371/journal.pone.0140333	http://dx.doi.org/10.1371/journal.pone.0140333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26480028	Green Submitted, Green Published, gold			2022-12-26	WOS:000363026600006
J	Fiarresga, A; Mata, MF; Cavaco-Goncalves, S; Selas, M; Simoes, IN; Oliveira, E; Carrapico, B; Cardim, N; Cabral, JMS; Ferreira, RC; da Silva, CL				Fiarresga, Antonio; Mata, Marcia F.; Cavaco-Goncalves, Sandra; Selas, Mafalda; Simoes, Irina N.; Oliveira, Eunice; Carrapico, Belmira; Cardim, Nuno; Cabral, Joaquim M. S.; Ferreira, Rui Cruz; da Silva, Claudia L.			Intracoronary Delivery of Human Mesenchymal/Stromal Stem Cells: Insights from Coronary Microcirculation Invasive Assessment in a Swine Model	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; MAGNETIC-RESONANCE; CARDIAC REPAIR; STROMAL CELLS; HEART; THERAPY; TRANSPLANTATION; THERAPEUTICS; INJECTION; EXPANSION	Background Mesenchymal stem/stromal cells have unique properties favorable to their use in clinical practice and have been studied for cardiac repair. However, these cells are larger than coronary microvessels and there is controversy about the risk of embolization and microinfarctions, which could jeopardize the safety and efficacy of intracoronary route for their delivery. The index of microcirculatory resistance (IMR) is an invasive method for quantitatively assessing the coronary microcirculation status. Objectives To examine heart microcirculation after intracoronary injection of mesenchymal stem/stromal cells with the index of microcirculatory resistance. Methods Healthy swine were randomized to receive by intracoronary route either 30x10(6) MSC or the same solution with no cells (1% human albumin/PBS) (placebo). Blinded operators took coronary pressure and flow measurements, prior to intracoronary infusion and at 5 and 30 minutes post-delivery. Coronary flow reserve (CFR) and the IMR were compared between groups. Results CFR and IMR were done with a variance within the 3 transit time measurements of 6% at rest and 11% at maximal hyperemia. After intracoronary infusion there were no significant differences in CFR. The IMR was significantly higher in MSC-injected animals (at 30 minutes, 14.2U vs. 8.8U, p = 0.02) and intragroup analysis showed a significant increase of 112% from baseline to 30 minutes after cell infusion, although no electrocardiographic changes or clinical deterioration were noted. Conclusion Overall, this study provides definitive evidence of microcirculatory disruption upon intracoronary administration of mesenchymal stem/stromal cells, in a large animal model closely resembling human cardiac physiology, function and anatomy.	[Fiarresga, Antonio; Selas, Mafalda; Oliveira, Eunice; Ferreira, Rui Cruz] Hosp Santa Marta, Dept Cardiol, Lisbon, Portugal; [Fiarresga, Antonio; Cardim, Nuno] Univ Nova Lisboa, Nova Med Sch, P-1200 Lisbon, Portugal; [Mata, Marcia F.; Simoes, Irina N.; Cabral, Joaquim M. S.; da Silva, Claudia L.] Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal; [Mata, Marcia F.; Simoes, Irina N.; Cabral, Joaquim M. S.; da Silva, Claudia L.] Univ Lisbon, Inst Super Tecn, iBB Inst Bioengn & Biosci, P-1699 Lisbon, Portugal; [Cavaco-Goncalves, Sandra] Natl Inst Agr & Vet Res, Oeiras, Portugal; [Carrapico, Belmira] Univ Lisbon, Fac Vet Med, P-1699 Lisbon, Portugal	Universidade Nova de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa	Fiarresga, A (corresponding author), Hosp Santa Marta, Dept Cardiol, Lisbon, Portugal.	a.fiarresga@gmail.com	da Silva, Claudia L./K-6104-2012; Mata, Márcia/M-5544-2016; Cabral, Joaquim M S/G-2052-2010	da Silva, Claudia L./0000-0002-1091-7651; Mata, Márcia/0000-0001-7034-1386; Cabral, Joaquim M S/0000-0002-2405-5845; Cavaco-Goncalves, Sandra/0000-0003-1280-229X	Cardiology Department of Hospital de Santa Marta; Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [EXPL/BIM-MED/1970/2013 CARDIOSAFER, SFRH/BD/90001/2012, SFRH/BD/51572/2011]; Fundação para a Ciência e a Tecnologia [EXPL/BIM-MED/1970/2013] Funding Source: FCT	Cardiology Department of Hospital de Santa Marta; Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This work was financially supported by research funds from the Cardiology Department of Hospital de Santa Marta and by Fundacao para a Ciencia e a Tecnologia (FCT), Portugal, through the project EXPL/BIM-MED/1970/2013 CARDIOSAFER and grants SFRH/BD/90001/2012 and SFRH/BD/51572/2011 awarded to M. F. Mata and I. N. Simoes, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Bartunek J, 2008, J CARDIOVASC TRANSL, V1, P115, DOI 10.1007/s12265-008-9021-5; Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; dos Santos F, 2011, METHODS MOL BIOL, V698, P189, DOI 10.1007/978-1-60761-999-4_15; Eggenhofer E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00148; Fearon WF, 2003, CIRCULATION, V107, P3129, DOI 10.1161/01.CIR.0000080700.98607.D1; Fiarresga A, 2014, REV PORT CARDIOL, V33, P207, DOI 10.1016/j.repc.2013.09.007; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Grieve SM, 2010, CIRC-HEART FAIL, V3, pE5, DOI 10.1161/CIRCHEARTFAILURE.109.931360; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hong SJ, 2012, CATHETER CARDIOVASC, V83, pE17; Houtgraaf JH, 2013, CIRC RES, V113, P153, DOI 10.1161/CIRCRESAHA.112.300730; Kraitchman DL, 2003, CIRCULATION, V107, P2290, DOI 10.1161/01.CIR.0000070931.62772.4E; Kudo M, 2003, J MOL CELL CARDIOL, V35, P1113, DOI 10.1016/S0022-2828(03)00211-6; Lennon DP, 2006, EXP HEMATOL, V34, P1604, DOI 10.1016/j.exphem.2006.07.014; Llano R, 2009, CATHETER CARDIO INTE, V73, P251, DOI 10.1002/ccd.21781; Lopes JP, 2013, REV PORT CARDIOL, V32, P43, DOI 10.1016/j.repc.2012.05.014; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mozid AM, 2011, BRIT MED BULL, V98, P143, DOI 10.1093/bmb/ldr014; Patel DM, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/496218; Penn EC, 2008, J MOL CELL CARDIOL, V44, P486, DOI 10.1016/j.yjmcc.2007.09.012; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Toma C, 2009, CIRC RES, V104, P398, DOI 10.1161/CIRCRESAHA.108.187724; Vulliet PR, 2004, LANCET, V363, P783, DOI 10.1016/S0140-6736(04)15695-X; Wang D, 2011, IRISH J MED SCI, V180, P379, DOI 10.1007/s11845-011-0687-3	32	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0139870	10.1371/journal.pone.0139870	http://dx.doi.org/10.1371/journal.pone.0139870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479722	Green Published, gold, Green Submitted			2022-12-26	WOS:000363026600004
J	Guttenberg, N; Laneuville, M; Ilardo, M; Aubert-Kato, N				Guttenberg, Nicholas; Laneuville, Matthieu; Ilardo, Melissa; Aubert-Kato, Nathanael			Transferable Measurements of Heredity in Models of the Origins of Life	PLOS ONE			English	Article							EVOLUTION; SETS	We propose a metric which can be used to compute the amount of heritable variation enabled by a given dynamical system. A distribution of selection pressures is used such that each pressure selects a particular fixed point via competitive exclusion in order to determine the corresponding distribution of potential fixed points in the population dynamics. This metric accurately detects the number of species present in artificially prepared test systems, and furthermore can correctly determine the number of heritable sets in clustered transition matrix models in which there are no clearly defined genomes. Finally, we apply our metric to the GARD model and show that it accurately reproduces prior measurements of the model's heritability.	[Guttenberg, Nicholas; Laneuville, Matthieu] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 152, Japan; [Ilardo, Melissa] Univ Copenhagen, Nat Hist Museum, Ctr GeoGenet, Copenhagen, Denmark; [Aubert-Kato, Nathanael] Ochanomizu Univ, Dept Informat Sci, Tokyo 112, Japan; [Aubert-Kato, Nathanael] Ochanomizu Univ, Leading Grad Sch Promot Ctr, Tokyo 112, Japan	Tokyo Institute of Technology; University of Copenhagen; Ochanomizu University; Ochanomizu University	Guttenberg, N (corresponding author), Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 152, Japan.	ngutten@gmail.com	Laneuville, Matthieu/F-8523-2010	Laneuville, Matthieu/0000-0001-6022-0046; Ilardo, Melissa/0000-0001-6535-8802; Aubert-Kato, Nathanael/0000-0002-9100-1855				Arnold SJ, 2008, EVOLUTION, V62, P2451, DOI 10.1111/j.1558-5646.2008.00472.x; BURGER R, 1989, EVOLUTION, V43, P1748, DOI [10.2307/2409390, 10.1111/j.1558-5646.1989.tb02624.x]; EIGEN M, 1988, J PHYS CHEM-US, V92, P6881, DOI 10.1021/j100335a010; England JL, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818538; FALCONER DS, 1953, J GENET, V51, P470, DOI 10.1007/BF02982939; FONTANA W, 1994, B MATH BIOL, V56, P1; Gross R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0265-1; Gutierrez JMP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6571; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hordijk W, 2004, J THEOR BIOL, V227, P451, DOI 10.1016/j.jtbi.2003.11.020; KAUFFMAN SA, 1986, J THEOR BIOL, V119, P1, DOI 10.1016/S0022-5193(86)80047-9; LANDE R, 1979, EVOLUTION, V33, P402, DOI 10.2307/2407630; Markovitch O, 2012, ARTIF LIFE, V18, P243, DOI 10.1162/artl_a_00064; Orgel LE, 2000, P NATL ACAD SCI USA, V97, P12503, DOI 10.1073/pnas.220406697; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Saladino R, 2012, PHYS LIFE REV, V9, P84, DOI 10.1016/j.plrev.2011.12.002; Segre D, 2001, ORIGINS LIFE EVOL B, V31, P119, DOI 10.1023/A:1006746807104; Segre D, 1998, ORIGINS LIFE EVOL B, V28, P501, DOI 10.1023/A:1006583712886; Segre D, 2000, P NATL ACAD SCI USA, V97, P4112, DOI 10.1073/pnas.97.8.4112; Steppan SJ, 2002, TRENDS ECOL EVOL, V17, P320, DOI 10.1016/S0169-5347(02)02505-3; Vasas V, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-1; Vasas V, 2010, P NATL ACAD SCI USA, V107, P1470, DOI 10.1073/pnas.0912628107; Virgo N, 2013, ADV ARTIFICIAL LIFE, V12, P240, DOI DOI 10.7551/978-0-262-31709-2-CH036	23	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140663	10.1371/journal.pone.0140663	http://dx.doi.org/10.1371/journal.pone.0140663			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26480478	Green Submitted, Green Published, gold			2022-12-26	WOS:000363026600016
J	Szameitat, AJ; Hamaida, Y; Tulley, RS; Saylik, R; Otermans, PCJ				Szameitat, Andre J.; Hamaida, Yasmin; Tulley, Rebecca S.; Saylik, Rahmi; Otermans, Pauldy C. J.			"Women Are Better Than Men"-Public Beliefs on Gender Differences and Other Aspects in Multitasking	PLOS ONE			English	Article							DUAL-TASK PERFORMANCE; NULL HYPOTHESIS	Reports in public media suggest the existence of a stereotype that women are better at multitasking than men. The present online survey aimed at supporting this incidental observation by empirical data. For this, 488 participants from various ethnic backgrounds (US, UK, Germany, the Netherlands, Turkey, and others) filled out a self-developed online-questionnaire. Results showed that overall more than 50% of the participants believed in gender differences in multitasking abilities. Of those who believed in gender differences, a majority of 80% believed that women were better at multitasking. The main reasons for this were believed to be an evolutionary advantage and more multitasking practice in women, mainly due to managing children and household and/or family and job. Findings were consistent across the different countries, thus supporting the existence of a widespread gender stereotype that women are better at multitasking than men. Further questionnaire results provided information about the participants' self-rated own multitasking abilities, and how they conceived multitasking activities such as childcare, phoning while driving, and office work.	[Szameitat, Andre J.; Hamaida, Yasmin; Tulley, Rebecca S.; Saylik, Rahmi; Otermans, Pauldy C. J.] Brunel Univ London, Dept Life Sci, Div Psychol, Uxbridge, Middx, England	Brunel University	Szameitat, AJ (corresponding author), Brunel Univ London, Dept Life Sci, Div Psychol, Uxbridge, Middx, England.	Andre.Szameitat@Brunel.ac.uk	saylik, rahmi/ABI-7776-2020	SAYLIK, RAHMI/0000-0003-3337-5266				Allport G. W., 1954, NATURE PREJUDICE; Boesveld S, 2013, NATL POST; Buser T, 2012, EXP ECON, V15, P641, DOI 10.1007/s10683-012-9318-8; Cortina JM, 1998, ORGAN RES METHODS, V1, P334, DOI 10.1177/109442819813004; DeLuca AN, 2013, NATL GEOGRAPHIC; Hossain A., 2013, FORBES; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Jersild AT, 1927, ARCH PSYCHOL, V14; Jimenez F., 2014, DIE WELT GERMAN; Joel D, 2014, P NATL ACAD SCI USA, V111, pE637, DOI 10.1073/pnas.1323319111; Kluger AN, 2001, PSYCHOL BULL, V127, P408, DOI 10.1037//0033-2909.127.3.408; Lauda L., 2013, BEWIESEN WAS FRAUEN; Mantyla T, 2013, PSYCHOL SCI, V24, P514, DOI 10.1177/0956797612459660; McCauley C.R., 1995, STEREOTYPE ACCURACY, P293, DOI 10.1037/10495-012; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Morgan J., 2013, BBC UK; Paridon HM, 2010, EUR J PSYCHOL, V6, P110; Pavlova MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114802; Pavlova MA, 2010, BRAIN RES, V1311, P81, DOI 10.1016/j.brainres.2009.11.046; Pease B, 2003, WHY MEN CAN ONLY DO; Redick TS, 2012, EUR J PSYCHOL ASSESS, V28, P164, DOI 10.1027/1015-5759/a000123; Sax LJ, 2003, RES HIGH EDUC, V44, P409, DOI 10.1023/A:1024232915870; Sayer LC, 2007, RES SOCIOL WORK, V17, P403, DOI 10.1016/S0277-2833(07)17013-8; Silverman I, 1992, ADAPTED MIND EVOLUTI, P487; Spencer B., 2013, DAILY MAIL; Stoet G., 2013, BMC PSYCHOL, V1, DOI [10.1186/2050-7283-1-18, DOI 10.1186/2050-7283-1-18]; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; Szameitat AJ, 2006, PSYCHOL RES-PSYCH FO, V70, P541, DOI 10.1007/s00426-005-0015-5; Tomsic ML, 2000, 40 ANN M ASS I RES M; Underwood D, 2000, AIR 2000 ANN FOR; Watson JM, 2010, PSYCHON B REV, V17, P479, DOI 10.3758/PBR.17.4.479	32	14	14	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140371	10.1371/journal.pone.0140371	http://dx.doi.org/10.1371/journal.pone.0140371			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7WW	26479359	gold, Green Published, Green Submitted			2022-12-26	WOS:000363026600010
J	Molina-Guijarro, JM; Garcia, C; Macias, A; Garcia-Fernandez, LF; Moreno, C; Reyes, F; Martinez-Leal, JF; Fernandez, R; Martinez, V; Valenzuela, C; Lillo, MP; Galmarini, CM				Manuel Molina-Guijarro, Jose; Garcia, Carolina; Macias, Alvaro; Francisco Garcia-Fernandez, Luis; Moreno, Cristina; Reyes, Fernando; Fernando Martinez-Leal, Juan; Fernandez, Rogelio; Martinez, Valentin; Valenzuela, Carmen; Pilar Lillo, M.; Galmarini, Carlos M.			Elisidepsin Interacts Directly with Glycosylceramides in the Plasma Membrane of Tumor Cells to Induce Necrotic Cell Death	PLOS ONE			English	Article							BACTERIAL PROTEIN TOXINS; GLUCOSYLCERAMIDE SYNTHASE; HKV1.5 CHANNELS; BIOACTIVE SPHINGOLIPIDS; CANCER MALIGNANCY; DRUG-RESISTANCE; PORE FORMATION; BREAST-CANCER; RAPID METHOD; CERAMIDE	Plasma membrane integrity is essential for cell life. Any major break on it immediately induces the death of the affected cell. Different molecules were described as disrupting this cell structure and thus showing antitumor activity. We have previously defined that elisidepsin (Irvalec (R), PM02734) inserts and self-organizes in the plasma membrane of tumor cells, inducing a rapid loss of membrane integrity, cell permeabilization and necrotic death. Here we show that, in sensitive HCT-116 colorectal cells, all these effects are consequence of the interaction of elisidepsin with glycosylceramides in the cell membrane. Of note, an elisidepsin-resistant subline (HCT-116-Irv) presented reduced levels of glycosylceramides and no accumulation of elisidepsin in the plasma membrane. Consequently, drug treatment did not induce the characteristic necrotic cell death. Furthermore, GM95, a mutant derivative from B16 mouse melanoma cells lacking ceramide glucosyltransferase (UGCG) activity and thus the synthesis of glycosylceramides, was also resistant to elisidepsin. Over-expression of UGCG gene in these deficient cells restored glycosylceramides synthesis, rendering them sensitive to elisidepsin, at a similar level than parental B16 cells. These results indicate that glycosylceramides act as membrane targets of elisidepsin, facilitating its insertion in the plasma membrane and the subsequent membrane permeabilization that leads to drug-induced cell death. They also indicate that cell membrane lipids are a plausible target for antineoplastic therapy.	[Manuel Molina-Guijarro, Jose; Francisco Garcia-Fernandez, Luis; Fernando Martinez-Leal, Juan; Fernandez, Rogelio; Martinez, Valentin; Galmarini, Carlos M.] PharmaMar SA, Dept Invest & Desarrollo, Madrid, Spain; [Garcia, Carolina; Pilar Lillo, M.] CSIC, Inst Quim Fis Rocasolano, Dept Quim Fis Biol, Madrid, Spain; [Macias, Alvaro; Moreno, Cristina; Valenzuela, Carmen] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Reyes, Fernando] Fdn MEDINA, Granada, Spain	PharmaMar; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Molina-Guijarro, JM (corresponding author), PharmaMar SA, Dept Invest & Desarrollo, Madrid, Spain.	jmmolina@pharmamar.com	molina-guijarro, jose manuel/B-1279-2018; Macias, Alvaro/N-7267-2015; Garcia, Carolina/E-9104-2015; Valenzuela, Carmen/L-3219-2015; Leal, Juan F Martinez/N-6328-2013; Reyes, Fernando/G-4027-2013; Lillo, M. Pilar/O-2556-2013	molina-guijarro, jose manuel/0000-0003-4013-7792; Macias, Alvaro/0000-0002-9952-6947; Garcia, Carolina/0000-0001-5138-6191; Valenzuela, Carmen/0000-0003-3929-1960; Leal, Juan F Martinez/0000-0002-7538-0875; Reyes, Fernando/0000-0003-1607-5106; Galmarini, Carlos Maria/0000-0001-5494-6617; Lillo, M. Pilar/0000-0001-8582-4591	Ministerio de Economia y Competitividad [SAF2010-14916, SAF2013-45800-R, CTQ 2010-1645]; Instituto de Salud Carlos III [FIS-RECAVA RD06/0014/0025, FIS-RIC RD12/0042/0019]; PharmaMar S.A.	Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); PharmaMar S.A.	The work of CV, AM and CM was partially supported by Ministerio de Economia y Competitividad (www.mineco.gob.es) [grant numbers SAF2010-14916 and SAF2013-45800-R], and Instituto de Salud Carlos III (www.isciii.es) [grant numbers FIS-RECAVA RD06/0014/0025 and FIS-RIC RD12/0042/0019]. The work of MPL and CG was partially supported by Ministerio de Economia y Competitividad [grant number CTQ 2010-1645]. CM and AM hold FPI and JAE-Predoc (www.csic.es) fellowships, respectively. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, the work of CV and MPL was supported in part by a grant from PharmaMar S.A. JMMG, LFGF, JFML, RF, VM and CMG are employees and shareholders of PharmaMar S.A. and played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias C, 2003, CARDIOVASC RES, V57, P660, DOI 10.1016/S0008-6363(02)00726-5; ASHKENAZI S, 1989, J CLIN MICROBIOL, V27, P1145, DOI 10.1128/JCM.27.6.1145-1150.1989; Bayley H, 2009, NATURE, V459, P651, DOI 10.1038/459651a; Beier UH, 2005, INT J CANCER, V115, P6, DOI 10.1002/ijc.20851; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Caiolfa VR, 2007, J CELL BIOL, V179, P1067, DOI 10.1083/jcb.200702151; Dziegiel P, 2010, BRIT J CANCER, V103, P524, DOI 10.1038/sj.bjc.6605750; Ekiz HA, 2010, INT J CANCER, V127, P1497, DOI 10.1002/ijc.25478; Franqueza L, 1997, CIRC RES, V81, P1053; Geny B, 2006, BIOL CELL, V98, P633, DOI 10.1042/BC20060038; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Gonzalez T, 2002, MOL PHARMACOL, V62, P1456, DOI 10.1124/mol.62.6.1456; Gorogh T, 1999, INT J CANCER, V83, P750, DOI 10.1002/(SICI)1097-0215(19991210)83:6<750::AID-IJC9>3.0.CO;2-V; Gouaze V, 2004, MOL CANCER THER, V3, P633; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; Hamann MT, 1996, J ORG CHEM, V61, P6594, DOI 10.1021/jo960877+; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; ICHIKAWA S, 1994, P NATL ACAD SCI USA, V91, P2703, DOI 10.1073/pnas.91.7.2703; Kiraly A, 2013, MAR DRUGS, V11, P4858, DOI 10.3390/md11124858; Liu YY, 2013, ADV CANCER RES, V117, P59, DOI 10.1016/B978-0-12-394274-6.00003-0; Liu YY, 2011, INT J ONCOL, V39, P425, DOI 10.3892/ijo.2011.1052; Liu YY, 2011, CANCER RES, V71, P2276, DOI 10.1158/0008-5472.CAN-10-3107; Losada A, 2004, BRIT J CANCER, V91, P1405, DOI 10.1038/sj.bjc.6602166; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Molina-Guijarro JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019042; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Oguro Y, 2014, CURR GENET, V60, P89, DOI 10.1007/s00294-013-0416-8; Oudes AJ, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-86; Ozbayraktar Fatma Betul Kavun, 2009, Biotechnology Journal, V4, P1028, DOI 10.1002/biot.200800322; Palacios DS, 2011, P NATL ACAD SCI USA, V108, P6733, DOI 10.1073/pnas.1015023108; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Poon IKH, 2014, ELIFE, V3, DOI 10.7554/eLife.01808; Popko B, 2002, J NEUROPATH EXP NEUR, V61, P329, DOI 10.1093/jnen/61.4.329; Ruckhaberle E, 2009, J CANCER RES CLIN, V135, P81, DOI 10.1007/s00432-008-0436-9; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Schneider-Schaulies Jurgen, 2013, Handb Exp Pharmacol, P321, DOI 10.1007/978-3-7091-1511-4_16; Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200; Valenzuela C, 1996, CIRCULATION, V94, P562, DOI 10.1161/01.CIR.94.3.562; van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8; Varadi T, 2011, EUR J PHARMACOL, V667, P91, DOI 10.1016/j.ejphar.2011.05.064; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Yandim MK, 2013, CANCER CHEMOTH PHARM, V71, P13, DOI 10.1007/s00280-012-1984-x; Yang J, 2004, CELL BIOCHEM BIOPHYS, V40, P323, DOI 10.1385/CBB:40:3:323; YANG LY, 1990, CANCER RES, V50, P3218	50	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140782	10.1371/journal.pone.0140782	http://dx.doi.org/10.1371/journal.pone.0140782			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474061	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500109
J	Matias, FS; Carelli, PV; Mirasso, CR; Copelli, M				Matias, Fernanda S.; Carelli, Pedro V.; Mirasso, Claudio R.; Copelli, Mauro			Self-Organized Near-Zero-Lag Synchronization Induced by Spike-Timing Dependent Plasticity in Cortical Populations	PLOS ONE			English	Article							ANTICIPATING SYNCHRONIZATION; PHASE SYNCHRONIZATION; SYNAPTIC PLASTICITY; NEURONAL SYNCHRONY; VISUAL-CORTEX; MEMORY; NETWORK; OSCILLATIONS; ENHANCEMENT; INTEGRATION	Several cognitive tasks related to learning and memory exhibit synchronization of macroscopic cortical areas together with synaptic plasticity at neuronal level. Therefore, there is a growing effort among computational neuroscientists to understand the underlying mechanisms relating synchrony and plasticity in the brain. Here we numerically study the interplay between spike-timing dependent plasticity (STDP) and anticipated synchronization (AS). AS emerges when a dominant flux of information from one area to another is accompanied by a negative time lag (or phase). This means that the receiver region pulses before the sender does. In this paper we study the interplay between different synchronization regimes and STDP at the level of three-neuron microcircuits as well as cortical populations. We show that STDP can promote auto-organized zero-lag synchronization in unidirectionally coupled neuronal populations. We also find synchronization regimes with negative phase difference (AS) that are stable against plasticity. Finally, we show that the interplay between negative phase difference and STDP provides limited synaptic weight distribution without the need of imposing artificial boundaries.	[Matias, Fernanda S.] Univ Fed Alagoas, Inst Fis, BR-57072970 Maceio, AL, Brazil; [Carelli, Pedro V.; Copelli, Mauro] Univ Fed Pernambuco, Dept Fis, BR-50670901 Recife, PE, Brazil; [Mirasso, Claudio R.] UIB, CSIC, IFISC, E-07122 Palma De Mallorca, Spain	Universidade Federal de Alagoas; Universidade Federal de Pernambuco; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC)	Matias, FS (corresponding author), Univ Fed Alagoas, Inst Fis, BR-57072970 Maceio, AL, Brazil.	fernanda@fis.ufal.br	Carelli, Pedro V/F-8551-2011; Copelli, Mauro/C-6336-2009; Copelli, Mauro/AAG-8110-2020; Matias, Fernanda/C-6402-2015; Mirasso, Claudio R/B-8661-2008	Carelli, Pedro V/0000-0002-5666-9606; Copelli, Mauro/0000-0001-7441-2858; Matias, Fernanda/0000-0002-5629-6416; Mirasso, Claudio/0000-0003-2980-7038	Ministerio de Economia y Competitividad, Espaa [FIS2012-30634]; Fondo Europeo de Desarrollo Regional; FAPESP Center for Neuromathematics (S. Paulo Research Foundation FAPESP) [2013/07699-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazilian project Ciencia Sem Fronteiras) [PVE 88881.068077/2014-01]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE); Programa de Apoio a Nucleos Emergentes (PRONEM)	Ministerio de Economia y Competitividad, Espaa; Fondo Europeo de Desarrollo Regional(European Commission); FAPESP Center for Neuromathematics (S. Paulo Research Foundation FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazilian project Ciencia Sem Fronteiras); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Programa de Apoio a Nucleos Emergentes (PRONEM)	This work was supported by project FIS2012-30634 (Intense@cosyp) from Ministerio de Economia y Competitividad, Espaa and Fondo Europeo de Desarrollo Regional. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazilian project Ciencia Sem Fronteiras PVE 88881.068077/2014-01); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE), special programs as Programa de Apoio a Nucleos Emergentes (PRONEM) and FAPESP Center for Neuromathematics (grant # 2013/07699-0, S. Paulo Research Foundation FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M., 1982, LOCAL CORTICAL CIRCU; Ambika G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056206; Barbour B, 2007, TRENDS NEUROSCI, V30, P622, DOI 10.1016/j.tins.2007.09.005; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Billings G, 2009, J NEUROPHYSIOL, V101, P2775, DOI 10.1152/jn.91007.2008; Blakely JN, 2008, CHAOS, V18, DOI 10.1063/1.2840778; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Burbank KS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002393; Buzsaki G., 2006, RHYTHMS BRAIN; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Che YQ, 2013, CHAOS, V23, DOI 10.1063/1.4793541; Ciszak M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.204102; Ciszak M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046203; Corron NJ, 2005, CHAOS, V15, DOI 10.1063/1.1898597; Dotson NM, 2014, J NEUROSCI, V34, P13600, DOI 10.1523/JNEUROSCI.1961-14.2014; Ermentrout GB, 1998, P NATL ACAD SCI USA, V95, P1259, DOI 10.1073/pnas.95.3.1259; Esfahani ZG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112688; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fischer I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.123902; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gerstner W, 1996, NEURAL COMPUT, V8, P1653, DOI 10.1162/neco.1996.8.8.1653; Gollo LL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003548; Gollo LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017756; Gollo LL, 2010, NEUROIMAGE, V52, P947, DOI 10.1016/j.neuroimage.2009.11.058; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Iyer R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003248; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Knoblauch A, 2003, NEUROCOMPUTING, V52-4, P301, DOI 10.1016/S0925-2312(02)00792-0; Knoblauch A, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00055; Koch Christof, 1999, P1; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Kostur M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036210; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Liebe S, 2012, NAT NEUROSCI, V15, P456, DOI 10.1038/nn.3038; Liu Y, 2002, APPL PHYS LETT, V80, P4306, DOI 10.1063/1.1485127; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Markram Henry, 2011, Front Synaptic Neurosci, V3, P4, DOI 10.3389/fnsyn.2011.00004; Masoller C, 2001, PHYSICA A, V300, P359, DOI 10.1016/S0378-4371(01)00362-4; Matias FS, 2014, NEUROIMAGE, V99, P411, DOI 10.1016/j.neuroimage.2014.05.063; Matias FS, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021922; Mayol C, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056216; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Nathan A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021916; Nowotny T, 2003, J NEUROSCI, V23, P9776; Phillips JM, 2014, CEREB CORTEX, V24, P1996, DOI 10.1093/cercor/bht050; Pisarchik AN, 2008, PHILOS T R SOC A, V366, P459, DOI 10.1098/rsta.2007.2103; Pyragas K, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046217; Pyragiene T, 2015, NONLINEAR DYNAM, V79, P1901, DOI 10.1007/s11071-014-1782-6; Pyragiene T, 2013, NONLINEAR DYNAM, V74, P297, DOI 10.1007/s11071-013-0968-7; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Rospars JP, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003975; Salazar RF, 2012, SCIENCE, V338, P1097, DOI 10.1126/science.1224000; Sausedo-Solorio JM, 2014, PHYS LETT A, V378, P2108, DOI 10.1016/j.physleta.2014.05.003; Senthilkumar DV, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016211; Sharott A, 2005, J PHYSIOL-LONDON, V562, P951, DOI 10.1113/jphysiol.2004.073189; Simonov AY, 2014, JETP LETT+, V98, P632, DOI 10.1134/S0021364013230136; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sivaprakasam S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.154101; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stephen DG, 2011, CHAOS SOLITON FRACT, V44, P160, DOI 10.1016/j.chaos.2011.01.005; Stepp N, 2010, COGN SYST RES, V11, P148, DOI 10.1016/j.cogsys.2009.03.003; Takahashi YK, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051904; Tang S, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.194101; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2008, P NATL ACAD SCI USA, V105, P17157, DOI 10.1073/pnas.0809353105; Viriyopase A, 2012, FRONT COMPUT NEUROSC, V6, P1, DOI 10.3389/fncom.2012.00049; Voss HU, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.014102; Voss HU, 2000, PHYS REV E, V61, P5115, DOI 10.1103/PhysRevE.61.5115; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Xu SY, 2009, PHYS LETT A, V373, P2226, DOI 10.1016/j.physleta.2009.03.028; Zhigulin VP, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021901	79	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140504	10.1371/journal.pone.0140504	http://dx.doi.org/10.1371/journal.pone.0140504			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474165	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500060
J	Tung, CW; Hsu, YC; Shih, YH; Lin, CL				Tung, Chun-Wu; Hsu, Yung-Chien; Shih, Ya-Hsueh; Lin, Chun-Liang			Association of Adiponectin with High-Sensitivity C-Reactive Protein and Clinical Outcomes in Peritoneal Dialysis Patients: A 3.5-Year Follow-Up Study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; ALL-CAUSE MORTALITY; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR-DISEASE; PLASMA ADIPONECTIN; CIRCULATING ADIPONECTIN; RECIPROCAL ASSOCIATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; KIDNEY-DISEASE	Introduction Adiponectin (ADPN), one of most abundant fat-derived biologically active substances, plays an important role in anti-atherosclerotic process. There are conflicting results about the impact of ADPN on cardiovascular (CV) outcomes and mortality, particularly in patients undergoing peritoneal dialysis (PD). Moreover, the relationship between ADPN and inflammatory mediators has been seldom explored in this population. Therefore, we examined the relationship between ADPN and longitudinal high-sensitivity C-reactive protein (hs-CRP) changes and investigated whether ADPN or hs-CRP levels could predict CV outcomes and mortality in prevalent PD patients after comprehensive adjustment of possible confounders. Methods In this prospective cohort study, 78 PD patients were enrolled and followed from February 2009 to August 2012. During follow-up, CV events and all-cause mortality were recorded. Results The mean baseline ADPN value was 29.46 +/- 18.01 mu g/ml and duration of PD treatment was 37.76 +/- 36.96 months. In multiple linear regression analysis, plasma ADPN levels positively correlated with high-density lipoprotein and negatively associated with hs-CRP, body mass index, D4/D0 glucose, triglyceride, and duration of PD treatment. After stratified by genders, the inverse association between baseline ADPN and hs-CRP was more significant in the female group. The hs-CRP levels were followed up annually and remained significantly lower in the high ADPN group in the first 2 years. Patients were then stratified into two groups according to the median ADPN value (23.8 mu g/ml). The results of Kaplan-Meier survival analysis demonstrated less CV events and better survival in high ADPN group. On multivariate Cox regression analysis, only ADPN level (HR: 0.93, 95% CI: 0.88-0.98, p = 0.02), age and history of CV diseases were independent risk factors for future CV events. Furthermore, hs-CRP (HR: 1.11, 95% CI: 1.001-1.22, p = 0.04) was identified as independent predictor of all-cause mortality. Conclusions Serum hs-CRP levels were consistently lower in the high ADPN group during 2-year follow-up. We also demonstrated the importance of ADPN and hs-CRP in predicting CV events and all-cause mortality in PD population during 3.5-year follow-up.	[Tung, Chun-Wu; Hsu, Yung-Chien; Shih, Ya-Hsueh; Lin, Chun-Liang] Chang Gung Mem Hosp, Dept Nephrol, Chiayi, Taiwan; [Tung, Chun-Wu] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Tung, Chun-Wu; Hsu, Yung-Chien; Shih, Ya-Hsueh; Lin, Chun-Liang] Chang Gung Mem Hosp, Dept Kidney & Diabet Complicat Res Team KDCRT, Chiayi, Taiwan; [Tung, Chun-Wu; Hsu, Yung-Chien; Shih, Ya-Hsueh; Lin, Chun-Liang] Chang Gung Mem Hosp, Chron Kidney Dis Ctr, Chiayi, Taiwan; [Lin, Chun-Liang] Chang Gung Univ, Sch Tradit Chinese Med, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lin, CL (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, Chiayi, Taiwan.	linchunliang@cgmh.org.tw			Chang Gung Memorial Hospital at Chiayi, Taiwan [CMRPG690191]	Chang Gung Memorial Hospital at Chiayi, Taiwan	This work was supported by grants from Chang Gung Memorial Hospital at Chiayi, Taiwan (CMRPG690191, to CWT), https://www.cgmh.org.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hamodi Z, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-99; Alemzadeh R, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-35; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Chaudhary K, 2011, CLIN J AM SOC NEPHRO, V6, P447, DOI 10.2215/CJN.07920910; Disthabanchong S, 2011, NEPHROL DIAL TRANSPL, V26, P592, DOI 10.1093/ndt/gfq410; Ducloux D, 2002, KIDNEY INT, V62, P1417, DOI 10.1111/j.1523-1755.2002.kid562.x; Fasshauer M, 2002, BIOCHEM BIOPH RES CO, V290, P1084, DOI 10.1006/bbrc.2001.6307; Funahashi T, 1999, INTERNAL MED, V38, P202, DOI 10.2169/internalmedicine.38.202; Huang JW, 2004, AM J KIDNEY DIS, V43, P1047, DOI 10.1053/j.ajkd.2004.02.017; Huh JY, 2012, PERITON DIALYSIS INT, V32, P20, DOI 10.3747/pdi.2009.00228; Ignacy W, 2005, NEPHRON CLIN PRACT, V101, pC18, DOI 10.1159/000085707; James LR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0052350, DOI 10.1371/JOURNAL.PONE.0052350]; Johnson DW, 2009, CLIN J AM SOC NEPHRO, V4, P1620, DOI 10.2215/CJN.01750309; Kalantar-Zadeh K, 2005, AM J KIDNEY DIS, V46, P489, DOI 10.1053/j.ajkd.2005.05.020; Kalantar-Zadeh K, 2006, CONTRIB NEPHROL, V151, P57, DOI 10.1159/000095319; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lai KN, 2012, PERITON DIALYSIS INT, V32, P280, DOI 10.3747/pdi.2010.00176; Li Y, 2012, PERITON DIALYSIS INT, V32, P507, DOI 10.3747/pdi.2011.00116; Liu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093063; Lui SL, 2012, AM J KIDNEY DIS, V60, P966, DOI 10.1053/j.ajkd.2012.05.018; Matsushita K, 2006, ATHEROSCLEROSIS, V188, P184, DOI 10.1016/j.atherosclerosis.2005.10.031; Mcdonald SP, 2003, J AM SOC NEPHROL, V14, P2894, DOI 10.1097/01.ASN.0000091587.55159.5F; Menon V, 2006, J AM SOC NEPHROL, V17, P2599, DOI 10.1681/ASN.2006040331; Ohashi N, 2008, INTERNAL MED, V47, P485, DOI 10.2169/internalmedicine.47.0614; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Ozdemir FN, 2001, ARTIF ORGANS, V25, P448, DOI 10.1046/j.1525-1594.2001.025006448.x; Pilz S, 2006, J CLIN ENDOCR METAB, V91, P4277, DOI 10.1210/jc.2006-0836; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Pliakogiannis T, 2007, INT UROL NEPHROL, V39, P281, DOI 10.1007/s11255-006-9142-1; Prichard S, 1999, PERITON DIALYSIS INT, V19, pS133; Rhee CM, 2015, AM J KIDNEY DIS, V66, P313, DOI 10.1053/j.ajkd.2015.02.325; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rodriguez-Carmona A, 2012, NEPHROL DIAL TRANSPL, V27, P369, DOI 10.1093/ndt/gfr244; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Selby NM, 2007, NEPHROL DIAL TRANSPL, V22, P870, DOI 10.1093/ndt/gfl654; Takeguchi F, 2008, THER APHER DIAL, V12, P243, DOI 10.1111/j.1744-9987.2008.00581.x; Tan CC, 2005, KIDNEY INT, V67, pS19, DOI 10.1111/j.1523-1755.2005.09405.x; Tsao YT, 2008, J NEPHROL, V21, P744; Tsigalou C, 2013, J RENAL NUTR, V23, P45, DOI 10.1053/j.jrn.2011.12.007; TWARDOWSKI ZJ, 1989, BLOOD PURIFICAT, V7, P95, DOI 10.1159/000169582; US Renal Data System, USRDS 2013 ANN DAT R; Wannamethee SG, 2007, ARCH INTERN MED, V167, P1510, DOI 10.1001/archinte.167.14.1510; Wu ZJ, 2014, METABOLISM, V63, P1157, DOI 10.1016/j.metabol.2014.05.001; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9; Yu ZZ, 2008, BLOOD PURIFICAT, V26, P386, DOI 10.1159/000141930; Zoccali C, 2005, J RENAL NUTR, V15, P125, DOI 10.1053/j.jrn.2004.09.036; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134	51	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0141058	10.1371/journal.pone.0141058	http://dx.doi.org/10.1371/journal.pone.0141058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474473	gold, Green Published, Green Submitted			2022-12-26	WOS:000363185500143
J	Chitarra, W; Siciliano, I; Ferrocino, I; Gullino, ML; Garibaldi, A				Chitarra, Walter; Siciliano, Ilenia; Ferrocino, Ilario; Gullino, Maria Lodovica; Garibaldi, Angelo			Effect of Elevated Atmospheric CO2 and Temperature on the Disease Severity of Rocket Plants Caused by Fusarium Wilt under Phytotron Conditions	PLOS ONE			English	Article							RHIZOSPHERE MICROBIOME; STYLOSANTHES-SCABRA; CARBON-DIOXIDE; CLIMATE-CHANGE; ENRICHMENT; PATHOGENS; PHOTOSYNTHESIS; RESISTANCE; COMMUNITY; RESPONSES	The severity of F. oxysporum f. sp. conglutinans on rocket plants grown under simulated climate change conditions has been studied. The rocket plants were cultivated on an infested substrate (4 log CFU g(-1)) and a non-infested substrate over three cycles. Pots were placed in six phytotrons in order to simulate different environmental conditions: 1) 400-450 ppm CO2, 18-22 degrees C; 2) 800-850 ppm CO2, 18-22 degrees C; 3) 400-450 ppm CO2, 22-26 degrees C, 4) 800-850 ppm CO2, 22-26 degrees C, 5) 400-450 ppm CO2, 26-30 degrees C; 6) 800-850 ppm CO2, 26-30 degrees C. Substrates from the infested and control samples were collected from each phytotron at 0, 60 and 120 days after transplanting. The disease index, microbial abundance, leaf physiological performances, root exudates and variability in the fungal profiles were monitored. The disease index was found to be significantly influenced by higher levels of temperature and CO2. Plate counts showed that fungal and bacterial development was not affected by the different CO2 and temperature levels, but a significant decreasing trend was observed from 0 up to 120 days. Conversely, the F. oxysporum f. sp. conglutinans plate counts did not show any significantly decrease from 0 up to 120 days. The fungal profiles, evaluated by means of polymerase chain reaction denaturing gradient gel electrophoresis (PCR-DGGE), showed a relationship to temperature and CO2 on fungal diversity profiles. Different exudation patterns were observed when the controls and infested plants were compared, and it was found that both CO2 and temperature can influence the release of compounds from the roots of rocket plants. In short, the results show that global climate changes could influence disease incidence, probably through plant-mediated effects, caused by soilborne pathogens.	[Chitarra, Walter; Siciliano, Ilenia; Gullino, Maria Lodovica; Garibaldi, Angelo] Univ Turin, Ctr Innovat, Agroenvironm Sect, AGROINNOVA, Grugliasco, TO, Italy; [Ferrocino, Ilario; Gullino, Maria Lodovica] Univ Turin, Dept Agr Forest & Food Sci DISAFA, Grugliasco, TO, Italy	University of Turin; University of Turin	Chitarra, W (corresponding author), Natl Res Council IPSP CNR, Inst Sustainable Plant Protect, Grugliasco Unit, Largo P Braccini 2, Grugliasco, TO, Italy.	walter.chitarra@ipsp.cnr.it	Ferrocino, Ilario/K-7234-2016; CHITARRA, WALTER/O-1353-2015	CHITARRA, WALTER/0000-0002-5382-3794; Siciliano, Ilenia/0000-0002-9258-0107; FERROCINO, ILARIO/0000-0002-1657-0054	European Union [634179]	European Union(European Commission)	This research was supported by the European Union's Horizon 2020 research and innovation programme under grant agreement No. 634179 "Effective Management of Pests and Harmful Alien Species - Integrated Solutions" (EMPHASIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Aulakh MS, 2001, PLANT BIOLOGY, V3, P139, DOI 10.1055/s-2001-12905; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bijanzadeh E, 2010, Pak J Biol Sci, V13, P699, DOI 10.3923/pjbs.2010.699.705; Chakraborty S, 2005, AUSTRALAS PLANT PATH, V34, P443, DOI 10.1071/AP05084; Chakraborty S, 2003, NEW PHYTOL, V159, P733, DOI 10.1046/j.1469-8137.2003.00842.x; Chakraborty S, 2000, ENVIRON POLLUT, V108, P381, DOI 10.1016/S0269-7491(99)00217-1; Chakraborty S, 2013, GLOBAL CHANGE BIOL, V19, P1985, DOI 10.1111/gcb.12205; Chakraborty S, 2012, GLOBAL CHANGE BIOL, V18, P2111, DOI 10.1111/j.1365-2486.2012.02667.x; Cheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021377; CORRELL JC, 1991, PHYTOPATHOLOGY, V81, P1061; Eastburn DM, 2010, GLOBAL CHANGE BIOL, V16, P320, DOI 10.1111/j.1365-2486.2009.01978.x; Ebersberger D, 2003, SOIL BIOL BIOCHEM, V35, P965, DOI 10.1016/S0038-0717(03)00156-1; Ferrocino I, 2014, APPL SOIL ECOL, V81, P12, DOI 10.1016/j.apsoil.2014.04.009; Ferrocino I, 2013, APPL SOIL ECOL, V72, P1, DOI 10.1016/j.apsoil.2013.05.015; Gao GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031806; Garibaldi A, 2010, ACTA HORTIC, V883, P37; Garibaldi A, 2006, PHYTOPARASITICA, V34, P115, DOI 10.1007/BF02981311; Gilardi G, 2014, J PHYTOPATHOL, V162, P557, DOI 10.1111/jph.12223; Gregory PJ, 2009, J EXP BOT, V60, P2827, DOI 10.1093/jxb/erp080; Guenet B, 2012, GEODERMA, V170, P331, DOI 10.1016/j.geoderma.2011.12.002; Gullino ML, 2012, SOIL SOLARIZATION TH, P187; Haichar FE, 2014, SOIL BIOL BIOCHEM, V77, P69, DOI 10.1016/j.soilbio.2014.06.017; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hartley SE, 2000, GLOBAL CHANGE BIOL, V6, P497, DOI 10.1046/j.1365-2486.2000.00333.x; IPCC Intergovernmental Panel on Climate Change. IPCC, 2013, 5 ASS REP SUMM POL; Kimball BA, 2002, ADV AGRON, V77, P293, DOI 10.1016/S0065-2113(02)77017-X; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; KOMADA H, 1975, Review of Plant Protection Research, V8, P114; Lake JA, 2009, J EXP BOT, V60, P3123, DOI 10.1093/jxb/erp147; Lobell DB, 2012, PLANT PHYSIOL, V160, P1686, DOI 10.1104/pp.112.208298; LOCKE T, 1974, Phytopathologische Zeitschrift, V79, P77; Lu PX, 2010, PHYTOPARASITICA, V38, P175, DOI 10.1007/s12600-010-0086-8; Mazzotti F, 2012, J MASS SPECTROM, V47, P932, DOI 10.1002/jms.3005; Melloy P, 2010, GLOBAL CHANGE BIOL, V16, P3363, DOI 10.1111/j.1365-2486.2010.02178.x; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Mitchell CE, 2003, GLOBAL CHANGE BIOL, V9, P438, DOI 10.1046/j.1365-2486.2003.00602.x; Niklaus PA, 2007, AGROECOSYSTEMS CHANG, P261; Pangga IB, 2004, PHYTOPATHOLOGY, V94, P221, DOI 10.1094/PHYTO.2004.94.3.221; PANGGA IB, 2002, THESIS U QUEENSLAND; Pavel AB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-9; Piattoni F, 2014, J PLANT DIS PROTECT, V121, P64, DOI 10.1007/BF03356493; Pickles BJ, 2012, MOL ECOL, V21, P5110, DOI 10.1111/j.1365-294X.2012.05739.x; Pritchard SG, 2011, PLANT PATHOL, V60, P82, DOI 10.1111/j.1365-3059.2010.02405.x; Pugliese M, 2012, Commun Agric Appl Biol Sci, V77, P241; Pugliese M, 2010, J PLANT DIS PROTECT, V117, P9; Pugliese M, 2012, PHYTOPATHOL MEDITERR, V51, P480; Runion GB, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00500; Scott JC, 2010, PLANT DIS, V94, P13, DOI 10.1094/PDIS-94-1-0013; Shabani F, 2014, AGR ECOSYST ENVIRON, V197, P96, DOI 10.1016/j.agee.2014.08.005; SHANNON AE, 1949, MATH THEORY COMMUNIT; Uselman SM, 2000, PLANT SOIL, V222, P191, DOI 10.1023/A:1004705416108; Vauterin L., 1992, EUROPEAN MICROBIOLOG, V1, P37; Zak DR, 2000, ECOL APPL, V10, P47, DOI 10.2307/2640985	57	19	20	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140769	10.1371/journal.pone.0140769	http://dx.doi.org/10.1371/journal.pone.0140769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469870	gold, Green Submitted, Green Published			2022-12-26	WOS:000363184600108
J	de Mola, CL; Quevedo, LD; Pinheiro, RT; Goncalves, H; Gigante, DP; Motta, JVD; Barros, FC; Horta, BL				de Mola, Christian Loret; Quevedo, Luciana de Avila; Pinheiro, Ricardo Tavares; Goncalves, Helen; Gigante, Denise Petrucci; dos Santos Motta, Janaina Vieira; Barros, Fernando C.; Horta, Bernardo Lessa			The Effect of Fetal and Childhood Growth over Depression in Early Adulthood in a Southern Brazilian Birth Cohort	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; RESTRICTION; SUICIDE; UNDERNUTRITION; CONSEQUENCES; ASSOCIATION; DISORDERS; SYMPTOMS; ORIGINS; ANXIETY	Background Poor nutrition and growth during fetal life and childhood might be associated with depression in adulthood; however, studies evaluating these associations present controversial results, especially when comparing studies using different proxies for fetal growth. We evaluated the association of fetal and childhood growth/nutrition with depression, in adulthood, using different approaches and measurement methods. Method In 1982, hospital births (n = 5914) in Pelotas, southern Brazil, were examined and have been prospectively followed. At 30 years, the presence of major depression and depressive symptoms severity was evaluated using the Mini International Neuropsychiatric Interview (MINI) and Beck Depression Inventory (BDI-II). The present study assessed their association with birth weight, premature birth, small for gestational age (SGA), stunting and conditional growth during childhood. Results At 30 years, 3576 individuals were evaluated and 7.9% had major depression. Low birth weight (PR = 1.01 95% CI [0.64-1.60]), having been born SGA (PR = 0.87 95% CI [0.64-1.19]) and premature birth (PR = 1.22 95% CI [0.72-2.07]) were not associated with major depression inmultivariable models. However, those born SGA who were also stunted in childhood had a higher prevalence of major depression (PR = 1.87 95% CI [1.06-3.29]) and greater odds of scoring a higher level of depression in the BDI-II (OR = 2.18 95% CI [1.34-3.53]). Conclusion In this Brazilian cohort of young adults, those born SGA who were also stunted during childhood had a higher risk of depression in adulthood. Our results show that the effect of growth impairment on depression is cumulative.	[de Mola, Christian Loret; Goncalves, Helen; Gigante, Denise Petrucci; dos Santos Motta, Janaina Vieira; Barros, Fernando C.; Horta, Bernardo Lessa] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Quevedo, Luciana de Avila; Pinheiro, Ricardo Tavares; dos Santos Motta, Janaina Vieira; Barros, Fernando C.] Univ Catolica Pelotas, Postgrad Program Hlth & Behav, Pelotas, Brazil	Universidade Federal de Pelotas; Universidade Catolica de Pelotas; Universidade Federal de Pelotas	de Mola, CL (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil.	chlmz@yahoo.com	Horta, Bernardo/A-7604-2008; Gonçalves, Helen/P-2381-2018; dos Santos Motta, Janaína Vieira/AAH-4968-2019; de Mola, Christian Loret/C-9534-2012; Gonçalves, Helen/M-1603-2017; Pinheiro, Ricardo Tavares/G-2658-2012	Horta, Bernardo/0000-0001-9843-412X; dos Santos Motta, Janaína Vieira/0000-0002-3755-845X; de Mola, Christian Loret/0000-0002-5264-5914; Gonçalves, Helen/0000-0001-6470-3352; Barros, Fernando/0000-0001-5973-1746	Wellcome Trust; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) Programa Pesquisador Gaucho [11/1815-8]; International Development Research Center; World Health Organization; Overseas Development Administration; European Union; National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq); Rio Grande do Sul State Research Support Foundation (FAPERGS); Brazilian Ministry of Health	Wellcome Trust(Wellcome TrustEuropean Commission); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) Programa Pesquisador Gaucho; International Development Research Center; World Health Organization(World Health Organization); Overseas Development Administration; European Union(European Commission); National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio Grande do Sul State Research Support Foundation (FAPERGS); Brazilian Ministry of Health	The present study was supported by Wellcome Trust and 'Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) Programa Pesquisador Gaucho, Processo No: 11/1815-8'. The International Development Research Center, World Health Organization, Overseas Development Administration, European Union, National Support Program for Centers of Excellence (PRONEX), the Brazilian National Research Council (CNPq), Rio Grande do Sul State Research Support Foundation (FAPERGS), and the Brazilian Ministry of Health supported previous phases of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford Aaron A, 2013, Front Psychiatry, V4, P96, DOI 10.3389/fpsyt.2013.00096; Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106; [Anonymous], 1995, PHYS STAT US INT ANT; BARKER DJP, 1995, BRIT MED J, V311, P1203, DOI 10.1136/bmj.311.7014.1203; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Barros FC, 2008, REV SAUDE PUBL, V42, P7, DOI 10.1590/S0034-89102008000900003; Baschat AA, 2011, ULTRASOUND OBST GYN, V37, P501, DOI 10.1002/uog.9008; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Betts KS, 2013, J AFFECT DISORDERS, V146, P231, DOI 10.1016/j.jad.2012.09.010; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brown AS, 1995, INCREASED RISK AFFEC, P601; Chiba S, 2012, PROG NEURO-PSYCHOPH, V39, P112, DOI 10.1016/j.pnpbp.2012.05.018; de Mola CL, 2014, BRIT J PSYCHIAT, V205, P340, DOI 10.1192/bjp.bp.113.139014; Ducharme S, 2014, CEREB CORTEX, V24, P2941, DOI 10.1093/cercor/bht151; Folstein M, 2007, AM J PSYCHIAT, V164, P861, DOI 10.1176/appi.ajp.164.6.861; Galler JR, 2010, J CHILD PSYCHOL PSYC, V51, P789, DOI 10.1111/j.1469-7610.2010.02208.x; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Horta BL, 2008, REV SAUDE PUBL, V42, P108, DOI 10.1590/S0034-89102008000900015; Horta BL, 2015, INT J EPIDEMIOL, V44, P441, DOI 10.1093/ije/dyv017; Kapoor A, 2006, J PHYSIOL-LONDON, V572, P31, DOI 10.1113/jphysiol.2006.105254; Keijzer-Veen MG, 2005, J CLIN EPIDEMIOL, V58, P1320, DOI 10.1016/j.jclinepi.2005.04.004; Koenen KC, 2009, AM J PSYCHIAT, V166, P50, DOI 10.1176/appi.ajp.2008.08030343; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Magnusson PKE, 2005, AM J PSYCHIAT, V162, P1373, DOI 10.1176/appi.ajp.162.7.1373; Mittendorfer-Rutz E, 2008, J EPIDEMIOL COMMUN H, V62, P168, DOI 10.1136/jech.2006.057133; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; Schlotz W, 2009, BRAIN BEHAV IMMUN, V23, P905, DOI 10.1016/j.bbi.2009.02.001; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Silva LM, 2007, BRAZ J MED BIOL RES, V40, P1187, DOI 10.1590/S0100-879X2006005000144; Suliman S, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00055; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Waber DP, 2011, J DEV BEHAV PEDIATR, V32, P225, DOI 10.1097/DBP.0b013e31820b7707; Walker SP, 2000, J PEDIATR-US, V137, P36, DOI 10.1067/mpd.2000.106227; Walker SP, 2007, J NUTR, V137, P2464, DOI 10.1093/jn/137.11.2464; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624; Wojcik W, 2013, PSYCHOL MED, V43, P1, DOI 10.1017/S0033291712000682	39	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140621	10.1371/journal.pone.0140621	http://dx.doi.org/10.1371/journal.pone.0140621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0CX	26469192	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600089
J	Joung, JY; Lim, J; Oh, CM; Jung, KW; Cho, H; Kim, SH; Seo, HK; Park, WS; Chung, J; Lee, KH; Won, YJ				Joung, Jae Young; Lim, Jiwon; Oh, Chang-Mo; Jung, Kyu-Won; Cho, Hyunsoon; Kim, Sung Han; Seo, Ho Kyung; Park, Weon Seo; Chung, Jinsoo; Lee, Kang Hyun; Won, Young-Joo			Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study	PLOS ONE			English	Article							RADIATION-THERAPY; RECTAL-CANCER; BLADDER; MALIGNANCIES; MEN; RADIOTHERAPY; CARCINOMA; TUMORS	As patients with prostate cancer have a long life expectancy, there is increasing interest in predicting the risk of development of a second primary cancer (SPC), and we therefore designed this study to estimate the overall risk of developing SPCs among Korean prostate cancer patients. We used a population-based cohort from the Korean Central Cancer Registry composed of 55,378 men diagnosed with a first primary prostate cancer between 1993 and 2011. Standardized incidence ratios (SIRs) of SPCs were analyzed by age at diagnosis, latency period, period of diagnosis, and type of initial treatment. Survival analysis was stratified by development of SPC. Men with primary prostate cancer had an overall lower risk of developing an SPC [SIR = 0.75; 95% CI, 0.72 - 0.78], which was significant for SPCs of the esophagus, stomach, rectum, liver, gallbladder, bile duct, pancreas, larynx, lung, and bronchus. In contrast, there were significant increases in the risk of bladder and thyroid cancers, which tended to decrease after longer follow-up. Patients who received initial radiation therapy had an increased risk of subsequent rectal cancer, although this was still lower than that of the general male population. Other urinary tract cancers including those of the kidney, renal pelvis, and ureter tended to be associated with a higher risk of developing an SPC, but this difference did not reach statistical significance. The patients with prostate cancer and SPC had lower overall survival rates than those with one primary prostate cancer. Our findings suggest that men with prostate cancer have a 25% lower risk of developing an SPC in Korea, but a higher risk of developing subsequent bladder and thyroid cancers, which suggests the need for continued cancer surveillance among prostate cancer survivors.	[Joung, Jae Young; Kim, Sung Han; Seo, Ho Kyung; Park, Weon Seo; Chung, Jinsoo; Lee, Kang Hyun] Natl Canc Ctr, Ctr Prostate Canc, Goyang, South Korea; [Lim, Jiwon; Oh, Chang-Mo; Jung, Kyu-Won; Cho, Hyunsoon; Won, Young-Joo] Natl Canc Ctr, Canc Registrat & Stat Branch, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Won, YJ (corresponding author), Natl Canc Ctr, Canc Registrat & Stat Branch, Goyang, South Korea.	astra67@ncc.re.kr		Lim, Jiwon/0000-0002-3322-7792	National Cancer Center [1310220]	National Cancer Center	1. This study was supported by a grant from the National Cancer Center (Grant No: 1310220). 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter NN, 2005, GASTROENTEROLOGY, V128, P819, DOI 10.1053/j.gastro.2004.12.038; Boorjian S, 2007, J UROLOGY, V177, P883, DOI 10.1016/j.juro.2006.10.071; Brenner DJ, 2000, CANCER, V88, P398, DOI 10.1002/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V; Chrouser K, 2008, J UROLOGY, V179, pS7, DOI 10.1016/j.juro.2008.03.131; Curado MP, 2007, CANC INCIDENCE 5 CON; Curtis RE, 2006, NEW MALIGNANCIES CAN, P265; Davis EJ, 2014, CANCER-AM CANCER SOC, V120, P2735, DOI 10.1002/cncr.28769; Gillessen S, 2010, J NATL CANCER I, V102, P1760, DOI 10.1093/jnci/djq419; GREENBERG RS, 1988, CANCER, V61, P396, DOI 10.1002/1097-0142(19880115)61:2<396::AID-CNCR2820610232>3.0.CO;2-F; Hsing AW, 2001, EPIDEMIOL REV, V23, P3, DOI 10.1093/oxfordjournals.epirev.a000792; Huang JY, 2011, RADIOTHER ONCOL, V98, P81, DOI 10.1016/j.radonc.2010.09.012; Johnstone PAS, 1998, J UROLOGY, V159, P946, DOI 10.1016/S0022-5347(01)63777-7; Joung JY, 2009, UROLOGY, V73, P153, DOI 10.1016/j.urology.2008.02.040; Jung KW, 2014, CANCER RES TREAT, V46, P109, DOI 10.4143/crt.2014.46.2.109; Kellen E, 2007, EUR J CANCER, V43, P1694, DOI 10.1016/j.ejca.2007.04.011; Kendal WS, 2006, INT J RADIAT ONCOL, V65, P661, DOI 10.1016/j.ijrobp.2005.11.013; Kleinerman RA, 1985, J NATL CANC I MONOGR, V68, P139; LISKOW AS, 1987, CANCER, V59, P380, DOI 10.1002/1097-0142(19870115)59:2<380::AID-CNCR2820590236>3.0.CO;2-E; McCredie M, 1996, CANCER CAUSE CONTROL, V7, P337, DOI 10.1007/BF00052939; Moon K, 2006, CANCER-AM CANCER SOC, V107, P991, DOI 10.1002/cncr.22083; Movsas B, 1998, INT J RADIAT ONCOL, V41, P251, DOI 10.1016/S0360-3016(97)00570-1; Muller AC, 2007, STRAHLENTHER ONKOL, V183, P605, DOI 10.1007/s00066-007-1786-y; Murray L, 2014, RADIOTHER ONCOL, V110, P213, DOI 10.1016/j.radonc.2013.12.012; Neugut AI, 1997, CANCER, V79, P1600, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1600::AID-CNCR24>3.0.CO;2-0; Nieder AM, 2008, J UROLOGY, V180, P2005, DOI 10.1016/j.juro.2008.07.038; Osterlind A, 1985, J NATL CANC I MONOGR, V68, P341; Park SK, 2006, PROSTATE, V66, P1285, DOI 10.1002/pros.20419; Rapiti E, 2008, INT J CANCER, V123, P1141, DOI 10.1002/ijc.23601; Shin Hai-Rim, 2005, Cancer Res Treat, V37, P325, DOI 10.4143/crt.2005.37.6.325; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Templeton A, 2009, FAM CANCER, V8, P167, DOI 10.1007/s10689-008-9222-8; TEPPO L, 1985, J NATL CANCER I, V75, P207	32	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140693	10.1371/journal.pone.0140693	http://dx.doi.org/10.1371/journal.pone.0140693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469085	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600101
J	Mahmmoud, RR; Sase, S; Aher, YD; Sase, A; Groger, M; Mokhtar, M; Hoger, H; Lubec, G				Mahmmoud, Rasha Refaat; Sase, Sunetra; Aher, Yogesh D.; Sase, Ajinkya; Groeger, Marion; Mokhtar, Maher; Hoeger, Harald; Lubec, Gert			Spatial and Working Memory Is Linked to Spine Density and Mushroom Spines	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; DECLARATIVE MEMORY; SYNAPTIC-TRANSMISSION; HIPPOCAMPUS; SYNAPSES; RATS; CA1; PLASTICITY; MICROSCOPY	Background Changes in synaptic structure and efficacy including dendritic spine number and morphology have been shown to underlie neuronal activity and size. Moreover, the shapes of individual dendritic spines were proposed to correlate with their capacity for structural change. Spine numbers and morphology were reported to parallel memory formation in the rat using a water maze but, so far, there is no information on spine counts or shape in the radial arm maze (RAM), a frequently used paradigm for the evaluation of complex memory formation in the rodent. Methods 24 male Sprague-Dawley rats were divided into three groups, 8 were trained, 8 remained untrained in the RAM and 8 rats served as cage controls. Dendritic spine numbers and individual spine forms were counted in CA1, CA3 areas and dentate gyrus of hippocampus using a DIL dye method with subsequent quantification by the Neuronstudio software and the image J program. Results Working memory errors (WME) and latency in the RAM were decreased along the training period indicating that animals performed the task. Total spine density was significantly increased following training in the RAM as compared to untrained rats and cage controls. The number of mushroom spines was significantly increased in the trained as compared to untrained and cage controls. Negative significant correlations between spine density and WME were observed in CA1 basal dendrites and in CA3 apical and basal dendrites. In addition, there was a significant negative correlation between spine density and latency in CA3 basal dendrites. Conclusion The study shows that spine numbers are significantly increased in the trained group, an observation that may suggest the use of this method representing a morphological parameter for memory formation studies in the RAM. Herein, correlations between WME and latency in the RAM and spine density revealed a link between spine numbers and performance in the RAM.	[Mahmmoud, Rasha Refaat; Sase, Sunetra; Aher, Yogesh D.; Sase, Ajinkya; Lubec, Gert] Univ Vienna, Dept Pharmaceut Chem, A-1090 Vienna, Austria; [Groeger, Marion] Med Univ Vienna, CF Imaging, A-1090 Vienna, Austria; [Hoeger, Harald] Med Univ Vienna, Div Lab Anim Sci & Genet, Core Unit Biomed Res, A-2325 Himberg, Austria; [Mahmmoud, Rasha Refaat; Mokhtar, Maher] Assiut Univ, Dept Pediat, Fac Med, Assiut, Egypt	University of Vienna; Medical University of Vienna; Medical University of Vienna; Egyptian Knowledge Bank (EKB); Assiut University	Lubec, G (corresponding author), Univ Vienna, Dept Pharmaceut Chem, A-1090 Vienna, Austria.	gert.lubec@univie.ac.at	Sase, Ajinkya/O-4904-2019	Lubec, Gert/0000-0002-6333-9461				ANDERSEN P, 1980, J PHYSIOL-LONDON, V307, P273, DOI 10.1113/jphysiol.1980.sp013435; Beltran-Campos V, 2011, BRAIN RES, V1369, P119, DOI 10.1016/j.brainres.2010.10.105; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bourne JN, 2011, HIPPOCAMPUS, V21, P354, DOI 10.1002/hipo.20768; Dumitriu D, 2011, NAT PROTOC, V6, P1391, DOI 10.1038/nprot.2011.389; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; Eilam-Stock T, 2012, BEHAV NEUROSCI, V126, P175, DOI 10.1037/a0025959; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Jedlicka P, 2008, BEHAV BRAIN RES, V192, P12, DOI 10.1016/j.bbr.2008.02.033; Jeltsch H, 2001, NEUROBIOL LEARN MEM, V76, P81, DOI 10.1006/nlme.2000.3986; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim BG, 2007, J NEUROSCI METH, V162, P237, DOI 10.1016/j.jneumeth.2007.01.016; Lassalle JM, 2000, NEUROBIOL LEARN MEM, V73, P243, DOI 10.1006/nlme.1999.3931; Leszczynski M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00168; Leuner B, 2004, MOL NEUROBIOL, V29, P117, DOI 10.1385/MN:29:2:117; Leuner B, 2003, J NEUROSCI, V23, P659, DOI 10.1523/JNEUROSCI.23-02-00659.2003; Levin ED, 2010, BEHAV BRAIN RES, V208, P319, DOI 10.1016/j.bbr.2009.11.007; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; Miranda R, 2006, SYNAPSE, V59, P177, DOI 10.1002/syn.20229; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Staffend NA, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00014; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; Wartman BC, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00128; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	35	77	79	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0139739	10.1371/journal.pone.0139739	http://dx.doi.org/10.1371/journal.pone.0139739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469788	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600016
J	Roleda, MY; Cornwall, CE; Feng, YY; McGraw, CM; Smith, AM; Hurd, CL				Roleda, Michael Y.; Cornwall, Christopher E.; Feng, Yuanyuan; McGraw, Christina M.; Smith, Abigail M.; Hurd, Catriona L.			Effect of Ocean Acidification and pH Fluctuations on the Growth and Development of Coralline Algal Recruits, and an Associated Benthic Algal Assemblage	PLOS ONE			English	Article							MACROCYSTIS-PYRIFERA LAMINARIALES; ULTRAVIOLET-RADIATION; CARBON-DIOXIDE; CLIMATE-CHANGE; PHOTOSYNTHESIS; MACROALGAE; MECHANISM; LIGHT; SENSITIVITY; PHYSIOLOGY	Coralline algae are susceptible to the changes in the seawater carbonate system associated with ocean acidification (OA). However, the coastal environments in which corallines grow are subject to large daily pH fluctuations which may affect their responses to OA. Here, we followed the growth and development of the juvenile coralline alga Arthrocardia corymbosa, which had recruited into experimental conditions during a prior experiment, using a novel OA laboratory culture system to simulate the pH fluctuations observed within a kelp forest. Microscopic life history stages are considered more susceptible to environmental stress than adult stages; we compared the responses of newly recruited A. corymbosa to static and fluctuating seawater pH with those of their field-collected parents. Recruits were cultivated for 16 weeks under static pH 8.05 and 7.65, representing ambient and 4x preindustrial pCO(2) concentrations, respectively, and two fluctuating pH treatments of daily (X) over tilde = 8.05 (daytime pH = 8.45, night-time pH = 7.65) and daily (X) over tilde = 7.65 (daytime pH = 8.05, night-time pH = 7.25). Positive growth rates of new recruits were recorded in all treatments, and were highest under static pH 8.05 and lowest under fluctuating pH 7.65. This pattern was similar to the adults' response, except that adults had zero growth under fluctuating pH 7.65. The % dry weight of MgCO3 in calcite of the juveniles was reduced from 10% at pH 8.05 to 8% at pH 7.65, but there was no effect of pH fluctuation. A wide range of fleshy macroalgae and at least 6 species of benthic diatoms recruited across all experimental treatments, from cryptic spores associated with the adult A. corymbosa. There was no effect of experimental treatment on the growth of the benthic diatoms. On the community level, pH-sensitive species may survive lower pH in the presence of diatoms and fleshy macroalgae, whose high metabolic activity may raise the pH of the local microhabitat.	[Roleda, Michael Y.; Cornwall, Christopher E.; Feng, Yuanyuan; Hurd, Catriona L.] Univ Otago, Dept Bot, Dunedin, New Zealand; [McGraw, Christina M.] Univ Otago, Dept Chem, Dunedin, New Zealand; [Smith, Abigail M.] Univ Otago, Dept Marine Sci, Dunedin, New Zealand; [Hurd, Catriona L.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	University of Otago; University of Otago; University of Otago; University of Tasmania	Roleda, MY (corresponding author), Norwegian Inst Bioecon Res, Bodo, Norway.	michael.roleda@nibio.no	Hurd, Catriona/J-2411-2013; Feng, Yuanyuan/K-5983-2012; Roleda, Michael Y./H-9645-2019; Smith, Abigail M/F-7714-2011; Cornwall, Christopher Edward/J-3982-2012; Roleda, Michael/AAA-3820-2022; /AAL-3738-2021	Hurd, Catriona/0000-0001-9965-4917; Feng, Yuanyuan/0000-0002-4565-8717; Roleda, Michael Y./0000-0003-0568-9081; Smith, Abigail M/0000-0001-6468-9124; Cornwall, Christopher Edward/0000-0002-6154-4082; McGraw, Christina/0000-0001-5841-0748	Royal Society of New Zealand Marsden Fund [UOO0914]; New Zealand Foundation for Research Science Technology [UOOX0802]	Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); New Zealand Foundation for Research Science Technology(New Zealand Foundation for Research, Science and Technology)	Financial support was provided by the Royal Society of New Zealand Marsden Fund (UOO0914) (http://www.royalsociety.org.nz/programmes/funds/marsden/) and the New Zealand Foundation for Research Science & Technology (UOOX0802) (http://www.msi.govt.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Bermudez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123945; Brown MT, 1999, MAR ENVIRON RES, V47, P175, DOI 10.1016/S0141-1136(98)00113-5; BRZEZINSKI MA, 1995, DEEP-SEA RES PT I, V42, P1215, DOI 10.1016/0967-0637(95)93592-3; Clark DR, 2000, P ROY SOC B-BIOL SCI, V267, P953, DOI 10.1098/rspb.2000.1096; Cornwall CE, 2015, MAR ECOL PROG SER, V525, P81, DOI 10.3354/meps11190; Cornwall CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097235; Cornwall CE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2201; Cornwall CE, 2013, LIMNOL OCEANOGR, V58, P121, DOI 10.4319/lo.2013.58.1.0121; Crawfurd KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026695; Cyronak T, 2016, ICES J MAR SCI, V73, P558, DOI 10.1093/icesjms/fsv075; Dickson A. G., 2007, PICES SPEC PUB, V3, P1, DOI DOI 10.1159/000331784; Gaitan-Espitia JD, 2014, J EXP MAR BIOL ECOL, V457, P51, DOI 10.1016/j.jembe.2014.03.018; Fernandez PA, 2015, PHOTOSYNTH RES, V124, P293, DOI 10.1007/s11120-015-0138-5; Fernandez PA, 2014, J PHYCOL, V50, P998, DOI 10.1111/jpy.12247; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; Gattuso J.-P., 2010, GUIDE BEST PRACTICES, P41, DOI DOI 10.1016/J.JOMS.2003.10.009; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Gray BE, 2004, PAC SCI, V58, P47, DOI [10.1353/PSC.2004.0005, DOI 10.1353/PSC.2004.0005]; Haigh R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117533; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Harley CDG, 2012, J PHYCOL, V48, P1064, DOI 10.1111/j.1529-8817.2012.01224.x; Hepburn CD, 2006, HYDROBIOLOGIA, V560, P373, DOI 10.1007/s10750-005-1573-7; Herve V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046722; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hopkinson BM, 2011, P NATL ACAD SCI USA, V108, P3830, DOI 10.1073/pnas.1018062108; Hunter K.A., 2007, SWCO2; Hurd CL, 2011, GLOBAL CHANGE BIOL, V17, P3254, DOI 10.1111/j.1365-2486.2011.02473.x; Hurd CL, 2009, J PHYCOL, V45, P1236, DOI 10.1111/j.1529-8817.2009.00768.x; James RK, 2014, MAR BIOL, V161, P1687, DOI 10.1007/s00227-014-2453-3; Jokiel PL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0031; Jokiel PL, 2014, PEERJ, V2, DOI 10.7717/peerj.378; Jury CP, 2013, WATER-SUI, V5, P1303, DOI 10.3390/w5031303; Kamenos NA, 2013, GLOBAL CHANGE BIOL, V19, P3621, DOI 10.1111/gcb.12351; Kato A, 2014, MAR ENVIRON RES, V94, P1, DOI 10.1016/j.marenvres.2013.10.010; Kim JM, 2006, LIMNOL OCEANOGR, V51, P1629, DOI 10.4319/lo.2006.51.4.1629; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2013, NAT CLIM CHANGE, V3, P156, DOI [10.1038/NCLIMATE1680, 10.1038/nclimate1680]; Martin S, 2013, ECOL EVOL, V3, P676, DOI 10.1002/ece3.475; McGraw CM, 2010, LIMNOL OCEANOGR-METH, V8, P686, DOI 10.4319/lom.2010.8.686; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Nelson WA, 2009, MAR FRESHWATER RES, V60, P787, DOI 10.1071/MF08335; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Porzio L, 2013, MAR BIOL, V160, P2247, DOI 10.1007/s00227-013-2251-3; Ragazzola F, 2012, GLOBAL CHANGE BIOL, V18, P2804, DOI 10.1111/j.1365-2486.2012.02756.x; Rautenberger R, 2015, ECOL EVOL, V5, P874, DOI 10.1002/ece3.1382; Raven J, 2005, OCEAN ACIDIFICATION; Rhein M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P255; Richier S, 2011, MAR BIOL, V158, P551, DOI 10.1007/s00227-010-1580-8; Roleda MY, 2007, PHOTOCHEM PHOTOBIOL, V83, P851, DOI 10.1562/2006-08-17-IR-1005; Roleda MY, 2012, J PHYCOL, V48, P840, DOI 10.1111/j.1529-8817.2012.01195.x; Roleda MY, 2012, GLOBAL CHANGE BIOL, V18, P854, DOI 10.1111/j.1365-2486.2011.02594.x; Roleda MY, 2009, J PHYCOL, V45, P600, DOI 10.1111/j.1529-8817.2009.00691.x; Roleda MY., 2012, SEAWEED BIOL, P407, DOI [10.1007/978-3-642-28451-9_19, DOI 10.1007/978-3-642-28451-9]; Smith AM, 1998, MAR GEOL, V151, P27, DOI 10.1016/S0025-3227(98)00055-3; Solorzano L, 1980, LIMNOL OCEANOGR, V25, P756; Sun J, 2011, LIMNOL OCEANOGR, V56, P829, DOI 10.4319/lo.2011.56.3.0829; Swanson AK, 2000, MAR BIOL, V136, P657, DOI 10.1007/s002270050725; Tatters AO, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0437; Tatters AO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032116; Torstensson A, 2012, POLAR BIOL, V35, P205, DOI 10.1007/s00300-011-1056-4; Wahl M, 2016, MAR FRESHWATER RES, V67, P25, DOI 10.1071/MF14154; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wiencke C, 2007, PHYSIOL PLANTARUM, V130, P601, DOI 10.1111/j.1399-3054.2007.00923.x; Zacher K, 2007, PLANTA, V225, P1505, DOI 10.1007/s00425-006-0436-4	66	48	48	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140394	10.1371/journal.pone.0140394	http://dx.doi.org/10.1371/journal.pone.0140394			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469945	gold, Green Published			2022-12-26	WOS:000363184600057
J	Boehlke, C; Janusch, H; Hamann, C; Powelske, C; Mergen, M; Herbst, H; Kotsis, F; Nitschke, R; Kuehn, EW				Boehlke, Christopher; Janusch, Heike; Hamann, Christoph; Powelske, Christian; Mergen, Miriam; Herbst, Henriette; Kotsis, Fruzsina; Nitschke, Roland; Kuehn, E. Wolfgang			A Cilia Independent Role of Ift88/Polaris during Cell Migration	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; INTRAFLAGELLAR TRANSPORT; EPITHELIAL-CELLS; PDGFR-ALPHA; GENE; POLARITY; MOUSE; POLARIZATION; CILIOPATHIES; FIBROBLASTS	Ift88 is a central component of the intraflagellar transport (Ift) complex B, essential for the building of cilia and flagella from single cell organisms to mammals. Loss of Ift88 results in the absence of cilia and causes left-right asymmetry defects, disordered Hedgehog signaling, and polycystic kidney disease, all of which are explained by aberrant ciliary function. In addition, a number of extraciliary functions of Ift88 have been described that affect the cell-cycle, mitosis, and targeting of the T-cell receptor to the immunological synapse. Similarly, another essential ciliary molecule, the kinesin-2 subunit Kif3a, which transports Ift-B in the cilium, affects microtubule (MT) dynamics at the leading edge of migrating cells independently of cilia. We now show that loss of Ift88 impairs cell migration irrespective of cilia. Ift88 is required for the polarization of migrating MDCK cells, and Ift88 depleted cells have fewer MTs at the leading edge. Neither MT dynamics nor MT nucleation are dependent on Ift88. Our findings dissociate the function of Ift88 from Kif3a outside the cilium and suggest a novel extraciliary function for Ift88. Future studies need to address what unifying mechanism underlies the different extraciliary functions of Ift88.	[Boehlke, Christopher; Janusch, Heike; Hamann, Christoph; Powelske, Christian; Mergen, Miriam; Herbst, Henriette; Kotsis, Fruzsina; Kuehn, E. Wolfgang] Univ Hosp, Dept Nephrol, Freiburg, Germany; [Nitschke, Roland] Univ Freiburg, Life Imaging Ctr, Ctr Biosyst Anal, D-79106 Freiburg, Germany; [Nitschke, Roland; Kuehn, E. Wolfgang] Univ Freiburg, Ctr Biol Signaling Studies Bioss, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Kuehn, EW (corresponding author), Univ Hosp, Dept Nephrol, Freiburg, Germany.	wolfgang.kuehn@uniklinik-freiburg.de	Nitschke, Roland/F-9525-2010; Boehlke, Christopher/AAZ-6627-2021	Nitschke, Roland/0000-0002-9397-8475; Boehlke, Christopher/0000-0002-6985-0201	DFG [1504/4-1, KFO 201]; German Research Foundation (DFG); Albert Ludwigs University Freiburg	DFG(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This work was supported by DFG 1504/4-1 (EWK) and DFG KFO 201 (EWK). The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Baudoin JP, 2012, NEURON, V76, P1108, DOI 10.1016/j.neuron.2012.10.027; Berbari NF, 2013, CYTOSKELETON, V70, P24, DOI 10.1002/cm.21088; Blitzer AL, 2011, P NATL ACAD SCI USA, V108, P2819, DOI 10.1073/pnas.1016702108; Boehlke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062165; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; de Vreede G, 2014, DEVELOPMENT, V141, P2796, DOI 10.1242/dev.105403; Delaval B, 2011, NAT CELL BIOL, V13, P461, DOI 10.1038/ncb2202; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Elsum I, 2012, ESSAYS BIOCHEM, V53, P141, DOI [10.1042/bse0530141, 10.1042/BSE0530141]; Etienne-Manneville S, 2013, ANNU REV CELL DEV BI, V29, P471, DOI 10.1146/annurev-cellbio-101011-155711; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Francis SS, 2011, J CELL BIOL, V193, P219, DOI 10.1083/jcb.201009001; HANSSON GC, 1986, EMBO J, V5, P483, DOI 10.1002/j.1460-2075.1986.tb04237.x; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; JONES DB, 1982, LAB INVEST, V46, P254; Kim JI, 2013, AM J PHYSIOL-RENAL, V304, pF1283, DOI 10.1152/ajprenal.00427.2012; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lehman JM, 2008, DEV DYNAM, V237, P1960, DOI 10.1002/dvdy.21515; Mergen M, 2013, NEPHROL DIAL TRANSPL, V28, P2744, DOI 10.1093/ndt/gft316; Mizuno N, 2012, J MOL BIOL, V422, P163, DOI 10.1016/j.jmb.2012.05.040; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nola S, 2008, HUM MOL GENET, V17, P3552, DOI 10.1093/hmg/ddn248; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Overgaard CE, 2009, MOL BIOL CELL, V20, P102, DOI 10.1091/mbc.E08-07-0741; Palmyre A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101304; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Satir P, 2008, CURR TOP DEV BIOL, V85, P63, DOI 10.1016/S0070-2153(08)00803-X; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Schneider L, 2010, CELL PHYSIOL BIOCHEM, V25, P279, DOI 10.1159/000276562; Schneider L, 2009, J CELL BIOL, V185, P163, DOI 10.1083/jcb.200806019; Shin K, 2005, J CELL BIOL, V168, P705, DOI 10.1083/jcb.200408064; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009; Vinogradova T, 2009, CELL CYCLE, V8, P2168, DOI 10.4161/cc.8.14.9074; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Yoder BK, 1995, P ASSOC AM PHYSICIAN, V107, P314	47	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140378	10.1371/journal.pone.0140378	http://dx.doi.org/10.1371/journal.pone.0140378			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465598	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100109
J	Sherman, S; Rathnayake, N; Mdzinarishvili, T				Sherman, Simon; Rathnayake, Nirosha; Mdzinarishvili, Tengiz			Invariant Characteristics of Carcinogenesis	PLOS ONE			English	Article							MULTISTAGE CARCINOGENESIS; AGE DISTRIBUTION; CANCER	Carcinogenic modeling is aimed at mathematical descriptions of cancer development in aging. In this work, we assumed that a small fraction of individuals in the population is susceptible to cancer, while the rest of the population is resistant to cancer. For individuals susceptible to cancer we adopted methods of conditional survival analyses. We performed computational experiments using data on pancreatic, stomach, gallbladder, colon and rectum, liver, and esophagus cancers from the gastrointestinal system collected for men and women in the SEER registries during 1975-2009. In these experiments, we estimated the time period effects, the birth cohort effects, the age effects and the population (unconditional) cancer hazard rates. We also estimated the individual cancer presentation rates and the individual cancer resistance rates, which are, correspondingly, the hazard and survival rates conditioned on the susceptibility to cancer. The performed experiments showed that for men and women, patterns of the age effects, the individual cancer presentation rates and the individual cancer resistance rates are: (i) intrinsic for each cancer subtype, (ii) invariant to the place of living of the individuals diagnosed with cancer, and (iii) well adjusted for the modifiable variables averaged at a given time period. Such specificity and invariability of the age effects, the individual cancer presentation rates and the individual cancer resistance rates suggest that these carcinogenic characteristics can be useful for predictive carcinogenic studies by methods of inferential statistics and for the development of novel strategies for cancer prevention.	[Sherman, Simon; Rathnayake, Nirosha] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA; [Sherman, Simon; Rathnayake, Nirosha] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE USA; [Mdzinarishvili, Tengiz] Ilia State Univ, Sch Nat Sci & Engn, Tbilisi, Georgia	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Ilia State University	Sherman, S (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA.	ssherm@unmc.edu			National Cancer Institute [1 R01 CA140940-05]; NATIONAL CANCER INSTITUTE [R01CA140940] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the 1 R01 CA140940-05 (National Cancer Institute, SS the PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aalen OO, 1999, CANCER CAUSE CONTROL, V10, P285, DOI 10.1023/A:1008916718152; Anfinsen KP, 2011, CANCER EPIDEM BIOMAR, V20, P1770, DOI 10.1158/1055-9965.EPI-11-0136; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; COOK PJ, 1969, INT J CANCER, V4, P93, DOI 10.1002/ijc.2910040113; Doll R, 2004, INT J EPIDEMIOL, V33, P1183, DOI 10.1093/ije/dyh359; Giannitrapani L, 2006, ANN NY ACAD SCI, V1089, P228, DOI 10.1196/annals.1386.044; Gsteiger S, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-13; Holford TR, 2005, AGE PERIOD COHORT AN, P17; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Luebeck EG, 2013, CANCER RES, V73, P1086, DOI 10.1158/0008-5472.CAN-12-2198; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Manton K, 2009, CANC MORTALITY MORBI; Mdzinarishvili E, 2014, CANCER INFORM, V13, P197, DOI 10.4137/CIN.S19777; Mdzinarishvili T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100087; Mdzinarishvili T, 2013, CANCER INFORM, V12, P67, DOI 10.4137/CIN.S8063; Mdzinarishvili T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034362; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Moger TA, 2004, BIOSTATISTICS, V5, P1, DOI 10.1093/biostatistics/5.1.1; Morgenthaler S, 2004, J MATH BIOL, V49, P455, DOI 10.1007/s00285-004-0271-9; Schollnberger H, 2010, CANCER RES, V70, P6797, DOI 10.1158/0008-5472.CAN-09-4392; Surveillance Epidemiology and End Results (SEER) Program, 2014, SEER STAT DAT INC SE; Surveillance Epidemiology and End Results (SEER) Program, 2013, SEER STAT DAT POP TO; Surveillance Research Program, NAT CANC I SEER STAT	23	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140405	10.1371/journal.pone.0140405	http://dx.doi.org/10.1371/journal.pone.0140405			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465159	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100115
J	Wang, LM; Liu, Y; Du, WL; Jing, F; Wang, ZH; Wu, J; Chen, XH				Wang, Liangming; Liu, Yang; Du, Wanli; Jing, Fan; Wang, Zhonghua; Wu, Jun; Chen, Xinhong			Anatomy and Cytogenetic Identification of a Wheat-Psathyrostachys huashanica Keng Line with Early Maturation	PLOS ONE			English	Article							RESISTANCE GENE; ADDITION LINE; VERNALIZATION; CHROMOSOME; CLONING; GISH	In previous studies, our research team successfully transferred the Ns genome from Psathyrostachys huashanica Keng into Triticum aestivum (common wheat cv. 7182) using embryo culture. In the present study, one of these lines, i.e., hybrid progeny 25-10-3, which matured about 10-14 days earlier than its wheat parent, was assessed using sequenced characterized amplified region (SCAR) analysis, EST-SSR and EST-STS molecular markers, and genomic in situ hybridization (GISH). We found that this was a stable wheat-P. huashanica disomic addition line (2n = 44 = 22 II) and the results demonstrated that it was a 6Ns disomic chromosome addition line, but it exhibited many different features compared with previously characterized lines, i.e., a longer awn, early maturation, and no twin spikelets. It was considered to be an early-maturing variety based on the early stage of inflorescence initiation in field experiments and binocular microscope observations over three consecutive years. This characteristic was distinct, especially from the single ridge stage and double ridge stage until the glume stage. In addition, it had a higher photosynthesis rate and economic values than common wheat cv. 7182, i.e., more spikelets per spike, more florets per spikelet, more kernels per spike, and a higher thousand-grain weight. These results suggest that this material may comprise a genetic pool of beneficial genes or chromosome segments, which are suitable for introgression to improve the quality of common wheat.	[Wang, Liangming; Liu, Yang; Du, Wanli; Jing, Fan; Wang, Zhonghua; Wu, Jun; Chen, Xinhong] Northwest Agr & Forestry Univ, Coll Agron, Shaanxi Key Lab Plant Genet Engn Breeding, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Wu, J (corresponding author), Northwest Agr & Forestry Univ, Coll Agron, Shaanxi Key Lab Plant Genet Engn Breeding, Yangling, Shaanxi, Peoples R China.	wjnwsu@yahoo.com.cn; cxh2089@126.com		Wang, Zhonghua/0000-0001-5470-3092	Ministry of Agriculture .948. project of the People's Republic of China [2013-Z28]; Shaanxi Natural Science Foundation [2012JM3001, 2013JZ007]; Major Innovation Project for Science and Technology of Shaanxi Province [2011KTZB02-01]; Basic Scientific Research Project in Central Universities [QN2011001]; Tang Zhong-Ying Breeding Funding Project of the Northwest A&F University Program for Innovative Research Team in Shannxi (PIRT) [2014KCT-25]	Ministry of Agriculture .948. project of the People's Republic of China; Shaanxi Natural Science Foundation(Natural Science Foundation of Shaanxi Province); Major Innovation Project for Science and Technology of Shaanxi Province; Basic Scientific Research Project in Central Universities; Tang Zhong-Ying Breeding Funding Project of the Northwest A&F University Program for Innovative Research Team in Shannxi (PIRT)	The Ministry of Agriculture .948. project of the People's Republic of China (No. 2013-Z28), the Shaanxi Natural Science Foundation (No. 2012JM3001 and No. 2013JZ007); the Major Innovation Project for Science and Technology of Shaanxi Province (No. 2011KTZB02-01); the Basic Scientific Research Project in Central Universities (No. QN2011001); the Tang Zhong-Ying Breeding Funding Project of the Northwest A&F University Program for Innovative Research Team in Shannxi (PIRT) 2014KCT-25.	Able JA, 2007, TRENDS PLANT SCI, V12, P71, DOI 10.1016/j.tplants.2006.12.002; Amasino RM, 2005, CURR OPIN BIOTECH, V16, P154, DOI 10.1016/j.copbio.2005.02.004; Cao ZJ, 2008, PLANT SCI, V174, P544, DOI 10.1016/j.plantsci.2008.02.007; Chen JY, 2014, COMPUTER COMPUTING T, P408; CHEN S, 1991, Acta Genetica Sinica, V18, P508; Chen Shiqiang, 2013, Journal of Yangzhou University (Agricultural and Life Science Edition), V34, P50; Cota-Sanchez JH, 2006, PLANT MOL BIOL REP, V24, P161, DOI 10.1007/BF02914055; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Du WL, 2013, GENET MOL RES, V12, P4797, DOI 10.4238/2013.October.18.16; Du WL, 2013, MOL BREEDING, V31, P879, DOI 10.1007/s11032-013-9841-0; Du WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053921; Efremova TT, 2006, EUPHYTICA, V151, P145, DOI 10.1007/s10681-006-9135-2; Ewert F, 1996, FIELD CROP RES, V47, P155, DOI 10.1016/0378-4290(96)00023-8; Farkas A, 2014, EUPHYTICA, V195, P45, DOI 10.1007/s10681-013-0970-7; Fu SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054057; Guo CuiHua, 2010, Acta Agronomica Sinica, V36, P673, DOI 10.3724/SP.J.1006.2010.00673; Guo DW, 2013, PLANT MOL BIOL REP, V31, P289, DOI 10.1007/s11105-012-0492-9; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Jiang SM, 2005, THEOR APPL GENET, V111, P923, DOI 10.1007/s00122-005-0022-3; Kang HY, 2012, GENOME, V55, P383, DOI [10.1139/G2012-025, 10.1139/g2012-025]; Liu WX, 2011, THEOR APPL GENET, V122, P1537, DOI 10.1007/s00122-011-1553-4; Mguis K, 2013, ACTA PHYSIOL PLANT, V35, P1453, DOI 10.1007/s11738-012-1185-6; Peng YuanYing, 2006, Agricultural Sciences in China, V5, P579, DOI 10.1016/S1671-2927(06)60095-3; Prasil IT, 2004, ANN BOT-LONDON, V94, P413, DOI 10.1093/aob/mch158; Reader SM, 1996, EUPHYTICA, V89, P121, DOI 10.1007/BF00015729; Sepsi A, 2008, THEOR APPL GENET, V116, P825, DOI 10.1007/s00122-008-0716-4; Shi WJ, 2013, FOOD SECUR, V5, P69, DOI 10.1007/s12571-012-0225-9; Wang J, 2013, SPAN J AGRIC RES, V11, P1094, DOI 10.5424/sjar/2013114-4245; Wang Y, 2011, AFR J BIOTECHNOL, V10, P2201; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; [张志诚 Zhang Zhicheng], 2004, [中国生态农业学报, Chinese journal of eco-agriculture], V12, P80; Zhao BingQiang, 2001, Scientia Agricultura Sinica, V34, P649	32	6	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0131841	10.1371/journal.pone.0131841	http://dx.doi.org/10.1371/journal.pone.0131841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461884	gold, Green Published, Green Submitted			2022-12-26	WOS:000362962300002
J	Zhu, XZ; Zelmer, A; Kapfhammer, JP; Wellmann, S				Zhu, Xinzhou; Zelmer, Andrea; Kapfhammer, Josef P.; Wellmann, Sven			Cold-inducible RBM3 inhibits PERK phosphorylation through cooperation with NF90 to protect cells from endoplasmic reticulum stress	FASEB JOURNAL			English	Article						RNA-binding protein; hypothermia; unfolded protein response; apoptosis	CIRCADIAN GENE-EXPRESSION; CEREBRAL-ISCHEMIA; ER STRESS; HYPOTHERMIA; TRANSLATION; DEATH; SHOCK; KINASE; NEURODEGENERATION; DEPRIVATION	The cold-inducible RNA-binding motif protein 3 (RBM3) is involved in the protection of neurons in hypoxic-ischemic and neurodegenerative disorders. RBM3 belongs to a small group of proteins whose synthesis increases during hypothermia while global protein production is slowed down. To investigate the molecular mechanisms underlying RBM3 action, we subjected hippocampal organotypic slice cultures from RBM3 knockout mice to various stressors and found exuberant signaling of the endoplasmic reticulum (ER) stress pathway PRKR-like ER kinase (PERK)-eukaryotic translation initiation factor 2 alpha (eIF2 alpha)-CCAAT/enhancer-binding protein homologous protein (CHOP) as compared with wild-type mice. Further, blocking RBM3 expression in human embryonic kidney HEK293 cells by specific small interfering RNAs increased phosphorylation of PERK and eIF2 alpha, whereas overexpression of RBM3 prevented PERK-eIF2 alpha-CHOP signaling during ER stress induced by thapsigargin or tunicamycin. RBM3 did not affect expression of the ER stress sensor immunoglobulin binding protein/GRP78. However, based on affinity purification coupled with mass spectrometry, coimmunoprecipitation, and proximity ligation assay, we revealed that nuclear factor 90 (NF90) is a novel protein interactor of PERK and that this interaction is essential for RBM3-mediated regulation of PERK activity, which requires an RNA-dependent interaction. In conclusion, our data provide evidence for a central role of RBM3 in preventing cell death by inhibiting the PERK-eIF2 alpha-CHOP ER stress pathway through cooperation with NF90.	[Zhu, Xinzhou; Zelmer, Andrea; Wellmann, Sven] Univ Basel Childrens Hosp UKBB, Spitalstr 33, CH-4056 Basel, Switzerland; [Kapfhammer, Josef P.] Univ Basel, Dept Biomed, Inst Anat, Basel, Switzerland	University of Basel	Wellmann, S (corresponding author), Univ Basel Childrens Hosp UKBB, Spitalstr 33, CH-4056 Basel, Switzerland.	sven.wellmann@ukbb.ch	Wellmann, Sven/A-2771-2017	Kapfhammer, Josef/0000-0002-2404-5778	Swiss National Science Foundation [31003A_141007]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors sincerely thank Prof. Tadatsugu Taniguchi for providing RBM3 KO mice. This research is funded by the Swiss National Science Foundation (31003A_141007). The authors declare no conflicts of interest.	Al Chawaf A, 2007, NEUROSCIENCE, V144, P1241, DOI 10.1016/j.neuroscience.2006.09.062; Al-Fageeh MB, 2006, BIOCHEM J, V397, P247, DOI 10.1042/BJ20060166; Anderson P, 2015, BBA-GENE REGUL MECH, V1849, P861, DOI 10.1016/j.bbagrm.2014.11.009; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bettaieb A, 2015, BBA-MOL CELL RES, V1853, P52, DOI 10.1016/j.bbamcr.2014.09.016; Bodalia A, 2013, ACTA PHARMACOL SIN, V34, P49, DOI 10.1038/aps.2012.139; Chaikam V, 2010, BMB REP, V43, P1, DOI 10.5483/BMBRep.2010.43.1.001; Chip S, 2014, JOVE-J VIS EXP, DOI 10.3791/52023; Chip S, 2013, J CEREBR BLOOD F MET, V33, P508, DOI 10.1038/jcbfm.2012.190; Chip S, 2011, NEUROBIOL DIS, V43, P388, DOI 10.1016/j.nbd.2011.04.010; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dresios J, 2005, P NATL ACAD SCI USA, V102, P1865, DOI 10.1073/pnas.0409764102; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Halliday M, 2014, NEUROPHARMACOLOGY, V76, P169, DOI 10.1016/j.neuropharm.2013.08.034; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hofmann S, 2012, MOL BIOL CELL, V23, P3786, DOI 10.1091/mbc.E12-04-0296; Kita H, 2002, HUM MOL GENET, V11, P2279, DOI 10.1093/hmg/11.19.2279; Knight JRP, 2015, BIOCHEM J, V465, P227, DOI 10.1042/BJ20141014; Kosakowska-Cholody T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.203; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053431; Liu YT, 2013, SCI REP-UK, V3, DOI 10.1038/srep02054; LLeonart ME, 2010, BBA-REV CANCER, V1805, P43, DOI 10.1016/j.bbcan.2009.11.001; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Papile LA, 2014, PEDIATRICS, V133, P1146, DOI 10.1542/peds.2014-0899; Parker LM, 2001, J BIOL CHEM, V276, P32522, DOI 10.1074/jbc.M104408200; Peretti D, 2015, NATURE, V518, P236, DOI 10.1038/nature14142; Pilotte J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028446; Poone GK, 2015, BRAIN SCI, V5, P178, DOI 10.3390/brainsci5020178; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rzechorzek NM, 2015, EBIOMEDICINE, V2, P528, DOI 10.1016/j.ebiom.2015.04.004; Schmal C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002986; Smart F, 2007, J NEUROCHEM, V101, P1367, DOI 10.1111/j.1471-4159.2007.04521.x; Sureban SM, 2008, ONCOGENE, V27, P4544, DOI 10.1038/onc.2008.97; Tong G, 2013, BRAIN RES, V1504, P74, DOI 10.1016/j.brainres.2013.01.041; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Wellmann S, 2010, PEDIATR RES, V67, P35, DOI 10.1203/PDR.0b013e3181c13326; Wen X, 2014, J IMMUNOL, V192, P3753, DOI 10.4049/jimmunol.1302813; Xin Q, 2014, NEUROCHEM INT, V68, P18, DOI 10.1016/j.neuint.2014.02.001; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yang W, 2009, EXP NEUROL, V219, P376, DOI 10.1016/j.expneurol.2009.07.009; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Zargar R, 2015, RES VET SCI, V98, P51, DOI 10.1016/j.rvsc.2014.11.016	47	38	42	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					624	634		10.1096/fj.15-274639	http://dx.doi.org/10.1096/fj.15-274639			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26472337				2022-12-26	WOS:000369391900015
J	Florio, P; Folli, C; Cianci, M; Del Rio, D; Zanotti, G; Berni, R				Florio, Paola; Folli, Claudia; Cianci, Michele; Del Rio, Daniele; Zanotti, Giuseppe; Berni, Rodolfo			Transthyretin Binding Heterogeneity and Anti-amyloidogenic Activity of Natural Polyphenols and Their Metabolites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATIVE-STATE STABILIZATION; STRUCTURAL EVIDENCE; THYROXINE; OLIGOMERS; VARIANTS; CURCUMIN; FEATURES; FIBRILS; PLASMA; SYSTEM	Transthyretin (TTR) is an amyloidogenic protein, the amyloidogenic potential of which is enhanced by a number of specific point mutations. The ability to inhibit TTR fibrillogenesis is known for several classes of compounds, including natural polyphenols, which protect the native state of TTR by specifically interacting with its thyroxine binding sites. Comparative analyses of the interaction and of the ability to protect the TTR native state for polyphenols, both stilbenoids and flavonoids, and some of their main metabolites have been carried out. A main finding of this investigation was the highly preferential binding of resveratrol and thyroxine, both characterized by negative binding cooperativity, to distinct sites in TTR, consistent with the data of x-ray analysis of TTR in complex with both ligands. Although revealing the ability of the two thyroxine binding sites of TTR to discriminate between different ligands, this feature has allowed us to evaluate the interactions of polyphenols with both resveratrol and thyroxine preferential binding sites, by using resveratrol and radiolabeled T4 as probes. Among flavonoids, genistein and apigenin were able to effectively displace resveratrol from its preferential binding site, whereas genistein also showed the ability to interact, albeit weakly, with the preferential thyroxine binding site. Several glucuronidated polyphenol metabolites did not exhibit significant competition for resveratrol and thyroxine preferential binding sites and lacked the ability to stabilize TTR. However, resveratrol-3-O-sulfate was able to significantly protect the protein native state. A rationale for the in vitro properties found for polyphenol metabolites was provided by x-ray analysis of their complexes with TTR.	[Florio, Paola; Berni, Rodolfo] Univ Parma, Dept Life Sci, I-43124 Parma, Italy; [Folli, Claudia; Del Rio, Daniele] Univ Parma, Dept Food Sci, I-43124 Parma, Italy; [Cianci, Michele] European Mol Biol Lab, D-22607 Hamburg, Germany; [Zanotti, Giuseppe] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy	University of Parma; University of Parma; European Molecular Biology Laboratory (EMBL); University of Padua	Berni, R (corresponding author), Univ Parma, Dept Life Sci, Parco Area Sci 23-A, I-43124 Parma, Italy.	rodolfo.berni@unipr.it	Cianci, Michele/AAD-7581-2019; Cianci, Michele/I-5577-2012; Del Rio, Daniele/E-8696-2010	Cianci, Michele/0000-0001-5607-6061; Cianci, Michele/0000-0001-5607-6061; Del Rio, Daniele/0000-0001-5394-1259; Berni, Rodolfo/0000-0002-1839-0479	European Community [283570]; MIUR (Ministero Istruzione Universita Ricerca) [2009KN2FBM, 2012A7LMS3_002]; Progetto Agroalimentare E Ricerca Grant [2011-0283]	European Community(European Commission); MIUR (Ministero Istruzione Universita Ricerca)(Ministry of Education, Universities and Research (MIUR)); Progetto Agroalimentare E Ricerca Grant	This work was supported in part by European Community Seventh Framework Program FP7/2007-2013 under Grant 283570 (to BioStruct-X), by MIUR (Ministero Istruzione Universita Ricerca) PRIN (Progetti di Rilevante Interesse Nazionale) Projects 2009KN2FBM and 2012A7LMS3_002, and by Progetto Agroalimentare E Ricerca Grant 2011-0283. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Bieschke J, 2013, NEUROTHERAPEUTICS, V10, P429, DOI 10.1007/s13311-013-0192-7; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Cendron L, 2009, J BIOL CHEM, V284, P25832, DOI 10.1074/jbc.M109.017657; Cianci M, 2015, ACTA CRYSTALLOGR D, V71, P1582, DOI 10.1107/S1399004715010585; Coelho T, 2013, J NEUROL, V260, P2802, DOI 10.1007/s00415-013-7051-7; Daval M, 2010, AMYLOID, V17, P118, DOI 10.3109/13506129.2010.530008; Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FERGUSON RN, 1975, BIOCHEMISTRY-US, V14, P282, DOI 10.1021/bi00673a014; Ferrao-Gonzales AD, 2003, J MOL BIOL, V328, P963, DOI 10.1016/S0022-2836(03)00368-1; Ge JF, 2012, NEUROCHEM INT, V61, P1192, DOI 10.1016/j.neuint.2012.08.012; Green NS, 2005, P NATL ACAD SCI USA, V102, P14545, DOI 10.1073/pnas.0501609102; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; Hirohata M, 2012, BBA-MOL BASIS DIS, V1822, P1316, DOI 10.1016/j.bbadis.2012.05.006; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Kolstoe SE, 2010, P NATL ACAD SCI USA, V107, P20483, DOI 10.1073/pnas.1008255107; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; MCCUTCHEN SL, 1993, BIOCHEMISTRY-US, V32, P12119, DOI 10.1021/bi00096a024; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Obici L, 2014, EXPERT OPIN INV DRUG, V23, P1239, DOI 10.1517/13543784.2014.922541; Pasquato N, 2007, J MOL BIOL, V366, P711, DOI 10.1016/j.jmb.2006.11.076; Pullakhandam R, 2009, ARCH BIOCHEM BIOPHYS, V485, P115, DOI 10.1016/j.abb.2009.02.013; Rigacci S, 2011, CURR ALZHEIMER RES, V8, P841, DOI 10.2174/156720511798192682; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Trivella DBB, 2012, J STRUCT BIOL, V180, P143, DOI 10.1016/j.jsb.2012.07.008; Trivella DBB, 2010, J STRUCT BIOL, V170, P522, DOI 10.1016/j.jsb.2010.03.002; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wojtczak A, 1996, ACTA CRYSTALLOGR D, V52, P758, DOI 10.1107/S0907444996003046; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zanotti G, 2013, FEBS LETT, V587, P2325, DOI 10.1016/j.febslet.2013.06.016	38	29	29	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29769	29780		10.1074/jbc.M115.690172	http://dx.doi.org/10.1074/jbc.M115.690172			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26468275	hybrid, Green Published			2022-12-26	WOS:000366614700012
J	Fadel, SA; Ram, U; Morris, SK; Begum, R; Shet, A; Jotkar, R; Jha, P				Fadel, Shaza A.; Ram, Usha; Morris, Shaun K.; Begum, Rehana; Shet, Anita; Jotkar, Raju; Jha, Prabhat			Facility Delivery, Postnatal Care and Neonatal Deaths in India: Nationally-Representative Case-Control Studies	PLOS ONE			English	Article							MATERNAL MORTALITY; NEWBORN BABIES; UTTAR-PRADESH; HEALTH; INTERVENTIONS; METAANALYSIS; MANAGEMENT; PROGRAM	Objective Clinical studies demonstrate the efficacy of interventions to reduce neonatal deaths, but there are fewer studies of their real-life effectiveness. In India, women often seek facility delivery after complications arise, rather than to avoid complications. Our objective was to quantify the association of facility delivery and postnatal checkups with neonatal mortality while examining the "reverse causality" in which the mothers deliver at a health facility due to adverse perinatal events. Methods We conducted nationally representative case-control studies of about 300,000 live births and 4,000 neonatal deaths to examine the effect of, place of delivery and postnatal checkup on neonatal mortality. We compared neonatal deaths to all live births and to a subset of live births reporting excessive bleeding or obstructed labour that were more comparable to cases in seeking care. Findings In the larger study of 2004-8 births, facility delivery without postnatal checkup was associated with an increased odds of neonatal death (Odds ratio = 2.5; 99% CI 2.2-2.9), especially for early versus late neonatal deaths. However, use of more comparable controls showed marked attenuation (Odds ratio = 0.5; 0.4-0.5). Facility delivery with postnatal checkup was associated with reduced odds of neonatal death. Excess risks were attenuated in the earlier study of 2001-4 births. Conclusion The combined effect of facility deliveries with postnatal checks ups is substantially higher than just facility delivery alone. Evaluation of the real-life effectiveness of interventions to reduce child and maternal deaths need to consider reverse causality. If these associations are causal, facility delivery with postnatal check up could avoid about 1/3 of all neonatal deaths in India (similar to 100,000/year).	[Fadel, Shaza A.; Ram, Usha; Begum, Rehana; Jha, Prabhat] Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON, Canada; [Fadel, Shaza A.; Ram, Usha; Begum, Rehana; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Ram, Usha] Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Bombay, Maharashtra, India; [Morris, Shaun K.] Hosp Sick Children, Div Infect Dis, Toronto, ON M5G 1X8, Canada; [Morris, Shaun K.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada; [Morris, Shaun K.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Shet, Anita] St Johns Med Coll Hosp, Dept Pediat, Bangalore, Karnataka, India; [Jotkar, Raju] Govt Maharashtra, Natl Hlth Mission, Bombay, Maharashtra, India	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; International Institute for Population Sciences; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; St. John's National Academy of Health Sciences; St. John's Medical College	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON, Canada.	Prabhat.jha@utoronto.ca	Ram, Usha/AAS-4140-2020	Ram, Usha/0000-0001-6722-7347; Jha, Prabhat/0000-0001-7067-8341; Shet, Anita/0000-0002-7204-8164; Fadel, Shaza/0000-0002-2336-6254	US National Institutes of Health [R01-TW05991-01, TW007939-01]; Canadian Institutes of Health Research, CGHR; University of Toronto; CIHR-Hope Fellowship; Endowed Chair at the University of Toronto; Canada Research Chairs program; FOGARTY INTERNATIONAL CENTER [R01TW007939, R01TW005991] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research, CGHR(Canadian Institutes of Health Research (CIHR)); University of Toronto(University of Toronto); CIHR-Hope Fellowship; Endowed Chair at the University of Toronto; Canada Research Chairs program(Canada Research Chairs); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study is supported by the grants from the US National Institutes of Health (R01-TW05991-01 and TW007939-01), Canadian Institutes of Health Research, CGHR and the University of Toronto to PJ. UR is a recipient of the CIHR-Hope Fellowship. PJ receives support from an Endowed Chair at the University of Toronto and the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions expressed in this article are those of the authors and do not necessarily represent those of the institutions with which they are affiliated or of the Government of India.	Agrawal PK, 2012, J EPIDEMIOL COMMUN H, V66, P755, DOI 10.1136/jech-2011-200362; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS72, DOI 10.1038/sj.jp.7211276; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Bhandari N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1634; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Chaturvedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096773; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ghosh R, 2010, J BIOSOC SCI, V42, P511, DOI 10.1017/S0021932010000040; Gogia S, 2010, B WORLD HEALTH ORGAN, V88, P658, DOI 10.2471/BLT.09.069369; Goudar SS, 2013, PEDIATRICS, V131, pE344, DOI 10.1542/peds.2012-2112; Gulmezoglu AM, REPROD MATERNAL NEWB, V2; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; International Institute for Population Sciences (IIPS), 2006, DISTR LEV HOUS SURV; Kesterton AJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-30; Kleinbaum DG, 2010, LOGISTIC REGRESSION, DOI DOI 10.1136/bmjopen-2015-008188; Koueta Fla, 2011, Sante, V21, P209, DOI 10.1684/san.2011.0271; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S12; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Malhotra C, 2014, ASIA-PAC J PUBLIC HE, V26, P401, DOI 10.1177/1010539511420418; Matthews M., 2010, WHO TECHNICAL CONSUL; Mbaruku G, 2009, INT J GYNECOL OBSTET, V106, P85, DOI 10.1016/j.ijgo.2009.04.008; Montgomery AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095696; National Rural Health Mission Ministry of Health & Family Welfare, 2013, STRAT APPR REPR MAT; Office of the Registrar General & Census Commissioner, 2013, SAMPLE REGISTRATION; Pasha O, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-215; Ram U, 2013, LANCET GLOB HEALTH, V1, pE219, DOI 10.1016/S2214-109X(13)70073-1; Rammohan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057244; Requejo J, 2014, INT J EPIDEMIOL, V43, P586, DOI 10.1093/ije/dyu034; Ronsmans C, 2010, B WORLD HEALTH ORGAN, V88, P289, DOI 10.2471/BLT.09.069385; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037037; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; UNICEF, 2010, COV EV SURV 2009 ALL; Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x; WHO, 2009, WHO UNICEF JOINT STA	37	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140448	10.1371/journal.pone.0140448	http://dx.doi.org/10.1371/journal.pone.0140448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479476	Green Published, Green Submitted, gold			2022-12-26	WOS:000363026600011
J	Miura, Y; Saito, M; Usuda, H; Woodward, E; Rittenschober-Bohm, J; Kannan, PS; Musk, GC; Matsuda, T; Newnham, JP; Kemp, MW				Miura, Yuichiro; Saito, Masatoshi; Usuda, Haruo; Woodward, Eleanor; Rittenschober-Boehm, Judith; Kannan, Paranthaman S.; Musk, Gabrielle C.; Matsuda, Tadashi; Newnham, John P.; Kemp, Matthew W.			Ex-Vivo Uterine Environment (EVE) Therapy Induced Limited Fetal Inflammation in a Premature Lamb Model	PLOS ONE			English	Article							EXTRACORPOREAL MEMBRANE-OXYGENATION; HUMAN HEPATOCYTES; CYTOKINE RELEASE; INTERLEUKIN-6; SHEEP; CIRCULATION; PROTEINS; HYPOXIA; BLOOD	Introduction Ex-vivo uterine environment (EVE) therapy uses an artificial placenta to provide gas exchange and nutrient delivery to a fetus submerged in an amniotic fluid bath. Development of EVE may allow us to treat very premature neonates without mechanical ventilation. Meanwhile, elevations in fetal inflammation are associated with adverse neonatal outcomes. In the present study, we analysed fetal survival, inflammation and pulmonary maturation in preterm lambs maintained on EVE therapy using a parallelised umbilical circuit system with a low priming volume. Methods Ewes underwent surgical delivery at 115 days of gestation (term is 150 days), and fetuses were transferred to EVE therapy (EVE group; n = 5). Physiological parameters were continuously monitored; fetal blood samples were intermittently obtained to assess wellbeing and targeted to reference range values for 2 days. Age-matched animals (Control group; n = 6) were surgically delivered at 117 days of gestation. Fetal blood and tissue samples were analysed and compared between the two groups. Results Fetal survival time in the EVE group was 27.0 +/- 15.5 (group mean +/- SD) hours. Only one fetus completed the pre-determined study period with optimal physiological parameters, while the other 4 animals demonstrated physiological deterioration or death prior to the predetermined study end point. Significant elevations (p< 0.05) in: i) inflammatory proteins in fetal plasma; ii) selected cytokine/chemokine mRNA expression levels in fetal tissues; and iii) histological inflammatory score in fetal lung, were observed in the EVE group compared to the Control group. There was no significant difference (p>0.05) in surfactant protein mRNA expression level between the two groups. Conclusion In this study, we achieved limited fetal survival using EVE therapy. Despite this, EVE therapy only induced a modest fetal inflammatory response and did not promote lung maturation. These data provide additional insight into markers of treatment efficacy for the assessment of future studies.	[Miura, Yuichiro; Woodward, Eleanor; Rittenschober-Boehm, Judith; Newnham, John P.; Kemp, Matthew W.] Univ Western Australia, Sch Womens & Infants Hlth, Crawley, WA, Australia; [Miura, Yuichiro; Saito, Masatoshi; Usuda, Haruo; Matsuda, Tadashi] Tohoku Univ Hosp, Ctr Perinatal & Neonatal Med, Sendai, Miyagi, Japan; [Rittenschober-Boehm, Judith] Med Univ Vienna, Div Neonatol Pediat Intens Care & Neuropediat, Vienna, Austria; [Kannan, Paranthaman S.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; [Musk, Gabrielle C.] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia; [Musk, Gabrielle C.] Univ Western Australia, Anim Care Serv, Crawley, WA, Australia	University of Western Australia; Tohoku University; Medical University of Vienna; Cincinnati Children's Hospital Medical Center; Murdoch University; University of Western Australia	Miura, Y (corresponding author), Univ Western Australia, Sch Womens & Infants Hlth, Crawley, WA, Australia.	yuichiro.miura@uwa.edu.au	Miura, Yuichiro/M-3838-2013; Senthamaraikannan, Paranthaman/H-3992-2018; Senthamaraikannan, Paranthaman/B-6428-2011	Miura, Yuichiro/0000-0002-6693-4119; Senthamaraikannan, Paranthaman/0000-0002-3333-3720; Senthamaraikannan, Paranthaman/0000-0002-3333-3720; Woodward, Eleanor/0000-0001-7259-6446; Newnham, John/0000-0001-9983-7457; Rittenschober-Bohm, Judith/0000-0003-2361-7196; Usuda, Haruo/0000-0002-9334-8086	Channel 7 Telethon Trust; Financial Markets Foundation for Children; National Health and Medical Research Council [APP1049148]; Women and Infants Research Foundation	Channel 7 Telethon Trust; Financial Markets Foundation for Children; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Women and Infants Research Foundation	This work was supported by grants from the Channel 7 Telethon Trust, http://telethon.7perth.com.au (MWK), the Financial Markets Foundation for Children, http://www.foundationforchildren.com.au (MWK), and the National Health and Medical Research Council APP1049148, https://www.nhmrc.gov.au (MWK, JPN). MWK is supported by the Women and Infants Research Foundation, http://wirf.com.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian K, 1998, ARTIF ORGANS, V22, P859, DOI 10.1046/j.1525-1594.1998.06121.x; Bachurski CJ, 2001, AM J PHYSIOL-LUNG C, V280, pL279, DOI 10.1152/ajplung.2001.280.2.L279; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CASTELL JV, 1988, FEBS LETT, V232, P347, DOI 10.1016/0014-5793(88)80766-X; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; CASTELL JV, 1989, ANN NY ACAD SCI, V557, P87; Fortenberry JD, 1996, J PEDIATR-US, V128, P670, DOI 10.1016/S0022-3476(96)80133-8; Fujii Y, 2015, J ARTIF ORGANS, V18, P35, DOI 10.1007/s10047-014-0804-y; Fujii Y, 2014, IEEE ENG MED BIO, P4483, DOI 10.1109/EMBC.2014.6944619; Golej J, 2003, SHOCK, V20, P110, DOI 10.1097/01.shk.0000075571.93053.2c; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gourlay T, 2001, ARTIF ORGANS, V25, P475, DOI 10.1046/j.1525-1594.2001.025006475.x; Halter Jeffrey, 2005, J Extra Corpor Technol, V37, P272; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Howson C, 2012, BORN TOO SOON GLOBAL; Jobe AH, 2000, AM J RESP CRIT CARE, V162, P1656, DOI 10.1164/ajrccm.162.5.2003044; Kemp MW, 2013, ANIMAL MODELS FOR THE STUDY OF HUMAN DISEASE, P863, DOI 10.1016/B978-0-12-415894-8.00035-X; MANN LI, 1970, PEDIATR RES, V4, P46, DOI 10.1203/00006450-197001000-00005; Marret S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062683; MciLwain RB, 2010, LAB INVEST, V90, P128, DOI 10.1038/labinvest.2009.119; Miura Y, 2012, PEDIATR RES, V72, P490, DOI 10.1038/pr.2012.108; RASMUSEN BA, 1962, ANN NY ACAD SCI, V97, P306, DOI 10.1111/j.1749-6632.1962.tb34645.x; Shimoya K, 2000, HUM REPROD, V15, P2234, DOI 10.1093/humrep/15.10.2234; Stoinska B, 2011, J PERINATOL, V31, P137, DOI 10.1038/jp.2010.75; Zimmermann AK, 2007, J BIOMED MATER RES B, V80B, P433, DOI 10.1002/jbm.b.30614	25	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140701	10.1371/journal.pone.0140701	http://dx.doi.org/10.1371/journal.pone.0140701			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473607	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500086
J	Nainys, J; Timinskas, A; Schneider, J; Ulrich, RG; Gedvilaite, A				Nainys, Juozas; Timinskas, Albertas; Schneider, Julia; Ulrich, Rainer G.; Gedvilaite, Alma			Identification of Two Novel Members of the Tentative Genus Wukipolyomavirus in Wild Rodents	PLOS ONE			English	Article							ROLLING-CIRCLE AMPLIFICATION; GENOME ANALYSIS; POLYOMAVIRUS; SEQUENCE; PROTEIN; EVOLUTIONARY; SIMIAN-VIRUS-40; PERFORMANCE; AGNOPROTEIN; PHYLOGENIES	Two novel polyomaviruses (PyVs) were identified in kidney and chest- cavity fluid samples of wild bank voles (Myodes glareolus) and common voles (Microtus arvalis) collected in Germany. All cloned and sequenced genomes had the typical PyV genome organization, including putative open reading frames for early regulatory proteins large T antigen and small T antigen on one strand and for structural late proteins (VP1, VP2 and VP3) on the other strand. Virus- like particles (VLPs) were generated by yeast expression of the VP1 protein of both PyVs. VLP- based ELISA and large T- antigen sequence- targeted polymerasechain reaction investigations demonstrated signs of infection of these novel PyVs in about 42% of bank voles and 18% of common voles. In most cases only viral DNA, but not VP1specific antibodies were detected. In additional animals exclusively VP1- specific antibodies, but no viral DNA was detected, indicative for virus clearance. Phylogenetic and clustering analysis including all known PyV genomes placed novel bank vole and common vole PyVs amongst members of the tentative Wukipolymavirus genus. The other known four rodent PyVs, Murine PyV and Hamster PyV, and Murine pneumotropic virus and Mastomys PyV belong to different phylogenetic clades, tentatively named Orthopolyomavirus I and Orthopolyomavirus II, respectively. In conclusion, the finding of novel vole- borne PyVs may suggest an evolutionary origin of ancient wukipolyomaviruses in rodents and may offer the possibility to develop a vole- based animal model for human wukipolyomaviruses.	[Nainys, Juozas; Timinskas, Albertas; Gedvilaite, Alma] Vilnius State Univ, Inst Biotechnol, Dept Eukaryote Genet Engn, Vilnius, Lithuania; [Schneider, Julia; Ulrich, Rainer G.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Greifswald, Germany	Vilnius University; Friedrich Loeffler Institute	Gedvilaite, A (corresponding author), Vilnius State Univ, Inst Biotechnol, Dept Eukaryote Genet Engn, Vilnius, Lithuania.	alma.gedvilaite@bti.vu.lt		Schneider, Julia/0000-0002-0494-1022	European Social Fund under National Integrated Program Biotechnology Biopharmacy [VP1-3.1-SMM-08-K01-005]; German Federal Ministry for Education and Research through the National Research Platform for zoonoses (Project "Netzwerk Nagetier-ubertragene Pathogene", NaUPa-Net2) [01KI1303]	European Social Fund under National Integrated Program Biotechnology Biopharmacy; German Federal Ministry for Education and Research through the National Research Platform for zoonoses (Project "Netzwerk Nagetier-ubertragene Pathogene", NaUPa-Net2)	This work was funded by the European Social Fund under National Integrated Program Biotechnology & Biopharmacy, grant VP1-3.1-SMM-08-K01-005. The investigations in the lab of RGU were supported by the German Federal Ministry for Education and Research through the National Research Platform for zoonoses (Project "Netzwerk Nagetier-ubertragene Pathogene", NaUPa-Net2, grant no 01KI1303).	Aberer AJ, 2015, SYST BIOL IN PRESS; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An P, 2015, ARCH BIOCHEM BIOPHYS, V573, P23, DOI 10.1016/j.abb.2015.02.033; An P, 2012, ANNU REV MICROBIOL, V66, P213, DOI 10.1146/annurev-micro-092611-150154; [Anonymous], 1958, STAT EXTREMES, DOI DOI 10.7312/GUMB92958; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Carter JJ, 2013, P NATL ACAD SCI USA, V110, P12744, DOI 10.1073/pnas.1303526110; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cornulier T, 2013, SCIENCE, V340, P63, DOI 10.1126/science.1228992; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dembo A., 1994, ANN PROBAB, V22, P2022; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Ehlers B, 2014, INFECT GENET EVOL, V26, P283, DOI 10.1016/j.meegid.2014.05.030; Feltkamp MCW, 2013, J GEN VIROL, V94, P482, DOI 10.1099/vir.0.048462-0; FITCH WM, 1966, J MOL BIOL, V16, P9, DOI 10.1016/S0022-2836(66)80258-9; FITCH WM, 1969, BIOCHEM GENET, V3, P99, DOI 10.1007/BF00520346; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Gerits N, 2012, VIROLOGY, V432, P316, DOI 10.1016/j.virol.2012.05.024; Giorda KM, 2012, J VIROL, V86, P3180, DOI 10.1128/JVI.07047-11; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GROSS L, 1953, P SOC EXP BIOL MED, V83, P414; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hill SC, 2015, J GEN VIROL, V96, P1411, DOI 10.1099/vir.0.000071; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Imperiale M.J., 2007, FIELDS VIROLOGY, V2, P2263; Jacob J, 2014, BUNDESGESUNDHEITSBLA, V57, P511, DOI 10.1007/s00103-013-1924-x; Johne R, 2006, J VIROL, V80, P3523, DOI 10.1128/JVI.80.7.3523-3531.2006; Johne R, 2005, J VIROL, V79, P3883, DOI 10.1128/JVI.79.6.3883-3887.2005; Johne R, 2007, J VIROL, V81, P11554, DOI 10.1128/JVI.01178-07; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Johne R, 2009, TRENDS MICROBIOL, V17, P205, DOI 10.1016/j.tim.2009.02.004; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Khalili K, 2005, J CELL PHYSIOL, V204, P1, DOI 10.1002/jcp.20266; Kinnunen PM, 2011, VECTOR-BORNE ZOONOT, V11, P1133, DOI 10.1089/vbz.2010.0170; Kobayashi S, 2015, ARCH VIROL, V160, P1075, DOI 10.1007/s00705-015-2349-7; Kwun HJ, 2009, J VIROL, V83, P12118, DOI 10.1128/JVI.01336-09; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; MAYER M, 1991, VIROLOGY, V181, P469, DOI 10.1016/0042-6822(91)90879-G; Mayer-Scholl A, 2014, INT J ENV RES PUB HE, V11, P7562, DOI 10.3390/ijerph110807562; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Meinke G, 2006, J VIROL, V80, P4304, DOI 10.1128/JVI.80.9.4304-4312.2006; Moens U, 2005, VIROLOGY, V331, P209, DOI 10.1016/j.virol.2004.10.021; Moens U, 2013, REV MED VIROL, V23, P250, DOI 10.1002/rmv.1747; Munoz LJ, 2013, ARCH VIROL, V158, P2255, DOI 10.1007/s00705-013-1737-0; Norkiene M, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0187-z; Orba Y, 2011, J GEN VIROL, V92, P789, DOI 10.1099/vir.0.027854-0; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Pei JM, 2007, NUCLEIC ACIDS RES, V35, pW649, DOI 10.1093/nar/gkm227; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Peng YC, 1998, J VIROL, V72, P7330, DOI 10.1128/JVI.72.9.7330-7340.1998; Peretti A, 2015, GENOME ANNOUNC, V3, P1, DOI [10.1128/genomeA.01476-14, DOI 10.1128/GEN0MEA.01476-14]; Pleckaityte M, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-109; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; Salichos L, 2014, MOL BIOL EVOL, V31, P1261, DOI 10.1093/molbev/msu061; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Sambrook JD, 2001, LAB MANUAL; Sasnauskas K, 1999, BIOL CHEM, V380, P381, DOI 10.1515/BC.1999.050; Scherneck S, 2001, VIRUS GENES, V22, P93, DOI 10.1023/A:1008190504521; Schlegel M, 2014, ROLE OF ANIMALS IN EMERGING VIRAL DISEASES, P235, DOI 10.1016/B978-0-12-405191-1.00010-7; Schlegel M, 2012, BIOCHEM GENET, V50, P440, DOI 10.1007/s10528-011-9487-8; Shen PS, 2011, VIROLOGY, V411, P142, DOI 10.1016/j.virol.2010.12.005; Slibinskas R, 2004, J BIOTECHNOL, V107, P115, DOI 10.1016/j.jbiotec.2003.10.018; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEWART SE, 1958, J NATL CANCER I, V20, P1223, DOI 10.1093/jnci/20.6.1223; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tao Y, 2013, J GEN VIROL, V94, P738, DOI 10.1099/vir.0.047928-0; Ulrich RG, 2008, PARASITOL RES, V103, pS121, DOI 10.1007/s00436-008-1054-9; Ulrich RG, 2011, LABLOEFFLER, V4, P13; Van Ghelue M, 2012, REV MED VIROL, V22, P354, DOI 10.1002/rmv.1711; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; White MK, 2009, J VIROL, V83, P10846, DOI 10.1128/JVI.00542-09	78	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140916	10.1371/journal.pone.0140916	http://dx.doi.org/10.1371/journal.pone.0140916			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474048	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500129
J	Kim, KH; Lee, YT; Hwang, HS; Kwon, YM; Jung, YJ; Lee, Y; Lee, JS; Lee, YN; Park, S; Kang, SM				Kim, Ki-Hye; Lee, Young-Tae; Hwang, Hye Suk; Kwon, Young-Man; Jung, Yu-Jin; Lee, Youri; Lee, Jong Seok; Lee, Yu-Na; Park, Soojin; Kang, Sang-Moo			Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; FORMALIN-INACTIVATED RSV; T-CELLS; BALB/C MICE; IN-VIVO; G GLYCOPROTEIN; FUSION PROTEIN; VACCINE; RESPONSES; DISEASE	Respiratory syncytial virus (RSV) is well-known for inducing vaccine-enhanced respiratory disease after vaccination of young children with formalin-inactivated RSV (FI-RSV) in alum formulation. Here, we investigated alum adjuvant effects on protection and disease after FI-RSV immunization with or without alum in comparison with live RSV reinfections. Despite viral clearance, live RSV reinfections caused weight loss and substantial pulmonary inflammation probably due to high levels of RSV specific IFN-gamma(+) IL4(-), IFN-gamma-TNF-alpha(+), IFN-gamma(+) TNF-a-effector CD4 and CD8 T cells. Alum adjuvant significantly improved protection as evidenced by effective viral clearance compared to unadjuvanted FI-RSV. However, in contrast to unadjuvanted FI-RSV, alum-adjuvanted FI-RSV (FI-RSV-A) induced severe vaccine-enhanced RSV disease including weight loss, eosinophilia, and lung histopathology. Alum adjuvant in the FI-RSV-A was found to be mainly responsible for inducing high levels of RSV-specific IFN-gamma-IL4(+), IFN-gamma-TNF-alpha(+) CD4(+) T cells, and proinflammatory cytokines IL-6 and IL-4 as well as B220(+) plasmacytoid and CD4(+) dendritic cells, and inhibiting the induction of IFN-gamma(+) CD8 T cells. This study suggests that alum adjuvant in FI-RSV vaccines increases immunogenicity and viral clearance but also induces atypical T helper CD4(+) T cells and multiple inflammatory dendritic cell subsets responsible for vaccine-enhanced severe RSV disease.	[Kim, Ki-Hye; Lee, Young-Tae; Hwang, Hye Suk; Kwon, Young-Man; Jung, Yu-Jin; Lee, Youri; Lee, Jong Seok; Lee, Yu-Na; Park, Soojin; Kang, Sang-Moo] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Lee, Jong Seok] Natl Inst Biol Resources, Inchon, Gyeonggi Do, South Korea	University System of Georgia; Georgia State University; National Institute of Biological Resources	Kang, SM (corresponding author), Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	skang24@gsu.edu			NIH/NIAID [AI105170, AI093772, AI119366]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105170, R01AI093772, R21AI119366] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID grants AI105170 (SMK), AI093772 (SMK), and AI119366 (SMK). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers JD, 2002, P NATL ACAD SCI USA, V99, P13020, DOI 10.1073/pnas.192251199; ALWAN WH, 1994, J EXP MED, V179, P81, DOI 10.1084/jem.179.1.81; Aung S, 2000, J IMMUNOL, V164, P3487, DOI 10.4049/jimmunol.164.7.3487; Awate S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00114; BANGHAM CRM, 1986, J GEN VIROL, V67, P623, DOI 10.1099/0022-1317-67-4-623; BANGHAM CRM, 1986, IMMUNOLOGY, V59, P37; Bendelac A, 2002, J EXP MED, V195, pF19, DOI 10.1084/jem.20020073; Blanco JCG, 2014, VACCINE, V32, P1495, DOI 10.1016/j.vaccine.2013.11.032; Boogaard I, 2007, IMMUNOLOGY, V122, P65, DOI 10.1111/j.1365-2567.2007.02613.x; Brewer JM, 1999, J IMMUNOL, V163, P6448; Castilow EM, 2008, J IMMUNOL, V180, P2376, DOI 10.4049/jimmunol.180.4.2376; Charbonnier AS, 2003, J LEUKOCYTE BIOL, V73, P91, DOI 10.1189/jlb.0602289; Cherukuri A, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-21; CONNORS M, 1992, J VIROL, V66, P7444, DOI 10.1128/JVI.66.12.7444-7451.1992; CONNORS M, 1994, J VIROL, V68, P5321, DOI 10.1128/JVI.68.8.5321-5325.1994; Dodge IL, 2003, J IMMUNOL, V170, P4457, DOI 10.4049/jimmunol.170.9.4457; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Garg R, 2012, EXPERT REV VACCINES, V11, P1441, DOI [10.1586/ERV.12.117, 10.1586/erv.12.117]; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Gill MA, 2005, J INFECT DIS, V191, P1105, DOI 10.1086/428589; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; Hammad H, 2003, EUR CYTOKINE NETW, V14, P219; Hammad H, 2001, BLOOD, V98, P1135, DOI 10.1182/blood.V98.4.1135; Hassantoufighi A, 2007, CLIN EXP IMMUNOL, V148, P218, DOI 10.1111/j.1365-2249.2007.03341.x; Hwang HS, 2014, CO IMMUNIZATION WITH; Jackson RJ, 2001, J VIROL, V75, P1205, DOI 10.1128/JVI.75.3.1205-1210.2001; Jiang SS, 2002, J GEN VIROL, V83, P429, DOI 10.1099/0022-1317-83-2-429; Johnson TR, 2008, J LEUKOCYTE BIOL, V84, P748, DOI 10.1189/jlb.0907621; Johnson TR, 2003, J IMMUNOL, V170, P2037, DOI 10.4049/jimmunol.170.4.2037; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kamphuis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036812; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kwon YM, 2014, ANTIVIR RES, V104, P1, DOI 10.1016/j.antiviral.2014.01.008; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Langlois RA, 2010, J IMMUNOL, V184, P4440, DOI 10.4049/jimmunol.0902984; Lukens MV, 2009, J VIROL, V83, P7235, DOI 10.1128/JVI.00452-09; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Meyerholz DK, 2009, TOXICOL PATHOL, V37, P249, DOI 10.1177/0192623308329342; Murawski MR, 2010, J VIROL, V84, P1110, DOI 10.1128/JVI.01709-09; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Olszewska W, 2004, VACCINE, V23, P215, DOI 10.1016/j.vaccine.2004.05.015; Ostler T, 2002, EUR J IMMUNOL, V32, P2562, DOI 10.1002/1521-4141(200209)32:9<2562::AID-IMMU2562>3.0.CO;2-4; Pape KA, 1997, J IMMUNOL, V159, P591; Plotnicky-Gilquin H, 2002, J VIROL, V76, P10203, DOI 10.1128/JVI.76.20.10203-10210.2002; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Prince GA, 2001, J GEN VIROL, V82, P2881, DOI 10.1099/0022-1317-82-12-2881; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Quan FS, 2011, J INFECT DIS, V204, P987, DOI 10.1093/infdis/jir474; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Simmons CP, 2001, J IMMUNOL, V166, P1106, DOI 10.4049/jimmunol.166.2.1106; Smit JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001720; Song JM, 2010, VIROLOGY, V405, P165, DOI 10.1016/j.virol.2010.05.034; Stevens WW, 2009, VIRAL IMMUNOL, V22, P243, DOI 10.1089/vim.2009.0016; Stokes KL, 2011, J VIROL, V85, P5782, DOI 10.1128/JVI.01693-10; TANG YW, 1994, J CLIN INVEST, V94, P1953, DOI 10.1172/JCI117546; Varga SM, 2000, J IMMUNOL, V165, P6487, DOI 10.4049/jimmunol.165.11.6487; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Waris ME, 1997, J VIROL, V71, P6935, DOI 10.1128/JVI.71.9.6935-6939.1997	62	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0139916	10.1371/journal.pone.0139916	http://dx.doi.org/10.1371/journal.pone.0139916			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468884	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600021
J	Malkowski, B; Harat, M; Zyromska, A; Wisniewski, T; Harat, A; Lopatto, R; Furtak, J				Malkowski, Bogdan; Harat, Maciej; Zyromska, Agnieszka; Wisniewski, Tomasz; Harat, Aleksandra; Lopatto, Rita; Furtak, Jacek			The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET	PLOS ONE			English	Article							DYNAMIC FET PET; UPTAKE KINETICS; F-18-FET PET; PREDICTIVE VALUES; MRI; NEUROONCOLOGY; SPECIFICITY; SENSITIVITY; PERFORMANCE; TRANSPORT	Gliomas are common brain tumours, but obtaining tissue for definitive diagnosis can be difficult. There is, therefore, interest in the use of non-invasive methods to diagnose and grade the disease. Although positron emission tomography (PET) with 18F-fluorethyltyrosine (18F-FET) can be used to differentiate between low-grade (LGG) and high-grade (HGG) gliomas, the optimal parameters to measure and their cut-points have yet to be established. We therefore assessed the value of single and dual time-point acquisition of 18F-FET PET parameters to differentiate between primary LGGs (n = 22) and HGGs (n = 24). PET examination was considered positive for glioma if the metabolic activity was 1.6-times higher than that of background (contralateral) brain, and maximum tissue-brain ratios (TBRmax) were calculated 10 and 60 min after isotope administration with their sums and differences calculated from individual time-point values. Using a threshold-based method, the overall sensitivity of PET was 97%. Several analysed parameters were significantly different between LGGs and HGGs. However, in a receiver operating characteristics analysis, TBR sum had the best diagnostic accuracy of 87% and sensitivity, specificity, and positive and negative predictive values of 100%, 72.7%, 80%, and 100%, respectively. 18F-FET PET is valuable for the non-invasive determination of glioma grade, especially when dual time-point metrics are used. TBR sum shows the greatest accuracy, sensitivity, and negative predictive value for tumour grade differentiation and is a simple method to implement. However, the cut-off may differ between institutions and calibration strategies would be useful.	[Malkowski, Bogdan] Nicolaus Copernicus Univ, Ludwik Rydygier Coll Med, Dept Positron Emiss Tomog & Mol Imaging, Bydgoszcz, Poland; [Harat, Maciej; Zyromska, Agnieszka; Wisniewski, Tomasz] Franciszek Lukaszczyk Oncol Ctr, Dept Radiotherapy, Bydgoszcz, Poland; [Harat, Aleksandra] Nicolaus Copernicus Univ, Dept Publ Hlth, Ludwik Rydygier Coll Med, Bydgoszcz, Poland; [Harat, Maciej; Zyromska, Agnieszka; Wisniewski, Tomasz] Nicolaus Copernicus Univ, Dept Oncol & Brachytherapy, Ludwik Rydygier Coll Med, Bydgoszcz, Poland; [Furtak, Jacek] 10th Mil Res Hosp & Polyclin, Dept Neurosurg, Bydgoszcz, Poland; [Lopatto, Rita] Franciszek Lukaszczyk Oncol Ctr, Dept Nucl Med, Bydgoszcz, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University; Nicolaus Copernicus University	Harat, M (corresponding author), Franciszek Lukaszczyk Oncol Ctr, Dept Radiotherapy, Bydgoszcz, Poland.	haratm@co.bydgoszcz.pl	Furtak, Jacek/GQR-0467-2022; Harat, Aleksandra/G-2110-2014	Malkowski, Bogdan/0000-0003-1421-4694; Harat, Aleksandra/0000-0003-1515-841X				Arvinda HR, 2009, J NEURO-ONCOL, V94, P87, DOI 10.1007/s11060-009-9807-6; Boellaard R, 2009, J NUCL MED, V50, p11S, DOI 10.2967/jnumed.108.057182; Dunet V, 2014, NUKLEARMED-NUCL MED, V53, P155, DOI 10.3413/Nukmed-0650-14-03; Dunet V, 2012, J NUCL MED, V53, P207, DOI 10.2967/jnumed.111.096859; Habermeier A, 2015, AMINO ACIDS, V47, P335, DOI 10.1007/s00726-014-1863-3; Heiss P, 1999, J NUCL MED, V40, P1367; Hutterer M, 2013, NEURO-ONCOLOGY, V15, P814, DOI 10.1093/neuonc/not081; Hutterer M, 2013, NEURO-ONCOLOGY, V15, P341, DOI 10.1093/neuonc/nos300; Jackson RJ, 2001, NEURO-ONCOLOGY, V3, P193, DOI 10.1093/neuonc/3.3.193; Jager PL, 2001, J NUCL MED, V42, P432; Jansen NL, 2012, EUR J NUCL MED MOL I, V39, P1021, DOI 10.1007/s00259-012-2109-9; Kracht LW, 2004, CLIN CANCER RES, V10, P7163, DOI 10.1158/1078-0432.CCR-04-0262; Kunz M, 2011, NEURO-ONCOLOGY, V13, P307, DOI 10.1093/neuonc/noq196; Langen KJ, 2003, NUCL MED BIOL, V30, P501, DOI 10.1016/S0969-8051(03)00023-4; Law M, 2003, AM J NEURORADIOL, V24, P1989; Miyagawa T, 1998, J CEREBR BLOOD F MET, V18, P500, DOI 10.1097/00004647-199805000-00005; Pauleit D, 2005, BRAIN, V128, P678, DOI 10.1093/brain/awh399; Pauleit D, 2009, NUCL MED BIOL, V36, P779, DOI 10.1016/j.nucmedbio.2009.05.005; Popperl G, 2007, EUR J NUCL MED MOL I, V34, P1933, DOI 10.1007/s00259-007-0534-y; Popperl G, 2006, J NUCL MED, V47, P393; Rapp M, 2013, J NUCL MED, V54, P229, DOI 10.2967/jnumed.112.109603; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Stockhammer F, 2008, J NEURO-ONCOL, V88, P205, DOI 10.1007/s11060-008-9551-3; Vander Borght T, 2006, EUR J NUCL MED MOL I, V33, P403, DOI 10.1007/s00259-005-0041-y; Weber WA, 2000, EUR J NUCL MED, V27, P542, DOI 10.1007/s002590050541; Weckesser M, 2005, EUR J NUCL MED MOL I, V32, P422, DOI 10.1007/s00259-004-1705-8	26	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140917	10.1371/journal.pone.0140917	http://dx.doi.org/10.1371/journal.pone.0140917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468649	Green Submitted, Green Published, gold			2022-12-26	WOS:000363184600124
J	Yu, Y; Savage, RE; Eathiraj, S; Meade, J; Wick, MJ; Hall, T; Abbadessa, G; Schwartz, B				Yu, Yi; Savage, Ronald E.; Eathiraj, Sudharshan; Meade, Justin; Wick, Michael J.; Hall, Terence; Abbadessa, Giovanni; Schwartz, Brian			Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; ADVANCED SOLID TUMORS; BREAST-CANCER CELLS; PIK3CA MUTATION; ACTIVATING MUTATION; ONCOGENIC MUTATION; SOMATIC MUTATIONS; SIGNALING PATHWAY; PROTEIN-KINASE; E17K MUTATION	As a critical component in the PI3K/AKT/mTOR pathway, AKT has become an attractive target for therapeutic intervention. ARQ 092 and a next generation AKT inhibitor, ARQ 751 are selective, allosteric, pan-AKT and AKT1-E17K mutant inhibitors that potently inhibit phosphorylation of AKT. Biochemical and cellular analysis showed that ARQ 092 and ARQ 751 inhibited AKT activation not only by dephosphorylating themembrane-associated active form, but also by preventing the inactive form from localizing into plasma membrane. In endometrial PDX models harboring mutant AKT1-E17K and other tumormodels with an activated AKT pathway, both compounds exhibited strong anti-tumor activity. Combination studies conducted in in vivo breast tumor models demonstrated that ARQ 092 enhanced tumor inhibition of a common chemotherapeutic agent (paclitaxel). In a large panel of diverse cancer cell lines, ARQ 092 and ARQ 751 inhibited proliferation across multiple tumor types but were most potent in leukemia, breast, endometrial, and colorectal cancer cell lines. Moreover, inhibition by ARQ 092 and ARQ 751 was more prevalent in cancer cell lines containing PIK3CA/PIK3R1 mutations compared to those with wt-PIK3CA/PIK3R1 or PTEN mutations. For both ARQ 092 and ARQ 751, PIK3CA/PIK3R1 and AKT1-E17Kmutations can potentially be used as predictive biomarkers for patient selection in clinical studies.	[Yu, Yi; Eathiraj, Sudharshan] ArQule Inc, Biol, Burlington, MA USA; [Savage, Ronald E.; Hall, Terence] ArQule Inc, Preclin Dev & Clin Pharmacol, Burlington, MA 01801 USA; [Meade, Justin; Wick, Michael J.] South Texas Accelerated Res Therapeut, Preclin Res, San Antonio, TX USA; [Abbadessa, Giovanni; Schwartz, Brian] ArQule Inc, Clin Dev, Burlington, MA USA		Savage, RE (corresponding author), ArQule Inc, Preclin Dev & Clin Pharmacol, Burlington, MA 01801 USA.	rsavage@ArQule.com		Schwartz, Brian/0000-0003-2632-6351	ArQule, Inc.	ArQule, Inc.	Funding for this work was provided by ArQule, Inc. The funder provided support in the form of salaries for all ArQule, Inc. authors. ArQule contracted START authors to perform some of the studies in the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell MA, 2012, J MED CHEM, V55, P5291, DOI 10.1021/jm300276x; Askham JM, 2010, ONCOGENE, V29, P150, DOI 10.1038/onc.2009.315; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Beaver JA, 2013, CLIN CANCER RES, V19, P5413, DOI 10.1158/1078-0432.CCR-13-0884; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Blake JF, 2012, J MED CHEM, V55, P8110, DOI 10.1021/jm301024w; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Boormans JL, 2010, BRIT J CANCER, V102, P1491, DOI 10.1038/sj.bjc.6605673; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chandarlapaty S, 2012, CLIN CANCER RES, V18, P6784, DOI 10.1158/1078-0432.CCR-12-1785; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Do H, 2014, CELL CYCLE, V9, P4411; Dumble M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100880; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Hanrahan AJ, 2012, CANCER DISCOV, V2, P56, DOI 10.1158/2159-8290.CD-11-0170; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hermanto U, 2001, ONCOGENE, V20, P7551, DOI 10.1038/sj.onc.1204964; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kalinsky K, 2009, CLIN CANCER RES, V15, P5049, DOI 10.1158/1078-0432.CCR-09-0632; Kim MS, 2008, BRIT J CANCER, V98, P1533, DOI 10.1038/sj.bjc.6604212; Kurebayashi J, 1999, BRIT J CANCER, V79, P707, DOI 10.1038/sj.bjc.6690114; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lin J, 2013, CLIN CANCER RES, V19, P1760, DOI 10.1158/1078-0432.CCR-12-3072; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Lindhurst MJ, 2015, SCI REP INT PRESS; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Malanga D, 2008, CELL CYCLE, V7, P665, DOI 10.4161/cc.7.5.5485; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; Meric-Bernstam F, 2012, CLIN CANCER RES, V18, P1777, DOI 10.1158/1078-0432.CCR-11-2123; Pal SK, 2010, EXPERT OPIN INV DRUG, V19, P1355, DOI 10.1517/13543784.2010.520701; Porta C, 2007, CLIN EXP MED, V7, P127, DOI 10.1007/s10238-007-0145-8; Raguz S, 2008, BRIT J CANCER, V99, P387, DOI 10.1038/sj.bjc.6604510; Sahm F, 2013, ACTA NEUROPATHOL, V126, P757, DOI 10.1007/s00401-013-1187-5; Saleh M, 2014, EUR J CANCER, V50, P104, DOI 10.1016/S0959-8049(14)70446-0; Sangai T, 2012, CLIN CANCER RES, V18, P5816, DOI 10.1158/1078-0432.CCR-12-1141; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Shoji K, 2009, BRIT J CANCER, V101, P145, DOI 10.1038/sj.bjc.6605109; Sommer EM, 2013, BIOCHEM J, V452, P499, DOI 10.1042/BJ20130342; STAAL SP, 1977, P NATL ACAD SCI USA, V74, P3065, DOI 10.1073/pnas.74.7.3065; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Weigelt B, 2011, ONCOGENE, V30, P3222, DOI 10.1038/onc.2011.42; Weigelt B, 2013, CLIN CANCER RES, V19, P3533, DOI 10.1158/1078-0432.CCR-12-3815; Wickenden JA, 2010, BREAST CANCER RES, V12, P1; Will M, 2014, CANCER DISCOV, V4, P334, DOI 10.1158/2159-8290.CD-13-0611; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zilberman DE, 2009, CANCER GENET CYTOGEN, V191, P34, DOI 10.1016/j.cancergencyto.2009.01.009	62	28	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140479	10.1371/journal.pone.0140479	http://dx.doi.org/10.1371/journal.pone.0140479			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469692	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600067
J	Zhang, ZZ; Wei, WJ; Zhu, HL; Challa, GS; Bi, CL; Trick, HN; Li, WL				Zhang, Zhengzhi; Wei, Wenjie; Zhu, Huilan; Challa, Ghana S.; Bi, Caili; Trick, Harold N.; Li, Wanlong			W3 Is a New Wax Locus That Is Essential for Biosynthesis of beta-Diketone, Development of Glaucousness, and Reduction of Cuticle Permeability in Common Wheat	PLOS ONE			English	Article							CUTICULAR WAX; ALKANE BIOSYNTHESIS; EPICUTICULAR WAXES; GAS-EXCHANGE; MAIZE; LEAF; BARLEY; WATER; GENE; ACCUMULATION	The cuticle plays important roles in plant development, growth and defense against biotic and abiotic attacks. Crystallized epicuticular wax, the outermost layer of cuticle, is visible as white-bluish glaucousness. In crops like barley and wheat, glaucousness is trait of adaption to the dry and hot cultivation conditions, and hentriacontane-14,16-dione (beta-diketone) and its hydroxy derivatives are the major and unique components of cuticular wax in the upper parts of adult plants. But their biosynthetic pathway and physiological role largely remain unknown. In the present research, we identified a novel wax mutant in wheat cultivar Bobwhite. The mutation is not allelic to the known wax production gene loci W1 and W2, and designated as W3 accordingly. Genetic analysis localized W3 on chromosome arm 2BS. The w3 mutation reduced 99% of beta-diketones, which account for 63.3% of the total wax load of the wild-type. W3 is necessary for beta-diketone synthesis, but has a different effect on beta-diketone hydroxylation because the hydroxy-beta-diketones to beta-diketone ratio increased 11-fold in the w3 mutant. Loss of beta-diketones caused failure to form glaucousness and significant increase of cuticle permeability in terms of water loss and chlorophyll efflux in the w3 mutant. Transcription of 23 cuticle genes from five functional groups was altered in the w3 mutant, 19 down-regulated and four up-regulated, suggesting a possibility that W3 encodes a transcription regulator coordinating expression of cuticle genes. Biosynthesis of beta-diketones in wheat and their implications in glaucousness formation and drought and heat tolerance were discussed.	[Zhang, Zhengzhi; Wei, Wenjie; Zhu, Huilan; Challa, Ghana S.; Li, Wanlong] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Bi, Caili; Trick, Harold N.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA	South Dakota State University; Kansas State University	Li, WL (corresponding author), S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA.	wanlong.li@sdstate.edu	Challa, Ghana/AAG-5407-2019; zhang, zhengzhi/I-5403-2016	Challa, Ghana/0000-0002-0047-1799; Trick, Harold/0000-0001-5255-5575	USDA/DOE Feedstock Genomics Program; South Dakota Agricultural Experimental Station (Brookings, SD); South Dakota Wheat Commission (Pierre, SD)	USDA/DOE Feedstock Genomics Program; South Dakota Agricultural Experimental Station (Brookings, SD); South Dakota Wheat Commission (Pierre, SD)	This work was partly supported by the USDA/DOE Feedstock Genomics Program, South Dakota Agricultural Experimental Station (Brookings, SD) and South Dakota Wheat Commission (Pierre, SD).	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Adamski NM, 2013, PLANT J, V74, P989, DOI 10.1111/tpj.12185; Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; BAENZIGER PS, 1983, CROP SCI, V23, P116, DOI 10.2135/cropsci1983.0011183X002300010034x; BARBER HN, 1968, PHYTOCHEMISTRY, V7, P2089, DOI 10.1016/S0031-9422(00)85661-7; Bennett D, 2012, THEOR APPL GENET, V124, P697, DOI 10.1007/s00122-011-1740-3; Bernard A, 2013, PROG LIPID RES, V52, P110, DOI 10.1016/j.plipres.2012.10.002; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; BIANCHI G, 1986, J AGR FOOD CHEM, V34, P429, DOI 10.1021/jf00069a012; Bianchi G., 1995, WAXES CHEM MOL BIOL, P175; Broun P, 2004, P NATL ACAD SCI USA, V101, P4706, DOI 10.1073/pnas.0305574101; CHEESBROUGH TM, 1984, P NATL ACAD SCI-BIOL, V81, P6613, DOI 10.1073/pnas.81.21.6613; Chen GX, 2011, P NATL ACAD SCI USA, V108, P12354, DOI 10.1073/pnas.1108444108; Dietrich CR, 2005, PLANT J, V42, P844, DOI 10.1111/j.1365-313X.2005.02418.x; Dubcovsky J, 1997, THEOR APPL GENET, V95, P1169, DOI 10.1007/s001220050678; Franckowiak JD, 2011, BARLEY GENETICS NEWS, V41, P54; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Hansen JD, 1997, PLANT PHYSIOL, V113, P1091, DOI 10.1104/pp.113.4.1091; Javelle M, 2011, PLANT PHYSIOL, V157, P790, DOI 10.1104/pp.111.182147; Javelle M, 2010, PLANT PHYSIOL, V154, P273, DOI 10.1104/pp.109.150540; JOHNSON DA, 1983, CROP SCI, V23, P318, DOI 10.2135/cropsci1983.0011183X002300020033x; Kannangara R, 2007, PLANT CELL, V19, P1278, DOI 10.1105/tpc.106.047076; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; KOLATTUKUDY PE, 1970, LIPIDS, V5, P259, DOI 10.1007/BF02532477; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kosma DK, 2010, PLANT J, V63, P31, DOI 10.1111/j.1365-313X.2010.04229.x; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lee SB, 2013, MOL PLANT, V6, P246, DOI 10.1093/mp/sss159; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Li WL, 2008, PLANT PHYSIOL, V146, P200, DOI 10.1104/pp.107.108852; Liu Q, 2007, EUPHYTICA, V155, P71, DOI 10.1007/s10681-006-9302-5; Liu SZ, 2009, GENETICS, V183, P1215, DOI 10.1534/genetics.109.108936; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2015, THEOR APPL GENET, V128, P1595, DOI 10.1007/s00122-015-2534-9; Lu SY, 2012, PLANT PHYSIOL, V159, P930, DOI 10.1104/pp.112.198697; LUNDQVIST U, 1988, HEREDITAS, V108, P1, DOI 10.1111/j.1601-5223.1988.tb00676.x; McIntosh RA, 2008, CAT GEN SYMB WHEAT 1; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; MIKKELSEN JD, 1978, CARLSBERG RES COMMUN, V43, P15, DOI 10.1007/BF02906546; Monneveux P, 2004, J AGRON CROP SCI, V190, P395, DOI 10.1111/j.1439-037X.2004.00116.x; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; Nawrath Christiane, 2002, Arabidopsis Book, V1, pe0021, DOI 10.1199/tab.0021; Neelakandan AK, 2012, PLANT CELL REP, V31, P597, DOI 10.1007/s00299-011-1202-z; NELSON JC, 1995, GENOME, V38, P516, DOI 10.1139/g95-067; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; RICHARDS RA, 1986, AUST J PLANT PHYSIOL, V13, P465, DOI 10.1071/PP9860465; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Simmonds JR, 2008, EUPHYTICA, V159, P333, DOI 10.1007/s10681-007-9514-3; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Sturaro M, 2005, PLANT PHYSIOL, V138, P478, DOI 10.1104/pp.104.058164; Tacke E, 1995, PLANT J, V8, P907, DOI 10.1046/j.1365-313X.1995.8060907.x; Tsunewaki K, 1999, GENES GENET SYST, V74, P33, DOI 10.1266/ggs.74.33; TULLOCH AP, 1980, CAN J BOT, V58, P2602, DOI 10.1139/b80-302; TULLOCH AP, 1973, PHYTOCHEMISTRY, V12, P2225, DOI 10.1016/0031-9422(73)85124-6; TULLOCH AP, 1973, PHYTOCHEMISTRY, V12, P2217, DOI 10.1016/0031-9422(73)85123-4; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Vioque J, 1997, ARCH BIOCHEM BIOPHYS, V340, P64, DOI 10.1006/abbi.1997.9932; von Wettstein-Knowles P., 1995, WAXES CHEM MOL BIOL, P91; von Wettstein-Knowles P, 2012, PLANT WAXES ELS, P1; VONWETTSTEINKNOWLES P, 1972, PLANTA, V106, P113, DOI 10.1007/BF00383991; Wang J, 2014, THEOR APPL GENET, V127, P831, DOI 10.1007/s00122-014-2260-8; Wu HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084691; Xu XJ, 1997, PLANT PHYSIOL, V115, P501, DOI 10.1104/pp.115.2.501; Yu DM, 2008, PLANTA, V228, P675, DOI 10.1007/s00425-008-0770-9; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]	67	30	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140524	10.1371/journal.pone.0140524	http://dx.doi.org/10.1371/journal.pone.0140524			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468648	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600072
J	Zhao, N; Mi, L; Liu, XJ; Pan, S; Xu, JJ; Xia, DY; Liu, ZW; Zhang, Y; Xiang, Y; Yuan, ZY; Guan, GC; Wang, JK				Zhao, Na; Mi, Lan; Liu, Xiaojun; Pan, Shuo; Xu, Jiaojiao; Xia, Dongyu; Liu, Zhongwei; Zhang, Yong; Xiang, Yu; Yuan, Zuyi; Guan, Gongchang; Wang, Junkui			Combined Value of Red Blood Cell Distribution Width and Global Registry of Acute Coronary Events Risk Score for Predicting Cardiovascular Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention	PLOS ONE			English	Article							LONG-TERM MORTALITY; HEART-FAILURE; MYOCARDIAL-INFARCTION; PROGNOSTIC MARKER; FASTING GLUCOSE; GRACE; ELEVATION; ASSOCIATION; COHORT; DEATH	Global Registry of Acute Coronary Events (GRACE) risk score and red blood cell distribution width (RDW) content can both independently predict major adverse cardiac events (MACEs) in patients with acute coronary syndrome (ACS). We investigated the combined predictive value of RDW and GRACE risk score for cardiovascular events in patients with ACS undergoing percutaneous coronary intervention (PCI) for the first time. We enrolled 480 ACS patients. During a median follow-up time of 37.2 months, 70 (14.58%) patients experienced MACEs. Patients were divided into tertiles according to the baseline RDW content (11.30-12.90, 13.00-13.50, 13.60-16.40). GRACE score was positively correlated with RDW content. Multivariate Cox analysis showed that both GRACE score and RDW content were independent predictors of MACEs (hazard ratio 1.039; 95% confidence interval [CI] 1.024-1.055; p < 0.001; 1.699; 1.294-2.232; p < 0.001; respectively). Furthermore, Kaplan-Meier analysis demonstrated that the risk of MACEs increased with increasing RDW content (p < 0.001). For GRACE score alone, the area under the receiver operating characteristic (ROC) curve for MACEs was 0.749 (95% CI: 0.707-0.787). The area under the ROC curve for MACEs increased to 0.805 (0.766-0.839, p = 0.034) after adding RDW content. The incremental predictive value of combining RDW content and GRACE risk score was significantly improved, also shown by the net reclassification improvement (NRI = 0.352, p < 0.001) and integrated discrimination improvement (IDI = 0.023, p = 0.002). Combining the predictive value of RDW and GRACE risk score yielded a more accurate predictive value for long-term cardiovascular events in ACS patients who underwent PCI as compared to each measure alone.	[Zhao, Na; Liu, Xiaojun; Pan, Shuo; Xu, Jiaojiao; Xia, Dongyu; Liu, Zhongwei; Zhang, Yong; Xiang, Yu; Guan, Gongchang; Wang, Junkui] Shaanxi Prov Peoples Hosp, Dept Cardiovasc Med, Xian, Shaanxi, Peoples R China; [Liu, Xiaojun; Yuan, Zuyi] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Cardiovasc Med, Xian 710049, Shaanxi, Peoples R China; [Mi, Lan] Peking Univ, Canc Hosp & Inst, Dept Med Affairs, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China	Xi'an Medical University; Xi'an Jiaotong University; Peking University	Wang, JK (corresponding author), Shaanxi Prov Peoples Hosp, Dept Cardiovasc Med, Xian, Shaanxi, Peoples R China.	11581053@qq.com; 173307845@qq.com			National Natural Science Fund for Distinguished Young Scholars of China [81400181]	National Natural Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was funded by the National Natural Science Fund for Distinguished Young Scholars of China (81400181) (http://www.nsfc.gov.cn/). NZ received the funding.	Allen LA, 2010, J CARD FAIL, V16, P230, DOI 10.1016/j.cardfail.2009.11.003; Anderson JL, 2011, CIRCULATION, V123, pE426, DOI 10.1161/CIR.0b013e318212bb8b; [Anonymous], 1972, World Health Organ Tech Rep Ser, V503, P1; Aronson D, 2007, DIABETES CARE, V30, P960, DOI 10.2337/dc06-1735; Cavusoglu E, 2010, INT J CARDIOL, V141, P141, DOI 10.1016/j.ijcard.2008.11.187; Chen PC, 2010, AM J EPIDEMIOL, V171, P214, DOI 10.1093/aje/kwp360; Cid-Alvarez B, 2009, AM HEART J, V158, P989, DOI 10.1016/j.ahj.2009.10.004; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Fatemi O, 2013, J THROMB THROMBOLYS, V35, P57, DOI 10.1007/s11239-012-0767-x; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Kolman L, 2009, AM J CARDIOL, V104, P470, DOI 10.1016/j.amjcard.2009.04.006; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; Loprinzi PD, 2015, PHYSIOL BEHAV, V142, P121, DOI 10.1016/j.physbeh.2015.01.020; Masson S, 2008, J AM COLL CARDIOL, V52, P997, DOI 10.1016/j.jacc.2008.04.069; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Polat N, 2014, CLIN APPL THROMB-HEM, V20, P577, DOI 10.1177/1076029613500707; Ramsay G, 2007, QJM-INT J MED, V100, P11, DOI 10.1093/qjmed/hcl133; Sinnaeve PR, 2009, ARCH INTERN MED, V169, P402, DOI 10.1001/archinternmed.2008.572; Skjelbakken T, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001109; Tang EW, 2007, AM HEART J, V153, P29, DOI 10.1016/j.ahj.2006.10.004; Timoteo AT, 2014, EUR HEART J-ACUTE CA, V3, P257, DOI 10.1177/2048872614528858; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; Wan ZF, 2014, PLATELETS, V25, P447, DOI 10.3109/09537104.2013.830708; Widera C, 2012, EUR HEART J, V33, P1095, DOI 10.1093/eurheartj/ehr444; Winchester DE, 2010, J AM COLL CARDIOL, V56, P1099, DOI 10.1016/j.jacc.2010.04.023; Yan AT, 2007, EUR HEART J, V28, P1072, DOI 10.1093/eurheartj/ehm004; Yao HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094887	32	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140532	10.1371/journal.pone.0140532	http://dx.doi.org/10.1371/journal.pone.0140532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468876	Green Submitted, Green Published, gold			2022-12-26	WOS:000363184600073
J	Xu, S; Jiao, Q; Cheng, Y; Sun, J; Lu, Q; Zhong, YS				Xu, Shuo; Jiao, Qin; Cheng, Yu; Sun, Jie; Lu, Qiong; Zhong, Yisheng			Short-Term Reproducibility of Twenty-Four-Hour Intraocular Pressure Curves in Untreated Patients with Primary Open-Angle Glaucoma and Ocular Hypertension	PLOS ONE			English	Article							CONTACT-LENS SENSOR; ON-YELLOW PERIMETRY; CORNEAL THICKNESS; TENSION GLAUCOMA; HEALTHY-SUBJECTS; PATTERNS; PROGRESSION; FLUCTUATION; SLEEP; PEAK	Purpose To assess the short-term day-to-day reproducibility of 24-hour intraocular pressure (IOP) curves in various respects in untreated primary open-angle glaucoma (POAG) and ocular hypertension (OHT) patients. Methods 47 subjects with POAG and 34 subjects with OHT underwent IOP measurements every 2 hours in both eyes for consecutive 48 hours by a non-contact tonometer (NCT). IOP values at each time point were recorded. Mean IOP, peak IOP, time difference of peak IOP between two days and IOP fluctuation were also calculated. Intraclass correlation coefficients (ICCs) and Bland-Altman plots were used to evaluate reproducibility. Results ICCs of the entire IOP values for a complete 24-hour curve were 0.577 and 0.561 in POAG and OHT patients, respectively. ICCs of IOP values at different time points ranged from 0.384 (10am) to 0.686 (4am) in POAG patients and from 0.347 (6am) to 0.760 (4am) in OHT patients. ICCs of mean IOP, peak IOP and IOP fluctuation were respectively 0.832, 0.704, 0.367 in POAG patients and 0.867, 0.816 0.633 in OHT patients. Only 37.23% and 35.29% of the peak IOP time points appeared within the time difference of 2 hours in POAG and OHT patients, respectively, while 53.19% and 48.53% appeared within 4 hours in POAG and OHT patients, respectively. Conclusion A 24-hour IOP curve in a single day is not highly reproducible in short-term and has limited use for evaluating individual IOP condition. Mean IOP and peak IOP for a 24-hour IOP curve are useful parameters in clinical follow-up, while IOP value at a certain time point, IOP fluctuation and peak IOP time point should be interpreted with caution.	[Xu, Shuo; Jiao, Qin; Cheng, Yu; Zhong, Yisheng] Shanghai Jiao Tong Univ, Ruijin Hosp Affiliated, Dept Ophthalmol, Sch Med, Shanghai 200030, Peoples R China; [Sun, Jie; Lu, Qiong] Ruijin Hosp, Dept Ophthalmol, Luwan Branch, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhong, YS (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp Affiliated, Dept Ophthalmol, Sch Med, Shanghai 200030, Peoples R China.	yszhong68@126.com						Aakre BM, 2003, OPHTHAL PHYSL OPT, V23, P271, DOI 10.1046/j.1475-1313.2003.00117.x; Aptel F, 2014, JAMA OPHTHALMOL, V132, P1232, DOI 10.1001/jamaophthalmol.2014.1761; Aptel F, 2014, OPHTHALMOLOGY, V121, P1998, DOI 10.1016/j.ophtha.2014.04.039; Bengtsson B, 2007, OPHTHALMOLOGY, V114, P205, DOI 10.1016/j.ophtha.2006.07.060; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; De Smedt S, 2012, J GLAUCOMA, V21, P539, DOI 10.1097/IJG.0b013e31821dac43; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Hara T, 2006, ARCH OPHTHALMOL-CHIC, V124, P165, DOI 10.1001/archopht.124.2.165; Hasegawa K, 2006, JPN J OPHTHALMOL, V50, P449, DOI 10.1007/s10384-006-0343-z; Hatanaka M, 2013, J GLAUCOMA, V22, P390, DOI 10.1097/IJG.0b013e3182447a03; Hatanaka M, 2011, CLINICS, V66, P1235, DOI 10.1590/S1807-59322011000700019; Kida T, 2006, INVEST OPHTH VIS SCI, V47, P4422, DOI 10.1167/iovs.06-0507; Konstas AGP, 2009, EYE, V23, P73, DOI 10.1038/sj.eye.6702995; Konstas AGP, 2007, ACTA OPHTHALMOLOGICA, V85; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leonardi M, 2004, INVEST OPHTH VIS SCI, V45, P3113, DOI 10.1167/iovs.04-0015; Leonardi M, 2009, ACTA OPHTHALMOL, V87, P433, DOI 10.1111/j.1755-3768.2008.01404.x; Liu JHK, 2003, INVEST OPHTH VIS SCI, V44, P1586, DOI 10.1167/iovs.02-0666; Mansouri K, 2012, INVEST OPHTH VIS SCI, V53, P8050, DOI 10.1167/iovs.12-10569; Mansouri K, 2011, BRIT J OPHTHALMOL, V95, P627, DOI 10.1136/bjo.2010.192922; Medeiros FA, 2008, OPHTHALMOLOGY, V115, P934, DOI 10.1016/j.ophtha.2007.08.012; Mosaed S, 2005, AM J OPHTHALMOL, V139, P320, DOI 10.1016/j.ajo.2004.09.062; Mottet B, 2013, JAMA OPHTHALMOL, V131, P1507, DOI 10.1001/jamaophthalmol.2013.5297; Noel C, 2001, OPHTHALMOLOGY, V108, P139, DOI 10.1016/S0161-6420(00)00411-5; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; Realini T, 2011, OPHTHALMOLOGY, V118, P47, DOI 10.1016/j.ophtha.2010.04.027; Realini T, 2010, OPHTHALMOLOGY, V117, P1700, DOI 10.1016/j.ophtha.2010.01.044; Song YK, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-127; Stewart WC, 2008, EUR J OPHTHALMOL, V18, P765, DOI 10.1177/112067210801800517; WEBER AK, 1981, ANN OPHTHALMOL, V13, P323; Willekens K, 2014, GRAEF ARCH CLIN EXP, V252, P477, DOI 10.1007/s00417-013-2533-y; YAMABAYASHI S, 1991, BRIT J OPHTHALMOL, V75, P652, DOI 10.1136/bjo.75.11.652; Yilmaz I, 2014, CLIN OPHTHALMOL, V8, P1069, DOI [10.2147/OPTH.S63915, 10.2147/OPTH.S6391]; [余红梅 Yu Hongmei], 2011, [中国卫生统计, Chinese Journal of Health Statistics], V28, P497; Zareei Athar, 2015, J Ophthalmic Vis Res, V10, P43, DOI 10.4103/2008-322X.156105; Zhong YS, 2013, LASER MED SCI, V28, P361, DOI 10.1007/s10103-012-1055-x; Zhong YS, 2009, JPN J OPHTHALMOL, V53, P574, DOI 10.1007/s10384-009-0726-z	37	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140206	10.1371/journal.pone.0140206	http://dx.doi.org/10.1371/journal.pone.0140206			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466325	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100089
J	Pozhitkov, AE; Daubert, D; Donimirski, AB; Goodgion, D; Vagin, MY; Leroux, BG; Hunter, CM; Flemmig, TF; Noble, PA; Bryers, JD				Pozhitkov, Alex E.; Daubert, Diane; Donimirski, Ashley Brochwicz; Goodgion, Douglas; Vagin, Mikhail Y.; Leroux, Brian G.; Hunter, Colby M.; Flemmig, Thomas F.; Noble, Peter A.; Bryers, James D.			Interruption of Electrical Conductivity of Titanium Dental Implants Suggests a Path Towards Elimination Of Corrosion	PLOS ONE			English	Article							KAPPA-B LIGAND; PERI-IMPLANTITIS; RECEPTOR ACTIVATOR; BIOACTIVE GLASS; PHOSPHATASE; FAILURE	Peri-implantitis is an inflammatory disease that results in the destruction of soft tissue and bone around the implant. Titanium implant corrosion has been attributed to the implant failure and cytotoxic effects to the alveolar bone. We have documented the extent of titanium release into surrounding plaque in patients with and without peri-implantitis. An in vitro model was designed to represent the actual environment of an implant in a patient's mouth. The model uses actual oral microbiota from a volunteer, allows monitoring electrochemical processes generated by biofilms growing on implants and permits control of biocorrosion electrical current. As determined by next generation DNA sequencing, microbial compositions in experiments with the in vitro model were comparable with the compositions found in patients with implants. It was determined that the electrical conductivity of titanium implants was the key factor responsible for the biocorrosion process. The interruption of the biocorrosion current resulted in a 4-5 fold reduction of corrosion. We propose a new design of dental implant that combines titanium in zero oxidation state for osseointegration and strength, interlaid with a nonconductive ceramic. In addition, we propose electrotherapy for manipulation of microbial biofilms and to induce bone healing in peri-implantitis patients.	[Pozhitkov, Alex E.; Donimirski, Ashley Brochwicz; Goodgion, Douglas; Leroux, Brian G.] Univ Washington, Dept Oral Hlth Sci, Seattle, WA 98195 USA; [Daubert, Diane] Univ Washington, Dept Periodont, Seattle, WA 98195 USA; [Vagin, Mikhail Y.] Linkoping Univ, Dept Phys Chem & Biol IFM, SE-58183 Linkoping, Sweden; [Hunter, Colby M.; Noble, Peter A.] Alabama State Univ, PhD Program Microbiol, Montgomery, AL 36101 USA; [Flemmig, Thomas F.] Univ Hong Kong, Prince Philip Dent Hosp, Fac Dent, Sai Ying Pun, Hong Kong, Peoples R China; [Bryers, James D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Linkoping University; University of Hong Kong; University of Washington; University of Washington Seattle	Pozhitkov, AE (corresponding author), Univ Washington, Dept Oral Hlth Sci, Box 357444, Seattle, WA 98195 USA.	pozhit@uw.edu	Noble, Peter/A-8117-2008; Vagin, Mikhail/M-5162-2013	Noble, Peter/0000-0002-6013-2588; Vagin, Mikhail/0000-0001-8478-4663; Pozhitkov, Alexander/0000-0001-6566-6450	National Institutes of Health [5 T90 D021984-03]; International Team for Implantology [954_2013]; National Science Foundation [454]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Team for Implantology; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	AEP received a training grant from the National Institutes of Health (grant number 5 T90 D021984-03) and funding from the International Team for Implantology (grant number 954_2013). PAN received funding from the National Science Foundation, which was used to purchase the 454 sequencer. The international team for Implantology reviewed and approved the study design before issuing the funding.	Addison O, 2012, J R SOC INTERFACE, V9, P3161, DOI 10.1098/rsif.2012.0438; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Bassetti M, 2014, CLIN ORAL IMPLAN RES, V25, P279, DOI 10.1111/clr.12155; Berge TI, 2000, CLIN ORAL IMPLAN RES, V11, P154, DOI 10.1034/j.1600-0501.2000.011002154.x; Chaturvedi T P, 2009, Indian J Dent Res, V20, P91; Cranin A N, 1993, J Oral Implantol, V19, P221; Daubert DM, 2015, J PERIODONTOL, V86, P337, DOI 10.1902/jop.2014.140438; Depprich R, 2014, CLIN IMPLANT DENT R, V16, P124, DOI 10.1111/j.1708-8208.2012.00454.x; Flatebo RS, 2006, J PERIODONTOL, V77, P1201, DOI 10.1902/jop.2006.050406; Fukushima A, 2014, J DENT RES, V93, P525, DOI 10.1177/0022034514524782; Gittens RA, 2011, J DENT RES, V90, P1389, DOI 10.1177/0022034511408428; Goodson JM, 2003, PERIODONTOL 2000, V31, P43, DOI 10.1034/j.1600-0757.2003.03104.x; Greenfield E., 1913, DENT COSMOS, V55, P364; Grenoble D E, 1977, Oral Implantol, V6, P509; Grimaud E, 2003, AM J PATHOL, V163, P2021, DOI 10.1016/S0002-9440(10)63560-2; Gupta S., 2011, MECH BIOMATERIALS FU; Haubold AD, 1998, HDB BIOMATERIAL PROP; Heimke G., 1990, OSSEO INTEGRATED IMP; Jacobi-Gresser E, 2013, INT J ORAL MAX SURG, V42, P537, DOI 10.1016/j.ijom.2012.07.018; Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015; Kalathil S, 2013, BIOTECHNOL ADV, V31, P915, DOI 10.1016/j.biotechadv.2013.05.001; Kawahara H., 1995, ENCY HDB BIOMATERI B, V1; Kim MS, 2006, J BIOL CHEM, V281, P1274, DOI 10.1074/jbc.M510156200; Krishnan V, 2013, J ADV PHARM TECHNOL, V4, P78, DOI 10.4103/2231-4040.111523; Kumar PS, 2012, J CLIN PERIODONTOL, V39, P425, DOI 10.1111/j.1600-051X.2012.01856.x; Lekholm U., 1994, INT J ORAL MAX IMPL, V6, P627; Li K, 2013, CORROS REV, V31, P73, DOI 10.1515/corrrev-2013-0019; Maruyama N, 2014, SCI REP-UK, V4, DOI 10.1038/srep06602; Meffert RM., 1983, J ORAL IMPLANTOL, V11, P286; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mistry S, 2011, AUST DENT J, V56, P68, DOI 10.1111/j.1834-7819.2010.01305.x; Mistry Surajit, 2011, J Indian Soc Periodontol, V15, P215, DOI 10.4103/0972-124X.85663; Nance WC, 2013, J ANTIMICROB CHEMOTH, V68, P2550, DOI 10.1093/jac/dkt211; Nobre MD, 2015, EUR J ORAL SCI, V123, P131, DOI 10.1111/eos.12185; Norton MR, 2002, INT J ORAL MAX IMPL, V17, P249; Oliva J, 2007, INT J ORAL MAX IMPL, V22, P430; Olmedo DG, 2013, J PERIODONTOL, V84, P78, DOI 10.1902/jop.2012.110757; Olmedo DG, 2012, J PERIODONTOL, V83, P973, DOI 10.1902/jop.2011.110392; Pesce P, 2014, INT J PROSTHODONT, V27, P15, DOI 10.11607/ijp.3785; Prathapachandran Jayachandran, 2012, Dent Res J (Isfahan), V9, P516; Rodrigues DC, 2013, MATERIALS, V6, P5258, DOI 10.3390/ma6115258; Rosenbaum M, 2011, BIORESOURCE TECHNOL, V102, P324, DOI 10.1016/j.biortech.2010.07.008; Rudney JD, 2012, J APPL MICROBIOL, V113, P1540, DOI 10.1111/j.1365-2672.2012.05439.x; Sanz M, 2012, J CLIN PERIODONTOL, V39, P202, DOI 10.1111/j.1600-051X.2011.01837.x; Sarmiento-Gonzalez A, 2005, ANAL BIOANAL CHEM, V382, P1001, DOI 10.1007/s00216-005-3165-9; Sarmiento-Gonzalez A, 2009, ANAL BIOANAL CHEM, V393, P335, DOI 10.1007/s00216-008-2449-2; Schaumann S, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-157; Souza JCM, 2013, J DENT, V41, P528, DOI 10.1016/j.jdent.2013.03.008; Strock AE, 1939, AM J ORTHOD ORAL SUR, V25, P467; Thomas YRJ, 2013, J POWER SOURCES, V241, P703, DOI 10.1016/j.jpowsour.2013.05.016; Wachi T, 2015, TOXICOLOGY, V327, P1, DOI 10.1016/j.tox.2014.10.016; Wingrove SS., 2013, PERIIMPLANT THERAPY; Yu F, 2015, INT J ORAL SCI, V7, P179, DOI 10.1038/ijos.2014.76; Zenobia C, 2014, INFECT IMMUN, V82, P650, DOI 10.1128/IAI.01136-13	54	16	16	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140393	10.1371/journal.pone.0140393	http://dx.doi.org/10.1371/journal.pone.0140393			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461491	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300089
J	Berscheminski, J; Brun, J; Speiseder, T; Wimmer, P; Ip, WH; Terzic, M; Dobner, T; Schreiner, S				Berscheminski, J.; Brun, J.; Speiseder, T.; Wimmer, P.; Ip, W. H.; Terzic, M.; Dobner, T.; Schreiner, S.			Sp100A is a tumor suppressor that activates p53-dependent transcription and counteracts E1A/E1B-55K-mediated transformation	ONCOGENE			English	Article							EARLY REGION 4; CELL-TRANSFORMATION; 55-KILODALTON PROTEIN; SUMO-1 MODIFICATION; NUCLEAR EXPORT; REPRESSES P53; ADENOVIRUS; ONCOPROTEIN; LOCALIZATION; EXPRESSION	Human adenoviruses (HAdV) are used as a model system to investigate tumorigenic processes in mammalian cells where the viral oncoproteins E1A and E1B-55K are absolutely required for oncogenic transformation, because they simultaneously accelerate cell cycle progression and inhibit tumor suppressor proteins such as p53, although the underlying mechanism is still not understood in detail. In our present study, we provide evidence that E1B-55K binding to the PML-NB component Sp100A apparently has an essential role in regulating adenovirus-mediated transformation processes. Specifically, when this E1B-55K/Sp100A complex recruits p53, Sp100A-induced activation of p53 transcriptional activity is effectively abolished. Hence, Sp100A exhibits tumor-suppressive activity, not only by stabilizing p53 transactivation but also by depressing E1A/E1B-55K-mediated transformation. E1B-55K counteracts this suppressive activity, inducing Sp100A SUMOylation and sequestering the modified cellular factor into the insoluble matrix of the nucleus or into cytoplasmic inclusions. These observations provide novel insights into how E1B-55K modulates cellular determinants to maintain growth-promoting activity during oncogenic processes and lytic infection.	[Berscheminski, J.; Brun, J.; Speiseder, T.; Wimmer, P.; Ip, W. H.; Dobner, T.; Schreiner, S.] Leibniz Inst Expt Virol, Heinrich Pette Inst, Dept Viral Transformat, D-20251 Hamburg, Germany; [Terzic, M.; Schreiner, S.] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, D-80290 Munich, Germany	Heinrich Pette Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Dobner, T (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Dept Viral Transformat, D-20251 Hamburg, Germany.; Schreiner, S (corresponding author), Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, D-80290 Munich, Germany.	thomas.dobner@hpi.uni-hamburg.de; sabrina.schreiner@tum.de		Brun, Juliane/0000-0002-0964-3681; Schreiner, Sabrina/0000-0002-5744-7159; Ip, Wing Hang/0000-0002-5367-1401	Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit (BMG); Deutsche Forschungsgemeinschaft (DFG) [DO 343/7-1]; Drager Stiftung; DFG; Wilhelm Sander-Stiftung; Else Kroner-Fresenius-Stiftung; Deutsche Krebshilfe e. V.; B. Braun Stiftung; Fonds der Chemischen Industrie	Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit (BMG); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Drager Stiftung; DFG(German Research Foundation (DFG)); Wilhelm Sander-Stiftung; Else Kroner-Fresenius-Stiftung; Deutsche Krebshilfe e. V.(Deutsche Krebshilfe); B. Braun Stiftung; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We thank Ron Hay, Ellis Jaffray, Roger Everett, Hans Will, Thomas Sternsdorf and Nicole Fischer for providing reagents and scientific discussion. The Heinrich Pette Institute, Leibniz Institute for Experimental Virology is supported by the Freie und Hansestadt Hamburg and the Bundesministerium fur Gesundheit (BMG). JB was supported by grant from the Deutsche Forschungsgemeinschaft (DFG) to TD (DO 343/7-1). MT was supported by the Drager Stiftung. TD is supported by the DFG and the Wilhelm Sander-Stiftung. SS was supported by the Else Kroner-Fresenius-Stiftung and the Deutsche Krebshilfe e. V. Part of this work was supported by the B. Braun Stiftung and the Fonds der Chemischen Industrie.	Adler M, 2011, J GEN VIROL, V92, P1532, DOI 10.1099/vir.0.030981-0; Berscheminski J, 2014, J VIROL, V88, P6076, DOI 10.1128/JVI.00469-14; Berscheminski J, 2013, J VIROL, V87, P965, DOI 10.1128/JVI.02023-12; Endter C, 2005, ONCOGENE, V24, P55, DOI 10.1038/sj.onc.1208170; Endter C, 2004, CURR TOP MICROBIOL, V273, P163; Endter C, 2001, P NATL ACAD SCI USA, V98, P11312, DOI 10.1073/pnas.191361798; Goodrum FD, 1996, J VIROL, V70, P6323, DOI 10.1128/JVI.70.9.6323-6335.1996; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Grotzinger T, 1996, EUR J BIOCHEM, V238, P554, DOI 10.1111/j.1432-1033.1996.0554z.x; Gunther T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004274; GULDNER HH, 1992, J IMMUNOL, V149, P4067; Guldner HH, 1999, J CELL SCI, V112, P733; Hartl B, 2008, ONCOGENE, V27, P3673, DOI 10.1038/sj.onc.1211039; Kim YE, 2011, J VIROL, V85, P11928, DOI 10.1128/JVI.00758-11; LEPPARD KN, 1989, EMBO J, V8, P2329, DOI 10.1002/j.1460-2075.1989.tb08360.x; Lethbridge KJ, 2003, J GEN VIROL, V84, P259, DOI 10.1099/vir.0.18820-0; Li W, 2010, MED SCI MONITOR, V16, pBR174; Ling PD, 2005, EMBO J, V24, P3565, DOI 10.1038/sj.emboj.7600820; Logan J, 1984, CANCER CELL, V2, P527; Martin MED, 1998, J VIROL, V72, P3146, DOI 10.1128/JVI.72.4.3146-3154.1998; MARTON MJ, 1990, J VIROL, V64, P2345, DOI 10.1128/JVI.64.5.2345-2359.1990; Mitsudomi T, 1992, Nihon Geka Gakkai Zasshi, V93, P944; Moller A, 2003, ONCOGENE, V22, P8731, DOI 10.1038/sj.onc.1207079; Muller D, 2012, J VIROL, V86, P8296, DOI 10.1128/JVI.00222-12; Muller S, 2008, CELL CYCLE, V7, P754, DOI 10.4161/cc.7.6.5495; Negorev D, 2001, J CELL SCI, V114, P59; Nevels M, 1999, ONCOGENE, V18, P9, DOI 10.1038/sj.onc.1202284; Nevels M, 2006, ADENOVIRUS METHODS P, P187; Newhart A, 2013, MOL BIOL CELL, V24, P1454, DOI 10.1091/mbc.E12-09-0669; ORNELLES DA, 1991, J VIROL, V65, P424, DOI 10.1128/JVI.65.1.424-429.1991; Pennella MA, 2010, J VIROL, V84, P12210, DOI 10.1128/JVI.01442-10; SARNOW P, 1982, VIROLOGY, V120, P510, DOI 10.1016/0042-6822(82)90054-X; Schreiner S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002549; Schreiner S, 2011, J VIROL, V85, P8752, DOI 10.1128/JVI.00440-11; Seeler JS, 1998, P NATL ACAD SCI USA, V95, P7316, DOI 10.1073/pnas.95.13.7316; Seeler JS, 2001, MOL CELL BIOL, V21, P3314, DOI 10.1128/MCB.21.10.3314-3324.2001; Sieber T, 2007, J VIROL, V81, P95, DOI 10.1128/JVI.01608-06; Stepp WH, 2013, MBIO, V4, DOI 10.1128/mBio.00845-13; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Teodoro JG, 1997, J VIROL, V71, P3620, DOI 10.1128/JVI.71.5.3620-3627.1997; Wimmer P, 2013, ONCOGENE, V32, P1626, DOI 10.1038/onc.2012.187; Wimmer P, 2010, ONCOGENE, V29, P5511, DOI 10.1038/onc.2010.284; Wimmer P, 2015, ONCOGENE, P53; YEW PR, 1994, GENE DEV, V8, P190, DOI 10.1101/gad.8.2.190; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0	46	14	14	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 16	2016	35	24					3178	3189		10.1038/onc.2015.378	http://dx.doi.org/10.1038/onc.2015.378			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO9GI	26477309				2022-12-26	WOS:000378092700009
J	Park, JW; Reed, JR; Backes, WL				Park, Ji Won; Reed, James R.; Backes, Wayne L.			The Localization of Cytochrome P450s CYP1A1 and CYP1A2 into Different Lipid Microdomains Is Governed by Their N-terminal and Internal Protein Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE MICRODOMAINS; NADPH; REDUCTION; INSERTION; 1A2; ADAPTATIONS; ACTIVATION; EXPRESSION; VESICLES; DOMAIN	In cellular membranes, different lipid species are heterogeneously distributed forming domains with different characteristics. Ordered domains are tightly packed with cholesterol, sphingomyelin, and saturated fatty acids, whereas disordered domains contain high levels of unsaturated fatty acids. Our laboratory has shown that membrane heterogeneity affects the organization of cytochrome P450s and their cognate redox partner, the cytochrome P450 reductase (CPR). Despite the high degree of sequence similarity, CYP1A1 was found to localize to disordered regions, whereas CYP1A2 resided in ordered domains. We hypothesized that regions of amino acid sequence variability may contain signal motifs that direct CYP1A proteins into ordered or disordered domains. Thus, chimeric constructs of CYP1A1 and CYP1A2 were created, and their localization was tested in HEK293T cells. CYP1A2, containing the N-terminal regions from CYP1A1, no longer localized in ordered domains, whereas the N terminus of CYP1A2 partially directed CYP1A1 into ordered regions. In addition, intact CYP1A2 containing a 206-302-residue peptide segment of CYP1A1 had less affinity to bind to ordered microdomains. After expression, the catalytic activity of CYP1A2 was higher than that of the CYP1A1-CYP1A2 chimera containing the N-terminal end of CYP1A1 with subsaturating CPR concentrations, but it was approximately equal with excess CPR suggesting that the localization of the CYP1A enzyme in ordered domains favored its interaction with CPR. These data demonstrate that both the N-terminal end and an internal region of CYP1A2 play roles in targeting CYP1A2 to ordered domains, and domain localization may influence P450 function under conditions that resemble those found in vivo.	[Backes, Wayne L.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Backes, WL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, 533 Bolivar St, New Orleans, LA 70112 USA.	wbacke@lsuhsc.edu		Park, Ji Won/0000-0002-7308-1986	National Institutes of Health from NIEHS, USPHS [ES004344, ES013648]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES004344, P42ES013648, R01ES004344] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS, USPHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants ES004344 and ES013648 from NIEHS, USPHS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguiar M, 2005, DRUG METAB REV, V37, P379, DOI 10.1081/DMR-200046136; Ahn T, 1998, BIOCHEMISTRY-US, V37, P12860, DOI 10.1021/bi980804f; Ahn T, 2005, BIOCHEMISTRY-US, V44, P9188, DOI 10.1021/bi050051e; BALVERS WG, 1993, EUR J BIOCHEM, V218, P1021, DOI 10.1111/j.1432-1033.1993.tb18461.x; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; BLANCK J, 1984, EUR J BIOCHEM, V144, P509, DOI 10.1111/j.1432-1033.1984.tb08495.x; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Brignac-Huber L, 2011, MOL PHARMACOL, V79, P549, DOI 10.1124/mol.110.068817; Brignac-Huber LM, 2013, DRUG METAB DISPOS, V41, P1896, DOI 10.1124/dmd.113.053611; Cermak L, 2002, J BIOL CHEM, V277, P7955, DOI 10.1074/jbc.M108048200; Cho EY, 2008, FEBS LETT, V582, P1771, DOI 10.1016/j.febslet.2008.04.048; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; EBERHART DC, 1991, ARCH BIOCHEM BIOPHYS, V291, P231, DOI 10.1016/0003-9861(91)90128-6; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Ghosh MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057919; Graham SE, 1999, ARCH BIOCHEM BIOPHYS, V369, P24, DOI 10.1006/abbi.1999.1350; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INGELMANSUNDBERG M, 1983, EUR J BIOCHEM, V134, P157, DOI 10.1111/j.1432-1033.1983.tb07546.x; IngelmanSundberg M, 1996, BIOCHEM BIOPH RES CO, V221, P318, DOI 10.1006/bbrc.1996.0593; Jang HH, 2010, ARCH BIOCHEM BIOPHYS, V493, P143, DOI 10.1016/j.abb.2009.10.012; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Liu JG, 2004, ARCH BIOCHEM BIOPHYS, V424, P33, DOI 10.1016/j.abb.2003.12.040; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; MURAKAMI K, 1994, J BIOCHEM, V116, P164, DOI 10.1093/oxfordjournals.jbchem.a124489; Oesch-Bartlomowicz B, 2001, INT J CANCER, V94, P733, DOI 10.1002/ijc.1517; Park JW, 2014, BIOCHEM J, V464, P241, DOI 10.1042/BJ20140787; PERSCHL A, 1995, J CELL SCI, V108, P1033; PETERSON JA, 1976, J BIOL CHEM, V251, P4010; Popik W, 2004, J BIOL CHEM, V279, P704, DOI 10.1074/jbc.M306380200; Reed James R, 2011, Drug Metab Lett, V5, P6; REMMER H, 1966, MOL PHARMACOL, V2, P187; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; SAKAGUCHI M, 1987, EMBO J, V6, P2425, DOI 10.1002/j.1460-2075.1987.tb02521.x; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; SEQUEIRA DJ, 1994, BBA-PROTEIN STRUCT M, V1207, P179, DOI 10.1016/0167-4838(94)00070-0; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Sirim D, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-34; Wang YQ, 2009, J BIOL CHEM, V284, P5671, DOI 10.1074/jbc.M806104200; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Yamabhai M, 2002, J BIOL CHEM, V277, P24843, DOI 10.1074/jbc.C200277200	44	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29449	U399		10.1074/jbc.M115.687103	http://dx.doi.org/10.1074/jbc.M115.687103			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468279	Green Published, hybrid			2022-12-26	WOS:000366613400029
J	Peche, LY; Ladelfa, MF; Toledo, MF; Mano, M; Laiseca, JE; Schneider, C; Monte, M				Peche, Leticia Y.; Ladelfa, Maria F.; Toledo, Maria F.; Mano, Miguel; Laiseca, Julieta E.; Schneider, Claudio; Monte, Martin			Human MageB2 Protein Expression Enhances E2F Transcriptional Activity, Cell Proliferation, and Resistance to Ribotoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; ANDROGEN RECEPTOR; E2F1-INDUCED APOPTOSIS; NEUROTROPHIN RECEPTOR; BINDING-PROTEIN; P53 FUNCTION; MELANOMA; CANCER; ANTIGENS; MAGE-11	MageB2 belongs to the melanoma antigen gene (MAGE-I) family of tumor-specific antigens. Expression of this gene has been detected in human tumors of different origins. However, little is known about the protein function and how its expression affects tumor cell phenotypes. In this work, we found that human MageB2 protein promotes tumor cell proliferation in a p53-independent fashion, as observed both in cultured cells and growing tumors in mice. Gene expression analysis showed that MageB2 enhances the activity of E2F transcription factors. Mechanistically, the activation of E2Fs is related to the ability of MageB2 to interact with the E2F inhibitor HDAC1. Cellular distribution of MageB2 protein includes the nucleoli. Nevertheless, ribotoxic drugs rapidly promote its nucleolar exit. Weshow that MageB2 counteracts E2 Finhibition by ribosomal proteins independently of Mdm2 expression. Importantly, MageB2 plays a critical role in impairing cell cycle arrest in response to Actinomycin D. The data presented here support a relevant function for human MageB2 in cancer cells both under cycling and stressed conditions, presenting a distinct functional feature with respect to other characterized MAGE-I proteins.	Lab Nazl Consorzio Interuniv Biotecnol, I-34149 Trieste, Italy; [Ladelfa, Maria F.; Toledo, Maria F.; Laiseca, Julieta E.; Monte, Martin] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Invest Cient & Tecn, Dept Quim Biol, RA-1428 Buenos Aires, DF, Argentina; [Ladelfa, Maria F.; Toledo, Maria F.; Laiseca, Julieta E.; Monte, Martin] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Invest Cient & Tecn, Inst Quim Biol Ciencias Exactas & Nat, RA-1428 Buenos Aires, DF, Argentina; [Mano, Miguel] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy; [Schneider, Claudio] Univ Udine, Dipartimento Sci & Tecnol Biomed, I-33100 Udine, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; International Center for Genetic Engineering & Biotechnology (ICGEB); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine	Schneider, C (corresponding author), Lab Nazl Consorzio Interuniv Biotecnol, Area Sci Pk,Padriciano 99, I-34149 Trieste, Italy.	claudio.schneider@lncib.it; mmonte@qb.fcen.uba.ar	Mano, Miguel/A-4462-2013	Mano, Miguel/0000-0003-1922-4824; Monte, Martin/0000-0002-5068-563X; Peche, Leticia Yamila/0000-0002-1666-9433	Ministry of Science and Technology-ANPCyT [PICT12/866]; University of Buenos Aires [UBACyT13/0013BA]; CONICET [PIP13/0411]; FIRB "Oncodiet" Grant [RBAP11LP2W_002]; Associazione Italiana per la Ricerca sul Cancro [AIRC/IG10433]; Instituto Nacional del Cancer fellowship; Consejo de Investigaciones Cientificas y Tecnicas fellowship	Ministry of Science and Technology-ANPCyT; University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FIRB "Oncodiet" Grant; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Instituto Nacional del Cancer fellowship; Consejo de Investigaciones Cientificas y Tecnicas fellowship	This work was supported by Ministry of Science and Technology-ANPCyT Grant PICT12/866, University of Buenos Aires Grant UBACyT13/0013BA, and CONICET Grant PIP13/0411 (to M. Monte) and FIRB "Oncodiet" Grant RBAP11LP2W_002 and Associazione Italiana per la Ricerca sul Cancro Grant AIRC/IG10433 (to C. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an Instituto Nacional del Cancer fellowship.; Recipient of a Consejo de Investigaciones Cientificas y Tecnicas fellowship.	Andorfer P, 2011, ONCOGENE, V30, P2679, DOI 10.1038/onc.2010.639; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Bai S, 2008, MOL HUM REPROD, V14, P107, DOI 10.1093/molehr/gam080; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Berkovich E, 2001, J BIOL CHEM, V276, P42851, DOI 10.1074/jbc.M103596200; Cheng S, 2009, ENDOCR-RELAT CANCER, V16, P455, DOI 10.1677/ERC-09-0002; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Demetrius L, 2005, EMBO REP, V6, pS39, DOI 10.1038/sj.embor.7400422; Donati G, 2011, J CELL SCI, V124, P3017, DOI 10.1242/jcs.086074; Engelmann D, 2010, DRUG RESIST UPDATE, V13, P119, DOI 10.1016/j.drup.2010.06.001; Ladelfa MF, 2012, CANCER LETT, V325, P11, DOI 10.1016/j.canlet.2012.05.031; Fedele M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-17; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Grandinetti KB, 2008, CELL CYCLE, V7, P1550, DOI 10.4161/cc.7.11.6052; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Hallstrom TC, 2006, GENE DEV, V20, P613, DOI 10.1101/gad.1345006; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Hans CP, 2003, BLOOD, V101, P2363, DOI 10.1182/blood-2002-07-2298; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Imai T, 2004, HUM PATHOL, V35, P1469, DOI 10.1016/j.humpath.2004.09.014; Jang SJ, 2001, CANCER RES, V61, P7959; Kramer BF, 2005, CANCER BIOL THER, V4, P943; Kuwako K, 2004, J BIOL CHEM, V279, P1703, DOI 10.1074/jbc.M308454200; Laduron S, 2004, NUCLEIC ACIDS RES, V32, P4340, DOI 10.1093/nar/gkh735; Lee TJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000488; Lian YS, 2012, J CANCER RES CLIN, V138, P519, DOI 10.1007/s00432-011-1122-x; Lin YQ, 2012, BIOCHEM J, V443, P779, DOI 10.1042/BJ20112054; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lu HR, 2011, CELL CYCLE, V10, P3317, DOI 10.4161/cc.10.19.17618; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Marcar L, 2010, CANCER RES, V70, P10362, DOI 10.1158/0008-5472.CAN-10-1341; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Muller H, 1997, MOL CELL BIOL, V17, P5508; Novy M, 2005, MOL BIOL CELL, V16, P2181, DOI 10.1091/mbc.E04-11-0975; Ogata K, 2011, ANN SURG ONCOL, V18, P1195, DOI 10.1245/s10434-010-1399-z; Olarte I, 2011, HEMATOLOGY, V16, P368, DOI 10.1179/102453311X13085644680384; Pattani KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045534; Peche LY, 2012, CELL DEATH DIFFER, V19, P926, DOI 10.1038/cdd.2011.173; Sang MX, 2011, VACCINE, V29, P8496, DOI 10.1016/j.vaccine.2011.09.014; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Stanelle J, 2006, TRENDS MOL MED, V12, P177, DOI 10.1016/j.molmed.2006.02.002; Su SF, 2013, J BIOL CHEM, V288, P24809, DOI 10.1074/jbc.M113.468579; Sypniewska RK, 2005, BREAST CANCER RES TR, V91, P19, DOI 10.1007/s10549-004-6454-7; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; van Duin M, 2011, HAEMATOL-HEMATOL J, V96, P1662, DOI 10.3324/haematol.2010.037978; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Wen CJ, 2004, FEBS LETT, V564, P171, DOI 10.1016/S0014-5793(04)00353-9; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yang B, 2007, J INVEST DERMATOL, V127, P267, DOI 10.1038/sj.jid.5700548; Zhang W, 2014, MOL CELL BIOL, V34, P765, DOI 10.1128/MCB.00878-13; Zhang YX, 2003, NUCLEIC ACIDS RES, V31, P2168, DOI 10.1093/nar/gkg318; Zhou FF, 2008, BIOCHEM BIOPH RES CO, V365, P149, DOI 10.1016/j.bbrc.2007.10.138; Zhou X, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.445122	56	17	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29652	29662		10.1074/jbc.M115.671982	http://dx.doi.org/10.1074/jbc.M115.671982			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468294	hybrid, Green Published			2022-12-26	WOS:000366613400045
J	Adamczyk, EM; Shurin, JB				Adamczyk, Emily M.; Shurin, Jonathan B.			Seasonal Changes in Plankton Food Web Structure and Carbon Dioxide Flux from Southern California Reservoirs	PLOS ONE			English	Article							NATURAL PHYTOPLANKTON COMMUNITIES; RAPID PHOTOSYNTHETIC ADAPTATION; ORGANIC-CARBON; TERRESTRIAL CARBON; GREENHOUSE GASES; LAKES; BIOMASS; SUPERSATURATION; THERMODYNAMICS; METABOLISM	Reservoirs around the world contribute to cycling of carbon dioxide (CO2) with the atmosphere, but there is little information on how ecosystem processes determine the absorption or emission of CO2. Reservoirs are the most prevalent freshwater systems in the arid southwest of North America, yet it is unclear whether they sequester or release CO2 and therefore how water impoundment impacts global carbon cycling. We sampled three reservoirs in San Diego, California, weekly for one year. We measured seasonal variation in the abundances of bacteria, phytoplankton, and zooplankton, as well as water chemistry (pH, nutrients, ions, dissolved organic carbon [DOC]), which were used to estimate partial pressure of CO2 (pCO(2)), and CO2 flux. We found that San Diego reservoirs are most often undersaturated with CO2 with respect to the atmosphere and are estimated to absorb on average 3.22 mmol C m(-2) day(-1). pCO(2) was highest in the winter and lower in the summer, indicating seasonal shifts in the magnitudes of photosynthesis and respiration associated with day length, temperature and water inputs. Abundances of microbes (bacteria) peaked in the winter along with pCO(2), while phytoplankton, nutrients, zooplankton and DOC were all unrelated to pCO(2). Our data indicate that reservoirs of semi-arid environments may primarily function as carbon sinks, and that carbon flux varies seasonally but is unrelated to nutrient or DOC availability, or the abundances of phytoplankton or zooplankton.	[Adamczyk, Emily M.; Shurin, Jonathan B.] Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Adamczyk, EM (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA.	emily.m.adamczyk@gmail.com			National Science Foundation Award [1457737]; University of California San Diego start up funds	National Science Foundation Award(National Science Foundation (NSF)); University of California San Diego start up funds	This work was supported by National Science Foundation Award 1457737; University of California San Diego start up funds.	Andersen M., 2009, OVERVIEW US RESERVOI; Atwood TB, 2013, NAT GEOSCI, V6, P191, DOI 10.1038/ngeo1734; Barros N, 2011, NAT GEOSCI, V4, P593, DOI 10.1038/ngeo1211; Barton K., 2014, MUMIN MULTIMODEL INF; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 2000, LIMNOL OCEANOGR, V45, P1718, DOI 10.4319/lo.2000.45.8.1718; Cottingham KL, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00128.1; Dean WE, 1998, GEOLOGY, V26, P535, DOI 10.1130/0091-7613(1998)026<0535:MASOCB>2.3.CO;2; Del Giorgio PA, 1999, ECOLOGY, V80, P1422, DOI 10.1890/0012-9658(1999)080[1422:LPBAMT]2.0.CO;2; DELGIORGIO PA, 1994, LIMNOL OCEANOGR, V39, P772, DOI 10.4319/lo.1994.39.4.0772; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; DICKSON AG, 1990, DEEP-SEA RES, V37, P755, DOI 10.1016/0198-0149(90)90004-F; DUMONT HJ, 1975, OECOLOGIA, V19, P75, DOI 10.1007/BF00377592; Finlay K, 2015, NATURE, V519, P215, DOI 10.1038/nature14172; Howarth RW, 1996, ESTUARIES, V19, P848, DOI 10.2307/1352302; Jansson M, 2000, ECOLOGY, V81, P3250, DOI 10.1890/0012-9658(2000)081[3250:AOCAPB]2.0.CO;2; Kelly CA, 1997, ENVIRON SCI TECHNOL, V31, P1334, DOI 10.1021/es9604931; Lapierre JF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3972; Larmola T, 2003, FRESHWATER BIOL, V48, P1295, DOI 10.1046/j.1365-2427.2003.01079.x; Lazzarino JK, 2009, HYDROBIOLOGIA, V627, P169, DOI 10.1007/s10750-009-9723-y; Lennon JT, 2004, OECOLOGIA, V138, P584, DOI 10.1007/s00442-003-1459-1; Malley D.F., 1989, RANGE VARIATION ESTI; Marotta H, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003434; McCauley E., 1984, IBP HDB, P228; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; MILLERO FJ, 1979, GEOCHIM COSMOCHIM AC, V43, P1651, DOI 10.1016/0016-7037(79)90184-4; Molot LA, 1996, GLOBAL BIOGEOCHEM CY, V10, P483, DOI 10.1029/96GB01666; Morales-Pineda M, 2014, J GEOPHYS RES-BIOGEO, V119, P509, DOI 10.1002/2013JG002317; Pacheco FS, 2014, INLAND WATERS, V4, P41, DOI 10.5268/IW-4.1.614; Peixoto RB, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00011; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Prairie YT, 2002, LIMNOL OCEANOGR, V47, P316, DOI 10.4319/lo.2002.47.1.0316; R Core Team, 2013, R LANG ENV STAT COMP; Rasband WS, 2014, IMAGEJ; Robbins L, 2010, 20101280 US GEOL SUR, V7, DOI DOI 10.1007/978-3-642-52335-9_1; Roehm CL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003297; ROSEN RA, 1981, J FRESHWATER ECOL, V1, P225, DOI 10.1080/02705060.1981.9664034; Schindler DE, 1997, SCIENCE, V277, P248, DOI 10.1126/science.277.5323.248; Sobek S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002264; Sobek S, 2003, GLOBAL CHANGE BIOL, V9, P630, DOI 10.1046/j.1365-2486.2003.00619.x; Sobek S, 2007, LIMNOL OCEANOGR, V52, P1208, DOI 10.4319/lo.2007.52.3.1208; Soumis N, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002197; St Louis VL, 2000, BIOSCIENCE, V50, P766, DOI 10.1641/0006-3568(2000)050[0766:RSASOG]2.0.CO;2; Therrien J, 2005, ENVIRONM SCI, P233; TRANVIK LJ, 1988, MICROBIAL ECOL, V16, P311, DOI 10.1007/BF02011702; VINCENT WF, 1979, J PHYCOL, V15, P429; VINCENT WF, 1980, J PHYCOL, V16, P568, DOI 10.1111/j.1529-8817.1980.tb03075.x; VYHNALEK V, 1993, WATER SCI TECHNOL, V28, P29, DOI 10.2166/wst.1993.0126; Watkins J. M, 2011, CORNELL BIOL FIELD S	50	7	8	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140464	10.1371/journal.pone.0140464	http://dx.doi.org/10.1371/journal.pone.0140464			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473601	Green Published, gold			2022-12-26	WOS:000363185500056
J	Akilimali, PZ; Kashala-Abotnes, E; Musumari, PM; Kayembe, PK; Tylleskar, T; Mapatano, MA				Akilimali, Pierre Zalagile; Kashala-Abotnes, Esperance; Musumari, Patou Masika; Kayembe, Patrick Kalambayi; Tylleskar, Thorkild; Mapatano, Mala Ali			Predictors of Persistent Anaemia in the First Year of Antiretroviral Therapy: A Retrospective Cohort Study from Goma, the Democratic Republic of Congo	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; SUB-SAHARAN AFRICA; SCALE-UP; PREVALENCE; ZIDOVUDINE; MORTALITY; PROGNOSIS; DISEASE; COMPLEX; RISK	Background Anaemia is associated with adverse outcomes including early death in the first year of anti-retroviral therapy (ART). This study reports on the factors associated with persistent anaemia among HIV-infected patients initiating ART in the Democratic Republic of Congo (DR Congo). Methods We conducted a retrospective cohort study and analyzed data from patients receiving HIV care between January 2004 and December 2012 at two major hospitals in Goma, DR Congo. Haemoglobin concentrations of all patients on ART regimen were obtained prior to and within one year of ART initiation. A logistic regression model was used to identify the predictors of persistent anaemia after 12 months of ART. Results Of 756 patients, 69% of patients were anaemic (IC95%: 65.7-72.3) at baseline. After 12 months of follow up, there was a 1.2 g/dl average increase of haemoglobin concentration (P < 0.001) with differences depending on the therapeutic regimen. Patients who received zidovudine (AZT) gained less than those who did not receive AZT (0.99 g/dl vs 1.33 g/dl; p < 0.001). Among 445 patient who had anaemia at the beginning, 33% (147/445) had the condition resolved. Among patients with anaemia at ART initiation, those who did not receive cotrimoxazole prophylaxis before starting ART(AOR 3.89; 95% CI 2.09-7.25; P < 0.001) and a AZT initial regimen (AOR 2.19; 95% CI 1.36-3.52; P < 0.001) were significantly at risk of persistent anaemia. Conclusions More than two thirds of patients had anaemia at baseline. The AZT-containing regimen and absence of cotrimoxazole prophylaxis before starting ART were associated with persistent anaemia 12 months, after initiation of treatment. Considering the large proportion of patients with persistence of anaemia at 12 months, we suggest that it is necessary to conduct a large study to assess anaemia among HIV-infected patients in Goma.	[Akilimali, Pierre Zalagile; Kayembe, Patrick Kalambayi; Mapatano, Mala Ali] Univ Kinshasa, Kinshasa Univ Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Kashala-Abotnes, Esperance; Tylleskar, Thorkild] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Musumari, Patou Masika] Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan	Universite de Kinshasa; University of Bergen; Kyoto University	Akilimali, PZ (corresponding author), Univ Kinshasa, Kinshasa Univ Sch Publ Hlth, Kinshasa, DEM REP CONGO.	pierretulanefp@gmail.com	Akilimali, Pierre Z/D-2564-2018; Tylleskär, Thorkild/S-5529-2017	Akilimali, Pierre Z/0000-0002-3828-6214; Tylleskär, Thorkild/0000-0003-4801-4324				Adane Asfaw, 2012, Ethiop Med J, V50, P13; Akilimali PZ, 2014, REV EPIDEMIOL SANTE, V62, P201, DOI 10.1016/j.respe.2014.03.004; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; DOUKAS MA, 1992, MED CLIN N AM, V76, P699, DOI 10.1016/S0025-7125(16)30348-0; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Forna Fatu, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P128, DOI 10.1177/1545109709333081; FRASER I, 1994, CLIN INFECT DIS, V19, P211, DOI 10.1093/clinids/19.1.211; GELMON K, 1989, AIDS, V3, P555, DOI 10.1097/00002030-198909000-00001; GROOPMAN JE, 1990, REV INFECT DIS, V12, P931; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Johannessen A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-190; KEISU M, 1990, J INTERN MED, V228, P353, DOI 10.1111/j.1365-2796.1990.tb00245.x; Kerkhoff AD, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0702-1; Kiragga AN, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-42; Laurent C, 2008, AIDS RES HUM RETROV, V24, P393, DOI 10.1089/aid.2007.0219; Levine AM, 2001, J ACQ IMMUN DEF SYND, V26, P28, DOI 10.1097/00126334-200101010-00004; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Ministere du Plan, 2014, ENQ DEM SANT 2013 20; MIR N, 1989, EUR J HAEMATOL, V42, P339; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Moore RD, 2002, J ACQ IMMUN DEF SYND, V29, P54, DOI 10.1097/00042560-200201010-00007; Mugisha JO, 2008, TROP MED INT HEALTH, V13, P788, DOI 10.1111/j.1365-3156.2008.02069.x; Obirikorang C, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-102; [Republique Democratique du Congo Ministere de la Sante], 2005, PROGR NAT LUTT VIH G; RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402; Russell EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-433; Semba RD, 2001, AIDS PATIENT CARE ST, V15, P473, DOI 10.1089/108729101753145466; Semba RD, 2002, CLIN INFECT DIS, V34, P260, DOI 10.1086/338151; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Subbaraman R, 2007, CLIN INFECT DIS, V45, P1093, DOI 10.1086/521150; Sullivan PS, 1998, BLOOD, V91, P301, DOI 10.1182/blood.V91.1.301.301_301_308; WHO, 2010, ANT THER HIV INF AD; Wills Todd S, 2004, AIDS Read, V14, P305; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2006, ANT THER HIV INF AD; Zhou JL, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-5	36	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140240	10.1371/journal.pone.0140240	http://dx.doi.org/10.1371/journal.pone.0140240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474481	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500033
J	Beseli, A; Noar, R; Daub, ME				Beseli, Aydin; Noar, Roslyn; Daub, Margaret E.			Characterization of Cercospora nicotianae Hypothetical Proteins in Cercosporin Resistance	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; POLYMERASE CHAIN-REACTION; GENE-EXPRESSION; TOXIN; TRANSPORTER; ACCUMULATION; MUTANTS; TOBACCO; MATRIX; CFP	The photoactivated toxin, cercosporin, produced by Cercospora species, plays an important role in pathogenesis of this fungus to host plants. Cercosporin has almost universal toxicity to cells due to its production of reactive oxygen species including singlet oxygen. For that reason, Cercospora species, which are highly resistant to their own toxin, are good candidates to identify genes for resistance to cercosporin and to the reactive oxygen species it produces. In previous research, the zinc cluster transcription factor CRG1 (cercosporin resistance gene 1) was found to be crucial for Cercospora species' resistance against cercosporin, and subtractive hybridization analysis identified 185 genes differentially expressed between Cercospora nicotianae wild type (wt) and a crg1 mutant. The focus of this work was to identify and characterize the hypothetical proteins that were identified in the Cercospora nicotianae subtractive library as potential resistance factors. Quantitative RT-PCR analysis of the 20 genes encoding hypothetical proteins showed that two, 24cF and 71cR, were induced under conditions of cercosporin toxicity, suggesting a role in resistance. Transformation and expression of 24cF and 71cR in the cercosporin-sensitive fungus, Neurospora crassa, showed that 71cR provided increased resistance to cercosporin toxicity, whereas no significant increase was observed in 24cF transformants. Gene disruption was used to generate C. nicotianae 71cR mutants; these mutants did not differ from wt C. nicotianae in cercosporin resistance or production. Quantitative RT-PCR analysis showed induction of other resistance genes in the 71cR mutant that may compensate for the loss of 71cR. Analysis of 71cR conserved domains and secondary and tertiary structure identify the protein as having an NTF2-like superfamily DUF1348 domain with unknown function, to be intracellular and localized in the cytosol, and to have similarities to proteins in the steroid delta-isomerase family.	[Beseli, Aydin; Noar, Roslyn; Daub, Margaret E.] N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Daub, ME (corresponding author), N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA.	margaret_daub@ncsu.edu		Noar, Roslyn/0000-0003-1645-7147	US-Egypt Science and Technology through the USDA [58-3148-1-161]	US-Egypt Science and Technology through the USDA	Funding was provided by US-Egypt Science and Technology Joint Fund through the USDA cooperative agreement# 58-3148-1-161, http://sites.nationalacademies.org/pga/dsc/egypt/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amnuaykanjanasin A, 2009, FUNGAL GENET BIOL, V46, P146, DOI 10.1016/j.fgb.2008.11.007; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beseli A, 2015, CURR GENET, V61, P601, DOI 10.1007/s00294-015-0486-x; Beseli A, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu036; Bilski P, 2000, PHOTOCHEM PHOTOBIOL, V71, P129, DOI 10.1562/0031-8655(2000)071&lt;0129:SIPVBP&gt;2.0.CO;2; Callahan TM, 1999, MOL PLANT MICROBE IN, V12, P901, DOI 10.1094/MPMI.1999.12.10.901; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chakravorty DK, 2010, J AM CHEM SOC, V132, P7549, DOI 10.1021/ja102714u; Chen HQ, 2007, MICROBIOL-SGM, V153, P2781, DOI 10.1099/mic.0.2007/007294-0; Chen HQ, 2007, MOL MICROBIOL, V64, P755, DOI 10.1111/j.1365-2958.2007.05689.x; Choquer M, 2007, FEBS LETT, V581, P489, DOI 10.1016/j.febslet.2007.01.011; Chung KR, 2003, BIOCHEM BIOPH RES CO, V302, P302, DOI 10.1016/S0006-291X(03)00171-2; Daub ME, 2013, ANTIOXID REDOX SIGN, V19, P970, DOI 10.1089/ars.2012.5080; Daub ME, 2000, ANNU REV PHYTOPATHOL, V38, P461, DOI 10.1146/annurev.phyto.38.1.461; DAUB ME, 1992, P NATL ACAD SCI USA, V89, P9588, DOI 10.1073/pnas.89.20.9588; Daub ME, 2010, CERCOSPORA LEAF SPOT, P157; Deininger P, 1990, ANAL BIOCHEM, V186, P182, DOI DOI 10.1016/0003-2697(90)90595-Z; Eberhardt RY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-327; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrenshaft M, 1999, P NATL ACAD SCI USA, V96, P9374, DOI 10.1073/pnas.96.16.9374; Goessweiner-Mohr N, 2013, J BIOL CHEM, V288, P2018, DOI 10.1074/jbc.M112.428847; Griffith Leslie C, 2003, Mol Interv, V3, P386, DOI 10.1124/mi.3.7.386; Grigoriev I. V., 2011, Mycology - An International Journal on Fungal Biology, V2, P192; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Herrero S, 2007, FEMS MICROBIOL LETT, V275, P326, DOI 10.1111/j.1574-6968.2007.00903.x; Herrero S, 2007, PLANT SCI, V172, P609, DOI 10.1016/j.plantsci.2006.11.011; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horinouchi M, 2010, J STEROID BIOCHEM, V122, P253, DOI 10.1016/j.jsbmb.2010.06.002; JENNS AE, 1989, PHYTOPATHOLOGY, V79, P213, DOI 10.1094/Phyto-79-213; JENNS AE, 1995, PHOTOCHEM PHOTOBIOL, V61, P488, DOI 10.1111/j.1751-1097.1995.tb02350.x; JENNS AE, 1995, PHYTOPATHOLOGY, V85, P906, DOI 10.1094/Phyto-85-906; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddison, 2018, MESQUITE MODULAR SYS; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V41, pD384; Michalak I, 2012, ORG DIVERS EVOL, V12, P333; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Smith KM, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-5; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Talalay P, 1972, ENZYMES, V6, P591; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Upchurch RG, 2005, BIOTECHNOL LETT, V27, P1543, DOI 10.1007/s10529-005-1780-3; Vogel H.J., 1956, MICROB GENET B, V13, P42; WANG H, 1993, NUCLEIC ACIDS RES, V21, P4153, DOI 10.1093/nar/21.17.4153; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Yachdav G, 2014, NUCLEIC ACIDS RES, DOI [10.1093/nar/gku36638, DOI 10.1093/NAR/GKU36638]; You BJ, 2009, ARCH MICROBIOL, V191, P615, DOI 10.1007/s00203-009-0489-4; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18	52	7	7	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140676	10.1371/journal.pone.0140676	http://dx.doi.org/10.1371/journal.pone.0140676			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474162	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500080
J	Deem, SL; Fevre, EM; Kinnaird, M; Browne, AS; Muloi, D; Godeke, GJ; Koopmans, M; Reusken, CB				Deem, Sharon L.; Fevre, Eric M.; Kinnaird, Margaret; Browne, A. Springer; Muloi, Dishon; Godeke, Gert-Jan; Koopmans, Marion; Reusken, Chantal B.			Serological Evidence of MERS-CoV Antibodies in Dromedary Camels (Camelus dromedaries) in Laikipia County, Kenya	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; LAND-USE; LANDSCAPE	Middle East respiratory syndrome coronavirus (MERS-CoV) is a recently identified virus causing severe viral respiratory illness in people. Little is known about the reservoir in the Horn of Africa. In Kenya, where no human MERS cases have been reported, our survey of 335 dromedary camels, representing nine herds in Laikipia County, showed a high sero-prevalence (46.9%) to MERS-CoV antibodies. Between herd differences were present (14.3%-82.9%), but was not related to management type or herd isolation. Further research should focus on identifying similarity between MERS-CoV viral isolates in Kenya and clinical isolates from the Middle East and elsewhere.	[Deem, Sharon L.] St Louis Zoo Inst Conservat Med, St Louis, MO 63110 USA; [Fevre, Eric M.] Univ Liverpool, Inst Infect & Global Hlth, Neston, England; [Fevre, Eric M.; Muloi, Dishon] Int Livestock Res Inst, Nairobi, Kenya; [Kinnaird, Margaret] Mpala Res Ctr, Nanyuki, Kenya; [Kinnaird, Margaret] Global Conservat Programs, Wildlife Conservat Soc, Bronx, NY USA; [Browne, A. Springer] Massey Univ, Hopkirk Res Inst, Mol Epidemiol & Publ Hlth Lab, Palmerston North, New Zealand; [Godeke, Gert-Jan; Koopmans, Marion; Reusken, Chantal B.] Natl Inst Publ Hlth & Environm, Netherlands Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Koopmans, Marion] Erasmus MC, Dept Virosci, Rotterdam, Netherlands	University of Liverpool; CGIAR; International Livestock Research Institute (ILRI); Wildlife Conservation Society; Massey University; Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC	Deem, SL (corresponding author), St Louis Zoo Inst Conservat Med, St Louis, MO 63110 USA.	deem@stlzoo.org	Muloi, Dishon/HII-7928-2022; Reusken, Chantal/ABD-5168-2021; Koopmans, Marion/Y-9170-2019; Muloi, Dishon/AAA-5534-2020	Reusken, Chantal/0000-0003-4605-9174; Koopmans, Marion/0000-0002-5204-2312; Muloi, Dishon/0000-0002-6236-2280; Fevre, Eric/0000-0001-8931-4986	Saint Louis Zoo Field Research for Conservation Grant [FRC 13-09]; Wellcome Trust [085308]; CGIAR Research Program for Agriculture for Nutrition and Health; BBSRC [BB/L019019/1] Funding Source: UKRI; MRC [G1100783] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L019019/1] Funding Source: researchfish; Medical Research Council [G1100783] Funding Source: researchfish	Saint Louis Zoo Field Research for Conservation Grant; Wellcome Trust(Wellcome TrustEuropean Commission); CGIAR Research Program for Agriculture for Nutrition and Health(CGIAR); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Saint Louis Zoo Field Research for Conservation Grant (FRC 13-09), the Wellcome Trust (to EMF; 085308), and the CGIAR Research Program for Agriculture for Nutrition and Health. The authors thank the the Mpala Research Centre and Wildlife Foundation for logistical support. The authors thank Tim O'Brien for statistical advice, Berend-Jan Bosch for provision of CoV S1 antigen, and Christine Annie Wang and Peter Larson for field assistance.	Adney DR, 2014, EMERG INFECT DIS, V20, P1999, DOI 10.3201/eid2012.141280; [Anonymous], 2015, SEV RESP DIS ASS MER; Corman VM, 2014, EMERG INFECT DIS, V20, P1319, DOI 10.3201/eid2008.140596; DePuy W, 2014, ECOHEALTH, V11, P429, DOI 10.1007/s10393-014-0924-0; Georgiadis NJ, 2007, BIOL CONSERV, V137, P461, DOI 10.1016/j.biocon.2007.03.005; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Hemida MG, 2014, EMERG INFECT DIS, V20, P1231, DOI 10.3201/eid2007.140571; Huho JM, 2009, ACTA GEOL SIN-ENGL, V83, P1017, DOI 10.1111/j.1755-6724.2009.00126.x; Kinnaird M., 2012, SAMPLE COUNT AERIAL; Kinnaird MF, 2012, CONSERV BIOL, V26, P1026, DOI 10.1111/j.1523-1739.2012.01942.x; Memish ZA, 2014, EMERG INFECT DIS, V20, P1012, DOI 10.3201/eid2006.140402; Meyer B, 2014, EMERG INFECT DIS, V20, P552, DOI 10.3201/eid2004.131746; Muller MA, 2014, EMERG INFECT DIS, V20, P2093, DOI 10.3201/eid2012.141026; Musinga M., 2008, CAMEL MILK IND KENYA; Reusken CB, 2013, MIDDL E RESP SYNDR C; Reusken CBEM, 2014, EMERG INFECT DIS, V20, P1370, DOI 10.3201/eid2008.140590; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; World Health Organization, 2015, MIDDL E RESP SYNDR C	18	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140125	10.1371/journal.pone.0140125	http://dx.doi.org/10.1371/journal.pone.0140125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473733	Green Submitted, gold, Green Published			2022-12-26	WOS:000363185500027
J	Floris, I; Billard, H; Boquien, CY; Joram-Gauvard, E; Simon, L; Legrand, A; Boscher, C; Roze, JC; Bolanos-Jimenez, F; Kaeffer, B				Floris, Ilaria; Billard, Helene; Boquien, Clair-Yves; Joram-Gauvard, Evelyne; Simon, Laure; Legrand, Arnaud; Boscher, Cecile; Roze, Jean-Christophe; Bolanos-Jimenez, Francisco; Kaeffer, Bertrand			MiRNA Analysis by Quantitative PCR in Preterm Human Breast Milk Reveals Daily Fluctuations of hsa-miR-16-5p	PLOS ONE			English	Article							HOUSEKEEPING GENES; CIRCADIAN-RHYTHM; FAT GLOBULES; EXPRESSION; MICRORNA; RNA; PROLIFERATION; VALIDATION; LACTATION; MOTHERS	Background and Aims Human breast milk is an extremely dynamic fluid containing many biologically-active components which change throughout the feeding period and throughout the day. We designed a miRNA assay on minimized amounts of raw milk obtained from mothers of preterm infants. We investigated changes in miRNA expression within month 2 of lactation and then over the course of 24 hours. Materials and Methods Analyses were performed on pooled breast milk, made by combining samples collected at different clock times from the same mother donor, along with time series collected over 24 hours from four unsynchronized mothers. Whole milk, lipids or skim milk fractions were processed and analyzed by qPCR. We measured hsa-miR-16-5p, hsa-miR-21-5p, hsa-miR-146-5p, and hsa-let-7a, d and g (all -5p). Stability of miRNA endogenous controls was evaluated using RefFinder, a web tool integrating geNorm, Normfinder, BestKeeper and the comparative Delta Delta Ct method. Results MiR-21 and miR-16 were stably expressed in whole milk collected within month 2 of lactation from four mothers. Analysis of lipids and skim milk revealed that miR-146b and let-7d were better references in both fractions. Time series (5H-23H) allowed the identification of a set of three endogenous reference genes (hsa-let-7d, hsa-let-7g and miR-146b) to normalize raw quantification cycle (Cq) data. We identified a daily oscillation of miR-16-5p. Perspectives Our assay allows exploring miRNA levels of breast milk from mother with preterm baby collected in time series over 48-72 hours.	[Floris, Ilaria; Billard, Helene; Boquien, Clair-Yves; Roze, Jean-Christophe; Bolanos-Jimenez, Francisco; Kaeffer, Bertrand] Univ Nantes, INRA, UMR 1280, Physiol Adaptat Nutr, Nantes, France; [Joram-Gauvard, Evelyne; Simon, Laure; Legrand, Arnaud; Boscher, Cecile; Roze, Jean-Christophe] Univ Nantes, Hosp Mother & Child, Nantes, France	INRAE; Nantes Universite; Nantes Universite; CHU de Nantes	Floris, I (corresponding author), Univ Nantes, INRA, UMR 1280, Physiol Adaptat Nutr, Nantes, France.	ilaria.floris84@gmail.com; Bertrand.Kaeffer@univ-nantes.fr	Boquien, Clair-Yves/AAP-5275-2020; Rozé, Jean-Christophe/AAS-1314-2021	Boquien, Clair-Yves/0000-0001-6944-5372; Floris, Ilaria/0000-0003-4089-3133; BILLARD, HELENE/0000-0002-1183-2959; Kaeffer, Bertrand/0000-0003-2459-5072; Roze, Jean-Christophe/0000-0003-3367-512X	Region Pays de la Loire; program Fonds Europeen de Developpement Economique et Regional (FEDER) Pays-de-la-Loire Fonds Europeen de Developpement Economique et Regional (FEDER, Project "Lactacol") [38395]; French Society of Nutrition	Region Pays de la Loire(Region Pays de la Loire); program Fonds Europeen de Developpement Economique et Regional (FEDER) Pays-de-la-Loire Fonds Europeen de Developpement Economique et Regional (FEDER, Project "Lactacol"); French Society of Nutrition	Postdoctoral grant by "Region Pays de la Loire", grant by the program Fonds Europeen de Developpement Economique et Regional (FEDER) Pays-de-la-Loire Fonds Europeen de Developpement Economique et Regional (FEDER, Project "Lactacol", grant #38395) and travel grant from the French Society of Nutrition for IF supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaweed M, 2015, J CELL BIOCHEM, V116, P2397, DOI 10.1002/jcb.25207; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Balakrishnan A, 2010, EXP CELL RES, V316, P3512, DOI 10.1016/j.yexcr.2010.07.007; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauer J, 2011, CLIN NUTR, V30, P215, DOI 10.1016/j.clnu.2010.08.003; Brenaut P, 2012, J DAIRY SCI, V95, P6130, DOI 10.3168/jds.2012-5604; BUCHI KN, 1991, GASTROENTEROLOGY, V101, P410, DOI 10.1016/0016-5085(91)90019-H; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074002; Cubero J, 2005, NEUROENDOCRINOL LETT, V26, P657; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Fu HJ, 2006, MOL BIOTECHNOL, V32, P197, DOI 10.1385/MB:32:3:197; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; Granot E, 2015, J MATERN-FETAL NEO M, P1; Guo Y, 2013, BIOTECHNIQUES, V55, P207, DOI 10.2144/000114090; Hassiotou F, 2013, J HUM LACT, V29, P171, DOI 10.1177/0890334413477242; ILLNEROVA H, 1993, J CLIN ENDOCR METAB, V77, P838, DOI 10.1210/jc.77.3.838; Izumi H, 2012, J DAIRY SCI, V95, P4831, DOI 10.3168/jds.2012-5489; Kaeffer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025562; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Laurent LC, 2008, J CELL MOL MED, V12, P2181, DOI 10.1111/j.1582-4934.2008.00513.x; Lopez C, 2011, CURR OPIN COLLOID IN, V16, P391, DOI 10.1016/j.cocis.2011.05.007; Maningat PD, 2009, PHYSIOL GENOMICS, V37, P12, DOI 10.1152/physiolgenomics.90341.2008; MARRA G, 1994, GASTROENTEROLOGY, V106, P982, DOI 10.1016/0016-5085(94)90757-9; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Munch EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050564; Na YJ, 2009, EXP MOL MED, V41, P638, DOI 10.3858/emm.2009.41.9.070; Nevinsky GA, 2000, APPL BIOCHEM BIOTECH, V83, P115, DOI 10.1385/ABAB:83:1-3:115; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Power ML, 2013, APPL TRANSL GENOM, V2, P55, DOI 10.1016/j.atg.2013.06.001; RAMASWAMY H, 1993, J BIOL CHEM, V268, P4181; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ribeiro DCO, 1998, J ENDOCRINOL, V158, P305, DOI 10.1677/joe.0.1580305; Saarela T, 2005, ACTA PAEDIATR, V94, P1176, DOI 10.1080/08035250510036499; Sanchez CL, 2009, NUTR NEUROSCI, V12, P2, DOI 10.1179/147683009X388922; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Spevacek AR, 2015, J NUTR; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wagner CL, 2002, J PEDIATR GASTR NUTR, V34, P513, DOI 10.1097/00005176-200205000-00007; Weber A, 2001, ACTA PAEDIATR, V90, P772, DOI 10.1080/080352501750315681; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118; Zonneveld MI, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24215	48	22	26	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140488	10.1371/journal.pone.0140488	http://dx.doi.org/10.1371/journal.pone.0140488			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474056	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500059
J	Horr, NK; Di Luca, M				Horr, Ninja K.; Di Luca, Massimiliano			Timing Rhythms: Perceived Duration Increases with a Predictable Temporal Structure of Short Interval Fillers	PLOS ONE			English	Article							NEURONAL OSCILLATIONS; TIME PERCEPTION; MECHANISMS; BRAIN	Variations in the temporal structure of an interval can lead to remarkable differences in perceived duration. For example, it has previously been shown that isochronous intervals, that is, intervals filled with temporally regular stimuli, are perceived to last longer than intervals left empty or filled with randomly timed stimuli. Characterizing the extent of such distortions is crucial to understanding how duration perception works. One account to explain effects of temporal structure is a non-linear accumulator-counter mechanism reset at the beginning of every subinterval. An alternative explanation based on entrainment to regular stimulation posits that the neural response to each filler stimulus in an isochronous sequence is amplified and a higher neural response may lead to an overestimation of duration. If entrainment is the key that generates response amplification and the distortions in perceived duration, then any form of predictability in the temporal structure of interval fillers should lead to the perception of an interval that lasts longer than a randomly filled one. The present experiments confirm that intervals filled with fully predictable rhythmically grouped stimuli lead to longer perceived duration than anisochronous intervals. No general over- or underestimation is registered for rhythmically grouped compared to isochronous intervals. However, we find that the number of stimuli in each group composing the rhythm also influences perceived duration. Implications of these findings for a non-linear clock model as well as a neural response magnitude account of perceived duration are discussed.	[Horr, Ninja K.; Di Luca, Massimiliano] Univ Birmingham, Dept Psychol, Ctr Computat Neurosci & Cognit Robot, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Di Luca, M (corresponding author), Univ Birmingham, Dept Psychol, Ctr Computat Neurosci & Cognit Robot, Birmingham B15 2TT, W Midlands, England.	m.diluca@bham.ac.uk	Di Luca, Massimiliano/A-7850-2012	Di Luca, Massimiliano/0000-0003-3085-7251	Marie Curie Grant "TICS" [CIG 304235]	Marie Curie Grant "TICS"	This research was funded by the Marie Curie Grant CIG 304235 "TICS". MD received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RD, 1977, PERCEPT PSYCHOPHYS, V21, P527, DOI 10.3758/BF03198733; BUFFARDI L, 1971, PERCEPT PSYCHOPHYS, V10, P292, DOI 10.3758/BF03212828; Ding J, 2006, CEREB CORTEX, V16, P1016, DOI 10.1093/cercor/bhj044; Eagleman DM, 2009, PHILOS T R SOC B, V364, P1841, DOI 10.1098/rstb.2009.0026; Horr NK, 2015, ATTEN PERCEPT PSYCHO, V77, P592, DOI 10.3758/s13414-014-0787-z; Horr NK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00114; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; Kononowicz TW, 2014, J NEUROSCI, V34, P2931, DOI 10.1523/JNEUROSCI.2523-13.2014; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Mathews WJ, 2014, TIMING TIME PERCEPT, V1, P5; Matthews WJ, 2013, COGNITIVE PSYCHOL, V66, P259, DOI 10.1016/j.cogpsych.2013.01.001; Mayo JP, 2013, P NATL ACAD SCI USA, V110, P1506, DOI 10.1073/pnas.1217177110; MERZENICH MM, 1993, ANN NY ACAD SCI, V682, P1; Miller J, 2001, PERCEPT PSYCHOPHYS, V63, P1399, DOI 10.3758/BF03194551; Narkiewicz M, 2015, J EXP PSYCHOL HUMAN, V41, P249, DOI 10.1037/a0038284; Noguchi Y, 2006, CEREB CORTEX, V16, P1797, DOI 10.1093/cercor/bhj117; Sadeghi NG, 2011, J COGNITIVE NEUROSCI, V23, P3829, DOI 10.1162/jocn_a_00071; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SCHIFFMAN HR, 1977, AM J PSYCHOL, V90, P85, DOI 10.2307/1421643; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; THOMAS EAC, 1974, PERCEPT PSYCHOPHYS, V16, P449, DOI 10.3758/BF03198571; Wearden JH, 2007, J EXP PSYCHOL HUMAN, V33, P716, DOI 10.1037/0096-1523.33.3.716; Zanto T. P., 2006, ADV COGN PSYCHOL, V2, P221, DOI [10.2478/v10053-008-0057-5, DOI 10.2478/V10053-008-0057-5]	24	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0141018	10.1371/journal.pone.0141018	http://dx.doi.org/10.1371/journal.pone.0141018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0DF	26474047	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500139
J	Rajapakse, CSK; Lisai, M; Deregnaucourt, C; Sinou, V; Latour, C; Roy, D; Schrevel, J; Sanchez-Delgado, RA				Rajapakse, Chandima S. K.; Lisai, Maryna; Deregnaucourt, Christiane; Sinou, Veronique; Latour, Christine; Roy, Dipankar; Schrevel, Joseph; Sanchez-Delgado, Roberto A.			Synthesis of New 4-Aminoquinolines and Evaluation of Their In Vitro Activity against Chloroquine-Sensitive and Chloroquine-Resistant Plasmodium falciparum	PLOS ONE			English	Article							ANTIMALARIAL ACTIVITY; BETA-HEMATIN; AMODIAQUINE; MALARIA; METABOLISM; COMPLEXES; ISOQUINE; ANALOGS; AGENTS; DENSITY	The efficacy of chloroquine, once the drug of choice in the fight against Plasmodium falciparum, is now severely limited due to widespread resistance. Amodiaquine is one of the most potent antimalarial 4-aminoquinolines known and remains effective against chloroquine-resistant parasites, but toxicity issues linked to a quinone-imine metabolite limit its clinical use. In search of new compounds able to retain the antimalarial activity of amodiaquine while circumventing quinone-imine metabolite toxicity, we have synthesized five 4-aminoquinolines that feature rings lacking hydroxyl groups in the side chain of the molecules and are thus incapable of generating toxic quinone-imines. The new compounds displayed high in vitro potency (low nanomolar IC50), markedly superior to chloroquine and comparable to amodiaquine, against chloroquine-sensitive and chloroquine-resistant strains of P. falciparum, accompanied by low toxicity to L6 rat fibroblasts and MRC5 human lung cells, and metabolic stability comparable or higher than that of amodiaquine. Computational studies indicate a unique mode of binding of compound 4 to heme through the HOMO located on a biphenyl moeity, which may partly explain the high antiplasmodial activity observed for this compound.	[Rajapakse, Chandima S. K.; Lisai, Maryna; Roy, Dipankar; Sanchez-Delgado, Roberto A.] CUNY Brooklyn Coll, Dept Chem, New York, NY 11210 USA; [Rajapakse, Chandima S. K.; Lisai, Maryna; Roy, Dipankar; Sanchez-Delgado, Roberto A.] CUNY, Grad Ctr, PhD Program Chem, New York, NY USA; [Deregnaucourt, Christiane; Schrevel, Joseph] Univ Paris 04, CNRS, UMR 7245,Museum Natl Hist Nat, Unite Mol Commun & Adaptat Microorganismes,MCAM, Paris, France; [Sinou, Veronique; Latour, Christine] Aix Marseille Univ, Fac Pharm, UMR MD3, Parasitol Lab, Marseille, France	City University of New York (CUNY) System; City University of New York (CUNY) System; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Aix-Marseille Universite	Sanchez-Delgado, RA (corresponding author), CUNY Brooklyn Coll, Dept Chem, New York, NY 11210 USA.	Rsdelgado@brooklyn.cuny.edu	Sinou, Véronique/I-5199-2015; ROY, DIPANKAR/K-9354-2014; Schrevel, Joseph/AAG-7085-2020	Sinou, Véronique/0000-0001-9248-3043; ROY, DIPANKAR/0000-0002-4703-0130; 	National Institute of General Medical Sciences of the National Institutes of Health [SC1GM089558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM089558] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grant # SC1GM089558 from the National Institute of General Medical Sciences of the National Institutes of Health funded the work performed at Brooklyn College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basco LK, 2004, AM J TROP MED HYG, V70, P474, DOI 10.4269/ajtmh.2004.70.474; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Blackie MAL, 2010, BIOORG MED CHEM LETT, V20, P1078, DOI 10.1016/j.bmcl.2009.12.030; Briolant S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-44; Aguiar ACC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037259; Casagrande M, 2008, BIOORGAN MED CHEM, V16, P6813, DOI 10.1016/j.bmc.2008.05.068; Casagrande M, 2012, BIOORGAN MED CHEM, V20, P5965, DOI 10.1016/j.bmc.2012.07.040; Casagrande M, 2010, BIOORGAN MED CHEM, V18, P6625, DOI 10.1016/j.bmc.2010.08.001; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; Ducharme J, 1996, CLIN PHARMACOKINET, V31, P257, DOI 10.2165/00003088-199631040-00003; Frisch M. J., 2010, GAUSSIAN 09; Gemma S, 2012, J MED CHEM, V55, P10387, DOI 10.1021/jm300831b; Glans L, 2012, DALTON T, V41, P2764, DOI 10.1039/c2dt12083f; Jensen M, 2009, PARASITOL RES, V105, P609, DOI 10.1007/s00436-009-1524-8; Joshi MC, 2013, EUR J MED CHEM, V69, P338, DOI 10.1016/j.ejmech.2013.08.046; Kumar A, 2010, BIOORG MED CHEM LETT, V20, P7059, DOI 10.1016/j.bmcl.2010.09.107; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li XQ, 2002, J PHARMACOL EXP THER, V300, P399, DOI 10.1124/jpet.300.2.399; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Navarro M, 2004, J MED CHEM, V47, P5204, DOI 10.1021/jm049792o; Navarro M, 2012, ORGANOMETALLICS, V31, P5715, DOI 10.1021/om300296n; O'Neill PM, 2009, J MED CHEM, V52, P1828, DOI 10.1021/jm8012757; O'Neill PM, 2009, J MED CHEM, V52, P1408, DOI 10.1021/jm8012618; O'Neill PM, 2003, J MED CHEM, V46, P4933, DOI 10.1021/jm030796n; Okombo J, 2013, J ANTIMICROB CHEMOTH, V68, P786, DOI 10.1093/jac/dks471; ONeill PM, 1997, J MED CHEM, V40, P437, DOI 10.1021/jm960370r; ONEILL PM, 1994, J MED CHEM, V37, P1362, DOI 10.1021/jm00035a017; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Rajapakse CSK, 2009, INORG CHEM, V48, P1122, DOI 10.1021/ic802220w; Raynes KJ, 1999, J MED CHEM, V42, P2747, DOI 10.1021/jm9901374; Rodrigues T, 2013, J MED CHEM, V56, P4811, DOI 10.1021/jm400246e; Shiraki H, 2011, J MED CHEM, V54, P131, DOI 10.1021/jm100911f; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tukulula M, 2013, ACS MED CHEM LETT, V4, P1198, DOI 10.1021/ml400311r; Wenzel NI, 2010, J MED CHEM, V53, P3214, DOI 10.1021/jm9018383; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Zishiri VK, 2011, J MED CHEM, V54, P6956, DOI 10.1021/jm2009698	40	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140878	10.1371/journal.pone.0140878	http://dx.doi.org/10.1371/journal.pone.0140878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473363	Green Published, gold			2022-12-26	WOS:000363185500124
J	Anusha, S; Baburajeev, CP; Mohan, CD; Mathai, J; Rangappa, S; Mohan, S; Chandra; Paricharak, S; Mervin, L; Fuchs, JE; Mahedra, M; Bender, A; Basappa; Rangappa, KS				Anusha, Sebastian; Baburajeev, C. P.; Mohan, Chakrabhavi Dhananjaya; Mathai, Jessin; Rangappa, Shobith; Mohan, Surender; Chandra; Paricharak, Shardul; Mervin, Lewis; Fuchs, Julian E.; Mahedra, M.; Bender, Andreas; Basappa; Rangappa, Kanchugarakoppal S.			A Nano-MgO and Ionic Liquid-Catalyzed 'Green' Synthesis Protocol for the Development of Adamantyl-Imidazolo-Thiadiazoles as Anti-Tuberculosis Agents Targeting Sterol 14 alpha-Demethylase (CYP51)	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; BIOLOGICAL EVALUATION; IN-VITRO; DESIGN; DRUG; INHIBITORS; SCAFFOLDS	In this work, we describe the 'green' synthesis of novel 6-(adamantan-1-yl)-2-substituted-imidazo[ 2,1-b][1,3,4] thiadiazoles (AITs) by ring formation reactions using 1-(adamantan-1-yl)- 2-bromoethanone and 5-alkyl/aryl-2-amino1,3,4-thiadiazoles on a nano material base in ionic liquid media. Given the established activity of imidazothiadiazoles against M. tuberculosis, we next examined the anti-TB activity of AITs against the H(37)Rv strain using Alamar blue assay. Among the tested compounds 6-(adamantan-1-yl)-2-(4-methoxyphenyl) imidazo[2,1-b][1,3,4] thiadiazole (3f) showed potent inhibitory activity towards M. tuberculosis with an MIC value of 8.5 mu M. The inhibitory effect of this molecule against M. tuberculosis was comparable to the standard drugs such as Pyrazinamide, Streptomycin, and Ciprofloxacin drugs. Mechanistically, an in silico analysis predicted sterol 14 alpha-demethylase (CYP51) as the likely target and experimental activity of 3f in this system corroborated the in silico target prediction. In summary, we herein report the synthesis and biological evaluation of novel AITs against M. tuberculosis that likely target CYP51 to induce their antimycobacterial activity.	[Anusha, Sebastian; Baburajeev, C. P.; Basappa] Bangalore Univ, Dept Chem, Biol Chem Lab, Bangalore 560001, Karnataka, India; [Mohan, Chakrabhavi Dhananjaya; Rangappa, Kanchugarakoppal S.] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India; [Mathai, Jessin] Gulf Med Univ, Ctr Adv Biomed Res & Innovat, Ajman, U Arab Emirates; [Rangappa, Shobith] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido 0600808, Japan; [Mohan, Surender] Jawaharlal Nehru Univ, Sch Biotechnol, Lab Mol Biol & Genet Engn, New Delhi 110067, India; [Chandra; Mahedra, M.] Univ Mysore, Dept Studies Phys, Mysore 570006, Karnataka, India; [Paricharak, Shardul; Mervin, Lewis; Fuchs, Julian E.; Bender, Andreas] Univ Cambridge, Dept Chem, Ctr Mol Informat, Cambridge CB2 1EW, England; [Paricharak, Shardul] Leiden Univ, Leiden Acad Ctr Drug Res, Div Med Chem, NL-2300 RA Leiden, Netherlands	Bangalore University; University of Mysore; Hokkaido University; Jawaharlal Nehru University, New Delhi; University of Mysore; University of Cambridge; Leiden University; Leiden University - Excl LUMC	Basappa (corresponding author), Bangalore Univ, Dept Chem, Biol Chem Lab, Cent Coll Campus,Palace Rd, Bangalore 560001, Karnataka, India.	salundibasappa@gmail.com; rangappaks@yahoo.com	Rangappa, Shobith/AAI-2169-2020; Mohan, Chakrabhavi Dhananjaya/AGO-1276-2022; Bender, Andreas/C-6942-2009; CHANDRA, CHANDRA/GQY-7098-2022; Mervin, Lewis/B-3759-2016	Rangappa, Shobith/0000-0002-9800-7192; Bender, Andreas/0000-0002-6683-7546; Mervin, Lewis/0000-0002-7271-0824; Basappa, Basappa/0000-0002-8844-468X; Mohan, Chakrabhavi Dhananjaya/0000-0002-6810-9219; , Chandra/0000-0002-8257-0271	University Grants Commission [41-257-2012-SR]; Vision Group Science and Technology, Department of Science and Technology [SR/FT/LS-142/2012]; Institution of Excellence, University of Mysore; European Research Commission (ERC); Netherlands Organization for Scientific Research (NWO) [NWO-017.009-065]; Prins Bernhard Cultuurfonds; University of Mysore for Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE) Research Associate fellowship; Biotechnology and Biological Sciences Research Council [1372344] Funding Source: researchfish	University Grants Commission(University Grants Commission, India); Vision Group Science and Technology, Department of Science and Technology; Institution of Excellence, University of Mysore; European Research Commission (ERC)(European Research Council (ERC)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Prins Bernhard Cultuurfonds; University of Mysore for Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE) Research Associate fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by University Grants Commission (41-257-2012-SR), Vision Group Science and Technology, Department of Science and Technology (NO. SR/FT/LS-142/2012). KSR thanks Institution of Excellence, University of Mysore for funding. AB thanks Unilever and the European Research Commission (ERC Starting Grant 2013) for funding. SP thanks the Netherlands Organization for Scientific Research (NWO, grant number NWO-017.009-065) and the Prins Bernhard Cultuurfonds for funding. CDM thanks University of Mysore for Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE) Research Associate fellowship.	Addla D, 2014, BIOORG MED CHEM LETT, V24, P1974, DOI 10.1016/j.bmcl.2014.02.061; [Anonymous], 2013, MOL OPERATING ENV MO; Anusha S, 2014, RSC ADV, V4, P52181, DOI 10.1039/c4ra07839j; Arendrup MC, 2012, CLIN MICROBIOL INFEC, V18, pE248, DOI 10.1111/j.1469-0691.2012.03890.x; Balderas-Renteria I, 2012, CURR MED CHEM, V19, P4377, DOI 10.2174/092986712803251593; Basappa, 2003, BIOORGAN MED CHEM, V11, P4539, DOI 10.1016/j.bmc.2003.08.007; Berg J, 2004, PATIENT EDUC COUNS, V52, P31, DOI 10.1016/S0738-3991(02)00268-9; Bharathkumar H, 2015, BIOORG MED CHEM LETT, V25, P1804, DOI 10.1016/j.bmcl.2015.01.030; Bharathkumar H, 2014, RSC ADV, V4, P45143, DOI 10.1039/c4ra08713e; Bocanegra-Garcia V., 2011, ANTITUBERCULAR DRUGS; Chen CK, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000372; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; DeLano W.L., PYMOL MOL GRAPHICS S; du Toit LC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-118; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Hubschle CB, 2011, J APPL CRYSTALLOGR, V44, P1281, DOI 10.1107/S0021889811043202; Jia J, 2005, BRIT J PHARMACOL, V144, P80, DOI 10.1038/sj.bjp.0705984; Kavitha CV, 2006, BIOORGAN MED CHEM, V14, P2290, DOI 10.1016/j.bmc.2005.11.017; Keerthy HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107118; Koser CU, 2015, LANCET, V385, P305, DOI 10.1016/S0140-6736(14)62450-8; Kolavi G, 2006, BIOORGAN MED CHEM, V14, P3069, DOI 10.1016/j.bmc.2005.12.020; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; Makobongo MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068917; Menezes CMS, 2012, CHEM BIOL DRUG DES, V79, P943, DOI 10.1111/j.1747-0285.2012.01354.x; Neelgundmath M, 2015, BIOORG MED CHEM LETT, V25, P893, DOI 10.1016/j.bmcl.2014.12.065; Oruc EE, 2004, J MED CHEM, V47, P6760, DOI 10.1021/jm0495632; Podust LM, 2007, ANTIMICROB AGENTS CH, V51, P3915, DOI 10.1128/AAC.00311-07; Priya BS, 2005, BIOORGAN MED CHEM, V13, P2623, DOI 10.1016/j.bmc.2005.01.026; Rakesh KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107182; Reddy MBM, 2010, CATAL LETT, V138, P82, DOI 10.1007/s10562-010-0372-6; Reis RS, 2004, J CLIN MICROBIOL, V42, P2247, DOI 10.1128/JCM.42.5.2247-2248.2004; Sacksteder KA, 2012, FUTURE MICROBIOL, V7, P823, DOI [10.2217/FMB.12.56, 10.2217/fmb.12.56]; Scherman MS, 2012, BIOORGAN MED CHEM, V20, P3255, DOI 10.1016/j.bmc.2012.03.058; Sink R, 2015, J MED CHEM, V58, P613, DOI 10.1021/jm501029r; Spek AL, 2009, ACTA CRYSTALLOGR D, V65, P148, DOI 10.1107/S090744490804362X; Tang ZX, 2014, BRAZ J CHEM ENG, V31, P591, DOI 10.1590/0104-6632.20140313s00002813; Wanka L, 2013, CHEM REV, V113, P3516, DOI 10.1021/cr100264t; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Xia YY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-267	39	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0139798	10.1371/journal.pone.0139798	http://dx.doi.org/10.1371/journal.pone.0139798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26470029	Green Published, Green Accepted, gold			2022-12-26	WOS:000363184600019
J	Braz, JM; Wang, F; Basbaum, AI				Braz, Joao M.; Wang, Fan; Basbaum, Allan I.			Presynaptic Inputs to Any CNS Projection Neuron Identified by Dual Recombinant Virus Infection	PLOS ONE			English	Article							PARABRACHIAL NUCLEUS; SPINAL-CORD; DORSAL-HORN; HORSERADISH-PEROXIDASE; SUBSTANTIA-GELATINOSA; EFFERENT PROJECTIONS; SOLITARY TRACT; BRAIN-STEM; RAT; CONNECTIONS	Although neuroanatomical tracing studies have defined the origin and targets of major projection neurons (PN) of the central nervous system (CNS), there is much less information about the circuits that influence these neurons. Recently, genetic approaches that use Cre recombinase-dependent viral vectors have greatly facilitated such circuit analysis, but these tracing approaches are limited by the availability of Cre-expressing mouse lines and the difficulty in restricting Cre expression to discrete regions of the CNS. Here, we illustrate an alternative approach to drive Cre expression specifically in defined subsets of CNS projection neurons, so as to map both direct and indirect presynaptic inputs to these cells. The method involves a combination of Cre-dependent transneuronal viral tracers that can be used in the adult and that does not require genetically modified mice. To trigger Cre-expression we inject a Cre-expressing adenovirus that is retrogradely transported to the projection neurons of interest. The region containing the retrogradely labeled projection neurons is next injected with Cre-dependent pseudorabies or rabies vectors, which results in labeling of poly-and monosynaptic neuronal inputs, respectively. In proof-of-concept experiments, we used this novel tracing system to study the circuits that engage projection neurons of the superficial dorsal horn of the spinal cord and trigeminal nucleus caudalis, neurons of the parabrachial nucleus of the dorsolateral pons that project to the amygdala and cortically-projecting neurons of the lateral geniculate nucleus. Importantly, because this dual viral tracing method does not require genetically derived Cre-expressing mouse lines, inputs to almost any projection system can be studied and the analysis can be performed in larger animals, such as the rat.	[Braz, Joao M.; Basbaum, Allan I.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Wang, Fan] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA	University of California System; University of California San Francisco; Duke University	Braz, JM (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	Joao.Braz2@ucsf.edu			NIH [NS-14627]; Wellcome Trust of the UK [DP1MH103908]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014627, R01NS014627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust of the UK(Wellcome Trust); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant NS-14627 and the Wellcome Trust of the UK to AB and DP1MH103908 to FW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschauer DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076310; BERNARD JF, 1993, J COMP NEUROL, V329, P201, DOI 10.1002/cne.903290205; Braz J, 2014, NEURON, V82, P522, DOI 10.1016/j.neuron.2014.01.018; Braz JM, 2011, J COMP NEUROL, V519, P2648, DOI 10.1002/cne.22645; Braz JM, 2009, J COMP NEUROL, V514, P145, DOI 10.1002/cne.22003; Card JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021141; Card JP, 2011, P NATL ACAD SCI USA, V108, P3377, DOI 10.1073/pnas.1015033108; Card JP, 1999, J COMP NEUROL, V407, P438, DOI 10.1002/(SICI)1096-9861(19990510)407:3<438::AID-CNE11>3.0.CO;2-2; Ciesielska A, 2011, MOL THER, V19, P922, DOI 10.1038/mt.2010.248; CLARK FM, 1993, BRAIN RES, V616, P200, DOI 10.1016/0006-8993(93)90210-E; Cordero-Erausquin M, 2009, J COMP NEUROL, V517, P601, DOI 10.1002/cne.22179; CRAIG AD, 1989, EXP BRAIN RES, V74, P431; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; GOBEL S, 1980, J COMP NEUROL, V194, P781, DOI 10.1002/cne.901940406; HERBERT H, 1990, J COMP NEUROL, V293, P540, DOI 10.1002/cne.902930404; HERMANN GE, 1985, J AUTONOM NERV SYST, V13, P1, DOI 10.1016/0165-1838(85)90002-5; Jasmin L, 1997, J NEUROSCI, V17, P3751; Krout KE, 1998, J COMP NEUROL, V401, P437; Kuo H, 1995, BRAIN RES, V705, P31, DOI 10.1016/0006-8993(95)01065-3; Lanciego JL, 2011, J CHEM NEUROANAT, V42, P157, DOI 10.1016/j.jchemneu.2011.07.001; LOEWY AD, 1978, J COMP NEUROL, V181, P421, DOI 10.1002/cne.901810211; Peltekian E, 2002, MOL THER, V5, P25, DOI 10.1006/mthe.2001.0517; POWELL EW, 1969, J COMP NEUROL, V136, P183, DOI 10.1002/cne.901360205; PRICE DD, 1979, J NEUROPHYSIOL, V42, P1590, DOI 10.1152/jn.1979.42.6.1590; RIDOUX V, 1994, BRAIN RES, V648, P171, DOI 10.1016/0006-8993(94)91919-4; Salegio EA, 2013, GENE THER, V20, P348, DOI 10.1038/gt.2012.27; SAPER CB, 1980, BRAIN RES, V197, P291, DOI 10.1016/0006-8993(80)91117-8; Sik A, 2006, J COMP NEUROL, V496, P229, DOI 10.1002/cne.20921; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takatoh J, 2013, NEURON, V77, P346, DOI 10.1016/j.neuron.2012.11.010; Tokita K, 2009, NEUROSCIENCE, V161, P475, DOI 10.1016/j.neuroscience.2009.03.046; TURLEJSKI K, 1993, NEUROSCI LETT, V160, P225, DOI 10.1016/0304-3940(93)90419-L; VEENING JG, 1984, BRAIN RES, V303, P337, DOI 10.1016/0006-8993(84)91220-4; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; WHEALY ME, 1988, J VIROL, V62, P2512, DOI 10.1128/JVI.62.7.2512-2515.1988; Yasaka T, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-3	37	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140681	10.1371/journal.pone.0140681	http://dx.doi.org/10.1371/journal.pone.0140681			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26470056	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600097
J	Grossschadl, F; Stolz, E; Mayerl, H; Rasky, E; Freidl, W; Stronegger, WJ				Grossschaedl, Franziska; Stolz, Erwin; Mayerl, Hannes; Rasky, Eva; Freidl, Wolfgang; Stronegger, Willibald J.			Prevalent Long-Term Trends of Hypertension in Austria: The Impact of Obesity and Socio-Demography	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; SOCIOECONOMIC INEQUALITIES; DIABETES-MELLITUS; HEALTH; PREVENTION; ADULTS; MANAGEMENT; AWARENESS; LIFE	Background Globally there are only less long-term-studies on hypertension available to provide reliable estimates and identify risk groups. This study aims to analyse the prevalence and long-term-trend of hypertension in Austria, recognize affected subpopulations and investigate social inequalities. Methods This representative population-based study is based on self-reported data of adults (mean age: 47.7 +/- 17.5; n = 178,818) that were taken from five health surveys between 1973 and 2007. An adjustment of self-reported BMI was performed based on a preliminary validation study. Absolute changes (AC) and aetiologic fractions (AF) were calculated from logistic regressions in order to measure trends. To quantify the extent of social inequality, a relative index of inequality (RII) was computed. Results During the study period the age-standardized hypertension prevalence increased from 1.0% to 18.8%, with a considerable rise from 1991 onwards. There was a positive trend in all subpopulations, with the highest AC among obese women (+ 50.2%) and obese subjects aged 75 years and older (+ 54.4%), whereas the highest risk was observed among the youngest obese adults (AF: 99.4%). The RII for hypertension was higher for women than men, but in general unstable during the investigation period. Conclusions Obesity and older age are significant factors for increased morbidity of hypertension. The most undesirable trends occurred in obese women and obese subjects aged 75 years and older. These risk groups should be given special attention when planning hypertension prevention programs. The high increase in the prevalence of hypertension is due to different aspects, e.g. a demographic change and a change in the definition of hypertension. These findings help to understand why hypertension is becoming more common in the Austrian population.	[Grossschaedl, Franziska] Med Univ Graz, Inst Nursing Sci, A-8010 Graz, Austria; [Stolz, Erwin; Mayerl, Hannes; Rasky, Eva; Freidl, Wolfgang; Stronegger, Willibald J.] Med Univ Graz, Inst Social Med & Epidemiol, A-8010 Graz, Austria	Medical University of Graz; Medical University of Graz	Grossschadl, F (corresponding author), Med Univ Graz, Inst Nursing Sci, Billrothgasse 6, A-8010 Graz, Austria.	franziska.grossschaedl@medunigraz.at	Stronegger, Willibald J./C-2425-2018	Stronegger, Willibald J./0000-0003-3496-1208; Grossschadl, Franziska/0000-0002-6726-0443; Stolz, Erwin/0000-0001-7393-1568; Mayerl, Hannes/0000-0001-8708-8831				Adebayo RA, 2013, INT J GEN MED, V6, P863, DOI 10.2147/IJGM.S51906; Alhawassi TM, 2015, J CLIN HYPERTENS, V17, P486, DOI 10.1111/jch.12536; Bray GA, 2002, AM J CLIN NUTR, V76, P497, DOI 10.1093/ajcn/76.3.497; Chau D, 2008, CURR OPIN CLIN NUTR, V11, P27, DOI 10.1097/MCO.0b013e3282f31744; Crawford AG, 2010, POPUL HEALTH MANAG, V13, P151, DOI 10.1089/pop.2009.0039; Diao D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006742.pub2; Dorner T, 2009, J HYPERTON, V13, P7; Espelt A, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112698; Flynn C, 2014, SEMIN NEPHROL, V34, P340, DOI 10.1016/j.semnephrol.2014.04.009; Gasche UP, 2013, ARZTE ERHOHEN SCHWEL; Grossschadl F, 2013, EUR J PUBLIC HEALTH, V23, P306, DOI 10.1093/eurpub/cks033; Grossschadl F, 2012, PUBLIC HEALTH NUTR, V15, P20, DOI 10.1017/S1368980011001911; Gupta R, 2012, EUR J PREV CARDIOL, V19, P1258, DOI 10.1177/1741826711424567; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Labounty TM, 2013, EUR HEART J-CARD IMG, V14, P456, DOI 10.1093/ehjci/jes179; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Magometschnigg D, 2004, J HYPERTON, V8, P12; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; NICE, 2005, CLIN MAN PRIM HYP AD; Niu JJ, 2014, PREV MED, V62, P113, DOI 10.1016/j.ypmed.2014.02.012; Oliveria SA, 2005, J GEN INTERN MED, V20, P219, DOI 10.1111/j.1525-1497.2005.30353.x; Praso Subhija, 2012, Mater Sociomed, V24, P87, DOI 10.5455/msm.2012.24.87-90; Regidor E, 2004, J EPIDEMIOL COMMUN H, V58, P900, DOI 10.1136/jech.2004.023036; Reichert FF, 2009, PREV MED, V49, P200, DOI 10.1016/j.ypmed.2009.06.009; Schaefer C, 2007, EUR HEART J SUPPL, V9, pB42, DOI 10.1093/eurheartj/sum008; Schmeiser-Rieder A, 2000, EUR HEART J, V21, P414, DOI 10.1053/euhj.1999.1912; Scholes S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-129; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wang SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114424; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; World Health Organization, 2005, EUR HLTH REP 2005	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140461	10.1371/journal.pone.0140461	http://dx.doi.org/10.1371/journal.pone.0140461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469176	gold, Green Submitted, Green Published			2022-12-26	WOS:000363184600063
J	Kirillova, Y; Boyarskaya, N; Dezhenkov, A; Tankevich, M; Prokhorov, I; Varizhuk, A; Eremin, S; Esipov, D; Smirnov, I; Pozmogova, G				Kirillova, Yuliya; Boyarskaya, Nataliya; Dezhenkov, Andrey; Tankevich, Mariya; Prokhorov, Ivan; Varizhuk, Anna; Eremin, Sergei; Esipov, Dmitry; Smirnov, Igor; Pozmogova, Galina			Polyanionic Carboxyethyl Peptide Nucleic Acids (ce-PNAs): Synthesis and DNA Binding	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; THYMINE-SUBSTITUTED POLYAMIDE; HYBRIDIZATION PROPERTIES; SUBMONOMERIC STRATEGY; STRAND-DISPLACEMENT; STEREOGENIC CENTERS; OPTICAL PURITY; AMINO-ACIDS; SIDE-CHAINS; CHIRAL PNAS	New polyanionic modifications of polyamide nucleic acid mimics were obtained. Thymine decamers were synthesized from respective chiral alpha- and gamma-monomers, and their enantiomeric purity was assessed. Here, we present the decamer synthesis, purification and characterization by MALDI-TOF mass spectrometry and an investigation of the hybridization properties of the decamers. We show that the modified gamma-S-carboxyethyl-T-10 PNA forms a stable triplex with polyadenine DNA.	[Kirillova, Yuliya; Boyarskaya, Nataliya; Dezhenkov, Andrey; Tankevich, Mariya; Prokhorov, Ivan; Eremin, Sergei] Moscow State Univ Fine Chem Technol, Dept Biotechnol & Bionanotechnol, Moscow, Russia; [Kirillova, Yuliya; Tankevich, Mariya; Varizhuk, Anna; Smirnov, Igor; Pozmogova, Galina] SRI Phys Chem Med, Dept Mol Biol & Genet, Moscow, Russia; [Varizhuk, Anna] Engelhardt Inst Mol Biol, Dept Struct Funct Anal Biopolymers, Moscow, Russia; [Esipov, Dmitry] Moscow MV Lomonosov State Univ, Fac Biol, Dept Bioorgan Chem, Moscow, Russia	MIREA - Russian Technological University; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University	Kirillova, Y (corresponding author), Moscow State Univ Fine Chem Technol, Dept Biotechnol & Bionanotechnol, Moscow, Russia.	pna-mitht@yandex.ru	Esipov, Dmitriy/J-9434-2012; Kirillova, Yuliya/F-5697-2016; Galina, Pozmogova/S-6204-2017; Varizhuk, Anna/Y-7558-2019	Esipov, Dmitriy/0000-0003-3973-0898; Kirillova, Yuliya/0000-0002-0988-8515; Galina, Pozmogova/0000-0001-9458-4972; Varizhuk, Anna/0000-0001-9359-8651	Russian Science Foundation [14-25-00013]; Russian Foundation for Basic Research [14-04-01244]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Science Foundation [14-25-00013, GP] URL: (http://www.rscf.ru) and Russian Foundation for Basic Research (in part) [14-04-01244, AV] URL: (http://www.rfbr.ru/rffi/ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avitabile C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035774; Bae YM, 2014, J CONTROL RELEASE, V175, P54, DOI 10.1016/j.jconrel.2013.12.015; Bahal R, 2014, CURR GENE THER, V14, P331, DOI 10.2174/1566523214666140825154158; Boyarskaya NP, 2006, DOKL CHEM, V408, P57, DOI 10.1134/S0012500806050016; Boyarskaya NP, 2005, TETRAHEDRON LETT, V46, P7359, DOI 10.1016/j.tetlet.2005.08.121; CHERNY DY, 1993, P NATL ACAD SCI USA, V90, P1667, DOI 10.1073/pnas.90.5.1667; Chin JY, 2013, MOL THER, V21, P580, DOI 10.1038/mt.2012.262; Christensen L, 1995, J Pept Sci, V1, P175; Corradini R, 1999, TETRAHEDRON-ASYMMETR, V10, P2063, DOI 10.1016/S0957-4166(99)00210-4; Corradini R, 2011, CURR TOP MED CHEM, V11, P1535, DOI 10.2174/156802611795860979; De Cola C, 2012, TETRAHEDRON, V68, P499, DOI 10.1016/j.tet.2011.11.017; De Costa NTS, 2014, BIOORG MED CHEM LETT, V24, P2360, DOI 10.1016/j.bmcl.2014.03.059; de Koning MC, 2006, TETRAHEDRON, V62, P3248, DOI 10.1016/j.tet.2006.01.065; DECOSTA NTS, 2013, PLOS ONE, V0008; DEMIDOV VV, 1994, BIOCHEM PHARMACOL, V48, P1310, DOI 10.1016/0006-2952(94)90171-6; Dezhenkov AV, 2015, MENDELEEV COMMUN, V25, P47, DOI 10.1016/j.mencom.2015.01.017; Doboszewski B, 2013, EUR J ORG CHEM, V2013, P4804, DOI 10.1002/ejoc.201300523; Dose C, 2005, ORG LETT, V7, P4365, DOI 10.1021/ol051489+; Dragulescu-Andrasi A, 2006, J AM CHEM SOC, V128, P10258, DOI 10.1021/ja0625576; DUEHOLM KL, 1994, BIOORG MED CHEM LETT, V4, P1077, DOI 10.1016/S0960-894X(01)80684-3; Efimov VA, 2003, NUCLEOS NUCLEOT NUCL, V22, P593, DOI 10.1081/NCN-120021962; Efimov VA, 1998, NUCLEIC ACIDS RES, V26, P566, DOI 10.1093/nar/26.2.566; Efimov VA, 1998, NUCLEOS NUCLEOT, V17, P1671, DOI 10.1080/07328319808004700; Efimov VA, 2006, NUCLEIC ACIDS RES, V34, P2247, DOI 10.1093/nar/gkl249; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; EGHOLM M, 1992, J AM CHEM SOC, V114, P9677, DOI 10.1021/ja00050a068; Englund EA, 2005, ORG LETT, V7, P3465, DOI 10.1021/ol051143z; Englund EA, 2007, ANGEW CHEM INT EDIT, V46, P1414, DOI 10.1002/anie.200603483; Falkiewicz B, 2001, TETRAHEDRON, V57, P7909, DOI 10.1016/S0040-4020(01)00759-1; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; Haaima G, 1996, ANGEW CHEM INT EDIT, V35, P1939; Huang H, 2012, ARCH PHARM RES, V35, P517, DOI 10.1007/s12272-012-0315-4; Huang H, 2010, B KOREAN CHEM SOC, V31, P2054, DOI 10.5012/bkcs.2010.31.7.2054; HYRUP B, 1994, J AM CHEM SOC, V116, P7964, DOI 10.1021/ja00097a002; Jain DR, 2014, J ORG CHEM, V79, P9567, DOI 10.1021/jo501639m; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Kirillova YG, 2013, RUSS J ORG CHEM+, V49, P1768, DOI 10.1134/S1070428013120117; Kolevzon N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086802; Krishnan-Ghosh Y, 2004, J AM CHEM SOC, V126, P5944, DOI 10.1021/ja031508f; Krupnik O L, 2005, Genetika, V41, P869; Kuznetsov MA, 2008, J ANAL CHEM+, V63, P57, DOI 10.1134/S1061934808010115; Kuznetsov MA, 2006, APPL BIOCHEM MICRO+, V42, P536, DOI 10.1134/S0003683806060020; MANZINI G, 1990, J MOL BIOL, V213, P833, DOI 10.1016/S0022-2836(05)80267-0; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni134; MILLIGAN JF, 1993, J MED CHEM, V36, P1923, DOI 10.1021/jm00066a001; Mitra R, 2012, J ORG CHEM, V77, P5696, DOI 10.1021/jo300860f; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Nielsen PE, 2001, CURR OPIN BIOTECH, V12, P16, DOI 10.1016/S0958-1669(00)00170-1; Nielsen PE, 2010, CHEM BIODIVERS, V7, P786, DOI 10.1002/cbdv.201000005; Nik-Ahd F, 2014, STEM CELLS, V32, P1817, DOI 10.1002/stem.1668; Peyman A, 1997, ANGEW CHEM INT EDIT, V36, P2809, DOI 10.1002/anie.199728091; Pozmogova GE, 2010, B EXP BIOL MED+, V150, P180, DOI 10.1007/s10517-010-1099-5; Prokhorov DI, 2005, PHARM CHEM J, V39, P323, DOI [DOI 10.1007/S11094-005-0145-5, 10.1007/s11094-005-0145-5]; Sahu B, 2011, J ORG CHEM, V76, P5614, DOI 10.1021/jo200482d; Sahu B, 2009, J ORG CHEM, V74, P1509, DOI 10.1021/jo802211n; Sforza S, 2003, EUR J ORG CHEM, V2003, P1056; Sforza S, 2000, EUR J ORG CHEM, V2000, P2905; Sforza S, 2007, EUR J ORG CHEM, V2007, P5879, DOI 10.1002/ejoc.200700644; Shiraishi T, 2014, CELLULAR DELIVERY PE, V1050, P193, DOI [10.1007/978-1-62703-553-8_16, DOI 10.1007/978-1-62703-553-8_16]; Shiraishi T, 2008, NUCLEIC ACIDS RES, V36, P4424, DOI 10.1093/nar/gkn401; Sugiyama T, 2013, MOLECULES, V18, P287, DOI 10.3390/molecules18010287; Sugiyama T, 2011, BIOORG MED CHEM LETT, V21, P7317, DOI 10.1016/j.bmcl.2011.10.017; TAM JP, 1986, J AM CHEM SOC, V108, P5242, DOI 10.1021/ja00277a031; Tedeschi T, 2005, TETRAHEDRON LETT, V46, P8395, DOI 10.1016/j.tetlet.2005.09.157; Tedeschi T, 2008, TETRAHEDRON LETT, V49, P4958, DOI 10.1016/j.tetlet.2008.05.114; Uhlmann E, 1998, ANGEW CHEM INT EDIT, V37, P2797; Uhlmann E, 1996, ANGEW CHEM INT EDIT, V35, P2632, DOI 10.1002/anie.199626321; VARGASBACA I, 2001, ANGEW CHEM, V113, P4765, DOI DOI 10.1002/1521-3757(20011217)113:24<4765::AID-ANGE4765>3.0.CO;2-D; Wang G, 1999, NUCLEIC ACIDS RES, V27, P2806, DOI 10.1093/nar/27.13.2806; WATKINS BE, 1982, J ORG CHEM, V47, P4471, DOI 10.1021/jo00144a014; Zhou P, 2003, J AM CHEM SOC, V125, P6878, DOI 10.1021/ja029665m; Zhou P, 2006, BIOORG MED CHEM LETT, V16, P4931, DOI 10.1016/j.bmcl.2006.06.052	72	10	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140468	10.1371/journal.pone.0140468	http://dx.doi.org/10.1371/journal.pone.0140468			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469337	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600065
J	Bassan, JC; Goulart, AJ; Nasser, ALM; Bezerra, TMS; Garrido, SS; Rustiguel, CB; Guimaraes, LHS; Monti, R				Bassan, Juliana C.; Goulart, Antonio J.; Nasser, Ana L. M.; Bezerra, Thais M. S.; Garrido, Saulo S.; Rustiguel, Cynthia B.; Guimaraes, Luis H. S.; Monti, Rubens			Buffalo Cheese Whey Proteins, Identification of a 24 kDa Protein and Characterization of Their Hydrolysates: In Vitro Gastrointestinal Digestion	PLOS ONE			English	Article							TRINITROBENZENESULFONIC ACID METHOD; AMINO-ACIDS; ANTIOXIDANT ACTIVITY; FUNCTIONAL-PROPERTIES; BETA-LACTOGLOBULIN; ALPHA-LACTALBUMIN; GENETIC-VARIANTS; PEPTIDES; QUANTIFICATION; MECHANISMS	Milk whey proteins are well known for their high biological value and versatile functional properties, characteristics that allow its wide use in the food and pharmaceutical industries. In this work, a 24 kDa protein from buffalo cheese whey was analyzed by mass spectrometry and presented homology with Bos taurus beta-lactoglobulin. In addition, the proteins present in buffalo cheese whey were hydrolyzed with pepsin and with different combinations of trypsin, chymotrypsin and carboxypeptidase-A. When the TNBS method was used the obtained hydrolysates presented DH of 55 and 62% for H1 and H2, respectively. Otherwise for the OPA method the DH was 27 and 43% for H1 and H2, respectively. The total antioxidant activities of the H1 and H2 samples with and without previous enzymatic hydrolysis, determined by DPPH using diphenyl-p-picrylhydrazyl radical, was 4.9 and 12 mM of Trolox equivalents (TE) for H2 and H2Dint, respectively. The increased concentrations for H1 and H2 samples were approximately 99% and 75%, respectively. The in vitro gastrointestinal digestion efficiency for the samples that were first hydrolyzed was higher compared with samples not submitted to previous hydrolysis. After in vitro gastrointestinal digestion, several amino acids were released in higher concentrations, and most of which were essential amino acids. These results suggest that buffalo cheese whey is a better source of bioavailable amino acids than bovine cheese whey.	[Bassan, Juliana C.; Goulart, Antonio J.; Nasser, Ana L. M.; Monti, Rubens] UNESP Univ EstadualPaulista, Fac Ciencias Farmaceut, Dept Alimentos & Nutr, Araraquara, SP, Brazil; [Bezerra, Thais M. S.; Garrido, Saulo S.] UNESP Univ EstadualPaulista, Inst Quim, Dept Bioquim & Quim Tecnol, Araraquara, SP, Brazil; [Rustiguel, Cynthia B.; Guimaraes, Luis H. S.] Univ Sao Paulo, Dept Biol, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Monti, R (corresponding author), UNESP Univ EstadualPaulista, Fac Ciencias Farmaceut, Dept Alimentos & Nutr, Araraquara, SP, Brazil.	montiru@fcfar.unesp.br	Garrido, Saulo S Santesso/D-4267-2012; Guimarães, Luis Henrique Souza/B-5437-2014; Monti, Rubens/C-9214-2012; BEZERRA, THAIS/C-3933-2015	Garrido, Saulo S Santesso/0000-0001-7122-1132; Guimarães, Luis Henrique Souza/0000-0002-2921-3929; BEZERRA, THAIS/0000-0001-5385-1157; Bassan, Juliana Cristina/0000-0002-2499-0024	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Programa Nacional de Pos-Doutorado (PNPD-CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa Nacional de Pos-Doutorado (PNPD-CAPES)	Financial and research support were provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (J. C. Bassan), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (T. M. S. Bezerra) and Programa Nacional de Pos-Doutorado (PNPD-CAPES) (A. J. Goulart). Rubens Monti is a Research Fellow of CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Salam MH, 2011, DAIRY SCI TECHNOL, V91, P663, DOI 10.1007/s13594-011-0029-2; ADLERNISSEN J, 1979, J AGR FOOD CHEM, V27, P1256, DOI 10.1021/jf60226a042; Akhavan T, 2010, AM J CLIN NUTR, V91, P966, DOI 10.3945/ajcn.2009.28406; Andras R, 2011, FOOD BIOPROCESS TECH, V4, P702, DOI 10.1007/s11947-009-0192-0; Asghar A, 2011, CRIT REV FOOD SCI, V51, P374, DOI 10.1080/10408391003605482; Athira S, 2015, J SCI FOOD AGR, V95, P2908, DOI 10.1002/jsfa.7032; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bonfatti V, 2013, FOOD CHEM, V136, P364, DOI 10.1016/j.foodchem.2012.09.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; British Standards Institution, 1989, DET FAT CONT MILK MI; Buffoni JN, 2011, FOOD CHEM, V127, P1515, DOI 10.1016/j.foodchem.2011.02.008; Cayot P, 1997, ANAL BIOCHEM, V249, P184, DOI 10.1006/abio.1997.2161; Chianese L, 2004, J DAIRY RES, V71, P14, DOI 10.1017/S0022029903006551; Conesa C, 2013, J AGR FOOD CHEM, V61, P10135, DOI 10.1021/jf401837a; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Contreras MD, 2011, LWT-FOOD SCI TECHNOL, V44, P9, DOI 10.1016/j.lwt.2010.06.017; Dryakova A, 2010, EUR FOOD RES TECHNOL, V230, P865, DOI 10.1007/s00217-010-1231-9; El-Salam MHA, 2009, FOOD REV INT, V25, P251, DOI 10.1080/87559120902956224; Espinoza AD, 2012, J AGR FOOD CHEM, V60, P5250, DOI 10.1021/jf300581r; Foucquier J, 2012, FOOD HYDROCOLLOID, V27, P1, DOI 10.1016/j.foodhyd.2011.08.002; Garrett AR, 2014, FOOD CHEM, V158, P490, DOI 10.1016/j.foodchem.2014.02.102; Goulart AJ, 2014, FOOD RES INT, V63, P62, DOI 10.1016/j.foodres.2014.01.037; Ha E, 2003, J NUTR BIOCHEM, V14, P251, DOI 10.1016/S0955-2863(03)00030-5; Hafeez Z, 2014, FOOD RES INT, V63, P71, DOI 10.1016/j.foodres.2014.06.002; Huppertz T, 2009, MILK PROCESSING QUAL, P23, DOI DOI 10.1002/9781444301649.CH2; Ishida Y, 1987, U.S. Patent, Patent No. [4,670,403, 4670403]; Jakubowicz D, 2013, J NUTR BIOCHEM, V24, P1, DOI 10.1016/j.jnutbio.2012.07.008; Jara F, 2011, FOOD HYDROCOLLOID, V25, P374, DOI 10.1016/j.foodhyd.2010.07.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leenders M, 2011, NUTR REV, V69, P675, DOI 10.1111/j.1753-4887.2011.00443.x; Leksrisompong PP, 2010, J AGR FOOD CHEM, V58, P6318, DOI 10.1021/jf100009u; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Livney YD, 2010, CURR OPIN COLLOID IN, V15, P73, DOI 10.1016/j.cocis.2009.11.002; Luten J, 1996, J SCI FOOD AGR, V72, P415, DOI [10.1002/(SICI)1097-0010(199612)72:4<415::AID-JSFA675>3.3.CO;2-O, 10.1002/(SICI)1097-0010(199612)72:4&lt;415::AID-JSFA675&gt;3.0.CO;2-X]; Martins SIFS, 2000, TRENDS FOOD SCI TECH, V11, P364, DOI 10.1016/S0924-2244(01)00022-X; McPhie P., 1971, ENZYME PURIFICATION, P23; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mills S, 2011, INT DAIRY J, V21, P377, DOI 10.1016/j.idairyj.2010.12.011; Nagpal R, 2011, FOOD FUNCT, V2, P18, DOI 10.1039/c0fo00016g; O'Keeffe MB, 2014, INT DAIRY J, V36, P128, DOI 10.1016/j.idairyj.2014.01.013; Peng XY, 2009, FOOD CHEM, V113, P196, DOI 10.1016/j.foodchem.2008.07.068; Phelan M, 2011, FOOD FUNCT, V2, P153, DOI 10.1039/c1fo10017c; Pihlanto A, 2006, INT DAIRY J, V16, P1306, DOI 10.1016/j.idairyj.2006.06.005; Power O, 2013, AMINO ACIDS, V44, P797, DOI 10.1007/s00726-012-1393-9; Rutherfurd SM, 2010, J AOAC INT, V93, P1515; Sanchez J, 2011, J FOOD ENG, V103, P147, DOI 10.1016/j.jfoodeng.2010.10.009; SASHIDHAR RB, 1994, J IMMUNOL METHODS, V167, P121, DOI 10.1016/0022-1759(94)90081-7; Sinha R, 2007, FOOD CHEM, V101, P1484, DOI 10.1016/j.foodchem.2006.04.021; SPADARO AC, 1979, ANAL BIOCHEM, V96, P317, DOI 10.1016/0003-2697(79)90587-6; Spellman D, 2003, INT DAIRY J, V13, P447, DOI 10.1016/S0958-6946(03)00053-0; Tavares TG, 2012, J FOOD ENG, V110, P547, DOI 10.1016/j.jfoodeng.2012.01.009; Tavares TG., 2013, BIOACTIVE FOOD PEPTI, P75, DOI [10.5772/52680, DOI 10.5772/52680, 10.5772/3318, DOI 10.5772/3318]; Tessari P, 2011, CLIN NUTR, V30, P267, DOI 10.1016/j.clnu.2011.02.009; Tong LM, 2000, J AGR FOOD CHEM, V48, P1473, DOI 10.1021/jf991342v; Vohra V, 2006, J DAIRY RES, V73, P499, DOI 10.1017/S0022029906002044; Wang XZ, 2011, NAT PROD COMMUN, V6, P1285; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0	57	11	11	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139550	10.1371/journal.pone.0139550	http://dx.doi.org/10.1371/journal.pone.0139550			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465145	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100051
J	Choi, H; Jeong, BC; Hur, SW; Kim, JW; Lee, KB; Koh, JT				Choi, Hyuck; Jeong, Byung-Chul; Hur, Sung-Woong; Kim, Jung-Woo; Lee, Keun-Bae; Koh, Jeong-Tae			The Angiopoietin-1 Variant COMP-Ang1 Enhances BMP2-Induced Bone Regeneration with Recruiting Pericytes in Critical Sized Calvarial Defects	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; SPINAL-FUSION; STEM-CELLS; ANGIOGENESIS; DIFFERENTIATION; ACTIVATION; PATHWAYS; PI3K/AKT; DELIVERY; KINASE	Craniofacial bone defects are observed in a variety of clinical situations, and their reconstructions require coordinated coupling between angiogenesis and osteogenesis. In this study, we explored the effects of cartilage oligomeric matrix protein-angiopoietin 1 (COMP-Ang1), a synthetic and soluble variant of angiopoietin 1, on bone morphogenetic protein 2 (BMP2)-induced cranial bone regeneration, and recruitment and osteogenic differentiation of perivascular pericytes. A critical-size calvarial defect was created in the C57BL/6 mouse and COMP-Ang1 and/or BMP2 proteins were delivered into the defects with absorbable collagen sponges. After 3 weeks, bone regeneration was evaluated using micro-computed tomography and histologic examination. Pericyte recruitment into the defects was examined using immunofluorescence staining with anti-NG2 and anti-CD31 antibodies. In vitro recruitment and osteoblastic differentiation of pericyte cells were assessed with Boyden chamber assay, staining of calcified nodules, RT-PCR and Western blot analyses. Combined administration of COMP-Ang1 and BMP2 synergistically enhanced bone repair along with the increased population of CD31 (an endothelial cell marker) and NG2 (a specific marker of pericyte) positive cells. In vitro cultures of pericytes consistently showed that pericyte infiltration into the membrane pore of Boyden chamber was more enhanced by the combination treatment. In addition, the combination further increased the osteoblast-specific gene expression, including bone sialoprotein (BSP), osteocalcin (OCN) and osterix (OSX), phosphorylation of Smad/1/5/8, and mineralized nodule formation. COMP-Ang1 can enhance BMP2-induced cranial bone regeneration with increased pericyte recruitment. Combined delivery of the proteins might be a therapeutic strategy to repair cranial bone damage.	[Choi, Hyuck; Jeong, Byung-Chul; Hur, Sung-Woong; Kim, Jung-Woo; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Res Ctr Biomineralizat Disorders, Gwangju, South Korea; [Lee, Keun-Bae] Chonnam Natl Univ, Med Sch & Hosp, Dept Orthoped Surg, Gwangju, South Korea	Chonnam National University; Chonnam National University	Koh, JT (corresponding author), Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Res Ctr Biomineralizat Disorders, Gwangju, South Korea.	jtkoh@chonnam.ac.kr			National Research Foundation of Korea Grant - Korea government MSIP [NRF-2011-0030121]; Chonnam National University Hospital Research Institute of Clinical Medicine Grant [CRI 11078-21, CRI 11078-22]	National Research Foundation of Korea Grant - Korea government MSIP; Chonnam National University Hospital Research Institute of Clinical Medicine Grant	This work was supported by the National Research Foundation of Korea Grant funded by the Korea government MSIP (NRF-2011-0030121) and by the Chonnam National University Hospital Research Institute of Clinical Medicine Grant (CRI 11078-21, 22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasopoulos AN, 2007, J BIOL CHEM, V282, P26746, DOI 10.1074/jbc.M705200200; Bautch VL, 2011, NAT MED, V17, P1437, DOI 10.1038/nm.2539; Brachvogel B, 2005, DEVELOPMENT, V132, P2657, DOI 10.1242/dev.01846; Cai J, 2008, INVEST OPHTH VIS SCI, V49, P2163, DOI 10.1167/iovs.07-1206; Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Collett GDM, 2005, CIRC RES, V96, P930, DOI 10.1161/01.RES.0000163634.51301.0d; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Duguy N, 2000, Ann Chir Plast Esthet, V45, P364; Franceschi RT, 2005, J DENT RES, V84, P1093, DOI 10.1177/154405910508401204; Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Jeong BC, 2010, BONE, V46, P479, DOI 10.1016/j.bone.2009.09.019; Kim I, 2000, CIRC RES, V86, P952, DOI 10.1161/01.RES.86.9.952; Koh GY, 2013, TRENDS MOL MED, V19, P31, DOI 10.1016/j.molmed.2012.10.010; Kook SH, 2014, BIOCHEM BIOPH RES CO, V455, P371, DOI 10.1016/j.bbrc.2014.11.025; Kuhn LT, 2013, J GERONTOL A-BIOL, V68, P1170, DOI 10.1093/gerona/glt018; Kwon JS, 2011, J MOL CELL CARDIOL, V50, P814, DOI 10.1016/j.yjmcc.2011.01.019; Lee HJ, 2009, CELL DEATH DIFFER, V16, P1395, DOI 10.1038/cdd.2009.78; Lee KN, 2010, PHARMACOLOGY, V86, P327, DOI 10.1159/000321885; Lim SS, 2015, J BIOMED MATER RES A, V103, P2942, DOI 10.1002/jbm.a.35439; Otsuru S, 2007, BIOCHEM BIOPH RES CO, V354, P453, DOI 10.1016/j.bbrc.2006.12.226; Ozerdem Ugur, 2003, Angiogenesis, V6, P241, DOI 10.1023/B:AGEN.0000021401.58039.a9; Park BH, 2011, BONE, V49, P447, DOI 10.1016/j.bone.2011.05.020; Park BH, 2010, BONE, V46, P1442, DOI 10.1016/j.bone.2010.02.004; Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708; Schrimpf C, 2014, J VASC RES, V51, P247, DOI 10.1159/000365149; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Vo TN, 2012, ADV DRUG DELIVER REV, V64, P1292, DOI 10.1016/j.addr.2012.01.016; Yu YY, 2010, BONE, V47, P65, DOI 10.1016/j.bone.2010.03.012; Zhang WJ, 2014, EUR CELLS MATER, V27, P1	32	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140502	10.1371/journal.pone.0140502	http://dx.doi.org/10.1371/journal.pone.0140502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465321	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100132
J	Harkitis, P; Daskalopoulos, EP; Malliou, F; Lang, MA; Marselos, M; Fotopoulos, A; Albucharali, G; Konstandi, M				Harkitis, P.; Daskalopoulos, E. P.; Malliou, F.; Lang, M. A.; Marselos, M.; Fotopoulos, A.; Albucharali, G.; Konstandi, M.			Dopamine D-2-Receptor Antagonists Down-Regulate CYP1A1/2 and CYP1B1 in the Rat Liver	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; POLYCYCLIC AROMATIC-HYDROCARBONS; SEXUALLY DIMORPHIC EXPRESSION; DRUG-METABOLIZING-ENZYMES; GENE-EXPRESSION; PSYCHOPHYSIOLOGICAL STRESS; SIGNALING PATHWAYS; BIOGENIC-AMINES; INDUCTION; HYPOXIA	Dopaminergic systems regulate the release of several hormones including growth hormone (GH), thyroid hormones, insulin, glucocorticoids and prolactin (PRL) that play significant roles in the regulation of various Cytochrome P450 (CYP) enzymes. The present study investigated the role of dopamine D-2-receptor-linked pathways in the regulation of CYP1A1, CYP1A2 and CYP1B1 that belong to a battery of genes controlled by the Aryl Hydrocarbon Receptor (AhR) and play a crucial role in the metabolism and toxicity of numerous environmental toxicants. Inhibition of dopamine D-2-receptors with sulpiride (SULP) significantly repressed the constitutive and benzo[a] pyrene (B[a] P)-induced CYP1A1, CYP1A2 and CYP1B expression in the rat liver. The expression of AhR, heat shock protein 90 (HSP90) and AhR nuclear translocator (ARNT) was suppressed by SULP in B[a] P-treated livers, whereas the AhRR expression was increased by the drug suggesting that the SULP-mediated repression of the CYP1 inducibility is due to inactivation of the AhR regulatory system. At signal transduction level, the D-2-mediated down-regulation of constitutive CYP1A1/2 and CYP1B1 expression appears to be mediated by activation of the insulin/PI3K/AKT pathway. PRL-linked pathways exerting a negative control on various CYPs, and inactivation of the glucocorticoid-linked pathways that positively control the AhR-regulated CYP1 genes, may also participate in the SULP-mediated repression of both, the constitutive and induced CYP1 expression. The present findings indicate that drugs acting as D-2-dopamine receptor antagonists can modify several hormone systems that regulate the expression of CYP1A1, CYP1A2 and CYP1B1, and may affect the toxicity and carcinogenicity outcome of numerous toxicants and pre-carcinogenic substances. Therefore, these drugs could be considered as a part of the strategy to reduce the risk of exposure to environmental pollutants and pre-carcinogens.	[Harkitis, P.; Daskalopoulos, E. P.; Malliou, F.; Marselos, M.; Konstandi, M.] Univ Ioannina, Fac Med, Dept Pharmacol, GR-45110 Ioannina, Greece; [Lang, M. A.] Univ Queensland, Natl Res Ctr Environm Toxicol Entox, Coopers Plains, Qld 4108, Australia; [Fotopoulos, A.; Albucharali, G.] Univ Ioannina, Fac Med, Dept Nucl Med, GR-45110 Ioannina, Greece	University of Ioannina; University of Queensland; University of Ioannina	Konstandi, M (corresponding author), Univ Ioannina, Fac Med, Dept Pharmacol, GR-45110 Ioannina, Greece.	mkonstan@cc.uoi.gr	Daskalopoulos, Evangelos/AAE-2815-2020	Malliou, Faye (Foteini)/0000-0001-9186-3466	European Regional Development Fund-ERDF NSRF [346985/80753]; Greek Ministry of Development-GSRT PENED [03EDelta/957]	European Regional Development Fund-ERDF NSRF; Greek Ministry of Development-GSRT PENED	European Regional Development Fund-ERDF NSRF 2007-2013, Grant 346985/80753, MK and Greek Ministry of Development-GSRT (20%) PENED (03E Delta/957, MK.	Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Bonci A, 2005, NEURON, V47, P335, DOI 10.1016/j.neuron.2005.07.015; BURKE MD, 1974, DRUG METAB DISPOS, V2, P583; Charmandari E, 2003, HORM RES, V59, P161, DOI 10.1159/000069325; CONNEY AH, 1982, CANCER RES, V42, P4875; Cooper J., 2003, BIOCH BASIS NEUROPHA; CRAIG TJ, 1981, COMPR PSYCHIAT, V22, P404, DOI 10.1016/0010-440X(81)90025-0; Cransac H, 1996, J NEURAL TRANSM, V103, P391, DOI 10.1007/BF01276416; Daskalopoulos EP, 2012, MOL PHARMACOL, V82, P668, DOI 10.1124/mol.112.078709; Daskalopoulos EP, 2012, AM J PHYSIOL-ENDOC M, V303, pE40, DOI 10.1152/ajpendo.00545.2011; ELO HA, 1989, ARCH TOXICOL, V63, P127, DOI 10.1007/BF00316434; Endo K, 2008, TOXICOL APPL PHARM, V230, P135, DOI 10.1016/j.taap.2008.02.009; Fitzgerald CT, 1998, DNA CELL BIOL, V17, P811, DOI 10.1089/dna.1998.17.811; Fitzgerald Peter, 2008, J Psychopharmacol, V22, P12, DOI 10.1177/0269216307087148; Flint MS, 2010, J PROTEOME RES, V9, P509, DOI 10.1021/pr900861j; FUHR U, 1994, PHARMACOGENETICS, V4, P109, DOI 10.1097/00008571-199406000-00001; GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243; Gonzalez FJ, 2006, ANNU REV PHARMACOL, V46, P41, DOI 10.1146/annurev.pharmtox.45.120403.100007; Hahn ME, 2009, BIOCHEM PHARMACOL, V77, P485, DOI 10.1016/j.bcp.2008.09.016; Hay N, 2011, BBA-MOL CELL RES, V1813, P1965, DOI 10.1016/j.bbamcr.2011.03.013; *IARC, 1983, MON EV CARC RISK C 1; IOANNIDES C, 1993, DRUG METAB REV, V25, P485, DOI 10.3109/03602539308993983; IOANNIDES C, 1990, DRUG METAB REV, V22, P1, DOI 10.3109/03602539008991444; JONES SN, 1991, NUCLEIC ACIDS RES, V19, P6547, DOI 10.1093/nar/19.23.6547; Kabbani N, 2012, CURR DRUG TARGETS, V13, P72, DOI 10.2174/138945012798868515; KAWAJIRI K, 1991, JPN J CANCER RES, V82, P1325, DOI 10.1111/j.1349-7006.1991.tb01800.x; Kilic T, 2006, HEART, V92, P1041, DOI 10.1136/hrt.2005.080382; Kim SK, 2007, PHARMACOL THERAPEUT, V113, P88, DOI 10.1016/j.pharmthera.2006.07.004; KLAUNIG JE, 1991, P SOC EXP BIOL MED, V198, P688; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Konstandi M, 2005, BIOCHEM PHARMACOL, V69, P277, DOI 10.1016/j.bcp.2004.09.024; Konstandi M, 2004, CHEM-BIOL INTERACT, V147, P65, DOI 10.1016/j.cbi.2003.10.007; Konstandi M, 1998, EUR J DRUG METAB PH, V23, P483, DOI 10.1007/BF03189999; Konstandi M, 2000, PHARMACOL RES, V41, P341, DOI 10.1006/phrs.1999.0597; Konstandi M, 1998, EUR J DRUG METAB PH, V23, P491, DOI 10.1007/BF03190000; Konstandi M, 2000, PHARMACOL RES, V42, P205, DOI 10.1006/phrs.2000.0675; Konstandi M, 2008, LIFE SCI, V82, P1, DOI 10.1016/j.lfs.2007.09.026; Konstandi M, 2006, LIFE SCI, V79, P331, DOI 10.1016/j.lfs.2006.01.012; Konstandi M, 2014, NEUROSCI BIOBEHAV R, V45, P149, DOI 10.1016/j.neubiorev.2014.05.011; Konstandi M, 2013, EXPERT OPIN DRUG MET, V9, P1317, DOI 10.1517/17425255.2013.816283; LANG MA, 1981, J BIOL CHEM, V256, P2068; LEGRAVEREND C, 1992, MOL ENDOCRINOL, V6, P259, DOI 10.1210/me.6.2.259; LEWIS DFV, 1993, MUTAT RES, V291, P61, DOI 10.1016/0165-1161(93)90018-U; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEFFORD IN, 1981, J NEUROSCI METH, V3, P207, DOI 10.1016/0165-0270(81)90056-X; Meredith C, 2003, XENOBIOTICA, V33, P511, DOI 10.1080/0049825031000085960; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; NEBERT DW, 1989, CRIT REV TOXICOL, V20, P153, DOI 10.3109/10408448909017908; Noordeen NA, 2010, DIABETES, V59, P153, DOI 10.2337/db08-0868; OKEY AB, 1990, PHARMACOL THERAPEUT, V45, P241, DOI 10.1016/0163-7258(90)90030-6; OMIECINSKI CJ, 1990, CANCER RES, V50, P4315; OMURA T, 1964, J BIOL CHEM, V239, P2379; Pampori NA, 1999, ENDOCRINOLOGY, V140, P1245, DOI 10.1210/en.140.3.1245; PELKONEN O, 1982, PHARMACOL REV, V34, P189; Rubi B, 2005, J BIOL CHEM, V280, P36824, DOI 10.1074/jbc.M505560200; Shimada T, 1998, CHEM RES TOXICOL, V11, P1048, DOI 10.1021/tx980090+; Stephanou P, 1998, EUR J DRUG METAB PH, V23, P475, DOI 10.1007/BF03189998; TUOMISTO J, 1985, PHARMACOL REV, V37, P249; Uno S, 2004, MOL PHARMACOL, V65, P1225, DOI 10.1124/mol.65.5.1225; Vorrink SU, 2014, TOXICOL APPL PHARM, V274, P408, DOI 10.1016/j.taap.2013.12.002; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; WAXMAN DJ, 1991, P NATL ACAD SCI USA, V88, P6868, DOI 10.1073/pnas.88.15.6868; Wiwi CA, 2004, GROWTH FACTORS, V22, P79, DOI 10.1080/08977190410001715172; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Woodcroft KJ, 2002, HEPATOLOGY, V35, P263, DOI 10.1053/jhep.2002.30691; Woodcroft KJ, 1997, CHEM-BIOL INTERACT, V107, P75, DOI 10.1016/S0009-2797(97)00075-6; Wu R, 2007, J PHARMACOL EXP THER, V320, P448, DOI 10.1124/jpet.106.111773; YAMAZOE Y, 1987, J BIOL CHEM, V262, P7423; Yoshida Y, 1996, BIOCHEM BIOPH RES CO, V229, P182, DOI 10.1006/bbrc.1996.1777; Yu J, 2012, BRAIN RES, V1430, P18, DOI 10.1016/j.brainres.2011.10.046; Zhang N, 2007, CARDIOVASC TOXICOL, V7, P282, DOI 10.1007/s12012-007-9007-6	76	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0128708	10.1371/journal.pone.0128708	http://dx.doi.org/10.1371/journal.pone.0128708			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466350	gold, Green Submitted, Green Published			2022-12-26	WOS:000363183100001
J	Morozov, VA; Morozov, AV; Rotem, A; Barkai, U; Bornstein, S; Denner, J				Morozov, Vladimir A.; Morozov, Alexey V.; Rotem, Avi; Barkai, Uriel; Bornstein, Stefan; Denner, Joachim			Extended Microbiological Characterization of Gottingen Minipigs in the Context of Xenotransplantation: Detection and Vertical Transmission of Hepatitis E Virus	PLOS ONE			English	Article							PORCINE ENDOGENOUS RETROVIRUSES; ANIMAL RESERVOIRS; CAPSID PROTEIN; INFECTION; SWINE; PIGS; PREVALENCE; IDENTIFICATION; EXPRESSION; ANTIBODIES	Xenotransplantation has been proposed as a solution to the shortage of suitable human donors. Pigs are currently favoured as donor animals for xenotransplantation of cells, including islet cells, or organs. To reduce the xenotransplantation-associated risk of infection of the recipient the pig donor should be carefully characterised. Gottingen minipigs from Ellegaard are often used for biomedical research and are regularly tested by their vendor for the presence of numerous bacteria, fungi, viruses and parasites. However, screening for some pathogens transmittable to humans had not been performed. The presence of microorganisms was examined in Gottingen Minipigs by PCR methods. Since zoonotic transmission of porcine hepatitis E virus HEV to humans has been demonstrated, extended search for HEV was considered as a priority. RNA from sera, islet and other cells from 40 minipigs were examined for HEV using different real-time reverse transcription (RT)-PCRs, among them two newly established. In addition, sera were examined by Western blot analysis using two recombinant capsid proteins of HEV as antigens. HEV RNA was not detected in pigs older than one year including gilts, but it was detected in the sera of three of ten animals younger than 1 year. Furthermore, HEV was also detected in the sera of three sows six days after delivery and their offspring, indicating vertical transmission of the virus. PCR amplicons were cloned, sequenced and the viruses were found to belong to the HEV genotype (gt) 3/4. Anti-HEV immunoglobulins G were detected in one sow and maternal antibodies in her six day old piglet. Since Gottingen minipigs were negative for many xenotransplantation-relevant microorganisms, they can now be classified as safe. HEV may be eliminated from the Ellegaard herd by selection of negative animals and/or by treatment of the animals.	[Morozov, Vladimir A.; Denner, Joachim] Robert Koch Inst, Berlin, Germany; [Morozov, Alexey V.] RAS, Engelhardt Inst Mol Biol, Moscow 117901, Russia; [Rotem, Avi; Barkai, Uriel] Beta O2 Technol Ltd, Rosh Haain, Israel; [Bornstein, Stefan] Tech Univ Dresden, Ctr Internal Med, Univ Clin Carl Gustav Carus, D-01062 Dresden, Germany	Robert Koch Institute; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Morozov, VA (corresponding author), Robert Koch Inst, Berlin, Germany.	MorozovV@rki.de; DennerJ@rki.de	Morozov, Alexey V/G-2480-2014; Barkai, Uriel/I-6316-2019	Morozov, Alexey V/0000-0003-4310-8073; Vladimir, Morozov/0000-0001-6587-572X	Beta-O2 Technologies Ltd.	Beta-O2 Technologies Ltd.	Beta-O2 Technologies Ltd. provided support in the form of salaries for authors AR and UB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abravanel F, 2013, J CLIN VIROL, V58, P624, DOI 10.1016/j.jcv.2013.10.003; Adlhoch C, 2009, VET MICROBIOL, V139, P270, DOI 10.1016/j.vetmic.2009.06.032; Andraud M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105527; BALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370; Baylis SA, 2011, J CLIN MICROBIOL, V49, P1234, DOI 10.1128/JCM.02578-10; Bollen P, 1997, PHARMACOL TOXICOL, V80, P3, DOI 10.1111/j.1600-0773.1997.tb01980.x; Bose PD, 2014, J GEN VIROL, V95, P1266, DOI 10.1099/vir.0.063602-0; Busby SA, 2013, XENOTRANSPLANTATION, V20, P188, DOI 10.1111/xen.12038; Casas M, 2011, VET MICROBIOL, V148, P27, DOI 10.1016/j.vetmic.2010.08.010; Chen XM, 2012, J MED VIROL, V84, P1396, DOI 10.1002/jmv.23237; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Denner J, 2012, CLIN MICROBIOL REV, V25, P318, DOI 10.1128/CMR.05011-11; Di Bartolo I, 2011, VET MICROBIOL, V149, P330, DOI 10.1016/j.vetmic.2010.12.007; Dremsek P, 2013, J VIROL METHODS, V190, P11, DOI 10.1016/j.jviromet.2013.03.010; Duvigneau JC, 2007, J IMMUNOL METHODS, V324, P38, DOI 10.1016/j.jim.2007.04.012; Fishman JA, 2001, J CARDIAC SURG, V16, P363, DOI 10.1111/j.1540-8191.2001.tb00536.x; Fishman JA, 2012, XENOTRANSPLANTATION, V19, P72, DOI 10.1111/j.1399-3089.2012.00693.x; Garkavenko O, 2008, TRANSPL P, V40, P590, DOI 10.1016/j.transproceed.2008.01.051; Garkavenko O, 2004, J MED VIROL, V72, P338, DOI 10.1002/jmv.10575; Garkavenko O, 2008, CELL TRANSPLANT, V17, P1381, DOI 10.3727/096368908787648056; Guu TSY, 2009, P NATL ACAD SCI USA, V106, P12992, DOI 10.1073/pnas.0904848106; HEWITT PE, 2014, LANCET, V14, P61034; Hofacre A, 2010, VIRUSES-BASEL, V2, P2618, DOI 10.3390/v2122618; Huang YW, 2005, J VIROL, V79, P1552, DOI 10.1128/JVI.79.3.1552-1558.2005; Jameel S, 1996, J VIROL, V70, P207, DOI 10.1128/JVI.70.1.207-216.1996; Johne R, 2014, INFECT GENET EVOL, V27, P212, DOI 10.1016/j.meegid.2014.06.024; Jothikumar N, 2006, J VIROL METHODS, V131, P65, DOI 10.1016/j.jviromet.2005.07.004; Kabrane-Lazizi Y, 1999, J VIROL, V73, P8848, DOI 10.1128/JVI.73.10.8848-8850.1999; Kamar N, 2014, NEW ENGL J MED, V370, P1111, DOI 10.1056/NEJMoa1215246; Kamar N, 2014, CLIN MICROBIOL REV, V27, P116, DOI 10.1128/CMR.00057-13; Kanai Y, 2010, J MED VIROL, V82, P69, DOI 10.1002/jmv.21647; Kasorndorkbua C, 2003, CAN J VET RES, V67, P303; Khudyakov YE, 1999, J CLIN MICROBIOL, V37, P2863, DOI 10.1128/JCM.37.9.2863-2871.1999; KHUROO MS, 1995, LANCET, V345, P1025, DOI 10.1016/S0140-6736(95)90761-0; Krumbholz A, 2013, VET MICROBIOL, V167, P394, DOI 10.1016/j.vetmic.2013.10.001; Kumar A, 2004, INT J GYNECOL OBSTET, V85, P240, DOI 10.1016/j.ijgo.2003.11.018; Kumar RM, 2001, EUR J OBSTET GYN R B, V100, P9, DOI 10.1016/S0301-2115(01)00448-1; Li TC, 2005, J VIROL, V79, P12999, DOI 10.1128/JVI.79.20.12999-13006.2005; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087600; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Matsuda H, 2003, J INFECT DIS, V188, P944, DOI 10.1086/378074; McAnulty PA, 2012, MINIPIG IN BIOMEDICAL RESEARCH, P1; Meng XJ, 2010, VET MICROBIOL, V140, P256, DOI 10.1016/j.vetmic.2009.03.017; Meng XJ, 2010, J VIRAL HEPATITIS, V17, P153, DOI 10.1111/j.1365-2893.2009.01257.x; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Morozov VA, 2007, VIROLOGY, V367, P59, DOI 10.1016/j.virol.2007.05.018; Nakai I, 2006, AM J TROP MED HYG, V75, P1171, DOI 10.4269/ajtmh.2006.75.1171; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; Palmarini M, 2001, J VIROL, V75, P11319, DOI 10.1128/JVI.75.23.11319-11327.2001; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Pavio N, 2010, VET RES, V41, DOI 10.1051/vetres/2010018; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Purcell R.H., 2001, FIELDS VIROLOGY, P3051; Riddell MA, 2000, J VIROL, V74, P8011, DOI 10.1128/JVI.74.17.8011-8017.2000; Robinson RA, 1998, PROTEIN EXPRES PURIF, V12, P75, DOI 10.1006/prep.1997.0817; Scobie L, 2013, J VIRAL HEPATITIS, V20, P1, DOI 10.1111/jvh.12024; Semaan M, 2013, XENOTRANSPLANTATION, V20, P148, DOI 10.1111/xen.12032; Smith DB, 2014, J GEN VIROL, V95, P2223, DOI 10.1099/vir.0.068429-0; Sonoda H, 2004, J CLIN MICROBIOL, V42, P5371, DOI 10.1128/JCM.42.11.5371-5374.2004; Takahashi K, 2004, VIROLOGY, V330, P501, DOI 10.1016/j.virol.2004.10.006; Takahashi K, 2004, HEPATOL RES, V29, P212, DOI 10.1016/j.hepres.2004.04.004; Takahashi M, 2005, J GEN VIROL, V86, P1807, DOI 10.1099/vir.0.80909-0; Takeuchi Y, 1998, J VIROL, V72, P9986, DOI 10.1128/JVI.72.12.9986-9991.1998; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Tanaka H, 2004, XENOTRANSPLANTATION, V11, P503, DOI 10.1111/j.1399-3089.2004.00170.x; Tang XH, 2011, P NATL ACAD SCI USA, V108, P10266, DOI 10.1073/pnas.1101309108; Ward P, 2009, J APPL MICROBIOL, V106, P1360, DOI 10.1111/j.1365-2672.2008.04104.x; Wibawa IDN, 2004, J MED VIROL, V73, P38, DOI 10.1002/jmv.20059; Wilson CA, 2008, CELL MOL LIFE SCI, V65, P3399, DOI 10.1007/s00018-008-8498-z; Wilson CA, 2000, J VIROL, V74, P49, DOI 10.1128/JVI.74.1.49-56.2000; Wynyard S, 2014, XENOTRANSPLANTATION, V21, P309, DOI 10.1111/xen.12102; Yamamoto H, 2008, EXP ANIM TOKYO, V57, P367, DOI 10.1538/expanim.57.367	72	28	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139893	10.1371/journal.pone.0139893	http://dx.doi.org/10.1371/journal.pone.0139893			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466154	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100064
J	Wang, JH; Guo, Q; Ma, ZX; Ma, QL; Yu, MX; Yin, XF; Lu, SS; Xie, HQ; Jiang, YH; Shen, D; Ma, LY; Shi, H; Yu, WJ; Lou, YJ; Li, Y; Yang, M; Xu, GX; Mao, LP; Li, JH; Wang, HP; Wang, DM; Wei, JY; Tong, HY; Huang, J; Jin, J				Wang, Jing-Han; Guo, Qi; Ma, Zhi-Xin; Ma, Qiu-Ling; Yu, Meng-Xia; Yin, Xiu-Feng; Lu, Sha-Sha; Xie, Hong-Qiong; Jiang, Yue-Hong; Shen, Dan; Ma, Li-Ya; Shi, Hui; Yu, Wen-Juan; Lou, Ye-Jiang; Li, Ying; Yang, Min; Xu, Gai-Xiang; Mao, Li-Ping; Li, Jian-Hu; Wang, Huan-Ping; Wang, Dong-Mei; Wei, Ju-Ying; Tong, Hong-Yan; Huang, Jian; Jin, Jie			Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; PROGNOSTIC-SIGNIFICANCE; INITIATION; DIAGNOSIS; YOUNGER; OLDER; TIME	The effect of time from diagnosis to treatment (TDT) on overall survival of patients with acute myeloid leukemia (AML) remains obscure. Furthermore, whether chemotherapy delay impacts overall survival (OS) of patients with a special molecular subtype has not been investigated. Here, we enrolled 364 cases of AML to assess the effect of TDT on OS by fractional polynomial regression in the context of clinical parameters and genes of FLT3ITD, NPM1, CEBPA, DNMT3a, and IDH1/2 mutations. Results of the current study show IDH1/2 mutations are associated with older age, M0 morphology, an intermediate cytogenetic risk group, and NPM1 mutations. TDT associates with OS for AML patients in a nonlinear pattern with a J shape. Moreover, adverse effect of delayed treatment on OS was observed in patients with IDH1/2 mutations, but not in those with IDH1/2 wildtype. Therefore, initiating chemotherapy as soon as possible after diagnosis might be a potential strategy to improve OS in AML patients with IDH1/2 mutations.	[Wang, Jing-Han; Ma, Zhi-Xin; Ma, Qiu-Ling; Yu, Meng-Xia; Yin, Xiu-Feng; Lu, Sha-Sha; Xie, Hong-Qiong; Jiang, Yue-Hong; Shen, Dan; Ma, Li-Ya; Shi, Hui; Yu, Wen-Juan; Lou, Ye-Jiang; Li, Ying; Yang, Min; Xu, Gai-Xiang; Mao, Li-Ping; Li, Jian-Hu; Wang, Huan-Ping; Wang, Dong-Mei; Wei, Ju-Ying; Tong, Hong-Yan; Huang, Jian; Jin, Jie] Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Jing-Han; Ma, Zhi-Xin; Ma, Qiu-Ling; Yu, Meng-Xia; Yin, Xiu-Feng; Lu, Sha-Sha; Xie, Hong-Qiong; Jiang, Yue-Hong; Shen, Dan; Ma, Li-Ya; Shi, Hui; Yu, Wen-Juan; Lou, Ye-Jiang; Li, Ying; Yang, Min; Xu, Gai-Xiang; Mao, Li-Ping; Li, Jian-Hu; Wang, Huan-Ping; Wang, Dong-Mei; Wei, Ju-Ying; Tong, Hong-Yan; Huang, Jian; Jin, Jie] Zhejiang Univ, Affiliated Hosp 1, Inst Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Jing-Han; Ma, Qiu-Ling; Tong, Hong-Yan; Huang, Jian; Jin, Jie] Key Lab Hematopoiet Malignancies, Hangzhou, Zhejiang, Peoples R China; [Guo, Qi] Zhejiang Univ, Affiliated Hosp 1, Dept Nephrol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Wei, JY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China.	weijuy@hotmail.com; hongyantong@aliyun.com; househuang@hotmail.com; zjuhematology@163.com			National Natural Science Foundation of China [81470305]; National Public Health Grant Research Foundation [201202017]; Foundation of Innovation Team for Basic and Clinical Research of Zhejiang Province [2011R50015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Public Health Grant Research Foundation; Foundation of Innovation Team for Basic and Clinical Research of Zhejiang Province	This work was supported by National Natural Science Foundation of China grants (81470305), National Public Health Grant Research Foundation (201202017) and the Foundation of Innovation Team for Basic and Clinical Research of Zhejiang Province (2011R50015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoli S, 2013, BLOOD, V121, P2618, DOI 10.1182/blood-2012-09-454553; Brothman AR, 2009, CYTOGENET GENOME RES, V127, P1, DOI 10.1159/000279442; Chen WL, 2014, BLOOD, V124, P1645, DOI 10.1182/blood-2014-02-554204; Feng JH, 2012, AM J BLOOD RES, V2, P254; Im AP, 2014, LEUKEMIA, V28, P1774, DOI 10.1038/leu.2014.124; Jin J, 2013, LANCET ONCOL, V14, P599, DOI 10.1016/S1470-2045(13)70152-9; Ma QL, 2015, INT J CANCER, V137, P1058, DOI 10.1002/ijc.29395; O'Donnell MR, 2012, J NATL COMPR CANC NE, V10, P984, DOI 10.6004/jnccn.2012.0103; Ostgard LSG, 2014, LEUKEMIA, V28, P1926, DOI 10.1038/leu.2014.157; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Rakheja D, 2012, HUM PATHOL, V43, P1541, DOI 10.1016/j.humpath.2012.05.003; Royston P, 2004, STAT MED, V23, P2509, DOI 10.1002/sim.1815; Sauerbrei WM-H C, 2006, COMPUTATIONAL STAT D, V50, P464; Sekeres MA, 2009, BLOOD, V113, P28, DOI 10.1182/blood-2008-05-157065; Wang JH, 2013, P NATL ACAD SCI USA, V110, P17017, DOI 10.1073/pnas.1315558110; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020	16	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140622	10.1371/journal.pone.0140622	http://dx.doi.org/10.1371/journal.pone.0140622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466372	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100154
J	Qin, XK; Jiang, YJ; Tse, YC; Wang, YL; Wong, TP; Paudel, HK				Qin, Xike; Jiang, Yongjun; Tse, Yiu Chung; Wang, Yunling; Wong, Tak Pan; Paudel, Hemant K.			Early Growth Response 1 (Egr-1) Regulates N-Methyl-D-aspartate Receptor (NMDAR)-dependent Transcription of PSD-95 and alpha-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid Receptor (AMPAR) Trafficking in Hippocampal Primary Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; POSTSYNAPTIC DENSITY 95; LONG-TERM POTENTIATION; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES; GENE-EXPRESSION; MAMMALIAN BRAIN; PLASTICITY; PHOSPHORYLATION; MECHANISMS	The N-methyl-D-aspartate receptor (NMDAR) controls synaptic plasticity and memory function and is one of the major inducers of transcription factor Egr-1 in the hippocampus. However, how Egr-1 mediates the NMDAR signal in neurons has remained unclear. Here, we show that the hippocampus of mice lacking Egr-1 displays electrophysiology properties and ultrastructure that are similar to mice overexpressing PSD-95, a major scaffolding protein of postsynaptic density involved in synapse formation, synaptic plasticity, and synaptic targeting of AMPA receptors (AMPARs), which mediate the vast majority of excitatory transmission in the CNS. We demonstrate that Egr-1 is a transcription repressor of the PSD-95 gene and is recruited to the PSD-95 promoter in response to NMDAR activation. Knockdown of Egr-1 in rat hippocampal primary neurons blocks NMDAR-induced PSD-95 down-regulation and AMPAR endocytosis. Likewise, overexpression of Egr-1 in rat hippocampal primary neurons causes reduction in PSD-95 protein level and promotes AMPAR endocytosis. Our data indicate that Egr-1 is involved in NMDAR-mediated PSD-95 down-regulation and AMPAR endocytosis, a process important in the expression of long term depression.	[Qin, Xike; Jiang, Yongjun; Wang, Yunling; Paudel, Hemant K.] Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; [Jiang, Yongjun; Paudel, Hemant K.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H4H 1R3, Canada; [Tse, Yiu Chung; Wong, Tak Pan] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ H4H 1R3, Canada; [Tse, Yiu Chung; Wong, Tak Pan] McGill Univ, Dept Psychiat, Montreal, PQ H4H 1R3, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Paudel, HK (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, 3755 Cote Ste, Montreal, PQ H3T 1E2, Canada.	hemant.paudel@mcgill.ca		Wong, Tak Pan/0000-0001-8611-4911	Canadian Institute for Health Research; Alzheimer's Society of Canada	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Society of Canada	This work was supported by grants from Canadian Institute for Health Research and Alzheimer's Society of Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Akama KT, 2003, J NEUROSCI, V23, P2333; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; Bao JX, 2004, NAT NEUROSCI, V7, P1250, DOI 10.1038/nn1342; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Beck H, 2008, AM J PATHOL, V173, P77, DOI 10.2353/ajpath.2008.070648; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Bianchetta MJ, 2011, J NEUROSCI, V31, P12029, DOI 10.1523/JNEUROSCI.2388-11.2011; Bingol B, 2004, NEUROPHARMACOLOGY, V47, P755, DOI 10.1016/j.neuropharm.2004.07.028; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen XB, 2005, P NATL ACAD SCI USA, V102, P11551, DOI 10.1073/pnas.0505359102; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dyrvig M, 2014, GENE, V539, P8, DOI 10.1016/j.gene.2014.01.072; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Han K, 2008, PROG NEUROBIOL, V84, P263, DOI 10.1016/j.pneurobio.2007.10.011; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Henley Jeremy M, 2013, Dialogues Clin Neurosci, V15, P11; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Kubosaki A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r41; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Li T, 2007, J BIOL CHEM, V282, P6619, DOI 10.1074/jbc.M606347200; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lu YF, 2011, J BIOL CHEM, V286, P20569, DOI 10.1074/jbc.M111.220962; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Mammen AL, 1997, J NEUROSCI, V17, P7351; Marra V, 2012, NEURON, V76, P579, DOI 10.1016/j.neuron.2012.08.042; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Nikonenko I, 2008, J CELL BIOL, V183, P1115, DOI 10.1083/jcb.200805132; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; de Arce KP, 2010, J NEUROSCI, V30, P3728, DOI 10.1523/JNEUROSCI.2024-09.2010; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Qureshi HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084615; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Stathakis DG, 1999, J NEUROCHEM, V73, P2250, DOI 10.1046/j.1471-4159.1999.0732250.x; Stein V, 2003, J NEUROSCI, V23, P5503; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Thiel G, 2010, CELL CALCIUM, V47, P397, DOI 10.1016/j.ceca.2010.02.005; Tsai NP, 2012, CELL, V151, P1581, DOI 10.1016/j.cell.2012.11.040; Tse YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027215; Yudowski GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053965	57	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29603	29616		10.1074/jbc.M115.668889	http://dx.doi.org/10.1074/jbc.M115.668889			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26475861	Green Published, hybrid			2022-12-26	WOS:000366613400041
J	Chen, Y; Wang, XM; Zhou, L; He, Y; Wang, D; Qi, YH; Jiang, DA				Chen, Yue; Wang, Xiao-Man; Zhou, Li; He, Yi; Wang, Dun; Qi, Yan-Hua; Jiang, De-An			Rubisco Activase Is Also a Multiple Responder to Abiotic Stresses in Rice	PLOS ONE			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE OXYGENASE; GIBBERELLIN-BINDING PHOSPHOPROTEIN; HEAT-STRESS; DROUGHT STRESS; 2 ISOFORMS; PROTEIN; EXPRESSION; SPINACH; PHOTOSYNTHESIS; ACCLIMATION	Ribulose-1,5-bisphosphate carboxylase/oxygenase activase (RCA) is a nuclear gene that encodes a chloroplast protein that plays an important role in photosynthesis. Some reports have indicated that it may play a role in acclimation to different abiotic stresses. In this paper, we analyzed the stress-responsive elements in the 2.0 kb 5'-upstream regions of the RCA gene promoter and the primary, secondary and tertiary structure of the protein. We identified some cis-elements of multiple stress-related components in the RCA promoter. Amino acid and evolution analyses showed that the RCA protein had conserved regions between different species; however, the size and type varied. The secondary structures, binding sites and tertiary structures of the RCA proteins were also different. This might reflect the differences in the transcription and translation levels of the two RCA isoforms during adaptation to different abiotic stresses. Although both the transcription and translation levels of RCA isoforms in the rice leaves increased under various stresses, the large isoform was increased more significantly in the chloroplast stroma and thylakoid. It can be concluded that RCA, especially RCA(L), is also a multiple responder to abiotic stresses in rice, which provides new insights into RCA functions.	[Chen, Yue; Wang, Xiao-Man; Zhou, Li; He, Yi; Wang, Dun; Qi, Yan-Hua; Jiang, De-An] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Jiang, DA (corresponding author), Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310058, Zhejiang, Peoples R China.	dajiang@zju.edu.cn	wang, xiaoman/GQH-0836-2022; He, Yi/Z-4347-2019	He, Yi/0000-0003-0465-7352				ANDREWS TJ, 1995, J EXP BOT, V46, P1293, DOI 10.1093/jxb/46.special_issue.1293; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; DEJIMENEZ ES, 1995, BIOCHEMISTRY-US, V34, P2826, DOI 10.1021/bi00009a012; Guha A, 2013, J PHOTOCH PHOTOBIO B, V119, P71, DOI 10.1016/j.jphotobiol.2012.12.006; Ji KX, 2012, J PLANT PHYSIOL, V169, P336, DOI 10.1016/j.jplph.2011.10.010; Kallis RP, 2000, PLANT PHYSIOL, V123, P1077, DOI 10.1104/pp.123.3.1077; Kaur C, 2014, PHYSIOL PLANTARUM, V152, P1, DOI 10.1111/ppl.12147; Komatsu S, 1996, FEBS LETT, V384, P167, DOI 10.1016/0014-5793(96)00275-X; Kurek I, 2007, PLANT CELL, V19, P3230, DOI 10.1105/tpc.107.054171; Law RD, 1999, PLANT PHYSIOL, V120, P173, DOI 10.1104/pp.120.1.173; Law RD, 2001, PLANTA, V214, P117, DOI 10.1007/s004250100592; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu B, 2012, PLANT CELL REP, V31, P1021, DOI 10.1007/s00299-011-1220-x; Nakamura R, 2014, J PROTEOME RES, V13, P489, DOI 10.1021/pr4006487; Ofran Y, 2007, BIOINFORMATICS, V23, pE13, DOI 10.1093/bioinformatics/btl303; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; QIAN J, 1993, PLANT PHYSIOL, V102, P683, DOI 10.1104/pp.102.2.683; ROBINSON SP, 1989, PLANT PHYSIOL, V90, P968, DOI 10.1104/pp.90.3.968; Rokka A, 2001, PLANT J, V25, P463, DOI 10.1046/j.1365-313x.2001.00981.x; Rollins JA, 2013, J EXP BOT, V64, P3201, DOI 10.1093/jxb/ert158; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RUNDLE SJ, 1991, J BIOL CHEM, V266, P14802; Sage RF, 2008, J EXP BOT, V59, P1581, DOI 10.1093/jxb/ern053; Salekdeh GH, 2002, PROTEOMICS, V2, P1131, DOI 10.1002/1615-9861(200209)2:9<1131::AID-PROT1131>3.0.CO;2-1; Salvucci ME, 2003, PLANTA, V216, P736, DOI 10.1007/s00425-002-0923-1; Sharma A, 2002, BIOCHEM BIOPH RES CO, V290, P690, DOI 10.1006/bbrc.2001.6269; SHEN JB, 1991, J BIOL CHEM, V266, P8963; Son JA, 2014, SAUDI J BIOL SCI, V21, P89, DOI 10.1016/j.sjbs.2013.06.002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; To KY, 1999, PLANTA, V209, P66, DOI 10.1007/s004250050607; Wang D, 2010, PHYSIOL PLANTARUM, V139, P55, DOI 10.1111/j.1399-3054.2009.01344.x; Way DA, 2008, PLANT CELL ENVIRON, V31, P1250, DOI 10.1111/j.1365-3040.2008.01842.x; WERNEKE JM, 1989, PLANT CELL, V1, P815, DOI 10.1105/tpc.1.8.815; WERNEKE JM, 1988, P NATL ACAD SCI USA, V85, P787, DOI 10.1073/pnas.85.3.787; Yamori W, 2006, PLANT CELL ENVIRON, V29, P1659, DOI 10.1111/j.1365-3040.2006.01550.x; Yang ZP, 2012, BIOCHEM BIOPH RES CO, V418, P565, DOI 10.1016/j.bbrc.2012.01.073; Yin ZT, 2010, PLANT PHYSIOL, V152, P1625, DOI 10.1104/pp.109.148312; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhang N, 1999, P NATL ACAD SCI USA, V96, P9438, DOI 10.1073/pnas.96.16.9438; Zhang N, 2002, P NATL ACAD SCI USA, V99, P3330, DOI 10.1073/pnas.042529999; Zhang N, 2001, PHOTOSYNTH RES, V68, P29, DOI 10.1023/A:1011845506196	44	37	41	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140934	10.1371/journal.pone.0140934	http://dx.doi.org/10.1371/journal.pone.0140934			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479064	gold, Green Submitted, Green Published			2022-12-26	WOS:000363026600026
J	Liu, QL; Krishnasamy, Y; Rehman, H; Lemasters, JJ; Schnellmann, RG; Zhong, Z				Liu, Qinlong; Krishnasamy, Yasodha; Rehman, Hasibur; Lemasters, John J.; Schnellmann, Rick G.; Zhong, Zhi			Disrupted Renal Mitochondrial Homeostasis after Liver Transplantation in Rats	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; PROLIFERATOR-ACTIVATED RECEPTOR; ACUTE TUBULAR-NECROSIS; CRITICAL ILLNESS; ISCHEMIA-REPERFUSION; HEPATORENAL-SYNDROME; MAMMALIAN-CELLS; PROTEIN-KINASE; RISK-FACTORS; BIOGENESIS	Background Suppressed mitochondrial biogenesis (MB) contributes to acute kidney injury (AKI) after many insults. AKI occurs frequently after liver transplantation (LT) and increases mortality. This study investigated whether disrupted mitochondrial homeostasis plays a role in AKI after LT. Methods Livers were explanted from Lewis rats and implanted after 18 h cold storage. Kidney and blood were collected 18 h after LT. Results In the kidney, oxidative phosphorylation (OXPHOS) proteins ATP synthase-beta and NADH dehydrogenase-3 decreased 44% and 81%, respectively, with marked reduction in associated mRNAs. Renal PGC-1 alpha, the major regulator of MB, decreased 57% with lower mRNA and increased acetylation, indicating inhibited synthesis and suppressed activation. Mitochondrial transcription factor-A, which controls mtDNA replication and transcription, protein and mRNA decreased 66% and 68%, respectively, which was associated with 64% decreases in mtDNA. Mitochondrial fission proteins Drp-1 and Fis-1 and mitochondrial fusion protein mitofusin-1 all decreased markedly. In contrast, PTEN-induced putative kinase 1 and microtubule-associated protein 1A/1B-light chain 3 increased markedly after LT, indicating enhanced mitophagy. Concurrently, 18- and 13-fold increases in neutrophil gelatinase-associated lipocalin and cleaved caspase-3 occurred in renal tissue. Both serum creatinine and blood urea nitrogen increased >= 2 fold. Mild to moderate histological changes were observed in the kidney, including loss of brush border, vacuolization of tubular cells in the cortex, cast formation and necrosis in some proximal tubular cells. Finally, myeloperoxidase and ED-1 also increased, indicating inflammation. Conclusion Suppression of MB, inhibition of mitochondrial fission/fusion and enhancement of mitophagy occur in the kidneys of recipients of liver grafts after long cold storage, which may contribute to the occurrence of AKI and increased mortality after LT.	[Liu, Qinlong; Krishnasamy, Yasodha; Rehman, Hasibur; Lemasters, John J.; Schnellmann, Rick G.; Zhong, Zhi] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Liu, Qinlong] Dalian Med Univ, Affiliated Hosp 2, Dalian, Liaoning Provin, Peoples R China; [Lemasters, John J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Schnellmann, Rick G.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA	Medical University of South Carolina; Dalian Medical University; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Zhong, Z (corresponding author), Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.	zhong@musc.edu	Rehman, Hasibur/K-5224-2019	Rehman, Hasibur/0000-0003-1551-6520	National Institutes of Health [DK70844, DK073336, DK037034]; Chinese National Natural Foundation [81470878]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK037034, R56DK037034, R01DK037034, R01DK073336, R01DK070844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R41ES023767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Natural Foundation(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in part, by grants DK70844, DK073336 and DK037034 from the National Institutes of Health and grant #81470878 from Chinese National Natural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alqahtani SA, 2012, CURR OPIN GASTROEN, V28, P230, DOI 10.1097/MOG.0b013e3283527f16; Altamirano J, 2012, CLIN GASTROENTEROL H, V10, P65, DOI 10.1016/j.cgh.2011.09.011; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Bagshaw SM, 2010, CAN J ANESTH, V57, P985, DOI 10.1007/s12630-010-9375-4; Bagshaw SM, 2010, CAN J ANESTH, V57, P999, DOI 10.1007/s12630-010-9376-3; Bahirwani R, 2011, TRANSPLANTATION, V92, P952, DOI 10.1097/TP.0b013e31822e6eda; Barri YM, 2009, LIVER TRANSPLANT, V15, P475, DOI 10.1002/lt.21682; Biancofiorea G, 2008, CURR OPIN ORGAN TRAN, V13, P291, DOI 10.1097/MOT.0b013e328300a058; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Cabezuelo JB, 2006, KIDNEY INT, V69, P1073, DOI 10.1038/sj.ki.5000216; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Choi HK, 2011, J CLIN VIROL, V52, P192, DOI 10.1016/j.jcv.2011.07.013; Cui J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003394; Dikov D, 2011, EMBO J, V30, P2751, DOI 10.1038/emboj.2011.219; FOX IJ, 1993, AM J GASTROENTEROL, V88, P1876; Fraley DS, 1998, KIDNEY INT, V54, P518, DOI 10.1046/j.1523-1755.1998.00004.x; Francoz C, 2012, CRIT CARE, V16, DOI 10.1186/cc11207; Funk JA, 2012, AM J PHYSIOL-RENAL, V302, pF853, DOI 10.1152/ajprenal.00035.2011; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Garrett SM, 2014, J PHARMACOL EXP THER, V350, P257, DOI 10.1124/jpet.114.214700; Gonwa TA, 2006, AM J TRANSPLANT, V6, P2651, DOI 10.1111/j.1600-6143.2006.01526.x; Gunst J, 2013, CRIT CARE MED, V41, P182, DOI 10.1097/CCM.0b013e3182676657; Harland RC, 1996, J HEPATOL, V25, P248, DOI 10.1016/S0168-8278(96)80082-1; Herrmann JM, 2012, ADV EXP MED BIOL, V748, P41, DOI 10.1007/978-1-4614-3573-0_3; Holt S, 1999, KIDNEY INT, V55, P271, DOI 10.1046/j.1523-1755.1999.00252.x; Hoppins S, 2014, CURR OPIN CELL BIOL, V29, P46, DOI 10.1016/j.ceb.2014.03.005; Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005; Huang PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020655; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Iglesias JI, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-30; Ishihara M, 2013, AM J PHYSIOL-RENAL, V305, pF495, DOI 10.1152/ajprenal.00642.2012; Jesinkey SR, 2014, J AM SOC NEPHROL, V25, P1157, DOI 10.1681/ASN.2013090952; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kobayashi N, 2000, SCIENCE, V287, P1258, DOI 10.1126/science.287.5456.1258; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Korrapati MC, 2012, J PHARMACOL EXP THER, V341, P126, DOI 10.1124/jpet.111.190249; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lee HT, 2009, LAB INVEST, V89, P196, DOI 10.1038/labinvest.2008.124; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Liu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041834; MANDAL AK, 1982, AM J KIDNEY DIS, V2, P363, DOI 10.1016/S0272-6386(82)80096-6; MANNY J, 1980, ISRAEL J MED SCI, V16, P153; MCCAULEY J, 1990, NEPHRON, V55, P121, DOI 10.1159/000185938; Mehta RL, 2003, J AM SOC NEPHROL, V14, P2178, DOI 10.1097/01.ASN.0000079042.13465.1A; Mehta RL, 2003, SEMIN NEPHROL, V23, P283, DOI 10.1016/S0270-9295(03)00064-0; Nadim MK, 2012, LIVER TRANSPLANT, V18, P539, DOI 10.1002/lt.23384; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; O'Riordan A, 2009, NEPHROL DIAL TRANSPL, V24, P2276, DOI 10.1093/ndt/gfp112; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Parikh SM, 2015, SEMIN NEPHROL, V35, P108, DOI 10.1016/j.semnephrol.2015.01.011; Pham PTT, 2009, ADV CHRONIC KIDNEY D, V16, P256, DOI 10.1053/j.ackd.2009.04.002; Pi HF, 2013, AUTOPHAGY, V9, P1780, DOI 10.4161/auto.25665; Pirola L, 2012, MOL CELL ENDOCRINOL, V362, P1, DOI 10.1016/j.mce.2012.05.011; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Redmann M, 2014, INT J BIOCHEM CELL B, V53, P127, DOI 10.1016/j.biocel.2014.05.010; Rehman H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065029; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Sampaio MS, 2014, CLIN LIVER DIS, V18, P543, DOI 10.1016/j.cld.2014.05.003; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Smith JA, 2015, J PHARMACOL EXP THER, V352, P346, DOI 10.1124/jpet.114.221085; Stallons L Jay, 2013, Curr Pathobiol Rep, V1, DOI 10.1007/s40139-013-0023-x; Stallons LJ, 2014, TOXICOL LETT, V224, P326, DOI 10.1016/j.toxlet.2013.11.014; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wadei HM, 2013, J INTENSIVE CARE MED, V28, P79, DOI 10.1177/0885066611408692; Warner NS, 2011, J INVEST MED, V59, P1244, DOI 10.2130/JIM.0b013e3182321471; Weber ML, 2012, LIVER TRANSPLANT, V18, P1290, DOI 10.1002/lt.23522; Wertheim JA, 2012, CURR OPIN ORGAN TRAN, V17, P235, DOI 10.1097/MOT.0b013e3283534ec9; Winder WW, 2006, MED SCI SPORT EXER, V38, P1945, DOI 10.1249/01.mss.0000233798.62153.50; Zhong Z, 2008, AM J PHYSIOL-GASTR L, V295, pG823, DOI 10.1152/ajpgi.90287.2008; Zhu M, 2010, TRANSPL P, V42, P3634, DOI 10.1016/j.transproceed.2010.08.059; Zsengeller ZK, 2012, J HISTOCHEM CYTOCHEM, V60, P521, DOI 10.1369/0022155412446227	77	4	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140906	10.1371/journal.pone.0140906	http://dx.doi.org/10.1371/journal.pone.0140906			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26480480	Green Published, gold, Green Submitted			2022-12-26	WOS:000363026600025
J	Torkashvand, F; Vaziri, B; Maleknia, S; Heydari, A; Vossoughi, M; Davami, F; Mahboudi, F				Torkashvand, Fatemeh; Vaziri, Behrouz; Maleknia, Shayan; Heydari, Amir; Vossoughi, Manouchehr; Davami, Fatemeh; Mahboudi, Fereidoun			Designed Amino Acid Feed in Improvement of Production and Quality Targets of a Therapeutic Monoclonal Antibody	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; SERUM-FREE MEDIUM; CHO-CELLS; OPTIMIZATION; MEDIA; GLYCOSYLATION; METABOLISM; COMPONENTS; HYBRIDOMA	Cell culture feeds optimization is a critical step in process development of pharmaceutical recombinant protein production. Amino acids are the basic supplements of mammalian cell culture feeds with known effect on their growth promotion and productivity. In this study, we reported the implementation of the Plackett-Burman (PB) multifactorial design to screen the effects of amino acids on the growth promotion and productivity of a Chinese hamster ovary DG-44 (CHO-DG44) cell line producing bevacizumab. After this screening, the amino acid combinations were optimized by the response surface methodology (RSM) to determine the most effective concentration in feeds. Through this strategy, the final monoclonal antibody (mAb) titre was enhanced by 70%, compared to the control group. For this particular cell line, aspartic acid, glutamic acid, arginine and glycine had the highest positive effects on the final mAb titre. Simultaneously, the impact of the designed amino acid feed on some critical quality attributes of bevacizumab was examined in the group with highest productivity. The product was analysed for N-glycan profiles, charge variant distribution, and low molecular weight forms. The results showed that the target product quality has been improved using this feeding strategy. It was shown how this strategy could significantly diminish the time and number of experiments in identifying the most effective amino acids and related concentrations in target product enhancement. This model could be successfully applied to other components of culture media and feeds.	[Torkashvand, Fatemeh; Vaziri, Behrouz; Davami, Fatemeh; Mahboudi, Fereidoun] Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran; [Maleknia, Shayan] Aryogen Biopharma Inc, Proc Dev Dept, Alborz, Iran; [Heydari, Amir; Vossoughi, Manouchehr] Sharif Univ Technol, Dept Chem & Petr Engn, Biochem & Bioenvironm Res Ctr, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Sharif University of Technology	Vaziri, B (corresponding author), Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran.	behrouz-vaziri@pasteur.ac.ir; mahboudi@pasteur.ac.ir	Heydari, Amir/W-6408-2019; Davami, Fatemeh/L-8916-2017; Mahboudi, Fereidoun/L-5057-2017; Vaziri, Behrouz/B-4619-2009; Torkashvand, Fatemeh/K-4247-2018	Heydari, Amir/0000-0001-8357-6694; Davami, Fatemeh/0000-0002-7693-2926; Mahboudi, Fereidoun/0000-0002-3380-5257; Torkashvand, Fatemeh/0000-0003-3066-1144	Aryogen Biopharma Inc.	Aryogen Biopharma Inc.	This work was funded by Aryogen Biopharma Inc. The funder provided support in the form of salaries for S. A., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Ahuja SK, 2004, BIOTECHNOL BIOENG, V85, P666, DOI 10.1002/bit.10880; Altamirano C, 2004, J BIOTECHNOL, V110, P171, DOI 10.1016/j.jbiotec.2004.02.004; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Carrillo-Cocom LM, 2015, CYTOTECHNOLOGY, V67, P809, DOI 10.1007/s10616-014-9720-5; Chen PF, 2005, J BIOTECHNOL, V117, P277, DOI 10.1016/j.jbiotec.2005.02.003; Chong WPK, 2010, J BIOTECHNOL, V147, P116, DOI 10.1016/j.jbiotec.2010.03.018; Chong WPK, 2012, BIOTECHNOL BIOENG, V109, P3103, DOI 10.1002/bit.24580; Costa AR, 2010, EUR J PHARM BIOPHARM, V74, P127, DOI 10.1016/j.ejpb.2009.10.002; del Val IJ, 2010, BIOTECHNOL PROGR, V26, P1505, DOI 10.1002/btpr.470; deZengotita VM, 2002, BIOTECHNOL BIOENG, V78, P741, DOI 10.1002/bit.10255; DUVAL D, 1991, BIOTECHNOL BIOENG, V38, P561, DOI 10.1002/bit.260380602; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Gheshlaghi R, 2005, BIOTECHNOL BIOENG, V90, P754, DOI 10.1002/bit.20474; Ghorbaniaghdam A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090832; Gonzalez-Leal IJ, 2011, BIOTECHNOL PROGR, V27, P1709, DOI 10.1002/btpr.674; Gramer MJ, 2011, BIOTECHNOL BIOENG, V108, P1591, DOI 10.1002/bit.23075; Hanczko R, 2007, J CHROMATOGR A, V1163, P25, DOI 10.1016/j.chroma.2007.06.013; HANSEN HA, 1994, APPL MICROBIOL BIOT, V41, P560, DOI 10.1007/BF00178489; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Jordan M, 2013, CYTOTECHNOLOGY, V65, P31, DOI 10.1007/s10616-012-9462-1; Kim EJ, 1998, IN VITRO CELL DEV-AN, V34, P757, DOI 10.1007/s11626-998-0029-6; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Kishishita S, 2015, J BIOSCI BIOENG, V120, P78, DOI 10.1016/j.jbiosc.2014.11.022; Li F, 2010, MABS-AUSTIN, V2, P466, DOI 10.4161/mabs.2.5.12720; Parampalli A, 2007, CYTOTECHNOLOGY, V54, P57, DOI 10.1007/s10616-007-9074-3; Quek LE, 2010, METAB ENG, V12, P161, DOI 10.1016/j.ymben.2009.09.002; Read EK, 2013, BIOTECHNOL PROGR, V29, P745, DOI 10.1002/btpr.1728; Rispoli F, 2009, BIOTECHNOL PROGR, V25, P980, DOI 10.1002/btpr.225; Rouiller Y, 2014, BIOTECHNOL PROGR, V30, P571, DOI 10.1002/btpr.1921; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Selvarasu S, 2012, BIOTECHNOL BIOENG, V109, P1415, DOI 10.1002/bit.24445; Sen S, 2013, CYTOTECHNOLOGY, V65, P233, DOI 10.1007/s10616-012-9480-z; Stockert R J, 1991, Targeted Diagn Ther, V4, P41; Tao YX, 2006, MOL IMMUNOL, V43, P335, DOI 10.1016/j.molimm.2005.02.018; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Zhang HF, 2013, CYTOTECHNOLOGY, V65, P363, DOI 10.1007/s10616-012-9488-4; Zhang YX, 2009, ADV BIOCHEM ENG BIOT, V113, P177, DOI 10.1007/10_2008_19	40	36	39	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140597	10.1371/journal.pone.0140597	http://dx.doi.org/10.1371/journal.pone.0140597			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26480023	Green Published, Green Submitted, gold			2022-12-26	WOS:000363026600014
J	Ding, H; Guo, MH; Vidhyasagar, V; Talwar, T; Wu, YL				Ding, Hao; Guo, Manhong; Vidhyasagar, Venkatasubramanian; Talwar, Tanu; Wu, Yuliang			The Q Motif Is Involved in DNA Binding but Not ATP Binding in ChlR1 Helicase	PLOS ONE			English	Article							WARSAW BREAKAGE SYNDROME; SINGLE-STRANDED-DNA; BOX RNA HELICASES; CRYSTAL-STRUCTURE; IN-VITRO; BIOCHEMICAL-CHARACTERIZATION; STRUCTURAL BASIS; REPAIR; PROTEIN; DOMAIN	Helicases are molecular motors that couple the energy of ATP hydrolysis to the unwinding of structured DNA or RNA and chromatin remodeling. The conversion of energy derived from ATP hydrolysis into unwinding and remodeling is coordinated by seven sequence motifs (I, Ia, II, III, IV, V, and VI). The Q motif, consisting of nine amino acids (GFXXPXPIQ) with an invariant glutamine (Q) residue, has been identified in some, but not all helicases. Compared to the seven well-recognized conserved helicase motifs, the role of the Q motif is less acknowledged. Mutations in the human ChlR1 (DDX11) gene are associated with a unique genetic disorder known as Warsaw Breakage Syndrome, which is characterized by cellular defects in genome maintenance. To examine the roles of the Q motif in ChlR1 helicase, we performed site directed mutagenesis of glutamine to alanine at residue 23 in the Q motif of ChlR1. ChlR1 recombinant protein was overexpressed and purified from HEK293T cells. ChlR1-Q23A mutant abolished the helicase activity of ChlR1 and displayed reduced DNA binding ability. The mutant showed impaired ATPase activity but normal ATP binding. A thermal shift assay revealed that ChlR1-Q23A has a melting point value similar to ChlR1-WT. Partial proteolysis mapping demonstrated that ChlR1-WT and Q23A have a similar globular structure, although some subtle conformational differences in these two proteins are evident. Finally, we found ChlR1 exists and functions as a monomer in solution, which is different from FANCJ, in which the Q motif is involved in protein dimerization. Taken together, our results suggest that the Q motif is involved in DNA binding but not ATP binding in ChlR1 helicase.	[Ding, Hao; Guo, Manhong; Vidhyasagar, Venkatasubramanian; Talwar, Tanu; Wu, Yuliang] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan	Wu, YL (corresponding author), Univ Saskatchewan, Dept Biochem, Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 0W0, Canada.	yuliang.wu@usask.ca	Vidhyasagar, Venkatasubramanian/M-9442-2013	Vidhyasagar, Venkatasubramanian/0000-0001-8679-4021	Natural Sciences and Engineering Research Council of Canada (NSERC) [418480]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by The Natural Sciences and Engineering Research Council of Canada (NSERC) to YW (No. 418480). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2012, INT J MULTIDISCIP SC, V3, P7, DOI DOI 10.1371/J0URNAL.P0NE.0049385; Andreou AZ, 2014, J MOL BIOL, V426, P51, DOI 10.1016/j.jmb.2013.09.027; Bailey C, 2015, EUR J MED GENET, V58, P235, DOI 10.1016/j.ejmg.2015.02.001; Banroques J, 2011, J MOL BIOL, V413, P451, DOI 10.1016/j.jmb.2011.08.032; Bernstein DA, 2003, NUCLEIC ACIDS RES, V31, P2778, DOI 10.1093/nar/gkg376; Bharti SK, 2014, CELL MOL LIFE SCI, V71, P2625, DOI 10.1007/s00018-014-1569-4; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Bouthier dIT, 2008, J BIOL CHEM, V283, P27395, DOI [10.1074/jbc.M800567200, DOI 10.1074/JBC.M800867200]; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Capo-Chichi JM, 2013, HUM MUTAT, V34, P103, DOI 10.1002/humu.22226; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Farina A, 2008, J BIOL CHEM, V283, P20925, DOI 10.1074/jbc.M802696200; Gallivan JP, 2003, FEBS LETT, V554, P485, DOI 10.1016/S0014-5793(03)01229-8; Gilhooly NS, 2014, NUCLEIC ACIDS RES, V42, P5633, DOI 10.1093/nar/gku188; Guo MH, 2015, J BIOL CHEM, V290, P5174, DOI 10.1074/jbc.M114.634923; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hajer BH, 2014, J BIOTECHNOL, V173, P1, DOI 10.1016/j.jbiotec.2014.01.005; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P1497, DOI 10.1093/nar/21.6.1497; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Kuper J, 2012, EMBO J, V31, P494, DOI 10.1038/emboj.2011.374; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lucic B, 2011, NUCLEIC ACIDS RES, V39, P1703, DOI 10.1093/nar/gkq1031; Mackeldanz P, 2013, BIOCHIMIE, V95, P817, DOI 10.1016/j.biochi.2012.11.014; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Mehta J, 2011, MOL BIOCHEM PARASIT, V176, P58, DOI 10.1016/j.molbiopara.2010.12.003; Nongkhlaw M, 2012, BIOCHEMISTRY-US, V51, P3711, DOI 10.1021/bi2014757; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Robert F, 2013, WIRES RNA, V4, P333, DOI 10.1002/wrna.1163; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rudolph MG, 2006, J MOL BIOL, V361, P731, DOI 10.1016/j.jmb.2006.06.065; Rudra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075435; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Sainsbury S, 2011, J MOL BIOL, V405, P173, DOI 10.1016/j.jmb.2010.10.024; Schutz P, 2010, J MOL BIOL, V400, P768, DOI 10.1016/j.jmb.2010.05.046; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Sinha KM, 2009, BIOCHEMISTRY-US, V48, P4019, DOI 10.1021/bi900103d; Strohmeier J, 2011, BIOL CHEM, V392, P357, DOI 10.1515/BC.2011.034; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Tanner NK, 2003, CELL CYCLE, V2, P16, DOI 10.4161/cc.2.1.296; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Tsay JM, 2009, P NATL ACAD SCI USA, V106, P14355, DOI 10.1073/pnas.0904364106; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wu Y, 2009, CELL MOL LIFE SCI, V66, P1209, DOI 10.1007/s00018-008-8580-6; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2012, J BIOL CHEM, V287, P21699, DOI 10.1074/jbc.M112.351338; Wu YL, 2012, J BIOL CHEM, V287, P1007, DOI 10.1074/jbc.M111.276022; Zegeye ED, 2014, MICROBIOL-SGM, V160, P217, DOI 10.1099/mic.0.072140-0	69	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140755	10.1371/journal.pone.0140755	http://dx.doi.org/10.1371/journal.pone.0140755			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474416	Green Submitted, gold, Green Published			2022-12-26	WOS:000363185500102
J	Ginsburg, AS; Delarosa, J; Brunette, W; Levari, S; Sundt, M; Larson, C; Agyemang, CT; Newton, S; Borriello, G; Anderson, R				Ginsburg, Amy Sarah; Delarosa, Jaclyn; Brunette, Waylon; Levari, Shahar; Sundt, Mitch; Larson, Clarice; Agyemang, Charlotte Tawiah; Newton, Sam; Borriello, Gaetano; Anderson, Richard			mPneumonia: Development of an Innovative mHealth Application for Diagnosing and Treating Childhood Pneumonia and Other Childhood Illnesses in Low-Resource Settings	PLOS ONE			English	Article							INTEGRATED MANAGEMENT; PULSE OXIMETRY; HEALTH-WORKERS; SOUTH-AFRICA; CARE; CHILDREN; IMPLEMENTATION; TECHNOLOGY; IMCI; EXPERIENCES	Pneumonia is the leading infectious cause of death in children worldwide. Each year, pneumonia kills an estimated 935,000 children under five years of age, with most of these deaths occurring in developing countries. The current approach for pneumonia diagnosis in low-resource settings-using the World Health Organization Integrated Management of Childhood Illness (IMCI) paper-based protocols and relying on a health care provider's ability to manually count respiratory rate-has proven inadequate. Furthermore, hypoxemia-a diagnostic indicator of the presence and severity of pneumonia often associated with an increased risk of death-is not assessed because pulse oximetry is frequently not available in low-resource settings. In an effort to address childhood pneumonia mortality and improve frontline health care providers' ability to diagnose, classify, and manage pneumonia and other childhood illnesses, PATH collaborated with the University of Washington to develop "mPneumonia," an innovative mobile health application using an Android tablet. mPneumonia integrates a digital version of the IMCI algorithm with a software-based breath counter and a pediatric pulse oximeter. We conducted a design-stage usability field test of mPneumonia in Ghana, with the goal of creating a user-friendly diagnostic and management tool for childhood pneumonia and other childhood illnesses that would improve diagnostic accuracy and facilitate adherence by health care providers to established guidelines in low-resource settings. The results of the field test provided valuable information for understanding the usability and acceptability of mPneumonia among health care providers, and identifying approaches to iterate and improve. This critical feedback helped ascertain the common failure modes related to the user interface design, navigation, and accessibility of mPneumonia and the modifications required to improve user experience and create a tool aimed at decreasing mortality from pneumonia and other childhood illnesses in low-resource settings.	[Ginsburg, Amy Sarah; Delarosa, Jaclyn] PATH, Seattle, WA 98109 USA; [Brunette, Waylon; Levari, Shahar; Sundt, Mitch; Larson, Clarice; Borriello, Gaetano; Anderson, Richard] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Agyemang, Charlotte Tawiah; Newton, Sam] Kintampo Hlth Res Ctr, Kintampo, Ghana	University of Washington; University of Washington Seattle; Kintampo Health Research Centre	Ginsburg, AS (corresponding author), PATH, Seattle, WA 98109 USA.	aginsburg@path.org	Brunette, Waylon/ABC-8255-2020	Brunette, Waylon/0000-0001-8254-9440	United States National Institutes of Health; National Science Foundation Research Grant [IIS-111143]; United Nations Children's Fund	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Research Grant(National Science Foundation (NSF)); United Nations Children's Fund	The development of mPneumonia was funded by United States National Institutes of Health (ASG, JD, WB, RA) and National Science Foundation Research Grant No. IIS-111143 (WB, SL, MS, CL, GB, RA). The field testing in Ghana was funded by the United Nations Children's Fund (ASG, JD, CTA, SN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T, 2005, B WORLD HEALTH ORGAN, V83, P369; Ahmed HM, 2010, HEALTH POLICY, V96, P128, DOI 10.1016/j.healthpol.2010.01.013; [Anonymous], 2013, PO DAT KIT 2 0 EXP R; Black J, 2015, INT J NURS STUD, V52, P963, DOI 10.1016/j.ijnurstu.2015.01.016; DeRenzi B, 2008, IMPROVING PEDIAT HLT; Duke T, 2010, INT J TUBERC LUNG D, V14, P1362; Duke T, 2009, ANN TROP PAEDIATR, V29, P165, DOI 10.1179/027249309X12467994190011; Ginsburg AS, 2012, J TROP PEDIATRICS, V58, P389, DOI 10.1093/tropej/fmr103; Horwood C, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-62; Kallander K, 2006, T ROY SOC TROP MED H, V100, P956, DOI 10.1016/j.trstmh.2005.11.004; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Mitchell M, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-95; Mitchell M, 2012, J HEALTH COMMUN, V17, P118, DOI 10.1080/10810730.2011.649105; Mitchell M, 2012, INT J MED INFORM, V81, P166, DOI 10.1016/j.ijmedinf.2011.11.003; Mitchell M, 2009, INT J HEALTHC TECHNO, V10, P156, DOI 10.1504/IJHTM.2009.025819; Mukanga D, 2011, TROP MED INT HEALTH, V16, P1234, DOI 10.1111/j.1365-3156.2011.02831.x; Rambaud-Althaus C, 2015, LANCET INFECT DIS, V15, P439, DOI 10.1016/S1473-3099(15)70017-4; Schellenberg JA, 2004, HEALTH POLICY PLANN, V19, P1, DOI 10.1093/heapol/czh001; Shao AF, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0805-4; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNICEF, 2011, SYN ARI TIM RES REP; UNICEF, 2013, STRENGTH PNEUM DIAGN; United Nations Children's Fund (UNICEF), 2013, PNEUM DIAGN CURR OUT; Victora CG, 2006, B WORLD HEALTH ORGAN, V84, P792, DOI 10.2471/BLT.06.030502; Walter ND, 2009, B WORLD HEALTH ORGAN, V87, P99, DOI 10.2471/BLT.08.050740; World Health Organization, 2014, INTEGRATED MANAGEMEN; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE	27	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0139625	10.1371/journal.pone.0139625	http://dx.doi.org/10.1371/journal.pone.0139625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474321	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500011
J	Kramer, G; Woolerton, Y; van Straalen, JP; Vissers, JPC; Dekker, N; Langridge, JI; Beynon, RJ; Speijer, D; Sturk, A; Aerts, JMFG				Kramer, Gertjan; Woolerton, Yvonne; van Straalen, Jan P.; Vissers, Johannes P. C.; Dekker, Nick; Langridge, James I.; Beynon, Robert J.; Speijer, Dave; Sturk, Auguste; Aerts, Johannes M. F. G.			Accuracy and Reproducibility in Quantification of Plasma Protein Concentrations by Mass Spectrometry without the Use of Isotopic Standards	PLOS ONE			English	Article							ABSOLUTE QUANTIFICATION; DIGESTION EFFICIENCY; SAMPLE PREPARATION; ABUNDANCE; EXPRESSION; PROTEOMICS; QUANTITATION; ASSAYS; BIOMARKERS; ENRICHMENT	Background Quantitative proteomic analysis with mass spectrometry holds great promise for simultaneously quantifying proteins in various biosamples, such as human plasma. Thus far, studies addressing the reproducible measurement of endogenous protein concentrations in human plasma have focussed on targeted analyses employing isotopically labelled standards. Non-targeted proteomics, on the other hand, has been less employed to this end, even though it has been instrumental in discovery proteomics, generating large datasets in multiple fields of research. Results Using a non-targeted mass spectrometric assay (LCMSE), we quantified abundant plasma proteins (43 mg/mL-40 ug/mL range) in human blood plasma specimens from 30 healthy volunteers and one blood serum sample (ProteomeXchange: PXD000347). Quantitative results were obtained by label-free mass spectrometry using a single internal standard to estimate protein concentrations. This approach resulted in quantitative results for 59 proteins (cut off >= 11 samples quantified) of which 41 proteins were quantified in all 31 samples and 23 of these with an inter-assay variability of <= 20%. Results for 7 apolipoproteins were compared with those obtained using isotope-labelled standards, while 12 proteins were compared to routine immunoassays. Comparison of quantitative data obtained by LCMSE and immunoassays showed good to excellent correlations in relative protein abundance (r = 0.72-0.96) and comparable median concentrations for 8 out of 12 proteins tested. Plasma concentrations of 56 proteins determined by LCMSE were of similar accuracy as those reported by targeted studies and 7 apolipoproteins quantified by isotope-labelled standards, when compared to reference concentrations from literature. Conclusions This study shows that LCMSE offers good quantification of relative abundance as well as reasonable estimations of concentrations of abundant plasma proteins.	[Kramer, Gertjan; Dekker, Nick; Speijer, Dave; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [van Straalen, Jan P.; Sturk, Auguste] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands; [Woolerton, Yvonne; Beynon, Robert J.] Univ Liverpool, Inst Integrat Biol, Ctr Proteome Res, Liverpool L69 3BX, Merseyside, England; [Vissers, Johannes P. C.; Langridge, James I.] Waters Corp, MS Technol Ctr, Manchester, Lancs, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Liverpool; Waters UK	Kramer, G (corresponding author), European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany.	gertjan.kramer@embl.de	Speijer, Dave/AAE-4613-2019; Aerts, Johannes/A-1028-2009; Beynon, Robert/K-1408-2014	Speijer, Dave/0000-0002-2340-2753; Aerts, Johannes/0000-0001-8168-2565; Beynon, Robert/0000-0003-0857-495X; Kramer, Gertjan/0000-0002-8541-0337	Academic Medical Center, University of Amsterdam; Waters Corporation; Alexander von Humboldt Stiftung; BBSRC [BB/M018725/1, BB/M025756/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M025756/1, BB/M018725/1] Funding Source: researchfish	Academic Medical Center, University of Amsterdam; Waters Corporation; Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was funded by the Academic Medical Center, University of Amsterdam. Coauthor JPCV and JIL are employed by Waters Corporation (MS Technologies Center, Manchester, United Kingdom). Waters Corporation provided support in the form of salary for authors JPCV and JIL. The Alexander von Humboldt Stiftung provided support in the form of salary for author GK. The specific role of these authors is articulated in the 'author contributions' section. All funders, Academic Medical Center, Waters Corporation and the Alexander von Humboldt Stiftung, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Agger SA, 2010, CLIN CHEM, V56, P1804, DOI 10.1373/clinchem.2010.152264; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Arike L, 2012, J PROTEOMICS, V75, P5437, DOI 10.1016/j.jprot.2012.06.020; Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529; Brownridge P, 2011, METHODS, V54, P351, DOI 10.1016/j.ymeth.2011.05.005; Brownridge Philip J, 2012, Methods Mol Biol, V893, P267, DOI 10.1007/978-1-61779-885-6_18; Carr SA, 2014, MOL CELL PROTEOMICS, V13, P907, DOI 10.1074/mcp.M113.036095; Distler U, 2014, NAT METHODS, V11, P167, DOI [10.1038/NMETH.2767, 10.1038/nmeth.2767]; Domanski D, 2012, PROTEOMICS, V12, P1222, DOI 10.1002/pmic.201100568; Ellington AA, 2010, CLIN CHEM, V56, P186, DOI 10.1373/clinchem.2009.127514; Fonslow BR, 2014, NAT METHODS, V11, P347, DOI 10.1038/nmeth0314-347; Fonslow BR, 2013, NAT METHODS, V10, P54, DOI [10.1038/NMETH.2250, 10.1038/nmeth.2250]; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Grossmann J, 2010, J PROTEOMICS, V73, P1740, DOI 10.1016/j.jprot.2010.05.011; Hoofnagle AN, 2008, CLIN CHEM, V54, P1796, DOI 10.1373/clinchem.2008.109652; Hoofnagle AN, 2012, CLIN CHEM, V58, P777, DOI 10.1373/clinchem.2011.173856; Hortin GL, 2008, CLIN CHEM, V54, P1608, DOI 10.1373/clinchem.2008.108175; Huttenhain R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003989; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Keshishian H, 2009, MOL CELL PROTEOMICS, V8, P2339, DOI 10.1074/mcp.M900140-MCP200; Kuhn E, 2009, CLIN CHEM, V55, P1108, DOI 10.1373/clinchem.2009.123935; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Lassman ME, 2012, RAPID COMMUN MASS SP, V26, P101, DOI 10.1002/rcm.5296; Leon IR, 2013, MOL CELL PROTEOMICS, V12, P2992, DOI 10.1074/mcp.M112.025585; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; Martens L, 2005, BIOINFORMATICS, V21, P3584, DOI 10.1093/bioinformatics/bti588; Mertens BJA, 2006, J COMPUT BIOL, V13, P1591, DOI 10.1089/cmb.2006.13.1591; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nicol GR, 2008, MOL CELL PROTEOMICS, V7, P1974, DOI 10.1074/mcp.M700476-MCP200; Ning K, 2012, J PROTEOME RES, V11, P2261, DOI 10.1021/pr201052x; Pagel O, 2015, EXPERT REV PROTEOMIC, V12, P235, DOI 10.1586/14789450.2015.1042867; Parker CE, 2014, MOL ONCOL, V8, P840, DOI 10.1016/j.molonc.2014.03.006; Parker CE, 2010, ANALYST, V135, P1830, DOI 10.1039/c0an00105h; Percy AJ, 2014, BBA-PROTEINS PROTEOM, V1844, P917, DOI 10.1016/j.bbapap.2013.06.008; Percy AJ, 2013, PROTEOMICS, V13, P2202, DOI 10.1002/pmic.201200316; Proc JL, 2010, J PROTEOME RES, V9, P5422, DOI 10.1021/pr100656u; Rivers J, 2007, MOL CELL PROTEOMICS, V6, P1416, DOI 10.1074/mcp.M600456-MCP200; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Valentine SJ, 2006, J PROTEOME RES, V5, P2977, DOI 10.1021/pr060232i; van Breemen MJ, 2008, CLIN CHIM ACTA, V396, P26, DOI 10.1016/j.cca.2008.06.018; Vissers JPC, 2007, MOL CELL PROTEOMICS, V6, P755, DOI 10.1074/mcp.M600303-MCP200; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Williams DK, 2009, J PROTEOME RES, V8, P1085, DOI 10.1021/pr800922p; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhang H, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M110.005678, 10.1074/mcp.M111.009936, 10.1186/1476-4598-10-108]	50	18	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140097	10.1371/journal.pone.0140097	http://dx.doi.org/10.1371/journal.pone.0140097			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474480	gold, Green Published, Green Submitted			2022-12-26	WOS:000363185500023
J	Rzezak, P; Squarzoni, P; Duran, FL; Alves, TDF; Tamashiro-Duran, J; Bottino, CM; Ribeiz, S; Lotufo, PA; Menezes, PR; Scazufca, M; Busatto, GF				Rzezak, Patricia; Squarzoni, Paula; Duran, Fabio L.; Ferraz Alves, Tania de Toledo; Tamashiro-Duran, Jaqueline; Bottino, Cassio M.; Ribeiz, Salma; Lotufo, Paulo A.; Menezes, Paulo R.; Scazufca, Marcia; Busatto, Geraldo F.			Relationship between Brain Age-Related Reduction in Gray Matter and Educational Attainment	PLOS ONE			English	Article							VOXEL-BASED-MORPHOMETRY; PRECLINICAL ALZHEIMERS-DISEASE; MENTAL-STATE-EXAMINATION; SAO-PAULO; COGNITIVE RESERVE; BRAZILIAN POPULATION; WORKING-MEMORY; STRUCTURAL MRI; OLDER-ADULTS; RISK-FACTORS	Inter-subject variability in age-related brain changes may relate to educational attainment, as suggested by cognitive reserve theories. This voxel-based morphometry study investigated the impact of very low educational level on the relationship between regional gray matter (rGM) volumes and age in healthy elders. Magnetic resonance imaging data were acquired in elders with low educational attainment (less than 4 years) (n = 122) and high educational level (n = 66), pulling together individuals examined using either of three MRI scanners/acquisition protocols. Voxelwise group comparisons showed no rGM differences (p<0.05, family-wise error corrected for multiple comparisons). When within-group voxel-wise patterns of linear correlation were compared between high and low education groups, there was one cluster of greater rGM loss with aging in low versus high education elders in the left anterior cingulate cortex (p<0.05, FWE-corrected), as well as a trend in the left dorsomedial prefrontal cortex (p<0.10). These results provide preliminary indication that education might exert subtle protective effects against age-related brain changes in healthy subjects. The anterior cingulate cortex, critical to inhibitory control processes, may be particularly sensitive to such effects, possibly given its involvement in cognitive stimulating activities at school or later throughout life.	[Rzezak, Patricia; Squarzoni, Paula; Duran, Fabio L.; Ferraz Alves, Tania de Toledo; Tamashiro-Duran, Jaqueline; Busatto, Geraldo F.] Univ Sao Paulo, Lab Psychiat Neuroimaging, Dept & Inst Psychiat, Fac Med, Sao Paulo, SP, Brazil; [Rzezak, Patricia; Squarzoni, Paula; Duran, Fabio L.; Ferraz Alves, Tania de Toledo; Tamashiro-Duran, Jaqueline; Busatto, Geraldo F.] Univ Sao Paulo, Ctr Interdisciplinary Res Appl Neurosci, Sao Paulo, SP, Brazil; [Bottino, Cassio M.; Ribeiz, Salma] Univ Sao Paulo, Old Age Res Grp PROTER, Dept & Inst Psychiat, Fac Med, Sao Paulo, SP, Brazil; [Lotufo, Paulo A.] Univ Sao Paulo, Ctr Clin & Epidemiol Res, Univ Hosp, Sao Paulo, SP, Brazil; [Lotufo, Paulo A.] Univ Sao Paulo, Fac Med, Sao Paulo, SP, Brazil; [Menezes, Paulo R.] Univ Sao Paulo, Dept Prevent Med, Fac Med, Sao Paulo, SP, Brazil; [Scazufca, Marcia] Univ Sao Paulo, Lab Psychopharmacol & Clin Psychophysiol LIM 23, Fac Med, Inst Psychiat, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Rzezak, P (corresponding author), Univ Sao Paulo, Lab Psychiat Neuroimaging, Dept & Inst Psychiat, Fac Med, Sao Paulo, SP, Brazil.	patriciarzezak@gmail.com	Busatto, Geraldo F/D-4431-2009; Souza-Duran, Fabio Luis/L-1371-2013; Rzezak, Patricia/P-5274-2017; Menezes, Paulo/AAM-3529-2021; Menezes, Paulo R/C-9985-2010; Squarzoni, Paula S/M-6155-2014; Tamashiro-Duran, Jaqueline Hatsuko/B-1023-2013; Alves, Tania/ABF-5712-2020; Scazufca, Marcia/K-7418-2012; Lotufo, Paulo/A-9843-2008; Alves, Tania CTF/B-6571-2008	Busatto, Geraldo F/0000-0003-4749-4602; Souza-Duran, Fabio Luis/0000-0002-7603-6152; Rzezak, Patricia/0000-0001-9023-9733; Menezes, Paulo/0000-0001-6330-3314; Menezes, Paulo R/0000-0001-6330-3314; Squarzoni, Paula S/0000-0002-5483-759X; Tamashiro-Duran, Jaqueline Hatsuko/0000-0002-5448-8158; Alves, Tania/0000-0003-3402-9656; Lotufo, Paulo/0000-0002-4856-8450; Alves, Tania CTF/0000-0003-3402-9656; Scazufca, Marcia/0000-0002-4545-006X	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/50329-6, 2004/09586-9, 2012/13065-0, 2013/03231-3]; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Project Grant number 2012/50329-6, 2004/09586-9, and scholarship to Patricia Rzezak, number 2012/13065-0; Paula Squarzoni, number 2013/03231-3) and CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Tania CTF Alves, Paulo A Lotufo, Geraldo Busatto Filho, Paulo R Menezes, Cassio MC Bottino, and Marcia Scazufca).	Allegri Ricardo F., 2010, Dement. neuropsychol., V4, P28, DOI 10.1590/S1980-57642010DN40100005; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bottino CMC, 2008, DEMENT GERIATR COGN, V26, P291, DOI 10.1159/000161053; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Busatto GF, 2003, NEUROBIOL AGING, V24, P221, DOI 10.1016/S0197-4580(02)00084-2; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Copeland JRM, 2002, INT J GERIATR PSYCH, V17, P729, DOI 10.1002/gps.667; Curiati PK, 2009, AM J NEURORADIOL, V30, P1850, DOI 10.3174/ajnr.A1727; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Alves TCDF, 2011, J ALZHEIMERS DIS, V27, P575, DOI 10.3233/JAD-2011-110827; Ferrari C, 2014, NEURODEGENER DIS, V13, P157, DOI 10.1159/000353690; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Foubert-Samier A, 2012, NEUROBIOL AGING, V33, pe15, DOI [10.1016/j.neurobiolaging.2010.09.023, DOI 10.1016/j.neurobiolaging.2010.09.023]; FULD PA, 1990, J CLIN EXP NEUROPSYC, V12, P520, DOI 10.1080/01688639008400998; Galluzzi S, 2008, NEUROL SCI, V29, pS296, DOI 10.1007/s10072-008-1002-6; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grieve SM, 2005, HUM BRAIN MAPP, V25, P391, DOI 10.1002/hbm.20115; Groves AR, 2012, NEUROIMAGE, V63, P365, DOI 10.1016/j.neuroimage.2012.06.038; Gutchess AH, 2005, J COGNITIVE NEUROSCI, V17, P84, DOI 10.1162/0898929052880048; Hall KS, 2000, INT J GERIATR PSYCH, V15, P521, DOI 10.1002/1099-1166(200006)15:6<521::AID-GPS182>3.0.CO;2-F; Harrison TM, 2012, J INT NEUROPSYCH SOC, V18, P1081, DOI 10.1017/S1355617712000847; Herrera E, 2002, ALZ DIS ASSOC DIS, V16, P103, DOI 10.1097/00002093-200204000-00007; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Kim J, 2015, NEUROSCI RES, V94, P50, DOI 10.1016/j.neures.2014.12.009; Lazarczyk MJ, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-127; Liu YW, 2012, NEURORADIOLOGY, V54, P929, DOI 10.1007/s00234-012-1005-0; Marstaller L, 2015, NEUROSCIENCE, V290, P369, DOI 10.1016/j.neuroscience.2015.01.049; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Miller MI, 2013, NEUROIMAGE-CLIN, V3, P352, DOI 10.1016/j.nicl.2013.09.001; MONSCH AU, 1992, ARCH NEUROL-CHICAGO, V49, P1253, DOI 10.1001/archneur.1992.00530360051017; Nitrini R, 2012, LANCET, V380, P1470, DOI 10.1016/S0140-6736(12)61838-8; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Perneczky R, 2009, J ALZHEIMERS DIS, V17, P855, DOI 10.3233/JAD-2009-1117; Persson N, 2014, NEUROIMAGE, V103, P334, DOI 10.1016/j.neuroimage.2014.09.042; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Resnick SM, 2003, J NEUROSCI, V23, P3295; Ribeiz SRI, 2013, CROSS SECTIONAL PROS, V8, P1, DOI [10.1371/journal.pone.0080049, DOI 10.1371/J0URNAL.P0NE.0080049]; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P1467, DOI 10.1001/archneur.65.11.1467; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Salmond CH, 2002, NEUROIMAGE, V17, P1027, DOI 10.1006/nimg.2002.1153; Scazufca M, 2008, INT J EPIDEMIOL, V37, P879, DOI 10.1093/ije/dyn125; Scazufca M, 2008, INT J EPIDEMIOL, V37, P721, DOI 10.1093/ije/dym154; Scazufca M, 2008, INT PSYCHOGERIATR, V20, P394, DOI 10.1017/S1041610207005625; Seo SW, 2011, NEUROBIOL AGING, V32, P200, DOI 10.1016/j.neurobiolaging.2009.02.004; Shum FWF, 2007, LEARN MEMORY, V14, P304, DOI 10.1101/lm.530607; Squarzoni P, 2012, J ALZHEIMERS DIS, V31, P45, DOI 10.3233/JAD-2012-111124; Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142; Streitburger DP, 2014, NEUROIMAGE, V87, P170, DOI 10.1016/j.neuroimage.2013.10.051; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Teipel SJ, 2007, NEUROIMAGE, V34, P985, DOI 10.1016/j.neuroimage.2006.07.047; Terribilli D, 2011, NEUROBIOL AGING, V32, P354, DOI 10.1016/j.neurobiolaging.2009.02.008; Tournoux P., 1988, COPLANAR STEREOTAXIC; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Younes L, 2014, NEUROIMAGE-CLIN, V5, P178, DOI 10.1016/j.nicl.2014.04.009; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	62	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140945	10.1371/journal.pone.0140945	http://dx.doi.org/10.1371/journal.pone.0140945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0DF	26474472	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500133
J	Sarker, MR; Franks, S; Sumien, N; Thangthaeng, N; Filipetto, F; Forster, M				Sarker, Marjana Rahman; Franks, Susan; Sumien, Nathalie; Thangthaeng, Nopporn; Filipetto, Frank; Forster, Michael			Curcumin Mimics the Neurocognitive and Anti-Inflammatory Effects of Caloric Restriction in a Mouse Model of Midlife Obesity	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MILD COGNITIVE IMPAIRMENT; LIFE-SPAN; OXIDATIVE STRESS; INFLAMMATORY CYTOKINES; ALZHEIMERS-DISEASE; EXECUTIVE FUNCTION; GENE-EXPRESSION; WEIGHT-LOSS; OVERWEIGHT	Dietary curcumin was studied for its potential to decrease adiposity and reverse obesity-associated cognitive impairment in a mouse model of midlife sedentary obesity. We hypothesized that curcumin intake, by decreasing adiposity, would improve cognitive function in a manner comparable to caloric restriction (CR), a weight loss regimen. 15-month-old male C57BL/6 mice were assigned in groups to receive the following dietary regimens for 12 weeks: (i) a base diet (Ain93M) fed ad libitum (AL), (ii) the base diet restricted to 70% of ad libitum (CR) or (iii) the base diet containing curcumin fed AL (1000 mg/kg diet, CURAL). Blood markers of inflammation, interleukin 6 (IL-6) and C-reactive protein (CRP), as well as an indicator of redox stress (GSH: GSSG ratio), were determined at different time points during the treatments, and visceral and subcutaneous adipose tissue were measured upon completion of the experiment. After 8 weeks of dietary treatment, the mice were tested for spatial cognition (Morris water maze) and cognitive flexibility (discriminated active avoidance). The CR group showed significant weight loss and reduced adiposity, whereas CURAL mice had stable weight throughout the experiment, consumed more food than the AL group, with no reduction of adiposity. However, both CR and CURAL groups took fewer trials than AL to reach criterion during the reversal sessions of the active avoidance task, suggesting an improvement in cognitive flexibility. The AL mice had higher levels of CRP compared to CURAL and CR, and GSH as well as the GSH: GSSG ratio were increased during curcumin intake, suggesting a reducing shift in the redox state. The results suggest that, independent of their effects on adiposity; dietary curcumin and caloric restriction have positive effects on frontal cortical functions that could be linked to anti-inflammatory or anti-oxidant actions.	[Sarker, Marjana Rahman; Sumien, Nathalie; Thangthaeng, Nopporn; Forster, Michael] Univ N Texas, Hlth Sci Ctr, IAADR, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Franks, Susan; Filipetto, Frank] Univ N Texas, Texas Coll Osteopath Med, Hlth Sci Ctr, Family Med, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Forster, M (corresponding author), Univ N Texas, Hlth Sci Ctr, IAADR, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA.	Michael.forster@unthsc.edu	Sarker, Marjana/J-7214-2019	Sarker, Marjana/0000-0001-6766-6737	National Institutes of Health, National Institute on Aging [AG022550]; University of North Texas Health Science Center, Faculty seed grant [RI6039]; NATIONAL INSTITUTE ON AGING [P01AG022550] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of North Texas Health Science Center, Faculty seed grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by P01 (Program project grant) AG022550 National Institutes of Health, National Institute on Aging; and RI6039, University of North Texas Health Science Center, Faculty seed grant.	Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Arfanakis K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073107; Banerjee M, 2003, IMMUNOPHARM IMMUNOT, V25, P213, DOI 10.1081/IPH-120020471; Bar-Sela G, 2010, CURR MED CHEM, V17, P190, DOI 10.2174/092986710790149738; Becskei C, 2009, NEUROENDOCRINOLOGY, V90, P371, DOI 10.1159/000251723; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Bermejo P, 2008, FREE RADICAL RES, V42, P162, DOI 10.1080/10715760701861373; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Bradford PG, 2013, BIOFACTORS, V39, P78, DOI 10.1002/biof.1074; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Burke LE, 2008, J AM DIET ASSOC, V108, P640, DOI 10.1016/j.jada.2008.01.012; Calabro P, 2003, CIRCULATION, V108, P1930, DOI 10.1161/01.CIR.0000096055.62724.C5; Chaudhari K, 2014, J SPORT HEALTH SCI, V3, P196, DOI 10.1016/j.jshs.2014.04.004; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Cohen AN, 2009, ARCH OTOLARYNGOL, V135, P190, DOI 10.1001/archotol.135.2.190; Cooke D, 2006, NAT REV DRUG DISCOV, V5, P919, DOI 10.1038/nrd2136; de Fiebre NC, 2006, AGE, V28, P235, DOI 10.1007/s11357-006-9027-3; Deckers K, 2015, INT J GERIATR PSYCH, V30, P234, DOI 10.1002/gps.4245; Dixit S, 2015, ACS CHEM NEUROSCI; Dubey A, 1996, ARCH BIOCHEM BIOPHYS, V333, P189, DOI 10.1006/abbi.1996.0380; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; Forster MJ, 1999, NEUROBIOL AGING, V20, P167, DOI 10.1016/S0197-4580(99)00041-X; Forster MJ, 2000, J GERONTOL A-BIOL, V55, pB522, DOI 10.1093/gerona/55.11.B522; Garcia-Ptacek S, 2014, EUR J CLIN NUTR, V68, P1204, DOI 10.1038/ejcn.2014.199; Guerreiro RJ, 2007, NEURODEGENER DIS, V4, P406, DOI 10.1159/000107700; Gupta A, 2015, NEUROIMAGE-CLIN, V7, P506, DOI 10.1016/j.nicl.2015.01.005; Gupta SC, 2013, BIOFACTORS, V39, P2, DOI 10.1002/biof.1079; Gupta SK, 2011, J OCUL PHARMACOL TH, V27, P123, DOI 10.1089/jop.2010.0123; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Kim T, 2009, BIOCHEM BIOPH RES CO, V388, P377, DOI 10.1016/j.bbrc.2009.08.018; Kim YW, 2013, J MOL MED, V91, P323, DOI 10.1007/s00109-013-1007-3; Latham JR, 2009, DIABETES, V58, P2656, DOI 10.2337/db08-1763; Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017; Lekander M, 2011, SCAND J PSYCHOL, V52, P229, DOI 10.1111/j.1467-9450.2010.00865.x; Madeo F, 2014, NAT REV DRUG DISCOV, V13, P727, DOI 10.1038/nrd4391; Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002; Mazzetti AP, 2015, NEUROCHEM INT, V82, P10, DOI 10.1016/j.neuint.2015.01.008; Mcdonald SR, 2005, FREE RADICAL BIO MED, V38, P729, DOI 10.1016/j.freeradbiomed.2004.11.014; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Pires RC, 2014, APPL PHYSIOL NUTR ME, V39, P895, DOI 10.1139/apnm-2013-0520; Priyadarsini KI, 2013, CURR PHARM DESIGN, V19, P2093; Priyadarsini KI, 2003, FREE RADICAL BIO MED, V35, P475, DOI 10.1016/S0891-5849(03)00325-3; Pu YF, 2013, CELL PHYSIOL BIOCHEM, V32, P1167, DOI 10.1159/000354516; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rebrin I, 2011, FREE RADICAL BIO MED, V51, P225, DOI 10.1016/j.freeradbiomed.2011.04.006; Shen LR, 2013, AGE, V35, P1133, DOI 10.1007/s11357-012-9438-2; Sohal RS, 2014, FREE RADICAL BIO MED, V73, P366, DOI 10.1016/j.freeradbiomed.2014.05.015; Spangler EL, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P177, DOI 10.1007/978-90-481-8556-6_10; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Spindler SR, 2005, MECH AGEING DEV, V126, P960, DOI 10.1016/j.mad.2005.03.016; Strong R, 2013, J GERONTOL A-BIOL, V68, P6, DOI 10.1093/gerona/gls070; Sturm R, 2013, INT J OBESITY, V37, P889, DOI 10.1038/ijo.2012.159; Sumien N, 2006, AGE, V28, P265, DOI 10.1007/s11357-006-9015-7; Sweat V, 2008, INFLAMMATION, V31, P198, DOI 10.1007/s10753-008-9065-3; Sykiotis GP, 2011, CURR OPIN CLIN NUTR, V14, P41, DOI 10.1097/MCO.0b013e32834136f2; Tang YC, 2014, LAB INVEST, V94, P503, DOI 10.1038/labinvest.2014.42; TAYLOR AW, 1990, J IMMUNOL, V145, P2507; Thangthaeng N, 2008, EXP GERONTOL, V43, P1077, DOI 10.1016/j.exger.2008.08.045; Torres LL, 2011, J ALZHEIMERS DIS, V26, P59, DOI 10.3233/JAD-2011-110284; Trujillo J, 2014, ARCH PHARM, V347, P873, DOI 10.1002/ardp.201400266; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; Wang J, 2013, NUTR METAB, V10; Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Weuve J, 2006, EPIDEMIOLOGY, V17, P183, DOI 10.1097/01.ede.0000198183.60572.c9; Xu WL, 2011, NEUROLOGY, V76, P1568, DOI 10.1212/WNL.0b013e3182190d09; Zheng DM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-138	67	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140431	10.1371/journal.pone.0140431	http://dx.doi.org/10.1371/journal.pone.0140431			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473740	Green Submitted, gold, Green Published			2022-12-26	WOS:000363185500047
J	Singh, VK; Dwivedi, P; Chaudhary, BR; Singh, R				Singh, Vineet Kumar; Dwivedi, Padmanabh; Chaudhary, B. R.; Singh, Ramesh			Immunomodulatory Effect of Gymnema sylvestre (R.Br.) Leaf Extract: An In Vitro Study in Rat Model	PLOS ONE			English	Article							VISCUM-ALBUM EXTRACTS; STIMULATES INSULIN-SECRETION; AQUEOUS EXTRACT; DIABETES-MELLITUS; PERITONEAL-MACROPHAGES; SEXUAL-DIMORPHISM; HUMAN ISLETS; VIVO; GLUCOSE; CELLS	Gymnema sylvestre Wild R.Br (family: Asclepidaceae) is a valuable medicinal plant used in folk medicine to treat diabetes, obesity, asthma etc. in India for antiquity. Diabetes mellitus is a syndrome characterized immunologically by lymphocyte apoptosis and reduced cell-mediated and humoral immunity. Modulation of immune responses to alleviate diseases has been of interest, and traditional herbal medicines may play an important role in this regard. In this study, we aim to evaluate the immunomodulatory potential of methanolic extract of G. sylvestre leaf using rat model. HPLC analysis of leaf extract was carried out for gymnemic acid. The method involves the initial hydrolysis of gymnemic acids, the active ingredients, to a common aglycone followed by the quantitative estimation of gymnemagenin, using gymnemagenin as reference standard. Gymnemic acid content was 2.40% (w/w) in G. sylvestre leaf extract. In vitro immunomodulatory activity of the methanolic extract of G. sylvestre leaf (1-200 mu g/ml) was evaluated by gauging its effects on nitroblue tetrazolium reduction and nitrite release in rat peritoneal macrophages and on mitogen (ConA, PHA and LPS) induced splenic lymphocyte proliferation. G. sylvestre leaf extract showed significant (<0.05) enhancement in NO and ROS generation in macrophages and in proliferation of lymphocytes in dose dependent manner. EC50 value was 3.10, 3.75 and 2.68 mu g/ml for NBT reduction, nitrite release and lymphoproliferation, respectively. Potential effect was observed at 100 mu g/ml in NO and ROS generation in macrophages and 20 mu g/ml in lymphocyte proliferation. G. sylvestre leaf extract stimulates macrophage reactivity, increasing the level of activity even higher when combined with PMA or LPS. These findings suggest the presence of active compounds, gymnemic acid, in methanolic extract of G. sylvestre leaf that stimulates both myeloid and lymphoid components of immune system, and therefore can restore the innate immune function. Through this study, the traditional knowledge of anti-diabetic property of G. sylvestre is scientifically supplemented with its immunomodulatory properties.	[Singh, Vineet Kumar; Chaudhary, B. R.] Banaras Hindu Univ, Ctr Adv Study Bot, Varanasi 221005, UP, India; [Dwivedi, Padmanabh] Banaras Hindu Univ, Inst Agr Sci, Dept Plant Physiol, Varanasi 221005, UP, India; [Singh, Ramesh] Udai Pratap Autonomous Coll, Dept Zool, Varanasi, UP, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU); Udai Pratap College, Varanasi	Singh, R (corresponding author), Udai Pratap Autonomous Coll, Dept Zool, Varanasi, UP, India.	upcrsingh@yahoo.com	Dwivedi, Padmanabh/L-5307-2019; Dwivedi, Padmanabh/AAJ-8808-2020					Al-Romaiyan A, 2013, PHYTOTHER RES, V27, P1006, DOI 10.1002/ptr.4815; Al-Romaiyan A, 2010, PHYTOTHER RES, V24, P1370, DOI 10.1002/ptr.3125; BABIOR BM, 1984, J CLIN INVEST, V73, P599, DOI 10.1172/JCI111249; BASKARAN K, 1990, J ETHNOPHARMACOL, V30, P295, DOI 10.1016/0378-8741(90)90108-6; Berger J., 2003, COMP CLIN PATHOL, V12, P84, DOI [10.1007/s00580-003-0478-y, DOI 10.1007/S00580-003-0478-Y]; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bishayi Biswadev, 2002, J Toxicol Sci, V27, P139, DOI 10.2131/jts.27.139; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Cruz GVB, 2007, J ETHNOPHARMACOL, V111, P148, DOI 10.1016/j.jep.2006.11.006; DING AH, 1988, J IMMUNOL, V141, P2407; Diwanay S, 2004, J ETHNOPHARMACOL, V90, P49, DOI 10.1016/j.jep.2003.09.023; ELIASHIV A, 1978, ARCH SURG-CHICAGO, V113, P1180; Elluru SR, 2015, TRANSL RES BIOMED, V4, P67, DOI 10.1159/000375427; Elluru SR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-161; Elluru SR, 2009, ANTICANCER RES, V29, P2945; Elluru S, 2007, MEDICINA-BUENOS AIRE, V67, P85; Elluru S, 2006, ARZNEIMITTEL-FORSCH, V56, P461; Flanagan KL, 2014, T ROY SOC TROP MED H, V108, P385, DOI 10.1093/trstmh/tru079; FUSHIKI T, 1992, J NUTR, V122, P2367, DOI 10.1093/jn/122.12.2367; Gautam M, 2009, J ETHNOPHARMACOL, V121, P41, DOI 10.1016/j.jep.2008.10.028; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; GIENI RS, 1995, J IMMUNOL METHODS, V187, P85, DOI 10.1016/0022-1759(95)00170-F; Hegde P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026312; Jayathirtha MG, 2004, PHYTOMEDICINE, V11, P361, DOI 10.1078/0944711041495236; Jeong SC, 2006, J MED FOOD, V9, P175, DOI 10.1089/jmf.2006.9.175; Khanna V, 2009, INT J GREEN PHARM, V3, P227, DOI DOI 10.4103/0973-8258.56280; Leach MJ, 2007, J ALTERN COMPLEM MED, V13, P977, DOI 10.1089/acm.2006.6387; Liu B, 2009, CELL PHYSIOL BIOCHEM, V23, P125, DOI 10.1159/000204101; Mandal S.C., 2007, BIODIVERSITY ENV BIO, P177; Manosroi A, 2005, J ETHNOPHARMACOL, V102, P5, DOI 10.1016/j.jep.2005.04.033; Manosroi A, 2005, J ETHNOPHARMACOL, V101, P90, DOI 10.1016/j.jep.2005.03.031; Manosroi A, 2004, FITOTERAPIA, V75, P302, DOI 10.1016/j.fitote.2004.01.009; Manosroi A, 2003, J ETHNOPHARMACOL, V89, P155, DOI 10.1016/S0378-8741(03)00278-2; Manosroi A, 2006, FITOTERAPIA, V77, P189, DOI 10.1016/j.fitote.2006.01.003; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; Otton R, 2004, J ENDOCRINOL, V182, P145, DOI 10.1677/joe.0.1820145; Persaud SJ, 1999, J ENDOCRINOL, V163, P207, DOI 10.1677/joe.0.1630207; Porchezhian E, 2003, PHARMAZIE, V58, P5; Sabu MC, 2002, J ETHNOPHARMACOL, V81, P155, DOI 10.1016/S0378-8741(02)00034-X; Saha C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114965; Saravanan S, 2012, J ETHNOPHARMACOL, V140, P239, DOI 10.1016/j.jep.2012.01.010; Sengupta M, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-102; Sengupta Mahuya, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P193, DOI 10.1016/S2221-1691(11)60026-9; SHANMUGASUNDARAM ERB, 1990, J ETHNOPHARMACOL, V30, P281, DOI 10.1016/0378-8741(90)90107-5; SHANMUGASUNDARAM ERB, 1990, J ETHNOPHARMACOL, V30, P265, DOI 10.1016/0378-8741(90)90106-4; Sharma U, 2012, J ETHNOPHARMACOL, V141, P918, DOI 10.1016/j.jep.2012.03.027; Toffoli-Kadri MC, 2014, J ETHNOPHARMACOL, V153, P461, DOI 10.1016/j.jep.2014.03.008; Tripathi MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116588; Tripathi MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104431; Van Huyen JPD, 2003, CHEMOTHERAPY, V49, P298, DOI 10.1159/000074530; Van Huyen JPD, 2002, MOL MED, V8, P600, DOI 10.1007/BF03402170; Van Huyen JPD, 2001, CHEMOTHERAPY, V47, P366, DOI 10.1159/000048545; VANDERNAT JM, 1987, J ETHNOPHARMACOL, V19, P125, DOI 10.1016/0378-8741(87)90036-5; Weissenstein U, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-6; WHO, 2011, QUAL CONTR METH HERB, P1; Wu XY, 2012, FOOD RES INT, V48, P935, DOI [10.1016/j.foodres.2011.01.031, 10.1016/j.foodres.2012.02.006]	57	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0139631	10.1371/journal.pone.0139631	http://dx.doi.org/10.1371/journal.pone.0139631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474420	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500012
J	Zinner, C; Hauser, A; Born, DP; Wehrlin, JP; Holmberg, HC; Sperlich, B				Zinner, Christoph; Hauser, Anna; Born, Dennis-Peter; Wehrlin, Jon P.; Holmberg, Hans-Christer; Sperlich, Billy			Influence of Hypoxic Interval Training and Hyperoxic Recovery on Muscle Activation and Oxygenation in Connection with Double-Poling Exercise	PLOS ONE			English	Article							VASTUS LATERALIS OXYGENATION; DEOXYGENATION KINETICS; PERFORMANCE; METABOLISM; CONSUMPTION; SATURATION; TRANSPORT; RESPONSES; ARM	Here, we evaluated the influence of breathing oxygen at different partial pressures during recovery from exercise on performance at sea-level and a simulated altitude of 1800 m, as reflected in activation of different upper body muscles, and oxygenation of the m. triceps brachii. Ten well-trained, male endurance athletes (25.3 +/- 4.1 yrs; 179.2 +/- 4.5 cm; 74.2 +/- 3.4 kg) performed four test trials, each involving three 3-min sessions on a double-poling ergometer with 3-min intervals of recovery. One trial was conducted entirely under normoxic (No) and another under hypoxic conditions (Ho; FiO2 = 0.165). In the third and fourth trials, the exercise was performed in normoxia and hypoxia, respectively, with hyperoxic recovery (HOX; FiO2 = 1.00) in both cases. Arterial hemoglobin saturation was higher under the two HOX conditions than without HOX (p<0.05). Integrated muscle electrical activity was not influenced by the oxygen content (best d = 0.51). Furthermore, the only difference in tissue saturation index measured via near-infrared spectroscopy observed was between the recovery periods during the NoNo and HoHOX interventions (P<0.05, d = 0.93). In the case of HoHo the athletes' P-mean declined from the first to the third interval (P < 0.05), whereas P-mean was unaltered under the HoHOX, NoHOX and NoNo conditions. We conclude that the less pronounced decline in P-mean during 3 x 3-min double-poling sprints in normoxia and hypoxia with hyperoxic recovery is not related to changes inmuscle activity or oxygenation. Moreover, we conclude that hyperoxia (FiO2 = 1.00) used in conjunction with hypoxic or normoxic work intervals may serve as an effective aid when inhaled during the subsequent recovery intervals.	[Zinner, Christoph; Born, Dennis-Peter; Sperlich, Billy] Univ Wurzburg, Dept Sport Sci, D-97070 Wurzburg, Germany; [Zinner, Christoph; Holmberg, Hans-Christer; Sperlich, Billy] Mid Sweden Univ, Dept Hlth Sci, Swedish Winter Sports Res Ctr, Ostersund, Sweden; [Hauser, Anna; Wehrlin, Jon P.] Swiss Fed Inst Sport, Sect Elite Sport, Magglingen, Switzerland	University of Wurzburg; Mid-Sweden University	Zinner, C (corresponding author), Univ Wurzburg, Dept Sport Sci, D-97070 Wurzburg, Germany.	christoph.zinner@uni-wuerzburg.de	Wehrlin, Jon Peter/G-5101-2011; Wehrlin, Jon Peter/P-1984-2019	Wehrlin, Jon Peter/0000-0002-8854-7937; Wehrlin, Jon Peter/0000-0002-8854-7937; Born, Dennis-Peter/0000-0002-1058-4367; Holmberg, Hans-Christer/0000-0002-3814-6246; Sperlich, Billy/0000-0003-4686-8561	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.	ADAMS RP, 1980, J APPL PHYSIOL, V49, P863, DOI 10.1152/jappl.1980.49.5.863; AHLBORG G, 1991, CLIN PHYSIOL, V11, P459, DOI 10.1111/j.1475-097X.1991.tb00818.x; Amann M, 2008, J APPL PHYSIOL, V104, P861, DOI 10.1152/japplphysiol.01008.2007; BenSira D, 1997, EUR J APPL PHYSIOL O, V75, P549, DOI 10.1007/s004210050203; Bigland-Ritchie B, 1981, Exerc Sport Sci Rev, V9, P75; Billaut F, 2013, SCAND J MED SCI SPOR, V23, pe185, DOI 10.1111/sms.12052; Bojsen-Moller J, 2010, J APPL PHYSIOL, V109, P1895, DOI 10.1152/japplphysiol.00671.2010; Buchheit M, 2009, J APPL PHYSIOL, V107, P460, DOI 10.1152/japplphysiol.91625.2008; Calbet JAL, 2005, AM J PHYSIOL-REG I, V289, pR1448, DOI 10.1152/ajpregu.00824.2004; Casey DP, 2012, J PHYSIOL-LONDON, V590, P6321, DOI 10.1113/jphysiol.2012.242396; CHANCE B, 1992, AM J PHYSIOL, V262, pC766, DOI 10.1152/ajpcell.1992.262.3.C766; Cleland SM, 2012, APPL PHYSIOL NUTR ME, V37, P138, DOI [10.1139/H11-143, 10.1139/h11-143]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dupont G, 2007, MED SCI SPORT EXER, V39, P1170, DOI 10.1249/mss.0b013e31804c9976; Edwards R H, 1981, Ciba Found Symp, V82, P1; Faiss R, 2015, MED SCI SPORT EXER, V47, P809, DOI 10.1249/MSS.0000000000000464; Faiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056522; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; GRAHAM TE, 1987, J APPL PHYSIOL, V63, P1457, DOI 10.1152/jappl.1987.63.4.1457; Grimby L, 1981, Ciba Found Symp, V82, P157; Hamaoka T, 1996, J APPL PHYSIOL, V81, P1410; Hauser A, 2014, MED SCI SPORT EXER, V46, P787, DOI 10.1249/MSS.0000000000000157; Hermens HJE, 1999, FUTURE APPL SURFACE; Hogan MC, 1999, J APPL PHYSIOL, V86, P1367, DOI 10.1152/jappl.1999.86.4.1367; KAYSER B, 1994, J APPL PHYSIOL, V76, P634, DOI 10.1152/jappl.1994.76.2.634; KNIGHT DR, 1993, J APPL PHYSIOL, V75, P2586, DOI 10.1152/jappl.1993.75.6.2586; Kounalakis SN, 2009, RES SPORTS MED, V17, P171, DOI 10.1080/15438620903120421; Linossier MT, 2000, ACTA PHYSIOL SCAND, V168, P403; Maeda Takafumi, 1998, Applied Human Science, V17, P33, DOI 10.2114/jpa.17.33; Maeda Takafumi, 1997, Applied Human Science, V16, P249, DOI 10.2114/jpa.16.249; Millet GY, 2012, J APPL PHYSIOL, V112, P1335, DOI 10.1152/japplphysiol.00804.2011; Mygind E., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P76; Nioka S, 1998, ADV EXP MED BIOL, V454, P63; Nummela A, 2002, SCAND J MED SCI SPOR, V12, P309, DOI 10.1034/j.1600-0838.2002.10157.x; Peeling P, 2011, J SPORT SCI, V29, P147, DOI 10.1080/02640414.2010.526133; PELTONEN JE, 1995, MED SCI SPORT EXER, V27, P573; POWERS SK, 1993, SPORTS MED, V16, P14, DOI 10.2165/00007256-199316010-00003; Prieur F, 2002, EUR J APPL PHYSIOL, V88, P235, DOI 10.1007/s00421-002-0707-0; Prieur F, 2012, J SPORT MED PHYS FIT, V52, P137; Richardson RS, 1999, J APPL PHYSIOL, V87, P325, DOI 10.1152/jappl.1999.87.1.325; Smith KJ, 2010, EUR J APPL PHYSIOL, V109, P989, DOI 10.1007/s00421-010-1444-4; Sperlich B, 2011, SCAND J MED SCI SPOR, V21, pE421, DOI 10.1111/j.1600-0838.2011.01349.x; Sperlich B, 2012, J SPORT SCI, V30, P851, DOI 10.1080/02640414.2012.671531; Sperlich B, 2010, EUR J APPL PHYSIOL, V110, P301, DOI 10.1007/s00421-010-1507-6; Stellingwerff T, 2005, J APPL PHYSIOL, V98, P250, DOI 10.1152/japplphysiol.00897.2004; Torres-Peralta R, 2014, HIGH ALT MED BIOL, V15, P472, DOI 10.1089/ham.2014.1027; Tucker R, 2007, EUR J APPL PHYSIOL, V101, P771, DOI 10.1007/s00421-007-0458-z; WOLFEL EE, 1991, J APPL PHYSIOL, V70, P1129, DOI 10.1152/jappl.1991.70.3.1129; Yamada E, 2005, CLIN PHYSIOL FUNCT I, V25, P203, DOI 10.1111/j.1475-097X.2005.00614.x	50	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140616	10.1371/journal.pone.0140616	http://dx.doi.org/10.1371/journal.pone.0140616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468885	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600086
J	Cathalot, C; Rabouille, C; Sauter, E; Schewe, I; Soltwedel, T				Cathalot, Cecile; Rabouille, Christophe; Sauter, Eberhard; Schewe, Ingo; Soltwedel, Thomas			Benthic Oxygen Uptake in the Arctic Ocean Margins - A Case Study at the Deep-Sea Observatory HAUSGARTEN (Fram Strait)	PLOS ONE			English	Article							ORGANIC-CARBON; IN-SITU; INTERANNUAL VARIABILITY; BACTERIAL COMMUNITIES; SEDIMENTS SVALBARD; SURFACE SEDIMENTS; ATLANTIC OCEAN; ICE-ZONE; MATTER; WATER	The past decades have seen remarkable changes in the Arctic, a hotspot for climate change. Nevertheless, impacts of such changes on the biogeochemical cycles and Arctic marine ecosystems are still largely unknown. During cruises to the deep-sea observatory HAUSGARTEN in July 2007 and 2008, we investigated the biogeochemical recycling of organic matter in Arctic margin sediments by performing shipboard measurements of oxygen profiles, bacterial activities and biogenic sediment compounds (pigment, protein, organic carbon, and phospholipid contents). Additional in situ oxygen profiles were performed at two sites. This study aims at characterizing benthic mineralization activity along local bathymetric and latitudinal transects. The spatial coverage of this study is unique since it focuses on the transition from shelf to Deep Ocean, and from close to the ice edge to more open waters. Biogeochemical recycling across the continental margin showed a classical bathymetric pattern with overall low fluxes except for the deepest station located in the Molloy Hole (5500 m), a seafloor depression acting as an organic matter depot center. A gradient in benthic mineralization rates arises along the latitudinal transect with clearly higher values at the southern stations (average diffusive oxygen uptake of 0.49 +/- 0.18 mmol O-2 m(-2) d(-1)) compared to the northern sites (0.22 +/- 0.09 mmol O-2 m(-2) d(-1)). The benthic mineralization activity at the HAUSGARTEN observatory thus increases southward and appears to reflect the amount of organic matter reaching the seafloor rather than its lability. Although organic matter content and potential bacterial activity clearly follow this gradient, sediment pigments and phospholipids exhibit no increase with latitude whereas satellite images of surface ocean chlorophyll a indicate local seasonal patterns of primary production. Our results suggest that predicted increases in primary production in the Arctic Ocean could induce a larger export of more refractory organic matter due to the longer production season and the extension of the ice-free zone.	[Cathalot, Cecile; Rabouille, Christophe] UMR CEA CNRS UVSQ, Lab Sci Climat & Environm, Gif Sur Yvette, France; [Sauter, Eberhard; Schewe, Ingo; Soltwedel, Thomas] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst 1, Bremerhaven, Germany	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Cathalot, C (corresponding author), IFREMER, Lab Geochim & Metallogenie LGM GM REM, Plouzane, France.	cecile.cathalot@ifremer.fr	RABOUILLE, Christophe/M-8806-2013; Soltwedel, Thomas/P-1852-2016	RABOUILLE, Christophe/0000-0003-1211-717X; Soltwedel, Thomas/0000-0002-8214-5937; Cathalot, Cecile/0000-0002-0868-7201	Laboratoire des Sciences du Climat et de l'Environnement (LSCE); Alfred Wegener Institute (AWI); INSTN (CEA) PhD scholarship	Laboratoire des Sciences du Climat et de l'Environnement (LSCE); Alfred Wegener Institute (AWI); INSTN (CEA) PhD scholarship	Financial support from Laboratoire des Sciences du Climat et de l'Environnement (LSCE) and Alfred Wegener Institute (AWI) made much of this work possible. C. Cathalot was sponsored by an INSTN (CEA) PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLER RC, 1990, PHILOS T R SOC A, V331, P51, DOI 10.1098/rsta.1990.0056; Anderson LG, 2001, POLAR RES, V20, P225, DOI 10.1111/j.1751-8369.2001.tb00060.x; Andersson JH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018756; ANDREWS D, 1981, GEOCHIM COSMOCHIM AC, V45, P2169, DOI 10.1016/0016-7037(81)90069-7; Bates NR, 2009, BIOGEOSCIENCES, V6, P2433, DOI 10.5194/bg-6-2433-2009; Bates NR, 2011, OCEANOGRAPHY, V24, P186, DOI 10.5670/oceanog.2011.71; Battin TJ, 1997, SCI TOTAL ENVIRON, V198, P51, DOI 10.1016/S0048-9697(97)05441-7; Bauerfeind E, 2009, DEEP-SEA RES PT I, V56, P1471, DOI 10.1016/j.dsr.2009.04.011; BENDER ML, 1984, GEOCHIM COSMOCHIM AC, V48, P977, DOI 10.1016/0016-7037(84)90189-3; Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; Berger BR, 1988, 1 NOAA; Beszczynska-Moller A, 2012, ICES J MAR SCI, V69, P852, DOI 10.1093/icesjms/fss056; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; BOETIUS A, 1994, MAR ECOL PROG SER, V104, P299, DOI 10.3354/meps104299; Boetius A, 1998, DEEP-SEA RES PT I, V45, P239, DOI 10.1016/S0967-0637(97)00052-6; BOUDREAU BP, 1993, GEOCHIM COSMOCHIM AC, V57, P317, DOI 10.1016/0016-7037(93)90434-X; Brussaard CPD, 2013, BIOGEOSCIENCES, V10, P719, DOI 10.5194/bg-10-719-2013; Burdige DJ, 2007, CHEM REV, V107, P467, DOI 10.1021/cr050347q; CANFIELD DE, 1993, MAR GEOL, V113, P27, DOI 10.1016/0025-3227(93)90147-N; Cherkasheva A, 2014, J MARINE SYST, V132, P196, DOI 10.1016/j.jmarsys.2013.11.008; Clough LM, 2005, CAN J FISH AQUAT SCI, V62, P1756, DOI 10.1139/F05-102; Clough LM, 1997, DEEP-SEA RES PT II, V44, P1683, DOI 10.1016/S0967-0645(97)00052-0; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Emerson S., 1985, CARBON CYCLE ATMOSPH, V32, P78, DOI DOI 10.1029/GM032P0078; Epping EHG, 1997, CONT SHELF RES, V17, P1737, DOI 10.1016/S0278-4343(97)00039-3; FINDLAY RH, 1989, APPL ENVIRON MICROB, V55, P2888, DOI 10.1128/AEM.55.11.2888-2893.1989; Forest A, 2010, POLAR BIOL, V33, P1733, DOI 10.1007/s00300-010-0855-3; GARD G, 1993, GEOLOGY, V21, P227, DOI 10.1130/0091-7613(1993)021<0227:LQCATN>2.3.CO;2; GLUD RN, 1994, DEEP-SEA RES PT I, V41, P1767; Glud RN, 2000, MAR ECOL PROG SER, V206, P59, DOI 10.3354/meps206059; Glud RN, 1998, MAR ECOL PROG SER, V173, P237, DOI 10.3354/meps173237; Glud RN, 2013, NAT GEOSCI, V6, P284, DOI [10.1038/NGEO1773, 10.1038/ngeo1773]; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd; Grebmeier JM, 2012, ANNU REV MAR SCI, V4, P63, DOI 10.1146/annurev-marine-120710-100926; GREBMEIER JM, 2010, EOS, V91, P161, DOI DOI 10.1029/2010EO180001; Greiser N., 1988, P79; Hall POJ, 2007, LIMNOL OCEANOGR, V52, P19, DOI 10.4319/lo.2007.52.1.0019; Hartnett HE, 1998, NATURE, V391, P572, DOI 10.1038/35351; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Hop H, 2006, PROG OCEANOGR, V71, P182, DOI 10.1016/j.pocean.2006.09.007; HULTH S, 1994, MAR CHEM, V46, P293, DOI 10.1016/0304-4203(94)90084-1; JAHNKE RA, 1992, NATO ADV SCI I C-MAT, V360, P295; Jeansson E, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003961; Kang SH, 2001, J PLANKTON RES, V23, P333, DOI 10.1093/plankt/23.4.333; Katsev S, 2006, LIMNOL OCEANOGR, V51, P1581, DOI 10.4319/lo.2006.51.4.1581; Klenke M, 2002, MAR GEOPHYS RES, V23, P367, DOI 10.1023/A:1025764206736; KOSTER M, 1991, BROCK SPR S, P298; Lalande C, 2013, PROG OCEANOGR, V109, P70, DOI 10.1016/j.pocean.2012.09.006; MANLEY TO, 1995, J GEOPHYS RES-OCEANS, V100, P20627, DOI 10.1029/95JC01251; Mayor DJ, 2012, ISME J, V6, P1740, DOI 10.1038/ismej.2012.14; NICHOLS PD, 1989, ANTARCT SCI, V1, P133, DOI 10.1017/S0954102089000209; O'Brien MC, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006890; Overland JE, 2011, POLAR RES, V30, DOI 10.3402/polar.v30i0.15787; Peinert R, 2001, NORTHERN NORTH ATLANTIC: A CHANGING ENVIRONMENT, P53; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Ploug H, 2000, LIMNOL OCEANOGR, V45, P1467, DOI 10.4319/lo.2000.45.7.1467; POREMBA K, 1995, FEMS MICROBIOL ECOL, V16, P213, DOI 10.1016/0168-6496(94)00085-B; Rabouille C, 2001, PROG OCEANOGR, V50, P147, DOI 10.1016/S0079-6611(01)00052-0; RASMUSSEN H, 1992, MAR ECOL PROG SER, V81, P289, DOI 10.3354/meps081289; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Sauter EJ, 2001, DEEP-SEA RES PT I, V48, P529, DOI 10.1016/S0967-0637(00)00061-3; Seiter K, 2004, DEEP-SEA RES PT I, V51, P2001, DOI 10.1016/j.dsr.2004.06.014; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; SHUMAN FR, 1975, LIMNOL OCEANOGR, V20, P580, DOI 10.4319/lo.1975.20.4.0580; Skogen MD, 2007, ICES J MAR SCI, V64, P889, DOI 10.1093/icesjms/fsm063; Soetaert K, 1996, GEOCHIM COSMOCHIM AC, V60, P1019, DOI 10.1016/0016-7037(96)00013-0; Soltwedel T, 2000, PROG OCEANOGR, V46, P59, DOI 10.1016/S0079-6611(00)00030-6; Soltwedel T., 2005, OCEANOGRAPHY, V18, P46, DOI [10.5670/oceanog.2005.24, DOI 10.5670/0CEAN0G.2005.24]; Soltwedel T, 2009, DEEP-SEA RES PT I, V56, P1856, DOI 10.1016/j.dsr.2009.05.012; Stein R, 2004, ORGANIC CARBON CYCLE, VXIX, P317; Stephens MP, 1997, GEOCHIM COSMOCHIM AC, V61, P4605, DOI 10.1016/S0016-7037(97)00358-X; Thamdrup B, 1996, LIMNOL OCEANOGR, V41, P1629, DOI 10.4319/lo.1996.41.8.1629; Thiel H., 1978, UPWELLING ECOSYSTEMS, p124?138; Urban-Rich J, 1999, J EXP MAR BIOL ECOL, V232, P107, DOI 10.1016/S0022-0981(98)00104-X; van Oevelen D, 2011, DEEP-SEA RES PT I, V58, P1069, DOI 10.1016/j.dsr.2011.08.002; Vancoppenolle M, 2013, QUATERNARY SCI REV, V79, P207, DOI 10.1016/j.quascirev.2013.04.011; Vernet M, 2008, DEEP-SEA RES PT II, V55, P2068, DOI 10.1016/j.dsr2.2008.05.021; VOLKMAN JK, 1988, HYDROBIOLOGIA, V165, P41, DOI 10.1007/BF00025573; Wassmann P, 2011, PROG OCEANOGR, V90, P1, DOI 10.1016/j.pocean.2011.02.002; Wenzhofer F, 2002, DEEP-SEA RES PT I, V49, P1255, DOI 10.1016/S0967-0637(02)00025-0	80	14	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138339	10.1371/journal.pone.0138339	http://dx.doi.org/10.1371/journal.pone.0138339			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465885	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100015
J	Hubbe, M; Strauss, A; Hubbe, A; Neves, WA				Hubbe, Mark; Strauss, Andre; Hubbe, Alex; Neves, Walter A.			Early South Americans Cranial Morphological Variation and the Origin of American Biological Diversity	PLOS ONE			English	Article							HUMAN SKELETAL REMAINS; LAGOA-SANTA; GENE FLOW; CRANIOFACIAL MORPHOLOGY; CRANIOMETRIC VARIATION; LINGUISTIC DIVERSITY; 1ST AMERICANS; EVOLUTION; SETTLEMENT; BRAZIL	Recent South Americans have been described as presenting high regional cranial morphological diversity when compared to other regions of the world. This high diversity is in accordance with linguistic and some of the molecular data currently available for the continent, but the origin of this diversity has not been satisfactorily explained yet. Here we explore if this high morphological variation was already present among early groups in South America, in order to refine our knowledge about the timing and origins of the modern morphological diversity. Between-group (Fst estimates) and within-group variances (trace of within-group covariance matrix) of the only two early American population samples available to date (Lagoa Santa and Sabana de Bogota) were estimated based on linear craniometric measurements and compared to modern human cranial series representing six regions of the world, including the Americas. The results show that early Americans present moderate within-group diversity, falling well within the range of modern human groups, despite representing almost three thousand years of human occupation. The between-group variance apportionment is very low between early Americans, but is high among recent South American groups, who show values similar to the ones observed on a global scale. Although limited to only two early South American series, these results suggest that the high morphological diversity of native South Americans was not present among the first human groups arriving in the continent and must have originated during the Middle Holocene, possibly due to the arrival of new morphological diversity coming from Asia during the Holocene.	[Hubbe, Mark] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Hubbe, Mark] Univ Catolica Norte, Inst Invest Arqueol & Museo, San Pedro De Atacama, Region De Antof, Chile; [Strauss, Andre] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Hubbe, Alex] Univ Fed Bahia, Inst Geociencias, Dept Oceanog, Salvador, BA, Brazil; [Neves, Walter A.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Lab Estudos Evolut Humanos, Sao Paulo, Brazil	University System of Ohio; Ohio State University; Universidad Catolica del Norte; Max Planck Society; Universidade Federal da Bahia; Universidade de Sao Paulo	Hubbe, M (corresponding author), Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA.	hubbe.1@osu.edu	Hubbe, Mark/AAC-1043-2020; Hubbe, Mark/G-3440-2012; Strauss, Andre/I-4408-2012; Neves, Walter A/Q-8316-2016; Strauss, Andre/K-4089-2015	Hubbe, Mark/0000-0003-4433-3942; Neves, Walter A/0000-0001-9124-3937; Strauss, Andre/0000-0002-2336-1381; Hubbe, Alex/0000-0002-3226-0144	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [99/0670-7, 04/01321-6, 12/24937-9]; Max Planck Institute for Evolutionary Anthropology [08/51747-0]; CNPq [300917/2010-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Max Planck Institute for Evolutionary Anthropology(Max Planck Society); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) through three research grants, 99/0670-7 and 04/01321-6 to WAN and 12/24937-9 to AH. AS received a MSc scholarship (Process 08/51747-0) and support from the Max Planck Institute for Evolutionary Anthropology. WAN also received support from CNPq (300917/2010-4).	Ackermann RR, 2004, P NATL ACAD SCI USA, V101, P17946, DOI 10.1073/pnas.0405919102; BERG RL, 1960, EVOLUTION, V14, P171, DOI 10.2307/2405824; Bernardo DV., 2009, FUMDHAMENTOS, V8, P95; Bernardo DV, 2011, PEUPLEMENTS PREHISTO, P31; Betti L, 2010, AM J PHYS ANTHROPOL, V141, P76, DOI 10.1002/ajpa.21115; Betti L, 2009, P ROY SOC B-BIOL SCI, V276, P809, DOI 10.1098/rspb.2008.1563; Carson EA, 2006, AM J PHYS ANTHROPOL, V131, P169, DOI 10.1002/ajpa.20424; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chernoff B, 1999, MORPHOLOGICAL INTEGR, P316; CHEVERUD JM, 1989, SYST ZOOL, V38, P201, DOI 10.2307/2992282; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; de Azevedo S, 2011, AM J PHYS ANTHROPOL, V146, P539, DOI 10.1002/ajpa.21564; DEVOR EJ, 1987, J CRAN GENET DEV BIO, V7, P95; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Gonzalez-Jose RG, 2005, AM J PHYS ANTHROPOL, V128, P757, DOI 10.1002/ajpa.20161; Gonzalez-Jose RG, 2003, NATURE, V425, P62, DOI 10.1038/nature01816; Gonzalez-Jose R, 2008, AM J PHYS ANTHROPOL, V137, P175, DOI 10.1002/ajpa.20854; Grine FE, 2007, SCIENCE, V315, P226, DOI 10.1126/science.1136294; Hansen TF, 2003, BIOSYSTEMS, V69, P83, DOI 10.1016/S0303-2647(02)00132-6; Harvati K, 2006, ANAT REC, V292, P1720; Harvati K, 2009, J HUM EVOL, V57, P751, DOI 10.1016/j.jhevol.2009.07.008; HOULE D, 1992, GENETICS, V130, P195; Howells W. W., 1973, PAPERS PEABODY MUSEU, V67; Howells WW, 1996, AM J PHYS ANTHROPOL, V101, P441, DOI 10.1002/ajpa.1331010302; HOWELLS WW, 1989, PAPERS PEABODY MUSEU, V79; Hubbe M, 2014, AM J PHYS ANTHROPOL, V155, P546, DOI 10.1002/ajpa.22607; Hubbe M, 2011, AM J PHYS ANTHROPOL, V144, P442, DOI 10.1002/ajpa.21425; Hubbe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011105; Hubbe M, 2009, ANAT REC, V292, P1720, DOI 10.1002/ar.20976; Perez SI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005746; Jantz RL, 2001, AM J PHYS ANTHROPOL, V114, P146, DOI 10.1002/1096-8644(200102)114:2<146::AID-AJPA1014>3.0.CO;2-E; LANDE R, 1979, EVOLUTION, V33, P234, DOI [10.2307/2407380, 10.1111/j.1558-5646.1979.tb04678.x]; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Marroig G, 2001, EVOLUTION, V55, P2576; Marroig G, 2009, EVOL BIOL, V36, P136, DOI 10.1007/s11692-009-9051-1; Martinez-Abadias N, 2009, J ANAT, V214, P19, DOI 10.1111/j.1469-7580.2008.01015.x; McGuigan K, 2006, MOL ECOL, V15, P883, DOI 10.1111/j.1365-294X.2006.02809.x; Nettle D, 1999, P NATL ACAD SCI USA, V96, P3325, DOI 10.1073/pnas.96.6.3325; Neves Walter A., 1989, Ciencia e Cultura (Sao Paulo), V41, P566; Neves WA, 2005, P NATL ACAD SCI USA, V102, P18309, DOI 10.1073/pnas.0507185102; Neves WA, 2005, J HUM EVOL, V48, P403, DOI 10.1016/j.jhevol.2004.12.001; Neves WA, 2003, J HUM EVOL, V45, P19, DOI 10.1016/S0047-2484(03)00081-2; NEVES WA, 1991, J HUM EVOL, V21, P261, DOI 10.1016/0047-2484(91)90107-7; Neves WA, 2004, REV CEPA, V28, P159; Neves WA, 2007, AM J PHYS ANTHROPOL, V133, P1080, DOI 10.1002/ajpa.20637; Neves WA, 2007, J HUM EVOL, V52, P16, DOI 10.1016/j.jhevol.2006.07.012; Neves Walter A., 2004, Rev. Antropol., V47, P159; Neves Walter A., 1999, Ciencia e Cultura (Sao Paulo), V51, P151; NICHOLS J, 1990, LANGUAGE, V66, P475, DOI 10.2307/414609; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olson EC., 1999, MORPHOLOGICAL INTEGR; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Perez SI, 2011, J BIOGEOGR, V38, P148, DOI 10.1111/j.1365-2699.2010.02392.x; Porto A, 2009, EVOL BIOL, V36, P118, DOI 10.1007/s11692-008-9038-3; Powell J.F., 2005, 1 AM RACE EVOLUTION; Powell JF, 1999, YEARB PHYS ANTHROPOL, V42, P153; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Pucciarelli HM, 2008, J HUM EVOL, V54, P296, DOI 10.1016/j.jhevol.2007.08.011; Pucciarelli HM, 2010, AM J PHYS ANTHROPOL, V143, P298, DOI 10.1002/ajpa.21347; R Core Team, 2021, R LANGUAGE ENV STAT; Ray N, 2010, MOL BIOL EVOL, V27, P337, DOI 10.1093/molbev/msp238; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Relethford JH, 1997, HUM BIOL, V69, P443; Relethford JH, 2002, AM J PHYS ANTHROPOL, V118, P393, DOI 10.1002/ajpa.10079; RELETHFORD JH, 1990, HUM BIOL, V62, P5; RELETHFORD JH, 1994, AM J PHYS ANTHROPOL, V95, P53, DOI 10.1002/ajpa.1330950105; Relethford JH, 2001, HUM BIOL, V73, P629, DOI 10.1353/hub.2001.0073; Reyes-Centeno H, 2014, P NATL ACAD SCI USA, V111, P7248, DOI 10.1073/pnas.1323666111; Ross AH, 2002, HUM BIOL, V74, P807, DOI 10.1353/hub.2003.0010; Ross AH, 2008, LAT AM ANTIQ, V19, P158, DOI 10.2307/25478221; Sardi ML, 2005, AM J PHYS ANTHROPOL, V128, P747, DOI 10.1002/ajpa.20235; Seguchi N, 2011, ANTHROPOL SCI, V119, P21, DOI 10.1537/ase.090921; Shirai LT, 2010, J EXP ZOOL PART B, V314B, P663, DOI 10.1002/jez.b.21367; Strauss A, 2015, AM J PHYS ANTHROPOL, V157, P202, DOI 10.1002/ajpa.22703; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Venables WN., 2002, MODERN APPL STAT S, V4; Volodko NV, 2008, AM J HUM GENET, V82, P1084, DOI 10.1016/j.ajhg.2008.03.019; von Cramon-Taubadel N, 2008, AM J PHYS ANTHROPOL, V136, P108, DOI 10.1002/ajpa.20775; Wagner GP, 1996, AM ZOOL, V36, P36; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; WILLIAMSBLANGERO S, 1990, HUM BIOL, V62, P131; WILLIAMSBLANGERO S, 1989, HUM BIOL, V61, P1; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009	85	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138090	10.1371/journal.pone.0138090	http://dx.doi.org/10.1371/journal.pone.0138090			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CU0CK	26465141	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100011
J	Okada, H; Masujin, K; Miyazawa, K; Yokoyama, T				Okada, Hiroyuki; Masujin, Kentaro; Miyazawa, Kohtaro; Yokoyama, Takashi			Transmissibility of H-Type Bovine Spongiform Encephalopathy to Hamster PrP Transgenic Mice	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN; SCRAPIE AGENT; CATTLE; STRAINS; ACCUMULATION; INFECTION; BSE; SUSCEPTIBILITY; IDENTIFICATION	Two distinct forms of atypical bovine spongiform encephalopathies (H-BSE and L-BSE) can be distinguished from classical (C-) BSE found in cattle based on biochemical signatures of disease-associated prion protein (PrPSc). H-BSE is transmissible to wild-type mice-with infected mice showing a long survival period that is close to their normal lifespan-but not to hamsters. Therefore, rodent-adapted H-BSE with a short survival period would be useful for analyzing H-BSE characteristics. In this study, we investigated the transmissibility of H-BSE to hamster prion protein transgenic (TgHaNSE) mice with long survival periods. Although none of the TgHaNSE mice manifested the disease during their lifespan, PrPSc accumulation was observed in some areas of the brain after the first passage. With subsequent passages, TgHaNSE mice developed the disease with a mean survival period of 220 days. The molecular characteristics of proteinase K-resistant PrPSc (PrPres) in the brain were identical to those observed in first-passage mice. The distribution of immunolabeled PrPSc in the brains of TgHaNSE mice differed between those infected with H-BSE as compared to C-BSE or L-BSE, and the molecular properties of PrPres in TgHaNSE mice infected with H-BSE differed from those of the original isolate. The strain-specific electromobility, glycoform profiles, and proteolytic cleavage sites of H-BSE in TgHaNSE mice were indistinguishable from those of C-BSE, in which the diglycosylated form was predominant. These findings indicate that strain-specific pathogenic characteristics and molecular features of PrPres in the brain are altered during cross-species transmission. Typical H-BSE features were restored after back passage from TgHaNSE to bovinized transgenic mice, indicating that the H-BSE strain was propagated in TgHaNSE mice. This could result from the overexpression of the hamster prion protein.	[Okada, Hiroyuki; Masujin, Kentaro; Miyazawa, Kohtaro; Yokoyama, Takashi] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Okada, H (corresponding author), Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Tsukuba, Ibaraki, Japan.	okadahi@affrc.go.jp; masujin@affrc.go.jp	Miyazawa, Kohtaro/ABB-1464-2021		BSE; Ministry of Agriculture, Forestry and Fisheries of Japan	BSE; Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This study was supported by grants-in-aid from the BSE and other prion disease project and the research project for improving food safety and animal health from the Ministry of Agriculture, Forestry and Fisheries of Japan.	Agrimi U, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000113; Asano M, 2006, BIOCHEM BIOPH RES CO, V342, P293, DOI 10.1016/j.bbrc.2006.01.149; Balkema-Buschmann A, 2011, J TOXICOL ENV HEAL A, V74, P103, DOI 10.1080/15287394.2011.529060; Baron T, 2007, VACCINE, V25, P5625, DOI 10.1016/j.vaccine.2006.10.058; Baron T, 2007, EMERG INFECT DIS, V13, P1887, DOI 10.3201/eid1312.070635; Baron T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015839; Baron TGM, 2006, EMERG INFECT DIS, V12, P1125; Bencsik A, 2013, J NEUROPATH EXP NEUR, V72, P211, DOI 10.1097/NEN.0b013e318285c7f9; Beringue V, 2006, PLOS PATHOG, V2, P956, DOI 10.1371/journal.ppat.0020112; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biacabe AG, 2007, PRION, V1, P61, DOI 10.4161/pri.1.1.3828; Brown P, 2006, EMERG INFECT DIS, V12, P1816; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Castilla J, 2004, J NEUROSCI, V24, P5063, DOI 10.1523/JNEUROSCI.5400-03.2004; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Dudas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010638; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Greenlee JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038678; Greenlee MHW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119431; Hagiwara K, 2007, JPN J INFECT DIS, V60, P305; Hill AF, 2003, BRIT MED BULL, V66, P161, DOI 10.1093/bmb/66.1.161; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Iwamaru Y, 2008, J NEUROCHEM, V107, P636, DOI 10.1111/j.1471-4159.2008.05628.x; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kascsak R, 2010, J BIOL CHEM, V285, pLE5, DOI 10.1074/jbc.L109.088831; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; Kobayashi A, 2007, J BIOL CHEM, V282, P30022, DOI 10.1074/jbc.M704597200; Konold T, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0243-2; Konold T, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-22; Nicot S, 2011, J VIROL, V85, P1906, DOI 10.1128/JVI.01872-10; Nonno R, 2006, PLOS PATHOG, V2, P112, DOI 10.1371/journal.ppat.0020012; Okada H, 2011, J COMP PATHOL, V144, P251, DOI 10.1016/j.jcpa.2010.10.001; Okada H, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-79; Priola SA, 2001, J VIROL, V75, P4673, DOI 10.1128/JVI.75.10.4673-4680.2001; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; RACE RE, 1995, NEURON, V15, P1183, DOI 10.1016/0896-6273(95)90105-1; Scott MR, 1997, P NATL ACAD SCI USA, V94, P14279, DOI 10.1073/pnas.94.26.14279; Shimizu Y, 2010, MICROBIOL IMMUNOL, V54, P112, DOI 10.1111/j.1348-0421.2009.00190.x; Shu YJ, 2011, PRION, V5, P103, DOI 10.4161/pri.5.2.15847; Taguchi Y, 2003, AM J PATHOL, V163, P2585, DOI 10.1016/S0002-9440(10)63613-9; Tomzig A, 2004, J BIOL CHEM, V279, P33847, DOI 10.1074/jbc.M403730200; Torres JM, 2011, EMERG INFECT DIS, V17, P1636, DOI 10.3201/eid1709.101403; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; WILESMITH JW, 1988, VET REC, V123, P638; Yokoyama T, 2009, J GEN VIROL, V90, P261, DOI 10.1099/vir.0.004754-0	50	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138977	10.1371/journal.pone.0138977	http://dx.doi.org/10.1371/journal.pone.0138977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466381	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100034
J	Tsakanikas, P; Pavlidis, D; Nychas, GJ				Tsakanikas, Panagiotis; Pavlidis, Dimitris; Nychas, George-John			High Throughput Multispectral Image Processing with Applications in Food Science	PLOS ONE			English	Article							QUALITY; SPOILAGE; TECHNOLOGY; VISION	Recently, machine vision is gaining attention in food science as well as in food industry concerning food quality assessment and monitoring. Into the framework of implementation of Process Analytical Technology (PAT) in the food industry, image processing can be used not only in estimation and even prediction of food quality but also in detection of adulteration. Towards these applications on food science, we present here a novel methodology for automated image analysis of several kinds of food products e.g. meat, vanilla creme and table olives, so as to increase objectivity, data reproducibility, low cost information extraction and faster quality assessment, without human intervention. Image processing's outcome will be propagated to the downstream analysis. The developed multispectral image processing method is based on unsupervised machine learning approach (Gaussian Mixture Models) and a novel unsupervised scheme of spectral band selection for segmentation process optimization. Through the evaluation we prove its efficiency and robustness against the currently available semi-manual software, showing that the developed method is a high throughput approach appropriate for massive data extraction from food samples.	[Tsakanikas, Panagiotis; Pavlidis, Dimitris; Nychas, George-John] Agr Univ Athens, Sch Food Biotechnol & Dev, Lab Microbiol & Biotechnol Foods, Dept Food Sci & Human Nutr, GR-11855 Athens, Greece	Agricultural University of Athens	Tsakanikas, P (corresponding author), Agr Univ Athens, Sch Food Biotechnol & Dev, Lab Microbiol & Biotechnol Foods, Dept Food Sci & Human Nutr, GR-11855 Athens, Greece.	p.tsakanikas@aua.gr	Tsakanikas, Panagiotis/I-5068-2019; Nychas, George/B-2734-2009; Tsakanikas, Panagiotis/B-5420-2010	Tsakanikas, Panagiotis/0000-0002-9361-5922; Nychas, George/0000-0002-2673-6425; Tsakanikas, Panagiotis/0000-0002-9361-5922; Pavlidis, Dimitrios/0000-0003-0772-0812	European Union (European Social Fund-ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: ARISTEIA	European Union (European Social Fund-ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: ARISTEIA	This work has been supported by the project "Intelligent multi-sensor system for meat analysis-iMeatSense_550" co-financed by the European Union (European Social Fund-ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: ARISTEIA.	Andresen MS, 2013, FOOD SCI NUTR, V1, P315, DOI 10.1002/fsn3.46; Argyri AA, 2013, FOOD CONTROL, V29, P461, DOI 10.1016/j.foodcont.2012.05.040; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; Carstensen J.M., 2003, European Patent, Patent No. [1051660, EP1051660]; Carstensen JM, 2006, 9 MED IM COMP COMP A; Celik T, 2012, IEEE T IMAGE PROCESS, V21, P145, DOI 10.1109/TIP.2011.2162419; Damez JL, 2008, MEAT SCI, V80, P132, DOI 10.1016/j.meatsci.2008.05.039; Damez JL, 2013, MEAT SCI, V95, P879, DOI 10.1016/j.meatsci.2013.04.037; Daugaard SB, 2010, FOOD CONTROL, V21, P626, DOI 10.1016/j.foodcont.2009.09.007; Dissing BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019032; Dissing BS, 2013, FOOD BIOPROCESS TECH, V6, P2268, DOI 10.1007/s11947-012-0886-6; Duda R.O., 2000, PATTERN CLASSIFICATI; Figueiredo MAT, 2002, IEEE T PATTERN ANAL, V24, P381, DOI 10.1109/34.990138; Food and Agriculture Organization, 2011, GUID IND CLIN CONS T, P1; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Hastie T, 1996, J ROY STAT SOC B MET, V58, P155; intVeld JHJH, 1996, INT J FOOD MICROBIOL, V33, P1, DOI 10.1016/0168-1605(96)01139-7; Jackman P, 2009, MEAT SCI, V83, P187, DOI 10.1016/j.meatsci.2009.03.010; McLachlan G., 2000, WILEY SER PROB STAT; Nychas GJE, 2008, MEAT SCI, V78, P77, DOI 10.1016/j.meatsci.2007.06.020; Panagou EZ, 2014, INT J FOOD MICROBIOL, V174, P1, DOI 10.1016/j.ijfoodmicro.2013.12.026; Ripley B. D., 1996, PATTERN RECOGNITION; Ropodi AI, 2015, FOOD RES INT, V67, P12, DOI 10.1016/j.foodres.2014.10.032; Schowengerdt R. A., 2007, REMOTE SENSING MODEL; Sofos JN, 2008, MEAT SCI, V78, P3, DOI 10.1016/j.meatsci.2007.07.027; Theodoridis S, 2006, PATTERN RECOGNITION, 3RD EDITION, P1; Titterington D. M., 1985, STAT ANAL FINITE MIX; Zhang BH, 2014, FOOD RES INT, V62, P326, DOI 10.1016/j.foodres.2014.03.012	28	18	18	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140122	10.1371/journal.pone.0140122	http://dx.doi.org/10.1371/journal.pone.0140122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466349	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100081
J	Yang, XF; Wang, CY; Li, X; Chen, CH; Tian, ZR; Wang, YJ; Ji, WQ				Yang, Xiaofei; Wang, Changyou; Li, Xin; Chen, Chunhuan; Tian, Zengrong; Wang, Yajuan; Ji, Wanquan			Development and Molecular Cytogenetic Identification of a Novel Wheat-Leymus mollis Lm#7Ns (7D) Disomic Substitution Line with Stripe Rust Resistance	PLOS ONE			English	Article							CHROMOSOME ADDITION LINES; THINOPYRUM-INTERMEDIUM; INSITU HYBRIDIZATION; TRITICUM-AESTIVUM; GENE; CONSTITUTION; DERIVATIVES; EXPRESSION; AGROPYRON; CHROMATIN	Leymus mollis (2n = 4x = 28, NsNsXmXm) possesses novel and important genes for resistance against multi-fungal diseases. The development of new wheat-L. mollis introgression lines is of great significance for wheat disease resistance breeding. M11003-3-1-15-8, a novel disomic substitution line of common wheat cv. 7182 -L. mollis, developed and selected from the BC1F5 progeny between wheat cv. 7182 and octoploid Tritileymus M47 (2n = 8x = 56, AABBDDNsNs), was characterized by morphological and cytogenetic identification, analysis of functional molecular markers, genomic in situ hybridization (GISH), sequential fluorescence in situ hybridization (FISH)-genomic in situ hybridization (GISH) and disease resistance evaluation. Cytological observations suggested that M11003-3-1-15-8 contained 42 chromosomes and formed 21 bivalents at meiotic metaphase I. The GISH investigations showed that line contained 40 wheat chromosomes and a pair of L. mollis chromosomes. EST-STS multiple loci markers and PLUG (PCR-based Landmark Unique Gene) markers confirmed that the introduced L. mollis chromosomes belonged to homoeologous group 7, it was designated as Lm#7Ns. While nulli-tetrasomic and sequential FISH-GISH analysis using the oligonucleotide Oligo-pSc119.2 and Oligo-pTa535 as probes revealed that the wheat 7D chromosomes were absent in M11003-3-1-15-8. Therefore, it was deduced that M11003-3-1-15-8 was a wheat-L. mollis Lm#7Ns (7D) disomic substitution line. Field disease resistance demonstrated that the introduced L. mollis chromosomes Lm#7Ns were responsible for the stripe rust resistance at the adult stage. Moreover, M11003-3-1-15-8 had a superior numbers of florets. The novel disomic substitution line M11003-3-1-15-8, could be exploited as an important genetic material in wheat resistance breeding programs and genetic resources.	[Yang, Xiaofei; Wang, Changyou; Li, Xin; Chen, Chunhuan; Tian, Zengrong; Wang, Yajuan; Ji, Wanquan] Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Ji, WQ (corresponding author), Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.	jiwanquan2008@126.com			National High Technology Research and Development Program of China (863 Program) [2011AA100102]; Zhongying Tang Breeding Funding Project of USA at the Northwest A&F University in China; Innovation Project of Science and Technology of Shaanxi province of China [2015KTZDNY01-01-02]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Zhongying Tang Breeding Funding Project of USA at the Northwest A&F University in China; Innovation Project of Science and Technology of Shaanxi province of China	This work was supported by the National High Technology Research and Development Program of China (863 Program) (Grant No. 2011AA100102), Zhongying Tang Breeding Funding Project of USA at the Northwest A&F University in China and the Innovation Project of Science and Technology of Shaanxi province of China (Grant No. 2015KTZDNY01-01-02).	Anamthawat-Jonsson K, 1995, BUVISINDI, V9, P101; AnamthawatJonsson K, 1997, EUPHYTICA, V93, P293, DOI 10.1023/A:1002965322262; Bao Y, 2012, GENET MOL RES, V11, P3198, DOI 10.4238/2012.May.22.2; Chen GL, 2012, J BIOSCIENCES, V37, P149, DOI 10.1007/s12038-011-9175-1; Chen S.Y., 1985, ACTA BOTANICA BOREAL, V4, P260; Chen XM, 2010, CAN J PLANT PATHOL, V32, P315, DOI 10.1080/07060661.2010.499271; Doyle J. J., 1987, PHYTOCHEM B, P11; Du WL, 2014, PLANTA, V239, P97, DOI 10.1007/s00425-013-1957-2; Du WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070879; Du WL, 2014, PLANT MOL BIOL REP, P1; FATIH AMB, 1983, HEREDITAS, V98, P287, DOI 10.1111/j.1601-5223.1983.tb00607.x; Habora MEE, 2013, BREEDING SCI, V63, P68, DOI 10.1270/jsbbs.63.68; Habora MEE, 2012, BREEDING SCI, V62, P78, DOI 10.1270/jsbbs.62.78; Han FP, 2004, THEOR APPL GENET, V109, P1070, DOI 10.1007/s00122-004-1720-y; Heslop-Harrison JS, 2000, PLANT CELL, V12, P617, DOI 10.1105/tpc.12.5.617; Hu LJ, 2011, J APPL GENET, V52, P279, DOI 10.1007/s13353-011-0038-0; Hu LJ, 2011, EUPHYTICA, V177, P169, DOI 10.1007/s10681-010-0216-x; Hu LJ, 2012, J GENET, V9, P69; Ishikawa G, 2009, THEOR APPL GENET, V118, P499, DOI 10.1007/s00122-008-0916-y; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Kishii M, 2003, CHROMOSOME RES, V11, P741, DOI 10.1023/B:CHRO.0000005774.00726.71; Kong F, 2008, J GENET GENOMICS, V35, P673, DOI 10.1016/S1673-8527(08)60089-2; Lei MP, 2011, J GENET, V90, P283, DOI 10.1007/s12041-011-0081-y; LEITCH IJ, 1992, GENOME, V35, P1013, DOI 10.1139/g92-155; Li GR, 2014, CYTOGENET GENOME RES, V143, P280, DOI 10.1159/000366051; MA H, 1995, EUPHYTICA, V83, P87, DOI 10.1007/BF01678034; MCGUIRE PE, 1981, CROP SCI, V21, P702, DOI 10.2135/cropsci1981.0011183X002100050018x; MERKER A, 1992, HEREDITAS, V116, P277, DOI 10.1111/j.1601-5223.1992.tb00154.x; Mujeeb-Kazi A., 1983, P 6 INT WHEAT GENETI, P223; Niu ZX, 2011, CROP SCI, V51, P667, DOI 10.2135/cropsci2010.04.0235; Pang YH, 2014, J GENET GENOMICS, V41, P205, DOI 10.1016/j.jgg.2013.11.008; Qi LL, 2011, THEOR APPL GENET, V123, P159, DOI 10.1007/s00122-011-1574-z; Rayburn A. L., 1986, PLANT MOL BIOL REP, V4, P102, DOI [10.1007/BF02732107, DOI 10.1007/BF02732107, /10.1007/BF02732107]; Said M, 2009, EUPHYTICA, V167, P253, DOI 10.1007/s10681-009-9895-6; SCHWARZACHER T, 1992, THEOR APPL GENET, V84, P778, DOI 10.1007/BF00227384; Sigurbjornsson B., 1960, THESIS CORNELL U ITH; Tang ZX, 2014, J APPL GENET, V55, P313, DOI 10.1007/s13353-014-0215-z; Uhrin A, 2012, EUPHYTICA, V186, P45, DOI 10.1007/s10681-011-0483-1; Wang D, 2010, EUPHYTICA, V176, P157, DOI 10.1007/s10681-010-0199-7; Wang J, 2013, GENET RESOUR CROP EV, V60, P1453, DOI 10.1007/s10722-012-9933-4; Wang XP, 2000, ACTA BOT SIN, V42, P582; Wu J, 2006, THEOR APPL GENET, V114, P13, DOI 10.1007/s00122-006-0405-0; Yang XF, 2014, GENOME, V57, P583, DOI 10.1139/gen-2014-0161; Yaniv E, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0238-0; Zhang P, 2007, AUST J AGR RES, V58, P498, DOI 10.1071/AR07054; Zhao JX, 2013, EUPHYTICA, V190, P45, DOI 10.1007/s10681-012-0772-3	46	9	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140227	10.1371/journal.pone.0140227	http://dx.doi.org/10.1371/journal.pone.0140227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465140	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100091
J	Lopez-Dee, ZP; Chittur, SV; Patel, H; Chinikaylo, A; Lippert, B; Patel, B; Lawler, J; Gutierrez, LS				Lopez-Dee, Zenaida P.; Chittur, Sridar V.; Patel, Hiral; Chinikaylo, Aleona; Lippert, Brittany; Patel, Bhumi; Lawler, Jack; Gutierrez, Linda S.			Thrombospondin-1 in a Murine Model of Colorectal Carcinogenesis	PLOS ONE			English	Article							GENE-EXPRESSION; PROMOTES ANGIOGENESIS; BETA-CATENIN; CANCER; GROWTH; OVEREXPRESSION; AZOXYMETHANE; SOMATOSTATIN; NEUROTENSIN; TRANSCRIPTION	Colorectal Cancer (CRC) is one of the late complications observed in patients suffering from inflammatory bowel diseases (IBD). Carcinogenesis is promoted by persistent chronic inflammation occurring in IBD. Understanding the mechanisms involved is essential in order to ameliorate inflammation and prevent CRC. Thrombospondin 1 (TSP-1) is a multidomain glycoprotein with important roles in angiogenesis. The effects of TSP-1 in colonic tumor formation and growth were analyzed in a model of inflammation-induced carcinogenesis. WT and TSP-1 deficient mice (TSP-1(-/-)) of the C57BL/6 strain received a single injection of azoxymethane (AOM) and multiple cycles of dextran sodium sulfate (DSS) to induce chronic inflammation-related cancers. Proliferation and angiogenesis were histologically analyzed in tumors. The intestinal transcriptome was also analyzed using a gene microarray approach. When the area containing tumors was compared with the entire colonic area of each mouse, the tumor burden was decreased in AOM/DSS-treated TSP-1(-/-) versus wild type (WT) mice. However, these lesions displayed more angiogenesis and proliferation rates when compared with the WT tumors. AOM-DSS treatment of TSP-1(-/-) mice resulted in significant deregulation of genes involved in transcription, canonical Wnt signaling, transport, defense response, regulation of epithelial cell proliferation and metabolism. Microarray analyses of these tumors showed down-regulation of 18 microRNAs in TSP-1(-/-) tumors. These results contribute new insights on the controversial role of TSP-1 in cancer and offer a better understanding of the genetics and pathogenesis of CRC.	[Lopez-Dee, Zenaida P.; Patel, Hiral; Chinikaylo, Aleona; Lippert, Brittany; Patel, Bhumi; Gutierrez, Linda S.] Wilkes Univ, Dept Biol, Wilkes Barre, PA 18766 USA; [Chittur, Sridar V.] SUNY Albany, Ctr Funct Genom, Renssaeler, NY USA; [Lawler, Jack] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA	Wilkes University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Gutierrez, LS (corresponding author), Wilkes Univ, Dept Biol, Wilkes Barre, PA 18766 USA.	linda.gutierrez@wilkes.edu	Lawler, Jack/AAJ-1379-2020; /W-2676-2019		National Institutes of Health (AREA) [R15 DK067901-02]; Howard Hughes Medical Institute [52006328]; Wilkes University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK067901] Funding Source: NIH RePORTER	National Institutes of Health (AREA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wilkes University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by The National Institutes of Health (AREA Grant #R15 DK067901-02), the Howard Hughes Medical Institute (Grant #52006328), Wilkes Mentoring funds and institutional funds from Wilkes University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Alkim C, 2012, LIBYAN J MED, V7, DOI 10.3402/ljm.v7i0.8942; Aust DE, 2001, MODERN PATHOL, V14, P29, DOI 10.1038/modpathol.3880253; Baek KH, 2013, J CLIN INVEST, V123, P4375, DOI 10.1172/JCI67465; Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; Borinstein SC, 2010, MOL CARCINOGEN, V49, P94, DOI 10.1002/mc.20581; Bossard C, 2007, PEPTIDES, V28, P2030, DOI 10.1016/j.peptides.2007.06.030; Bugni JM, 2012, INT J CANCER, V130, P1798, DOI 10.1002/ijc.26208; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Chidlow JH, 2006, AM J PATHOL, V169, P2014, DOI 10.2353/ajpath.2006.051021; Chu LY, 2013, BLOOD, V122, P1822, DOI 10.1182/blood-2013-01-482315; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Dejong V, 1999, ONCOGENE, V18, P3143, DOI 10.1038/sj.onc.1202654; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dogar AM, 2014, NUCLEIC ACID THER, V24, P149, DOI 10.1089/nat.2013.0467; Firlej V, 2011, CANCER RES, V71, P7649, DOI 10.1158/0008-5472.CAN-11-0833; Furukawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080609; Gao YY, 2013, CARCINOGENESIS, V34, P1861, DOI 10.1093/carcin/bgt135; Guda K, 2003, MOL CARCINOGEN, V37, P51, DOI 10.1002/mc.10120; Gui XY, 2013, WORLD J GASTROENTERO, V19, P4504, DOI 10.3748/wjg.v19.i28.4504; Gutierrez LS, 2003, CARCINOGENESIS, V24, P199, DOI 10.1093/carcin/24.2.199; Isenberg JS, 2009, NAT REV CANCER, V9, P182, DOI 10.1038/nrc2561; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Kaur S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01673; Kawai S, 2012, BIOCHEM BIOPH RES CO, V421, P696, DOI 10.1016/j.bbrc.2012.04.064; Kazerounian S, 2011, BLOOD, V117, P4658, DOI 10.1182/blood-2010-09-305284; Kerr Caroline A., 2013, BMC Physiology, V13, P2, DOI 10.1186/1472-6793-13-2; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Law IK, 2015, RNA DIS, V2, pe472; Lawler J, 2001, AM J PATHOL, V159, P1949, DOI 10.1016/S0002-9440(10)63042-8; Li Q, 1999, ONCOGENE, V18, P3284, DOI 10.1038/sj.onc.1202663; Lopez-Dee Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/296069; Lopez-Dee ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034590; Luo ZH, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-3; Menschikowski M, 2013, PATHOL ONCOL RES, V19, P839, DOI 10.1007/s12253-013-9652-y; Michaud-Levesque J, 2009, J BIOL CHEM, V284, P21338, DOI 10.1074/jbc.M109.005322; Miyanaga K, 2002, ANTICANCER RES, V22, P3941; Miyata Y, 2013, INT J MOL SCI, V14, P12249, DOI 10.3390/ijms140612249; Mojica W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-5; Muller KM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-421; Nambiar PR, 2002, CANCER RES, V62, P3667; NICOSIA RF, 1994, J CELL BIOL, V124, P183, DOI 10.1083/jcb.124.1.183; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Nucera C, 2010, P NATL ACAD SCI USA, V107, P10649, DOI 10.1073/pnas.1004934107; Oue N, 2003, ONCOLOGY-BASEL, V64, P423, DOI 10.1159/000070302; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; Primo L, 2005, FASEB J, V19, P1713, DOI 10.1096/fj.05-3697fje; Punekar S, 2008, PATHOBIOLOGY, V75, P9, DOI 10.1159/000113790; REUBI JC, 1995, J CLIN ENDOCR METAB, V80, P2806, DOI 10.1210/jc.80.9.2806; SLACK JL, 1994, CELL GROWTH DIFFER, V5, P1373; Streit M, 1999, AM J PATHOL, V155, P441, DOI 10.1016/S0002-9440(10)65140-1; Sundaram P, 2011, CANCER RES, V71, P7490, DOI 10.1158/0008-5472.CAN-11-1124; Suzuki R, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-84; Talme T, 2001, CLIN EXP IMMUNOL, V125, P71, DOI 10.1046/j.1365-2249.2001.01577.x; Tanaka T, CARCINOGENESIS; TATSUTA M, 1990, BRIT J CANCER, V62, P368, DOI 10.1038/bjc.1990.299; TUSZYNSKI GP, 1987, CANCER RES, V47, P4130; Yasui Yumiko, 2009, J Carcinog, V8, P10, DOI 10.4103/1477-3163.51851; Yee KO, 2009, BREAST CANCER RES TR, V114, P85, DOI 10.1007/s10549-008-9992-6; Yoshida Y, 1999, INT J ONCOL, V15, P1221; Zak S, 2008, INT J COLORECTAL DIS, V23, P297, DOI 10.1007/s00384-007-0397-5; Zhang D, 2007, J NEUROSCI RES, V85, P3515, DOI 10.1002/jnr.21356; Zhou LM, 2010, CANCER RES, V70, P8199, DOI 10.1158/0008-5472.CAN-09-4562	66	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139918	10.1371/journal.pone.0139918	http://dx.doi.org/10.1371/journal.pone.0139918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461935	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300035
J	Chien, MW; Lin, MH; Huang, SH; Fu, SH; Hsu, CY; Yen, BLJ; Chen, JT; Chang, DM; Sytwu, HK				Chien, Ming-Wei; Lin, Ming-Hong; Huang, Shing-Hwa; Fu, Shin-Huei; Hsu, Chao-Yuan; Yen, B. Lin-Ju; Chen, Jiann-Torng; Chang, Deh-Ming; Sytwu, Huey-Kang			Glucosamine Modulates T Cell Differentiation through Down-regulating N-Linked Glycosylation of CD25	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE RECEPTORS; IL-2 RECEPTOR; ACTIVATION; EXPRESSION; INTERLEUKIN-2; STAT5; INHIBITION; COMPLEX; GLUT1; ACETYLGLUCOSAMINYLTRANSFERASE	Glucosamine has immunomodulatory effects on autoimmune diseases. However, the mechanism(s) through which glucosamine modulates different T cell subsets and diseases remain unclear. We demonstrate that glucosamine impedes Th1, Th2, and iTreg but promotes Th17 differentiation through down-regulating N-linked glycosylation of CD25 and subsequently inhibiting its downstream Stat5 signaling in a dose-dependent manner. The effect of glucosamine on T helper cell differentiation was similar to that induced by anti-IL-2 treatment, further supporting an IL-2 signaling-dependent modulation. Interestingly, excess glucose rescued this glucosamine-mediated regulation, suggesting a functional competition between glucose and glucosamine. High-dose glucosamine significantly decreased Glut1 N-glycosylation in Th1-polarized cells. This finding suggests that both down-regulated IL-2 signaling and Glut1-dependent glycolytic metabolism contribute to the inhibition of Th1 differentiation by glucosamine. Finally, glucosamine treatment inhibited Th1 cells in vivo, prolonged the survival of islet grafts in diabetic recipients, and exacerbated the severity of EAE. Taken together, our results indicate that glucosamine interferes with N-glycosylation of CD25, and thereby attenuates IL-2 downstream signaling. These effects suggest that glucosamine may be an important modulator of T cell differentiation and immune homeostasis.	[Chien, Ming-Wei; Hsu, Chao-Yuan; Sytwu, Huey-Kang] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan; [Chien, Ming-Wei; Lin, Ming-Hong; Fu, Shin-Huei; Hsu, Chao-Yuan; Sytwu, Huey-Kang] Natl Def Med Ctr, Dept & Grad Inst Microbiol & Immunol, Taipei, Taiwan; [Huang, Shing-Hwa] Natl Def Med Ctr, Dept Biol & Anat & Surg, Taipei 11490, Taiwan; [Chen, Jiann-Torng] Natl Def Med Ctr, Triserv Gen Hosp, Dept Ophthalmol, Taipei 11490, Taiwan; [Chang, Deh-Ming] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Taipei 11490, Taiwan; [Yen, B. Lin-Ju] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 35053, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Health Research Institutes - Taiwan	Sytwu, HK (corresponding author), Natl Def Med Ctr, Dept & Grad Inst Microbiol & Immunol, 161 Sect 6,Min Chuan East Rd, Taipei, Taiwan.	sytwu@ndmctsgh.edu.tw	Fu, Shinhuei/AAM-2877-2021	Fu, Shinhuei/0000-0001-9697-6814	Ministry of Science and Technology, ROC [MOST 103-2321-B-016-001, MOST 103-2320-B-016-017-MY3, MOST 104-2320-B-016-014-MY3]; Tri-Service General Hospital [TSGH-C103-005-007-009-S01, TSGH-C104-008-S02]; C. Y. Foundation for Advancement of Education, Sciences, and Medicine	Ministry of Science and Technology, ROC; Tri-Service General Hospital; C. Y. Foundation for Advancement of Education, Sciences, and Medicine	This work was supported by the Ministry of Science and Technology, ROC (MOST 103-2321-B-016-001, MOST 103-2320-B-016-017-MY3, MOST 104-2320-B-016-014-MY3), Tri-Service General Hospital (TSGH-C103-005-007-009-S01, TSGH-C104-008-S02), and in part by the C. Y. Foundation for Advancement of Education, Sciences, and Medicine. The authors declare that they have no conflicts of interest with the contents of this article.	ASANO T, 1991, J BIOL CHEM, V266, P24632; ASANO T, 1993, FEBS LETT, V324, P258, DOI 10.1016/0014-5793(93)80129-I; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen CL, 2012, INVEST OPHTH VIS SCI, V53, P2281, DOI 10.1167/iovs.11-9291; Chen Q, 2011, J IMMUNOL, V186, P6329, DOI 10.4049/jimmunol.1100061; Chesnokov V, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-45; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Forchhammer L, 2003, SCAND J IMMUNOL, V58, P404, DOI 10.1046/j.1365-3083.2003.01313.x; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Golks A, 2007, EMBO J, V26, P4368, DOI 10.1038/sj.emboj.7601845; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Hong CW, 2014, IMMUNITY, V40, P910, DOI 10.1016/j.immuni.2014.04.020; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jang BC, 2007, J BIOL CHEM, V282, P27622, DOI 10.1074/jbc.M610778200; Jeon JH, 2014, STEM CELLS DEV, V23, P2067, DOI 10.1089/scd.2013.0583; Kang ES, 2008, EXP CELL RES, V314, P2238, DOI 10.1016/j.yexcr.2008.04.014; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Kelly E, 2002, J IMMUNOL, V168, P597, DOI 10.4049/jimmunol.168.2.597; Kim CH, 2011, SCAND J IMMUNOL, V73, P536, DOI 10.1111/j.1365-3083.2011.02526.x; KLENK HD, 1972, VIROLOGY, V49, P723, DOI 10.1016/0042-6822(72)90529-6; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Lockyer HM, 2007, J IMMUNOL, V179, P5301, DOI 10.4049/jimmunol.179.8.5301; Ma LL, 2002, J BIOL CHEM, V277, P39343, DOI 10.1074/jbc.M204924200; Macauley MS, 2010, BBA-GEN SUBJECTS, V1800, P107, DOI 10.1016/j.bbagen.2009.07.028; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MALEK TR, 1986, IMMUNOL REV, V92, P81, DOI 10.1111/j.1600-065X.1986.tb01495.x; Miller AT, 2002, J IMMUNOL, V168, P2163, DOI 10.4049/jimmunol.168.5.2163; MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Moon JJ, 2004, J BIOL CHEM, V279, P5520, DOI 10.1074/jbc.M308998200; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nicoletti F, 1996, ENDOCRINOLOGY, V137, P5567, DOI 10.1210/en.137.12.5567; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; PLAGEMANN PG, 1973, CANCER RES, V33, P482; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; RABINOVITCH A, 1995, J IMMUNOL, V154, P4874; Ramakrishnan P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004097; SEMMES OJ, 1992, INT J IMMUNOPHARMACO, V14, P583, DOI 10.1016/0192-0561(92)90119-6; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Suh HN, 2014, J CELL PHYSIOL, V229, P1557, DOI 10.1002/jcp.24599; Takahashi T., 1998, INT IMMUNOL, V10, P1969; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; YANG XD, 1994, P NATL ACAD SCI USA, V91, P12604, DOI 10.1073/pnas.91.26.12604; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zhang GX, 2005, J IMMUNOL, V175, P7202, DOI 10.4049/jimmunol.175.11.7202	60	26	26	8	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29329	29344		10.1074/jbc.M115.674671	http://dx.doi.org/10.1074/jbc.M115.674671			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468284	Green Published, hybrid			2022-12-26	WOS:000366613400020
J	Fang, YQ; Yan, J; Li, CH; Zhou, X; Yao, LM; Pang, T; Yan, M; Zhang, LY; Mao, L; Liao, H				Fang, Yinquan; Yan, Jun; Li, Chenhui; Zhou, Xiao; Yao, Lemeng; Pang, Tao; Yan, Ming; Zhang, Luyong; Mao, Lei; Liao, Hong			The Nogo/Nogo Receptor (NgR) Signal Is Involved in Neuroinflammation through the Regulation of Microglial Inflammatory Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microglia; neurodegenerative disease; neuroinflammation; NF-kappaB; STAT3; NgR; Nogo peptide	NF-KAPPA-B; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NOGO-A; AXONAL REGENERATION; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; CELLS; PATHWAY	Microglia have been proposed to play a pivotal role in the inflammation response of the CNS by expressing a range of proinflammatory enzymes and cytokines under pathological stimulus. Our previous study has confirmed that Nogo receptor (NgR), an axon outgrowth inhibition receptor, is also expressed on microglia and regulates cell adhesion and migration behavior in vitro. In the present study, we further investigated the proinflammatory effects and possible mechanisms of Nogo on microglia in vitro. In this study, Nogo peptide, Nogo-P4, a 25-amino acid core inhibitory peptide sequence of Nogo-66, was used. We found that Nogo-P4 was able to induce the expression of inducible nitric-oxide synthase and cyclooxygenase-2 and the release of proinflammatory cytokines, including IL-1, TNF-, NO, and prostaglandin E-2 in microglia, which could be reversed by NEP1-40 (Nogo-66(1-40) antagonist peptide), phosphatidylinositol-specificphospholipase C, or NgR siRNA treatment. After Nogo-P4 stimulated microglia, the phosphorylation levels of NF-B and STAT3 were increased obviously, which further mediated microglia expressing proinflammatory factors induced by Nogo-P4. Taken together, we concluded that Nogo peptide could directly take part in CNS inflammatory process by influencing the expression of proinflammatory factors in microglia, which were related to the NF-B and STAT3 signal pathways. Besides neurite outgrowth restriction, the Nogo/NgR signal might be involved in multiple processes in various inflammation-associated CNS diseases.	[Fang, Yinquan; Yan, Jun; Li, Chenhui; Yao, Lemeng; Pang, Tao; Yan, Ming; Zhang, Luyong; Liao, Hong] China Pharmaceut Univ, Jiangsu Key Lab Drug Screening, Nanjing 210009, Jiangsu, Peoples R China; [Zhou, Xiao] Univ Saarland, Dept Biophys, D-66421 Homburg, Germany; [Mao, Lei] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China	China Pharmaceutical University; Saarland University; Nanjing University	Mao, L (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China.	leiching@163.com; hliao@cpu.edu.cn			National Natural Science Foundation of China [81070967, 81271338]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20130096110011]; China Pharmaceutical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Pharmaceutical University	This work was supported by National Natural Science Foundation of China Grants 81070967 and 81271338, Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 20130096110011, and the Initial Fund of China Pharmaceutical University (to H. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Acarin L, 2000, J NEUROPATH EXP NEUR, V59, P151, DOI 10.1093/jnen/59.2.151; Bethea JR, 1998, J NEUROSCI, V18, P3251; Cao Q, 2010, J NEUROSCI RES, V88, P2701, DOI 10.1002/jnr.22429; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Choi Y, 2009, BRIT J PHARMACOL, V156, P933, DOI 10.1111/j.1476-5381.2009.00022.x; Doi Y, 2009, AM J PATHOL, V175, P2121, DOI 10.2353/ajpath.2009.090418; Fontoura P, 2004, J IMMUNOL, V173, P6981, DOI 10.4049/jimmunol.173.11.6981; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fry EJ, 2007, NEURON, V53, P649, DOI 10.1016/j.neuron.2007.02.009; Gil V, 2006, J NEUROPATH EXP NEUR, V65, P433, DOI 10.1097/01.jnen.0000222894.59293.98; GIULIAN D, 1993, STROKE, V24, pI84; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Gveric D, 1998, J NEUROPATH EXP NEUR, V57, P168, DOI 10.1097/00005072-199802000-00008; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hasegawa Y, 2004, J NEUROSCI, V24, P6826, DOI 10.1523/JNEUROSCI.1856-04.2004; He GL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-49; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; Heese K, 1998, GLIA, V22, P401, DOI 10.1002/(SICI)1098-1136(199804)22:4<401::AID-GLIA9>3.0.CO;2-5; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; KALTSCHMIDT C, 1994, J NEUROIMMUNOL, V55, P99, DOI 10.1016/0165-5728(94)90151-1; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Liu Y, 2014, J NEUROSCI, V34, P12982, DOI 10.1523/JNEUROSCI.1348-14.2014; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; McDonald CL, 2011, CURR MED CHEM, V18, P234; McDonald CL, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-113; Nam KN, 2008, EUR J PHARMACOL, V589, P53, DOI 10.1016/j.ejphar.2008.03.034; Oertle T, 2003, J NEUROSCI, V23, P5393; Pool M, 2009, EXP NEUROL, V217, P371, DOI 10.1016/j.expneurol.2009.03.014; Ren S, 2013, INT J BIOCHEM CELL B, V45, P335, DOI 10.1016/j.biocel.2012.11.012; Rolando C, 2012, J NEUROSCI, V32, P17788, DOI 10.1523/JNEUROSCI.3142-12.2012; Ryu JK, 2006, NEUROSCIENCE, V141, P1835, DOI 10.1016/j.neuroscience.2006.05.043; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129, DOI 10.1093/jnen/64.2.129; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Su ZD, 2007, J CELL SCI, V120, P1877, DOI 10.1242/jcs.03448; Vila M, 2001, CURR OPIN NEUROL, V14, P483, DOI 10.1097/00019052-200108000-00009; Wang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001856; Weydt Patrick, 2002, Curr Opin Investig Drugs, V3, P1720; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yan J, 2012, J NEUROCHEM, V120, P721, DOI 10.1111/j.1471-4159.2011.07619.x; Zhang ZH, 2014, BRAIN RES, V1563, P72, DOI 10.1016/j.brainres.2014.03.036; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	44	26	28	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28901	28914		10.1074/jbc.M115.678326	http://dx.doi.org/10.1074/jbc.M115.678326			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26472924	hybrid, Green Published			2022-12-26	WOS:000365762300030
J	Warschburger, P; Calvano, C; Richter, EM; Engbert, R				Warschburger, Petra; Calvano, Claudia; Richter, Eike M.; Engbert, Ralf			Analysis of Attentional Bias towards Attractive and Unattractive Body Regions among Overweight Males and Females: An Eye-Movement Study	PLOS ONE			English	Article							EATING-DISORDERS; CHECKING QUESTIONNAIRE; SELECTIVE ATTENTION; COGNITIVE BIAS; WEIGHT-LOSS; OWN BODY; DISSATISFACTION; SELF; AVOIDANCE; WOMEN	Background Body image distortion is highly prevalent among overweight individuals. Whilst there is evidence that body-dissatisfied women and those suffering from disordered eating show a negative attentional bias towards their own unattractive body parts and others' attractive body parts, little is known about visual attention patterns in the area of obesity and with respect to males. Since eating disorders and obesity share common features in terms of distorted body image and body dissatisfaction, the aim of this study was to examine whether overweight men and women show a similar attentional bias. Methods/Design We analyzed eye movements in 30 overweight individuals (18 females) and 28 normal-weight individuals (16 females) with respect to the participants' own pictures as well as gender- and BMI-matched control pictures (front and back view). Additionally, we assessed body image and disordered eating using validated questionnaires. Discussion The overweight sample rated their own body as less attractive and showed a more disturbed body image. Contrary to our assumptions, they focused significantly longer on attractive compared to unattractive regions of both their own and the control body. For one's own body, this was more pronounced for women. A higher weight status and more frequent body checking predicted attentional bias towards attractive body parts. We found that overweight adults exhibit an unexpected and stable pattern of selective attention, with a distinctive focus on their own attractive body regions despite higher levels of body dissatisfaction. This positive attentional bias may either be an indicator of a more pronounced pattern of attentional avoidance or a self-enhancing strategy. Further research is warranted to clarify these results.	[Warschburger, Petra; Calvano, Claudia] Univ Potsdam, Div Counseling Psychol, Dept Psychol, Potsdam, Germany; [Richter, Eike M.; Engbert, Ralf] Univ Potsdam, Div Expt & Biol Psychol, Dept Psychol, Potsdam, Germany	University of Potsdam; University of Potsdam	Warschburger, P (corresponding author), Univ Potsdam, Div Counseling Psychol, Dept Psychol, Potsdam, Germany.	warschb@uni-potsdam.de	Engbert, Ralf/AAC-4860-2020	Engbert, Ralf/0000-0002-2909-5811; Warschburger, Petra/0000-0001-7979-7451				[Anonymous], 1995, PHYS STAT US INT ANT; Berger U, 2011, PSYCHOTHER PSYCH MED, V61, P311, DOI 10.1055/s-0031-1271786; Blechert J, 2009, PSYCHOSOM MED, V71, P907, DOI 10.1097/PSY.0b013e3181b4434d; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brooks S, 2011, CLIN PSYCHOL REV, V31, P37, DOI 10.1016/j.cpr.2010.09.006; Cho A, 2013, BODY IMAGE, V10, P95, DOI 10.1016/j.bodyim.2012.09.005; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; CROCKER J, 1989, PSYCHOL REV, V96, P608, DOI 10.1037/0033-295X.96.4.608; Dobson KS, 2004, CLIN PSYCHOL REV, V23, P1001, DOI 10.1016/j.cpr.2003.09.004; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Faulconbridge LF, 2014, CURR OBES REP, V3, P127, DOI 10.1007/s13679-013-0080-9; Forman EM, 2015, CURR OPIN PSYCHOL, V2, P87, DOI 10.1016/j.copsyc.2014.12.020; Forrester-Knauss C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-809; Frederick David A, 2006, Body Image, V3, P413, DOI 10.1016/j.bodyim.2006.08.002; FREEMAN R, 1991, INT J EAT DISORDER, V10, P709, DOI 10.1002/1098-108X(199111)10:6&lt;709::AID-EAT2260100609&gt;3.0.CO;2-N; Gao X, 2013, BODY IMAGE, V10, P191, DOI 10.1016/j.bodyim.2012.12.005; GARDNER RM, 1990, INT J EAT DISORDER, V9, P537, DOI 10.1002/1098-108X(199009)9:5&lt;537::AID-EAT2260090509&gt;3.0.CO;2-A; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; Glauert R, 2010, INT J EAT DISORDER, V43, P42, DOI 10.1002/eat.20663; Grilo CM, 2005, BEHAV RES THER, V43, P629, DOI 10.1016/j.brat.2004.05.003; Hansson LM, 2014, BODY IMAGE, V11, P43, DOI 10.1016/j.bodyim.2013.10.004; Hewig J, 2008, PSYCHOSOM MED, V70, P729, DOI 10.1097/PSY.0b013e31817e41d3; Hilbert A, 2002, J PSYCHOSOM RES, V52, P137, DOI 10.1016/S0022-3999(01)00314-2; Hilbert A, 2008, OBESITY, V16, P1529, DOI 10.1038/oby.2008.263; Horndasch S, 2012, PSYCHIAT RES, V198, P321, DOI 10.1016/j.psychres.2011.12.029; Janelle C M, 2003, Eat Weight Disord, V8, P138; Janelle CM, 2009, PSYCHOL HEALTH, V24, P351, DOI 10.1080/08870440701697367; Jansen A, 2005, BEHAV RES THER, V43, P183, DOI 10.1016/j.brat.2004.01.003; Jansen A, 2008, APPETITE, V51, P214, DOI 10.1016/j.appet.2008.01.011; Latner J.D., 2012, ENCY BODY IMAGE HUMA, V1, P264; Latner JD, 2008, BODY IMAGE, V5, P91, DOI 10.1016/j.bodyim.2007.08.001; Legenbauer T., 2010, KORPERBILDTHERAPIE B; Legenbauer T, 2011, BEHAV MODIF, V35, P162, DOI 10.1177/0145445510393478; Lykins AD, 2014, BODY IMAGE, V11, P404, DOI 10.1016/j.bodyim.2014.05.003; Martijn C, 2013, HEALTH PSYCHOL, V32, P433, DOI 10.1037/a0028592; Meermann R, 1987, THERAPIE DER MAGERSU; Mele S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081378; Menzel JE, 2010, BODY IMAGE, V7, P261, DOI 10.1016/j.bodyim.2010.05.004; Meyer C, 2011, BEHAV COGN PSYCHOTH, V39, P591, DOI 10.1017/S1352465811000270; Mountford V, 2006, INT J EAT DISORDER, V39, P708, DOI 10.1002/eat.20279; Nissen NK, 2015, OBES REV, V16, P150, DOI 10.1111/obr.12231; Olson KL, 2015, PSYCHOSOM MED, V77, P59, DOI 10.1097/PSY.0000000000000127; Powell PA, 2015, BODY IMAGE, V12, P98, DOI 10.1016/j.bodyim.2014.10.006; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Reas DL, 2005, INT J EAT DISORDER, V37, P342, DOI 10.1002/eat.20092; Reas DL, 2002, INT J EAT DISORDER, V31, P324, DOI 10.1002/eat.10012; Roefs A, 2008, APPETITE, V51, P552, DOI 10.1016/j.appet.2008.04.008; Rosen J., 1991, PSYCHOL ASSESSMENT J, V3, P32, DOI [https://doi.org/10.1037/1040-3590.3.1.32, DOI 10.1037/1040-3590.3.1.32]; Schwartz Marlene B, 2004, Body Image, V1, P43, DOI 10.1016/S1740-1445(03)00007-X; Seifert A L, 2008, Eat Weight Disord, V13, pe84; Shafran R, 2004, INT J EAT DISORDER, V35, P93, DOI 10.1002/eat.10228; Smeets E, 2011, HEALTH PSYCHOL, V30, P360, DOI 10.1037/a0022095; Smeets E, 2011, INT J EAT DISORDER, V44, P50, DOI 10.1002/eat.20776; Smith E, 2010, INT J EAT DISORDER, V43, P358, DOI 10.1002/eat.20703; Striegel-Moore RH, 2003, INT J EAT DISORDER, V34, pS19, DOI 10.1002/eat.10202; Svaldi J, 2012, PSYCHOTHER PSYCHOSOM, V81, P52, DOI 10.1159/000329110; Svaldi J, 2011, PSYCHOTHER PSYCHOSOM, V80, P186, DOI 10.1159/000317538; Thompson J Kevin, 2004, Body Image, V1, P7, DOI 10.1016/S1740-1445(03)00004-4; Thompson JK, 1995, HDB ASSESSMENT METHO, P119; THOMPSON MA, 1995, J PERS ASSESS, V64, P258, DOI 10.1207/s15327752jpa6402_6; Tsai SA, 2016, AM J MENS HEALTH, V10, P389, DOI 10.1177/1557988314567223; Vocks S, 2008, Z KL PSYCH PSYCHOTH, V37, P131, DOI 10.1026/1616-3443.37.2.131; Vocks S, 2007, J PSYCHOSOM RES, V62, P231, DOI 10.1016/j.jpsychores.2006.08.007; von Wietersheim J, 2012, PSYCHOSOM MED, V74, P107, DOI 10.1097/PSY.0b013e31823ba787; Wadlinger HA, 2011, PERS SOC PSYCHOL REV, V15, P75, DOI 10.1177/1088868310365565; Walker D. C., 2012, ENCY BODY IMAGE HUMA, V1, P166, DOI DOI 10.1016/B978-0-12-384925-0.00025-0; Williamson DA, 1999, BEHAV MODIF, V23, P556, DOI 10.1177/0145445599234003	69	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140813	10.1371/journal.pone.0140813	http://dx.doi.org/10.1371/journal.pone.0140813			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT7WW	26479500	Green Submitted, Green Published, gold			2022-12-26	WOS:000363026600020
J	Frischknecht, M; Jagannathan, V; Plattet, P; Neuditschko, M; Signer-Hasler, H; Bachmann, I; Pacholewska, A; Drogemuller, C; Dietschi, E; Flury, C; Rieder, S; Leeb, T				Frischknecht, Mirjam; Jagannathan, Vidhya; Plattet, Philippe; Neuditschko, Markus; Signer-Hasler, Heidi; Bachmann, Iris; Pacholewska, Alicja; Droegemueller, Cord; Dietschi, Elisabeth; Flury, Christine; Rieder, Stefan; Leeb, Tosso			A Non-Synonymous HMGA2 Variant Decreases Height in Shetland Ponies and Other Small Horses	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DETERMINANT; MUTATION; VELVET; ADULT; YIELD; SIZE	The identification of quantitative trait loci (QTL) such as height and their underlying causative variants is still challenging and often requires large sample sizes. In humans hundreds of loci with small effects control the heritable portion of height variability. In domestic animals, typically only a few loci with comparatively large effects explain a major fraction of the heritability. We investigated height at withers in Shetland ponies and mapped a QTL to ECA 6 by genome-wide association (GWAS) using a small cohort of only 48 animals and the Illumina equine SNP70 BeadChip. Fine-mapping revealed a shared haplotype block of 793 kb in small Shetland ponies. The HMGA2 gene, known to be associated with height in horses and many other species, was located in the associated haplotype. After closing a gap in the equine reference genome we identified a non-synonymous variant in the first exon of HMGA2 in small Shetland ponies. The variant was predicted to affect the functionally important first AT-hook DNA binding domain of the HMGA2 protein (c.83G>A; p.G28E). We assessed the functional impact and found impaired DNA binding of a peptide with the mutant sequence in an electrophoretic mobility shift assay. This suggests that the HMGA2 variant also affects DNA binding in vivo and thus leads to reduced growth and a smaller stature in Shetland ponies. The identified HMGA2 variant also segregates in several other pony breeds but was not found in regular-sized horse breeds. We therefore conclude that we identified a quantitative trait nucleotide for height in horses.	[Frischknecht, Mirjam; Jagannathan, Vidhya; Pacholewska, Alicja; Dietschi, Elisabeth; Leeb, Tosso] Univ Bern, Vetsuisse Fac, Inst Genet, CH-3001 Bern, Switzerland; [Frischknecht, Mirjam; Neuditschko, Markus; Bachmann, Iris; Rieder, Stefan] Agroscope, Swiss Natl Stud Farm, CH-1580 Avenches, Switzerland; [Frischknecht, Mirjam; Jagannathan, Vidhya; Neuditschko, Markus; Signer-Hasler, Heidi; Pacholewska, Alicja; Droegemueller, Cord; Dietschi, Elisabeth; Flury, Christine; Rieder, Stefan; Leeb, Tosso] Univ Bern, Bern Univ Appl Sci HAFL, Swiss Competence Ctr Anim Breeding & Genet, CH-3001 Bern, Switzerland; [Frischknecht, Mirjam; Jagannathan, Vidhya; Neuditschko, Markus; Signer-Hasler, Heidi; Pacholewska, Alicja; Droegemueller, Cord; Dietschi, Elisabeth; Flury, Christine; Rieder, Stefan; Leeb, Tosso] Agroscope, CH-3001 Bern, Switzerland; [Plattet, Philippe; Flury, Christine] Univ Bern, Vetsuisse Fac, Div Expt & Clin Res, CH-3001 Bern, Switzerland; [Signer-Hasler, Heidi] Bern Univ Appl Sci, Sch Agr Forest & Food Sci, CH-3052 Zollikofen, Switzerland; [Pacholewska, Alicja] Univ Bern, Swiss Inst Equine Med, Vetsuisse Fac, CH-3001 Bern, Switzerland	University of Bern; Swiss Federal Research Station Agroscope; University of Bern; Swiss Federal Research Station Agroscope; University of Bern; University of Bern	Leeb, T (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, CH-3001 Bern, Switzerland.	tosso.leeb@vetsuisse.unibe.ch	Leeb, Tosso/G-3187-2014; Jagannathan, Vidhya/P-1055-2019; Pacholewska, Alicja/A-3267-2015	Leeb, Tosso/0000-0003-0553-4880; Jagannathan, Vidhya/0000-0002-8155-0041; Pacholewska, Alicja/0000-0002-4888-4883; Flury, Christine/0000-0002-8649-5571; Drogemuller, Cord/0000-0001-9773-522X	Schweizerischer Verband fur Ponys und Kleinpferde	Schweizerischer Verband fur Ponys und Kleinpferde	We would like to thank the pony owners who participated in this study and the "Schweizerischer Verband fur Ponys und Kleinpferde", especially Jacqueline Wondergem and Angela Glatthaar, for their support. Furthermore we thank Nathalie Besuchet-Schmutz, Muriel Fragniere and Marianne Wyss for excellent technical support, Arnaud Galichet for helping with the Odyssey Imager, and Doreen Becker, Eva Moors, and Regula Hauswirth for help during sample collection. We acknowledge the NGS Platform of the University of Bern for whole-genome sequencing, and vital-IT for providing the IT infrastructure for computationally intense analyses.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bedell FL, 1959, THE SHETLAND PONY; Buysse K, 2009, EUR J MED GENET, V52, P101, DOI 10.1016/j.ejmg.2009.03.001; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cui TJ, 2007, BIOCHEMISTRY-US, V46, P13059, DOI 10.1021/bi701269s; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Federico A, 2014, BIOL OPEN, V3, P372, DOI 10.1242/bio.20146759; Fonfria-Subiros E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037120; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Makvandi-Nejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039929; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Pacholewska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122011; Petersen JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003211; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Rimbault M, 2013, GENOME RES, V23, P1985, DOI 10.1101/gr.157339.113; Signer-Hasler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037282; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Tetens J, 2013, ANIM GENET, V44, P467, DOI 10.1111/age.12031; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Weikard R, 2010, PHYSIOL GENOMICS, V42A, P79, DOI 10.1152/physiolgenomics.00120.2010; Womack JE, 2012, ANN NY ACAD SCI, V1271, P33, DOI 10.1111/j.1749-6632.2012.06733.x; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407; Zhang KQ, 2014, CLIN CANCER RES, V20, P1179, DOI 10.1158/1078-0432.CCR-13-1452; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	33	35	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140749	10.1371/journal.pone.0140749	http://dx.doi.org/10.1371/journal.pone.0140749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474182	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500100
J	Almas, A; Forsell, Y; Iqbal, R; Janszky, I; Moller, J				Almas, Aysha; Forsell, Yvonne; Iqbal, Romaina; Janszky, Imre; Moller, Jette			Severity of Depression, Anxious Distress and the Risk of Cardiovascular Disease in a Swedish Population-Based Cohort	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MAJOR DEPRESSION; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; ONSET DEPRESSION; META-ANALYSIS; ANXIETY; MEN; DISORDERS; SYMPTOMS	Background Depression is known to be associated with cardiovascular diseases (CVD). This population-based cohort study aimed to determine the association between depression of varying severity and risk for CVD and to study the effect of concomitant anxious distress on this association. Methods We utilized data from a longitudinal cohort study of mental health, work and relations among adults (20-64 years), with a total of 10,443 individuals. Depression and anxious distress were assessed using psychiatric rating scales and defined according to DSM-5. Outcomes were register-based and self-reported cardiovascular diseases. Findings Overall increased odds ratios of 1.5 to 2.6 were seen for the different severity levels of depression, with the highest adjusted OR for moderate depression (OR 2.1 (95% CI 1.3, 3.5). Similar odds ratios were seen for sub-groups of CVD: ischemic/hypertensive heart disease and stroke, 2.4 (95% CI 1.4, 3.9) and OR 2.1 (95% CI 1.2, 3.8) respectively. Depression with anxious distress as a specifier of severity showed OR of 2.1 (95% CI 1.5, 2.9) for CVD. Conclusion This study found that severity level of depression seems to be of significance for increased risk of CVD among depressed persons, although not in a dose-response manner which might be obscured due to treatment of depression. Further, we found a higher risk of CVD among depressed individuals with symptoms of anxious distress.	[Almas, Aysha; Forsell, Yvonne; Janszky, Imre; Moller, Jette] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Almas, Aysha] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci & Med, Karachi, Pakistan; [Janszky, Imre] Norwegian Univ Sci & Technol, Dept Publ Hlth, Fac Med, N-7034 Trondheim, Norway; [Janszky, Imre] Norwegian Univ Sci & Technol, Dept Gen Practice, Fac Med, N-7034 Trondheim, Norway	Karolinska Institutet; Aga Khan University; Aga Khan University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Almas, A (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	aysha.almas@aku.edu	Forsell, Yvonne/ABB-8879-2020	Iqbal, Romaina/0000-0002-5364-4366; Moller, Jette/0000-0001-9513-5896	Swedish Research Council; Stockholm County Council (ALF); Karolinska Institutet Faculty Funds; Faculty development award, Aga Khan University, Karachi, Pakistan	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council (ALF)(Stockholm County Council); Karolinska Institutet Faculty Funds; Faculty development award, Aga Khan University, Karachi, Pakistan	Funding for the PART was provided by the Swedish Research Council (to YF, the Stockholm County Council (ALF) (to YF), the Karolinska Institutet Faculty Funds (to YF). The PhD student support was provided by Faculty development award, Aga Khan University, Karachi, Pakistan. None of the funding organizations have had any influence on the design and conduct of the study; the collection, management, analysis or interpretation of the data; or the preparation, review or approval of the manuscript. Competing Interests: The authors have declared	American Psychiatric A American Psychiatric A Force DSMT, DIAGN STAT MAN MENT; Association AP, 2003, DIAGN STAT MAN MENT; Bech P, 2001, J AFFECT DISORDERS, V66, P159, DOI 10.1016/S0165-0327(00)00309-8; Bergman P, 2010, INT J SOC PSYCHIATR, V56, P119, DOI 10.1177/0020764008098838; Brunner EJ, 2014, EUR J PREV CARDIOL, V21, P340, DOI 10.1177/2047487314520785; Charlson M, 2002, BIOL PSYCHIAT, V52, P226, DOI 10.1016/S0006-3223(02)01422-1; Cornelius Jack R, 2003, Recent Dev Alcohol, V16, P361; Covey LS, 1998, J ADDICT DIS, V17, P35, DOI 10.1300/J069v17n01_04; Cragg JJ, 2015, NEUROEPIDEMIOLOGY, V44, P130, DOI 10.1159/000377726; Cuijpers P, 2007, EUR PSYCHIAT, V22, P9, DOI 10.1016/j.eurpsy.2006.11.001; Dong JY, 2012, STROKE, V43, P32, DOI 10.1161/STROKEAHA.111.630871; Eaton WW, 2008, ARCH GEN PSYCHIAT, V65, P513, DOI 10.1001/archpsyc.65.5.513; Eurelings LSM, 2014, INT J GERIATR PSYCH, V29, P454, DOI 10.1002/gps.4026; Ferketich AK, 2000, ARCH INTERN MED, V160, P1261, DOI 10.1001/archinte.160.9.1261; Ford DE, 1998, ARCH INTERN MED, V158, P1422, DOI 10.1001/archinte.158.13.1422; Forsberg L RH, 2009, KVALITET INNEHALL PA; Forsell Y, 2005, SOC PSYCH PSYCH EPID, V40, P209, DOI 10.1007/s00127-005-0876-3; Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4; Gump BB, 2005, STROKE, V36, P98, DOI 10.1161/01.STR.0000149626.50127.d0; Gustad LT, 2014, EUR HEART J, V35, P1394, DOI 10.1093/eurheartj/eht387; Hallstrom T, 2003, PART STUDY POPULATIO; Hashimoto K, 2013, PROG NEUROBIOL, V100, P15, DOI 10.1016/j.pneurobio.2012.09.001; Hassmiller KM, 2003, AM J PUBLIC HEALTH, V93, P1321, DOI 10.2105/AJPH.93.8.1321; Jackson CA, 2013, STROKE, V44, P1555, DOI 10.1161/STROKEAHA.113.001147; Janszky I, 2010, J AM COLL CARDIOL, V56, P31, DOI 10.1016/j.jacc.2010.03.033; Kallmen H, 2007, NORD J PSYCHIAT, V61, P466, DOI 10.1080/08039480701773303; Lambiase MJ, 2014, STROKE, V45, P438, DOI 10.1161/STROKEAHA.113.003741; Li C, 2012, ANN SURG ONCOL, V7, P7, DOI DOI 10.1504/IJHPCN.2012.046371; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lundberg I, 2005, SOC PSYCH PSYCH EPID, V40, P475, DOI 10.1007/s00127-005-0911-4; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Moser DK, 2010, HEART LUNG, V39, P378, DOI 10.1016/j.hrtlng.2009.10.017; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Nilsson AC, 1994, LAKARTIDNINGEN, V91, P603; Olsen LR, 2003, PSYCHOL MED, V33, P351, DOI 10.1017/S0033291702006724; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Penninx BWJH, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-129; Pizzi C, 2010, ATHEROSCLEROSIS, V212, P292, DOI 10.1016/j.atherosclerosis.2010.04.038; Prescott E, 1998, BMJ-BRIT MED J, V316, P1043; Rahman I, 2013, EUR J EPIDEMIOL, V28, P589, DOI 10.1007/s10654-013-9821-z; Roest AM, 2012, BRIT J PSYCHIAT, V200, P324, DOI 10.1192/bjp.bp.111.103549; Roose SP, 1999, DRUG SAFETY, V20, P459, DOI 10.2165/00002018-199920050-00006; Rowan PJ, 2005, ANN EPIDEMIOL, V15, P316, DOI 10.1016/j.annepidem.2004.08.006; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Seldenrijk A, 2015, J PSYCHOSOM RES, V78, P123, DOI 10.1016/j.jpsychores.2014.10.007; SNAITH RP, 1986, BRIT J PSYCHIAT, V148, P599, DOI 10.1192/bjp.148.5.599; Statistiska centralbyra&DEG;n, 1989, OCC POP HOUS CENS 19; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Thurston RC, 2014, STROKE, V45, P954, DOI 10.1161/STROKEAHA.113.004162; Tully PJ, 2014, SOC PSYCH PSYCH EPID, V49, P683, DOI 10.1007/s00127-013-0784-x; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; VANVALKENBURG C, 1984, J AFFECT DISORDERS, V6, P67, DOI 10.1016/0165-0327(84)90009-0; Wallerblad A., 2012, INT J FAMILY MED, DOI DOI 10.1155/2012/895425; Wang GF, 2013, PSYCHOSOM MED, V75, P530, DOI 10.1097/PSY.0b013e3182984317; Watkins LL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000068; Wu RH, 2014, INT J MED SCI, V11, P587, DOI 10.7150/ijms.8025; Wulsin LR, 2003, PSYCHOSOM MED, V65, P201, DOI 10.1097/01.PSY.0000058371.50240.E3; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	58	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140742	10.1371/journal.pone.0140742	http://dx.doi.org/10.1371/journal.pone.0140742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0CX	26469703	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600106
J	Rudd, JR; Barnett, LM; Butson, ML; Farrow, D; Berry, J; Polman, RCJ				Rudd, James R.; Barnett, Lisa M.; Butson, Michael L.; Farrow, Damian; Berry, Jason; Polman, Remco C. J.			Fundamental Movement Skills Are More than Run, Throw and Catch: The Role of Stability Skills	PLOS ONE			English	Article							CHILDREN; RELIABILITY; BALANCE; COMPETENCE; PREVALENCE; EDUCATION; VALIDITY; KICKING; TGMD-2	Introduction In motor development literature fundamental movement skills are divided into three constructs: locomotive, object control and stability skills. Most fundamental movement skills research has focused on children's competency in locomotor and object control skills. The first aim of this study was to validate a test battery to assess the construct of stability skills, in children aged 6 to 10 (M age = 8.2, SD = 1.2). Secondly we assessed how the stability skills construct fitted into a model of fundamental movement skill. Method The Delphi method was used to select the stability skill battery. Confirmatory factor analysis (CFA) was used to assess if the skills loaded onto the same construct and a new model of FMS was developed using structural equation modelling. Results Three postural control tasks were selected (the log roll, rock and back support) because they had good face and content validity. These skills also demonstrated good predictive validity with gymnasts scoring significantly better than children without gymnastic training and children from a high SES school performing better than those from a mid and low SES schools and the mid SES children scored better than the low SES children (all p < .05). Inter rater reliability tests were excellent for all three skills (ICC = 0.81, 0.87, 0.87) as was test retest reliability (ICC 0.87-0.95). CFA provided good construct validity, and structural equation modelling revealed stability skills to be an independent factor in an overall FMS model which included locomotor (r = .88), object control (r = .76) and stability skills (r = .81). Discussion This study provides a rationale for the inclusion of stability skills in FMS assessment. The stability skills could be used alongside other FMS assessment tools to provide a holistic assessment of children's fundamental movement skills.	[Rudd, James R.; Butson, Michael L.; Farrow, Damian; Berry, Jason; Polman, Remco C. J.] Victoria Univ, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia; [Barnett, Lisa M.] Deakin Univ, Sch Hlth & Social Dev, Melbourne, Vic, Australia; [Farrow, Damian] Australian Inst Sport, Movement Sci, Canberra, ACT, Australia; [Polman, Remco C. J.] Bournemouth Univ, Dept Psychol, Bournemouth, Dorset, England	Victoria University; Deakin University; Australian Institute of Sport; Bournemouth University	Rudd, JR (corresponding author), Victoria Univ, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia.	james.rudd@vu.edu.au	Barnett, Lisa/C-9997-2014; Polman, Remco/D-1877-2013	Barnett, Lisa/0000-0002-9731-625X; Polman, Remco/0000-0003-2951-0904; Rudd, James/0000-0003-1546-576X				Bardid F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00964; Barnett LM, 2008, MED SCI SPORT EXER, V40, P2137, DOI 10.1249/MSS.0b013e31818160d3; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BOLLEN KA, 1989, SOCIOL METHOD RES, V17, P303, DOI 10.1177/0049124189017003004; Booth M L, 1999, J Sci Med Sport, V2, P93; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Buck D., 2012, IMPLICATIONS POLICY; BUTTERFIELD SA, 1994, PERCEPT MOTOR SKILL, V79, P691, DOI 10.2466/pms.1994.79.1.691; Chew-Bullock TSY, 2012, HUM MOVEMENT SCI, V31, P1615, DOI 10.1016/j.humov.2012.07.001; Collins DR, 2006, COMPREHENSIVE GUIDE; De Villiers MR, 2005, MED TEACH, V27, P639, DOI 10.1080/13611260500069947; Elgar FJ, 2015, LANCET, V385, P2088, DOI 10.1016/S0140-6736(14)61460-4; Faigenbaum AD, 2014, INT J SPORTS PHYS TH, V9, P140; Gabbard C., 2012, LIFELONG MOTOR DEV; Gallahue D.L., 2012, UNDERSTANDING MOTOR, V7th, P461; Garcia C, 2011, NEUROSCI LETT, V492, P29, DOI 10.1016/j.neulet.2011.01.047; Gwet KL., 2014, HDB INTERRATER RELIA, P428; Hardy LL, 2013, MED SCI SPORT EXER, V45, P1965, DOI 10.1249/MSS.0b013e318295a9fc; Hardy LL, 2012, PEDIATRICS, V130, pE390, DOI 10.1542/peds.2012-0345; Hardy LL, 2010, J SCI MED SPORT, V13, P503, DOI 10.1016/j.jsams.2009.05.010; Hooper D., 2008, ARTICLES, V2, DOI DOI 10.1080/10705519909540118; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jaakkola T, 2015, SCAND J MED SCI SPOR, DOI [10.1111/sms, DOI 10.1111/SMS]; Kim S, 2014, J MOTOR BEHAV, V46, P351, DOI 10.1080/00222895.2014.914886; Kiphard E. J., 2007, KORPERKOORDINATIONST, V2nd; Kirk D., 2012, DEFINING PHYS ED ROU, P190; Kline R.B., 2011, PRINCIPLES PRACTICE; Loitz C., 2014, WELLSPRING, V25, P1; Lubans DR, 2010, SPORTS MED, V40, P1019, DOI 10.2165/11536850-000000000-00000; MARDIA KV, 1970, BIOMETRIKA, V57, P519, DOI 10.1093/biomet/57.3.519; Moneghetti S, 1993, PHYS SPORT ED VICTOR; Morgan PJ, 2008, RES Q EXERCISE SPORT, V79, P506, DOI 10.1080/02701367.2008.10599517; Okely AD, 2004, J SCI MED SPORT, V7, P358, DOI 10.1016/S1440-2440(04)80031-8; Roberton MA, 2001, RES Q EXERCISE SPORT, V72, P91, DOI 10.1080/02701367.2001.10608939; Tester G., 2014, APE, V4, P127, DOI [10.4236/ape.2014.43017, DOI 10.4236/APE.2014.43017]; Ullman JB, 2006, J PERS ASSESS, V87, P35, DOI 10.1207/s15327752jpa8701_03; Ulrich BD, 1985, MOTOR DEV CURRENT SE, V1, P87; Ulrich D. A., 2000, TEST GROSS MOTOR DEV, V2; Valentini NC, 2012, J MOTOR BEHAV, V44, P275, DOI 10.1080/00222895.2012.700967; Vine K, 2007, PHYS EDUC SPORT PEDA, V12, P61, DOI DOI 10.1080/17408980601060291; Walkley J., 1993, ACHPER National Journal, P11; Wright J, 1996, J CURRICULUM STUD, V28, P331, DOI 10.1080/0022027980280306	43	59	60	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140224	10.1371/journal.pone.0140224	http://dx.doi.org/10.1371/journal.pone.0140224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0CX	26468644	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600033
J	Saarinen, I; Mirtti, T; Seikkula, H; Bostrom, PJ; Taimen, P				Saarinen, Irena; Mirtti, Tuomas; Seikkula, Heikki; Bostrom, Peter J.; Taimen, Pekka			Differential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer Progression	PLOS ONE			English	Article							EXPRESSION; RECURRENCE; MIGRATION; PROTEIN	Background Prostate cancer (PCa) is the most common cancer among men in western countries. While active surveillance is increasingly utilized, the majority of patients are currently treated with radical prostatectomy. In order to avoid over-treatment, there is an indisputable need for reliable biomarkers to identify the potentially aggressive and lethal cases. Nuclear intermediate filament proteins called lamins play a role in chromatin organization, gene expression and cell stiffness. The expression of lamin A is associated with poor outcome in colorectal cancer but to date the prognostic value of the lamins has not been tested in other solid tumors. Methods We studied the expression of different lamins with immunohistochemistry in a tissue microarray material of 501 PCa patients undergoing radical prostatectomy and lymph node dissection. Patients were divided into two staining categories (low and high expression). The correlation of lamin expression with clinicopathological variables was tested and the association of lamin status with biochemical recurrence (BCR) and disease specific survival (DSS) was further analyzed. Results Low expression of lamin A associated with lymph node positivity (p<0.01) but not with other clinicopathological variables and low expression had a borderline independent significant association with DSS (HR = 0.4; 95% CI 0.2-1.0; p = 0.052). Similarly, low lamin C expression associated with poorer survival (HR = 0.2; 95% CI 0.1-0.6; p = 0.004). Lamin B1 expression did not associate with clinicopathological variables but high expression independently predicted BCR in multivariable Cox regression analysis (HR = 1.8; 95% CI 1.1-2.9; p = 0.023). Low expression of lamin B2 correlated with lymph node positivity (p<0.01) and predicted unfavorable DSS (HR = 0.4; 95% CI 0.2-1.0; p = 0.047). Conclusions These results suggest differential roles for lamins in PCa progression. Reduced amounts of lamin A/C and B2 increase risk for lymph node metastasis and disease specific death possibly through increased nuclear deformability while high expression of lamin B1 predicts disease recurrence.	[Saarinen, Irena; Taimen, Pekka] Univ Turku, Dept Pathol, Turku, Finland; [Saarinen, Irena; Taimen, Pekka] Turku Univ Hosp, FIN-20520 Turku, Finland; [Saarinen, Irena; Taimen, Pekka] Univ Turku, Res Lab, MediC, Turku, Finland; [Mirtti, Tuomas] Helsinki Univ Hosp, Dept Pathol, Helsinki, Finland; [Mirtti, Tuomas] Univ Helsinki, Finnish Inst Mol Med, Helsinki, Finland; [Seikkula, Heikki; Bostrom, Peter J.] Turku Univ Hosp, Dept Urol, FIN-20520 Turku, Finland	University of Turku; University of Turku; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Turku	Taimen, P (corresponding author), Univ Turku, Dept Pathol, Turku, Finland.	pekka.taimen@utu.fi	Seikkula, Heikki/AAK-8564-2020	Seikkula, Heikki/0000-0001-9942-1582; Mirtti, Tuomas/0000-0003-0455-9891; Bostrom, Peter/0000-0003-3647-0015	Paivikki and Sakari Sohlberg Foundation; Finnish Medical Foundation; Hospital District of Southwest Finland; Sigrid Juselius	Paivikki and Sakari Sohlberg Foundation; Finnish Medical Foundation; Hospital District of Southwest Finland; Sigrid Juselius(Sigrid Juselius Foundation)	The work was supported by the following: Paivikki and Sakari Sohlberg Foundation, http://www.pss-saatio.fi/, PT; Sigrid Juselius, http://www.sigridjuselius.fi/foundation/, PT; The Finnish Medical Foundation, http://www.laaketieteensaatio.fi/, PT; and The Hospital District of Southwest Finland, http://www.vsshp.fi/en/Pages/default.aspx, PT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbio F, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-19; Barboro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040617; Belt EJT, 2011, EUR J CANCER, V47, P1837, DOI 10.1016/j.ejca.2011.04.025; Boorjian SA, 2012, J UROLOGY, V188, P1761, DOI 10.1016/j.juro.2012.07.037; Butin-Israeli V, 2014, MOL CELL BIOL; Butin-Israeli V, 2012, TRENDS GENET, V28, P464, DOI 10.1016/j.tig.2012.06.001; Coradeghini R, 2006, ONCOL REP, V15, P609; Davidson PM, 2014, CELL MOL BIOENG, V7, P293, DOI 10.1007/s12195-014-0342-y; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Eggener SE, 2011, J UROLOGY, V185, P869, DOI 10.1016/j.juro.2010.10.057; Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046; FURUKAWA K, 1993, EMBO J, V12, P97, DOI 10.1002/j.1460-2075.1993.tb05635.x; Gann Peter H, 2002, Rev Urol, V4 Suppl 5, pS3; Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029; Helfand BT, 2012, J PATHOL, V226, P735, DOI 10.1002/path.3033; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kong L, 2012, CARCINOGENESIS, V33, P751, DOI 10.1093/carcin/bgs022; Kuga T, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.6; Lee JM, 2014, MOL BIOL CELL, V25, P1666, DOI 10.1091/mbc.E14-01-0683; Loeb S, 2014, EUR UROL, V65, P1046, DOI 10.1016/j.eururo.2013.12.062; Melcer S, 2007, EXP CELL RES, V313, P2157, DOI 10.1016/j.yexcr.2007.03.004; Mirtti T, 2013, HUM PATHOL, V44, P310, DOI 10.1016/j.humpath.2012.06.001; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Skvortsov S, 2011, J PROTEOME RES, V10, P259, DOI 10.1021/pr100921j; Sobin L, 2009, TNM CLASSIFICATION M; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Willis ND, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002988; Worman HJ, 2012, J PATHOL, V226, P316, DOI 10.1002/path.2999	31	23	24	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140671	10.1371/journal.pone.0140671	http://dx.doi.org/10.1371/journal.pone.0140671			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469707	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600093
J	Shou, YY; Smithson, M				Shou, Yiyun; Smithson, Michael			Adapting to an Uncertain World: Cognitive Capacity and Causal Reasoning with Ambiguous Observations	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; INDIVIDUAL-DIFFERENCES; HYPOTHESIS GENERATION; MISSING INFORMATION; JUDGMENT; COVARIATION; INDUCTION; CONTINGENCY; INFERENCES; ATTENTION	Ambiguous causal evidence in which the covariance of the cause and effect is partially known is pervasive in real life situations. Little is known about how people reason about causal associations with ambiguous information and the underlying cognitive mechanisms. This paper presents three experiments exploring the cognitive mechanisms of causal reasoning with ambiguous observations. Results revealed that the influence of ambiguous observations manifested by missing information on causal reasoning depended on the availability of cognitive resources, suggesting that processing ambiguous information may involve deliberative cognitive processes. Experiment 1 demonstrated that subjects did not ignore the ambiguous observations in causal reasoning. They also had a general tendency to treat the ambiguous observations as negative evidence against the causal association. Experiment 2 and Experiment 3 included a causal learning task requiring a high cognitive demand in which paired stimuli were presented to subjects sequentially. Both experiments revealed that processing ambiguous or missing observations can depend on the availability of cognitive resources. Experiment 2 suggested that the contribution of working memory capacity to the comprehensiveness of evidence retention was reduced when there were ambiguous or missing observations. Experiment 3 demonstrated that an increase in cognitive demand due to a change in the task format reduced subjects' tendency to treat ambiguous-missing observations as negative cues.	[Shou, Yiyun; Smithson, Michael] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia	Australian National University	Shou, YY (corresponding author), Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia.	yiyun.shou@anu.edu.au		Shou, Yiyun/0000-0002-7386-0031				Baron J, 2006, THINKING DECIDING; Beck SR, 2006, CHILD DEV, V77, P413, DOI 10.1111/j.1467-8624.2006.00879.x; Black M., 1990, International Journal of General Systems, V17, P107, DOI 10.1080/03081079008935103; Buehner M, 2005, INTELLIGENCE, V33, P251, DOI 10.1016/j.intell.2005.01.002; Buehner MJ, 2003, J EXP PSYCHOL LEARN, V29, P1119, DOI 10.1037/0278-7393.29.6.1119; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Cheng PW, 1997, PSYCHOL REV, V104, P367, DOI 10.1037/0033-295X.104.2.367; Chuderski A, 2012, J EXP PSYCHOL LEARN, V38, P1689, DOI 10.1037/a0028465; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Del Missier F, 2013, J EXP PSYCHOL LEARN, V39, P1344, DOI 10.1037/a0032379; Faraco CC, 2011, NEUROIMAGE, V55, P773, DOI 10.1016/j.neuroimage.2010.12.033; Fox CR, 2003, PSYCHOL SCI, V14, P195, DOI 10.1111/1467-9280.02431; Garcia-Retamero R, 2008, PSYCHOL REC, V58, P547, DOI 10.1007/BF03395637; Garcia-Retamero R, 2009, Q J EXP PSYCHOL, V62, P1991, DOI 10.1080/17470210802602615; Garcia-Retamero R, 2009, LEARN MOTIV, V40, P284, DOI 10.1016/j.lmot.2009.04.001; Griffiths TL, 2007, COGNITION, V103, P180, DOI 10.1016/j.cognition.2006.03.004; Griffiths TL, 2011, COGNITIVE SCI, V35, P1407, DOI 10.1111/j.1551-6709.2011.01203.x; Griffiths TL, 2009, PSYCHOL REV, V116, P661, DOI 10.1037/a0017201; Griffiths TL, 2005, COGNITIVE PSYCHOL, V51, P334, DOI 10.1016/j.cogpsych.2005.05.004; Jaeggi SM, 2010, INTELLIGENCE, V38, P625, DOI 10.1016/j.intell.2010.09.001; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; JENKINS HM, 1965, PSYCHOL MONOGR, V79, P1, DOI 10.1037/h0093874; Johnson SGB, 2014, J EXP PSYCHOL GEN, V143, P2223, DOI 10.1037/a0038192; Lange ND, 2013, PSYCHON B REV, V20, P171, DOI 10.3758/s13423-012-0316-9; Lauriola M, 2001, J BEHAV DECIS MAKING, V14, P107, DOI 10.1002/bdm.368; Liljeholm M, 2009, J EXP PSYCHOL LEARN, V35, P157, DOI 10.1037/a0013972; Liu HH, 2009, J ECON PSYCHOL, V30, P277, DOI 10.1016/j.joep.2009.02.001; Lu HJ, 2008, PSYCHOL REV, V115, P955, DOI 10.1037/a0013256; MACDONAL.AP, 1970, PSYCHOL REP, V26, P791, DOI 10.2466/pr0.1970.26.3.791; Marsh JK, 2009, J EXP PSYCHOL LEARN, V35, P334, DOI 10.1037/a0014929; Mutter SA, 1996, J GERONTOL B-PSYCHOL, V51, pP70, DOI 10.1093/geronb/51B.2.P70; Mutter SA, 2004, PSYCHOL AGING, V19, P13, DOI 10.1037/0882-7974.19.1.13; Mutter SA, 2007, MEM COGNITION, V35, P875, DOI 10.3758/BF03193462; Oberauer K, 2003, INTELLIGENCE, V31, P167, DOI 10.1016/S0160-2896(02)00115-0; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Perales JC, 2007, PSYCHON B REV, V14, P577, DOI 10.3758/BF03196807; Pushkarskaya H, 2010, COGN AFFECT BEHAV NE, V10, P382, DOI 10.3758/CABN.10.3.382; Sasaki T, 2009, PSYCHOL REP, V104, P545, DOI 10.2466/PR0.104.2.545-548; Satpute AB, 2005, EUR J NEUROSCI, V22, P1233, DOI 10.1111/j.1460-9568.2005.04292.x; Shou YY, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00467; Smithson M, 1999, ORGAN BEHAV HUM DEC, V79, P179, DOI 10.1006/obhd.1999.2844; Smithson M., 2000, RISK DECISION POLICY, V5, P135; Smithson Michael, 2013, GEN LINEAR MODELS CA; Sobel DM, 2009, DEV PSYCHOL, V45, P511, DOI 10.1037/a0014944; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Thomas RP, 2008, PSYCHOL REV, V115, P155, DOI 10.1037/0033-295X.115.1.155; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Unsworth N, 2010, J MEM LANG, V62, P392, DOI 10.1016/j.jml.2010.02.001; Vallee-Tourangeau F, 2008, EUR J COGN PSYCHOL, V20, P177, DOI 10.1080/09541440601056588	49	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140608	10.1371/journal.pone.0140608	http://dx.doi.org/10.1371/journal.pone.0140608			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0CX	26468653	Green Submitted, Green Published, gold			2022-12-26	WOS:000363184600085
J	Yang, J; Liu, XX; Fan, H; Tang, Q; Shou, ZX; Zuo, DM; Zou, Z; Xu, M; Chen, QY; Peng, Y; Deng, SJ; Liu, YJ				Yang, Jia; Liu, Xing-Xing; Fan, Heng; Tang, Qing; Shou, Zhe-Xing; Zuo, Dong-Mei; Zou, Zhou; Xu, Meng; Chen, Qian-Yun; Peng, Ying; Deng, Shuang-Jiao; Liu, Yu-Jin			Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells Protect against Experimental Colitis via Attenuating Colon Inflammation, Oxidative Stress and Apoptosis	PLOS ONE			English	Article							EXPERIMENTAL ULCERATIVE-COLITIS; FACTOR-KAPPA-B; BOWEL-DISEASE; MICROVESICLES PROTECT; CYTOKINE PROFILE; KIDNEY INJURY; RATS; CANCER; DIFFERENTIATION; MICROPARTICLES	The administration of bone mesenchymal stem cells (BMSCs) could reverse experimental colitis, and the predominant mechanism in tissue repair seems to be related to their paracrine activity. BMSCs derived extracellular vesicles (BMSC-EVs), including mcirovesicles and exosomes, containing diverse proteins, mRNAs and micro-RNAs, mediating various biological functions, might be a main paracrine mechanism for stem cell to injured cell communication. We aimed to investigate the potential alleviating effects of BMSC-EVs in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis model. Intravenous injection of BMSC-EVs attenuated the severity of colitis as evidenced by decrease of disease activity index (DAI) and histological colonic damage. In inflammation response, the BMSC-EVs treatment significantly reduced both the mRNA and protein levels of nuclear factor kappaBp65 (NF-kappa Bp65), tumor necrosis factor-alpha (TNF-alpha), induciblenitric oxidesynthase (iNOS) and cyclooxygenase-2 (COX-2) in injured colon. Additionally, the BMSC-EVs injection resulted in a markedly decrease in interleukin-1 beta (IL-1 beta) and an increase in interleukin-10 (IL-10) expression. Therapeutic effect of BMSC-EVs associated with suppression of oxidative perturbations was manifested by a decrease in the activity of myeloperoxidase (MPO) and Malondialdehyde (MDA), as well as an increase in superoxide dismutase (SOD) and glutathione (GSH). BMSC-EVs also suppressed the apoptosis via reducing the cleavage of caspase-3, caspase-8 and caspase-9 in colitis rats. Data obtained indicated that the beneficial effects of BMSC-EVs were due to the down regulation of pro-inflammatory cytokines levels, inhibition of NF-kappa Bp65 signal transduction pathways, modulation of anti-oxidant/oxidant balance, and moderation of the occurrence of apoptosis.	[Yang, Jia; Liu, Xing-Xing; Fan, Heng; Tang, Qing; Shou, Zhe-Xing; Zuo, Dong-Mei; Zou, Zhou; Xu, Meng; Chen, Qian-Yun; Peng, Ying; Deng, Shuang-Jiao; Liu, Yu-Jin] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Integrated Tradit Chinese & Western Med, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Fan, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Integrated Tradit Chinese & Western Med, Wuhan 430074, Peoples R China.	fanheng009@aliyun.com			National Natural Science Foundation of China [81273906]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by grants from the National Natural Science Foundation of China ( No. 81273906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achitei D, 2013, DIGEST DIS SCI, V58, P1244, DOI 10.1007/s10620-012-2510-z; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Amirshahrokhi K, 2011, TOXICOL APPL PHARM, V253, P197, DOI 10.1016/j.taap.2011.03.017; Arab HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097193; Baglio SR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00359; Becker C, 2013, GASTROENTEROLOGY, V144, P283, DOI 10.1053/j.gastro.2012.11.035; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Bitzer M, 2012, KIDNEY INT, V82, P375, DOI 10.1038/ki.2012.152; Brito TV, 2014, J PHARM PHARMACOL, V66, P1161, DOI 10.1111/jphp.12231; Brittan M, 2007, GASTROENTEROLOGY, V132, P1171, DOI 10.1053/j.gastro.2007.01.064; Brune JC, 2011, INT J CANCER, V129, P319, DOI 10.1002/ijc.25697; Camussi G, 2013, BIOCHEM SOC T, V41, P283, DOI 10.1042/BST20120192; Cheng CH, 2015, AQUAT TOXICOL, V164, P61, DOI 10.1016/j.aquatox.2015.04.004; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; de Luca A, 2014, P NATL ACAD SCI USA, V111, P3526, DOI 10.1073/pnas.1322831111; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 2009, CANCER LETT, V281, P128, DOI 10.1016/j.canlet.2008.11.023; Galvez J, 2001, ALIMENT PHARM THERAP, V15, P2027, DOI 10.1046/j.1365-2036.2001.01133.x; Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-005-0052-6; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; He J, 2012, NEPHROLOGY, V17, P493, DOI 10.1111/j.1440-1797.2012.01589.x; Jansen F, 2013, CIRCULATION, V128, P2026, DOI 10.1161/CIRCULATIONAHA.113.001720; Ju GQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121534; Karakas M, 2012, CURR ATHEROSCLER REP, V14, P277, DOI 10.1007/s11883-012-0242-3; Kidd S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030563; Lee C, 2012, CIRCULATION, V126, P2601, DOI 10.1161/CIRCULATIONAHA.112.114173; Lee TW, 2010, GASTROENTEROL CLIN N, V39, P543, DOI 10.1016/j.gtc.2010.08.018; Li TS, 2008, CELL TRANSPLANT, V17, P695, DOI 10.3727/096368908786092702; Lin SS, 2014, NEUROCHEM RES, V39, P922, DOI 10.1007/s11064-014-1288-0; Lin TM, 2007, BIOCHEM BIOPH RES CO, V361, P883, DOI 10.1016/j.bbrc.2007.07.116; Marquez L, 2012, GUT, V61, P528, DOI 10.1136/gut.2011.240978; Martin AR, 2004, BIOCHEM PHARMACOL, V67, P1399, DOI 10.1016/j.bcp.2003.12.024; MURATA Y, 1995, J GASTROENTEROL, V30, P56; Nieto N, 2000, DIGEST DIS SCI, V45, P1820, DOI 10.1023/A:1005565708038; Pan SF, 2014, J CELL PHYSIOL, V229, P631, DOI 10.1002/jcp.24486; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Qidwai T, 2011, SCAND J IMMUNOL, V74, P522, DOI 10.1111/j.1365-3083.2011.02602.x; Qu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107891; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rosario CM, 1997, DEVELOPMENT, V124, P4213; Sakthivel KM, 2013, INT IMMUNOPHARMACOL, V17, P907, DOI 10.1016/j.intimp.2013.09.022; Schreiber S, 2005, GUT, V54, P444, DOI 10.1136/gut.2004.051797; Sklyarov AY, 2011, J PHYSIOL PHARMACOL, V62, P65; Sydora BC, 2010, CLIN EXP IMMUNOL, V161, P187, DOI 10.1111/j.1365-2249.2010.04140.x; Tuzun A, 2002, CLIN BIOCHEM, V35, P569, DOI 10.1016/S0009-9120(02)00361-2; Wang J, 2005, IMMUNOL REV, V204, P144, DOI 10.1111/j.0105-2896.2005.00218.x; Wendland BE, 2001, AM J CLIN NUTR, V74, P259; Wullaert A, 2010, INT J MED MICROBIOL, V300, P49, DOI 10.1016/j.ijmm.2009.08.007; Xu XM, 2011, J CANCER RES CLIN, V137, P495, DOI 10.1007/s00432-010-0908-6; Zhou YH, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/92642; Zuo DM, 2015, MOL MED REP, V11, P2741, DOI 10.3892/mmr.2014.3038	53	148	159	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140551	10.1371/journal.pone.0140551	http://dx.doi.org/10.1371/journal.pone.0140551			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469068	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600075
J	Kwon, SM; Kang, SH; Park, CK; Jung, S; Park, ES; Lee, JS; Kim, SH; Woo, HG				Kwon, So Mee; Kang, Shin-Hyuk; Park, Chul-Kee; Jung, Shin; Park, Eun Sung; Lee, Ju-Seog; Kim, Se-Hyuk; Woo, Hyun Goo			Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance	PLOS ONE			English	Article							MALIGNANT GLIOMA; SELF-RENEWAL; STEM-CELLS; AURORA KINASE; DNA-REPAIR; TEMOZOLOMIDE; SIGNATURE; THERAPY; CHEMOTHERAPY; CONCOMITANT	Previously, transcriptomic profiling studies have shown distinct molecular subtypes of glioblastomas. It has also been suggested that the recurrence of glioblastomas could be achieved by transcriptomic reprograming of tumors, however, their characteristics are not yet fully understood. Here, to gain the mechanistic insights on the molecular phenotypes of recurrent glioblastomas, gene expression profiling was performed on the 43 cases of glioblastomas including 15 paired primary and recurrent cases. Unsupervised clustering analyses revealed two subtypes of G1 and G2, which were characterized by proliferation and neuron-like gene expression traits, respectively. While the primary tumors were classified as G1 subtype, the recurrent glioblastomas showed two distinct expression types. Compared to paired primary tumors, the recurrent tumors in G1 subtype did not show expression alteration. By contrast, the recurrent tumors in G2 subtype showed expression changes from proliferation type to neuron-like one. We also observed the expression of stemness-related genes in G1 recurrent tumors and the altered expression of DNA-repair genes (i.e., AURK, HOX, MGMT, and MSH6) in the G2 recurrent tumors, which might be responsible for the acquisition of drug resistance mechanism during tumor recurrence in a subtype-specific manner. We suggest that recurrent glioblastomas may choose two different strategies for transcriptomic reprograming to escape the chemotherapeutic treatment during tumor recurrence. Our results might be helpful to determine personalized therapeutic strategy against heterogeneous glioma recurrence.	[Kwon, So Mee; Woo, Hyun Goo] Ajou Univ, Sch Med, Dept Physiol, Suwon 441749, South Korea; [Kwon, So Mee; Woo, Hyun Goo] Ajou Univ, Sch Med, Grad Sch Biomed Sci, Suwon 441749, South Korea; [Kang, Shin-Hyuk] Korea Univ, Coll Med, Dept Neurosurg, Seoul 136705, South Korea; [Park, Chul-Kee] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Jung, Shin] Chonnam Natl Univ, Res Inst Med Sci, Dept Neurosurg, Hwasun Hosp & Med Sch, Gwangju, South Korea; [Park, Eun Sung] Yonsei Univ, Coll Med, Inst Med Convergence, Seoul, South Korea; [Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Kim, Se-Hyuk] Ajou Univ, Sch Med, Dept Neurosurg, Suwon 441749, South Korea	Ajou University; Ajou University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Chonnam National University; Yonsei University; Yonsei University Health System; University of Texas System; UTMD Anderson Cancer Center; Ajou University	Woo, HG (corresponding author), Ajou Univ, Sch Med, Dept Physiol, Suwon 441749, South Korea.	ajnsksh@gmail.com; hg@ajou.ac.kr	Park, Eun-Cheol/O-5644-2019; Park, Chul-Kee/J-5499-2012; Park, Chul-Kee/O-7842-2019; Lee, Ju-Seog/X-1786-2018; Woo, Hyun Goo | 우현구/I-8954-2019; Woo, Hyun Goo/AEJ-7372-2022	Park, Eun-Cheol/0000-0002-2306-5398; Park, Chul-Kee/0000-0002-2350-9876; Lee, Ju-Seog/0000-0002-5666-9753; Woo, Hyun Goo | 우현구/0000-0002-0916-893X; Woo, Hyun Goo/0000-0002-0916-893X; gang, sinhyeog/0000-0002-8912-7985	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [NRF-2014R1A2A2A01005274, NRF-2012R1A5A2048183]; Korea Healthcare technology R&D Project, Ministry of Health Welfare [HI13C2162]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning; Korea Healthcare technology R&D Project, Ministry of Health Welfare	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (NRF-2014R1A2A2A01005274 and NRF-2012R1A5A2048183), and Korea Healthcare technology R&D Project, Ministry of Health & Welfare (HI13C2162).	Alexander BM, 2012, J NEURO-ONCOL, V107, P463, DOI 10.1007/s11060-011-0765-4; Bartek J, 2012, J NEUROL NEUROSUR PS, V83, P753, DOI 10.1136/jnnp-2011-300709; Barton VN, 2010, J NEUROSURG-PEDIATR, V6, P98, DOI 10.3171/2010.3.PEDS10120; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Borges KS, 2012, J CANCER RES CLIN, V138, P405, DOI 10.1007/s00432-011-1111-0; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Caldera V, 2012, CANCER GENOM PROTEOM, V9, P171; Cheng CK, 2012, P NATL ACAD SCI USA, V109, P12722, DOI 10.1073/pnas.1202492109; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Gaspar N, 2010, CANCER RES, V70, P9243, DOI 10.1158/0008-5472.CAN-10-1250; Giese A, 2004, J NEURO-ONCOL, V66, P351, DOI 10.1023/B:NEON.0000014539.90077.db; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kim Jin Wook, 2014, Genes Cancer, V5, P165; Kim J, 2015, CANCER CELL, V28, P318, DOI 10.1016/j.ccell.2015.07.013; Kinsella TJ, 2009, CLIN CANCER RES, V15, P1853, DOI 10.1158/1078-0432.CCR-08-1307; Kondo N, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/543531; Lehman NL, 2012, CELL CYCLE, V11, P489, DOI 10.4161/cc.11.3.18996; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Madhusudan S, 2005, TRENDS MOL MED, V11, P503, DOI 10.1016/j.molmed.2005.09.004; Maher EA, 2006, CANCER RES, V66, P11502, DOI 10.1158/0008-5472.CAN-06-2072; Mannino M, 2014, STEM CELL RES, V13, P135, DOI 10.1016/j.scr.2014.05.001; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; NEWLANDS ES, 1992, BRIT J CANCER, V65, P287, DOI 10.1038/bjc.1992.57; Park ES, 2011, P NATL ACAD SCI USA, V108, P17456, DOI 10.1073/pnas.1114210108; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Raza SM, 2004, CLIN CANCER RES, V10, P212, DOI 10.1158/1078-0432.CCR-0155-3; Shen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035236; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tilghman J, 2014, CANCER RES, V74, P3168, DOI 10.1158/0008-5472.CAN-13-2103; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Xia ZB, 2013, MOL CANCER RES, V11, P1101, DOI 10.1158/1541-7786.MCR-13-0044; Yoshimoto K, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00186; Zeng WFF, 2007, J CLIN PATHOL, V60, P218, DOI 10.1136/jcp.2006.036806; Zhang WW, 2011, J CELL BIOCHEM, V112, P942, DOI 10.1002/jcb.23010; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	43	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140528	10.1371/journal.pone.0140528	http://dx.doi.org/10.1371/journal.pone.0140528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466313	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100137
J	Pinto, CM; Ocana-Mayorga, S; Tapia, EE; Lobos, SE; Zurita, AP; Aguirre-Villacis, F; MacDonald, A; Villacis, AG; Lima, L; Teixeira, MMG; Grijalva, MJ; Perkins, SL				Pinto, C. Miguel; Ocana-Mayorga, Sofia; Tapia, Elicio E.; Lobos, Simon E.; Zurita, Alejandra P.; Aguirre-Villacis, Fernanda; MacDonald, Amber; Villacis, Anita G.; Lima, Luciana; Teixeira, Marta M. G.; Grijalva, Mario J.; Perkins, Susan L.			Bats, Trypanosomes, and Triatomines in Ecuador: New Insights into the Diversity, Transmission, and Origins of Trypanosoma cruzi and Chagas Disease	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; CYTOCHROME-B; RISK-FACTORS; FRUIT BAT; INFECTION; GENE; DNA; CLASSIFICATION; SCHIZOTRYPANUM; AMPLIFICATION	The generalist parasite Trypanosoma cruzi has two phylogenetic lineages associated almost exclusively with bats-Trypanosoma cruzi Tcbat and the subspecies T. c. marinkellei. We present new information on the genetic variation, geographic distribution, host associations, and potential vectors of these lineages. We conducted field surveys of bats and triatomines in southern Ecuador, a country endemic for Chagas disease, and screened for trypanosomes by microscopy and PCR. We identified parasites at species and genotype levels through phylogenetic approaches based on 18S ribosomal RNA (18S rRNA) and cytochrome b (cytb) genes and conducted a comparison of nucleotide diversity of the cytb gene. We document for the first time T. cruzi Tcbat and T. c. marinkellei in Ecuador, expanding their distribution in South America to the western side of the Andes. In addition, we found the triatomines Cavernicola pilosa and Triatoma dispar sharing shelters with bats. The comparisons of nucleotide diversity revealed a higher diversity for T. c. marinkellei than any of the T. c. cruzi genotypes associated with Chagas disease. Findings from this study increased both the number of host species and known geographical ranges of both parasites and suggest potential vectors for these two trypanosomes associated with bats in rural areas of southern Ecuador. The higher nucleotide diversity of T. c. marinkellei supports a long evolutionary relationship between T. cruzi and bats, implying that bats are the original hosts of this important parasite.	[Pinto, C. Miguel; Ocana-Mayorga, Sofia; Lobos, Simon E.; Zurita, Alejandra P.; Aguirre-Villacis, Fernanda; MacDonald, Amber; Villacis, Anita G.; Grijalva, Mario J.] Pontificia Univ Catolica Ecuador, Ctr Invest Enfermedades Infecciosas, Quito, Ecuador; [Pinto, C. Miguel; Perkins, Susan L.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Pinto, C. Miguel] Amer Museum Nat Hist, Dept Mammal, New York, NY 10024 USA; [Pinto, C. Miguel] CUNY, Grad Ctr, New York, NY USA; [Pinto, C. Miguel] Smithsonian Inst, Natl Museum Nat Hist, Div Mammals, Washington, DE USA; [Ocana-Mayorga, Sofia; Grijalva, Mario J.] Ohio Univ, Trop Dis Inst, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Tapia, Elicio E.] Fdn Otonga, Quito, Ecuador; [Lima, Luciana; Teixeira, Marta M. G.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, SP, Brazil	Pontificia Universidad Catolica del Ecuador; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); City University of New York (CUNY) System; Smithsonian Institution; University System of Ohio; Ohio University; Universidade de Sao Paulo	Pinto, CM (corresponding author), Pontificia Univ Catolica Ecuador, Ctr Invest Enfermedades Infecciosas, Quito, Ecuador.	pintom@si.edu	Teixeira, Marta M G/B-1115-2009; Grijalva, Mario J/U-8356-2018; Perkins, Susan/D-3408-2018	Grijalva, Mario J/0000-0003-1964-1425; Perkins, Susan/0000-0002-5400-5662; Pinto, C. Miguel/0000-0002-3640-2357; Ocana-Mayorga, Sofia/0000-0003-3861-9784	NIH Academic Research Enhancement Award [1R15AI077896-01]; Latin American Student Field Research Award from the American Society of Mammalogists; NSF-DDIG grant [DEB-1311582]; Global Infectious Disease Training Grant of Fogarty International Center [1D43TW008261-01A1]; Graduate Student Fellowship of the American Museum of Natural History;  [PUCE I13048]; FOGARTY INTERNATIONAL CENTER [D43TW008261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI077896] Funding Source: NIH RePORTER	NIH Academic Research Enhancement Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Latin American Student Field Research Award from the American Society of Mammalogists; NSF-DDIG grant; Global Infectious Disease Training Grant of Fogarty International Center; Graduate Student Fellowship of the American Museum of Natural History; ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Fieldwork support was provided by Proyecto PUCE I13048 to SO-M and MJG, NIH Academic Research Enhancement Award 1R15AI077896-01 to MJG, and a Latin American Student Field Research Award from the American Society of Mammalogists to CMP. Laboratory work was supported by a NSF-DDIG grant DEB-1311582 to SLP and CMP, and Global Infectious Disease Training Grant 1D43TW008261-01A1 of Fogarty International Center to MJG. Data analyses was supported by a Graduate Student Fellowship of the American Museum of Natural History to CMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2001, MEM I OSWALDO CRUZ, V96, P611, DOI 10.1590/S0074-02762001000500004; Albuja L., 1999, MURCIELAGOS ECUADOR; [Anonymous], 2014, BIOMATTERS GENEIOUS; BAKER JR, 1978, AM J TROP MED HYG, V27, P483, DOI 10.4269/ajtmh.1978.27.483; Barnabe C, 2003, INFECT GENET EVOL, V2, P201, DOI 10.1016/S1567-1348(02)00130-2; BARRETO M, 1984, J MED ENTOMOL, V21, P750, DOI 10.1093/jmedent/21.6.750; Black CL, 2007, J PARASITOL, V93, P12, DOI 10.1645/GE-899R.1; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Cavazzana M, 2010, INT J PARASITOL, V40, P345, DOI 10.1016/j.ijpara.2009.08.015; Cottontail VM, 2009, PARASITOLOGY, V136, P1133, DOI 10.1017/S0031182009990485; Cottontail VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108603; Ramirez JD, 2014, INFECT GENET EVOL, V22, P250, DOI 10.1016/j.meegid.2013.06.022; Ramirez JD, 2011, ACTA TROP, V119, P61, DOI 10.1016/j.actatropica.2011.04.009; de Sousa MA, 2014, PARASITOL RES, V113, P4471, DOI 10.1007/s00436-014-4132-1; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Flores-Lopez CA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001272; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Garcia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036578; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Grijalva MJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-17; Grijalva MJ, 2005, J MED ENTOMOL, V42, P68, DOI 10.1603/0022-2585(2005)042[0068:HHIRBS]2.0.CO;2; Grijalva MJ, 2003, AM J TROP MED HYG, V69, P380, DOI 10.4269/ajtmh.2003.69.380; Guevara A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-358; Guhl F, 1997, LANCET, V349, P1370, DOI 10.1016/S0140-6736(05)63207-2; Guhl F, 2014, INT J PARASITOL, V44, P605, DOI 10.1016/j.ijpara.2014.02.005; Guhl F, 2011, ACTA TROP, V119, P1, DOI 10.1016/j.actatropica.2011.04.002; Hamilton PB, 2012, TRENDS PARASITOL, V28, P136, DOI 10.1016/j.pt.2012.01.006; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kirchhoff LV, 1996, J CLIN MICROBIOL, V34, P1171, DOI 10.1128/JCM.34.5.1171-1175.1996; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Lima L, 2015, ACTA TROP, V151, P166, DOI 10.1016/j.actatropica.2015.07.015; Lima L, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-221; Lima L, 2012, PROTIST, V163, P856, DOI 10.1016/j.protis.2011.12.003; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Llewellyn MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000410; Marcili A, 2009, PARASITOLOGY, V136, P641, DOI 10.1017/S0031182009005861; Marcili A, 2013, J PARASITOL, V99, P1071, DOI 10.1645/12-156.1; Marcili A, 2009, INFECT GENET EVOL, V9, P1265, DOI 10.1016/j.meegid.2009.07.003; Marinkelle C.J., 1976, P175; MARINKELLE CJ, 1982, REV BIOL TROP, V30, P107; Murphy WJ, 2007, NAT PROTOC, V2, P3022, DOI 10.1038/nprot.2007.429; Nei M., 2000, MOL EVOLUTION PHYLOG; Noyes HA, 1999, INT J PARASITOL, V29, P331, DOI 10.1016/S0020-7519(98)00167-2; Oliveira RLF, 2008, ECOTROPICA, V14, P63; Pereira JLA., 1977, REV SAUDE PUBL, V11, P427; Pinto C. Miguel, 2003, Revista de la Pontificia Universidad Catolica del Ecuador, V71, P225; Pinto CM, 2006, J PARASITOL, V92, P1251, DOI 10.1645/GE-886R.1; Pinto CM, 2012, INFECT GENET EVOL, V12, P1328, DOI 10.1016/j.meegid.2012.04.013; Pinto CM, 2013, ACTA CHIROPTEROL, V15, P85, DOI 10.3161/150811013X667885; Pinto CM, 2010, EMERG INFECT DIS, V16, P356, DOI 10.3201/eid1602.090998; Pinto CM, 2015, MAMMALIAWEBECUADOR; Ramirez JD, 2014, ZOONOSES PUBLIC HLTH, V61, P477, DOI 10.1111/zph.12094; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rich SM, 2009, P NATL ACAD SCI USA, V106, P14902, DOI 10.1073/pnas.0907740106; Schofield CJ, 1999, MEM I OSWALDO CRUZ, V94, P375, DOI 10.1590/S0074-02761999000700073; Silva-Iturriza A, 2013, PARASITOL INT, V62, P95, DOI 10.1016/j.parint.2012.10.003; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tomasini N, 2013, INFECT GENET EVOL, V20, P188, DOI 10.1016/j.meegid.2013.08.029; Vallejo GA, 1999, ACTA TROP, V72, P203, DOI 10.1016/S0001-706X(98)00085-0; WINCKER P, 1994, AM J TROP MED HYG, V51, P771, DOI 10.4269/ajtmh.1994.51.771; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602; Zelwer M, 2004, MOL PHYLOGENET EVOL, V33, P687, DOI 10.1016/j.ympev.2004.08.013; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	66	36	38	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139999	10.1371/journal.pone.0139999	http://dx.doi.org/10.1371/journal.pone.0139999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465748	Green Published, gold			2022-12-26	WOS:000363183100070
J	Schut, AGT; Ivits, E; Conijn, JG; ten Brink, B; Fensholt, R				Schut, Antonius G. T.; Ivits, Eva; Conijn, Jacob G.; ten Brink, Ben; Fensholt, Rasmus			Trends in Global Vegetation Activity and Climatic Drivers Indicate a Decoupled Response to Climate Change	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; LAND DEGRADATION; WHEAT YIELD; TIME-SERIES; DATA SET; MODIS; PRODUCTIVITY; NDVI; AVHRR; SAHEL	Detailed understanding of a possible decoupling between climatic drivers of plant productivity and the response of ecosystems vegetation is required. We compared trends in six NDVI metrics (1982-2010) derived from the GIMMS3g dataset with modelled biomass productivity and assessed uncertainty in trend estimates. Annual total biomass weight (TBW) was calculated with the LINPAC model. Trends were determined using a simple linear regression, a Thiel-Sen medium slope and a piecewise regression (PWR) with two segments. Values of NDVI metrics were related to Net Primary Production (MODIS-NPP) and TBW per biome and land-use type. The simple linear and Thiel-Sen trends did not differ much whereas PWR increased the fraction of explained variation, depending on the NDVI metric considered. A positive trend in TBW indicating more favorable climatic conditions was found for 24% of pixels on land, and for 5% a negative trend. A decoupled trend, indicating positive TBW trends and monotonic negative or segmented and negative NDVI trends, was observed for 17-36% of all productive areas depending on the NDVI metric used. For only 1-2% of all pixels in productive areas, a diverging and greening trend was found despite a strong negative trend in TBW. The choice of NDVI metric used strongly affected outcomes on regional scales and differences in the fraction of explained variation in MODIS-NPP between biomes were large, and a combination of NDVI metrics is recommended for global studies. We have found an increasing difference between trends in climatic drivers and observed NDVI for large parts of the globe. Our findings suggest that future scenarios must consider impacts of constraints on plant growth such as extremes in weather and nutrient availability to predict changes in NPP and CO2 sequestration capacity.	[Schut, Antonius G. T.] Wageningen Univ, Plant Prod Syst Grp, NL-6708 PB Wageningen, Netherlands; [Ivits, Eva] Joint Res Ctr, I-21027 Ispra, Italy; [Schut, Antonius G. T.; ten Brink, Ben] PBL Assessment Agcy Environm, NL-3721 MA Bilthoven, Netherlands; [Conijn, Jacob G.] Wageningen UR, Plant Res Int, NL-6708 PB Wageningen, Netherlands; [Fensholt, Rasmus] Univ Copenhagen, Sect Geog, Dept Geosci & Nat Resource Management, Fac Sci, DK-1350 Copenhagen, Denmark	Wageningen University & Research; European Commission Joint Research Centre; EC JRC ISPRA Site; Wageningen University & Research; University of Copenhagen	Schut, AGT (corresponding author), Wageningen Univ, Plant Prod Syst Grp, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.	tom.schut@wur.nl	; Fensholt, Rasmus/L-7951-2014	Conijn, Sjaak/0000-0002-0046-7730; Schut, Antonius/0000-0002-7512-728X; Fensholt, Rasmus/0000-0003-3067-4527	Dutch government; PBL-Netherlands Environmental Assessment Agency	Dutch government; PBL-Netherlands Environmental Assessment Agency	The project is funded by the Dutch government and PBL-Netherlands Environmental Assessment Agency as an in kind contribution to the Rio Conventions. PBL is the national institute for strategic policy analysis in the fields of the environment, nature and spatial planning. It contributed to improving the quality of political and administrative decision-making by conducting outlook studies, analyses and evaluations in which an integrated approach is considered paramount. Policy relevance is the prime concern in all studies. PBL conduct solicited and unsolicited research that is always independent and scientifically sound. PBL is an autonomous research institute in the fields of the environment, nature and spatial planning. It is part of the Dutch Government organisation. The independence of PBL and its partner agencies CPB Netherlands Bureau for Economic Policy Analysis and the Netherlands Institute for Social Research (SCP) is safeguarded in the Protocol for the Policy Assessment Agencies, Staatscourant (government gazette) 3200, 21 February 2012.	[Anonymous], 2013, 5 IPCCWGIAR5; Bader MKF, 2013, J ECOL, V101, P1509, DOI 10.1111/1365-2745.12149; Bai ZG, 2008, SOIL USE MANAGE, V24, P223, DOI 10.1111/j.1475-2743.2008.00169.x; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Bassu S, 2014, GLOBAL CHANGE BIOL, V20, P2301, DOI 10.1111/gcb.12520; Bates BC, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017077; Batjes NH, 1996, GEODERMA, V71, P31, DOI 10.1016/0016-7061(95)00089-5; Beck PSA, 2011, ECOL LETT, V14, P373, DOI 10.1111/j.1461-0248.2011.01598.x; Begue A, 2011, GLOBAL ENVIRON CHANG, V21, P413, DOI 10.1016/j.gloenvcha.2011.02.002; Bobee C, 2012, J ARID ENVIRON, V84, P38, DOI 10.1016/j.jaridenv.2012.03.005; Bouman BAM, 1996, AGR SYST, V52, P171, DOI 10.1016/0308-521X(96)00011-X; Breman H, 2001, GLOBAL ENVIRON CHANG, V11, P59, DOI 10.1016/S0959-3780(00)00045-5; Brisson N, 2010, FIELD CROP RES, V119, P201, DOI 10.1016/j.fcr.2010.07.012; Conijn J, 2013, 201301 ISRIC; Conijn J. G., 2011, 380 PLANT RES INT; Cook BI, 2013, REMOTE SENS-BASEL, V5, P2492, DOI 10.3390/rs5052492; CRU, 2008, CRU TIM SER CRUTS HI; Damberg L, 2014, THEOR APPL CLIMATOL, V117, P441, DOI 10.1007/s00704-013-1019-5; Dardel C, 2014, REMOTE SENS ENVIRON, V140, P350, DOI 10.1016/j.rse.2013.09.011; de Jong R, 2013, GLOBAL CHANGE BIOL, V19, P1953, DOI 10.1111/gcb.12193; de Jong R, 2013, REMOTE SENS-BASEL, V5, P1117, DOI 10.3390/rs5031117; de Jong R, 2012, GLOBAL CHANGE BIOL, V18, P642, DOI 10.1111/j.1365-2486.2011.02578.x; de Jong R, 2011, INT J REMOTE SENS, V32, P6823, DOI 10.1080/01431161.2010.512946; Delgado-Baquerizo M, 2013, NATURE, V502, P672, DOI 10.1038/nature12670; Dent D, 2009, SOIL USE MANAGE, V25, P93, DOI 10.1111/j.1475-2743.2009.00197.x; Erb KH, 2007, J LAND USE SCI, V2, P191, DOI 10.1080/17474230701622981; Fensholt R, 2013, REMOTE SENS-BASEL, V5, P664, DOI 10.3390/rs5020664; Fensholt R, 2012, REMOTE SENS ENVIRON, V119, P131, DOI 10.1016/j.rse.2011.12.015; Fensholt R, 2011, REMOTE SENS ENVIRON, V115, P438, DOI 10.1016/j.rse.2010.09.014; Fernandes R, 2005, REMOTE SENS ENVIRON, V95, P303, DOI 10.1016/j.rse.2005.01.005; Fisher JB, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004252; Giglio L, 2013, J GEOPHYS RES-BIOGEO, V118, P317, DOI 10.1002/jgrg.20042; Giller KE, 2011, AGR SYST, V104, P191, DOI 10.1016/j.agsy.2010.07.002; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; Guay KC, 2014, GLOBAL CHANGE BIOL, V20, P3147, DOI 10.1111/gcb.12647; GUNDERSON CA, 1994, PHOTOSYNTH RES, V39, P369, DOI 10.1007/BF00014592; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hein L, 2006, GLOBAL CHANGE BIOL, V12, P751, DOI 10.1111/j.1365-2486.2006.01135.x; Huang Y, 2006, CHINESE SCI BULL, V51, P1785, DOI 10.1007/s11434-006-2056-6; Huete A, 2010, REMOTE SENSING TROPI; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Ivits E, 2013, ECOL INDIC, V27, P17, DOI 10.1016/j.ecolind.2012.11.010; Ivits E, 2013, ECOL INDIC, V26, P49, DOI 10.1016/j.ecolind.2012.10.012; Ivits E, 2012, GLOBAL PLANET CHANGE, V88-89, P85, DOI 10.1016/j.gloplacha.2012.03.010; Ivits E, 2014, REMOTE SENS-BASEL, V6, P4266, DOI 10.3390/rs6054266; Jamali S, 2014, REMOTE SENS ENVIRON, V141, P79, DOI 10.1016/j.rse.2013.10.019; Jonard M, 2015, GLOBAL CHANGE BIOL, V21, P418, DOI 10.1111/gcb.12657; Jonsson P, 2004, COMPUT GEOSCI-UK, V30, P833, DOI 10.1016/j.cageo.2004.05.006; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Krishnaswamy J, 2014, GLOBAL CHANGE BIOL, V20, P203, DOI 10.1111/gcb.12362; Ling Q, 2012, BIOMASS BIOENERG, V46, P618, DOI 10.1016/j.biombioe.2012.06.035; Lobell DB, 2013, AGR SYST, V115, P137, DOI 10.1016/j.agsy.2012.09.003; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lobell DB, 2005, FIELD CROP RES, V94, P250, DOI 10.1016/j.fcr.2005.01.007; Los SO, 2013, GLOBAL BIOGEOCHEM CY, V27, P318, DOI 10.1002/gbc.20027; Los SO, 1998, IEEE T GEOSCI REMOTE, V36, P206, DOI 10.1109/36.655330; Maltais-Landry G, 2012, AGRON J, V104, P301, DOI 10.2134/agronj2011.0220; Mao JF, 2013, REMOTE SENS-BASEL, V5, P1484, DOI 10.3390/rs5031484; Mbow C, 2013, J ARID ENVIRON, V97, P56, DOI 10.1016/j.jaridenv.2013.05.011; Mkhabela MS, 2011, AGR FOREST METEOROL, V151, P385, DOI 10.1016/j.agrformet.2010.11.012; Nabuurs GJ, 2013, NAT CLIM CHANGE, V3, P792, DOI [10.1038/NCLIMATE1853, 10.1038/nclimate1853]; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Pinzon JE, 2005, INTERD MATH SCI, V5, P167; Pouliot D, 2009, INT J REMOTE SENS, V30, P149, DOI 10.1080/01431160802302090; Rijk B, 2013, FIELD CROP RES, V149, P262, DOI 10.1016/j.fcr.2013.05.008; Ruiz-Benito P, 2014, ECOSYSTEMS, V17, P1439, DOI 10.1007/s10021-014-9806-0; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Schut AGT, 2009, CROP PASTURE SCI, V60, P60, DOI 10.1071/CP08182; Seaquist JW, 2009, BIOGEOSCIENCES, V6, P469, DOI 10.5194/bg-6-469-2009; Sjostrom M, 2011, REMOTE SENS ENVIRON, V115, P1081, DOI 10.1016/j.rse.2010.12.013; Stephens DJ, 1998, AUST J AGR RES, V49, P211, DOI 10.1071/A96139; Stephens DJ, 1989, J R SOC W AUST, V71, P77; Tappan GG, 2004, J ARID ENVIRON, V59, P427, DOI 10.1016/j.jaridenv.2004.03.018; Tome AR, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019100; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Turner DP, 2006, REMOTE SENS ENVIRON, V102, P282, DOI 10.1016/j.rse.2006.02.017; van der Sleen JP, 2014, THESIS WAGENINGEN U; van Ittersum MK, 2003, EUR J AGRON, V18, P201, DOI 10.1016/S1161-0301(02)00106-5; van Leeuwen WJD, 2013, REMOTE SENS-BASEL, V5, P1177, DOI 10.3390/rs5031177; Verbesselt J, 2010, REMOTE SENS ENVIRON, V114, P106, DOI 10.1016/j.rse.2009.08.014; VERMOTE E, 1995, INT J REMOTE SENS, V16, P2317, DOI 10.1080/01431169508954561; Vicente-Serrano SM, 2013, P NATL ACAD SCI USA, V110, P52, DOI 10.1073/pnas.1207068110; Visser H, 2004, ATMOS ENVIRON, V38, P4135, DOI 10.1016/j.atmosenv.2004.04.014; Volante JN, 2012, AGR ECOSYST ENVIRON, V154, P12, DOI 10.1016/j.agee.2011.08.012; Wessels KJ, 2007, J ARID ENVIRON, V68, P271, DOI 10.1016/j.jaridenv.2006.05.015; Wessels KJ, 2009, SOIL USE MANAGE, V25, P91, DOI 10.1111/j.1475-2743.2009.00195.x; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; Xu L, 2013, NAT CLIM CHANGE, V3, P581, DOI [10.1038/nclimate1836, 10.1038/NCLIMATE1836]; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011	90	15	16	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138013	10.1371/journal.pone.0138013	http://dx.doi.org/10.1371/journal.pone.0138013			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466347	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100009
J	Forni, MF; Lobba, ARM; Ferreira, HP; Sogayar, MC				Forni, Maria Fernanda; Maia Lobba, Aline Ramos; Pereira Ferreira, Alexandre Hamilton; Sogayar, Mari Cleide			Simultaneous Isolation of Three Different Stem Cell Populations from Murine Skin	PLOS ONE			English	Article							MYELINATING SCHWANN-CELLS; SURFACE; ENRICHMENT; DERMIS; NICHE	The skin is a rich source of readily accessible stem cells. The level of plasticity afforded by these cells is becoming increasingly important as the potential of stem cells in Cell Therapy and Regenerative Medicine continues to be explored. Several protocols described single type stem cell isolation from skin; however, none of them afforded simultaneous isolation of more than one population. Herein, we describe the simultaneous isolation and characterization of three stem cell populations from the dermis and epidermis of murine skin, namely Epidermal Stem Cells (EpiSCs), Skin-derived Precursors (SKPs) and Mesenchymal Stem Cells (MSCs). The simultaneous isolation was possible through a simple protocol based on culture selection techniques. These cell populations are shown to be capable of generating chondrocytes, adipocytes, osteocytes, terminally differentiated keratinocytes, neurons and glia, rendering this protocol suitable for the isolation of cells for tissue replenishment and cell based therapies. The advantages of this procedure are far-reaching since the skin is not only the largest organ in the body, but also provides an easily accessible source of stem cells for autologous graft.	[Forni, Maria Fernanda; Maia Lobba, Aline Ramos; Pereira Ferreira, Alexandre Hamilton; Sogayar, Mari Cleide] Univ Sao Paulo, Fac Med, Dept Clin Med, Nucleo Terapia Celular & Mol NUCEL NETCEM, BR-05360130 Sao Paulo, SP, Brazil; [Forni, Maria Fernanda; Sogayar, Mari Cleide] Univ Sao Paulo, Dept Bioquim, Inst Quim, BR-05508000 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Sogayar, MC (corresponding author), Univ Sao Paulo, Fac Med, Dept Clin Med, Nucleo Terapia Celular & Mol NUCEL NETCEM, BR-05360130 Sao Paulo, SP, Brazil.	mcsoga@iq.usp.br	Sogayar, Mari C/B-3980-2017; Forni, Maria Fernanda/N-1096-2017; Lobba, Aline/N-9982-2016	Sogayar, Mari C/0000-0003-4805-4609; Forni, Maria Fernanda/0000-0002-3335-9023; Lobba, Aline/0000-0003-1827-3528	FAPESP [2006/59199-7, 2001/10707-7, 08/53972-1]; CNPq [401828/2012-3, 404552/2012-9]; FINEP [01.08.0622.00]; BNDES [09.2.1066.1]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FINEP(Financiadora de Inovacao e Pesquisa (Finep)); BNDES	This work was supported by FAPESP grants (2006/59199-7, 2001/10707-7, 08/53972-1), CNPq (401828/2012-3; 404552/2012-9), FINEP 01.08.0622.00, BNDES 09.2.1066.1.	Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Biernaskie J, 2007, J NEUROSCI, V27, P9545, DOI 10.1523/JNEUROSCI.1930-07.2007; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Braun KM, 2006, STEM CELL REV, V2, P221, DOI 10.1007/s12015-006-0050-7; Crigler L, 2007, FASEB J, V21, P2050, DOI 10.1096/fj.06-5880com; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dunnwald M, 2001, EXP DERMATOL, V10, P45, DOI 10.1034/j.1600-0625.2001.100106.x; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Forni MF, 2012, BIOL RES, V45, P215, DOI 10.4067/S0716-97602012000300003; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Halcsik E, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-47; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Kairuz E, 2007, WOUND REPAIR REGEN, V15, P266, DOI 10.1111/j.1524-475X.2007.00215.x; Kaur P, 2000, J INVEST DERMATOL, V114, P413, DOI 10.1046/j.1523-1747.2000.00884.x; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Liu SX, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-141; Maleki Masoud, 2014, International Journal of Stem Cells, V7, P118, DOI 10.15283/ijsc.2014.7.2.118; McKenzie IA, 2006, J NEUROSCI, V26, P6651, DOI 10.1523/JNEUROSCI.1007-06.2006; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Yan XH, 2008, STEM CELL REV, V4, P113, DOI 10.1007/s12015-008-9022-4	31	16	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140143	10.1371/journal.pone.0140143	http://dx.doi.org/10.1371/journal.pone.0140143			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462205	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300059
J	Yu, EJ; Kim, SH; Kim, HJ; Heo, K; Ou, CY; Stallcup, MR; Kim, JH				Yu, E. J.; Kim, S-H; Kim, H. J.; Heo, K.; Ou, C-Y; Stallcup, M. R.; Kim, J. H.			Positive regulation of beta-catenin-PROX1 signaling axis by DBC1 in colon cancer progression	ONCOGENE			English	Article							BETA-CATENIN; WNT/BETA-CATENIN; COLORECTAL TUMORIGENESIS; ANDROGEN RECEPTOR; GENE ACTIVATION; GROWTH; P53; PROX1; CELLS; SIRT1	Aberrant activation of Wnt/beta-catenin pathway contributes to colorectal cancer (CRC) progression. However, little is known about regulatory mechanisms of the beta-catenin activity in cancer progression. Here we investigated the role of DBC1, which was recently reported as a negative regulator of SIRT1 and a transcriptional coactivator, in the regulation of Wnt/beta-catenin signaling. We identified the genome-wide targets of DBC1 and found that loss of DBC1 inhibits the expression of beta-catenin target genes including PROX1, a transcription factor linked to CRC progression. Mechanistically, DBC1 stabilizes LEF1-beta-catenin interaction by inhibiting SIRT1-mediated beta-catenin deacetylation, thereby enhancing LEF1-beta-catenin complex formation and long-range chromatin looping at the PROX1 locus. Furthermore, DBC1 is also required for the transcriptional activity of PROX1, suggesting that DBC1 has a dual function in regulating beta-catenin-PROX1 signaling axis: as a coactivator for both beta-catenin and PROX1. Importantly, loss of DBC1 inhibited growth and tumorigenic potential of colon cancer cells, and DBC1 expression correlated with shorter relapse-free survival in patients with advanced CRC. Our results firmly establish DBC1 as a critical positive regulator of beta-catenin-PROX1 signaling axis and a key factor in beta-catenin-PROX1-mediated CRC progression.	[Yu, E. J.; Kim, S-H; Kim, H. J.; Kim, J. H.] Sungkyunkwan Univ, Samsung Canc Ctr, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul 135710, South Korea; [Yu, E. J.; Kim, H. J.; Kim, J. H.] Samsung Med Ctr, Samsung Biomed Res Inst, Dept Biomed Sci, Seoul, South Korea; [Kim, S-H] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Heo, K.] Dongnam Inst Radiol & Med Sci, Dept Clin Res, Busan, South Korea; [Ou, C-Y; Stallcup, M. R.] Univ Southern Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Korea Institute of Radiological & Medical Sciences; University of Southern California	Kim, JH (corresponding author), Sungkyunkwan Univ, Samsung Canc Ctr, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul 135710, South Korea.; Kim, JH (corresponding author), Samsung Med Ctr, Samsung Biomed Res Inst, Dept Biomed Sci, Seoul, South Korea.; Stallcup, MR (corresponding author), Univ Southern Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.	stallcup@usc.edu; jeongkim@skku.edu	Ou, Chenyin/AAM-7473-2020	Ou, Chenyin/0000-0002-8036-7317; Heo, Kyu/0000-0001-8833-4731	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MISP) [NRF-2013R1A1A2059697]; National R&D Program through the Dongnam Institute of Radiological and Medical Sciences (DIRAMS) - MISP [50590-2015]; National Institutes of Health [DK043093]; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093] Funding Source: NIH RePORTER	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MISP); National R&D Program through the Dongnam Institute of Radiological and Medical Sciences (DIRAMS) - MISP; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr Woo-Young Seo (Sungkyunkwan University) for expert technical assistance and Dr Yong-Kwon Hong (University of Southern California) for providing PROX1 expression and reporter constructs. This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (MISP) (NRF-2013R1A1A2059697 to JHK), National R&D Program through the Dongnam Institute of Radiological and Medical Sciences (DIRAMS) funded by MISP (50590-2015), and the National Institutes of Health (DK043093 to MRS).	BAKER SJ, 1990, CANCER RES, V50, P7717; Chini EN, 2013, BIOSCIENCE REP, V33, P637, DOI 10.1042/BSR20130062; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Kim HJ, 2015, ONCOGENE, V34, P4500, DOI 10.1038/onc.2014.381; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Kim SH, 2012, HISTOL HISTOPATHOL, V27, P49, DOI 10.14670/HH-27.49; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Li HW, 2004, J BIOL CHEM, V279, P4212, DOI 10.1074/jbc.M311374200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Ou CY, 2009, J BIOL CHEM, V284, P20629, DOI 10.1074/jbc.M109.014332; Pangon L, 2015, INT J CANCER, V136, P55, DOI 10.1002/ijc.28967; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Qin B, 2015, CELL REP, V10, P1324, DOI 10.1016/j.celrep.2015.01.066; Ragusa S, 2014, CELL REP, V8, P1957, DOI 10.1016/j.celrep.2014.08.041; Sebio A, 2014, EXPERT OPIN THER TAR, V18, P611, DOI 10.1517/14728222.2014.906580; Seo WY, 2013, NUCLEIC ACIDS RES, V41, P8526, DOI 10.1093/nar/gkt644; SINICROPE FA, 1995, CANCER RES, V55, P237; Skog M, 2011, BRIT J CANCER, V105, P1346, DOI 10.1038/bjc.2011.297; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Tutter AV, 2001, GENE DEV, V15, P3342, DOI 10.1101/gad.946501; Wiener Z, 2014, CELL REP, V8, P1943, DOI 10.1016/j.celrep.2014.08.034; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Yang CK, 2006, J BIOL CHEM, V281, P3389, DOI 10.1074/jbc.M510403200; Yu EJ, 2013, ONCOGENE, V32, P4160, DOI 10.1038/onc.2012.420; Yu EJ, 2011, NUCLEIC ACIDS RES, V39, P6932, DOI 10.1093/nar/gkr347; Zhang YG, 2014, INT J CLIN ONCOL, V19, P106, DOI 10.1007/s10147-012-0506-5	31	20	21	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 30	2016	35	26					3410	3418		10.1038/onc.2015.401	http://dx.doi.org/10.1038/onc.2015.401			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DQ5UI	26477307	Green Accepted			2022-12-26	WOS:000379270100006
J	LoPiccolo, J; Kim, SJ; Shi, Y; Wu, B; Wu, HY; Chait, BT; Singer, RH; Sali, A; Brenowitz, M; Bresnick, AR; Backer, JM				LoPiccolo, Jaclyn; Kim, Seung Joong; Shi, Yi; Wu, Bin; Wu, Haiyan; Chait, Brian T.; Singer, Robert H.; Sali, Andrej; Brenowitz, Michael; Bresnick, Anne R.; Backer, Jonathan M.			Assembly and Molecular Architecture of the Phosphoinositide 3-Kinase p85 alpha Homodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; NUCLEAR-PORE COMPLEX; FLUORESCENCE FLUCTUATION SPECTROSCOPY; PROTEIN HOMOLOGY DETECTION; SMALL-ANGLE SCATTERING; TERMINAL SH2 DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; REGULATORY SUBUNIT; CRYSTAL-STRUCTURE; MACROMOLECULAR ASSEMBLIES	Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases that are activated by growth factor and G-protein-coupled receptors and propagate intracellular signals for growth, survival, proliferation, and metabolism. p85 alpha, a modular protein consisting of five domains, binds and inhibits the enzymatic activity of class IA PI3K catalytic subunits. Here, we describe the structural states of the p85 alpha dimer, based on data from in vivo and in vitro solution characterization. Our in vitro assembly and structural analyses have been enabled by the creation of cysteine-free p85 alpha that is functionally equivalent to native p85 alpha. Analytical ultracentrifugation studies showed that p85 alpha undergoes rapidly reversible monomer-dimer assembly that is highly exothermic in nature. In addition to the documented SH3-PR1 dimerization interaction, we identified a second intermolecular interaction mediated by cSH2 domains at the C-terminal end of the polypeptide. We have demonstrated in vivo concentration-dependent dimerization of p85 alpha using fluorescence fluctuation spectroscopy. Finally, we have defined solution conditions under which the protein is predominantly monomeric or dimeric, providing the basis for small angle x-ray scattering and chemical cross-linking structural analysis of the discrete dimer. These experimental data have been used for the integrative structure determination of the p85 alpha dimer. Our study provides new insight into the structure and assembly of the p85 alpha homodimer and suggests that this protein is a highly dynamic molecule whose conformational flexibility allows it to transiently associate with multiple binding proteins.	[LoPiccolo, Jaclyn; Wu, Haiyan] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Brenowitz, Michael; Bresnick, Anne R.; Backer, Jonathan M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Wu, Bin; Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Kim, Seung Joong; Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Kim, Seung Joong; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Shi, Yi; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Rockefeller University	Brenowitz, M (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	michael.brenowitz@einstein.yu.edu; anne.bresnick@einstein.yu.edu; jonathan.backer@einstein.yu.edu	Shi, Yi/P-7972-2018; Kim, Seung Joong/S-6970-2018; Regan, Clinton/E-6250-2012	Shi, Yi/0000-0002-2761-8324; 	National Institutes of Health [R01 GM112524, R01 NS83085, T32 GM007288]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health, NCRR, Biomedical Technology Program [P41RR001209]; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL CANCER INSTITUTE [P30CA013330, P01CA100324] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103314, P41GM103393, R01GM112524, T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NCRR, Biomedical Technology Program; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 GM112524 (to J. M. B. and A. R. B.), R01 NS83085 (to R. H. S.), and T32 GM007288 (to J. L.). Portions of this research were carried out at the SSRL, SLAC National Accelerator Laboratory operated for the United States Department of Energy by Stanford University. The SSRL SMBP is supported by the Department of Energy Office of Biological and Environmental Research; by National Institutes of Health, NCRR, Biomedical Technology Program Grant P41RR001209; and by NIGMS, National Institutes of Health, Grant P41GM103393. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Backer JM, 2010, CURR TOP MICROBIOL, V346, P87, DOI 10.1007/82_2010_52; Batra-Safferling R, 2010, BIOL CHEM, V391, P33, DOI 10.1515/BC.2010.003; Bernauer J, 2008, BIOINFORMATICS, V24, P652, DOI 10.1093/bioinformatics/btn022; BOOKER GW, 1992, NATURE, V358, P684, DOI 10.1038/358684a0; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burke JE, 2015, TRENDS BIOCHEM SCI, V40, P88, DOI 10.1016/j.tibs.2014.12.003; Carter L, 2015, BIOPHYS J, V109, P793, DOI 10.1016/j.bpj.2015.06.065; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Cheung LWT, 2015, ELIFE, V4, DOI 10.7554/eLife.06866; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Erzberger JP, 2014, CELL, V158, P1123, DOI 10.1016/j.cell.2014.07.044; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Fernandez-Martinez J, 2012, J CELL BIOL, V196, P419, DOI 10.1083/jcb.201109008; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Fu Z, 2003, P NATL ACAD SCI USA, V100, P3275, DOI 10.1073/pnas.0535975100; Hale BG, 2008, J BIOL CHEM, V283, P1372, DOI 10.1074/jbc.M708862200; Harpur AG, 1999, J BIOL CHEM, V274, P12323, DOI 10.1074/jbc.274.18.12323; Hersleth HP, 2008, BIOCHEM J, V412, P257, DOI 10.1042/BJ20070921; Hoedemaeker FJ, 1999, J MOL BIOL, V292, P763, DOI 10.1006/jmbi.1999.3111; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KAPELLER R, 1994, J BIOL CHEM, V269, P1927; Kim SJ, 2014, MOL CELL PROTEOMICS, V13, P2911, DOI 10.1074/mcp.M114.040915; KOYAMA S, 1993, CELL, V72, P945, DOI 10.1016/0092-8674(93)90582-B; Kuwamoto S, 2004, J SYNCHROTRON RADIAT, V11, P462, DOI 10.1107/S0909049504019272; LAWLER EL, 1966, OPER RES, V14, P699, DOI 10.1287/opre.14.4.699; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Marino SM, 2012, J BIOL CHEM, V287, P4419, DOI 10.1074/jbc.R111.275578; Marino SM, 2010, J MOL BIOL, V404, P902, DOI 10.1016/j.jmb.2010.09.027; Marsden RL, 2002, PROTEIN SCI, V11, P2814, DOI 10.1110/ps.0209902; Martel A, 2012, J SYNCHROTRON RADIAT, V19, P431, DOI 10.1107/S0909049512008072; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Molnar KS, 2014, STRUCTURE, V22, P1239, DOI 10.1016/j.str.2014.04.019; Musacchio A, 1996, P NATL ACAD SCI USA, V93, P14373, DOI 10.1073/pnas.93.25.14373; Nolte RT, 1996, NAT STRUCT BIOL, V3, P364, DOI 10.1038/nsb0496-364; Park SW, 2014, CELL METAB, V20, P73, DOI 10.1016/j.cmet.2014.04.006; Pauptit RA, 2001, ACTA CRYSTALLOGR D, V57, P1397, DOI 10.1107/S0907444901012434; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Perez-Garcia V, 2014, MOL CELL BIOL, V34, P3359, DOI 10.1128/MCB.00167-14; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Pieper U, 2014, NUCLEIC ACIDS RES, V42, pD336, DOI 10.1093/nar/gkt1144; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428; Rotkiewicz P, 2008, J COMPUT CHEM, V29, P1460, DOI 10.1002/jcc.20906; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sali A, 2015, STRUCTURE, V23, P1156, DOI 10.1016/j.str.2015.05.013; Sanchez-Andres A, 2005, BIOPHYS J, V89, P3531, DOI 10.1529/biophysj.105.067082; Schneidman-Duhovny D, 2014, CURR OPIN STRUC BIOL, V28, P96, DOI 10.1016/j.sbi.2014.08.001; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-17; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi Y, 2015, NAT METHODS, V12, P1135, DOI 10.1038/nmeth.3617; Shi Y, 2014, MOL CELL PROTEOMICS, V13, P2927, DOI 10.1074/mcp.M114.041673; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sprules T, 1998, BIOTECHNIQUES, V25, P20, DOI 10.2144/98251bm02; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Vincent TL, 2013, BIOINFORMATICS, V29, P69, DOI 10.1093/bioinformatics/bts648; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Ward AB, 2013, SCIENCE, V339, P913, DOI 10.1126/science.1228565; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Webb B, 2011, METHODS MOL BIOL, V781, P377, DOI 10.1007/978-1-61779-276-2_19; Wu B, 2012, BIOPHYS J, V102, P2936, DOI 10.1016/j.bpj.2012.05.017; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Zhang XX, 2011, MOL CELL, V41, P567, DOI 10.1016/j.molcel.2011.01.026; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	85	16	16	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30390	30405		10.1074/jbc.M115.689604	http://dx.doi.org/10.1074/jbc.M115.689604			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26475863	Green Published, hybrid			2022-12-26	WOS:000366738200017
J	Wang, C; Liu, WY; Liu, ZJ; Chen, L; Liu, XQ; Kuang, SH				Wang, Chao; Liu, Weiyi; Liu, Zuojun; Chen, Long; Liu, Xiaoqi; Kuang, Shihuan			Hypoxia Inhibits Myogenic Differentiation through p53 Protein-dependent Induction of Bhlhe40 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; SATELLITE CELL; GENE-EXPRESSION; DEC1 STRA13; MUSCLE; MYOD; BETA; OXYGENATION; CARCINOMA; PERFUSION	Satellite cells are muscle-resident stem cells capable of self-renewal and differentiation to repair injured muscles. However, muscle injury often leads to an ischemic hypoxia environment that impedes satellite cell differentiation and reduces the efficiency of muscle regeneration. Here we performed microarray analyses and identified the basic helix-loop-helix family transcription factor Bhlhe40 as a candidate mediator of the myogenic inhibitory effect of hypoxia. Bhlhe40 is strongly induced by hypoxia in satellite cell-derived primary myoblasts. Overexpression of Bhlhe40 inhibits Myog expression and mimics the effect of hypoxia on myogenesis. Inhibition of Bhlhe40, conversely, up-regulates Myog expression and promotes myogenic differentiation. Importantly, Bhlhe40 knockdown rescues myogenic differentiation under hypoxia. Mechanistically, Bhlhe40 binds to the proximal E-boxes of the Myog promoter and reduces the binding affinity and transcriptional activity of MyoD on Myog. Interestingly, hypoxia induces Bhlhe40 expression independent of HIF1 alpha but through a novel p53-dependent signaling pathway. Our study establishes a crucial role of Bhlhe40 in mediating the repressive effect of hypoxia on myogenic differentiation and suggests that inhibition of Bhlhe40 or p53 may facilitate muscle regeneration after ischemic injuries.	[Wang, Chao; Liu, Weiyi; Liu, Zuojun; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47906 USA; [Chen, Long; Liu, Xiaoqi] Purdue Univ, Dept Biochem, W Lafayette, IN 47906 USA; [Liu, Xiaoqi; Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47906 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kuang, SH (corresponding author), 174B Smith Hall,901 W State St, W Lafayette, IN 47907 USA.	skuang@purdue.edu	Wang, Chao/V-8994-2019; Regan, Clinton/E-6250-2012	Wang, Chao/0000-0002-4051-364X; Kuang, Shihuan/0000-0001-9180-3180	Muscular Dystrophy Association; National Institutes of Health [R01 AR060652]; NATIONAL CANCER INSTITUTE [R01CA192894, P30CA023168, K01CA114401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060652] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was partially sponsored by the Muscular Dystrophy Association and the National Institutes of Health Grant R01 AR060652 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Di Carlo A, 2004, J BIOL CHEM, V279, P16332, DOI 10.1074/jbc.M313931200; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Giatromanolaki A, 2003, J PATHOL, V200, P222, DOI 10.1002/path.1330; Greenbaum AR, 1997, J MUSCLE RES CELL M, V18, P149, DOI 10.1023/A:1018653521686; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Hoppeler H, 2001, J EXP BIOL, V204, P3133; Hsiao SP, 2009, BIOCHEM J, V422, P343, DOI 10.1042/BJ20090072; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu Y, 2013, TUMOR BIOL, V34, P1641, DOI 10.1007/s13277-013-0697-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Ma JF, 2012, AGEING RES REV, V11, P432, DOI 10.1016/j.arr.2012.05.004; Majmundar AJ, 2012, MOL CELL BIOL, V32, P36, DOI 10.1128/MCB.05857-11; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Sair M, 2001, CRIT CARE MED, V29, P1343, DOI 10.1097/00003246-200107000-00008; Sun H, 2007, J CELL BIOL, V177, P647, DOI 10.1083/jcb.200609007; Tong JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE917, DOI 10.1152/ajpendo.90924.2008; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; Yun Z, 2005, MOL CELL BIOL, V25, P3040, DOI 10.1128/MCB.25.8.3040-3055.2005; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.261714999	38	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29707	29716		10.1074/jbc.M115.688671	http://dx.doi.org/10.1074/jbc.M115.688671			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26468276	Green Published, hybrid			2022-12-26	WOS:000366614700004
J	Honsho, M; Abe, Y; Fujiki, Y				Honsho, Masanori; Abe, Yuichi; Fujiki, Yukio			Dysregulation of Plasmalogen Homeostasis Impairs Cholesterol Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell metabolism; cholesterol; endoplasmic reticulum (ER); peroxisome; plasmalogen; squalen; squalene monooxygenase	COENZYME-A REDUCTASE; E3 UBIQUITIN LIGASE; HMG-COA REDUCTASE; LIVER-X-RECEPTOR; SQUALENE EPOXIDASE; ZELLWEGER-SYNDROME; PEROXISOME DEFICIENCY; BINDING PROTEINS; LIPID-METABOLISM; MOUSE MODEL	Plasmalogen biosynthesis is regulated by modulating fatty acyl-CoA reductase 1 stability in a manner dependent on cellular plasmalogen level. However, physiological significance of the regulation of plasmalogen biosynthesis remains unknown. Here we show that elevation of the cellular plasmalogen level reduces cholesterol biosynthesis without affecting the isoprenylation of proteins such as Rab and Pex19p. Analysis of intermediate metabolites in cholesterol biosynthesis suggests that the first oxidative step in cholesterol biosynthesis catalyzed by squalene monooxygenase (SQLE), an important regulator downstream HMG-CoA reductase in cholesterol synthesis, is reduced by degradation of SQLE upon elevation of cellular plasmalogen level. By contrast, the defect of plasmalogen synthesis causes elevation of SQLE expression, resulting in the reduction of 2,3-epoxysqualene required for cholesterol synthesis, hence implying a novel physiological consequence of the regulation of plasmalogen biosynthesis.	[Honsho, Masanori; Abe, Yuichi; Fujiki, Yukio] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Fujiki, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yfujiki@kyudai.jp		Honsho, Masanori/0000-0001-6165-4516	CREST from the Science and Technology Agency of Japan; Global COE Program from The Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants for Excellent Graduate Schools from The Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; Takeda Science Foundation; Japan Foundation for Applied Enzymology;  [23570236];  [26440102];  [24247038];  [25112518];  [25116717];  [26116007];  [15K14511]; Grants-in-Aid for Scientific Research [15K14511] Funding Source: KAKEN	CREST from the Science and Technology Agency of Japan; Global COE Program from The Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants for Excellent Graduate Schools from The Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Foundation for Applied Enzymology; ; ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a CREST grant (to Y. F.) from the Science and Technology Agency of Japan, grants from the Global COE Program and Grants for Excellent Graduate Schools from The Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grants-in-Aid for Scientific Research 23570236 and 26440102 (to M. H.) and 24247038, 25112518, 25116717, 26116007, and 15K14511 (to Y. F.), Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (to M. H. and Y. F.), the Takeda Science Foundation (to M. H. and Y. F.), and the Japan Foundation for Applied Enzymology (to Y. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2014, BBA-MOL CELL BIOL L, V1841, P610, DOI 10.1016/j.bbalip.2014.01.001; ASTRUC M, 1977, BIOCHIM BIOPHYS ACTA, V487, P204, DOI 10.1016/0005-2760(77)90056-X; BALAKRISHNAN S, 1961, J NEUROCHEM, V8, P276, DOI 10.1111/j.1471-4159.1961.tb13553.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brown AJ, 2009, INT J BIOCHEM CELL B, V41, P744, DOI 10.1016/j.biocel.2008.05.029; BROWN MS, 1973, P NATL ACAD SCI USA, V70, P2162, DOI 10.1073/pnas.70.7.2162; Buchert R, 2014, AM J HUM GENET, V95, P602, DOI 10.1016/j.ajhg.2014.10.003; Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002; Chan P, 1996, J CLIN PHARMACOL, V36, P422, DOI 10.1002/j.1552-4604.1996.tb05029.x; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Dang HX, 2009, J BIOL CHEM, V284, P6218, DOI 10.1074/jbc.M803702200; Doblas VG, 2013, PLANT CELL, V25, P728, DOI 10.1105/tpc.112.108696; Du XM, 2006, MOL BIOL CELL, V17, P2735, DOI 10.1091/mbc.E05-11-1094; Faust PL, 2014, BIOCHIMIE, V98, P75, DOI 10.1016/j.biochi.2013.10.019; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Ghaedi K, 2000, AM J HUM GENET, V67, P976, DOI 10.1086/303086; Gill S, 2008, PROG LIPID RES, V47, P391, DOI 10.1016/j.plipres.2008.04.002; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GONZALEZ R, 1979, ARCH BIOCHEM BIOPHYS, V196, P574, DOI 10.1016/0003-9861(79)90310-2; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hayashi H, 2011, BIOL PHARM BULL, V34, P453, DOI 10.1248/bpb.34.453; HIDAKA Y, 1991, J BIOL CHEM, V266, P13171; HIDAKA Y, 1990, J LIPID RES, V31, P2087; HODGE VJ, 1991, BIOCHEM BIOPH RES CO, V181, P537, DOI 10.1016/0006-291X(91)91222-X; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Honsho M, 2008, BBA-MOL CELL RES, V1783, P1857, DOI 10.1016/j.bbamcr.2008.05.018; Honsho M, 2013, J BIOL CHEM, V288, P34588, DOI 10.1074/jbc.M113.498345; Honsho M, 2010, J BIOL CHEM, V285, P8537, DOI 10.1074/jbc.M109.083311; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; JAMES GL, 1994, J BIOL CHEM, V269, P14182; JOLLOW D, 1968, J CELL BIOL, V37, P221, DOI 10.1083/jcb.37.2.221; KINSELLA BT, 1992, J BIOL CHEM, V267, P3940; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Kovacs WJ, 2009, J BIOL CHEM, V284, P7232, DOI 10.1074/jbc.M809064200; Kovacs WJ, 2004, MOL CELL BIOL, V24, P1, DOI 10.1128/MCB.24.1.1-13.2004; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Mandel H, 1998, BIOCHEM BIOPH RES CO, V250, P369, DOI 10.1006/bbrc.1998.9321; MANGOLD HK, 1987, LIPIDS, V22, P789, DOI 10.1007/BF02535533; Mankidy R, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-62; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Morand OH, 1997, J LIPID RES, V38, P373; Munn NJ, 2003, J LIPID RES, V44, P182, DOI 10.1194/jlr.M200363-JLR200; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; NAGUMO A, 1995, J LIPID RES, V36, P1489; Nieweg K, 2009, J NEUROCHEM, V109, P125, DOI 10.1111/j.1471-4159.2009.05917.x; Okumoto K, 1997, EXP CELL RES, V233, P11, DOI 10.1006/excr.1997.3552; Okumoto K, 1998, HUM MOL GENET, V7, P1399, DOI 10.1093/hmg/7.9.1399; Ostrowski SM, 2007, J BIOL CHEM, V282, P26832, DOI 10.1074/jbc.M702640200; RIZZO WB, 1993, BIOCHEM MED METAB B, V50, P93, DOI 10.1006/bmmb.1993.1050; SAKAKIBARA J, 1995, J BIOL CHEM, V270, P17, DOI 10.1074/jbc.270.1.17; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Sawada M, 2001, EUR J PHARMACOL, V431, P11, DOI 10.1016/S0014-2999(01)01411-X; Sharpe LJ, 2014, TRENDS BIOCHEM SCI, V39, P527, DOI 10.1016/j.tibs.2014.08.008; Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Teigler A, 2009, HUM MOL GENET, V18, P1897, DOI 10.1093/hmg/ddp110; Thai TP, 2001, HUM MOL GENET, V10, P127, DOI 10.1093/hmg/10.2.127; Vanhorebeek I, 2001, BBA-MOL CELL BIOL L, V1532, P28, DOI 10.1016/S1388-1981(01)00108-1; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang BT, 2011, P NATL ACAD SCI USA, V108, P15201, DOI 10.1073/pnas.1103746108; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; Wong J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-10; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Wu LC, 2011, J BIOL CHEM, V286, P24916, DOI 10.1074/jbc.M111.247163; Zavacki AM, 2009, MOL CELL BIOL, V29, P5339, DOI 10.1128/MCB.01498-08; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1350, DOI 10.1016/j.bbalip.2012.07.006; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1269, DOI 10.1016/j.bbalip.2011.11.009	75	36	36	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28822	28833		10.1074/jbc.M115.656983	http://dx.doi.org/10.1074/jbc.M115.656983			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26463208	Green Published, hybrid			2022-12-26	WOS:000365762300024
J	Dowling, TE; Anderson, CD; Marsh, PC; Rosenberg, MS				Dowling, Thomas E.; Anderson, Corey D.; Marsh, Paul C.; Rosenberg, Michael S.			Population Structure in the Roundtail Chub (Gila robusta Complex) of the Gila River Basin as Determined by Microsatellites: Evolutionary and Conservation Implications	PLOS ONE			English	Article							AMERICAN FRESH-WATER; GENETIC-STRUCTURE; TELEOSTEI; LAHONTAN; PROGRAM; FISHES; LOCI; DIVERSIFICATION; DIVERGENCE; VICARIANCE	Ten microsatellite loci were characterized for 34 locations from roundtail chub (Gila robusta complex) to better resolve patterns of genetic variation among local populations in the lower Colorado River basin. This group has had a complex taxonomic history and previous molecular analyses failed to identify species diagnostic molecular markers. Our results supported previous molecular studies based on allozymes and DNA sequences, which found that most genetic variance was explained by differences among local populations. Samples from most localities were so divergent species-level diagnostic markers were not found. Some geographic samples were discordant with current taxonomy due to admixture or mis-identification; therefore, additional morphological studies are necessary. Differences in spatial genetic structure were consistent with differences in connectivity of stream habitats, with the typically mainstem species, G. robusta, exhibiting greater genetic connectedness within the Gila River drainage. No species exhibited strong isolation by distance over the entire stream network, but the two species typically found in headwaters, G. nigra and G. intermedia, exhibited greater than expected genetic similarity between geographically proximate populations, and usually clustered with individuals from the same geographic location and/or sub-basin. These results highlight the significance of microevolutionary processes and importance of maintaining local populations to maximize evolutionary potential for this complex. Augmentation stocking as a conservation management strategy should only occur under extreme circumstances, and potential source populations should be geographically proximate stocks of the same species, especially for the headwater forms.	[Dowling, Thomas E.; Anderson, Corey D.; Marsh, Paul C.; Rosenberg, Michael S.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe	Dowling, TE (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	thomas.dowling@wayne.edu	Rosenberg, Michael S/A-4621-2008	Rosenberg, Michael S/0000-0001-7882-2467	Arizona Game and Fish Department [AGR 4/21/04]; US Bureau of Reclamation [02FG320070]; U.S. Forest Service [43-8399-2-1069]	Arizona Game and Fish Department; US Bureau of Reclamation; U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	This study was supported by the Arizona Game and Fish Department, AGR 4/21/04, https://azgfdportal.az.gov/; US Bureau of Reclamation, 02FG320070, http://www.usbr.gov/; U.S. Forest Service, 43-8399-2-1069, http://www.fs.fed.us/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardren WR, 2010, CONSERV GENET, V11, P1299, DOI 10.1007/s10592-009-9959-0; Arizona Game and Fish Department, 2006, AR STAT CONS AGR ROU; Axelrod D. I., 1979, OCCAS PAPERS CALIFOR, V132, P1; Billman EJ, 2010, WEST N AM NATURALIST, V70, P39, DOI 10.3398/064.070.0105; Borcard D, 2012, ECOLOGY, V93, P1473; Bryson Jr RW, 2013, PLOS ONE, V8, pe5282; Bryson RW, 2012, BIOL J LINN SOC, V105, P382, DOI 10.1111/j.1095-8312.2011.01798.x; Clarkson RW, 2012, AQUAT CONSERV, V22, P498, DOI 10.1002/aqc.2257; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; DeMarais BD, 1992, THESIS ARIZONA STATE; Demarais BD, 1986, THESIS ARIZ STATE; Diniz JAF, 2013, GENET MOL BIOL, V36, P475, DOI 10.1590/S1415-47572013000400002; Douglas ME, 1999, EVOLUTION, V53, P238, DOI 10.1111/j.1558-5646.1999.tb05349.x; Douglas ME, 2006, MOL ECOL, V15, P3353, DOI 10.1111/j.1365-294X.2006.03007.x; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; ESRI, 1994, DIGITAL CHART WORLD; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Frantz AC, 2009, J APPL ECOL, V46, P493, DOI 10.1111/j.1365-2664.2008.01606.x; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hopken MW, 2013, MOL ECOL, V22, P956, DOI 10.1111/mec.12156; Houston DD, 2011, BIOL J LINN SOC, V104, P163, DOI 10.1111/j.1095-8312.2011.01723.x; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jelks HL, 2008, FISHERIES, V33, P372, DOI 10.1577/1548-8446-33.8.372; Johnson JB, 2004, SYST BIOL, V53, P841, DOI 10.1080/10635150490522557; Johnson JB, 2002, EVOLUTION, V56, P948; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Keeler-Foster CL, 2004, MOL ECOL NOTES, V4, P23, DOI 10.1046/j.1471-8286.2003.00553.x; MEFFE G K, 1988, Conservation Biology, V2, P157, DOI 10.1111/j.1523-1739.1988.tb00167.x; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Meredith EP, 2002, MOL ECOL NOTES, V2, P156, DOI 10.1046/j.1471-8286.2002.00188.x; Minckley W.L., 1991, P7; Minckley W. L, 1973, FISHES ARIZONA; Minckley W. L, 2009, INLAND FISHES GREATE; Minckley WL, 2000, COPEIA, P251; Morrison R.B., 1991, QUATERNARY NONGLACIA, P283; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nei M., 1987, MOL EVOLUTIONARY GEN; Neiswenter SA, 2011, J MAMMAL, V92, P982, DOI 10.1644/11-MAMM-A-037.1; Polyak VJ, 2001, SCIENCE, V294, P148, DOI 10.1126/science.1062771; Pritchard JK, 2000, GENETICS, V155, P945; Rinne JN., 1976, WASMANN J BIOL, V34, P65; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schwemm MR, 2006, THESIS ARIZONA STATE; Smith G.R., 1981, P125; Smith GR, 2010, EVOL ECOL RES, V12, P693; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tibbets CA, 1996, EVOLUTION, V50, P1280, DOI 10.1111/j.1558-5646.1996.tb02368.x; U.S. Fish and Wildlife Service, 2002, FED REGISTER, V67, P51948; U.S. Fish and Wildlife Service, 2006, FED REGISTER, V71; U.S. Fish and Wildlife Service, 2009, FED REGISTER, V74, P32352; Utah Department of Natural Resources, 2006, UT DEP NAT RES PUBL, V06-18; Voeltz JB, 2002, 186 AR GAM FISH DEP; WEEDMAN D., 1996, 91 AR GAM FISH DEP N; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whiteley AR, 2006, MOL ECOL, V15, P2767, DOI 10.1111/j.1365-294X.2006.02972.x; Whiteley AR, 2004, MOL ECOL, V13, P3675, DOI 10.1111/j.1365-294X.2004.02365.x	63	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0139832	10.1371/journal.pone.0139832	http://dx.doi.org/10.1371/journal.pone.0139832			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473600	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500016
J	Epsztejn-Litman, S; Cohen-Hadad, Y; Aharoni, S; Altarescu, G; Renbaum, P; Levy-Lahad, E; Schonberger, O; Eldar-Geva, T; Zeligson, S; Eiges, R				Epsztejn-Litman, Silvina; Cohen-Hadad, Yaara; Aharoni, Shira; Altarescu, Gheona; Renbaum, Paul; Levy-Lahad, Ephrat; Schonberger, Oshrat; Eldar-Geva, Talia; Zeligson, Sharon; Eiges, Rachel			Establishment of Homozygote Mutant Human Embryonic Stem Cells by Parthenogenesis	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; LINES; BLASTOCYSTS; DERIVATION; SIGNATURE; TERATOMA; OOCYTES; ORIGIN; EGGS	We report on the derivation of a diploid 46(XX) human embryonic stem cell (HESC) line that is homozygous for the common deletion associated with Spinal muscular atrophy type 1 (SMA) from a pathenogenetic embryo. By characterizing the methylation status of three different imprinted loci (MEST, SNRPN and H19), monitoring the expression of two parentally imprinted genes (SNRPN and H19) and carrying out genome-wide SNP analysis, we provide evidence that this cell line was established from the activation of a mutant oocyte by diploidization of the entire genome. Therefore, our SMA parthenogenetic HESC (pHESC) line provides a proof-of-principle for the establishment of diseased HESC lines without the need for gene manipulation. As mutant oocytes are easily obtained and readily available during preimplantation genetic diagnosis (PGD) cycles, this approach should provide a powerful tool for disease modelling and is especially advantageous since it can be used to induce large or complex mutations in HESCs, including gross DNA alterations and chromosomal rearrangements, which are otherwise hard to achieve.	[Epsztejn-Litman, Silvina; Cohen-Hadad, Yaara; Aharoni, Shira; Eiges, Rachel] Hebrew Univ Jerusalem, Sch Med, Shaare Zedek Med Ctr, Stem Cell Res Lab, IL-91010 Jerusalem, Israel; [Altarescu, Gheona; Renbaum, Paul; Levy-Lahad, Ephrat; Zeligson, Sharon] Hebrew Univ Jerusalem, Sch Med, Shaare Zedek Med Ctr, Zohar PGD Lab,Med Genet Inst, IL-91010 Jerusalem, Israel; [Schonberger, Oshrat; Eldar-Geva, Talia] Hebrew Univ Jerusalem, Sch Med, Shaare Zedek Med Ctr, IVF Unit, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Eiges, R (corresponding author), Hebrew Univ Jerusalem, Sch Med, Shaare Zedek Med Ctr, Stem Cell Res Lab, IL-91010 Jerusalem, Israel.	rachela@szmc.org.il	Levy-Lahad, Ephrat/F-2186-2018	Levy-Lahad, Ephrat/0000-0002-2637-1921; eiges, rachel/0000-0001-8139-0933				Ahmad R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042800; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Ben-Yosef D, 2012, STEM CELLS DEV, V21, P363, DOI 10.1089/scd.2011.0102; Brevini TAL, 2012, STEM CELL REV REP, V8, P1076, DOI 10.1007/s12015-012-9379-2; Cheng LZ, 2008, CELL RES, V18, P215, DOI 10.1038/cr.2008.19; Daughtry B, 2014, STEM CELL TRANSL MED, V3, P290, DOI 10.5966/sctm.2013-0127; De Sousa PA, 2009, STEM CELL RES, V2, P188, DOI 10.1016/j.scr.2009.01.002; Eckardt S, 2011, J CLIN INVEST, V121, P623, DOI 10.1172/JCI45377; Espejel S, 2014, STEM CELLS, V32, P1983, DOI 10.1002/stem.1726; Isaev DA, 2012, REGEN MED, V7, P37, DOI [10.2217/RME.11.110, 10.2217/rme.11.110]; KAUFMAN MH, 1977, NATURE, V265, P53, DOI 10.1038/265053a0; Kim K, 2007, CELL STEM CELL, V1, P346, DOI 10.1016/j.stem.2007.07.001; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Kuno N, 2004, BIRTH DEFECTS RES A, V70, P40, DOI 10.1002/bdra.10133; Labrum R, 2007, NEUROMUSCULAR DISORD, V17, P684, DOI 10.1016/j.nmd.2007.05.005; Li WB, 2012, INVEST OPHTH VIS SCI, V53, P5334, DOI 10.1167/iovs.12-8303; Liang Rui, 2013, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V27, P559; Lin G, 2007, CELL RES, V17, P999, DOI 10.1038/cr.2007.97; Mai QY, 2007, CELL RES, V17, P1008, DOI 10.1038/cr.2007.102; Mutter GL, 1997, MUTAT RES-FUND MOL M, V396, P141, DOI 10.1016/S0027-5107(97)00180-2; Oliveira FG, 2004, HUM REPROD, V19, P1867, DOI 10.1093/humrep/deh345; Paffoni A, 2007, FERTIL STERIL, V87, P77, DOI 10.1016/j.fertnstert.2006.05.063; Park JI, 1998, JPN J VET RES, V46, P29; PARRINGTON JM, 1984, J MED GENET, V21, P4, DOI 10.1136/jmg.21.1.4; Revazova ES, 2008, CLONING STEM CELLS, V10, P11, DOI 10.1089/clo.2007.0063; Stelzer Y, 2013, STEM CELL REP, V1, P79, DOI 10.1016/j.stemcr.2013.03.005; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; SZOLLOSI MS, 1993, J CELL SCI, V104, P861; Tobin SC, 2013, STEM CELLS DEV, V22, P1016, DOI 10.1089/scd.2012.0577; Turovets N, 2011, METHODS MOL BIOL, V767, P37, DOI 10.1007/978-1-61779-201-4_4; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7; Zimmermann A, 2012, STEM CELLS DEV, V21, P2364, DOI 10.1089/scd.2012.0088	32	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0138893	10.1371/journal.pone.0138893	http://dx.doi.org/10.1371/journal.pone.0138893			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473610	gold, Green Published, Green Submitted			2022-12-26	WOS:000363185500006
J	Idalencio, R; Kalichak, F; Rosa, JGS; de Oliveira, TA; Koakoski, G; Gusso, D; de Abreu, MS; Giacomini, ACV; Barcellos, HHD; Piato, AL; Barcellos, LJG				Idalencio, Renan; Kalichak, Fabiana; Santos Rosa, Joao Gabriel; de Oliveira, Tiago Acosta; Koakoski, Gessi; Gusso, Darlan; de Abreu, Murilo Sander; Varrone Giacomini, Ana Cristina; de Alcantara Barcellos, Heliosa Helena; Piato, Angelo L.; Gil Barcellos, Leonardo Jose			Waterborne Risperidone Decreases Stress Response in Zebrafish	PLOS ONE			English	Article							JUNDIA RHAMDIA-QUELEN; DANIO-RERIO; SUBLETHAL CONCENTRATIONS; CORTISOL RESPONSE; IN-VIVO; FISH; BIOMAGNIFICATION; PHARMACEUTICALS; OLANZAPINE; ENDOCRINE	The presence of drugs and their metabolites in surface waters and municipal effluents has been reported in several studies, but its impacts on aquatic organisms are not yet well understood. This study investigated the effects of acute exposure to the antipsychotic risperidone on the stress and behavioral responses in zebrafish. It became clear that intermediate concentration of risperidone inhibited the hypothalamic-pituitary-interrenal axis and displayed anxiolytic-like effects in zebrafish. The data presented here suggest that the presence of this antipsychotic in aquatic environments can alter neuroendocrine and behavior profiles in zebrafish.	[Idalencio, Renan; Gil Barcellos, Leonardo Jose] Univ Passo Fundo, Programa Posgrad Bioexpt, Passo Fundo, RS, Brazil; [Idalencio, Renan; Gusso, Darlan; de Alcantara Barcellos, Heliosa Helena; Gil Barcellos, Leonardo Jose] Univ Passo Fundo, Lab Fisiol Peixes, Passo Fundo, RS, Brazil; [Kalichak, Fabiana; Santos Rosa, Joao Gabriel; de Oliveira, Tiago Acosta; Koakoski, Gessi; de Abreu, Murilo Sander; Varrone Giacomini, Ana Cristina; de Alcantara Barcellos, Heliosa Helena; Gil Barcellos, Leonardo Jose] Univ Fed Santa Maria, Programa Posgrad Farmacol, BR-97119900 Santa Maria, RS, Brazil; [Piato, Angelo L.] Univ Fed Rio Grande do Sul, Programa Posgrad Farmacol & Terapeut, Lab Psicofarmacol & Comportamento LAPCOM, Porto Alegre, RS, Brazil	Universidade de Passo Fundo; Universidade de Passo Fundo; Universidade Federal de Santa Maria (UFSM); Universidade Federal do Rio Grande do Sul	Barcellos, LJG (corresponding author), Univ Passo Fundo, Programa Posgrad Bioexpt, Passo Fundo, RS, Brazil.	lbarcellos@upf.br	Sander de Abreu, Murilo/J-9756-2015; Rosa, João Gabriel/AAV-6893-2021; PIATO, ANGELO/K-3444-2012; Gusso, Darlan/ABA-6552-2021	Sander de Abreu, Murilo/0000-0001-5562-0715; PIATO, ANGELO/0000-0001-5109-7306; Gusso, Darlan/0000-0003-0293-239X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [301992/2014-2, 472715/2012-7]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-research fellowships for LJGB and ALP have a CNPq (301992/2014-2 and 472715/2012-7, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu Murilo Sander de, 2014, PLoS One, V9, pe103232, DOI 10.1371/journal.pone.0103232; Baldessarini RJ, 2000, BIPOLAR DISORD, V2, P3, DOI 10.1034/j.1399-5618.2000.020102.x; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Barcellos LJG, 2010, J FISH BIOL, V76, P1032, DOI 10.1111/j.1095-8649.2010.02542.x; Barcellos LJG, 2007, AQUACULTURE, V272, P774, DOI 10.1016/j.aquaculture.2007.09.002; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bascunana H, 2000, REV NEUROLOGIA, V30, P850, DOI 10.33588/rn.3009.99434; BLANCHARD DC, 1988, ANNU REV PSYCHOL, V39, P43, DOI 10.1146/annurev.ps.39.020188.000355; Blanchard RJ, 1990, NEUROSCIENCES BEHAV, P125; Blin O, 1996, J CLIN PSYCHOPHARM, V16, P38, DOI 10.1097/00004714-199602000-00007; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Brodin T, 2013, SCIENCE, V339, P814, DOI 10.1126/science.1226850; Brooks BW, 2005, ENVIRON TOXICOL CHEM, V24, P464, DOI 10.1897/04-081R.1; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Calamari D, 2003, ENVIRON SCI TECHNOL, V37, P1241, DOI 10.1021/es020158e; Calisto V, 2011, WATER RES, V45, P6097, DOI 10.1016/j.watres.2011.09.008; Calisto V, 2009, CHEMOSPHERE, V77, P1257, DOI 10.1016/j.chemosphere.2009.09.021; Cericato L, 2008, COMP BIOCHEM PHYS C, V148, P281, DOI 10.1016/j.cbpc.2008.06.008; Cericato L, 2009, COMP BIOCHEM PHYS C, V149, P363, DOI 10.1016/j.cbpc.2008.09.002; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Cuesta MJ, 2001, SCHIZOPHR RES, V48, P17, DOI 10.1016/S0920-9964(00)00112-2; Dal Santo G, 2014, NEUROSCI LETT, V558, P103, DOI 10.1016/j.neulet.2013.11.011; Daniel DG, 2000, J CLIN PSYCHIAT, V61, P49; DUGATKIN LA, 1992, BEHAV ECOL, V3, P124, DOI 10.1093/beheco/3.2.124; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Goerke H, 2004, MAR POLLUT BULL, V48, P295, DOI 10.1016/j.marpolbul.2003.08.004; Goldsmith P, 2004, CURR OPIN PHARMACOL, V4, P504, DOI 10.1016/j.coph.2004.04.005; Alonso SG, 2010, ENVIRON INT, V36, P195, DOI 10.1016/j.envint.2009.11.004; Graeff Frederico Guilherme, 2010, Psychol. Neurosci., V3, P3, DOI 10.3922/j.psns.2010.1.002; Heberer T, 2002, J HYDROL, V266, P175, DOI 10.1016/S0022-1694(02)00165-8; HIGNITE C, 1977, LIFE SCI, V20, P337, DOI 10.1016/0024-3205(77)90329-0; Hontela A, 1998, ENVIRON TOXICOL CHEM, V17, P44, DOI [10.1897/1551-5028(1998)017&lt;0044:IDIFFC&gt;2.3.CO;2, 10.1002/etc.5620170107]; Jones OA, 2005, TRENDS BIOTECHNOL, V23, P163, DOI 10.1016/j.tibtech.2005.02.001; Kelly BC, 2007, SCIENCE, V317, P236, DOI 10.1126/science.1138275; Kowakowska E, 1999, EUR NEUROPSYCHOPHARM, V9, P421, DOI 10.1016/S0924-977X(99)00021-8; Krishnamurthy S, 2013, NEUROPHARMACOLOGY, V75, P62, DOI 10.1016/j.neuropharm.2013.07.005; Mancera JM, 2002, GEN COMP ENDOCR, V129, P95, DOI 10.1016/S0016-6480(02)00522-1; Mariano W. dos S., 2009, Revista Brasileira de Saude e Producao Animal, V10, P210; NIETHAMMER KR, 1984, ARCH ENVIRON CON TOX, V13, P63, DOI 10.1007/BF01055647; Oliveira Irismar R., 2000, Revista Brasileira de Psiquiatria, V22, P38; Oliveira TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075780; Pacheco M, 2001, ECOTOX ENVIRON SAFE, V49, P64, DOI 10.1006/eesa.2000.2025; Magno LDP, 2015, PHARMACOL BIOCHEM BE, V135, P169, DOI 10.1016/j.pbb.2015.05.014; Piato AL, 2011, PROG NEURO-PSYCHOPH, V35, P561, DOI 10.1016/j.pnpbp.2010.12.018; Rogoz Z, 2011, PHARMACOL REP, V63, P1547, DOI 10.1016/S1734-1140(11)70719-8; Schilling TM, 2013, PSYCHONEUROENDOCRINO, V38, P1565, DOI 10.1016/j.psyneuen.2013.01.001; Sink TD, 2008, FISH PHYSIOL BIOCHEM, V34, P95, DOI 10.1007/s10695-007-9150-9; Sun T, 2010, PHARMACOL BIOCHEM BE, V95, P298, DOI 10.1016/j.pbb.2010.02.005; Winberg S, 1997, NEUROSCI LETT, V230, P113, DOI 10.1016/S0304-3940(97)00488-6	50	33	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140800	10.1371/journal.pone.0140800	http://dx.doi.org/10.1371/journal.pone.0140800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473477	Green Submitted, gold, Green Published			2022-12-26	WOS:000363185500115
J	Jhin, C; Hwang, KT				Jhin, Changho; Hwang, Keum Taek			Adaptive Neuro-Fuzzy Inference System Applied QSAR with Quantum Chemical Descriptors for Predicting Radical Scavenging Activities of Carotenoids	PLOS ONE			English	Article							DIETARY CAROTENOIDS; ANTIOXIDANT ACTIVITIES; NDDO APPROXIMATIONS; OPTIMIZATION; PARAMETERS; REGRESSION; ACCEPTOR; VALUES; OXYGEN; ANFIS	One of the physiological characteristics of carotenoids is their radical scavenging activity. In this study, the relationship between radical scavenging activities and quantum chemical descriptors of carotenoids was determined. Adaptive neuro-fuzzy inference system (ANFIS) applied quantitative structure-activity relationship models (QSAR) were also developed for predicting and comparing radical scavenging activities of carotenoids. Semi-empirical PM6 and PM7 quantum chemical calculations were done by MOPAC. Ionisation energies of neutral and monovalent cationic carotenoids and the product of chemical potentials of neutral and monovalent cationic carotenoids were significantly correlated with the radical scavenging activities, and consequently these descriptors were used as independent variables for the QSAR study. The ANFIS applied QSAR models were developed with two triangular-shaped input membership functions made for each of the independent variables and optimised by a backpropagation method. High prediction efficiencies were achieved by the ANFIS applied QSAR. The R-square values of the developed QSAR models with the variables calculated by PM6 and PM7 methods were 0.921 and 0.902, respectively. The results of this study demonstrated reliabilities of the selected quantum chemical descriptors and the significance of QSAR models.	[Jhin, Changho; Hwang, Keum Taek] Seoul Natl Univ, Dept Food & Nutr, Res Inst Human Ecol, Seoul, South Korea	Seoul National University (SNU)	Hwang, KT (corresponding author), Seoul Natl Univ, Dept Food & Nutr, Res Inst Human Ecol, Seoul, South Korea.	keum@snu.ac.kr						Agatonovic-Kustrin S, 2000, J PHARMACEUT BIOMED, V22, P717, DOI 10.1016/S0731-7085(99)00272-1; Amic D, 2010, BIOORGAN MED CHEM, V18, P28, DOI 10.1016/j.bmc.2009.11.015; Beg H, 2013, COMPUT THEOR CHEM, V1005, P1, DOI 10.1016/j.comptc.2012.10.023; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Britton G, 1995, FASEB J, V9, P1551, DOI 10.1096/fasebj.9.15.8529834; Cantrell A, 2003, ARCH BIOCHEM BIOPHYS, V412, P47, DOI 10.1016/S0003-9861(03)00014-6; Edge R, 1998, J AM CHEM SOC, V120, P4087, DOI 10.1021/ja974191q; El-Agamey A, 2004, ARCH BIOCHEM BIOPHYS, V430, P37, DOI 10.1016/j.abb.2004.03.007; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; GEMPERLINE PJ, 1991, ANAL CHEM, V63, P2313, DOI 10.1021/ac00020a022; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; JEEVARAJAN AS, 1994, J PHYS CHEM-US, V98, P7777, DOI 10.1021/j100083a006; Jeevarajan JA, 1996, J ELECTROANAL CHEM, V411, P57, DOI 10.1016/0022-0728(96)04572-X; Jhin C, 2014, INT J MOL SCI, V15, P14715, DOI 10.3390/ijms150814715; Jimenez-Escrig A, 2000, J SCI FOOD AGR, V80, P1686, DOI 10.1002/1097-0010(20000901)80:11<1686::AID-JSFA694>3.0.CO;2-Y; Karelson M, 1996, CHEM REV, V96, P1027, DOI 10.1021/cr950202r; Kiralj R, 2009, J BRAZIL CHEM SOC, V20, P770, DOI 10.1590/S0103-50532009000400021; Kleinova M, 2007, GEN PHYSIOL BIOPHYS, V26, P97; Kontogiorgis AC, 2005, MINI-REV MED CHEM, V5, P563, DOI 10.2174/1389557054023233; Koopmans T, 1934, PHYSICA, V1, P104, DOI 10.1016/S0031-8914(34)90011-2; KRINSKY NI, 1982, J NATL CANCER I, V69, P205; MAIRANOVSKY VG, 1975, J ELECTROANAL CHEM, V66, P123, DOI 10.1016/S0022-0728(75)80218-X; Miller NJ, 1996, FEBS LETT, V384, P240, DOI 10.1016/0014-5793(96)00323-7; Mortensen A, 2001, ARCH BIOCHEM BIOPHYS, V385, P13, DOI 10.1006/abbi.2000.2172; Muller L, 2011, FOOD CHEM, V129, P139, DOI 10.1016/j.foodchem.2011.04.045; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; PARK SU, 1986, J AM CHEM SOC, V108, P240, DOI 10.1021/ja00262a009; PARR RG, 1983, J AM CHEM SOC, V105, P7512, DOI 10.1021/ja00364a005; PARR RG, 1978, J CHEM PHYS, V68, P3801, DOI 10.1063/1.436185; Pasha FA, 2007, MED CHEM RES, V16, P408, DOI 10.1007/s00044-007-9060-5; POBLET JM, 1983, CAN J CHEM, V61, P2068, DOI 10.1139/v83-359; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Sarkar A, 2012, J MOL MODEL, V18, P2621, DOI 10.1007/s00894-011-1274-2; SCHWARTZ JL, 1989, TUMOR BIOL, V10, P297, DOI 10.1159/000217629; Soffers AEMF, 1999, FREE RADICAL RES, V30, P233, DOI 10.1080/10715769900300251; Stahl W, 2003, MOL ASPECTS MED, V24, P345, DOI 10.1016/S0098-2997(03)00030-X; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Stewart JJP, 2013, J MOL MODEL, V19, P1, DOI 10.1007/s00894-012-1667-x; Stewart JJP, 2014, MOPAC2012; Vasil'ev RF, 2010, KINET CATAL+, V51, P507, DOI 10.1134/S0023158410040087; Worachartcheewan A, 2011, CHEMOMETR INTELL LAB, V109, P207, DOI 10.1016/j.chemolab.2011.09.010	43	3	3	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140154	10.1371/journal.pone.0140154	http://dx.doi.org/10.1371/journal.pone.0140154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474167	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500030
J	He, Q; Chang, CK; Xu, F; Zhang, QX; Shi, WH; Li, X				He, Qi; Chang, Chun-Kang; Xu, Feng; Zhang, Qing-Xia; Shi, Wen-Hui; Li, Xiao			Purification of Bone Marrow Clonal Cells from Patients with Myelodysplastic Syndrome via IGF-IR	PLOS ONE			English	Article							GROWTH-FACTOR-I; RECEPTOR TYROSINE KINASE; FACTOR SYSTEM; INHIBITION; APOPTOSIS; LEUKEMIA; FEATURES; CANCER; TUMORS; VITRO	Malignant clonal cells purification can greatly benefit basic and clinical studies in myelodys-plastic syndrome (MDS). In this study, we investigated the potential of using type 1 insulin-like growth factor receptor (IGF-IR) as a marker for purification of malignant bone marrow clonal cells from patients with MDS. The average percentage of IGF-IR expression in CD34(+) bone marrow cells among 15 normal controls was 4.5%, 70% of which also express the erythroid lineage marker CD235a. This indicates that IGF-IR mainly express in erythropoiesis. The expression of IGF-IR in CD34(+) cells of 55 MDS patients was significantly higher than that of cells from the normal controls (54.0 vs. 4.5%). Based on the pattern of IGF-IR expression in MDS patients and normal controls, sorting of IGF-IR-positive and removal of CD235a-positive erythroid lineage cells with combination of FISH detection were performed on MDS samples with chromosomal abnormalities. The percentage of malignant clonal cells significantly increased after sorting. The enrichment effect was more significant in clonal cells with a previous percentage lower than 50%. This enrichment effect was present in samples from patients with +8, 5q-/-5, 20q-/-20 or 7q-/-7 chromosomal abnormalities. These data suggest that IGF-IR can be used as a marker for MDS bone marrow clonal cells and using flow cytometry for positive IGF-IR sorting may effectively purify MDS clonal cells.	[He, Qi; Chang, Chun-Kang; Xu, Feng; Zhang, Qing-Xia; Shi, Wen-Hui; Li, Xiao] Shanghai Jiao Tong Univ, Hosp 6, Dept Hematol, Shanghai 200233, Peoples R China	Shanghai Jiao Tong University	Chang, CK (corresponding author), Shanghai Jiao Tong Univ, Hosp 6, Dept Hematol, Shanghai 200233, Peoples R China.	changchunkang7010@aliyun.com	SHI, wen/GPW-9531-2022		National Natural Science Foundation of China [81100341]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 81100341). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dong AQ, 2007, CELL BIOL INT, V31, P500, DOI 10.1016/j.cellbi.2006.11.017; Greenberg PL, 2013, J NATL COMPR CANC NE, V11, P877, DOI 10.6004/jnccn.2013.0105; Guerreiro AS, 2006, DRUG NEWS PERSPECT, V19, P261, DOI 10.1358/dnp.2006.19.5.985933; Haase D, 2008, ANN HEMATOL, V87, P515, DOI 10.1007/s00277-008-0483-y; He Q, 2006, ANN HEMATOL, V85, P95, DOI 10.1007/s00277-005-0031-y; He Q, 2010, CANCER INVEST, V28, P983, DOI 10.3109/07357907.2010.489537; Huang ZW, 2014, LEUKEMIA LYMPHOMA, V55, P1876, DOI 10.3109/10428194.2013.862241; Jones RA, 2009, ONCOGENE, V28, P2152, DOI 10.1038/onc.2009.79; Ratajczak J, 1998, LEUKEMIA, V12, P371, DOI 10.1038/sj.leu.2400927; Schayek H, 2009, CLIN CANCER RES, V15, P1558, DOI 10.1158/1078-0432.CCR-08-1440; Schillaci R, 2005, BRIT J HAEMATOL, V130, P58, DOI 10.1111/j.1365-2141.2005.05579.x; Scotlandi K, 2005, CANCER RES, V65, P3868, DOI 10.1158/0008-5472.CAN-04-3192; Shaffer LG, 2005, ISCN INT SYSTEM HUMA; SHIMON I, 1995, LEUKEMIA RES, V19, P233, DOI 10.1016/0145-2126(94)00133-U; Stromberg T, 2006, BLOOD, V107, P669, DOI 10.1182/blood-2005-01-0306; Valent P, 2007, LEUKEMIA RES, V31, P727, DOI 10.1016/j.leukres.2006.11.009; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Whelan JT, 2008, LEUKEMIA, V22, P1161, DOI 10.1038/leu.2008.57; Yavari K, 2010, INT J COLORECTAL DIS, V25, P9, DOI 10.1007/s00384-009-0783-2; Zumkeller W, 1999, BLOOD, V94, P3653, DOI 10.1182/blood.V94.11.3653.423k42_3653_3657	20	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140372	10.1371/journal.pone.0140372	http://dx.doi.org/10.1371/journal.pone.0140372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469401	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600053
J	Laporta, J; Penagaricano, F; Hernandez, LL				Laporta, Jimena; Penagaricano, Francisco; Hernandez, Laura L.			Transcriptomic Analysis of the Mouse Mammary Gland Reveals New Insights for the Role of Serotonin in Lactation	PLOS ONE			English	Article							BRAIN-SEROTONIN; EXPRESSION; PREGNANCY; BIOLOGY; MICE; ACTIVATION; TRANSITION; CLOCKS	Serotonin regulates numerous processes in the mammary gland. Our objective was to discover novel genes, pathways and functions which serotonin modulates during lactation. The rate limiting enzyme in the synthesis of non-neuronal serotonin is tryptophan-hydroxylase (TPH1). Therefore, we used TPH1 deficient dams (KO; serotonin deficient, n = 4) and compared them to wild-type (WT; n = 4) and rescue (RC; KO + 100 mg/kg 5-hydroxytryptophan injected daily, n = 4) dams. Mammary tissues were collected on day 10 of lactation. Total RNA extraction, amplification, library preparation and sequencing were performed following the Illumina mRNA-Seq. Overall, 97 and 204 genes (false discovery rate, FDR <= 0.01) exhibited a minimum of a 2-fold expression difference between WT vs. KO and WT vs. RC dams, respectively. Most differentially expressed genes were related to calcium homeostasis, apoptosis regulation, cell cycle, cell differentiation and proliferation, and the immune response. Additionally, gene set enrichment analysis using Gene Ontology and Medical Subject Headings databases revealed the alteration of several biological processes (FDR <= 0.01) including fat cell differentiation and lipid metabolism, regulation of extracellular signal-related kinase and mitogen-activated kinase cascades, insulin resistance, nuclear transport, membrane potential regulation, and calcium release from the endoplasmic reticulum into the cytosol. The majority of the biological processes and pathways altered in the KO dams are central for mammary gland homeostasis. Increasing peripheral serotonin in the RC dams affects specific pathways that favor lactation. Our data confirms the importance of serotonin during lactation in the mammary gland.	[Laporta, Jimena; Penagaricano, Francisco] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Penagaricano, Francisco] Univ Florida, Genet Inst, Gainesville, FL USA; [Hernandez, Laura L.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Madison	Hernandez, LL (corresponding author), Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA.	llhernandez@wisc.edu	Peñagaricano, Francisco/C-8083-2015; Laporta, Jimena/AAX-3093-2021	Peñagaricano, Francisco/0000-0001-6661-3991; Hernandez, Laura/0000-0001-7591-5203	College of Agriculture and Life Sciences, University of Wisconsin-Madison; Florida Agricultural Experiment Station; Department of Animal Sciences, University of Florida	College of Agriculture and Life Sciences, University of Wisconsin-Madison; Florida Agricultural Experiment Station; Department of Animal Sciences, University of Florida	LLH acknowledges financial support from the College of Agriculture and Life Sciences, University of Wisconsin-Madison. FP acknowledges financial support from the Florida Agricultural Experiment Station and the Department of Animal Sciences, University of Florida.	Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Angoa-Perez M, 2014, ACS CHEM NEUROSCI, V5, P908, DOI 10.1021/cn500096g; Bauman DE, 2003, ANNU REV NUTR, V23, P203, DOI 10.1146/annurev.nutr.23.011702.073408; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Casey TM, 2012, J ANIM SCI, V90, P744, DOI 10.2527/jas.2011-4590; Casey TM, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116137; Chabbi-Achengli Y, 2012, P NATL ACAD SCI USA, V109, P2567, DOI 10.1073/pnas.1117792109; Clarkson RWE, 2003, J MAMMARY GLAND BIOL, V8, P309, DOI 10.1023/B:JOMG.0000010031.53310.92; Collier RJ, 2012, DOMEST ANIM ENDOCRIN, V43, P161, DOI 10.1016/j.domaniend.2012.03.006; de las Casas-Engel M, 2014, ADV EXP MED BIOL, V824, P89, DOI 10.1007/978-3-319-07320-0_9; Derleth C, 2010, CLIN BREAST CANCER, V10, pE23, DOI 10.3816/CBC.2010.s.004; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Hernandez LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032598; Hernandez LL, 2012, AM J PHYSIOL-ENDOC M, V302, pE1009, DOI 10.1152/ajpendo.00666.2011; Hernandez LL, 2009, J ENDOCRINOL, V203, P123, DOI 10.1677/JOE-09-0187; Holtje M, 2003, J BIOL CHEM, V278, P15850, DOI 10.1074/jbc.M212816200; Horseman ND, 2014, TRENDS ENDOCRIN MET, V25, P34, DOI 10.1016/j.tem.2013.08.004; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kim K, 2015, ENDOCRINOLOGY, V156, P444, DOI 10.1210/en.2014-1687; Kirsz K, 2012, GEN COMP ENDOCR, V179, P248, DOI 10.1016/j.ygcen.2012.08.025; Kritas SK, 2014, J BIOL REG HOMEOS AG, V28, P377; Laporta J, 2013, DOMEST ANIM ENDOCRIN, V44, P176, DOI 10.1016/j.domaniend.2013.01.005; Laporta J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110190; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Marshall AM, 2014, J MAMMARY GLAND BIOL, V19, P139, DOI 10.1007/s10911-013-9304-6; Matias SL, 2014, AM J CLIN NUTR, V99, P115, DOI 10.3945/ajcn.113.073049; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Monassier L, 2010, PHARMACOL THERAPEUT, V128, P559, DOI 10.1016/j.pharmthera.2010.08.004; Morota G, 2015, ANIM GENET, V46, P381, DOI 10.1111/age.12307; Pai VP, 2008, J BIOL CHEM, V283, P30901, DOI 10.1074/jbc.M802476200; Penagaricano Francisco, 2013, Frontiers in Genetics, V3, P307, DOI 10.3389/fgene.2012.00307; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAPPORT MM, 1948, J BIOL CHEM, V176, P1237; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Shajib MS, 2015, ACTA PHYSIOL, V213, P561, DOI 10.1111/apha.12430; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsuyuzaki K, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0453-z; Uchida-Kitajima S, 2008, FEBS LETT, V582, P3037, DOI 10.1016/j.febslet.2008.07.044; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Watts SW, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.103; Watts SW, 2012, PHARMACOL REV, V64, P359, DOI 10.1124/pr.111.004697; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540	51	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140425	10.1371/journal.pone.0140425	http://dx.doi.org/10.1371/journal.pone.0140425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26470019	Green Submitted, Green Published, gold			2022-12-26	WOS:000363184600058
J	Nemeth, M; Millesi, E; Wagner, KH; Wallner, B				Nemeth, Matthias; Millesi, Eva; Wagner, Karl-Heinz; Wallner, Bernard			Sex-Specific Effects of Diets High in Unsaturated Fatty Acids on Spatial Learning and Memory in Guinea Pigs	PLOS ONE			English	Article							STRESS; CORTISOL; BRAIN; RAT; PERFORMANCE; BEHAVIOR; OXYTOCIN; LEVEL; TRANS	Unsaturated fatty acids (UFAs), including omega-3, omega-6 polyunsaturated and omega-9 monounsaturated fatty acids, are essential components and modulators of neuromembranes and may affect various aspects of physiology and cognition. UFAs are suggested to positively affect spatial learning and memory and also to diminish the negative consequences of physiological stress on cognitive abilities. Due to pronounced sex differences in neurophysiological functions, we hypothesize that these UFA-related effects might differ between male and female individuals. We therefore determined the effects of dietary UFAs on cognitive performances in a radial-Y-maze in male and female guinea pigs in relation to saliva cortisol concentrations, a marker for physiological stress. Animals were assigned to four treatment groups and maintained on diets enriched in either chia seeds (omega-3), walnuts (omega-6), or peanuts (omega-9), or a control diet. Female learning abilities throughout a three-day learning phase were positively affected by omega-3 and omega-9, as determined by a decreasing latency to pass the test and the number of conducted errors, while males generally showed distinct learning abilities, irrespective of the diet. A sex difference in learning performances was found in the control group, with males outperforming females, which was not detected in the UFA-supplemented groups. This was paralleled by significantly increased saliva cortisol concentrations in males throughout the cognition test compared to females. Three days after this learning phase, UFA-supplemented males and all females showed unchanged performances, while control males showed an increased latency and therefore an impaired performance. These results were corroborated by pronounced differences in the plasma UFA-status, corresponding to the different dietary treatments. Our findings indicate sex-specific effects of dietary UFAs, apparently enhancing spatial learning abilities only in females and protecting males from long-term memory impairment, while male learning abilities seem to be more strongly affected by an acute physiological stress response to the maze task.	[Nemeth, Matthias; Millesi, Eva; Wallner, Bernard] Univ Vienna, Dept Behav Biol, Fac Life Sci, Vienna, Austria; [Wagner, Karl-Heinz] Univ Vienna, Dept Nutr Sci, Fac Life Sci, Vienna, Austria; [Wallner, Bernard] Univ Vienna, Dept Anthropol, Fac Life Sci, Vienna, Austria	University of Vienna; University of Vienna; University of Vienna	Nemeth, M (corresponding author), Univ Vienna, Dept Behav Biol, Fac Life Sci, Vienna, Austria.	matthias.nemeth@univie.ac.at	Wallner, Bernard/B-1089-2009; Wagner, Karl-Heinz/B-9098-2013	Wagner, Karl-Heinz/0000-0002-1683-7265; Millesi, Eva/0000-0003-0740-0413	Faculty of Life Sciences, University of Vienna, Austria; Open Access Publishing Fund of the University of Vienna	Faculty of Life Sciences, University of Vienna, Austria; Open Access Publishing Fund of the University of Vienna	This study was part of an 'intrafaculty networks' research activity by the departments of Behavioural Biology, Anthropology, and Nutritional Sciences, funded by the dean's office of the Faculty of Life Sciences, University of Vienna, Austria. This article was supported by the Open Access Publishing Fund of the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo-Coblijn G, 2009, PROG LIPID RES, V48, P355, DOI 10.1016/j.plipres.2009.07.002; BEZARD J, 1994, REPROD NUTR DEV, V34, P539, DOI 10.1051/rnd:19940603; Bourre J M, 2004, J Nutr Health Aging, V8, P163; Bourre JME, 1997, J NUTR, V127, P488, DOI 10.1093/jn/127.3.488; Bowman RE, 2003, HORM BEHAV, V43, P48, DOI 10.1016/S0018-506X(02)00022-3; Brenna JT, 2011, MATERN CHILD NUTR, V7, P59, DOI 10.1111/j.1740-8709.2011.00301.x; Buchanan TW, 2001, PSYCHONEUROENDOCRINO, V26, P307, DOI 10.1016/S0306-4530(00)00058-5; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Chow C, 2013, PSYCHONEUROENDOCRINO, V38, P1236, DOI 10.1016/j.psyneuen.2012.11.007; De Rosario-Martinez H, 2013, PHIA POSTHOC INTERAC; Dringenberg HC, 2001, BEHAV BRAIN RES, V124, P97, DOI 10.1016/S0166-4328(01)00188-7; Fedorova I, 2007, PROSTAG LEUKOTR ESS, V77, P269, DOI 10.1016/j.plefa.2007.10.013; Fedorova I, 2009, BEHAV NEUROSCI, V123, P196, DOI 10.1037/a0013801; Fenske M, 1997, EXP CLIN ENDOCR DIAB, V105, P163, DOI 10.1055/s-0029-1211746; Ferraz AC, 2011, BEHAV BRAIN RES, V219, P116, DOI 10.1016/j.bbr.2010.12.028; Gamoh S, 2001, CLIN EXP PHARMACOL P, V28, P266, DOI 10.1046/j.1440-1681.2001.03437.x; Greenwood CE, 1996, BEHAV NEUROSCI, V110, P451, DOI 10.1037/0735-7044.110.3.451; Haider S, 2011, PLANT FOOD HUM NUTR, V66, P335, DOI 10.1007/s11130-011-0260-2; Harris AP, 2008, ANIM BEHAV, V76, P1579, DOI 10.1016/j.anbehav.2008.07.016; Igarashi M, 2007, J LIPID RES, V48, P1150, DOI 10.1194/jlr.M600549-JLR200; Ikemoto A, 2001, J LIPID RES, V42, P1655; Jonasson Z, 2005, NEUROSCI BIOBEHAV R, V28, P811, DOI 10.1016/j.neubiorev.2004.10.006; Lee JS, 2013, MULTIMED TOOLS APPL, V67, P31, DOI 10.1007/s11042-012-1011-6; Lewejohann L, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-9; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Machatschke IH, 2004, ETHOLOGY, V110, P161, DOI 10.1111/j.1439-0310.2004.00966.x; Machatschke IH, 2011, PHYSIOL BEHAV, V102, P311, DOI 10.1016/j.physbeh.2010.12.001; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McFadden LM, 2011, PHYSIOL BEHAV, V102, P266, DOI 10.1016/j.physbeh.2010.10.022; Millesi E, 2001, J BIOL RHYTHM, V16, P264, DOI 10.1177/074873001129001971; Naqvi AZ, 2011, J AM GERIATR SOC, V59, P837, DOI 10.1111/j.1532-5415.2011.03402.x; Nemeth M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116292; Palme R, 1997, Z SAUGETIERKD, V62, P192; Pinheiro J., 2019, NLME LINEAR NONLINEA; R Development Core Team, R A LANGUAGE AND ENV; Rabinovitz S, 2004, PSYCHONEUROENDOCRINO, V29, P113, DOI 10.1016/S0306-4530(02)00149-X; Rapoport SI, 2001, J LIPID RES, V42, P678; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Sartorius T, 2012, DIABETES, V61, P1669, DOI 10.2337/db11-1521; SINCLAIR AJ, 1975, P NUTR SOC, V34, P287, DOI 10.1079/PNS19750051; Solfrizzi V, 2006, NEUROBIOL AGING, V27, P1694, DOI 10.1016/j.neurobiolaging.2005.09.026; Sprecher H, 1995, J LIPID RES, V36, P2471; SVENNERHOLM L, 1968, J LIPID RES, V9, P570; Wagner KH, 2000, EUR FOOD RES TECHNOL, V210, P237, DOI 10.1007/s002179900080; Wallner B, 2006, BIOL RES, V39, P251, DOI 10.4067/S0716-97602006000200007; Yehuda S, 2003, WORLD REV NUTR DIET, V92, P37; Yehuda S, 2012, MED HYPOTHESES, V79, P456, DOI 10.1016/j.mehy.2012.06.021; YEHUDA S, 1993, P NATL ACAD SCI USA, V90, P10345, DOI 10.1073/pnas.90.21.10345; Yehuda S., 2005, NEUROBIOL AGING S1, V26, P98, DOI DOI 10.1016/j.neurobiolaging.2005.09.013	50	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140485	10.1371/journal.pone.0140485	http://dx.doi.org/10.1371/journal.pone.0140485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469777	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600068
J	Di Maio, D; Chandramouli, B; Brancato, G				Di Maio, Danilo; Chandramouli, Balasubramanian; Brancato, Giuseppe			Pathways and Barriers for Ion Translocation through the 5-HT(3)A Receptor Channel	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CHARGED AMINO-ACIDS; X-RAY STRUCTURES; CYS-LOOP; MOLECULAR-DYNAMICS; 5-HT3 RECEPTOR; AGONIST-BINDING; SELECTIVITY FILTER; GATING MECHANISM; 5-HYDROXYTRYPTAMINE TYPE-3	Pentameric ligand gated ion channels (pLGICs) are ionotropic receptors that mediate fast intercellular communications at synaptic level and include either cation selective (e.g., nAChR and 5-HT3) or anion selective (e.g., GlyR, GABAA and GluCl) membrane channels. Among others, 5-HT3 is one of the most studied members, since its first cloning back in 1991, and a large number of studies have successfully pinpointed protein residues critical for its activation and channel gating. In addition, 5-HT3 is also the target of a few pharmacological treatments due to the demonstrated benefits of its modulation in clinical trials. Nonetheless, a detailed molecular analysis of important protein features, such as the origin of its ion selectivity and the rather low conductance as compared to other channel homologues, has been unfeasible until the recent crystallization of the mouse 5-HT(3)A receptor. Here, we present extended molecular dynamics simulations and free energy calculations of the whole 5-HT(3)A protein with the aim of better understanding its ion transport properties, such as the pathways for ion permeation into the receptor body and the complex nature of the selectivity filter. Our investigation unravels previously unpredicted structural features of the 5-HT(3)A receptor, such as the existence of alternative intersubunit pathways for ion translocation at the interface between the extracellular and the transmembrane domains, in addition to the one along the channel main axis. Moreover, our study offers a molecular interpretation of the role played by an arginine triplet located in the intracellular domain on determining the characteristic low conductance of the 5-HT(3)A receptor, as evidenced in previous experiments. In view of these results, possible implications on other members of the superfamily are suggested.	[Di Maio, Danilo; Chandramouli, Balasubramanian; Brancato, Giuseppe] Scuola Normale Super Pisa, I-56127 Pisa, Italy	Scuola Normale Superiore di Pisa	Brancato, G (corresponding author), Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56127 Pisa, Italy.	giuseppe.brancato@sns.it	CHANDRAMOULI, BALASUBRAMANIAN/L-9556-2018; Brancato, Giuseppe/A-4346-2010; Brancato, Giuseppe/U-7083-2019	CHANDRAMOULI, BALASUBRAMANIAN/0000-0002-6837-4709; Brancato, Giuseppe/0000-0001-8059-2517	Ministero dell'Istruzione, dell'Universita e della Ricerca [RBFR10DAK6, 2012SK7ASN]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	Funded by Ministero dell'Istruzione, dell'Universita e della Ricerca through the FIRB and PRIN projects (contract no RBFR10DAK6 and no 2012SK7ASN) (GB).	Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; Beene DL, 2004, J NEUROSCI, V24, P9097, DOI 10.1523/JNEUROSCI.2429-04.2004; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; Carland JE, 2013, J BIOL CHEM, V288, P31592, DOI 10.1074/jbc.M113.503300; Cheng X, 2006, PLOS COMPUTATIONAL B, V2; Cheng XL, 2007, BIOPHYS J, V93, P2622, DOI 10.1529/biophysj.107.109843; Cheng XL, 2006, J MOL BIOL, V355, P310, DOI 10.1016/j.jmb.2005.10.039; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; Darve E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829861; Deeb TZ, 2007, J BIOL CHEM, V282, P6172, DOI 10.1074/jbc.M607698200; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Henchman RH, 2005, BIOPHYS J, V88, P2564, DOI 10.1529/biophysj.104.053934; Henin J, 2010, J CHEM THEORY COMPUT, V6, P35, DOI 10.1021/ct9004432; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ilegems E, 2005, CHEMBIOCHEM, V6, P2180, DOI 10.1002/cbic.200500191; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Ivanov I, 2007, J AM CHEM SOC, V129, P8217, DOI 10.1021/ja070778l; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2002, J GEN PHYSIOL, V119, P393, DOI 10.1085/jgp.20028552; Keramidas A, 2013, CELL MOL LIFE SCI, V70, P1241, DOI 10.1007/s00018-012-1133-z; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kozuska JL, 2014, BRIT J PHARMACOL, V171, P1617, DOI 10.1111/bph.12536; Law RJ, 2005, P NATL ACAD SCI USA, V102, P6813, DOI 10.1073/pnas.0407739102; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lemoine D, 2012, CHEM REV, V112, P6285, DOI 10.1021/cr3000829; Limapichat W, 2010, J BIOL CHEM, V285, P8976, DOI 10.1074/jbc.M109.060939; Liu XL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040019; Livesey MR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.219618; Livesey MR, 2008, J BIOL CHEM, V283, P19301, DOI 10.1074/jbc.M802406200; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Melis C, 2009, J PHYS CHEM B, V113, P12148, DOI 10.1021/jp9046962; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Paulsen IM, 2009, J NEUROCHEM, V110, P870, DOI 10.1111/j.1471-4159.2009.06180.x; Peters JA, 2010, J PHYSIOL-LONDON, V588, P587, DOI 10.1113/jphysiol.2009.183137; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Price KL, 2008, BIOCHEMISTRY-US, V47, P6370, DOI 10.1021/bi800222n; Purohit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3984; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Reeves DC, 2003, BIOPHYS J, V84, P2338, DOI 10.1016/S0006-3495(03)75039-5; Reeves DC, 2001, J BIOL CHEM, V276, P42035, DOI 10.1074/jbc.M106066200; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sullivan NL, 2006, MOL MEMBR BIOL, V23, P442, DOI 10.1080/09687860600831539; Thompson AJ, 2008, BIOPHYS J, V95, P5728, DOI 10.1529/biophysj.108.135624; Thompson AJ, 2003, BRIT J PHARMACOL, V140, P359, DOI 10.1038/sj.bjp.0705424; Thompson AJ, 2006, BIOPHYS J, V90, P1979, DOI 10.1529/biophysj.105.069385; Thompson AJ, 2005, J BIOL CHEM, V280, P20476, DOI 10.1074/jbc.M413610200; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Thompson AJ, 2006, J BIOL CHEM, V281, P16576, DOI 10.1074/jbc.M601265200; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Walstab J, 2010, PHARMACOL THERAPEUT, V128, P146, DOI 10.1016/j.pharmthera.2010.07.001; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Wang HL, 2009, BIOPHYS J, V96, P3582, DOI 10.1016/j.bpj.2009.02.020; Wotring VE, 2003, J PHYSIOL-LONDON, V548, P527, DOI 10.1113/jphysiol.2002.032045; Xu YC, 2005, J AM CHEM SOC, V127, P1291, DOI 10.1021/ja044577i; Yaffe E, 2008, NUCLEIC ACIDS RES, V36, pW210, DOI 10.1093/nar/gkn223; Yi MG, 2008, P NATL ACAD SCI USA, V105, P8280, DOI 10.1073/pnas.0710530105; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107	97	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140258	10.1371/journal.pone.0140258	http://dx.doi.org/10.1371/journal.pone.0140258			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465896	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100095
J	Ellis, S; Robinson, EJH				Ellis, Samuel; Robinson, Elva J. H.			The Role of Non-Foraging Nests in Polydomous Wood Ant Colonies	PLOS ONE			English	Article							HYMENOPTERA; MECHANISMS; EFFICIENCY; PHENOLOGY; NETWORKS	A colony of red wood ants can inhabit more than one spatially separated nest, in a strategy called polydomy. Some nests within these polydomous colonies have no foraging trails to aphid colonies in the canopy. In this study we identify and investigate the possible roles of non-foraging nests in polydomous colonies of the wood ant Formica lugubris. To investigate the role of non-foraging nests we: (i) monitored colonies for three years; (ii) observed the resources being transported between non-foraging nests and the rest of the colony; (iii) measured the amount of extra-nest activity around non-foraging and foraging nests. We used these datasets to investigate the extent to which non-foraging nests within polydomous colonies are acting as: part of the colony expansion process; hunting and scavenging specialists; brood-development specialists; seasonal foragers; or a selfish strategy exploiting the foraging effort of the rest of the colony. We found that, rather than having a specialised role, non-foraging nests are part of the process of colony expansion. Polydomous colonies expand by founding new nests in the area surrounding the existing nests. Nests founded near food begin foraging and become part of the colony; other nests are not founded near food sources and do not initially forage. Some of these non-foraging nests eventually begin foraging; others do not and are abandoned. This is a method of colony growth not available to colonies inhabiting a single nest, and may be an important advantage of the polydomous nesting strategy, allowing the colony to expand into profitable areas.	[Ellis, Samuel; Robinson, Elva J. H.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Ellis, Samuel; Robinson, Elva J. H.] Univ York, York Ctr Complex Syst Anal, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK	Ellis, S (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	se619@york.ac.uk	Ellis, Sam/AGH-4882-2022; Robinson, Elva J H/AAC-9785-2019	Robinson, Elva/0000-0003-4914-9327; Ellis, Samuel/0000-0001-9019-6040	NERC; NAtional Trust; royal society Dorothy Hodgkin fellowship; CASE	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NAtional Trust; royal society Dorothy Hodgkin fellowship(Royal Society of London); CASE	SE is supported by a NERC PhD Funding with a CASE parternetship with the NAtional Trust. EJHR is supported by a royal society Dorothy Hodgkin fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Banschbach VS, 1997, INSECT SOC, V44, P109, DOI 10.1007/s000400050034; Bargum K, 2007, P ROY SOC B-BIOL SCI, V274, P1547, DOI 10.1098/rspb.2007.0295; Bernasconi C, 2011, MYRMECOL NEWS, V14, P37; Buhl J, 2009, BEHAV ECOL SOCIOBIOL, V63, P451, DOI 10.1007/s00265-008-0680-7; Chen YH, 2013, INSECT SOC, V60, P351, DOI 10.1007/s00040-013-0300-z; Chen YP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086159, 10.1371/journal.pone.0109012, 10.1371/journal.pone.0094614]; CHERIX D, 1980, INSECT SOC, V27, P226, DOI 10.1007/BF02223666; Cherix D., 1987, Experientia Supplementum (Basel), V54, P93; Debout G, 2007, BIOL J LINN SOC, V90, P319, DOI 10.1111/j.1095-8312.2007.00728.x; Ellis S, 2014, INSECT SOC, V61, P111, DOI 10.1007/s00040-013-0337-z; Ellis S, BEHAV ECOL; Ellis S, 2014, BEHAV ECOL, V25, P1183, DOI 10.1093/beheco/aru108; GORDON DM, 1992, ECOL ENTOMOL, V17, P114, DOI 10.1111/j.1365-2311.1992.tb01167.x; Goropashnaya AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041697; Hoffmann BD, 2014, J INSECT SCI, V14, DOI 10.1673/031.014.25; HOLLDOBLER B, 1983, BIOTROPICA, V15, P241, DOI 10.2307/2387648; Holway DA, 2000, ANIM BEHAV, V59, P433, DOI 10.1006/anbe.1999.1329; Huey RB, 2001, AM NAT, V158, P204, DOI 10.1086/321314; Lanan M, 2014, MYRMECOL NEWS, V20, P53; Lange R., 1967, Zeitschrift fuer Tierpsychologie, V24, P513; MABELIS AA, 1979, NETH J ZOOL, V29, P109, DOI 10.1163/002829679X00124; MABELIS AA, 1984, NETH J ZOOL, V34, P1; Met-Office, 2015, MET OFF UK CLIM SUMM; Nakagaki T, 2004, P ROY SOC B-BIOL SCI, V271, P2305, DOI 10.1098/rspb.2004.2856; Perna A, 2008, PHYSICA A, V387, P6235, DOI 10.1016/j.physa.2008.07.019; Pratt SC, 2005, INSECT SOC, V52, P383, DOI 10.1007/s00040-005-0823-z; R Core Team, 2016, R FDN STAT COMP; Rasband WS, 1997, IMAGEJ; Robinson EJH, 2014, CURR OPIN INSECT SCI, V5, P37, DOI 10.1016/j.cois.2014.09.002; Robinson Elva J.H., 2008, Myrmecological News, V11, P1; ROSENGREN R, 1991, ANT - PLANT INTERACTIONS, P80; ROSENGREN R, 1987, ANN ZOOL FENN, V24, P147; Rosengren R., 1971, Acta Zoologica Fennica, V133, P1; Rosengren R., 1977, ACTA ZOOL FENN, V150, P2; SAVOLAINEN R, 1988, OIKOS, V51, P135, DOI 10.2307/3565636; Schultner E, 2013, BEHAV ECOL, V24, P1306, DOI 10.1093/beheco/art067; Stephens D., 2007, FORAGING BEHAV ECOLO; SUDD JH, 1983, INSECT SOC, V30, P298, DOI 10.1007/BF02223987; Sundstrom L, 2005, ANN ZOOL FENN, V42, P163; Udan RS, 2013, WIRES DEV BIOL, V2, P327, DOI 10.1002/wdev.91	41	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138321	10.1371/journal.pone.0138321	http://dx.doi.org/10.1371/journal.pone.0138321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465750	Green Published, gold, Green Accepted			2022-12-26	WOS:000363183100014
J	Hosein, S; Rodriguez-Cortes, A; Blake, DP; Allenspach, K; Alberola, J; Solano-Gallego, L				Hosein, Shazia; Rodriguez-Cortes, Alheli; Blake, Damer P.; Allenspach, Karin; Alberola, Jordi; Solano-Gallego, Laia			Transcription of Toll-Like Receptors 2, 3, 4 and 9, FoxP3 and Th17 Cytokines in a Susceptible Experimental Model of Canine Leishmania infantum Infection	PLOS ONE			English	Article							REGULATORY T-CELLS; REAL-TIME PCR; VISCERAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; MAJOR INFECTION; LYMPH-NODES; INTERFERON-GAMMA; GENE-EXPRESSION; INNATE IMMUNITY; NITRIC-OXIDE	Canine leishmaniosis (CanL) due to Leishmania infantum is a chronic zoonotic systemic disease resulting from complex interactions between protozoa and the canine immune system. Toll-like receptors (TLRs) are essential components of the innate immune system and facilitate the early detection of many infections. However, the role of TLRs in CanL remains unknown and information describing TLR transcription during infection is extremely scarce. The aim of this research project was to investigate the impact of L. infantum infection on canine TLR transcription using a susceptible model. The objectives of this study were to evaluate transcription of TLRs 2, 3, 4 and 9 by means of quantitative reverse transcription polymerase chain reaction (qRT-PCR) in skin, spleen, lymph node and liver in the presence or absence of experimental L. infantum infection in Beagle dogs. These findings were compared with clinical and serological data, parasite densities in infected tissues and transcription of IL-17, IL-22 and FoxP3 in different tissues in non-infected dogs (n = 10), and at six months (n = 24) and 15 months (n = 7) post infection. Results revealed significant down regulation of transcription with disease progression in lymph node samples for TLR3, TLR4, TLR9, IL-17, IL-22 and FoxP3. In spleen samples, significant down regulation of transcription was seen in TLR4 and IL-22 when both infected groups were compared with controls. In liver samples, down regulation of transcription was evident with disease progression for IL-22. In the skin, upregulation was seen only for TLR9 and FoxP3 in the early stages of infection. Subtle changes or down regulation in TLR transcription, Th17 cytokines and FoxP3 are indicative of the silent establishment of infection that Leishmania is renowned for. These observations provide new insights about TLR transcription, Th17 cytokines and Foxp3 in the liver, spleen, lymph node and skin in CanL and highlight possible markers of disease susceptibility in this model.	[Hosein, Shazia; Blake, Damer P.; Solano-Gallego, Laia] Univ London, Royal Vet Coll, Pathol & Pathogen Biol, N Mymms AL9 7TA, England; [Rodriguez-Cortes, Alheli; Alberola, Jordi] Univ Autonoma Barcelona, Dept Farmacol Terapeut & Toxicol, LeishLAB SAF, E-08193 Barcelona, Spain; [Allenspach, Karin] Univ London, Royal Vet Coll, Clin Sci & Serv, N Mymms AL9 7TA, England; [Solano-Gallego, Laia] Univ Autonoma Barcelona, Fac Vet, E-08193 Barcelona, Spain	University of London; University of London Royal Veterinary College; Autonomous University of Barcelona; University of London; University of London Royal Veterinary College; Autonomous University of Barcelona	Hosein, S (corresponding author), Univ London, Royal Vet Coll, Pathol & Pathogen Biol, Hawkshead Lane, N Mymms AL9 7TA, England.	shaziahosein@gmail.com; laia.solano@uab.cat	Alberola, Jordi/N-9695-2013; Solano-Gallego, Laia/H-6470-2015	Alberola, Jordi/0000-0002-1033-6339; Solano-Gallego, Laia/0000-0001-8479-4896; Blake, Damer/0000-0003-1077-2306; RODRIGUEZ-CORTES, Alheli/0000-0003-3617-0119	MSD Animal Health; Biotechnology and Biological Sciences Research Council [BB/F016891/1]; Ministerio de Ciencia e Innovacion (Spain); European Social Fund; Biotechnology and Biological Sciences Research Council [987846] Funding Source: researchfish	MSD Animal Health(Merck & CompanyIntervet International B.V.); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Social Fund(European Social Fund (ESF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by MSD Animal Health and the Biotechnology and Biological Sciences Research Council Doctoral Training Grant BB/F016891/1 awarded to Shazia Hosein. Dr. Laia Solano-Gallego holds a Ramon y Cajal senior researcher contract awarded by the Ministerio de Ciencia e Innovacion (Spain) and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MAO, 2005, VET PARASITOL, V127, P227, DOI 10.1016/j.vetpar.2004.10.010; Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Baneth G, 2008, TRENDS PARASITOL, V24, P324, DOI 10.1016/j.pt.2008.04.001; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Boaventura VS, 2010, EUR J IMMUNOL, V40, P2830, DOI 10.1002/eji.200940115; Bourreau E, 2009, INFECT IMMUN, V77, P1465, DOI 10.1128/IAI.01398-08; Carvalho LP, 2012, J IMMUNOL, V188, P1394, DOI 10.4049/jimmunol.1101018; Castilho TM, 2010, EUR J IMMUNOL, V40, P2816, DOI 10.1002/eji.201040384; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Courtenay O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002583; da Matta VLR, 2000, J CLIN LAB ANAL, V14, P5, DOI 10.1002/(SICI)1098-2825(2000)14:1&lt;5::AID-JCLA2&gt;3.0.CO;2-F; de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Ehrchen JM, 2008, INFECT IMMUN, V76, P4241, DOI 10.1128/IAI.01714-07; ELASSAD AMS, 1994, CLIN EXP IMMUNOL, V95, P294, DOI 10.1111/j.1365-2249.1994.tb06526.x; Engwerda CR, 2000, IMMUNOL TODAY, V21, P73, DOI 10.1016/S0167-5699(99)01549-2; Figueiredo MM, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-22; Figueiredo MM, 2014, INFECT IMMUN, V82, P3704, DOI 10.1128/IAI.01862-14; Flandin JF, 2006, EUR J IMMUNOL, V36, P411, DOI 10.1002/eji.200535079; Francino O, 2006, VET PARASITOL, V137, P214, DOI 10.1016/j.vetpar.2006.01.011; Gallego C, 2011, INFECT IMMUN; Garden OA, 2011, INT IMMUNOPHARMACOL, V11, P576, DOI 10.1016/j.intimp.2010.11.003; Ghosh K, 2013, J INFECT DIS, V207, P1016, DOI 10.1093/infdis/jis771; Cezario GAG, 2011, MEM I OSWALDO CRUZ, V106, P573, DOI 10.1590/S0074-02762011000500010; Gonzalez-Lombana C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003243; Holzmuller P, 2005, VET IMMUNOL IMMUNOP, V106, P247, DOI 10.1016/j.vetimm.2005.03.001; House AK, 2008, VET IMMUNOL IMMUNOP, V124, P230, DOI 10.1016/j.vetimm.2008.03.012; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Katara GK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001171; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kostka SL, 2009, J IMMUNOL, V182, P3039, DOI 10.4049/jimmunol.0713598; Kropf P, 2004, INFECT IMMUN, V72, P1920, DOI 10.1128/IAI.72.4.1920-1928.2004; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Kumar R, 2014, PARASITE IMMUNOL, V36, P721, DOI 10.1111/pim.12145; Liese J, 2007, EUR J IMMUNOL, V37, P3424, DOI 10.1002/eji.200737182; Nascimento MSL, 2015, J INFECT DIS, V211, P1015, DOI 10.1093/infdis/jiu531; Maia C, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/541571; Maia C, 2010, ACTA TROP, V116, P193, DOI 10.1016/j.actatropica.2010.08.001; Melo GD, 2014, PARASITE IMMUNOL; Melo LM, 2014, INT IMMUNOPHARMACOL, V18, P373, DOI 10.1016/j.intimp.2013.12.012; Menezes-Souza D, 2011, VET PARASITOL, V177, P39, DOI 10.1016/j.vetpar.2010.11.025; Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4; Nylen S, 2010, J GLOB INFECT DIS, V2, P135, DOI 10.4103/0974-777X.62876; Silva KLO, 2014, VET PARASITOL, V202, P313, DOI 10.1016/j.vetpar.2014.03.010; ONEIL CE, 1993, AM J TROP MED HYG, V49, P181, DOI 10.4269/ajtmh.1993.49.181; PENG Z, 1991, J IMMUNOL METHODS, V145, P255, DOI 10.1016/0022-1759(91)90335-D; Peters IR, 2007, VET IMMUNOL IMMUNOP, V117, P55, DOI 10.1016/j.vetimm.2007.01.011; Peters N, 2006, IMMUNOL REV, V213, P159, DOI 10.1111/j.1600-065X.2006.00432.x; Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813; Rai AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031551; Raman VS, 2010, J IMMUNOL, V185, P1701, DOI 10.4049/jimmunol.1000238; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; Rica-Capela MJ, 2003, PARASITOL RES, V89, P163, DOI 10.1007/s00436-002-0738-9; Riera C, 1999, VET PARASITOL, V84, P33, DOI 10.1016/S0304-4017(99)00084-9; Rodrigues OR, 2009, IMMUNOBIOLOGY, V214, P101, DOI 10.1016/j.imbio.2008.07.001; Rodriguez A, 2006, J VET INTERN MED, V20, P495, DOI 10.1892/0891-6640(2006)20[495:DOLIII]2.0.CO;2; Rodriguez-Cortes A, 2007, INT J PARASITOL, V37, P683, DOI 10.1016/j.ijpara.2006.11.007; Rodriguez-Cortes A, 2007, VET IMMUNOL IMMUNOP, V116, P190, DOI 10.1016/j.vetimm.2007.01.015; Rodriguez-Cortes A, 2010, AM J TROP MED HYG, V82, P251, DOI 10.4269/ajtmh.2010.09-0366; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Sano J, 2005, RES VET SCI, V78, P183, DOI 10.1016/j.rvsc.2004.07.008; Santos-Gomes GM, 2002, VET IMMUNOL IMMUNOP, V88, P21, DOI 10.1016/S0165-2427(02)00134-4; Schmitz S, 2012, VET IMMUNOL IMMUNOP, V146, P87, DOI 10.1016/j.vetimm.2012.01.013; Solano-Gallego L, 2001, J CLIN MICROBIOL, V39, P560, DOI 10.1128/JCM.39.2.560-563.2001; Solano-Gallego L, 2009, VET PARASITOL, V165, P1, DOI 10.1016/j.vetpar.2009.05.022; Strauss-Ayali D, 2004, J INFECT DIS, V189, P1729, DOI 10.1086/383281; Tiwananthagorn S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001798; Tolouei S, 2013, SCAND J IMMUNOL, V78, P478, DOI 10.1111/sji.12105; Travi BL, 2001, AM J TROP MED HYG, V64, P119, DOI 10.4269/ajtmh.2001.64.119; Tuon FF, 2010, PARASITE IMMUNOL, V32, P769, DOI 10.1111/j.1365-3024.2010.01243.x; Tuon FF, 2008, INFECT IMMUN, V76, P866, DOI 10.1128/IAI.01090-07; Vargas-Inchaustegui DA, 2009, INFECT IMMUN, V77, P2948, DOI 10.1128/IAI.00154-09; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wood SH, 2008, VET IMMUNOL IMMUNOP, V126, P392, DOI 10.1016/j.vetimm.2008.08.006	75	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140325	10.1371/journal.pone.0140325	http://dx.doi.org/10.1371/journal.pone.0140325			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465878	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100103
J	Lamoke, F; Shaw, S; Yuan, JH; Ananth, S; Duncan, M; Martin, P; Bartoli, M				Lamoke, Folami; Shaw, Sean; Yuan, Jianghe; Ananth, Sudha; Duncan, Michael; Martin, Pamela; Bartoli, Manuela			Increased Oxidative and Nitrative Stress Accelerates Aging of the Retinal Vasculature in the Diabetic Retina	PLOS ONE			English	Article							NF-KAPPA-B; PIGMENT EPITHELIUM-CELLS; PREMATURE SENESCENCE; CELLULAR SENESCENCE; DNA-DAMAGE; ENDOTHELIAL DYSFUNCTION; SECRETORY PHENOTYPE; NITROSATIVE STRESS; HYDROGEN-PEROXIDE; PROTEIN-KINASE	Hyperglycemia-induced retinal oxidative and nitrative stress can accelerate vascular cell aging, which may lead to vascular dysfunction as seen in diabetes. There is no information on whether this may contribute to the progression of diabetic retinopathy (DR). In this study, we have assessed the occurrence of senescence-associated markers in retinas of streptozotocin-induced diabetic rats at 8 and 12 weeks of hyperglycemia as compared to normoglycemic aging (12 and 14 months) and adult (4.5 months) rat retinas. We have found that in the diabetic retinas there was an up-regulation of senescence-associated markers SA-beta-Gal, p16(INK4a) and miR34a, which correlated with decreased expression of SIRT1, a target of miR34a. Expression of senescence-associated factors primarily found in retinal microvasculature of diabetic rats exceeded levels measured in adult and aging rat retinas. In aging rats, retinal expression of senescence associated-factors was mainly localized at the level of the retinal pigmented epithelium and only minimally in the retinal microvasculature. The expression of oxidative/nitrative stress markers such as 4-hydroxynonenal and nitrotyrosine was more pronounced in the retinal vasculature of diabetic rats as compared to normoglycemic aging and adult rat retinas. Treatments of STZ-rats with the anti-nitrating drug FeTPPS (10mg/Kg/day) significantly reduced the appearance of senescence markers in the retinal microvasculature. Our results demonstrate that hyperglycemia accelerates retinal microvascular cell aging whereas physiological aging affects primarily cells of the retinal pigmented epithelium. In conclusion, hyperglycemia-induced retinal vessel dysfunction and DR progression involve vascular cell senescence due to increased oxidative/nitrative stress.	[Lamoke, Folami; Shaw, Sean; Yuan, Jianghe; Bartoli, Manuela] Georgia Regents Univ, Med Coll Georgia, Dept Ophthalmol, Augusta, GA 30912 USA; [Lamoke, Folami; Ananth, Sudha; Martin, Pamela] Georgia Regents Univ, Dept Biochem & Mol Biol, Med Coll Georgia, Augusta, GA USA; [Duncan, Michael] Georgia Regents Univ, Sect Gastroenterol Hepatol, Dept Med, Med Coll Georgia, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Bartoli, M (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Ophthalmol, Augusta, GA 30912 USA.	mbartoli@gru.edu			National Eye Institute Predoctoral Individual National Research Service Award [F31EY022289]; National Eye Institute Research Project Grant [(R01) EY220416]; NATIONAL EYE INSTITUTE [F31EY022289, R01EY022704, R01EY022416] Funding Source: NIH RePORTER	National Eye Institute Predoctoral Individual National Research Service Award; National Eye Institute Research Project Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Eye Institute F31EY022289 Predoctoral Individual National Research Service Award given to Folami Lamoke, Ph.D. and by the National Eye Institute Research Project Grant (R01) EY220416 awarded to Manuela Bartoli, Ph.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams T, 2010, EXP EYE RES, V90, P368, DOI 10.1016/j.exer.2009.10.002; Al-Hussaini H, 2008, MOL VIS, V14, P1784; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3239, DOI 10.1167/iovs.08-1755; Arend N, 2015, OPHTHALMOLOGICA, V234, P73, DOI 10.1159/000381726; Arora M, 2008, EUR J PHARMACOL, V596, P77, DOI 10.1016/j.ejphar.2008.08.003; Austad SN, 2009, J GERONTOL A-BIOL, V64, P199, DOI 10.1093/gerona/gln060; Avogaro A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000262; Badi I, 2015, J GERONTOL A-BIOL, V70, P1304, DOI 10.1093/gerona/glu180; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Bhayadia R, 2016, J GERONTOL A-BIOL, V71, P161, DOI 10.1093/gerona/glv008; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P729, DOI 10.1016/j.bbadis.2011.12.003; Caldwelll RB, 2003, DIABETES-METAB RES, V19, P442, DOI 10.1002/dmrr.415; Chen J, 2002, CIRC RES, V90, P1290, DOI 10.1161/01.RES.0000022161.42655.98; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chen QM, 2000, BIOGERONTOLOGY, V1, P335, DOI 10.1023/A:1026590501344; Chen SL, 2003, AM J PHYSIOL-ENDOC M, V284, pE1089, DOI 10.1152/ajpendo.00540.2002; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021; Donato AJ, 2014, J PHYSIOL-LONDON, V592, P4083, DOI 10.1113/jphysiol.2014.274175; El Assar M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00132; El-Remessy AB, 2007, FASEB J, V21, P2528, DOI 10.1096/fj.06-7854com; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Gano LB, 2014, AM J PHYSIOL-HEART C, V307, pH1754, DOI 10.1152/ajpheart.00377.2014; Hanna MA, 2014, J APPL PHYSIOL, V117, P616, DOI 10.1152/japplphysiol.01296.2013; Herbert KE, 2008, CIRC RES, V102, P201, DOI 10.1161/CIRCRESAHA.107.158626; Hunten S, 2015, MOL CELL PROTEOMICS, V14, P2609, DOI 10.1074/mcp.M115.050237; Hyland P, 2001, MECH AGEING DEV, V122, P1151, DOI 10.1016/S0047-6374(01)00254-8; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Kokkinopoulos I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018921; Kubota S, 2011, INVEST OPHTH VIS SCI, V52, P9142, DOI 10.1167/iovs.11-8041; Lamoke F, 2011, EXP EYE RES, V93, P350, DOI 10.1016/j.exer.2011.02.007; Lasta M, 2013, INVEST OPHTH VIS SCI, V54, P842, DOI 10.1167/iovs.12-10873; Mortuza R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054514; Obrosova IG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1645, DOI 10.1152/ajpendo.00479.2007; Pacher P, 2005, CURR MED CHEM, V12, P267, DOI 10.2174/0929867053363207; Park HYL, 2011, BRIT J OPHTHALMOL, V95, P1223, DOI 10.1136/bjo.2010.191841; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Rippo MR, 2014, EXP GERONTOL, V56, P154, DOI 10.1016/j.exger.2014.03.002; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Rodriguez-Manas L, 2009, AGING CELL, V8, P226, DOI 10.1111/j.1474-9726.2009.00466.x; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Servillo L, 2013, J CELL BIOCHEM, V114, P2522, DOI 10.1002/jcb.24598; Simo R, 2014, TRENDS ENDOCRIN MET, V25, P23, DOI 10.1016/j.tem.2013.09.005; Sivaprasad S, 2012, SURV OPHTHALMOL, V57, P347, DOI 10.1016/j.survophthal.2012.01.004; Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5; Steinle JJ, 2009, J GERONTOL A-BIOL, V64, P325, DOI 10.1093/gerona/gln052; STITT AW, 1995, BRIT J OPHTHALMOL, V79, P362, DOI 10.1136/bjo.79.4.362; Sun S, 2015, EXP BIOL MED, V240, P1606, DOI 10.1177/1535370215587914; Suzuki E, 2013, SCI WORLD J, DOI 10.1155/2013/754735; Tabuchi T, 2012, CLIN SCI, V123, P161, DOI 10.1042/CS20110563; Tremolada G, 2012, EXP DIABETES RES, DOI 10.1155/2012/728325; Venkatesh D, 2011, ARTERIOSCL THROM VAS, V31, P876, DOI 10.1161/ATVBAHA.110.221945; Wang S, 2012, CURR DIABETES REP, V12, P355, DOI 10.1007/s11892-012-0289-0; Yang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046364; Yoshida Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100359; Zhong Q, 2013, INVEST OPHTH VIS SCI, V54, P3941, DOI 10.1167/iovs.13-11598; Zhong WL, 2010, DIABETES RES CLIN PR, V89, P38, DOI 10.1016/j.diabres.2010.03.013; Zhu K, 2015, FREE RADICAL BIO MED, V83, P21, DOI 10.1016/j.freeradbiomed.2015.02.009; Zhu Y, 2014, CURR OPIN CLIN NUTR, V17, P324, DOI 10.1097/MCO.0000000000000065; Zou HF, 2011, MECH AGEING DEV, V132, P533, DOI 10.1016/j.mad.2011.11.001	65	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139664	10.1371/journal.pone.0139664	http://dx.doi.org/10.1371/journal.pone.0139664			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466127	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100056
J	Lin, HYH; Hung, CC; Chang, YH; Lin, MY; Yang, MY; Liang, SS; Liu, WT; Chen, HC; Hwang, SJ				Lin, Hugo You-Hsien; Hung, Chi-Chih; Chang, Yu-Han; Lin, Ming-Yen; Yang, Ming-Yu; Liang, Shih-Shin; Liu, Wangta; Chen, Hung-Chun; Hwang, Shang-Jyh			Nonapnea Sleep Disorders in Patients Younger than 65 Years Are Significantly Associated with CKD: A Nationwide Population-Based Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; C-REACTIVE PROTEIN; HIGH PREVALENCE; BLOOD-PRESSURE; UNITED-STATES; WAKE CYCLE; APNEA; RISK; INSOMNIA	Background Nonapnea sleep disorders (NASD) and sleep-related problems are associated with poor health outcomes. However, the association between NASD and the development and prognosis of chronic kidney disease (CKD) has not been investigated thoroughly. We explored the association between CKD and NASD in Taiwan. Methods We conducted a population-based study using the Taiwan National Health Insurance database with 1,000,000 representative data for the period from January 1, 2000 to December 31, 2009. We investigated the incidence and risk of CKD in 7,006 newly diagnosed NASD cases compared with 21,018 people without NASD matched according to age, sex, index year, urbanization, region, and monthly income at a 1:3 ratio. Results The subsequent risk of CKD was 1.48-foldhigher in the NASD cohort than in the control cohort (95% confidence interval [CI] = 1.26-1.73, p<0.001). Men, older age, type 2 diabetes mellitus, and gout were significant factors associated with the increased risk of CKD (p<0.001). Among different types of NASDs, patients with insomnia had a 52% increased risk of developing CKD (95% CI = 1.23-1.84; P<0.01), whereas patients with sleep disturbance had a 49% increased risk of subsequent CKD (95% CI = 1.19-1.87; P<0.001). Younger women (aged < 65 years) were at a high risk of CKD with NASD (adjusted hazard ratio, [HR] = 1.81; 95% CI = 1.35-2.40, p<0.001). Conclusions In this nationwide population-based cohort study, patients with NASD, particularly men of all ages and women aged younger than 65 years, were at high risk of CKD.	[Lin, Hugo You-Hsien; Hung, Chi-Chih; Lin, Ming-Yen; Chen, Hung-Chun; Hwang, Shang-Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Hugo You-Hsien; Chang, Yu-Han] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Hugo You-Hsien; Hwang, Shang-Jyh] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Yang, Ming-Yu] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Liang, Shih-Shin; Liu, Wangta] Kaohsiung Med Univ, Coll Life Sci, Dept Biotechnol, Kaohsiung, Taiwan; [Chen, Hung-Chun; Hwang, Shang-Jyh] Kaohsiung Med Univ, Fac Renal Care, Coll Med, Kaohsiung, Taiwan; [Hwang, Shang-Jyh] Natl Hlth Res Inst, Inst Populat Sci, Miaoli, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University; National Health Research Institutes - Taiwan	Hwang, SJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan.	sjhwang@kmu.edu.tw	Lin, Ming Yen/A-8637-2010	Lin, Ming Yen/0000-0002-8194-4833; Liang, Shih-Shin/0000-0003-1437-177X				Agarwal R, 2011, CLIN J AM SOC NEPHRO, V6, P1258, DOI 10.2215/CJN.10581110; Agarwal R, 2009, NEPHROL DIAL TRANSPL, V24, P2400, DOI 10.1093/ndt/gfp074; Benz RL, 2000, AM J KIDNEY DIS, V35, P1052, DOI 10.1016/S0272-6386(00)70039-4; BRANDENBERGER G, 1994, J HYPERTENS, V12, P277; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Charloux A, 1999, AM J PHYSIOL-ENDOC M, V276, pE43, DOI 10.1152/ajpendo.1999.276.1.E43; Chung WS, 2013, SLEEP, V36, P1963, DOI 10.5665/sleep.3240; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Hanly P, 2004, SEMIN DIALYSIS, V17, P109, DOI 10.1111/j.0894-0959.2004.17206.x; Huang ST, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000429; Iseki K, 2008, HYPERTENS RES, V31, P249, DOI 10.1291/hypres.31.249; Jalal DI, 2013, AM J KIDNEY DIS, V61, P134, DOI 10.1053/j.ajkd.2012.07.021; KLINK M, 1987, CHEST, V91, P540, DOI 10.1378/chest.91.4.540; Knutson KL, 2009, ARCH INTERN MED, V169, P1055, DOI 10.1001/archinternmed.2009.119; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Massy ZA, 2013, KIDNEY INT, V84, P451, DOI 10.1038/ki.2013.181; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Morphy H, 2007, SLEEP, V30, P274; Murck H, 2006, PHARMACOPSYCHIATRY, V39, P23, DOI 10.1055/s-2006-931476; Narkiewicz K, 1998, CIRCULATION, V98, P1071, DOI 10.1161/01.CIR.98.11.1071; Neumann J, 2004, KIDNEY INT, V65, P1568, DOI 10.1111/j.1523-1755.2004.00552.x; Ohkuma T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078968; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Plantinga L, 2011, AM J KIDNEY DIS, V58, P554, DOI 10.1053/j.ajkd.2011.05.024; Prabhakar NR, 2002, AM J RESP CRIT CARE, V165, P859, DOI 10.1164/ajrccm.165.7.2202030c; Roddy E, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-119; Roumelioti ME, 2010, NEPHROL DIAL TRANSPL, V25, P3733, DOI 10.1093/ndt/gfq234; Sakaguchi Y, 2011, CLIN J AM SOC NEPHRO, V6, P995, DOI 10.2215/CJN.08670910; Sauvet F, 2010, J APPL PHYSIOL, V108, P68, DOI 10.1152/japplphysiol.00851.2009; Shamsuzzaman ASM, 2002, CIRCULATION, V105, P2462, DOI 10.1161/01.CIR.0000018948.95175.03; Shankar A, 2011, KIDNEY INT, V80, P1231, DOI 10.1038/ki.2011.283; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Stenvinkel P, 2013, J AM SOC NEPHROL, V24, P1727, DOI 10.1681/ASN.2013040330; TM C, 6 COUNTRIES 6 REFORM, P71; Tochikubo O, 1996, HYPERTENSION, V27, P1318, DOI 10.1161/01.HYP.27.6.1318; Turner JM, 2012, KIDNEY INT, V81, P351, DOI 10.1038/ki.2011.380; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; WEYERER S, 1991, SLEEP, V14, P392; Xu Q, 2010, DIABETES CARE, V33, P78, DOI 10.2337/dc09-1143	43	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140401	10.1371/journal.pone.0140401	http://dx.doi.org/10.1371/journal.pone.0140401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466096	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100112
J	Ruschioni, S; van Loon, JJA; Smid, HM; van Lenteren, JC				Ruschioni, Sara; van Loon, Joop J. A.; Smid, Hans M.; van Lenteren, Joop C.			Insects Can Count: Sensory Basis of Host Discrimination in Parasitoid Wasps Revealed	PLOS ONE			English	Article							TRIALEURODES-VAPORARIORUM HOMOPTERA; ENCARSIA-FORMOSA HYMENOPTERA; PSEUDEUCOILA-BOCHEI; EVOLUTIONARY ARGUMENT; SUPERPARASITISM; OVIPOSITION; APHELINIDAE; BRACONIDAE; SELECTION; BEHAVIOR	The solitary parasitoid Leptopilina heterotoma is one of the best studied organisms concerning the ecology, behaviour and physiology of host discrimination. Behavioural evidence shows that L. heterotoma uses its ovipositor to discriminate not only between parasitized and unparasitized Drosophila melanogaster larvae, but also to discriminate between hosts with different numbers of parasitoid eggs. The existing knowledge about how and when the parasitoid marks the host motivated us to unravel the chemosensory basis of host discrimination by L. heterotoma that allows it to choose the "best" host available. In this paper we report on electrophysiological recordings of multi-neural responses from the single taste sensillum on the tip of the unpaired ovipositor valve. We stimulated this sensillum with haemolymph of unparasitized, one-time-parasitized and two-times-parasitized Drosophila larvae. We demonstrate for the first time that quantitative characteristics of the neural responses to these haemolymph samples differed significantly, implying that host discrimination is encoded by taste receptor neurons in the multi-neuron coeloconic ovipositor sensillum. The activity of three of the six neurons present in the sensillum suffices for host discrimination and support the hypothesis that L. heterotoma females employ an ensemble code of parasitization status of the host.	[Ruschioni, Sara; van Loon, Joop J. A.; Smid, Hans M.; van Lenteren, Joop C.] Wageningen Univ, Entomol Lab, NL-6700 AP Wageningen, Netherlands; [Ruschioni, Sara] Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambiental, Ancona, Italy; [van Lenteren, Joop C.] Univ Sao Paolo, Dept Entomol & Acarol, ESALQ, Lab Chem Ecol & Insect Behav, Piracicaba, SP, Brazil	Wageningen University & Research; Marche Polytechnic University; Universidade de Sao Paulo	Ruschioni, S (corresponding author), Wageningen Univ, Entomol Lab, NL-6700 AP Wageningen, Netherlands.	sara.ruschioni@hotmail.it	van Lenteren, Joop/J-1748-2014; van Loon, Joop J.A./B-3744-2009	van Lenteren, Joop/0000-0003-3620-1392; van Loon, Joop J.A./0000-0002-4260-0501; Smid, Hans/0000-0001-5867-2799	Wageningen University; Universita Politecnica delle Marche	Wageningen University(European Commission); Universita Politecnica delle Marche	This work was supported by Wageningen University (http://www.wageningenur.nl/en.htm) and Universita Politecnica delle Marche.	Anderson P, 2002, CHEMOECOLOGY OF INSECT EGGS AND EGG DEPOSITION, P235; Bakker K., 1961, Archives Neerlandaises de Zoologie Leiden, V14, P200; BAKKER K, 1967, ENTOMOL EXP APPL, V10, P295, DOI 10.1007/BF00430053; BAKKER K, 1985, OECOLOGIA, V67, P572, DOI 10.1007/BF00790029; BAKKER K, 1972, OECOLOGIA, V10, P29, DOI 10.1007/BF00822760; Bell HA, 2005, J EXP BIOL, V208, P3199, DOI 10.1242/jeb.01759; Boivin G, 2000, ECOL LETT, V3, P469, DOI 10.1046/j.1461-0248.2000.00174.x; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; FRANSEN JJ, 1993, ENTOMOL EXP APPL, V69, P239, DOI 10.1007/BF02381996; FRANSEN JJ, 1987, J APPL ENTOMOL, V103, P55, DOI 10.1111/j.1439-0418.1987.tb00960.x; Gandon S, 2006, AM NAT, V167, pE1, DOI 10.1086/498398; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; HOLMES H B, 1972, Entomophaga, V17, P79, DOI 10.1007/BF02371075; IKAWA T, 1982, APPL ENTOMOL ZOOL, V17, P119, DOI 10.1303/aez.17.119; KAINOH Y, 1988, J CHEM ECOL, V14, P1475, DOI 10.1007/BF01012419; Kainoh Y, 1999, PHEROMONES OF NON-LEPIDOPTERAN INSECTS ASSOCIATED WITH AGRICULTURAL PLANTS, P383; Keasar T, 2006, ECOL ENTOMOL, V31, P277, DOI 10.1111/j.1365-2311.2006.00788.x; LEMASURIER AD, 1990, ENTOMOL EXP APPL, V54, P65, DOI 10.1007/BF00353988; LERALEC A, 1990, ENTOMOPHAGA, V35, P293, DOI 10.1007/BF02374805; Meunier N, 2003, CHEM SENSES, V28, P671, DOI 10.1093/chemse/bjg059; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; NELL HW, 1976, Z ANGEW ENTOMOL, V81, P372; NETTLES WC, 1983, ENTOMOL EXP APPL, V33, P283, DOI 10.1111/j.1570-7458.1983.tb03270.x; Nufio CR, 2001, ENTOMOL EXP APPL, V99, P273, DOI 10.1023/A:1019204817341; Plantegenest M, 2004, J ANIM ECOL, V73, P802, DOI 10.1111/j.0021-8790.2004.00844.x; Prokopy Ronald J., 1993, P308; Qin J. D., 1988, Colloques de l'INRA, P379; Quicke D., 1999, RENDICONTI, V47, P197; RAJENDRAM GF, 1978, ANN ENTOMOL SOC AM, V71, P92, DOI 10.1093/aesa/71.1.92; Rosenheim JA, 1996, EVOLUTION, V50, P2089, DOI 10.1111/j.1558-5646.1996.tb03595.x; SALT GEORGE, 1961, SYMPOSIA SOC EXPTL BIOL, V15, P96; Santolamazza-Carbone S, 2004, BIOL CONTROL, V29, P24, DOI 10.1016/S1049-9644(03)00134-8; Sevenster JG, 1998, EVOLUTION, V52, P1241, DOI [10.2307/2411256, 10.1111/j.1558-5646.1998.tb01853.x]; Stitt JP, 1998, CHEM SENSES, V23, P531, DOI 10.1093/chemse/23.5.531; Strand M.R., 1986, P97; TILDEN RL, 1988, ANN ENTOMOL SOC AM, V81, P152, DOI 10.1093/aesa/81.1.152; UENO T, 1994, ANIM BEHAV, V47, P988, DOI 10.1006/anbe.1994.1134; van Baaren J, 1998, BEHAV ECOL SOCIOBIOL, V42, P9, DOI 10.1007/s002650050406; Van Baaren J, 1999, FUNCT ECOL, V13, P66, DOI 10.1046/j.1365-2435.1999.00283.x; Van Lenteren J.C., 1972, Netherlands J Zool, V22, P347; van Lenteren J.C., 1981, P153; Van Lenteren J.C., 1975, NETHERLANDS J ZOOL, V26, P1, DOI DOI 10.1163/002829676X00055; van Lenteren JC, 1998, INT J INSECT MORPHOL, V27, P263, DOI 10.1016/S0020-7322(98)00019-1; Van Lenteren Joop C., 2000, Atti della Accademia Nazionale Italiana di Entomologia Rendiconti, V47, P265; van Lenteren JC, 2007, ARTHROPOD STRUCT DEV, V36, P271, DOI 10.1016/j.asd.2007.02.001; Van Loon J.J.A., 2008, INSECT TASTE, V63, P103; VANALPHEN JJM, 1990, ANNU REV ENTOMOL, V35, P59, DOI 10.1146/annurev.en.35.010190.000423; VANDIJKEN MJ, 1987, ENTOMOL EXP APPL, V43, P183, DOI 10.1007/BF00301751; VANLENTEREN JC, 1976, ENTOMOL EXP APPL, V20, P123, DOI 10.1111/j.1570-7458.1976.tb02624.x; VANLENTEREN JC, 1991, NETH J ZOOL, V41, P144; VANLENTEREN JC, 1980, Z ANGEW ENTOMOL, V89, P442; VANLENTEREN JC, 1975, NATURE, V254, P417, DOI 10.1038/254417a0; VINSON S B, 1972, Entomophaga, V17, P241, DOI 10.1007/BF02371134; VINSON SB, 1980, ANNU REV ENTOMOL, V25, P397, DOI 10.1146/annurev.en.25.010180.002145; Vinson SB, 1998, BIOL CONTROL, V11, P79, DOI 10.1006/bcon.1997.0601; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; WERREN JH, 1984, NETH J ZOOL, V34, P123, DOI 10.1163/002829684X00100; WU ZX, 1982, ACTA ENTOMOL SINICA, V25, P363	60	23	23	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138045	10.1371/journal.pone.0138045	http://dx.doi.org/10.1371/journal.pone.0138045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466380	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100010
J	White, D; Dunn, JD; Schmid, AC; Kemp, RI				White, David; Dunn, James D.; Schmid, Alexandra C.; Kemp, Richard I.			Error Rates in Users of Automatic Face Recognition Software	PLOS ONE			English	Article							PEOPLE; IMAGES; PERFORMANCE; BIOMETRICS; QUALITY; VIDEO	In recent years, wide deployment of automatic face recognition systems has been accompanied by substantial gains in algorithm performance. However, benchmarking tests designed to evaluate these systems do not account for the errors of human operators, who are often an integral part of face recognition solutions in forensic and security settings. This causes a mismatch between evaluation tests and operational accuracy. We address this by measuring user performance in a face recognition system used to screen passport applications for identity fraud. Experiment 1 measured target detection accuracy in algorithm-generated 'candidate lists' selected from a large database of passport images. Accuracy was notably poorer than in previous studies of unfamiliar face matching: participants made over 50% errors for adult target faces, and over 60% when matching images of children. Experiment 2 then compared performance of student participants to trained passport officers-who use the system in their daily work-and found equivalent performance in these groups. Encouragingly, a group of highly trained and experienced "facial examiners" outperformed these groups by 20 percentage points. We conclude that human performance curtails accuracy of face recognition systems-potentially reducing benchmark estimates by 50% in operational settings. Mere practise does not attenuate these limits, but superior performance of trained examiners suggests that recruitment and selection of human operators, in combination with effective training and mentorship, can improve the operational accuracy of face recognition systems.	[White, David; Dunn, James D.; Kemp, Richard I.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Schmid, Alexandra C.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney	White, D (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	david.white@unsw.edu.au	White, David/AAS-9824-2021; White, David/B-5883-2008	White, David/0000-0002-6366-2699; Kemp, Richard/0000-0003-2819-265X; Dunn, James/0000-0002-6964-909X	Australian Research Council [LP110100448, LP130100702]	Australian Research Council(Australian Research Council)	This research was supported by Australian Research Council grants to Kemp (LP110100448, LP130100702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenezi HM, 2013, APPL COGNITIVE PSYCH, V27, P735, DOI 10.1002/acp.2968; [Anonymous], 2007, 10000 PASSP GO FRAUS; [Anonymous], 2014, 8009 NIST; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; Burton AM, 2010, BEHAV RES METHODS, V42, P286, DOI 10.3758/BRM.42.1.286; Burton AM, 1999, PSYCHOL SCI, V10, P243, DOI 10.1111/1467-9280.00144; Chakravarty MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020241; Davis JP, 2009, APPL COGNITIVE PSYCH, V23, P482, DOI 10.1002/acp.1490; Dowsett AJ, 2015, BRIT J PSYCHOL, V106, P433, DOI 10.1111/bjop.12103; Dror i.E., 2010, LAW PROBAB RISK, V9, P47, DOI DOI 10.1093/LPR/MGP031; Dror IE, 2012, J FORENSIC SCI, V57, P343, DOI 10.1111/j.1556-4029.2011.02013.x; Facial Identification Scientific Working Group, 2011, GUID REC FAC COMP TR; Ferrario VF, 1999, AM J ORTHOD DENTOFAC, V116, P215, DOI 10.1016/S0889-5406(99)70220-9; Graves I, 2011, STUD COMPUT INTELL, V338, P147; Heyer R, 2013, J APPL RES MEM COGN, V2, P68, DOI 10.1016/j.jarmac.2013.01.008; Jain AK, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0254; Jain AK, 2012, IEEE MULTIMEDIA, V19, P20, DOI 10.1109/MMUL.2012.4; Kemp R, 1997, APPL COGNITIVE PSYCH, V11, P211; Klare BF, 2012, IEEE T INF FOREN SEC, V7, P1789, DOI 10.1109/TIFS.2012.2214212; Ling HB, 2007, IEEE I CONF COMP VIS, P1887; Megreya AM, 2006, MEM COGNITION, V34, P865, DOI 10.3758/BF03193433; Megreya AM, 2013, APPL COGNITIVE PSYCH, V27, P700, DOI 10.1002/acp.2965; Megreya AM, 2011, Q J EXP PSYCHOL, V64, P1473, DOI 10.1080/17470218.2011.575228; Norell K, 2015, J FORENSIC SCI, V60, P331, DOI 10.1111/1556-4029.12660; O'Toole AJ, 2012, ACM T APPL PERCEPT, V9, DOI 10.1145/2355598.2355599; Papesh MH, 2014, ATTEN PERCEPT PSYCHO, V76, P1335, DOI 10.3758/s13414-014-0630-6; Phillips PJ, 2014, IMAGE VISION COMPUT, V32, P74, DOI 10.1016/j.imavis.2013.12.002; Phillips PJ, 2011, ACM T APPL PERCEPT, V8, DOI 10.1145/1870076.1870082; Photograph Guidelines, 2012, PHOT GUID; Ricanek K, 2006, PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION - PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE, P341; Russell R, 2009, PSYCHON B REV, V16, P252, DOI 10.3758/PBR.16.2.252; Spaun NA, 2009, LECT NOTES COMPUT SC, V5558, P161, DOI 10.1007/978-3-642-01793-3_17; Sternberg RJ, 1996, ROAD TO EXCELLENCE, P347; Towler A, 2014, PERCEPTION, V43, P214, DOI 10.1068/p7676; US Government Accountability Office State Department, 2010, UND TESTS SHOW PASSP; White D, 2015, P ROY SOC B-BIOL SCI, V282, P73, DOI 10.1098/rspb.2015.1292; White D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103510; White D, 2014, PSYCHON B REV, V21, P100, DOI 10.3758/s13423-013-0475-3; Wilmer JB, 2010, P NATL ACAD SCI USA, V107, P5238, DOI 10.1073/pnas.0913053107; WOODHEAD MM, 1979, ERGONOMICS, V22, P333, DOI 10.1080/00140137908924617	41	63	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139827	10.1371/journal.pone.0139827	http://dx.doi.org/10.1371/journal.pone.0139827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0CK	26465631	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100061
J	Montes, M; Coiras, M; Becerra, S; Moreno-Castro, C; Mateos, E; Majuelos, J; Oliver, FJ; Hernandez-Munain, C; Alcami, J; Sune, C				Montes, Marta; Coiras, Mayte; Becerra, Soraya; Moreno-Castro, Cristina; Mateos, Elena; Majuelos, Jara; Javier Oliver, F.; Hernandez-Munain, Cristina; Alcami, Jose; Sune, Carlos			Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing	PLOS ONE			English	Article							PRE-MESSENGER-RNA; POLYMERASE-II; CELL-DEATH; IN-VIVO; ANTISENSE OLIGONUCLEOTIDES; PROTEIN PHOSPHATASE-1; BREAST-CANCER; FAS MOLECULE; SERUM-LEVELS; GENOME-WIDE	Here, we present evidence for a specific role of the splicing-related factor TCERG1 in regulating apoptosis in live cells by modulating the alternative splicing of the apoptotic genes Bcl-x and Fas. We show that TCERG1 modulates Bcl-x alternative splicing during apoptosis and its activity in Bcl-x alternative splicing correlates with the induction of apoptosis, as determined by assessing dead cells, sub-G1-phase cells, annexin-V binding, cell viability, and cleavage of caspase-3 and PARP-1. Furthermore, the effect of TCERG1 on apoptosis involved changes in mitochondrial membrane permeabilization. We also found that depletion of TCERG1 reduces the expression of the activated form of the pro-apoptotic mitochondrial membrane protein Bak, which remains inactive by heterodimerizing with Bcl-xL, preventing the initial step of cytochrome c release in Bak-mediated mitochondrial apoptosis. In addition, we provide evidence that TCERG1 also participates in the death receptor-mediated apoptosis pathway. Interestingly, TCERG1 also modulates Fas/CD95 alternative splicing. We propose that TCERG1 sensitizes a cell to apoptotic agents, thus promoting apoptosis by regulating the alternative splicing of both the Bcl-x and Fas/CD95 genes. Our findings may provide a new link between the control of alternative splicing and the molecular events leading to apoptosis.	[Montes, Marta; Becerra, Soraya; Moreno-Castro, Cristina; Sune, Carlos] CSIC, IPBLN, PTS, Dept Mol Biol, Granada, Spain; [Coiras, Mayte; Mateos, Elena; Alcami, Jose] Inst Salud Carlos III, Ctr Nacl Microbiol, AIDS Immunopathol Unit, Madrid, Spain; [Majuelos, Jara; Javier Oliver, F.; Hernandez-Munain, Cristina] CSIC, IPBLN, PTS, Dept Cell Biol & Immunol, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Sune, C (corresponding author), CSIC, IPBLN, PTS, Dept Mol Biol, Granada, Spain.	csune@ipb.csic.es	Montes, Marta/ABF-8298-2020; Coiras, Mayte/R-9530-2019; Castro, Cristina Moreno/AAH-4497-2021; Montes, Marta/G-2751-2016; Suñé, Carlos/AAA-8198-2019; Oliver, Javier/S-1725-2018; Alcami, Pepe/T-2242-2018; de Munain, Cristina Hernandez Lopez/S-4389-2018; Majuelos-Melguizo, Jara/Z-5254-2019	Montes, Marta/0000-0003-1223-8385; Castro, Cristina Moreno/0000-0002-7172-7341; Montes, Marta/0000-0003-1223-8385; Suñé, Carlos/0000-0002-7991-0458; Oliver, Javier/0000-0001-8468-1998; Alcami, Pepe/0000-0003-0023-7377; de Munain, Cristina Hernandez Lopez/0000-0002-6058-2458; Majuelos-Melguizo, Jara/0000-0003-1841-1345; Coiras, Mayte/0000-0001-6464-5770	Spanish Ministry of Economy and Competitiveness [BFU2011-24577, BFU2014-54660-R, BFU2013-44660-R, SAF2013-44677-R, FIS PI12/00506]; Andalusian Government [CVI-4626/2009, BIO-2515/2012, CTS-6587]; SPANISH AIDS Research Network [RD12/0017/0015]; Accion Estrategica en Salud; Plan Nacional de Investigacion Cientifica; Desarrollo e Innovacion Tecnologica; Instituto de Salud Carlos III; European Region Development Fund, ERDF (FEDER); Spanish Ministry of Education (FPU program)	Spanish Ministry of Economy and Competitiveness(Spanish Government); Andalusian Government; SPANISH AIDS Research Network; Accion Estrategica en Salud; Plan Nacional de Investigacion Cientifica(Instituto de Salud Carlos IIIEuropean Commission); Desarrollo e Innovacion Tecnologica; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Region Development Fund, ERDF (FEDER); Spanish Ministry of Education (FPU program)(German Research Foundation (DFG))	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness [grant numbers BFU2011-24577 and BFU2014-54660-R] and the Andalusian Government [Excellence Projects CVI-4626/2009 and BIO-2515/2012] to CS; the Spanish Ministry of Economy and Competitiveness [grant number BFU2013-44660-R] and the Andalusian Government [Excellence Project CTS-6587] to CHM; the Spanish Ministry of Economy and Competitiveness [grant numbers SAF2013-44677-R and FIS PI12/00506], the SPANISH AIDS Research Network RD12/0017/0015 that is included in Accion Estrategica en Salud, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica 2008-2011, Instituto de Salud Carlos III, European Region Development Fund, ERDF (FEDER) to MC and JA. MM was supported by a fellowship from the Spanish Ministry of Education (FPU program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Akgul C, 2004, CELL MOL LIFE SCI, V61, P2189, DOI 10.1007/s00018-004-4001-7; Al-Maini MH, 2000, LUPUS, V9, P132, DOI 10.1191/096120300678828145; Biamonti G, 2009, TRENDS BIOCHEM SCI, V34, P146, DOI 10.1016/j.tibs.2008.11.004; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; CASCINO I, 1995, J IMMUNOL, V154, P2706; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; CLARKE MF, 1995, P NATL ACAD SCI USA, V92, P11024, DOI 10.1073/pnas.92.24.11024; Cloutier P, 2008, J BIOL CHEM, V283, P21315, DOI 10.1074/jbc.M800353200; Coiras M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-124; COTTER TG, 1990, ANTICANCER RES, V10, P1153; Dowling P, 1996, J EXP MED, P184; Esposti MD, 2003, BIOCHEM BIOPH RES CO, V304, P455, DOI 10.1016/S0006-291X(03)00617-X; FARROW SN, 1995, NATURE, V374, P731, DOI 10.1038/374731a0; Finch A, 2006, CANCER CELL, V10, P113, DOI 10.1016/j.ccr.2006.06.017; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Ghazi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000639; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Kim KH, 2005, CANCER BIOL THER, V4, P398; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; KRAJEWSKI S, 1994, CANCER RES, V54, P5501; Leu S, 2012, J CELL SCI, V125, P3164, DOI 10.1242/jcs.100859; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Lin KT, 2004, MOL CELL BIOL, V24, P9176, DOI 10.1128/MCB.24.20.9176-9185.2004; Lindenboim L, 2000, ONCOGENE, V19, P1783, DOI 10.1038/sj.onc.1203495; LIU CD, 1995, BIOCHEM J, V310, P957, DOI 10.1042/bj3100957; Lopez-Huertas MR, 2010, NUCLEIC ACIDS RES, V38, P3287, DOI 10.1093/nar/gkq037; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McKenna S L, 1998, Adv Biochem Eng Biotechnol, V62, P1, DOI 10.1007/BFb0102304; Mercatante DR, 2001, CURR CANCER DRUG TAR, V1, P211, DOI 10.2174/1568009013334124; Mercatante DR, 2001, J BIOL CHEM, V276, P16411, DOI 10.1074/jbc.M009256200; Minn AJ, 1996, J BIOL CHEM, V271, P6306, DOI 10.1074/jbc.271.11.6306; Montes M, 2012, GENE, V501, P104, DOI 10.1016/j.gene.2012.04.006; Montes M, 2012, MOL CELL BIOL, V32, P751, DOI 10.1128/MCB.06255-11; Olopade OI, 1997, CANCER J SCI AM, V3, P230; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Paradis C, 2007, RNA, V13, P1287, DOI 10.1261/rna.403607; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Pearson JL, 2008, J BIOL CHEM, V283, P7949, DOI 10.1074/jbc.M709402200; Pushpa K, 2013, DEVELOPMENT, V140, P1312, DOI 10.1242/dev.087833; Tejedor JR, 2015, MOL CELL, V57, P23, DOI 10.1016/j.molcel.2014.10.029; Renshaw SA, 2004, J BIOL CHEM, V279, P2846, DOI 10.1074/jbc.M309769200; Revil T, 2007, MOL CELL BIOL, V27, P8431, DOI 10.1128/MCB.00565-07; Roesler J, 2005, BLOOD, V106, P1652, DOI 10.1182/blood-2004-08-3104; Sanchez-Alvarez M, 2010, J BIOL CHEM, V285, P15220, DOI 10.1074/jbc.M109.063750; Sanchez-Alvarez M, 2006, MOL CELL BIOL, V26, P4998, DOI 10.1128/MCB.01991-05; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Shkreta L, 2008, MOL CANCER THER, V7, P1398, DOI 10.1158/1535-7163.MCT-08-0192; Shkreta L, 2011, J BIOL CHEM, V286, P331, DOI 10.1074/jbc.M110.162644; Shultz JC, 2012, MOL CANCER RES, V10, P660, DOI 10.1158/1541-7786.MCR-11-0363; Simonian PL, 1997, ONCOGENE, V15, P1871, DOI 10.1038/sj.onc.1201350; Singh S, 2007, BRAIN RES REV, V54, P233, DOI 10.1016/j.brainresrev.2007.02.001; Smith MJ, 2004, MOL CELL BIOL, V24, P9274, DOI 10.1128/MCB.24.21.9274-9285.2004; SUMANTRAN VN, 1995, CANCER RES, V55, P2507; Sune C, 1999, MOL CELL BIOL, V19, P4719; Sune C, 1997, MOL CELL BIOL, V17, P6029, DOI 10.1128/MCB.17.10.6029; Taylor JK, 1999, NAT BIOTECHNOL, V17, P1097, DOI 10.1038/15079; Ule J, 2007, ADV EXP MED BIOL, V623, P148, DOI 10.1007/978-0-387-77374-2_9; Vaux DL, 2011, BBA-MOL CELL RES, V1813, P546, DOI 10.1016/j.bbamcr.2010.08.002; Villunger A, 2011, CELL DEATH DIFFER, V18, P1545, DOI 10.1038/cdd.2011.100; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang KC, 2000, EXP HEMATOL, V28, P1441, DOI 10.1016/S0301-472X(00)00546-4; Wetzig T, 1998, ARCH DERMATOL RES, V290, P187, DOI 10.1007/s004030050288	77	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139812	10.1371/journal.pone.0139812	http://dx.doi.org/10.1371/journal.pone.0139812			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462236	gold, Green Published, Green Submitted			2022-12-26	WOS:000362962300026
J	Trusch, F; Matena, A; Vuk, M; Koerver, L; Knaevelsrud, H; Freemont, PS; Meyer, H; Bayer, P				Trusch, Franziska; Matena, Anja; Vuk, Maja; Koerver, Lisa; Knaevelsrud, Helene; Freemont, Paul S.; Meyer, Hemmo; Bayer, Peter			The N-terminal Region of the Ubiquitin Regulatory X (UBX) Domain-containing Protein 1 (UBXD1) Modulates Interdomain Communication within the Valosin-containing Protein p97	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; ATPASE ACTIVITY; AAA-ATPASE; SUBSTOICHIOMETRIC INHIBITION; SECONDARY STRUCTURE; CRYSTAL-STRUCTURES; MOLECULAR-BASIS; VCP/P97; DISEASE; CAVEOLIN-1	Valosin-containing protein/p97 is an ATP-driven protein segregase that cooperates with distinct protein cofactors to control various aspects of cellular homeostasis. Mutations at the interface between the regulatory N-domain and the first of two ATPase domains (D1 and D2) deregulate the ATPase activity and cause a multisystem degenerative disorder, inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia/amyotrophic lateral sclerosis. Intriguingly, the mutations affect only a subset of p97-mediated pathways correlating with unbalanced cofactor interactions and most prominently compromised binding of the ubiquitin regulatory X domain-containing protein 1 (UBXD1) cofactor during endolysosomal sorting of caveolin-1. However, how the mutations impinge on the p97-cofactor interplay is unclear so far. In cell-based endosomal localization studies, we identified a critical role of the N-terminal region of UBXD1 (UBXD1-N). Biophysical studies using NMR and CD spectroscopy revealed that UBXD1-N can be classified as intrinsically disordered. NMR titration experiments confirmed a valosin-containing protein/p97 interaction motif and identified a second binding site at helices 1 and 2 of UBXD1-N as binding interfaces for p97. In reverse titration experiments, we identified two distant epitopes on the p97 N-domain that include disease-associated residues and an additional interaction between UBXD1-N and the D1D2 barrel of p97 that was confirmed by fluorescence anisotropy. Functionally, binding of UBXD1-N to p97 led to a reduction of ATPase activity and partial protection from proteolysis. These findings indicate that UBXD1-N intercalates into the p97-ND1 interface, thereby modulating interdomain communication of p97 domains and its activity with relevance for disease pathogenesis. We propose that the polyvalent binding mode characterized for UBXD1-N is a more general principle that defines a subset of p97 cofactors.	[Trusch, Franziska; Matena, Anja; Bayer, Peter] Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Struct & Med Biochem, D-45117 Essen, Germany; [Vuk, Maja; Koerver, Lisa; Knaevelsrud, Helene; Meyer, Hemmo] Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Mol Biol 1, D-45117 Essen, Germany; [Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Struct Biol, London SW7 2AZ, England	University of Duisburg Essen; University of Duisburg Essen; Imperial College London	Bayer, P (corresponding author), Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol ZMB, Struct & Med Biochem, Rm S03 S01 A35,Univ Str 1-5, D-45141 Essen, Germany.	peter.bayer@uni-due.de	Bayer, Peter/B-8803-2009; Meyer, Hemmo/GNH-5784-2022; Knævelsrud, Helene/G-9302-2016	Bayer, Peter/0000-0003-0435-7202; Meyer, Hemmo/0000-0003-1883-1796; Knævelsrud, Helene/0000-0001-8848-8829	Deutsche Forschungsgemeinschaft Collaborative Research Centre [1093]	Deutsche Forschungsgemeinschaft Collaborative Research Centre(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Collaborative Research Centre 1093 (to P. B. and H. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Benirschke RC, 2010, STRUCTURE, V18, P955, DOI 10.1016/j.str.2010.04.017; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Christensen LC, 2012, J BIOL CHEM, V287, P26388, DOI 10.1074/jbc.M112.346775; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Frye JJ, 2013, NAT STRUCT MOL BIOL, V20, P827, DOI 10.1038/nsmb.2593; Gersch M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7320; Grum D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065346; Hanzelmann P, 2011, J BIOL CHEM, V286, P38679, DOI 10.1074/jbc.M111.274506; Haines DS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016444; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Isaacson RL, 2007, J BIOL CHEM, V282, P21361, DOI 10.1074/jbc.M610069200; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Ju JS, 2010, AUTOPHAGY, V6, P283, DOI 10.4161/auto.6.2.11063; Kern M, 2009, BIOCHEM BIOPH RES CO, V380, P303, DOI 10.1016/j.bbrc.2009.01.076; Kirchner P, 2013, J BIOL CHEM, V288, P7363, DOI 10.1074/jbc.M112.429076; Kloppsteck P, 2012, BBA-MOL CELL RES, V1823, P125, DOI 10.1016/j.bbamcr.2011.09.006; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035628; Liu J, 2013, BIOCHEMISTRY-US, V52, P3051, DOI 10.1021/bi4001358; Liu S, 2013, BBA-PROTEINS PROTEOM, V1834, P2672, DOI 10.1016/j.bbapap.2013.09.021; Madsen L, 2008, INT J BIOCHEM CELL B, V40, P2927, DOI 10.1016/j.biocel.2008.06.008; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer HH, 1998, FEBS LETT, V437, P255, DOI 10.1016/S0014-5793(98)01232-0; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Mustafi SM, 2010, BIOCHEM BIOPH RES CO, V397, P509, DOI 10.1016/j.bbrc.2010.05.144; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Orosz F, 1999, BIOCHEMISTRY-US, V38, P1857, DOI 10.1021/bi981350p; PlengeTellechea F, 1997, J BIOL CHEM, V272, P2794, DOI 10.1074/jbc.272.5.2794; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; SMITH SL, 1992, BIOCHEM PHARMACOL, V44, P65, DOI 10.1016/0006-2952(92)90039-L; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tanaka N, 2006, J MOL BIOL, V356, P312, DOI 10.1016/j.jmb.2005.11.076; Tang WK, 2013, J BIOL CHEM, V288, P36624, DOI 10.1074/jbc.M113.488924; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009; Williams R M, 2001, Pac Symp Biocomput, P89; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wu JW, 2013, BIOCHEM BIOPH RES CO, V440, P173, DOI 10.1016/j.bbrc.2013.09.056; Xu Y, 2013, J BIOL CHEM, V288, P18068, DOI 10.1074/jbc.M112.449199; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	58	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29414	29427		10.1074/jbc.M115.680686	http://dx.doi.org/10.1074/jbc.M115.680686			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26475856	hybrid, Green Published			2022-12-26	WOS:000366613400026
J	Wang, WJ; Cheng, W; Luo, M; Yan, QY; Yu, HM; Li, Q; Cao, DD; Huang, SF; Xu, AL; Mariuzza, RA; Chen, YX; Zhou, CZ				Wang, Wen-Jie; Cheng, Wang; Luo, Ming; Yan, Qingyu; Yu, Hong-Mei; Li, Qiong; Cao, Dong-Dong; Huang, Shengfeng; Xu, Anlong; Mariuzza, Roy A.; Chen, Yuxing; Zhou, Cong-Zhao			Activity Augmentation of Amphioxus Peptidoglycan Recognition Protein BbtPGRP3 via Fusion with a Chitin Binding Domain	PLOS ONE			English	Article							URTICA-DIOICA AGGLUTININ; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GENOMIC ANALYSIS; CLASS-I; PATTERN; RECEPTOR; PHAGOCYTOSIS; COMPLEXITY; SIMILARITY	Peptidoglycan recognition proteins (PGRPs), which have been identified in most animals, are pattern recognition molecules that involve antimicrobial defense. Resulting from extraordinary expansion of innate immune genes, the amphioxus encodes many PGRPs of diverse functions. For instance, three isoforms of PGRP encoded by Branchiostoma belcheri tsingtauense, termed BbtPGRP1 similar to 3, are fused with a chitin binding domain (CBD) at the N-terminus. Here we report the 2.7 angstrom crystal structure of BbtPGRP3, revealing an overall structure of an N-terminal hevein-like CBD followed by a catalytic PGRP domain. Activity assays combined with site-directed mutagenesis indicated that the individual PGRP domain exhibits amidase activity towards both DAP-type and Lys-type peptidoglycans (PGNs), the former of which is favored. The N-terminal CBD not only has the chitin-binding activity, but also enables BbtPGRP3 to gain a five-fold increase of amidase activity towards the Lys-type PGNs, leading to a significantly broadened substrate spectrum. Together, we propose that modular evolution via domain shuffling combined with gene horizontal transfer makes BbtPGRP1 similar to 3 novel PGRPs of augmented catalytic activity and broad recognition spectrum.	[Wang, Wen-Jie; Cheng, Wang; Luo, Ming; Yu, Hong-Mei; Li, Qiong; Cao, Dong-Dong; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Wang, Wen-Jie; Cheng, Wang; Luo, Ming; Yu, Hong-Mei; Li, Qiong; Cao, Dong-Dong; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Innovat Ctr Cell Signaling Network, Hefei 230026, Anhui, Peoples R China; [Yan, Qingyu; Huang, Shengfeng; Xu, Anlong] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Mariuzza, Roy A.] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD USA; [Mariuzza, Roy A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Sun Yat Sen University; University System of Maryland; University of Maryland College Park	Chen, YX (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	cyxing@ustc.edu.cn; zcz@ustc.edu.cn	Chen, Yuxing/P-4156-2014; Zhou, Cong-Zhao/E-9174-2011; yan, qing/GZN-2287-2022	Chen, Yuxing/0000-0002-7560-1922; Zhou, Cong-Zhao/0000-0002-6881-7151; Cao, Dongdong/0000-0002-2031-9321	Ministry of Science and Technology of China [2013CB835300, 2014CB910100]; Hefei Science Center of CAS [2015SRG-HSC045, 2015SRG-HSC046]; Program for Changjiang Scholars and Innovative Research Team in University	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Hefei Science Center of CAS; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was funded by the project 2013CB835300 and 2014CB910100 from the Ministry of Science and Technology of China (http://www.most.gov.cn/), the Scientific Research Grants 2015SRG-HSC045 and 2015SRG-HSC046 from Hefei Science Center of CAS (http://www.cas.cn/), and the Program for Changjiang Scholars and Innovative Research Team in University [http://www.moe.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Destoumieux D, 2000, J CELL SCI, V113, P461; Dishaw LJ, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-78; DOOLITTLE RF, 1993, SCI AM, V269, P50, DOI 10.1038/scientificamerican1093-50; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii T, 2004, ACTA CRYSTALLOGR D, V60, P665, DOI 10.1107/S090744490400232X; Garver LS, 2006, P NATL ACAD SCI USA, V103, P660, DOI 10.1073/pnas.0506182103; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Guan RJ, 2006, PROTEIN SCI, V15, P1199, DOI 10.1110/ps.062077606; Guan RJ, 2004, P NATL ACAD SCI USA, V101, P17168, DOI 10.1073/pnas.0407856101; Guan RJ, 2005, J MOL BIOL, V347, P683, DOI 10.1016/j.jmb.2005.01.070; Guan RJ, 2007, TRENDS MICROBIOL, V15, P127, DOI 10.1016/j.tim.2007.01.006; Harata K, 2001, ACTA CRYSTALLOGR D, V57, P1513, DOI 10.1107/S090744490101232X; HAWKINS AR, 1995, EUR J BIOCHEM, V232, P7, DOI 10.1111/j.1432-1033.1995.tb20775.x; Hayashida M, 2003, J MOL BIOL, V334, P551, DOI 10.1016/j.jmb.2003.09.076; Hemmi H, 2003, J BIOL CHEM, V278, P22820, DOI 10.1074/jbc.M301025200; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Huang SF, 2011, J IMMUNOL, V186, P2042, DOI 10.4049/jimmunol.1001824; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jimenez-Barbero J, 2006, ADV CARBOHYD CHEM BI, V60, P303, DOI 10.1016/S0065-2318(06)60007-3; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; Kawabata S, 1996, J BIOCHEM-TOKYO, V120, P1253; Kezuka Y, 2010, PROTEINS, V78, P2295, DOI 10.1002/prot.22742; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; LLC S, 2010, PYMOL MOL GRAPHICS S; Martinez-Caballero S, 2014, FEBS J, V281, P4535, DOI 10.1111/febs.12962; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Mellroth P, 2006, BIOCHEM BIOPH RES CO, V350, P994, DOI 10.1016/j.bbrc.2006.09.139; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Osaki T, 1999, J BIOL CHEM, V274, P26172, DOI 10.1074/jbc.274.37.26172; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JW, 2006, J BIOL CHEM, V281, P7747, DOI 10.1074/jbc.M510058200; Patthy L, 1996, MATRIX BIOL, V15, P301, DOI 10.1016/S0945-053X(96)90131-6; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Saul FA, 2000, STRUCTURE, V8, P593, DOI 10.1016/S0969-2126(00)00142-8; Schwefel D, 2010, J AM CHEM SOC, V132, P8704, DOI 10.1021/ja101646k; Shen ZC, 1999, J MOL EVOL, V48, P341, DOI 10.1007/PL00006478; Suetake T, 2000, J BIOL CHEM, V275, P17929, DOI 10.1074/jbc.C000184200; Sumathipala N, 2010, INSECT BIOCHEM MOLEC, V40, P487, DOI 10.1016/j.ibmb.2010.04.008; Swaminathan CP, 2006, P NATL ACAD SCI USA, V103, P684, DOI 10.1073/pnas.0507656103; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Velikovsky CA, 2009, NAT STRUCT MOL BIOL, V16, P725, DOI 10.1038/nsmb.1619; Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200; WRIGHT CS, 1990, J MOL BIOL, V215, P635, DOI 10.1016/S0022-2836(05)80174-3; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; ZHOU RQ, 1988, ANAL BIOCHEM, V171, P141, DOI 10.1016/0003-2697(88)90134-0	65	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140953	10.1371/journal.pone.0140953	http://dx.doi.org/10.1371/journal.pone.0140953			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479246	Green Submitted, Green Published, gold			2022-12-26	WOS:000363026600027
J	Santos, EAD; Marques, TEBS; Matos, HD; Leite, JP; Garcia-Cairasco, N; Paco-Larson, ML; Gitai, DLG				da Silva Santos, Evelin Antonieli; Batista Sales Marques, Thalita Ewellyn; Matos, Heloisa de Carvalho; Leite, Joao Pereira; Garcia-Cairasco, Norberto; Paco-Larson, Maria Luisa; Goes Gitai, Daniel Leite			Diurnal Variation Has Effect on Differential Gene Expression Analysis in the Hippocampus of the Pilocarpine-Induced Model of Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							SUBUNIT MESSENGER-RNAS; TIME QUANTITATIVE PCR; SUPRACHIASMATIC NUCLEUS; CIRCADIAN EXPRESSION; NEURONAL MORPHOLOGY; MICROARRAY ANALYSIS; KEY PATHWAYS; RT-PCR; CLOCK; MOUSE	The molecular mechanisms underlying epileptogenesis have been widely investigated by differential gene expression approach, especially RT-qPCR methodology. However, controversial findings highlight the occurrence of unpredictable sources of variance in the experimental designs. Here, we investigated if diurnal rhythms of transcript's levels may impact on differential gene expression analysis in hippocampus of rats with experimental epilepsy. For this, we have selected six core clock genes (Per1, Per3, Bmal1, Clock, Cry1 and Cry2), whose rhythmic expression pattern in hippocampus had been previously reported. Initially, we identified Tubb2a/Rplp1 and Tubb2a/Ppia as suitable normalizers for circadian studies in hippocampus of rats maintained to 12:12 hour light: dark (LD) cycle. Next, we confirmed the temporal profiling of Per1, Per3, Bmal1, Cry1 and Cry2 mRNA levels in the hippocampus of naive rats by both Acrophase and CircWave statistical tests for circadian analysis. Finally, we showed that temporal differences of sampling can change experimental results for Per1, Per3, Bmal1, Cry1 and Cry2, but not for Clock, which was consistently decreased in rats with epilepsy in all comparison to the naive group. In conclusion, our study demonstrates it is mandatory to consider diurnal oscillations, in order to avoid erroneous conclusions in gene expression analysis in hippocampus of rats with epilepsy. Investigators, therefore, should be aware that genes with circadian expression could be out of phase in different animals of experimental and control groups. Moreover, our results indicate that a sub-expression of Clock may be involved in epileptogenicity, although the functional significance of this remains to be investigated.	[da Silva Santos, Evelin Antonieli; Batista Sales Marques, Thalita Ewellyn; Matos, Heloisa de Carvalho; Goes Gitai, Daniel Leite] Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Cellular & Mol Biol, Maceio, Alagoas, Brazil; [Leite, Joao Pereira] Univ Sao Paulo, Dept Neurol, Ribeirao Preto Sch Med, Sao Paulo, Brazil; [Garcia-Cairasco, Norberto] Univ Sao Paulo, Dept Physiol, Ribeirao Preto Sch Med, Sao Paulo, Brazil; [Paco-Larson, Maria Luisa] Univ Sao Paulo, Dept Cellular & Mol Biol, Ribeirao Preto Sch Med, Sao Paulo, Brazil	Universidade Federal de Alagoas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Gitai, DLG (corresponding author), Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Cellular & Mol Biol, Maceio, Alagoas, Brazil.	danielgitai@gmail.com	Gitai, Daniel LG/A-7982-2019; Cairasco, Norberto Garcia/E-3250-2015; Leite, Joao/B-9070-2012; Paço-Larson, Maria L/I-8613-2012	Gitai, Daniel LG/0000-0001-7056-2373; Cairasco, Norberto Garcia/0000-0001-8857-3775; Leite, Joao/0000-0003-0558-3519; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [484911/2012-0]; Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [23038.007934/2010]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Apoio ao Ensino Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA-HCRP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Apoio ao Ensino Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA-HCRP)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grant number: 484911/2012-0, to DLGG; Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL) to DLGG; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (EASS and TEBSM received scholarship 23038.007934/2010); and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Fundacao de Apoio ao Ensino Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA-HCRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Amitai Y, 2013, EPILEPSY CURR, V13, P124, DOI 10.5698/1535-7511-13.3.124; Marques TEBS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071892; Boone DR, 2012, PLOS ONE, V7; Bouchard-Cannon P, 2013, CELL REP, V5, P961, DOI 10.1016/j.celrep.2013.10.037; Brooks-Kayal AR, 2009, NEUROTHERAPEUTICS, V6, P312, DOI 10.1016/j.nurt.2009.01.019; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Cardoso ALC, 2010, J CONTROL RELEASE, V142, P392, DOI 10.1016/j.jconrel.2009.11.004; Chaudhury D, 2005, J BIOL RHYTHM, V20, P225, DOI 10.1177/0748730405276352; Cikos S, 2009, ANAL BIOCHEM, V384, P1, DOI 10.1016/j.ab.2008.08.031; CLIFFORD DB, 1987, NEUROSCIENCE, V23, P953, DOI 10.1016/0306-4522(87)90171-0; Colwell CS, 2011, NAT REV NEUROSCI, V12, P553, DOI 10.1038/nrn3086; Corton JC, 2012, MUTAT RES-GEN TOX EN, V746, P104, DOI 10.1016/j.mrgentox.2011.12.017; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Curia G, 2014, CURR MED CHEM, V21, P663, DOI 10.2174/0929867320666131119152201; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; De Araujo MA, 2014, PLOS ONE, V9; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Drexel M, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00142; Eun B, 2011, NEUROSCI LETT, V498, P110, DOI 10.1016/j.neulet.2011.03.039; Figueredo DD, 2015, BLOOD CELL MOL DIS, V54, P364, DOI 10.1016/j.bcmd.2015.01.004; Fonken LK, 2013, J BIOL RHYTHM, V28, P262, DOI 10.1177/0748730413493862; Gerstner JR, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00121; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gleeson LC, 2010, BRAIN BEHAV IMMUN, V24, P1354, DOI 10.1016/j.bbi.2010.06.015; Golini RS, 2012, HIPPOCAMPUS, V22, P1720, DOI 10.1002/hipo.22007; Harbour VL, 2014, PHASE DIFFERENCES EX, V9, P1, DOI [10.1371/journal.pone.0103309, DOI 10.1371/J0URNAL.P0NE.0103309]; Hsu PY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049853; Ikeno T, 2014, NEUROSCIENCE, V270, P69, DOI 10.1016/j.neuroscience.2014.04.002; Ikeno T, 2015, HIPPOCAMPUS, V25, P142, DOI 10.1002/hipo.22358; Ikeno T, 2013, CHRONOBIOL INT, V30, P1089, DOI 10.3109/07420528.2013.800090; Jilg A, 2010, HIPPOCAMPUS, V20, P377, DOI 10.1002/hipo.20637; Johnston JD, 2005, EUR J NEUROSCI, V21, P2967, DOI 10.1111/j.1460-9568.2005.04148.x; Joseph SA, 2006, NEUROSCIENCE, V140, P1051, DOI 10.1016/j.neuroscience.2006.02.075; Kamphuis W, 2005, BIOCHEM BIOPH RES CO, V330, P18, DOI 10.1016/j.bbrc.2005.02.118; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Kondratova Dubrovsky Y.V., 2010, AGING ALBANY NY, V2, P285; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; LIU Z, 1994, EPILEPSY RES, V17, P237; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; O'Callaghan EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047087; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pernot F, 2011, EPILEPSIA, V52, P2315, DOI 10.1111/j.1528-1167.2011.03273.x; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rawashdeh O, 2014, HIPPOCAMPUS, V24, P712, DOI 10.1002/hipo.22262; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Romcy-Pereira RN, 2008, REV ASSOC MED BRAS, V54, P461; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Ruiz N, 2011, BRAIN RES, V1426, P86, DOI 10.1016/j.brainres.2011.10.006; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sherman H, 2011, J CELL MOL MED, V15, P2745, DOI 10.1111/j.1582-4934.2010.01160.x; Smarr BL, 2014, BEHAV NEUROSCI, V128, P283, DOI 10.1037/a0035963; Soldovieri MV, 2006, J BIOL CHEM, V281, P418, DOI 10.1074/jbc.M510980200; Steiger JL, 2004, PHARMACOL THERAPEUT, V101, P259, DOI 10.1016/j.pharmthera.2003.12.002; Sukumaran S, 2010, ADV DRUG DELIVER REV, V62, P904, DOI 10.1016/j.addr.2010.05.009; Sumanont Y, 2007, BIOL PHARM BULL, V30, P1732, DOI 10.1248/bpb.30.1732; Takahashi Y, 2013, BEHAV BRAIN RES, V256, P488, DOI 10.1016/j.bbr.2013.08.040; Tamai SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003835; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Vedell PT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-167; Vilches N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091313; Vosko AM, 2009, AM J PHYSIOL-REG I, V296, pR353, DOI 10.1152/ajpregu.90392.2008; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Wang Xiaojia, 2006, J Circadian Rhythms, V4, P9, DOI 10.1186/1740-3391-4-9; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wiater MF, 2011, AM J PHYSIOL-REG I, V301, pR1569, DOI 10.1152/ajpregu.00168.2011; Wilson DN, 2005, J MOL NEUROSCI, V25, P285, DOI 10.1385/JMN:25:3:285; Wyse CA, 2010, BRAIN RES, V1337, P21, DOI 10.1016/j.brainres.2010.03.113; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Yang SZ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r247	81	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0141121	10.1371/journal.pone.0141121	http://dx.doi.org/10.1371/journal.pone.0141121			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473354	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500144
J	Guo, JQ; Huang, XM; Wang, H; Yang, HJ				Guo, Jianquan; Huang, Xuemei; Wang, Hui; Yang, Huanjie			Celastrol Induces Autophagy by Targeting AR/miR-101 in Prostate Cancer Cells	PLOS ONE			English	Article							ANDROGEN RECEPTOR; ENZALUTAMIDE; DEPRIVATION; EXPRESSION; MICRORNA-101; RESISTANCE; INHIBITOR; MECHANISM	Autophagy is an evolutionarily conserved process responsible for the degradation and recycling of cytoplasmic components through autolysosomes. Targeting AR axis is a standard strategy for prostate cancer treatment; however, the role of AR in autophagic processes is still not fully understood. In the present study, we found that AR played a negative role in AR degrader celastrol-induced autophagy. Knockdown of AR in AR-positive prostate cancer cells resulted in enhanced autophagy. Ectopic expression of AR in AR-negative prostate cancer cells, or gain of function of the AR signaling in AR-positive cells, led to suppression of autophagy. Since miR-101 is an inhibitor of autophagy and its expression was decreased along with AR in the process of celastrol-induced autophagy, we hypothesize that AR inhibits autophagy through transactivation of miR-101. AR binding site was defined in the upstream of miR-101 gene by luciferase reporter and ChIP assays. MiR-101 expression correlated with AR status in prostate cancer cell lines. The inhibition of celastrol-induced autophagy by AR was compromised by blocking miR-101; while transfection of miR-101 led to inhibition of celastrol-induced autophagy in spite of AR depletion. Furthermore, mutagenesis of the AR binding site in miR-101 gene led to decreased suppression of autophagy by AR. Finally, autophagy inhibition by miR-101 mimic was found to enhance the cytotoxic effect of celastrol in prostate cancer cells. Our results demonstrate that AR inhibits autophagy via transactivation of miR-101, thus combination of miR-101 mimics with celastrol may represent a promising therapeutic approach for treating prostate cancer.	[Guo, Jianquan; Huang, Xuemei; Wang, Hui; Yang, Huanjie] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China	Harbin Institute of Technology	Yang, HJ (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China.	yanghj@hit.edu.cn			Natural Science Foundation of Heilongjiang Province, China [C201432]; Innovation Research Project of Harbin, China [2012RFLXS011]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	Natural Science Foundation of Heilongjiang Province, China(Natural Science Foundation of Heilongjiang Province); Innovation Research Project of Harbin, China; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was partially supported by Natural Science Foundation of Heilongjiang Province, China (C201432), Innovation Research Project of Harbin, China (2012RFLXS011) and Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry.	Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Bennett HL, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.50; Boutin B, 2013, PROSTATE, V73, P1090, DOI 10.1002/pros.22658; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Castoria G, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.497; Chhipa RR, 2011, CELL SIGNAL, V23, P1466, DOI 10.1016/j.cellsig.2011.04.008; Frankel LB, 2011, EMBO J, V30, P4628, DOI 10.1038/emboj.2011.331; Frezza M, 2011, J CELL PHYSIOL, V226, P2731, DOI 10.1002/jcp.22758; Han XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100380; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hoy SM, 2013, DRUGS, V73, P2077, DOI 10.1007/s40265-013-0150-z; Huang WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032960; Jiang Q, 2012, J UROLOGY, V188, P1361, DOI 10.1016/j.juro.2012.06.004; Kung Hsing-Jien, 2011, Hormones & Cancer, V2, P38, DOI 10.1007/s12672-010-0053-3; Li MQ, 2008, AUTOPHAGY, V4, P54, DOI 10.4161/auto.5209; Lippai M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/832704; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Nguyen HG, 2014, ONCOGENE, V33, P4521, DOI 10.1038/onc.2014.25; Reddy GPV, 2006, J CELL BIOCHEM, V98, P1408, DOI 10.1002/jcb.20927; Shao LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058391; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Tombal B, 2014, LANCET ONCOL, V15, P592, DOI 10.1016/S1470-2045(14)70129-9; Yang HJ, 2004, CANCER BIOL THER, V3, P1277, DOI 10.4161/cbt.3.12.1370; Yang HJ, 2008, J CELL PHYSIOL, V217, P569, DOI 10.1002/jcp.21565; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Zhao X, 2014, CURR MOL MED, V14, P555, DOI 10.2174/1566524014666140414211223	27	49	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140745	10.1371/journal.pone.0140745	http://dx.doi.org/10.1371/journal.pone.0140745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473737	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500097
J	Ramirez-Velez, R; Rodrigues-Bezerra, D; Correa-Bautista, JE; Izquierdo, M; Lobelo, F				Ramirez-Velez, Robinson; Rodrigues-Bezerra, Diogo; Enrique Correa-Bautista, Jorge; Izquierdo, Mikel; Lobelo, Felipe			Reliability of Health-Related Physical Fitness Tests among Colombian Children and Adolescents: The FUPRECOL Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; ANTHROPOMETRIC MEASUREMENTS; CARDIORESPIRATORY FITNESS; METABOLIC RISK; SHUTTLE RUN; JUMP; HARMONIZATION; MULTICENTER; CHILDHOOD; STRENGTH	Substantial evidence indicates that youth physical fitness levels are an important marker of lifestyle and cardio-metabolic health profiles and predict future risk of chronic diseases. The reliability physical fitness tests have not been explored in Latino-American youth population. This study's aim was to examine the reliability of health-related physical fitness tests that were used in the Colombian health promotion "Fuprecol study". Participants were 229 Colombian youth (boys n = 124 and girls n = 105) aged 9 to 17.9 years old. Five components of health-related physical fitness were measured: 1) morphological component: height, weight, body mass index (BMI), waist circumference, triceps skinfold, subscapular skinfold, and body fat (%) via impedance; 2) musculoskeletal component: handgrip and standing long jump test; 3) motor component: speed/agility test (4x10 m shuttle run); 4) flexibility component (hamstring and lumbar extensibility, sit-and-reach test); 5) cardiorespiratory component: 20-meter shuttle-run test (SRT) to estimate maximal oxygen consumption. The tests were performed two times, 1 week apart on the same day of the week, except for the SRT which was performed only once. Intra-observer technical errors of measurement (TEMs) and inter-rater (reliability) were assessed in the morphological component. Reliability for the Musculoskeletal, motor and cardiorespiratory fitness components was examined using Bland-Altman tests. For the morphological component, TEMs were small and reliability was greater than 95% of all cases. For the musculoskeletal, motor, flexibility and cardiorespiratory components, we found adequate reliability patterns in terms of systematic errors (bias) and random error (95% limits of agreement). When the fitness assessments were performed twice, the systematic error was nearly 0 for all tests, except for the sit and reach (mean difference: -1.03% [95% CI = -4.35% to -2.28%]. The results from this study indicate that the "Fuprecol study" health-related physical fitness battery, administered by physical education teachers, was reliable for measuring health-related components of fitness in children and adolescents aged 9-17.9 years old in a school setting in Colombia.	[Ramirez-Velez, Robinson; Rodrigues-Bezerra, Diogo; Enrique Correa-Bautista, Jorge] Univ Rosario, Escuela Med & Ciencias Salud, Ctr Estudios Med Actividad Fis CEMA, Bogota, DC, Colombia; [Ramirez-Velez, Robinson; Izquierdo, Mikel] Univ Santo Tomas, Fac Cultura Fis Deporte & Recreac, Grp GICAEDS, Bogota, DC, Colombia; [Izquierdo, Mikel] Univ Publ Navarra, Dept Hlth Sci, Pamplona, Spain; [Lobelo, Felipe] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Universidad del Rosario; Universidad Santo Tomas USTA; Universidad Publica de Navarra; Emory University; Rollins School Public Health	Ramirez-Velez, R (corresponding author), Univ Rosario, Escuela Med & Ciencias Salud, Ctr Estudios Med Actividad Fis CEMA, Bogota, DC, Colombia.	robin640@hotmail.com	Lobelo, R.L Felipe/AAB-2264-2021; Ramírez-Vélez, Robinson/D-5311-2016; Izquierdo, Mikel/O-8049-2019; Correa-Bautista, Jorge Enrique/N-2741-2015; Izquierdo, Mikel/A-4894-2010	Lobelo, R.L Felipe/0000-0003-4185-7193; Ramírez-Vélez, Robinson/0000-0003-3075-6960; Correa-Bautista, Jorge Enrique/0000-0002-0646-2316; Izquierdo, Mikel/0000-0002-1506-4272; Castro-Reina, Andres/0000-0002-0607-5076	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas" COLCIENCIAS [671-2014, 122265743978]	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas" COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	The "Fuprecol Study" was carried out with the financial support of Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas" COLCIENCIAS (Contract No 671-2014 Code 122265743978). The authors are grateful to the Bogota District Education Secretary for the data used in this study. The authors also thank the participating Bogota District students, teachers, schools, and staff. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artero EG, 2011, INT J SPORTS MED, V32, P159, DOI 10.1055/s-0030-1268488; Australian Council for Health Physical Education and Recreation (ACHPER), 1996, HDB AUSTR FITN ED AW; Beets M. W., 2006, J PHYS ACTIVITY H S2, V3, pS21; Bianco A, 2015, INT J OCCUP MED ENV, V28, P445, DOI 10.13075/ijomeh.1896.00393; Buchan DS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-498; Canadian Society for Exercise Physiology, 2003, CAN PHYS ACT FITN LI; Caprio S, 2008, DIABETES CARE, V31, P2211, DOI 10.2337/dc08-9024; Castro-Pinero J, 2009, INT J SPORTS MED, V30, P366, DOI 10.1055/s-0028-1105934; Castro-Pinero J, 2010, J STRENGTH COND RES, V24, P1810, DOI 10.1519/JSC.0b013e3181ddb03d; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cooper Institute for Aerobics Research, 2004, PRUD FITN TEST ADM M; Council of Europe Committee forthe Development of Sport, 1993, EUROFIT HDB EUROFIT; De Miguel-Etayo P, 2014, OBES REV, V15, P67, DOI 10.1111/obr.12181; Departamento Administrative Nacional de Estadfstica (DANE), 2007, LOS GRUP ETN COL CEN; Dumith SC, 2012, J SPORT MED PHYS FIT, V52, P181; Eisenmann JC, 2007, ACTA PAEDIATR, V96, P1723, DOI 10.1111/j.1651-2227.2007.00534.x; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Espana-Romero V, 2010, INT J SPORTS MED, V31, P490, DOI 10.1055/s-0030-1251990; Garcia S, 2012, PUBLIC HEALTH NUTR, V13, P1; Gomez-Cabello A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041752; Gonzalez SA, 2014, J PHYS ACT HEALTH, V11, pS33, DOI 10.1123/jpah.2014-0170; Grontved A, 2015, BRIT J SPORT MED, V49, P90, DOI 10.1136/bjsports-2012-091907; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; HARTMAN J. G., 2003, MEASUREMENT IN PHYSI, V7, P71, DOI DOI 10.1207/S15327841MPEE0702_2; Hurtig-Wennlof A, 2007, EUR J CARDIOV PREV R, V14, P575, DOI 10.1097/HJR.0b013e32808c67e3; Kaminsky LA, 2013, CIRCULATION, V127, P652, DOI 10.1161/CIR.0b013e31827ee100; Kelishadi R, 2007, INT J CARDIOL, V117, P340, DOI 10.1016/j.ijcard.2006.06.012; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; LIU NYS, 1992, RES Q EXERCISE SPORT, V63, P360, DOI 10.1080/02701367.1992.10608757; Lopez AD, 2006, GLOBAL BURDEN DIS RI; Moir G, 2008, J STRENGTH COND RES, V22, P1779, DOI 10.1519/JSC.0b013e318185f0df; Moreno LA, 2003, NUTRITION, V19, P481, DOI 10.1016/S0899-9007(03)00040-6; Nagy E, 2008, INT J OBESITY, V32, pS58, DOI 10.1038/ijo.2008.184; Norman K, 2011, CLIN NUTR, V30, P135, DOI 10.1016/j.clnu.2010.09.010; Nuzzo JL, 2011, J STRENGTH COND RES, V25, P2580, DOI 10.1519/JSC.0b013e3181fee650; Ortega FB, 2008, INT J OBESITY, V32, pS49, DOI 10.1038/ijo.2008.183; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Ortega FB, 2011, MED SCI SPORT EXER, V43, P1891, DOI 10.1249/MSS.0b013e3182190d71; Parra DC, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-014-0057-5; Pitetti KH, 2002, PEDIATR EXERC SCI, V14, P125, DOI 10.1123/pes.14.2.125; Pratt M, 2014, BRIT J SPORT MED, V48, P171, DOI 10.1136/bjsports-2012-091810; ROBERTSON DGE, 1987, CAN J SPORT SCI, V12, P19; Ruiz JR, 2009, BRIT J SPORT MED, V43, P909, DOI 10.1136/bjsm.2008.056499; Ruiz JR, 2011, BRIT J SPORT MED, V45, P518, DOI 10.1136/bjsm.2010.075341; Santos EJAM, 2012, J STRENGTH COND RES, V26, P2641, DOI 10.1519/JSC.0b013e31823f8dd4; Steene-Johannessen J, 2009, MED SCI SPORT EXER, V41, P1361, DOI 10.1249/MSS.0b013e31819aaae5; Stomfai S, 2011, INT J OBESITY, V35, pS45, DOI 10.1038/ijo.2011.34; Ulijaszek S. J., 1994, ANTHROPOMETRY INDIVI, P30, DOI DOI 10.1017/CBO9780511600500.004; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; Vanhelst J, 2016, CLIN PHYSIOL FUNCT I, V36, P106, DOI 10.1111/cpf.12202	51	84	87	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140875	10.1371/journal.pone.0140875	http://dx.doi.org/10.1371/journal.pone.0140875			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474474	gold, Green Submitted, Green Published			2022-12-26	WOS:000363185500123
J	Bekele, T; Gebremariam, A; Kaso, M; Ahmed, K				Bekele, Tolesa; Gebremariam, Alem; Kaso, Muhammedawel; Ahmed, Kemal			Factors Associated with Occupational Needle Stick and Sharps Injuries among Hospital Healthcare Workers in Bale Zone, Southeast Ethiopia	PLOS ONE			English	Article								Background Needle stick and sharps injuries are occupational hazards to healthcare workers. Every day healthcare workers are exposed to deadly blood borne pathogens through contaminated needles and other sharp objects. About twenty blood borne pathogens can be transmitted through accidental needle stick and sharp injury. The study was conducted to determine the lifetime and past one year prevalence of needle stick and sharps injuries and factors associated with the past one year injuries among hospital healthcare workers in Southeast Ethiopia. Methods An institutional based cross sectional study was conducted in December 2014 among healthcare workers in four hospitals of Bale zone, Southeast of Ethiopia. A total of 362 healthcare workers were selected randomly from each department in the hospitals. Data were collected using self-administered questionnaire. The collected data were entered into Epi-Info version 3.5 and analyzed using SPSS version 20.0. Multivariable logistic regression analysis was used to identify the independent effect of each independent variable on the outcome variable. Written informed consent was secured from the participants. Results The prevalence of lifetime needle stick and sharp injury was 37.1% with 95% CI of 32.0% to 42.5%. The prevalence of injury within the past one year was 19.1% with 95% CI of 14.9% to 23.3%. Emergency ward was a department with highest needle stick and sharp injury (31.7%). The main cause of injury was syringe needles (69.8%). Participants who practiced needle recapping had higher odds of needle stick and sharp injury within the past 12 months (AOR = 3.23, 95% CI: 1.78, 5.84) compared to their counterparts. Conclusions Nearly one out of five respondents had experienced needle stick and/or sharp injury at least once within past one year. There were practices and behaviors that put healthcare workers at risk of needle stick and sharp injury at the study area. Needle recapping was key modifiable risk behavior. Health policy makers and hospital administrators should formulate strategies to improve the working condition for healthcare workers and increase their adherence to universal precautions.	[Bekele, Tolesa; Kaso, Muhammedawel; Ahmed, Kemal] Madda Walabu Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Bale Goba, Oromia, Ethiopia; [Gebremariam, Alem] Adigrat Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Adigrat, Tigray, Ethiopia	University of Gondar; University of Gondar	Bekele, T (corresponding author), Madda Walabu Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Bale Goba, Oromia, Ethiopia.	tolesa2003@yahoo.com						Adejumo OP, 2014, J NURS ED PRACT, V4, P229; [Anonymous], 2010, OCCUPATIONAL HLTH SA, V20, P20; De Laune S, 1990, Infect Control Hosp Epidemiol, V11, P563; Deisenhammer S, 2006, J HOSP INFECT, V63, P263, DOI 10.1016/j.jhin.2006.01.019; Feleke BE., 2013, SCI J PUBLIC HLTH, V1, P189; Gholami A., 2013, INT J HOSP RES, V2, P31; Goswami M, 2010, NATL J COMMUNITY MED, V1, P114; Hanafi M. I., 2011, Eastern Mediterranean Health Journal, V17, P26; Kakizaki Mayo, 2011, BMC Res Notes, V4, P184, DOI 10.1186/1756-0500-4-184; Lulie W, 2013, INT J INFECT CONTROL, V9, P1996; Nwankwo TO, 2011, NIGER J CLIN PRACT, V14, P34, DOI 10.4103/1119-3077.79237; Rapiti E, 2005, WHO ENV BURDEN DIS S, V11; Reda AA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014420; Sagoe-Moses C, 2001, NEW ENGL J MED, V345, P538, DOI 10.1056/NEJM200108163450711; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; Singhal Varsha, 2009, J Lab Physicians, V1, P41, DOI 10.4103/0974-2727.59697; Sofola O O, 2008, Nig Q J Hosp Med, V18, P145; Stewardson Dominic A, 2003, Prim Dent Care, V10, P23, DOI 10.1308/135576103322504076; Vaz K, 2010, INT J OCCUP MED ENV, V23, P133, DOI 10.2478/v10001-010-0016-5	19	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140382	10.1371/journal.pone.0140382	http://dx.doi.org/10.1371/journal.pone.0140382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469776	Green Submitted, Green Published, gold			2022-12-26	WOS:000363184600055
J	Carvalho-Santos, A; Ribeiro-Alves, M; Cardoso-Weide, LC; Nunes, J; Kuhnert, LRB; Xavier, AR; Cunha, S; Hahne, M; Villa-Verde, DMS; Carvalho-Pinto, CE				Carvalho-Santos, Adriana; Ribeiro-Alves, Marcelo; Cardoso-Weide, Luciene Carvalho; Nunes, Joyce; Ballard Kuhnert, Lia Rafaella; Xavier, Analucia Rampazzo; Cunha, Samuel; Hahne, Michael; Serra Villa-Verde, Dea Maria; Carvalho-Pinto, Carla Eponina			Decreased Circulating Levels of APRIL: Questioning Its Role in Diabetes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; OBESITY; HYPOXIA; TYPE-1; FAMILY	Diabetes mellitus is a chronic disease that affects over 382 million people worldwide. Type-1 Diabetes (T1D) is classified as an autoimmune disease that results from pancreatic beta-cell destruction and insulin deficiency. Type-2 Diabetes (T2D) is characterized principally by insulin resistance in target tissues followed by decreased insulin production due to beta-cell failure. It is challenging to identify immunological markers such as inflammatory molecules that are triggered in response to changes during the pathogenesis of diabetes. APRIL is an important member of the TNF family and has been linked to chronic inflammatory processes of various diseases since its discovery in 1998. Therefore, this study aimed to evaluate APRIL serum levels in T1D and T2D. For this, we used the ELISA assay to measure serum APRIL levels of 33 T1D and 30 T2D patients, and non-diabetic subjects as control group. Our data showed a decrease in serum APRIL levels in T1D patients when compared with healthy individuals. The same pattern was observed in the group of T2D patients when compared with the control. The decrease of serum APRIL levels in diabetic patients suggests that this cytokine has a role in T1D and T2D. Diabetes is already considered as an inflammatory condition with different cytokines being implicated in its physiopathology. Our data suggest that APRIL can be considered as a potential modulating cytokine in the inflammatory process of diabetes.	[Carvalho-Santos, Adriana; Serra Villa-Verde, Dea Maria] Inst Oswaldo Cruz, Lab Thymus Res, FIOCRUZ, BR-20001 Rio De Janeiro, Brazil; [Ribeiro-Alves, Marcelo] Natl Inst Infectol, INI, FIOCRUZ, HIV AIDS Clin Res Ctr, Rio De Janeiro, Brazil; [Cardoso-Weide, Luciene Carvalho; Xavier, Analucia Rampazzo; Cunha, Samuel] Univ Fed Fluminense, UFF, Fac Med, Rio De Janeiro, Brazil; [Nunes, Joyce; Ballard Kuhnert, Lia Rafaella; Carvalho-Pinto, Carla Eponina] Univ Fed Fluminense, UFF, Inst Biol, Lab Expt Pathol, Rio De Janeiro, Brazil; [Hahne, Michael] Inst Mol Genet Montpellier, Montpellier, France	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Universidade Federal Fluminense; Universite de Montpellier	Carvalho-Santos, A (corresponding author), Inst Oswaldo Cruz, Lab Thymus Res, FIOCRUZ, BR-20001 Rio De Janeiro, Brazil.	adcarvalhosantos@gmail.com; carlaeponina@gmail.com	Villa-Verde, Dea M.S./Q-1238-2016; Carla, Carvalho-Pinto Eponina/GXG-7917-2022; Nunes Vieira, Joyce/AFX-9540-2022; Xavier, Analúcia/G-9255-2011	Villa-Verde, Dea M.S./0000-0002-2685-5512; Carla, Carvalho-Pinto Eponina/0000-0002-1815-8418; Nunes Vieira, Joyce/0000-0003-0142-0835; Xavier, Analúcia/0000-0003-4501-1857; Kuhnert, Lia Rafaella Ballard/0000-0001-8372-8926; Ribeiro-Alves, Marcelo/0000-0002-8663-3364	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Oswaldo Cruz (Fiocruz); Programa de Fomento a Pesquisa (FOPESQ, PROPPI - UFF)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Oswaldo Cruz (Fiocruz); Programa de Fomento a Pesquisa (FOPESQ, PROPPI - UFF)	Carvalho-Santos A has a Post-doctoral position at Instituto Oswaldo Cruz, Fiocruz, with a grant from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The work also received support from Fundacao Oswaldo Cruz (Fiocruz) and Programa de Fomento a Pesquisa (FOPESQ, PROPPI - UFF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, DIABETES ATLAS; [Anonymous], 2014, CARE DIABETES S1, V37, pS14; Boghdadi G, 2014, RHEUMATOL INT, V34, P1217, DOI 10.1007/s00296-014-3020-4; Carvalho-Pinto C, 2004, EUR J IMMUNOL, V34, P548, DOI 10.1002/eji.200324285; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Corte-Real J, 2009, ANN NY ACAD SCI, V1173, P442, DOI 10.1111/j.1749-6632.2009.04661.x; Dillon SR, 2006, NAT REV DRUG DISCOV, V5, P235, DOI 10.1038/nrd1982; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Fabris M, 2010, AUTOIMMUN REV, V9, P165, DOI 10.1016/j.autrev.2009.07.005; Fernandez L, 2013, ANN RHEUM DIS, V72, P1367, DOI 10.1136/annrheumdis-2012-202382; Gomes CP, 2013, AM J REPROD IMMUNOL, V69, P545, DOI 10.1111/aji.12088; Gumus P, 2015, J PERIODONTOL, V86, P387, DOI 10.1902/jop.2014.140444; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hendriks J, 2005, CELL DEATH DIFFER, V12, P637, DOI 10.1038/sj.cdd.4401647; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Lopez-Fraga M, 2001, EMBO REP, V2, P945, DOI 10.1093/embo-reports/kve198; Marino E, 2009, DIABETES, V58, P1568, DOI 10.2337/db08-1504; Morel J, 2009, ANN RHEUM DIS, V68, P997, DOI 10.1136/ard.2008.090928; R Development Core Team, 2014, R LANG ENV STAT COMP; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Spranger J., INFLAMMATORY CYTOKIN, P812; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Wascher TC, 2011, MOL MED, V17, P189, DOI 10.2119/molmed.2010.00221; Yin J, 2009, AM J PHYSIOL-ENDOC M, V296, pE333, DOI 10.1152/ajpendo.90760.2008	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140150	10.1371/journal.pone.0140150	http://dx.doi.org/10.1371/journal.pone.0140150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469782	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600029
J	Nowacka, N; Nowak, R; Drozd, M; Olech, M; Los, R; Malm, A				Nowacka, Natalia; Nowak, Renata; Drozd, Marta; Olech, Marta; Los, Renata; Malm, Anna			Antibacterial, Antiradical Potential and Phenolic Compounds of Thirty-One Polish Mushrooms	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; ANTIOXIDANT; WILD; RESISTANCE; POLAND	Background Among many sources of natural bioactive substances, mushrooms constitute a huge and almost unexplored group. Fungal compounds have been repeatedly reported to exert biological effects which have prompted their use in pharmaceutical and cosmetic industry. Therefore, the aim of this study was analysis of chemical composition and biological activity of 31 wild growing mushroom species (including saprophytic and parasitic) from Poland. Methods Qualitative and quantitative LC-ESI-MS/MS analysis of fourteen phenolic acids in the mushrooms analysed was performed. Moreover, total phenolic content was determined by the modified Folin-Ciocalteau method. Antioxidative activity of ethanolic extracts towards DPPH center dot free radical was examined. Antibacterial activity against Gram-positive (S. epidermidis, S. aureus, B. subtilis, M. luteus) and Gram-negative (E. coli, K. pneumoniae, P. aeruginosa, P. mirabilis) microbial strains was analyzed. Results As a result, the first such broad report on polyphenolic composition, antiradical and antimicrobial potential of wild growing Polish mushrooms was developed. Mushroom extracts were found to contain both benzoic (protocatechuic, 4-OH-benzoic, vanillic, syringic) and cinnamic acid derivatives (caffeic, p-coumaric, ferulic). Total phenolic content in mushrooms ranged between 2.79 and 53.13 mg gallic acid equivalent/g of dried extract in Tri-chaptum fuscoviolaceum and Fomes fomentarius, respectively. Fungi showed much differentiated antiradical activity, from highly active F. fomentarius to poorly effective Russula fragilis (IC50 1.39 to 120.54 mg per mg DPPH center dot, respectively). A quite considerable relationship between phenolic content and antiradical activity has been demonstrated. Mushrooms varied widely in antimicrobial potential (MIC from 0.156 to 5 mg/ml). Generally, a slightly higher activity against Gram-positive than Gram-negative strains was observed. This is the first study concerning the chemical composition and biological activity of the majority of investigated species.	[Nowacka, Natalia; Nowak, Renata; Drozd, Marta; Olech, Marta] Med Univ Lublin, Chair & Dept Pharmaceut Bot, Lublin, Poland; [Los, Renata; Malm, Anna] Med Univ Lublin, Dept Pharmaceut Microbiol, Lublin, Poland	Medical University of Lublin; Medical University of Lublin	Nowak, R (corresponding author), Med Univ Lublin, Chair & Dept Pharmaceut Bot, Lublin, Poland.	renata.nowak@umlub.pl	Olech, Marta/L-3799-2019	Olech, Marta/0000-0002-2838-550X; Nowak, Renata/0000-0003-4952-3147; Nowacka-Jechalke, Natalia/0000-0003-1133-2150; Malm, Anna/0000-0003-1503-7634	Medical University of Lublin [DS 46]	Medical University of Lublin	The study was performed with the financial support of Medical University of Lublin, grant DS 46, to RN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MJ, 2012, PLANTA MED, V78, P1707, DOI 10.1055/s-0032-1315370; Chen YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108140; Choi Y, 2006, FOOD CHEM, V99, P381, DOI 10.1016/j.foodchem.2005.08.004; Dogan Hasan Huseyin, 2013, Pak J Biol Sci, V16, P1279, DOI 10.3923/pjbs.2013.1279.1286; Ferreira ICFR, 2009, CURR MED CHEM, V16, P1543, DOI 10.2174/092986709787909587; Fukumoto LR, 2000, J AGR FOOD CHEM, V48, P3597, DOI 10.1021/jf000220w; Gan C. H., 2013, International Food Research Journal, V20, P1095; Guminska B., 1985, GRZYBY ICH OZNACZANI; Heleno SA, 2012, J AGR FOOD CHEM, V60, P4634, DOI 10.1021/jf300739m; Kalac P, 2013, J SCI FOOD AGR, V93, P209, DOI 10.1002/jsfa.5960; Karaman M, 2014, INT J FOOD SCI NUTR, V65, P311, DOI 10.3109/09637486.2013.860584; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Mathew S, 2015, J FOOD SCI TECH MYS, V52, P5790, DOI 10.1007/s13197-014-1704-0; Nowacka N, 2014, LWT-FOOD SCI TECHNOL, V59, P689, DOI 10.1016/j.lwt.2014.05.041; Olech M, 2012, ACTA POL PHARM, V69, P501; Olech M, 2012, CENT EUR J BIOL, V7, P172, DOI 10.2478/s11535-011-0105-x; Shirmila Jose G, 2013, INT J PHARM PHARM SC, V5, P161; Smith JE, 2002, BIOTECHNOL LETT, V24, P1839, DOI 10.1023/A:1020994628109; Soumitra Paloi, 2013, International Journal of PharmTech Research, V5, P1645; Sulkowska-Ziaja K, 2012, INT J MED MUSHROOMS, V14, P385, DOI 10.1615/IntJMedMushr.v14.i4.60; Wasser SP, 2011, APPL MICROBIOL BIOT, V89, P1323, DOI 10.1007/s00253-010-3067-4; Woolhouse M, 2014, NATURE, V509, P555, DOI 10.1038/509555a; World Health Organization, 2014, ANT RES GLOB REP SUR	24	55	57	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140355	10.1371/journal.pone.0140355	http://dx.doi.org/10.1371/journal.pone.0140355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468946	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600048
J	Izquierdo, EJ; Williams, PL; Beer, RD				Izquierdo, Eduardo J.; Williams, Paul L.; Beer, Randall D.			Information Flow through a Model of the C-elegans Klinotaxis Circuit	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; NEURONAL-ACTIVITY; NEURAL CIRCUITS; CHEMOTAXIS; BEHAVIOR; SYNERGY; SYSTEM; INDEPENDENCE; MECHANISMS; REDUNDANCY	Understanding how information about external stimuli is transformed into behavior is one of the central goals of neuroscience. Here we characterize the information flow through a complete sensorimotor circuit: from stimulus, to sensory neurons, to interneurons, to motor neurons, to muscles, to motion. Specifically, we apply a recently developed framework for quantifying information flow to a previously published ensemble of models of salt klinotaxis in the nematode worm Caenorhabditis elegans. Despite large variations in the neural parameters of individual circuits, we found that the overall information flow architecture circuit is remarkably consistent across the ensemble. This suggests structural connectivity is not necessarily predictive of effective connectivity. It also suggests information flow analysis captures general principles of operation for the klinotaxis circuit. In addition, information flow analysis reveals several key principles underlying how the models operate: (1) Interneuron class AIY is responsible for integrating information about positive and negative changes in concentration, and exhibits a strong left/right information asymmetry. (2) Gap junctions play a crucial role in the transfer of information responsible for the information symmetry observed in interneuron class AIZ. (3) Neck motor neuron class SMB implements an information gating mechanism that underlies the circuit's state-dependent response. (4) The neck carries more information about small changes in concentration than about large ones, and more information about positive changes in concentration than about negative ones. Thus, not all directions of movement are equally informative for the worm. Each of these findings corresponds to hypotheses that could potentially be tested in the worm. Knowing the results of these experiments would greatly refine our understanding of the neural circuit underlying klinotaxis.	[Izquierdo, Eduardo J.; Williams, Paul L.; Beer, Randall D.] Indiana Univ, Cognit Sci Program, Bloomington, IN 47405 USA; [Izquierdo, Eduardo J.; Beer, Randall D.] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Izquierdo, EJ (corresponding author), Indiana Univ, Cognit Sci Program, Bloomington, IN 47405 USA.	edizquie@indiana.edu			NSF [IIC-1216739]; Div Of Information & Intelligent Systems [1216739] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by NSF grant IIC-1216739 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Balduzzi D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000091; BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Beer RD, 1999, J COMPUT NEUROSCI, V7, P119, DOI 10.1023/A:1008920021246; Beer RD, 2014, COGNITIVE SCI; Bertschinger N, 2014, ENTROPY-SWITZ, V16, P2161, DOI 10.3390/e16042161; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; BRENNER S, 1974, GENETICS, V77, P71; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; Butts DA, 2003, NETWORK-COMP NEURAL, V14, P177, DOI 10.1088/0954-898X/14/2/301; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Clark DA, 2007, J NEUROSCI, V27, P6083, DOI 10.1523/JNEUROSCI.1032-07.2007; Cover TM, 2006, ELEMENTS INFORM THEO, V2nd; DAVIS RE, 1989, J NEUROSCI, V9, P403; Dayan P, 2001, COMPUTATIONAL NEUROS; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; DeWeese MR, 1999, NETWORK-COMP NEURAL, V10, P325, DOI 10.1088/0954-898X/10/4/303; ECKHORN R, 1975, BIOL CYBERN, V17, P7, DOI 10.1007/BF00326705; Faumont S, 2006, J NEUROPHYSIOL, V95, P1976, DOI 10.1152/jn.01050.2005; Ferree TC, 1999, J COMPUT NEUROSCI, V6, P263, DOI 10.1023/A:1008857906763; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Gabel CV, 2007, J NEUROSCI, V27, P7586, DOI 10.1523/JNEUROSCI.0775-07.2007; GARDNER D, 1989, J NEUROPHYSIOL, V61, P845, DOI 10.1152/jn.1989.61.4.845; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Griffith V, 2014, EMERGENCE COMPLEX CO, V9, P159, DOI 10.1007/978-3-642-53734-9_6; Griffith V, 2014, ENTROPY-SWITZ, V16, P1985, DOI 10.3390/e16041985; Harder M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012130; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; Hobert O, 2003, J NEUROBIOL, V54, P203, DOI 10.1002/neu.10168; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Izquierdo EJ, 2015, ECAL 2015: THE THIRTEENTH EUROPEAN CONFERENCE ON ARTIFICIAL LIFE, P199, DOI 10.7551/978-0-262-33027-5-ch040; Izquierdo EJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002890; Izquierdo EJ, 2010, J NEUROSCI, V30, P12908, DOI 10.1523/JNEUROSCI.2606-10.2010; Kaiser A, 2002, PHYSICA D, V166, P43, DOI 10.1016/S0167-2789(02)00432-3; Kane EA, 2013, P NATL ACAD SCI USA, V110, pE3868, DOI 10.1073/pnas.1215295110; Kjaer T W, 1994, J Comput Neurosci, V1, P109, DOI 10.1007/BF00962721; Latham PE, 2005, J NEUROSCI, V25, P5195, DOI 10.1523/JNEUROSCI.5319-04.2005; Liu Q, 2006, J BIOL CHEM, V281, P7881, DOI 10.1074/jbc.M512382200; Lizier JT, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026110; Lizier JT, 2013, IEEE SYMP ART LIFE, P43, DOI 10.1109/ALIFE.2013.6602430; Lizier JT, 2012, INFORM SCIENCES, V208, P39, DOI 10.1016/j.ins.2012.04.016; Lizier JT, 2011, J COMPUT NEUROSCI, V30, P85, DOI 10.1007/s10827-010-0271-2; Lizier JT, 2010, CHAOS, V20, DOI 10.1063/1.3486801; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; Luo LJ, 2006, J EXP BIOL, V209, P4652, DOI 10.1242/jeb.02590; McCormick K, 2013, THESIS U OREGON; McCormick KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025710; Nemenman I, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.056111; Neymotin SA, 2011, J COMPUT NEUROSCI, V30, P69, DOI 10.1007/s10827-010-0253-4; Oda S, 2011, J NEUROPHYSIOL, V106, P301, DOI 10.1152/jn.01029.2010; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Panzeri S, 1999, P ROY SOC B-BIOL SCI, V266, P1001, DOI 10.1098/rspb.1999.0736; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; Prevedel R, 2014, NAT METHODS, V11, P727, DOI [10.1038/NMETH.2964, 10.1038/nmeth.2964]; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Rieke F., 1999, SPIKES EXPLORING NEU; Rozell CJ, 2005, NEUROCOMPUTING, V65, P429, DOI 10.1016/j.neucom.2004.10.042; Schneidman E, 2003, J NEUROSCI, V23, P11539; Schnitzer M. J., 1990, S SOC GEN MICROBIOL, V46, P15; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; SCOTT DW, 1985, ANN STAT, V13, P1024, DOI 10.1214/aos/1176349654; Sengupta P, 2009, CURR OPIN NEUROBIOL, V19, P637, DOI 10.1016/j.conb.2009.09.009; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shipley FB, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00028; Sporns O., 2011, NETWORKS BRAIN; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; THEUNISSEN FE, 1991, J NEUROPHYSIOL, V66, P1690, DOI 10.1152/jn.1991.66.5.1690; Thiele TR, 2009, J NEUROSCI, V29, P11904, DOI 10.1523/JNEUROSCI.0594-09.2009; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Victor Jonathan D, 2006, Biol Theory, V1, P302, DOI 10.1162/biot.2006.1.3.302; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wibral M, 2014, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-3-642-54474-3; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006; Williams PL, 2010, LECT NOTES ARTIF INT, V6226, P38, DOI 10.1007/978-3-642-15193-4_4; Williams PL, 2010, NONNEGATIVE DECOMPOS, P1004; Yoshida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1750	82	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140397	10.1371/journal.pone.0140397	http://dx.doi.org/10.1371/journal.pone.0140397			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465883	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100111
J	Jashnsaz, H; Nguyen, T; Petrache, HI; Presse, S				Jashnsaz, Hossein; Nguyen, Tyler; Petrache, Horia I.; Presse, Steve			Inferring Models of Bacterial Dynamics toward Point Sources	PLOS ONE			English	Article							ESCHERICHIA-COLI; CHEMOTACTIC RESPONSE; ROBUSTNESS; STIMULI; NOISE	Experiments have shown that bacteria can be sensitive to small variations in chemoattractant (CA) concentrations. Motivated by these findings, our focus here is on a regime rarely studied in experiments: bacteria tracking point CA sources (such as food patches or even prey). In tracking point sources, the CA detected by bacteria may show very large spatio-temporal fluctuations which vary with distance from the source. We present a general statistical model to describe how bacteria locate point sources of food on the basis of stochastic event detection, rather than CA gradient information. We show how all model parameters can be directly inferred from single cell tracking data even in the limit of high detection noise. Once parameterized, our model recapitulates bacterial behavior around point sources such as the "volcano effect". In addition, while the search by bacteria for point sources such as prey may appear random, our model identifies key statistical signatures of a targeted search for a point source given any arbitrary source configuration.	[Jashnsaz, Hossein; Petrache, Horia I.; Presse, Steve] Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46202 USA; [Nguyen, Tyler] Indiana Univ Sch Med, Stark Neurosci Inst, Indianapolis, IN 46202 USA; [Presse, Steve] Indiana Univ Sch Med, Dept Cell & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Presse, S (corresponding author), Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46202 USA.	stevenpresse@gmail.com	Nguyen, Tyler/GRX-6421-2022		IUPUI Office of the Vice Chancellor for Research	IUPUI Office of the Vice Chancellor for Research	SP acknowledges the NSF (MCB 1412259) and a Graduate Student Imaging Research Fellowship from the IUPUI Office of the Vice Chancellor for Research.	ADLER J, 1974, SCIENCE, V184, P1293, DOI 10.1126/science.184.4143.1292; Alber M, 2003, J MOL BIOL, V329, P291; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; Andrews BW, 2006, PLOS COMPUT BIOL, V2, P1407, DOI 10.1371/journal.pcbi.0020154; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bennett RR, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.148102; Berg, 2018, RANDOM WALKS BIOL; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; BERG HC, 1975, P NATL ACAD SCI USA, V72, P3235, DOI 10.1073/pnas.72.8.3235; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BERG HC, 2004, BIOL MED PHYS BIOMED, P1; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; Bray D, 2007, CURR BIOL, V17, P12, DOI 10.1016/j.cub.2006.11.027; BROWN D A, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1388, DOI 10.1073/pnas.71.4.1388; Eisenbach M, 2004, CHEMOTAXIS, DOI DOI 10.1142/P303; Goryanin II, 2011, ADV SYSTEMS BIOL; Jennings HS, 1901, AM J PHYSIOL, V6, P31, DOI 10.1152/ajplegacy.1901.6.1.31; Jiang LL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000735; Kalinin YV, 2009, BIOPHYS J, V96, P2439, DOI 10.1016/j.bpj.2008.10.027; Kollmann M, 2007, CURR BIOL, V17, pR132, DOI 10.1016/j.cub.2006.12.034; Lalanne JB, 2015, P NATL ACAD SCI USA, V112, P1898, DOI 10.1073/pnas.1420903112; Lambert C, 2011, J BACTERIOL, V193, P3139, DOI 10.1128/JB.00224-11; Masson JB, 2012, P NATL ACAD SCI USA, V109, P1802, DOI 10.1073/pnas.1116772109; Morehouse KA, 2011, J BACTERIOL, V193, P932, DOI 10.1128/JB.00941-10; Mukherjee S, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/066002; Mukherjee S, 2013, P NATL ACAD SCI USA, V110, P18531, DOI 10.1073/pnas.1311069110; Patnaik PR, 2012, BIOSCIENCE, V62, P1030, DOI 10.1525/bio.2012.62.12.5; Rothert W, 1901, FLORA, V88, P371; Saragosti J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035412; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Shimizu TS, 2003, J MOL BIOL, V329, P291, DOI 10.1016/S0022-2836(03)00437-6; Simons JE, 2011, MATH COMPUT MODEL, V53, P1374, DOI 10.1016/j.mcm.2010.01.019; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Spiro PA, 1997, P NATL ACAD SCI USA, V94, P7263, DOI 10.1073/pnas.94.14.7263; STRALEY SC, 1977, J BACTERIOL, V132, P628, DOI 10.1128/JB.132.2.628-640.1977; Tindall MJ, 2008, B MATH BIOL, V70, P1525, DOI 10.1007/s11538-008-9321-6; Tu YH, 2013, ANNU REV BIOPHYS, V42, P337, DOI 10.1146/annurev-biophys-083012-130358; Tu YH, 2008, P NATL ACAD SCI USA, V105, P14855, DOI 10.1073/pnas.0807569105; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Vergassola M, 2007, NATURE, V445, P406, DOI 10.1038/nature05464; Vladimirov N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000717; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Zonia L, 2009, J R SOC INTERFACE, V6, P1035, DOI 10.1098/rsif.2008.0397	48	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140428	10.1371/journal.pone.0140428	http://dx.doi.org/10.1371/journal.pone.0140428			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466373	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100122
J	Labriere, N; Laumonier, Y; Locatelli, B; Vieilledent, G; Comptour, M				Labriere, Nicolas; Laumonier, Yves; Locatelli, Bruno; Vieilledent, Ghislain; Comptour, Marion			Ecosystem Services and Biodiversity in a Rapidly Transforming Landscape in Northern Borneo	PLOS ONE			English	Article							SHIFTING CULTIVATION; OIL PALM; CARBON STORAGE; SWIDDEN AGRICULTURE; FOREST BIODIVERSITY; TROPICAL FORESTS; SOIL-EROSION; DIVERSITY; SUCCESSION; WORLDWIDE	Because industrial agriculture keeps expanding in Southeast Asia at the expense of natural forests and traditional swidden systems, comparing biodiversity and ecosystem services in the traditional forest-swidden agriculture system vs. monocultures is needed to guide decision making on land-use planning. Focusing on tree diversity, soil erosion control, and climate change mitigation through carbon storage, we surveyed vegetation and monitored soil loss in various land-use areas in a northern Bornean agricultural landscape shaped by swidden agriculture, rubber tapping, and logging, where various levels and types of disturbance have created a fine mosaic of vegetation from food crop fields to natural forest. Tree species diversity and ecosystem service production were highest in natural forests. Logged-over forests produced services similar to those of natural forests. Land uses related to the swidden agriculture system largely outperformed oil palm or rubber monocultures in terms of tree species diversity and service production. Natural and logged-over forests should be maintained or managed as integral parts of the swidden system, and landscape multifunctionality should be sustained. Because natural forests host a unique diversity of trees and produce high levels of ecosystem services, targeting carbon stock protection, e.g. through financial mechanisms such as Reducing Emissions from Deforestation and Forest Degradation (REDD+), will synergistically provide benefits for biodiversity and a wide range of other services. However, the way such mechanisms could benefit communities must be carefully evaluated to counter the high opportunity cost of conversion to monocultures that might generate greater income, but would be detrimental to the production of multiple ecosystem services.	[Labriere, Nicolas; Laumonier, Yves; Locatelli, Bruno; Vieilledent, Ghislain] Ctr Cooperat Int Rech Agron Dev CIRAD, UPR Biens & Serv Ecosyst Forestiers Trop BSEF, Montpellier, France; [Labriere, Nicolas] AgroParisTech, Ecole Doctorale ABIES, Paris, France; [Laumonier, Yves] Ctr Int Forestry Res CIFOR, CGIAR Res Program Forests Trees & Agroforestry, Bogor, Indonesia; [Locatelli, Bruno] Ctr Int Forestry Res CIFOR, CGIAR Res Program Forests Trees & Agroforestry, Lima, Peru; [Locatelli, Bruno] Univ Montpellier 2, CNRS, Ctr Ecol Fonct & Evolut CEFE, Montpellier, France	CIRAD; AgroParisTech; CGIAR; Center for International Forestry Research (CIFOR); CGIAR; Center for International Forestry Research (CIFOR); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Labriere, N (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, UPR Biens & Serv Ecosyst Forestiers Trop BSEF, Montpellier, France.	nicolas.labriere@cirad.fr	Vieilledent, Ghislain/D-8323-2011; Locatelli, Bruno/C-9957-2009	Vieilledent, Ghislain/0000-0002-1685-4997; Locatelli, Bruno/0000-0003-2983-1644	CoLUPSIA (EU Financed Project - DCI); CRP-FTA (CGIAR Research Program on Forests, Trees, and Agroforestry); ABIES (Ecole Doctorale Agriculture, Alimentation, Biologie, Environnements et Sante); AusAid (Center for International Forestry Research) [63650]; CIRAD	CoLUPSIA (EU Financed Project - DCI); CRP-FTA (CGIAR Research Program on Forests, Trees, and Agroforestry)(CGIAR); ABIES (Ecole Doctorale Agriculture, Alimentation, Biologie, Environnements et Sante); AusAid (Center for International Forestry Research)(CGIAR); CIRAD	This research received financial support from CoLUPSIA (EU Financed Project - DCI), AusAid (Agreement 63650 with Center for International Forestry Research), CIRAD, CRP-FTA (CGIAR Research Program on Forests, Trees, and Agroforestry) and ABIES (Ecole Doctorale Agriculture, Alimentation, Biologie, Environnements et Sante).	Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], FORESTS POVERTY REDU; Aratrakorn S, 2006, BIRD CONSERV INT, V16, P71, DOI 10.1017/S0959270906000062; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Bivand R, 2015, J STAT SOFTW, V63, P1; Bivand R, 2013, GEOGR ANAL, V45, P150, DOI 10.1111/gean.12008; BROOKFIELD H, 1990, GLOBAL ENVIRON CHANG, V1, P42, DOI 10.1016/0959-3780(90)90006-U; BROWN S, 1990, PLANT SOIL, V124, P53, DOI 10.1007/BF00010931; Bruijnzeel LA, 2004, AGR ECOSYST ENVIRON, V104, P185, DOI 10.1016/j.agee.2004.01.015; Bruun TB, 2006, AGR ECOSYST ENVIRON, V113, P139, DOI 10.1016/j.agee.2005.09.012; Cannon CH, 1998, SCIENCE, V281, P1366, DOI 10.1126/science.281.5381.1366; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Colwell R.K., 2009, PRINCET GUIDE ECOL P, V663, P257, DOI DOI 10.1515/9781400833023.257; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Costa C, 2013, SOIL TILL RES, V134, P207, DOI 10.1016/j.still.2013.08.010; deJong W, 1997, AGR ECOSYST ENVIRON, V62, P187, DOI 10.1016/S0167-8809(96)01144-9; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; DOVE MR, 1993, ECON BOT, V47, P136, DOI 10.1007/BF02862016; Dressler W, 2015, J DEV EFFECT, V7, P210, DOI 10.1080/19439342.2014.991799; Edwards DP, 2011, P ROY SOC B-BIOL SCI, V278, P82, DOI 10.1098/rspb.2010.1062; Fisher B, 2011, FRONT ECOL ENVIRON, V9, P329, DOI 10.1890/100079; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Germer J., 2008, Environment Development and Sustainability, V10, P697, DOI 10.1007/s10668-006-9080-1; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gilroy JJ, 2014, GLOBAL CHANGE BIOL, V20, P2162, DOI 10.1111/gcb.12482; Gomez-Delgado F, 2010, THESIS; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Haining R, 1990, SPATIAL DATA ANAL SO; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jarvis A, 2008, HOLE FILLED SEAMLESS; Kessler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047192; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Labriere N, 2015, AGR ECOSYST ENVIRON, V203, P127, DOI 10.1016/j.agee.2015.01.027; Lawrence D, 2005, ECOLOGY, V86, P26, DOI 10.1890/03-0564; Lawrence D, 2004, ECOL APPL, V14, P1855, DOI 10.1890/03-5321; Lawrence D, 2001, ECOLOGY, V82, P2769, DOI 10.1890/0012-9658(2001)082[2769:CISPDY]2.0.CO;2; Lawrence DC, 1996, AGROFOREST SYST, V34, P83, DOI 10.1007/BF00129634; Locatelli B, 2014, ENVIRON CONSERV, V41, P27, DOI 10.1017/S0376892913000234; MacKinnon K., 1996, ECOLOGY KALIMANTAN, V3; Martin PA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2236; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Meijaard Erik, 2005, pi; Michon Genevieve, 1995, P90; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Penot E., 2004, Beyond tropical deforestation: from tropical deforestation to forest cover dynamics and forest development, P221; Putz FE, 2012, CONSERV LETT, V5, P296, DOI 10.1111/j.1755-263X.2012.00242.x; R Core Team, 2021, R LANGUAGE ENV STAT; Raudsepp-Hearne C, 2010, Proc Natl Acad Sci U S A, V107, P5242, DOI 10.1073/pnas.0907284107; Rijsdijk A, 2005, IAHS-AISH P, V292, P16; Robichaud PR, 2002, RMRSGTR94 USDA FOR S; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Savilaakso S, 2014, ENVIRON EVID, V3, DOI 10.1186/2047-2382-3-4; Sidle RC, 2006, FOREST ECOL MANAG, V224, P199, DOI 10.1016/j.foreco.2005.12.019; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Strassburg BBN, 2010, CONSERV LETT, V3, P98, DOI 10.1111/j.1755-263X.2009.00092.x; Walker S.M., 2012, STANDARD OPERATING P; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Werner S., 1999, Management of secondary and logged-over forests in Indonesia. Selected proceedings of an international workshop, 17-19 November 1997, Bogor, Indonesia., P33; Wischmeier W. H., 1978, U. S. Department of Agriculture, Agriculture Handbook	70	21	21	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140423	10.1371/journal.pone.0140423	http://dx.doi.org/10.1371/journal.pone.0140423			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466120	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100120
J	Tsai, CW; Kao, YT; Chiang, IN; Wang, JH; Young, TH				Tsai, Ching-Wen; Kao, Yu-Ting; Chiang, I-Ni; Wang, Jyh-Horng; Young, Tai-Horng			Chitosan Treatment Delays the Induction of Senescence in Human Foreskin Fibroblast Strains	PLOS ONE			English	Article							HUMAN-DIPLOID FIBROBLASTS; REPLICATIVE LIFE-SPAN; CELLULAR SENESCENCE; BETA-GALACTOSIDASE; PREMATURE SENESCENCE; SECRETORY PHENOTYPE; TUMOR SUPPRESSION; INDUCED APOPTOSIS; HUMAN-CELLS; P53	Fibroblasts have been extensively used as a model to study cellular senescence. The purpose of this study was to investigate whether the human foreskin fibroblast aging process could be regulated by using the biomaterial chitosan. Fibroblasts cultured on commercial tissue culture polystyrene (TCPS) entered senescence after 55-60 population doublings (PDs), and were accompanied by larger cell shape, higher senescence-associated beta-galactosidase (SA beta-gal) activity, lower proliferation capacity, and upregulation of senescence-associated molecular markers p21, p53, retinoblastoma (pRB), and p16. Before senescence was reached, PD48 cells were collected from TCPS and seeded on chitosan for three days (PD48-Cd3) to form multicellular spheroids. The protein expression of senescence-associated secretory phenotypes (SASPs) and senescence-associated molecular markers of these cells in PD48-Cd3 spheroids were downregulated significantly. Following chitosan treatment, fibroblasts reseeded on TCPS showed lower SA beta-gal activity, increased cellular motility, and a higher proliferation ability of 70-75 PDs. These phenotypic changes were not accompanied by colonies forming in soft agar and a continuous decrease in the senescence-associated proteins p53 and pRB which act as a barrier to tumorigenesis. These results demonstrate that chitosan treatment could delay the induction of senescence which may be useful and safe for future tissue engineering applications.	[Tsai, Ching-Wen; Kao, Yu-Ting; Chiang, I-Ni; Young, Tai-Horng] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 100, Taiwan; [Tsai, Ching-Wen; Kao, Yu-Ting; Chiang, I-Ni; Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 100, Taiwan; [Chiang, I-Ni] Natl Taiwan Univ Hosp, Dept Urol, Taipei 100, Taiwan; [Wang, Jyh-Horng] Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Wang, JH (corresponding author), Natl Taiwan Univ Hosp, Dept Orthoped Surg, 7 Chung Shan S Rd, Taipei 100, Taiwan.	jhwang@ntuh.gov.tw; thyoung@ntu.edu.tw		Wang, Jyh- Horng/0000-0002-1531-5297; YOUNG, TAI-HORNG/0000-0001-5338-4747	Ministry of Science and Technology of the Republic of China [102-2221-E-002-226-MY3, 104-2314-B-002-008-MY3]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	This work is supported by the Ministry of Science and Technology of the Republic of China (102-2221-E-002-226-MY3 and 104-2314-B-002-008-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archana D, 2013, CARBOHYD POLYM, V95, P530, DOI 10.1016/j.carbpol.2013.03.034; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bielak-Zmijewska A, 2014, BIOGERONTOLOGY, V15, P47, DOI 10.1007/s10522-013-9477-9; BOND JA, 1994, ONCOGENE, V9, P1885; Bond JA, 1999, MOL CELL BIOL, V19, P3103; Buttiglieri S, 2011, EXP HEMATOL, V39, P1171, DOI 10.1016/j.exphem.2011.08.009; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Chae HJ, 2000, PHARMACOL RES, V42, P373, DOI 10.1006/phrs.2000.0700; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Cheng NC, 2012, BIOMATERIALS, V33, P1748, DOI 10.1016/j.biomaterials.2011.11.049; Choi HR, 2011, AGING CELL, V10, P148, DOI 10.1111/j.1474-9726.2010.00654.x; Coates SSA, 2007, J PHARMACOL EXP THER, V322, P70, DOI 10.1124/jpet.106.118018; COMINGS DE, 1970, EXP CELL RES, V61, P295, DOI 10.1016/0014-4827(70)90451-9; CRISTOFA.VJ, 1969, MED EXP, V19, P313; CRISTOFALO VJ, 1975, MECH AGEING DEV, V4, P19, DOI 10.1016/0047-6374(75)90004-4; CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617; Decherchi P, 1997, J NEUROSCI METH, V71, P205, DOI 10.1016/S0165-0270(96)00146-X; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Drummond CJ, 2011, INVEST NEW DRUG, V29, P1102, DOI 10.1007/s10637-010-9473-8; GREENBERG SB, 1977, IN VITRO CELL DEV B, V13, P297; Hodjat M, 2013, J VASC RES, V50, P109, DOI 10.1159/000343000; Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820; Kato Yoshinori, 2003, Current Pharmaceutical Biotechnology, V4, P303, DOI 10.2174/1389201033489748; Kerch G, 2015, MAR DRUGS, V13, P2158, DOI 10.3390/md13042158; Kim K., 2014, J MARKETING THOUGHT, V1, P1, DOI DOI 10.4161/15384047; Kim KM, 2012, INT J MOL MED, V29, P619, DOI 10.3892/ijmm.2012.892; Kim SY, 2011, APOPTOSIS, V16, P795, DOI 10.1007/s10495-011-0612-2; Kiyono T, 2007, EXPERT OPIN THER TAR, V11, P1623, DOI 10.1517/14728222.11.12.1623; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Leontieva OV, 2010, AGING-US, V2, P924, DOI 10.18632/aging.100265; Lou PJ, 2010, BIOMATERIALS, V31, P1568, DOI 10.1016/j.biomaterials.2009.11.048; MITSUI Y, 1976, MECH AGEING DEV, V5, P45, DOI 10.1016/0047-6374(76)90007-5; NICHOLS MG, 1994, PHYS MED BIOL, V39, P2161, DOI 10.1088/0031-9155/39/12/003; Pandamooz S, 2012, BIOTECHNOL APPL BIOC, V59, P254, DOI 10.1002/bab.1020; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Passos Joao F, 2013, Methods Mol Biol, V965, P253, DOI 10.1007/978-1-62703-239-1_17; Passos Joao F, 2007, Methods Mol Biol, V371, P33; Peng CC, 2008, MACROMOL BIOSCI, V8, P316, DOI 10.1002/mabi.200700188; Piegari E, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0334-4; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Sato Y, 2013, REPRODUCTION, V145, P505, DOI 10.1530/REP-12-0086; Sawai H, 2011, BIOCHEM BIOPH RES CO, V411, P569, DOI 10.1016/j.bbrc.2011.06.186; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Singla AK, 2001, BIOTECH HISTOCHEM, V76, P165, DOI 10.1080/714028147; STOKER M, 1968, INT J CANCER, V3, P683, DOI 10.1002/ijc.2910030517; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Zhu Y, 2014, CURR OPIN CLIN NUTR, V17, P324, DOI 10.1097/MCO.0000000000000065; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584	60	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140747	10.1371/journal.pone.0140747	http://dx.doi.org/10.1371/journal.pone.0140747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465338	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100164
J	Kumar, P; Lakshmi, YS; Bhaskar, C; Golla, K; Kondapi, AK				Kumar, Prashant; Lakshmi, Yeruva Samrajya; Bhaskar, C.; Golla, Kishore; Kondapi, Anand K.			Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BONE-MARROW TOXICITY; DRUG-DELIVERY; MICRONUCLEUS TEST; IN-VITRO; 3'-AZIDO-3'-DEOXYTHYMIDINE AZT; 3-AZIDO-3-DEOXYTHYMIDINE AZT; HIV; AZIDOTHYMIDINE; AIDS	Zidovudine (AZT) is one of the most referred antiretroviral drug. In spite of its higher bioavailability (50-75%) the most important reason of its cessation are bone marrow suppression, anemia, neutropenia and various organs related toxicities. This study aims at the improvement of oral delivery of AZT through its encapsulation in lactoferrin nanoparticles (AZT-lactonano). The nanoparticles (NPs) are of 50-60 nm in size and exhibit 67% encapsulation of the AZT. They are stable in simulated gastric and intestinal fluids. Anti-HIV-1 activity of AZT remains unaltered in nanoformulation in acute infection. The bioavailability and tissue distribution of AZT is higher in blood followed by liver and kidney. AZT-lactonano causes the improvement of pharmacokinetic profile as compared to soluble AZT; a more than 4 fold increase in AUC and AUMC in male and female rats. The serum C-max for AZT-lactonano was increased by 30%. Similarly there was nearly 2-fold increase in T-max and t(1/2). Our in vitro study confirms that, the endosomal pH is ideal for drug release from NPs and shows constant release from up to 96h. Bone marrow micronucleus assay show that nanoformulation exhibits approximately 2fold lower toxicity than soluble form. Histopathological and biochemical analysis further confirms that less or no significant organ toxicities when nanoparticles were used. AZT-lactonano has shown its higher efficacy, low organs related toxicities, improved pharmacokinetics parameter while keeping the antiviral activity intact. Thus, the nanoformulation are safe for the target specific drug delivery.	[Kumar, Prashant; Lakshmi, Yeruva Samrajya; Bhaskar, C.; Golla, Kishore; Kondapi, Anand K.] Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Hyderabad 500046, Andhra Pradesh, India	University of Hyderabad	Kondapi, AK (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Hyderabad 500046, Andhra Pradesh, India.	akondapi@gmail.com	Kumar, Prashant/GOE-5954-2022	Kumar, Prashant/0000-0003-1038-6149	Department of Science and Technology, Government of India; UGC BSR FRCP one time grant	Department of Science and Technology, Government of India(Department of Science & Technology (India)); UGC BSR FRCP one time grant	Funded by the Department of Science and Technology, Government of India, through a research project under nanomission and UGC BSR FRCP one time grant.	AARON CS, 1989, MUTAT RES, V223, P129, DOI 10.1016/0165-1218(89)90041-4; Acosta EP, 1996, CLIN PHARMACOKINET, V30, P251, DOI 10.2165/00003088-199630040-00001; Balakrishnan A, 2010, INDIAN J PHARMACOL, V42, P189, DOI 10.4103/0253-7613.66845; Barbier O, 2000, DRUG METAB DISPOS, V28, P497; BARRY M, 1994, BRIT J CLIN PHARMACO, V37, P7, DOI 10.1111/j.1365-2125.1994.tb04231.x; BOUDINOT FD, 1990, AIDS RES HUM RETROV, V6, P219, DOI 10.1089/aid.1990.6.219; BURGER DM, 1993, J CHROMATOGR-BIOMED, V622, P235, DOI 10.1016/0378-4347(93)80271-5; Callender DP, 1999, ANTIMICROB AGENTS CH, V43, P972, DOI 10.1128/AAC.43.4.972; Calogeropoulou T, 2003, CURR TOP MED CHEM, V3, P1467, DOI 10.2174/1568026033451763; D'Andrea G, 2008, CURR CLIN PHARMACOL, V3, P20, DOI 10.2174/157488408783329913; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fillebeen C, 1999, J BIOL CHEM, V274, P7011, DOI 10.1074/jbc.274.11.7011; Gandapu U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023388; Garg M, 2006, J DRUG TARGET, V14, P1, DOI 10.1080/10611860500525370; GENDELMAN HE, 1989, AIDS, V3, P475, DOI 10.1097/00002030-198908000-00001; Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931; Golla K, 2013, J CANCER, V4, P644, DOI 10.7150/jca.7093; Golla K, 2013, DRUG DELIV, V20, P156, DOI 10.3109/10717544.2013.801051; Golla K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051960; Groot F, 2005, J VIROL, V79, P3009, DOI 10.1128/JVI.79.5.3009-3015.2005; Guerard M, 2013, TOXICOL SCI, V135, P309, DOI 10.1093/toxsci/kft148; Jain Subheet, 2008, Current Drug Delivery, V5, P275, DOI 10.2174/156720108785915078; Jin SX, 2005, PHARMAZIE, V60, P840; Kaur CD, 2008, J DRUG TARGET, V16, P798, DOI 10.1080/10611860802475688 ; KIEBURTZ KD, 1992, J ACQ IMMUN DEF SYND, V5, P60; Krishna ADS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007240; Kuksal A, 2006, AAPS PHARMSCITECH, V7, DOI 10.1208/pt070101; Kumar PN, 2006, HIV MED, V7, P85, DOI 10.1111/j.1468-1293.2006.00346.x; KURTZBERG J, 1990, EXP HEMATOL, V18, P1094; Lobenberg R, 1998, J CONTROL RELEASE, V50, P21, DOI 10.1016/S0168-3659(97)00105-3; Lobenberg R, 1996, AIDS RES HUM RETROV, V12, P1709, DOI 10.1089/aid.1996.12.1709; LUZIER A, 1993, ANTIVIR RES, V21, P267, DOI 10.1016/0166-3542(93)90032-E; Mallipeddi R, 2010, INT J NANOMED, V5, P533; McNeil SE, 2011, METHODS MOL BIOL, V697, P3, DOI 10.1007/978-1-60327-198-1_1; MELTZER MS, 1990, IMMUNOL TODAY, V11, P217, DOI 10.1016/0167-5699(90)90086-O; Moh R, 2005, ANTIVIR THER, V10, P615; Nayak UY, 2009, J MICROENCAPSUL, V26, P214, DOI 10.1080/02652040802246325; Panhard X, 2007, EUR J CLIN PHARMACOL, V63, P1019, DOI 10.1007/s00228-007-0337-x; Parang K, 2000, CURR MED CHEM, V7, P995, DOI 10.2174/0929867003374372; PHILLIPS MD, 1991, ENVIRON MOL MUTAGEN, V18, P168, DOI 10.1002/em.2850180305; PHILLIPS NC, 1991, J ACQ IMMUN DEF SYND, V4, P959; Quevedo MA, 2011, EUR J PHARM SCI, V43, P151, DOI 10.1016/j.ejps.2011.04.007; Ravi PR, 2008, AAPS PHARMSCITECH, V9, P302, DOI 10.1208/s12249-007-9030-8; ROY S, 1988, J LEUKOCYTE BIOL, V43, P91, DOI 10.1002/jlb.43.1.91; Sanvicens N, 2008, TRENDS BIOTECHNOL, V26, P425, DOI 10.1016/j.tibtech.2008.04.005; SCHEDING S, 1994, EXP HEMATOL, V22, P60; SCHMID W, 1975, MUTAT RES, V31, P9, DOI 10.1016/0165-1161(75)90058-8; Scruggs ER, 2008, PHARMACOLOGY, V82, P83, DOI 10.1159/000134943; Sturmer M, 2007, ANTIVIR THER, V12, P695; SUZUKI Y, 1989, MUTAGENESIS, V4, P420, DOI 10.1093/mutage/4.6.420; Villard AL, 2008, BIOORGAN MED CHEM, V16, P7321, DOI 10.1016/j.bmc.2008.06.024; VOLBERDING P, 1988, BRIT J HOSP MED, V40, P101; VONBRIESEN H, 1990, RES VIROLOGY, V141, P225, DOI 10.1016/0923-2516(90)90025-E; Zeller A, 2013, TOXICOL SCI, V135, P317, DOI 10.1093/toxsci/kft149; ZHANG RW, 1993, ANTIMICROB AGENTS CH, V37, P1771, DOI 10.1128/AAC.37.9.1771	55	32	34	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140399	10.1371/journal.pone.0140399	http://dx.doi.org/10.1371/journal.pone.0140399			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461917	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300090
J	Edwards, HA; Hajduk, GK; Durieux, G; Burke, T; Dugdale, HL				Edwards, Hannah A.; Hajduk, Gabriela K.; Durieux, Gillian; Burke, Terry; Dugdale, Hannah L.			No Association between Personality and Candidate Gene Polymorphisms in a Wild Bird Population	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; LINKAGE DISEQUILIBRIUM; INDIVIDUAL-DIFFERENCES; EXPLORATORY-BEHAVIOR; PARENTAGE ASSIGNMENT; DRD4 POLYMORPHISMS; ANIMAL PERSONALITY; GREAT TITS; SEYCHELLES; EVOLUTION	Consistency of between-individual differences in behaviour or personality is a phenomenon in populations that can have ecological consequences and evolutionary potential. One way that behaviour can evolve is to have a genetic basis. Identifying the molecular genetic basis of personality could therefore provide insight into how and why such variation is maintained, particularly in natural populations. Previously identified candidate genes for personality in birds include the dopamine receptor D4 (DRD4), and serotonin transporter (SERT). Studies of wild bird populations have shown that exploratory and bold behaviours are associated with polymorphisms in both DRD4 and SERT. Here we tested for polymorphisms in DRD4 and SERT in the Seychelles warbler (Acrocephalus sechellensis) population on Cousin Island, Seychelles, and then investigated correlations between personality and polymorphisms in these genes. We found no genetic variation in DRD4, but identified four polymorphisms in SERT that clustered into five haplotypes. There was no correlation between bold or exploratory behaviours and SERT polymorphisms/haplotypes. The null result was not due to lack of power, and indicates that there was no association between these behaviours and variation in the candidate genes tested in this population. These null findings provide important data to facilitate representative future meta-analyses on candidate personality genes.	[Edwards, Hannah A.; Hajduk, Gabriela K.; Durieux, Gillian; Burke, Terry; Dugdale, Hannah L.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Dugdale, Hannah L.] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands; [Dugdale, Hannah L.] Nat Seychelles, Mahe, Seychelles	University of Sheffield; University of Groningen	Edwards, HA (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	bop12hae@sheffield.ac.uk	Burke, Terry/B-3196-2011; Dugdale, Hannah L/C-7138-2008	Burke, Terry/0000-0003-3848-1244; Dugdale, Hannah L/0000-0001-8769-0099; Hajduk, Gabriela Karolina/0000-0002-6100-8482	NERC studentship [X/007/001-15]; NERC [NE/I021748/1]; Genetics Society Summer Studentship [SSA2013_Dugdale]; two Schure Beijerinck Popping grants [SBP2013/46, SBP2012/26]; Natural Environment Research Council [NE/B504106/1, 1233724, NE/I021748/1] Funding Source: researchfish	NERC studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Genetics Society Summer Studentship; two Schure Beijerinck Popping grants; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by a NERC studentship (HAE: X/007/001-15), NERC fellowship (HLD: NE/I021748/1, http://www.nerc.ac.uk/funding/available/fellowships/index.asp?cookieConsent=A), Genetics Society Summer Studentship (HLD, GKH & HAE: SSA2013_Dugdale http://www.genetics.org.uk/Funding/GeneticsSocietySummerStudentships.aspx) and two Schure Beijerinck Popping grants (HAE, SBP2013/46 & HLD, SBP2012/26, http://www.knaw.nl/en/awards/subsidies/academy-ecology-fund).	Archard GA, 2010, J ZOOL, V281, P149, DOI 10.1111/j.1469-7998.2010.00714.x; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Brouwer L, 2010, MOL ECOL, V19, P3444, DOI 10.1111/j.1365-294X.2010.04750.x; Bruford Michael W., 1998, P287; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Class B, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2777; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coyne SP, 2015, BEHAV BRAIN RES, V292, P50, DOI 10.1016/j.bbr.2015.06.014; Crook J, 1960, SEYCHELLES GOVT B; de Azevedo CS, 2006, REV BRAS ZOOL, V23, P202, DOI 10.1590/S0101-81752006000100012; Deans C, 2015, GENETICS, V199, P887, DOI 10.1534/genetics.114.173492; Dingemanse NJ, 2012, J ANIM ECOL, V81, P116, DOI 10.1111/j.1365-2656.2011.01877.x; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Dochtermann NA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2201; Eccard JA, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-43; Favati A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2531; Fisher DN, 2015, BEHAV ECOLOGY, V00, P1; Flisikowski K, 2009, ANIM GENET, V40, P192, DOI 10.1111/j.1365-2052.2008.01821.x; Garamszegi LZ, 2014, ECOL EVOL, V4, P1466, DOI 10.1002/ece3.1041; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Graffelman J, 2008, HUM HERED, V65, P77, DOI 10.1159/000108939; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hansson B, 2004, EVOLUTION, V58, P870; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x; Kenta T, 2008, MOL ECOL RESOUR, V8, P1230, DOI 10.1111/j.1755-0998.2008.02190.x; Kluger AN, 2002, MOL PSYCHIATR, V7, P712, DOI 10.1038/sj.mp.4001082; Komdeur J, 2004, IBIS, V146, P298, DOI 10.1046/j.1474-919X.2004.00255.x; Komdeur J, 2001, P ROY SOC B-BIOL SCI, V268, P2007, DOI 10.1098/rspb.2001.1742; Komdeur J, 2015, COOPERATIVE BREEDING; Komdeur J., 1991, TRENDS ECOLOGY EVOLU, V7, P330; Korsten P, 2010, MOL ECOL, V19, P832, DOI 10.1111/j.1365-294X.2009.04518.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mueller JC, 2014, MOL ECOL, V23, P2876, DOI 10.1111/mec.12763; Mueller JC, 2013, MOL ECOL, V22, P3629, DOI 10.1111/mec.12288; Murphy DL, 2008, NEUROPHARMACOLOGY, V55, P932, DOI 10.1016/j.neuropharm.2008.08.034; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; R Core Team, 2021, R LANGUAGE ENV STAT; Raynaud J, 2014, PHYSIOL BEHAV, V129, P57, DOI 10.1016/j.physbeh.2014.02.005; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; Savitz JB, 2004, AM J MED GENET B, V131B, P20, DOI 10.1002/ajmg.b.20155; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Serretti A, 2006, CURR DRUG TARGETS, V7, P1659, DOI 10.2174/138945006779025419; Sih A, 2015, TRENDS ECOL EVOL, V30, P50, DOI 10.1016/j.tree.2014.11.004; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Sneddon LU, 2003, J FISH BIOL, V62, P971, DOI 10.1046/j.1095-8649.2003.00084.x; Spurgin LG, 2014, EVOL APPL, V7, P1134, DOI 10.1111/eva.12191; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Steinmeyer C, 2009, GENETICA, V136, P109, DOI 10.1007/s10709-008-9318-y; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Oers K., 2013, ANIMAL PERSONALITIES, P149; van Oers K, 2010, PHILOS T R SOC B, V365, P3991, DOI 10.1098/rstb.2010.0178; Veen T, 2000, P ROY SOC B-BIOL SCI, V267, P2253, DOI 10.1098/rspb.2000.1276; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Weigensberg I, 1996, EVOLUTION, V50, P2149, DOI 10.1111/j.1558-5646.1996.tb03605.x; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wolf M, 2012, AM NAT, V179, P679, DOI 10.1086/665656; Wright David J., 2014, Conservation Evidence, V11, P20; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823	70	16	17	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0138439	10.1371/journal.pone.0138439	http://dx.doi.org/10.1371/journal.pone.0138439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473495	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000363185500005
J	Esber, N; Le Billan, F; Resche-Rigon, M; Loosfelt, H; Lombes, M; Chabbert-Buffet, N				Esber, Nathalie; Le Billan, Florian; Resche-Rigon, Michele; Loosfelt, Hugues; Lombes, Marc; Chabbert-Buffet, Nathalie			Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L-1 Expression	PLOS ONE			English	Article							CELL-LINE; TGF-BETA; UTERINE; HORMONE; BINDING; KINASE; GROWTH; TRANSACTIVATION; RESPONSIVENESS; TRANSCRIPTION	The progesterone receptor (PR) with its isoforms and ligands are involved in breast tumorigenesis and prognosis. We aimed at analyzing the respective contribution of PR isoforms, PRA and PRB, in breast cancer cell proliferation in a new estrogen-independent cell based-model, allowing independent PR isoforms analysis. We used the bi-inducible human breast cancer cell system MDA-iPRAB. We studied the effects and molecular mechanisms of action of progesterone (P4) and ulipristal acetate (UPA), a new selective progesterone receptor modulator, alone or in combination. P4 significantly stimulated MDA-iPRA expressing cells proliferation. This was associated with P4-stimulated expression of the anti-apoptotic factor BCL2-L1 and enhanced recruitment of PRA, SRC-1 and RNA Pol II onto the +58 kb PR binding motif of the BCL2-L-1 gene. UPA decreased cell proliferation and repressed BCL2-L-1 expression in the presence of PRA, correlating with PRA and SRC1 but not RNA Pol II recruitment. These results bring new information on the mechanism of action of PR ligands in controlling breast cancer cell proliferation through PRA in an estrogen independent model. Evaluation of PR isoforms ratio, as well as molecular signature studies based on PRA target genes could be proposed to facilitate personalized breast cancer therapy. In this context, UPA could be of interest in endocrine therapy. Further confirmation in the clinical setting is required.	[Esber, Nathalie; Le Billan, Florian; Loosfelt, Hugues; Lombes, Marc] Fac Med Paris Sud, INSERM, Unite Mixte Rech Sci 1185, Le Kremlin Bicetre, France; [Esber, Nathalie; Le Billan, Florian; Loosfelt, Hugues; Lombes, Marc] Univ Paris 11, Fac Med Paris Sud, Unite Mixte Rech Sci 1185, Le Kremlin Bicetre, France; [Esber, Nathalie; Resche-Rigon, Michele] HRA Pharma, Paris, France; [Lombes, Marc] Hop Bicetre, Assistance Publ Hop Paris, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France; [Chabbert-Buffet, Nathalie] Hop Univ Est Parisien Site Tenon, AP HP, Serv Gynecol Obstet Med Reprod, Paris, France; [Chabbert-Buffet, Nathalie] Univ Paris 06, INSERM, Unite Mixte Rech Sci 938, Ctr Rech St Antoine, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Chabbert-Buffet, N (corresponding author), Hop Univ Est Parisien Site Tenon, AP HP, Serv Gynecol Obstet Med Reprod, Paris, France.	nathalie.chabbert-buffet@tnn.aphp.fr	Lombes, Marc/L-5933-2018	Lombes, Marc/0000-0003-3189-023X; Le Billan, Florian/0000-0002-3400-9295	HRA Pharma; national agency for Research (ANRT/HRA pharma CIFRE i.e. Conventions Industrielles de Formation par la Recherche, in English Research Training Industrial Grant Contract)	HRA Pharma; national agency for Research (ANRT/HRA pharma CIFRE i.e. Conventions Industrielles de Formation par la Recherche, in English Research Training Industrial Grant Contract)	The funder HRA Pharma provided support in the form of salary for one author [MRR], joint grant together with the national agency for Research (ANRT/HRA pharma CIFRE i.e. Conventions Industrielles de Formation par la Recherche, in English Research Training Industrial Grant Contract) [NE] but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. Data from the paper have been discussed twice a year with MRR, as required in the joint ANRT /HRAPharma CIFRE. The final MS has been approved by all coauthors before submission. The specific roles of these authors are articulated in the 'author contributions' section	Alvarez LD, 2011, BIOORGAN MED CHEM, V19, P1683, DOI 10.1016/j.bmc.2011.01.033; Attardi BJ, 2002, MOL CELL ENDOCRINOL, V188, P111, DOI 10.1016/S0303-7207(01)00743-2; Ballare C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Bellance C, 2013, MOL BIOL CELL, V24, P1363, DOI 10.1091/mbc.E12-11-0807; Bertucci PY, 2013, NUCLEIC ACIDS RES, V41, P6072, DOI 10.1093/nar/gkt327; Brisken C, 2013, NAT REV CANCER, V13, P385, DOI 10.1038/nrc3518; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Chabbert-Buffet N, 2005, HUM REPROD UPDATE, V11, P293, DOI 10.1093/humupd/dmi002; Chlebowski RT, 2009, NEW ENGL J MED, V360, P573, DOI 10.1056/NEJMoa0807684; Clarke CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035859; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Communal L, 2012, HUM REPROD, V27, P2785, DOI 10.1093/humrep/des221; Comsa S, 2015, ANTICANCER RES, V35, P3147; DARBRE PD, 1990, J STEROID BIOCHEM, V37, P753, DOI 10.1016/0960-0760(90)90416-I; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Diep CH, 2015, J MOL ENDOCRINOL, V54, pR31, DOI 10.1530/JME-14-0252; Donnez J, 2014, FERTIL STERIL, V101, P1565, DOI 10.1016/j.fertnstert.2014.02.008; Donnez J, 2012, NEW ENGL J MED, V366, P421, DOI 10.1056/NEJMoa1103180; Engman M, 2008, HUM REPROD, V23, P2072, DOI 10.1093/humrep/den228; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Giulianelli S, 2013, VITAM HORM, V93, P161, DOI 10.1016/B978-0-12-416673-8.00009-5; Glasier AF, 2010, LANCET, V375, P555, DOI 10.1016/S0140-6736(10)60101-8; Groshong SD, 1997, MOL ENDOCRINOL, V11, P1593, DOI 10.1210/me.11.11.1593; Hagan CR, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-32; Hagan CR, 2013, NUCLEIC ACIDS RES, V41, P8926, DOI 10.1093/nar/gkt706; Horwitz KB, 2008, J CLIN ENDOCR METAB, V93, P3295, DOI 10.1210/jc.2008-0938; Jackson SE, 2015, INT J CANCER, V137, P262, DOI 10.1002/ijc.28940; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; Khan JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045993; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Knutson TP, 2014, PHARMACOL THERAPEUT, V142, P114, DOI 10.1016/j.pharmthera.2013.11.010; Le Billan F, 2015, FASEB J; Leibowitz Brian, 2010, Cancer Biol Ther, V9, P417, DOI 10.4161/cbt.9.6.11392; Leo JCL, 2008, INT J CANCER, V122, P230, DOI 10.1002/ijc.23081; Lindet C, 2012, INT J BIOL MARKER, V27, pE111, DOI 10.5301/JBM.2012.9198; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McGowan EM, 1999, MOL ENDOCRINOL, V13, P1657, DOI 10.1210/me.13.10.1657; McGowan EM, 2003, J MOL ENDOCRINOL, V31, P241, DOI 10.1677/jme.0.0310241; Moore MR, 2000, BIOCHEM BIOPH RES CO, V277, P650, DOI 10.1006/bbrc.2000.3728; Mote PA, 2008, ERNST SCHERING FOUND, V1, P77, DOI 10.1007/2789_2008_076; Mote PA, 2002, BREAST CANCER RES TR, V72, P163, DOI 10.1023/A:1014820500738; Mote PA, 2004, GENE CHROMOSOME CANC, V39, P236, DOI 10.1002/gcc.10321; Mote PA, 2015, BREAST CANCER RES TR, V151, P309, DOI 10.1007/s10549-015-3397-0; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; SARTORIUS CA, 1994, MOL ENDOCRINOL, V8, P1347, DOI 10.1210/me.8.10.1347; Shah R, 2014, WORLD J CLIN ONCOL, V5, P283, DOI 10.5306/wjco.v5.i3.283; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Tung L, 2006, MOL ENDOCRINOL, V20, P2656, DOI 10.1210/me.2006-0105; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; Wargon V, 2015, INT J CANCER, V136, P2680, DOI 10.1002/ijc.29304; Wargon V, 2009, BREAST CANCER RES TR, V116, P449, DOI 10.1007/s10549-008-0150-y; Whittle JR, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0523-1; Xu Q, 2005, J CLIN ENDOCR METAB, V90, P953, DOI 10.1210/jc.2004-1569; Yin P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029021; Yun BS, 2015, EUR J OBSTET GYN R B, V191, P62, DOI 10.1016/j.ejogrb.2015.05.022	57	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140795	10.1371/journal.pone.0140795	http://dx.doi.org/10.1371/journal.pone.0140795			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474308	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500111
J	Knoos, P; Svensson, AV; Ulvenlund, S; Wahlgren, M				Knoos, Patrik; Svensson, Anna V.; Ulvenlund, Stefan; Wahlgren, Marie			Release of a Poorly Soluble Drug from Hydrophobically Modified Poly (Acrylic Acid) in Simulated Intestinal Fluids	PLOS ONE			English	Article							IN-VIVO PERFORMANCE; POLY(ACRYLIC ACID); DOSAGE FORMS; DISSOLUTION MEDIA; MATRIX TABLETS; SOLUBILITY; SURFACTANT; BIOAVAILABILITY; FORMULATIONS; MECHANISM	A large part of new pharmaceutical substances are characterized by a poor solubility and high hydrophobicity, which might lead to a difference in drug adsorption between fasted and fed patients. We have previously evaluated the release of hydrophobic drugs from tablets based on Pemulen TR2 and showed that the release can be manipulated by adding surfactants. Here we further evaluate the possibility to use Pemulen TR2 in controlled release tablet formulations containing a poorly soluble substance, griseofulvin. The release is evaluated in simulated intestinal media that model the fasted state (FaSSIF medium) or fed state (FeSSIF). The rheology of polymer gels is studied in separate experiments, in order to gain more information on possible interactions. The release of griseofulvin in tablets without surfactant varied greatly and the slowest release were observed in FeSSIF. Addition of SDS to the tablets eliminated the differences and all tablets showed a slow linear release, which is of obvious relevance for robust drug delivery. Comparing the data from the release studies and the rheology experiment showed that the effects on the release from the different media could to a large extent be rationalised as a consequence of the interactions between the polymer and the surfactants in the media. The study shows that Pemulen TR2 is a candidate for controlled release formulations in which addition of surfactant provides a way to eliminate food effects on the release profile. However, the formulation used needs to be designed to give a faster release rate than the tablets currently investigated.	[Knoos, Patrik] Lund Univ, Div Phys Chem, Dept Chem, Lund, Sweden; [Svensson, Anna V.] Teknol Inst, Taastrup, Denmark; [Ulvenlund, Stefan] CR Competence AB, Lund, Sweden; [Wahlgren, Marie] Lund Univ, Dept Food Technol Engn & Nutr, Lund, Sweden	Lund University; Lund University	Wahlgren, M (corresponding author), Lund Univ, Dept Food Technol Engn & Nutr, Lund, Sweden.	marie.wahlgren@food.lth.se		Wahlgren, Marie/0000-0002-1705-3964	FLAK Research School of Pharmaceutics Lund University	FLAK Research School of Pharmaceutics Lund University	This work was funded by FLAK Research School of Pharmaceutics Lund University (no grant number available) to Patrik Knoos.	Abrahamsson B, 2004, EUR J PHARM SCI, V22, P165, DOI 10.1016/j.ejps.2004.03.004; Adler J, 1999, J PHARM SCI, V88, P371, DOI 10.1021/js970376j; AMIDON GL, 1995, PHARMACEUT RES, V12, P413, DOI 10.1023/A:1016212804288; Bettini R, 2001, J CONTROL RELEASE, V70, P383, DOI 10.1016/S0168-3659(00)00366-7; Borgquist P, 2006, J CONTROL RELEASE, V113, P216, DOI 10.1016/j.jconrel.2006.05.004; Colombo, 2000, Pharm Sci Technol Today, V3, P198, DOI 10.1016/S1461-5347(00)00269-8; COLOMBO P, 1993, ADV DRUG DELIVER REV, V11, P37, DOI 10.1016/0169-409X(93)90026-Z; Dressman JB, 1998, PHARMACEUT RES, V15, P11, DOI 10.1023/A:1011984216775; DUALEH AJ, 1990, MACROMOLECULES, V23, P251, DOI 10.1021/ma00203a043; Galia E, 1998, PHARMACEUT RES, V15, P698, DOI 10.1023/A:1011910801212; Holmberg K., 2003, SURFACTANTS POLYM AQ; Jantratid E, 2008, PHARM RES-DORDR, V25, P1663, DOI 10.1007/s11095-008-9569-4; Kavanagh N, 2004, INT J PHARMACEUT, V279, P141, DOI 10.1016/j.ijpharm.2004.04.016; Kleberg K, 2010, J PHARM PHARMACOL, V62, P1656, DOI 10.1111/j.2042-7158.2010.01023.x; Knoos P, 2013, LANGMUIR; Knoos Patrik, 2013, Results Pharma Sci, V3, P7, DOI 10.1016/j.rinphs.2013.08.001; Korner A, 2005, J PHYS CHEM B, V109, P11530, DOI 10.1021/jp044332s; Kostewicz ES, 2014, EUR J PHARM SCI, V57, P342, DOI 10.1016/j.ejps.2013.08.024; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Magny B., 1992, TRENDS COLLOID INTER, P118; Marques EF, 2000, LANGMUIR, V16, P5178, DOI 10.1021/la9912803; MAZER NA, 1979, BIOCHEMISTRY-US, V18, P3064, DOI 10.1021/bi00581a024; Miller-Chou BA, 2003, PROG POLYM SCI, V28, P1223, DOI 10.1016/S0079-6700(03)00045-5; Mithani SD, 1996, PHARMACEUT RES, V13, P163, DOI 10.1023/A:1016062224568; Mylonas Y, 1999, POLYMER, V40, P6841, DOI 10.1016/S0032-3861(98)00861-1; Philippova OE, 1997, MACROMOLECULES, V30, P8278, DOI 10.1021/ma970957v; Piculell I, 2001, POLYM ADVAN TECHNOL, V12, P44; Porter CJH, 2007, NAT REV DRUG DISCOV, V6, P231, DOI 10.1038/nrd2197; Reynolds TD, 1998, J PHARM SCI, V87, P1115, DOI 10.1021/js980004q; Simovic S, 1999, INT J PHARMACEUT, V184, P207, DOI 10.1016/S0378-5173(99)00097-6; SKOUG JW, 1993, J CONTROL RELEASE, V27, P227, DOI 10.1016/0168-3659(93)90154-W; Stegemann S, 2007, EUR J PHARM SCI, V31, P249, DOI 10.1016/j.ejps.2007.05.110; Tabandeh H, 2014, PAK J PHARM SCI, V27, P495; TAHARA K, 1995, J CONTROL RELEASE, V35, P59, DOI 10.1016/0168-3659(95)00021-Y; Tajarobi F, 2011, J PHARM SCI-US, V100, P275, DOI 10.1002/jps.22248; Wahlgren M, 2009, DRUG DEV IND PHARM, V35, P922, DOI 10.1080/03639040802698810; Weitschies W, 2005, J CONTROL RELEASE, V108, P375, DOI 10.1016/j.jconrel.2005.08.018; Wilson C.G., 2011, CONTROLLED RELEASE O, P27; Woo JS, 2008, EUR J PHARM SCI, V33, P159, DOI 10.1016/j.ejps.2007.11.001	39	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140709	10.1371/journal.pone.0140709	http://dx.doi.org/10.1371/journal.pone.0140709			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473964	gold, Green Published, Green Submitted			2022-12-26	WOS:000363185500088
J	Raveh, O; David, N; Rilov, G; Rahav, E				Raveh, Ofrat; David, Niv; Rilov, Gil; Rahav, Eyal			The Temporal Dynamics of Coastal Phytoplankton and Bacterioplankton in the Eastern Mediterranean Sea	PLOS ONE			English	Article							MICROBIAL FOOD-WEB; DINITROGEN FIXATION; LEVANTINE BASIN; BACTERIAL PRODUCTION; PRIMARY PRODUCTIVITY; CRETAN SEA; COMMUNITY STRUCTURE; SEASONAL DYNAMICS; STANDING STOCKS; P-LIMITATION	This study considers variability in phytoplankton and heterotrophic bacterial abundances and production rates, in one of the most oligotrophic marine regions in the world-the Levantine Basin. The temporal dynamics of these planktonic groups were studied in the coastal waters of the southeastern Mediterranean Sea approximately every two weeks for a total of two years. Heterotrophic bacteria were abundant mostly during late summer and midwinter, and were positively correlated with bacterial production and with N-2 fixation. Based on size fractionating, picophytoplankton was abundant during the summer, whereas nano-microphytoplankton predominated during the winter and early spring, which were also evident in the size-fractionated primary production rates. Autotrophic abundance and production correlated negatively with temperature, but did not correlate with inorganic nutrients. Furthermore, a comparison of our results with results from the open Levantine Basin demonstrates that autotrophic and heterotrophic production, as well as N-2 fixation rates, are considerably higher in the coastal habitat than in the open sea, while nutrient levels or cell abundance are not different. These findings have important ecological implications for food web dynamics and for biological carbon sequestration in this understudied region.	[Raveh, Ofrat; David, Niv; Rilov, Gil; Rahav, Eyal] Natl Inst Oceanog, Israel Oceanog & Limnol Res, IL-31080 Haifa, Israel	Israel Oceanographic & Limnological Research Institute	Rahav, E (corresponding author), Natl Inst Oceanog, Israel Oceanog & Limnol Res, IL-31080 Haifa, Israel.	eyal.rahav@ocean.org.il		Rilov, Gil/0000-0002-1334-4887	Ministry of National Infrastructures, Energy and Water Resources [3-11519]	Ministry of National Infrastructures, Energy and Water Resources	This work was supported by the Ministry of National Infrastructures, Energy and Water Resources (grant number 3-11519) to E.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HE, 2010, ENVIRON MICROBIOL, V12, P1319, DOI 10.1111/j.1462-2920.2010.02176.x; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; AZOV Y, 1986, J PLANKTON RES, V8, P41, DOI 10.1093/plankt/8.1.41; Bar-Zeev E, 2011, MAR ECOL PROG SER, V431, P107, DOI 10.3354/meps09110; Bar-Zeev E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00403; Behrenfeld MJ, 2010, ECOLOGY, V91, P977, DOI 10.1890/09-1207.1; Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; BERMAN T, 1984, OCEANOL ACTA, V7, P367; Berman-Frank I., 2012, LIFE MEDITERRANEAN S, P199; BILLEN G, 1990, HYDROBIOLOGIA, V207, P37, DOI 10.1007/BF00041438; Bonnet S, 2011, BIOGEOSCIENCES, V8, P2257, DOI 10.5194/bg-8-2257-2011; Bosc E, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002034; CEDERWALL H, 1990, AMBIO, V19, P109; Chen BZ, 2010, MAR ECOL PROG SER, V407, P43, DOI 10.3354/meps08572; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; Christaki U, 2011, BIOGEOSCIENCES, V8, P1839, DOI 10.5194/bg-8-1839-2011; Christaki U, 1999, MAR ECOL PROG SER, V181, P297, DOI 10.3354/meps181297; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; Denis M, 2010, BIOGEOSCIENCES, V7, P2227, DOI 10.5194/bg-7-2227-2010; Edwards KF, 2012, LIMNOL OCEANOGR, V57, P554, DOI 10.4319/lo.2012.57.2.0554; Efrati S, 2013, BIOGEOSCIENCES, V10, P3349, DOI 10.5194/bg-10-3349-2013; Foster RA, 2009, LIMNOL OCEANOGR, V54, P219, DOI 10.4319/lo.2009.54.1.0219; Fussel HM, 2009, CLIMATIC CHANGE, V97, P469, DOI 10.1007/s10584-009-9648-5; Garneau ME, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004281; Gertman I., 2013, RAPP CONGRESS CIESM, V40, P211; Gotsis-Skretas O, 1999, PROG OCEANOGR, V44, P625, DOI 10.1016/S0079-6611(99)00048-8; Groom S, 2005, DEEP-SEA RES PT II, V52, P2990, DOI 10.1016/j.dsr2.2005.08.019; Grover JP, 2006, J PLANKTON RES, V28, P1, DOI 10.1093/plankt/fbi095; HARRIS GP, 1991, J PLANKTON RES, V13, pS109; Herut B, 2005, DEEP-SEA RES PT II, V52, P3024, DOI 10.1016/j.dsr2.2005.09.003; Herut B, 2002, FRESEN ENVIRON BULL, V11, P782; Herut B, 2000, OCEANOL ACTA, V23, P771, DOI 10.1016/S0399-1784(00)01118-X; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; Hoshiai G, 2003, FISHERIES SCI, V69, P1303, DOI 10.1111/j.0919-9268.2003.00760.x; Ibello V, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041635; Ignatiades L, 2002, J MARINE SYST, V36, P11, DOI 10.1016/S0924-7963(02)00132-X; Ignatiades L, 2009, J PLANKTON RES, V31, P411, DOI 10.1093/plankt/fbn124; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Kirchman DL, 1997, MICROBIAL ECOL, V33, P11, DOI 10.1007/s002489900003; Kirchman DL, 1992, MICROBIAL ECOLOGY OC, P85; Kostadinov TS, 2010, BIOGEOSCIENCES, V7, P3239, DOI 10.5194/bg-7-3239-2010; Kress N, 2005, DEEP-SEA RES PT II, V52, P3054, DOI 10.1016/j.dsr2.2005.08.013; Kress N, 2001, DEEP-SEA RES PT I, V48, P2347, DOI 10.1016/S0967-0637(01)00022-X; Kress N, 2014, J MARINE SYST, V135, P6, DOI 10.1016/j.jmarsys.2013.11.016; Krom MD, 2010, PROG OCEANOGR, V85, P236, DOI 10.1016/j.pocean.2010.03.003; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; Li WKW, 1998, CAN DATA REP FISH AQ, V0, P1; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Lomas MW, 2013, DEEP-SEA RES PT II, V93, P16, DOI 10.1016/j.dsr2.2013.01.008; Luna GM, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004168; MAGAZZU G, 1995, AQUAT MICROB ECOL, V9, P97, DOI 10.3354/ame009097; Marty JC, 2002, DEEP-SEA RES PT II, V49, P1965, DOI 10.1016/S0967-0645(02)00022-X; Mohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012583; Moran XAG, 2010, AQUAT MICROB ECOL, V58, P229, DOI 10.3354/ame01374; Moutin T, 2002, J MARINE SYST, V33, P273, DOI 10.1016/S0924-7963(02)00062-3; Moutin T, 2002, LIMNOL OCEANOGR, V47, P1562, DOI 10.4319/lo.2002.47.5.1562; Oviatt C, 2002, ESTUAR COAST SHELF S, V54, P1013, DOI 10.1006/ecss.2001.0872; Paytan A, 2009, P NATL ACAD SCI USA, V106, P4601, DOI 10.1073/pnas.0811486106; Pinhassi J, 2000, AQUAT MICROB ECOL, V21, P245, DOI 10.3354/ame021245; Psarra S, 2000, PROG OCEANOGR, V46, P187, DOI 10.1016/S0079-6611(00)00018-5; Pulido-Villena E., 2012, LIFE MEDITERRANEAN S, P227; Rahav E, 2013, OCEAN SCI, V9, P489, DOI 10.5194/os-9-489-2013; Rahav E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00227; Rahav E, 2013, J GEOPHYS RES-BIOGEO, V118, P195, DOI 10.1002/jgrg.20023; ress N., 2012, LIFE MEDITERRANEAN S, P157; Reynolds C, 2000, HYDROBIOLOGIA, V424, P147, DOI 10.1023/A:1003973532706; Robertson BR, 1998, APPL ENVIRON MICROB, V64, P3900; SHIAH FK, 1994, LIMNOL OCEANOGR, V39, P1243, DOI 10.4319/lo.1994.39.6.1243; SIMON M, 1990, MAR ECOL PROG SER, V65, P205, DOI 10.3354/meps065205; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; SIMON N, 1994, J PHYCOL, V30, P922, DOI 10.1111/j.0022-3646.1994.00922.x; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Stambler N, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003373; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; Tait LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074413; TAKAHASHI M, 1984, MAR BIOL, V79, P177, DOI 10.1007/BF00951826; Tanaka T, 2011, BIOGEOSCIENCES, V8, P525, DOI 10.5194/bg-8-525-2011; Tanaka T, 2003, LIMNOL OCEANOGR, V48, P1150, DOI 10.4319/lo.2003.48.3.1150; Tanaka T, 2007, DEEP-SEA RES PT I, V54, P1721, DOI 10.1016/j.dsr.2007.06.008; TOWNSEND DW, 1994, DEEP-SEA RES PT I, V41, P747, DOI 10.1016/0967-0637(94)90075-2; Turley CM, 2000, MAR ECOL PROG SER, V193, P11, DOI 10.3354/meps193011; Van Wambeke F, 2000, PROG OCEANOGR, V46, P205, DOI 10.1016/S0079-6611(00)00019-7; Van Wambeke F, 2011, BIOGEOSCIENCES, V8, P1853, DOI 10.5194/bg-8-1853-2011; Van Wambeke F, 2002, MICROB ECOL, V43, P119, DOI 10.1007/s00248-001-0038-4; Vaulot D, 1999, J GEOPHYS RES-OCEANS, V104, P3297, DOI 10.1029/98JC01333; YACOBI YZ, 1995, J MARINE SYST, V6, P179, DOI 10.1016/0924-7963(94)00028-A; Yogev T, 2011, ENVIRON MICROBIOL, V13, P854, DOI 10.1111/j.1462-2920.2010.02402.x; Zohary T, 2005, DEEP-SEA RES PT II, V52, P3011, DOI 10.1016/j.dsr2.2005.08.011; Zohary T, 1998, LIMNOL OCEANOGR, V43, P387, DOI 10.4319/lo.1998.43.3.0387; Zohary T, 1998, MAR ECOL PROG SER, V167, P47, DOI 10.3354/meps167047	93	47	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140690	10.1371/journal.pone.0140690	http://dx.doi.org/10.1371/journal.pone.0140690			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474399	gold, Green Submitted, Green Published			2022-12-26	WOS:000363185500082
J	Zacca, ER; Crespo, MI; Acland, RP; Roselli, E; Nunez, NG; Maccioni, M; Maletto, BA; Pistoresi-Palencia, MC; Moron, G				Zacca, Estefania R.; Crespo, Maria I.; Acland, Rachel P.; Roselli, Emiliano; Nunez, Nicolas G.; Maccioni, Mariana; Maletto, Belkys A.; Pistoresi-Palencia, Maria C.; Moron, Gabriel			Aging Impairs the Ability of Conventional Dendritic Cells to Cross-Prime CD8(+) T Cells upon Stimulation with a TLR7 Ligand	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; AGE-ASSOCIATED DECREASE; IMMUNE-RESPONSES; ACTIVATION; EXPANSION; SYSTEM; IMMUNOSENESCENCE; PATHWAYS; SUBSETS; MICE	The aging process is accompanied by altered immune system functioning and an increased risk of infection. Dendritic cells (DCs) are antigen-presenting cells that play a key role in both adaptive and innate immunity, but how aging affects DCs and their influence on immunity has not been thoroughly established. Here we examined the function of conventional DCs (cDCs) in old mice after TLR7 stimulation, focusing on their ability to cross-prime CD8(+) T cells. Using polyU, a synthetic ssRNA analog, as TLR7 ligand and OVA as an antigen (Ag) model, we found that cDCs from old mice have a poor ability to stimulate a CD8(+) T cell-mediated cytotoxic response. cDCs from old mice exhibit alterations in Ag-processing machinery and TLR7 activation. Remarkably, CD8 alpha(+) cDCs from old mice have an impaired ability to activate naive CD8(+) T cells and, moreover, a lower capacity to mature and to process exogenous Ag. Taken together, our results suggest that immunosenescence impacts cDC function, affecting the activation of naive CD8(+) T cells and the generation of effector cytotoxic T cells.	[Zacca, Estefania R.; Crespo, Maria I.; Acland, Rachel P.; Roselli, Emiliano; Nunez, Nicolas G.; Maccioni, Mariana; Maletto, Belkys A.; Pistoresi-Palencia, Maria C.; Moron, Gabriel] Univ Nacl Cordoba, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Moron, G (corresponding author), Univ Nacl Cordoba, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol, RA-5000 Cordoba, Argentina.	gmoron@fcq.unc.edu.ar		Roselli, Emiliano/0000-0001-6048-7170; Moron, Victor Gabriel/0000-0003-2122-6730	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2012-0591]; Fundacion Antorchas; Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET) [PIP 11220120100420]; Universidad Nacional de Cordoba; Fundacion Florencio Fiorini	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fundacion Antorchas; Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Cordoba; Fundacion Florencio Fiorini	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2012-0591), Fundacion Antorchas, Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET, PIP 11220120100420), Universidad Nacional de Cordoba and Fundacion Florencio Fiorini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, AGEING RES REV, V10, P336, DOI 10.1016/j.arr.2010.06.004; Brossart P, 1997, BLOOD, V90, P1594, DOI 10.1182/blood.V90.4.1594.1594_1594_1599; Budimir N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063163; Cambier J, 2005, IMMUNOL REV, V205, P5, DOI 10.1111/j.0105-2896.2005.00276.x; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Crespo MI, 2013, J IMMUNOL, V190, P948, DOI 10.4049/jimmunol.1102725; Curtsinger JM, 2003, J IMMUNOL, V171, P5165, DOI 10.4049/jimmunol.171.10.5165; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dorrington MG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00171; Dresch C, 2012, TRENDS IMMUNOL, V33, P381, DOI 10.1016/j.it.2012.04.009; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Grolleau-Julius A, 2008, CANCER RES, V68, P6341, DOI 10.1158/0008-5472.CAN-07-5769; Grolleau-Julius A, 2006, J GERONTOL A-BIOL, V61, P1039, DOI 10.1093/gerona/61.10.1039; Guermonprez P, 2005, SPRINGER SEMIN IMMUN, V26, P257, DOI 10.1007/s00281-004-0176-0; Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009; He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hwang JS, 2007, J GERONTOL A-BIOL, V62, P490, DOI 10.1093/gerona/62.5.490; Jing Y, 2009, HUM IMMUNOL, V70, P777, DOI 10.1016/j.humimm.2009.07.005; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kanno A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7119; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kovacs EJ, 2009, TRENDS IMMUNOL, V30, P319, DOI 10.1016/j.it.2009.03.012; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Larange A, 2009, J LEUKOCYTE BIOL, V85, P673, DOI 10.1189/jlb.0808504; Li G, 2012, AGING CELL, V11, P968, DOI 10.1111/j.1474-9726.2012.00867.x; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008; Maletto Belkys A., 2010, Current Immunology Reviews, V6, P329; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; Molinari P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024108; Moron G, 2002, J EXP MED, V195, P1233, DOI 10.1084/jem.20011930; Moron G, 1998, CLIN IMMUNOL IMMUNOP, V87, P256, DOI 10.1006/clin.1998.4534; Ordemann R, 2002, J CLIN INVEST, V109, P1249, DOI 10.1172/JCI200214793; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Pereira LF, 2011, MECH AGEING DEV, V132, P187, DOI 10.1016/j.mad.2011.03.005; Peter L, 2011, GEN COMP ENDOCR, V172, P39, DOI 10.1016/j.ygcen.2011.02.005; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002; Schulz O, 2002, IMMUNOLOGY, V107, P183, DOI 10.1046/j.1365-2567.2002.01513.x; Shen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004097; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Tan SY, 2012, IMMUNOL CELL BIOL, V90, P722, DOI 10.1038/icb.2011.104; Tesar BM, 2006, AGING CELL, V5, P473, DOI 10.1111/j.1474-9726.2006.00245.x; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785; van Dommelen SLH, 2010, CELL MOL IMMUNOL, V7, P108, DOI 10.1038/cmi.2009.114; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Watts C, 2007, CURR OPIN IMMUNOL, V19, P73, DOI 10.1016/j.coi.2006.11.014; Wong CP, 2010, EXP GERONTOL, V45, P163, DOI 10.1016/j.exger.2009.11.005; Wong C, 2013, CURR OPIN IMMUNOL, V25, P535, DOI 10.1016/j.coi.2013.05.016	58	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140672	10.1371/journal.pone.0140672	http://dx.doi.org/10.1371/journal.pone.0140672			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474053	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500079
J	DeVito, N; Henderson, E; Han, G; Reed, D; Bui, MM; Lavey, R; Robinson, L; Zager, JS; Gonzalez, RJ; Sondak, VK; Letson, GD; Conley, A				DeVito, Nicholas; Henderson, Evita; Han, Gang; Reed, Damon; Bui, Marilyn M.; Lavey, Robert; Robinson, Lary; Zager, Jonathan S.; Gonzalez, Ricardo J.; Sondak, Vernon K.; Letson, G. Douglas; Conley, Anthony			Clinical Characteristics and Outcomes for Solitary Fibrous Tumor (SFT): A Single Center Experience	PLOS ONE			English	Article							MENINGEAL HEMANGIOPERICYTOMA; RECURRENT; PLEURA; FUSION; GENE	Solitary fibrous tumor (SFT) is a mesenchymal neoplasm of fibrous origin. The 2013 WHO classification of soft tissue tumors defines malignant forms as hypercellular, mitotically active (>4 mitosis/10 high-power fields), with cytological atypia, tumor necrosis, and/or infiltrative margins. With an IRB-approved protocol, we investigated patient records and clinicopathologic data from our Sarcoma Database to describe the clinical characteristics of both benign and malignant SFT. All pathology specimens were reviewed by two pathologists. Descriptive statistics and univariate/multivariate survival analysis were performed. Patient records and Social Security Death Index were used to evaluate vital status. Of 82 patients, 47 (57%) were women and 73 (89%) were Caucasian. Median age was 62 years (range, 20 to 89). Thirty-two (39%) patients succumbed to the disease. Primary tumor site was lung/pleura in 28 (34%), abdomen/pelvis in 23 (28%), extremity in 13 (16%), and head/neck in 9 (11%) patients. Pathology was described as benign in 42 (51%) and malignant in 40 (49%) patients. Compared to benign SFT, malignant histology is associated with larger tumor size, higher mitotic counts, metastatic disease at diagnosis, and greater use of chemotherapy and radiation therapy. Gender, age, and tumor site were not significantly different between benign and malignant subtypes. By univariate analysis, only benign vs. malignant variant and complete resection positively impacted overall survival (P = 0.02 and P<0.0001, respectively). In the multivariable analysis of overall survival, receiving chemotherapy or not receiving surgery were two variables significantly associated with higher failure rate in overall survival: patients with chemotherapy vs. no chemotherapy (P = 0.003, HR = 4.55, with 95% CI: 1.68-12.34) and patients without surgery vs. with surgery (P = 0.005, HR = 25.49, with 95% CI: 2.62-247.57). Clear survival differences exist between benign and malignant SFT. While surgery appears to be the best treatment option for benign and malignant SFT, better systemic therapies are needed to improve outcomes of patients with metastatic, malignant SFT.	[DeVito, Nicholas; Henderson, Evita; Reed, Damon; Bui, Marilyn M.; Lavey, Robert; Zager, Jonathan S.; Gonzalez, Ricardo J.; Sondak, Vernon K.; Letson, G. Douglas; Conley, Anthony] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Sarcoma Dept, Tampa, FL 33612 USA; [Henderson, Evita; Bui, Marilyn M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Anat Pathol, Tampa, FL 33612 USA; [Han, Gang] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Lavey, Robert] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL 33612 USA; [Robinson, Lary] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Thorac Oncol Dept, Tampa, FL 33612 USA; [Zager, Jonathan S.; Gonzalez, Ricardo J.; Sondak, Vernon K.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol Dept, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Yale University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Conley, A (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Sarcoma Dept, Tampa, FL 33612 USA.	AConley@MDAnderson.org	Reed, Damon/R-8179-2019; DeVito, Nicholas/M-6810-2016	Han, Gang/0000-0002-5781-5169; Reed, Damon/0000-0002-8238-2465; DeVito, Nicholas/0000-0001-7537-8647; Conley, Anthony/0000-0002-6232-1163				BEADLE GF, 1983, J SURG ONCOL, V22, P167; Chamberlain MC, 2008, NEUROSURGERY, V63, P720, DOI 10.1227/01.NEU.0000325494.69836.51; Chmielecki J, 2013, NAT GENET, V45, P131, DOI 10.1038/ng.2522; ENGLAND DM, 1989, AM J SURG PATHOL, V13, P640, DOI 10.1097/00000478-198908000-00003; ENZINGER FM, 1976, HUM PATHOL, V7, P61, DOI 10.1016/S0046-8177(76)80006-8; Espat NJ, 2002, CANCER-AM CANCER SOC, V95, P1746, DOI 10.1002/cncr.10867; Fletcher C DM., 2013, EXTRAPLEURAL SOLITAR, P81; Galanis E, 1998, CANCER-AM CANCER SOC, V82, P1915; Gengler C, 2006, HISTOPATHOLOGY, V48, P63, DOI 10.1111/j.1365-2559.2005.02290.x; GUTHRIE BL, 1989, NEUROSURGERY, V25, P514, DOI 10.1227/00006123-198910000-00003; Magdeleinat P, 2002, EUR J CARDIO-THORAC, V21, P1087, DOI 10.1016/S1010-7940(02)00099-4; MENA H, 1991, HUM PATHOL, V22, P84, DOI 10.1016/0046-8177(91)90067-Y; Mohajeri A, 2013, GENE CHROMOSOME CANC, V52, P873, DOI 10.1002/gcc.22083; Park MS, 2013, CLIN SARCOMA RES, V3, DOI 10.1186/2045-3329-3-7; Park MS, 2011, CANCER-AM CANCER SOC, V117, P4939, DOI 10.1002/cncr.26098; Park MS, 2009, CURR OPIN ONCOL, V21, P327, DOI 10.1097/CCO.0b013e32832c9532; Robinson DR, 2013, NAT GENET, V45, P180, DOI 10.1038/ng.2509; Robinson Lary A, 2006, Cancer Control, V13, P264; Soyuer S, 2004, CANCER-AM CANCER SOC, V100, P1491, DOI 10.1002/cncr.20109; Spitz FR, 1998, ANN SURG ONCOL, V5, P350, DOI 10.1007/BF02303499; Stacchiotti S, 2010, MOL CANCER THER, V9, P1286, DOI 10.1158/1535-7163.MCT-09-1205; Vallat-Decouvelaere AV, 1998, AM J SURG PATHOL, V22, P1501, DOI 10.1097/00000478-199812000-00007; van Houdt WJ, 2013, ANN SURG ONCOL, V20, P4090, DOI 10.1245/s10434-013-3242-9	23	51	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140362	10.1371/journal.pone.0140362	http://dx.doi.org/10.1371/journal.pone.0140362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469269	Green Submitted, Green Published, gold			2022-12-26	WOS:000363184600051
J	Fiorani, L; Passacantando, M; Santucci, S; Di Marco, S; Bisti, S; Maccarone, R				Fiorani, Lavinia; Passacantando, Maurizio; Santucci, Sandro; Di Marco, Stefano; Bisti, Silvia; Maccarone, Rita			Cerium Oxide Nanoparticles Reduce Microglial Activation and Neurodegenerative Events in Light Damaged Retina	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MACULAR DEGENERATION; MAMMALIAN RETINA; ALBINO-RAT; PHOTORECEPTORS; MECHANISMS; EXPOSURE; SURVIVAL; SAFFRON; DEATH	The first target of any therapy for retinal neurodegeneration is to slow down the progression of the disease and to maintain visual function. Cerium oxide or ceria nanoparticles reduce oxidative stress, which is known to play a pivotal role in neurodegeneration. Our aim was to investigate whether cerium oxide nanoparticles were able to mitigate neurodegeneration including microglial activation and related inflammatory processes induced by exposure to high intensity light. Cerium oxide nanoparticles were injected intravitreally or intraveinously in albino Sprague-Dawley rats three weeks before exposing them to light damage of 1000 lux for 24 h. Electroretinographic recordings were performed a week after light damage. The progression of retinal degeneration was evaluated by measuring outer nuclear layer thickness and TUNEL staining to quantify photoreceptors death. Immunohistochemical analysis was used to evaluate retinal stress, neuroinflammatory cytokines and microglial activation. Only intravitreally injected ceria nanoparticles were detected at the level of photoreceptor outer segments 3 weeks after the light damage and electoretinographic recordings showed that ceria nanoparticles maintained visual response. Moreover, this treatment reduced neuronal death and "hot spot" extension preserving the outer nuclear layer morphology. It is noteworthy that in this work we demonstrated, for the first time, the ability of ceria nanoparticles to reduce microglial activation and their migration toward outer nuclear layer. All these evidences support ceria nanoparticles as a powerful therapeutic agent in retinal neurodegenerative processes.	[Fiorani, Lavinia; Di Marco, Stefano; Bisti, Silvia; Maccarone, Rita] Univ Aquila, Dept Appl Clin Sci & Biotechnol, I-67100 Laquila, Italy; [Passacantando, Maurizio; Santucci, Sandro] Univ Aquila, Dept Phys & Chem Sci, I-67100 Laquila, Italy	University of L'Aquila; University of L'Aquila	Maccarone, R (corresponding author), Univ Aquila, Dept Appl Clin Sci & Biotechnol, Via Vetoio,Coppito 2, I-67100 Laquila, Italy.	rita.maccarone@univaq.it	Di Marco, Stefano/C-6386-2009; Di Marco, Stefano/AAO-8073-2020; PASSACANTANDO, Maurizio/A-2122-2019	Di Marco, Stefano/0000-0003-4847-6270; Di Marco, Stefano/0000-0003-4847-6270; PASSACANTANDO, Maurizio/0000-0002-3680-5295; MACCARONE, Rita/0000-0003-0648-3771	LF	LF	PRIN 2011 to SB contributed to the fellowship for LF for a year.	Chen HI, 2005, CERAM INT, V31, P795, DOI 10.1016/j.ceramint.2004.09.006; Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91; Gargini C, 2004, NEUROSCIENCE, V126, P775, DOI 10.1016/j.neuroscience.2004.04.028; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Li F, 2003, INVEST OPHTH VIS SCI, V44, P4968, DOI 10.1167/iovs.03-0140; Mac Nair CE, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0194-3; Maccarone R, 2008, INVEST OPHTH VIS SCI, V49, P1254, DOI 10.1167/iovs.07-0438; Maslim J, 1997, INVEST OPHTH VIS SCI, V38, P1667; Natoli R, 2010, MOL VIS, V16, P1801; Nelson CM, 2013, J NEUROSCI, V33, P6524, DOI 10.1523/JNEUROSCI.3838-12.2013; Passacantando M, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1785-0; Portioli C, 2013, NANOSCI NANOTECH LET, V5, P1174, DOI 10.1166/nnl.2013.1715; Rutar M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0224-1; Rutar M, 2010, CURR EYE RES, V35, P631, DOI 10.3109/02713681003682925; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Ting AYC, 2009, CURR OPIN OPHTHALMOL, V20, P369, DOI 10.1097/ICU.0b013e32832f8016; Wong LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121977; Wong LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058431; Wong WT, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00022	20	49	50	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140387	10.1371/journal.pone.0140387	http://dx.doi.org/10.1371/journal.pone.0140387			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469804	gold, Green Submitted, Green Published			2022-12-26	WOS:000363184600056
J	Menis, M; Forshee, RA; Kumar, S; McKean, S; Warnock, R; Izurieta, HS; Gondalia, R; Johnson, C; Mintz, PD; Walderhaug, MO; Worrall, CM; Kelman, JA; Anderson, SA				Menis, Mikhail; Forshee, Richard A.; Kumar, Sanjai; McKean, Stephen; Warnock, Rob; Izurieta, Hector S.; Gondalia, Rahul; Johnson, Chris; Mintz, Paul D.; Walderhaug, Mark O.; Worrall, Christopher M.; Kelman, Jeffrey A.; Anderson, Steven A.			Babesiosis Occurrence among the Elderly in the United States, as Recorded in Large Medicare Databases during 2006-2013	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; NEW-YORK-STATE; LYME-DISEASE; PHYSICAL-ACTIVITY; LEISURE-TIME; BLOOD-TRANSFUSION; IXODES-SCAPULARIS; MICROTI; USA	Background Human babesiosis, caused by intraerythrocytic protozoan parasites, can be an asymptomatic or mild-to-severe disease that may be fatal. The study objective was to assess babesiosis occurrence among the U.S. elderly Medicare beneficiaries, ages 65 and older, during 2006-2013. Methods Our retrospective claims-based study utilized large Medicare administrative databases. Babesiosis occurrence was ascertained by recorded ICD-9-CM diagnosis code. The study assessed babesiosis occurrence rates (per 100,000 elderly Medicare beneficiaries) overall and by year, age, gender, race, state of residence, and diagnosis months. Results A total of 10,305 elderly Medicare beneficiaries had a recorded babesiosis diagnosis during the eight-year study period, for an overall rate of about 5 per 100,000 persons. Study results showed a significant increase in babesiosis occurrence over time (p < 0.05), with the largest number of cases recorded in 2013 (N = 1,848) and the highest rates (per 100,000) in five Northeastern states: Connecticut (46), Massachusetts (45), Rhode Island (42), New York (27), and New Jersey (14). About 75% of all cases were diagnosed from May through October. Babesiosis occurrence was significantly higher among males vs. females and whites vs. non-whites. Conclusion Our study reveals increasing babesiosis occurrence among the U.S. elderly during 20062013, with highest rates in the babesiosis-endemic states. The study also shows variation in babesiosis occurrence by age, gender, race, state of residence, and diagnosis months. Overall, our study highlights the importance of large administrative databases in assessing the occurrence of emerging infections in the United States.	[Menis, Mikhail; Forshee, Richard A.; Kumar, Sanjai; Izurieta, Hector S.; Mintz, Paul D.; Walderhaug, Mark O.; Anderson, Steven A.] US FDA, Silver Spring, MD 20993 USA; [McKean, Stephen; Warnock, Rob; Gondalia, Rahul; Johnson, Chris] Acumen LLC, Burlingame, CA USA; [Worrall, Christopher M.; Kelman, Jeffrey A.] Ctr Medicare & Medicaid Serv, Baltimore, MD USA	US Food & Drug Administration (FDA); Centers for Medicare & Medicaid Services	Menis, M (corresponding author), US FDA, Silver Spring, MD 20993 USA.	Mikhail.Menis@fda.hhs.gov		Forshee, Richard/0000-0002-5805-2837; Gondalia, Rahul/0000-0001-5976-4863	U.S. Food and Drug Administration, Center for Biologics Evaluation and Research; FDA	U.S. Food and Drug Administration, Center for Biologics Evaluation and Research; FDA(United States Department of Health & Human Services)	This study was internally funded by the U.S. Food and Drug Administration, Center for Biologics Evaluation and Research. Acumen LLC is a CMS contractor funded by FDA to conduct analyses of CMS data. All authors made substantial contributions to research design, or the acquisition, analysis or interpretation of data and were involved in drafting of the paper or revising it critically.	AABB, 2014, AABB ASS B, V14-05; [Anonymous], FIL ORD GEN INF; [Anonymous], MED PROGR GEN INF; Apostolou A, 2014, EMERG INFECT DIS, V20, P1407, DOI 10.3201/eid2008.131591; Asad S, 2009, TRANSFUSION, V49, P2564, DOI 10.1111/j.1537-2995.2009.02380.x; Belongia EA, 2002, VECTOR-BORNE ZOONOT, V2, P265, DOI 10.1089/153036602321653851; Brownstein John S., 2005, EcoHealth, V2, P38, DOI 10.1007/s10393-004-0139-x; Brownstein JS, 2003, ENVIRON HEALTH PERSP, V111, P1152, DOI 10.1289/ehp.6052; Centers for Disease Control and Prevention, 2014, MMWR-MORBID MORTAL W, V62, pND; Centers for Disease Control and Prevention, BAB TREATM INF; Centers for Disease Control and Prevention, BAB LAB DIAGN; Centers for Disease Control and Prevention, DAT STAT BAB; Cobain TJ, 2007, TRANSFUSION MED, V17, P1, DOI 10.1111/j.1365-3148.2006.00709.x; Connecticut Department of Public Health, DIS STAT NUMB CAS AL; Crespo CJ, 2000, AM J PREV MED, V18, P46, DOI 10.1016/S0749-3797(99)00105-1; Crespo CJ, 1996, ARCH INTERN MED, V156, P93, DOI 10.1001/archinte.156.1.93; FDA, 2010, BLOOD PROD ADV COMM; Gubernot DM, 2009, TRANSFUSION, V49, P2759, DOI 10.1111/j.1537-2995.2009.02429.x; Gubernot DM, 2009, CLIN INFECT DIS, V48, P25, DOI 10.1086/595010; Hatcher JC, 2001, CLIN INFECT DIS, V32, P1117, DOI 10.1086/319742; He XXZ, 2005, J GEN INTERN MED, V20, P259, DOI 10.1111/j.1525-1497.2005.40198.x; Herwaldt Barbara L., 2012, Morbidity and Mortality Weekly Report, V61, P505; Herwaldt BL, 2011, ANN INTERN MED, V155, P509, DOI 10.7326/0003-4819-155-8-201110180-00362; Johnson ST, 2009, TRANSFUSION, V49, P2574, DOI 10.1111/j.1537-2995.2009.02430.x; Joseph JT, 2011, EMERG INFECT DIS, V17, P843, DOI 10.3201/eid1705.101334; Kleinman S, 2004, TRANSFUSION, V44, P386, DOI 10.1111/j.1537-2995.2003.00660.x; Krause PJ, 2003, AM J TROP MED HYG, V68, P431, DOI 10.4269/ajtmh.2003.68.431; Krause PJ, 1996, JAMA-J AM MED ASSOC, V275, P1657, DOI 10.1001/jama.275.21.1657; Krause PJ, 2000, NEW ENGL J MED, V343, P1454, DOI 10.1056/NEJM200011163432004; Krause PJ, 1998, NEW ENGL J MED, V339, P160, DOI 10.1056/NEJM199807163390304; Krause PJ, 2002, CLIN INFECT DIS, V34, P1184, DOI 10.1086/339813; Leiby DA., 2003, BACTERIAL PARASITIC, P179; Leiby DA, 2011, CLIN MICROBIOL REV, V24, P14, DOI 10.1128/CMR.00022-10; Levin AE, 2014, TRANSFUSION, V54, P2237, DOI 10.1111/trf.12763; Lindsay LR, 1999, J MED ENTOMOL, V36, P255, DOI 10.1093/jmedent/36.3.255; Massachusetts Department of Public Health, 2013, BAB SURV MASS; McQuiston JH, 2000, TRANSFUSION, V40, P274, DOI 10.1046/j.1537-2995.2000.40030274.x; MELDRUM SC, 1992, CLIN INFECT DIS, V15, P1019, DOI 10.1093/clind/15.6.1019; Menis M, 2012, EMERG INFECT DIS, V18, P128, DOI 10.3201/eid1801.110305; Minnesota Department of Health, BAB STAT; Moritz ED, 2014, TRANSFUSION, V54, P2226, DOI 10.1111/trf.12693; New Jersey Department of Health, NEW JERS REP DIS STA; Rhode Island Department of Health Division of Infectious Disease & Epidemiology, BAB SURV 2008 2012; Sjogren K, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-34; Smith RP, 2014, EMERG INFECT DIS, V20, P1727, DOI 10.3201/eid2010.130938; Spaete J, 2009, J CLIN APHERESIS, V24, P97, DOI 10.1002/jca.20197; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Thompson C, 2001, CLIN INFECT DIS, V33, P676, DOI 10.1086/322681; Tonnetti L, 2009, TRANSFUSION, V49, P2557, DOI 10.1111/j.1537-2995.2009.02317.x; VAMVAKAS EC, 1994, TRANSFUSION, V34, P464, DOI 10.1046/j.1537-2995.1994.34694295059.x; Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018; Vannier EG, 2015, INFECT DIS CLIN N AM, V29, P357, DOI 10.1016/j.idc.2015.02.008; Virnig BA, 2001, ANNU REV PUBL HEALTH, V22, P213, DOI 10.1146/annurev.publhealth.22.1.213; Wells AW, 2002, BRIT MED J, V325, P803, DOI 10.1136/bmj.325.7368.803; White DJ, 1998, ARCH INTERN MED, V158, P2149, DOI 10.1001/archinte.158.19.2149; Wisconsin Department of Health Services, BAB MORB DAT; Young C, 2012, TRANSFUSION, V52, P1523, DOI 10.1111/j.1537-2995.2012.03612.x	58	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140332	10.1371/journal.pone.0140332	http://dx.doi.org/10.1371/journal.pone.0140332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469785	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600042
J	Xiao, XD; Chen, Y; Mugabe, S; Gao, CS; Tkaczyk, C; Mazor, Y; Pavlik, P; Wu, H; Dall'Acqua, W; Chowdhury, PS				Xiao, Xiaodong; Chen, Yan; Mugabe, Sheila; Gao, Changshou; Tkaczyk, Christine; Mazor, Yariv; Pavlik, Peter; Wu, Herren; Dall'Acqua, William; Chowdhury, Partha Sarathi			A Novel Dual Expression Platform for High Throughput Functional Screening of Phage Libraries in Product like Format	PLOS ONE			English	Article							HUMAN-ANTIBODIES; SURFACE DISPLAY; SELECTION; EVOLUTION; INTRONS; RECOGNITION; PROTEINS; YEAST	High throughput screenings of single chain Fv (scFv) antibody phage display libraries are currently done as soluble scFvs produced in E.coli. Due to endotoxin contaminations from bacterial cells these preparations cannot be reliably used in mammalian cell based assays. The monovalent nature and lack of Fc in soluble scFvs prevent functional assays that are dependent on target cross linking and/or Fc functions. A convenient approach is to convert scFvs into scFv. Fc fusion proteins and express them in mammalian cell lines for screening. This approach is low throughput and is only taken after primary screening of monovalent scFvs that are expressed in bacteria. There is no platform at present that combines the benefits of both bacterial and mammalian expression system for screening phage library output. We have, therefore, developed a novel dual expression vector, called pSplice, which can be used to express scFv. Fc fusion proteins both in E.coli and mammalian cell lines. The hallmark of the vector is an engineered intron which houses the bacterial promoter and signal peptide for expression and secretion of scFv. Fc in E.coli. When the vector is transfected into a mammalian cell line, the intron is efficiently spliced out resulting in a functional operon for expression and secretion of the scFv. Fc fusion protein into the culture medium. By applying basic knowledge of mammalian introns and splisosome, we designed this vector to enable screening of phage libraries in a product like format. Like IgG, the scFv. Fc fusion protein is bi-valent for the antigen and possesses Fc effector functions. Expression in E.coli maintains the speed of the bacterial expression platform and is used to triage clones based on binding and other assays that are not sensitive to endotoxin. Triaged clones are then expressed in a mammalian cell line without the need for any additional cloning steps. Conditioned media from the mammalian cell line containing the fusion proteins are then used for different types of cell based assays. Thus this system retains the speed of the current screening system for phage libraries and adds additional functionality to it.	[Xiao, Xiaodong; Chen, Yan; Gao, Changshou; Mazor, Yariv; Pavlik, Peter; Wu, Herren; Dall'Acqua, William; Chowdhury, Partha Sarathi] MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA; [Mugabe, Sheila] MedImmune LLC, Dept Biopharmaceut Dev, Gaithersburg, MD 20878 USA; [Tkaczyk, Christine] MedImmune LLC, Dept Infect Dis, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune	Chowdhury, PS (corresponding author), MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.	chowdhuryp@medimmune.com			MedImmune; Astra-Zeneca Plc.	MedImmune(AstraZenecaMedimmune); Astra-Zeneca Plc.(AstraZeneca)	This study was funded solely by MedImmune which is a subsidiary of Astra-Zeneca Plc. MedImmune has provided support in the form of salaries for all the authors and procurement of all materials for the study, but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript. It has approved the decision to publish. The specific roles of all the authors are articulated in the 'author contributions' section.	Akamatsu Y, 2007, J IMMUNOL METHODS, V327, P40, DOI 10.1016/j.jim.2007.07.007; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Beerli RR, 2008, P NATL ACAD SCI USA, V105, P14336, DOI 10.1073/pnas.0805942105; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chen CG, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1142; Cumbers SJ, 2002, NAT BIOTECHNOL, V20, P1129, DOI 10.1038/nbt752; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; Ferrara F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049535; FRANCISCO JA, 1993, BIO-TECHNOL, V11, P491, DOI 10.1038/nbt0493-491; Fukuda I, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl618; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; He MY, 1997, NUCLEIC ACIDS RES, V25, P5132, DOI 10.1093/nar/25.24.5132; Higuchi K, 1997, J IMMUNOL METHODS, V202, P193, DOI 10.1016/S0022-1759(97)00010-0; Ho M, 2009, METHODS MOL BIOL, V562, P99, DOI 10.1007/978-1-60327-302-2_8; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Iwata H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-45; Jager V, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-52; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; McCullough AJ, 2000, MOL CELL BIOL, V20, P9225, DOI 10.1128/MCB.20.24.9225-9235.2000; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Sharp PA, 1997, CELL, V91, P875, DOI 10.1016/S0092-8674(00)80479-1; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; Steinwand M, 2014, MABS-AUSTIN, V6, P204, DOI 10.4161/mabs.27227; Sumida T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp776; Trott M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097478; Urban JH., 2005, NUCLEIC ACIDS RES, V33, P1; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Verma R, 1998, J IMMUNOL METHODS, V216, P165, DOI 10.1016/S0022-1759(98)00077-5; Wang XH, 2011, CANCER RES, V71, P7410, DOI 10.1158/0008-5472.CAN-10-1134; Xiao XS, 2009, NAT STRUCT MOL BIOL, V16, P1094, DOI 10.1038/nsmb.1661; Yang L, 2007, CYTOM PART A, V71A, P625, DOI 10.1002/cyto.a.20417; Yoon H, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-62; Zauderer M, 2002, US patent application, Patent No. [2002-0123057 A1, 20020123057]; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919; Zhang XH, 2011, EUKARYOT CELL, V10, P1422, DOI 10.1128/EC.05193-11	37	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140691	10.1371/journal.pone.0140691	http://dx.doi.org/10.1371/journal.pone.0140691			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468955	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600100
J	Carmichael, SL; Blumenfeld, YJ; Mayo, J; Wei, E; Gould, JB; Stevenson, DK; Shaw, GM				Carmichael, Suzan L.; Blumenfeld, Yair J.; Mayo, Jonathan; Wei, Emily; Gould, Jeffrey B.; Stevenson, David K.; Shaw, Gary M.		Stanford Univ Sch Med	Prepregnancy Obesity and Risks of Stillbirth	PLOS ONE			English	Article							BODY-MASS INDEX; VITAL-STATISTICS; MATERNAL WEIGHT; INFANT-DEATH; FETAL-DEATH; GAIN	Background We examined the association of maternal obesity with risk of stillbirth, focusing on whether the pattern of results varied by gestational age or maternal race-ethnicity or parity. Methods Analyses included 4,012 stillbirths and 1,121,234 liveborn infants delivered in California from 2007-2010. We excluded stillbirths due to congenital anomalies, women with hypertensive disorders or diabetes, and plural births, to focus on fetuses and women without these known contributing conditions. We used Poisson regression to estimate relative risks (RR) and 95% confidence intervals (CI). Separate models were run for stillbirths delivered at 20-23, 24-27, 28-31, 32-36, 37-41 weeks, relative to liveborn deliveries at 37-41 weeks. Results For stillbirth at 20-23 weeks, RRs were elevated for all race-ethnicity and parity groups. The RR for a 20-unit change in BMI (which reflects the approximate BMI difference between a normal weight and an Obese III woman) was 3.5 (95% CI 2.2, 5.6) for nulliparous white women and ranged from 1.8 to 5.0 for other sub-groups. At 24-27 weeks, the association was significant (p<0.05) only for multiparous non-Hispanic whites; at 28-31 weeks, for multiparous whites and nulliparous whites and blacks; at 32-36 weeks, for multiparous whites and nulliparous blacks; and at 37-41 weeks, for all groups except nulliparous blacks. The pattern of results was similar when restricted to stillbirths due to unknown causes and somewhat stronger when restricted to stillbirths attributable to obstetric causes. Conclusion Increased risks were observed across all gestational ages, and some evidence of heterogeneity of the associations was observed by race-ethnicity and parity.	[Carmichael, Suzan L.; Mayo, Jonathan; Wei, Emily; Gould, Jeffrey B.; Stevenson, David K.; Shaw, Gary M.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Blumenfeld, Yair J.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA	Stanford University; Stanford University	Carmichael, SL (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.	scarmichael@stanford.edu	Blumenfeld, Yair/P-9396-2019	Blumenfeld, Yair/0000-0002-9440-8175; Shaw, Gary/0000-0001-7438-4914	March of Dimes Prematurity Research Center at Stanford University; Stanford Child Health Research Institute	March of Dimes Prematurity Research Center at Stanford University; Stanford Child Health Research Institute	This work was supported by the March of Dimes Prematurity Research Center at Stanford University and the Stanford Child Health Research Institute.	Auger N, 2014, INT J EPIDEMIOL, V43, P1154, DOI 10.1093/ije/dyu011; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Duke Wes, 2014, J Registry Manag, V41, P13; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Gold KJ, 2014, OBSTET GYNECOL, V123, p6S, DOI 10.1097/AOG.0000000000000204; Herrchen B, 1997, COMPUT BIOMED RES, V30, P290, DOI 10.1006/cbmr.1997.1448; Heuser CC, 2010, OBSTET GYNECOL, V116, P1296, DOI 10.1097/AOG.0b013e3181fb8838; Hutcheon JA, 2013, AM J CLIN NUTR, V97, P1062, DOI 10.3945/ajcn.112.051706; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lyndon A, 2012, J MATERN-FETAL NEO M, V25, P2529, DOI 10.3109/14767058.2012.710280; MacDorman Marian F, 2012, Natl Vital Stat Rep, V60, P1; MacDorman Marian F, 2009, Natl Vital Stat Rep, V57, P1; Michels KB, 1998, AM J EPIDEMIOL, V147, P167; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Park S, 2011, MATERN CHILD HLTH J, V15, P851, DOI 10.1007/s10995-009-0544-4; Salihu HM, 2007, OBSTET GYNECOL, V110, P552, DOI 10.1097/01.AOG.0000270159.80607.10; Shaw GM, 2014, PAEDIATR PERINAT EP, V28, P302, DOI 10.1111/ppe.12125; Spector LG, 2014, PEDIATRICS, V133, pE1632, DOI 10.1542/peds.2013-3118; Stephansson O, 2001, AM J OBSTET GYNECOL, V184, P463, DOI 10.1067/mob.2001.109591; Yao RF, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.044; Yasmeen S, 2006, AM J OBSTET GYNECOL, V194, P992, DOI 10.1016/j.ajog.2005.08.058	22	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138549	10.1371/journal.pone.0138549	http://dx.doi.org/10.1371/journal.pone.0138549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466315	Green Submitted, Green Published, gold			2022-12-26	WOS:000363183100017
J	Fonvielle, JA; Reynaud, S; Jacquet, S; LeBerre, B; Ferrier-Pages, C				Fonvielle, J. A.; Reynaud, S.; Jacquet, S.; LeBerre, B.; Ferrier-Pages, C.			First Evidence of an Important Organic Matter Trophic Pathway between Temperate Corals and Pelagic Microbial Communities	PLOS ONE			English	Article							CLADOCORA-CAESPITOSA; HETEROTROPHIC BACTERIA; NUTRIENT LIMITATION; SEASONAL-CHANGES; WATER-COLUMN; MUCUS; REEF; DIVERSITY; GROWTH; BACTERIOPLANKTON	Mucus, i.e., particulate and dissolved organic matter (POM, DOM) released by corals, acts as an important energy carrier in tropical ecosystems, but little is known on its ecological role in temperate environments. This study assessed POM and DOM production by the temperate coral Cladocora caespitosa under different environmental conditions. The subsequent enzymatic degradation, growth of prokaryotes and virus-like particles (VLPs) as well as changes in the structure of the prokaryotic communities were also monitored. C. caespitosa produced an important quantity of mucus, which varied according to the environmental conditions (from 37.8 to 67.75 nmol carbon h(-1) cm(-2)), but remained higher or comparable to productions observed in tropical corals. It has an important nutritional value, as highlighted by the high content in dissolved nitrogen (50% to 90% of the organic matter released). Organic matter was rapidly degraded by prokaryotes' enzymatic activities, and due to its nitrogen content, aminopeptidase activity was 500 fold higher than the a-glucosidase activity. Prokaryotes, as well as VLPs, presented a rapid growth in the mucus, with prokaryote production rates as high as 0.31 mu g h(-1) L-1. Changes in bacterial and archaeal communities were observed in the ageing mucus and between mucus and the water column, suggesting a clear impact of mucus on microorganism diversity. Overall, our results show that the organic matter released by temperate corals, such as C. caespitosa, which can form reef structures in the Mediterranean Sea, stimulates microbial activity and thereby functions as a significant carbon and nitrogen supplier to the microbial loop.	[Fonvielle, J. A.; Reynaud, S.; Ferrier-Pages, C.] Ctr Sci Monaco, Ecophysiol Team, Dept Marine Biol, Monaco, Monaco; [Jacquet, S.; LeBerre, B.] INRA, UMR CARRTEL, Stn Hydrobiol Lacustre, Thonon Les Bains, France	INRAE	Fonvielle, JA (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Expt Limnol, Stechlin, Germany.	fonvielle.jeremy@gmail.com	Jacquet, Stéphan/AAJ-7846-2021	Jacquet, Stéphan/0000-0001-6017-3892; Ferrier-Pages, Christine/0000-0002-0357-4486; Fonvielle, Jeremy/0000-0002-8077-2419	government of the principality of Monaco	government of the principality of Monaco	The funding for this study came from the government of the principality of Monaco.	Agostini Sylvain, 2009, Galaxea - Tokyo, V11, P1; Allers E, 2008, APPL ENVIRON MICROB, V74, P3274, DOI 10.1128/AEM.01870-07; ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bednarz VN, 2012, J EXP BIOL, V215, P3672, DOI 10.1242/jeb.072884; Berdjeb L, 2013, FEMS MICROBIOL ECOL, V86, P215, DOI 10.1111/1574-6941.12154; Bythell JC, 2011, J EXP MAR BIOL ECOL, V408, P88, DOI 10.1016/j.jembe.2011.07.028; Chen CA, 2005, CORAL REEFS, V24, P11, DOI 10.1007/s00338-004-0389-7; CHO BC, 1988, NATURE, V332, P441, DOI 10.1038/332441a0; Christaki U, 1999, MAR ECOL PROG SER, V181, P297, DOI 10.3354/meps181297; CHROST RJ, 1991, BROCK SPR S, P29; COFFROTH MA, 1990, MAR BIOL, V105, P39, DOI 10.1007/BF01344269; Cole JJ, 1999, ECOSYSTEMS, V2, P215, DOI 10.1007/s100219900069; Comeau S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06681; Csaszar NBM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009751; D'Elia CF, 1988, CONCEPTS ECOSYSTEM E, P195; DENNISON WC, 1988, J EXP MAR BIOL ECOL, V115, P67, DOI 10.1016/0022-0981(88)90190-6; Dorigo U, 2006, FEMS MICROBIOL ECOL, V58, P109, DOI 10.1111/j.1574-6941.2006.00139.x; Erwin PM, 2014, ISME J, V8, P575, DOI 10.1038/ismej.2013.188; Ferrier-Pages C, 2011, LIMNOL OCEANOGR, V56, P1429, DOI 10.4319/lo.2011.56.4.1429; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Gori A, 2012, CORAL REEFS, V31, P823, DOI 10.1007/s00338-012-0904-1; HALEMEJKO GZ, 1986, ARCH HYDROBIOL, V107, P1; HALEMEJKO GZ, 1984, ARCH HYDROBIOL, V101, P489; HERNDL GJ, 1986, MAR BIOL, V90, P363, DOI 10.1007/BF00428560; HOPPE HG, 1983, MAR ECOL PROG SER, V11, P299, DOI 10.3354/meps011299; Hoppe HG, 2002, ECOLOGICAL SIGNIFICA; Jacquet S, 2013, FEW TESTS PRIOR FLOW; Jokiel P., 1978, CORAL REEFS RES METH, P529; KEIL RG, 1991, MAR ECOL PROG SER, V73, P1, DOI 10.3354/meps073001; KIRCHMAN DL, 1990, MAR ECOL PROG SER, V62, P47, DOI 10.3354/meps062047; Krediet CJ, 2009, APPL ENVIRON MICROB, V75, P3851, DOI 10.1128/AEM.00457-09; Kruzic P, 2003, CORAL REEFS, V22, P536, DOI 10.1007/s00338-003-0345-y; Lagaria A, 2011, BIOGEOSCIENCES, V8, P2595, DOI 10.5194/bg-8-2595-2011; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; Lemee R, 2002, AQUAT MICROB ECOL, V29, P227, DOI 10.3354/ame029227; Loh WKW, 2001, MAR ECOL PROG SER, V222, P97, DOI 10.3354/meps222097; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nakajima R, 2010, B MAR SCI, V86, P861, DOI 10.5343/bms.2009.1069; Nakajima R, 2009, AQUAT ECOL, V43, P815, DOI 10.1007/s10452-008-9210-y; Naumann MS, 2010, CORAL REEFS, V29, P649, DOI 10.1007/s00338-010-0612-7; Naumann MS, 2009, CORAL REEFS, V28, P109, DOI 10.1007/s00338-008-0459-3; Naumann MS, 2012, J MARINE SYST, V105, P20, DOI 10.1016/j.jmarsys.2012.05.007; Nguyen-Kim H, 2014, ENV MICROBIOL REP, V6, P675, DOI 10.1111/1758-2229.12185; Patten NL, 2006, J MAR BIOL ASSOC UK, V86, P563, DOI 10.1017/S0025315406013476; Peirano A, 1999, MAR ECOL PROG SER, V185, P195, DOI 10.3354/meps185195; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Pinhassi J, 2006, AQUAT MICROB ECOL, V44, P241, DOI 10.3354/ame044241; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rodolfo-Metalpa R, 2010, BIOGEOSCIENCES, V7; Rodolfo-Metalpa R, 2008, J EXP BIOL, V211, P1579, DOI 10.1242/jeb.016345; Rodolfo-Metalpa R, 2006, J EXP BIOL, V209, P4546, DOI 10.1242/jeb.02550; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Savage AM, 2002, MAR ECOL PROG SER, V244, P17, DOI 10.3354/meps244017; Schauer M, 2003, AQUAT MICROB ECOL, V31, P163, DOI 10.3354/ame031163; Schottner S, 2009, ISME J, V3, P756, DOI 10.1038/ismej.2009.15; Sebastian M, 2013, ISME J, V7, P1665, DOI 10.1038/ismej.2013.42; Sharon G, 2008, CURR MICROBIOL, V56, P481, DOI 10.1007/s00284-008-9100-5; Sobczak WV, 2002, P NATL ACAD SCI USA, V99, P8101, DOI 10.1073/pnas.122614399; Sun W, 2014, MICROB ECOL, V67, P942, DOI 10.1007/s00248-014-0395-4; Tanaka Y, 2008, B MAR SCI, V82, P237; Taniguchi A, 2014, J EXP MAR BIOL ECOL, V461, P331, DOI 10.1016/j.jembe.2014.09.004; Thingstad TF, 1998, LIMNOL OCEANOGR, V43, P88, DOI 10.4319/lo.1998.43.1.0088; Tremblay P, 2013, BIOGEOSCIENCES, V10, P3997, DOI 10.5194/bg-10-3997-2013; Uthicke S, 2001, MAR ECOL PROG SER, V210, P125, DOI 10.3354/meps210125; Vissers EW, 2009, FEMS MICROBIOL LETT, V298, P193, DOI 10.1111/j.1574-6968.2009.01718.x; Wild C, 2005, MAR ECOL PROG SER, V287, P87, DOI 10.3354/meps287087; Wild C, 2004, MAR ECOL PROG SER, V267, P159, DOI 10.3354/meps267159; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; Wild C, 2008, MAR ECOL PROG SER, V372, P67, DOI 10.3354/meps07724; Xu J, 2013, MICROB ECOL, V66, P60, DOI 10.1007/s00248-013-0207-2	74	6	6	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139175	10.1371/journal.pone.0139175	http://dx.doi.org/10.1371/journal.pone.0139175			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466126	Green Published, gold			2022-12-26	WOS:000363183100040
J	Grose, JH; Langston, K; Wang, XH; Squires, S; Mustafi, SB; Hayes, W; Neubert, J; Fischer, SK; Fasano, M; Saunders, GM; Dai, Q; Christians, E; Lewandowski, ED; Ping, P; Benjamin, IJ				Grose, Julianne H.; Langston, Kelsey; Wang, Xiaohui; Squires, Shayne; Mustafi, Soumyajit Banerjee; Hayes, Whitney; Neubert, Jonathan; Fischer, Susan K.; Fasano, Matthew; Saunders, Gina Moore; Dai, Qiang; Christians, Elisabeth; Lewandowski, E. Douglas; Ping, Peipei; Benjamin, Ivor J.			Characterization of the Cardiac Overexpression of HSPB2 Reveals Mitochondrial and Myogenic Roles Supported by a Cardiac HspB2 Interactome	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE GAPDH; ALPHA-B-CRYSTALLIN; ALZHEIMERS-DISEASE; HUNTINGTONS-DISEASE; GENE ONTOLOGY; ASSOCIATION; PROTECTION; CYTOSCAPE; ISCHEMIA	Small Heat Shock Proteins (sHSPs) are molecular chaperones that transiently interact with other proteins, thereby assisting with quality control of proper protein folding and/or degradation. They are also recruited to protect cells from a variety of stresses in response to extreme heat, heavy metals, and oxidative-reductive stress. Although ten human sHSPs have been identified, their likely diverse biological functions remain an enigma in health and disease, and much less is known about non-redundant roles in selective cells and tissues. Herein, we set out to comprehensively characterize the cardiac-restricted Heat Shock Protein B-2 (HspB2), which exhibited ischemic cardioprotection in transgenic overexpressing mice including reduced infarct size and maintenance of ATP levels. Global yeast two-hybrid analysis using HspB2 (bait) and a human cardiac library (prey) coupled with co-immunoprecipitation studies for mitochondrial target validation revealed the first HspB2 "cardiac interactome" to contain many myofibril and mitochondrial-binding partners consistent with the overexpression phenotype. This interactome has been submitted to the Biological General Repository for Interaction Datasets (BioGRID). A related sHSP chaperone HspB5 had only partially overlapping binding partners, supporting specificity of the interactome as well as non-redundant roles reported for these sHSPs. Evidence that the cardiac yeast two-hybrid HspB2 interactome targets resident mitochondrial client proteins is consistent with the role of HspB2 in maintaining ATP levels and suggests new chaperone-dependent functions for metabolic homeostasis. One of the HspB2 targets, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), has reported roles in HspB2 associated phenotypes including cardiac ATP production, mitochondrial function, and apoptosis, and was validated as a potential client protein of HspB2 through chaperone assays. From the clientele and phenotypes identified herein, it is tempting to speculate that small molecule activators of HspB2 might be deployed to mitigate mitochondrial related diseases such as cardiomyopathy and neurodegenerative disease.	[Grose, Julianne H.; Langston, Kelsey; Hayes, Whitney; Neubert, Jonathan] Brigham Young Univ, Microbiol & Mol Biol Dept, Provo, UT 84602 USA; [Wang, Xiaohui; Squires, Shayne; Mustafi, Soumyajit Banerjee; Saunders, Gina Moore; Christians, Elisabeth; Benjamin, Ivor J.] Univ Utah, Sch Med, Div Cardiol, Lab Cardiac Dis Redox Signaling & Cell Regenerat, Salt Lake City, UT 84132 USA; [Squires, Shayne; Dai, Qiang; Benjamin, Ivor J.] Med Coll Wisconsin, Dept Med, Div Cardiovasc Med, Milwaukee, WI 53226 USA; [Fischer, Susan K.; Fasano, Matthew; Lewandowski, E. Douglas] Univ Illinois, Chicago Coll Med, Ctr Cardiovasc Res, Program Integrat Cardiac Metab, Chicago, IL 60612 USA; [Ping, Peipei] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Ping, Peipei] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Ping, Peipei] Univ Calif Los Angeles, Dept Cardiol, Los Angeles, CA 90095 USA	Brigham Young University; Utah System of Higher Education; University of Utah; Medical College of Wisconsin; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Grose, JH (corresponding author), Brigham Young Univ, Microbiol & Mol Biol Dept, Provo, UT 84602 USA.	julianne_grose@byu.edu; ibenjamin@mcw.edu		Grose, Julianne/0000-0001-8816-6635	National Institute of Health (NIH) [2R01 HL063834-06, 5R01HL074370-03, NIH 5DP1OD006438-03]; Leducq Transatlantic Network "Redox and Nitrosative Regulation of Cardiac Remodeling: Novel Therapeutic Approaches for Heart Failure"; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074370, R01HL063834] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006438] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Transatlantic Network "Redox and Nitrosative Regulation of Cardiac Remodeling: Novel Therapeutic Approaches for Heart Failure"; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Health (NIH): 2R01 HL063834-06, 5R01HL074370-03, and NIH 5DP1OD006438-03 to I.J.B, and the Leducq Transatlantic Network "Redox and Nitrosative Regulation of Cardiac Remodeling: Novel Therapeutic Approaches for Heart Failure" to I.J.B.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benjamin IJ, 2007, AM J PHYSIOL-HEART C, V293, pH3201, DOI 10.1152/ajpheart.01363.2006; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bobba A, 2013, MITOCHONDRION, V13, P298, DOI 10.1016/j.mito.2013.03.008; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Butterfield DA, 2010, J ALZHEIMERS DIS, V20, P369, DOI 10.3233/JAD-2010-1375; Cerella C, 2014, BIOCHEM PHARMACOL, V92, P22, DOI 10.1016/j.bcp.2014.07.005; Christians ES, 2012, INT J BIOCHEM CELL B, V44, P1632, DOI 10.1016/j.biocel.2012.06.006; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; den Engelsman J, 2009, J MOL BIOL, V393, P1022, DOI 10.1016/j.jmb.2009.08.052; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Franck E, 2004, J MOL EVOL, V59, P792, DOI 10.1007/s00239-004-0013-z; Ganong W.F., 1987, REV MED PHYSL; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Gavin AC, 2011, CURR OPIN BIOTECH, V22, P42, DOI 10.1016/j.copbio.2010.09.007; Girish V, 2004, Indian J Cancer, V41, P47; Golenhofen N, 2006, PFLUG ARCH EUR J PHY, V451, P518, DOI 10.1007/s00424-005-1488-1; Griffin JL, 2000, AM J PHYSIOL-HEART C, V279, pH361, DOI 10.1152/ajpheart.2000.279.1.H361; Gulick J, 1997, CIRC RES, V80, P655, DOI 10.1161/01.RES.80.5.655; Guo CM, 2013, CLIN TRANSL ONCOL, V15, P167, DOI 10.1007/s12094-012-0924-x; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; Hroudova J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/175062; Ishiwata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042118; James P, 1996, GENETICS, V144, P1425; Jang M, 2009, MOL CELLS, V28, P559, DOI 10.1007/s10059-009-0151-7; Jiao Y, 2012, CHEMBIOCHEM, V13, P2335, DOI 10.1002/cbic.201200465; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kadono T, 2006, J MOL CELL CARDIOL, V40, P783, DOI 10.1016/j.yjmcc.2006.03.003; Kampinga HH, 2012, INT J BIOCHEM CELL B, V44, P1706, DOI 10.1016/j.biocel.2012.06.005; Katsogiannou M, 2014, MOL CELL PROTEOMICS, V13, P3585, DOI 10.1074/mcp.M114.041228; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Kumarapeli ARK, 2010, AM J TRANSL RES, V2, P390; Lazarev VF, 2013, ACTA NATURAE, V5, P81, DOI 10.32607/20758251-2013-5-2-81-89; LEWANDOWSKI ED, 1991, CIRC RES, V68, P578, DOI 10.1161/01.RES.68.2.578; Liu S, 2014, BBA-GENE REGUL MECH, V1839, P592, DOI 10.1016/j.bbagrm.2014.05.017; Luban Jeremy, 1995, Current Opinion in Biotechnology, V6, P59, DOI 10.1016/0958-1669(95)80010-7; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Morrison LE, 2004, AM J PHYSIOL-HEART C, V286, pH847, DOI 10.1152/ajpheart.00715.2003; Muth JE, 2006, BASIC STAT PHARM STA, P229; Nakagawa M, 2001, EXP CELL RES, V271, P161, DOI 10.1006/excr.2001.5362; Nicholls C, 2012, CLIN EXP PHARMACOL P, V39, P674, DOI 10.1111/j.1440-1681.2011.05599.x; Ojha J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016550; Pinz I, 2008, FASEB J, V22, P84, DOI 10.1096/fj.07-8130com; Pohjoismaki JLO, 2013, MOL BIOSYST, V9, P1210, DOI 10.1039/c3mb25556e; Pound KM, 2011, J MOL CELL CARDIOL, V51, P236, DOI 10.1016/j.yjmcc.2011.05.014; Prabhu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029810; Praneenararat T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S24; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Rajagopala SV, 2012, METHODS, V58, P392, DOI 10.1016/j.ymeth.2012.07.015; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Ramzan R, 2013, BIOCHEM SOC T, V41, P1294, DOI 10.1042/BST20130067; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Liang S, 2015, TOXICOL LETT, V234, P162, DOI 10.1016/j.toxlet.2015.02.017; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzer Gil, 2011, Human Genomics, V5, P709; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; Sun XK, 2004, J BIOL CHEM, V279, P2394, DOI 10.1074/jbc.M311324200; SUNAGA K, 1995, NEUROSCI LETT, V200, P133, DOI 10.1016/0304-3940(95)12098-O; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; Tan WZ, 2014, BBA-MOL BASIS DIS, V1842, P1295, DOI 10.1016/j.bbadis.2014.02.009; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Toda T, 2007, AM J PHYSIOL-HEART C, V293, pH3517, DOI 10.1152/ajpheart.00483.2006; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Vos MJ, 2009, BBA-MOL CELL RES, V1793, P1343, DOI 10.1016/j.bbamcr.2009.05.005; Wilhelmus MMM, 2006, NEUROPATH APPL NEURO, V32, P119, DOI 10.1111/j.1365-2990.2006.00689.x; Willis MS, 2013, NEW ENGL J MED, V368, P455, DOI 10.1056/NEJMra1106180; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; Yao LL, 2012, J CELL PHYSIOL, V227, P3518, DOI 10.1002/jcp.24053; Yoshida K, 1999, CELL STRUCT FUNCT, V24, P181, DOI 10.1247/csf.24.181; Younger JF, 2007, HEART, V93, P1547, DOI 10.1136/hrt.2006.109249; Zhang J, 2008, PROTEOMICS, V8, P1564, DOI 10.1002/pmic.200700851	76	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0133994	10.1371/journal.pone.0133994	http://dx.doi.org/10.1371/journal.pone.0133994			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465331	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100004
J	Krasteva, V; Jekova, I; Leber, R; Schmid, R; Abacherli, R				Krasteva, Vessela; Jekova, Irena; Leber, Remo; Schmid, Ramun; Abaecherli, Roger			Superiority of Classification Tree versus Cluster, Fuzzy and Discriminant Models in a Heartbeat Classification System	PLOS ONE			English	Article							ECG BEAT CLASSIFICATION; VENTRICULAR CONTRACTION CLASSIFICATION; DECISION TREE; RECOGNITION; FEATURES; SELECTION; CRITERIA; DATABASE; RULE	This study presents a 2-stage heartbeat classifier of supraventricular (SVB) and ventricular (VB) beats. Stage 1 makes computationally-efficient classification of SVB-beats, using simple correlation threshold criterion for finding close match with a predominant normal (reference) beat template. The non-matched beats are next subjected to measurement of 20 basic features, tracking the beat and reference template morphology and RR-variability for subsequent refined classification in SVB or VB-class by Stage 2. Four linear classifiers are compared: cluster, fuzzy, linear discriminant analysis (LDA) and classification tree (CT), all subjected to iterative training for selection of the optimal feature space among extended 210-sized set, embodying interactive second-order effects between 20 independent features. The optimization process minimizes at equal weight the false positives in SVB-class and false negatives in VB-class. The training with European ST-T, AHA, MIT-BIH Supraventricular Arrhythmia databases found the best performance settings of all classification models: Cluster (30 features), Fuzzy (72 features), LDA (142 coefficients), CT (221 decision nodes) with top-3 best scored features: normalized current RR-interval, higher/lower frequency content ratio, beat-to-template correlation. Unbiased test-validation with MIT-BIH Arrhythmia database rates the classifiers in descending order of their specificity for SVBclass: CT (99.9%), LDA (99.6%), Cluster (99.5%), Fuzzy (99.4%); sensitivity for ventricular ectopic beats as part from VB-class (commonly reported in published beat-classification studies): CT (96.7%), Fuzzy (94.4%), LDA (94.2%), Cluster (92.4%); positive predictivity: CT (99.2%), Cluster (93.6%), LDA (93.0%), Fuzzy (92.4%). CT has superior accuracy by 0.3-6.8% points, with the advantage for easy model complexity configuration by pruning the tree consisted of easy interpretable 'if-then' rules.	[Krasteva, Vessela; Jekova, Irena] Bulgarian Acad Sci, Inst Biophys & Biomed Engn, Sofia, Bulgaria; [Leber, Remo; Schmid, Ramun; Abaecherli, Roger] Schiller AG, Biomed Res & Signal Proc, Baar, Switzerland; [Schmid, Ramun; Abaecherli, Roger] Bern Univ Appl Sci, Med Technol Ctr, Bern, Switzerland; [Abaecherli, Roger] Univ Basel Hosp, Cardiovasc Res Inst Basel, Bazel, Switzerland	Bulgarian Academy of Sciences	Krasteva, V (corresponding author), Bulgarian Acad Sci, Inst Biophys & Biomed Engn, Sofia, Bulgaria.	vessika@biomed.bas.bg	Jekova, Irena/AAC-8668-2019; Krasteva, Vessela/Q-7236-2017	Jekova, Irena/0000-0002-8626-7819; Krasteva, Vessela/0000-0001-5385-2109	SCHILLER AG, Baar, Switzerland	SCHILLER AG, Baar, Switzerland	SCHILLER AG, Baar, Switzerland partially founded the study with employment payment. The funder did not play a role in the study design, nor in the data collection (all databases used are open source and have not been modified). The funder helped the analysis of the resulting data and made decision to publish, as well as helped writing and counterchecked the manuscript.	Acir N, 2006, EXPERT SYST APPL, V31, P150, DOI 10.1016/j.eswa.2005.09.013; American Heart Association (AHA), PLYM M PA 19462 US; [Anonymous], 1998, TEST REP PERF RES CA; Bartels PH, 2013, ANAL QUANT CYTOL, V35, P181; Behadada O., 2013, ARTIFICIAL INTELLIGE, V2, P45, DOI [DOI 10.5430/AIR.V2N3P45, 10.5430/air.v2n3p45]; Breiman L., 1984, CLASSIFICATION REGRE; Charfi F, 2013, J DECIS SYST, V22, P109, DOI 10.1080/12460125.2013.773640; Christov I, 2005, PHYSIOL MEAS, V26, P123, DOI 10.1088/0967-3334/26/1/011; Christov I, 2006, MED ENG PHYS, V28, P876, DOI 10.1016/j.medengphy.2005.12.010; de Chazal P, 2006, IEEE T BIO-MED ENG, V53, P2535, DOI 10.1109/TBME.2006.883802; Dutta S, 2010, MED ENG PHYS, V32, P1161, DOI 10.1016/j.medengphy.2010.08.007; Garcia A, 2011, J PHYS CONF SER, V332, DOI 10.1088/1742-6596/332/1/012023; Gomez-Herrero G., 2006, COMPUT CARDIOL, V33, P569; Greenwald SD, 1990, THESIS HARVARD MIT; Haibo He, 2009, IEEE Transactions on Knowledge and Data Engineering, V21, P1263, DOI 10.1109/TKDE.2008.239; HASTIE T, 2009, SPRINGER SERIES STAT; Tran HL, 2014, INT J AP MAT COM-POL, V24, P647, DOI 10.2478/amcs-2014-0047; Hu YH, 1997, IEEE T BIO-MED ENG, V44, P891, DOI 10.1109/10.623058; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jekova I, 2004, COMPUT CARDIOL, V31, P357, DOI 10.1109/CIC.2004.1442946; Jiang W, 2007, IEEE T NEURAL NETWOR, V18, P1750, DOI 10.1109/TNN.2007.900239; Khazaee A, 2010, BIOMED SIGNAL PROCES, V5, P252, DOI 10.1016/j.bspc.2010.07.006; Krasteva V, 2007, ANN BIOMED ENG, V35, P2065, DOI 10.1007/s10439-007-9368-9; Kutlu Y, 2012, COMPUT METH PROG BIO, V105, P257, DOI 10.1016/j.cmpb.2011.10.002; Kutlu Y, 2011, COMPUT BIOL MED, V41, P37, DOI 10.1016/j.compbiomed.2010.11.003; Lagerholm M, 2000, IEEE T BIO-MED ENG, V47, P838, DOI 10.1109/10.846677; Lin Y, 2007, P INT MED INF S TAIW, P109; Lix LM, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00146; Llamedo M, 2011, IEEE T BIO-MED ENG, V58, P616, DOI 10.1109/TBME.2010.2068048; Malhotra Rahul, 2010, INT J COMPUTER SCI T, V1, P183; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Martis RJ, 2013, BIOMED SIGNAL PROCES, V8, P437, DOI 10.1016/j.bspc.2013.01.005; Mert A., 2012, J TRENDS DEV MACH AS, V16, P179; Mingers J., 1989, Machine Learning, V3, P319, DOI 10.1007/BF00116837; Moody GA, 2001, IEEE ENG MED BIOL, V20, P45, DOI 10.1109/51.932724; Pantelopoulos A, 2010, P 10 IEEE INT C INF, P1, DOI [10.1109/ITAB.2010.5687731, DOI 10.1109/ITAB.2010.5687731]; Park J, 2014, TELEMED E-HEALTH, V20, P1069, DOI 10.1089/tmj.2014.0033; Park J, 2014, COMPUT BIOL MED, V54, P79, DOI 10.1016/j.compbiomed.2014.08.013; Patra D, 2010, INT J COMPUTER SCI I, V36, P3; Ripley B. D., 1996, PATTERN RECOGNITION; Rodriguez J, 2005, IEEE T INF TECHNOL B, V9, P23, DOI 10.1109/TITB.2004.838369; Rodriguez-Sotelo JL, 2012, ADV ELECTROCARDIOGRA, DOI [10.5772/24486, DOI 10.5772/24486]; Taddei A., 1992, J EUROPEAN HEART, V13, P1164; Taylor G. J., 2002, 150 PRACTICE ECGS IN; TAYLOR PC, 1993, STAT COMPUT, V3, P147, DOI 10.1007/BF00141771; Venables W.N., 2013, MODERN APPL STAT S; Wieben O, 1999, MED BIOL ENG COMPUT, V37, P560, DOI 10.1007/BF02513349; Ye C, 2012, IEEE T BIO-MED ENG, V59, P2930, DOI 10.1109/TBME.2012.2213253; Zidelmal Z, 2013, COMPUT METH PROG BIO, V111, P570, DOI 10.1016/j.cmpb.2013.05.011	49	25	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140123	10.1371/journal.pone.0140123	http://dx.doi.org/10.1371/journal.pone.0140123			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461492	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300056
J	Zheng, ZJ; Xu, Y; Sun, Y; Mei, WD; Ouyang, J				Zheng, Zhaojuan; Xu, Ying; Sun, Ye; Mei, Wending; Ouyang, Jia			Biocatalytic Production of Trehalose from Maltose by Using Whole Cells of Permeabilized Recombinant Escherichia coli	PLOS ONE			English	Article							TREHALOSE-6-PHOSPHATE SYNTHASE; SEQUENTIAL REACTIONS; CONVERTING MALTOSE; GENE CLONING; EXPRESSION; IDENTIFICATION; OVERPRODUCTION; ACID	Trehalose is a non-reducing disaccharide, which can protect proteins, lipid membranes, and cells from desiccation, refrigeration, dehydration, and other harsh environments. Trehalose can be produced by different pathways and trehalose synthase pathway is a convenient, practical, and low-cost pathway for the industrial production of trehalose. In this study, 3 candidate treS genes were screened from genomic databases of Pseudomonas and expressed in Escherichia coli. One of them from P. stutzeri A1501 exhibited the best transformation ability from maltose into trehalose and the least byproduct. Thus, whole cells of this recombinant E. coli were used as biocatalyst for trehalose production. In order to improve the conversion rate of maltose to trehalose, optimization of the permeabilization and biotransformation were carried out. Under optimal conditions, 92.2 g/l trehalose was produced with a high productivity of 23.1 g/(l h). No increase of glucose was detected during the whole course. The biocatalytic process developed in this study might serve as a candidate for the large scale production of trehalose.	[Zheng, Zhaojuan; Xu, Ying; Sun, Ye; Mei, Wending; Ouyang, Jia] Nanjing Forestry Univ, Coll Chem Engn, Nanjing 210037, Jiangsu, Peoples R China; [Zheng, Zhaojuan] Jiangsu Key Lab Biomass Based Green Fuels & Chem, Nanjing 210037, Jiangsu, Peoples R China; [Ouyang, Jia] Minist Educ, Key Lab Forest Genet & Biotechnol, Nanjing 210037, Jiangsu, Peoples R China	Nanjing Forestry University	Ouyang, J (corresponding author), Nanjing Forestry Univ, Coll Chem Engn, Nanjing 210037, Jiangsu, Peoples R China.	hgouyj@njfu.edu.cn			National Natural Science Foundation of China [31300487]; Natural Science Foundation of Jiangsu Province of China [BK20130970]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions	Funding provided by the National Natural Science Foundation of China, 31300487, http://www.nsfc.gov.cn/, ZZ; the Natural Science Foundation of Jiangsu Province of China, BK20130970, http://www.jskjjh.gov.cn/13kjskj2/default.jsp, ZZ; the Priority Academic Program Development of Jiangsu Higher Education Institutions, ZZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang SW, 2012, FOOD CHEM, V134, P1745, DOI 10.1016/j.foodchem.2012.03.065; Chen PT, 2012, J AGR FOOD CHEM, V60, P6063, DOI 10.1021/jf301593e; Chen RRZ, 2007, APPL MICROBIOL BIOT, V74, P730, DOI 10.1007/s00253-006-0811-x; Chen YS, 2006, J AGR FOOD CHEM, V54, P7098, DOI 10.1021/jf060828q; Chiba R, 2013, ORG LETT, V15, P594, DOI 10.1021/ol303408a; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; Djonovic S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003217; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Freeman BC, 2010, ENVIRON MICROBIOL, V12, P1486, DOI 10.1111/j.1462-2920.2010.02171.x; Gao YY, 2014, BIOCHIMIE, V101, P215, DOI 10.1016/j.biochi.2014.01.018; Guerard-Helaine C, 2015, CHEMCATCHEM, V7, P1871, DOI 10.1002/cctc.201500014; Habe H, 2015, BIORESOURCE TECHNOL, V177, P381, DOI 10.1016/j.biortech.2014.11.048; HELFERICH B, 1956, CHEM BER-RECL, V89, P314, DOI 10.1002/cber.19560890220; Jiang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077437; Jung DH, 2013, BIORESOURCE TECHNOL, V130, P801, DOI 10.1016/j.biortech.2012.12.162; Kandror O, 2002, P NATL ACAD SCI USA, V99, P9727, DOI 10.1073/pnas.142314099; Kim YH, 2000, APPL ENVIRON MICROB, V66, P4620, DOI 10.1128/AEM.66.11.4620-4624.2000; Koh S, 2003, CARBOHYD RES, V338, P1339, DOI 10.1016/S0008-6215(03)00172-1; Lee JH, 2005, APPL MICROBIOL BIOT, V68, P213, DOI 10.1007/s00253-004-1862-5; LEMIEUX RU, 1954, CAN J CHEM, V32, P340, DOI 10.1139/v54-044; Liang JY, 2013, J MOL CATAL B-ENZYM, V90, P26, DOI 10.1016/j.molcatb.2013.01.014; Ma Y, 2006, J FOOD ENG, V77, P342, DOI 10.1016/j.jfoodeng.2005.06.042; Nishimoto T, 1996, BIOSCI BIOTECH BIOCH, V60, P835, DOI 10.1271/bbb.60.835; NISHIMOTO T, 1995, BIOSCI BIOTECH BIOCH, V59, P2189, DOI 10.1271/bbb.59.2189; Ohtake S, 2011, J PHARM SCI-US, V100, P2020, DOI 10.1002/jps.22458; Padilla L, 2004, APPL ENVIRON MICROB, V70, P370, DOI 10.1128/AEM.70.1.370-376.2004; Pan YT, 2008, FEBS J, V275, P3408, DOI 10.1111/j.1742-4658.2008.06491.x; Ruhal R, 2012, J IND MICROBIOL BIOT, V39, P1153, DOI 10.1007/s10295-012-1124-y; Schiraldi C, 2002, TRENDS BIOTECHNOL, V20, P420, DOI 10.1016/S0167-7799(02)02041-3; TEWARI YB, 1991, BIOPHYS CHEM, V40, P59, DOI 10.1016/0301-4622(91)85029-P; Van der Borght J, 2011, APPL ENVIRON MICROB, V77, P6939, DOI 10.1128/AEM.05190-11; Wang LJ, 2011, BIORESOURCE TECHNOL, V102, P7023, DOI 10.1016/j.biortech.2011.04.046; Wang TF, 2014, CAN J MICROBIOL, V60, P599, DOI 10.1139/cjm-2014-0330; Wang TF, 2014, PAK J PHARM SCI, V27, P659; Wu TT, 2015, PROCESS BIOCHEM, V50, P928, DOI 10.1016/j.procbio.2015.03.006; Wu XL, 2009, APPL MICROBIOL BIOT, V83, P477, DOI 10.1007/s00253-009-1863-5; Yue M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-34; Zhu YM, 2010, EXTREMOPHILES, V14, P1, DOI 10.1007/s00792-009-0281-z	40	17	20	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140477	10.1371/journal.pone.0140477	http://dx.doi.org/10.1371/journal.pone.0140477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462117	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300102
J	Schabath, MB; Welsh, EA; Fulp, WJ; Chen, L; Teer, JK; Thompson, ZJ; Engel, BE; Xie, M; Berglund, AE; Creelan, BC; Antonia, SJ; Gray, JE; Eschrich, SA; Chen, DT; Cress, WD; Haura, EB; Beg, AA				Schabath, M. B.; Welsh, E. A.; Fulp, W. J.; Chen, L.; Teer, J. K.; Thompson, Z. J.; Engel, B. E.; Xie, M.; Berglund, A. E.; Creelan, B. C.; Antonia, S. J.; Gray, J. E.; Eschrich, S. A.; Chen, D-T; Cress, W. D.; Haura, E. B.; Beg, A. A.			Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma	ONCOGENE			English	Article							NF-KAPPA-B; TUMOR MICROENVIRONMENT; CANCER-IMMUNOTHERAPY; SOMATIC MUTATIONS; T-CELLS; LKB1; SIGNATURE; METASTASIS; SURVIVAL; INNATE	While mutations in the KRAS oncogene are among the most prevalent in human cancer, there are few successful treatments to target these tumors. It is also likely that heterogeneity in KRAS-mutant tumor biology significantly contributes to the response to therapy. We hypothesized that the presence of commonly co-occurring mutations in STK11 and TP53 tumor suppressors may represent a significant source of heterogeneity in KRAS-mutant tumors. To address this, we utilized a large cohort of resected tumors from 442 lung adenocarcinoma patients with data including annotation of prevalent driver mutations (KRAS and EGFR) and tumor suppressor mutations (STK11 and TP53), microarray-based gene expression and clinical covariates, including overall survival (OS). Specifically, we determined impact of STK11 and TP53 mutations on a new KRAS mutation-associated gene expression signature as well as previously defined signatures of tumor cell proliferation and immune surveillance responses. Interestingly, STK11, but not TP53 mutations, were associated with highly elevated expression of KRAS mutation-associated genes. Mutations in TP53 and STK11 also impacted tumor biology regardless of KRAS status, with TP53 strongly associated with enhanced proliferation and STK11 with suppression of immune surveillance. These findings illustrate the remarkably distinct ways through which tumor suppressor mutations may contribute to heterogeneity in KRAS-mutant tumor biology. In addition, these studies point to novel associations between gene mutations and immune surveillance that could impact the response to immunotherapy.	[Schabath, M. B.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA; [Welsh, E. A.; Teer, J. K.; Berglund, A. E.; Eschrich, S. A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Bioinformat, Tampa, FL 33612 USA; [Fulp, W. J.; Chen, L.; Thompson, Z. J.; Chen, D-T] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL 33612 USA; [Engel, B. E.; Xie, M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Biol Grad Program, Tampa, FL 33612 USA; [Creelan, B. C.; Antonia, S. J.; Gray, J. E.; Haura, E. B.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA; [Cress, W. D.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Beg, A. A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Schabath, MB; Beg, AA (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	matthew.schabath@moffitt.org; amer.beg@moffitt.org	Fulp, William/AAD-2369-2022; Schabath, Matthew B./J-3763-2016; Eschrich, Steven/K-6848-2013	Schabath, Matthew B./0000-0003-3241-3216; Eschrich, Steven/0000-0002-9833-2788; Creelan, Ben/0000-0002-2728-8070; Berglund, Anders/0000-0002-0393-3530; Fulp, William/0000-0001-6888-0794	National Institutes of Health SPORE Grant [P50 CA119997]; DeBartolo Family; Cancer Center Support Grant (CCSG grant) at the H. Lee Moffitt Cancer Center and Research Institute, a National Cancer Institute-designated Comprehensive Cancer Center [P30-CA76292]; NATIONAL CANCER INSTITUTE [P50CA070907, P30CA076292, P50CA119997, R25CA174664] Funding Source: NIH RePORTER	National Institutes of Health SPORE Grant; DeBartolo Family; Cancer Center Support Grant (CCSG grant) at the H. Lee Moffitt Cancer Center and Research Institute, a National Cancer Institute-designated Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health SPORE Grant (P50 CA119997). We would also like to thank Mr Andrew 'Ross' Myers, Anastasia Belock, Mercedes Rodriguez, Edward T Chwieseni, Marek Wloch, Hiba Gohar, and Moffitt's Tissue Core facility, Moffitt's Cancer Registry (Director: Karen A Coyne), Research Information Technology (IT) group, and the Data Management and Integration Technology (DMIT) group. Total Cancer Care is enabled, in part, by the generous support of the DeBartolo Family, and we thank the many patients who provided data and tissue to the Total Cancer Care Consortium. Our study also received valuable assistance from the following Core Facilities at the Moffitt Cancer Center: Biostatistics and Cancer Informatics, Tissue, and Molecular Genomics. This work has been supported in part by a Cancer Center Support Grant (CCSG grant P30-CA76292) at the H. Lee Moffitt Cancer Center and Research Institute, a National Cancer Institute-designated Comprehensive Cancer Center.	Baker NM, 2014, CLIN CANCER RES, V20, P4740, DOI 10.1158/1078-0432.CCR-13-1727; Bang D, 2013, CANCER DISCOV, V3, P690, DOI 10.1158/2159-8290.CD-12-0541; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Chen DT, 2011, JNCI-J NATL CANCER I, V103, P1859, DOI 10.1093/jnci/djr420; Chen DT, 2010, BREAST CANCER RES TR, V119, P335, DOI 10.1007/s10549-009-0344-y; Cox Adrienne D, 2010, Small GTPases, V1, P2; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fridman WH, 2011, CANCER RES, V71, P5601, DOI 10.1158/0008-5472.CAN-11-1316; Fuertes MB, 2013, TRENDS IMMUNOL, V34, P67, DOI 10.1016/j.it.2012.10.004; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gajewski TF, 2013, CURR OPIN IMMUNOL, V25, P259, DOI 10.1016/j.coi.2013.03.008; Gajewski TF, 2013, CURR OPIN IMMUNOL, V25, P268, DOI 10.1016/j.coi.2013.02.009; Gao YJ, 2011, PROTEIN CELL, V2, P99, DOI 10.1007/s13238-011-1021-6; Gao YJ, 2010, P NATL ACAD SCI USA, V107, P18892, DOI 10.1073/pnas.1004952107; Gibbons DL, 2014, MOL CANCER RES, V12, P3, DOI 10.1158/1541-7786.MCR-13-0539; Hopewell EL, 2013, J CLIN INVEST, V123, P2509, DOI 10.1172/JCI67250; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Kaufman JM, 2014, J THORAC ONCOL, V9, P794, DOI 10.1097/JTO.0000000000000173; Kim HS, 2013, CELL, V155, P552, DOI 10.1016/j.cell.2013.09.041; Loboda A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-26; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Meng DQ, 2013, LUNG CANCER, V81, P1, DOI 10.1016/j.lungcan.2013.03.019; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sanchez-Cespedes M, 2011, FAM CANCER, V10, P447, DOI 10.1007/s10689-011-9443-0; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shah U, 2008, CANCER RES, V68, P3562, DOI 10.1158/0008-5472.CAN-07-6620; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Ulloa-Montoya F, 2013, J CLIN ONCOL, V31, P2388, DOI 10.1200/JCO.2012.44.3762; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	46	179	184	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 16	2016	35	24					3209	3216		10.1038/onc.2015.375	http://dx.doi.org/10.1038/onc.2015.375			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO9GI	26477306	Green Accepted			2022-12-26	WOS:000378092700012
J	Cao, GS; Wang, J; Zheng, XD; Wei, HM; Tian, ZG; Sun, R				Cao, Guoshuai; Wang, Jian; Zheng, Xiaodong; Wei, Haiming; Tian, Zhigang; Sun, Rui			Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING RECEPTOR NKP30; IMMUNE-SYSTEM; TRIGGERING RECEPTOR; TNF-ALPHA; T-CELLS; CHAIN-A; CHEMOTHERAPY; RADIATION; CANCER; NKG2D	Immune cells are believed to participate in initiating anti-tumor effects during regular tumor therapy such as chemotherapy, radiation, hyperthermia, and cytokine injection. One of the mechanisms underlying this process is the expression of so-called stress-inducible immunostimulating ligands. Although the activating receptor NKG2D has been proven to play roles in tumor therapy through targeting its ligands, the role of NKp30, another key activating receptor, is seldom addressed. In this study, we found that the NKp30 ligand B7-H6 was widely expressed in tumor cells and closely correlated to their susceptibility to NK cell lysis. Further studies showed that treatment of tumor cells with almost all standard tumor therapeutics, including chemotherapy (cisplatin, 5-fluorouracil), radiation therapy, non-lethal heat shock, and cytokine therapy (TNF-alpha), could upregulate the expression of B7-H6 in tumor cells and enhance tumor sensitivity to NK cell cytolysis. B7-H6 shRNA treatment effectively dampened sensitization of tumor cells to NK-mediated lysis. Our study not only reveals the possibility that tumor therapeutics work as stress inducers to enhance tumor sensitivity to NK cell cytolysis but also suggests that B7-H6 could be a potential target for tumor therapy in the future.	[Cao, Guoshuai; Wang, Jian; Zheng, Xiaodong; Wei, Haiming; Tian, Zhigang; Sun, Rui] Univ Sci & Technol China, Chinese Acad Sci, Sch Life Sci, Inst Immunol,Key Lab Innate Immun & Chron Dis, Hefei 230027, Anhui, Peoples R China; [Cao, Guoshuai; Wang, Jian; Zheng, Xiaodong; Wei, Haiming; Tian, Zhigang; Sun, Rui] Univ Sci & Technol China, Med Ctr, Hefei 230027, Anhui, Peoples R China; [Wei, Haiming; Tian, Zhigang; Sun, Rui] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China; [Sun, Rui] Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Xiamen University	Wang, J (corresponding author), Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei 230027, Anhui, Peoples R China.	ustcwj@mail.ustc.edu.cn; sunr@ustc.edu.cn	Tian, Zhigang/J-3512-2013; Wei, Haiming/G-7703-2018; Zheng, Xiaodong/N-2830-2013	Wei, Haiming/0000-0002-1675-6502; 	Ministry of Science & Technology of China [2013CB530506, 2012ZX10002014, 2012AA020901]; Natural Science Foundation of China [91029303]	Ministry of Science & Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science & Technology of China (2013CB530506, 2012ZX10002014, and 2012AA020901) and Natural Science Foundation of China (#91029303). The authors declare that they have no conflicts of interest with the contents of this article.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Cheng M, 2013, CELL MOL IMMUNOL, V10, P230, DOI 10.1038/cmi.2013.10; Cheng M, 2011, CELL TRANSPLANT, V20, P1731, DOI 10.3727/096368911X580536; Fiegler N, 2013, BLOOD, V122, P684, DOI 10.1182/blood-2013-02-482513; Frey B, 2014, CANCER IMMUNOL IMMUN, V63, P29, DOI 10.1007/s00262-013-1474-y; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Ghiringhelli F, 2014, EXPERT REV CLIN IMMU, V10, P19, DOI 10.1586/1744666X.2014.865520; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Jinushi M, 2003, J IMMUNOL, V170, P1249, DOI 10.4049/jimmunol.170.3.1249; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Lin D, 2012, J BIOL CHEM, V287, P4299, DOI 10.1074/jbc.M111.282152; Luevano M, 2012, CELL MOL IMMUNOL, V9, P310, DOI 10.1038/cmi.2012.17; Manusama ER, 1996, EUR J SURG ONCOL, V22, P152, DOI 10.1016/S0748-7983(96)90671-X; Matsui S, 1999, J IMMUNOL, V163, P184; Matta J, 2013, BLOOD, V122, P394, DOI 10.1182/blood-2013-01-481705; Morandi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039170; Moretta L, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00087; Nice TJ, 2009, J EXP MED, V206, P287, DOI 10.1084/jem.20081335; Park B, 2014, INT J MOL SCI, V15, P927, DOI 10.3390/ijms15010927; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Schlecker E, 2014, CANCER RES, V74, P3429, DOI 10.1158/0008-5472.CAN-13-3017; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Sonn CH, 2012, J RADIAT RES, V53, P823, DOI 10.1093/jrr/rrs037; Takeshima T, 2010, CANCER RES, V70, P2697, DOI 10.1158/0008-5472.CAN-09-2982; TARNOWSKI GS, 1978, CANCER RES, V38, P4540; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Toraya-Brown S, 2014, NANOMED-NANOTECHNOL, V10, P1273, DOI 10.1016/j.nano.2014.01.011; Venkataraman GM, 2007, J IMMUNOL, V178, P961, DOI 10.4049/jimmunol.178.2.961; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Zitvogel L, 2008, J CLIN INVEST, V118, P1991, DOI 10.1172/JCI35180; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	38	52	59	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29964	29973		10.1074/jbc.M115.674010	http://dx.doi.org/10.1074/jbc.M115.674010			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26472927	Green Published, hybrid			2022-12-26	WOS:000366614700028
J	Lin, KY; Kao, SH; Lai, CM; Chen, CT; Wu, CY; Hsu, HJ; Wang, WD				Lin, Kun-Yang; Kao, Shih-Han; Lai, Chun-Ming; Chen, Ciao-Ting; Wu, Chang-Yi; Hsu, Hwei-Jan; Wang, Wen-Der			Tumor Suppressor Lzap Suppresses Wnt/beta-Catenin Signaling to Promote Zebrafish Embryonic Ventral Cell Fates via the Suppression of Inhibitory Phosphorylation of Glycogen Synthase Kinase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSOVENTRAL PATTERN-FORMATION; BMP ACTIVITY GRADIENT; BINDING PROTEIN; BETA-CATENIN; GENE-EXPRESSION; AXIS FORMATION; CHORDIN; WNT; PATHWAY; XENOPUS	Wnt/beta-catenin signaling controls various cell fates in metazoan development, and its dysregulation is often associated with cancer formation. However, regulations of this signaling pathway are not completely understood. Here, we report that Lzap, a tumor suppressor, controls nuclear translocation of beta-catenin. In zebrafish embryos disruption of lzap increases the expression of chordin (chd), which encodes a bone morphogenetic protein (BMP) antagonist that is localized in prospective dorsal cells and promotes dorsal fates. Consistently, lzap-deficient embryos with attenuated BMP signaling are dorsalized, which can be rescued by overexpression of zebrafish lzap or bmp2b or human LZAP. The expansion of chd expression in embryos lacking lzap is due to the accumulation of nuclear beta-catenin in ventral cells, in which beta-catenin is usually degraded. Furthermore, the activity of GSK3, a master regulator of beta-catenin degradation, is suppressed in lzap-deficient embryos via inhibitory phosphorylation. Finally, we also report that a similar regulatory axis is also likely to be present in a human tongue carcinoma cell line, SAS. Our results reveal that Lzap is a novel regulator of GSK3 for the maintenance of ventral cell properties and may prevent carcinogenesis via the regulation of beta-catenin degradation.	[Lin, Kun-Yang; Kao, Shih-Han; Hsu, Hwei-Jan] Acad Sinica, Inst Cellular & Organism Biol, Taipei 11529, Taiwan; [Lai, Chun-Ming] Natl Chung Hsing Univ, Taiwan Int Grad Program, Mol & Biol Agr Sci Program, Taipei 11529, Taiwan; [Lai, Chun-Ming] Acad Sinica, Taipei 11529, Taiwan; [Lin, Kun-Yang; Chen, Ciao-Ting; Wang, Wen-Der] Natl Chiayi Univ, Dept BioAgr Sci, Chiayi 60004, Taiwan; [Wu, Chang-Yi] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan	Academia Sinica - Taiwan; National Chung Hsing University; Academia Sinica - Taiwan; National Chiayi University; National Sun Yat Sen University	Hsu, HJ (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	cohsu@gate.sinica.edu.tw; wangw4@mail.ncyu.edu.tw	Wang, Wen-Der/AGO-2974-2022; Hsu, Hwei-Jan/AAD-1518-2022	Hsu, Hwei-Jan/0000-0001-7892-2310; Lin, Kun-Yang/0000-0002-6197-3995	Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan	Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by intramural funding from the Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan. The authors declare that they have no conflicts of interest with the contents of this article.	An HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016427; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Branam AM, 2010, DEV BIOL, V341, P444, DOI 10.1016/j.ydbio.2010.03.001; Cao Y, 2004, DEV BIOL, V271, P130, DOI 10.1016/j.ydbio.2004.03.032; Cha SW, 2008, DEVELOPMENT, V135, P3719, DOI 10.1242/dev.029025; Chen CY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-100; Chen YF, 2015, AM J PHYSIOL-CELL PH, V309, pC148, DOI 10.1152/ajpcell.00031.2015; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davuluri G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000240; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Detrich HW, 1999, METHODS CELL BIOL, V59, P3, DOI 10.1016/S0091-679X(08)61816-6; Dick A, 2000, DEVELOPMENT, V127, P343; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dougan ST, 2003, DEVELOPMENT, V130, P1837, DOI 10.1242/dev.00400; Furthauer M, 2004, DEVELOPMENT, V131, P2853, DOI 10.1242/dev.01156; Furthauer M, 1999, DEV BIOL, V214, P181, DOI 10.1006/dbio.1999.9401; GRIFFIN K, 1995, DEVELOPMENT, V121, P2983; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jurynec MJ, 2010, DIS MODEL MECH, V3, P733, DOI 10.1242/dmm.000703; Kane D, 2002, RES PRO CEL, V40, P117; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kwon J, 2010, J BIOL CHEM, V285, P12232, DOI 10.1074/jbc.M109.065920; Langdon YG, 2011, ANNU REV GENET, V45, P357, DOI 10.1146/annurev-genet-110410-132517; Larrain J, 2000, DEVELOPMENT, V127, P821; Lee HC, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-93; Lepage SE, 2010, INT J DEV BIOL, V54, P1213, DOI 10.1387/ijdb.093028sl; Liang J, 2011, J ZHEJIANG UNIV-SC B, V12, P951, DOI 10.1631/jzus.B1100121; Lin CW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386235; Liu D, 2011, DEV DYNAM, V240, P1613, DOI 10.1002/dvdy.22644; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu FI, 2011, P NATL ACAD SCI USA, V108, P15876, DOI 10.1073/pnas.1106801108; Maegawa S, 2006, DEVELOPMENT, V133, P3265, DOI 10.1242/dev.02483; MartinezBarbera JP, 1997, GENE, V198, P53, DOI 10.1016/S0378-1119(97)00292-8; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Miller-Bertoglio VE, 1997, DEV BIOL, V192, P537, DOI 10.1006/dbio.1997.8788; Muller II, 2006, DEV DYNAM, V235, P2881, DOI 10.1002/dvdy.20925; Mullins MC, 1996, DEVELOPMENT, V123, P81; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Ramel MC, 2013, DEV BIOL, V378, P170, DOI 10.1016/j.ydbio.2013.03.003; Sandoval J, 2009, J PHARMACOL EXP THER, V331, P609, DOI 10.1124/jpet.109.157537; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Schmid B, 2000, DEVELOPMENT, V127, P957; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Shao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036655; Sherwood V, 2015, MOL CELL BIOL, V35, P2, DOI 10.1128/MCB.00992-14; Shimizu T, 2005, DEV BIOL, V279, P125, DOI 10.1016/j.ydbio.2004.12.007; Shimizu T, 2000, MECH DEVELOP, V91, P293, DOI 10.1016/S0925-4773(99)00319-6; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sun ZH, 2006, DEV DYNAM, V235, P2999, DOI 10.1002/dvdy.20945; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wang JL, 2006, BIOCHEM J, V393, P489, DOI 10.1042/BJ20050960; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Westfall TA, 2003, DEV BIOL, V259, P380, DOI 10.1016/S0012-1606(03)00209-4; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Wu JC, 2010, J BIOL CHEM, V285, P15126, DOI 10.1074/jbc.M110.110619	64	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29808	29819		10.1074/jbc.M115.669309	http://dx.doi.org/10.1074/jbc.M115.669309			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26475862	hybrid, Green Published			2022-12-26	WOS:000366614700016
J	Wichelecki, DJ; Vetting, MW; Chou, LYS; Al-Obaidi, N; Bouvier, JT; Almo, SC; Gerlt, JA				Wichelecki, Daniel J.; Vetting, Matthew W.; Chou, Liyushang; Al-Obaidi, Nawar; Bouvier, Jason T.; Almo, Steven C.; Gerlt, John A.			ATP-binding Cassette (ABC) Transport System Solute-binding Protein-guided Identification of Novel D-Altritol and Galactitol Catabolic Pathways in Agrobacterium tumefaciens C58	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; bioinformatics; carbohydrate metabolism; enzyme; transcriptomics; Agrobacterium tumefaciens C58; D-altritol catabolism; genome neighborhood networks; sequence similarity networks	D-TAGATOSE; D-TALITOL; PLANT-CELLS; D-PSICOSE; METABOLISM; DATABASE; ENZYME; GENES; DEHYDROGENASE; EVOLUTION	Innovations in the discovery of the functions of uncharacterized proteins/enzymes have become increasingly important as advances in sequencing technology flood protein databases with an exponentially growing number of open reading frames. This study documents one such innovation developed by the Enzyme Function Initiative (EFI; U54GM093342), the use of solute-binding proteins for transport systems to identify novel metabolic pathways. In a previous study, this strategy was applied to the tripartite ATP-independent periplasmic transporters. Here, we apply this strategy to the ATP-binding cassette transporters and report the discovery of novel catabolic pathways for d-altritol and galactitol in Agrobacterium tumefaciens C58. These efforts resulted in the description of three novel enzymatic reactions as follows: 1) oxidation of d-altritol to d-tagatose via a dehydrogenase in Pfam family PF00107, a previously unknown reaction; 2) phosphorylation of d-tagatose to d-tagatose 6-phosphate via a kinase in Pfam family PF00294, a previously orphan EC number; and 3) epimerization of d-tagatose 6-phosphate C-4 to d-fructose 6-phosphate via a member of Pfam family PF08013, another previously unknown reaction. The epimerization reaction catalyzed by a member of PF08013 is especially noteworthy, because the functions of members of PF08013 have been unknown. These discoveries were assisted by the following two synergistic bioinformatics web tools made available by the Enzyme Function Initiative: the EFI-Enzyme Similarity Tool and the EFI-Genome Neighborhood Tool.	[Wichelecki, Daniel J.; Chou, Liyushang; Bouvier, Jason T.; Gerlt, John A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Wichelecki, Daniel J.; Chou, Liyushang; Bouvier, Jason T.; Gerlt, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Wichelecki, Daniel J.; Chou, Liyushang; Bouvier, Jason T.; Gerlt, John A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Vetting, Matthew W.; Al-Obaidi, Nawar; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Yeshiva University; Albert Einstein College of Medicine	Gerlt, JA (corresponding author), Univ Illinois, Inst Genom Biol, 1206 W Gregory Dr, Urbana, IL 61801 USA.	j-gerlt@illinois.edu	Regan, Clinton/E-6250-2012	Al Obaidi, Nawar/0000-0002-3659-9233	National Institutes of Health [U54GM093342]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM093342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant U54GM093342. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alajarin R., 1995, BEILSTEIN J ORG CHEM, V9, P2434; ARTHUR LO, 1973, J BACTERIOL, V116, P304, DOI 10.1128/JB.116.1.304-313.1973; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Beerens K, 2012, J IND MICROBIOL BIOT, V39, P823, DOI 10.1007/s10295-012-1089-x; Bouvier JT, 2014, BIOCHEMISTRY-US, V53, P614, DOI 10.1021/bi5000492; Brenner D. J., 2005, BERGEYS MANUAL SYSTE, V2, P326; Brinkkotter A, 2000, MOL MICROBIOL, V37, P125, DOI 10.1046/j.1365-2958.2000.01969.x; Brinkkotter A, 2002, ARCH MICROBIOL, V177, P410, DOI 10.1007/s00203-002-0406-6; CANGELOSI GA, 1990, P NATL ACAD SCI USA, V87, P6708, DOI 10.1073/pnas.87.17.6708; CHILTON MD, 1977, CELL, V11, P263, DOI 10.1016/0092-8674(77)90043-5; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; Erb TJ, 2012, NAT CHEM BIOL, V8, P926, DOI [10.1038/NCHEMBIO.1087, 10.1038/nchembio.1087]; Fisher M, 2007, NUCLEIC ACIDS RES, V35, P1064, DOI 10.1093/nar/gkl1126; FOX TC, 1986, PLANT PHYSIOL, V82, P307, DOI 10.1104/pp.82.1.307; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; Gilks WR, 2002, BIOINFORMATICS, V18, P1641, DOI 10.1093/bioinformatics/18.12.1641; Groninger-Poe FP, 2014, BIOCHEMISTRY-US, V53, P4192, DOI 10.1021/bi5005377; Hean Justin, 2010, Artif DNA PNA XNA, V1, P17; Jagtap SS, 2014, ENZYME MICROB TECH, V58-59, P44, DOI 10.1016/j.enzmictec.2014.02.012; Jones CE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-170; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Li ZJ, 2013, BEILSTEIN J ORG CHEM, V9, P2434, DOI 10.3762/bjoc.9.281; Luo Y, 2001, BIOCHEMISTRY-US, V40, P14763, DOI 10.1021/bi0112513; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Mojzita D, 2012, FUNGAL GENET BIOL, V49, P152, DOI 10.1016/j.fgb.2011.11.005; Moore LW, 1997, APPL ENVIRON MICROB, V63, P201, DOI 10.1128/AEM.63.1.201-207.1997; MUNIRUZZAMAN S, 1994, J FERMENT BIOENG, V78, P346, DOI 10.1016/0922-338X(94)90278-X; Nobelmann B, 1996, J BACTERIOL, V178, P6790, DOI 10.1128/jb.178.23.6790-6795.1996; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poonperm W, 2008, BIOSCI BIOTECH BIOCH, V72, P231, DOI 10.1271/bbb.70475; Raven JA, 2001, PHYTOCHEMISTRY, V58, P389, DOI 10.1016/S0031-9422(01)00286-2; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Reizer J, 1996, MICROBIOL-SGM, V142, P231, DOI 10.1099/13500872-142-2-231; Sasahara H, 1998, J FERMENT BIOENG, V85, P84, DOI 10.1016/S0922-338X(97)80359-5; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; SHAW DRD, 1956, BIOCHEM J, V64, P394, DOI 10.1042/bj0640394; SZUMILO T, 1981, BIOCHIM BIOPHYS ACTA, V660, P366, DOI 10.1016/0005-2744(81)90182-0; Toporowski MC, 2004, J BACTERIOL, V186, P8000, DOI 10.1128/JB.186.23.8000-8009.2004; VANKEER C, 1976, A VAN LEEUW J MICROB, V42, P13, DOI 10.1007/BF00399445; Vetting MW, 2015, BIOCHEMISTRY-US, V54, P909, DOI 10.1021/bi501388y; Wichelecki DJ, 2014, BIOCHEMISTRY-US, V53, P2722, DOI 10.1021/bi500264p; Yoshihara K, 2006, J BIOSCI BIOENG, V101, P219, DOI 10.1263/jbb.101.219; ZAMBRYSKI P, 1983, EMBO J, V2, P2143, DOI 10.1002/j.1460-2075.1983.tb01715.x; Zhao JL, 2014, J BACTERIOL, V196, P3150, DOI 10.1128/JB.01648-14; Zhao SW, 2014, ELIFE, V3, DOI 10.7554/eLife.03275; Zhao SW, 2013, NATURE, V502, P698, DOI 10.1038/nature12576	52	20	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28963	28976		10.1074/jbc.M115.686857	http://dx.doi.org/10.1074/jbc.M115.686857			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26472925	Green Published, hybrid			2022-12-26	WOS:000365762300035
J	Ma, SS; Kang, ZQ; Lu, P; Yang, YH; Yao, Q; Xia, HC; Chen, KP				Ma, Shangshang; Kang, Zhiqiong; Lu, Peng; Yang, Yanhua; Yao, Qin; Xia, Hengchuan; Chen, Keping			Molecular and Physiological Characterization of Two Novel Multirepeat beta-Thymosins from Silkworm, Bombyx mori	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITIES; REPEAT PROTEIN; ACTIN; NUCLEOPOLYHEDROVIRUS; INVASION; CELLS; GENE; IDENTIFICATION; MIGRATION; DOMAIN	beta-thymosin plays important roles in the development of the lymphatic system and the central nervous system in vertebrates. However, its role and function in invertebrates remain much less explored. Here, we firstly isolated a gene encoding beta-thymosin in silkworm (Bombyx mori L.). Interestingly, this gene encodes two polypeptides, named as BmTHY1 and BmTHY2, via two different modes of RNA splicing. The recombinant proteins fused with an N-term GST tag were over-expressed in Escherichia coli (E. coli) and further purified to near homogenity to prepare mouse antibodies. The Western blot analysis showed that these proteins were expressed in various tissues and organs, as well as in different developmental stages. Amazingly, the expression of BmTHY2 was hugely increased during the pupae stage, indicating a specialized role in this period. The expression of these proteins was gradually decreased in BmN cells infected by BmNPV, suggesting they may play different roles in the virus infection. In addition, both BmTHY1 and BmTHY2 can interact with 14-3-3 of silkworm and Ubiquitin of BmNPV as shown by GST pull down and Co-IP assays, consistent with their roles in the regulation of the development of nervous system.	[Ma, Shangshang; Kang, Zhiqiong; Lu, Peng; Yang, Yanhua; Yao, Qin; Xia, Hengchuan; Chen, Keping] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University	Xia, HC (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	hchxia@mail.ujs.edu.cn; kpchen@ujs.edu.cn	Xia, Hengchuan/AAB-1301-2020; Xia, hengchuan/GQB-2955-2022	Xia, hengchuan/0000-0002-5701-6092	Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundation of China [31572467, 31372259]; National Basic Research Program of China "973" [2012CB114604]	Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China "973"(National Basic Research Program of China)	Funded by Priority Academic Program Development of Jiangsu Higher Education Institutions (http://jsycw.ec.js.edu.cn), National Natural Science Foundation of China (31572467, 31372259) (http://www.nsfc.gov.cn/), and National Basic Research Program of China "973" (2012CB114604) (http://program.most.gov.cn/).	Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Boquet I, 2000, CELL, V102, P797, DOI 10.1016/S0092-8674(00)00068-4; Cavasin MA, 2004, HYPERTENSION, V43, P1140, DOI 10.1161/01.HYP.0000126172.01673.84; Chen HQ, 2007, FEBS LETT, V581, P5836, DOI 10.1016/j.febslet.2007.11.059; Crow T, 2004, BIOCHEM BIOPH RES CO, V323, P395, DOI 10.1016/j.bbrc.2004.08.103; Crow T, 2007, NEUROSCI LETT, V424, P6, DOI 10.1016/j.neulet.2007.07.013; Domanski M, 2004, J BIOL CHEM, V279, P23637, DOI 10.1074/jbc.M311413200; Eccles SA, 2005, BIOTECHNOL ANN REV, V11, P391, DOI 10.1016/S1387-2656(05)11013-8; Freeman KW, 2011, FASEB J, V25, P907, DOI 10.1096/fj.10-169417; Gai YC, 2009, DEV COMP IMMUNOL, V33, P867, DOI 10.1016/j.dci.2009.02.003; GOLDSCHMIDTCLERMONT PJ, 1992, MOL BIOL CELL, V3, P1015, DOI 10.1091/mbc.3.9.1015; GOLDSTEI.AL, 1966, P NATL ACAD SCI USA, V56, P1010, DOI 10.1073/pnas.56.3.1010; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; GOLDSTEIN AL, 1972, P NATL ACAD SCI USA, V69, P1800, DOI 10.1073/pnas.69.7.1800; Herrmann D, 2005, MECH DEVELOP, V122, P1183, DOI 10.1016/j.mod.2005.07.003; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Kasman LM, 2000, J GEN VIROL, V81, P1881, DOI 10.1099/0022-1317-81-7-1881; KOKKINOPOULOS D, 1985, BLUT, V50, P341, DOI 10.1007/BF00320927; Kong LY, 2007, BBA-GEN SUBJECTS, V1770, P1598, DOI 10.1016/j.bbagen.2007.08.005; Koshikawa S, 2005, FEBS LETT, V579, P1365, DOI 10.1016/j.febslet.2005.01.031; Koshikawa S, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-63; Liu HP, 2011, DEV COMP IMMUNOL, V35, P716, DOI 10.1016/j.dci.2011.02.015; LOW TLK, 1979, J BIOL CHEM, V254, P981; Lu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064962; Luo L, 2014, PROTEOMICS, V14, P19, DOI 10.1002/pmic.201300315; Manuel M, 2000, J MOL EVOL, V51, P378, DOI 10.1007/s002390010100; Marleen VT, 2007, ACTIN MONOMER BINDIN, P71; Netnapa S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060974PMID, DOI 10.1371/J0URNAL.P0NE.0060974]; Ohkawa T, 2002, J VIROL, V76, P12281, DOI 10.1128/JVI.76.23.12281-12289.2002; Piao Z, 2014, BIOCHEM BIOPH RES CO, V452, P858, DOI 10.1016/j.bbrc.2014.09.012; Ramirez GF, 2007, IMMUNOGENETICS, V60, P57; Sosne G, 2010, FASEB J, V24, P2144, DOI 10.1096/fj.09-142307; Telford MJ, 2004, EVOL DEV, V6, P90, DOI 10.1111/j.1525-142X.2004.04013.x; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; Wang Q, 2007, VIRUS RES, V127, P81, DOI 10.1016/j.virusres.2007.03.021; Wang WS, 2004, ONCOGENE, V23, P6666, DOI 10.1038/sj.onc.1207888; Wu LJ, 2009, FISH SHELLFISH IMMUN, V27, P379, DOI 10.1016/j.fsi.2009.05.019; Yang H, 2008, NEUROCHEM RES, V33, P2269, DOI 10.1007/s11064-008-9712-y; [姚勤 Yao Qin], 2002, [生命科学研究, Life science research], V6, P322; Zhang FX, 2011, INSECT MOL BIOL, V20, P519, DOI 10.1111/j.1365-2583.2011.01082.x; Zhang WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031040	41	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140182	10.1371/journal.pone.0140182	http://dx.doi.org/10.1371/journal.pone.0140182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474303	Green Submitted, gold, Green Published			2022-12-26	WOS:000363185500031
J	Dennis, EA; Coats, MT; Griffin, SE; Hale, JY; Novak, L; Briles, DE; Crain, MJ				Dennis, Evida A.; Coats, Mamie T.; Griffin, Sarah E.; Hale, Joanetha Y.; Novak, Lea; Briles, David E.; Crain, Marilyn J.			The Effects of CFTR and Mucoid Phenotype on Susceptibility and Innate Immune Responses in a Mouse Model of Pneumococcal Lung Disease	PLOS ONE			English	Article							CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; PULMONARY INFECTION; COLONIZATION; CONVERSION; CLEARANCE; MICE; MICROBIOLOGY; INFLAMMATION; TRANSITION	Recent studies have reported the isolation of highly mucoid serotype 3 Streptococcus pneumoniae (Sp) from the respiratory tracts of children with cystic fibrosis (CF). Whether these highly mucoid Sp contribute to, or are associated with, respiratory failure among patients with CF remains unknown. Other mucoid bacteria, predominately Pseudomonas aeruginosa, are associated with CF respiratory decline. We used a mouse model of CF to study pneumococcal pneumonia with highly mucoid serotype 3 and non-mucoid serotype 19A Sp isolates. We investigated susceptibility to infection, survival, and bacterial counts from bronchoaviolar lavage samples and lung homogenates, as well as associated inflammatory cytokines at the site of infection, and lung pathology. Congenic CFTR-/- mice and wild-type (WT)-mice were infected intranasally with CHB756, CHB1126, and WU2 (highly mucoid capsular serotype 3, intermediately mucoid serotype 3, and less mucoid serotype 3, respectively), or CHB1058 (non-mucoid serotype 19A). BAL, lung homogenates, and blood were collected from mice 5 days post-infection. Higher CFU recovery and shorter survival were observed following infection of CFTR-/- mice with CHB756 compared to infection with CHB1126, WU2, or CHB1058 (P <= 0.001). Additionally, CFTR-/- mice infected with CHB756 and CHB1126 were more susceptible to infection than WT-mice (P <= 0.05). Between CFTR-/- mice and WT-mice, no significant differences in TNF-alpha, CXCL1/KC concentrations, or lung histopathology were observed. Our results indicate that highly mucoid type 3 Sp causes more severe lung disease than non-mucoid Sp, and does so more readily in the lungs of CFTR-/- than WT-mice.	[Dennis, Evida A.; Coats, Mamie T.; Griffin, Sarah E.; Hale, Joanetha Y.; Briles, David E.; Crain, Marilyn J.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Coats, Mamie T.] Alabama State Univ, Dept Biol Sci, Montgomery, AL 36101 USA; [Novak, Lea] Univ Alabama Birmingham, Dept Anat Pathol, Birmingham, AL USA; [Briles, David E.; Crain, Marilyn J.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Dennis, EA (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	edennis1@uab.edu		Dennis, Evida/0000-0001-9963-0392	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [P30 DK072482]; Gregory Fleming James Cystic Fibrosis Research Center at the University of Alabama at Birmingham; NIH [R01 AI021548]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118805, R01AI021548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Gregory Fleming James Cystic Fibrosis Research Center at the University of Alabama at Birmingham; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award P30 DK072482 (MJC), the Gregory Fleming James Cystic Fibrosis Research Center at the University of Alabama at Birmingham (MJC), and NIH R01 AI021548 (DEB).	BALOUGH K, 1995, PEDIATR PULM, V20, P63, DOI 10.1002/ppul.1950200203; BRILES DE, 1989, INFECT IMMUN, V57, P1457, DOI 10.1128/IAI.57.5.1457-1464.1989; Briles DE, 2005, INFECT IMMUN, V73, P6945, DOI 10.1128/IAI.73.10.6945-6951.2005; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; BRILES DE, 1992, INFECT IMMUN, V60, P111, DOI 10.1128/IAI.60.1.111-116.1992; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; Calbo E, 2010, INT J ANTIMICROB AG, V35, P107, DOI 10.1016/j.ijantimicag.2009.10.002; Chroneos ZC, 2000, J IMMUNOL, V165, P3941, DOI 10.4049/jimmunol.165.7.3941; Conese Massimo, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P8; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; Dallaire F, 2001, J INFECT DIS, V184, P292, DOI 10.1086/322021; del Campo R, 2005, J CLIN MICROBIOL, V43, P2207, DOI 10.1128/JCM.43.5.2207-2214.2005; Emerson J, 2010, PEDIATR PULM, V45, P363, DOI 10.1002/ppul.21198; Esposito S, 2015, J CYST FIBROS; Gosselin D, 1998, AM J RESP CRIT CARE, V157, P1253, DOI 10.1164/ajrccm.157.4.9702081; GOSSELIN D, 1995, INFECT IMMUN, V63, P3272, DOI 10.1128/IAI.63.9.3272-3278.1995; Gray Barry M., 2008, P3; HOIBY N, 1976, SCAND J RESPIR DIS, V57, P37; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Laurans M, 2006, ARCH PEDIATRIE, V13, pS22; Lee B, 2011, APMIS, V119, P263, DOI 10.1111/j.1600-0463.2011.02726.x; Maeda Y, 2011, J CYST FIBROS, V10, P133, DOI 10.1016/j.jcf.2010.11.003; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; Martha B, 2010, CLIN MICROBIOL INFEC, V16, P617, DOI 10.1111/j.1469-0691.2009.02786.x; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; MARTIN DW, 1993, MOL MICROBIOL, V9, P497, DOI 10.1111/j.1365-2958.1993.tb01711.x; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; Moser C, 2009, APMIS, V117, P95, DOI 10.1111/j.1600-0463.2008.00018.x; Nelson S, 1990, Prog Clin Biol Res, V325, P211; Noah TL, 1997, J INFECT DIS, V175, P638, DOI 10.1093/infdis/175.3.638; Paroni M, 2012, J INFECT DIS; Rau MH, 2010, ENVIRON MICROBIOL, V12, P1643, DOI 10.1111/j.1462-2920.2010.02211.x; SAIMAN L, 1992, INFECT IMMUN, V60, P2808, DOI 10.1128/IAI.60.7.2808-2814.1992; Schroeder TH, 2001, J IMMUNOL, V166, P7410, DOI 10.4049/jimmunol.166.12.7410; van Heeckeren A, 1997, J CLIN INVEST, V100, P2810, DOI 10.1172/JCI119828; van Heeckeren AM, 2006, AM J RESP CRIT CARE, V173, P288, DOI 10.1164/rccm.200506-917OC; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Wu HY, 1997, MICROB PATHOGENESIS, V23, P127, DOI 10.1006/mpat.1997.0142; Yu H, 2000, INFECT IMMUN, V68, P2142, DOI 10.1128/IAI.68.4.2142-2147.2000; ZHOU L, 1994, SCIENCE, V266, P1705, DOI 10.1126/science.7527588	44	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140335	10.1371/journal.pone.0140335	http://dx.doi.org/10.1371/journal.pone.0140335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469863	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600043
J	Kim, SY; Sim, CK; Tang, H; Han, WP; Zhang, KL; Xu, F				Kim, Sun-Yee; Sim, Choon Kiat; Tang, Hui; Han, Weiping; Zhang, Kangling; Xu, Feng			Acetylome Analysis Identifies SIRT1 Targets in mRNA-Processing and Chromatin-Remodeling in Mouse Liver	PLOS ONE			English	Article							HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS; LYSINE ACETYLATION; METABOLISM; SIRTUINS; GLUCOSE; ROLES; INFLAMMATION; DEACETYLASES; RESVERATROL; PGC-1-ALPHA	Lysine acetylation is a post-translational modification found on numerous proteins, a strategy used in cell signaling to change protein activity in response to internal or external cues. Sirtuin 1 (SIRT1) is a central lysine deacetylase involved in a variety of cellular processes including metabolism, apoptosis, and DNA repair. Here we characterize the lysine acetylome in mouse liver, and by using a model of Sirt1(-/-) knockout mouse, show that SIRT1 regulates the deacetylation of 70 proteins in the liver in-vivo. Amongst these SIRT1-regulated proteins, we find that four RNA-processing proteins and a chromatin-remodeling protein can be deacetylated by SIRT1 directly in-vitro. The discovery that SIRT1 has a potential role in RNA-processing suggests a new layer of regulation in the variety of functions performed by SIRT1.	[Kim, Sun-Yee; Sim, Choon Kiat; Xu, Feng] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Tang, Hui; Zhang, Kangling] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Han, Weiping] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore; [Han, Weiping; Xu, Feng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Han, Weiping; Xu, Feng] Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); University of Texas System; University of Texas Medical Branch Galveston; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore; National University of Singapore	Zhang, KL (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.	kazhang@utmb.edu; xu_feng@sics.a-star.edu.sg		Xu, Feng/0000-0003-2016-7521; KIM, Sun-Yee/0000-0002-8061-2271	Academic Center of Excellence Research Grant from GSK [100019545]; Industry Alignment Fund from the Agency for Science, Technology and Research (A*STAR) of Singapore [IAF111002]; A*STAR of Singapore	Academic Center of Excellence Research Grant from GSK; Industry Alignment Fund from the Agency for Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); A*STAR of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Academic Center of Excellence Research Grant (No. 100019545) from GSK and the Industry Alignment Fund (IAF111002) from the Agency for Science, Technology and Research (A*STAR) of Singapore to F.X. Funding for the open-access charge was provided by A*STAR of Singapore. GSK provided the liver tissue from SIRT1 wild-type and knockout mice for this study. Other than that, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Bosch-Presegue Laia, 2011, Genes Cancer, V2, P648, DOI 10.1177/1947601911417862; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Dominy JE, 2010, BBA-PROTEINS PROTEOM, V1804, P1676, DOI 10.1016/j.bbapap.2009.11.023; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Herskovits AZ, 2013, CELL RES, V23, P746, DOI 10.1038/cr.2013.70; Holcik M, 2003, MOL CELL BIOL, V23, P280, DOI 10.1128/MCB.23.1.280-288.2003; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Huynh Frank K, 2013, Diabetes Manag (Lond), V3, P245; Kelly G, 2010, ALTERN MED REV, V15, P245; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Koumbadinga GA, 2015, BBA-GENE REGUL MECH, V1849, P1095, DOI 10.1016/j.bbagrm.2015.05.001; Lin WY, 2015, J HEPATOL, V62, P1024, DOI 10.1016/j.jhep.2014.11.038; Liu TF, 2015, J BIOL CHEM, V290, P396, DOI 10.1074/jbc.M114.566349; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Peng LR, 2012, MOL CELL BIOL, V32, P2823, DOI 10.1128/MCB.00496-12; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Thompson JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075753; Trapp J, 2007, CHEMMEDCHEM, V2, P1419, DOI 10.1002/cmdc.200700003; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Wang YB, 2013, EMBO MOL MED, V5, P1431, DOI 10.1002/emmm.201302663; Yang L, 2011, J PROTEOME RES, V10, P4134, DOI 10.1021/pr200313x; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	40	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140619	10.1371/journal.pone.0140619	http://dx.doi.org/10.1371/journal.pone.0140619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468954	Green Submitted, Green Published, gold			2022-12-26	WOS:000363184600087
J	Shikano, T; Jarvinen, A; Marjamaki, P; Kahilainen, KK; Merila, J				Shikano, Takahito; Jarvinen, Antero; Marjamaki, Paula; Kahilainen, Kimmo K.; Merila, Juha			Genetic Variability and Structuring of Arctic Charr (Salvelinus alpinus) Populations in Northern Fennoscandia	PLOS ONE			English	Article							CROSS-SPECIES AMPLIFICATION; SALMON SALMO-SALAR; MICROSATELLITE LOCI; PHYLOGENETIC TREES; DIVERSITY ANALYSIS; COMPUTER-PROGRAM; DOLLY-VARDEN; BROWN TROUT; SIZE; DNA	Variation in presumably neutral genetic markers can inform us about evolvability, historical effective population sizes and phylogeographic history of contemporary populations. We studied genetic variability in 15 microsatellite loci in six native landlocked Arctic charr (Salvelinus alpinus) populations in northern Fennoscandia, where this species is considered near threatened. We discovered that all populations were genetically highly (mean F-ST approximate to 0.26) differentiated and isolated from each other. Evidence was found for historical, but not for recent population size bottlenecks. Estimates of contemporary effective population size (N-e) ranged from seven to 228 and were significantly correlated with those of historical N-e but not with lake size. A census size (N-C) was estimated to be approximately 300 individuals in a pond (0.14 ha), which exhibited the smallest N-e (i.e. N-e/N-C = 0.02). Genetic variability in this pond and a connected lake is severely reduced, and both genetic and empirical estimates of migration rates indicate a lack of gene flow between them. Hence, albeit currently thriving, some northern Fennoscandian populations appear to be vulnerable to further loss of genetic variability and are likely to have limited capacity to adapt if selection pressures change.	[Shikano, Takahito; Marjamaki, Paula; Merila, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland; [Jarvinen, Antero; Kahilainen, Kimmo K.] Univ Helsinki, Kilpisjarvi Biol Stn, Kilpisjarvi, Finland; [Kahilainen, Kimmo K.] Univ Helsinki, Dept Environm Sci, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Shikano, T (corresponding author), Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland.	takahito.shikano@helsinki.fi	Merila, Juha/A-4061-2008	Merila, Juha/0000-0001-9614-0072; Kahilainen, Kimmo/0000-0002-1539-014X	Academy of Finland; Ministry of Agriculture and Forestry	Academy of Finland(Academy of Finland); Ministry of Agriculture and Forestry	This research was supported by grants from Academy of Finland (to JM) and Ministry of Agriculture and Forestry (to KKK).	Alekseyev SS, 2009, J FISH BIOL, V75, P368, DOI 10.1111/j.1095-8649.2009.02331.x; Angers B, 1995, J FISH BIOL, V47, P177, DOI 10.1111/j.1095-8649.1995.tb06054.x; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bernatchez L, 2002, T AM FISH SOC, V131, P1106, DOI 10.1577/1548-8659(2002)131&lt;1106:MGDAIL&gt;2.0.CO;2; Bernatchez L, 1998, CAN J FISH AQUAT SCI, V55, P1264, DOI 10.1139/cjfas-55-5-1264; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Brunner PC, 1998, MOL ECOL, V7, P209, DOI 10.1046/j.1365-294x.1998.00341.x; Brunner PC, 2001, EVOLUTION, V55, P573, DOI 10.1554/0014-3820(2001)055[0573:HPOACS]2.0.CO;2; Caballero A, 2013, GENETICS, V195, P1373, DOI 10.1534/genetics.113.158410; Chapman DG, 1948, INT PAC SALMON FISH, V2, P67; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Crane PA, 2004, CONSERV GENET, V5, P737, DOI 10.1007/s10592-004-1853-1; Dehaan PW, 2005, MOL ECOL NOTES, V5, P582, DOI 10.1111/j.1471-8286.2005.00997.x; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; ESTOUP A, 1993, HEREDITY, V71, P488, DOI 10.1038/hdy.1993.167; Estoup A, 1998, NATO ADV SCI I A-LIF, V306, P55; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R., 2002, INTRODUCTION TO CONS; Franklin IR, 1998, ANIM CONSERV, V1, P69, DOI 10.1111/j.1469-1795.1998.tb00228.x; Franklin I.R., 1980, CONSERVATION BIOL EV; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gislason D, 1999, CAN J FISH AQUAT SCI, V56, P2229, DOI 10.1139/cjfas-56-12-2229; Gordeeva N.V., 2010, J ICHTHYOL+, V50, P351, DOI DOI 10.1134/S0032945210050012; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hansen MM, 2007, MOL ECOL, V16, P1413, DOI 10.1111/j.1365-294X.2007.03255.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt Godfrey M, 2004, Front Zool, V1, P4; HINDAR K, 1986, BIOL J LINN SOC, V27, P269, DOI 10.1111/j.1095-8312.1986.tb01737.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Johansson P, 2005, POHJOIS SUOMEN MAAPE, P236; Jonsson B, 2001, J FISH BIOL, V58, P605, DOI 10.1006/jfbi.2000.1515; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kapralova KH, 2011, HEREDITY, V106, P472, DOI 10.1038/hdy.2010.161; Klemetsen A, 2003, ECOL FRESHW FISH, V12, P1, DOI 10.1034/j.1600-0633.2003.00010.x; Klemetsen A., 2013, J ICHTHYOL, V53, P781, DOI [10.1134/S0032945213100044, DOI 10.1134/S0032945213100044]; Kopp M, 2014, EVOL APPL, V7, P169, DOI 10.1111/eva.12127; Koskinen MT, 2000, MOL ECOL, V9, P1609, DOI 10.1046/j.1365-294x.2000.01065.x; Kujansuu R., 1967, B COMMISSION GEOLOGI, V232, P1; Langella O, 2002, POPULATIONS 1 2 28 L; Lippe C, 2006, MOL ECOL, V15, P1769, DOI 10.1111/j.1365-294X.2006.02902.x; Lotterhos KE, 2014, EVOL APPL, V7, P238, DOI 10.1111/eva.12115; Lundqvist J, 1965, THE GEOLOGIC SYSTEMS, P139; Lundqvist J., 1972, BOREAS, V1, P27, DOI DOI 10.1111/J.1502-3885.1972.TB00142.X; Maitland Peter S., 1995, Nordic Journal of Freshwater Research, V71, P113; Mangerud J, 2004, QUATERNARY SCI REV, V23, P1313, DOI 10.1016/j.quascirev.2003.12.009; Merila J, 2014, J LIMNOL, V73, P33, DOI 10.4081/jlimnol.2014.805; Moore JS, 2013, CAN J FISH AQUAT SCI, V70, P1327, DOI 10.1139/cjfas-2013-0138; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nesbo CL, 1999, MOL ECOL, V8, P1387, DOI 10.1046/j.1365-294x.1999.00699.x; OReilly PT, 1996, CAN J FISH AQUAT SCI, V53, P2292, DOI 10.1139/cjfas-53-10-2292; Ostbye K, 2005, MOL ECOL, V14, P4371, DOI 10.1111/j.1365-294X.2005.02737.x; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Phillips R, 2001, BIOL REV, V76, P1, DOI 10.1017/S1464793100005613; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Porras-Hurtado Liliana, 2013, Frontiers in Genetics, V4, P98, DOI 10.3389/fgene.2013.00098; Presa P, 1996, J FISH BIOL, V49, P1326, DOI 10.1111/j.1095-8649.1996.tb01800.x; Primmer CR, 1999, HEREDITAS, V130, P277, DOI 10.1111/j.1601-5223.1999.00277.x; Pritchard JK, 2000, GENETICS, V155, P945; Reed DH, 2005, CONSERV BIOL, V19, P563, DOI 10.1111/j.1523-1739.2005.00444.x; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Scribner KT, 1996, CAN J FISH AQUAT SCI, V53, P833, DOI 10.1139/cjfas-53-4-833; Shikano T, 2010, MOL ECOL, V19, P1147, DOI 10.1111/j.1365-294X.2010.04553.x; Sinnatamby RN, 2012, ECOL FRESHW FISH, V21, P309, DOI 10.1111/j.1600-0633.2012.00552.x; Sollid J., 1973, J GEOGR, V27, P233, DOI DOI 10.1080/00291951.1973.9728306; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Takezaki N, 1996, GENETICS, V144, P389; Tanner V, 1907, BULL COMM GEOL FINL, V20, P1; Taylor EB, 2001, CAN J FISH AQUAT SCI, V58, P406, DOI 10.1139/cjfas-58-2-406; Teacher AGF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019476; Urho Lauri, 2010, P336; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whiteley AR, 2010, CONSERV GENET, V11, P1929, DOI 10.1007/s10592-010-0083-y; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Wilson AJ, 2004, MOL ECOL, V13, P1129, DOI 10.1111/j.1365-294X.2004.02149.x; Wilson CC, 1996, MOL ECOL, V5, P187, DOI 10.1046/j.1365-294X.1996.00265.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x	88	8	8	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140344	10.1371/journal.pone.0140344	http://dx.doi.org/10.1371/journal.pone.0140344			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468642	Green Published, gold, Green Submitted			2022-12-26	WOS:000363184600046
J	Yeh, HC; Jan, HC; Wu, WJ; Li, CC; Li, WM; Ke, HL; Huang, SP; Liu, CC; Lee, YC; Yang, SF; Liang, PI; Huang, CN				Yeh, Hsin-Chih; Jan, Hau-Chern; Wu, Wen-Jeng; Li, Ching-Chia; Li, Wei-Ming; Ke, Hung-Lung; Huang, Shu-Pin; Liu, Chia-Chu; Lee, Yung-Chin; Yang, Sheau-Fang; Liang, Peir-In; Huang, Chun-Nung			Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial Carcinoma	PLOS ONE			English	Article							UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; PROGNOSTIC-FACTORS; PATHOLOGICAL OUTCOMES; RENAL PELVIS; NEPHROURETERECTOMY; SURVIVAL; GRADE; TAIWAN; RECURRENCE	Objectives To investigate the impact of preoperative hydronephrosis and flank pain on prognosis of patients with upper tract urothelial carcinoma. Methods In total, 472 patients with upper tract urothelial carcinoma managed by radical nephroureterectomy were included from Kaohsiung Medical University Hospital Healthcare System. Clinicopathological data were collected retrospectively for analysis. The significance of hydronephrosis, especially when combined with flank pain, and other relevant factors on overall and cancer-specific survival were evaluated. Results Of the 472 patients, 292 (62%) had preoperative hydronephrosis and 121 (26%) presented with flank pain. Preoperative hydronephrosis was significantly associated with age, hematuria, flank pain, tumor location, and pathological tumor stage. Concurrent presence of hydronephrosis and flank pain was a significant predictor of non-organ-confined disease (multivariate-adjusted hazard ratio = 2.10, P = 0.025). Kaplan-Meier analysis showed significantly poorer overall and cancer-specific survival in patients with preoperative hydronephrosis (P = 0.005 and P = 0.026, respectively) and in patients with flank pain (P < 0.001 and P = 0.001, respectively) than those without. However, only simultaneous hydronephrosis and flank pain independently predicted adverse outcome (hazard ratio = 1.98, P = 0.016 for overall survival and hazard ratio = 1.87, P = 0.036 for and cancer-specific survival, respectively) in multivariate Cox proportional hazards models. In addition, concurrent presence of hydronephrosis and flank pain was also significantly predictive of worse survival in patient with high grade or muscle-invasive disease. Notably, there was no difference in survival between patients with hydronephrosis but devoid of flank pain and those without hydronephrosis. Conclusion Concurrent preoperative presence of hydronephrosis and flank pain predicted non-organ-confined status of upper tract urothelial carcinoma. When accompanied with flank pain, hydronephrosis represented an independent predictor for worse outcome in patients with upper tract urothelial carcinoma.	[Yeh, Hsin-Chih; Wu, Wen-Jeng; Li, Ching-Chia] Kaohsiung Municipal Tatung Hosp, Dept Urol, Kaohsiung, Taiwan; [Yeh, Hsin-Chih; Wu, Wen-Jeng; Li, Ching-Chia; Li, Wei-Ming; Ke, Hung-Lung; Huang, Shu-Pin; Liu, Chia-Chu; Lee, Yung-Chin; Huang, Chun-Nung] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Yeh, Hsin-Chih; Wu, Wen-Jeng; Li, Ching-Chia; Li, Wei-Ming; Ke, Hung-Lung; Huang, Shu-Pin; Liu, Chia-Chu; Lee, Yung-Chin; Huang, Chun-Nung] Kaohsiung Med Univ, Sch Med, Dept Urol, Coll Med, Kaohsiung, Taiwan; [Yeh, Hsin-Chih; Wu, Wen-Jeng; Li, Ching-Chia; Li, Wei-Ming; Ke, Hung-Lung] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Jan, Hau-Chern] Kaohsiung Med Univ, Sch Post Baccalaureate Med, Coll Med, Kaohsiung, Taiwan; [Wu, Wen-Jeng] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Wu, Wen-Jeng] Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung, Taiwan; [Li, Wei-Ming; Liu, Chia-Chu] Minist Hlth, Dept Urol, Pingtung, Taiwan; [Li, Wei-Ming; Liu, Chia-Chu] Welf Pingtung Hosp, Pingtung, Taiwan; [Yang, Sheau-Fang] Kaohsiung Municipal Tatung Hosp, Dept Pathol, Kaohsiung, Taiwan; [Yang, Sheau-Fang; Liang, Peir-In] Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Yang, Sheau-Fang] Kaohsiung Med Univ, Sch Med, Dept Pathol, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Huang, CN (corresponding author), Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan.	patrick1201@gmail.com	LIU, CHIA CHU/T-2880-2019; Yeh, Hsin-Chih/ABI-1268-2020; Ke, Hung-Lung/HCH-9079-2022	wu, wen jeng/0000-0002-9691-7416; Yang, Sheau-Fang/0000-0002-1773-3716; Li, Wei-Ming/0000-0001-6155-0696; Yeh, Hsin-Chih/0000-0003-4113-629X; Liang, Peir-In/0000-0002-0101-7061	Kaohsiung Medical University [KMU-TP103E19, KMU-TP103G00, KMU-TP103G01, KMU-TP103G04, KMU-TP103G05]; health and welfare surcharge of tobacco products, Ministry of Health and Welfare [MOHW104-TDU-B-212-124-003]	Kaohsiung Medical University; health and welfare surcharge of tobacco products, Ministry of Health and Welfare	This study was supported by Kaohsiung Medical University "Aim for the Top Universities Grant, grant No. KMU-TP103E19, KMU-TP103G00, KMU-TP103G01, KMU-TP103G04, KMU-TP103G05", and a grant from the health and welfare surcharge of tobacco products, Ministry of Health and Welfare (MOHW104-TDU-B-212-124-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataus S, 2006, INT UROL NEPHROL, V38, P9, DOI 10.1007/s11255-005-3151-3; Bozzini G, 2013, WORLD J UROL, V31, P83, DOI 10.1007/s00345-012-0964-4; Brien JC, 2010, J UROLOGY, V184, P69, DOI 10.1016/j.juro.2010.03.030; Chen CY, 2007, J FORMOS MED ASSOC, V106, P992, DOI 10.1016/S0929-6646(08)60074-1; Chen XP, 2013, BJU INT, V112, P917, DOI 10.1111/bju.12238; Cho KS, 2007, UROLOGY, V70, P662, DOI 10.1016/j.urology.2007.06.1106; Chou YH, 1999, CANCER, V85, P1342, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1342::AID-CNCR17>3.3.CO;2-2; Chromecki TF, 2011, NAT REV UROL, V8, P440, DOI 10.1038/nrurol.2011.96; Chung PH, 2014, UROL ONCOL-SEMIN ORI, V32, P981, DOI 10.1016/j.urolonc.2014.02.018; Favaretto RL, 2010, EUR UROL, V58, P574, DOI 10.1016/j.eururo.2010.07.003; Gurbuz C, 2011, J ENDOUROL, V25, P775, DOI 10.1089/end.2010.0396; Hall MC, 1998, UROLOGY, V52, P594, DOI 10.1016/S0090-4295(98)00295-7; Hoshino K, 2012, JPN J CLIN ONCOL, V42, P202, DOI 10.1093/jjco/hyr199; Hwang I, 2013, CUAJ-CAN UROL ASSOC, V7, pE215, DOI 10.5489/cuaj.11236; Inman BA, 2009, CANCER-AM CANCER SOC, V115, P2853, DOI 10.1002/cncr.24339; Ito Y, 2011, J UROLOGY, V185, P1621, DOI 10.1016/j.juro.2010.12.035; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Luo HL, 2013, BJU INT, V112, P489, DOI 10.1111/bju.12157; Margulis V, 2009, CANCER-AM CANCER SOC, V115, P1224, DOI 10.1002/cncr.24135; Matin SF, 2010, CANCER-AM CANCER SOC, V116, P3127, DOI 10.1002/cncr.25050; Messer JC, 2013, UROL ONCOL-SEMIN ORI, V31, P904, DOI 10.1016/j.urolonc.2011.07.011; Morizane S, 2013, INT UROL NEPHROL, V45, P99, DOI 10.1007/s11255-012-0347-1; Ng CK, 2011, UROL ONCOL-SEMIN ORI, V29, P27, DOI 10.1016/j.urolonc.2008.10.023; Raman JD, 2011, BJU INT, V107, P1059, DOI 10.1111/j.1464-410X.2010.09675.x; Raman JD, 2011, UROL ONCOL-SEMIN ORI, V29, P716, DOI 10.1016/j.urolonc.2009.11.007; Roupret M, 2013, EUR UROL, V63, P1059, DOI 10.1016/j.eururo.2013.03.032; Sakano S, 2013, ANN SURG ONCOL, V20, P4389, DOI 10.1245/s10434-013-3259-0; Stimson CJ, 2010, J UROLOGY, V183, P1732, DOI 10.1016/j.juro.2010.01.028; Yang MH, 2002, UROLOGY, V59, P681, DOI 10.1016/S0090-4295(02)01529-7; Zhang XH, 2013, WORLD J UROL, V31, P155, DOI 10.1007/s00345-012-0885-2	30	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0139624	10.1371/journal.pone.0139624	http://dx.doi.org/10.1371/journal.pone.0139624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469704	gold, Green Published, Green Submitted			2022-12-26	WOS:000363184600015
J	Alam, MK; Rahaman, SA; Basri, R; Yi, TTS; Si-Jie, JW; Saha, S				Alam, Mohammad Khursheed; Rahaman, Shaifulizan Abdul; Basri, Rehana; Yi, Tiffany Tang Sing; Si-Jie, Justin Wong; Saha, Soumendra			Dental Implants - Perceiving Patients' Satisfaction in Relation to Clinical and Electromyography Study on Implant Patients	PLOS ONE			English	Article							PLACEMENT; PAIN	The aim of this study is to evaluate the satisfaction of patients with posterior implants in relation to the clinical success criteria and surface electromyography (sEMG) findings of the masseter and temporalis muscles. Total 42 subjects were investigated. Twenty one subjects with posterior dental implants were interviewed using a questionnaire and the clinical success criteria were determined based on The International Congress of Oral Implantologists. The myofunction of the masticatory muscles were assessed using sEMG (21 subjects) and compared to the control group of subjects without implants (21 subjects). Out of 21 subjects, all were satisfied with the aesthetics of their implant. Twenty of them (95.2%) were satisfied with its function and stability. As for clinical criteria, 100% (50) of the implants were successful with no pain, mobility or exudates. sEMG findings showed that patients have significantly lower (p<0.01) basal or resting median power frequency but with muscle burst. During chewing, control subjects showed faster chewing action. There was no difference in reaction and recovery time of clenching for both groups. In conclusion, the satisfaction of implant patients was high, and which was in relation to the successful clinical success criteria and sEMG findings.	[Alam, Mohammad Khursheed] Univ Sains Malaysia, Sch Dent Sci, Orthodont Unit, Kota Baharu, Kelantan, Malaysia; [Rahaman, Shaifulizan Abdul; Yi, Tiffany Tang Sing; Si-Jie, Justin Wong] Univ Sains Malaysia, Sch Dent Sci, Oral & Maxillofacial Surg Dept, Kota Baharu, Kelantan, Malaysia; [Basri, Rehana] Univ Sains Malaysia, Sch Dent Sci, Craniofacial Biol, Kota Baharu, Kelantan, Malaysia; [Saha, Soumendra] Univ Sains Malaysia, Sch Hlth Sci, Dept Exercise & Sports Sci, Kota Baharu, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia	Alam, MK (corresponding author), Univ Sains Malaysia, Sch Dent Sci, Orthodont Unit, Kota Baharu, Kelantan, Malaysia.	dralam@gmail.com	Alam, Mohammad Khursheed/D-3062-2012; Alam, Mohammad/GQR-2648-2022; Saha, Soumendra/ABB-6224-2020; alam, mohammed/GXH-3645-2022; Basri, Rehana/ABD-2007-2020	Alam, Mohammad Khursheed/0000-0001-7131-1752; Saha, Soumendra/0000-0002-7184-6906				Al-Khabbaz AK, 2007, J PERIODONTOL, V78, P239, DOI 10.1902/jop.2007.060032; Alam MK, 2013, INT MED J, V20, P247; Annibali S, 2010, ANN STOMATOL, V1, P2; Criswell E, 2011, CRAMS INTRO SURFACE, V17, P271; DE LUCA CJ, 1984, CRIT REV BIOMED ENG, V11, P251; Eli I, 1997, J ENDODONT, V23, P694, DOI 10.1016/S0099-2399(97)80404-9; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; GARRETT N, 1991, Journal of Dental Research, V70, P477; Gonzalez-Santana Hector, 2005, Med Oral Patol Oral Cir Bucal, V10, P258; JAMES RA, 1980, DENT CLIN N AM, V24, P415; Muller F, 1994, Gerodontology, V11, P7, DOI 10.1111/j.1741-2358.1994.tb00096.x; Op Heij DG, 2000, PERIODONTOL, V172-184, P2003; Palmer R, 1999, BRIT DENT J, V187, P127, DOI 10.1038/sj.bdj.4800222a; PASERO F, 1991, Journal of Dental Research, V70, P330; Penarrocha M, 2006, J ORAL MAXIL SURG, V64, P429, DOI 10.1016/j.joms.2005.11.014; Pjetursson BE, 2005, CLIN ORAL IMPLAN RES, V16, P185, DOI 10.1111/j.1600-0501.2004.01094.x; Satpathy A, 2011, INT J PUBLIC HLTH DE, V2, P1; Spin-Neto Rubens, 2014, Oral Health Dent Manag, V13, P441; Sulieman AJ, 2010, SAUDI DENT J, V22, P183, DOI [10.1016/j.sdentj.2010.07.006, DOI 10.1016/J.SDENTJ.2010.07.006]; Tepper G, 2003, CLIN ORAL IMPLAN RES, V14, P621, DOI 10.1034/j.1600-0501.2003.00916.x; Urban T, 2010, CLIN ORAL IMPLAN RES, V21, P1271, DOI 10.1111/j.1600-0501.2010.01943.x; Vermylen K, 2003, CLIN ORAL IMPLAN RES, V14, P119, DOI 10.1034/j.1600-0501.2003.140116.x; Zitzmann NU, 2000, J PROSTHET DENT, V83, P424, DOI 10.1016/S0022-3913(00)70037-0	23	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140438	10.1371/journal.pone.0140438	http://dx.doi.org/10.1371/journal.pone.0140438			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465146	Green Submitted, gold, Green Published			2022-12-26	WOS:000363183100123
J	Brasil, A; Castro, AJO; Martins, ICVS; Lacerda, EMCB; Souza, GS; Herculano, AM; Rosa, AAM; Rodrigues, AR; Silveira, LCL				Brasil, Alodia; Castro, Antonio Jose O.; Martins, Isabelle Christine V. S.; Lacerda, Eliza Maria C. B.; Souza, Givago S.; Herculano, Anderson Manoel; Rosa, Alexandre Antonio M.; Rodrigues, Anderson R.; Silveira, Luiz Carlos L.			Colour Vision Impairment in Young Alcohol Consumers	PLOS ONE			English	Article							CONTRAST SENSITIVITY; CHEMICAL TOXICITY; CONSUMPTION; DEPENDENCE; DRINKING; MEMORY; ONSET; RISK; MERCURY; SYSTEM	Alcohol consumption among young adults is widely accepted in modern society and may be the starting point for abusive use of alcohol at later stages of life. Chronic alcohol exposure can lead to visual function impairment. In the present study, we investigated the spatial luminance contrast sensitivity, colour arrangement ability, and colour discrimination thresholds on young adults that weekly consume alcoholic beverages without clinical concerns. Twenty-four young adults were evaluated by an ophthalmologist and performed three psychophysical tests to evaluate their vision functions. We estimated the spatial luminance contrast sensitivity function at 11 spatial frequencies ranging from 0.1 to 30 cycles/degree. No difference in contrast sensitivity was observed comparing alcohol consumers and control subjects. For the evaluation of colour vision, we used the Farnsworth-Munsell 100 hue test (FM 100 test) to test subject's ability to perform a colour arrangement task and the Mollon- Reffin test (MR test) to measure subject's colour discrimination thresholds. Alcohol consumers made more mistakes than controls in the FM100 test, and their mistakes were diffusely distributed in the FM colour space without any colour axis preference. Alcohol consumers also performed worse than controls in the MR test and had higher colour discrimination thresholds compared to controls around three different reference points of a perceptually homogeneous colour space, the CIE 1976 chromaticity diagram. There was no colour axis preference in the threshold elevation observed among alcoholic subjects. Young adult weekly alcohol consumers showed subclinical colour vision losses with preservation of spatial luminance contrast sensitivity. Adolescence and young adult age are periods of important neurological development and alcohol exposure during this period of life might be responsible for deficits in visual functions, especially colour vision that is very sensitive to neurotoxicants.	[Brasil, Alodia; Martins, Isabelle Christine V. S.; Souza, Givago S.; Herculano, Anderson Manoel; Silveira, Luiz Carlos L.] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Castro, Antonio Jose O.; Rosa, Alexandre Antonio M.] Fed Univ Para, Inst Ciencias Saude, BR-66059 Belem, Para, Brazil; [Lacerda, Eliza Maria C. B.; Souza, Givago S.; Rodrigues, Anderson R.; Silveira, Luiz Carlos L.] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil; [Rosa, Alexandre Antonio M.] Fed Univ Para, Hosp Univ Bettina Ferro de Souza, BR-66059 Belem, Para, Brazil; [Silveira, Luiz Carlos L.] Univ Ceuma, Sao Luis, Maranhao, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para; Universidade Ceuma	Silveira, LCL (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	luiz@ufpa.br	Rodrigues, Anderson Raiol/AAE-4365-2021; Souza, Givago/W-6393-2019; Lacerda, Eliza/AAT-9989-2020; Herculano, Anderson M/M-9016-2017	Rodrigues, Anderson Raiol/0000-0002-3115-7903; Souza, Givago/0000-0002-4525-3971; Lacerda, Eliza/0000-0002-8525-205X; 	Brazilian funding agency: FINEP IBN-Net [1723]; Brazilian funding agency: CNPq-PRONEX / FAPESPA [2268]; Brazilian funding agency: CNPq [620037/2008-3, 476744/2009-1, 442191/2014-6]; Brazilian funding agency: CAPES-PROCAD [182/2007]	Brazilian funding agency: FINEP IBN-Net; Brazilian funding agency: CNPq-PRONEX / FAPESPA; Brazilian funding agency: CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian funding agency: CAPES-PROCAD	This work was supported by research grants from these Brazilian funding agencies: FINEP IBN-Net #1723; CNPq-PRONEX / FAPESPA #2268; CNPq #620037/2008-3, #476744/2009-1, and #442191/2014-6; CAPES-PROCAD #182/2007. LCLS and AMH are CNPq research fellows. AB received a CNPq fellowship for undergraduate students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addolorato G, 2002, ALCOHOL ALCOHOLISM, V37, P504, DOI 10.1093/alcalc/37.5.504; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; [Anonymous], 2004, YOUNG PEOPLES HLTH C; Atilola O, 2014, J PSYCHIATR MENT HLT, V21, P609, DOI 10.1111/jpm.12133; Bailey SM, 1998, HEPATOLOGY, V28, P1318, DOI 10.1002/hep.510280521; Bonomo YA, 2004, ADDICTION, V99, P1520, DOI 10.1111/j.1360-0443.2004.00846.x; Bruce KR, 1997, EXP CLIN PSYCHOPHARM, V5, P242, DOI 10.1037/1064-1297.5.3.242; Bruckner JV, 2000, REGUL TOXICOL PHARM, V31, P280, DOI 10.1006/rtph.2000.1393; CAMPBELL FW, 1965, J PHYSIOL-LONDON, V181, P576, DOI 10.1113/jphysiol.1965.sp007784; Canto-Pereira LHM, 2005, ENVIRON TOXICOL PHAR, V19, P517, DOI 10.1016/j.etap.2004.12.015; Castro Antonio José de Oliveira, 2009, Psychol. Neurosci., V2, P179, DOI 10.3922/j.psns.2009.2.009; Cavalcanti-Galdino MK, 2014, BRAZ J MED BIOL RES, V47, P321, DOI 10.1590/1414-431X20143209; Celino AC, 2001, REV BRAS OFTALMOL, V60, P229; Costa Marcelo Fernandes, 2011, Psychol. Neurosci., V4, P67, DOI 10.3922/j.psns.2011.1.008; CRUZCOKE R, 1965, LANCET, V2, P1348; Lacerda EMDB, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/784390; Dourson M, 2002, REGUL TOXICOL PHARM, V35, P448, DOI 10.1006/rtph.2002.1559; Faeh D, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-169; Farnsworth D, 1943, J OPT SOC AM, V33, P568, DOI 10.1364/JOSA.33.000568; Farnsworth D., 1957, FARNSWORTH MUNSELL 1; Feitosa-Santana C, 2006, VISUAL NEUROSCI, V23, P663, DOI 10.1017/S0952523806233546; Francis JM, 2014, TROP MED INT HEALTH, V19, P476, DOI 10.1111/tmi.12267; Freitas JD, 2015, INV OPHTHALMOL VIS S, V56; Fukumura A, 2003, ALCOHOL CLIN EXP RES, V27, p12S, DOI 10.1097/01.ALC.0000078609.36825.48; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Grant JD, 2006, PSYCHOL MED, V36, P109, DOI 10.1017/S0033291705006045; Hantson P, 1999, CRIT CARE MED, V27, P2707, DOI 10.1097/00003246-199912000-00018; Hewitt GP, 1996, NEUROBIOL LEARN MEM, V65, P269, DOI 10.1006/nlme.1996.0032; Hingson RW, 2006, ARCH PEDIAT ADOL MED, V160, P739, DOI 10.1001/archpedi.160.7.739; HORTON JC, 1981, NATURE, V292, P762, DOI 10.1038/292762a0; HUBEL DH, 1987, J NEUROSCI, V7, P3378; Ishihara S., 1997, SERIES PLATES DESIGN; Kalev-Zylinska ML, 2007, J NEUROSCI, V27, P10456, DOI 10.1523/JNEUROSCI.2789-07.2007; KAPITANY T, 1993, BIOL PSYCHIAT, V33, P415, DOI 10.1016/0006-3223(93)90169-E; Kilb W, 2012, NEUROSCIENTIST, V18, P613, DOI 10.1177/1073858411422114; KJELLSTROM C, 1994, ALCOHOL CLIN EXP RES, V18, P1392, DOI 10.1111/j.1530-0277.1994.tb01441.x; Kumari M, 2000, Prog Drug Res, V54, P152; Lantz CL, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00107; Lebel J, 1996, NEUROTOXICOLOGY, V17, P157; Lingford-Hughes AR, 1998, BRIT J PSYCHIAT, V173, P116, DOI 10.1192/bjp.173.2.116; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Lobo IA, 2008, PHARMACOL BIOCHEM BE, V90, P90, DOI 10.1016/j.pbb.2008.03.006; MERGLER D, 1988, NEUROTOXICOL TERATOL, V10, P255, DOI 10.1016/0892-0362(88)90025-6; MOLLON JD, 1989, J PHYSIOL-LONDON, V414, pP5; Moschos Marilita M, 2013, BMC Res Notes, V6, P479, DOI 10.1186/1756-0500-6-479; Most Dana, 2014, Handb Clin Neurol, V125, P89, DOI 10.1016/B978-0-444-62619-6.00006-9; NEVO I, 1995, NEUROCHEM INT, V26, P305, DOI 10.1016/0197-0186(94)00139-L; Pai JK, 2006, ATHEROSCLEROSIS, V186, P113, DOI 10.1016/j.atherosclerosis.2005.06.037; PARKER ES, 1981, PSYCHOPHARMACOLOGY, V74, P88, DOI 10.1007/BF00431763; Pelli DG, 2010, HDB OPTICS, DOI DOI 10.1109/MCSE.2014.4; PISHKIN V, 1985, ALCOHOL CLIN EXP RES, V9, P400, DOI 10.1111/j.1530-0277.1985.tb05571.x; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-5; Raster M, 2011, DOC OPHTHALMOL, V122, P77, DOI 10.1007/s10633-011-9262-5; REGAN BC, 1994, VISION RES, V34, P1279, DOI 10.1016/0042-6989(94)90203-8; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Rodrigues AR, 2007, BRAZ J MED BIOL RES, V40, P415, DOI 10.1590/S0100-879X2007000300018; ROQUELAURE Y, 1995, ALCOHOL ALCOHOLISM, V30, P681; Ruitenberg A, 2002, LANCET, V359, P281, DOI 10.1016/S0140-6736(02)07493-7; Barboni MTS, 2008, ENVIRON RES, V107, P124, DOI 10.1016/j.envres.2007.07.004; Sancho-Tello M, 2008, ALCOHOL ALCOHOLISM, V43, P254, DOI 10.1093/alcalc/agn006; Silveira LCL, 2003, NORMAL DEFECTIVE COL, P407; Silveira LCL, 2005, PRIMATE VISUAL SYSTEM: A COMPARATIVE APPROACH, P127; Spagnolli F, 2013, MAGN RESON IMAGING, V31, P1325, DOI 10.1016/j.mri.2013.04.007; Tzekov R, 2005, DOC OPHTHALMOL, V110, P111, DOI 10.1007/s10633-005-7349-6; Valenzuela CF, 1997, ALCOHOL HEALTH RES W, V21, P144; Ventura DF, 2005, ENVIRON TOXICOL PHAR, V19, P523, DOI 10.1016/j.etap.2004.12.016; Ventura Dora F., 2003, Arq. Bras. Oftalmol., V66, P9, DOI 10.1590/S0004-27492003000600002; VERRIEST G, 1980, OPHTHALMOLOGICA, V180, P247, DOI 10.1159/000308982; Watten RG, 1996, OPHTHAL PHYSL OPT, V16, P460, DOI 10.1016/0275-5408(96)00020-8; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WILD JM, 1990, JPN J OPHTHALMOL, V34, P291; ZRENNER E, 1986, DOC OPHTHALMOL, V63, P305, DOI 10.1007/BF00220220	72	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140169	10.1371/journal.pone.0140169	http://dx.doi.org/10.1371/journal.pone.0140169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU0CK	26465148	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100083
J	Kerrigan, JF; Engstrom, DR; Yee, D; Sueper, C; Erickson, PR; Grandbois, M; McNeill, K; Arnold, WA				Kerrigan, Jill F.; Engstrom, Daniel R.; Yee, Donald; Sueper, Charles; Erickson, Paul R.; Grandbois, Matthew; McNeill, Kristopher; Arnold, William A.			Quantification of Hydroxylated Polybrominated Diphenyl Ethers (OH-BDEs), Triclosan, and Related Compounds in Freshwater and Coastal Systems	PLOS ONE			English	Article							DIBENZO-P-DIOXINS; BROMINATED FLAME RETARDANTS; SPONGE DYSIDEA-HERBACEA; SALMON SALMO-SALAR; TREATMENT PLANTS; BALTIC SEA; PHOTOCHEMICAL FORMATION; MASS-SPECTROMETRY; MARINE-SEDIMENTS; AQUEOUS-SOLUTION	Hydroxylated polybrominated diphenyl ethers (OH-BDEs) are a new class of contaminants of emerging concern, but the relative roles of natural and anthropogenic sources remain uncertain. Polybrominated diphenyl ethers (PBDEs) are used as brominated flame retardants, and they are a potential source of OH-BDEs via oxidative transformations. OH-BDEs are also natural products in marine systems. In this study, OH-BDEs were measured in water and sediment of freshwater and coastal systems along with the anthropogenic wastewater-marker compound triclosan and its photoproduct dioxin, 2,8-dichlorodibenzo- p-dioxin. The 6-OH-BDE 47 congener and its brominated dioxin (1,3,7-tribromodibenzo- p-dioxin) photoproduct were the only OH-BDE and brominated dioxin detected in surface sediments from San Francisco Bay, the anthropogenically impacted coastal site, where levels increased along a north-south gradient. Triclosan, 6-OH-BDE 47, 6-OH-BDE 90, 6-OH-BDE 99, and (only once) 6'-OH-BDE 100 were detected in two sediment cores from San Francisco Bay. The occurrence of 6-OH-BDE 47 and 1,3,7-tribromodibenzo- p-dioxin sediments in Point Reyes National Seashore, a marine system with limited anthropogenic impact, was generally lower than in San Francisco Bay surface sediments. OH-BDEs were not detected in freshwater lakes. The spatial and temporal trends of triclosan, 2,8-dichlorodibenzo-p-dioxin, OH-BDEs, and brominated dioxins observed in this study suggest that the dominant source of OH-BDEs in these systems is likely natural production, but their occurrence may be enhanced in San Francisco Bay by anthropogenic activities.	[Kerrigan, Jill F.; Arnold, William A.] Univ Minnesota, Dept Civil Environm & Geoengn, Minneapolis, MN 55455 USA; [Engstrom, Daniel R.] Sci Museum Minnesota, St Croix Watershed Res Stn, Marine St Croix, MN USA; [Yee, Donald] San Francisco Estuary Inst, Oakland, CA USA; [Sueper, Charles] Pace Analyt Serv Inc, Minneapolis, MN USA; [Erickson, Paul R.; McNeill, Kristopher] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Grandbois, Matthew] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Minnesota System; University of Minnesota Twin Cities	Arnold, WA (corresponding author), Univ Minnesota, Dept Civil Environm & Geoengn, Minneapolis, MN 55455 USA.	arnol032@umn.edu	McNeill, Kristopher/A-9834-2009	McNeill, Kristopher/0000-0002-2981-2227; Arnold, William/0000-0003-0814-5469; Engstrom, Daniel/0000-0002-8066-029X	U.S. National Science Foundation, Chemical, Bioengineering, Environmental, and Transport Systems [0967163]; Pace Analytical	U.S. National Science Foundation, Chemical, Bioengineering, Environmental, and Transport Systems; Pace Analytical	Funding was provided by the U.S. National Science Foundation, Chemical, Bioengineering, Environmental, and Transport Systems 0967163 to WAA with subcontracts to DRE and DY. CS (Pace Analytical) conducted dioxin analyses on a fee per sample basis. Pace Analytical provided support in the form of salaries for authors [CS] but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ENVIRON SCI TECHNOL, V49, P1339, DOI 10.1021/es505440j; Agarwal V, 2014, ACS CHEM BIOL, V9, P1980, DOI 10.1021/cb5004338; Agarwal V, 2014, NAT CHEM BIOL, V10, P640, DOI 10.1038/nchembio.1564; Aguera A, 2003, ANAL CHIM ACTA, V480, P193, DOI 10.1016/S0003-2670(03)00040-0; Anger CT, 2013, ENVIRON SCI TECHNOL, V47, P1833, DOI 10.1021/es3045289; Anima RJ, 1991, POLLUTION STUDIES DR; Anjaneyulu V, 1996, INDIAN J CHEM B, V35, P89; Appleby PG, 2002, DEV PALEOENVIRON RES, V1, P171; Arnoldsson K, 2012, ENVIRON SCI TECHNOL, V46, P7567, DOI 10.1021/es301256x; Asplund L, 1999, AMBIO, V28, P67; Athanasiadou M, 2008, ENVIRON HEALTH PERSP, V116, P400, DOI 10.1289/ehp.10713; Birnbaum LS, 2003, ENVIRON INT, V29, P855, DOI 10.1016/S0160-4120(03)00106-5; Blumentritt DJ, 2013, J PALEOLIMNOL, V50, P293, DOI 10.1007/s10933-013-9724-8; BUSER HR, 1986, ENVIRON SCI TECHNOL, V20, P404, DOI 10.1021/es00146a015; Buth JM, 2011, CHEMOSPHERE, V84, P1238, DOI [10.1016/j.chemosphere.2011.09.003, 10.1016/j.chemosphere.2011.05.017]; Buth JM, 2010, ENVIRON SCI TECHNOL, V44, P4545, DOI 10.1021/es1001105; Cameron GM, 2000, TETRAHEDRON, V56, P5247, DOI 10.1016/S0040-4020(00)00434-8; Ciba Specialty Chemical, 1998, IRG DP 300 IRG MP TO; Dann AB, 2011, J APPL TOXICOL, V31, P285, DOI 10.1002/jat.1660; DeLorenzo ME, 2008, ENVIRON TOXICOL, V23, P224, DOI 10.1002/tox.20327; Dingemans MML, 2008, ENVIRON HEALTH PERSP, V116, P637, DOI 10.1289/ehp.11059; EAKINS JD, 1978, INT J APPL RADIAT IS, V29, P531, DOI 10.1016/0020-708X(78)90161-8; Erickson PR, 2012, ENVIRON SCI TECHNOL, V46, P8174, DOI 10.1021/es3016183; Erratico CA, 2011, TOXICOL SCI, V123, P37, DOI 10.1093/toxsci/kfr155; Fan Y, 2014, CHEMOSPHERE, V114, P247, DOI 10.1016/j.chemosphere.2014.04.103; Haglund P, 2007, ENVIRON SCI TECHNOL, V41, P3069, DOI 10.1021/es0624725; Hale RC, 2003, ENVIRON INT, V29, P771, DOI 10.1016/S0160-4120(03)00113-2; Hale RC, 2002, CHEMOSPHERE, V46, P729, DOI 10.1016/S0045-6535(01)00237-5; Handayani D, 1997, J NAT PROD, V60, P1313, DOI 10.1021/np970271w; Hensley RN, 2015, ENVIRON SCI-WAT RES, V1, P316, DOI [10.1039/C4EW00102H, 10.1039/c4ew00102h]; Hovander L, 2002, ARCH ENVIRON CON TOX, V42, P105; Hua WY, 2005, ENVIRON INT, V31, P621, DOI 10.1016/j.envint.2004.10.019; Hyde CH, 1914, AM J PUBLIC HLTH, V4; Jacobs MN, 2005, TOXICOL APPL PHARM, V209, P123, DOI 10.1016/j.taap.2005.03.015; Kim UJ, 2014, ENVIRON SCI TECHNOL, V48, P7245, DOI 10.1021/es5006972; Klosterhaus SL, 2012, ENVIRON INT, V47, P56, DOI 10.1016/j.envint.2012.06.005; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Lai YQ, 2012, CHEMOSPHERE, V86, P727, DOI 10.1016/j.chemosphere.2011.10.047; Latch DE, 2005, ENVIRON TOXICOL CHEM, V24, P517, DOI 10.1897/04-243R.1; Latch DE, 2003, J PHOTOCH PHOTOBIO A, V158, P63, DOI 10.1016/S1010-6030(03)00103-5; Legler J, 2008, CHEMOSPHERE, V73, P216, DOI 10.1016/j.chemosphere.2008.04.081; Legradi J, 2014, ENVIRON SCI TECHNOL, V48, P14703, DOI 10.1021/es5039744; Lin KD, 2014, ENVIRON SCI TECHNOL, V48, P263, DOI 10.1021/es403583b; Lishman L, 2006, SCI TOTAL ENVIRON, V367, P544, DOI 10.1016/j.scitotenv.2006.03.021; Liu H, 2011, CHEMOSPHERE, V84, P512, DOI 10.1016/j.chemosphere.2011.03.011; Lofstrand K, 2011, CHEMOSPHERE, V84, P527, DOI 10.1016/j.chemosphere.2011.01.001; Lofstrand K, 2010, ENVIRON SCI POLLUT R, V17, P1460, DOI 10.1007/s11356-010-0331-1; Feo ML, 2013, J CHROMATOGR A, V1301, P80, DOI 10.1016/j.chroma.2013.05.062; Malmvarn A, 2005, ENVIRON SCI TECHNOL, V39, P2990, DOI 10.1021/es0482886; Malmvarn A, 2008, CHEMOSPHERE, V72, P910, DOI 10.1016/j.chemosphere.2008.03.036; Marsh G, 2004, ENVIRON SCI TECHNOL, V38, P10, DOI 10.1021/es034671j; MASON G, 1987, TOXICOLOGY, V44, P245, DOI 10.1016/0300-483X(87)90027-8; MASON G, 1986, TOXICOLOGY, V41, P21, DOI 10.1016/0300-483X(86)90101-0; McAvoy DC, 2002, ENVIRON TOXICOL CHEM, V21, P1323, DOI 10.1897/1551-5028(2002)021<1323:MOTIWT>2.0.CO;2; McKinney MA, 2006, ENVIRON SCI TECHNOL, V40, P6275, DOI 10.1021/es061061l; North KD, 2004, ENVIRON SCI TECHNOL, V38, P4484, DOI 10.1021/es049627y; Oros DR, 2005, ENVIRON SCI TECHNOL, V39, P33, DOI 10.1021/es048905q; Perron MM, 2012, ENVIRON TOXICOL CHEM, V31, P1861, DOI 10.1002/etc.1884; Rodenburg LA, 2014, CHEMOSPHERE, V106, P36, DOI 10.1016/j.chemosphere.2013.12.083; Routti H, 2008, ENVIRON SCI TECHNOL, V42, P8952, DOI 10.1021/es801682f; San Francisco Estuary Institute, CONT DAT DISPL DOWNL; Sedlak D., 2014, WATER 4 0 PRESENT FU; Soderstrom G, 2002, ENVIRON SCI TECHNOL, V36, P1959, DOI 10.1021/es010135k; SOVOCOOL GW, 1988, BIOMED ENVIRON MASS, V15, P669, DOI 10.1002/bms.1200151205; Stapleton HM, 2011, ENVIRON HEALTH PERSP, V119, P1454, DOI 10.1289/ehp.1003235; Stasinakis AS, 2008, WATER RES, V42, P1796, DOI 10.1016/j.watres.2007.11.003; Steen PO, 2009, ENVIRON SCI TECHNOL, V43, P4405, DOI 10.1021/es9003679; Sutton R, 2015, ENVIRON SCI TECHNOL, V49, P777, DOI 10.1021/es503727b; Tu LK, 2011, AEROSOL AIR QUAL RES, V11, P596, DOI 10.4209/aaqr.2011.05.0071; U.S. EPA, 1994, METHOD; Ucan-Marin F, 2009, TOXICOL SCI, V107, P440, DOI 10.1093/toxsci/kfn240; Ueno D, 2008, ENVIRON SCI TECHNOL, V42, P1657, DOI 10.1021/es7021279; Unger M, 2009, ENVIRON SCI TECHNOL, V43, P8245, DOI 10.1021/es901705r; UNSON MD, 1994, MAR BIOL, V119, P1, DOI 10.1007/BF00350100; Valters K, 2005, ENVIRON SCI TECHNOL, V39, P5612, DOI 10.1021/es0506410; Van Boxtel AL, 2008, ENVIRON SCI TECHNOL, V42, P1773, DOI 10.1021/es0720863; van den Berg M, 2013, TOXICOL SCI, V133, P197, DOI 10.1093/toxsci/kft070; Venkatesan AK, 2012, J HAZARD MATER, V229, P29, DOI 10.1016/j.jhazmat.2012.05.049; Wan Y, 2009, ENVIRON SCI TECHNOL, V43, P7536, DOI 10.1021/es901357u; Wang LC, 2007, ENVIRON SCI TECHNOL, V41, P1159, DOI 10.1021/es061801q; Ying GG, 2007, ENVIRON INT, V33, P199, DOI 10.1016/j.envint.2006.09.008; Zhang K, 2012, ENVIRON SCI TECHNOL, V46, P2148, DOI 10.1021/es203195s; Zhao Q, 2015, ENVIRON SCI TECHNOL, V49, P9092, DOI 10.1021/acs.est.5b01240; Zota AR, 2011, ENVIRON SCI TECHNOL, V45, P7896, DOI 10.1021/es200422b	84	12	12	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0138805	10.1371/journal.pone.0138805	http://dx.doi.org/10.1371/journal.pone.0138805			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466159	Green Submitted, gold, Green Published			2022-12-26	WOS:000363183100024
J	Luo, ZC; Tian, DY; Zhou, M; Xiao, WJ; Zhang, YC; Li, MM; Sui, BK; Wang, W; Guan, HS; Chen, HC; Fu, ZF; Zhao, L				Luo, Zhaochen; Tian, Dayong; Zhou, Ming; Xiao, Wenjie; Zhang, Yachun; Li, Mingming; Sui, Baokun; Wang, Wei; Guan, Huashi; Chen, Huanchun; Fu, Zhen F.; Zhao, Ling			lambda-Carrageenan P32 Is a Potent Inhibitor of Rabies Virus Infection	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; ANTIVIRAL ACTIVITY; SULFATED POLYSACCHARIDES; HEPARAN-SULFATE; DENGUE VIRUS; CELLS; TRANSCRIPTION; GLYCOPROTEIN; DOG	Rabies, caused by rabies virus (RABV), is an acute, fatal encephalitic disease that affects many warm-blooded mammals. Currently, post-exposure prophylaxis regimens are effective for most rabies cases, but once the clinical signs of the disease appear, current treatment options become ineffective. Carrageenan has been reported as a potent inhibitor of many viruses. In this study, the lambda-carrageenan (lambda-CG) P32 was investigated for its potential role in inhibiting RABV infection. Our results show that P32 specifically inhibits the replication of several RABV strains but not vesicular stomatitis virus in multiple cell lines and shows low cytotoxicity. P32 mainly abrogated viral replication during the early stage of the post-adsorption period. Further studies demonstrated that P32 could affect not only viral internalization but also viral uncoating by blocking cell fusion mediated by RABV glycoprotein. Moreover, P32 can fully inhibit RABV infection in vitro during the post-adsorption period, whereas heparin and heparan sulfate, which possess similar structures to P32, showed significant but not complete inhibition of RABV infectivity. Collectively, our results indicate that lambda-CG P32 is a promising agent that can inhibit RABV infection mainly by inhibiting viral internalization and glycoprotein-mediated cell fusion and can be used for the development of novel anti-RABV drugs.	[Luo, Zhaochen; Tian, Dayong; Zhou, Ming; Xiao, Wenjie; Zhang, Yachun; Li, Mingming; Sui, Baokun; Chen, Huanchun; Fu, Zhen F.; Zhao, Ling] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Hunan, Peoples R China; [Wang, Wei; Guan, Huashi] Ocean Univ China, Sch Med & Pharm, Glycosci & Glycoengn Lab, Qingdao 266100, Shandong, Peoples R China; [Fu, Zhen F.] Univ Georgia, Dept Pathol, Athens, GA 30602 USA	Huazhong Agricultural University; Ocean University of China; University System of Georgia; University of Georgia	Fu, ZF (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Hunan, Peoples R China.	zhenfu@uga.edu; lingzhao@mail.hzau.edu.cn	Tian, Dayong/ABB-6400-2020; zhao, ling/AAC-9806-2020; Zhou, Ming/K-7968-2017; Wang, Wei/W-8492-2019	Tian, Dayong/0000-0001-8978-8970; zhao, ling/0000-0003-0569-8105; Zhou, Ming/0000-0001-7012-017X; Sui, Baokun/0000-0003-2738-5804	Wuhan Science and Technology Bureau of China [2014020101010071]; National Natural Science Foundation of China [31372419, 31330078]; Seventh Framework Program [FP7-613804]	Wuhan Science and Technology Bureau of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Seventh Framework Program(European Commission)	This work was supported by Wuhan Science and Technology Bureau of China, http://www.whst.gov.cn, Grant No.: 2014020101010071 to LZ; The National Natural Science Foundation of China, http://www.nsfc.gov.cn, Grant No.: 31372419 to LZ; The Seventh Framework Program, http://ec.europa.eu/research/participants/portal/desktop/en/home.html, Grant No.: FP7-613804 to LZ; and The National Natural Science Foundation of China, http://www.nsfc.gov.cn, Grant No.: 31330078 to ZF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini AAV, 2011, ADV VIRUS RES, V79, P1, DOI 10.1016/B978-0-12-387040-7.00001-9; BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742, DOI 10.1128/AAC.32.11.1742; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Campo VL, 2009, CARBOHYD POLYM, V77, P167, DOI 10.1016/j.carbpol.2009.01.020; Carlucci MJ, 2004, ANTIVIR RES, V64, P137, DOI 10.1016/j.antiviral.2004.07.001; Carlucci MJ, 2002, J MED VIROL, V68, P92, DOI 10.1002/jmv.10174; Carlucci MJ, 1999, CHEMOTHERAPY, V45, P429, DOI 10.1159/000007236; Carlucci MJ, 1997, PLANTA MED, V63, P429, DOI 10.1055/s-2006-957727; Chen Mei-zhen, 2010, Virologica Sinica, V25, P341, DOI 10.1007/s12250-010-3137-x; Chiu YH, 2012, ANTIVIR RES, V95, P128, DOI 10.1016/j.antiviral.2012.05.009; Cleaveland S, 2002, B WORLD HEALTH ORGAN, V80, P304; Damonte EB, 2004, CURR MED CHEM, V11, P2399, DOI 10.2174/0929867043364504; Faber M, 2005, J VIROL, V79, P14141, DOI 10.1128/JVI.79.22.14141-14148.2005; FLAMAND A, 1993, VIROLOGY, V194, P302, DOI 10.1006/viro.1993.1261; Foley HD, 2002, J VIROL, V76, P19, DOI 10.1128/JVI.76.1.19-31.2002; GIROND S, 1991, RES VIROLOGY, V142, P261, DOI 10.1016/0923-2516(91)90011-Q; GONZALEZ ME, 1987, ANTIMICROB AGENTS CH, V31, P1388, DOI 10.1128/AAC.31.9.1388; Grassauer A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-107; HELENIUS A, 1982, J GEN VIROL, V58, P47, DOI 10.1099/0022-1317-58-1-47; Jackson AC, 2011, ADV VIRUS RES, V79, P365, DOI 10.1016/B978-0-12-387040-7.00017-2; Klimstra WB, 1998, J VIROL, V72, P7357, DOI 10.1128/JVI.72.9.7357-7366.1998; Konlee M, 1998, Posit Health News, P4; Leibbrandt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014320; LOCKHART BP, 1992, ANTIMICROB AGENTS CH, V36, P1750, DOI 10.1128/AAC.36.8.1750; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mandal P, 2008, PHYTOCHEMISTRY, V69, P2193, DOI 10.1016/j.phytochem.2008.05.004; NAKASHIMA H, 1987, ANTIMICROB AGENTS CH, V31, P1524, DOI 10.1128/AAC.31.10.1524; Nicklin S, 1988, Adv Exp Med Biol, V237, P821; Perotti ME, 2003, BIOL REPROD, V69, P933, DOI 10.1095/biolreprod.102.014555; Piccinotti S, 2013, J VIROL, V87, P11637, DOI 10.1128/JVI.01648-13; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Schnell MJ, 2010, NAT REV MICROBIOL, V8, P51, DOI 10.1038/nrmicro2260; SEN AK, 1994, INT J BIOL MACROMOL, V16, P279; Shao Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126577; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; SUPERTI F, 1984, J GEN VIROL, V65, P781, DOI 10.1099/0022-1317-65-4-781; Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043; Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001; TSIANG H, 1978, J GEN VIROL, V40, P665, DOI 10.1099/0022-1317-40-3-665; Wang W, 2011, ANTIVIR RES, V92, P237, DOI 10.1016/j.antiviral.2011.08.010; WARRELL MJ, 1989, BMJ-BRIT MED J, V299, P830, DOI 10.1136/bmj.299.6703.830; WEINMANN E, 1979, INFECT IMMUN, V24, P24, DOI 10.1128/IAI.24.1.24-31.1979; Wen YJ, 2011, J VIROL, V85, P1634, DOI 10.1128/JVI.01552-10; WHO, 2005, WHO TECH REP SER, V931, P1; Yamada K, 2012, VIRUS RES, V165, P34, DOI 10.1016/j.virusres.2012.01.002; Yao ZA, 2014, NEUROCHEM RES, V39, P333, DOI 10.1007/s11064-013-1228-4; Yu FL, 2012, J VIROL, V86, P10890, DOI 10.1128/JVI.01775-12; Zacharopoulos VR, 1997, CLIN DIAGN LAB IMMUN, V4, P465, DOI 10.1128/CDLI.4.4.465-468.1997; Zhao L, 2010, J VIROL, V84, P9642, DOI 10.1128/JVI.00326-10; Zhou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063384; Zhou SH, 2004, CHINESE MED J-PEKING, V117, P1597	51	23	24	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140586	10.1371/journal.pone.0140586	http://dx.doi.org/10.1371/journal.pone.0140586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465753	Green Submitted, gold, Green Published			2022-12-26	WOS:000363183100150
J	Hensel, G; Floss, DM; Arcalis, E; Sack, M; Melnik, S; Altmann, F; Rutten, T; Kumlehn, J; Stoger, E; Conrad, U				Hensel, Goetz; Floss, Doreen M.; Arcalis, Elsa; Sack, Markus; Melnik, Stanislav; Altmann, Friedrich; Rutten, Twan; Kumlehn, Jochen; Stoger, Eva; Conrad, Udo			Transgenic Production of an Anti HIV Antibody in the Barley Endosperm	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; PROTEINS; LOCALIZATION; EXPRESSION; TRANSFORMATION; GLYCOSYLATION; GENERATION; TRANSPORT; CULTURES; GENE	Barley is an attractive vehicle for producing recombinant protein, since it is a readily transformable diploid crop species in which doubled haploids can be routinely generated. High amounts of protein are naturally accumulated in the grain, but optimal endosperm-specific promoters have yet to be perfected. Here, the oat GLOBULIN1 promoter was combined with the legumin B4 (LeB4) signal peptide and the endoplasmic reticulum (ER) retention signal (SE) KDEL. Transgenic barley grain accumulated up to 1.2 g/kg dry weight of recombinant protein (GFP), deposited in small roundish compartments assumed to be ER-derived protein bodies. The molecular farming potential of the system was tested by generating doubled haploid transgenic lines engineered to synthesize the anti-HIV-1 monoclonal antibody 2G12 with up to 160 mu g recombinant protein per g grain. The recombinant protein was deposited at the periphery of protein bodies in the form of a mixture of various N-glycans (notably those lacking terminal N-acetylglucosamine residues), consistent with their vacuolar localization. Inspection of protein-A purified antibodies using surface plasmon resonance spectroscopy showed that their equilibrium and kinetic rate constants were comparable to those associated with recombinant 2G12 synthesized in Chinese hamster ovary cells.	[Hensel, Goetz; Kumlehn, Jochen] Leibniz Inst Plant Genet & Crop Plant Res IPK, Plant Reprod Biol, D-06466 Stadt Seeland OT Gatersl, Germany; [Floss, Doreen M.; Conrad, Udo] Leibniz Inst Plant Genet & Crop Plant Res IPK, Phytoantibodies, D-06466 Stadt Seeland OT Gatersl, Germany; [Floss, Doreen M.] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany; [Arcalis, Elsa; Melnik, Stanislav; Stoger, Eva] Univ Resources & Life Sci, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Sack, Markus] Rhein Westfal TH Aachen, Inst Mol Biotechnol, Biol 7, D-52074 Aachen, Germany; [Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria; [Rutten, Twan] Leibniz Inst Plant Genet & Crop Plant Res IPK, Struct Cell Biol, D-06466 Stadt Seeland OT Gatersl, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Heinrich Heine University Dusseldorf; RWTH Aachen University; University of Natural Resources & Life Sciences, Vienna; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Hensel, G (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Plant Reprod Biol, Corrensstr 3, D-06466 Stadt Seeland OT Gatersl, Germany.	hensel@ipk-gatersleben.de	Kumlehn, Jochen/AAF-8241-2020; Sack, Markus/AAP-9252-2021; Hensel, G./F-9957-2010; Hensel, Goetz/ABA-8238-2020; Sack, Markus/K-6681-2013	Kumlehn, Jochen/0000-0001-7080-7983; Hensel, G./0000-0002-5539-3097; Hensel, Goetz/0000-0002-5539-3097; Sack, Markus/0000-0002-7380-9228; Stoeger, Eva/0000-0002-7651-7992; Altmann, Friedrich/0000-0002-0112-7877; Arcalis, Elsa/0000-0001-9883-465X; Rutten, Twan/0000-0001-5891-6503	Austrian Science Fund FWF [W 1224] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Arcalis E, 2004, PLANT PHYSIOL, V136, P3457, DOI 10.1104/pp.104.050153; Arcalis E, 2013, PLANT MOL BIOL, V83, P105, DOI 10.1007/s11103-013-0049-9; Arcalis E, 2010, PLANT PHYSIOL, V153, P693, DOI 10.1104/pp.109.152363; Aviezer D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004792; CAMERONMILLS V, 1980, CARLSBERG RES COMMUN, V45, P577, DOI 10.1007/BF02932924; CAMERONMILLS V, 1980, CARLSBERG RES COMMUN, V45, P557, DOI 10.1007/BF02932923; Coronado MJ, 2005, ACTA PHYSIOL PLANT, V27, P591, DOI 10.1007/s11738-005-0063-x; De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x; Fischer R., 2014, COMMERCIAL PLANT PRO, P27; Floss DM, 2008, PLANT BIOTECHNOL J, V6, P379, DOI 10.1111/j.1467-7652.2008.00326.x; Floss DM, 2009, PLANT BIOTECHNOL J, V7, P899, DOI 10.1111/j.1467-7652.2009.00452.x; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Hensel G, 2008, J PLANT PHYSIOL, V165, P71, DOI 10.1016/j.jplph.2007.06.015; Hensel G, 2011, J PLANT PHYSIOL, V168, P30, DOI 10.1016/j.jplph.2010.07.007; Kapusi E, 2013, PLANT MOL BIOL, V81, P149, DOI 10.1007/s11103-012-9988-9; Kumlehn J, 2006, PLANT BIOTECHNOL J, V4, P251, DOI 10.1111/j.1467-7652.2005.00178.x; Kumlehn J, 2014, BIOTECH AGR FOREST, V69, P379, DOI 10.1007/978-3-662-44406-1_20; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; LEVANONY H, 1992, J CELL BIOL, V119, P1117, DOI 10.1083/jcb.119.5.1117; Ma J, 2015, PLANT BIOTECHNOL J; Magnusdottir A, 2013, TRENDS BIOTECHNOL, V31, P572, DOI 10.1016/j.tibtech.2013.06.002; Mogelsvang S, 1998, J PLANT PHYSIOL, V153, P1, DOI 10.1016/S0176-1617(98)80038-2; Naqvi S, 2011, BIOTECHNOL ADV, V29, P40, DOI 10.1016/j.biotechadv.2010.08.009; Pallotta MA, 2000, THEOR APPL GENET, V101, P1100, DOI 10.1007/s001220051585; Patel M, 2000, MOL BREEDING, V6, P113, DOI 10.1023/A:1009640427515; Popelka JC, 2002, THESIS; Rademacher T, 2008, PLANT BIOTECHNOL J, V6, P189, DOI 10.1111/j.1467-7652.2007.00306.x; Ramessar Koreen, 2008, Phytochemistry Reviews, V7, P579, DOI 10.1007/s11101-008-9087-3; RECHINGER KB, 1993, PLANT J, V4, P841, DOI 10.1046/j.1365-313X.1993.04050841.x; Rosenberg Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058724; Sack M, 2015, PLANT BIOTE IN PRESS; Sainsbury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013976; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schunmann PHD, 2002, MOL BREEDING, V9, P113, DOI 10.1023/A:1026752805494; Shewry PR, 2007, J CEREAL SCI, V46, P239, DOI 10.1016/j.jcs.2007.06.006; Spok A, 2008, TRENDS BIOTECHNOL, V26, P506, DOI 10.1016/j.tibtech.2008.05.007; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; THIEBAUT J, 1978, CAN J GENET CYTOL, V20, P513, DOI 10.1139/g78-060; Vamvaka E, 2016, PLANT BIOTECHNOL J, V14, P97, DOI 10.1111/pbi.12360; Van Droogenbroeck B, 2007, P NATL ACAD SCI USA, V104, P1430, DOI 10.1073/pnas.0609997104; Vickers CE, 2006, PLANT MOL BIOL, V62, P195, DOI 10.1007/s11103-006-9014-1; Vuylsteker C, 2000, J EXP BOT, V51, P839, DOI 10.1093/jexbot/51.346.839; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017	44	18	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140476	10.1371/journal.pone.0140476	http://dx.doi.org/10.1371/journal.pone.0140476			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461955	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300101
J	Chakedis, J; French, R; Babicky, M; Jaquish, D; Howard, H; Mose, E; Lam, R; Holman, P; Miyamoto, J; Walterscheid, Z; Lowy, AM				Chakedis, J.; French, R.; Babicky, M.; Jaquish, D.; Howard, H.; Mose, E.; Lam, R.; Holman, P.; Miyamoto, J.; Walterscheid, Z.; Lowy, A. M.			A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells	ONCOGENE			English	Article							MACROPHAGE-STIMULATING PROTEIN; THERAPEUTIC TARGET; CANCER CELLS; TUMORIGENIC ACTIVITIES; PROGNOSTIC MARKER; SPLICING VARIANT; BREAST-CANCER; MET FAMILY; EXPRESSION; IDENTIFICATION	The MST1R gene is overexpressed in pancreatic cancer producing elevated levels of the RON tyrosine kinase receptor protein. While mutations in MST1R are rare, alternative splice variants have been previously reported in epithelial cancers. We report the discovery of a novel RON isoform discovered in human pancreatic cancer. Partial splicing of exons 5 and 6 (P5P6) produces a RON isoform that lacks the first extracellular immunoglobulin-plexin-transcription domain. The splice variant is detected in 73% of xenografts derived from pancreatic adenocarcinoma patients and 71% of pancreatic cancer cell lines. Peptides specific to RON P5P6 detected in human pancreatic cancer specimens by mass spectrometry confirm translation of the protein isoform. The P5P6 isoform is found to be constitutively phosphorylated, present in the cytoplasm, and it traffics to the plasma membrane. Expression of P5P6 in immortalized human pancreatic duct epithelial (HPDE) cells activates downstream AKT, and in human pancreatic epithelial nestin-expressing cells, activates both the AKT and MAPK pathways. Inhibiting RON P5P6 in HPDE cells using a small molecule inhibitor BMS-777607 blocked constitutive activation and decreased AKT signaling. P5P6 transforms NIH3T3 cells and induces tumorigenicity in HPDE cells. Resultant HPDE-P5P6 tumors develop a dense stromal compartment similar to that seen in pancreatic cancer. In summary, we have identified a novel and constitutively active isoform of the RON tyrosine kinase receptor that has transforming activity and is expressed in human pancreatic cancer. These findings provide additional insight into the biology of the RON receptor in pancreatic cancer and are clinically relevant to the study of RON as a potential therapeutic target.	[Chakedis, J.; French, R.; Babicky, M.; Jaquish, D.; Howard, H.; Mose, E.; Lam, R.; Holman, P.; Miyamoto, J.; Walterscheid, Z.; Lowy, A. M.] Univ Calif San Diego, Moores Canc Ctr, Div Surg Oncol, Dept Surg, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Lowy, AM (corresponding author), Univ Calif San Diego, Moores Canc Ctr, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	alowy@ucsd.edu			National Cancer Institute of the National Institutes of Health [R01 CA155620, T32 CA121938]; NCI Cancer Center Support Grant [2 P30 CA023100-23]; NATIONAL CANCER INSTITUTE [R01CA155620, T32CA121938, P30CA023100] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge the generosity of our patients who supported this work through both monetary contributions and/or by allowing tumor tissue to be used for research. Without their contributions, this work would not have been possible. We thank the Tsao and Klemke labs for providing HPDE and HPNE ells, respectively. Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number R01 CA155620 (AML) and T32 CA121938 (JC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. DNA sequencing was performed by the DNA Sequencing Shared Resource, UCSD Moore's Cancer Center, which is funded in part by NCI Cancer Center Support Grant # 2 P30 CA023100-23.	Angeloni D, 2004, J BIOL CHEM, V279, P3726, DOI 10.1074/jbc.M309342200; Angeloni D, 2000, GENE CHROMOSOME CANC, V29, P147, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1015>3.3.CO;2-E; Bardella C, 2004, CANCER RES, V64, P5154, DOI 10.1158/0008-5472.CAN-04-0600; Benight NM, 2012, EXPERT OPIN THER TAR, V16, P921, DOI 10.1517/14728222.2012.710200; Braga E., 2011, Experimental Oncology, V33, P33; Camp ER, 2007, CANCER-AM CANCER SOC, V109, P1030, DOI 10.1002/cncr.22490; Catenacci DVT, 2011, CANCER BIOL THER, V12, P9, DOI 10.4161/cbt.12.1.15747; Chao KLL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041912; Collesi C, 1996, MOL CELL BIOL, V16, P5518; Conrotto P, 2004, ONCOGENE, V23, P5131, DOI 10.1038/sj.onc.1207650; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Eckerich C, 2009, J NEUROCHEM, V109, P969, DOI 10.1111/j.1471-4159.2009.06027.x; Eyob H, 2013, CANCER DISCOV, V3, P751, DOI 10.1158/2159-8290.CD-12-0480; Feres KJ, 2009, ONCOGENE, V28, P279, DOI 10.1038/onc.2008.383; Furukawa T, 1996, AM J PATHOL, V148, P1763; Gurusamy D, 2013, CANCER RES, V73, P1752, DOI 10.1158/0008-5472.CAN-12-2474; Guttman M, 2009, PROTEOMICS, V9, P5016, DOI 10.1002/pmic.200900457; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Kumanogoh A, 2013, NAT REV IMMUNOL, V13, P802, DOI 10.1038/nri3545; Liu Xuemei, 2011, Genes Cancer, V2, P753, DOI 10.1177/1947601911421924; Logan-Collins J, 2010, CANCER RES, V70, P1130, DOI 10.1158/0008-5472.CAN-09-0761; Ma Q, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-307; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; O'Toole JM, 2006, CANCER RES, V66, P9162, DOI 10.1158/0008-5472.CAN-06-0283; Pfaffl M.W., 2004, A Z QUANT PCR, P87; RONSIN C, 1993, ONCOGENE, V8, P1195; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Schroeder GM, 2009, J MED CHEM, V52, P1251, DOI 10.1021/jm801586s; Tactacan CM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-395; Thomas RM, 2007, CANCER RES, V67, P6075, DOI 10.1158/0008-5472.CAN-06-4128; Thomas RM, 2010, PANCREAS, V39, P301, DOI 10.1097/MPA.0b013e3181bb9f73; Wang J, 2009, J BIOL CHEM, V284, P10912, DOI 10.1074/jbc.M809551200; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; Wang QR, 2013, CANCER LETT, V340, P43, DOI 10.1016/j.canlet.2013.06.022; Wang X, 2013, CRIT REV IMMUNOL, V33, P549; Xu XM, 2005, J BIOL CHEM, V280, P25087, DOI 10.1074/jbc.M414699200; Yao HP, 2013, CURR CANCER DRUG TAR, V13, P686, DOI 10.2174/15680096113139990038; Yao HP, 2013, NAT REV CANCER, V13, P466, DOI 10.1038/nrc3545; Zeng JY, 2014, MOL CANCER THER, V13, P37, DOI 10.1158/1535-7163.MCT-13-0242; Zhou YQ, 2003, ONCOGENE, V22, P186, DOI 10.1038/sj.onc.1206075	42	27	28	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 23	2016	35	25					3249	3259		10.1038/onc.2015.384	http://dx.doi.org/10.1038/onc.2015.384			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP2GN	26477314	Green Submitted, Green Accepted			2022-12-26	WOS:000378306400004
J	Cho, Y; Hazen, BC; Gandra, PG; Ward, SR; Schenk, S; Russell, AP; Kralli, A				Cho, Yoshitake; Hazen, Bethany C.; Gandra, Paulo G.; Ward, Samuel R.; Schenk, Simon; Russell, Aaron P.; Kralli, Anastasia			Perm1 enhances mitochondrial biogenesis, oxidative capacity, and fatigue resistance in adult skeletal muscle	FASEB JOURNAL			English	Article						oxidative metabolism; angiogenesis; endurance exercise responses; skeletal muscle plasticity	PROLIFERATOR-ACTIVATED-RECEPTOR; TRANSCRIPTIONAL COACTIVATOR PGC-1; FIBER-TYPE; PROTEIN-KINASE; NUCLEAR RECEPTOR; GENE-EXPRESSION; KEY REGULATOR; ERR-ALPHA; SIRTUIN 1; PGC-1-ALPHA	Skeletal muscle mitochondrial content and oxidative capacity are important determinants of muscle function and whole-body health. Mitochondrial content and function are enhanced by endurance exercise and impaired in states or diseases where muscle function is compromised, such as myopathies, muscular dystrophies, neuromuscular diseases, and age-related muscle atrophy. Hence, elucidating the mechanisms that control muscle mitochondrial content and oxidative function can provide new insights into states and diseases that affect muscle health. In past studies, we identified Perm1 (PPARGC1- and ESRR-induced regulator, muscle 1) as a gene induced by endurance exercise in skeletal muscle, and regulating mitochondrial oxidative function in cultured myotubes. The capacity of Perm1 to regulate muscle mitochondrial content and function in vivo is not yet known. In this study, we use adeno-associated viral (AAV) vectors to increase Perm1 expression in skeletal muscles of 4-wk-old mice. Compared to control vector, AAV1-Perm1 leads to significant increases in mitochondrial content and oxidative capacity (by 40-80%). Moreover, AAV1-Perm1-transduced muscles show increased capillary density and resistance to fatigue (by 33 and 31%, respectively), without prominent changes in fiber-type composition. These findings suggest that Perm1 selectively regulates mitochondrial biogenesis and oxidative function, and implicate Perm1 in muscle adaptations that also occur in response to endurance exercise.	[Cho, Yoshitake; Hazen, Bethany C.; Gandra, Paulo G.; Kralli, Anastasia] Scripps Res Inst, Dept Physiol Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Ward, Samuel R.; Schenk, Simon] Univ Calif San Diego, Sch Med, Dept Orthoped Surg, La Jolla, CA 92093 USA; [Russell, Aaron P.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Burwood, Australia	Scripps Research Institute; University of California System; University of California San Diego; Deakin University	Kralli, A (corresponding author), Scripps Res Inst, Dept Physiol Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kralli@scripps.edu		Schenk, Simon/0000-0002-8224-3203; Russell, Aaron/0000-0002-7323-9501	U.S. National Institutes of Health (NIH); American Heart Association [12POST8610009, 14SDG17790005, 14POST20450112]; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [R01DK095686]; NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30AR061303]; NIH/National Institute of Child Health and Human Development [R24 HD050837]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105126, R01DK095686] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016357] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Erica Young, Dr. Marin Gantner, and members of the Saez laboratory for technical help and discussions; Dr. Espen Spangenburg (University of Maryland, College Park, MD, USA) for help and discussions on the study of single FDB fibers; Mary Esparza and Shannon Bremner for technical assistance; Dr. Malcolm Wood (The Scripps Research Institute) for the electron microscopy studies; and Drs. Erin Brown and Shizuko Tachibana for helpful discussions and critical reading of the manuscript. This work was supported by U.S. National Institutes of Health (NIH) and American Heart Association awards: American Heart Association 12POST8610009 and 14SDG17790005 to Y.C.; American Heart Association 14POST20450112 to P.G.G.; NIH/National Institute of Diabetes and Digestive and Kidney Diseases R01DK095686 to A.K.; NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases P30AR061303; and NIH/National Institute of Child Health and Human Development R24 HD050837.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brenmoehl J, 2013, MITOCHONDRION, V13, P755, DOI 10.1016/j.mito.2013.04.002; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Chao LC, 2012, J LIPID RES, V53, P2610, DOI 10.1194/jlr.M029355; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Chleboun GS, 1997, ACTA ANAT, V159, P147; Cho Y, 2013, J BIOL CHEM, V288, P25207, DOI 10.1074/jbc.M113.489674; Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652; Garcia-Roves PM, 2008, J BIOL CHEM, V283, P35724, DOI 10.1074/jbc.M805078200; Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008; Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030; Gokhin DS, 2011, J CELL BIOL, V194, P105, DOI 10.1083/jcb.201011128; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Hondares E, 2007, BIOCHEM BIOPH RES CO, V354, P1021, DOI 10.1016/j.bbrc.2007.01.092; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Louboutin JP, 2005, J GENE MED, V7, P442, DOI 10.1002/jgm.686; Matsakas A, 2013, FASEB J, V27, P4004, DOI 10.1096/fj.13-228296; Matsakas A, 2012, CIRC RES, V110, P1087, DOI 10.1161/CIRCRESAHA.112.266478; McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490; Minamoto VB, 2007, DEV MED CHILD NEUROL, V49, P907, DOI 10.1111/j.1469-8749.2007.00907.x; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Mokbel N, 2013, BRAIN, V136, P494, DOI 10.1093/brain/aws348; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Pearen MA, 2012, MOL ENDOCRINOL, V26, P372, DOI 10.1210/me.2011-1274; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Pogozelski AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007934; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Rose AJ, 2003, J PHYSIOL-LONDON, V553, P303, DOI 10.1113/jphysiol.2003.054171; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Russell AP, 2014, BBA-GEN SUBJECTS, V1840, P1276, DOI 10.1016/j.bbagen.2013.11.016; Sakamoto K, 2002, J APPL PHYSIOL, V93, P369, DOI 10.1152/japplphysiol.00167.2002; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schild M, 2015, J PROTEOMICS, V122, P119, DOI 10.1016/j.jprot.2015.03.028; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Schuh RA, 2012, AM J PHYSIOL-REG I, V302, pR712, DOI 10.1152/ajpregu.00229.2011; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tiraby C, 2011, CANCER RES, V71, P2518, DOI 10.1158/0008-5472.CAN-10-1315; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	64	28	28	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					674	687		10.1096/fj.15-276360	http://dx.doi.org/10.1096/fj.15-276360			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26481306	Green Submitted, Green Published			2022-12-26	WOS:000369391900019
J	Riss, A; Scheer, E; Joint, M; Trowitzsch, S; Berger, I; Tora, L				Riss, Anne; Scheer, Elisabeth; Joint, Mathilde; Trowitzsch, Simon; Berger, Imre; Tora, Laszlo			Subunits of ADA-two-A-containing (ATAC) or Spt-Ada-Gcn5-acetyltrasferase (SAGA) Coactivator Complexes Enhance the Acetyltransferase Activity of GCN5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromatin modification; chromatin regulation; complex; histone; histone acetylase; histone acetylation; human; mass spectrometry (MS); KAT2A	GENE REGULATORY ELEMENTS; DROSOPHILA ADA2 HOMOLOGS; TATA-BINDING PROTEIN; RNA-POLYMERASE-II; MULTIPROTEIN COMPLEXES; ACETYLASE COMPLEX; SANT DOMAIN; TAF(II)-CONTAINING COMPLEX; TRANSCRIPTIONAL ADAPTERS; LYSINE ACETYLATION	Histone acetyl transferases (HATs) play a crucial role in eukaryotes by regulating chromatin architecture and locus specific transcription. GCN5 (KAT2A) is a member of the GNAT (Gcn5-related N-acetyltransferase) family of HATs. In metazoans this enzyme is found in two functionally distinct coactivator complexes, SAGA (Spt Ada Gcn5 acetyltransferase) and ATAC (Ada Two A-containing). These two multiprotein complexes comprise complex-specific and shared subunits, which are organized in functional modules. The HAT module of ATAC is composed of GCN5, ADA2a, ADA3, and SGF29, whereas in the SAGA HAT module ADA2b is present instead of ADA2a. To better understand how the activity of human (h) hGCN5 is regulated in the two related, but different, HAT complexes we carried out in vitro HAT assays. We compared the activity of hGCN5 alone with its activity when it was part of purified recombinant hATAC or hSAGA HAT modules or endogenous hATAC or hSAGA complexes using histone tail peptides and full-length histones as substrates. We demonstrated that the subunit environment of the HAT complexes into which GCN5 incorporates determines the enhancement of GCN5 activity. On histone peptides we show that all the tested GCN5-containing complexes acetylate mainly histone H3K14. Our results suggest a stronger influence of ADA2b as compared with ADA2a on the activity of GCN5. However, the lysine acetylation specificity of GCN5 on histone tails or full-length histones was not changed when incorporated in the HAT modules of ATAC or SAGA complexes. Our results thus demonstrate that the catalytic activity of GCN5 is stimulated by subunits of the ADA2a- or ADA2b-containing HAT modules and is further increased by incorporation of the distinct HAT modules in the ATAC or SAGA holo-complexes.	[Joint, Mathilde] Univ Strasbourg, CNRS UMR 7104, Inst Genet & Biol Moleculaire & Cellulaire, Prote platform, F-67404 Illkirch Graffenstaden, France; [Trowitzsch, Simon; Berger, Imre] EMBL Grenoble Outstat, F-38042 Grenoble, France; [Riss, Anne; Scheer, Elisabeth; Tora, Laszlo] Univ Strasbourg, Cellular Signaling & Nucl Dynam Program, F-67404 Illkirch Graffenstaden, CU Strasbourg, France; [Joint, Mathilde] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS UMR 7104, INSERM U964,Prote Platform, F-67404 Illkirch Graffenstaden, CU Strasbourg, France; [Trowitzsch, Simon; Berger, Imre] EMBL Grenoble Outstat, F-38042 Grenoble, France; [Trowitzsch, Simon; Berger, Imre] Univ Bristol, Sch Biochem, Clifton BS8 1TD, Avon, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; European Molecular Biology Laboratory (EMBL); University of Bristol		laszlo@igbmc.fr	Tora, Laszlo/E-9999-2018; Trowitzsch, Simon/O-4957-2016	Tora, Laszlo/0000-0001-7398-2250; Trowitzsch, Simon/0000-0001-9143-766X; Berger, Imre/0000-0001-7518-9045	Association pour la Recherche sur le Cancer grant (Orbitrap)	Association pour la Recherche sur le Cancer grant (Orbitrap)	We are grateful to Z. Nagy, J. Bonnet, M. Stierle, P. Tropberger, C. Bieniossek, E. Y. D. Chua, and C. A. Davey for materials, helpful discussions, and advice. We thank D. Devys for critically reading the manuscript and for helpful comments, the Institut de Genetique et de Biologie Moleculaire et Cellulaire cell culture facility for HeLa cells, I. Kolb-Cheynel for help in baculovirus overexpression, P. Eberling for peptide synthesis, K. J. Babu for technical help, and F. Garzoni for tissue culture work. The Institut de Genetique et de Biologie Moleculaire et Cellulaire Proteomics platform is supported by an Association pour la Recherche sur le Cancer grant (Orbitrap).	Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Bonnet J, 2014, GENE DEV, V28, P1999, DOI 10.1101/gad.250225.114; Boyer LA, 2002, MOL CELL, V10, P935, DOI 10.1016/S1097-2765(02)00634-2; Brand M, 1999, J BIOL CHEM, V274, P18285, DOI 10.1074/jbc.274.26.18285; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Candau R, 1996, MOL CELL BIOL, V16, P593; Cieniewicz AM, 2014, MOL CELL PROTEOMICS, V13, P2896, DOI 10.1074/mcp.M114.038174; Ciurciu A, 2006, MOL CELL BIOL, V26, P9413, DOI 10.1128/MCB.01401-06; Demeny MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000316; Eberharter A, 1998, METHODS, V15, P315, DOI 10.1006/meth.1998.0635; Feller C, 2015, MOL CELL, V57, P559, DOI 10.1016/j.molcel.2014.12.008; Gamper AM, 2009, MOL CELL BIOL, V29, P266, DOI 10.1128/MCB.00315-08; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Guelman S, 2006, MOL CELL BIOL, V26, P871, DOI 10.1128/MCB.26.3.871-882.2006; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; HINNEBUSCH AG, 1983, P NATL ACAD SCI-BIOL, V80, P5374, DOI 10.1073/pnas.80.17.5374; HONG L, 1993, J BIOL CHEM, V268, P305; HORIUCHI J, 1995, MOL CELL BIOL, V15, P1203; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krebs AR, 2010, EMBO REP, V11, P541, DOI 10.1038/embor.2010.75; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Kuo YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054896; Kusch T, 2003, MOL CELL BIOL, V23, P3305, DOI 10.1128/MCB.23.9.3305-3319.2003; Lang G, 2011, MOL CELL BIOL, V31, P3734, DOI 10.1128/MCB.05231-11; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; LI R, 1993, COLD SPRING HARB SYM, V58, P403, DOI 10.1101/SQB.1993.058.01.047; Lu R, 2013, TRENDS BIOCHEM SCI, V38, P546, DOI 10.1016/j.tibs.2013.08.002; MARCUS GA, 1994, EMBO J, V13, P4807, DOI 10.1002/j.1460-2075.1994.tb06806.x; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; Muratoglu S, 2003, MOL CELL BIOL, V23, P306, DOI 10.1128/MCB.23.1.306-321.2003; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Nagy Z, 2010, CELL MOL LIFE SCI, V67, P611, DOI 10.1007/s00018-009-0199-8; Nguyen-Huynh NT, 2015, PROTEIN SCI, V24, P1232, DOI 10.1002/pro.2676; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pankotai T, 2005, MOL CELL BIOL, V25, P8215, DOI 10.1128/MCB.25.18.8215-8227.2005; PENN MD, 1983, P NATL ACAD SCI-BIOL, V80, P2704, DOI 10.1073/pnas.80.9.2704; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Schnitzler G R, 2001, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2105s50; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Sterner DE, 2002, J BIOL CHEM, V277, P8178, DOI 10.1074/jbc.M108601200; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Trievel RC, 2000, ANAL BIOCHEM, V287, P319, DOI 10.1006/abio.2000.4855; Tropberger P, 2013, CELL, V152, P859, DOI 10.1016/j.cell.2013.01.032; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283	59	28	28	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28997	29009		10.1074/jbc.M115.668533	http://dx.doi.org/10.1074/jbc.M115.668533			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26468280	Green Published, hybrid			2022-12-26	WOS:000365762300038
J	Wood, SA; Depree, C; Brown, L; McAllister, T; Hawes, I				Wood, Susanna A.; Depree, Craig; Brown, Logan; McAllister, Tara; Hawes, Ian			Entrapped Sediments as a Source of Phosphorus in Epilithic Cyanobacterial Proliferations in Low Nutrient Rivers	PLOS ONE			English	Article							HOMOANATOXIN-A; ANATOXIN-A; BENTHIC CYANOBACTERIA; DOG NEUROTOXICOSIS; 1ST REPORT; LAKE; MATS; RELEASE; RATES; PHOTOINHIBITION	Proliferations of the benthic mat-forming cyanobacteria Phormidium have been reported in rivers worldwide. Phormidium commonly produces natural toxins which pose a health risk to animal and humans. Recent field studies in New Zealand identified that sites with Phormidium proliferations consistently have low concentrations of water column dissolved reactive phosphorus (DRP). Unlike other river periphyton, Phormidium mats are thick and cohesive, with water and fine sediment trapped in a mucilaginous matrix. We hypothesized that daytime photosynthetic activity would elevate pH inside the mats, and/or night time respiration would reduce dissolved oxygen. Either condition could be sufficient to facilitate desorption of phosphates from sediment incorporated within mats, thus allowing Phormidium to utilize it for growth. Using microelectrodes, optodes and pulse amplitude modulation fluorometry we demonstrated that photosynthetic activity results in elevated pH (>9) during daytime, and that night-time respiration causes oxygen depletion (<4 mg L-1) within mats. Water trapped within the mucilaginous Phormidium mat matrix had on average 320-fold higher DRP concentrations than bulk river water and this, together with elevated concentrations of elements, including iron, suggest phosphorus release from entrapped sediment. Sequential extraction of phosphorus from trapped sediment was used to investigate the role of sediment at sites on the Mangatainoka River (New Zealand) with and without Phormidium proliferations. Deposition of fine sediment (<63 mu m) was significantly higher at the site with the most extensive proliferations and concentrations of biological available phosphorus were two-to four-fold higher. Collectively these results provide evidence that fine sediment can provide a source of phosphorus to support Phormidium growth and proliferation.	[Wood, Susanna A.] Cawthron Inst, Nelson, New Zealand; [Wood, Susanna A.] Univ Waikato, Environm Res Inst, Hamilton, New Zealand; [Depree, Craig] NIWA, Hamilton, New Zealand; [Brown, Logan] Horizons Reg Council, Palmerston North, New Zealand; [McAllister, Tara; Hawes, Ian] Univ Canterbury, Waterways Ctr Freshwater Management, Christchurch 1, New Zealand	Cawthron Institute; University of Waikato; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Canterbury	Wood, SA (corresponding author), Cawthron Inst, Nelson, New Zealand.	Susie.wood@cawthron.org.nz		Hawes, Ian/0000-0003-2471-6903	Horizons Regional Council; New Zealand Ministry for Business, Innovation and Employment Cumulative Effects programme [CO1X0803]	Horizons Regional Council; New Zealand Ministry for Business, Innovation and Employment Cumulative Effects programme(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This project was funded by the Horizons Regional Council and the New Zealand Ministry for Business, Innovation and Employment Cumulative Effects programme (CO1X0803).	Aboal M, 2002, J APPL PHYCOL, V14, P49, DOI 10.1023/A:1015298905510; Aboal M, 2000, INT VER THEOR ANGEW, V27, P555; American Public Health Association (APHA), 2005, STANDARD METHODS EXA; ANDERSEN JM, 1975, ARCH HYDROBIOL, V76, P411; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2014, R LANG ENV STAT COMP; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Beer S, 2004, EUR J PHYCOL, V39, P1, DOI 10.1080/0967026032000157138; Beuzenberg V, 2014, NEW ZEAL J BOT, V52, P136, DOI 10.1080/0028825X.2013.859627; BIGGS BJF, 1990, NEW ZEAL J MAR FRESH, V24, P9, DOI 10.1080/00288330.1990.9516398; BOTHWELL ML, 1989, CAN J FISH AQUAT SCI, V46, P1293, DOI 10.1139/f89-166; Brady AL, 2010, CHEM GEOL, V274, P56, DOI 10.1016/j.chemgeo.2010.03.016; Brasell KA, 2015, MICROB ECOL, V69, P254, DOI 10.1007/s00248-014-0538-7; Bridge B., 2014, 2537 CAWTHR NELS CIT, V16; Denis L, 2012, J SOIL SEDIMENT, V12, P1517, DOI 10.1007/s11368-012-0588-8; Des Marais D., 2010, MICROBIAL MATS, V14, P401; Dodds WK, 2003, J PHYCOL, V39, P840, DOI 10.1046/j.1529-8817.2003.02081.x; Eckert W, 1997, WATER AIR SOIL POLL, V99, P401, DOI 10.1007/BF02406880; Faassen EJ, 2012, TOXICON, V60, P378, DOI 10.1016/j.toxicon.2012.04.335; Frantz CM, 2015, GEOBIOLOGY, V13, P409, DOI 10.1111/gbi.12145; Gugger M, 2005, TOXICON, V45, P919, DOI 10.1016/j.toxicon.2005.02.031; Hall K., 2008, THESIS TRINITY COLL; Heath MW, 2015, RIVER RES APPL, V31, P98, DOI 10.1002/rra.2722; Heath MW, 2011, AQUAT MICROB ECOL, V64, P69, DOI 10.3354/ame01516; HICKEY CW, 1988, J ENVIRON ENG-ASCE, V114, P828, DOI 10.1061/(ASCE)0733-9372(1988)114:4(828); HOFSTRAAT JW, 1994, MAR ECOL PROG SER, V103, P187, DOI 10.3354/meps103187; Hoiczyk E, 1998, J BACTERIOL, V180, P3923, DOI 10.1128/JB.180.15.3923-3932.1998; House WA, 2003, APPL GEOCHEM, V18, P739, DOI 10.1016/S0883-2927(02)00158-0; Hupfer M, 2008, INT REV HYDROBIOL, V93, P415, DOI 10.1002/iroh.200711054; JORGENSEN BB, 1990, LIMNOL OCEANOGR, V35, P1343, DOI 10.4319/lo.1990.35.6.1343; Kozerski HP, 2002, WATER RES, V36, P2983, DOI 10.1016/S0043-1354(01)00533-4; Krienitz L, 2003, FEMS MICROBIOL ECOL, V43, P141, DOI 10.1111/j.1574-6941.2003.tb01053.x; Li HL, 2009, LIMNOLOGICA, V39, P255, DOI 10.1016/j.limno.2008.08.002; Lukkari K, 2007, LIMNOL OCEANOGR-METH, V5, P433, DOI 10.4319/lom.2007.5.433; Mohamed ZA, 2006, TOXICON, V47, P584, DOI 10.1016/j.toxicon.2006.01.029; Pajdak-Stos A, 2001, AQUAT MICROB ECOL, V23, P237, DOI 10.3354/ame023237; Pearl HW, 1989, MICROBIAL MATS PHYSL, P326; PETTERSSON K, 1988, HYDROBIOLOGIA, V170, P91, DOI 10.1007/BF00024900; Psenner R., 1988, ADV LIMNOLOGY, V30, P43; Quiblier C, 2013, WATER RES, V47, P5464, DOI 10.1016/j.watres.2013.06.042; REVSBECH NP, 1983, POLAROGRAPHIC OXYGEN, P265; Romani AM, 2000, MICROB ECOL, V40, P16, DOI 10.1007/s002480000041; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Stal LJ, 2012, ECOLOGY CYANOBACTERI, P65, DOI [DOI 10.1007/978-94-007-3855-3_4, 10.1007/978-94-007-3855-3_4]; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; STORCH TA, 1990, APPL ENVIRON MICROB, V56, P466, DOI 10.1128/AEM.56.2.466-471.1990; Stumm W, 1995, AQUATIC CHEM CHEM EQ, V3rd, DOI [DOI 10.1094/ASBCMOA-BEER-13, 10.1094/asbcmoa-beer-13]; Tyystjarvi E, 2013, INT REV CEL MOL BIO, V300, P243, DOI 10.1016/B978-0-12-405210-9.00007-2; Wang SR, 2008, COLLOID SURFACE A, V316, P245, DOI 10.1016/j.colsurfa.2007.09.007; Withers PJA, 2008, SCI TOTAL ENVIRON, V400, P379, DOI 10.1016/j.scitotenv.2008.08.002; Wood SA, 2010, J APPL MICROBIOL, V109, P2011, DOI 10.1111/j.1365-2672.2010.04831.x; Wood SA, 2014, 2624 CAWTHR; Wood SA, 2014, 2575 CAWTHR; Wood SA, 2007, TOXICON, V50, P292, DOI 10.1016/j.toxicon.2007.03.025; Wood SA, 2010, TOXICON, V55, P897, DOI 10.1016/j.toxicon.2009.12.019; Xu D, 2013, J ENVIRON SCI-CHINA, V25, P637, DOI 10.1016/S1001-0742(12)60136-3; Zhou QX, 2001, CHEMOSPHERE, V42, P221, DOI 10.1016/S0045-6535(00)00129-6	57	49	51	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0141063	10.1371/journal.pone.0141063	http://dx.doi.org/10.1371/journal.pone.0141063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26479491	Green Submitted, Green Published, gold			2022-12-26	WOS:000363026600029
J	Boysen, C; Davis, EG; Beard, LA; Lubbers, BV; Raghavan, RK				Boysen, Courtney; Davis, Elizabeth G.; Beard, Laurie A.; Lubbers, Brian V.; Raghavan, Ram K.			Bayesian Geostatistical Analysis and Ecoclimatic Determinants of Corynebacterium pseudotuberculosis Infection among Horses	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION; PIGEON FEVER; COLORADO	Kansas witnessed an unprecedented outbreak in Corynebacterium pseudotuberculosis infection among horses, a disease commonly referred to as pigeon fever during fall 2012. Bayesian geostatistical models were developed to identify key environmental and climatic risk factors associated with C. pseudotuberculosis infection in horses. Positive infection status among horses (cases) was determined by positive test results for characteristic abscess formation, positive bacterial culture on purulent material obtained from a lanced abscess (n = 82), or positive serologic evidence of exposure to organism (>= 1:512)(n = 11). Horses negative for these tests (n = 172)(controls) were considered free of infection. Information pertaining to horse demographics and stabled location were obtained through review of medical records and/or contact with horse owners via telephone. Covariate information for environmental and climatic determinants were obtained from USDA (soil attributes), USGS (land use/land cover), and NASA MODIS and NASA Prediction of Worldwide Renewable Resources (climate). Candidate covariates were screened using univariate regression models followed by Bayesian geostatistical models with and without covariates. The best performing model indicated a protective effect for higher soil moisture content (OR = 0.53, 95% CrI = 0.25, 0.71), and detrimental effects for higher land surface temperature (>= 35 degrees C) (OR = 2.81, 95% CrI = 2.21, 3.85) and habitat fragmentation (OR = 1.31, 95% CrI = 1.27, 2.22) for C. pseudotuberculosis infection status in horses, while age, gender and breed had no effect. Preventative and ecoclimatic significance of these findings are discussed.	[Boysen, Courtney; Davis, Elizabeth G.; Beard, Laurie A.] Kansas State Univ, Coll Vet Med, Dept Clin Sci, Manhattan, KS 66506 USA; [Lubbers, Brian V.; Raghavan, Ram K.] Kansas State Univ, Dept Diagnost Med & Pathobiol, Kansas State Vet Diagnost Lab, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Raghavan, RK (corresponding author), Kansas State Univ, Dept Diagnost Med & Pathobiol, Kansas State Vet Diagnost Lab, Manhattan, KS 66506 USA.	rkraghavan@vet.k-state.edu	Lubbers, Brian/AAS-4286-2020	Raghavan, Ram/0000-0002-2657-3398	Kansas State Veterinary Diagnostic Laboratory; Veterinary Health Center at Kansas State University	Kansas State Veterinary Diagnostic Laboratory; Veterinary Health Center at Kansas State University	This study was financially supported by the Kansas State Veterinary Diagnostic Laboratory and Veterinary Health Center at Kansas State University. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2014, APPL SOIL ECOL, V75, P43, DOI 10.1016/j.apsoil.2013.10.008; Aleman M, 1996, J AM VET MED ASSOC, V209, P804; Andersson M, 2011, MALARIA J, P10; Banerjee S., 2014, HIERARCHICAL MODELIN; Blunden J, 2013, B AM METEOROL SOC, V94, pS1, DOI 10.1175/2013BAMSStateoftheClimate.1; CLIFF A, 1972, GEOGR ANAL, V4, P267; Doherr MG, 1998, PREV VET MED, V35, P229, DOI 10.1016/S0167-5877(98)00071-3; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Dunson DB, 2001, AM J EPIDEMIOL, V153, P1222, DOI 10.1093/aje/153.12.1222; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Gelman A, 2004, BAYESIAN DATA ANAL, P283; Goodin DouglasG., 2004, CLIMATE WEATHER ATLA; Hall K, 2001, J EQUINE VET SCI, V21, P284, DOI 10.1016/S0737-0806(01)70058-5; Halos L, 2010, APPL ENVIRON MICROB, V76, P4413, DOI 10.1128/AEM.00610-10; Harrington Jr JA, 2013, PAPERS APPL GEOGRAPH, V36, P11; Henry HAL, 2012, SOIL BIOL BIOCHEM, V47, P53, DOI 10.1016/j.soilbio.2011.12.026; Hoerling M, 2014, B AM METEOROL SOC, V95, P269, DOI 10.1175/BAMS-D-13-00055.1; Hueso S, 2012, SOIL BIOL BIOCHEM, V50, P167, DOI 10.1016/j.soilbio.2012.03.026; Jeske JM, 2013, JAVMA-J AM VET MED A, V242, P86, DOI 10.2460/javma.242.1.86; Kansas Office of the Governor, DECL FED DIS AR; Kelly EJ, 2012, J WILDLIFE DIS, V48, P803, DOI 10.7589/0090-3558-48.3.803; Kilcoyne I, 2014, JAVMA-J AM VET MED A, V245, P309, DOI 10.2460/javma.245.3.309; Kuhn NJ, 2014, SOIL UNDERFOOT INFIN, P37; Lawson AB, 2013, BAYESIAN DIS MAPPING, V2; Lemeshow S., 1990, APPL LOGISTIC REGRES, P91; LIPSKY BA, 1982, REV INFECT DIS, V4, P1220; LP DAAC, MODIS OV; McGarigal K., 2012, FRAGSTATS V4 SPATIAL; Munson SM, 2011, P NATL ACAD SCI USA, V108, P3854, DOI 10.1073/pnas.1014947108; Natural Resources Conservation Service, SOIL GEOGRAPHY; NOAA National Climatic Data Center, 2012, BAMS STAT CLIM 2012; NOAA National Climatic Data Center, 2012, NAT OV ANN 2012; Pratt SM, 2005, JAVMA-J AM VET MED A, V227, P441, DOI 10.2460/javma.2005.227.441; ROBINSON GR, 1992, SCIENCE, V257, P524, DOI 10.1126/science.257.5069.524; Schabenberger O., 2004, STAT METHODS SPATIAL; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; Spier SJ, 2012, VET REC, V170, DOI 10.1136/vr.100543; Spier SJ, 2004, AM J VET RES, V65, P829, DOI 10.2460/ajvr.2004.65.829; Szonyi B, 2014, J EQUINE VET SCI, V34, P281, DOI 10.1016/j.jevs.2013.06.006; Warren KLH, 2014, CASE REPORTS VET MED, V2014, DOI [10.1155/2014/436287, DOI 10.1155/2014/436287]; White JW, 2008, AGR FOREST METEOROL, V148, P1574, DOI 10.1016/j.agrformet.2008.05.017	42	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140666	10.1371/journal.pone.0140666	http://dx.doi.org/10.1371/journal.pone.0140666			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473728	Green Published, gold, Green Submitted			2022-12-26	WOS:000363185500077
J	Davis, MB; Walens, A; Hire, R; Mumin, K; Brown, AM; Ford, D; Howerth, EW; Monteil, M				Davis, Melissa B.; Walens, Andrea; Hire, Rupali; Mumin, Kauthar; Brown, Andrea M.; Ford, DeJuana; Howerth, Elizabeth W.; Monteil, Michele			Distinct Transcript Isoforms of the Atypical Chemokine Receptor 1 (ACKR1) / Duffy Antigen Receptor for Chemokines (DARC) Gene Are Expressed in Lymphoblasts and Altered Isoform Levels Are Associated with Genetic Ancestry and the Duffy-Null Allele	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; NEGATIVE INDIVIDUALS; ERYTHROCYTE RECEPTOR; HEMOLYTIC-DISEASE; PLASMODIUM-VIVAX; BLOOD-GROUP; ANTIGEN/RECEPTOR; PROTEIN; ENDOTHELIUM; BINDING	The Atypical ChemoKine Receptor 1 (ACKR1) gene, better known as Duffy Antigen Receptor for Chemokines (DARC or Duffy), is responsible for the Duffy Blood Group and plays a major role in regulating the circulating homeostatic levels of pro-inflammatory chemokines. Previous studies have shown that one common variant, the Duffy Null (Fy-) allele that is specific to African Ancestry groups, completely removes expression of the gene on erythrocytes; however, these individuals retain endothelial expression. Additional alleles are associated with a myriad of clinical outcomes related to immune responses and inflammation. In addition to allele variants, there are two distinct transcript isoforms of DARC which are expressed from separate promoters, and very little is known about the distinct transcriptional regulation or the distinct functionality of these protein isoforms. Our objective was to determine if the African specific Fy-allele alters the expression pattern of DARC isoforms and therefore could potentially result in a unique signature of the gene products, commonly referred to as antigens. Our work is the first to establish that there is expression of DARC on lymphoblasts. Our data indicates that people of African ancestry have distinct relative levels of DARC isoforms expressed in these cells. We conclude that the expression of both isoforms in combination with alternate alleles yields multiple Duffy antigens in ancestry groups, depending upon the haplotypes across the gene. Importantly, we hypothesize that DARC isoform expression patterns will translate into ancestry-specific inflammatory responses that are correlated with the axis of pro-inflammatory chemokine levels and distinct isoform-specific interactions with these chemokines. Ultimately, this work will increase knowledge of biological mechanisms underlying disparate clinical outcomes of inflammatory-related diseases among ethnic and geographic ancestry groups.	[Davis, Melissa B.; Walens, Andrea; Hire, Rupali; Mumin, Kauthar; Brown, Andrea M.; Ford, DeJuana] Univ Georgia, Dept Genet, Franklin Coll Arts & Sci, Athens, GA 30602 USA; [Howerth, Elizabeth W.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Davis, Melissa B.; Monteil, Michele] Univ Georgia Med Partnership, Georgia Regents Univ, Dept Mol Biol & Biochem, Athens, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; Augusta University; University of Georgia	Davis, MB (corresponding author), Univ Georgia, Dept Genet, Franklin Coll Arts & Sci, Athens, GA 30602 USA.	mbdavis@uga.edu; mmonteil@uga.edu	Walens, Andrea/AAT-8221-2020	Walens, Andrea/0000-0001-8706-563X; Davis, Melissa/0000-0002-6124-6923				Addison CL, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-28; Afenyi-Annan A, 2008, TRANSFUSION, V48, P917, DOI 10.1111/j.1537-2995.2007.01622.x; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Buchanan CC, 2012, J AM MED INFORM ASSN, V19, P289, DOI 10.1136/amiajnl-2011-000652; Carvalho TL, 2009, VET IMMUNOL IMMUNOP, V132, P153, DOI 10.1016/j.vetimm.2009.05.016; CHANSHU SA, 1980, TRANSFUSION, V20, P358, DOI 10.1046/j.1537-2995.1980.20380214907.x; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hiraoka N, 2011, GASTROENTEROLOGY, V140, P310, DOI 10.1053/j.gastro.2010.10.009; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; Iwamoto S, 1996, BLOOD, V87, P378; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Kalogeropoulos M, 2010, FASEB J, V24, P2893, DOI 10.1096/fj.09-148908; Oliveira TYK, 2012, IMMUNOGENETICS, V64, P497, DOI 10.1007/s00251-012-0608-2; LEPENNEC PY, 1987, VOX SANG, V52, P246; Liu XF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-374; LIVINGSTONE FB, 1984, HUM BIOL, V56, P413; Mayr FB, 2008, CRIT CARE MED, V36, P159, DOI 10.1097/01.CCM.0000297875.55969.DB; Meny G M, 2010, Immunohematology, V26, P51; Nemesure B, 2015, J IMMIGR MINOR HEALT, V17, P679, DOI 10.1007/s10903-013-9970-x; Nickel RG, 1999, HUM IMMUNOL, V60, P738, DOI 10.1016/S0198-8859(99)00039-7; Parasol N, 2001, HUM BIOL, V73, P307, DOI 10.1353/hub.2001.0024; Patterson AM, 2002, J PATHOL, V197, P108, DOI 10.1002/path.1100; PEIPER SC, 1995, J EXP MED, V181, P1311, DOI 10.1084/jem.181.4.1311; Pogo AO, 2000, SEMIN HEMATOL, V37, P122, DOI 10.1016/S0037-1963(00)90037-4; Pruenster M, 2006, BIOCHEM SOC T, V34, P1005, DOI 10.1042/BST0341005; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schmid P, 2012, TRANSFUSION, V52, P1260, DOI 10.1111/j.1537-2995.2011.03431.x; Segerer S, 2000, KIDNEY INT, V58, P1546, DOI 10.1046/j.1523-1755.2000.00316.x; Shen H, 2006, FASEB J, V20, P59, DOI 10.1096/fj.05-4764com; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; SZABO MC, 1995, J BIOL CHEM, V270, P25348, DOI 10.1074/jbc.270.43.25348; Talano JAM, 2003, PEDIATRICS, V111, pE661, DOI 10.1542/peds.111.6.e661; Thobakgale CF, 2014, CURR OPIN HEMATOL, V21, P50, DOI 10.1097/MOH.0000000000000007; Tournamille C, 2004, IMMUNOGENETICS, V55, P682, DOI 10.1007/s00251-003-0633-2; Tournamille C, 1998, BLOOD, V92, P2147, DOI 10.1182/blood.V92.6.2147.418k04_2147_2156; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; VanBuskirk KM, 2004, P NATL ACAD SCI USA, V101, P15754, DOI 10.1073/pnas.0405421101; VESCIO LAC, 1987, TRANSFUSION, V27, P366, DOI 10.1046/j.1537-2995.1987.27487264751.x; Wang J, 2006, ONCOGENE, V25, P7201, DOI 10.1038/sj.onc.1209703; WEINSTEIN L, 1975, AM J OBSTET GYNECOL, V121, P643, DOI 10.1016/0002-9378(75)90467-6; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	48	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140098	10.1371/journal.pone.0140098	http://dx.doi.org/10.1371/journal.pone.0140098			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473357	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500024
J	Lin, P; Lu, JM; Wang, YF; Gu, W; Yu, J; Zhao, RH				Lin, Pei; Lu, Jianmei; Wang, Yanfang; Gu, Wen; Yu, Jie; Zhao, Ronghua			Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TETRAHYDROXYSTILBENE GLUCOSIDE; METABOLIC-SYNDROME; CONTROLLED-TRIAL; VITAMIN-E; IN-VITRO; HEALTH; DIET; PIOGLITAZONE; ACTIVATION	The gut-liver axis is largely involved in the development of non-alcoholic fatty liver disease (NAFLD). We investigated whether 2, 3, 5, 4'-tetrahydroxy-stilbene-2-O-beta-D-glucoside (TSG) could reverse NAFLD induced by a high-fat diet (HFD) and whether it did so via the gut-liver axis. Results showed that TSG could reduce the accumulation of FFA and it did so by reducing the expression of L-FABP and FATP4. TSG regulated gut microbiota balanced and increased the protein expression of ZO-1 and occludin, which could improve the function of the intestinal mucosal barrier and reduce serum LPS content by about 25%. TSG reduced TL4 levels by 56% and NF-kappa B expression by 23% relative to the NAFLD model group. This suggests that prevention of NAFLD by TSG in HFD-fed rats is mediated by modulation of the gut microbiota and TLR4/NF-kappa B pathway, which may alleviate chronic low-grade inflammation by reducing the exogenous antigen load on the host.	[Lin, Pei; Lu, Jianmei; Wang, Yanfang; Gu, Wen; Yu, Jie; Zhao, Ronghua] Yunnan Univ Tradit Chinese Med, Dept Pharm, Kunming, Yunnan, Peoples R China	Yunnan University of Chinese Medicine	Yu, J (corresponding author), Yunnan Univ Tradit Chinese Med, Dept Pharm, Kunming, Yunnan, Peoples R China.	cz.yujie@gmail.com; kmzhaoronghua@hotmail.com			National Natural Science Foundation of China [81060337, 81260553, 81460623]; Natural Science Foundation of Yunnan Province [2014FA035, 2012FD043]; Southern Medicine Collaborative And Innovation Center [30270100500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Southern Medicine Collaborative And Innovation Center	This research was financially supported by the National Natural Science Foundation of China (Grant no. 81060337, Grant no. 81260553, and Grant no. 81460623), the Natural Science Foundation of Yunnan Province (Grant no. 2014FA035 and Grant no. 2012FD043) and the Southern Medicine Collaborative And Innovation Center (30270100500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Broering R, 2011, CLIN SCI, V121, P415, DOI 10.1042/CS20110065; Bugianesi E, 2005, AM J GASTROENTEROL, V100, P1082, DOI 10.1111/j.1572-0241.2005.41583.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chassaing B, 2014, HEPATOLOGY, V59, P328, DOI 10.1002/hep.26494; Dai X, 2014, HEPATO-GASTROENTEROL, V61, P136, DOI 10.5754/hge12760; Fan JG, 2003, WORLD J GASTROENTERO, V9, P2045, DOI 10.3748/wjg.v9.i9.2045; Feng Ai-juan, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P776; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Goldsmith JR, 2014, J GASTROENTEROL, V49, P785, DOI 10.1007/s00535-014-0953-z; Heinrichsdorff J, 2012, NAT MED, V18, P1182, DOI 10.1038/nm.2869; Ito-Nagahata T, 2013, BIOSCI BIOTECH BIOCH, V77, P1229, DOI 10.1271/bbb.121000; Jiang WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08096; Machado MV, 2012, ANN HEPATOL, V11, P440, DOI 10.1016/S1665-2681(19)31457-7; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Mehal WZ, 2013, NAT REV GASTRO HEPAT, V10, P637, DOI 10.1038/nrgastro.2013.146; Miura K, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/362847; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; Sun FL, 2011, EUR J PHARMACOL, V660, P283, DOI 10.1016/j.ejphar.2011.03.046; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Tilg H, 2011, J HEPATOL, V55, P960, DOI 10.1016/j.jhep.2011.04.007; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang WE, 2014, J ETHNOPHARMACOL, V153, P763, DOI 10.1016/j.jep.2014.03.042; Wattacheril J, 2012, HEPATOLOGY, V56, P1580, DOI 10.1002/hep.26031; Yu J, 2014, CHIN PHARM J, V23, P2077; Zhang SH, 2009, ACTA PHARMACOL SIN, V30, P1479, DOI 10.1038/aps.2009.144; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhong L, 2000, J CHIN PRAC MED, V2, P3; Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285	39	35	36	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140346	10.1371/journal.pone.0140346	http://dx.doi.org/10.1371/journal.pone.0140346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474417	gold, Green Published, Green Submitted			2022-12-26	WOS:000363185500042
J	Guglielmelli, P; Bisognin, A; Saccoman, C; Mannarelli, C; Coppe, A; Vannucchi, AM; Bortoluzzi, S				Guglielmelli, Paola; Bisognin, Andrea; Saccoman, Claudia; Mannarelli, Carmela; Coppe, Alessandro; Vannucchi, Alessandro M.; Bortoluzzi, Stefania			Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; MICRORNA-OFFSET RNAS; MYELOPROLIFERATIVE NEOPLASMS; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; MYELOID DEVELOPMENT; PROGENITOR CELLS; MESSENGER-RNA; BREAST-CANCER; IDENTIFICATION	Myeloproliferative neoplasms (MPN) are chronic myeloid cancers thought to arise at the level of CD34+ hematopoietic stem/progenitor cells. They include essential thrombocythemia (ET), polycythemia vera (PV) and primary myelofibrosis (PMF). All can progress to acute leukemia, but PMF carries the worst prognosis. Increasing evidences indicate that deregulation of microRNAs (miRNAs) might plays an important role in hematologic malignancies, including MPN. To attain deeper knowledge of short RNAs (sRNAs) expression pattern in CD34+ cells and of their possible role in mediating post-transcriptional regulation in PMF, we sequenced with Illumina HiSeq2000 technology CD34+ cells from healthy subjects and PMF patients. We detected the expression of 784 known miRNAs, with a prevalence of miRNA up-regulation in PMF samples, and discovered 34 new miRNAs and 99 new miRNA-offset RNAs (moRNAs), in CD34+ cells. Thirty-seven small RNAs were differentially expressed in PMF patients compared with healthy subjects, according to microRNA sequencing data. Five miRNAs (miR-10b-5p, miR-19b-3p, miR-29a-3p, miR-379-5p, and miR-543) were deregulated also in PMF granulocytes. Moreover, 3'-moR-128-2 resulted consistently downregulated in PMF according to RNA-seq and qRT-PCR data both in CD34+ cells and granulocytes. Target predictions of these validated small RNAs de-regulated in PMF and functional enrichment analyses highlighted many interesting pathways involved in tumor development and progression, such as signaling by FGFR and DAP12 and Oncogene Induced Senescence. As a whole, data obtained in this study deepened the knowledge of miRNAs and moRNAs altered expression in PMF CD34+ cells and allowed to identify and validate a specific small RNA profile that distinguishes PMF granulocytes from those of normal subjects. We thus provided new information regarding the possible role of miRNAs and, specifically, of new moRNAs in this disease.	[Guglielmelli, Paola; Mannarelli, Carmela; Vannucchi, Alessandro M.] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Bisognin, Andrea; Coppe, Alessandro; Bortoluzzi, Stefania] Univ Padua, Dept Mol Med, Padua, Italy; [Saccoman, Claudia] Univ Padua, Dept Biol, Padua, Italy	University of Florence; University of Padua; University of Padua	Bortoluzzi, S (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	stefania.bortoluzzi@unipd.it	Guglielmelli, Paola/K-7509-2016; Vannucchi, Alessandro M./K-7499-2016; Bortoluzzi, Stefania/G-8211-2011	Guglielmelli, Paola/0000-0003-1809-284X; Vannucchi, Alessandro M./0000-0001-5755-0730; Bortoluzzi, Stefania/0000-0001-8240-3070	Fondazione Cassa di Risparmio di Padova e Rovigo Progetti di Eccellenza; Ministero dell'Istruzione, dell'Universita e della Ricerca PRIN [2010NYKNS7_002]; Ministero dell'Istruzione, dell'Universita e della Ricerca FIRB [RBAP11CZLK]; "Special Program Molecular Clinical Oncology 5x1000" to Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative	Fondazione Cassa di Risparmio di Padova e Rovigo Progetti di Eccellenza; Ministero dell'Istruzione, dell'Universita e della Ricerca PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministero dell'Istruzione, dell'Universita e della Ricerca FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); "Special Program Molecular Clinical Oncology 5x1000" to Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative(Fondazione AIRC per la ricerca sul cancro)	The study received funding by Fondazione Cassa di Risparmio di Padova e Rovigo Progetti di Eccellenza 2011/2012 (http://www.fondazionecariparo.net/english-version/) to SB and PG; by Ministero dell'Istruzione, dell'Universita e della Ricerca (http://www.istruzione.it/) PRIN 2010/11 (2010NYKNS7_002) and FIRB 2011 (RBAP11CZLK) to AMV and SB; and by "Special Program Molecular Clinical Oncology 5x1000" to Associazione Italiana per la Ricerca sul Cancro (http://www.airc.it/english/) Gruppo Italiano Malattie Mieloproliferative (http://www.progettoagimm.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird KM, CANC LETT; Aoki N, 2000, J IMMUNOL, V165, P3790, DOI 10.4049/jimmunol.165.7.3790; Aoki N, 2002, BIOCHEM BIOPH RES CO, V291, P296, DOI 10.1006/bbrc.2002.6434; Asikainen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116668; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Baez A, 2014, BIOL BLOOD MARROW TR, V20, P630, DOI 10.1016/j.bbmt.2014.01.022; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bortoluzzi S, 2012, BLOOD, V119, pE120, DOI 10.1182/blood-2011-07-368001; Bortoluzzi S, 2011, TRENDS MOL MED, V17, P473, DOI 10.1016/j.molmed.2011.05.005; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Bruchova H, 2008, HAEMATOL-HEMATOL J, V93, P1009, DOI 10.3324/haematol.12706; Bruchova H, 2007, EXP HEMATOL, V35, P1657, DOI 10.1016/j.exphem.2007.08.021; Chan M, 2013, CLIN CANCER RES, V19, P4477, DOI 10.1158/1078-0432.CCR-12-3401; Chan Y, 2013, CONCORDANT DISCORDAN, V8, DOI [10.1371/journal.pone.0058169, DOI 10.1371/JOURNAL.PONE.0058169]; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen E, 2010, CANCER CELL, V18, P524, DOI 10.1016/j.ccr.2010.10.013; Chen XH, 2009, BLOOD, V113, P3226, DOI 10.1182/blood-2008-07-168245; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Enright AJ, 2004, GENOME BIOL, V5; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Fukunaga R, 2012, CELL, V151, P533, DOI 10.1016/j.cell.2012.09.027; Gaffo E, 2014, ANIM GENET, V45, P685, DOI 10.1111/age.12192; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Gingras MC, 2002, MOL IMMUNOL, V38, P817, DOI 10.1016/S0161-5890(02)00004-4; Grasso D, 2014, MACROAUTOPHAGY ONCOG, P5; Guglielmelli P, 2007, EXP HEMATOL, V35, P1708, DOI 10.1016/j.exphein.2007.08.020; Guglielmelli P, 2011, BLOOD, V117, P6923, DOI 10.1182/blood-2010-09-306506; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Hills SA, 2014, CURR BIOL, V24, pR435, DOI 10.1016/j.cub.2014.04.012; Huang L, 2012, DOWNREGULATION 6 MIC, P7; Hussein K, 2009, PLATELETS, V20, P391, DOI 10.1080/09537100903114537; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jaskiewicz L, 2012, GENOME BIOL, P13; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Klampfl T, 2011, BLOOD, V118, P167, DOI 10.1182/blood-2011-01-331678; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kumar MS, 2011, BLOOD, V118, P4666, DOI 10.1182/blood-2010-12-324715; Langenberger D, 2009, BIOINFORMATICS, V25, P2298, DOI 10.1093/bioinformatics/btp419; Lin X, 2013, LEUKEMIA, V27, P344, DOI 10.1038/leu.2012.224; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Ma HM, 2013, P NATL ACAD SCI USA, V110, P20687, DOI 10.1073/pnas.1311639110; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Norfo R, 2014, BLOOD; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Ooi AGL, 2010, P NATL ACAD SCI USA, V107, P21505, DOI 10.1073/pnas.1016218107; Ouyang M, 2014, MICRORAN PROFILING I, P9; Raghavachari N, 2014, EXP HEMATOL, V42, P14, DOI 10.1016/j.exphem.2013.10.003; Reese TA, 2010, J VIROL, V84, P10344, DOI 10.1128/JVI.00707-10; Romero-Cordoba SL, 2014, CANCER BIOL THER, V15, P1444, DOI 10.4161/15384047.2014.955442; Sdassi N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-149; Singh CP, 2012, J VIROL, V86, P7867, DOI 10.1128/JVI.00064-12; Slezak S, 2009, GENE MICRORNA ANAL N, V7; Su R, 2014, ONCOGENE; Tan GC, 2014, NUCLEIC ACIDS RES, V42, P9424, DOI 10.1093/nar/gku656; Tan L, 2014, DEV COVALENT INHIBIT; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Tiong KH, 2013, APOPTOSIS, V18, P1447, DOI 10.1007/s10495-013-0886-7; Tsukamoto O, 2014, GYNECOL ONCOL, V132, P715, DOI 10.1016/j.ygyno.2014.01.029; Umbach JL, 2010, VIROLOGY, V405, P592, DOI 10.1016/j.virol.2010.06.036; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Vannucchi AM, 2009, CA-CANCER J CLIN, V59, P171, DOI 10.3322/caac.20009; Vannucchi AM, 2011, HAEMATOLOGICA; Vian L, 2014, CELL DEATH DIFFER, V21, P290, DOI 10.1038/cdd.2013.145; Winter J, 2013, RNA BIOL, V10, P1631, DOI 10.4161/rna.26424; Witkos TM, 2011, CURR MOL MED, V11, P93; Wu X, 2012, IDENTIFICATION 4 MIC, P7; Yuen HF, 2012, CLIN CANCER RES, V18, P380, DOI 10.1158/1078-0432.CCR-11-2035; Zaravinos A, 2012, J UROLOGY, V188, P615, DOI 10.1016/j.juro.2012.03.122; Zhan HC, 2013, BRIT J HAEMATOL, V161, P471, DOI 10.1111/bjh.12276; Zhan HC, 2013, BLOOD CELL MOL DIS, V50, P190, DOI 10.1016/j.bcmd.2012.11.009; Zhang L, 2012, LEUKEMIA, V26, P2310, DOI 10.1038/leu.2012.137	86	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0140445	10.1371/journal.pone.0140445	http://dx.doi.org/10.1371/journal.pone.0140445			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26468945	Green Submitted, gold, Green Published			2022-12-26	WOS:000363184600061
J	Yeung, BHY; Shek, FH; Lee, NP; Wong, CKC				Yeung, Bonnie H. Y.; Shek, Felix H.; Lee, Nikki P.; Wong, Chris K. C.			Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; CLINICAL-SIGNIFICANCE; UP-REGULATION; SERUM-LEVELS; CANCER; CELLS; APOPTOSIS; INTERLEUKIN-8; REGULATOR; GROWTH	Growing evidence has revealed high expression levels of stanniocalcin-1 (STC1) in different types of human cancers. Numerous experimental studies using cancer cell lines demonstrated the involvement of STC1 in inflammatory and apoptotic processes; however the role of STC1 in carcinogenesis remains elusive. Hepatocellular carcinoma (HCC) an exemplified model of inflammation-related cancer, represents a paradigm of studying the association between STC1 and tumor development. Therefore, we conducted a statistical analysis on the expression levels of STC1 using clinicopathological data from 216 HCC patients. We found that STC1 was upregulated in the tumor tissues and its expression levels was positively correlated with the levels of interleukin (IL)-6 and IL-8. Intriguingly tumors with greater expression levels of STC1 (tumor/normal >= 2) were significantly smaller than the lower level (tumor/normal<2) samples (p = 0.008). A pharmacological approach was implemented to reveal the functional correlation between STC1 and the ILs in the HCC cell-lines. IL-6 and IL-8 treatment of Hep3B cells induced STC1 expression. Lentiviral-based STC1 over-expression in Hep3B and MHCC-97L cells however showed inhibitory action on the pro-migratory effects of IL-6 and IL-8 and reduced size of tumor spheroids. The inhibitory effect of STC1 on tumor growth was confirmed in vivo using the stable STC1-overexpressing 97L cells on a mouse xenograft model. Genetic analysis of the xenografts derived from the STC1-overexpressing 97L cells, showed upregulation of the pro-apoptotic genes interleukin-12 and NOD-like receptor family, pyrin domain-containing 3. Collectively, the anti-inflammatory and pro-apoptotic functions of STC1 were suggested to relate its inhibitory effect on the growth of HCC cells. This study supports the notion that STC1 may be a potential therapeutic target for inflammatory tumors in HCC patients.	[Yeung, Bonnie H. Y.; Wong, Chris K. C.] Hong Kong Baptist Univ, Dept Biol, Kowloon Tong, Hong Kong, Peoples R China; [Shek, Felix H.; Lee, Nikki P.] Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China	Hong Kong Baptist University; University of Hong Kong	Wong, CKC (corresponding author), Hong Kong Baptist Univ, Dept Biol, Kowloon Tong, Hong Kong, Peoples R China.	ckcwong@hkbu.edu.hk	wong, chris/GSN-0962-2022		General Research Fund [HKBU 261610]; University Grants Committee (CKCW)	General Research Fund; University Grants Committee (CKCW)	This work was supported by the General Research Fund (HKBU 261610), University Grants Committee (CKCW).	Arigami T, 2012, ONCOLOGY-BASEL, V83, P158, DOI 10.1159/000341390; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Bell SE, 2001, J CELL SCI, V114, P2755; Block GJ, 2009, STEM CELLS, V27, P670, DOI [10.1634/stemcells.stemcells.2008-0742, 10.1002/stem.20080742]; Capece D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/187204; Chang ACM, 2003, ENDOCR-RELAT CANCER, V10, P359, DOI 10.1677/erc.0.0100359; CHANG ACM, 1995, MOL CELL ENDOCRINOL, V112, P241, DOI 10.1016/0303-7207(95)03601-3; Chang ACM, 1996, MOL CELL ENDOCRINOL, V124, P185, DOI 10.1016/S0303-7207(96)03929-9; Chang ACM, 2008, ENDOCRINOLOGY, V149, P2403, DOI 10.1210/en.2007-1219; Chen CY, 2008, ARTERIOSCL THROM VAS, V28, P906, DOI 10.1161/ATVBAHA.108.163667; Fujiwara Y, 2000, INT J ONCOL, V16, P799; Guo FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053989; He LF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-39; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Huang LP, 2009, AM J PATHOL, V174, P1368, DOI 10.2353/ajpath.2009.080476; Jauhiainen S, 2011, ARTERIOSCL THROM VAS, V31, P1617, DOI 10.1161/ATVBAHA.111.225961; Kahn J, 2000, AM J PATHOL, V156, P1887, DOI 10.1016/S0002-9440(10)65062-6; Komita H, 2006, J HEPATOL, V45, P662, DOI 10.1016/j.jhep.2006.05.018; Kubo F, 2005, ANN SURG ONCOL, V12, P800, DOI 10.1245/ASO.2005.07.015; Lai KP, 2007, BIOCHEM BIOPH RES CO, V356, P968, DOI 10.1016/j.bbrc.2007.03.074; Law AYS, 2008, EXP CELL RES, V314, P2975, DOI 10.1016/j.yexcr.2008.07.002; Law AYS, 2010, MOL CELL ENDOCRINOL, V314, P118, DOI 10.1016/j.mce.2009.07.007; Law AYS, 2013, MOL CELL ENDOCRINOL, V374, P73, DOI 10.1016/j.mce.2013.04.024; Law AYS, 2011, J CELL BIOCHEM, V112, P2089, DOI 10.1002/jcb.23127; Lee NP, 2010, INT J CANCER, V127, P968, DOI 10.1002/ijc.25100; Liu D, 2003, ARTERIOSCL THROM VAS, V23, P2002, DOI 10.1161/01.ATV.0000098644.03153.6F; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Nguyen A, 2009, ONCOGENE, V28, P1982, DOI 10.1038/onc.2009.65; Ohkouchi S, 2012, MOL THER, V20, P417, DOI 10.1038/mt.2011.259; Okabe H, 2001, CANCER RES, V61, P2129; Olsen HS, 1996, P NATL ACAD SCI USA, V93, P1792, DOI 10.1073/pnas.93.5.1792; Pena C, 2013, CANCER RES, V73, P1287, DOI 10.1158/0008-5472.CAN-12-1875; Sheikh-Hamad D, 2010, AM J PHYSIOL-RENAL, V298, pF248, DOI 10.1152/ajprenal.00260.2009; Shirakawa M, 2012, ONCOL REP, V27, P940, DOI 10.3892/or.2011.1607; Song HZ, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-35; Tamura S, 2011, ANTICANCER RES, V31, P325; Tang SE, 2014, FREE RADICAL BIO MED, V71, P321, DOI 10.1016/j.freeradbiomed.2014.03.034; TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K; Tohmiya Y, 2004, TOHOKU J EXP MED, V204, P125, DOI 10.1620/tjem.204.125; UEDA T, 1994, J GASTROENTEROL, V29, P423, DOI 10.1007/BF02361238; Varghese R, 1998, ENDOCRINOLOGY, V139, P4714, DOI 10.1210/en.139.11.4714; WANG Y, 2013, PLOS ONE, V2013; Wang YL, 2009, J LEUKOCYTE BIOL, V86, P981, DOI 10.1189/jlb.0708454; Wary Kishore K, 2003, Mol Cancer, V2, P25, DOI 10.1186/1476-4598-2-25; Watanabe T, 2002, AM J PATHOL, V161, P249, DOI 10.1016/S0002-9440(10)64176-4; Wei Q, 2014, LAB INVEST, V94, P52, DOI 10.1038/labinvest.2013.126; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; Westberg JA, 2007, STROKE, V38, P1025, DOI 10.1161/01.STR.0000258113.67252.fa; Wu SF, 2006, J BIOL CHEM, V281, P5120, DOI 10.1074/jbc.M506667200; Xie YF, 2010, CANCER INVEST, V28, P598, DOI 10.3109/07357900903287030; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yeung BHY, 2012, MOL CELL ENDOCRINOL, V349, P272, DOI 10.1016/j.mce.2011.11.007; Yeung BHY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027094; Yeung HY, 2005, ENDOCRINOLOGY, V146, P4951, DOI 10.1210/en.2005-0365; Yoshiko Y, 2004, PEPTIDES, V25, P1663, DOI 10.1016/j.peptides.2004.04.015; Zhang KZ, 2000, P NATL ACAD SCI USA, V97, P3637, DOI 10.1073/pnas.070045897	56	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0139977	10.1371/journal.pone.0139977	http://dx.doi.org/10.1371/journal.pone.0139977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469082	Green Submitted, Green Published, gold			2022-12-26	WOS:000363184600023
J	Chang, WJ; Pan, YH; Tzeng, JJ; Wu, TL; Fong, TH; Feng, SW; Huang, HM				Chang, Wei-Jen; Pan, Yu-Hwa; Tzeng, Jy-Jiunn; Wu, Ting-Lin; Fong, Tsorng-Harn; Feng, Sheng-Wei; Huang, Haw-Ming			Development and Testing of X-Ray Imaging-Enhanced Poly-L-Lactide Bone Screws	PLOS ONE			English	Article							FE3O4 NANOPARTICLES; CONTRAST AGENT; RADIOPACITY; THERMOGEL	Nanosized iron oxide particles exhibit osteogenic and radiopaque properties. Thus, iron oxide (Fe3O4) nanoparticles were incorporated into a biodegradable polymer (poly-L-lactic acid, PLLA) to fabricate a composite bone screw. This multifunctional, 3D printable bone screw was detectable on X-ray examination. In this study, mechanical tests including three-point bending and ultimate tensile strength were conducted to evaluate the optimal ratio of iron oxide nanoparticles in the PLLA composite. Both injection molding and 3D printing techniques were used to fabricate the PLLA bone screws with and without the iron oxide nanoparticles. The fabricated screws were implanted into the femoral condyles of New Zealand White rabbits. Bone blocks containing the PLLA screws were resected 2 and 4 weeks after surgery. Histologic examination of the surrounding bone and the radiopacity of the iron-oxide-containing PLLA screws were evaluated. Our results indicated that addition of iron oxide nanoparticles at 30% significantly decreased the ultimate tensile stress properties of the PLLA screws. The screws with 20% iron oxide exhibited strong radiopacity compared to the screws fabricated without the iron oxide nanoparticles. Four weeks after surgery, the average bone volume of the iron oxide PLLA composite screws was significantly greater than that of PLLA screws without iron oxide. These findings suggested that biodegradable and X-ray detectable PLLA bone screws can be produced by incorporation of 20% iron oxide nanoparticles. Furthermore, these screws had significantly greater osteogenic capability than the PLLA screws without iron oxide.	[Chang, Wei-Jen; Feng, Sheng-Wei] Taipei Med Univ, Sch Dent, Taipei, Taiwan; [Pan, Yu-Hwa] Chang Gung Mem Hosp, Dept Gen Dent, Taipei 10591, Taiwan; [Pan, Yu-Hwa] Chang Gung Univ, Taoyuan, Taiwan; [Tzeng, Jy-Jiunn; Wu, Ting-Lin; Huang, Haw-Ming] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan; [Fong, Tsorng-Harn] Taipei Med Univ, Sch Med, Dept Anat, Taipei, Taiwan	Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; Taipei Medical University	Huang, HM (corresponding author), Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan.	hhm@tmu.edu.tw						Albertini G, 2009, TISSUE ENG PART C-ME, V15, P403, DOI 10.1089/ten.tec.2008.0270; Aldenhoff YBJ, 2002, BIOMATERIALS, V23, P881, DOI 10.1016/S0142-9612(01)00197-1; Ayukawa Y, 1998, J BIOMED MATER RES, V41, P111; Baumgartner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057070; Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017; CABASSO I, 1989, J APPL POLYM SCI, V38, P1653, DOI 10.1002/app.1989.070380906; Coutu JM, 2013, J BIOMED MATER RES B, V101B, P153, DOI 10.1002/jbm.b.32828; Giordano RA, 1996, J BIOMAT SCI-POLYM E, V8, P63, DOI 10.1163/156856297X00588; Jackson DW, 1999, CLIN ORTHOP RELAT R, pS31, DOI 10.1097/00003086-199910001-00005; James NR, 2006, BIOMATERIALS, V27, P160, DOI 10.1016/j.biomaterials.2005.05.099; Kiran S, 2012, J BIOMED MATER RES A, V100A, P3472, DOI 10.1002/jbm.a.34295; Lei KW, 2015, CHEM COMMUN, V51, P6080, DOI 10.1039/c5cc00049a; Meng J, 2010, NANOSCALE, V2, P2565, DOI 10.1039/c0nr00178c; Mottu F, 2002, BIOMATERIALS, V23, P121, DOI 10.1016/S0142-9612(01)00087-4; Shan DY, 2013, MAT SCI ENG C-MATER, V33, P3498, DOI 10.1016/j.msec.2013.04.040; Shen LK, 2014, J POLYM ENG, V34, P231, DOI 10.1515/polyeng-2013-0207; Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3; Torrente Y, 2006, FEBS LETT, V580, P5759, DOI 10.1016/j.febslet.2006.09.031; Wei Q, 2010, BIOMATERIALS, V31, P7332, DOI 10.1016/j.biomaterials.2010.06.014; Wu Y, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/1/015001; XIANG W, 1993, J ORAL MAXIL SURG, V51, P647, DOI 10.1016/S0278-2391(10)80264-2; Xu B, 2011, LANGMUIR, V27, P12134, DOI 10.1021/la202096x	22	14	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140354	10.1371/journal.pone.0140354	http://dx.doi.org/10.1371/journal.pone.0140354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466309	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100105
J	Li, CL; Ashworth, MP; Witkowski, A; Dabek, P; Medlin, LK; Kooistra, WHCF; Sato, S; Zglobicka, I; Kurzydlowski, KJ; Theriot, EC; Sabir, JSM; Khiyami, MA; Mutwakil, MHZ; Sabir, MJ; Alharbi, NS; Hajarah, NH; Qing, S; Jansen, RK				Li, Chun L.; Ashworth, Matt P.; Witkowski, Andrzej; Dabek, Przemyslaw; Medlin, Linda K.; Kooistra, Wiebe H. C. F.; Sato, Shinya; Zglobicka, Izabela; Kurzydlowski, Krzysztof J.; Theriot, Edward C.; Sabir, Jamal S. M.; Khiyami, Mohammad A.; Mutwakil, Mohammed H. Z.; Sabir, Meshaal J.; Alharbi, Njud S.; Hajarah, Nahid H.; Qing, Song; Jansen, Robert K.			New Insights into Plagiogrammaceae (Bacillariophyta) Based on Multigene Phylogenies and Morphological Characteristics with the Description of a New Genus and Three New Species	PLOS ONE			English	Article							NOV BACILLARIOPHYTA; DIATOM GENUS; EVOLUTION	Plagiogrammaceae, a poorly described family of diatoms, are common inhabitants of the shallow marine littoral zone, occurring either in the sediments or as epiphytes. Previous molecular phylogenies of the Plagiogrammaceae were inferred but included only up to six genera: Plagiogramma, Dimeregramma, Neofragilaria, Talaroneis, Psammogramma and Psammoneis. In this paper, we describe a new plagiogrammoid genus, Orizaformis, obtained from Bohai Sea (China) and present molecular phylogenies of the family based on three and four genes (nuclear-encoded large and small subunit ribosomal RNAs and chloroplast-encoded rbcL and psbC). Also included in the new phylogenies is Glyphodesmis. The phylogenies suggest that the Plagiogrammaceae is composed of two major clades: one consisting of Talaroneis, Orizaformis and Psammoneis, and the second of Glyphodesmis, Psammogramma, Neofragilaria, Dimeregramma and Plagiogramma. In addition, we describe three new species within established genera: Psammoneis obaidii, which was collected from the Red Sea, Saudi Arabia; and Neofragilaria stilus and Talaroneis biacutifrons from the Mozambique Channel, Indian Ocean, and illustrate two new combination taxa: Neofragilaria anomala and Neofragilaria lineata. Our observations suggest that the biodiversity of the family is strongly needed to be researched, and the phylogenetic analyses provide a useful framework for future studies of Plagiogrammaceae.	[Li, Chun L.; Witkowski, Andrzej; Dabek, Przemyslaw] Univ Szczecin, Fac Geosci, Palaeoceanol Unit, PL-70383 Szczecin, Poland; [Ashworth, Matt P.; Jansen, Robert K.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Medlin, Linda K.] Marine Biol Assoc UK, Plymouth PL1 2PB, Devon, England; [Kooistra, Wiebe H. C. F.] Stn Zool Anton Dohrn, Dept Integrat Marine Ecol, I-80121 Naples, Italy; [Sato, Shinya] Fukui Prefectural Univ, Fac Marine Biosci, Fukui, Japan; [Zglobicka, Izabela; Kurzydlowski, Krzysztof J.] Warsaw Univ Technol, Fac Mat Sci & Engn, Warsaw, Poland; [Theriot, Edward C.] Univ Texas Austin, Texas Mem Museum, Austin, TX 78712 USA; [Sabir, Jamal S. M.; Mutwakil, Mohammed H. Z.; Sabir, Meshaal J.; Alharbi, Njud S.; Hajarah, Nahid H.; Jansen, Robert K.] King Abdulaziz Univ, Dept Biol Sci, Biotechnol Res Grp, Fac Sci, Jeddah 21589, Saudi Arabia; [Khiyami, Mohammad A.] King Abdulaziz City Sci & Technol, Riyadh, Saudi Arabia; [Qing, Song] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai, Peoples R China	University of Szczecin; University of Texas System; University of Texas Austin; Marine Biological Association United Kingdom; Stazione Zoologica Anton Dohrn di Napoli; Fukui Prefectural University; Warsaw University of Technology; University of Texas System; University of Texas Austin; King Abdulaziz University; King Abdulaziz City for Science & Technology; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS	Li, CL (corresponding author), Univ Szczecin, Fac Geosci, Palaeoceanol Unit, Mickiewicza 18, PL-70383 Szczecin, Poland.	chunlian.li@univ.szczecin.pl	Sabir, Jamal S M/C-8102-2014	Kooistra, Wiebe/0000-0002-8641-9739; Zglobicka, Izabela/0000-0002-4432-9196; Dabek, Przemyslaw/0000-0002-3736-3011; Kurzydlowski, Krzysztof/0000-0003-3875-4820; Witkowski, Andrzej/0000-0003-1714-218X	Polish National Science Centre (NCN) in Cracow [N2012/04/A/ST10/00544]; King Abdulaziz University (KAU); Chinese Academy of Sciences President's International Fellowship Initiative	Polish National Science Centre (NCN) in Cracow; King Abdulaziz University (KAU); Chinese Academy of Sciences President's International Fellowship Initiative	This research has been funded by Polish National Science Centre (NCN) in Cracow grant no. N2012/04/A/ST10/00544, Grant Recipent AW, available http://www.marinebenthicdiatoms.univ.szczecin.pl/homepage-1. This study also get funded from King Abdulaziz University (KAU) Vice President for Educational Affairs Prof. Dr. Abdulrahman O. Alyoubi and from Chinese Academy of Sciences President's International Fellowship Initiative (PIFI). The funder has no contributions to study design, data collection and preparation of the manuscript.	Alverson AJ, 2006, J PHYCOL, V42, P655, DOI 10.1111/j.1529-8817.2006.00228.x; Ashworth MP, 2012, PHYCOLOGIA, V51, P684, DOI 10.2216/12-004.1; Ashworth MP, 2013, THESIS U TEXAS; Crawford RM, 1993, NOVA HEDW BEIH, V106, P151; De Toni G.B., 1890, LETTERE ARTI, P967; DESIKACHARY TV, 1987, DIATOM FLORA SOME SE; Garcia M, 2006, PHYCOL RES, V54, P87, DOI 10.1111/j.1440-1835.2006.00412.x; Giffen M, 1980, BACILLARIA, V3, p[150, 33]; Greville R.K., 1859, Q J MICROSC SCI, V7, P207; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Haste G.R., 1973, NOVA HEDWIGIA S, V45, P1; Hustedt F, 1959, RABENHORSTS KRYPTOGA, V7; Kooistra WHCF, 2004, PHYCOLOGIA, V43, P58, DOI 10.2216/i0031-8884-43-1-58.1; Kooistra WHCF, 2009, MAR ECOL-EVOL PERSP, V30, P1, DOI 10.1111/j.1439-0485.2008.00262.x; Krammer K., 1986, SUSSWASSERFLORA MITT, V2/1, P1; Krammer K., 1991, BACILLARIOPHYCEAE 4; Kulikovskiy M, 2013, PHYTOTAXA, V109, P1; Lobban Christopher S., 2014, Marine Biodiversity Records, V7, pe90, DOI 10.1017/S1755267214000918; Medlin L, 2008, NOVA HEDWIGIA, P81; Medlin L, 2012, NOVA HEDWIGIA, P505; Medlin LK, 2004, PHYCOLOGIA, V43, P245, DOI 10.2216/i0031-8884-43-3-245.1; Medlin LK, NOVA HEDWIG IN PRESS; NAVARRO JN, 1982, BOT MAR, V25, P247, DOI 10.1515/botm.1982.25.6.247; PRITCHARD A., 1861, HIST INFUSORIA INCLU, P1; Rioual P, 2014, FOTTEA, V14, P91, DOI 10.5507/fot.2014.007; Round F. E., 1996, Diatom Research, V11, P345; Round F. E., 1990, DIATOMS BIOL MORPHOL; Sato S, 2008, PHYCOL RES, V56, P255, DOI 10.1111/j.1440-1835.2008.00507.x; Sato S, 2008, PHYCOLOGIA, V47, P510, DOI 10.2216/08-04.1; Sato S, 2009, PHYCOL RES, V57, P25, DOI 10.1111/j.1440-1835.2008.00518.x; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SIMONSEN R, 1979, Bacillaria, V2, P9; Sorhannus U, 2007, MAR MICROPALEONTOL, V65, P1, DOI 10.1016/j.marmicro.2007.05.002; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Williams DM, 2011, CELL ORIG LIFE EXTRE, V19, P47, DOI 10.1007/978-94-007-1327-7_3; Witkowski A., 2000, ICONOGRAPHIA DIATOMO, V7, P1	38	35	35	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139300	10.1371/journal.pone.0139300	http://dx.doi.org/10.1371/journal.pone.0139300			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465289	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000363183100044
J	Lu, XX; Liu, F; Durham, SE; Tarasov, SG; Walters, KJ				Lu, Xiuxiu; Liu, Fen; Durham, Sarah E.; Tarasov, Sergey G.; Walters, Kylie J.			A High Affinity hRpn2-Derived Peptide That Displaces Human Rpn13 from Proteasome in 293T Cells	PLOS ONE			English	Article							DEUBIQUITINATING ENZYME; UBIQUITIN RECEPTOR; 26S PROTEASOMES; SUBUNIT; UCH37; ACTIVATION; CANCER; DOMAIN; ADRM1; S5A	Rpn13 is a proteasome ubiquitin receptor that has emerged as a therapeutic target for human cancers. Its ubiquitin-binding activity is confined to an N-terminal Pru (pleckstrin-like receptor for ubiquitin) domain that also docks it into the proteasome, while its C-terminal DEUBAD (DEUBiquitinase ADaptor) domain recruits deubiquitinating enzyme Uch37 to the proteasome. Bis-benzylidine piperidone derivatives that were found to bind covalently to Rpn13 C88 caused the accumulation of polyubiquitinated proteins as well as ER stress-related apoptosis in various cancer cell lines, including bortezomib-resistant multiple myeloma lines. We find that a 38-amino acid peptide derived from the C-terminus of proteasome PC repeat protein hRpn2/PSMD1 binds to hRpn13 Pru domain with 12 nM affinity. By using NMR, we identify the hRpn13-interacting amino acids in this hRpn2 fragment, some of which are conserved among eukaryotes. Importantly, we find the hRpn2-derived peptide to immunoprecipitate endogenous Rpn13 from 293T cells, and to displace it from the proteasome. These findings indicate that this region of hRpn2 is the primary binding site for hRpn13 in the proteasome. Moreover, the hRpn2-derived peptide was no longer able to interact with endogenous hRpn13 when a strictly conserved phenylalanine (F948 in humans) was replaced with arginine or a stop codon, or when Y950 and I951 were substituted with aspartic acid. Finally, over-expression of the hRpn2-derived peptide leads to an increased presence of ubiquitinated proteins in 293T cells. We propose that this hRpn2-derived peptide could be used to develop peptide-based strategies that specifically target hRpn13 function in the proteasome.	[Lu, Xiuxiu; Liu, Fen; Durham, Sarah E.; Walters, Kylie J.] NCI, Prot Proc Sect, Struct Biophys Lab, Ctr Canc Res, Frederick, MD 21701 USA; [Durham, Sarah E.] Middletown High Sch, Middletown, MD USA; [Tarasov, Sergey G.] NCI, Biophys Resource, Struct Biophys Lab, Ctr Canc Res, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Walters, KJ (corresponding author), NCI, Prot Proc Sect, Struct Biophys Lab, Ctr Canc Res, Frederick, MD 21701 USA.	kylie.walters@nih.gov			Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research [1ZIABC011490]; Werner H. Kirsten student internship program; NATIONAL CANCER INSTITUTE [ZIABC011490] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Werner H. Kirsten student internship program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, awarded to KJW (project number 1ZIABC011490). Sarah Durham was funded by the Werner H. Kirsten student internship program. The funders had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Anchoori RK, 2013, CANCER CELL, V24, P791, DOI 10.1016/j.ccr.2013.11.001; Asano S, 2015, SCIENCE, V347, P439, DOI 10.1126/science.1261197; Bieri M, 2011, J BIOMOL NMR, V50, P147, DOI 10.1007/s10858-011-9509-1; Chen Jie, 2009, Zhonghua Zhongliu Zazhi, V31, P15, DOI 10.3760/cma.j.issn.0253-3766.2009.01.004; Chen W, 2009, ONCOL REP, V21, P531, DOI 10.3892/or_00000254; Chen X, 2012, METHODS MOL BIOL, V832, P279, DOI 10.1007/978-1-61779-474-2_20; Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Ehlinger A, 2013, BIOCHEMISTRY-US, V52, P3618, DOI 10.1021/bi400417a; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Fejzo MS, 2013, INT J MOL SCI, V14, P3094, DOI 10.3390/ijms14023094; Hamazaki J, 2007, MOL CELL BIOL, V27, P6629, DOI 10.1128/MCB.00509-07; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hamazaki J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005401; He J, 2012, STRUCTURE, V20, P513, DOI 10.1016/j.str.2011.12.015; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Sanchez-Pulido L, 2012, BIOINFORMATICS, V28, P1953, DOI 10.1093/bioinformatics/bts319; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Yang X, 2012, ONCOL REP, V28, P283, DOI 10.3892/or.2012.1767; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010	26	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140518	10.1371/journal.pone.0140518	http://dx.doi.org/10.1371/journal.pone.0140518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466095	Green Published, Green Submitted, gold			2022-12-26	WOS:000363183100136
J	Murray, DD; Suzuki, K; Law, M; Trebicka, J; Neuhaus, J; Wentworth, D; Johnson, M; Vjecha, MJ; Kelleher, AD; Emery, S				Murray, Daniel D.; Suzuki, Kazuo; Law, Matthew; Trebicka, Jonel; Neuhaus, Jacquie; Wentworth, Deborah; Johnson, Margaret; Vjecha, Michael J.; Kelleher, Anthony D.; Emery, Sean		INSIGHT ESPRIT Study Grp; SMART Study Grp	Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study	PLOS ONE			English	Article							ESSENTIAL-HYPERTENSION; EXPRESSION PROFILE; PLASMA-LEVELS; D-DIMER; RISK; AIDS; DEATH; INFLAMMATION; COAGULATION; SIGNATURE	Introduction The use of anti-retroviral therapy (ART) has dramatically reduced HIV-1 associated morbidity and mortality. However, HIV-1 infected individuals have increased rates of morbidity and mortality compared to the non-HIV-1 infected population and this appears to be related to end-organ diseases collectively referred to as Serious Non-AIDS Events (SNAEs). Circulating miRNAs are reported as promising biomarkers for a number of human disease conditions including those that constitute SNAEs. Our study sought to investigate the potential of selected miRNAs in predicting mortality in HIV-1 infected ART treated individuals. Materials and Methods A set of miRNAs was chosen based on published associations with human disease conditions that constitute SNAEs. This case: control study compared 126 cases (individuals who died whilst on therapy), and 247 matched controls (individuals who remained alive). Cases and controls were ART treated participants of two pivotal HIV-1 trials. The relative abundance of each miRNA in serum was measured, by RTqPCR. Associations with mortality (all-cause, cardiovascular and malignancy) were assessed by logistic regression analysis. Correlations between miRNAs and CD4+ T cell count, hs-CRP, IL-6 and D-dimer were also assessed. Results None of the selected miRNAs was associated with all-cause, cardiovascular or malignancy mortality. The levels of three miRNAs (miRs -21, -122 and -200a) correlated with IL-6 while miR-21 also correlated with D-dimer. Additionally, the abundance of miRs -31, -150 and -223, correlated with baseline CD4+ T cell count while the same three miRNAs plus miR-145 correlated with nadir CD4+ T cell count. Discussion No associations with mortality were found with any circulating miRNA studied. These results cast doubt onto the effectiveness of circulating miRNA as early predictors of mortality or the major underlying diseases that contribute to mortality in participants treated for HIV-1 infection.	[Murray, Daniel D.; Suzuki, Kazuo; Law, Matthew; Kelleher, Anthony D.; Emery, Sean] Univ New S Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia; [Trebicka, Jonel] Univ Bonn, Dept Internal Med, Bonn, Germany; [Neuhaus, Jacquie; Wentworth, Deborah] Univ Minnesota, Minneapolis, MN USA; [Johnson, Margaret] Royal Free Hampstead NHS Trust, Ian Charleson Day Ctr, London, England; [Vjecha, Michael J.] Vet Affairs Med Ctr, Inst Clin Res, Washington, DC 20422 USA	University of New South Wales Sydney; Kirby Institute; University of Bonn; University of Minnesota System; University of Minnesota Twin Cities; University of London; University College London; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Murray, DD (corresponding author), Univ New S Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia.	dmurray@kirby.unsw.edu.au	Emery, Sean/J-3825-2017; Soriano, Vicente/O-5730-2018; Rusconi, Stefano/H-9263-2012; Martellotta, Ferdinando/ABE-2332-2020; Emery, Sean/O-9122-2019; Bruno, Raffaele/AAB-9491-2022; Snapp, Sieglinde/AAU-8121-2020; Blanco Garcia, Francisco J/C-3192-2014; Williams, Graham/F-3389-2017; Pulido, Federico/B-8417-2009; Klein, Martin/N-6958-2017; DeHovitz, Joan P/C-2129-2018; Arribas, Jose/A-1595-2015	Emery, Sean/0000-0001-6072-8309; Soriano, Vicente/0000-0002-4624-5199; Rusconi, Stefano/0000-0002-0375-9990; Martellotta, Ferdinando/0000-0002-5646-0036; Emery, Sean/0000-0001-6072-8309; Bruno, Raffaele/0000-0002-0235-9207; Snapp, Sieglinde/0000-0002-9738-0649; Rubio Garcia, Rafael/0000-0001-8132-4303; Medland, Nicholas Andrew/0000-0003-0403-8930; Blanco Garcia, Francisco J/0000-0001-9821-7635; Williams, Graham/0000-0001-6379-7174; Szymczak, Aleksandra/0000-0001-6695-2942; Obel, Niels/0000-0002-5031-0045; Angel, Jonathan B/0000-0003-3102-4462; Miller, Ted/0000-0002-0958-2639; Goetz, Matthew/0000-0003-4542-992X; Kvale, Dag/0000-0001-6410-2530; Trebicka, Jonel/0000-0002-7028-3881; Suzuki, Kazuo/0000-0002-2531-794X; Benfield, Thomas/0000-0003-0698-9385; Lelievre, Jean-Daniel/0000-0002-8182-3628; Law, Matthew/0000-0002-3540-8837; Vaz, Ines Regio/0000-0003-2410-7307; Ong, Edmund/0000-0002-6594-0509; Rogers, Gary D./0000-0003-4655-0131; Gonzalez-Garcia, Juan/0000-0002-3652-002X; Kumar, Professor Amit/0000-0002-5913-4308; Andersen, Aase Bengaard/0000-0003-4779-7603; Pulido, Federico/0000-0002-7414-8812; Gijon, Paloma/0000-0002-5011-1927; Bessesen, Mary/0000-0001-9305-1293; Klein, Martin/0000-0002-1027-0923; Britton, Philip/0000-0002-2993-6000; Walmsley, Sharon/0000-0002-3959-5692; Murray, Daniel/0000-0001-8501-8661; Anderson, Jonathan/0000-0002-7316-428X; Nozza, Silvia/0000-0002-2673-2731; DeHovitz, Joan P/0000-0003-0835-1983; Leen, Clifford/0000-0001-8439-7719; /0000-0002-1692-1475; Deeks, Steven/0000-0001-6371-747X; Kinghorn, George/0000-0001-6608-5076; Valadas, Emilia/0000-0001-5213-1473; Ruxrungtham, Kiat/0000-0001-7348-2352; Guaragna, Graciela/0000-0002-9649-664X; Lundgren, Jens/0000-0001-8901-7850; Kelleher, Anthony/0000-0002-0009-3337; Krolewiecki, Alejandro/0000-0001-9054-1211; Kozal, Michael/0000-0002-3100-8254; Tambussi, Giuseppe/0000-0002-0604-2960; Arribas, Jose/0000-0002-7410-9450; MARTIN CARBONERO, LUZ/0000-0001-8102-4079	Australian National Health and Medical Research Council [1052979]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Work performed in this report was supported by the Australian National Health and Medical Research Council through Program Grant 1052979. The funding agency played no role in the creation, analysis or interpretation of data presented in the report. The agency took no decisions relating to preparation, submission of this manuscript or its publication.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Achhra AC, 2012, AIDS, V26, P1707, DOI 10.1097/QAD.0b013e328355d659; Achhra AC, 2010, AIDS, V24, P1877, DOI 10.1097/QAD.0b013e32833b1b26; Allegra A, 2012, INT J ONCOL, V41, P1897, DOI 10.3892/ijo.2012.1647; Andrade BB, 2013, J INFECT DIS, V207, P1379, DOI 10.1093/infdis/jit033; [Anonymous], 2012, MICRORNA PROF MON LT; [Anonymous], 2014, GLOB UPD HLTH SECT R; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; BAUER K, 1981, J CLIN CHEM CLIN BIO, V19, P971; Borges AH, 2013, AIDS, V27, P1433, DOI 10.1097/QAD.0b013e32835f6b0c; Chen X, 2012, PROTEIN CELL, V3, P28, DOI 10.1007/s13238-012-2003-z; de Candia P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075348; Deeks SG, 2009, HIV INFECTION ANTIRE; Duan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060170; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; El-Sadr WM, 2008, ANN INTERN MED, V149, P289, DOI 10.7326/0003-4819-149-5-200809020-00003; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Emery S, 2002, CONTROL CLIN TRIALS, V23, P198, DOI 10.1016/S0197-2456(01)00179-9; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Ford ES, 2010, AIDS, V24, P1509, DOI 10.1097/QAD.0b013e32833ad914; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Funderburg NT, 2010, BLOOD, V115, P161, DOI 10.1182/blood-2009-03-210179; Gao W, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-55; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Hunt PW, 2011, AIDS, V25, P2123, DOI 10.1097/QAD.0b013e32834c4ac1; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; KAMM RC, 1972, CLIN BIOCHEM, V5, P198, DOI 10.1016/S0009-9120(72)80033-X; Karolina DS, 2012, J CLIN ENDOCR METAB, V97, pE2271, DOI 10.1210/jc.2012-1996; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Kinet Virginie, 2013, Frontiers in Genetics, V4, P214, DOI 10.3389/fgene.2013.00214; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Lifson AR, 2008, HIV CLIN TRIALS, V9, P177, DOI 10.1310/hct0903-177; Liu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044906; Marques FZ, 2012, CIRCULATION, V125, pE337, DOI 10.1161/CIRCULATIONAHA.111.061788; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Munshi SU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095920; Nahvi S, 2009, AIDS EDUC PREV, V21, P14, DOI 10.1521/aeap.2009.21.3_supp.14; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Pacheco AG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001531; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pu XX, 2010, J GASTROEN HEPATOL, V25, P1674, DOI 10.1111/j.1440-1746.2010.06417.x; Reynoso R, 2014, SCI REP-UK, V4, DOI 10.1038/srep05915; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Shen J, 2012, PROSTATE, V72, P1469, DOI 10.1002/pros.22499; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Swaminathan S, 2013, IMMUNOL REV, V254, P265, DOI 10.1111/imr.12077; Thapa DR, 2014, JAIDS-J ACQ IMM DEF, V66, P229, DOI 10.1097/QAI.0000000000000146; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Torti C, 2007, INT J ANTIMICROB AG, V29, P185, DOI 10.1016/j.ijantimicag.2006.08.015; Trebicka J, 2012, COMMUNICATION; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Witwer KW, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-5; Witwer KW, 2011, AIDS, V25, P2057, DOI 10.1097/QAD.0b013e32834b95bf; Xiao JJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-159; Zampetaki A, 2012, J AM COLL CARDIOL, V60, P290, DOI 10.1016/j.jacc.2012.03.056; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610	68	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139981	10.1371/journal.pone.0139981	http://dx.doi.org/10.1371/journal.pone.0139981			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465293	Green Published, gold			2022-12-26	WOS:000363183100068
J	Llaurado, G; Megia, A; Cano, A; Gimenez-Palop, O; Simon, I; Gonzalez-Sastre, M; Berlanga, E; Fernandez-Veledo, S; Vendrell, J; Gonzalez-Clemente, JM				Llaurado, Gemma; Megia, Ana; Cano, Albert; Gimenez-Palop, Olga; Simon, Inmaculada; Gonzalez-Sastre, Montserrat; Berlanga, Eugenio; Fernandez-Veledo, Sonia; Vendrell, Joan; Gonzalez-Clemente, Jose-Miguel			FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-23; CHRONIC KIDNEY-DISEASE; VITAMIN-D LEVELS; CARDIOVASCULAR-DISEASE; ALL-CAUSE; MORTALITY; FGF23; RISK; CALCIFICATION; EVENTS	Objective To investigate the usefulness of Fibroblast Growth Factor 23 (FGF-23) and vitamin D as possible biomarkers of pre-clinical atherosclerosis, assessed as arterial stiffness (AS), in a group of subjects with type 1 diabetes (T1DM) and no previous cardiovascular events. Research Design and Methods 68 T1DM patients and 68 age-and sex-matched controls were evaluated for 1) age, sex, diabetes duration, physical activity, smoking, alcohol intake, BMI, blood pressure, fasting plasma glucose, HbA(1c), estimated glomerular filtration rate (eGFR) and lipid profile; 2) microvascular complications; 3) blood concentrations of FGF-23 and mineral metabolism parameters (calcium, phosphate, parathyroid hormone (PTH) and 25-hydroxy-vitamin D (25 (OH)D)); 4) AS, assessed as aortic pulse wave velocity (aPWV); and 5) low-grade inflammation (hsCRP, IL-6, sTNF alpha R1, sTNF alpha R2) and endothelial dysfunction (ED) markers (ICAM-1, VCAM-1, E-Selectin). Results Patients with T1DM had higher aPWV compared with controls (rho<0.001), but they did not present differences in 25(OH)D (70.3(50.4-86.2) nmol/L vs. 70.7(59.7-83.0) nmol/L; rho = 0.462) and in FGF-23 plasma concentrations (70.1(38.4-151.9) RU/mL vs. 77.6(51.8-113.9) RU/mL; rho = 0.329). In T1DM patients, higher concentrations of FGF-23 were positively associated with aPWV after adjusting for eGFR and classical cardiovascular risk factors (model 1: beta = 0.202, rho = 0.026), other mineral metabolism parameters (model 2: beta = 0.214, p = 0.015), microvascular complications, low-grade inflammation and ED markers (model 3: beta = 0.170, rho = 0.045). Lower 25(OH)D concentrations were also associated with higher aPWV after adjusting for all the above-mentioned factors (model 3: beta = -0.241, rho = 0.015). Conclusions We conclude that both FGF-23 plasma concentrations (positively) and 25(OH)D serum concentrations (negatively) are associated with AS in patients with T1DM and no previous cardiovascular events.	[Llaurado, Gemma; Megia, Ana; Simon, Inmaculada; Fernandez-Veledo, Sonia; Vendrell, Joan] Univ Rovira & Virgili, IISPV, Hosp Univ Joan Tarragona 23, E-43007 Tarragona, Spain; [Llaurado, Gemma] Hosp del Mar, IMIM Hosp Del Mar Med Res Inst, Dept Endocrinol & Nutr, Barcelona, Spain; [Cano, Albert; Gimenez-Palop, Olga; Gonzalez-Clemente, Jose-Miguel] Univ Autonoma Barcelona, Corp Sanit & Univ Parc Tauli, Dept Endocrinol & Nutr, Hosp Sabadell, Sabadell, Spain; [Gonzalez-Sastre, Montserrat] Univ Autonoma Barcelona, Corp Sanit & Univ Parc Tauli, Hosp Sabadell, Dept Ophthalmol, Sabadell, Spain; [Berlanga, Eugenio] Univ Autonoma Barcelona, Corp Sanit & Univ Parc Tauli, UDIAT, Dept Biochem, Sabadell, Spain; [Llaurado, Gemma; Megia, Ana; Simon, Inmaculada; Fernandez-Veledo, Sonia; Vendrell, Joan; Gonzalez-Clemente, Jose-Miguel] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedad Metabol, Madrid, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III	Vendrell, J (corresponding author), Univ Rovira & Virgili, IISPV, Hosp Univ Joan Tarragona 23, E-43007 Tarragona, Spain.	jvortega2002@gmail.com; josmi.gonza@gmail.com	Stefanadis, Christodoulos/ABH-2232-2020; Megia, Ana/W-5556-2019; Vendrell, Joan j/V-4034-2018; Llauradó, Gemma/AAB-9839-2020; Fernández-Veledo, Sonia/V-4625-2018	Stefanadis, Christodoulos/0000-0001-5974-6454; Vendrell, Joan j/0000-0002-6994-6115; Fernández-Veledo, Sonia/0000-0003-2906-3788; Megia, Ana/0000-0002-5101-9452; Cano Palomares, Albert/0000-0002-2804-3745	Fondo de Investigacion Sanitaria (FIS) by Instituto de Salud Carlos III (Spain) [PS09/01360, PI12/00954]; Fundacio La Marato de TV3 [081410]; Fondos FEDER; CIBER de Diabetes y Enfermedades Metabolicas asociadas CIBERDEM (Spanish Ministry of Economy and Competitiveness) [CB07/08/0012, SAF2012-36186, CP10/00438]; "Rio Hortega" research fellowship from the Instituto de Salud Carlos III (Spain) [CM12/00044]; "Miguel Servet" tenure track program [CP10/00438]; Fondo de Investigacion Sanitaria (FIS); European Regional Development Fund (ERDF)	Fondo de Investigacion Sanitaria (FIS) by Instituto de Salud Carlos III (Spain); Fundacio La Marato de TV3; Fondos FEDER(European Commission); CIBER de Diabetes y Enfermedades Metabolicas asociadas CIBERDEM (Spanish Ministry of Economy and Competitiveness); "Rio Hortega" research fellowship from the Instituto de Salud Carlos III (Spain); "Miguel Servet" tenure track program; Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); European Regional Development Fund (ERDF)(European Commission)	Financial support was provided by a grant from the Fondo de Investigacion Sanitaria (FIS) (PS09/01360 and PI12/00954) by Instituto de Salud Carlos III (Spain) and the Fundacio La Marato de TV3-2008 (Project No 081410). The study was also cofunded by Fondos FEDER and CIBER de Diabetes y Enfermedades Metabolicas asociadas CIBERDEM (CB07/08/0012), SAF2012-36186 and CP10/00438 to SF-V (Spanish Ministry of Economy and Competitiveness). CIBERDEM de Diabetes y Enfermedades Metabolicas asociadas (CB07708/0012) is an initiative of the Instituto de Salud Carlos III. GL was supported by a "Rio Hortega" research fellowship (CM12/00044) from the Instituto de Salud Carlos III (Spain). SF-V acknowledges support from the "Miguel Servet" tenure track program (CP10/00438), from the Fondo de Investigacion Sanitaria (FIS), co-financed by the European Regional Development Fund (ERDF).	Angelin B, 2012, CELL METAB, V16, P693, DOI 10.1016/j.cmet.2012.11.001; Arnlov J, 2013, CLIN J AM SOC NEPHRO, V8, P781, DOI 10.2215/CJN.09570912; Arnlov J, 2013, KIDNEY INT, V83, P160, DOI 10.1038/ki.2012.327; Balci M, 2010, HEMODIAL INT, V14, P425, DOI 10.1111/j.1542-4758.2010.00480.x; Bierschenk L, 2009, DIABETES CARE, V32, P1977, DOI 10.2337/dc09-1089; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; de Ferranti SD, 2014, CIRCULATION, V130, P1110, DOI [10.1161/CIR.0000000000000034, 10.2337/dc14-1720]; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hallal PC, 2004, MED SCI SPORT EXER, V36, P556, DOI 10.1249/01.MSS.0000117161.66394.07; Hanks LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122885; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Ix JH, 2012, J AM COLL CARDIOL, V60, P200, DOI 10.1016/j.jacc.2012.03.040; Joergensen C, 2011, DIABETES CARE, V34, P1081, DOI 10.2337/dc10-2459; Joergensen C, 2010, DIABETES CARE, V33, P2238, DOI 10.2337/dc10-0582; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Libby P, 2005, CIRCULATION, V111, P3489, DOI 10.1161/CIRCULATIONAHA.104.529651; Lieberman R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077272; Littorin B, 2006, DIABETOLOGIA, V49, P2847, DOI 10.1007/s00125-006-0426-x; Llaurado G, 2013, DIABETES METAB, V39, P355, DOI 10.1016/j.diabet.2013.03.006; Llaurado G, 2012, DIABETES CARE, V35, P1083, DOI 10.2337/dc11-1475; Lundberg S, 2012, CLIN J AM SOC NEPHRO, V7, P727, DOI 10.2215/CJN.10331011; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Nakayama M, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-22; Nasrallah MM, 2010, NEPHROL DIAL TRANSPL, V25, P2679, DOI 10.1093/ndt/gfq089; Olauson H, 2014, SEMIN NEPHROL, V34, P586, DOI 10.1016/j.semnephrol.2014.09.005; Pozzilli P, 2005, HORM METAB RES, V37, P680, DOI 10.1055/s-2005-870578; Reis JP, 2009, PEDIATRICS, V124, pE371, DOI 10.1542/peds.2009-0213; Reyes-Garcia R, 2014, DIABETES CARE, V37, pE89, DOI 10.2337/dc13-2235; Sachs MC, 2013, DIABETES CARE, V36, P2423, DOI 10.2337/dc12-2020; Saito Y, 1998, BIOCHEM BIOPH RES CO, V248, P324, DOI 10.1006/bbrc.1998.8943; Semba RD, 2012, CLIN J AM SOC NEPHRO, V7, P85, DOI 10.2215/CJN.08070811; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Young KA, 2011, DIABETES CARE, V34, P454, DOI 10.2337/dc10-0757; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	41	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140222	10.1371/journal.pone.0140222	http://dx.doi.org/10.1371/journal.pone.0140222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462160	gold, Green Submitted, Green Published			2022-12-26	WOS:000362962300069
J	Obeidat, M; Fishbane, N; Nie, YL; Chen, V; Hollander, Z; Tebbutt, SJ; Bosse, Y; Ng, RT; Miller, BE; McManus, B; Rennard, S; Pare, PD; Sin, DD				Obeidat, Ma'en; Fishbane, Nick; Nie, Yunlong; Chen, Virginia; Hollander, Zsuzsanna; Tebbutt, Scott J.; Bosse, Yohan; Ng, Raymond T.; Miller, Bruce E.; McManus, Bruce; Rennard, Stephen; Pare, Peter D.; Sin, Don D.			The Effect of Statins on Blood Gene Expression in COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; LUNG-FUNCTION; ABCG1; ABCA1; SIMVASTATIN; MORTALITY; EFFLUX; EXACERBATIONS; DEFICIENCY	Background COPD is currently the fourth leading cause of death worldwide. Statins are lipid lowering agents with documented cardiovascular benefits. Observational studies have shown that statins may have a beneficial role in COPD. The impact of statins on blood gene expression from COPD patients is largely unknown. Objective Identify blood gene signature associated with statin use in COPD patients, and the pathways underpinning this signature that could explain any potential benefits in COPD. Methods Whole blood gene expression was measured on 168 statin users and 451 non-users from the ECLIPSE study using the Affymetrix Human Gene 1.1 ST microarray chips. Factor Analysis for Robust Microarray Summarization (FARMS) was used to process the expression data. Differential gene expression analysis was undertaken using the Linear Models for Microarray data (Limma) package adjusting for propensity score and surrogate variables. Similarity of the expression signal with published gene expression profiles was performed in ProfileChaser. Results 25 genes were differentially expressed between statin users and non-users at an FDR of 10%, including LDLR, CXCR2, SC4MOL, FAM108A1, IFI35, FRYL, ABCG1, MYLIP, and DHCR24. The 25 genes were significantly enriched in cholesterol homeostasis and metabolism pathways. The resulting gene signature showed correlation with Huntington's disease, Parkinson's disease and acute myeloid leukemia gene signatures. Conclusion The blood gene signature of statins' use in COPD patients was enriched in cholesterol homeostasis pathways. Further studies are needed to delineate the role of these pathways in lung biology.	[Obeidat, Ma'en; Fishbane, Nick; Nie, Yunlong; Tebbutt, Scott J.; McManus, Bruce; Pare, Peter D.; Sin, Don D.] Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V5Z 1M9, Canada; [Chen, Virginia; Hollander, Zsuzsanna; Tebbutt, Scott J.; Ng, Raymond T.; McManus, Bruce] Prevent Organ Failure PROOF Ctr Excellence, Vancouver, BC, Canada; [Tebbutt, Scott J.; Pare, Peter D.; Sin, Don D.] Univ British Columbia, Dept Med, Div Resp, Vancouver, BC, Canada; [Bosse, Yohan] Univ Laval, Dept Mol Med, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Miller, Bruce E.] GlaxoSmithKline R&D, Resp Therapy Area Unit, King Of Prussia, PA USA; [Rennard, Stephen] Univ Nebraska Med Ctr, Div Pulm & Crit Care Med, Omaha, NE USA	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; Laval University; GlaxoSmithKline; University of Nebraska System; University of Nebraska Medical Center	Sin, DD (corresponding author), Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V5Z 1M9, Canada.	don.sin@hli.ubc.ca	Sin, Don/AAC-2219-2021; Pare, Peter D/C-7425-2011; Fishbane, Nick/GYE-0318-2022	Fishbane, Nick/0000-0003-4316-1341; Tebbutt, Scott/0000-0002-7908-1581	GlaxoSmithKline [NCT00292552]; GSK [SCO104960]	GlaxoSmithKline(GlaxoSmithKline); GSK(GlaxoSmithKline)	ECLIPSE study (http://www.eclipse-copd.com/) was funded by GlaxoSmithKline ClinicalTrials.gov identifier NCT00292552 and GSK No. SCO104960. The funder had no role in study design, data collection, analysis, interpretation or preparing the manuscript.	Alexeeff SE, 2007, AM J RESP CRIT CARE, V176, P742, DOI 10.1164/rccm.200705-656OC; Andreux PA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05285; [Anonymous], [No title captured]; Arnaud C, 2005, ARTERIOSCL THROM VAS, V25, P1231, DOI 10.1161/01.ATV.0000163840.63685.0c; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auerbach RK, 2013, BIOINFORMATICS; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Azzam KM, 2012, TRENDS ENDOCRIN MET, V23, P169, DOI 10.1016/j.tem.2012.02.001; Baldan A, 2008, J IMMUNOL, V180, P3560, DOI 10.4049/jimmunol.180.5.3560; Bates SR, 2005, AM J PHYSIOL-LUNG C, V289, pL980, DOI 10.1152/ajplung.00234.2005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blamoun AI, 2008, INT J CLIN PRACT, V62, P1373, DOI 10.1111/j.1742-1241.2008.01731.x; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Burkart KM, 2014, EUR RESPIR J, V43, P1003, DOI 10.1183/09031936.00147612; Burke LP, 2003, LEUKEMIA, V17, P267, DOI 10.1038/sj.leu.2402695; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cirillo DJ, 2002, AM J EPIDEMIOL, V155, P842, DOI 10.1093/aje/155.9.842; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Criner GJ, 2014, NEW ENGL J MED, V370, P2201, DOI 10.1056/NEJMoa1403086; Crosbie J, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-33; Davis BB, 2013, EUR RESPIR J, V42, P350, DOI 10.1183/09031936.00042512; Decramer M, 2013, LANCET RESP MED, V1, P73, DOI 10.1016/S2213-2600(12)70060-7; Dobler Claudia C, 2009, BMC Pulm Med, V9, P32, DOI 10.1186/1471-2466-9-32; Dolga AM, 2011, EXP NEUROL, V228, P1, DOI 10.1016/j.expneurol.2010.11.013; Draper DW, 2010, AM J RESP CRIT CARE, V182, P404, DOI 10.1164/rccm.200910-1580OC; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Engreitz JM, 2011, BIOINFORMATICS, V27, P3317, DOI 10.1093/bioinformatics/btr548; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997; Genvigir Fabiana D. V., 2011, Drug Metabolism and Drug Interactions, V26, P33, DOI 10.1515/DMDI.2011.101; Goldklang M, 2012, AM J PHYSIOL-LUNG C, V302, pL1200, DOI 10.1152/ajplung.00454.2010; Gowdy KM, 2013, PULM PHARMACOL THER, V26, P430, DOI 10.1016/j.pupt.2012.06.002; HASS MA, 1980, LIPIDS, V15, P401, DOI 10.1007/BF02534063; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Holstein SA, 2001, LEUKEMIA RES, V25, P651, DOI 10.1016/S0145-2126(00)00162-4; Horita N, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-80; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janda S, 2009, CHEST, V136, P734, DOI 10.1378/chest.09-0194; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kumar A, 2013, EUR J PHARMACOL, V709, P1, DOI 10.1016/j.ejphar.2013.03.042; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Leszczynska A, 2011, ACTA BIOCHIM POL, V58, P635; Massaro D, 2011, PEDIATR RES, V70, P458, DOI 10.1203/PDR.0b013e31822f24df; McGrath KCY, 2009, ARTERIOSCL THROM VAS, V29, P877, DOI 10.1161/ATVBAHA.109.184663; Mei JJ, 2012, J CLIN INVEST, V122, P974, DOI 10.1172/JCI60588; Miserez AR, 2002, ATHEROSCLEROSIS, V164, P15, DOI 10.1016/S0021-9150(01)00762-6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; NISTOR A, 1986, AM REV RESPIR DIS, V134, P1266; Qiu YS, 2003, AM J RESP CRIT CARE, V168, P968, DOI 10.1164/rccm.200208-794OC; Ramos MC, 2012, J ALZHEIMERS DIS, V28, P297, DOI 10.3233/JAD-2011-111118; Reed RM, 2011, J HEART LUNG TRANSPL, V30, P674, DOI 10.1016/j.healun.2010.12.010; Roy A, 2011, NEUROSCIENTIST, V17, P244, DOI 10.1177/1073858410385006; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Shen YB, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/709724; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sorrentino V, 2013, EUR HEART J, V34, P1292, DOI 10.1093/eurheartj/ehs472; Stadtmann A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00263; Stancu C, 2001, J CELL MOL MED, V5, P378, DOI 10.1111/j.1582-4934.2001.tb00172.x; TISI GM, 1981, METABOLISM, V30, P340, DOI 10.1016/0026-0495(81)90113-X; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wojcik AJ, 2008, J IMMUNOL, V180, P4273, DOI 10.4049/jimmunol.180.6.4273; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Wright JL, 2011, AM J RESP CRIT CARE, V183, P50, DOI 10.1164/rccm.201003-0399OC; Young RP, 2009, EUR RESPIR REV, V18, P222, DOI 10.1183/09059180.00005309; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283	68	11	11	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140022	10.1371/journal.pone.0140022	http://dx.doi.org/10.1371/journal.pone.0140022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26462087	gold, Green Submitted, Green Published			2022-12-26	WOS:000362962300047
J	Arighi, A; Rango, M; Bozzali, M; Pietroboni, AM; Fumagalli, G; Ghezzi, L; Fenoglio, C; Biondetti, PR; Bresolin, N; Galimberti, D; Scarpini, E				Arighi, Andrea; Rango, Mario; Bozzali, Marco; Pietroboni, Anna M.; Fumagalli, Giorgio; Ghezzi, Laura; Fenoglio, Chiara; Biondetti, Pietro R.; Bresolin, Nereo; Galimberti, Daniela; Scarpini, Elio			Usefulness of Multi-Parametric MRI for the Investigation of Posterior Cortical Atrophy	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; NORMATIVE DATA; CSF-TAU; PET; PRESENTATIONS; SPECTROSCOPY; MORPHOMETRY; DEMENTIAS; MARKERS	Background Posterior Cortical Atrophy (PCA) is a neurodegenerative disease characterized by a progressive decline in selective cognitive functions anatomically referred to occipital, parietal and temporal brain regions, whose diagnosis is rather challenging for clinicians. The aim of this study was to assess, using quantitative Magnetic Resonance Imaging techniques, the pattern of regional grey matter loss and metabolism in individuals with PCA to improve pathophysiological comprehension and diagnostic confidence. Methods We enrolled 5 patients with PCA and 5 matched controls who all underwent magnetic resonance imaging (MRI) and spectroscopy (MRS). Patients also underwent neuropsychological and cerebrospinal fluid (CSF) assessments. MRI data were used for unbiased assessment of regional grey matter loss in PCA patients compared to controls. MRS data were obtained from a set of brain regions, including the occipital lobe and the centrum semiovale bilaterally, and the posterior and anterior cingulate. Results VBM analysis documented the presence of focal brain atrophy in the occipital lobes and in the posterior parietal and temporal lobes bilaterally but more pronounced on the right hemisphere. MRS revealed, in the occipital lobes and in the posterior cingulate cortex of PCA patients, reduced levels of N-Acetyl Aspartate (NAA, a marker of neurodegeneration) and increased levels of Myo-Inositol (Ins, a glial marker), with no hemispheric lateralization. Conclusion The bilateral but asymmetric pattern of regional grey matter loss is consistent with patients' clinical and neuropsychological features and with previous literature. The MRS findings reveal different stages of neurodegeneration (neuronal loss; gliosis), which coexist and likely precede the occurrence of brain tissue loss, and might represent early biomarkers. In conclusion, this study indicates the potential usefulness of a multi-parametric MRI approach for an early diagnosis and staging of patients with PCA.	[Arighi, Andrea; Rango, Mario; Pietroboni, Anna M.; Fumagalli, Giorgio; Ghezzi, Laura; Fenoglio, Chiara; Bresolin, Nereo; Galimberti, Daniela; Scarpini, Elio] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Neurol Unit, I-20121 Milan, Italy; [Rango, Mario; Bresolin, Nereo] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Magnet Resonance Spect Ctr, I-20121 Milan, Italy; [Bozzali, Marco] IRCCS Santa Lucia Fdn, Neuorimaging Lab, Rome, Italy; [Biondetti, Pietro R.] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Radiol, I-20121 Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Santa Lucia; IRCCS Ca Granda Ospedale Maggiore Policlinico	Arighi, A (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Neurol Unit, Via Francesco Sforza 35, I-20121 Milan, Italy.	andrea.arighi@yahoo.it	Pietroboni, Anna Margherita/L-2970-2015; Bozzali, Marco/AAC-1031-2022; Arighi, Andrea/J-6010-2015; Ghezzi, Laura/V-5280-2019; Ghezzi, Laura/J-2284-2018; Fumagalli, Giorgio/L-8306-2013; Galimberti, Daniela/N-7209-2019; rango, mario/AIA-9372-2022; Scarpini, Elio/K-6547-2016	Pietroboni, Anna Margherita/0000-0003-1538-1830; Arighi, Andrea/0000-0003-2865-3970; Ghezzi, Laura/0000-0001-8180-9730; Fumagalli, Giorgio/0000-0003-0687-7199; Galimberti, Daniela/0000-0002-9284-5953; Scarpini, Elio/0000-0002-6395-2119; Bozzali, Marco/0000-0002-0568-2026; Bresolin, Nereo/0000-0001-6694-3595				Aharon-Peretz J, 1999, DEMENT GERIATR COGN, V10, P483, DOI 10.1159/000017194; Alladi S, 2007, BRAIN, V130, P2636, DOI 10.1093/brain/awm213; Alves J, 2013, BRAIN IMAGING BEHAV, V7, P353, DOI 10.1007/s11682-013-9236-1; Andreasen N, 2003, WORLD J BIOL PSYCHIA, V4, P147, DOI 10.1080/15622970310029912; Andreasen N, 2001, ARCH NEUROL-CHICAGO, V58, P373, DOI 10.1001/archneur.58.3.373; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Baumann TP, 2010, DEMENT GERIATR COGN, V29, P530, DOI 10.1159/000314679; BENSON DF, 1988, ARCH NEUROL-CHICAGO, V45, P789, DOI 10.1001/archneur.1988.00520310107024; Borroni B, 2012, NEUROBIOL AGING, V33, P2506, DOI 10.1016/j.neurobiolaging.2011.10.031; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Croisile B, 1999, DEMENT GERIATR COGN, V10, P226, DOI 10.1159/000017124; Crutch SJ, 2013, ALZHEIMERS DEMENT, V9, P463, DOI 10.1016/j.jalz.2012.11.004; Crutch SJ, 2012, LANCET NEUROL, V11, P170, DOI 10.1016/S1474-4422(11)70289-7; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Ernst T, 1997, RADIOLOGY, V203, P829, DOI 10.1148/radiology.203.3.9169712; Galton CJ, 2000, BRAIN, V123, P484, DOI 10.1093/brain/123.3.484; Giannakopoulos P, 1999, NEUROLOGY, V52, P71, DOI 10.1212/WNL.52.1.71; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Goethals M, 2001, CLIN NEUROL NEUROSUR, V103, P115, DOI 10.1016/S0303-8467(01)00114-7; Goodglass H., 1983, BOSTON NAMING TEST; HOF PR, 1989, BRAIN RES, V493, P368, DOI 10.1016/0006-8993(89)91173-6; Kantarci K, 2000, NEUROLOGY, V55, P210, DOI 10.1212/WNL.55.2.210; Kantarci K, 2004, NEUROLOGY, V63, P1393; Kas A, 2011, BRAIN, V134, P1464, DOI 10.1093/brain/awr055; Kim EH, 2005, CLIN NEUROL NEUROSUR, V108, P97, DOI 10.1016/j.clineuro.2004.11.022; MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545; Mendez MF, 2002, DEMENT GERIATR COGN, V14, P33, DOI 10.1159/000058331; Nestor PJ, 2003, J NEUROL NEUROSUR PS, V74, P1521, DOI 10.1136/jnnp.74.11.1521; Novelli G, 1986, TRE TEST CLIN RICERC; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Renner JA, 2004, NEUROLOGY, V63, P1175, DOI 10.1212/01.WNL.0000140290.80962.BF; Schmidtke K, 2005, J NEUROL, V252, P27, DOI 10.1007/s00415-005-0594-5; Seguin J, 2011, NEUROLOGY, V76, P1782, DOI 10.1212/WNL.0b013e31821ccc98; Serra L, 2010, J ALZHEIMERS DIS, V21, P627, DOI 10.3233/JAD-2010-100048; Shames H, 2015, J NEUROL, V262, P1751, DOI 10.1007/s00415-015-7774-8; Spinnler H., 1987, ITAL J NEUROL SCI, VS8, P6; Tang-Wai DF, 2004, NEUROLOGY, V63, P1168, DOI 10.1212/01.WNL.0000140289.18472.15; TEIXEIRA F, 1995, J PSYCHIATR NEUROSCI, V20, P276; WAKAI M, 1994, ACTA NEUROL SCAND, V89, P458; Warren JD, 2012, NAT REV NEUROL, V8, P451, DOI 10.1038/nrneurol.2012.135; Warrington EK., 1991, VISUAL OBJECT SPACE; Whitwell JL, 2007, NEUROBIOL AGING, V28, P1051, DOI 10.1016/j.neurobiolaging.2006.05.026	44	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2015	10	10							e0140639	10.1371/journal.pone.0140639	http://dx.doi.org/10.1371/journal.pone.0140639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT7WW	26480294	Green Published, gold, Green Submitted			2022-12-26	WOS:000363026600015
J	Craig, EC; Dorr, BS; Hanson-Dorr, KC; Sparks, JP; Curtis, PD				Craig, Elizabeth C.; Dorr, Brian S.; Hanson-Dorr, Katie C.; Sparks, Jed P.; Curtis, Paul D.			Isotopic Discrimination in the Double-Crested Cormorant (Phalacrocorax auritus)	PLOS ONE			English	Article							MULTIPLE STABLE ISOTOPES; CARBON ISOTOPES; MIXING MODELS; GREAT-LAKES; FOOD WEBS; BIRDS; DIET; FISHERIES; POPULATIONS; NITROGEN	The diet-tissue discrimination factor is the amount by which a consumer's tissue varies isotopically from its diet, and is therefore a key element in models that use stable isotopes to estimate diet composition. In this study we measured discrimination factors in blood (whole blood, red blood cells and plasma), liver, muscle and feathers of Double-crested Cormorants (Phalacrocorax auritus) for stable isotope ratios of carbon, nitrogen and sulfur. Cormorants exhibited discrimination factors that differed significantly among tissue types (for carbon and nitrogen), and differed substantially (in the context of the isotopic variation among relevant prey species) from those observed in congeneric species. The Double-crested Cormorant has undergone rapid population expansion throughout much of its historic range over the past three decades, leading to both real and perceived conflicts with fisheries throughout North America, and this study provides an essential link for the use of stable isotope analysis in researching foraging ecology, diet, and resource use of this widespread and controversial species.	[Craig, Elizabeth C.] Cornell Univ, Field Zool & Wildlife Conservat, Ithaca, NY 10021 USA; [Dorr, Brian S.; Hanson-Dorr, Katie C.] USDA, Wildlife Serv, Natl Wildlife Res Ctr, Mississippi Field Stn, Mississippi State, MS USA; [Sparks, Jed P.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 10021 USA; [Curtis, Paul D.] Cornell Univ, Dept Nat Resources, Ithaca, NY 10021 USA	Cornell University; Mississippi State University; United States Department of Agriculture (USDA); Cornell University; Cornell University	Craig, EC (corresponding author), Cornell Univ, Field Zool & Wildlife Conservat, Ithaca, NY 10021 USA.	ecc79@cornell.edu	Dorr, Brian/AAX-9033-2020	Dorr, Brian/0000-0001-6857-8560; Hanson-Dorr, Katie/0000-0003-4559-938X	United States Department of Agriculture, Wildlife Services, National Wildlife Research Center, MS Field Station; Berryman Institute;  [62383]	United States Department of Agriculture, Wildlife Services, National Wildlife Research Center, MS Field Station; Berryman Institute; 	This work was funded by the United States Department of Agriculture, Wildlife Services, National Wildlife Research Center, MS Field Station (http://www.aphis.usda.gov/wps/portal/aphis/ourfocus/wildlifedamage/sa_programs/sa_nwrc/sa_field/ct_mississippi/!ut/p/a0/04_Sj9CPykssy0xPLMnMz0vMAfGjzOK9_D2MDJ0MjDzd3V2dDDz93HwCzL29jAwMTfQLsh0VAXWczqE!/). Funding was received by PDC and ECC (Grant #62383). These funders participated in study design, data collection, decision to publish, and preparation of the manuscript; and provided facilities, staff, and funding to support capture and care of cormorants for this study. This work was also funded by Berryman Institute (http://www.berrymaninstitute.org/). Funding was received by ECC. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauchinger U, 2009, PHYSIOL BIOCHEM ZOOL, V82, P787, DOI 10.1086/605548; Bearhop S, 1999, J APPL ECOL, V36, P75, DOI 10.1046/j.1365-2664.1999.00378.x; Ben-David M, 2001, OECOLOGIA, V127, P180, DOI 10.1007/s004420000570; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Bond Alexander L., 2009, Marine Ornithology, V37, P183; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Diana JS, 2006, J GREAT LAKES RES, V32, P306, DOI 10.3394/0380-1330(2006)32[306:DICPTS]2.0.CO;2; Dorr BS, 2012, J WORLD AQUACULT SOC, V43, P502, DOI 10.1111/j.1749-7345.2012.00586.x; Dorr Brian S., 2012, Human-Wildlife Interactions, V6, P155; Doucette JL, 2011, ECOL APPL, V21, P2987, DOI 10.1890/10-2384.1; Doucette JL, 2010, WATERBIRDS, V33, P273, DOI 10.1675/063.033.0302; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; France RL, 1995, LIMNOL OCEANOGR, V40, P1310, DOI 10.4319/lo.1995.40.7.1310; Glahn J.F., 2002, HUMAN CONFLICTS WILD, P138; Hatch J.J., 1999, DOUBLE CRESTED CORMO; Hatch JJ, 1995, COLON WATERBIRD, V18, P8, DOI 10.2307/1521520; Hebert CE, 2008, ECOL APPL, V18, P561, DOI 10.1890/07-1278.1; Hebert CE, 2009, AQUAT ECOSYST HEALTH, V12, P37, DOI 10.1080/14634980802700995; HESSLEIN RH, 1991, CAN J FISH AQUAT SCI, V48, P2258, DOI 10.1139/f91-265; Hobson KA, 1997, AUK, V114, P467, DOI 10.2307/4089247; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Hobson KA, 2009, WATERBIRDS, V32, P481, DOI 10.1675/063.032.0401; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; Lott CA, 2003, OECOLOGIA, V134, P505, DOI 10.1007/s00442-002-1153-8; MIZUTANI H, 1992, ECOLOGY, V73, P1391, DOI 10.2307/1940684; Ofukany A, 2012, ENVIRON SCI TECHNOL, V46, P3253; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Rudstam LG, 2004, ECOL APPL, V14, P149, DOI 10.1890/03-5010; Taylor JD, 2003, P WILDL DAM MAN C, V10, P43; Wires LR, 2006, WATERBIRDS, V29, P9, DOI 10.1675/1524-4695(2006)29[9:HPOTDC]2.0.CO;2	37	11	11	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140946	10.1371/journal.pone.0140946	http://dx.doi.org/10.1371/journal.pone.0140946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473353	Green Published, gold			2022-12-26	WOS:000363185500134
J	Dewanjee, S; Dua, TK; Khanra, R; Das, S; Barma, S; Joardar, S; Bhattacharjee, N; Zia-Ul-Haq, M; Jaafar, HZE				Dewanjee, Saikat; Dua, Tarun K.; Khanra, Ritu; Das, Shilpa; Barma, Sujata; Joardar, Swarnalata; Bhattacharjee, Niloy; Zia-Ul-Haq, M.; Jaafar, Hawa Z. E.			Water Spinach, Ipomoea aquatic (Convolvulaceae), Ameliorates Lead Toxicity by Inhibiting Oxidative Stress and Apoptosis	PLOS ONE			English	Article							HEAVY-METALS; INVOLVEMENT; IMAGE; ACID; QUANTIFICATION; MECHANISMS; EXPOSURE	Background Ipomoea aquatica (Convolvulaceae), an aquatic edible plant, is traditionally used against heavy metal toxicity in India. The current study intended to explore the protective role of edible (aqueous) extract of I. aquatica (AEIA) against experimentally induced Pb-intoxication. Methods The cytoprotective role of AEIA was measured on mouse hepatocytes by cell viability assay followed by Hoechst staining and flow cytometric assay. The effect on ROS production, lipid peroxidation, protein carbonylation, intracellular redox status were measured after incubating the hepatocytes with Pb-acetate (6.8 mu M) along with AEIA (400 mu g/ml). The effects on the expressions of apoptotic signal proteins were estimated by western blotting. The protective role of AEIA was measured by in vivo assay in mice. Haematological, serum biochemical, tissue redox status, Pb bioaccumulation and histological parameters were evaluated to estimate the protective role of AEIA (100 mg/kg) against Pb-acetate (5 mg/kg) intoxication. Results Pb-acetate treated hepatocytes showed a gradual reduction of cell viability dose-dependently with an IC50 value of 6.8 mu M. Pb-acetate treated hepatocytes exhibited significantly enhanced levels (p < 0.01) of ROS production, lipid peroxidation, protein carbonylation with concomitant depletion (p < 0.01) of antioxidant enzymes and GSH. However, AEIA treatment could significantly restore the aforementioned parameters in murine hepatocytes near to normalcy. Besides, AEIA significantly reversed (p < 0.05-0.01) the alterations of transcription levels of apoptotic proteins viz. Bcl 2, Bad, Cyt C, Apaf-1, cleaved caspases [caspase 3, caspase 8 and caspase 9], Fas and Bid. In in vivo bioassay, Pb-acetate treatment caused significantly high intracellular Pb burden and oxidative pressure in the kidney, liver, heart, brain and testes in mice. In addition, the haematological and serum biochemical factors were changed significantly in Pb-acetate-treated animals. AEIA treatment restored significantly the evaluated-parameters to the near-normal position. Conclusion The extract may offer the protective effect via counteracting with Pb mediated oxidative stress and/or promoting the elimination of Pb by chelating. The presence of substantial quantities of flavonoids, phenolics and saponins would be responsible for the overall protective effect.	[Dewanjee, Saikat; Dua, Tarun K.; Khanra, Ritu; Das, Shilpa; Barma, Sujata; Joardar, Swarnalata; Bhattacharjee, Niloy] Jadavpur Univ, Dept Pharmaceut Technol, Adv Pharmacognosy Res Lab, Kolkata 700032, India; [Zia-Ul-Haq, M.] Univ Karachi, Dept Pharmacognosy, Karachi 75270, Pakistan; [Jaafar, Hawa Z. E.] Univ Putra, Fac Agr, Dept Crop Sci, Selangor 43400, Malaysia	Jadavpur University; University of Karachi; Universiti Putra Malaysia	Dewanjee, S (corresponding author), Jadavpur Univ, Dept Pharmaceut Technol, Adv Pharmacognosy Res Lab, Kolkata 700032, India.	s.dewanjee@yahoo.com; hawazej@gmail.com	Dua, Tarun Kumar/AAM-4891-2020; Dewanjee, Saikat/U-9778-2017; KHANRA, RITU/AAV-4351-2021	Dua, Tarun Kumar/0000-0001-5136-7564; Dewanjee, Saikat/0000-0001-9085-4226	Council for Scientific and Industrial Research [09/096(773)/2013-EMR-I]	Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by the Council for Scientific and Industrial Research-senior research fellowship Ref. No.: 09/096(773)/2013-EMR-I dated 15th March, 2013.	Bouayed J, 2010, OXID MED CELL LONGEV, V3, P228, DOI 10.4161/oxim.3.4.12858; Bressler J, 1999, NEUROCHEM RES, V24, P595, DOI 10.1023/A:1022596115897; Chopra R.N., 1956, GLOSSARY INDIAN MED; DEFIGUEIREDO RJP, 1995, NEUROBIOL AGING, V16, P211, DOI 10.1016/0197-4580(94)00151-0; DESILVA PE, 1981, BRIT J IND MED, V38, P209; Dewanjee S, 2013, FOOD CHEM TOXICOL, V60, P188, DOI 10.1016/j.fct.2013.07.043; Dewanjee S, 2013, FOOD CHEM TOXICOL, V55, P78, DOI 10.1016/j.fct.2012.12.040; Douki T, 1998, CHEM RES TOXICOL, V11, P150, DOI 10.1021/tx970157d; Dua TK, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0598-6; Dua TK, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0430-3; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S; GELMAN BB, 1978, TOXICOL APPL PHARM, V45, P119, DOI 10.1016/0041-008X(78)90033-9; Ghosh J, 2010, FOOD CHEM, V123, P1062, DOI 10.1016/j.foodchem.2010.05.062; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hong KJ, 2000, CHEMOSPHERE, V41, P345, DOI 10.1016/S0045-6535(99)00489-0; Hsu PC, 2002, TOXICOLOGY, V180, P33, DOI 10.1016/S0300-483X(02)00380-3; HUMPHREYS DJ, 1991, BRIT VET J, V147, P18, DOI 10.1016/0007-1935(91)90063-S; Jackie Tan, 2011, BMC Res Notes, V4, P67, DOI 10.1186/1756-0500-4-67; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Kannan, 2000, Pathophysiology, V7, P153, DOI 10.1016/S0928-4680(00)00053-5; KHALILMANESH F, 1993, AM J HYPERTENS, V6, P723, DOI 10.1093/ajh/6.9.723; Khanra R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0364-1; Kim JD, 1996, AGING-CLIN EXP RES, V8, P123, DOI 10.1007/BF03339566; LANCRANJAN I, 1975, ARCH ENVIRON HEALTH, V30, P396, DOI 10.1080/00039896.1975.10666733; LEBEL CP, 1990, NEUROCHEM INT, V17, P435, DOI 10.1016/0197-0186(90)90025-O; Mansoor TA, 2013, J ETHNOPHARMACOL, V149, P463, DOI 10.1016/j.jep.2013.06.051; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pal S, 2011, TOXICOLOGY, V283, P129, DOI 10.1016/j.tox.2011.03.006; PHS (Public Health Service), 1986, PUBL HLTH SERV POL H; Rangan GK, 2007, NEPHROLOGY, V12, P553, DOI 10.1111/j.1440-1797.2007.00855.x; Ruegg MA, 2014, HISTOPATHOLOGY HEMAT; Saeed K, 2015, J PAK MED ASSOC, V65, P43; Sarkar K, 2006, TOXICOL IN VITRO, V20, P634, DOI 10.1016/j.tiv.2005.11.003; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHARMA RP, 1980, J AM VET MED ASSOC, V177, P149; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; Wu DD, 2015, MED GAS RES, V5, DOI 10.1186/s13618-014-0022-y; ZHANG YY, 1995, J NUTR, V125, P446	40	28	29	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0139831	10.1371/journal.pone.0139831	http://dx.doi.org/10.1371/journal.pone.0139831			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26473485	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000363185500015
J	Huentelman, MJ; Muppana, L; Corneveaux, JJ; Dinu, V; Pruzin, JJ; Reiman, R; Borish, CN; De Both, M; Ahmed, A; Todorov, A; Cloninger, CR; Zhang, R; Ma, J; Gallitano, AL				Huentelman, Matthew J.; Muppana, Leela; Corneveaux, Jason J.; Dinu, Valentin; Pruzin, Jeremy J.; Reiman, Rebecca; Borish, Cassie N.; De Both, Matt; Ahmed, Amber; Todorov, Alexandre; Cloninger, C. Robert; Zhang, Rui; Ma, Jie; Gallitano, Amelia L.			Association of SNPs in EGR3 and ARC with Schizophrenia Supports a Biological Pathway for Schizophrenia Risk	PLOS ONE			English	Article							FAMILY-BASED ASSOCIATION; TRANSCRIPTION FACTOR; SYNAPTIC PLASTICITY; GENE POLYMORPHISMS; FACTOR EXPRESSION; BIPOLAR DISORDER; CELL GROWTH; LINKAGE; SUSCEPTIBILITY; METAANALYSIS	We have previously hypothesized a biological pathway of activity-dependent synaptic plasticity proteins that addresses the dual genetic and environmental contributions to schizophrenia. Accordingly, variations in the immediate early gene EGR3, and its target ARC, should influence schizophrenia susceptibility. We used a pooled Next-Generation Sequencing approach to identify variants across these genes in U.S. populations of European (EU) and African (AA) descent. Three EGR3 and one ARC SNP were selected and genotyped for validation, and three SNPs were tested for association in a replication cohort. In the EU group of 386 schizophrenia cases and 150 controls EGR3 SNP rs1877670 and ARC SNP rs35900184 showed significant associations (p = 0.0078 and p = 0.0275, respectively). In the AA group of 185 cases and 50 controls, only the ARC SNP revealed significant association (p = 0.0448). The ARC SNP did not show association in the Han Chinese (CH) population. However, combining the EU, AA, and CH groups revealed a highly significant association of ARC SNP rs35900184 (p = 2.353 x 10(-7); OR [95% CI] = 1.54 [1.310-1.820]). These findings support previously reported associations between EGR3 and schizophrenia. Moreover, this is the first report associating an ARC SNP with schizophrenia and supports recent large-scale GWAS findings implicating the ARC complex in schizophrenia risk. These results support the need for further investigation of the proposed pathway of environmentally responsive, synaptic plasticity-related, schizophrenia genes.	[Huentelman, Matthew J.; Corneveaux, Jason J.; Pruzin, Jeremy J.; Reiman, Rebecca; Borish, Cassie N.; De Both, Matt] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ USA; [Muppana, Leela; Ahmed, Amber; Gallitano, Amelia L.] Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ 85004 USA; [Dinu, Valentin] Arizona State Univ, Dept Biomed Informat, Scottsdale, AZ USA; [Todorov, Alexandre; Cloninger, C. Robert] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Zhang, Rui] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp, Xian Hong Hui Hosp, Xian 710049, Shaanxi, Peoples R China; [Ma, Jie] Xi An Jiao Tong Univ, Sch Med, Dept Biochem & Mol Biol, Xian 710049, Shaanxi, Peoples R China	Translational Genomics Research Institute; University of Arizona; Arizona State University; Washington University (WUSTL); Xi'an Jiaotong University; Xi'an Jiaotong University	Gallitano, AL (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ 85004 USA.	amelia@email.arizona.edu	Cloninger, Claude/F-5357-2012; Gallitano, Amelia L./C-5591-2014	Cloninger, Claude/0000-0003-3096-4807; Gallitano, Amelia L./0000-0002-0544-7114; Zhang, Rui/0000-0002-8664-6915; Dinu, Valentin/0000-0001-6192-7836	NIH [U01 MH046276, R01 MH097803, R01 MH-083823, R01 MH-067921]; Pfizer Fellowship in Biological Psychiatry; National Alliance for Research on Schizophrenia and Depression/Sidney R Baer Jr. Foundation Young Investigator Award; Arizona Biomedical Research Collaborative grant; Institute of Mental Health Research award; State of Arizona Department of Health Services; Fundamental Research Funds for the Central Universities [2012JDGZ07, XJJ2012124]; Ministry of Education, PRC [20090201120062]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083823, R01MH067921, U01MH046276, R01MH097803] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Fellowship in Biological Psychiatry; National Alliance for Research on Schizophrenia and Depression/Sidney R Baer Jr. Foundation Young Investigator Award; Arizona Biomedical Research Collaborative grant; Institute of Mental Health Research award; State of Arizona Department of Health Services; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Education, PRC; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The collection of data and biomaterials for this study was supported by funding from NIH U01 MH046276 (to CRC). This work was supported by a Pfizer Fellowship in Biological Psychiatry, a National Alliance for Research on Schizophrenia and Depression/Sidney R Baer Jr. Foundation Young Investigator Award, an Arizona Biomedical Research Collaborative grant, NIH R01 MH097803 (to ALG), NIH R01 MH-083823 (to MJH), NIH R01 MH-083823 (to AT), NIH R01 MH-067921 (PI-Todd RD), an Institute of Mental Health Research award (to ALG and MJH), and the State of Arizona Department of Health Services. Additional support was from the Fundamental Research Funds for the Central Universities (No. 2012JDGZ07, No. XJJ2012124) and the Ministry of Education, PRC (No. 20090201120062) (to JM and RZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bresnahan M, 2007, INT J EPIDEMIOL, V36, P751, DOI 10.1093/ije/dym041; Cheng MC, 2012, PROG NEURO-PSYCHOPH, V39, P149, DOI 10.1016/j.pnpbp.2012.06.004; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Fahmy RG, 2007, J CELL BIOCHEM, V100, P1526, DOI 10.1002/jcb.21145; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gallitano A, 2008, DYSFUNCTION IMMEDIAT; Gallitano AL, 2012, J AFFECT DISORDERS, V138, P387, DOI 10.1016/j.jad.2012.01.011; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; Gallitano-Mendel A, 2008, NEUROPSYCHOPHARMACOL, V33, P1266, DOI 10.1038/sj.npp.1301505; Guo AY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-10; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; Holliday EG, 2008, AM J MED GENET B, V147B, P1080, DOI 10.1002/ajmg.b.30722; Jacobson C, 2004, P NATL ACAD SCI USA, V101, P12218, DOI 10.1073/pnas.0404240101; Jessen KR, 2002, J ANAT, V200, P367, DOI 10.1046/j.1469-7580.2002.00046.x; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.0.CO;2-W; Kim SH, 2010, AM J MED GENET B, V153B, P1355, DOI 10.1002/ajmg.b.31115; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kyogoku C, 2011, PSYCHIAT RES, V185, P16, DOI 10.1016/j.psychres.2009.11.003; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Liu BC, 2010, PROG NEURO-PSYCHOPH, V34, P506, DOI 10.1016/j.pnpbp.2010.02.005; Maier W, 2008, EUR ARCH PSY CLIN N, V258, P37, DOI 10.1007/s00406-008-2008-z; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; Mechtcheriakova D, 1999, BLOOD, V93, P3811, DOI 10.1182/blood.V93.11.3811.411k40_3811_3823; Mexal S, 2005, MOL BRAIN RES, V139, P317, DOI 10.1016/j.molbrainres.2005.06.006; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Ning Qi-Lan, 2012, Yichuan, V34, P307, DOI 10.3724/SP.J.1005.2012.00307; Nishimura Y, 2014, NEUROIMAGE, V85, P527, DOI 10.1016/j.neuroimage.2013.08.021; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; RAO DC, 1981, HUM HERED, V31, P325, DOI 10.1159/000153233; Schrauwen I, 2013, AM J MED GENET A, V161A, P145, DOI 10.1002/ajmg.a.35737; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tabares-Seisdedos R, 2009, MOL PSYCHIATR, V14, P563, DOI 10.1038/mp.2009.2; Takahashi S, 2005, PSYCHIAT RES, V133, P111, DOI 10.1016/j.psychres.2004.12.003; Tam GWC, 2009, BIOL PSYCHIAT, V66, P1005, DOI 10.1016/j.biopsych.2009.07.027; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Yamada K, 2007, P NATL ACAD SCI USA, V104, P2815, DOI 10.1073/pnas.0610765104; Yamagata K, 1994, Learn Mem, V1, P140; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030237; Zhang WC, 2015, NEURON, V86, P490, DOI 10.1016/j.neuron.2015.03.030	59	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0135076	10.1371/journal.pone.0135076	http://dx.doi.org/10.1371/journal.pone.0135076			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474411	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500002
J	Wu, CL; Wang, J; Yang, YJ; Li, Z; Guo, T; Li, YC; Wang, XT				Wu, Changlu; Wang, Jiao; Yang, Yanjian; Li, Zhuang; Guo, Ting; Li, Yongchuan; Wang, Xiaotong			Adult Pacific Oyster (Crassostrea gigas) May Have Light Sensitivity	PLOS ONE			English	Article							PALLIAL EYES; BIVALVIA; SCALLOP; RESPONSES; EVOLUTION; SEA	Light-sensitivity is an important aspect of mollusk survival as it plays a vital role in reproduction and predator avoidance. In the Pacific oyster Crassostrea gigas light sensitivity has been demonstrated in the larval stage but has not yet been conclusively demonstrated in adult oysters. In this paper we describe an experiment which was undertaken to determine if adult Pacific oysters were sensitive to light. One LED flashlight was used to shine light onto adult oysters while they were filtering seawater through their shell openings. We found that the degree of opening increased gradually during the light period but rapidly decreased when the flashlight was turned off in the treated group but not in the control group. These results suggest that adult Pacific oyster may be sensitive to light.	[Wu, Changlu; Wang, Jiao; Yang, Yanjian; Li, Zhuang; Guo, Ting; Li, Yongchuan; Wang, Xiaotong] Ludong Univ, Sch Agr, Yantai 264025, Peoples R China	Ludong University	Wang, XT (corresponding author), Ludong Univ, Sch Agr, Yantai 264025, Peoples R China.	wangxiaotong999@163.com			National Natural Science Foundation of China [31302181]; Shandong Provincial Natural Science Foundation, China [ZR2013CM026]; Science and Technology Development Plan of Yantai [2017ZZ357]; School Foundation of Ludong University [LY2013032]; Enterprise project [2013HX007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Science and Technology Development Plan of Yantai; School Foundation of Ludong University; Enterprise project	The work was supported by National Natural Science Foundation of China (No. 31302181), Shandong Provincial Natural Science Foundation, China (No. ZR2013CM026), Science and Technology Development Plan of Yantai (No. 2017ZZ357), School Foundation of Ludong University (No. LY2013032), and Enterprise project (No. 2013HX007).	ADAL MN, 1973, J ZOOL, V170, P533; BARBER VC, 1967, Z ZELLFORSCH MIK ANA, V76, P295, DOI 10.1007/BF00339290; BAYNE BL, 1964, OIKOS, V15, P162, DOI 10.2307/3564753; Brokordt KB, 2000, J EXP MAR BIOL ECOL, V251, P205, DOI 10.1016/S0022-0981(00)00215-X; Cheirsilp B, 2012, BIORESOURCE TECHNOL, V110, P510, DOI 10.1016/j.biortech.2012.01.125; FANKBONER PV, 1981, VELIGER, V23, P245; FUKUYAMA AK, 1985, OPHELIA, V24, P17, DOI 10.1080/00785236.1985.10426616; Hall K. R. L., 1964, Journal of Mammalogy, V45, P287, DOI 10.2307/1376994; Hecht S, 1919, J GEN PHYSIOL, V1, P545, DOI 10.1085/jgp.1.5.545; HULSCHER JB, 1982, ARDEA, V70, P89; INGOLFSSON A, 1978, AUK, V95, P577; Kobak J, 2007, FUND APPL LIMNOL, V169, P341, DOI 10.1127/1863-9135/2007/0169-0341; Laming SR, 2013, J EXP BIOL, V216, P3264, DOI 10.1242/jeb.080416; LAND MF, 1965, J PHYSIOL-LONDON, V179, P138, DOI 10.1113/jphysiol.1965.sp007653; Magalhaes TRF, 2014, AN ACAD BRAS CIENC, V86, P1197, DOI 10.1590/0001-3765201420130093; Malkowsky Y, 2015, ACTA ZOOL-STOCKHOLM, V96, P167, DOI 10.1111/azo.12064; Malkowsky Y, 2014, ORG DIVERS EVOL, V14, P173, DOI 10.1007/s13127-013-0165-z; Morton B, 2000, J MOLLUS STUD, V66, P449, DOI 10.1093/mollus/66.4.449; Morton B., 2000, EVOLUTIONARY BIOL BI, P252; Morton B, 2008, ACTA ZOOL-STOCKHOLM, V89, P19, DOI 10.1111/j.1463-6395.2007.00288.x; NILSSON DE, 1994, PHILOS T ROY SOC B, V346, P195, DOI 10.1098/rstb.1994.0141; Ramirez MD, 2011, VISUAL NEUROSCI, V28, P265, DOI 10.1017/S0952523811000150; Serb Jeanne M., 2008, Evolution Education and Outreach, V1, P439, DOI 10.1007/s12052-008-0084-1; Speiser DI, 2008, J EXP BIOL, V211, P2066, DOI 10.1242/jeb.017038; Toomey MB, 2002, J N AM BENTHOL SOC, V21, P468, DOI 10.2307/1468483; WILKENS LA, 1988, J COMP PHYSIOL A, V163, P73, DOI 10.1007/BF00611998; Yumiko U, 1996, J MOLLUS STUD, V62, P327; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	28	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140149	10.1371/journal.pone.0140149	http://dx.doi.org/10.1371/journal.pone.0140149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474058	Green Published, Green Submitted, gold			2022-12-26	WOS:000363185500029
J	Xu, YP; Li, ZQ; Ai, FL; Chen, JH; Xing, Q; Zhou, P; Wei, ZL; Shi, YY; He, XJ; Cao, YX				Xu, Yuping; Li, Zhiqiang; Ai, Fenglian; Chen, Jianhua; Xing, Qiong; Zhou, Ping; Wei, Zhaolian; Shi, Yongyong; He, Xiao-Jin; Cao, Yunxia			Systematic Evaluation of Genetic Variants for Polycystic Ovary Syndrome in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHROMOSOME 2P16.3; SUSCEPTIBILITY LOCI; WOMEN; PCOS; PREVALENCE; DENND1A; COHORT; RISK; GWAS	To date, eleven genome-wide significant (GWS) loci (P < 5x10(-8)) for polycystic ovary syndrome (PCOS) have been identified through genome-wide association studies (GWAS). Some of the risk loci have been selected for replications and validated in multiple ethnicities, however, few previous studies investigated all loci. Scanning all the GWAS variants would demonstrate a more informative profile of variance they explained. Thus, we analyzed all the 17 single nucleotide polymorphisms (SNPs) mapping to the 11 GWAS loci in an independent sample set of 800 Chinese subjects with PCOS and 1110 healthy controls systematically. Variants of rs3802457 in C9orf3 locus (P = 5.99x10(-4)) and rs13405728 in LHCGR locus (P = 3.73x10(-4)) were significantly associated with PCOS after the strict Bonferroni correction in our data set. The further haplotype analysis indicated that in the block of C9orf3 gene (rs4385527 and rs3802457), GA haplotype played a protective role in PCOS (8.7 vs 5.0, P = 9.85x10(-6), OR = 0.548, 95% CI = 0.418-0.717), while GG haplotype was found suffering from an extraordinarily increased risk of PCOS (73.6% vs79.2%, P = 3.41x10(-5), OR = 1.394, 95% CI = 1.191-1.632). Moreover, the directions of effects for all SNPs were consistent with previous GWAS reports (P = 1.53x10(-5)). Polygenic score analysis demonstrated that these 17 SNPs have a significant capacity on predicting case-control status in our samples (P = 7.17x10(-9)), meanwhile all these gathered 17 SNPs explained about 2.40% of variance. Our findings supported that C9orf3 and LHCGR loci variants were vital susceptibility of PCOS.	[Xu, Yuping; Ai, Fenglian; Xing, Qiong; Zhou, Ping; Wei, Zhaolian; He, Xiao-Jin; Cao, Yunxia] Anhui Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Reprod Med Ctr, Hefei 230022, Peoples R China; [Xu, Yuping; Ai, Fenglian; Xing, Qiong; Zhou, Ping; Wei, Zhaolian; He, Xiao-Jin; Cao, Yunxia] Anhui Med Univ, Inst Reprod Genet, Hefei 230022, Peoples R China; [Xu, Yuping; Ai, Fenglian; Xing, Qiong; Zhou, Ping; Wei, Zhaolian; He, Xiao-Jin; Cao, Yunxia] Anhui Prov Engn Technol Res Ctr Biopreservat & Ar, Hefei 230022, Peoples R China; [Li, Zhiqiang; Chen, Jianhua; Shi, Yongyong] Shanghai Jiao Tong Univ, Bio X Inst, Shanghai 200030, Peoples R China	Anhui Medical University; Anhui Medical University; Shanghai Jiao Tong University	Shi, YY (corresponding author), Shanghai Jiao Tong Univ, Bio X Inst, 1954 Huashan Rd, Shanghai 200030, Peoples R China.	shiyongyong@gmail.com; hxj0117@126.com; caoyunxia6@126.com	Shi, Yongyong/GSO-1627-2022; Chen, Jianhua/AAS-8417-2020; Li, Zhiqiang/AAI-4003-2021	Shi, Yongyong/0000-0003-1710-1505; Li, Zhiqiang/0000-0002-0174-9254; He, Xiao-Jin/0000-0001-5919-8478	National Basic Research Program of China [2012CB944704, 2015CB559100]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China 2012CB944704 (recipient: YC) and 2015CB559100 (recipient: YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefi S, 2013, GYNECOL ENDOCRINOL, V29, P470, DOI 10.3109/09513590.2013.769513; ATGER M, 1995, MOL CELL ENDOCRINOL, V111, P113, DOI 10.1016/0303-7207(95)03557-N; Brower MA, 2015, J CLIN ENDOCR METAB, V100, pE182, DOI 10.1210/jc.2014-2689; Carmina E, 2009, CLIMACTERIC, V12, P22, DOI 10.1080/13697130903003842; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Cui LL, 2013, HUM REPROD, V28, P538, DOI 10.1093/humrep/des424; Diaz-Perales A, 2005, J BIOL CHEM, V280, P14310, DOI 10.1074/jbc.M413222200; Dufau ML, 1998, ANNU REV PHYSIOL, V60, P461, DOI 10.1146/annurev.physiol.60.1.461; Goodarzi MO, 2012, J MED GENET, V49, P90, DOI 10.1136/jmedgenet-2011-100427; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Kandaraki E, 2009, ARQ BRAS ENDOCRINOL, V53, P227, DOI 10.1590/S0004-27302009000200014; Kerns SL, 2010, INT J RADIAT ONCOL, V78, P1292, DOI 10.1016/j.ijrobp.2010.07.036; Kubota Toshiro, 2013, Reproductive Medicine and Biology, V12, P71, DOI 10.1007/s12522-013-0145-1; LEGRO RS, 1995, AM J MED, V98, pS9, DOI 10.1016/S0002-9343(99)80053-9; Lerchbaum E, 2011, HORM METAB RES, V43, P743, DOI 10.1055/s-0031-1286279; Li R, 2013, HUM REPROD, V28, P2562, DOI 10.1093/humrep/det262; Li XC, 2006, AM J PHYSIOL-RENAL, V290, pF1024, DOI 10.1152/ajprenal.00221.2005; Lindholm A, 2008, INT J GYNECOL OBSTET, V102, P39, DOI 10.1016/j.ijgo.2008.01.023; Louwers YV, 2013, J CLIN ENDOCR METAB, V98, pE2006, DOI 10.1210/jc.2013-2495; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McAllister JM, 2015, TRENDS ENDOCRIN MET, V26, P118, DOI 10.1016/j.tem.2014.12.004; Mutharasan P, 2013, J CLIN ENDOCR METAB, V98, pE185, DOI 10.1210/jc.2012-2471; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Uncu G, 2002, GYNECOL ENDOCRINOL, V16, P447, DOI 10.1080/713603158; Welt CK, 2012, J CLIN ENDOCR METAB, V97, pE1342, DOI 10.1210/jc.2011-3478	27	13	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2015	10	10							e0140695	10.1371/journal.pone.0140695	http://dx.doi.org/10.1371/journal.pone.0140695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0DF	26474478	Green Submitted, Green Published, gold			2022-12-26	WOS:000363185500083
J	Mannan, AA; Toya, Y; Shimizu, K; McFadden, J; Kierzek, AM; Rocco, A				Mannan, Ahmad A.; Toya, Yoshihiro; Shimizu, Kazuyuki; McFadden, Johnjoe; Kierzek, Andrzej M.; Rocco, Andrea			Integrating Kinetic Model of E. coli with Genome Scale Metabolic Fluxes Overcomes Its Open System Problem and Reveals Bistability in Central Metabolism	PLOS ONE			English	Article							CENTRAL CARBON METABOLISM; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; ISOCITRATE DEHYDROGENASE; BALANCE ANALYSIS; GROWTH; ACETATE; GLYOXYLATE; MECHANISM; TOOLBOX	An understanding of the dynamics of the metabolic profile of a bacterial cell is sought from a dynamical systems analysis of kinetic models. This modelling formalism relies on a deterministic mathematical description of enzyme kinetics and their metabolite regulation. However, it is severely impeded by the lack of available kinetic information, limiting the size of the system that can be modelled. Furthermore, the subsystem of the metabolic network whose dynamics can be modelled is faced with three problems: how to parameterize the model with mostly incomplete steady state data, how to close what is now an inherently open system, and how to account for the impact on growth. In this study we address these challenges of kinetic modelling by capitalizing on multi-'omics' steady state data and a genome-scale metabolic network model. We use these to generate parameters that integrate knowledge embedded in the genome-scale metabolic network model, into the most comprehensive kinetic model of the central carbon metabolism of E. coli realized to date. As an application, we performed a dynamical systems analysis of the resulting enriched model. This revealed bistability of the central carbon metabolism and thus its potential to express two distinct metabolic states. Furthermore, since our model-informing technique ensures both stable states are constrained by the same thermodynamically feasible steady state growth rate, the ensuing bistability represents a temporal coexistence of the two states, and by extension, reveals the emergence of a phenotypically heterogeneous population.	[Mannan, Ahmad A.; McFadden, Johnjoe; Kierzek, Andrzej M.; Rocco, Andrea] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England; [Toya, Yoshihiro] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka 5650871, Japan; [Toya, Yoshihiro; Shimizu, Kazuyuki] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970017, Japan; [Shimizu, Kazuyuki] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka 8208502, Japan	University of Surrey; Osaka University; Keio University; Kyushu Institute of Technology	Kierzek, AM (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England.	a.kierzek@surrey.ac.uk; a.rocco@surrey.ac.uk	Shimizu, Kazuyuki/GVT-4698-2022; Mannan, Ahmad/AAT-1820-2021; Rocco, Andrea/N-7076-2017	Shimizu, Kazuyuki/0000-0002-4847-0197; Mannan, Ahmad/0000-0001-7628-8416; Rocco, Andrea/0000-0002-0974-5522; McFadden, Johnjoe/0000-0003-2145-0046; Kierzek, Andrzej/0000-0002-2605-9057; Toya, Yoshihiro/0000-0001-9670-6961	United Kingdom Medical Research Council (MRC); UK Biotechnology and Biological Sciences Research Council [BB/J002097/1]; Era SysBioPlus TB-HOST-NET grant [BB/I00453X/1]; BBSCR; Japan Science and Technology Agency; BBSRC [BB/J002097/1, BB/I00453X/1, BB/G530284/1, BB/L022869/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L022869/1, BB/G530284/1, BB/J002097/1, BB/I00453X/1] Funding Source: researchfish	United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Era SysBioPlus TB-HOST-NET grant; BBSCR; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the United Kingdom Medical Research Council (MRC Capacity Building Area Studentship Competition 2008) (www.mrc.ac.uk), the UK Biotechnology and Biological Sciences Research Council (BB/J002097/1) (www.bbsrc.ac.uk), and Era SysBioPlus TB-HOST-NET grant (BB/I00453X/1) (www.erasysbio.net). The United Kingdom/Japancollaboration was supported by BBSCR (www.bbsrc.ac.uk) and the Japan Science and Technology Agency (www.jst.go.jp/EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUR OPT; [Anonymous], 2011, GUR OPT REF MAN; Beste DJV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r89; Bettenbrock K, 2006, J BIOL CHEM, V281, P2578, DOI 10.1074/jbc.M508090200; Branch MA, 2002, MATLAB OPTIMIZATION; Chassagnole C, 2002, BIOTECHNOL BIOENG, V79, P53, DOI 10.1002/bit.10288; El-Mansi M, 2006, CURR OPIN MICROBIOL, V9, P173, DOI 10.1016/j.mib.2006.02.002; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Fischer E, 2003, J BIOL CHEM, V278, P46446, DOI 10.1074/jbc.M307968200; Furusawa C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040003; Gerstmeir R, 2003, J BIOTECHNOL, V104, P99, DOI 10.1016/S0168-1656(03)00167-6; Hatzimanikatis V, 1997, CHEM ENG SCI, V52, P2579, DOI 10.1016/S0009-2509(97)00074-2; Holzhutter HG, 2004, EUR J BIOCHEM, V271, P2905, DOI 10.1111/j.1432-1033.2004.04213.x; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Kadir TAA, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-88; Keating S., 2011, SBML TOOLBOX; Keating SM, 2006, BIOINFORMATICS, V22, P1275, DOI 10.1093/bioinformatics/btl111; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Kim BH, 2008, BACTERIAL PHYSIOLOGY AND METABOLISM, P1; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kochanowski K, 2013, P NATL ACAD SCI USA, V110, P1130, DOI 10.1073/pnas.1202582110; Kotte O, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20135022; Kotte O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.10; Lazebnik Y, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1403, DOI 10.1007/s10541-005-0088-1; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Mannan AA, 2012, INTEGRATION KINETIC; MathWorks, 2007, MATLAB 7 5 0 R2007B; MathWorks, 2011, PROD SUPP 1510 DIFF; Mendum TA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r127; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Nikolic N, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-258; NIMMO HG, 1986, BIOCHEM J, V234, P317, DOI 10.1042/bj2340317; O'Beirne D, 2000, BIOPROCESS ENG, V23, P375, DOI 10.1007/s004499900176; Ogawa T, 2007, J BACTERIOL, V189, P1176, DOI 10.1128/JB.01628-06; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Peskov K, 2012, FEBS J, V279, P3374, DOI 10.1111/j.1742-4658.2012.08719.x; Poolman MG, 2009, PLANT PHYSIOL, V151, P1570, DOI 10.1104/pp.109.141267; Ramseier TM, 1996, RES MICROBIOL, V147, P489, DOI 10.1016/0923-2508(96)84003-4; Rocco A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054272; RUIZHERRERA J, 1972, J GEN MICROBIOL, V72, P29, DOI 10.1099/00221287-72-1-29; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Singh VK, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-27; Solopova A, 2014, P NATL ACAD SCI USA, V111, P7427, DOI 10.1073/pnas.1320063111; Stelling J, 2004, CURR OPIN MICROBIOL, V7, P513, DOI 10.1016/j.mib.2004.08.004; Tomita M, 2007, ESCHERICHIA COLI MUL; Usuda Y, 2010, J BIOTECHNOL, V147, P17, DOI 10.1016/j.jbiotec.2010.02.018; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; VARMA A, 1995, BIOTECHNOL BIOENG, V45, P69, DOI 10.1002/bit.260450110; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Xiao N, 2008, TRANSCRIPTIONAL REGU, P1; Yin W., GUROBIMEX MATLAB INT; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4	58	16	17	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2015	10	10							e0139507	10.1371/journal.pone.0139507	http://dx.doi.org/10.1371/journal.pone.0139507			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CX	26469081	Green Published, Green Submitted, gold			2022-12-26	WOS:000363184600010
J	Chen, XB; Giambini, H; Ben-Abraham, E; An, KN; Nassr, A; Zhao, CF				Chen, Xiaobin; Giambini, Hugo; Ben-Abraham, Ephraim; An, Kai-Nan; Nassr, Ahmad; Zhao, Chunfeng			Effect of Bone Mineral Density on Rotator Cuff Tear: An Osteoporotic Rabbit Model	PLOS ONE			English	Article							GREATER TUBEROSITY; POSTMENOPAUSAL WOMEN; SUPRASPINATUS TENDON; ARTHROSCOPIC REPAIR; PARATHYROID-HORMONE; SUTURE ANCHORS; FAILURE; ESTROGEN; TERIPARATIDE	Introduction An increased bone mineral density (BMD) in the proximity to tendon insertion can improve rotator cuff repair and healing. However, how a decrease of BMD in the humeral head affects the biomechanical properties of the rotator cuff tendon is still unclear. Previous studies have demonstrated ovariectomy in animals to lead to osteoporosis and decreased BMD, and Teriparatide (PTH) administration to improve BMD and strength of bone. This study aimed to explore the correlation between humeral head BMD and infraspinatus (ISP) tendon insertion strength, and if an increase in bone quantity of the humeral head can improve the strength of the rotator cuff. Materials and Methods Eighteen New England white rabbits were divided into the 3 groups: Control, Ovariectomy-Saline (OVX-Saline), and Ovariectomy-PTH (OVX-PTH). The OVX-Saline group and the OVX-PTH were administered daily saline and Teriparatide injections for 8 weeks starting at 17 weeks of OVX. BMD of the humeral head was measured, the ISP tendon failure load was tested and the failure stress was calculated. One specimen from each group was used for histological analysis. Linear regression analysis was used to derive equations for the BMD and failure stress. Results Significant differences were observed in the measured humeral head BMD of the Control and OVX-PTH groups compared to the OVX-Saline group (P = 0.0004 and P = 0.0024, respectively). No significant difference was found in failure stress among the three groups, but an expected trend with the control group and OVX-PTH group presenting higher failure strength compared to the OVX-Saline group. BMD at the humeral head showed a positive linear correlation with stress (r(2) = 0.54). Histology results showed the superiority in OVX-PTH group ISP enthesis compared to the OVX-Saline group. Conclusion Bone loss of the humeral head leads to decreased tendon/bone insertion strength of the infraspinatus tendon enthesis. Teriparatide administration can increase bone density of the humeral head and may improve the mechanical properties of the infraspinatus tendon enthesis.	[Chen, Xiaobin; Giambini, Hugo; An, Kai-Nan; Zhao, Chunfeng] Mayo Clin, Div Orthoped Res, Biomech Lab, Rochester, MN 55905 USA; [Chen, Xiaobin] Beijing Army Gen Hosp, Inst Orthopaed, Chinese PLA, Beijing, Peoples R China; [Giambini, Hugo; Nassr, Ahmad] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA; [Ben-Abraham, Ephraim] Mayo Clin, Dept Radiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Zhao, CF (corresponding author), Mayo Clin, Div Orthoped Res, Biomech Lab, Rochester, MN 55905 USA.	zhao.chunfeng@mayo.edu			Mayo Foundation; National Institute of Arthritis and Musculoskeletal and Skin Diseases [T32-AR56950]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056950] Funding Source: NIH RePORTER	Mayo Foundation; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was internally funded by the Mayo Foundation. The authors also acknowledge the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program (T32-AR56950). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin A, 2013, ARCH IRAN MED, V16, P271, DOI 013165/AIM.006; Baquie P, 1997, CLIN J SPORT MED, V7, P28, DOI 10.1097/00042752-199701000-00006; Cadet ER, 2008, J SHOULDER ELB SURG, V17, P73, DOI 10.1016/j.jse.2007.04.017; Cadet ER, 2010, J ORTHOP RES, V28, P308, DOI 10.1002/jor.20972; CANIGGIA M, 1995, J ORTHOP TRAUMA, V9, P312, DOI 10.1097/00005131-199509040-00007; Cao T, 2001, CLIN ORAL IMPLAN RES, V12, P604, DOI 10.1034/j.1600-0501.2001.120608.x; Charousset C, 2010, ARTHROSCOPY, V26, P302, DOI 10.1016/j.arthro.2009.08.027; Chen PQ, 2005, J BONE MINER RES, V20, P962, DOI 10.1359/JBMR.050105; Chung SW, 2011, AM J SPORT MED, V39, P2099, DOI 10.1177/0363546511415659; Circi E, 2009, INT ORTHOP, V33, P1461, DOI 10.1007/s00264-009-0778-1; Cosman F, 2010, J CLIN ENDOCR METAB, V95, P151, DOI 10.1210/jc.2009-0358; Cummins CA, 2003, J SHOULDER ELB SURG, V12, P128, DOI 10.1067/mse.2003.21; Galland A, 2013, INT ORTHOP, V37, P2017, DOI 10.1007/s00264-013-1984-4; Genant HK, 1996, J BONE MINER RES, V11, P707; GOLDSTEIN SA, 1991, J BIOMECH, V24, P135, DOI 10.1016/0021-9290(91)90384-Y; Hock J. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V2, P33; Iannotti JP, 2013, J BONE JOINT SURG AM, V95A, P965, DOI 10.2106/JBJS.L.00708; Jiang YB, 2002, SKELETAL RADIOL, V31, P522, DOI 10.1007/s00256-002-0536-6; Koike Y, 2005, J ORTHOP RES, V23, P1433, DOI 10.1016/j.orthres.2005.02.015; Lee DJ, 2015, NANOSCALE RES LETT, V10, P1, DOI 10.1186/s11671-015-0729-2; Lindsay R, 1997, LANCET, V350, P550, DOI 10.1016/S0140-6736(97)02342-8; Maffulli N, 2011, SPORTS MED ARTHROSC, V19, P194, DOI 10.1097/JSA.0b013e3182250cad; Mirsky EC, 1998, J BONE JOINT SURG AM, V80A, P1687, DOI 10.2106/00004623-199811000-00018; MULLENDER MG, 1995, J ORTHOPAED RES, V13, P503, DOI 10.1002/jor.1100130405; NEER CS, 1983, J BONE JOINT SURG AM, V65, P1232, DOI 10.2106/00004623-198365090-00003; Postl LK, 2013, ARCH ORTHOP TRAUM SU, V133, P81, DOI 10.1007/s00402-012-1620-6; RODRIGUEZ JI, 1992, TERATOLOGY, V45, P213, DOI 10.1002/tera.1420450215; Rubin MR, 2002, OSTEOPOROSIS INT, V13, P267, DOI 10.1007/s001980200026; Sato M, 2000, OSTEOPOROSIS INT, V11, P871, DOI 10.1007/s001980070047; Schwartz AG, 2013, BONE, V55, P44, DOI 10.1016/j.bone.2013.03.010; Torricelli P, 2013, AGE, V35, P2125, DOI 10.1007/s11357-012-9500-0; Waldorff EI, 2011, J SHOULDER ELB SURG, V20, P904, DOI 10.1016/j.jse.2010.12.009; Wren TAL, 2001, CLIN BIOMECH, V16, P529, DOI 10.1016/S0268-0033(01)00033-X	33	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139384	10.1371/journal.pone.0139384	http://dx.doi.org/10.1371/journal.pone.0139384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466092	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100048
J	Digilio, L; Yap, CC; Winckler, B				Digilio, Laura; Yap, Chan Choo; Winckler, Bettina			Ctip2-, Satb2-, Prox1-, and GAD65-Expressing Neurons in Rat Cultures: Preponderance of Single- and Double-Positive Cells, and Cell Type-Specific Expression of Neuron-Specific Gene Family Members, Nsg-1 (NEEP21) and Nsg-2 (P19)	PLOS ONE			English	Article							ENRICHED ENDOSOMAL PROTEIN; GOLGI-APPARATUS; GRANULE CELLS; IDENTITY; DIFFERENTIATION; ENDOCYTOSIS; DEFINES; FATE	The brain consists of many distinct neuronal cell types, but which cell types are present in widely used primary cultures of embryonic rodent brain is often not known. We characterized how abundantly four cell type markers (Ctip2, Satb2, Prox1, GAD65) were represented in cultured rat neurons, how easily neurons expressing different markers can be transfected with commonly used plasmids, and whether neuronal-enriched endosomal proteins Nsg-1 (NEEP21) and Nsg-2 (P19) are ubiquitously expressed in all types of cultured neurons. We found that cultured neurons stably maintain cell type identities that are reflective of cell types in vivo. This includes neurons maintaining simultaneous expression of two transcription factors, such as Ctip2+/Satb2+ or Prox1+/Ctip2+ double-positive cells, which have also been described in vivo. Secondly, we established the superior efficiency of CAG promoters for both Lipofectamine-mediated transfection as well as for electroporation. Thirdly, we discovered that Nsg-1 and Nsg-2 were not expressed equally in all neurons: whereas high levels of both Nsg-1 and Nsg-2 were found in Satb2-, Ctip2-, and GAD65-positive neurons, Prox1-positive neurons in hippocampal cultures expressed low levels of both. Our findings thus highlight the importance of identifying neuronal cell types for doing cell biology in cultured neurons: Keeping track of neuronal cell type might uncover effects in assays that might otherwise be masked by the mixture of responsive and non-responsive neurons in the dish.	[Digilio, Laura; Yap, Chan Choo; Winckler, Bettina] Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA	University of Virginia	Winckler, B (corresponding author), Univ Virginia, Dept Neurosci, 409 Lane Rd, Charlottesville, VA 22908 USA.	BWinckler@virginia.edu			National Institutes of Health [R01NS081674, R01NS083378]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083378, R01NS081674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health R01NS081674 and R01NS083378 to BW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2004, NEUROPHARMACOLOGY, V47, P694, DOI 10.1016/j.neuropharm.2004.07.023; Arango-Lievano M, 2014, BIOL PSYCHIAT, V76, P794, DOI 10.1016/j.biopsych.2014.02.012; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Cabezas C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00060; Carcea I, 2010, J NEUROSCI, V30, P15317, DOI 10.1523/JNEUROSCI.1821-10.2010; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Debaigt C, 2004, J BIOL CHEM, V279, P35687, DOI 10.1074/jbc.M402751200; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Friocourt G, 2011, ACTA NEUROPATHOL, V121, P149, DOI 10.1007/s00401-010-0768-9; Ha JH, 2008, J CELL BIOL, V181, P1027, DOI 10.1083/jcb.200803150; Higgins D, 1997, CURR OPIN NEUROBIOL, V7, P599, DOI 10.1016/S0959-4388(97)80078-5; Hoogenraad CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000283; Iwano T, 2012, DEVELOPMENT, V139, P3051, DOI 10.1242/dev.080002; Lara E, 2012, EXP NEUROL, V237, P134, DOI 10.1016/j.expneurol.2012.06.022; Lasiecka ZM, 2014, J NEUROSCI, V34, P14633, DOI 10.1523/JNEUROSCI.1837-14.2014; Lavado A, 2007, DEV DYNAM, V236, P518, DOI 10.1002/dvdy.21024; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Li GN, 2007, PROG BRAIN RES, V163, P143, DOI 10.1016/S0079-6123(07)63008-8; Li GG, 2014, WIRES DEV BIOL, V3, P165, DOI 10.1002/wdev.127; Lickiss T, 2012, J ANAT, V220, P201, DOI 10.1111/j.1469-7580.2011.01466.x; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Molnar Z, 2006, NEUROSCI RES, V55, P105, DOI 10.1016/j.neures.2006.02.008; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Muthusamy N, 2015, J NEUROCHEM, V132, P20, DOI 10.1111/jnc.12989; Muthusamy N, 2009, J MOL EVOL, V69, P319, DOI 10.1007/s00239-009-9273-y; Myers KR, 2012, J NEUROSCI, V32, P11716, DOI 10.1523/JNEUROSCI.1942-12.2012; Nefzger CM, 2012, STEM CELLS, V30, P1349, DOI 10.1002/stem.1105; Newell-Litwa K, 2010, J NEUROSCI, V30, P820, DOI 10.1523/JNEUROSCI.3400-09.2010; Nielsen JV, 2014, CEREB CORTEX, V24, P1216, DOI 10.1093/cercor/bhs400; Norstrom EM, 2010, J NEUROSCI, V30, P15677, DOI 10.1523/JNEUROSCI.4464-10.2010; Romito-DiGiacomo RR, 2007, J NEUROSCI, V27, P8496, DOI 10.1523/JNEUROSCI.1008-07.2007; Rubin AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077339; Saberan-Djoneidi D, 1998, J BIOL CHEM, V273, P3909, DOI 10.1074/jbc.273.7.3909; SABERANDJONEIDI D, 1995, J BIOL CHEM, V270, P1888, DOI 10.1074/jbc.270.4.1888; Simon R, 2012, EMBO J, V31, P2922, DOI 10.1038/emboj.2012.142; Steiner P, 2005, EMBO J, V24, P2873, DOI 10.1038/sj.emboj.7600755; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Sugiyama T, 2014, J COMP NEUROL, V522, P3520, DOI 10.1002/cne.23621; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; Tiberi L, 2012, CURR OPIN CELL BIOL, V24, P269, DOI 10.1016/j.ceb.2012.01.010; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143; Yap CC, 2012, J NEUROSCI, V32, P7439, DOI 10.1523/JNEUROSCI.5318-11.2012; Yap CCC, 2010, J NEUROSCI, V30, P6646, DOI 10.1523/JNEUROSCI.5428-09.2010	47	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140010	10.1371/journal.pone.0140010	http://dx.doi.org/10.1371/journal.pone.0140010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465886	gold, Green Submitted, Green Published			2022-12-26	WOS:000363183100071
J	Kakudo, N; Morimoto, N; Ogawa, T; Taketani, S; Kusumoto, K				Kakudo, Natsuko; Morimoto, Naoki; Ogawa, Takeshi; Taketani, Shigeru; Kusumoto, Kenji			Hypoxia Enhances Proliferation of Human Adipose-Derived Stem Cells via HIF-1 alpha Activation	PLOS ONE			English	Article							OXYGEN SPECIES GENERATION; IN-VITRO; DIFFERENTIATION; TISSUE; STIMULATION; SURVIVAL; INCREASE; CULTURE	Background Adipose tissue-derived stem cells (ASCs) have been recently isolated from human subcutaneous adipose tissue. ASCs may be useful in regenerative medicine as an alternative to bone marrow-derived stem cells. Changes in the oxygen concentration influence physiological activities, such as stem cell proliferation. However, the effects of the oxygen concentration on ASCs remain unclear. In the present study, the effects of hypoxia on ASC proliferation were examined. Methods Normal human adipose tissue was collected from the lower abdomen, and ASCs were prepared with collagenase treatment. The ASCs were cultured in hypoxic (1%) or normoxic (20%) conditions. Cell proliferation was investigated in the presence or absence of inhibitors of various potentially important kinases. Hypoxia inducible factor (HIF)-1 alpha expression and MAP kinase phosphorylation in the hypoxic culture were determined with western blotting. In addition, the mRNA expression of vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF)-2 in hypoxic or normoxic conditions were determined with real-time RT-PCR. The effects of these growth factors on ASC proliferation were investigated. Chromatin immunoprecipitation (ChIP) of the HIF-1 alpha-binding hypoxia responsive element in FGF-2 was performed. HIF-1 alpha was knocked down by siRNA, and FGF-2 expression was investigated. Results ASC proliferation was significantly enhanced in the hypoxic culture and was inhibited by ERK and Akt inhibitors. Hypoxia for 5-15 minutes stimulated the phosphorylation of ERK1/2 among MAP kinases and induced HIF-1 alpha expression. The levels of VEGF and FGF-2 mRNA and protein in the ASCs were significantly enhanced in hypoxia, and FGF-2 increased ASC proliferation. The ChIP assay revealed an 8-fold increase in the binding of HIF-1 alpha to FGF-2 in hypoxia. HIF-1 alpha knockdown by siRNA partially inhibited the FGF-2 expression of ASCs induced by hypoxia. Conclusion ASC proliferation was enhanced by hypoxia. HIF-1 alpha activation, FGF-2 production, and the ERK1/2 and Akt pathway were involved in this regulatory mechanism.	[Kakudo, Natsuko; Morimoto, Naoki; Ogawa, Takeshi; Kusumoto, Kenji] Kansai Med Univ, Dept Plast & Reconstruct Surg, Osaka, Japan; [Taketani, Shigeru] Kyoto Inst Technol, Dept Biotechnol, Kyoto 606, Japan	Kansai Medical University; Kyoto Institute of Technology	Kakudo, N (corresponding author), Kansai Med Univ, Dept Plast & Reconstruct Surg, Osaka, Japan.	kakudon@hirakata.kmu.ac.jp		Kakudo, Natsuko/0000-0001-9785-1490; Morimoto, Naoki/0000-0002-0712-3172	Japanese Ministry of Education, Science, Sports and Culture;  [26861515]	Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This research was supported in part by the Japanese Ministry of Education, Science, Sports and Culture and a Grant-in-Aid for Young Scientists (B) (26861515, Natsuko Kakudo).	Dos Santos F, 2010, J CELL PHYSIOL, V223, P27, DOI 10.1002/jcp.21987; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Hung SP, 2012, J ORTHOP RES, V30, P260, DOI 10.1002/jor.21517; Kakudo N, 2008, J BIOMED MATER RES A, V84A, P191, DOI 10.1002/jbm.a.31311; Kakudo N, 2007, BIOCHEM BIOPH RES CO, V359, P239, DOI 10.1016/j.bbrc.2007.05.070; Kakudo N, 2011, HUM CELL, V24, P165, DOI 10.1007/s13577-011-0033-0; Kakudo N, 2008, PLAST RECONSTR SURG, V122, P1352, DOI 10.1097/PRS.0b013e3181882046; Kang S, 2014, CELL BIOL INT, V38, P553, DOI 10.1002/cbin.10246; Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446; Kim JH, 2014, CELL BIOL INT, V38, P32, DOI 10.1002/cbin.10170; Kim JH, 2012, STEM CELLS DEV, V21, P2212, DOI 10.1089/scd.2011.0561; Kim JH, 2011, STEM CELLS DEV, V20, P1753, DOI 10.1089/scd.2010.0469; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Rajala K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010246; Rasmussen JG, 2011, CYTOTHERAPY, V13, P318, DOI 10.3109/14653249.2010.506505; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Stubbs SL, 2012, STEM CELLS DEV, V21, P1887, DOI 10.1089/scd.2011.0289; Suga H, 2009, STEM CELLS, V27, P238, DOI 10.1634/stemcells.2008-0261; Yamamoto Y, 2013, BIORESEARCH OPEN ACC, V2, P199, DOI 10.1089/biores.2013.0004; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zaragosi LE, 2006, STEM CELLS, V24, P2412, DOI 10.1634/stemcells.2006-0006; Zeng GF, 2013, ORGANOGENESIS, V9, P287, DOI 10.4161/org.27153; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	28	66	71	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0139890	10.1371/journal.pone.0139890	http://dx.doi.org/10.1371/journal.pone.0139890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465938	gold, Green Submitted, Green Published			2022-12-26	WOS:000363183100063
J	Nanbu, T; Nguyen, LC; Habib, AGK; Hirata, N; Ukimori, S; Tanaka, D; Masuda, K; Takahashi, K; Yukawa, M; Tsuchiya, E; Ueno, M				Nanbu, Tomoko; Nguyen, Luan C.; Habib, Ahmed G. K.; Hirata, Naoya; Ukimori, Shinobu; Tanaka, Daiki; Masuda, Kenta; Takahashi, Katsunori; Yukawa, Masashi; Tsuchiya, Eiko; Ueno, Masaru			Fission Yeast Exo1 and Rqh1-Dna2 Redundantly Contribute to Resection of Uncapped Telomeres	PLOS ONE			English	Article							DNA END RESECTION; BREAK REPAIR; CELL-CYCLE; RECQ HELICASE; PROTEIN; APOLLO; DAMAGE; SGS1; MAINTENANCE; GENERATION	The uncapping of telomeres induces a DNA damage response. In Schizosaccharomyces pombe, deletion of pot1(+) causes telomere uncapping and rapid telomere resection, resulting in chromosome fusion. Using the nmt-pot1-aid strain, we previously reported that Pot1 shut-off causes telomere loss and chromosome fusion in S. pombe. However, the factors responsible for the resection of uncapped telomeres remain unknown. In this study, we investigated these factors and found that concomitant deletion of rqh1(+) and exo1(+) alleviated the loss of telomeres following Pot1 shut-off, suggesting that Rqh1 and Exo1 are redundantly involved in the resection of uncapped telomeres. We also investigated the role of Rqh1 helicase activity and found it to be essential for the resection of uncapped telomeres. Moreover, we found that Dna2 and Exo1 function redundantly in the resection of uncapped telomeres. Taken together, these results suggest that Exo1 and Rqh1-Dna2 redundantly contribute to the resection of uncapped telomeres. Therefore, our results demonstrate that nmt-pot1-aid is an important model strain to study the role of helicases and nucleases in the resection of uncapped telomeres and to improve our understanding of DNA double-strand break repair.	[Nanbu, Tomoko; Nguyen, Luan C.; Habib, Ahmed G. K.; Hirata, Naoya; Ukimori, Shinobu; Tanaka, Daiki; Masuda, Kenta; Takahashi, Katsunori; Yukawa, Masashi; Tsuchiya, Eiko; Ueno, Masaru] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima 7398530, Japan; [Ueno, Masaru] Hiroshima Univ, Res Ctr Math Chromatin Live Dynam, Higashihiroshima 7398530, Japan	Hiroshima University; Hiroshima University	Ueno, M (corresponding author), Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, 1-3-1 Kagamiyama, Higashihiroshima 7398530, Japan.	scmueno@hiroshima-u.ac.jp	Ueno, Masaru/G-3990-2019		Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED); Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research is (partially) supported by the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and Japan Agency for Medical Research and Development (AMED), and by Grants-in-Aid for Scientific Research in Priority Areas, provided to M. U. from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bonetti D, 2014, CHROMOSOMA, V123, P57, DOI 10.1007/s00412-013-0440-y; Cannavo E, 2013, P NATL ACAD SCI USA, V110, pE1661, DOI 10.1073/pnas.1305166110; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Dewar JM, 2012, CHROMOSOMA, V121, P117, DOI 10.1007/s00412-011-0357-2; Dewar JM, 2010, EMBO J, V29, P4020, DOI 10.1038/emboj.2010.267; DUCOMMUN B, 1990, J CELL SCI, V96, P683; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Janes S, 2012, J CELL SCI, V125, P4487, DOI 10.1242/jcs.104075; Kanke M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-8; Lam YC, 2010, EMBO J, V29, P2230, DOI 10.1038/emboj.2010.58; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Laursen LV, 2003, MOL CELL BIOL, V23, P3692, DOI 10.1128/MCB.23.10.3692-3705.2003; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lydall D, 2009, EMBO J, V28, P2174, DOI 10.1038/emboj.2009.176; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nanbu T, 2013, MOL CELL BIOL, V33, P1175, DOI 10.1128/MCB.01713-12; Narayanan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132240; Ngo GHP, 2014, NUCLEIC ACIDS RES, V42, P10516, DOI 10.1093/nar/gku746; Ngo HP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001072; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Pitt CW, 2010, NUCLEIC ACIDS RES, V38, P6968, DOI 10.1093/nar/gkq580; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Singh DK, 2012, MUTAT RES-FUND MOL M, V736, P15, DOI 10.1016/j.mrfmmm.2011.06.002; Sugawara N., 1988, THESIS HARVARD U CAM; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Tsabar M, 2015, NUCLEIC ACIDS RES, V43, P6889, DOI 10.1093/nar/gkv520; Wang X, 2008, MOL CELL, V31, P463, DOI 10.1016/j.molcel.2008.05.028; Wellinger RJ, 2010, FEBS LETT, V584, P3734, DOI 10.1016/j.febslet.2010.06.031; Wu P, 2012, CELL, V150, P39, DOI 10.1016/j.cell.2012.05.026; Wu P, 2010, MOL CELL, V39, P606, DOI 10.1016/j.molcel.2010.06.031; Zhang JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001946; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zubko MK, 2004, GENETICS, V168, P103, DOI 10.1534/genetics.104.027904	43	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140456	10.1371/journal.pone.0140456	http://dx.doi.org/10.1371/journal.pone.0140456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26465752	Green Published, gold, Green Submitted			2022-12-26	WOS:000363183100126
J	Gutierrez, MS; Rojas, MC; Sepulveda, D; Baeza, M; Cifuentes, V; Alcaino, J				Soledad Gutierrez, Maria; Cecilia Rojas, Maria; Sepulveda, Dionisia; Baeza, Marcelo; Cifuentes, Victor; Alcaino, Jennifer			Molecular Characterization and Functional Analysis of Cytochrome b5 Reductase (CBR) Encoding Genes from the Carotenogenic Yeast Xanthophyllomyces dendrorhous	PLOS ONE			English	Article							ASTAXANTHIN SYNTHASE GENE; PHAFFIA-RHODOZYMA; REDOX PARTNER; BETA-CAROTENE; EXPRESSION; BIOSYNTHESIS; EVOLUTION; CLONING; B(5); CRTS	The eukaryotic microsomal cytochrome P450 systems consist of a cytochrome P450 enzyme (P450) and a cytochrome P450 redox partner, which generally is a cytochrome P450 reductase (CPR) that supplies electrons from NADPH. However, alternative electron donors may exist such as cytochrome b5 reductase and cytochrome b5 (CBR and CYB5, respectively) via, which is NADH-dependent and are also anchored to the endoplasmic reticulum. In the carotenogenic yeast Xanthophyllomyces dendrorhous, three P450-encoding genes have been described: crtS is involved in carotenogenesis and the CYP51 and CYP61 genes are both implicated in ergosterol biosynthesis. This yeast has a single CPR (encoded by the crtR gene), and a crtR(-) mutant does not produce astaxanthin. Considering that this mutant is viable, the existence of alternative cytochrome P450 electron donors like CBR and CYB5 could operate in this yeast. The aim of this work was to characterize the X. dendrorhous CBR encoding gene and to study its involvement in P450 reactions in ergosterol and carotenoid biosynthesis. Two CBRs genes were identified (CBR.1 and CBR.2), and deletion mutants were constructed. The two mutants and the wild-type strain showed similar sterol production, with ergosterol being the main sterol produced. The crtR(-) mutant strain produced a lower proportion of ergosterol than did the parental strain. These results indicate that even though one of the two CBR genes could be involved in ergosterol biosynthesis, crtR complements their absence in the cbr(-) mutant strains, at least for ergosterol production. The higher NADH-dependent cytochrome c reductase activity together with the higher transcript levels of CBR.1 and CYB5 in the crtR(-) mutant as well as the lower NADH-dependent activity in CBS-cbr.1(-) strongly suggest that CBR. 1-CYB5 via participates as an alternative electron donor pathway for P450 enzymes involved in ergosterol biosynthesis in X. dendrorhous.	[Soledad Gutierrez, Maria; Sepulveda, Dionisia; Baeza, Marcelo; Cifuentes, Victor; Alcaino, Jennifer] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile; [Cecilia Rojas, Maria] Univ Chile, Fac Ciencias, Dept Quim, Santiago, Chile	Universidad de Chile; Universidad de Chile	Alcaino, J (corresponding author), Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile.	jalcainog@u.uchile.cl	Alcaino, Jennifer/H-4576-2012; /C-6686-2008	Alcaino, Jennifer/0000-0001-8984-0943; 	Fondo Nacional de Desarrollo Cientifico y Tecnologico [11121200]; Comision Nacional de Investigacion Cientifica y Tecnologica [21130807]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion Cientifica y Tecnologica	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico 11121200, (http://www.conicyt.cl/fondecyt/), to JA, and Comision Nacional de Investigacion Cientifica y Tecnologica 21130807 (http://www.conicyt.cl/), to MSG.	Alcaino J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096626; Alcaino J, 2012, J AGR FOOD CHEM, V60, P8640, DOI 10.1021/jf302287f; Alcaino J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-169; Alvarez V, 2006, FUNGAL GENET BIOL, V43, P261, DOI 10.1016/j.fgb.2005.12.004; AN GH, 1989, APPL ENVIRON MICROB, V55, P116, DOI 10.1128/AEM.55.1.116-124.1989; Arinc E, 1999, INT J BIOCHEM CELL B, V31, P345, DOI 10.1016/S1357-2725(98)00099-5; Baeza M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1493-5; Bagnaresi P, 1997, PLANTA, V202, P427, DOI 10.1007/s004250050146; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; BOYLE JS, 1995, TRENDS GENET, V11, P8, DOI 10.1016/S0168-9525(00)88977-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cifuentes V, 1997, ANTON LEEUW INT J G, V72, P111, DOI 10.1023/A:1000200119447; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Contreras G, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-84; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DEGTYARENKO KN, 1993, FEBS LETT, V332, P1, DOI 10.1016/0014-5793(93)80470-F; Estabrook RW, 2003, DRUG METAB DISPOS, V31, P1461, DOI 10.1124/dmd.31.12.1461; Hermosilla G, 2003, ANTON LEEUW INT J G, V84, P279, DOI 10.1023/A:1026090008405; Higuera-Ciapara I, 2006, CRIT REV FOOD SCI, V46, P185, DOI 10.1080/10408690590957188; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Horton P., 1996, P INT SYST MOL BIOL, V4, P109; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ichinose H, 2012, ARCH BIOCHEM BIOPHYS, V518, P8, DOI 10.1016/j.abb.2011.12.010; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kimmich N, 2007, J BIOL CHEM, V282, P27006, DOI 10.1074/jbc.M703790200; KITAJIMA S, 1981, ARCH BIOCHEM BIOPHYS, V210, P330, DOI 10.1016/0003-9861(81)90196-X; Lah L, 2008, FUNGAL GENET BIOL, V45, P446, DOI 10.1016/j.fgb.2007.10.004; Lamb DC, 1999, FEBS LETT, V462, P283, DOI 10.1016/S0014-5793(99)01548-3; Leiva K, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0428-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodato P, 2007, BIOL RES, V40, P73, DOI 10.4067/S0716-97602007000100008; Loto I, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-235; Malmstrom L, 2007, PLOS BIOL, V5, P758, DOI 10.1371/journal.pbio.0050076; McLean KJ, 2005, BIOCHEM SOC T, V33, P796, DOI 10.1042/BST0330796; Munro AW, 2007, BBA-GEN SUBJECTS, V1770, P345, DOI 10.1016/j.bbagen.2006.08.018; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Niklitschek M, 2008, BIOL RES, V41, P93, DOI 10.4067/S0716-97602008000100011; Ojima K, 2006, MOL GENET GENOMICS, V275, P148, DOI 10.1007/s00438-005-0072-x; Porter TD, 2002, J BIOCHEM MOL TOXIC, V16, P311, DOI 10.1002/jbt.10052; PORTER TD, 1991, J BIOL CHEM, V266, P13469; Sambrook J., 2001, MOL CLONING LAB MANU; Shang F, 2006, J BIOTECHNOL, V122, P285, DOI 10.1016/j.jbiotec.2005.11.020; Sharma R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1380-0; STRITTMATTER P, 1957, BIOCHIM BIOPHYS ACTA, V25, P228, DOI 10.1016/0006-3002(57)90462-6; Subramanian V, 2010, CURR MICROBIOL, V61, P306, DOI 10.1007/s00284-010-9612-7; Syed K, 2011, ARCH BIOCHEM BIOPHYS, V509, P26, DOI 10.1016/j.abb.2011.02.023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Troncoso C, 2008, PHYTOCHEMISTRY, V69, P672, DOI 10.1016/j.phytochem.2007.08.026; TRUAN G, 1994, GENE, V142, P123, DOI 10.1016/0378-1119(94)90366-2; Ukibe K, 2009, APPL ENVIRON MICROB, V75, P7205, DOI 10.1128/AEM.01249-09; van den Brink HJM, 1998, FUNGAL GENET BIOL, V23, P1, DOI 10.1006/fgbi.1997.1021; van den Brink JM, 2000, MOL GEN GENET, V263, P601, DOI 10.1007/s004380051207; Venkateswarlu K, 1998, ANTIMICROB AGENTS CH, V42, P1756, DOI 10.1128/AAC.42.7.1756; VERMILION JL, 1974, BIOCHEM BIOPH RES CO, V60, P1315, DOI 10.1016/0006-291X(74)90341-6; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhang Yong-Qiang, 2010, Virulence, V1, P551, DOI 10.4161/viru.1.6.13802	56	10	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2015	10	10							e0140424	10.1371/journal.pone.0140424	http://dx.doi.org/10.1371/journal.pone.0140424			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0CK	26466337	gold, Green Published, Green Submitted			2022-12-26	WOS:000363183100121
J	Ishiki, A; Okamura, N; Furukawa, K; Furumoto, S; Harada, R; Tomita, N; Hiraoka, K; Watanuki, S; Ishikawa, Y; Tago, T; Funaki, Y; Iwata, R; Tashiro, M; Yanai, K; Kudo, Y; Arai, H				Ishiki, Aiko; Okamura, Nobuyuki; Furukawa, Katsutoshi; Furumoto, Shozo; Harada, Ryuichi; Tomita, Naoki; Hiraoka, Kotaro; Watanuki, Shoichi; Ishikawa, Yoichi; Tago, Tetsuro; Funaki, Yoshihito; Iwata, Ren; Tashiro, Manabu; Yanai, Kazuhiko; Kudo, Yukitsuka; Arai, Hiroyuki			Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [F-18] THK-5117 Positron Emission Tomography	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MEDIAL TEMPORAL-LOBE; CEREBROSPINAL-FLUID; AMYLOID DEPOSITION; SENILE PLAQUES; PET; ATROPHY; HYPOTHESIS; STRATEGIES; TANGLES	The formation of neurofibrillary tangles is believed to contribute to the neurodegeneration observed in Alzheimer's disease (AD). Postmortem studies have shown strong associations between the neurofibrillary pathology and both neuronal loss and the severity of cognitive impairment. However, the temporal changes in the neurofibrillary pathology and its association with the progression of the disease are not well understood. Tau positron emission tomography (PET) imaging is expected to be useful for the longitudinal assessment of neurofibrillary pathology in the living brain. Here, we performed a longitudinal PET study using the tau-selective PET tracer [F-18] THK-5117 in patients with AD and in healthy control subjects. Annual changes in [F-18] THK-5117 binding were significantly elevated in the middle and inferior temporal gyri and in the fusiform gyrus of patients with AD. Compared to patients with mild AD, patients with moderate AD showed greater changes in the tau load that were more widely distributed across the cortical regions. Furthermore, a significant correlation was observed between the annual changes in cognitive decline and regional [F-18] THK-5117 binding. These results suggest that the cognitive decline observed in patients with AD is attributable to the progression of neurofibrillary pathology. Longitudinal assessment of tau pathology will contribute to the assessment of disease progression and treatment efficacy.	[Ishiki, Aiko; Furukawa, Katsutoshi; Tomita, Naoki; Arai, Hiroyuki] Tohoku Univ, Dept Geriatr & Gerontol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Okamura, Nobuyuki; Yanai, Kazuhiko] Tohoku Univ, Sch Med, Dept Pharmacol, Sendai, Miyagi 980, Japan; [Okamura, Nobuyuki; Kudo, Yukitsuka] Tohoku Univ, Inst Dev Aging & Canc, Div Neuroimaging, Sendai, Miyagi 980, Japan; [Furumoto, Shozo; Ishikawa, Yoichi; Tago, Tetsuro; Funaki, Yoshihito; Iwata, Ren; Kudo, Yukitsuka] Tohoku Univ, Ctr Cyclotron & Radioisotope, Div Radiopharmaceut Chem, Sendai, Miyagi 980, Japan; [Hiraoka, Kotaro; Watanuki, Shoichi; Tashiro, Manabu] Tohoku Univ, Ctr Cyclotron & Radioisotope, Div Cyclotron Nucl Med, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Okamura, N (corresponding author), Tohoku Univ, Sch Med, Dept Pharmacol, Sendai, Miyagi 980, Japan.	nookamura@med.tohoku.ac.jp	Okamura, Nobuyuki/C-3541-2017; Tashiro, Manabu/T-2859-2019; Yanai, Kazuhiko/X-3911-2019	Okamura, Nobuyuki/0000-0002-5991-7812; Yanai, Kazuhiko/0000-0001-9068-7907; Furumoto, Shozo/0000-0002-9296-3079; Tago, Tetsuro/0000-0002-9545-0922	GE Healthcare; Sumitomo Electric Industries, Ltd., Group CSR Foundation; Industrial Technology Research Grant Program of the NEDO in Japan [09E51025a]; Health and Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare of Japan; "Japan Advanced Molecular Imaging Program (J-AMP)" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan;  [15H04900];  [26117003];  [15K19767]; Grants-in-Aid for Scientific Research [15K15268, 15K08127] Funding Source: KAKEN	GE Healthcare(General ElectricGE Healthcare); Sumitomo Electric Industries, Ltd., Group CSR Foundation; Industrial Technology Research Grant Program of the NEDO in Japan; Health and Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare of Japan; "Japan Advanced Molecular Imaging Program (J-AMP)" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by research funds from GE Healthcare; the Sumitomo Electric Industries, Ltd., Group CSR Foundation; the Industrial Technology Research Grant Program of the NEDO in Japan (09E51025a); Health and Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare of Japan; a Grant-in-Aid for Scientific Research (B) (15H04900); a Grant-in-Aid for Scientific Research on Innovative Areas (Brain Protein Aging and Dementia Control) (26117003); a Grant-in-Aid for Young Scientists (B) (15K19767); and a Grant-in-Aid for JSPS Fellows and "Japan Advanced Molecular Imaging Program (J-AMP)" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI H, 1995, ANN NEUROL, V38, P649, DOI 10.1002/ana.410380414; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Barage SH, 2015, NEUROPEPTIDES, V52, P1, DOI 10.1016/j.npep.2015.06.008; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chien DT, 2014, J ALZHEIMERS DIS, V38, P171, DOI 10.3233/JAD-130098; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Engler H, 2006, BRAIN, V129, P2856, DOI 10.1093/brain/awl178; Harada R, 2015, EUR J NUCL MED MOL I, V42, P1052, DOI 10.1007/s00259-015-3035-4; Harada R, 2013, EUR J NUCL MED MOL I, V40, P125, DOI 10.1007/s00259-012-2261-2; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; HYMAN BT, 1993, J NEUROPATH EXP NEUR, V52, P594, DOI 10.1097/00005072-199311000-00006; Itoh N, 2001, ANN NEUROL, V50, P150, DOI 10.1002/ana.1054; Jack CR, 2010, BRAIN, V133, P3336, DOI 10.1093/brain/awq277; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; JOBST KA, 1994, LANCET, V343, P829, DOI 10.1016/S0140-6736(94)92028-1; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kuzuhara S, 1989, No To Shinkei, V41, P465; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Mendonca MD, 2015, AM J ALZHEIMERS DIS; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Okamura N, 2013, J NUCL MED, V54, P1420, DOI 10.2967/jnumed.112.117341; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Rowe CC, 2013, MED CLIN N AM, V97, P377, DOI 10.1016/j.mcna.2012.12.017; Sun Y, 2015, CNS NEUROSCI THER, V21, P768, DOI 10.1111/cns.12395; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Wischik C, 2009, J NUTR HEALTH AGING, V13, P367, DOI 10.1007/s12603-009-0046-5; Xia CF, 2013, ALZHEIMERS DEMENT, V9, P666, DOI 10.1016/j.jalz.2012.11.008	33	62	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140311	10.1371/journal.pone.0140311	http://dx.doi.org/10.1371/journal.pone.0140311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461913	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300079
